Citrus Sinensis ID: 006522

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640--
Protein Sequence
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccEEEEEEcccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccHHHHcHHccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccEEEEcccccccHHHHHHccccEEccccccEEEEEEEccccccccccEEEEEEEccccccccHHHHHHHHHHHccccccccccccEEEEcccccEEEEcccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEEcccccccccccccccccEEEEEEccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cHHHHHEEHHHHHHHHHHcccccHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccEEEEEEccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEHEEcccccccccccHHHccccccEEEEEcccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHccccccccccccccccccccccccEEEEcccccEEcHHHHHHHHcccEcccccEEEEEEEEcccccccccEEEEEEEccccccccccHHHHHHHHHHHHHHcccEEEEEEEEcccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHccEEccccccHEHccccHHHHcccccccEEEEEEEcccccccccccccccccHHHHHccccEcHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
MLLPLLFFALLLlfpaplcfslNQDGLALLALKAAIAqdptraldswsesdstpchwsgihcirnrvtslylpnrnltgympselgllnsltrlslasnnfskpipanlfnatnlvyldlahnsfcgpipDRIKTLknlthldlssnllngslpEFLLDLRALTGtlnlsfnqfsgqipemyghfpVMVSLDlrnnnlsgeipqvgsllnqgptafsgnpglcgfplqspcpepenpkvhanpevedgpqnpkntnfgysgdvkdrgrngSVVVSVISGVSVVVGVVSVSVWLFRRKRRaregkmgkeektndavlvtdeeegqkgkffiideGFSLELEDLLRASAYVVGKSKNGIMYKVVVgrgsgmgapTVVAVRRLTEgdatwrfkDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIrngslyaalhagpsdslpplpweARLKIAQGTARGLMyiheysprkyvhgnikstkillddelhpcisgfglnrllpgtskvtknetivtsgtgsriSAISnvylapeariygskftqkcdvySFGIVLLEILtgrlpdagpendgkGLESLVRKAFrerrplsevidpaLVKEIHAKRQVLATFHIAlncteldpefrprmrtvsesldrvklq
Flexible Loop (DISEMBL)
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHAnpevedgpqnpKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGvvsvsvwlfrrkrraregkmgkeektndavlvtdeeegqkgKFFIIDEGFSLELEDLLRASAyvvgkskngIMYKVVvgrgsgmgaPTVVAVRRLTEGDATWRFKDFESEVEaiarvqhpnivRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGlnrllpgtskvTKNEtivtsgtgsrisaiSNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRlpdagpendgKGLESLVRKafrerrplsevidpalVKEIHAKRQVLATFHIALncteldpefrprmrtvsesldrvklq
Low Complexity Region (SEG)
MllpllffallllfpaplCFSLNQDGlallalkaaiaQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPselgllnsltrlslasnnFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHldlssnllngslPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNgsvvvsvisgvsvvvgvvsvsvWLFRRKRRAREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ
Disordered region (IsUnstruct)
**LPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN**********GLCG********************************************NGSVVVSVISGVSVVVGVVSVSVWLFRR****************************KGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL*************************LSEVIDPALVKEIHAKRQVLATFHIALNCTELD********************
Disordered Region (DISOPRED)
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQ******************************************SVVVSVISGVSVVVGVVSVSVWLFRR*******************************FFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTE********DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG***DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK**
Disordered Region (DISEMBL)
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQD***************CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRA***********NDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV**********
Disordered Region (DISPRO)
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHA*************************GRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRR************************QKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE*RP***************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	642	2.2.26 [Sep-21-2011]
Q9C9N5	685	Probable inactive leucine	no	no	0.945	0.886	0.349	1e-101
C0LGS3	768	Probable LRR receptor-lik	no	no	0.961	0.803	0.329	2e-90
Q94C77	757	Receptor protein kinase-l	no	no	0.943	0.800	0.332	2e-82
Q9M9C5	670	Probable leucine-rich rep	no	no	0.903	0.865	0.354	3e-78
O48788	658	Probable inactive recepto	no	no	0.878	0.857	0.350	3e-76
Q9C9Y8	640	Probable inactive recepto	no	no	0.919	0.921	0.324	4e-71
Q9LP77	655	Probable inactive recepto	no	no	0.886	0.868	0.332	2e-70
Q9LVM0	654	Probable inactive recepto	no	no	0.892	0.876	0.326	7e-70
Q9M8T0	627	Probable inactive recepto	no	no	0.909	0.931	0.327	2e-68
Q9SCT4	836	Probably inactive leucine	no	no	0.841	0.645	0.327	8e-67

>sp|Q9C9N5|Y1668_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 OS=Arabidopsis thaliana GN=At1g66830 PE=1 SV=1

 Score =  368 bits (945), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 248/709 (34%), Positives = 364/709 (51%), Gaps = 102/709 (14%)

Query: 2   LLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIH 61
           L  +L F L   F   +  SLN  GLALL+ K +I         +W+ SDS PC W G+ 
Sbjct: 4   LFLILCFILTHFFA--IATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVT 61

Query: 62  CIRN-RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
           C  + RV S+ LPN+ L+G +   +G L SL  ++L  N+F   +P  LF    L  L L
Sbjct: 62  CNYDMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVL 121

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSL--------------------------- 153
           + NSF G +P+ I +LK+L  LDLS N  NGS+                           
Sbjct: 122 SGNSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTG 181

Query: 154 ----------------------PEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSL 191
                                 PE +  L  L GTL+LS N FSG IP   G+ P ++ +
Sbjct: 182 LGSNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYV 241

Query: 192 DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQN 251
           DL  NNLSG IP+   LLN GP AF GNP LCG P++  C       V +          
Sbjct: 242 DLSYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISCSTRNTQVVPSQL-------- 293

Query: 252 PKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGK------- 304
                  Y+       R   ++ +    V+ ++ + S+ ++ + RK  AR  K       
Sbjct: 294 -------YTRRANHHSRLCIILTATGGTVAGIIFLASLFIY-YLRKASARANKDQNNRTC 345

Query: 305 --------MGKEE----KTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGK 352
                     K E    KT ++   T +E   +  F  +D     +L+ LL+ASA+++GK
Sbjct: 346 HINEKLKKTTKPEFLCFKTGNSESETLDENKNQQVFMPMDPEIEFDLDQLLKASAFLLGK 405

Query: 353 SKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-RFKDFESEVEAIARVQHPNIVRLK 411
           S+ G++YKVV+  G       ++AVRRL   D  W R K+F ++VEA+A+++HPN++ LK
Sbjct: 406 SRIGLVYKVVLENG------LMLAVRRLE--DKGWLRLKEFLADVEAMAKIKHPNVLNLK 457

Query: 412 AFYYANDEKLLISDFIRNGSLYAALHAGP-SDSLPPLPWEARLKIAQGTARGLMYIHEYS 470
           A  ++ +EKLLI D+I NG L +A+   P S S   L W  RLKI +G A+GL YIHE+S
Sbjct: 458 ACCWSPEEKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFS 517

Query: 471 PRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV 530
           P++YVHG+I ++ ILL   L P +SGFGL R++  +S + +++ I    T S I +  + 
Sbjct: 518 PKRYVHGHINTSNILLGPNLEPKVSGFGLGRIVDTSSDI-RSDQISPMETSSPILSRESY 576

Query: 531 YLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPL 590
           Y APEA    +K +QK DVYSFG+V+LE++TG+ P    E D   L   V  A    +P 
Sbjct: 577 YQAPEAASKMTKPSQKWDVYSFGLVILEMVTGKSP-VSSEMD---LVMWVESASERNKPA 632

Query: 591 SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
             V+DP L ++   +  ++    I L C + +P+ RP MR+V ES +++
Sbjct: 633 WYVLDPVLARDRDLEDSMVQVIKIGLACVQKNPDKRPHMRSVLESFEKL 681

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGS3|Y4372_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g37250 OS=Arabidopsis thaliana GN=At4g37250 PE=2 SV=1

 Score =  333 bits (855), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 253/767 (32%), Positives = 363/767 (47%), Gaps = 150/767 (19%)

Query: 2   LLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIH 61
           L+ ++FF    +  +    +LN DGL L+  K+++  DP   L +W+    +PC W GI 
Sbjct: 5   LISVIFFFFCSVLSSS---ALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGIS 61

Query: 62  CIRN-RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
           C  + +V +L LPN  L G +PS+LG L +L  L L++N+F+ P+P + FNA  L +LDL
Sbjct: 62  CNNDSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLDL 121

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT---------------- 164
           + N   G IP  I  L NL  L+LS N L G LP  L  LR LT                
Sbjct: 122 SSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPGG 181

Query: 165 ---------------------------GTLNLSFNQFSGQIPEMYG-HFPVMVSLDLRNN 196
                                        LN+SFNQ SG+IP   G +FP  V++DL  N
Sbjct: 182 WRVVEFLDLSSNLINGSLPPDFGGYSLQYLNVSFNQISGEIPPEIGVNFPRNVTVDLSFN 241

Query: 197 NLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKV-------HANPEVEDGP 249
           NL+G IP     LNQ    FSGNPGLCG P ++PC  P +P +        + P +   P
Sbjct: 242 NLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPTSTPAIAAIP 301

Query: 250 Q----NPKNTNFGYSGDVKDR-GRNGSVVVSVISGVSVVVGVVSVS-VWLFRRKRR--AR 301
                NP         D   R G    V++ ++ G    +G+++V  ++++R K+     
Sbjct: 302 NTIGSNPVTDPNSQQTDPNPRTGLRPGVIIGIVVGDIAGIGILAVIFLYIYRCKKNKIVD 361

Query: 302 EGKMGKEEKTNDAVLVTD------------------------------------------ 319
                K+    D + ++                                           
Sbjct: 362 NNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRKDPETTPSEEEDEDDEDEESG 421

Query: 320 ---EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVA 376
               +     K   +D    +E+E LL+ASAY++G + + IMYK V+  G       V A
Sbjct: 422 YNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGR------VFA 475

Query: 377 VRRLTE-GDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA 435
           VRRL E G +  RFKDFE  + AI ++ HPN+VRL  FY+  DEKL+I DF+ NGSL   
Sbjct: 476 VRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSLVNP 535

Query: 436 LH--AGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
            +   G S S   LPWE RLKIA+G ARGL Y+HE   +K+VHGN+K + ILL  ++ P 
Sbjct: 536 RYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHDMEPK 592

Query: 494 ISGFGLNRLLP---------GTSKVTKNETIVTSG------------TGSRISAISNVYL 532
           I  FGL RLL          G+S++  ++   TS             + S + A+S  Y 
Sbjct: 593 IGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGAMS-PYC 651

Query: 533 APEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
           APE+     K + K DVY FG++LLE+LTG++        G GL   V    R  R    
Sbjct: 652 APES-FRSLKPSPKWDVYGFGVILLELLTGKIVSVEEIVLGNGLT--VEDGHRAVR---- 704

Query: 593 VIDPALVKEIHAKRQ-VLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           + D A+  E+  K++ +L  F +  +C    P+ RP M+     L+R
Sbjct: 705 MADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLER 751

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1

 Score =  307 bits (786), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 257/774 (33%), Positives = 368/774 (47%), Gaps = 168/774 (21%)

Query: 6   LFFALLL---LFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHC 62
           L F+L+L   LF      +LN DG+ LL  K +I  DP   L +W+  D+TPC W+G+ C
Sbjct: 8   LLFSLVLFHFLFVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTC 67

Query: 63  IR---------NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNAT 113
                       RVTSL LPN++L G +  +L  +  L  L L+SN F+  +P ++FNAT
Sbjct: 68  TELGKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNAT 127

Query: 114 ------------------------NLVYLDLAHNSFCGPIPDRIKTLKNLTH-------- 141
                                   NL  L+L+ N+F G IP  I  LKNLT         
Sbjct: 128 ELQSISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTF 187

Query: 142 -------------LDLSSNLLNGSLPEFLLDLRALT-GTLNLSFNQFSGQI-PEMYGHFP 186
                        LDLSSNLLNGSLP+   DL   +   LNLS N+  G+I P     FP
Sbjct: 188 SGDIPSGFEAAQILDLSSNLLNGSLPK---DLGGKSLHYLNLSHNKVLGEISPNFAEKFP 244

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPE----------- 235
              ++DL  NNL+G IP   SLLNQ   +FSGN  LCG PL+  C  P            
Sbjct: 245 ANATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPPNISET 304

Query: 236 -NPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRN-GSVVVSVISGVSVVVGVVSVSVWL 293
            +P +   P     P NP       +G  K +     ++ V+ I G++ + G++ + V+ 
Sbjct: 305 TSPAIAVKPR-STAPINPLTEKPNQTGKSKLKPSTIAAITVADIVGLAFI-GLLVLYVYQ 362

Query: 294 FRRKRR---------------AREGKMGK------------EEKTN--DAVLVT----DE 320
            R++RR                 E K  K            E KT     +++T    DE
Sbjct: 363 VRKRRRYPESSKFSFFKFCLEKNEAKKSKPSTTEVTVPESPEAKTTCGSCIILTGGRYDE 422

Query: 321 -------------------------EEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKN 355
                                    ++  + +   +D    L+L+ LL+ASAY++G +  
Sbjct: 423 TSTSESDVENQQTVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAYILGTTGT 482

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
           GI+YK V+  G      T  AVRR+ TE  A  + K+FE EV AIA+++HPN+VR++ F 
Sbjct: 483 GIVYKAVLENG------TAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFC 536

Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLP--------PLPWEARLKIAQGTARGLMYI 466
           + +DEKLLISD++ NGSL     A  + S          PL +EARLKIA+G ARGL YI
Sbjct: 537 WGDDEKLLISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYI 596

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           +E   +K VHGNIK   ILL+ E  P I+  GL+RL+      T      T+G  S    
Sbjct: 597 NE---KKQVHGNIKPNNILLNAENEPIITDLGLDRLM------TPARESHTTGPTS---- 643

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
            S+ Y  PE      K   K DVYSFG++LLE+LT ++     ++D     +L   A  E
Sbjct: 644 -SSPYQPPEWST-SLKPNPKWDVYSFGVILLELLTSKVFSV--DHDIDQFSNLSDSAAEE 699

Query: 587 RRPLSEVIDPALVKEI-HAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                 +ID A+  ++   +   +A F + + C    P+ RP M+ + + L+++
Sbjct: 700 NGRFLRLIDGAIRSDVARHEDAAMACFRLGIECVSSLPQKRPSMKELVQVLEKI 753

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  293 bits (750), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 228/643 (35%), Positives = 325/643 (50%), Gaps = 63/643 (9%)

Query: 25  DGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSE 84
           D   LL  K  +  D T  L+SW+ + + PC W+G+ C RNRVT L L + NLTG + S 
Sbjct: 31  DSETLLNFK--LTADSTGKLNSWNTT-TNPCQWTGVSCNRNRVTRLVLEDINLTGSISSL 87

Query: 85  LGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL 144
             L +    LSL  NN S PIP NL N T L  L L++N F G  P  I +L  L  LDL
Sbjct: 88  TSLTSLRV-LSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDL 145

Query: 145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ 204
           S N  +G +P  L DL  L      S N+FSGQIP +  +   +   ++  NN +G+IP 
Sbjct: 146 SFNNFSGQIPPDLTDLTHLLTLRLES-NRFSGQIPNI--NLSDLQDFNVSGNNFNGQIPN 202

Query: 205 VGSLLNQGP-TAFSGNPGLCGFPLQSPCPEPENPKVHANP-EVEDGPQN-----PKNTNF 257
               L+Q P + F+ NP LCG PL        +P     P E +  P N     P +   
Sbjct: 203 S---LSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTS 259

Query: 258 GYSGDVKDRGRNGSVV--VSVISGVSVVVGVVSVSVW-LFRRKRRAREGKMGKEEKTNDA 314
            + GD  +     S +  +++I G  +++  VS+ ++  F R+    + K  K  +    
Sbjct: 260 IHGGDKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKI 319

Query: 315 VLVTD-------------EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKV 361
           V  ++             ++ G KGK    +     ELEDLLRASA ++GK   G  YK 
Sbjct: 320 VYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKA 379

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
           V+  G+       VAV+RL +       K+FE ++E + R++H N+V LKA+Y+A +EKL
Sbjct: 380 VLEDGN------EVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKL 433

Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH-EYSPRKYVHGNIK 480
           L+ D++ NGSL+  LH        PL W  RLKIA G ARGL +IH      K  HG+IK
Sbjct: 434 LVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIK 493

Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           ST +LLD   +  +S FGL+   P                 S+  A SN Y APE  I G
Sbjct: 494 STNVLLDRSGNARVSDFGLSIFAP-----------------SQTVAKSNGYRAPEL-IDG 535

Query: 541 SKFTQKCDVYSFGIVLLEILTGRLP---DAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
            K TQK DVYSFG++LLEILTG+ P   + G       L   V+   RE    +EV D  
Sbjct: 536 RKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWT-AEVFDLE 594

Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           L++    + +++    IA+ CT +  + RP+M  V + ++ ++
Sbjct: 595 LMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  286 bits (733), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 222/634 (35%), Positives = 319/634 (50%), Gaps = 70/634 (11%)

Query: 31  ALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNR--VTSLYLPNRNLTGYMPS-ELGL 87
           AL   + Q P      W+ESDS  C+W G+ C  N+  + SL LP   L G +PS  LG 
Sbjct: 31  ALLTFLQQIPHENRLQWNESDSA-CNWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGR 89

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           L  L  LSL SN  S  IP++  N T+L  L L HN F G  P     L NL  LD+SSN
Sbjct: 90  LTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSN 149

Query: 148 LLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGS 207
              GS+P  + +L  LTG L L  N FSG +P +      +V  ++ NNNL+G IP   S
Sbjct: 150 NFTGSIPFSVNNLTHLTG-LFLGNNGFSGNLPSISLG---LVDFNVSNNNLNGSIPS--S 203

Query: 208 LLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRG 267
           L      +F+GN  LCG PL+ PC          +P       NP N         K + 
Sbjct: 204 LSRFSAESFTGNVDLCGGPLK-PCK-----SFFVSPSPSPSLINPSN----RLSSKKSKL 253

Query: 268 RNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEK---------------TN 312
              ++V  +++   V + ++++ ++L  RKRR       K+ K               ++
Sbjct: 254 SKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASS 313

Query: 313 DAVLVTDEEEGQKGKF----FIIDEG--FSLELEDLLRASAYVVGKSKNGIMYKVVVGRG 366
               VT    G  G+      +  EG  +S +LEDLLRASA V+GK   G  YK V+  G
Sbjct: 314 SKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEG 373

Query: 367 SGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF 426
                 T V V+RL   D     K+FE+++E + +++HPN++ L+A+YY+ DEKLL+ DF
Sbjct: 374 ------TTVVVKRLK--DVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDF 425

Query: 427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           +  GSL A LH        PL W+ R++IA   ARGL ++H  +  K VHGNIK++ ILL
Sbjct: 426 MPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILL 483

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
                 C+S +GLN+L   +S              +R++     Y APE  +   K T K
Sbjct: 484 HPNQDTCVSDYGLNQLFSNSSP------------PNRLAG----YHAPEV-LETRKVTFK 526

Query: 547 CDVYSFGIVLLEILTGRLPD-AGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DVYSFG++LLE+LTG+ P+ A    +G  L   V    RE    +EV D  L++  + +
Sbjct: 527 SDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEW-TAEVFDVELMRYHNIE 585

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +++    IA+ C    P+ RP M+ V   ++ V
Sbjct: 586 EEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  269 bits (688), Expect = 4e-71,   Method: Compositional matrix adjust.
 Identities = 215/662 (32%), Positives = 330/662 (49%), Gaps = 72/662 (10%)

Query: 1   MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGI 60
           ++   LF  +       L   +  D  ALL   + +    +R L+ W+ +      W+GI
Sbjct: 4   IIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPH--SRKLN-WNSTIPICASWTGI 60

Query: 61  HCIRN--RVTSLYLPNRNLTGYMPSE-LGLLNSLTRLSLASNNFSKPIPANLFNATNLVY 117
            C +N  RVT+L LP   L G +P +    L++L  +SL SN+    IP+ + +   +  
Sbjct: 61  TCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRS 120

Query: 118 LDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ 177
           L    N+F G IP  +     L +LDLS+N L+G++P  L +L  LT  L+L  N  SG 
Sbjct: 121 LYFHENNFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLT-DLSLQNNSLSGP 177

Query: 178 IPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENP 237
           IP +    P +  L+L  NNL+G +P   S+ +   ++F GN  LCG PL +PCPE    
Sbjct: 178 IPNLP---PRLKYLNLSFNNLNGSVPS--SVKSFPASSFQGNSLLCGAPL-TPCPENTTA 231

Query: 238 KVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRK 297
               +P      + P  TN G  G  K     G++V   + G  ++  ++++      +K
Sbjct: 232 ---PSPSPTTPTEGPGTTNIG-RGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKK 287

Query: 298 R----------RAREGKM-GKEEKTNDAVLVTDEEEGQKGKF-FIIDEGFSLELEDLLRA 345
           R          +A+ G+   K E+    V     +E +K K  F     ++ +LEDLLRA
Sbjct: 288 RDGGQDSTAVPKAKPGRSDNKAEEFGSGV-----QEAEKNKLVFFEGSSYNFDLEDLLRA 342

Query: 346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-H 404
           SA V+GK   G  YK ++  G      T V V+RL E  A  R  +FE ++EA+ R+  H
Sbjct: 343 SAEVLGKGSYGTTYKAILEEG------TTVVVKRLKEVAAGKR--EFEQQMEAVGRISPH 394

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
            N+  L+A+Y++ DEKLL+ D+ + G+    LH         L WE RL+I    ARG+ 
Sbjct: 395 VNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGIS 454

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +IH  S  K +HGNIKS  +LL  ELH C+S FG+  L+        + T++ S      
Sbjct: 455 HIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLM-------SHHTLIPSR----- 502

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG-----KGLESL 579
              S  Y APEA I   K TQK DVYSFG++LLE+LTG+       ++      K ++S+
Sbjct: 503 ---SLGYRAPEA-IETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSV 558

Query: 580 VRKAFRERRPLSEVIDPALVKEIH-AKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           VR+ +       EV D  L+K+ H  + +++    IA+ C    P+ RP M  V   ++ 
Sbjct: 559 VREEWT-----GEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEE 613

Query: 639 VK 640
           ++
Sbjct: 614 IR 615

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  267 bits (682), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 220/661 (33%), Positives = 321/661 (48%), Gaps = 92/661 (13%)

Query: 22  LNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYM 81
           LN D  ALL+L++A+     R    W+   ++PC+W+G+ C  NRVT+L LP   L+G +
Sbjct: 33  LNADRTALLSLRSAVGGRTFR----WNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDI 88

Query: 82  PSEL-GLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLT 140
           P  + G L  L  LSL  N  S  +P +L  ++NL +L L  N F G IP+ + +L +L 
Sbjct: 89  PEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLV 148

Query: 141 HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
            L+L+SN   G +     +L  L  TL L  NQ SG IP++    P +V  ++ NN+L+G
Sbjct: 149 RLNLASNSFTGEISSGFTNLTKLK-TLFLENNQLSGSIPDL--DLP-LVQFNVSNNSLNG 204

Query: 201 EIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPE----PENPKVHAN---PEVEDGPQNPK 253
            IP+    L +  +       LCG PL+  CP+    P  P    N   P VE G +  K
Sbjct: 205 SIPKN---LQRFESDSFLQTSLCGKPLK-LCPDEETVPSQPTSGGNRTPPSVE-GSEEKK 259

Query: 254 NTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEE-KTN 312
             N    G +        +V+  + G +++V ++ V   L R+K   R   +     K  
Sbjct: 260 KKNKLSGGAI------AGIVIGCVVGFALIVLILMV---LCRKKSNKRSRAVDISTIKQQ 310

Query: 313 DAVLVTDEEEGQKGKFFIID--------------EGFS---------------LELEDLL 343
           +  +  D+E    G  + +               EG                  +LEDLL
Sbjct: 311 EPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLL 370

Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           RASA V+GK   G  YK V      + A TVVAV+RL   D     K+F+ ++E +  + 
Sbjct: 371 RASAEVLGKGTFGTAYKAV------LDAVTVVAVKRLK--DVMMADKEFKEKIELVGAMD 422

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           H N+V L+A+Y++ DEKLL+ DF+  GSL A LH        PL W+ R +IA G ARGL
Sbjct: 423 HENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGL 482

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y+H        HGNIKS+ ILL       +S FGL +L+ G+S    N       TG  
Sbjct: 483 DYLHSQGTSTS-HGNIKSSNILLTKSHDAKVSDFGLAQLV-GSSATNPNR-----ATG-- 533

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN-DGKGLESLVRK 582
                  Y APE      + +QK DVYSFG+VLLE++TG+ P     N +G  L   V+ 
Sbjct: 534 -------YRAPEV-TDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKS 585

Query: 583 AFRE--RRPLSEVIDPALVKEIHAKRQVLATF-HIALNCTELDPEFRPRMRTVSESLDRV 639
             R+  RR   EV D  L+     + +++A    + L CT   P+ RP M  V   ++ +
Sbjct: 586 VARDEWRR---EVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642

Query: 640 K 640
           +
Sbjct: 643 R 643

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  265 bits (677), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 207/634 (32%), Positives = 322/634 (50%), Gaps = 61/634 (9%)

Query: 22  LNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRN--RVTSLYLPNRNLTG 79
           LN D  ALLA  A++     R L+ W+ ++     W G+ C  +   V +L LP   L G
Sbjct: 45  LNSDRQALLAFAASVPH--LRRLN-WNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLG 101

Query: 80  YMP-SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKN 138
            +P + LG L SL  LSL SN  S  +P ++ +  +L Y+ L HN+F G +P  +   + 
Sbjct: 102 PIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVS--RQ 159

Query: 139 LTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNL 198
           L  LDLS N   G +P    +L+ LTG L+L  N+ SG +P +      +  L+L NN+L
Sbjct: 160 LNILDLSFNSFTGKIPATFQNLKQLTG-LSLQNNKLSGPVPNL--DTVSLRRLNLSNNHL 216

Query: 199 SGEIPQVGSLLNQGPTA-FSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNF 257
           +G IP   S L   P++ FSGN  LCG PLQ PC    +P     P +   P  P    F
Sbjct: 217 NGSIP---SALGGFPSSSFSGNTLLCGLPLQ-PCAT-SSPPPSLTPHISTPPLPP----F 267

Query: 258 GYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAV-- 315
            +    K +    +++     G ++++ +  + +    +K+  RE  + K +   +    
Sbjct: 268 PHKEGSKRKLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTLTEKAKQ 327

Query: 316 -LVTDEEEGQKGKF-FIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPT 373
              +  +E +K K  F     ++ +LEDLLRASA V+GK   G  YK V+         T
Sbjct: 328 EFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEES------T 381

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
            V V+RL E  A  R  +FE ++E I+RV  HP++V L+A+YY+ DEKL++ D+   G+L
Sbjct: 382 TVVVKRLKEVAAGKR--EFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNL 439

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            + LH        PL W++R+KI    A+G+ ++H     K+ HGNIKS+ +++  E   
Sbjct: 440 SSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDA 499

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
           CIS FGL  L+       +       G G         Y APE  +   K T K DVYSF
Sbjct: 500 CISDFGLTPLMAVPIAPMR-------GAG---------YRAPEV-METRKHTHKSDVYSF 542

Query: 553 GIVLLEILTGRLPDAGPENDG-----KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ 607
           G+++LE+LTG+ P   P  D      + ++S+VR+ +      SEV D  L++  + + +
Sbjct: 543 GVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWT-----SEVFDIELMRFQNIEEE 597

Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLDRVKL 641
           ++    IA+ C    PE RP M  V   ++ +++
Sbjct: 598 MVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRV 631

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1

 Score =  261 bits (666), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 217/662 (32%), Positives = 318/662 (48%), Gaps = 78/662 (11%)

Query: 3   LPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHC 62
           L L    L + + A +   L  D  ALLA++ ++   P      W+ S S+PC+W G+HC
Sbjct: 7   LSLSVVFLFVFYLAAVTSDLESDRRALLAVRNSVRGRPLL----WNMSASSPCNWHGVHC 62

Query: 63  IRNRVTSLYLPNRNLTGYMP-SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
              RVT+L LP   L G +P   +G L  L  LSL  N+ S PIP++  N   L YL L 
Sbjct: 63  DAGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQ 122

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
            N+F G IP  + TL ++  ++L  N  +G +P+ +     L  TL L  NQ SG IPE+
Sbjct: 123 GNAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLV-TLYLERNQLSGPIPEI 181

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHA 241
               P+    ++ +N L+G IP   SL +   TAF GN  LCG PL + C E E+P    
Sbjct: 182 T--LPLQ-QFNVSSNQLNGSIPS--SLSSWPRTAFEGNT-LCGKPLDT-C-EAESP---- 229

Query: 242 NPEVEDGPQNPKNTNFGYSGDVKDRGR-NGSVVVSVISGVSVVVGVVSVSVWLFRRKRRA 300
           N     GP  P         + KD  + +   +V ++ G  V + ++ + ++   RKR+ 
Sbjct: 230 NGGDAGGPNTPP--------EKKDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCRKRKK 281

Query: 301 REGKMGKE------EKTNDAVL------------VTDEEEGQKGK---FFIIDEGFSLEL 339
            E    +         T+ A +             T  E G   K   FF+   G   +L
Sbjct: 282 EENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSESGAVNKDLTFFVKSFG-EFDL 340

Query: 340 EDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAI 399
           + LL+ASA V+GK   G  YK     G       VVAV+RL   D     K+F   +  +
Sbjct: 341 DGLLKASAEVLGKGTVGSSYKASFEHG------LVVAVKRLR--DVVVPEKEFRERLHVL 392

Query: 400 ARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
             + H N+V L A+Y++ DEKLL+ +++  GSL A LH    +   PL WE R  IA G 
Sbjct: 393 GSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRAGIALGA 452

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           AR + Y+H        HGNIKS+ ILL D     +S +GL  ++  TS            
Sbjct: 453 ARAISYLHSRDGTTS-HGNIKSSNILLSDSYEAKVSDYGLAPIISSTS------------ 499

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN-DGKGLES 578
             +RI      Y APE      K +QK DVYSFG+++LE+LTG+ P     N +G  L  
Sbjct: 500 APNRIDG----YRAPEI-TDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGVDLPR 554

Query: 579 LVRKAFRERRPLSEVIDPALVK-EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            V+    ++ P S+V+DP L + +      ++    I ++CT   P+ RP M  V+  ++
Sbjct: 555 WVQSVTEQQTP-SDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIE 613

Query: 638 RV 639
            V
Sbjct: 614 EV 615

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1

 Score =  255 bits (651), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 193/589 (32%), Positives = 305/589 (51%), Gaps = 49/589 (8%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
           C  + +  + + +  L+G +P E G L  L  L  + N+ +  IP +  N ++LV L+L 
Sbjct: 260 CKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSINGTIPDSFSNLSSLVSLNLE 319

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
            N   GPIPD I  L NLT L+L  N +NG +PE + ++  +   L+LS N F+G IP  
Sbjct: 320 SNHLKGPIPDAIDRLHNLTELNLKRNKINGPIPETIGNISGIK-KLDLSENNFTGPIPLS 378

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPK-VH 240
             H   + S ++  N LSG +P V S      ++F GN  LCG+   +PCP P++   + 
Sbjct: 379 LVHLAKLSSFNVSYNTLSGPVPPVLS-KKFNSSSFLGNIQLCGYSSSNPCPAPDHHHPLT 437

Query: 241 ANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRA 300
            +P     P+   +        VKD      V++  I  +  ++ ++   +     K+RA
Sbjct: 438 LSPTSSQEPRKHHHRKL----SVKD------VILIAIGALLAILLLLCCILLCCLIKKRA 487

Query: 301 ----REGKMGKEEKTNDAVLVTDEEEGQK--GKFFIIDEGFSLELEDLLRASAYVVGKSK 354
               ++GK    EKT  A +      G +  GK    D  F    +DLL A+A ++GKS 
Sbjct: 488 ALKQKDGKDKTSEKTVSAGVAGTASAGGEMGGKLVHFDGPFVFTADDLLCATAEIMGKST 547

Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G  YK  +  G+       VAV+RL E   T   K+FE EV A+ +++H N++ L+A+Y
Sbjct: 548 YGTAYKATLEDGN------EVAVKRLRE-KTTKGVKEFEGEVTALGKIRHQNLLALRAYY 600

Query: 415 YA-NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK 473
                EKLL+ D++  GSL A LHA   ++L  +PWE R+KIA+G +RGL ++H  S   
Sbjct: 601 LGPKGEKLLVFDYMSKGSLSAFLHARGPETL--IPWETRMKIAKGISRGLAHLH--SNEN 656

Query: 474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLA 533
            +H N+ ++ ILLD++ +  I+ +GL+RL+   +       I T+GT          Y A
Sbjct: 657 MIHENLTASNILLDEQTNAHIADYGLSRLM---TAAAATNVIATAGTLG--------YRA 705

Query: 534 PE-ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
           PE ++I  +  + K DVYS GI++LE+LTG+ P  G   +G  L   V    +E    +E
Sbjct: 706 PEFSKIKNA--SAKTDVYSLGIIILELLTGKSP--GEPTNGMDLPQWVASIVKEEW-TNE 760

Query: 593 VIDPALVKEIHA-KRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           V D  L++E  +   ++L T  +AL+C +  P  RP    V E L+ ++
Sbjct: 761 VFDLELMRETQSVGDELLNTLKLALHCVDPSPAARPEANQVVEQLEEIR 809

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	642
255587441	654	ATP binding protein, putative [Ricinus c	0.981	0.963	0.703	0.0
297739718	739	unnamed protein product [Vitis vinifera]	0.973	0.845	0.680	0.0
359481828	640	PREDICTED: probable inactive leucine-ric	0.973	0.976	0.680	0.0
224139838	652	predicted protein [Populus trichocarpa]	0.987	0.972	0.683	0.0
224120204	652	predicted protein [Populus trichocarpa]	0.962	0.947	0.689	0.0
356572062	648	PREDICTED: probable inactive leucine-ric	0.979	0.970	0.652	0.0
356503468	653	PREDICTED: probable inactive leucine-ric	0.985	0.969	0.646	0.0
15230877	662	leucine-rich repeat protein kinase-like	0.957	0.929	0.628	0.0
297817114	655	hypothetical protein ARALYDRAFT_486237 [	0.945	0.926	0.629	0.0
26452274	662	putative receptor-like protein kinase [A	0.957	0.929	0.626	0.0

>gi|255587441|ref|XP_002534272.1| ATP binding protein, putative [Ricinus communis] gi|223525595|gb|EEF28109.1| ATP binding protein, putative [Ricinus communis]

 Score =  905 bits (2339), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/647 (70%), Positives = 531/647 (82%), Gaps = 17/647 (2%)

Query: 10  LLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTS 69
            L+ F APL FSL +DGLALLALKAAI  DPTR LDSWS+SD TPCHW GI CI +RVTS
Sbjct: 11  FLIFFFAPLSFSLTRDGLALLALKAAITTDPTRVLDSWSDSDQTPCHWHGITCINHRVTS 70

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI 129
           L LPN++ TGY+PSELGLL+SLTRL+L+ NNFS+PIP++LFNAT+L  LDL+HNS  GP+
Sbjct: 71  LILPNKSFTGYLPSELGLLDSLTRLTLSHNNFSEPIPSHLFNATSLRSLDLSHNSLSGPV 130

Query: 130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV 189
           P +IK+L+ LTHLDLSSN LNGSLP+ L +LR+L+GTLNLS+NQF+G+IP  YG FPV V
Sbjct: 131 PTQIKSLQELTHLDLSSNFLNGSLPDVLTELRSLSGTLNLSYNQFTGEIPVSYGDFPVFV 190

Query: 190 SLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGP 249
           SLDLR+NNLSG++P VGSL+NQGPTAFSGNP LCGFPLQ+ CPE  N     N E    P
Sbjct: 191 SLDLRHNNLSGKVPLVGSLVNQGPTAFSGNPSLCGFPLQTLCPEATNITSSENTE---NP 247

Query: 250 QNPKNTNFGYSGDV--KDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKR--RAREGKM 305
           +NP+N NFG    +  K R +NGSV V +ISGV VV+G VS+S WL R+K      + KM
Sbjct: 248 ENPRNPNFGLLPQIEEKQREKNGSVAVPLISGVFVVIGAVSLSAWLLRKKWGGSGEKDKM 307

Query: 306 GKEEKTNDAVLVTD-EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVV- 363
           GKEE T      +D  EEGQKGKF +IDEGF+LELEDLLRASAYVVGKS+NGI+YKVVV 
Sbjct: 308 GKEESTGGNHASSDISEEGQKGKFVVIDEGFNLELEDLLRASAYVVGKSRNGIVYKVVVG 367

Query: 364 GRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI 423
           GRGSG   PTVVAVRRL EGDATW+FK+FESEVEAI RV HPNIV+L+A+YYA+DEKLL+
Sbjct: 368 GRGSGTVVPTVVAVRRLNEGDATWKFKEFESEVEAIGRVHHPNIVQLRAYYYAHDEKLLV 427

Query: 424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTK 483
           SD+IRNGSLY+ALH GPS++LPPL W ARL++AQGTARGLMY+HE SPRKYVHGN+KSTK
Sbjct: 428 SDYIRNGSLYSALHGGPSNTLPPLSWAARLQVAQGTARGLMYVHECSPRKYVHGNLKSTK 487

Query: 484 ILLDDELHPCISGFGLNRLLPGTSKVTK--------NETIVTSGTGSRISAISNVYLAPE 535
           ILLDDEL P IS FGL RL+ GTSK +         N+T V    GS+ISA  N YLAPE
Sbjct: 488 ILLDDELQPYISSFGLTRLVSGTSKFSTSASKKQYLNQTTVNPTMGSKISAPCNFYLAPE 547

Query: 536 ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVID 595
           AR + +KF+QKCDVYSFGI+L+E+LTGRLPDAG ENDGKGLESLVRK FRE RPLSE+ID
Sbjct: 548 ARGFSNKFSQKCDVYSFGIILMELLTGRLPDAGSENDGKGLESLVRKVFREERPLSEIID 607

Query: 596 PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           PAL+ E+HAK+QV+A FHIALNCTELDPEFRPRMRTVSESLDR+KLQ
Sbjct: 608 PALLSEVHAKKQVVAVFHIALNCTELDPEFRPRMRTVSESLDRIKLQ 654

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739718|emb|CBI29900.3| unnamed protein product [Vitis vinifera]

 Score =  863 bits (2231), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/645 (68%), Positives = 515/645 (79%), Gaps = 20/645 (3%)

Query: 6   LFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRN 65
           L  A  L+F   L  SLN DGL+LLALKAAI  DPT  LD+WSESD  PCHW GI C   
Sbjct: 107 LGLASFLIFFTCLSSSLNSDGLSLLALKAAIVSDPTGVLDTWSESDLVPCHWGGISCTHG 166

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
           RVT ++LPNR+ TGY+PSELG L +L +LSLA+NNFSKPIP+ LFNAT L+ LDL+HNS 
Sbjct: 167 RVTGVFLPNRSFTGYIPSELGALVNLRQLSLANNNFSKPIPSRLFNATTLLSLDLSHNSL 226

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
            GP+P ++K LK L HLDLSSNLLNGSLPE L +L  L G+LNLS N+FSG++P  YG  
Sbjct: 227 SGPLPTQVKALKYLVHLDLSSNLLNGSLPEELAELENLAGSLNLSHNRFSGEVPASYGKI 286

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEV 245
           P+MVSLDLR+NNL+G+IPQ+GSLLNQGPTAFSGNP LCGFPLQ+PCPE  NPK+  NPE 
Sbjct: 287 PLMVSLDLRHNNLTGKIPQIGSLLNQGPTAFSGNPSLCGFPLQTPCPEASNPKIFVNPE- 345

Query: 246 EDGPQNPKNTNFGYSGDVKDRGRN------GSVVVSVISGVSVVVGVVSVSVWLFRRKRR 299
                NP+  N  +     D G        GSV V +ISG+SVVVGVVSVSVWLFR+KR 
Sbjct: 346 -----NPRKPNPSFPNGAADEGEERQKIGGGSVAVPLISGISVVVGVVSVSVWLFRKKRS 400

Query: 300 AREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMY 359
           + EGK+G+E+   +      E+EGQKGKF ++DEGF LELEDLLRASAYVVGKS++GI+Y
Sbjct: 401 SGEGKIGREKLAKEV-----EDEGQKGKFVVVDEGFGLELEDLLRASAYVVGKSRSGIVY 455

Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           +VV GR SG  +PTVVAVRRL+EGD TWR KDFESEVEAIARV H NIVRL+A+YYANDE
Sbjct: 456 RVVAGRVSG-ASPTVVAVRRLSEGDGTWRLKDFESEVEAIARVHHQNIVRLRAYYYANDE 514

Query: 420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           KLL+SDFIRNGSL+ ALH GPS++LPPL W ARLKIAQG ARGLM+IHE SPRKYVHGNI
Sbjct: 515 KLLVSDFIRNGSLHTALHGGPSNTLPPLSWAARLKIAQGAARGLMHIHECSPRKYVHGNI 574

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT--GSRISAISNVYLAPEAR 537
           KS+KILLDD L P +SGFGL RL+ G S   +N   V++ +  GS+ SA S  YLAPEAR
Sbjct: 575 KSSKILLDDHLQPYVSGFGLTRLVSGASSKKQNSHQVSTNSVLGSKASANSIAYLAPEAR 634

Query: 538 IYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
           + G++FTQKCDVYSFGIVL+E+LT RLPDAGPENDGKGLESLVRK FR+ RPLSE+IDPA
Sbjct: 635 VSGTRFTQKCDVYSFGIVLMEVLTARLPDAGPENDGKGLESLVRKVFRDERPLSEIIDPA 694

Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           L+ E++AK+QVL+ FH+ALNCTELDPE RPRMRTVSESLDR+K Q
Sbjct: 695 LLHEVYAKKQVLSAFHVALNCTELDPELRPRMRTVSESLDRIKSQ 739

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481828|ref|XP_002277291.2| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Vitis vinifera]

 Score =  862 bits (2228), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/645 (68%), Positives = 515/645 (79%), Gaps = 20/645 (3%)

Query: 6   LFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRN 65
           L  A  L+F   L  SLN DGL+LLALKAAI  DPT  LD+WSESD  PCHW GI C   
Sbjct: 8   LGLASFLIFFTCLSSSLNSDGLSLLALKAAIVSDPTGVLDTWSESDLVPCHWGGISCTHG 67

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
           RVT ++LPNR+ TGY+PSELG L +L +LSLA+NNFSKPIP+ LFNAT L+ LDL+HNS 
Sbjct: 68  RVTGVFLPNRSFTGYIPSELGALVNLRQLSLANNNFSKPIPSRLFNATTLLSLDLSHNSL 127

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
            GP+P ++K LK L HLDLSSNLLNGSLPE L +L  L G+LNLS N+FSG++P  YG  
Sbjct: 128 SGPLPTQVKALKYLVHLDLSSNLLNGSLPEELAELENLAGSLNLSHNRFSGEVPASYGKI 187

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEV 245
           P+MVSLDLR+NNL+G+IPQ+GSLLNQGPTAFSGNP LCGFPLQ+PCPE  NPK+  NPE 
Sbjct: 188 PLMVSLDLRHNNLTGKIPQIGSLLNQGPTAFSGNPSLCGFPLQTPCPEASNPKIFVNPE- 246

Query: 246 EDGPQNPKNTNFGYSGDVKDRGRN------GSVVVSVISGVSVVVGVVSVSVWLFRRKRR 299
                NP+  N  +     D G        GSV V +ISG+SVVVGVVSVSVWLFR+KR 
Sbjct: 247 -----NPRKPNPSFPNGAADEGEERQKIGGGSVAVPLISGISVVVGVVSVSVWLFRKKRS 301

Query: 300 AREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMY 359
           + EGK+G+E+   +      E+EGQKGKF ++DEGF LELEDLLRASAYVVGKS++GI+Y
Sbjct: 302 SGEGKIGREKLAKEV-----EDEGQKGKFVVVDEGFGLELEDLLRASAYVVGKSRSGIVY 356

Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           +VV GR SG  +PTVVAVRRL+EGD TWR KDFESEVEAIARV H NIVRL+A+YYANDE
Sbjct: 357 RVVAGRVSG-ASPTVVAVRRLSEGDGTWRLKDFESEVEAIARVHHQNIVRLRAYYYANDE 415

Query: 420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           KLL+SDFIRNGSL+ ALH GPS++LPPL W ARLKIAQG ARGLM+IHE SPRKYVHGNI
Sbjct: 416 KLLVSDFIRNGSLHTALHGGPSNTLPPLSWAARLKIAQGAARGLMHIHECSPRKYVHGNI 475

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT--GSRISAISNVYLAPEAR 537
           KS+KILLDD L P +SGFGL RL+ G S   +N   V++ +  GS+ SA S  YLAPEAR
Sbjct: 476 KSSKILLDDHLQPYVSGFGLTRLVSGASSKKQNSHQVSTNSVLGSKASANSIAYLAPEAR 535

Query: 538 IYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
           + G++FTQKCDVYSFGIVL+E+LT RLPDAGPENDGKGLESLVRK FR+ RPLSE+IDPA
Sbjct: 536 VSGTRFTQKCDVYSFGIVLMEVLTARLPDAGPENDGKGLESLVRKVFRDERPLSEIIDPA 595

Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           L+ E++AK+QVL+ FH+ALNCTELDPE RPRMRTVSESLDR+K Q
Sbjct: 596 LLHEVYAKKQVLSAFHVALNCTELDPELRPRMRTVSESLDRIKSQ 640

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139838|ref|XP_002323301.1| predicted protein [Populus trichocarpa] gi|222867931|gb|EEF05062.1| predicted protein [Populus trichocarpa]

 Score =  827 bits (2137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 449/657 (68%), Positives = 525/657 (79%), Gaps = 23/657 (3%)

Query: 2   LLPLLFFALLLLFP---APLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWS 58
           ++P    A L+LF     PL  SLN DGLALLALKAAI  DPT  L SWSE+D TPCHW 
Sbjct: 3   VIPFKVTACLILFTFTNLPLLSSLNTDGLALLALKAAITADPTDTLASWSETDPTPCHWH 62

Query: 59  GIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYL 118
           GI CI +RVTSL LP++N TGY+P ELGLL SLTRL+L+ NNFSK IP++LFNAT L +L
Sbjct: 63  GITCINDRVTSLSLPDKNFTGYIPFELGLLGSLTRLTLSRNNFSKSIPSHLFNATTLRFL 122

Query: 119 DLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI 178
           DL+HNS  GPIP  + +L+ LTHLDLSSN LNGSLP  L  L++LTG LNLS+N FSG+I
Sbjct: 123 DLSHNSLSGPIPANVVSLEALTHLDLSSNCLNGSLPASLNKLKSLTGALNLSYNSFSGEI 182

Query: 179 PEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPK 238
           P  YG FPVMVSLDLR+NNLSG++P  GSL+NQGPTAF+GNP LCGFPLQ+ CPE     
Sbjct: 183 PGSYGFFPVMVSLDLRHNNLSGKVPLFGSLVNQGPTAFAGNPSLCGFPLQTACPEA---- 238

Query: 239 VHANPEVEDGPQNPKNTN-FGYSGDV-KDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRR 296
              N  V D P+NPK+ N   + G V K + + GSV V +ISG SVV+GVV+VSVWL+R+
Sbjct: 239 --VNITVSDNPENPKDPNPVLFPGSVGKVKVKTGSVAVPLISGFSVVIGVVTVSVWLYRK 296

Query: 297 KRRAREGKMGKEEKTN--DAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSK 354
           KRRA EGKMGKEEK    D   VT  EE QKGKF ++DEGF++ELEDLLRASAYVVGKS+
Sbjct: 297 KRRADEGKMGKEEKIEKGDNNEVTFNEEEQKGKFVVMDEGFNMELEDLLRASAYVVGKSR 356

Query: 355 NGIMYKVVVGRGSGMGA-PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAF 413
           +GI+YKVVVG G    A PTVVAVRRL+EGDATW+ K+FESEVEAI RV HPNI RL+A+
Sbjct: 357 SGIVYKVVVGGGGSGTAMPTVVAVRRLSEGDATWKLKEFESEVEAIERVHHPNIARLRAY 416

Query: 414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK 473
           Y+A+DEKLL+SDFIRNGSLY+ALH GPS++LP L W ARLKIAQGTARGLMYIHE+SPRK
Sbjct: 417 YFAHDEKLLVSDFIRNGSLYSALHGGPSNTLPVLSWTARLKIAQGTARGLMYIHEHSPRK 476

Query: 474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK--------NETIVTSGTGSRIS 525
           YVHGN+KSTKILLDDEL P IS FGL RL+  +SK           N+TI +S  G +IS
Sbjct: 477 YVHGNLKSTKILLDDELQPYISSFGLTRLVWNSSKFATSASKKQYLNQTI-SSAMGLKIS 535

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
           A SN+YLAPEAR+ GSKF+QKCDVYSFGIVL+E+LTGRLP AG ENDG+GLESLVRK F+
Sbjct: 536 APSNIYLAPEARVSGSKFSQKCDVYSFGIVLMELLTGRLPGAGSENDGEGLESLVRKVFQ 595

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           E RPLSE+IDPAL+ E+HAK+QV+A FHI+LNCTELDPE RPRMRTVSESLDR+KL 
Sbjct: 596 EERPLSEIIDPALLSEVHAKKQVIAVFHISLNCTELDPELRPRMRTVSESLDRIKLH 652

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120204|ref|XP_002330990.1| predicted protein [Populus trichocarpa] gi|222872920|gb|EEF10051.1| predicted protein [Populus trichocarpa]

 Score =  826 bits (2134), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 439/637 (68%), Positives = 515/637 (80%), Gaps = 19/637 (2%)

Query: 18  LCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNL 77
           L  SLN DGLALLALKAAI  DPT  L SW+E+D TPCHW GI CI +RVTSL LPN+NL
Sbjct: 23  LSLSLNTDGLALLALKAAITTDPTDTLASWTETDPTPCHWHGITCINHRVTSLSLPNKNL 82

Query: 78  TGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLK 137
           TGY+PSELGLL+SLTRL+L+ NNFSK IP +LFNA+ L +LDL+HNS  GPIP +I++L+
Sbjct: 83  TGYIPSELGLLDSLTRLTLSRNNFSKLIPLHLFNASTLRFLDLSHNSLSGPIPAKIESLQ 142

Query: 138 NLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNN 197
            LTHLDLSSN LNGSLP  L+ L++LTGTLNLS+N FSG+IP  YG FPVM+ LDLR+NN
Sbjct: 143 ALTHLDLSSNCLNGSLPASLIKLKSLTGTLNLSYNSFSGEIPGSYGFFPVMLGLDLRHNN 202

Query: 198 LSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNF 257
           LSG++P VGSL+NQGPTAF+GNP LCGFPLQ+PCPE        N  + D P+NPK  N 
Sbjct: 203 LSGKVPLVGSLVNQGPTAFAGNPSLCGFPLQTPCPEA------VNITISDNPENPKGPNP 256

Query: 258 GY-SGDVKD-RGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEE-KTNDA 314
            +  G V++ + +  S+ V +ISGVSVV+GVVSVS WL+R+K  A EGK+GKE+   +D 
Sbjct: 257 VFIPGSVENVKIKTESIAVPLISGVSVVIGVVSVSAWLYRKKWWANEGKVGKEKIDKSDN 316

Query: 315 VLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVV-GRGSGMGAPT 373
             VT +EEGQ GKF +IDEGF LELEDLLRASA VVGKS+ GI+YKVVV GRGSG   P 
Sbjct: 317 NEVTFKEEGQDGKFLVIDEGFDLELEDLLRASASVVGKSRTGIVYKVVVGGRGSGTVVPM 376

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VVAVRRL+E DATW+ K+FESEVEAI RV HPNI RL+A+Y+A+DEKLL+SDFIRNGSLY
Sbjct: 377 VVAVRRLSEDDATWKLKEFESEVEAIGRVHHPNIARLRAYYFAHDEKLLVSDFIRNGSLY 436

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
           +ALH GPS++LP L W ARLKIAQGTARGLMYIHE+SPRK+VHGN+KSTKILLDDEL P 
Sbjct: 437 SALHGGPSNTLPVLSWAARLKIAQGTARGLMYIHEHSPRKHVHGNLKSTKILLDDELQPY 496

Query: 494 ISGFGLNRLLPGTSKVTK--------NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           IS FGL RL+   SK T         N+TI +S TG +ISA  NVYLAPEAR+ G KFTQ
Sbjct: 497 ISSFGLARLVSSGSKFTTSASKKLYLNQTI-SSATGLKISAPYNVYLAPEARVSGRKFTQ 555

Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
           KCDVYSFGIVL+E+LTGRLPDA PENDGKGL+SLVR  FRE RPLSE+IDPAL+ E+HA+
Sbjct: 556 KCDVYSFGIVLMELLTGRLPDARPENDGKGLDSLVRNMFREERPLSEIIDPALLSEVHAE 615

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           R V+A FHIALNCTELDPE RPRMRTVSE+LD +KL 
Sbjct: 616 RHVVAVFHIALNCTELDPELRPRMRTVSENLDCIKLH 652

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356572062|ref|XP_003554189.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max]

 Score =  825 bits (2130), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/650 (65%), Positives = 506/650 (77%), Gaps = 21/650 (3%)

Query: 5   LLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIR 64
           L+ F +  L P P   SLN DGL+LLALKAA+  DPT  L SWSE+D TPCHW G+ C  
Sbjct: 7   LISFLIFSLTPTPTT-SLNSDGLSLLALKAAVDSDPTGVLSSWSETDGTPCHWPGVSCSG 65

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
           ++V+ + LPN+ L+GY+PSELG L SL RLSL  NNFS  IP +LFNAT+L+ LDL+HNS
Sbjct: 66  DKVSQVSLPNKTLSGYIPSELGFLTSLKRLSLPHNNFSNAIPPSLFNATSLIVLDLSHNS 125

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
             G +P  +++LK L H+DLS N LNGSLPE L DL +L GTLNLSFN FSG IP   G+
Sbjct: 126 LSGSLPTELRSLKFLRHVDLSDNSLNGSLPETLSDLTSLAGTLNLSFNHFSGGIPASLGN 185

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPE 244
            PV VSLDLRNNNL+G+IPQ GSLLNQGPTAFSGNPGLCGFPLQS CPE + P + ANP 
Sbjct: 186 LPVSVSLDLRNNNLTGKIPQKGSLLNQGPTAFSGNPGLCGFPLQSACPEAQKPGIFANP- 244

Query: 245 VEDG-PQNPKNTN-FGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRARE 302
            EDG PQNP   +  G    VK  G  GSV V VISG+SV VG VS+S+W+FRR+    E
Sbjct: 245 -EDGFPQNPNALHPDGNDQRVKQHG-GGSVAVLVISGLSVAVGAVSLSLWVFRRRWGGEE 302

Query: 303 GKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVV 362
           GK+G  +  N+     D  EGQ+GKF ++DEGF LELEDLLRASAYV+GKS++GI+YKVV
Sbjct: 303 GKLGGPKLENE----VDGGEGQEGKFVVVDEGFELELEDLLRASAYVIGKSRSGIVYKVV 358

Query: 363 -VGRGSG--MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
            VG+GS    GA  VVAVRRL+EGDATWRFK+FESEVEAIARV+HPN+V L+A+Y+A+DE
Sbjct: 359 GVGKGSSSAAGAANVVAVRRLSEGDATWRFKEFESEVEAIARVRHPNVVPLRAYYFAHDE 418

Query: 420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           KLLI+DFIRNGSL+ ALH GPS+SLPP+ W ARLKIAQ  ARGLMYIHE+S RKY+HGNI
Sbjct: 419 KLLITDFIRNGSLHTALHGGPSNSLPPISWAARLKIAQEAARGLMYIHEFSGRKYIHGNI 478

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTK--------NETIVTSGTGSRISAISNVY 531
           KSTKILLDDELHP +SGFGL RL  G +K T         N++ +T+   S+++A SN Y
Sbjct: 479 KSTKILLDDELHPYVSGFGLARLGLGPTKSTTMAPKRNSLNQSSITTAISSKVAASSNHY 538

Query: 532 LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           LAPE R  G KFTQKCDVYSFGIVLLE+LTGR+PD GPEND K LES VRKAF+E +PLS
Sbjct: 539 LAPEVRFTGGKFTQKCDVYSFGIVLLELLTGRMPDFGPENDDKVLESFVRKAFKEEQPLS 598

Query: 592 EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL 641
           ++IDPAL+ E++AK+QV+A FHIALNCTELDPE RPRM+TVSESLD +K+
Sbjct: 599 DIIDPALIPEVYAKKQVIAAFHIALNCTELDPELRPRMKTVSESLDHIKI 648

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503468|ref|XP_003520530.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max]

 Score =  823 bits (2126), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/653 (64%), Positives = 504/653 (77%), Gaps = 20/653 (3%)

Query: 1   MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGI 60
           ++L L+  +L L   +P+  SLN DGL+LLALKAA+  DPT  L SWSE+D TPCHW GI
Sbjct: 10  VILSLVLRSLYLCL-SPMT-SLNSDGLSLLALKAAVDADPTGVLTSWSETDVTPCHWPGI 67

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
            C  ++VT L LP +NLTGY+PSELG L SL RLSL  NNFS  IP +LFNA +L+ LDL
Sbjct: 68  SCTGDKVTQLSLPRKNLTGYIPSELGFLTSLKRLSLPYNNFSNAIPPSLFNARSLIVLDL 127

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
           +HNS  G +P+++++LK L HLDLS N LNGSLPE L DL +L GTLNLSFN FSG IP 
Sbjct: 128 SHNSLSGSLPNQLRSLKFLRHLDLSDNSLNGSLPETLSDLTSLAGTLNLSFNHFSGGIPA 187

Query: 181 MYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVH 240
             G+ PV VSLDLRNNNL+G+IPQ+G+LLNQGPTAFSGNPGLCGFPLQS CPE + P + 
Sbjct: 188 TLGNLPVAVSLDLRNNNLTGKIPQMGTLLNQGPTAFSGNPGLCGFPLQSACPEAQKPGIF 247

Query: 241 ANPEVEDG-PQNPKNTN-FGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKR 298
           ANP  EDG PQNP   +  G    VK  G  GSV V VISG+SV VG VS+S+W+FRR+ 
Sbjct: 248 ANP--EDGFPQNPNALHPDGNYERVKQHG-GGSVAVLVISGLSVAVGAVSLSLWVFRRRW 304

Query: 299 RAREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIM 358
              EGK+    K  D V   D  EGQ+GKF ++DEGF LELEDLLRASAYVVGKS++GI+
Sbjct: 305 GGEEGKL-VGPKLEDNV---DAGEGQEGKFVVVDEGFELELEDLLRASAYVVGKSRSGIV 360

Query: 359 YKVV-VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           YKVV VG+G    A  VVAVRRL+EGDATWRFK+FESEVEAIARV+HPN+V L+A+Y+A 
Sbjct: 361 YKVVGVGKGLSSAAANVVAVRRLSEGDATWRFKEFESEVEAIARVRHPNVVPLRAYYFAR 420

Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
           DEKL+I+DFIRNGSL+ ALH GPS+SLPPL W  RLKIAQ  ARGLMYIHE+S RKY+HG
Sbjct: 421 DEKLIITDFIRNGSLHTALHGGPSNSLPPLSWAVRLKIAQEAARGLMYIHEFSGRKYIHG 480

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK--------NETIVTSGTGSRISAISN 529
           NIKSTKILLDDELHP +SGFGL RL  G +K           N++ +T+   S+++A  N
Sbjct: 481 NIKSTKILLDDELHPYVSGFGLTRLGLGPTKSATMAPKRNSLNQSSITTAMSSKVAASLN 540

Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP 589
            YLAPE R  G KFTQKCDVYSFGIVLLE+LTGR+PD G END K LES VRKAF+E +P
Sbjct: 541 HYLAPEVRNTGGKFTQKCDVYSFGIVLLELLTGRMPDFGAENDHKVLESFVRKAFKEEKP 600

Query: 590 LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
           LS++IDPAL+ E++AK+QV+  FHIALNCTELDPE RPRM+TVSE+LD +K+Q
Sbjct: 601 LSDIIDPALIPEVYAKKQVIVAFHIALNCTELDPELRPRMKTVSENLDHIKIQ 653

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15230877|ref|NP_191342.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|6729526|emb|CAB67611.1| receptor-like protein kinase [Arabidopsis thaliana] gi|224589606|gb|ACN59336.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332646186|gb|AEE79707.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana]

 Score =  784 bits (2024), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 402/640 (62%), Positives = 492/640 (76%), Gaps = 25/640 (3%)

Query: 22  LNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYM 81
           LN DGL+LLALK+AI +DPTR + SWSESD TPCHW GI C   RVTSL L  R L+GY+
Sbjct: 25  LNPDGLSLLALKSAILRDPTRVMTSWSESDPTPCHWPGIICTHGRVTSLVLSGRRLSGYI 84

Query: 82  PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTH 141
           PS+LGLL+SL +L LA NNFSKP+P  LFNA NL Y+DL+HNS  GPIP +I++LKNLTH
Sbjct: 85  PSKLGLLDSLIKLDLARNNFSKPVPTRLFNAVNLRYIDLSHNSISGPIPAQIQSLKNLTH 144

Query: 142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE 201
           +D SSNLLNGSLP+ L  L +L GTLNLS+N FSG+IP  YG FPV VSLDL +NNL+G+
Sbjct: 145 IDFSSNLLNGSLPQSLTQLGSLVGTLNLSYNSFSGEIPPSYGRFPVFVSLDLGHNNLTGK 204

Query: 202 IPQVGSLLNQGPTAFSGNPGLCGFPLQSPCP-EPENPKVHANPEVEDGPQNPK--NTNFG 258
           IPQ+GSLLNQGPTAF+GN  LCGFPLQ  C  E  NPK+ A P+ E     PK  N +F 
Sbjct: 205 IPQIGSLLNQGPTAFAGNSELCGFPLQKLCKDEGTNPKLVA-PKPEGSQILPKKPNPSFI 263

Query: 259 YSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVT 318
                K++   GSV VS+ISGVS+V+G VS+SVWL RRK  +    +   EK N A  + 
Sbjct: 264 DKDGRKNKPITGSVTVSLISGVSIVIGAVSISVWLIRRKLSS---TVSTPEKNNTAAPLD 320

Query: 319 D--EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAP---- 372
           D  +EE ++GKF ++DEGF LELEDLLRASAYVVGKS++GI+Y+VV G GSG  A     
Sbjct: 321 DAADEEEKEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFTS 380

Query: 373 -TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
            TVVAVRRL++GDATWR KDFE+EVEAI+RVQHPNIVRL+A+YYA DE+LLI+D+IRNGS
Sbjct: 381 STVVAVRRLSDGDATWRRKDFENEVEAISRVQHPNIVRLRAYYYAEDERLLITDYIRNGS 440

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
           LY+ALH GPS++LP L W  RL IAQGTARGLMYIHEYSPRKYVHGN+KSTKILLDDEL 
Sbjct: 441 LYSALHGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDDELL 500

Query: 492 PCISGFGLNRLLPGTSKV---------TKNETIVTSGTG-SRISAISNVYLAPEARI-YG 540
           P ISGFGL RL+ G SK+         + ++T +TS T  +RI+A +  YLAPEAR   G
Sbjct: 501 PRISGFGLTRLVSGYSKLIGSLSATRQSLDQTYLTSATTVTRITAPTVAYLAPEARASSG 560

Query: 541 SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            K +QKCDVYSFG+VL+E+LTGRLP+A  +N+G+ L  +VR   +E +PLSE++DP ++ 
Sbjct: 561 CKLSQKCDVYSFGVVLMELLTGRLPNASSKNNGEELVRVVRNWVKEEKPLSEILDPEILN 620

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           + HA +QV+A  H+ALNCTE+DPE RPRMR+VSESL R+K
Sbjct: 621 KGHADKQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRIK 660

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297817114|ref|XP_002876440.1| hypothetical protein ARALYDRAFT_486237 [Arabidopsis lyrata subsp. lyrata] gi|297322278|gb|EFH52699.1| hypothetical protein ARALYDRAFT_486237 [Arabidopsis lyrata subsp. lyrata]

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/635 (62%), Positives = 488/635 (76%), Gaps = 28/635 (4%)

Query: 25  DGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSE 84
           DGL+LLALK+AI +DPTR + SWSESD TPCHW GI C   RVTSL L  R L+GY+PSE
Sbjct: 28  DGLSLLALKSAIFKDPTRVMTSWSESDPTPCHWPGIICTHGRVTSLVLSGRRLSGYIPSE 87

Query: 85  LGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL 144
           LGLL+SL +L LA NNFSKP+P  LFNA NL Y+DL+HNS  GPIP +I+++KNLTH+D 
Sbjct: 88  LGLLDSLIKLDLARNNFSKPLPTRLFNAVNLRYIDLSHNSISGPIPAQIQSIKNLTHIDF 147

Query: 145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ 204
           SSNLLNGSLPE L  L +L GTLNLS+N+FSG+IP  YG FPV VSLDL +NNL+G+IPQ
Sbjct: 148 SSNLLNGSLPESLTQLGSLVGTLNLSYNRFSGEIPPSYGRFPVFVSLDLGHNNLTGKIPQ 207

Query: 205 VGSLLNQGPTAFSGNPGLCGFPLQSPCP-EPENPKVHANPEVEDGPQNPK--NTNFGYSG 261
           +GSLLNQGPTAF+GN  LCGFPLQ  C  E  NPK+ A P+ E     PK  N +F    
Sbjct: 208 IGSLLNQGPTAFAGNSDLCGFPLQKLCKEETTNPKLVA-PKPEGSQILPKRPNPSFIDKD 266

Query: 262 DVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVTDEE 321
             K++   GSV VS+ISGVS+V+G VS+SVWL RR       K+ K EK N A  + DEE
Sbjct: 267 GRKNKPITGSVTVSLISGVSIVIGAVSISVWLIRR-------KLSKSEKKNTAAPLDDEE 319

Query: 322 EGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAP-----TVVA 376
           + Q+GKF ++DEGF LELEDLLRASAYVVGKS++GI+Y+VV G GSG  A      TVVA
Sbjct: 320 D-QEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFTSSTVVA 378

Query: 377 VRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL 436
           VRRL++GDATW+ KDFE+EVEAI RVQHPNIVRL+A+YYA DE+LLI+D++RNGSLY+AL
Sbjct: 379 VRRLSDGDATWQRKDFENEVEAIGRVQHPNIVRLRAYYYAEDERLLITDYLRNGSLYSAL 438

Query: 437 HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG 496
           H GPS++LP L W  RL IAQGTARGLMYIHEYSPRKYVHGN+KSTKILLDDEL P ISG
Sbjct: 439 HGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDDELQPRISG 498

Query: 497 FGLNRLLPGTSKVTK---------NETIVTSGTG-SRISAISNVYLAPEARI-YGSKFTQ 545
           FGL RL+ G SK+T          ++T +T  T  +RI+A S  YLAPEAR   G K +Q
Sbjct: 499 FGLTRLVSGYSKLTGSLSAIRQSLDQTYLTPATTVTRITAPSVAYLAPEARASSGCKLSQ 558

Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
           KCDVYSFG+VL+E+LTGRLP+   +N+G+ L  +VR   +E +PL+E++DP ++ + HA 
Sbjct: 559 KCDVYSFGVVLMELLTGRLPNGSYKNNGEELVHVVRNWVKEEKPLAEILDPEILNKSHAD 618

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           +QV+A  H+ALNCTE+DPE RPRMR+VSESL R+K
Sbjct: 619 KQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRIK 653

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|26452274|dbj|BAC43224.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|38564248|gb|AAR23703.1| At3g57830 [Arabidopsis thaliana]

 Score =  782 bits (2020), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/640 (62%), Positives = 492/640 (76%), Gaps = 25/640 (3%)

Query: 22  LNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYM 81
           LN DGL+LLALK+AI +DPTR + SWSESD TPCHW GI C   RVTSL L  R L+GY+
Sbjct: 25  LNPDGLSLLALKSAILRDPTRVMTSWSESDPTPCHWPGIICTHGRVTSLVLSGRRLSGYI 84

Query: 82  PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTH 141
           PS+LGLL+SL +L LA NNFSKP+P  LFNA NL Y+DL+HNS  GPIP +I++LKNLTH
Sbjct: 85  PSKLGLLDSLIKLDLARNNFSKPVPTRLFNAVNLRYIDLSHNSISGPIPAQIQSLKNLTH 144

Query: 142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE 201
           +D SSNLLNGSLP+ L  L +L GTLNLS+N FSG+IP  YG FPV VSLDL +NNL+G+
Sbjct: 145 IDFSSNLLNGSLPQSLTQLGSLVGTLNLSYNSFSGEIPPSYGRFPVFVSLDLGHNNLTGK 204

Query: 202 IPQVGSLLNQGPTAFSGNPGLCGFPLQSPCP-EPENPKVHANPEVEDGPQNPK--NTNFG 258
           IPQ+GSLLNQGPTAF+GN  LCGFPLQ  C  E  NPK+ A P+ E     PK  N +F 
Sbjct: 205 IPQIGSLLNQGPTAFAGNSELCGFPLQKLCKDEGTNPKLVA-PKPEGSQILPKKPNPSFI 263

Query: 259 YSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVT 318
                K++   GSV VS+ISGVS+V+G VS+SVWL RRK  +    +   +K N A  + 
Sbjct: 264 DKDGRKNKPITGSVTVSLISGVSIVIGAVSISVWLIRRKLSS---TVSTPKKNNTAAPLD 320

Query: 319 D--EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAP---- 372
           D  +EE ++GKF ++DEGF LELEDLLRASAYVVGKS++GI+Y+VV G GSG  A     
Sbjct: 321 DAADEEEKEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFTS 380

Query: 373 -TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
            TVVAVRRL++GDATWR KDFE+EVEAI+RVQHPNIVRL+A+YYA DE+LLI+D+IRNGS
Sbjct: 381 STVVAVRRLSDGDATWRRKDFENEVEAISRVQHPNIVRLRAYYYAEDERLLITDYIRNGS 440

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
           LY+ALH GPS++LP L W  RL IAQGTARGLMYIHEYSPRKYVHGN+KSTKILLDDEL 
Sbjct: 441 LYSALHGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDDELL 500

Query: 492 PCISGFGLNRLLPGTSKV---------TKNETIVTSGTG-SRISAISNVYLAPEARI-YG 540
           P ISGFGL RL+ G SK+         + ++T +TS T  +RI+A +  YLAPEAR   G
Sbjct: 501 PRISGFGLTRLVSGYSKLIGSLSATRQSLDQTYLTSATTVTRITAPTVAYLAPEARASSG 560

Query: 541 SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            K +QKCDVYSFG+VL+E+LTGRLP+A  +N+G+ L  +VR   +E +PLSE++DP ++ 
Sbjct: 561 CKLSQKCDVYSFGVVLMELLTGRLPNASSKNNGEELVRVVRNWVKEEKPLSEILDPEILN 620

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           + HA +QV+A  H+ALNCTE+DPE RPRMR+VSESL R+K
Sbjct: 621 KGHADKQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRIK 660

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	642
TAIR|locus:2053751	646	AT2G42290 [Arabidopsis thalian	0.956	0.950	0.529	5.2e-168
TAIR|locus:2095773	662	AT3G57830 [Arabidopsis thalian	0.799	0.774	0.554	3.3e-143
TAIR|locus:2008793	719	AT1G67510 [Arabidopsis thalian	0.394	0.351	0.503	2.1e-92
TAIR|locus:2033000	702	AT1G25320 [Arabidopsis thalian	0.869	0.794	0.375	1.6e-86
TAIR|locus:2038706	716	AT2G01210 [Arabidopsis thalian	0.280	0.251	0.484	6.8e-84
TAIR|locus:2033379	685	AT1G66830 [Arabidopsis thalian	0.493	0.462	0.400	1.4e-80
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.884	0.847	0.337	4.3e-70
TAIR|locus:2157182	751	RLK "receptor-like kinase" [Ar	0.470	0.402	0.383	2.6e-67
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.674	0.658	0.333	3.7e-66
TAIR|locus:2058598	773	AT2G23300 [Arabidopsis thalian	0.457	0.380	0.391	2.7e-65

TAIR|locus:2053751 AT2G42290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1634 (580.3 bits), Expect = 5.2e-168, P = 5.2e-168
 Identities = 336/634 (52%), Positives = 417/634 (65%)

Query:    19 CFSLNQDGXXXXXXXXXXXQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLT 78
             C SLN DG            DPTR +  WSESD TPCHWSGI C   RVT+L L  ++L+
Sbjct:    21 CSSLNSDGLSLLALKSAVDNDPTRVMTHWSESDPTPCHWSGIVCTNGRVTTLVLFGKSLS 80

Query:    79 GYMPXXXXXXXXXXXXXXXXXXFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKN 138
             GY+P                  FSK IP  LF AT L Y+DL+HNS  GPIP +IK++K+
Sbjct:    81 GYIPSELGLLNSLNRLDLAHNNFSKTIPVRLFEATKLRYIDLSHNSLSGPIPAQIKSMKS 140

Query:   139 LTHXXXXXXXXXXXXPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNL 198
             L H            PE L +L +L GTLN SFNQF+G+IP  YG F V VSLD  +NNL
Sbjct:   141 LNHLDFSSNHLNGSLPESLTELGSLVGTLNFSFNQFTGEIPPSYGRFRVHVSLDFSHNNL 200

Query:   199 SGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPK-VHANPEVEDGPQNPKNTNF 257
             +G++PQVGSLLNQGP AF+GN  LCGFPLQ+PC + + P  V A PE     Q P N + 
Sbjct:   201 TGKVPQVGSLLNQGPNAFAGNSHLCGFPLQTPCEKIKTPNFVAAKPEGTQELQKP-NPSV 259

Query:   258 GYSGDVKDRGRNXXXXXXXXXXXXXXXX--XXXXXXWLFRRKRRAREGKMGKEEKTNDAV 315
               + D K++ +                         WL RRKR + +G    E KT   V
Sbjct:   260 ISNDDAKEKKQQITGSVTVSLISGVSVVIGAVSLSVWLIRRKRSS-DG-YNSETKTTTVV 317

Query:   316 LVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVV 375
                DEE GQ+GKF   DEGF LELEDLLRASAYV+GKS++GI+Y+VV    S     TVV
Sbjct:   318 SEFDEE-GQEGKFVAFDEGFELELEDLLRASAYVIGKSRSGIVYRVVAAESSS----TVV 372

Query:   376 AVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA 435
             AVRRL++G+ TWRFKDF +EVE+I R+ HPNIVRL+A+YYA DEKLLI+DFI NGSLY+A
Sbjct:   373 AVRRLSDGNDTWRFKDFVNEVESIGRINHPNIVRLRAYYYAEDEKLLITDFINNGSLYSA 432

Query:   436 LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS 495
             LH GPS++ P L W  RL IAQGTARGLMYIHEYS RKYVHGN+KS+KILLD+ELHP +S
Sbjct:   433 LHGGPSNTRPTLSWAERLCIAQGTARGLMYIHEYSSRKYVHGNLKSSKILLDNELHPHVS 492

Query:   496 GFGLNRLLPGTSKVTKNETI-----VTSGTGSR--ISAISNVYLAPEARIYGS-KFTQKC 547
             GFGL RL+ G  KVT +        +  G  +R  +SA +  YLAPEAR     K + KC
Sbjct:   493 GFGLTRLVSGYPKVTDHSLSSMTQSIDQGFATRLSVSAPAAAYLAPEARASSDCKLSHKC 552

Query:   548 DVYSFGIVLLEILTGRLPDAGPENDGKG-LESLVRKAFRERRPLSEVIDPALVKEIHAKR 606
             DVYSFG++LLE+LTGRLP    EN+G+  L +++RK  +E R L+E++DP L+K+  A +
Sbjct:   553 DVYSFGVILLELLTGRLPYGSSENEGEEELVNVLRKWHKEERSLAEILDPKLLKQDFANK 612

Query:   607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
             QV+AT H+ALNCTE+DP+ RPRMR+VSE L R+K
Sbjct:   613 QVIATIHVALNCTEMDPDMRPRMRSVSEILGRIK 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095773 AT3G57830 [Arabidopsis thaliana (taxid:3702)]

 Score = 1400 (497.9 bits), Expect = 3.3e-143, P = 3.3e-143
 Identities = 298/537 (55%), Positives = 356/537 (66%)

Query:    21 SLNQDGXXXXXXXXXXXQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGY 80
             SLN DG           +DPTR + SWSESD TPCHW GI C   RVTSL L  R L+GY
Sbjct:    24 SLNPDGLSLLALKSAILRDPTRVMTSWSESDPTPCHWPGIICTHGRVTSLVLSGRRLSGY 83

Query:    81 MPXXXXXXXXXXXXXXXXXXFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLT 140
             +P                  FSKP+P  LFNA NL Y+DL+HNS  GPIP +I++LKNLT
Sbjct:    84 IPSKLGLLDSLIKLDLARNNFSKPVPTRLFNAVNLRYIDLSHNSISGPIPAQIQSLKNLT 143

Query:   141 HXXXXXXXXXXXXPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
             H            P+ L  L +L GTLNLS+N FSG+IP  YG FPV VSLDL +NNL+G
Sbjct:   144 HIDFSSNLLNGSLPQSLTQLGSLVGTLNLSYNSFSGEIPPSYGRFPVFVSLDLGHNNLTG 203

Query:   201 EIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCP-EPENPKVHANPEVEDGPQNPK--NTNF 257
             +IPQ+GSLLNQGPTAF+GN  LCGFPLQ  C  E  NPK+ A P+ E     PK  N +F
Sbjct:   204 KIPQIGSLLNQGPTAFAGNSELCGFPLQKLCKDEGTNPKLVA-PKPEGSQILPKKPNPSF 262

Query:   258 GYSGDVKDRGRNXXXXXXXXXXXXXXXXXXXXXXWLFRRKRRAREGKMGKEEKTNDAVLV 317
                   K++                         WL RRK  +    +   EK N A  +
Sbjct:   263 IDKDGRKNKPITGSVTVSLISGVSIVIGAVSISVWLIRRKLSST---VSTPEKNNTAAPL 319

Query:   318 TD--EEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPT-- 373
              D  +EE ++GKF ++DEGF LELEDLLRASAYVVGKS++GI+Y+VV G GSG  A T  
Sbjct:   320 DDAADEEEKEGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGTVAATFT 379

Query:   374 ---VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
                VVAVRRL++GDATWR KDFE+EVEAI+RVQHPNIVRL+A+YYA DE+LLI+D+IRNG
Sbjct:   380 SSTVVAVRRLSDGDATWRRKDFENEVEAISRVQHPNIVRLRAYYYAEDERLLITDYIRNG 439

Query:   431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
             SLY+ALH GPS++LP L W  RL IAQGTARGLMYIHEYSPRKYVHGN+KSTKILLDDEL
Sbjct:   440 SLYSALHGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKILLDDEL 499

Query:   491 HPCISGFGLNRLLPGTSKV------TK---NETIVTSGTG-SRISAISNVYLAPEAR 537
              P ISGFGL RL+ G SK+      T+   ++T +TS T  +RI+A +  YLAPEAR
Sbjct:   500 LPRISGFGLTRLVSGYSKLIGSLSATRQSLDQTYLTSATTVTRITAPTVAYLAPEAR 556

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2008793 AT1G67510 [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 2.1e-92, Sum P(2) = 2.1e-92
 Identities = 138/274 (50%), Positives = 180/274 (65%)

Query:   310 KTNDAVLVTDEE-EGQ-KGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGS 367
             K +D+    +E  EG+  G+   ID+GFS EL++LLRASAYV+GKS  GI+YKVV+G G 
Sbjct:   374 KEDDSEAEGNERGEGKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNG- 432

Query:   368 GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI 427
                 P  VAVRRL EG    R+K+F +EV+A+ +V+HPN+V+L+A+Y+A DEKLLISDF+
Sbjct:   433 ---VP--VAVRRLGEGGEQ-RYKEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFV 486

Query:   428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
              NGSL  AL        P L W  R+KIA+G ARGL Y+HE SPRK VHG++K + ILLD
Sbjct:   487 NNGSLADALRGRNGQPSPSLTWSTRIKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLD 546

Query:   488 DELHPCISGFGLNRLLPGTS-KVTKNETIVTSGTGSRISAI-----------SNVYLAPE 535
                 P IS FGL RL+  T+   + NE   +S  G  +              SN Y APE
Sbjct:   547 SSFTPYISDFGLTRLITITAASASSNEPSSSSAAGGFLGGALPYTSIKPSDRSNGYKAPE 606

Query:   536 ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
             AR+ G + TQK DVYSFG+VL+E+LTG+ PD+ P
Sbjct:   607 ARLPGGRPTQKWDVYSFGVVLMELLTGKSPDSSP 640

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2033000 AT1G25320 [Arabidopsis thaliana (taxid:3702)]

 Score = 865 (309.6 bits), Expect = 1.6e-86, P = 1.6e-86
 Identities = 225/600 (37%), Positives = 323/600 (53%)

Query:    69 SLYLPNRNLTGYMPXXXXXXXXXXXXXXXXXXFSKPIPANLFNATNLVYLDLAHNSFCGP 128
             SL L    L+G +P                   +  IP ++     L   DL+ N+  G 
Sbjct:   119 SLVLYGNFLSGSIPNEIGDLKFLQILDLSRNSLNGSIPESVLKCNRLRSFDLSQNNLTGS 178

Query:   129 IPDRI-KTLKNLTHXXXXXXXXXXXXPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             +P    ++L +L              P+ L +L  L GTL+LS N FSG IP   G+ P 
Sbjct:   179 VPSGFGQSLASLQKLDLSSNNLIGLVPDDLGNLTRLQGTLDLSHNSFSGSIPASLGNLPE 238

Query:   188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPC-PEPENPKVHANPEVE 246
              V ++L  NNLSG IPQ G+L+N+GPTAF GNP LCG PL+ PC P+ ++    ++P V 
Sbjct:   239 KVYVNLAYNNLSGPIPQTGALVNRGPTAFLGNPRLCGPPLKDPCLPDTDSSST-SHPFV- 296

Query:   247 DGPQNPKNTNFGYSGDVKDRGRNXXXXXXXXXXXXXXXXXXXXXX---WL---FRRKRRA 300
                  P N   G  G  K  G +                         +L    RR    
Sbjct:   297 -----PDNNEQGGGGSKKGEGLSKTAIVAIVVCDFIGICIVGFLFSCCYLKICARRNSVD 351

Query:   301 REG----KMGKEEKTN-----DAVLVTDEE--EGQKGKFFIIDEGFSLELEDLLRASAYV 349
              EG    K GKE+K +     D       E  E Q+    ++D+  +L+L++LL+ASA+V
Sbjct:   352 EEGYVLEKEGKEKKGSFCFRRDGSESPSSENLEPQQD-LVLLDKHIALDLDELLKASAFV 410

Query:   350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
             +GK  NGI+YKVV+  G        VAVRRL EG +  R K+F++EVEAI +++HPNIV 
Sbjct:   411 LGKGGNGIVYKVVLEDG------LTVAVRRLGEGGSQ-RCKEFQTEVEAIGKLRHPNIVS 463

Query:   410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSD-SLPPLPWEARLKIAQGTARGLMYIHE 468
             LKA+Y++ +EKLLI D+I NGSL  ALH  P   S  PL W  RLKI +G +RGL+Y+HE
Sbjct:   464 LKAYYWSVEEKLLIYDYIPNGSLTNALHGNPGMVSFKPLSWGVRLKIMRGISRGLVYLHE 523

Query:   469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL--LPGT---SKVTKNETIVTSGTGSR 523
             +SP+KYVHG++K + ILL  ++ P IS FGL  L  + GT   + V +      S  GS 
Sbjct:   524 FSPKKYVHGSLKLSNILLGQDMEPHISDFGLMHLSSIAGTLESTTVDRPSNKTASSIGSS 583

Query:   524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
              + +S+ YLAPEA     K +QK DVYSFG++LLE++TGRLP          +   ++  
Sbjct:   584 AN-LSSFYLAPEATKATVKPSQKWDVYSFGVILLEMITGRLPIVFVGKSEMEIVKWIQMC 642

Query:   584 FRERRPLSEVIDPALV-KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
               E++ +S+++DP LV  +   + +V+A   IA+ C    PE RP M+ ++++L ++ LQ
Sbjct:   643 IDEKKEMSDILDPYLVPNDTEIEEEVIAVLKIAMACVSTSPEKRPPMKHIADALTQICLQ 702

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2038706 AT2G01210 [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 6.8e-84, Sum P(3) = 6.8e-84
 Identities = 93/192 (48%), Positives = 131/192 (68%)

Query:   331 IDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFK 390
             +D   +  LE+LL+ASA+V+GKS  GI+YKVV+  G        +AVRRL EG +  RFK
Sbjct:   391 LDAQVAFNLEELLKASAFVLGKSGIGIVYKVVLENG------LTLAVRRLGEGGSQ-RFK 443

Query:   391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSD-SLPPLPW 449
             +F++EVEAI +++HPNI  L+A+Y++ DEKLLI D++ NG+L  ALH  P   ++ PL W
Sbjct:   444 EFQTEVEAIGKLKHPNIASLRAYYWSVDEKLLIYDYVSNGNLATALHGKPGMMTIAPLTW 503

Query:   450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL--LPGTS 507
               RL+I +G A GL+Y+HE+SP+KYVHG++K + IL+  ++ P IS FGL RL  + G S
Sbjct:   504 SERLRIMKGIATGLVYLHEFSPKKYVHGDLKPSNILIGQDMEPKISDFGLARLANIAGGS 563

Query:   508 KVT--KNETIVT 517
               T   N  I T
Sbjct:   564 SPTIQSNRIIQT 575

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009507 "chloroplast" evidence=IDA

GO:0009570 "chloroplast stroma" evidence=IDA

GO:0006346 "methylation-dependent chromatin silencing" evidence=RCA

GO:0016246 "RNA interference" evidence=RCA

GO:0031048 "chromatin silencing by small RNA" evidence=RCA

GO:0048451 "petal formation" evidence=RCA

GO:0048453 "sepal formation" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 1.4e-80, Sum P(2) = 1.4e-80
 Identities = 133/332 (40%), Positives = 204/332 (61%)

Query:   310 KTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGM 369
             KT ++   T +E   +  F  +D     +L+ LL+ASA+++GKS+ G++YKVV+  G   
Sbjct:   363 KTGNSESETLDENKNQQVFMPMDPEIEFDLDQLLKASAFLLGKSRIGLVYKVVLENG--- 419

Query:   370 GAPTVVAVRRLTEGDATW-RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR 428
                 ++AVRRL   D  W R K+F ++VEA+A+++HPN++ LKA  ++ +EKLLI D+I 
Sbjct:   420 ---LMLAVRRLE--DKGWLRLKEFLADVEAMAKIKHPNVLNLKACCWSPEEKLLIYDYIP 474

Query:   429 NGSLYAALHAGP-SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
             NG L +A+   P S S   L W  RLKI +G A+GL YIHE+SP++YVHG+I ++ ILL 
Sbjct:   475 NGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRYVHGHINTSNILLG 534

Query:   488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKC 547
               L P +SGFGL R++  +S + +++ I    T S I +  + Y APEA    +K +QK 
Sbjct:   535 PNLEPKVSGFGLGRIVDTSSDI-RSDQISPMETSSPILSRESYYQAPEAASKMTKPSQKW 593

Query:   548 DVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ 607
             DVYSFG+V+LE++TG+ P    E D   L   V  A    +P   V+DP L ++   +  
Sbjct:   594 DVYSFGLVILEMVTGKSP-VSSEMD---LVMWVESASERNKPAWYVLDPVLARDRDLEDS 649

Query:   608 VLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
             ++    I L C + +P+ RP MR+V ES +++
Sbjct:   650 MVQVIKIGLACVQKNPDKRPHMRSVLESFEKL 681

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 710 (255.0 bits), Expect = 4.3e-70, P = 4.3e-70
 Identities = 212/629 (33%), Positives = 304/629 (48%)

Query:    39 DPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPXXXXXXXXXXXXXXXX 98
             D T  L+SW+ + + PC W+G+ C RNRVT L L + NLTG +                 
Sbjct:    43 DSTGKLNSWNTT-TNPCQWTGVSCNRNRVTRLVLEDINLTGSI-SSLTSLTSLRVLSLKH 100

Query:    99 XXFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHXXXXXXXXXXXXPEFLL 158
                S PIP NL N T L  L L++N F G  P  I +L  L              P  L 
Sbjct:   101 NNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLT 159

Query:   159 DLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGP-TAFS 217
             DL  L  TL L  N+FSGQIP +  +   +   ++  NN +G+IP   + L+Q P + F+
Sbjct:   160 DLTHLL-TLRLESNRFSGQIPNI--NLSDLQDFNVSGNNFNGQIP---NSLSQFPESVFT 213

Query:   218 GNPGLCGFPL------QSPCPEPENP-KVHANP--EVEDGPQNPKNTNFGYSGDVKDRGR 268
              NP LCG PL       S   +P  P +  A+P  + E  P +P + + G   +   R  
Sbjct:   214 QNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRIS 273

Query:   269 NXXXXXXXXXXXXXXXXXXXXXXWLFRRK---RRAREGKMGKEEK----TNDAVLVT--- 318
                                    + F R+    + +  K+ + EK    +N     T   
Sbjct:   274 TISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSSNPYPTSTQNN 333

Query:   319 ---DEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVV 375
                +++ G KGK    +     ELEDLLRASA ++GK   G  YK V+  G+       V
Sbjct:   334 NNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNE------V 387

Query:   376 AVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA 435
             AV+RL +       K+FE ++E + R++H N+V LKA+Y+A +EKLL+ D++ NGSL+  
Sbjct:   388 AVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWL 447

Query:   436 LHAGPSDSLPPLPWEARLKIAQGTARGLMYIH-EYSPRKYVHGNIKSTKILLDDELHPCI 494
             LH        PL W  RLKIA G ARGL +IH      K  HG+IKST +LLD   +  +
Sbjct:   448 LHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARV 507

Query:   495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
             S FGL+   P       ++T+          A SN Y APE  I G K TQK DVYSFG+
Sbjct:   508 SDFGLSIFAP-------SQTV----------AKSNGYRAPEL-IDGRKHTQKSDVYSFGV 549

Query:   555 VLLEILTGRLP---DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
             +LLEILTG+ P   + G       L   V+   RE    +EV D  L++    + +++  
Sbjct:   550 LLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWT-AEVFDLELMRYKDIEEEMVGL 608

Query:   612 FHIALNCTELDPEFRPRMRTVSESLDRVK 640
               IA+ CT +  + RP+M  V + ++ ++
Sbjct:   609 LQIAMACTAVAADHRPKMGHVVKLIEDIR 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157182 RLK "receptor-like kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 502 (181.8 bits), Expect = 2.6e-67, Sum P(2) = 2.6e-67
 Identities = 128/334 (38%), Positives = 192/334 (57%)

Query:   319 DEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVR 378
             D++E +KG    +D    LE+E LL+ASAY++G + + IMYK V+  G      T VAVR
Sbjct:   428 DDQE-KKGTLVNLDSEKELEIETLLKASAYILGATGSSIMYKAVLQDG------TAVAVR 480

Query:   379 RLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA 438
             R+ E     RF+DFE++V A+A++ HPN+VR++ FY+ +DEKL+I DF+ NGSL  A + 
Sbjct:   481 RIAECGLD-RFRDFEAQVRAVAKLIHPNLVRIRGFYWGSDEKLVIYDFVPNGSLANARYR 539

Query:   439 GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG 498
                 S   LPW+ARLKIA+G ARGL Y+H+   +KYVHGN+K + ILL  ++ P ++ FG
Sbjct:   540 KVGSSPCHLPWDARLKIAKGIARGLTYVHD---KKYVHGNLKPSNILLGLDMEPKVADFG 596

Query:   499 LNRLL--------PGTSKVTKNETIVTS-----GTGSRISAISNVYLAPEARIYGSKFTQ 545
             L +LL         G++ +  ++   TS           S++   Y APE+ +   K   
Sbjct:   597 LEKLLIGDMSYRTGGSAPIFGSKRSTTSLEFGPSPSPSPSSVGLPYNAPES-LRSIKPNS 655

Query:   546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
             K DVYSFG++LLE+LTG++          GL  ++    R  R    + D A+  E+  K
Sbjct:   656 KWDVYSFGVILLELLTGKIVVVDELGQVNGL--VIDDGERAIR----MADSAIRAELEGK 709

Query:   606 RQ-VLATFHIALNCTELDPEFRPRMRTVSESLDR 638
              + VLA   + L C    P+ RP ++   + L+R
Sbjct:   710 EEAVLACLKMGLACASPIPQRRPNIKEALQVLER 743

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 3.7e-66, Sum P(2) = 3.7e-66
 Identities = 162/486 (33%), Positives = 223/486 (45%)

Query:    47 WSESDSTPCHWSGIHCIRNR--VTSLYLPNRNLTGYMPXXXXXXXXXXXXXXXXXX-FSK 103
             W+ESDS  C+W G+ C  N+  + SL LP   L G +P                    S 
Sbjct:    47 WNESDSA-CNWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSG 105

Query:   104 PIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHXXXXXXXXXXXXPEFLLDLRAL 163
              IP++  N T+L  L L HN F G  P     L NL              P  + +L  L
Sbjct:   106 QIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHL 165

Query:   164 TGTLNLSFNQFSGQIPEM-YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             TG L L  N FSG +P +  G    +V  ++ NNNL+G IP   SL      +F+GN  L
Sbjct:   166 TG-LFLGNNGFSGNLPSISLG----LVDFNVSNNNLNGSIPS--SLSRFSAESFTGNVDL 218

Query:   223 CGFPLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNXXXXXXXXXXXXX 282
             CG PL+ PC          +P       NP N         K +                
Sbjct:   219 CGGPLK-PCKS-----FFVSPSPSPSLINPSNR----LSSKKSKLSKAAIVAIIVASALV 268

Query:   283 XXXXXXXXXWLFRRKRRAREGKMGKEEK-----TNDAVL----------VTDEEEGQKGK 327
                      +L  RKRR       K+ K     T +  L          VT    G  G+
Sbjct:   269 ALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGE 328

Query:   328 F----FIIDEG--FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT 381
                   +  EG  +S +LEDLLRASA V+GK   G  YK V+  G      T V V+RL 
Sbjct:   329 TERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEG------TTVVVKRLK 382

Query:   382 EGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPS 441
             +  A+   K+FE+++E + +++HPN++ L+A+YY+ DEKLL+ DF+  GSL A LH    
Sbjct:   383 DVMASK--KEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRG 440

Query:   442 DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR 501
                 PL W+ R++IA   ARGL ++H  +  K VHGNIK++ ILL      C+S +GLN+
Sbjct:   441 SGRTPLDWDNRMRIAITAARGLAHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQ 498

Query:   502 LLPGTS 507
             L   +S
Sbjct:   499 LFSNSS 504

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2058598 AT2G23300 [Arabidopsis thaliana (taxid:3702)]

 Score = 474 (171.9 bits), Expect = 2.7e-65, Sum P(2) = 2.7e-65
 Identities = 130/332 (39%), Positives = 184/332 (55%)

Query:   322 EGQKGKFFIIDEGFS-LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL 380
             E +KG    ID G   LE+E LL+ASAY++G + + IMYK V+  G      TV+AVRRL
Sbjct:   432 ENKKGTLVTIDGGEKELEVETLLKASAYILGATGSSIMYKTVLEDG------TVLAVRRL 485

Query:   381 TEGDATW--RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA 438
              E   +   RFKDFE+ + AI ++ HPN+VRL+ FY+  DEKL+I DF+ NGSL  A + 
Sbjct:   486 GENGLSQQRRFKDFEAHIRAIGKLVHPNLVRLRGFYWGTDEKLVIYDFVPNGSLVNARYR 545

Query:   439 GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG 498
                 S   LPWE RLKI +G ARGL Y+H+   +K+VHGN+K + ILL  ++ P I  FG
Sbjct:   546 KGGSSPCHLPWETRLKIVKGLARGLAYLHD---KKHVHGNLKPSNILLGQDMEPKIGDFG 602

Query:   499 LNRLLPG---------TSKVTKNETIVTS----GT-GSRIS-AISNVY-LAPEAR---IY 539
             L RLL G         +S++  ++ +  S    GT G   S + S+V  ++P      + 
Sbjct:   603 LERLLAGDTSYNRASGSSRIFSSKRLTASSREFGTIGPTPSPSPSSVGPISPYCAPESLR 662

Query:   540 GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
               K   K DV+ FG++LLE+LTG++        G GL   V       R L  + D A+ 
Sbjct:   663 NLKPNPKWDVFGFGVILLELLTGKIVSIDEVGVGNGLT--VEDG---NRALI-MADVAIR 716

Query:   600 KEIHAKRQ-VLATFHIALNCTELDPEFRPRMR 630
              E+  K   +L  F +  +C    P+ RP M+
Sbjct:   717 SELEGKEDFLLGLFKLGYSCASQIPQKRPTMK 748

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	642
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-30
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-27
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-17
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-16
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-16
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-11
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-08
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-06
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-05
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-04
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	0.001
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.001
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.001
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.001
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	0.001
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.001
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.001
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.002
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.003
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	0.003
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.004
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.004
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  188 bits (480), Expect = 1e-50
 Identities = 177/610 (29%), Positives = 268/610 (43%), Gaps = 125/610 (20%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
           V  L + N NL G + S    + SL  LSLA N F   +P + F +  L  LDL+ N F 
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFS 488

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
           G +P ++ +L  L  L LS N L+G +P+ L   + L  +L+LS NQ SGQIP  +   P
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSGQIPASFSEMP 547

Query: 187 VMVSLDLRNNNLSGEIP----------QV--------GSLLNQG------PTAFSGNPGL 222
           V+  LDL  N LSGEIP          QV        GSL + G       +A +GN  L
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL 607

Query: 223 CGFPLQS---PCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISG 279
           CG    S   PC      +V   P                         +    ++   G
Sbjct: 608 CGGDTTSGLPPC-----KRVRKTP-------------------------SWWFYITCTLG 637

Query: 280 VSVVVGVVSVSVWLFRRKRRAREGKMGKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLEL 339
             +V+ +V+   ++F R R   E K            V +E+   + +FF      S+ +
Sbjct: 638 AFLVLALVA-FGFVFIRGRNNLELKR-----------VENEDGTWELQFFDSKVSKSITI 685

Query: 340 EDLLRA--SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVE 397
            D+L +     V+ + K G  YK     G  +       V+ + + ++        SE+ 
Sbjct: 686 NDILSSLKEENVISRGKKGASYK-----GKSIKNGMQFVVKEINDVNSI-----PSSEIA 735

Query: 398 AIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQ 457
            + ++QHPNIV+L     +     LI ++I   +L        S+ L  L WE R KIA 
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAI 787

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLPGTSKVTKNETI 515
           G A+ L ++H       V GN+   KI++D  DE H  +S       LPG    T  +  
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS-------LPG-LLCTDTKCF 839

Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
                      IS+ Y+APE R      T+K D+Y FG++L+E+LTG+ P A  E    G
Sbjct: 840 -----------ISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHG 886

Query: 576 LESLVRKAFRERRPLSEV-----IDPALVKEIHA-KRQVLATFHIALNCTELDPEFRPRM 629
             S+V  A   R   S+      IDP++  ++   + +++   ++AL+CT  DP  RP  
Sbjct: 887 --SIVEWA---RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA 941

Query: 630 RTVSESLDRV 639
             V ++L+  
Sbjct: 942 NDVLKTLESA 951

Length = 968

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  129 bits (326), Expect = 9e-34
 Identities = 73/274 (26%), Positives = 116/274 (42%), Gaps = 38/274 (13%)

Query: 365 RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS 424
           +G G G  T VAV+ L EG +    ++F  E   + ++ HPNIVRL       +   +++
Sbjct: 21  KGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVT 80

Query: 425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI 484
           +++  G L   L          L  +  L++A   A+G+ Y+     + +VH ++ +   
Sbjct: 81  EYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNC 133

Query: 485 LLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT 544
           L+ + L   IS FGL+R +               G    I      ++APE+ +   KFT
Sbjct: 134 LVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIK-----WMAPES-LKDGKFT 182

Query: 545 QKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV-KEI 602
            K DV+SFG++L EI T G  P  G  N        V +   +   L     P     E+
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSN------EEVLELLEDGYRLPR---PENCPDEL 233

Query: 603 HAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           +          + L C   DPE RP    + E L
Sbjct: 234 Y---------ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  125 bits (317), Expect = 5e-33
 Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 20/199 (10%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
            V           VA++ + + D++   ++   E+E + ++ HPNIV+L   +   +   
Sbjct: 8   TVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLY 67

Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           L+ ++   GSL   L          L  +  L+I      GL Y+H       +H ++K 
Sbjct: 68  LVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKP 120

Query: 482 TKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
             ILLD D     ++ FGL++LL     + K       GT +        Y+APE  +  
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKT----IVGTPA--------YMAPEVLLGK 168

Query: 541 SKFTQKCDVYSFGIVLLEI 559
             +++K D++S G++L E+
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  122 bits (309), Expect = 2e-31
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 362 VVGRGSG--------MGAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKA 412
            +G GS          G   +VAV+ L    + + + +    E+  + R+ HPNIVRL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 413 FYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPR 472
            +   D   L+ ++   G L+  L  G      PL  +   KIA    RGL Y+H     
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHS---N 117

Query: 473 KYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYL 532
             +H ++K   ILLD+     I+ FGL + L       K+ + +T+  G+        Y+
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKL------LKSSSSLTTFVGTP------WYM 165

Query: 533 APEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           APE  + G+ +  K DV+S G++L E+LTG+ P
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  119 bits (302), Expect = 2e-30
 Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 41/281 (14%)

Query: 360 KVVVG--RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           +V  G  +G G      VAV+ L E  +  + ++F  E   + ++ HPN+V+L       
Sbjct: 14  EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEE 73

Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
           +   ++ +++  G L + L      + P L     L  A   ARG+ Y+     + ++H 
Sbjct: 74  EPLYIVMEYMEGGDLLSYLR----KNRPKLSLSDLLSFALQIARGMEYLES---KNFIHR 126

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEA 536
           ++ +   L+ + L   IS FGL+R L       K         G ++     + ++APE+
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK--------RGGKL----PIRWMAPES 174

Query: 537 RIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID 595
              G KFT K DV+SFG++L EI T G  P  G  N  + +   ++  +R  +P +    
Sbjct: 175 LKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLEYLKNGYRLPQPPN---C 228

Query: 596 PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           P  +            + + L C   DPE RP    + E L
Sbjct: 229 PPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (297), Expect = 9e-30
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 40/281 (14%)

Query: 360 KVVVG--RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           +V  G  +G G G    VAV+ L E  +  + ++F  E   + ++ HPNIV+L       
Sbjct: 14  EVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73

Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
           +  +++ +++  G L   L     +    L     L  A   ARG+ Y+     + ++H 
Sbjct: 74  EPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQIARGMEYLES---KNFIHR 127

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEA 536
           ++ +   L+ + L   IS FGL+R L                 G ++     + ++APE+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--------KGGKL----PIRWMAPES 175

Query: 537 RIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID 595
              G KFT K DV+SFG++L EI T G  P  G  N    +   ++K +R  +P +    
Sbjct: 176 LKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN--AEVLEYLKKGYRLPKPPN---C 229

Query: 596 PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           P  +            + + L C   DPE RP    + E L
Sbjct: 230 PPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  118 bits (297), Expect = 2e-27
 Identities = 80/231 (34%), Positives = 121/231 (52%), Gaps = 31/231 (13%)

Query: 4   PLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCI 63
           P L F L  LF         +  L LL+ K++I  DP + L +W+ S +  C W GI C 
Sbjct: 10  PYLIFMLFFLFLNFSMLHAEELEL-LLSFKSSI-NDPLKYLSNWNSS-ADVCLWQGITCN 66

Query: 64  R-NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFN-ATNLVYLDLA 121
             +RV S+ L  +N++G + S +  L  +  ++L++N  S PIP ++F  +++L YL+L+
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFL--------LDL--RALTGT----- 166
           +N+F G IP    ++ NL  LDLS+N+L+G +P  +        LDL    L G      
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 167 --------LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP-QVGSL 208
                   L L+ NQ  GQIP   G    +  + L  NNLSGEIP ++G L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (276), Expect = 6e-27
 Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 36/273 (13%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN 429
           G  T VAV+ L E  +    KDF  E   + ++ HPN+VRL       +   L+ +++  
Sbjct: 21  GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80

Query: 430 GSLYAAL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
           G L   L       PS     L  +  L  A   A+G+ Y+     +K+VH ++ +   L
Sbjct: 81  GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCL 137

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           + ++L   IS FGL+R       V  ++       G     +   ++APE+ +    FT 
Sbjct: 138 VGEDLVVKISDFGLSR------DVYDDDYYRKKTGG----KLPIRWMAPES-LKDGIFTS 186

Query: 546 KCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHA 604
           K DV+SFG++L EI T G  P  G  N+   +   +RK +R  +P             + 
Sbjct: 187 KSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRKGYRLPKP------------EYC 232

Query: 605 KRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
             ++   + + L+C +LDPE RP    + E L+
Sbjct: 233 PDEL---YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  109 bits (274), Expect = 1e-26
 Identities = 50/192 (26%), Positives = 92/192 (47%), Gaps = 22/192 (11%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VA++ + +       +    E++ + +++HPNIVRL   +   D+  L+ ++   G L+
Sbjct: 26  LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L      S      EAR  + Q     L Y+H    +  VH ++K   ILLD++ H  
Sbjct: 86  DLLKKRGRLS----EDEARFYLRQ-ILSALEYLHS---KGIVHRDLKPENILLDEDGHVK 137

Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           ++ FGL       ++       +T+  G+        Y+APE  + G  + +  D++S G
Sbjct: 138 LADFGL-------ARQLDPGEKLTTFVGTPE------YMAPE-VLLGKGYGKAVDIWSLG 183

Query: 554 IVLLEILTGRLP 565
           ++L E+LTG+ P
Sbjct: 184 VILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  114 bits (288), Expect = 2e-26
 Identities = 60/135 (44%), Positives = 80/135 (59%), Gaps = 1/135 (0%)

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI 129
           +YL   NL+G +P E+G L SL  L L  NN + PIP++L N  NL YL L  N   GPI
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276

Query: 130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV 189
           P  I +L+ L  LDLS N L+G +PE ++ L+ L   L+L  N F+G+IP      P + 
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE-ILHLFSNNFTGKIPVALTSLPRLQ 335

Query: 190 SLDLRNNNLSGEIPQ 204
            L L +N  SGEIP+
Sbjct: 336 VLQLWSNKFSGEIPK 350

Length = 968

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 46/270 (17%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L  G  T   + F  E + + +++H  +V+L A     +   ++++++  GSL
Sbjct: 31  TKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88

Query: 433 YAALHAGPSDSL--PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +G    L  P L     + +A   A G+ Y+     R Y+H ++ +  IL+ + L
Sbjct: 89  LDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENL 140

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL RL+         +   T+  G++       + APEA  YG +FT K DV+
Sbjct: 141 VCKIADFGLARLI--------EDDEYTAREGAKFPI---KWTAPEAANYG-RFTIKSDVW 188

Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESL--VRKAFRERRPLSEVIDPALVKEIHAKRQ 607
           SFGI+L EI+T GR+P  G  N     E L  V + +R  RP      P   +E++    
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNR----EVLEQVERGYRMPRP------PNCPEELY---- 234

Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLD 637
                 + L C + DPE RP    +   L+
Sbjct: 235 -----DLMLQCWDKDPEERPTFEYLQSFLE 259

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 9e-22
 Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 42/266 (15%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L   D   + +DF+ EV+A+ R++H +++ L A     +   +I++ +  GSL A
Sbjct: 33  VAIKILKS-DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91

Query: 435 ALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            L +  G    +  L     + +A   A G+ Y+ E   +  +H ++ +  IL+ ++L  
Sbjct: 92  FLRSPEGQVLPVASL-----IDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVC 143

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            ++ FGL RL+       K +  ++S        I   + APEA  +G  F+ K DV+SF
Sbjct: 144 KVADFGLARLI-------KEDVYLSSDK-----KIPYKWTAPEAASHG-TFSTKSDVWSF 190

Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
           GI+L E+ T G++P  G  N    +   +   +R   P          +EI+        
Sbjct: 191 GILLYEMFTYGQVPYPGMNN--HEVYDQITAGYRMPCP------AKCPQEIY-------- 234

Query: 612 FHIALNCTELDPEFRPRMRTVSESLD 637
             I L C   +PE RP  + + E LD
Sbjct: 235 -KIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 22/189 (11%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G +  +  DF +E   + +  HPNI+RL+     +   ++I++++ NGSL  
Sbjct: 35  VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94

Query: 435 AL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            L  + G             + + +G A G+ Y+   S   YVH ++ +  IL++  L  
Sbjct: 95  FLRENDG------KFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVC 145

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            +S FGL+R L          T  T G       I   + APEA  Y  KFT   DV+SF
Sbjct: 146 KVSDFGLSRRLE-----DSEATYTTKG-----GKIPIRWTAPEAIAYR-KFTSASDVWSF 194

Query: 553 GIVLLEILT 561
           GIV+ E+++
Sbjct: 195 GIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.8 bits (233), Expect = 9e-20
 Identities = 54/134 (40%), Positives = 77/134 (57%), Gaps = 1/134 (0%)

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI 129
           L L +  L G +P ELG + SL  + L  NN S  IP  +   T+L +LDL +N+  GPI
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252

Query: 130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV 189
           P  +  LKNL +L L  N L+G +P  +  L+ L  +L+LS N  SG+IPE+      + 
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI-SLDLSDNSLSGEIPELVIQLQNLE 311

Query: 190 SLDLRNNNLSGEIP 203
            L L +NN +G+IP
Sbjct: 312 ILHLFSNNFTGKIP 325

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 1e-19
 Identities = 53/129 (41%), Positives = 72/129 (55%), Gaps = 1/129 (0%)

Query: 77  LTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTL 136
           L G +P+ L  L SL  L+LASN     IP  L    +L ++ L +N+  G IP  I  L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 137 KNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNN 196
            +L HLDL  N L G +P  L +L+ L   L L  N+ SG IP        ++SLDL +N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQ-YLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 197 NLSGEIPQV 205
           +LSGEIP++
Sbjct: 295 SLSGEIPEL 303

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 22/200 (11%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VA++ L +G  +   + F +E   + ++QHP +VRL A     +   +I++++ NGSL
Sbjct: 31  TKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    +     L     + +A   A G+ +I     + Y+H ++++  IL+ + L  
Sbjct: 88  VDFLK---TPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCC 141

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 142 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 189

Query: 553 GIVLLEILT-GRLPDAGPEN 571
           GI+L EI+T GR+P  G  N
Sbjct: 190 GILLTEIVTYGRIPYPGMTN 209

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 70/283 (24%), Positives = 113/283 (39%), Gaps = 51/283 (18%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
            VAV+ L          DFE E+E +  + H NIV+ K        +   LI +++ +GS
Sbjct: 35  QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94

Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H     +L  L     L  +    +G+ Y+     ++Y+H ++ +  IL++ E
Sbjct: 95  LRDYLQRHR-DQINLKRL-----LLFSSQICKGMDYLGS---QRYIHRDLAARNILVESE 145

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               IS FGL ++LP                    S I   + APE  +  SKF+   DV
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYY-------VKEPGESPI--FWYAPEC-LRTSKFSSASDV 195

Query: 550 YSFGIVLLEILT-GR---------LPDAGPENDGKGLESLVR---KAFRERRPLSEVIDP 596
           +SFG+ L E+ T G          L   G       +  L+    +  R  RP      P
Sbjct: 196 WSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP------P 249

Query: 597 ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           +   E++          +   C E +P+ RP    +   +DR+
Sbjct: 250 SCPDEVY---------DLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.8 bits (228), Expect = 3e-19
 Identities = 58/157 (36%), Positives = 81/157 (51%), Gaps = 9/157 (5%)

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI 129
           L+L + N TG +P  L  L  L  L L SN FS  IP NL    NL  LDL+ N+  G I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372

Query: 130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV 189
           P+ + +  NL  L L SN L G +P+ L   R+L   + L  N FSG++P  +   P++ 
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR-RVRLQDNSFSGELPSEFTKLPLVY 431

Query: 190 SLDLRNNNLSG-------EIPQVGSLLNQGPTAFSGN 219
            LD+ NNNL G       ++P +  +L+     F G 
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSL-QMLSLARNKFFGG 467

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 42/268 (15%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L  G  T   KDF +E + + +++HP +++L A     +   ++++ ++ GSL
Sbjct: 31  TPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88

Query: 433 YAALH--AGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L   AG +  LP L     + +A   A G+ Y+   +   Y+H ++ +  +L+ +  
Sbjct: 89  LEYLQGGAGRALKLPQL-----IDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENN 140

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              ++ FGL R++         E I  +  G++       + APEA +Y ++F+ K DV+
Sbjct: 141 ICKVADFGLARVI--------KEDIYEAREGAKFPI---KWTAPEAALY-NRFSIKSDVW 188

Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           SFGI+L EI+T GR+P  G  N     E L +     R P        L           
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMPCPPGCPKEL----------- 233

Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLD 637
             + I L+C + DP+ RP   T+   L+
Sbjct: 234 --YDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 1e-18
 Identities = 53/143 (37%), Positives = 73/143 (51%), Gaps = 4/143 (2%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVY-LDL 120
           C    +  L L + +L G +P  LG   SL R+ L  N+FS  +P+  F    LVY LD+
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE-FTKLPLVYFLDI 435

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
           ++N+  G I  R   + +L  L L+ N   G LP+     R     L+LS NQFSG +P 
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKR--LENLDLSRNQFSGAVPR 493

Query: 181 MYGHFPVMVSLDLRNNNLSGEIP 203
             G    ++ L L  N LSGEIP
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIP 516

Length = 968

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 42/293 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G +YK V     G      VA++ L E  +    K+   E   +A V HP++V
Sbjct: 14  VLGSGAFGTVYKGV-WIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 409 RLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           RL     +  +  LI+  +  G L  Y   H     S   L W  ++      A+G+ Y+
Sbjct: 73  RLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
            E   ++ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++  
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE-------GGKVPI 175

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR 585
               ++A E+ ++   +T K DV+S+G+ + E++T G  P  G       +  L+ K  R
Sbjct: 176 ---KWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGI--PAVEIPDLLEKGER 229

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
             +P    ID                + + + C  +D E RP  + +     +
Sbjct: 230 LPQPPICTID---------------VYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 87/288 (30%), Positives = 138/288 (47%), Gaps = 42/288 (14%)

Query: 341 DLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIA 400
           ++ R S  ++ K  NG   +V +G  +G    T VAV+ L  G  T   + F  E + + 
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGN---TKVAVKTLKPG--TMSPESFLEEAQIMK 56

Query: 401 RVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           +++H  +V+L A   + +   ++++++  GSL   L  G   +L  LP    + +A   A
Sbjct: 57  KLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALK-LP--NLVDMAAQVA 112

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
            G+ YI   +   Y+H +++S  IL+ D L   I+ FGL RL      +  NE     G 
Sbjct: 113 AGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARL------IEDNEYTARQGA 163

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL 579
              I      + APEA +YG +FT K DV+SFGI+L E++T GR+P  G  N+ + LE +
Sbjct: 164 KFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQV 216

Query: 580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
            R     R P  +    +L               + L C + DPE RP
Sbjct: 217 ERGY---RMPCPQDCPISL-------------HELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 28/229 (12%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+   G ++              +VAV+ L E  +    KDFE E E +   QH NIV
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 409 RLKAFYYANDEKLLISDFIRNGSL---------YAALHAGPSDSLPPLPWEARLKIAQGT 459
           +        D  +++ +++ +G L          AA    P   +  L     L+IA   
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS--KVTKNETIVT 517
           A G++Y+   + + +VH ++ +   L+  +L   I  FG++R +  T   +V        
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV-------- 180

Query: 518 SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP 565
              G  +  I   ++ PE+ +Y  KFT + DV+SFG+VL EI T G+ P
Sbjct: 181 --GGHTMLPIR--WMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.0 bits (206), Expect = 3e-17
 Identities = 58/244 (23%), Positives = 91/244 (37%), Gaps = 20/244 (8%)

Query: 390 KDFESEVEAIARVQHP-NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
           + F  E++ +A + HP NIV+L  F+       L+ +++  GSL   L         PL 
Sbjct: 42  ERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR--KGPLS 99

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH-PCISGFGLNRLLPGTS 507
               L I       L Y+H    +  +H +IK   ILLD +     +  FGL +LLP   
Sbjct: 100 ESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             +    + ++  G+        Y+APE    +  +  +   D++S GI L E+LTG  P
Sbjct: 157 STSSIPALPSTSVGTPG------YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Query: 566 DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
                       S   K   E       +   L           A   +       DP+ 
Sbjct: 211 --FEGEKNSSATSQTLKIILELPT--PSLASPLSPSNPELISKAA-SDLLKKLLAKDPKN 265

Query: 626 RPRM 629
           R   
Sbjct: 266 RLSS 269

Length = 384

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 56/187 (29%), Positives = 95/187 (50%), Gaps = 15/187 (8%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPNI+ L+     +   ++I++F+ NG+L +
Sbjct: 35  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L          +     L+   G A G+ Y+ E +   YVH ++ +  IL++  L   +
Sbjct: 95  FLRQN-DGQFTVIQLVGMLR---GIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKV 147

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R L   +    ++   TS  G +I      + APEA  Y  KFT   DV+S+GI
Sbjct: 148 SDFGLSRFLEDDT----SDPTYTSSLGGKIPI---RWTAPEAIAY-RKFTSASDVWSYGI 199

Query: 555 VLLEILT 561
           V+ E+++
Sbjct: 200 VMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 27/220 (12%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L  G  T   + F  E   +  +QH  +VRL A     +   +I++++  GSL
Sbjct: 31  TKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88

Query: 433 YAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L    G    LP L     +  +   A G+ YI     + Y+H ++++  +L+ + L
Sbjct: 89  LDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESL 140

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +GS FT K DV+
Sbjct: 141 MCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGS-FTIKSDVW 188

Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           SFGI+L EI+T G++P  G  N    + S +++ +R  R 
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGYRMPRM 226

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 77/315 (24%), Positives = 136/315 (43%), Gaps = 59/315 (18%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+ + G + K    R  G    T VAV+ L E  ++   +D  SE   + +V HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALH----AGPS---------------DSLPPLPW 449
           +L      +   LLI ++ + GSL + L      GPS                    L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
              +  A   +RG+ Y+ E    K VH ++ +  +L+ +     IS FGL+R       V
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSR------DV 177

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT---GRLPD 566
            + ++ V    G     I   ++A E+ ++   +T + DV+SFG++L EI+T      P 
Sbjct: 178 YEEDSYVKRSKGR----IPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Query: 567 AGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE 624
             PE     L +L++  +R  RP   SE                   +++ L C + +P+
Sbjct: 233 IAPER----LFNLLKTGYRMERPENCSE-----------------EMYNLMLTCWKQEPD 271

Query: 625 FRPRMRTVSESLDRV 639
            RP    +S+ L+++
Sbjct: 272 KRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 24/193 (12%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            VA++ +       + +   +E++ + + +HPNIV+    Y   DE  ++ +F   GSL 
Sbjct: 27  EVAIKVIKLESKE-KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L +    +   L       + +   +GL Y+H       +H +IK+  ILL  +    
Sbjct: 86  DLLKS----TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVK 138

Query: 494 ISGFGL-NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
           +  FGL  +L    S      T+V    G+        ++APE  I G  +  K D++S 
Sbjct: 139 LIDFGLSAQL----SDTKARNTMV----GTPY------WMAPE-VINGKPYDYKADIWSL 183

Query: 553 GIVLLEILTGRLP 565
           GI  +E+  G+ P
Sbjct: 184 GITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 64/313 (20%), Positives = 111/313 (35%), Gaps = 81/313 (25%)

Query: 359 YKVVVGRGSGM-GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           +       +    AP +VAV+ L    +    +DF  EV+ ++R+  PNI RL      +
Sbjct: 32  FSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD 91

Query: 418 DEKLLISDFIRNGSL------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSP 471
               +I +++ NG L      + A  +G + +   L +   L +A   A G+ Y+     
Sbjct: 92  PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ES 148

Query: 472 RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY 531
             +VH ++ +   L+       I+ FG++R                       +  S+ Y
Sbjct: 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSR-----------------------NLYSSDY 185

Query: 532 LAPEAR------------IYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
              + R            +   KFT K DV++FG+ L EILT                  
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT------------------ 227

Query: 580 VRKAFRERRPLSEVIDPALVKEIH-----AKRQVL---------ATFHIALNCTELDPEF 625
                   +P   + D  +++          RQ+            + + L C   D E 
Sbjct: 228 ----LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEED 283

Query: 626 RPRMRTVSESLDR 638
           RP  R +   L R
Sbjct: 284 RPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 26/202 (12%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ +  G  +   + F +E   +  +QH  +V+L A     +   +I++F+  GSL
Sbjct: 31  TKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSL 87

Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ +I +   R Y+H ++++  IL+   L
Sbjct: 88  LDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 139

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +GS FT K DV+
Sbjct: 140 VCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGS-FTIKSDVW 187

Query: 551 SFGIVLLEILT-GRLPDAGPEN 571
           SFGI+L+EI+T GR+P  G  N
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSN 209

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 362 VVGRGS------GMGAPT--VVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKA 412
           ++GRGS       +   T  ++AV+ +   GD+    +  E E+  ++ +QHPNIVR   
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 413 FYYANDEK--LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI-AQGTARGLMYIHEY 469
                ++    +  +++  GSL + L          LP E  ++   +    GL Y+H  
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLP-EPVIRKYTRQILEGLAYLHS- 119

Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
                VH +IK   IL+D +    ++ FG        +K    +     GTGS     + 
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFG-------CAKR-LGDIETGEGTGSVRG--TP 167

Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            ++APE  I G ++ +  D++S G  ++E+ TG+ P
Sbjct: 168 YWMAPEV-IRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 50/283 (17%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPT--VVAVRRL-TEGDATWRFKDFESEVEAIARVQHP 405
           ++G+   G++YK       G+   T   VA++++  E       K    E++ +  ++HP
Sbjct: 7   LIGRGAFGVVYK-------GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           NIV+       +D   +I ++  NGSL   +        P       + + Q   +GL Y
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPES--LVAVYVYQ-VLQGLAY 114

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +HE   +  +H +IK+  IL   +    ++ FG+       +K+        S  G+   
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGV------ATKLNDVSKDDASVVGT--- 162

Query: 526 AISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
                Y +APE  I  S  +   D++S G  ++E+LTG  P   P  D   + +L R   
Sbjct: 163 ----PYWMAPEV-IEMSGASTASDIWSLGCTVIELLTGN-P---PYYDLNPMAALFRIVQ 213

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
            +  PL E I P L       +  L      + C + DP  RP
Sbjct: 214 DDHPPLPEGISPEL-------KDFL------MQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 53/285 (18%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAF-YYANDEKL-LISDFIRNGS 431
           VVAV++L    A    +DFE E+E +  +QH NIV+ K   Y A    L L+ +++  GS
Sbjct: 35  VVAVKKLQHSTAE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93

Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D    L + +++       +G+ Y+     ++YVH ++ +  IL++ E
Sbjct: 94  LRDYLQKHRERLDHRKLLLYASQI------CKGMEYL---GSKRYVHRDLATRNILVESE 144

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP      K    V     S I      + APE+ +  SKF+   DV
Sbjct: 145 NRVKIGDFGLTKVLP----QDKEYYKVREPGESPI-----FWYAPES-LTESKFSVASDV 194

Query: 550 YSFGIVLLEILT----GRLPDA------GPENDGKG----LESLVRKAFRERRPLSEVID 595
           +SFG+VL E+ T       P A      G +  G+     L  L++   R   P      
Sbjct: 195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP------ 248

Query: 596 PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           P    EI+A         I   C   DP  RP    ++  ++ ++
Sbjct: 249 PGCPAEIYA---------IMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 52/139 (37%), Positives = 73/139 (52%), Gaps = 1/139 (0%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
           ++ SL L + +L+G +P  +  L +L  L L SNNF+  IP  L +   L  L L  N F
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
            G IP  +    NLT LDLS+N L G +PE L     L   L L  N   G+IP+  G  
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF-KLILFSNSLEGEIPKSLGAC 403

Query: 186 PVMVSLDLRNNNLSGEIPQ 204
             +  + L++N+ SGE+P 
Sbjct: 404 RSLRRVRLQDNSFSGELPS 422

Length = 968

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 76/269 (28%), Positives = 122/269 (45%), Gaps = 41/269 (15%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL-- 432
           VA++ L  G    + +DF SE   + +  H NI+RL+         ++I++++ NG+L  
Sbjct: 36  VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
           Y   H G   S         + + +G A G+ Y+ + +   YVH ++ +  IL++  L  
Sbjct: 96  YLRDHDGEFSSY------QLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLEC 146

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            +S FGL+R+L    +     T  TSG       I   + APEA  Y  KFT   DV+SF
Sbjct: 147 KVSDFGLSRVLEDDPEG----TYTTSG-----GKIPIRWTAPEAIAY-RKFTSASDVWSF 196

Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVLA 610
           GIV+ E+++ G  P     N        V KA  +   L   +D P+            A
Sbjct: 197 GIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRLPAPMDCPS------------A 238

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDRV 639
            + + L C + D   RPR   +   LD++
Sbjct: 239 VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 40/266 (15%)

Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL 422
           V  G+  G  T VA++ L  G  T   + F  E + + +++H  +V+L A   + +   +
Sbjct: 22  VWMGTWNGT-TRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYI 77

Query: 423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
           +++++  GSL   L  G       LP    + +A   A G+ Y+   +   YVH ++++ 
Sbjct: 78  VTEYMSKGSLLDFLK-GEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YVHRDLRAA 131

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
            IL+ + L   ++ FGL RL      +  NE     G    I      + APEA +YG +
Sbjct: 132 NILVGENLVCKVADFGLARL------IEDNEYTARQGAKFPIK-----WTAPEAALYG-R 179

Query: 543 FTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKE 601
           FT K DV+SFGI+L E+ T GR+P  G  N  + +   V + +R   P      P   + 
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCP------PECPES 231

Query: 602 IHAKRQVLATFHIALNCTELDPEFRP 627
           +H          +   C   +PE RP
Sbjct: 232 LH---------DLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 51/286 (17%)

Query: 367 SGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF 426
           +   + T VA++ L E       ++F  E E ++ +QHPNIV L           ++ ++
Sbjct: 30  NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89

Query: 427 IRNGSLYAAL-----HAGPS------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
           + +G L+  L     H+              L     L IA   A G+ Y+   S   +V
Sbjct: 90  LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFV 146

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---YL 532
           H ++ +   L+ + L   IS FGL+R              + S    R+ + S +   ++
Sbjct: 147 HRDLAARNCLVGEGLTVKISDFGLSRD-------------IYSADYYRVQSKSLLPVRWM 193

Query: 533 APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLS 591
            PEA +YG KFT + D++SFG+VL EI + G  P  G  N        V +  R R+ L 
Sbjct: 194 PPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------VIEMIRSRQLLP 246

Query: 592 EVID-PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
              D PA V            + + + C    P  RPR + +   L
Sbjct: 247 CPEDCPARV------------YALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 75.2 bits (186), Expect = 4e-15
 Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 57/259 (22%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D  +EV+ + ++ HPNI++    +    +  ++ ++   G L   +     +   P P 
Sbjct: 44  EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPE 102

Query: 450 EARLKI-AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
           E  L    Q     L Y+H    RK +H +IK   I L       +  FG++++L  T  
Sbjct: 103 EQILDWFVQ-LCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
           + K  T+V  GT          YL+PE       +  K D++S G VL E+ T + P   
Sbjct: 159 LAK--TVV--GTPY--------YLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHP--- 202

Query: 569 PENDGKGLESLVRKAFRERRP---------LSEVIDPALVKEIHAKRQVLATFHIALNCT 619
              +G+ L  L  K  + + P         L  ++   L K                   
Sbjct: 203 --FEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQK------------------- 241

Query: 620 ELDPEFRPRMRTVSESLDR 638
             DPE RP   ++++ L  
Sbjct: 242 --DPEERP---SIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 6e-15
 Identities = 43/116 (37%), Positives = 64/116 (55%), Gaps = 3/116 (2%)

Query: 118 LDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ 177
           L L +    G IP+ I  L++L  ++LS N + G++P  L  + +L   L+LS+N F+G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGS 481

Query: 178 IPEMYGHFPVMVSLDLRNNNLSGEIPQV--GSLLNQGPTAFSGNPGLCGFPLQSPC 231
           IPE  G    +  L+L  N+LSG +P    G LL++    F+ N GLCG P    C
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537

Length = 623

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 41/269 (15%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPNI+ L+     +   +++++++ NGSL A
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94

Query: 435 AL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            L  H G    +        + + +G A G+ Y+ +     YVH ++ +  IL++  L  
Sbjct: 95  FLRKHDGQFTVI------QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVC 145

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            +S FGL+R+L         E   T+  G     I   + APEA  Y  KFT   DV+S+
Sbjct: 146 KVSDFGLSRVLEDDP-----EAAYTTRGGK----IPIRWTAPEAIAY-RKFTSASDVWSY 195

Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVLA 610
           GIV+ E+++ G  P     N        V KA  E   L   +D PA            A
Sbjct: 196 GIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLPAPMDCPA------------A 237

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDRV 639
              + L+C + D   RP+   +   LD++
Sbjct: 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 65/261 (24%), Positives = 120/261 (45%), Gaps = 45/261 (17%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEK------LLISDFIRNGSLYA-ALHAGPSD 442
           +DF SE   +    HPN++RL        E       ++I  F+++G L++  L++   D
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 443 SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL 502
               LP +  +K     A G+ Y+   S + ++H ++ +   +L++ ++ C++ FGL   
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGL--- 158

Query: 503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA---RIYGSKFTQKCDVYSFGIVLLEI 559
               SK   N      G   RI+ +   ++A E+   R+Y    T K DV+SFG+ + EI
Sbjct: 159 ----SKKIYNGDYYRQG---RIAKMPVKWIAIESLADRVY----TTKSDVWSFGVTMWEI 207

Query: 560 LT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNC 618
            T G+ P  G EN    +   +R+  R ++P  + +D                + +  +C
Sbjct: 208 ATRGQTPYPGVEN--SEIYDYLRQGNRLKQP-PDCLD--------------GLYSLMSSC 250

Query: 619 TELDPEFRPRMRTVSESLDRV 639
             L+P+ RP   T+   L++ 
Sbjct: 251 WLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 74.5 bits (183), Expect = 9e-15
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 38/265 (14%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L 
Sbjct: 33  TVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     
Sbjct: 91  DYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVK 144

Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           ++ FGL+RL+ G           T+  G++       + APE+  Y +KF+ K DV++FG
Sbjct: 145 VADFGLSRLMTGD--------TYTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFG 192

Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           ++L EI T G  P   P  D   +  L+ K +R  RP  E   P + + + A        
Sbjct: 193 VLLWEIATYGMSP--YPGIDLSQVYELLEKGYRMERP--EGCPPKVYELMRA-------- 240

Query: 613 HIALNCTELDPEFRPRMRTVSESLD 637
                C + +P  RP    + ++ +
Sbjct: 241 -----CWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 55/153 (35%), Positives = 74/153 (48%), Gaps = 25/153 (16%)

Query: 76  NLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS----------- 124
           NLTG +PS LG L +L  L L  N  S PIP ++F+   L+ LDL+ NS           
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Query: 125 -------------FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSF 171
                        F G IP  + +L  L  L L SN  +G +P+ L     LT  L+LS 
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-VLDLST 365

Query: 172 NQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ 204
           N  +G+IPE       +  L L +N+L GEIP+
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Length = 968

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 31/206 (15%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI--------- 423
           T+VAV+ L E  +     DF+ E   +A   HPNIV+L           L+         
Sbjct: 36  TMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95

Query: 424 SDFIRNGSLYAALHAGPSDSL--------PPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
           ++F+R+ S  A      S S          PL    +L IA+  A G+ Y+ E   RK+V
Sbjct: 96  NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFV 152

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE 535
           H ++ +   L+ + +   I+ FGL+R +        +E            AI   ++ PE
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN----------DAIPIRWMPPE 202

Query: 536 ARIYGSKFTQKCDVYSFGIVLLEILT 561
           +  Y +++T + DV+++G+VL EI +
Sbjct: 203 SIFY-NRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 26/202 (12%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VA++ L  G  T   + F  E + + +++H  +V L A   + +   ++++F+  GSL
Sbjct: 31  TKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSL 87

Query: 433 YAALHAGPSD--SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L  G      LP L     + +A   A G+ YI   +   Y+H ++++  IL+ D L
Sbjct: 88  LDFLKEGDGKYLKLPQL-----VDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNL 139

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL RL      +  NE     G    I      + APEA +YG +FT K DV+
Sbjct: 140 VCKIADFGLARL------IEDNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVW 187

Query: 551 SFGIVLLEILT-GRLPDAGPEN 571
           SFGI+L E++T GR+P  G  N
Sbjct: 188 SFGILLTELVTKGRVPYPGMVN 209

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 40/248 (16%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           F +E   +  ++HPN+V+L       +   ++++++  GSL   L    S     +    
Sbjct: 47  FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR---SRGRAVITLAQ 103

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
           +L  A     G+ Y+ E   + +VH ++ +  +L+ ++L   +S FGL +      + ++
Sbjct: 104 QLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK------EASQ 154

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE 570
            +             +   + APEA +   KF+ K DV+SFGI+L EI + GR+P   P 
Sbjct: 155 GQDS---------GKLPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP--YPR 202

Query: 571 NDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
              K +   V K +R   P  E   P +             + +  +C ELDP  RP  +
Sbjct: 203 IPLKDVVPHVEKGYRMEAP--EGCPPEV-------------YKVMKDCWELDPAKRPTFK 247

Query: 631 TVSESLDR 638
            + E L  
Sbjct: 248 QLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 71.8 bits (177), Expect = 5e-14
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 25/169 (14%)

Query: 399 IARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLP-WEARLKIA 456
           ++R+ HP IV+L  + +  +EKL L+ ++   G L++ L               AR   A
Sbjct: 47  LSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS-----KEGRFSEERARFYAA 100

Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           +     L Y+H       ++ ++K   ILLD + H  ++ FGL + L      T   T  
Sbjct: 101 E-IVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN--TFC 154

Query: 517 TSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             GT          YLAPE  + G  + +  D +S G++L E+LTG+ P
Sbjct: 155 --GTPE--------YLAPEV-LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 41/241 (17%)

Query: 340 EDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAI 399
            DL R    V+G+  +G++YKV   + +G     + A++++         K    E++ +
Sbjct: 1   SDLERVK--VLGQGSSGVVYKVR-HKPTG----KIYALKKIHVDGDEEFRKQLLRELKTL 53

Query: 400 ARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALH---AGPSDSL----PPLPWEAR 452
              + P +V+    Y A         F + G +   L     G    L      +P    
Sbjct: 54  RSCESPYVVK---CYGA---------FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL 101

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
             IA+   +GL Y+H  + R  +H +IK + +L++ +    I+ FG++++L  T      
Sbjct: 102 AYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-- 157

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
            T V  GT          Y++PE RI G  ++   D++S G+ LLE   G+ P   P   
Sbjct: 158 NTFV--GTV--------TYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206

Query: 573 G 573
            
Sbjct: 207 S 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 52/285 (18%)

Query: 370 GAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEK------LL 422
           G+   VAV+ +     T+   ++F SE   +    HPN+++L    +           ++
Sbjct: 25  GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84

Query: 423 ISDFIRNGSLYAALHAGPSDSLPP-LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           I  F+++G L++ L       LP  LP +  LK     A G+ Y+   S R ++H ++ +
Sbjct: 85  ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAA 141

Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA---RI 538
              +L +++  C++ FGL       SK   +      G   RI+ +   ++A E+   R+
Sbjct: 142 RNCMLREDMTVCVADFGL-------SKKIYSGDYYRQG---RIAKMPVKWIAIESLADRV 191

Query: 539 YGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP---LSEVI 594
           Y    T K DV++FG+ + EI T G+ P  G EN    +   +R   R ++P   L E+ 
Sbjct: 192 Y----TSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHGNRLKQPEDCLDELY 245

Query: 595 DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           D                  +  +C   DP+ RP    + E L+ +
Sbjct: 246 D------------------LMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 64.3 bits (157), Expect = 2e-13
 Identities = 21/41 (51%), Positives = 28/41 (68%)

Query: 22 LNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHC 62
          LN D  ALLA K+++  DP+ AL SW+ S S PC W+G+ C
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.0 bits (179), Expect = 3e-13
 Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 2/141 (1%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
            N +T L L   NLTG +P  L    +L +L L SN+    IP +L    +L  + L  N
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
           SF G +P     L  +  LD+S+N L G +     D+ +L   L+L+ N+F G +P+ +G
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-MLSLARNKFFGGLPDSFG 473

Query: 184 HFPVMVSLDLRNNNLSGEIPQ 204
               + +LDL  N  SG +P+
Sbjct: 474 S-KRLENLDLSRNQFSGAVPR 493

Length = 968

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 48/284 (16%)

Query: 368 GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI 427
           GM    +VA++ L + +   ++ +F+ E   +A + HPNIV L           ++ +++
Sbjct: 30  GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89

Query: 428 RNGSLYAAL-----HAG---PSDS----LPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
             G L+  L     H+     SD        L     L IA   A G+ Y+   S   +V
Sbjct: 90  NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFV 146

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTS--KVTKNETIVTSGTGSRISAISNVYLA 533
           H ++ +  IL+ ++LH  IS  GL+R +      +V               S +   ++ 
Sbjct: 147 HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK------------SLLPIRWMP 194

Query: 534 PEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
           PEA +YG KF+   D++SFG+VL EI + G  P  G  N  + +  +VRK  R+  P SE
Sbjct: 195 PEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMVRK--RQLLPCSE 249

Query: 593 VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
              P +             + +   C +  P  RPR + +   L
Sbjct: 250 DCPPRM-------------YSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 73/289 (25%), Positives = 115/289 (39%), Gaps = 58/289 (20%)

Query: 348 YVVGKSKNGIMYKVVV---GRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH 404
             +GK   G+++KVV     R   M    +  + R    +A         E   +A++  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-------DEARVLAKLDS 58

Query: 405 PNIVRLKAFYY---ANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
             I+R    YY    +  KL ++ ++  NG L+  L         PLP +   +      
Sbjct: 59  SYIIR----YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQIL 111

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
            GL ++H    +K +H +IKS  + LD   +  I   G+ +LL   +      TIV  GT
Sbjct: 112 LGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN--TIV--GT 164

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP-DAGPENDGKGLESL 579
                     YL+PE       + +K DV++ G+VL E  TG+ P DA   N G    +L
Sbjct: 165 --------PYYLSPEL-CEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQG----AL 209

Query: 580 VRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
           + K  R    P+S++    L + I               C   D   RP
Sbjct: 210 ILKIIRGVFPPVSQMYSQQLAQLIDQ-------------CLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 24/201 (11%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L +     R KDF  E E +  +QH +IV+        D  +++ +++++G L 
Sbjct: 37  LVAVKTLKDASDNAR-KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 434 AALHA-GPSDSL-----PP--LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             L A GP   L      P  L     L IAQ  A G++Y+   + + +VH ++ +   L
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCL 152

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           + + L   I  FG++R       V   +     G     + +   ++ PE+ +Y  KFT 
Sbjct: 153 VGENLLVKIGDFGMSR------DVYSTDYYRVGGH----TMLPIRWMPPESIMY-RKFTT 201

Query: 546 KCDVYSFGIVLLEILT-GRLP 565
           + DV+S G+VL EI T G+ P
Sbjct: 202 ESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 46/285 (16%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
           ++G GSG   P  VAV+ L +G      K+F  E   ++   HPNIV+L      N+ + 
Sbjct: 19  ILGPGSG---PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY 75

Query: 422 LISDFIRNGSLYAALHAGPSDSLPP--LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +I + +  G L + L     +   P  L  +  L I    A+G +Y+ +     ++H ++
Sbjct: 76  IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDL 132

Query: 480 KSTKILLDDELHPC-----ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
            +   L+ ++ +       I  FGL R       + K++     G G     +   ++AP
Sbjct: 133 AARNCLVSEKGYDADRVVKIGDFGLAR------DIYKSDYYRKEGEG----LLPVRWMAP 182

Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL--VRKAFRERRPLS 591
           E+ + G KFT + DV+SFG+++ EILT G+ P     N     E L  V    R ++P  
Sbjct: 183 ESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAGGRLQKP-- 235

Query: 592 EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                    +I         + +  NC   DP  RP    + E L
Sbjct: 236 ----ENCPDKI---------YQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 19/195 (9%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            VA++R+          +   EV+A+++  HPN+V+    +   DE  L+  ++  GSL 
Sbjct: 28  KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 434 AAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
             +  + P   L        LK      +GL Y+H       +H +IK+  ILL ++   
Sbjct: 88  DIMKSSYPRGGLDEAIIATVLK---EVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSV 141

Query: 493 CISGFGLNRLL--PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
            I+ FG++  L   G       +T V  GT          ++APE       +  K D++
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFV--GT--------PCWMAPEVMEQVHGYDFKADIW 191

Query: 551 SFGIVLLEILTGRLP 565
           SFGI  +E+ TG  P
Sbjct: 192 SFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
            +VAV+ L E   + R +DF+ E E +  +QH +IVR           L++ +++R+G L
Sbjct: 36  MLVAVKALKEASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94

Query: 433 YAALHA-GPS---------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
              L + GP           +   L     L IA   A G++Y+   +   +VH ++ + 
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
             L+   L   I  FG++R +  T              G R + +   ++ PE+ +Y  K
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYR---------VGGR-TMLPIRWMPPESILY-RK 200

Query: 543 FTQKCDVYSFGIVLLEILT-GRLP 565
           FT + D++SFG+VL EI T G+ P
Sbjct: 201 FTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 47/270 (17%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA+  L  G +  + + F +E   + +  H NIVRL+      +  +++++++ NG+L +
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95

Query: 435 AL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            L  H G       L     + +  G A G+ Y+ E     YVH  + + K+L++ +L  
Sbjct: 96  FLRKHEG------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            ISGF             K+E I T+ +G        ++ APEA  Y   F+   DV+SF
Sbjct: 147 KISGFR-----RLQED--KSEAIYTTMSGKSPV----LWAAPEAIQYH-HFSSASDVWSF 194

Query: 553 GIVLLEILT-GRLP--DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           GIV+ E+++ G  P  D   ++  K +E      FR                + A R   
Sbjct: 195 GIVMWEVMSYGERPYWDMSGQDVIKAVED----GFR----------------LPAPRNCP 234

Query: 610 ATFH-IALNCTELDPEFRPRMRTVSESLDR 638
              H + L+C + +   RPR   +   L +
Sbjct: 235 NLLHQLMLDCWQKERGERPRFSQIHSILSK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 42/289 (14%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G +YK V+         T VAV+           + F  E E + +  HPNIV+
Sbjct: 3   IGKGNFGDVYKGVLKGN------TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           ++ + +  GSL   L     + L     +  L+++   A G+ Y+   
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTV---KKLLQMSLDAAAGMEYLES- 111

Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H ++ +   L+ +     IS FG++R      +       V+ G       I  
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSR------EEEGGIYTVSDGLKQ----IPI 159

Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APEA  YG ++T + DV+S+GI+L E  + G  P  G  N  +     +   +R   
Sbjct: 160 KWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMPA 216

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           P      P  +            + + L C   DPE RP    +   L 
Sbjct: 217 PQLC---PEEI------------YRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 27/225 (12%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G   +G++ KV+  R +G     ++AV+ +         K    E++ + +   P IV
Sbjct: 8   ELGAGNSGVVSKVLH-RPTGK----IMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                +Y N +  +  +++  GSL   L     +    +P     KIA    +GL Y+HE
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H ++K + IL++      +  FG++  L   + + K       GT S      
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV----GTSS------ 164

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG 573
             Y+APE RI G+ ++ K D++S G+ L+E+ TGR P   PEND 
Sbjct: 165 --YMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFP-YPPENDP 205

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 44/246 (17%)

Query: 370 GAPTVVAVRRLTEGDATWRFK-DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR 428
           G P +VAV+ L   DA    + DF  EV+ ++R++ PNI+RL       D   +I++++ 
Sbjct: 44  GRPLLVAVKIL-RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYME 102

Query: 429 NGSLYAALHA--------------GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
           NG L   L +               P+  LP + + + L +A   A G+ Y+   S   +
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159

Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---Y 531
           VH ++ +   L+ + L   I+ FG++R L              +G   RI   + +   +
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNL-------------YAGDYYRIQGRAVLPIRW 206

Query: 532 LAPEARIYGSKFTQKCDVYSFGIVLLEILT-------GRLPDAGP-ENDGKGLESLVRKA 583
           +A E  + G KFT   DV++FG+ L EIL        G L D    EN G+      R+ 
Sbjct: 207 MAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQV 265

Query: 584 FRERRP 589
           +  R P
Sbjct: 266 YLFRPP 271

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 61/303 (20%)

Query: 360 KVVVGRGSGMGAPT---VVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFY 414
           +VV     G+  P     VAV+ L + DAT +   D  SE+E +  + +H NI+ L    
Sbjct: 27  QVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85

Query: 415 YANDEKLLISDFIRNGSLYAALHA--------GPSDSLPP---LPWEARLKIAQGTARGL 463
                  ++ ++  +G+L   L A         P D  PP   L  +  +  A   ARG+
Sbjct: 86  TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++   + +K +H ++ +  +L+ ++    I+ FGL R +       K        T  R
Sbjct: 146 EFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-------TNGR 195

Query: 524 ISAISNVYLAPEA---RIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG---PENDGKGL 576
           +      ++APEA   R+Y    T + DV+SFG++L EI T G  P  G    E     L
Sbjct: 196 LPV---KWMAPEALFDRVY----THQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----L 243

Query: 577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             L+++ +R  +P +   +                +H+  +C    P  RP  + + E L
Sbjct: 244 FKLLKEGYRMEKPQNCTQE---------------LYHLMRDCWHEVPSQRPTFKQLVEDL 288

Query: 637 DRV 639
           DR+
Sbjct: 289 DRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 26/232 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHP 405
            +G+ + G   +V + +  G+   G  T+V V+ L +        +F  E++   ++ H 
Sbjct: 12  TLGRGEFG---EVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHK 68

Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAG----PSDSLPPLPWEARLKIAQGTAR 461
           N+VRL       +   +I ++   G L   L A          PPL  + ++ +    A 
Sbjct: 69  NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ ++   S  ++VH ++ +   L+  +    +S       L   SK   N         
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVS-------LLSLSKDVYNSEYYKL--- 175

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND 572
            R + I   +LAPEA +    F+ K DV+SFG+++ E+ T G LP  G  ++
Sbjct: 176 -RNALIPLRWLAPEA-VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 65/272 (23%), Positives = 108/272 (39%), Gaps = 38/272 (13%)

Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL 422
           V  G+ M    V  VR  T  +     +    E+  +AR+ HP+I+R+      +    L
Sbjct: 22  VKTGTLMAVKQVTYVRN-TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80

Query: 423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
             +++  GS+   L                +   +   RGL Y+HE    + +H ++K  
Sbjct: 81  FVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGA 132

Query: 483 KILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSG--TGSRISAISNVYLAPEARIY 539
            +L+D       I+ FG        +          +G   G  +  I+  ++APE  + 
Sbjct: 133 NLLIDSTGQRLRIADFG--------AAARLAAKGTGAGEFQGQLLGTIA--FMAPEV-LR 181

Query: 540 GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP-LSEVIDPAL 598
           G ++ + CDV+S G V++E+ T + P    E     L  + + A     P + E + P L
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
                  R V       L C EL PE RP  R
Sbjct: 241 -------RDVT------LRCLELQPEDRPPSR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 46/296 (15%)

Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + V  G  +  P  VA++ L E        +F  E   +A + HP++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIP--VAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           VRL     +   +L ++  + +G L  Y   H     S   L W  ++      A+G+MY
Sbjct: 72  VRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMY 124

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E   R+ VH ++ +  +L+    H  I+ FGL RLL G  K    +       G ++ 
Sbjct: 125 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-------GGKMP 174

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDAGPENDGKGLESLVRKA 583
                ++A E  I+  KFT + DV+S+G+ + E++T  G+  D  P  +   +  L+ K 
Sbjct: 175 I---KWMALEC-IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEKG 227

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            R  +P    ID                + + + C  +D + RP+ + ++    R+
Sbjct: 228 ERLPQPPICTID---------------VYMVMVKCWMIDADSRPKFKELAAEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 68/287 (23%), Positives = 123/287 (42%), Gaps = 55/287 (19%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN 429
           G P +VAV+ L          DF  E++ ++R+++PNI+RL     ++D   +I++++ N
Sbjct: 42  GQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101

Query: 430 GSLYAALHA-------GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
           G L   L           ++++P +     L +A   A G+ Y+   +   +VH ++ + 
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---YLAPEARIY 539
             L+ +     I+ FG++R L              SG   RI   + +   ++A E+ + 
Sbjct: 159 NCLVGNHYTIKIADFGMSRNL-------------YSGDYYRIQGRAVLPIRWMAWESILL 205

Query: 540 GSKFTQKCDVYSFGIVLLEILTGRLPDAGP----------ENDGKGLESLVRKAFRERRP 589
           G KFT   DV++FG+ L E+ T  L    P          EN G+   +  R+ +  + P
Sbjct: 206 G-KFTTASDVWAFGVTLWEMFT--LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTP 262

Query: 590 LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           L     P+ V            F + + C   D + RP    +   L
Sbjct: 263 LC----PSPV------------FKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 39/263 (14%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG       DF  E + + ++ HPN+V+L           ++++++ NG L  
Sbjct: 31  VAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L          L  E  L +       + Y+       ++H ++ +   L+ ++    +
Sbjct: 89  YLRERKGK----LGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKV 141

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL R       V  ++   TS  G++      V  AP      S+F+ K DV+SFG+
Sbjct: 142 SDFGLARY------VLDDQ--YTSSQGTKFP----VKWAPPEVFDYSRFSSKSDVWSFGV 189

Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           ++ E+ + G++P     N  + +ES V   +R  RP              A  +V   + 
Sbjct: 190 LMWEVFSEGKMPYERFSN-SEVVES-VSAGYRLYRPKL------------APTEV---YT 232

Query: 614 IALNCTELDPEFRPRMRTVSESL 636
           I  +C    PE RP  + +   L
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 27/195 (13%)

Query: 373 TVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
            VVA++ +  E D     ++   E+  + +   P IV+    Y+ N +  ++ ++   GS
Sbjct: 29  QVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84

Query: 432 LYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           +   +    + +L     E  +  I   T +GL Y+H     K +H +IK+  ILL++E 
Sbjct: 85  VSDIMKI-TNKTLT----EEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEG 136

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              ++ FG++  L  T    K  T++  GT          ++APE  I    +  K D++
Sbjct: 137 QAKLADFGVSGQLTDTMA--KRNTVI--GT--------PFWMAPEV-IQEIGYNNKADIW 183

Query: 551 SFGIVLLEILTGRLP 565
           S GI  +E+  G+ P
Sbjct: 184 SLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 34/187 (18%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +   + P IV     +   +   +  +F+  GSL             P+P E   K
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGK 107

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           IA     GL Y+  Y+  + +H +IK + IL++      +  FG+               
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGV--------------- 150

Query: 515 IVTSGTGSRISAISN------VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
                +G  I++I++       Y++PE RI G K+T K DV+S GI ++E+  G+ P A 
Sbjct: 151 -----SGELINSIADTFVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Query: 569 PENDGKG 575
              D  G
Sbjct: 205 SNIDDDG 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 18/112 (16%)

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
           KIA+   +GL Y+H    RK +H +IK + ILL  +    +  FG++  L          
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---------- 155

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             V S  G+     ++ Y+APE RI G  ++   DV+S G+ LLE+   R P
Sbjct: 156 --VNSLAGTFTG--TSFYMAPE-RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 30/191 (15%)

Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLI-SDFIRNGSLYAALHAGPSDSL 444
            K+   E++ +  ++HPN+V+    YY    + EK+ I  ++   G+L   L  G     
Sbjct: 43  IKEIADEMKVLELLKHPNLVK----YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE 98

Query: 445 PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP 504
             +    R+   Q    GL Y+H       VH +IK   I LD          G+ +L  
Sbjct: 99  HVI----RVYTLQLL-EGLAYLHS---HGIVHRDIKPANIFLDHN--------GVIKLGD 142

Query: 505 -GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK---CDVYSFGIVLLEIL 560
            G +   KN T  T G   +  A +  Y+APE  I G K        D++S G V+LE+ 
Sbjct: 143 FGCAVKLKNNT-TTMGEEVQSLAGTPAYMAPEV-ITGGKGKGHGRAADIWSLGCVVLEMA 200

Query: 561 TGRLPDAGPEN 571
           TG+ P +  +N
Sbjct: 201 TGKRPWSELDN 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 31/220 (14%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVR--RLTEGDATWRFKDFESEVEAIARVQHPNI 407
           +G    G +YK      +G     +VA++  +L  GD    F+  + E+  +   +HPNI
Sbjct: 11  IGSGTYGDVYKARD-IATG----ELVAIKVIKLEPGDD---FEIIQQEISMLKECRHPNI 62

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V     Y   D+  ++ ++   GSL             PL       + + T +GL Y+H
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLH 118

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           E      +H +IK   ILL ++    ++ FG++  L  T+ + K ++ +  GT       
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFI--GTP------ 165

Query: 528 SNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              ++APE  A      +  KCD+++ GI  +E+   + P
Sbjct: 166 --YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L +     R KDF+ E E +  +QH +IV+        D  +++ +++++G L 
Sbjct: 37  LVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 434 AALHA-GPS-----DSLP-----PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
             L A GP      D  P      L     L IA   A G++Y+   + + +VH ++ + 
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATR 152

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
             L+   L   I  FG++R       V   +     G     + +   ++ PE+ +Y  K
Sbjct: 153 NCLVGANLLVKIGDFGMSR------DVYSTDYYRVGGH----TMLPIRWMPPESIMY-RK 201

Query: 543 FTQKCDVYSFGIVLLEILT-GRLP 565
           FT + DV+SFG++L EI T G+ P
Sbjct: 202 FTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 31/276 (11%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFI 427
           G   +VAV+ L           ++ E+  +  + H NIV+ K        K   LI +++
Sbjct: 31  GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   L     L  AQ    G+ Y+H    + Y+H ++ +  +L
Sbjct: 91  PLGSL--------RDYLPKHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVL 139

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY-LAPEARIYGSKFT 544
           LD++    I  FGL + +P       +E       G      S V+  A E  +  +KF+
Sbjct: 140 LDNDRLVKIGDFGLAKAVP-----EGHEYYRVREDGD-----SPVFWYAVEC-LKENKFS 188

Query: 545 QKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL-VRKAFRERRPLSEVIDPALVKEIH 603
              DV+SFG+ L E+LT       P    K  E +  ++       L E+++  + +   
Sbjct: 189 YASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIELLERGM-RLPC 245

Query: 604 AKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            K      + +  NC E + +FRP  R++   L  +
Sbjct: 246 PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 36/264 (13%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L     +    DF  E   +  + H N++RL      +    ++++    GSL  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLD 84

Query: 435 ALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
            L              +  ++IA G      Y+     ++++H ++ +  ILL  +    
Sbjct: 85  RLRKDALGHFLISTLCDYAVQIANGMR----YLES---KRFIHRDLAARNILLASDDKVK 137

Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           I  FGL R LP      +NE         ++      + APE+      F+   DV+ FG
Sbjct: 138 IGDFGLMRALP------QNEDHYVMEEHLKVPF---AWCAPESLRTR-TFSHASDVWMFG 187

Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           + L E+ T G  P AG  +  + L+ + ++  R  RP       A  ++I+         
Sbjct: 188 VTLWEMFTYGEEPWAG-LSGSQILKKIDKEGERLERP------EACPQDIYN-------- 232

Query: 613 HIALNCTELDPEFRPRMRTVSESL 636
            + L C   +P  RP    + E L
Sbjct: 233 -VMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 69/287 (24%)

Query: 349 VVGKSKNGIMYKVVVGR-GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPN 406
           V+G+   G + + ++ + G  M A    A++ L E  +    +DF  E+E + ++  HPN
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNA----AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 407 IVRLK-----------AFYYANDEKLLISDFIRNGSL------YAALHAGPSDSLPPLPW 449
           I+ L            A  YA    LL  DF+R   +      +A  H   S     L  
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLL--DFLRKSRVLETDPAFAKEHGTAST----LTS 118

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           +  L+ A   A G+ Y+ E   ++++H ++ +  +L+ + L   I+ FGL+R        
Sbjct: 119 QQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-------- 167

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
              E +    T  R+      ++A E+  Y S +T K DV+SFG++L EI++ G  P  G
Sbjct: 168 --GEEVYVKKTMGRLPV---RWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221

Query: 569 ------------------PENDGKGLESLVRKAFR----ERRPLSEV 593
                             P N    +  L+R+ +R    ER P +++
Sbjct: 222 MTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 66/267 (24%), Positives = 105/267 (39%), Gaps = 41/267 (15%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L +       K+F  E   +A++ HP IVRL       +  +L+ +    G L  
Sbjct: 26  VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLK 84

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  L      ++A   A G+ Y+     + +VH ++ +  +LL +     I
Sbjct: 85  YLKKRREIPVSDL-----KELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKI 136

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG++R L G            + T  R       + APE  I   KF+ K DV+S+G+
Sbjct: 137 SDFGMSRAL-GA-----GSDYYRATTAGRWPL---KWYAPEC-INYGKFSSKSDVWSYGV 186

Query: 555 VLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
            L E  + G  P        KG E  +++    R  RP  E                   
Sbjct: 187 TLWEAFSYGAKPYGEM----KGAEVIAMLESGERLPRP-EECPQE--------------I 227

Query: 612 FHIALNCTELDPEFRPRMRTVSESLDR 638
           + I L+C +  PE RP    +  +  R
Sbjct: 228 YSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 41/248 (16%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           F  E   + ++ H N+VRL      N    ++ + +  G+L   L      +L  +    
Sbjct: 46  FLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRT-RGRALVSVI--Q 101

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            L+ +   A G+ Y+     +K VH ++ +  IL+ ++    +S FGL R+         
Sbjct: 102 LLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGS------- 151

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE 570
                    G   S +   + APEA  +  KF+ K DV+S+G++L E+ + GR P   P+
Sbjct: 152 --------MGVDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAP--YPK 200

Query: 571 NDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
              K ++  V K +R   P          +   A   VL T     +C E +P+ RP   
Sbjct: 201 MSLKEVKECVEKGYRMEPP----------EGCPADVYVLMT-----SCWETEPKKRPSFH 245

Query: 631 TVSESLDR 638
            + E L++
Sbjct: 246 KLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 43/250 (17%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 12  IGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA---QGTARGLMYI 466
               Y    +  +I +++  GS    L AGP D           +IA   +   +GL Y+
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD---------EFQIATMLKEILKGLDYL 117

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H     K +H +IK+  +LL ++    ++ FG+   L  T    K  T V  GT      
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFV--GT------ 164

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGL 576
               ++APE  I  S +  K D++S GI  +E+  G  P++           P+N+   L
Sbjct: 165 --PFWMAPEV-IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL 221

Query: 577 ESLVRKAFRE 586
                K F+E
Sbjct: 222 TGEFSKPFKE 231

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 22/192 (11%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + + ++ H  +V+L           ++++++ NG L  
Sbjct: 31  VAIKMIKEGSMSE--DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L        P       L++ +    G+ Y+     ++++H ++ +   L+DD+    +
Sbjct: 89  YLREHGKRFQP----SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKV 141

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K DV++FG+
Sbjct: 142 SDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLLY-SKFSSKSDVWAFGV 189

Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 190 LMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)

Query: 395 EVEAIARV-QHPNIVRLKAFY-YANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           E E + R+  HP I++L  +Y + ++E L  + ++  NG L   +    S          
Sbjct: 51  EKEVLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CT 104

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG----LNRLLPGTS 507
           R   A+     L Y+H    +  +H ++K   ILLD ++H  I+ FG    L+      S
Sbjct: 105 RFYAAE-ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160

Query: 508 KVTKNETIVTSGTGSRISAISNV----YLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  I +    +R    S V    Y++PE  +      +  D+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGK 219

Query: 564 LP 565
            P
Sbjct: 220 PP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 62/263 (23%), Positives = 113/263 (42%), Gaps = 45/263 (17%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 12  IGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL-KIAQGTARGLMYIHE 468
               Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H 
Sbjct: 67  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS 119

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H +IK+  +LL +     ++ FG+   L  T ++ +N  + T           
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTP---------- 165

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P +           P+N+   LE 
Sbjct: 166 -FWMAPEV-IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG 223

Query: 579 LVRKAFRERRPLSEVIDPALVKE 601
              K      PL E ++  L KE
Sbjct: 224 NYSK------PLKEFVEACLNKE 240

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 26/199 (13%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
           P +VAV+ L E        DF  E++ ++R++ PNI+RL A    +D   +I++++ NG 
Sbjct: 46  PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 432 LYAAL------HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
           L   L       A     +  + +   + +A   A G+ Y+   S   +VH ++ +   L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---YLAPEARIYGSK 542
           +       I+ FG++R L              SG   RI   + +   +++ E+ + G K
Sbjct: 163 VGKNYTIKIADFGMSRNL-------------YSGDYYRIQGRAVLPIRWMSWESILLG-K 208

Query: 543 FTQKCDVYSFGIVLLEILT 561
           FT   DV++FG+ L EILT
Sbjct: 209 FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 33/182 (18%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           +E + +++ Q P +V+    YY+    + L L+ +++  G L + L      ++  L  +
Sbjct: 42  TERDILSQAQSPYVVK---LYYSFQGKKNLYLVMEYLPGGDLASLLE-----NVGSLDED 93

Query: 451 -ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL------NRLL 503
            AR+ IA+     L Y+H       +H ++K   IL+D   H  ++ FGL       R +
Sbjct: 94  VARIYIAE-IVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  +++ IV  GT          Y+APE  I G   ++  D +S G +L E L G 
Sbjct: 150 NLNDDEKEDKRIV--GTPD--------YIAPEV-ILGQGHSKTVDWWSLGCILYEFLVGI 198

Query: 564 LP 565
            P
Sbjct: 199 PP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.5 bits (144), Expect = 8e-10
 Identities = 57/264 (21%), Positives = 110/264 (41%), Gaps = 39/264 (14%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E + + ++ HP +V+L           ++++F+ NG L  
Sbjct: 31  VAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L          L  +  L + Q    G+ Y+   S   ++H ++ +   L+       +
Sbjct: 89  YLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKV 141

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R       V  +E   +SG    +      +  PE   + SK++ K DV+SFG+
Sbjct: 142 SDFGMTRY------VLDDEYTSSSGAKFPVK-----WSPPEVFNF-SKYSSKSDVWSFGV 189

Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           ++ E+ T G++P     N    +  ++ + FR  RP               K   +  + 
Sbjct: 190 LMWEVFTEGKMPFEKKSN--YEVVEMISRGFRLYRP---------------KLASMTVYE 232

Query: 614 IALNCTELDPEFRPRMRTVSESLD 637
           +  +C    PE RP    +  ++ 
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 62/248 (25%), Positives = 109/248 (43%), Gaps = 39/248 (15%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G +YK +  R        VVA++ +   +A    +D + E+  +++   P I R
Sbjct: 12  IGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL-KIAQGTARGLMYIHE 468
               Y    +  +I +++  GS    L  GP +       E  +  I +   +GL Y+H 
Sbjct: 67  YYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLE-------ETYIATILREILKGLDYLH- 118

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
            S RK +H +IK+  +LL ++    ++ FG+   L  T ++ +N  + T           
Sbjct: 119 -SERK-IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTP---------- 165

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P++           P+N    LE 
Sbjct: 166 -FWMAPEV-IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 579 LVRKAFRE 586
              K F+E
Sbjct: 224 QYSKPFKE 231

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 34/242 (14%)

Query: 351 GKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRL 410
           GK   G +YKV     +   A   V +  +++ +     +D  +E+  +A V HPNI+  
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER----EDAVNEIRILASVNHPNIISY 64

Query: 411 K-AFYYANDEKLLI-SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           K AF   N  KL I  ++   G L  A+          +P +   +I     RGL  +HE
Sbjct: 65  KEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQALHE 121

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +K +H ++KS  ILL       I   G++++L       KN      GT        
Sbjct: 122 ---QKILHRDLKSANILLVANDLVKIGDLGISKVL------KKNMAKTQIGT-------- 164

Query: 529 NVYLAPEARIY-GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER 587
             Y+APE  ++ G  ++ K D++S G +L E+ T   P      + + ++ L  K  R +
Sbjct: 165 PHYMAPE--VWKGRPYSYKSDIWSLGCLLYEMATFAPP-----FEARSMQDLRYKVQRGK 217

Query: 588 RP 589
            P
Sbjct: 218 YP 219

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 29/180 (16%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKL----LISDFIRNGSLYAALHAGPSDSLPPL 447
            E+E++ + R+   NI+++  F     + L    LI ++   G L   L     D    L
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDL 119

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
            ++ +L +A    +GL  +++Y+ + Y   N+ S   L+ +     I   GL        
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKPY--KNLTSVSFLVTENYKLKIICHGL-------- 169

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                E I++S     ++ +  VY + +    I+ S++T K D+YS G+VL EI TG++P
Sbjct: 170 -----EKILSSPPFKNVNFM--VYFSYKMLNDIF-SEYTIKDDIYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 72/307 (23%), Positives = 129/307 (42%), Gaps = 53/307 (17%)

Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFES 394
           ++L +++L       +GK + G    V++G   G      VAV+ + + DAT   + F +
Sbjct: 1   WALNMKEL--KLLQTIGKGEFG---DVMLGDYRG----NKVAVKCI-KNDAT--AQAFLA 48

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLI-SDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           E   + +++H N+V+L          L I ++++  GSL   L    S     L  +  L
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLL 105

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
           K +      + Y+   +   +VH ++ +  +L+ ++    +S FGL +    T    K  
Sbjct: 106 KFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-- 160

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND 572
                        +   + APEA +   KF+ K DV+SFGI+L EI + GR+P   P   
Sbjct: 161 -------------LPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIP 204

Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            K +   V K ++   P  +   P +             + +   C  LD   RP    +
Sbjct: 205 LKDVVPRVEKGYKMDAP--DGCPPVV-------------YDVMKQCWHLDAATRPSFLQL 249

Query: 633 SESLDRV 639
            E L+ +
Sbjct: 250 REQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 38/179 (21%)

Query: 395 EVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSL-YAALHAGPSDSLPPLPWE 450
           E   +  + HP +V L   +Y+  ++E + L+ D +  G L Y                E
Sbjct: 50  ERRILQELNHPFLVNL---WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-------E 99

Query: 451 ARLKI-AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            ++K         L Y+H    +  +H +IK   ILLD++ H  I+ F +   +   +  
Sbjct: 100 EQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156

Query: 510 TKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T      TSGT          Y+APE    + Y        D +S G+   E L G+ P
Sbjct: 157 TS-----TSGT--------PGYMAPEVLCRQGYSV----AVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 64/302 (21%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGD------------ATWRFKD---FESEVEAIARVQHPN 406
           V+G+GS  G   V  VR++T  D            AT + +D    + E + +A V HP 
Sbjct: 3   VLGQGS-FG--KVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF 59

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           IV+L   +    +  LI DF+R G L+  L    S  +     + +  +A+  A  L ++
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAE-LALALDHL 114

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H       ++ ++K   ILLD+E H  ++ FGL++     S   + +     GT      
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVE---- 163

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG-----------------P 569
               Y+APE  +     TQ  D +SFG+++ E+LTG LP  G                 P
Sbjct: 164 ----YMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Query: 570 ENDGKGLESLVRKAFRERRPLSEV-IDPALVKEIHAKRQVLATFHIALNC---TELDPEF 625
           +      +SL+R  F+ R P + +   P  V+EI  KR    +  I  N     E+ P F
Sbjct: 219 QFLSPEAQSLLRALFK-RNPANRLGAGPDGVEEI--KRHPFFS-TIDWNKLYRREIKPPF 274

Query: 626 RP 627
           +P
Sbjct: 275 KP 276

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 17/174 (9%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
             E+  +  +QH NIV+        D   +  +++  GS+ A L     ++         
Sbjct: 54  AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL-----NNYGAFEETLV 108

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
               +   +GL Y+H    R  +H +IK   IL+D++    IS FG+++      K+  N
Sbjct: 109 RNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK------KLEAN 159

Query: 513 ETIVTSGTGSRISAISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                +  G+R S   +V+ +APE  +  + +T+K D++S G +++E+LTG+ P
Sbjct: 160 SLSTKTN-GARPSLQGSVFWMAPEV-VKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 34/241 (14%)

Query: 342 LLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIAR 401
           LLRA    +G    G +Y+ +     G      VAV+ L E  +     DF  E   +++
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 402 VQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEARLKIAQGT 459
             H NIVRL    +    + ++ + +  G L + L    P    P  L  +  L  A+  
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLPGTSKVTK 511
           A+G  Y+ E     ++H +I +   LL      C        I+ FG+ R +   S   K
Sbjct: 126 AKGCKYLEE---NHFIHRDIAARNCLLT-----CKGPGRVAKIADFGMARDIYRASYYRK 177

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE 570
                    G  +  I   ++ PEA + G  FT K DV+SFG++L EI + G +P  G  
Sbjct: 178 G--------GRAMLPIK--WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Query: 571 N 571
           N
Sbjct: 227 N 227

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 41/231 (17%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPT--VVAVRRL---TEGDATWRFKDFESEVEAIARVQ 403
           ++G+   G +Y+       G   PT  VVA++ +   T  D      D + EV  +++++
Sbjct: 8   LIGRGAYGAVYR-------GKHVPTGRVVALKIINLDTPDDDV---SDIQREVALLSQLR 57

Query: 404 H---PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
               PNI +    Y       +I ++   GS+   + AGP        + +   I +   
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE----KYIS--VIIREVL 111

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
             L YIH+      +H +IK+  IL+ +  +  +  FG+  LL                +
Sbjct: 112 VALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL-------------NQNS 155

Query: 521 GSRISAISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
             R + +   Y +APE    G  +  K D++S GI + E+ TG  P +  +
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 46/290 (15%)

Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 71

Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 72  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 124

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 125 LEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-------GGKVP 174

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 175 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 227

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS 633
            R  +P    ID                + I + C  +D + RP+ R + 
Sbjct: 228 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 4/162 (2%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI 133
           N N      SEL  L +LT L L +NN +   P      +NL  LDL+ N     +P  +
Sbjct: 101 NLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159

Query: 134 KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDL 193
           + L NL +LDLS N L+  LP+ L +L  L   L+LS N+ S  +P        +  LDL
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN-NLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 194 RNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPE 235
            NN++   +  + +L N      S N               E
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLE 258

Length = 394

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 46/296 (15%)

Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V  P +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIP--VAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L ++  +  G L  Y   +     S   L W  ++      A+G+ Y
Sbjct: 72  CRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSY 124

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E    + VH ++ +  +L+    H  I+ FGL RLL     + + E     G      
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL----DIDETEYHADGGK----- 172

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
            +   ++A E+ I   +FT + DV+S+G+ + E++T G  P D  P  +   +  L+ K 
Sbjct: 173 -VPIKWMALES-ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKG 227

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            R  +P      P    ++         + I + C  +D E RPR R + +   R+
Sbjct: 228 ERLPQP------PICTIDV---------YMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.4 bits (138), Expect = 6e-09
 Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 64/259 (24%)

Query: 376 AVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK-----------AFYYANDEKLLI 423
           A++R+ E  +    +DF  E+E + ++  HPNI+ L            A  YA    LL 
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL- 84

Query: 424 SDFIRNGSL------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
            DF+R   +      +A  ++  S     L  +  L  A   ARG+ Y+ +   ++++H 
Sbjct: 85  -DFLRKSRVLETDPAFAIANSTAST----LSSQQLLHFAADVARGMDYLSQ---KQFIHR 136

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++ +  IL+ +     I+ FGL+R           + +    T  R+      ++A E+ 
Sbjct: 137 DLAARNILVGENYVAKIADFGLSR----------GQEVYVKKTMGRLPV---RWMAIESL 183

Query: 538 IYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG------------------PENDGKGLES 578
            Y S +T   DV+S+G++L EI++ G  P  G                  P N    +  
Sbjct: 184 NY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD 242

Query: 579 LVRKAFR----ERRPLSEV 593
           L+R+ +R    ER   +++
Sbjct: 243 LMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 39/239 (16%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           SE+E +  + H NIV+   F    +   +  +++  GS+ + L            +E +L
Sbjct: 57  SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-------YGRFEEQL 109

Query: 454 --KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
                +    GL Y+H    +  +H ++K+  +L+D +    IS FG+++         K
Sbjct: 110 VRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK---------K 157

Query: 512 NETIVTSGTGSRISAISNVYLAPEA-RIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
           ++ I  +     +   S  ++APE    Y   ++ K D++S G V+LE+  GR P +  E
Sbjct: 158 SDDIYDNDQNMSMQG-SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216

Query: 571 NDGKGLESLVRKAFRERR--PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                    + K   +R   P+   +   L                   C  ++P+ RP
Sbjct: 217 AIAA-----MFKLGNKRSAPPIPPDVSMNLSPV---------ALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 22/226 (9%)

Query: 345 ASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT-EGDATWRFKDFESEVEAIARVQ 403
               ++GK    +M  V + +       T+VAV+++  +  +    K  + E+    ++Q
Sbjct: 1   ELLTLIGKCFEDLMI-VHLAKHKPTN--TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ 57

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           HPNI+     +  + E  ++S  +  GS    L     + LP L   A   I +     L
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---AIAFILKDVLNAL 114

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            YIH    + ++H ++K++ ILL  +    +SG   +  +    K  +   +        
Sbjct: 115 DYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK--RQRVVHDFP---- 165

Query: 524 ISAISNVY-LAPEA---RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            S++ N+  L+PE     + G  + +K D+YS GI   E+  G +P
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 58/261 (22%), Positives = 110/261 (42%), Gaps = 53/261 (20%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E + + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 31  VAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L A           E  L +      G+ Y+   +    +H ++ +   L+ +     +
Sbjct: 89  YLRAQRGK----FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKV 141

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R       V  ++   TS TG++       + +PE   + SK++ K DV+SFG+
Sbjct: 142 SDFGMTRF------VLDDQ--YTSSTGTKFPV---KWSSPEVFSF-SKYSSKSDVWSFGV 189

Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL---- 609
           ++ E+ + G+ P                    E R  SEV     V+ I+A  ++     
Sbjct: 190 LMWEVFSEGKTP-------------------YENRSNSEV-----VETINAGFRLYKPRL 225

Query: 610 ---ATFHIALNCTELDPEFRP 627
              + + +  +C +  PE RP
Sbjct: 226 ASQSVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 22/164 (13%)

Query: 403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTAR 461
           +HPNIV     Y   DE  ++ +++  GSL   +    + +   +  E ++  + +   +
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMN-EPQIAYVCREVLQ 127

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           GL Y+H    +  +H +IKS  ILL  +    ++ FG    L  T + +K  ++V  GT 
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVV--GT- 179

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                    ++APE  I    +  K D++S GI+ +E+  G  P
Sbjct: 180 -------PYWMAPEV-IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 29/209 (13%)

Query: 375 VAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK------LLISDFI 427
           VAV+ L  +  ++   ++F  E   +    HPN+++L      +  K      ++I  F+
Sbjct: 30  VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89

Query: 428 RNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           ++G L+  L        P  LP +  ++     A G+ Y+   S + ++H ++ +   +L
Sbjct: 90  KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCML 146

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---YLAPEARIYGSKF 543
           ++ +  C++ FGL++              + SG   R    S +   +LA E+ +  + +
Sbjct: 147 NENMTVCVADFGLSKK-------------IYSGDYYRQGCASKLPVKWLALES-LADNVY 192

Query: 544 TQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
           T   DV++FG+ + EI+T G+ P AG EN
Sbjct: 193 TTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 23/191 (12%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK----LLISDFIRNG 430
           VAV+ L          D + E+E +  + H NIV+ K      ++      LI +F+ +G
Sbjct: 36  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI--CTEDGGNGIKLIMEFLPSG 93

Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           SL   L   P +    +  + +LK A    +G+ Y+     R+YVH ++ +  +L++ E 
Sbjct: 94  SLKEYL---PRNK-NKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I  FGL + +    +  K    V     S +      + APE  I  SKF    DV+
Sbjct: 147 QVKIGDFGLTKAI----ETDKEYYTVKDDLDSPV-----FWYAPECLIQ-SKFYIASDVW 196

Query: 551 SFGIVLLEILT 561
           SFG+ L E+LT
Sbjct: 197 SFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 29/172 (16%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAG-----PSDSLPPLPW 449
           EV  ++ ++HPNIV+ +  +  N    ++ D+   G LY  ++A      P D +  L W
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDW 106

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
             ++ +A      L ++H+   RK +H +IKS  I L  +    +  FG+ R+L  T ++
Sbjct: 107 FVQICLA------LKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
                       +R    +  YL+PE       +  K D+++ G VL E+ T
Sbjct: 158 ------------ARTCIGTPYYLSPEI-CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.8 bits (137), Expect = 3e-08
 Identities = 61/271 (22%), Positives = 98/271 (36%), Gaps = 42/271 (15%)

Query: 388 RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL-ISDFIRNGSLYAALHAGPSDSLPP 446
           +   F  E    AR+ HPNIV L     A    L  + +++   +L   L A        
Sbjct: 21  QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADG-----A 75

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLL 503
           LP     ++       L   H    +  VH ++K   I++       H  +  FG+  LL
Sbjct: 76  LPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
           PG       +  V + T +     +  Y APE ++ G   T   D+Y++G++ LE LTG+
Sbjct: 133 PGV-----RDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIFLECLTGQ 186

Query: 564 LPDAGPENDGKGLESLVRKAFR-------------ERRPLSEVIDPALVKEIHAKR---Q 607
               G         S+    ++                PL +V+  AL K+   +     
Sbjct: 187 RVVQG--------ASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAP 238

Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLDR 638
            LA    AL    L    R       E++  
Sbjct: 239 ALAERFRALELCALVGILRMGEGAGREAIAA 269

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 74/311 (23%), Positives = 127/311 (40%), Gaps = 52/311 (16%)

Query: 349 VVGKS-KNGIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV 402
           V+GK    G   +VV     G+          VAV+ L +        D  SE+E +  +
Sbjct: 15  VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74

Query: 403 -QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA----GPSDSL-------PPLPWE 450
            +H NI+ L           +I ++   G+L   L A    GP  +          L ++
Sbjct: 75  GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             +  A   ARG+ Y+     R+ +H ++ +  +L+ ++    I+ FGL R +       
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG- 568
           K        +  R+      ++APEA ++   +T + DV+SFGI++ EI T G  P  G 
Sbjct: 192 KT-------SNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240

Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
           P  +   L  L+R+  R  +P           E++   +          C    P  RP 
Sbjct: 241 PVEE---LFKLLREGHRMDKP------SNCTHELYMLMR---------ECWHAVPTQRPT 282

Query: 629 MRTVSESLDRV 639
            + + E+LD+V
Sbjct: 283 FKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 20/229 (8%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   G++Y+ +          T VA++ + E  +     +F +E   +      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGLM 464
           L          L++ + +  G L + L +   ++     L P   +  +++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           Y+     +K+VH ++ +   ++ ++L   I  FG+ R +         ET      G  +
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI--------YETDYYRKGGKGL 182

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND 572
             +   ++APE+   G  FT K DV+SFG+VL E+ T    P  G  N+
Sbjct: 183 LPVR--WMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 30/176 (17%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E+E +  V HPN+V+    +  N E  ++ +F+  GSL    H      L  +       
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-HIADEQFLADV------- 173

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            A+    G+ Y+H    R  VH +IK + +L++   +  I+ FG++R+L         +T
Sbjct: 174 -ARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--------AQT 221

Query: 515 IVTSGTGSRISAISNVYLAPEARI-----YGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +      S +  I+  Y++PE RI     +G+      D++S G+ +LE   GR P
Sbjct: 222 M--DPCNSSVGTIA--YMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 64/265 (24%), Positives = 109/265 (41%), Gaps = 36/265 (13%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+   E         F  E   + +  HPNIVRL           ++ + ++ G  
Sbjct: 21  TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L        P L  +  +++ +  A G+ Y+     +  +H ++ +   L+ ++   
Sbjct: 81  LTFLR----TEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVL 133

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            IS FG++R         + E  V + TG  +  I   + APEA  YG +++ + DV+SF
Sbjct: 134 KISDFGMSR---------EEEDGVYASTGG-MKQIPVKWTAPEALNYG-RYSSESDVWSF 182

Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
           GI+L E  + G +P A   N  +     + +  R       +  P L  +        A 
Sbjct: 183 GILLWEAFSLGAVPYANLSN--QQTREAIEQGVR-------LPCPELCPD--------AV 225

Query: 612 FHIALNCTELDPEFRPRMRTVSESL 636
           + +   C E DP  RP   TV + L
Sbjct: 226 YRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 30/213 (14%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G    G +YK    R    G    + V +L  G+    F   + E+  +   +H NIV 
Sbjct: 17  IGSGTYGDVYK---ARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVA 70

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
               Y   D+  +  +F   GSL    H        PL       +++ T +GL Y+H  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS- 124

Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IK   ILL D  H  ++ FG++               +T+    R S I  
Sbjct: 125 --KGKMHRDIKGANILLTDNGHVKLADFGVS-------------AQITATIAKRKSFIGT 169

Query: 530 VY-LAPEARIYGSK--FTQKCDVYSFGIVLLEI 559
            Y +APE      K  + Q CD+++ GI  +E+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 24/171 (14%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +  + HPNI++L   +    +  L+ +F+    LY  +     D    LP E+ +K
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLI----KDRQRGLP-ESLIK 101

Query: 455 -IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
                  +GL + H +     +H ++K   +L++ E    ++ FGL R   G+       
Sbjct: 102 SYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTH 157

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKF-TQKCDVYSFGIVLLEILTGR 563
            +VT             Y APE  + G K  +   D++S G +  E+L+ R
Sbjct: 158 YVVT-----------RWYRAPEL-LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 30/182 (16%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLI-SDFIRNGSL--YAALHAGPSDS 443
              E E++ +  +QH  IV+    YY    +DE L I  +++  GS+      +   +++
Sbjct: 49  NALECEIQLLKNLQHERIVQ----YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET 104

Query: 444 LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL 503
           +       R K  +    G+ Y+H       VH +IK   IL D   +  +  FG ++ L
Sbjct: 105 V------TR-KYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                    +TI +SGTG +    +  +++PE  I G  + +K DV+S G  ++E+LT +
Sbjct: 155 ---------QTICSSGTGMKSVTGTPYWMSPEV-ISGEGYGRKADVWSVGCTVVEMLTEK 204

Query: 564 LP 565
            P
Sbjct: 205 PP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 27/176 (15%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           K   SE+E + +   P I+     ++  +   + ++F+  GSL         D    +P 
Sbjct: 44  KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL---------DVYRKIPE 94

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
               +IA    +GL Y+      K +H ++K + +L++      +  FG++  L      
Sbjct: 95  HVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----- 146

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
               +I  +  G+      N Y+APE RI G ++    DV+S GI  +E+  GR P
Sbjct: 147 ---NSIAKTYVGT------NAYMAPE-RISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 45/290 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFK-DFESEVEAIARVQHPNI 407
           ++GK   G ++K  +         T VAV+   E D     K  F SE   + +  HPNI
Sbjct: 2   LLGKGNFGEVFKGTLKD------KTPVAVKTCKE-DLPQELKIKFLSEARILKQYDHPNI 54

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V+L           ++ + +  G   + L     +    L  +  +K A   A G+ Y+ 
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLE 110

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
               +  +H ++ +   L+ +     IS FG++R         +++ I +S   S +  I
Sbjct: 111 S---KNCIHRDLAARNCLVGENNVLKISDFGMSR--------QEDDGIYSS---SGLKQI 156

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRE 586
              + APEA  YG +++ + DV+S+GI+L E  + G  P  G  N  +     V K +R 
Sbjct: 157 PIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTN--QQAREQVEKGYRM 213

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             P               ++     + +   C +  PE RP+   + + L
Sbjct: 214 SCP---------------QKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 54/286 (18%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           P  VAV+ L +        D  SE+E +  + +H NI+ L      +    ++ ++   G
Sbjct: 44  PVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103

Query: 431 SLYAALHAGPSDSLPP----------LPWEAR-----LKIAQGTARGLMYIHEYSPRKYV 475
           +L   L A      PP          LP E       +  A   ARG+ Y+   + +K +
Sbjct: 104 NLREYLRA----RRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCI 156

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE 535
           H ++ +  +L+ ++    I+ FGL R +       K        T  R+      ++APE
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT-------TNGRLPV---KWMAPE 206

Query: 536 ARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEV 593
           A ++   +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +  
Sbjct: 207 A-LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LFKLLKEGHRMDKPANCT 262

Query: 594 IDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +                + I   C    P  RP  + + E LDRV
Sbjct: 263 HE---------------LYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 46/185 (24%), Positives = 87/185 (47%), Gaps = 24/185 (12%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +     P IV     +Y++ E  +  + +  GSL   L          +P E   K
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-----IPEEILGK 107

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           ++    RGL Y+ E    + +H ++K + IL++      +  FG++  L         ++
Sbjct: 108 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DS 157

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
           +  S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K
Sbjct: 158 MANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP--DAK 208

Query: 575 GLESL 579
            LE++
Sbjct: 209 ELEAI 213

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+  +G   KV   +    G   V+A  ++ +  +    +D+  E++ +A   HPNIV
Sbjct: 9   IIGELGDGAFGKVYKAQNKETG---VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 65

Query: 409 R-LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA-QGTARGLMYI 466
           + L AFYY N+  +LI +F   G++ A +     +   PL  E ++++  + T   L Y+
Sbjct: 66  KLLDAFYYENNLWILI-EFCAGGAVDAVM----LELERPLT-EPQIRVVCKQTLEALNYL 119

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE    K +H ++K+  IL   +    ++ FG++          KN    T     R S 
Sbjct: 120 HE---NKIIHRDLKAGNILFTLDGDIKLADFGVS---------AKN----TRTIQRRDSF 163

Query: 527 ISNVY-LAPEARIYGSK----FTQKCDVYSFGIVLLEI 559
           I   Y +APE  +  +     +  K DV+S GI L+E+
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 61/308 (19%)

Query: 350 VGKSKNGIMYKVVVGR--GSGMGAPT-VVAVRRLTEGDATWRFKDFESEVEAIARVQHPN 406
           +G+ + G +YK   G   G+  G  T  VA++ L +       ++F+ E    +R+QHPN
Sbjct: 13  LGEDRFGKVYK---GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAAL-----HA--GPSD-------SLPPLPWEAR 452
           IV L           +I  +  +  L+  L     H+  G +D       +L P  +   
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF--- 126

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS--KVT 510
           + I    A G+ ++   S    VH ++ +  +L+ D+L+  IS  GL R +      K+ 
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            N            S +   +++PEA +YG KF+   D++S+G+VL E+ + G  P  G 
Sbjct: 184 GN------------SLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230

Query: 570 ENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            N        V +  R R+ L    D PA V            + + L C    P  RPR
Sbjct: 231 SNQD------VIEMIRNRQVLPCPDDCPAWV------------YTLMLECWNEFPSRRPR 272

Query: 629 MRTVSESL 636
            + +   L
Sbjct: 273 FKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 20/176 (11%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALHAGPSDSLPPLPW 449
            E E++ +  +QH  IV+         EK L    +++  GS+   L A        L  
Sbjct: 51  LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-----YGALTE 105

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
               K  +    G+ Y+H       VH +IK   IL D   +  +  FG ++ L      
Sbjct: 106 SVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL------ 156

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              +TI  SGTG R    +  +++PE  I G  + +K DV+S G  ++E+LT + P
Sbjct: 157 ---QTICMSGTGIRSVTGTPYWMSPEV-ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 42/212 (19%)

Query: 376 AVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK-----------AFYYANDEKLLI 423
           A++R+ E  +    +DF  E+E + ++  HPNI+ L            A  YA    LL 
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL- 96

Query: 424 SDFIRNGSL------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
            DF+R   +      +A  ++  S     L  +  L  A   ARG+ Y+   S ++++H 
Sbjct: 97  -DFLRKSRVLETDPAFAIANSTAST----LSSQQLLHFAADVARGMDYL---SQKQFIHR 148

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++ +  IL+ +     I+ FGL+R           + +    T  R+      ++A E+ 
Sbjct: 149 DLAARNILVGENYVAKIADFGLSR----------GQEVYVKKTMGRLPV---RWMAIESL 195

Query: 538 IYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            Y S +T   DV+S+G++L EI++ G  P  G
Sbjct: 196 NY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 28/182 (15%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALH-AGPSDSLPPLPWE 450
           SE E +    HP IV+L   +   D+K +  + ++   G L+  L   G  D      + 
Sbjct: 42  SEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGGELWTILRDRGLFDE-----YT 94

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
           AR  IA        Y+H    R  ++ ++K   +LLD   +  +  FG  + L       
Sbjct: 95  ARFYIACVV-LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQ 147

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
           K  T    GT          Y+APE  I    +    D +S GI+L E+LTGR P    +
Sbjct: 148 KTWTFC--GTPE--------YVAPEI-ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196

Query: 571 ND 572
            D
Sbjct: 197 ED 198

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 25/220 (11%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ +  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 14  LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA-------GPSDSLPPLPWEARLKIAQGTAR 461
           RL          L+I + +  G L + L +        P  + P L  +  +++A   A 
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIAD 130

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ Y+   +  K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G
Sbjct: 131 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK------GGKG 181

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
                +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 182 ----LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 17/195 (8%)

Query: 375 VAVRRLTEGDATWRFKDF-ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           V VRR+     T     F + E+       HPNIV  +A + A++E  +++ F+  GS  
Sbjct: 28  VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 87

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             +     D +  L   A   I QG  + L YIH      YVH ++K++ IL+  +    
Sbjct: 88  DLICTHFMDGMSEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVY 141

Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA---RIYGSKFTQKCDVY 550
           +SG   N      S +   + +       + S     +L+PE     + G  +  K D+Y
Sbjct: 142 LSGLRSN-----LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG--YDAKSDIY 194

Query: 551 SFGIVLLEILTGRLP 565
           S GI   E+  G +P
Sbjct: 195 SVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 69/250 (27%)

Query: 375 VAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           VA+RRL  G  +   R      E++A+   QHP +V+L   +      +L+ +++    L
Sbjct: 33  VALRRLEGGIPNQALR------EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL 85

Query: 433 YAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
              L     D   PLP EA++K   +   +G+ Y+H       +H ++K   +L+  +  
Sbjct: 86  SEVLR----DEERPLP-EAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGV 137

Query: 492 PCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-KFTQKCDV 549
             I+ FGL RL      ++       +    +R       Y APE  +YG+ K+    D+
Sbjct: 138 LKIADFGLARLFSEEEPRL------YSHQVATRW------YRAPEL-LYGARKYDPGVDL 184

Query: 550 YSFGIVLLEILTG--------------------------------RLPDAG----PENDG 573
           ++ G +  E+L G                                 LPD      PE+  
Sbjct: 185 WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKP 244

Query: 574 KGLESLVRKA 583
             LE +   A
Sbjct: 245 IPLEEIFPDA 254

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 65/259 (25%)

Query: 391 DFESEVEAIA---RVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           D  +  E  +   ++ H ++V+L       DE +++ ++++ G L   LH   ++    L
Sbjct: 44  DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSL 100

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL-----DDELHPCI--SGFGLN 500
            W  +L +A+  A  L Y+ +   +K VHGN+    IL+     ++   P I  S  G+ 
Sbjct: 101 HW--KLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI- 154

Query: 501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA-RIYGSKFTQKCDVYSFGIVLLEI 559
                 + +++ E +       RI      ++APE  R   +  T   D +SFG  LLEI
Sbjct: 155 ----PITVLSREERV------ERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Query: 560 LTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIA---- 615
            +      G E                  PLS  +  +  +  +  +  L     A    
Sbjct: 200 CSN-----GEE------------------PLST-LSSSEKERFYQDQHRLPMPDCAELAN 235

Query: 616 --LNCTELDPEFRPRMRTV 632
               C   DP  RP  R +
Sbjct: 236 LINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 47/253 (18%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFY--YANDEKLLIS-DFIRNGSLYAALHAGPSDSLPP 446
           +D  +E+  ++ +QHPNI+   A+Y  + +D  LLI  ++   G+LY  +       L  
Sbjct: 44  RDALNEIVILSLLQHPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQL-- 97

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
              E  L         + YIH+      +H +IK+  I L       +  FG++++L   
Sbjct: 98  FEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--G 152

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           S+ +  ET+V  GT          Y++PE    G K+  K D+++ G VL E+LT +   
Sbjct: 153 SEYSMAETVV--GT--------PYYMSPEL-CQGVKYNFKSDIWALGCVLYELLTLK--- 198

Query: 567 AGPENDGKGLESLVRKAFR-ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
                D     +LV K  +    P+  V    L+  +H             +  + DPE 
Sbjct: 199 --RTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH-------------SLLQQDPEK 243

Query: 626 RPRMRTVSESLDR 638
           RP   T  E LD+
Sbjct: 244 RP---TADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 33/193 (17%)

Query: 401 RVQHPNIVRLK-AFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
            V HP+++R+K          +++  +  +  LY  L    +    PLP +  L I +  
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMVLPHY--SSDLYTYL----TKRSRPLPIDQALIIEKQI 166

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
             GL Y+H    ++ +H ++K+  I ++D    CI   G  +       V     +  +G
Sbjct: 167 LEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF-----PVVAPAFLGLAG 218

Query: 520 TGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILT-----GRLPDAGPEND 572
           T       +N   APE  AR    K+  K D++S GIVL E+L         P + PE  
Sbjct: 219 TVE-----TN---APEVLAR---DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267

Query: 573 GKGLESLVRKAFR 585
            K   S + K   
Sbjct: 268 VKSCHSHLLKIIS 280

Length = 357

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 9e-07
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 29/163 (17%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP--WEARLKIAQGTARG 462
           P + +L   + + D   L+ +++  G   + +      +L  LP  W A+  IA+    G
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK-----TLGGLPEDW-AKQYIAE-VVLG 109

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           +  +H+   R  +H +IK   +L+D   H  ++ FGL+R         +N+  V  GT  
Sbjct: 110 VEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFV--GTPD 158

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                   YLAPE  I G    +  D +S G V+ E L G  P
Sbjct: 159 --------YLAPET-ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 52/245 (21%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
           ++E + +  + HPNI+     YY N        F+ + +L   +   P  +L     +  
Sbjct: 47  QNECQVLKLLSHPNIIE----YYEN--------FLEDKALMIVMEYAPGGTLAEYIQKRC 94

Query: 453 LK------IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPG 505
                   I     + L+ +H    +  +H ++K+  ILLD       I  FG++++L  
Sbjct: 95  NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            SK     T+V  GT          Y++PE    G  + QK D+++ G VL E+ +  L 
Sbjct: 155 KSKAY---TVV--GTPC--------YISPEL-CEGKPYNQKSDIWALGCVLYELAS--LK 198

Query: 566 DAGPENDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE 624
            A    +   L +LV K       P+S+   P L               + L+   LDP 
Sbjct: 199 RA---FEAANLPALVLKIMSGTFAPISDRYSPDLR-------------QLILSMLNLDPS 242

Query: 625 FRPRM 629
            RP++
Sbjct: 243 KRPQL 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 26/194 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALH-AGPSDSLPPLPWEA 451
           +E   +A+V  P IV LK F + + EKL L+  FI  G L+  L   G  D      + A
Sbjct: 42  AERTVLAQVNCPFIVPLK-FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA 100

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            L  A      L  +H+++    ++ ++K   ILLD + H  +  FGL +L        K
Sbjct: 101 ELLCA------LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDK 149

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             T    GT          YLAPE  + G  +T+  D ++ G++L E+LTG LP    EN
Sbjct: 150 TNTFC--GTPE--------YLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTG-LPPFYDEN 197

Query: 572 DGKGLESLVRKAFR 585
             +    ++++  R
Sbjct: 198 VNEMYRKILQEPLR 211

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 35/206 (16%)

Query: 373 TVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T+V VR +T+ +       K  ++EV      +HPNI+     +       +IS F+  G
Sbjct: 26  TLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 431 SLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           S  + L        P    EA +  I  G  RGL Y+H+     Y+H NIK++ IL    
Sbjct: 85  SANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHIL---- 133

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI-------SAISNVYLAPE---ARIY 539
               ISG GL  L    S ++   ++V +G  +++       S     +L+PE     +Y
Sbjct: 134 ----ISGDGLVSL----SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185

Query: 540 GSKFTQKCDVYSFGIVLLEILTGRLP 565
           G  +  K D+YS GI   E+ TGR+P
Sbjct: 186 G--YNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 28/174 (16%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           EV  +   QHPNIV + + Y   DE  ++ +F+  G+L   +     +       E    
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAT 119

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           +     + L ++H    +  +H +IKS  ILL  +    +S FG    +  + +V + ++
Sbjct: 120 VCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKS 174

Query: 515 IVTSGTGSRISAISNVYLAPE--ARI-YGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +V  GT          ++APE  +R+ YG+    + D++S GI+++E++ G  P
Sbjct: 175 LV--GT--------PYWMAPEVISRLPYGT----EVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 25/202 (12%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGK 107

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           ++    +GL Y+ E    K +H ++K + IL++      +  FG++  L         ++
Sbjct: 108 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DS 157

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
           +  S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K
Sbjct: 158 MANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP--DAK 208

Query: 575 GLESLVRKAFRERRPLSEVIDP 596
            LE +      E  P      P
Sbjct: 209 ELELMFGCPV-EGDPAESETSP 229

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 42/222 (18%)

Query: 359 YKV--VVGRGS-GMGAPTVVAVRRLTEGD--ATWRFKDFES----------EVEAIARVQ 403
           Y+V  VVG G+ G+    V+  R    G+  A  +FK+ E           EV+ + +++
Sbjct: 3   YEVLGVVGEGAYGV----VLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           H NIV LK  +       L+ +++   +L   L A P   LPP     R  I Q   + +
Sbjct: 59  HENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG-GLPPD--AVRSYIWQ-LLQAI 113

Query: 464 MYIHEYSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
            Y H       +H +IK   IL+     L  C   FG  R L         + + T    
Sbjct: 114 AYCHS---HNIIHRDIKPENILVSESGVLKLC--DFGFARALRARPASPLTDYVATRW-- 166

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                    Y APE  +  + + +  DV++ G ++ E+L G 
Sbjct: 167 ---------YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 47/260 (18%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
           E  V A+A  +HP + +L + +   D    + +++  G L    H   S        E R
Sbjct: 45  EKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFD----EPR 97

Query: 453 LKI-AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR--LLPGTSKV 509
            +  A     GL ++HE   R  ++ ++K   +LLD E H  I+ FG+ +  +L G    
Sbjct: 98  ARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---- 150

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
               T    GT          Y+APE  +    +    D ++ G++L E+L G+ P  G 
Sbjct: 151 --VTTSTFCGTPD--------YIAPEI-LSYQPYGPAVDWWALGVLLYEMLAGQSPFEG- 198

Query: 570 ENDGKGLESLVRKAFRERRPLSE----VIDPALVKEIHAKRQVLAT----------FH-- 613
           +++ +  +S++    R  R LS+    ++   L K    +   L T          F   
Sbjct: 199 DDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Query: 614 --IALNCTELDPEFRPRMRT 631
               L   E+ P F+P+++ 
Sbjct: 259 DWDKLERKEIKPPFKPKIKG 278

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 51/273 (18%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + +      F++    + A+  + H  IVRL         +L ++     GSL  
Sbjct: 39  VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLD 97

Query: 435 ALHAGPSDSLPP---LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
            +     DSL P   L W  ++      A+G+ Y+ E+   + VH N+ +  ILL  +  
Sbjct: 98  HVRQH-RDSLDPQRLLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSI 147

Query: 492 PCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
             I+ FG+  LL P   K   +E                 ++A E+ ++G ++T + DV+
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEH-----------KTPIKWMALESILFG-RYTHQSDVW 195

Query: 551 SFGIVLLEILT-GRLPDAG---PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKR 606
           S+G+ + E+++ G  P AG    E     +  L+ K  R  +P    ID           
Sbjct: 196 SYGVTVWEMMSYGAEPYAGMRPHE-----VPDLLEKGERLAQPQICTID----------- 239

Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                + + + C  +D   RP  + ++    R+
Sbjct: 240 ----VYMVMVKCWMIDENVRPTFKELANEFTRM 268

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 26/180 (14%)

Query: 394 SEVEAIARVQHPNIVRLKAFYY------ANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           SEV  +  ++HPNIVR    YY      +N    ++ ++   G L   +     +    +
Sbjct: 48  SEVNILRELKHPNIVR----YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-I 102

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYV--HGNIKSTKILLDDELHPCISGFGLNRLLPG 505
             E   +I       L   H  S       H ++K   I LD   +  +  FGL ++L  
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            S   K  T V  GT          Y++PE  +    + +K D++S G ++ E+     P
Sbjct: 163 DSSFAK--TYV--GT--------PYYMSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 24/172 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +  ++HP +V L   +  +    L+ +++  G L++ L         P P  AR 
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPV-ARF 105

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             AQ     L Y+H       V+ ++K   +LLD + +  I+ FG        +K  K  
Sbjct: 106 YAAQVVL-ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGF-------AKRVKGR 154

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T    GT          YLAPE  I    + +  D ++ GI++ E+L G  P
Sbjct: 155 TYTLCGTPE--------YLAPEI-ILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 38/217 (17%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           VG    G +YK    R    G    V + +L  GD    F   + E+  +   +H NIV 
Sbjct: 17  VGSGTYGDVYK---ARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVA 70

Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALH-AGPSDSLPPLPWEARLKIA---QGTARGLMY 465
               Y + ++  +  ++   GSL    H  GP          + L+IA   + T +GL Y
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPL---------SELQIAYVCRETLQGLAY 121

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +H    +  +H +IK   ILL D     ++ FG+                +T+    R S
Sbjct: 122 LHS---KGKMHRDIKGANILLTDNGDVKLADFGV-------------AAKITATIAKRKS 165

Query: 526 AISNVY-LAPE--ARIYGSKFTQKCDVYSFGIVLLEI 559
            I   Y +APE  A      + Q CD+++ GI  +E+
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+GK   GI+Y         +     +A++ + E D+ +  +    E+   + ++H NIV
Sbjct: 15  VLGKGTYGIVYA-----ARDLSTQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIV 68

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA--GP-SDSLPPLPWEARLKIAQGTARGLMY 465
           +       N    +  + +  GSL A L +  GP  D+   + +  + +I +G    L Y
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEG----LKY 123

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +H+    + VH +IK   +L++       IS FG ++ L G +  T+  T    GT    
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT----GTLQ-- 174

Query: 525 SAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 Y+APE      R YG+      D++S G  ++E+ TG+ P
Sbjct: 175 ------YMAPEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 71/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)

Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 51  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109

Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G      P       L ++  +  A   ARG+ Y+   + +K +H ++
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDL 166

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 215

Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 216 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 266

Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 267 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 30/178 (16%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLPWEARLKIAQGTARGL 463
           P IV     +Y++ E  +  + +  GSL   L  AG       +P     KI+    RGL
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPENILGKISIAVLRGL 112

Query: 464 MYIHEYSPRKYVHGNIKSTKILL--DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
            Y+ E    K +H ++K + IL+    E+  C   FG++  L         +++  S  G
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLC--DFGVSGQL--------IDSMANSFVG 160

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
           +R       Y++PE R+ G+ +T + D++S G+ L+E+  GR P   P  D K LE++
Sbjct: 161 TR------SYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP--DAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAG--PSDSLPPLPWEARLKIAQGTAR 461
           P IV LK  +  + +  L++D++  G L+  L   G    D        A+  IA+    
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-------RAKFYIAE-LVL 107

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT-SGT 520
            L ++H+Y     V+ ++K   ILLD   H  +  FGL++     + +T N+T  T  GT
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTFCGT 159

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                     YLAPE  +    +T+  D +S G+++ E+  G  P
Sbjct: 160 TE--------YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 47/164 (28%), Positives = 68/164 (41%), Gaps = 21/164 (12%)

Query: 402 VQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR 461
           V+HP +V L   +   ++   + DF+  G L+  L    S   P     AR   A+  A 
Sbjct: 53  VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP----RARFYAAE-IAS 107

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
            L Y+H       V+ ++K   ILLD + H  ++ FGL +           E I  S T 
Sbjct: 108 ALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK-----------EGIAQSDTT 153

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +        YLAPE  I    +    D +  G VL E+L G  P
Sbjct: 154 TTFCGTPE-YLAPEV-IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL----HAGPSDSLPPL-PW 449
           E + ++++ HP IV+  A +   D   +I+++     L   L    H G + S   +  W
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
             +L +      G+ Y+H+   R+ +H ++K+  I L + L   I  FG++RLL G+   
Sbjct: 112 FIQLLL------GVHYMHQ---RRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCD- 160

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEI 559
                + T+ TG      +  Y++PEA +    +  K D++S G +L E+
Sbjct: 161 -----LATTFTG------TPYYMSPEA-LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 31/181 (17%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLIS-DFIRNGSLYAALHAGPSDSLP 445
           K  E E+  ++++QHPNIV+    Y      ++ L I  + +  GSL   L      S P
Sbjct: 47  KQLEQEIALLSKLQHPNIVQ----YLGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFP 100

Query: 446 -PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP 504
            P+    RL   Q    GL Y+H+   R  VH +IK   IL+D      ++ FG+     
Sbjct: 101 EPV---IRLYTRQ-ILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGM----- 148

Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
             +K     +   S  G      S  ++APE       +    D++S G  +LE+ TG+ 
Sbjct: 149 --AKQVVEFSFAKSFKG------SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200

Query: 565 P 565
           P
Sbjct: 201 P 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 45/197 (22%), Positives = 87/197 (44%), Gaps = 30/197 (15%)

Query: 374 VVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF-IRNG 430
           VVA+++++     +  +++D   EV+ + R++HPN +  K  Y       L+ ++ + + 
Sbjct: 52  VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA 111

Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           S    +H  P   +          I  G  +GL Y+H ++    +H +IK+  ILL +  
Sbjct: 112 SDLLEVHKKPLQEV------EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 162

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCD 548
              ++ FG        S  +   + V  GT          ++APE  +     ++  K D
Sbjct: 163 QVKLADFG------SASIASPANSFV--GT--------PYWMAPEVILAMDEGQYDGKVD 206

Query: 549 VYSFGIVLLEILTGRLP 565
           V+S GI  +E+   + P
Sbjct: 207 VWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 20/176 (11%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALHAGPSDSLPPLPW 449
            E E++ +  + H  IV+         E+ L    + +  GS+   L      S   L  
Sbjct: 51  LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTE 105

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
               K  +    G+ Y+H       VH +IK   IL D   +  +  FG ++ L      
Sbjct: 106 NVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL------ 156

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              +TI  SGTG +    +  +++PE  I G  + +K D++S G  ++E+LT + P
Sbjct: 157 ---QTICLSGTGMKSVTGTPYWMSPEV-ISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 47/173 (27%), Positives = 73/173 (42%), Gaps = 24/173 (13%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEARL 453
           E + + +V    IV L   +   D+  L+   +  G L Y   + G     P  P EAR 
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE----PGFP-EARA 97

Query: 454 KI-AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
              A     GL ++H+   R+ V+ ++K   +LLDD  +  IS  GL   L G  K+   
Sbjct: 98  IFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG- 153

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                        A +  Y+APE  + G  +    D ++ G  L E++ GR P
Sbjct: 154 ------------RAGTPGYMAPEV-LQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 40/219 (18%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAG-----PSDSLPPL 447
           + EV  +A+++HPNIV   A +  N    ++ ++   G L   ++         D +  L
Sbjct: 47  KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI--L 104

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGLNRLLPGT 506
            W  ++ +      GL +IH+   RK +H +IKS  I L    +   +  FG+ R L  +
Sbjct: 105 SWFVQISL------GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
            ++            +     +  YL+PE       +  K D++S G VL E+ T + P 
Sbjct: 156 MEL------------AYTCVGTPYYLSPEI-CQNRPYNNKTDIWSLGCVLYELCTLKHP- 201

Query: 567 AGPENDGKGLESLVRKAFRER-RPLSEVIDPALVKEIHA 604
                +G  L  LV K  +    P+S    P   +++ +
Sbjct: 202 ----FEGNNLHQLVLKICQGYFAPIS----PNFSRDLRS 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 62/279 (22%), Positives = 116/279 (41%), Gaps = 46/279 (16%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VAV+ L +        D  SE+E +  + +H NI+ L      +    +I ++   G+L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 434 AALHAGPSDSLP-----------PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
             L A     +             + ++  +      ARG+ Y+   + +K +H ++ + 
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
            +L+ +     I+ FGL R +       K        T  R+      ++APEA ++   
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKT-------TNGRLPV---KWMAPEA-LFDRV 215

Query: 543 FTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
           +T + DV+SFG+++ EI T G  P  G P  +   L  L+++  R  +P +         
Sbjct: 216 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKEGHRMDKPAN------CTN 266

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           E+         + +  +C    P  RP  + + E LDR+
Sbjct: 267 EL---------YMMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 31/194 (15%)

Query: 444 LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL 503
             PL  E  +  +   ARG+ ++   + RK +H ++ +  ILL +     I  FGL R  
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-- 222

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-G 562
                + K+   V  G+    + +   ++APE+ I+   +T + DV+SFG++L EI + G
Sbjct: 223 ----DIYKDPDYVRKGS----ARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFSLG 273

Query: 563 RLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELD 622
             P  G + + +  + L +   R R P  E   P +             + I L C + D
Sbjct: 274 ASPYPGVQINEEFCQRL-KDGTRMRAP--ENATPEI-------------YRIMLACWQGD 317

Query: 623 PEFRPRMRTVSESL 636
           P+ RP    + E L
Sbjct: 318 PKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 21/167 (12%)

Query: 399 IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           +  V+HP +V L   +   D+   + D+I  G L+  L        P     AR   A+ 
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAE- 104

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A  L Y+H  +    V+ ++K   ILLD + H  ++ FGL +           E I  +
Sbjct: 105 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-----------ENIEHN 150

Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           GT S        YLAPE  ++   + +  D +  G VL E+L G  P
Sbjct: 151 GTTSTFCGTPE-YLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 49/234 (20%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-----QH 404
           +GK   G +YKV   +   + A  ++               D + E+EA   +      H
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----------PISDVDEEIEAEYNILQSLPNH 78

Query: 405 PNIVRLKAFYYANDEKL-----LISDFIRNGS----LYAALHAGPSDSLPPLPWEARLKI 455
           PN+V+    +Y  D+ +     L+ +    GS    +   L  G       + +     I
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-----I 133

Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
             G   GL ++H     + +H ++K   ILL  E    +  FG++  L  T ++ +N ++
Sbjct: 134 LYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNTSV 189

Query: 516 VTSGTGSRISAISNVYLAPEA----RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            T             ++APE     + Y   +  +CDV+S GI  +E+  G  P
Sbjct: 190 GTP-----------FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 31/192 (16%)

Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG 505
           PL  E  +  +   ARG+ ++   + RK +H ++ +  ILL +     I  FGL R    
Sbjct: 169 PLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR---- 221

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRL 564
              + K+   V  G     + +   ++APE+ I+   +T + DV+SFG++L EI + G  
Sbjct: 222 --DIYKDPDYVRKGD----ARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFSLGAS 274

Query: 565 PDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE 624
           P  G + D +    L ++  R R P             +A  ++   + I L+C   +PE
Sbjct: 275 PYPGVQIDEEFCRRL-KEGTRMRAPE------------YATPEI---YSIMLDCWHNNPE 318

Query: 625 FRPRMRTVSESL 636
            RP    + E L
Sbjct: 319 DRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 18/174 (10%)

Query: 389 FKDFESEVEAI-ARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             D  SEV  I  +++HPNIVR    +  ND   ++ D I    L         +     
Sbjct: 52  IGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRF 110

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             E    I       L Y+H+   ++ VH ++    I+L ++    I+ FGL +     S
Sbjct: 111 TEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES 168

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
           K+T           S +  I  +Y  PE  +    + +K DV++FG +L ++ T
Sbjct: 169 KLT-----------SVVGTI--LYSCPEI-VKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 2e-05
 Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 1/61 (1%)

Query: 138 NLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNN 197
           NL  LDLS+N L          L  L   L+LS N  +   PE +   P + SLDL  NN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLK-VLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 198 L 198
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 40/274 (14%)

Query: 360 KVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY 415
           KVV     G+    A   VAV+ L     +   +   SE++ ++ +  H NIV L     
Sbjct: 50  KVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109

Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
                L+I+++   G L   L     +S   L  E  L  +   A+G+ ++   + +  +
Sbjct: 110 IGGPILVITEYCCYGDLLNFLRRK-RESF--LTLEDLLSFSYQVAKGMAFL---ASKNCI 163

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAP 534
           H ++ +  +LL       I  FGL R       +  +   V  G     +A   V ++AP
Sbjct: 164 HRDLAARNVLLTHGKIVKICDFGLAR------DIMNDSNYVVKG-----NARLPVKWMAP 212

Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEV 593
           E+ I+   +T + DV+S+GI+L EI + G  P  G   D K    L+++ +R  +P    
Sbjct: 213 ES-IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYRMAQP---- 266

Query: 594 IDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                    HA  ++   + I   C + DP  RP
Sbjct: 267 --------EHAPAEI---YDIMKTCWDADPLKRP 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 31/111 (27%), Positives = 56/111 (50%), Gaps = 16/111 (14%)

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           GL ++H+   +  ++ ++K   +LLD + H  I+ FG+ +           E +   G  
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----------ENMNGEGKA 153

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
           S      + Y+APE  + G K+ +  D +SFG++L E+L G+ P  G + D
Sbjct: 154 STFCGTPD-YIAPEI-LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 20/116 (17%)

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
           KIA    + L Y+H       +H ++K + +L++      +  FG++  L     V K  
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAK-- 160

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYG----SKFTQKCDVYSFGIVLLEILTGRLP 565
              T   G +       Y+APE RI        +  K DV+S GI ++E+ TGR P
Sbjct: 161 ---TIDAGCK------PYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 44/221 (19%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEV----EAIARVQ-----------HPN 406
           V+GRGS       V + RL + +  +  K  + E+    E I  VQ           HP 
Sbjct: 2   VIGRGS----YAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L + +        + +++  G L    H      LP     AR   A+  +  L Y+
Sbjct: 58  LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE--EHARFYSAE-ISLALNYL 112

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR--LLPGTSKVTKNETIVTSGTGSRI 524
           HE   R  ++ ++K   +LLD E H  ++ +G+ +  L PG              T S  
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------------TTSTF 156

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
               N Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 157 CGTPN-YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 55/245 (22%), Positives = 107/245 (43%), Gaps = 41/245 (16%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLP--WEA 451
           E++ + ++ HPN+++  A +  N+E  ++ +    G L   + H      L P    W+ 
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            +++       L ++H    ++ +H +IK   + +       +   GL R    +SK T 
Sbjct: 112 FVQL----CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTA 162

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             ++V  GT          Y++PE RI+ + +  K D++S G +L E+   + P  G   
Sbjct: 163 AHSLV--GT--------PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--- 208

Query: 572 DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK--RQVLATFHIALNCTELDPEFRPRM 629
           D   L SL +K       + +   P L  + +++  R +++       C   DPE RP +
Sbjct: 209 DKMNLYSLCKK-------IEKCDYPPLPADHYSEELRDLVSR------CINPDPEKRPDI 255

Query: 630 RTVSE 634
             V +
Sbjct: 256 SYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 35/224 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +GK   G +YK +  + +      VVA++ +   +A    +D + E++ +++ + P I 
Sbjct: 8   CIGKGSFGEVYKAID-KRTN----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 409 RLKAFYYA---NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
           +    YY       KL +I ++   GS    L  G       L       I +    GL 
Sbjct: 63  K----YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLE 112

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           Y+HE      +H +IK+  ILL +E    ++ FG++  L  TS ++K  T V  GT    
Sbjct: 113 YLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFV--GT---- 161

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
                 ++APE  I  S + +K D++S GI  +E+  G  P + 
Sbjct: 162 ----PFWMAPEV-IKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 3e-05
 Identities = 50/197 (25%), Positives = 72/197 (36%), Gaps = 24/197 (12%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
            +E E +A + HP +  L A +       L+ D+   G L+  L   P   L      AR
Sbjct: 49  LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV--AR 106

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
              A+     L Y+H       V+ ++K   ILL +  H  +S F L++           
Sbjct: 107 FYAAEVLL-ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162

Query: 513 ETIVTSGTGSRI-----------SAISNV------YLAPEARIYGSKFTQKCDVYSFGIV 555
                S   S             S  SN       Y+APE  I G       D ++ GI+
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGIL 221

Query: 556 LLEILTGRLPDAGPEND 572
           L E+L G  P  G   D
Sbjct: 222 LYEMLYGTTPFKGSNRD 238

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 28/173 (16%)

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           A+G+ Y+     +K+VH ++ +   +LD+     ++ FGL R +       K    V + 
Sbjct: 108 AKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDI-----YDKEYYSVHNH 159

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
           TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P   P  D    + +
Sbjct: 160 TGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVDSFD-I 211

Query: 580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                + RR L     P               + + L+C    PE RP    +
Sbjct: 212 TVYLLQGRRLLQPEYCPD------------PLYEVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 48/235 (20%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-----Q 403
           V+G+   G +YK    + +G     +VA++ +   D      D E E++    +      
Sbjct: 13  VIGEGTYGKVYKARHKK-TGQ----LVAIKIM---DIIE---DEEEEIKEEYNILRKYSN 61

Query: 404 HPNIVRLKAFYYAN------DEKLLISDFIRNGS---LYAALHAGPSDSLPPLPWEARLK 454
           HPNI      +         D+  L+ +    GS   L   L          L  E    
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK----RLKEEWIAY 117

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           I + T RGL Y+HE    K +H +IK   ILL       +  FG++  L   S + +  T
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNT 172

Query: 515 IVTSGTGSRISAISNVYLAPEA----RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            +  GT          ++APE         + +  + DV+S GI  +E+  G+ P
Sbjct: 173 FI--GT--------PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 33/143 (23%)

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL---------- 499
           E R  IA+ T   +  IH+     Y+H +IK   +LLD + H  +S FGL          
Sbjct: 102 ETRFYIAE-TILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 500 --NRLLPGTSKVTKNETIVTSGTGS----------RISAISNV----YLAPEARIYGSK- 542
              R+L         + I    +            R  A S V    Y+APE  ++    
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE--VFLQTG 215

Query: 543 FTQKCDVYSFGIVLLEILTGRLP 565
           + ++CD +S G+++ E+L G  P
Sbjct: 216 YNKECDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 37/190 (19%)

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           GL ++H    +  ++ ++K   ++LD + H  I+ FG+ +           E +      
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-----------ENVFGDNRA 153

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND--------- 572
           S      + Y+APE  + G K+T   D +SFG++L E+L G+ P  G + D         
Sbjct: 154 STFCGTPD-YIAPEI-LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211

Query: 573 --------GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE 624
                    K  + ++ K F ER P   +    +V  I            AL   ELDP 
Sbjct: 212 TPHYPRWITKESKDILEKLF-ERDPTRRL---GVVGNIRGHPFFKTINWTALEKRELDPP 267

Query: 625 FRPRMRTVSE 634
           F+P++++ S+
Sbjct: 268 FKPKVKSPSD 277

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 23/168 (13%)

Query: 399 IARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQ 457
           +  V+HP +V L  + +   +KL  + D++  G L+  L    S   P     AR   A+
Sbjct: 50  LKNVKHPFLVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP----RARFYAAE 104

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
             A  L Y+H       ++ ++K   ILLD + H  ++ FGL +           E I  
Sbjct: 105 -IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-----------EGIEH 149

Query: 518 SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           S T S        YLAPE  +    + +  D +  G VL E+L G  P
Sbjct: 150 SKTTSTFCGTPE-YLAPEV-LRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 38/195 (19%)

Query: 391 DFESEVEA-----IARVQHPNIVRLKAFYYANDEK-----LLISDFIRNGSLY----AAL 436
           D + E+EA      A   HPN+V+    YY  D K      L+ +    GS+       L
Sbjct: 56  DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115

Query: 437 HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG 496
             G     P + +     I      GL ++H     K +H ++K   ILL  E    +  
Sbjct: 116 KRGERMEEPIIAY-----ILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA----RIYGSKFTQKCDVYSF 552
           FG++  L  T ++ +N ++ T             ++APE     +   S +  +CDV+S 
Sbjct: 168 FGVSAQLTST-RLRRNTSVGTP-----------FWMAPEVIACEQQLDSTYDARCDVWSL 215

Query: 553 GIVLLEILTGRLPDA 567
           GI  +E+  G  P A
Sbjct: 216 GITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 19/194 (9%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G L
Sbjct: 37  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96

Query: 433 YAALHAGPSDS-----LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
            + L +   ++      PP   +  +++A   A G+ Y+   + +K+VH ++ +   ++ 
Sbjct: 97  KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVA 153

Query: 488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKC 547
            +    I  FG+ R +  T    K         G  +  +   ++APE+   G  FT   
Sbjct: 154 HDFTVKIGDFGMTRDIYETDYYRKG--------GKGLLPVR--WMAPESLKDGV-FTTSS 202

Query: 548 DVYSFGIVLLEILT 561
           D++SFG+VL EI +
Sbjct: 203 DMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.2 bits (107), Expect = 5e-05
 Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 33/197 (16%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRN 429
           T+V   +  E   T R       +EA+ R   P +V L   +YA   D KL LI D++  
Sbjct: 40  TIVQKAKTAEHTRTER-----QVLEAVRRC--PFLVTL---HYAFQTDTKLHLILDYVNG 89

Query: 430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           G L+  L+     +      E R+ IA+     L ++H+      ++ +IK   ILLD E
Sbjct: 90  GELFTHLYQREHFTES----EVRVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSE 141

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKC-D 548
            H  ++ FGL++       + + E    S  G+ I      Y+APE    GS    K  D
Sbjct: 142 GHVVLTDFGLSKEF-----LAEEEERAYSFCGT-IE-----YMAPEVIRGGSGGHDKAVD 190

Query: 549 VYSFGIVLLEILTGRLP 565
            +S G++  E+LTG  P
Sbjct: 191 WWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 30/175 (17%)

Query: 395 EVEAIARVQHPNIVRLKAFYYAN--DEKLLISDFIRN--GSLYAALHAGPSDSLP-PLPW 449
           E+  +  ++HPNIV LK        D   L+ ++      SL         D++P P   
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--------DNMPTPFS- 106

Query: 450 EARLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
           E+++K +     RGL Y+HE      +H ++K + +LL D+    I+ FGL R   G   
Sbjct: 107 ESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPA 162

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 +VT             Y APE  +  + +T   D+++ G +L E+L  +
Sbjct: 163 KPMTPKVVTLW-----------YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 20/176 (11%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALHAGPSDSLPPLPW 449
            E E++ +  ++H  IV+        +EK L    +++  GS+   L A        L  
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-----YGALTE 105

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
               +  +   +G+ Y+H       VH +IK   IL D   +  +  FG ++ +      
Sbjct: 106 NVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI------ 156

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              +TI  SGTG +    +  +++PE  I G  + +K DV+S    ++E+LT + P
Sbjct: 157 ---QTICMSGTGIKSVTGTPYWMSPEV-ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 17/177 (9%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           SE+  +A   H  IV+    + ++D+ LLI ++   G L   +     + LP   +E  L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
              Q     ++ + E   RK +H ++KS  I L       +  FG ++    +       
Sbjct: 174 LFYQI----VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS------- 222

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGP 569
             V+    S     +  YLAPE  ++  K +++K D++S G++L E+LT   P  GP
Sbjct: 223 --VSLDVASSFCG-TPYYLAPE--LWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274

Length = 478

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 7e-05
 Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 30/165 (18%)

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           +PN ++L          +LI D+I++G L+  L      S      E +  I Q     L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA----EVKKIIRQ-LVEAL 122

Query: 464 MYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
             +H++     +H +IK   +L D   D ++ C   +GL        K+    +    GT
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLC--DYGL-------CKIIGTPS-CYDGT 169

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                     Y +PE +I G  +    D ++ G++  E+LTG+ P
Sbjct: 170 --------LDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 41/138 (29%), Positives = 66/138 (47%), Gaps = 19/138 (13%)

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L+ +H    +  +H +IKS  ILL      C +G  L +L  G    +K      S    
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILL------CSNG--LVKL--GDFGFSKMYAATVSDDVG 202

Query: 523 RISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR 581
           R    +  Y+APE  I+  K +++K D++S G++L E+LT + P      DG+ +E ++ 
Sbjct: 203 RTFCGTPYYVAPE--IWRRKPYSKKADMFSLGVLLYELLTLKRP-----FDGENMEEVMH 255

Query: 582 KAFRER-RPLSEVIDPAL 598
           K    R  PL   I P +
Sbjct: 256 KTLAGRYDPLPPSISPEM 273

Length = 496

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 21/170 (12%)

Query: 403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           +HP +  L   +   +    + +++  G L   + +     LP   + A   I      G
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----G 108

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L ++H    +  V+ ++K   ILLD + H  I+ FG+ +     + +   +T    GT  
Sbjct: 109 LQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK----ENMLGDAKTCTFCGTPD 161

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                   Y+APE  + G K+    D +SFG++L E+L G+ P  G + +
Sbjct: 162 --------YIAPEI-LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 37/188 (19%)

Query: 391 DFESEVEAIARVQHPNIVRL-KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           DF  E++ ++  +HPNIV L +A++Y N   +LI +F   G+L         DS+  L  
Sbjct: 48  DFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGAL---------DSI-MLEL 96

Query: 450 EARLK------IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL 503
           E  L       + +     L ++H     K +H ++K+  ILL  +    ++ FG++   
Sbjct: 97  ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAK- 152

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEA----RIYGSKFTQKCDVYSFGIVLLEI 559
              S + K +T +  GT          ++APE         + +  K D++S GI L+E+
Sbjct: 153 -NKSTLQKRDTFI--GT--------PYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201

Query: 560 LTGRLPDA 567
                P  
Sbjct: 202 AQMEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 30/197 (15%)

Query: 374 VVAVRRLT-EGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF-IRNG 430
           VVAV++++  G  T  +++D   EV+ + +++HPN +  K  Y       L+ ++ + + 
Sbjct: 48  VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSA 107

Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           S    +H  P   L  +   A   I  G  +GL Y+H ++    +H +IK+  ILL +  
Sbjct: 108 SDLLEVHKKP---LQEVEIAA---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 158

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCD 548
              ++ FG        SK +   + V  GT          ++APE  +     ++  K D
Sbjct: 159 QVKLADFG------SASKSSPANSFV--GT--------PYWMAPEVILAMDEGQYDGKVD 202

Query: 549 VYSFGIVLLEILTGRLP 565
           V+S GI  +E+   + P
Sbjct: 203 VWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 28/179 (15%)

Query: 397 EAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI- 455
           E     +HP +V L A +   D    + ++   G L   +H            E R    
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-------EPRAVFY 106

Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           A     GL Y+HE    K V+ ++K   +LLD E    I+ FGL +           E +
Sbjct: 107 AACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----------EGM 152

Query: 516 VTSGTGSRISAISNV--YLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
              G G R S       +LAPE  +  + +T+  D +  G+++ E+L G  P  G + +
Sbjct: 153 ---GFGDRTSTFCGTPEFLAPEV-LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 44.0 bits (105), Expect = 1e-04
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 32/175 (18%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E+  +  ++HPNIV+L    +   +  L+ ++     L   L   P    P L     +K
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-----IK 101

Query: 455 -IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN- 512
            I     RGL Y H     + +H ++K   IL++ +    ++ FGL R       +    
Sbjct: 102 SIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYT 156

Query: 513 ETIVTSGTGSRISAISNVYLAPE----ARIYGSKFTQKCDVYSFGIVLLEILTGR 563
             +VT             Y APE    ++ Y +      D++S G +  E++TG+
Sbjct: 157 HEVVTLW-----------YRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 50/255 (19%)

Query: 393 ESEVEA---IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           ES  EA   ++++ H ++V         DE +++ ++++ GSL   L    + +L  + W
Sbjct: 44  ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISW 101

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL-PGTSK 508
             +L++A+  A  L ++ +   +   HGN+ +  +LL  E           +L  PG S 
Sbjct: 102 --KLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
               + I+      RI      ++ PE        +   D +SFG  L EI +G      
Sbjct: 157 TVLPKEILL----ERIP-----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG------ 201

Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT---FHIAL---NCTELD 622
                              +PLS  +D     + +  R  L       +A     C + +
Sbjct: 202 -----------------GDKPLS-ALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYE 243

Query: 623 PEFRPRMRTVSESLD 637
           P+FRP  R +   L+
Sbjct: 244 PDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 43/172 (25%), Positives = 81/172 (47%), Gaps = 22/172 (12%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +EV  +   QH N+V +   Y   +E  ++ +F++ G+L   +      S   L  E   
Sbjct: 67  NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQTRLNEEQIA 120

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
            + +   + L Y+H    +  +H +IKS  ILL  +    +S FG    +  +  V K +
Sbjct: 121 TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRK 175

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           ++V  GT          ++APE  I  + +  + D++S GI+++E++ G  P
Sbjct: 176 SLV--GT--------PYWMAPEV-ISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 2e-04
 Identities = 27/62 (43%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 114 NLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFN 172
           NL  LDL++N     IPD   K L NL  LDLS N L    PE    L +L  +L+LS N
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLR-SLDLSGN 58

Query: 173 QF 174
             
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 43.7 bits (104), Expect = 2e-04
 Identities = 43/183 (23%), Positives = 70/183 (38%), Gaps = 59/183 (32%)

Query: 402 VQHPNIVRLKAFYYANDEKLLISDFIRNGSLY----------AALHAGPSDSLPPLPWEA 451
           ++HPNIVRLK    +             GS+Y            L   P         E+
Sbjct: 55  LRHPNIVRLKEIVTSKG----------KGSIYMVFEYMDHDLTGLLDSPEVKFT----ES 100

Query: 452 RLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG----- 505
           ++K   +    GL Y+H       +H +IK + IL++++    ++ FGL R         
Sbjct: 101 QIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157

Query: 506 -TSKVTKNETIVTSGTGSRISAISNVYLAPE----ARIYGSKFTQKCDVYSFGIVLLEIL 560
            T++V                 I+  Y  PE    A  YG +     D++S G +L E+ 
Sbjct: 158 YTNRV-----------------ITLWYRPPELLLGATRYGPEV----DMWSVGCILAELF 196

Query: 561 TGR 563
            G+
Sbjct: 197 LGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 23/173 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +   D    + +++  G L+  L      S   +  E R 
Sbjct: 44  TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL------SRERVFSEDRT 97

Query: 454 KI-AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H     K V+ ++K   ++LD + H  I+ FGL +           
Sbjct: 98  RFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK----------- 143

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           E I  + T          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 144 EGITDAATMKTFCGTPE-YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 37/164 (22%), Positives = 57/164 (34%), Gaps = 28/164 (17%)

Query: 66  RVTSLYLPNRNLTGY----MPSELGLLNSLTRLSLASNNFSKPIPANLFNA----TNLVY 117
            +  L L    L G     +   L     L  L+LA+N         L        NL  
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 118 LDLAHNSF----CGPIPDRIKTLKNLTHLDLSSNLL-NGSLPEFLLDLRALTGTL---NL 169
           LDL +N         + + + +LK+L  L+L  N L +         L +   +L   +L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257

Query: 170 SFN--------QFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
           S N          +  + E       ++ LDLR N    E  Q+
Sbjct: 258 SCNDITDDGAKDLAEVLAEK----ESLLELDLRGNKFGEEGAQL 297

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 45/200 (22%), Positives = 91/200 (45%), Gaps = 22/200 (11%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L   +      +   E E + ++ +P IVR+     A +  +L+ +    G L  
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNK 83

Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L +G  D +        +++    + G+ Y+     + +VH ++ +  +LL ++ +  I
Sbjct: 84  FL-SGKKDEITV---SNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKI 136

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL++ L        +++   + +  +       + APE  I   KF+ + DV+S+GI
Sbjct: 137 SDFGLSKALGA------DDSYYKARSAGKWPL---KWYAPEC-INFRKFSSRSDVWSYGI 186

Query: 555 VLLEILT-GRLPD---AGPE 570
            + E  + G+ P     GPE
Sbjct: 187 TMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 43.6 bits (102), Expect = 2e-04
 Identities = 36/173 (20%), Positives = 81/173 (46%), Gaps = 24/173 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E+  +  +++PNIV     +   DE  ++ +++  GSL   +     D       EA++
Sbjct: 65  NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-------EAQI 117

Query: 454 -KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
             + +   + L ++H     + +H +IKS  +LL  +    ++ FG        +++T  
Sbjct: 118 AAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGF------CAQITPE 168

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           ++  ++  G      +  ++APE  +    +  K D++S GI+ +E++ G  P
Sbjct: 169 QSKRSTMVG------TPYWMAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 60/254 (23%), Positives = 110/254 (43%), Gaps = 42/254 (16%)

Query: 384 DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSD 442
           DA  R  D   E++ + ++ HPN+++  A +  ++E  ++ +    G L   + H     
Sbjct: 42  DAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 100

Query: 443 SLPP--LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN 500
            L P    W+  +++       L ++H    R+ +H +IK   + +       +   GL 
Sbjct: 101 RLIPEKTVWKYFVQLCSA----LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG 153

Query: 501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEIL 560
           R    +SK T   ++V  GT          Y++PE RI+ + +  K D++S G +L E+ 
Sbjct: 154 RFF--SSKTTAAHSLV--GT--------PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMA 200

Query: 561 TGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK--RQVLATFHIALNC 618
             + P  G   D   L SL +K       + +   P L  + +++  RQ++        C
Sbjct: 201 ALQSPFYG---DKMNLYSLCKK-------IEQCDYPPLPSDHYSEELRQLVNM------C 244

Query: 619 TELDPEFRPRMRTV 632
              DPE RP +  V
Sbjct: 245 INPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 29/182 (15%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSD-SLPPLP 448
           FE E + ++    P I +L+  +   D   L+ ++   G L + L  +    D  +    
Sbjct: 48  FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---- 103

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
             A+  +A+      + IH      YVH +IK   +L+D   H  ++ FG        ++
Sbjct: 104 --AQFYLAELV----LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG------SAAR 151

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPEARI-----YGSKFTQKCDVYSFGIVLLEILTGR 563
           +T N+ +      S++   +  Y+APE            +  +CD +S G++  E++ GR
Sbjct: 152 LTANKMVN-----SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Query: 564 LP 565
            P
Sbjct: 207 SP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 40/202 (19%)

Query: 374 VVAVRRL--TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
           VVA++++  +   +  +++D   EV  + +++HPN +  K  Y       L+ ++   GS
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS 100

Query: 432 LYAALHAGPSDSL----PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
                    SD L     PL       I  G  +GL Y+H +   + +H +IK+  ILL 
Sbjct: 101 --------ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLT 149

Query: 488 DELHPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKF 543
           +     ++ FG   L+ P  S V         GT          ++APE   A   G ++
Sbjct: 150 EPGTVKLADFGSASLVSPANSFV---------GT--------PYWMAPEVILAMDEG-QY 191

Query: 544 TQKCDVYSFGIVLLEILTGRLP 565
             K DV+S GI  +E+   + P
Sbjct: 192 DGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 3e-04
 Identities = 22/61 (36%), Positives = 30/61 (49%), Gaps = 2/61 (3%)

Query: 90  SLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNL 148
           +L  L L++N  +  IP   F    NL  LDL+ N+     P+    L +L  LDLS N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 149 L 149
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 28/216 (12%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+  +G   KV   +    GA   +A  ++ E  +    +D+  E+E +A   HP IV
Sbjct: 16  IIGELGDGAFGKVYKAKNKETGA---LAAAKVIETKSEEELEDYMVEIEILATCNHPYIV 72

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L   +Y + +  ++ +F   G++ A +         P   + ++ I +     L Y+H 
Sbjct: 73  KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS 128

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H ++K+  +LL  +    ++ FG++          KN          R S I 
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVS---------AKN----VKTLQRRDSFIG 172

Query: 529 NVY-LAPEA----RIYGSKFTQKCDVYSFGIVLLEI 559
             Y +APE      +  + +  K D++S GI L+E+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 22/198 (11%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L    S         AR 
Sbjct: 44  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARF 99

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H    R  V+ +IK   ++LD + H  I+ FGL +           E
Sbjct: 100 YGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-----------E 144

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG 573
            I + G   +    +  YLAPE  +  + + +  D +  G+V+ E++ GRLP    +++ 
Sbjct: 145 GI-SDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE- 201

Query: 574 KGLESLVRKAFRERRPLS 591
           +  E ++ +  R  R LS
Sbjct: 202 RLFELILMEEIRFPRTLS 219

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 46/183 (25%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           +E   +  V HP I+RL  F+  +D++ L  + +++  G L++ L               
Sbjct: 50  NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL-------------RN 94

Query: 452 RLKIAQGTAR--------GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL 503
             + +  T           L Y+H    ++ V+ ++K   ILLD E H  ++ FG     
Sbjct: 95  SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGF---- 147

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKC-DVYSFGIVLLEILTG 562
              +K  ++ T    GT          YLAPE  +  SK   K  D ++ GI++ E+L G
Sbjct: 148 ---AKKLRDRTWTLCGTPE--------YLAPE--VIQSKGHNKAVDWWALGILIYEMLVG 194

Query: 563 RLP 565
             P
Sbjct: 195 YPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 26/222 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL----TEGDATWR-FKDFESEVEAIARVQ 403
           V+GK   G +Y  +  +G       ++AV+++    +   A  + ++  + EV+ +  ++
Sbjct: 7   VLGKGAYGTVYCGLTNQGQ------LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           H NIV+       ++   +  +F+  GS+ + L     +   PLP     K  +    G+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGV 115

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y+H       VH +IK   ++L       +  FG  R L        +  ++ S  G+ 
Sbjct: 116 AYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT- 171

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                  ++APE  I  S + +K D++S G  + E+ TG+ P
Sbjct: 172 -----PYWMAPEV-INESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 19/115 (16%)

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
           KIA  T + L Y+ E    K +H ++K + ILLD   +  +  FG++  L        + 
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-------VDS 161

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGS---KFTQKCDVYSFGIVLLEILTGRLP 565
              T   G R       Y+APE RI  S    +  + DV+S GI L E+ TG+ P
Sbjct: 162 IAKTRDAGCR------PYMAPE-RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 99

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H       V+ ++K   ++LD + H  I+ FGL +       ++   
Sbjct: 100 YGAE-IVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGA 150

Query: 514 TIVT-SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T+ T  GT          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 151 TMKTFCGTPE--------YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 60/265 (22%), Positives = 115/265 (43%), Gaps = 45/265 (16%)

Query: 356 GIMYKVVVGRGSGMGAPTVV---------AVRRLTEGDATWR-FKDFESEVEAIARVQHP 405
              +  VVG+GS  G  ++V          +++L   +A+ R  K  E E + +++++HP
Sbjct: 1   AYCFVRVVGKGS-YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHP 59

Query: 406 NIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPP---LPWEARLKIAQGTAR 461
           NIV  +  +   D  L ++  F   G LY  L       LP    + W  ++ +A     
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA----- 114

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
            L Y+HE   +  +H ++K+  + L       +   G+ R+L   ++     T++  GT 
Sbjct: 115 -LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLI--GT- 165

Query: 522 SRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV 580
                    Y++PE  ++ +K +  K DV++ G  + E+ T +        + K + SLV
Sbjct: 166 -------PYYMSPE--LFSNKPYNYKSDVWALGCCVYEMATLK-----HAFNAKDMNSLV 211

Query: 581 RKAFRERRP-LSEVIDPALVKEIHA 604
            +    + P + +   P L + I  
Sbjct: 212 YRIIEGKLPPMPKDYSPELGELIAT 236

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 27/205 (13%)

Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRL--KAFYYANDEKLLISDFIRNGSL 432
           VAV+++   D     K    E++ I R+ H NIV++        +D    +       S+
Sbjct: 33  VAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSV 91

Query: 433 YAALHAGPSD-----SLPPLPWE-ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           Y       +D        PL  E ARL + Q   RGL YIH  +    +H ++K   + +
Sbjct: 92  YIVQEYMETDLANVLEQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLKPANVFI 147

Query: 487 D-DELHPCISGFGLNRLL-PGTS-KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
           + ++L   I  FGL R++ P  S K   +E +VT             Y +P   +  + +
Sbjct: 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-----------YRSPRLLLSPNNY 196

Query: 544 TQKCDVYSFGIVLLEILTGRLPDAG 568
           T+  D+++ G +  E+LTG+   AG
Sbjct: 197 TKAIDMWAAGCIFAEMLTGKPLFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 33/181 (18%)

Query: 393 ESEVEAI--ARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAG-----PSDSLP 445
           +S  EA+  A+++HPNIV  K  + A+    ++ ++   G L   +        P D++ 
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI- 102

Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG 505
            L W  ++ +      G+ +IHE   ++ +H +IKS  I L       +  FG  RLL  
Sbjct: 103 -LQWFVQMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-- 150

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-KFTQKCDVYSFGIVLLEILTGRL 564
           TS      T V  GT          Y+ PE  I+ +  +  K D++S G +L E+ T + 
Sbjct: 151 TSPGAYACTYV--GT--------PYYVPPE--IWENMPYNNKSDIWSLGCILYELCTLKH 198

Query: 565 P 565
           P
Sbjct: 199 P 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 31/178 (17%)

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           A+G+ ++   + RK +H ++ +  ILL +     I  FGL R       + K+   V  G
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR------DIYKDPDYVRKG 239

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLES 578
                + +   ++APE  I+   +T + DV+SFG++L EI + G  P  G + D +    
Sbjct: 240 D----ARLPLKWMAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294

Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           L ++  R R P  +   P +             +   L+C   +P  RP    + E L
Sbjct: 295 L-KEGTRMRAP--DYTTPEM-------------YQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 42.0 bits (98), Expect = 6e-04
 Identities = 41/198 (20%), Positives = 86/198 (43%), Gaps = 32/198 (16%)

Query: 374 VVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF-IRNG 430
           VVA+++++     +  +++D   EV  + +++HPN ++ +  Y       L+ ++ + + 
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101

Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           S    +H  P   +          +  G  +GL Y+H ++    +H ++K+  ILL +  
Sbjct: 102 SDLLEVHKKPLQEV------EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPG 152

Query: 491 HPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKC 547
              +  FG   ++ P    V         GT          ++APE  +     ++  K 
Sbjct: 153 LVKLGDFGSASIMAPANXFV---------GT--------PYWMAPEVILAMDEGQYDGKV 195

Query: 548 DVYSFGIVLLEILTGRLP 565
           DV+S GI  +E+   + P
Sbjct: 196 DVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 33/180 (18%)

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR-LLPGTSKVTKNETIVTS 518
           ARG+ ++   + +  VH ++ +  +LL       I  FGL R ++  ++ V+K  T +  
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
                       ++APE+ I+ + +T   DV+S+GI+L EI + G  P  G   D     
Sbjct: 304 K-----------WMAPES-IFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FY 350

Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           + ++  +R  +P             HA ++V   + I + C   +PE RP    +S+ ++
Sbjct: 351 NKIKSGYRMAKP------------DHATQEV---YDIMVKCWNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 49/183 (26%), Positives = 78/183 (42%), Gaps = 29/183 (15%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +  + HP+I++LK  +  N    LI    +   LY  L A  +     +     L
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRN-----IAICDIL 185

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP---CISGFGLNRLLPGTSKVT 510
            I +   R + Y+HE      +H +IK+  I ++   HP   C+  FG     P    + 
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGA-ACFP--VDIN 236

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
            N+    +GT   I+  +   LA +   YG       D++S GIVL E+ T    D+  E
Sbjct: 237 ANKYYGWAGT---IATNAPELLARDP--YGPA----VDIWSAGIVLFEMATCH--DSLFE 285

Query: 571 NDG 573
            DG
Sbjct: 286 KDG 288

Length = 391

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 34/127 (26%), Positives = 52/127 (40%), Gaps = 36/127 (28%)

Query: 474 YVHGNIKSTKILLDDELHPCISGFGLN-------------RLLPGTS------------- 507
           ++H +IK   IL+D   H  +S FGL+             +LL G S             
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 508 -----KVTKNETIVTSGTGSRISAISNV----YLAPEARIYGSKFTQKCDVYSFGIVLLE 558
                 ++  + I T     R+ A S V    Y+APE  +    + Q+CD +S G ++ E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFE 240

Query: 559 ILTGRLP 565
            L G  P
Sbjct: 241 CLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 31/173 (17%)

Query: 401 RVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           +V H +IV L      + E +++ +F+  G L   +H   SD L   PW  + K+A+  A
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTT-PW--KFKVAKQLA 115

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILL-----DDELHPCISGFGLNRLLPGT--SKVTKNE 513
             L Y+ +   +  VHGN+ +  ILL     D E  P I    L+   PG   + +++ E
Sbjct: 116 SALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIK---LSD--PGIPITVLSRQE 167

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEI-LTGRLP 565
            +       RI      ++APE        +   D +SFG  L EI   G +P
Sbjct: 168 CV------ERIP-----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 26/163 (15%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARG 462
           P IV +   ++  D+   I D +  G L+  L  H   S+       E R    +    G
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK------EMRFYATE-IILG 109

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L ++H    R  V+ ++K   ILLD+  H  IS  GL          +K +   + GT  
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL------ACDFSKKKPHASVGTHG 160

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                   Y+APE    G+ +    D +S G +L ++L G  P
Sbjct: 161 --------YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 21/198 (10%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 44  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 99

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +           E
Sbjct: 100 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------E 145

Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG 573
            I    T          YLAPE  +  + + +  D +  G+V+ E++ GRLP    +++ 
Sbjct: 146 GIKDGATMKTFCGTPE-YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE- 202

Query: 574 KGLESLVRKAFRERRPLS 591
           K  E ++ +  R  R LS
Sbjct: 203 KLFELILMEEIRFPRTLS 220

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 23/165 (13%)

Query: 402 VQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           ++HP +V L  + +   EKL  + D++  G L+  L        P     AR   A+  A
Sbjct: 53  LKHPFLVGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARFYAAE-VA 106

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
             + Y+H  +    ++ ++K   ILLD + H  ++ FGL +           E +    T
Sbjct: 107 SAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-----------EGVEPEET 152

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            S        YLAPE  +    + +  D +  G VL E+L G  P
Sbjct: 153 TSTFCGTPE-YLAPEV-LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 24/173 (13%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLPWEAR 452
           +EV  +    H N+V +   Y   DE  ++ +F+  G+L   + H   ++       E  
Sbjct: 68  NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQI 120

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
             +     R L Y+H    +  +H +IKS  ILL  +    +S FG    +  + +V K 
Sbjct: 121 ATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKR 175

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +++V  GT          ++APE  I    +  + D++S GI+++E++ G  P
Sbjct: 176 KSLV--GT--------PYWMAPEV-ISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 41/185 (22%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN-GSLYAALHAGPSDSLPPLPWEARL 453
           E++ + ++ H NIV LK       + L   DF ++ G+ Y        D +  L  E+ L
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDAL---DFKKDKGAFYLVFEYMDHDLMGLL--ESGL 110

Query: 454 ---------KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL- 503
                       +    GL Y H+   + ++H +IK + ILL+++    ++ FGL RL  
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 504 -----PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLE 558
                P T+KV                 I+  Y  PE  +   ++    DV+S G +L E
Sbjct: 168 SEESRPYTNKV-----------------ITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210

Query: 559 ILTGR 563
           + T +
Sbjct: 211 LFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 33/181 (18%)

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L Y+     +++VH +I +  +L+       +  FGL+R L       ++E+   +  G 
Sbjct: 120 LAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-------EDESYYKASKG- 168

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR 581
               +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G +N+    + + R
Sbjct: 169 ---KLPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR 220

Query: 582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL 641
               ER P+     P L             + +   C   DP  RPR   +   L  +  
Sbjct: 221 IENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Query: 642 Q 642
           +
Sbjct: 268 E 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 25/181 (13%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ + +++HPN+V L        E+   S   R GS+Y        D L  L     +K
Sbjct: 57  EIKILKKLKHPNVVPLIDMAV---ERPDKSKRKR-GSVYMVTPYMDHD-LSGLLENPSVK 111

Query: 455 IAQGTARGLM--------YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
           + +   +  M        Y+HE      +H +IK+  IL+D++    I+ FGL R   G 
Sbjct: 112 LTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 507 SKVTKNETIVTSGTGSRISAISNV----YLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
               K       G G      + V    Y  PE  +   ++T   D++  G V  E+ T 
Sbjct: 169 PPNPKG-----GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Query: 563 R 563
           R
Sbjct: 224 R 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 31/117 (26%), Positives = 57/117 (48%), Gaps = 16/117 (13%)

Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           A   + GL ++H    R  ++ ++K   ++LD E H  I+ FG+ +           E +
Sbjct: 107 AAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----------EHM 152

Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
           V  G  +R    +  Y+APE   Y   + +  D +++G++L E+L G+ P  G + D
Sbjct: 153 V-DGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 37/169 (21%), Positives = 72/169 (42%), Gaps = 23/169 (13%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           P + +L + +   D    + +++  G L Y     G       + + A + I      GL
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++H    +  ++ ++K   ++LD E H  I+ FG+ +           E +    T   
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----------ENMWDGVTTKT 160

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                + Y+APE   Y   + +  D ++FG++L E+L G+ P  G + D
Sbjct: 161 FCGTPD-YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 37/126 (29%), Positives = 53/126 (42%), Gaps = 23/126 (18%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L L + N    +P E+ LL++L  L L SNN    + ++L N  NL  L+L++N    
Sbjct: 189 NNLDL-SGNKISDLPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLED 246

Query: 128 PI---------------------PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
                                     + +L NL  LDLS N L+ +LP   L L  L   
Sbjct: 247 LPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306

Query: 167 LNLSFN 172
           LNL   
Sbjct: 307 LNLLLT 312

Length = 394

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 15/103 (14%)

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           RGL Y H+   RK +H ++K   +L++++    ++ FGL R     +K   NE +     
Sbjct: 114 RGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW-- 168

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                     Y  P+  +  ++++   D++  G +L E+ TGR
Sbjct: 169 ----------YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 31/194 (15%)

Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG 505
           PL  +  L+ +   A+G+ ++   + +  +H ++ +  +LL D     I  FGL R    
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---- 260

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRL 564
              +  +   V  G  +R+      ++APE+ I+   +T + DV+S+GI+L EI + G+ 
Sbjct: 261 --DIMNDSNYVVKGN-ARLPV---KWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Query: 565 PDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPE 624
           P  G   + K    +V++ ++  RP     D A   EI         + I   C  L+P 
Sbjct: 314 PYPGILVNSK-FYKMVKRGYQMSRP-----DFAP-PEI---------YSIMKMCWNLEPT 357

Query: 625 FRPRMRTVSESLDR 638
            RP    +S+ + R
Sbjct: 358 ERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 25/163 (15%)

Query: 410 LKAFYYA-NDEK--LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +   +YA  DE    L+ D+   G L   L +   D LP     AR  IA+     ++ I
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPED--MARFYIAEM----VLAI 115

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H      YVH +IK   +LLD   H  ++ FG         K+ ++ T+ +S     ++ 
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG------SCLKMNQDGTVQSS-----VAV 164

Query: 527 ISNVYLAPE---ARIYG-SKFTQKCDVYSFGIVLLEILTGRLP 565
            +  Y++PE   A   G  K+  +CD +S G+ + E+L G  P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 23/165 (13%)

Query: 403 QHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG-TA 460
           Q P +V L  + +  + KL LI D++  G ++  L+   + S      E  ++   G   
Sbjct: 63  QSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEII 115

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
             L ++H+      V+ +IK   ILLD E H  ++ FGL++         K  T    GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE---KERTYSFCGT 169

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                     Y+APE         +  D +S GI++ E+LTG  P
Sbjct: 170 IE--------YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 50/209 (23%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNG---SLYAALHAGPSDSLPPL 447
           ++E + +A   +  +V+L  +Y   D+  L  + D+I  G   SL   L     D     
Sbjct: 49  KAERDILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---- 102

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL-------- 499
              AR  IA+ T   +  +H+     ++H +IK   IL+D + H  ++ FGL        
Sbjct: 103 ---ARFYIAELTC-AIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155

Query: 500 NRLLPGTSKVTKNETIVTSGTGS-------------------RISAISNV----YLAPEA 536
           +          + +++  S   S                   R  A S V    Y+APE 
Sbjct: 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215

Query: 537 RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            +  + +TQ CD +S G++L E+L G+ P
Sbjct: 216 -LLRTGYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.003
 Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 30/193 (15%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRNGSLYAALHAGPSDSLPPLPW 449
             +E + +A    P IV+L  +Y   DE+ L  + +++  G L   L     D  P    
Sbjct: 48  VRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEE-- 101

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP--GTS 507
            AR  IA+     L  +H+     ++H +IK   IL+D + H  ++ FGL + +      
Sbjct: 102 TARFYIAELVL-ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157

Query: 508 KVTKNETIVTSGTGSRISAI---------------SNVYLAPEARIYGSKFTQKCDVYSF 552
           +   N++       + +                  +  Y+APE  + G+ +  +CD +S 
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV-LRGTPYGLECDWWSL 216

Query: 553 GIVLLEILTGRLP 565
           G++L E+L G  P
Sbjct: 217 GVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 56/263 (21%), Positives = 115/263 (43%), Gaps = 42/263 (15%)

Query: 384 DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSD 442
           DA  R +D   E++ + ++ HPN+++    +  ++E  ++ +    G L   + +     
Sbjct: 42  DAKAR-QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK 100

Query: 443 SLPP--LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN 500
            L P    W+  +++       + ++H    R+ +H +IK   + +       +   GL 
Sbjct: 101 RLIPERTVWKYFVQLCSA----VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG 153

Query: 501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEIL 560
           R    +SK T   ++V  GT          Y++PE RI+ + +  K D++S G +L E+ 
Sbjct: 154 RFF--SSKTTAAHSLV--GT--------PYYMSPE-RIHENGYNFKSDIWSLGCLLYEMA 200

Query: 561 TGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK--RQVLATFHIALNC 618
             + P  G   D   L SL +K       + +   P L  E +++  R++++       C
Sbjct: 201 ALQSPFYG---DKMNLFSLCQK-------IEQCDYPPLPTEHYSEKLRELVSM------C 244

Query: 619 TELDPEFRPRMRTVSESLDRVKL 641
              DP+ RP +  V +   ++ +
Sbjct: 245 IYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 39.3 bits (92), Expect = 0.004
 Identities = 38/136 (27%), Positives = 59/136 (43%), Gaps = 30/136 (22%)

Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD--ELHPC---ISGFGLN 500
           P+P +   K+     + L Y+ E      +H ++K + ILLD    +  C   ISG    
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGR--- 164

Query: 501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVL 556
                         +V S   +R SA    Y+APE RI       K+  + DV+S GI L
Sbjct: 165 --------------LVDSKAKTR-SAGCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISL 208

Query: 557 LEILTGRLPDAGPEND 572
           +E+ TG+ P    + +
Sbjct: 209 VELATGQFPYKNCKTE 224

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 26/163 (15%)

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARG 462
           P IV +   ++  D+   I D +  G L+  L  H   S++      E R   A+    G
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFYAAE-IILG 109

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L ++H    R  V+ ++K   ILLD+  H  IS  GL       SK   + ++ T G   
Sbjct: 110 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHG--- 160

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                   Y+APE    G  +    D +S G +L ++L G  P
Sbjct: 161 --------YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 22/173 (12%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEAR 452
           +E + + +V    +V L   Y   D   L+   +  G L +   + G     P    E  
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERA 104

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +  A     GL  +H     + V+ ++K   ILLDD  H  IS  GL        ++ + 
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL------AVEIPEG 155

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           ETI       R+  +   Y+APE  +   ++T   D +  G ++ E++ G+ P
Sbjct: 156 ETI-----RGRVGTVG--YMAPEV-VKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	642
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PLN03150	623	hypothetical protein; Provisional	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
smart00090	237	RIO RIO-like kinase.	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.53
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.43
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.42
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.39
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.37
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
PLN03150	623	hypothetical protein; Provisional	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.22
KOG1243	690	consensus Protein kinase [General function predict	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.08
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.07
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.06
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.03
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.02
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.02
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.01
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.0
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.9
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.9
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.86
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.85
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.83
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.8
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.77
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.76
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.73
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.69
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.58
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.53
PRK09902	216	hypothetical protein; Provisional	98.43
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.41
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.4
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.4
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.25
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.24
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.17
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.12
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.07
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-63  Score=589.46  Aligned_cols=496  Identities=28%  Similarity=0.489  Sum_probs=346.6

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecc
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  145 (642)
                      .++.|+|++|.+.|.+|..+ .+++|+.|+|++|++++.+|..+.++++|+.|+|++|++.+.+|..+..+++|+.|+|+
T Consensus       453 ~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  531 (968)
T PLN00113        453 SLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS  531 (968)
T ss_pred             CCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence            34555555555555555544 34667777777777777777777788888888888888888888888888888888888


Q ss_pred             cccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCCCCCCC
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGF  225 (642)
Q Consensus       146 ~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~  225 (642)
                      +|.++|.+|..+..+++|+ .|+|++|+++|.+|..+.+++.|+.|++++|+++|.+|....+..+....+.||+.+|+.
T Consensus       532 ~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  610 (968)
T PLN00113        532 HNQLSGQIPASFSEMPVLS-QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG  610 (968)
T ss_pred             CCcccccCChhHhCcccCC-EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCC
Confidence            8888888888888888888 888888888888888888888888888888888888887666667777778888888874


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcEEEEeeehhHHHHHHHhhhhhhhhhhhhhhcCCC
Q 006522          226 PLQSPCPEPENPKVHANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRRAREGKM  305 (642)
Q Consensus       226 ~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~vi~~~~vvl~lv~v~~~~~~r~r~~~~~~~  305 (642)
                      +....     .       +       +..     .   ........++++++.+++++++++++++++++++++.+..+.
T Consensus       611 ~~~~~-----~-------~-------~c~-----~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  663 (968)
T PLN00113        611 DTTSG-----L-------P-------PCK-----R---VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRV  663 (968)
T ss_pred             ccccC-----C-------C-------CCc-----c---ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccc
Confidence            32100     0       0       000     0   000001112222222222222222222222222221111110


Q ss_pred             CCcccccccccccccccccCCceEEecC--CccccHHHHHhh--cccccCccCCceeEEEEecCCCCCCCCeEEEEEEec
Q 006522          306 GKEEKTNDAVLVTDEEEGQKGKFFIIDE--GFSLELEDLLRA--SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT  381 (642)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~  381 (642)
                         +.. ..          ......++.  ...++++++...  ..++||+|+||.||+|+...++     +.||||++.
T Consensus       664 ---~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~  724 (968)
T PLN00113        664 ---ENE-DG----------TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG-----MQFVVKEIN  724 (968)
T ss_pred             ---ccc-cc----------cccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCC-----cEEEEEEcc
Confidence               000 00          000111111  122445554443  3468999999999999986554     899999987


Q ss_pred             CCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH
Q 006522          382 EGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR  461 (642)
Q Consensus       382 ~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  461 (642)
                      .....     ..+|++++++++|||||+++|+|...+..++||||+++|+|.++++.        ++|..+.+|+.|||+
T Consensus       725 ~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~  791 (968)
T PLN00113        725 DVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAK  791 (968)
T ss_pred             CCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHH
Confidence            54322     23568899999999999999999999999999999999999999952        899999999999999


Q ss_pred             HHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC
Q 006522          462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS  541 (642)
Q Consensus       462 gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  541 (642)
                      ||+|||+.+.++|+||||||+||+++.++.+++. ||.+......                ....||..|||||++. +.
T Consensus       792 ~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----------------~~~~~t~~y~aPE~~~-~~  853 (968)
T PLN00113        792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----------------TKCFISSAYVAPETRE-TK  853 (968)
T ss_pred             HHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----------------CCccccccccCccccc-CC
Confidence            9999997655899999999999999999988876 6655432111                1235678899999854 47


Q ss_pred             CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhch-hHHHHHHHHHHHHHhcCC
Q 006522          542 KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEI-HAKRQVLATFHIALNCTE  620 (642)
Q Consensus       542 ~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~l~~~Cl~  620 (642)
                      .++.++|||||||++|||+||+.||+........+..|++...... .....+|+.+.... ...++..++.+++.+||+
T Consensus       854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  932 (968)
T PLN00113        854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTA  932 (968)
T ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCc
Confidence            7999999999999999999999999765444556677766554332 23445555543221 223566788899999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhc
Q 006522          621 LDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       621 ~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      .||++||||+||+++|+++..
T Consensus       933 ~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        933 TDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCchhCcCHHHHHHHHHHhhc
Confidence            999999999999999998743

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-55  Score=450.36  Aligned_cols=281  Identities=38%  Similarity=0.630  Sum_probs=239.7

Q ss_pred             ccccHHHHHhhc-----ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeee
Q 006522          335 FSLELEDLLRAS-----AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR  409 (642)
Q Consensus       335 ~~~~~~~~~~~~-----~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  409 (642)
                      ..|+++++..++     .++||+|+||.||+|.+.++      +.||||++....... .++|.+|++++++++|||+|+
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~------~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG------TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC------CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCccc
Confidence            346777777765     37999999999999999998      799999887754432 367999999999999999999


Q ss_pred             EEEEEEeCC-ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC
Q 006522          410 LKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD  488 (642)
Q Consensus       410 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  488 (642)
                      |+|||.+.+ +.+||||||++|+|.++|+.....   +++|.+|++||.++|+||+|||+.+.++||||||||+|||||+
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            999999998 599999999999999999986542   6999999999999999999999998889999999999999999


Q ss_pred             CCCeEEecccccccCCC-CCcccccceeeecCCCcccc-cCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 006522          489 ELHPCISGFGLNRLLPG-TSKVTKNETIVTSGTGSRIS-AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD  566 (642)
Q Consensus       489 ~~~~kl~DfGla~~~~~-~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~  566 (642)
                      ++++||+|||+|+.... ...             .... .||.+|+|||++.. +..+.|+|||||||+|+||+||+.|.
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~~-------------~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~  278 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDTS-------------VSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAV  278 (361)
T ss_pred             CCCEEccCccCcccCCccccc-------------eeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCccc
Confidence            99999999999976543 210             0011 68999999999655 78999999999999999999999998


Q ss_pred             CCCC-CCcccHHHHHHHHHhccCCCccccChhhh-hchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          567 AGPE-NDGKGLESLVRKAFRERRPLSEVIDPALV-KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       567 ~~~~-~~~~~l~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      +... .....+..|+....... .+.+++||.+. ......+++.++..+|++|++.+|++||+|.||+++|+.+.
T Consensus       279 d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  279 DQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            7543 33445888887777766 57999999987 33332368889999999999999999999999999997765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=380.25  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=215.2

Q ss_pred             ccHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe
Q 006522          337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA  416 (642)
Q Consensus       337 ~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  416 (642)
                      +++.++.  ....||+|..|+|||+.++.++     +.+|+|.+....+....+++.+|++++.+.+||+||++||.|+.
T Consensus        76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~-----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTG-----KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhh--hhhhcccCCCcEEEEEEEcCCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            3444443  4578999999999999999887     89999999665555556899999999999999999999999999


Q ss_pred             CC-ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          417 ND-EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       417 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +. +..++||||.+|||++++...+     .+++...-+|+.+|++||.|||+.  .+||||||||+|||++..|++|||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence            99 5999999999999999998764     389999999999999999999963  799999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      |||.++.+..+              ...+.+||..|||||.+ .+..|+.++||||||+.++|+++|+.||.........
T Consensus       222 DFGVS~~lvnS--------------~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~  286 (364)
T KOG0581|consen  222 DFGVSGILVNS--------------IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD  286 (364)
T ss_pred             cccccHHhhhh--------------hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC
Confidence            99999877543              11256899999999984 4589999999999999999999999999876444556


Q ss_pred             HHHHHHHHHhccCC-Cccc-cChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          576 LESLVRKAFRERRP-LSEV-IDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~-~~~~-~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+.+..+..+..| +++- +++++.             +++-.|+++||.+||+++|+++
T Consensus       287 ~~~Ll~~Iv~~ppP~lP~~~fS~ef~-------------~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  287 IFELLCAIVDEPPPRLPEGEFSPEFR-------------SFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHHHHHHhcCCCCCCCcccCCHHHH-------------HHHHHHhcCCcccCCCHHHHhc
Confidence            77777777764433 3332 555444             4666699999999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=392.97  Aligned_cols=252  Identities=31%  Similarity=0.444  Sum_probs=203.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-ceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~  424 (642)
                      ...+|+|+||+||++.+...      ..||||++...+.. ...++|.+|+.+|.+++|||||+++|+|.+.. ...+||
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGT------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hhhcccCCceeEEEEEeCCc------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            34499999999999998875      45999999875322 22579999999999999999999999999987 799999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCCeeeCCCC-CeEEeccccccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK-YVHGNIKSTKILLDDEL-HPCISGFGLNRL  502 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDlkp~NILl~~~~-~~kl~DfGla~~  502 (642)
                      |||++|+|+++++....   ..+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus       120 Ey~~~GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EeCCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999999987411   359999999999999999999999   56 99999999999999997 999999999987


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCcccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .....            .......||+.|||||++.. ...|+.|+|||||||+||||+||+.||.+...     .+.+.
T Consensus       194 ~~~~~------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~  256 (362)
T KOG0192|consen  194 KVISK------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVAS  256 (362)
T ss_pred             ecccc------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            64321            01113578999999999653 36799999999999999999999999986433     12222


Q ss_pred             HH-HhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          582 KA-FRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       582 ~~-~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      .. ....+ .++....+.             +..++.+||+.||+.||++.|++..|+.+.
T Consensus       257 ~v~~~~~Rp~~p~~~~~~-------------l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  257 AVVVGGLRPPIPKECPPH-------------LSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             HHHhcCCCCCCCccCCHH-------------HHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            22 22222 223333333             345777799999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-48  Score=377.32  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=203.0

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc------cHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW------RFKDFESEVEAIARVQHPNIVRLKAFYYANDE  419 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  419 (642)
                      ..+.+|+|+||.|-+|+.++++     +.||||++.+.....      ......+|+++|++++|||||+++++|...+.
T Consensus       176 i~~~LGsGafg~Vkla~e~~tg-----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  176 ISKTLGSGAFGLVKLAYEKKTG-----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             eeeeecCCceeEEEEEEEcccC-----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            4678999999999999998887     999999998752211      22345799999999999999999999999999


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC---CCeEEec
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISG  496 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~D  496 (642)
                      .|||||||+||+|.+.+-.++.     +.+.....+++|++.|+.|||+   ++|+||||||+|||+..+   ..+||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999987764     7778889999999999999999   899999999999999655   8899999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS--KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK  574 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~  574 (642)
                      ||+|+......             ...+.|||+.|.|||++..++  .+..+.|+||+|||||-+++|.+||.+...+. 
T Consensus       323 FGlAK~~g~~s-------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-  388 (475)
T KOG0615|consen  323 FGLAKVSGEGS-------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-  388 (475)
T ss_pred             cchhhccccce-------------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-
Confidence            99999865332             123679999999999966532  23458899999999999999999998754432 


Q ss_pred             cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       575 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                         ...+++.+++.++....+.+         -..+..+++.++|..||++|||+.|+++
T Consensus       389 ---sl~eQI~~G~y~f~p~~w~~---------Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 ---SLKEQILKGRYAFGPLQWDR---------ISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---cHHHHHhcCcccccChhhhh---------hhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence               23344444444433222222         2235677999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=387.50  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=207.1

Q ss_pred             hcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          345 ASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       345 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...+.||+|-||.|+.|.+...      ..||+|.++......  ++|.+|+++|++|+|+|||+++|+|...+.+||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m~~--~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSMSP--EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCC------CcccceEEeccccCh--hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3467899999999999999887      689999998764333  88999999999999999999999999988999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |||+.|+|.++|+...+   ..+.-.+.+.++.|||+||+||++   +++|||||.++|||++++..+||+|||+||...
T Consensus       281 E~m~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EecccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999997333   248889999999999999999999   899999999999999999999999999999554


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ++.+...      .     ...-+..|.|||.+.. +.++.|||||||||+||||+| |+.||......  ...+.+.+.
T Consensus       355 d~~Y~~~------~-----~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~~le~G  420 (468)
T KOG0197|consen  355 DDEYTAS------E-----GGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLELLERG  420 (468)
T ss_pred             CCceeec------C-----CCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHHHHhcc
Confidence            4322111      1     1223456999999665 789999999999999999999 99998764432  233333333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ++-.+|  +.+             ...++++|..||+.+|++|||++.+...|+.+..
T Consensus       421 yRlp~P--~~C-------------P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  421 YRLPRP--EGC-------------PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CcCCCC--CCC-------------CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            332222  222             2345678999999999999999999999998754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.8e-47  Score=405.25  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=218.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|......-......||||.+++..+.....+|+||+++|+.++|||||+++|.|..++..++|+|
T Consensus       490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE  569 (774)
T KOG1026|consen  490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE  569 (774)
T ss_pred             ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence            45789999999999999887765566689999999988766566999999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEec
Q 006522          426 FIRNGSLYAALHAGPSDS---------LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG  496 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D  496 (642)
                      ||..|||.++|+.+....         ..+|+..+.+.||.|||.||+||-+   +.+|||||..+|+|+.++..+||+|
T Consensus       570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsD  646 (774)
T KOG1026|consen  570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISD  646 (774)
T ss_pred             ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecc
Confidence            999999999997654221         3459999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKG  575 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~  575 (642)
                      ||++|.+-..+++.....          ..-..+||+||.+.. ++||++||||||||+|||++| |+.||.+..+++  
T Consensus       647 fGLsRdiYssDYYk~~~~----------t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--  713 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGN----------TLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--  713 (774)
T ss_pred             cccchhhhhhhhhcccCC----------ceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence            999998766655543321          122456999999776 899999999999999999998 999998765532  


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                          +-...+.+.-+.           ..+.+-.++++||+.||+..|++||+++||-.+|+..
T Consensus       714 ----VIe~i~~g~lL~-----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  714 ----VIECIRAGQLLS-----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ----HHHHHHcCCccc-----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                222222222111           1123345678899999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=370.23  Aligned_cols=193  Identities=26%  Similarity=0.409  Sum_probs=173.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      .||+|+|++||+|+++..+     ..||||.+.+.. .....+....|+.+|+.++|||||+++++++.++..|||||||
T Consensus        17 ~iG~GsfavVykg~h~~~~-----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   17 EIGSGSFAVVYKGRHKKSG-----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             hccCcceEEEEEeEeccCC-----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            3999999999999999886     899999998763 3344577899999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC------CCeEEecccccc
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE------LHPCISGFGLNR  501 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DfGla~  501 (642)
                      .||||.++++.++.     +++.....++.|+|.||++||+   ++||||||||.||||+..      -.+||+|||+||
T Consensus        92 ~gGDLs~yi~~~~~-----l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   92 NGGDLSDYIRRRGR-----LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             CCCCHHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999998763     8999999999999999999999   899999999999999764      568999999999


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .+....             ...+.+|++.|||||+... ++|+.|+|+||.|+|+|++++|+.||+.
T Consensus       164 ~L~~~~-------------~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  164 FLQPGS-------------MAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hCCchh-------------HHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            886432             1236799999999999554 8999999999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-46  Score=380.62  Aligned_cols=245  Identities=21%  Similarity=0.320  Sum_probs=210.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .+.+||+|||..+|+++....+     ..||+|++.+.  ......+...+||+|.++|+|||||+++++|++.+..|+|
T Consensus        22 ~g~~LGkGgFA~cYe~~~~~tg-----e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   22 RGRFLGKGGFARCYEARDLDTG-----EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             eeeeeccCcceEEEEEEEcCCC-----cEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            4689999999999999995554     89999999874  2333458899999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      .|+|++|+|.++++..+     ++++.++..+++||+.||.|||+   .+|+|||||..|++|++++++||+|||||..+
T Consensus        97 LELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeee
Confidence            99999999999998443     59999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ..+..            ...+.||||-|+|||++. ...++..+||||+||+||.|++|++||..     ..+.+....+
T Consensus       169 e~~~E------------rk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFet-----k~vkety~~I  230 (592)
T KOG0575|consen  169 EYDGE------------RKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFET-----KTVKETYNKI  230 (592)
T ss_pred             cCccc------------ccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCccc-----chHHHHHHHH
Confidence            64421            223679999999999955 58899999999999999999999999974     4466666666


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......++..++.+.             .+|+...|+.||.+|||+.+|+.
T Consensus       231 k~~~Y~~P~~ls~~A-------------~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  231 KLNEYSMPSHLSAEA-------------KDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HhcCcccccccCHHH-------------HHHHHHHhcCCcccCCCHHHHhc
Confidence            666666666555443             34777799999999999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=356.30  Aligned_cols=238  Identities=21%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .-++||+|+||.||.++..+.+     +.+|+|.+++..  .....+....|..+|.+++||.||+++..|++.+..|+|
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~-----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTG-----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccC-----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            3578999999999999998776     899999998762  223357788999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      +||+.||.|+.+|.+.+.     +++..+..++.+|+.||.|||+   .+||||||||+|||||++|+++|+|||+++..
T Consensus       104 ld~~~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999987654     8899999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....            ..+...+||+.|||||++.. ..|+..+|.||+||++|||+||.+||..     .+...+.+..
T Consensus       176 ~~~~------------~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~-----~~~~~~~~~I  237 (357)
T KOG0598|consen  176 LKDG------------DATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYA-----EDVKKMYDKI  237 (357)
T ss_pred             ccCC------------CccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcC-----ccHHHHHHHH
Confidence            4332            12335799999999999665 7999999999999999999999999985     3456677777


Q ss_pred             Hhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC
Q 006522          584 FRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP  627 (642)
Q Consensus       584 ~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  627 (642)
                      ...+ ...+..++++..+             ++.+.++.||++|.
T Consensus       238 ~~~k~~~~p~~ls~~ard-------------ll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  238 LKGKLPLPPGYLSEEARD-------------LLKKLLKRDPRQRL  269 (357)
T ss_pred             hcCcCCCCCccCCHHHHH-------------HHHHHhccCHHHhc
Confidence            7766 3333445655443             56669999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-46  Score=344.56  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcccCCCeeeEEE-EEEeCCc-eEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKA-FYYANDE-KLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lv  423 (642)
                      ...||+|.||.|||+....++     +.||.|.+.-. .+.....+...|+.+|++++|||||++++ .+..+.+ .++|
T Consensus        24 l~~IG~GsFg~vykv~~~~~g-----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   24 LKKIGRGSFGEVYKVQCLLDG-----KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHcCCcchheEEeeeccCc-----chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            467999999999999987776     89999998744 23334477899999999999999999998 4444455 8999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPR-KYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||..|||.+.++..+... ..+++..+++++.|++.||.++|+..++ -|+||||||.||+|+.+|.+|++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999997544332 3599999999999999999999995532 389999999999999999999999999998


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      +....            +-..+.+|||.||+||.+. +..|+.||||||+||++|||+.-+.||.+.     .+.+.-++
T Consensus       178 l~s~~------------tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~K  239 (375)
T KOG0591|consen  178 LSSKT------------TFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKK  239 (375)
T ss_pred             hcchh------------HHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHH
Confidence            86542            1123678999999999854 589999999999999999999999999853     56666666


Q ss_pred             HHhccCC-Cc-cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          583 AFRERRP-LS-EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       583 ~~~~~~~-~~-~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      +.+...+ ++ +..+             ..+-+++..|+..||+.||+.-.++..+.
T Consensus       240 I~qgd~~~~p~~~YS-------------~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  240 IEQGDYPPLPDEHYS-------------TDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHcCCCCCCcHHHhh-------------hHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            6655432 22 2222             23445777799999999998544444443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=385.51  Aligned_cols=260  Identities=27%  Similarity=0.442  Sum_probs=216.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..++||.|-||.||+|.++..+...  ..||||.++......+..+|+.|+.||.+++||||++|.|........++|.|
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre--~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKRE--ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             EEEEEecccccceecccccCCCCcc--eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3589999999999999998765333  78999999998777777999999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||+||+|+.+|+.+..    .|++.+...+.++||.||.||-+   .++|||||..+|||++.+..+||+|||++|.+.+
T Consensus       711 yMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999998764    39999999999999999999999   8999999999999999999999999999998876


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      +.....+         +.......+|.|||.+.. +++|.+||||||||||||.++ |+.||.++.++  +...    ..
T Consensus       784 d~~~~yt---------t~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--dVIk----aI  847 (996)
T KOG0196|consen  784 DPEAAYT---------TLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVIK----AI  847 (996)
T ss_pred             CCCcccc---------ccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchH--HHHH----HH
Confidence            6421110         111233567999999665 899999999999999999987 99999876553  2223    33


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      .+...++...|           +...+.+||+.||++|-.+||++.+++..|+++-.
T Consensus       848 e~gyRLPpPmD-----------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  848 EQGYRLPPPMD-----------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HhccCCCCCCC-----------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            33333333222           33456779999999999999999999999999843

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-44  Score=354.49  Aligned_cols=259  Identities=19%  Similarity=0.265  Sum_probs=204.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCC-ceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAND-EKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lv~  424 (642)
                      .+.||.|.||.||+|+....+     ..||||++++.-..+..-.=+||+..|++++ |||||++.+.+.+.+ ..|+||
T Consensus        15 i~klGDGTfGsV~la~~~~~~-----~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   15 IRKLGDGTFGSVYLAKSKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHhcCCcceeEEEeeecCCC-----ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            467999999999999988876     7899999988744432223368999999998 999999999999988 999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |||+. +|+++++++.    .+|++..+..|+.||++||+|+|.   +|++|||+||+|||+.....+||+|||+||.+.
T Consensus        90 E~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             Hhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            99987 9999998874    369999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...             ..+..+.|.+|+|||+++..+.|+.+.||||+|||++|+++-++-|.+...- +.+.++....-
T Consensus       162 Skp-------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLG  227 (538)
T KOG0661|consen  162 SKP-------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLG  227 (538)
T ss_pred             cCC-------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhC
Confidence            442             2235677889999999998899999999999999999999999888874331 11222211110


Q ss_pred             hc---------------cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RE---------------RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~---------------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..               ...++....-.+...+.  ....++++++.+|+.+||.+|||+.|+++
T Consensus       228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p--~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP--NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCccccchhHHHHHHHhccCCCcCCCCChHHhCc--ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            00               00111111111111111  14567788999999999999999999886

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-43  Score=349.58  Aligned_cols=257  Identities=20%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      -..||+|.||.||+++...++     +.||+|+++... ......-..|||.||++|+|||||+|.+...+.  ..+|||
T Consensus       122 i~kIGeGTyg~VYkAr~~~tg-----kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETG-----KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHhcCcchhheeEeeecccC-----cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            357999999999999998876     899999998653 333345668999999999999999999999887  589999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      +|||++ ||..++.....    .|++.++..+++|++.||+|+|+   ++|+|||||.+|||||.+|.+||+|||||+++
T Consensus       197 FeYMdh-DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            999988 99999876543    49999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......           ..+..+.|.+|+|||.+++...|+.+.|+||.||||.||++|++.|.+...     .+.+..+
T Consensus       269 ~~~~~~-----------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-----veQl~kI  332 (560)
T KOG0600|consen  269 TPSGSA-----------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-----VEQLHKI  332 (560)
T ss_pred             cCCCCc-----------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-----HHHHHHH
Confidence            655321           123557789999999989888999999999999999999999999986432     2222323


Q ss_pred             HhccCCCccccCh------------------hhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDP------------------ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~------------------~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +.......+...+                  .+.+..  ..-....++|+-.+|..||.+|.|+.++++
T Consensus       333 fklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~--~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  333 FKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETF--KDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHhCCCChhccccccCCcccccCCCCcccchHHHHh--ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            2221111111111                  111100  011245678888999999999999998874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=332.50  Aligned_cols=258  Identities=19%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccH-HHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..+|+|+||+|||++.++++     +.||||++.+..+...+ +-.+||+++|++++|+|+|.+++.|......+||+||
T Consensus         8 gkvGEGSYGvV~KCrnk~Tg-----qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTG-----QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             hccccCcceEEEEeccCCcc-----cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            46899999999999999887     99999999887554333 5578999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |+. ++.+-|.....    .++.....+++.|+++|+.|+|+   +++|||||||+|||++.++.+|+||||+|+.+...
T Consensus        83 ~dh-TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   83 CDH-TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             cch-HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            988 66566655443    38889999999999999999999   89999999999999999999999999999988643


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH-----
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR-----  581 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~-----  581 (642)
                      ..            ..+..+.|.+|+|||.+.+..+|+..+||||.||++.||+||.+-|.+...-  +....++     
T Consensus       155 gd------------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~  220 (396)
T KOG0593|consen  155 GD------------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGN  220 (396)
T ss_pred             cc------------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcc
Confidence            21            2235577889999999888789999999999999999999999888764331  1111222     


Q ss_pred             ------HHHhccCCC-----ccccChhhhh-chhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 ------KAFRERRPL-----SEVIDPALVK-EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ------~~~~~~~~~-----~~~~d~~l~~-~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                            ..+...+-+     ++.-+++-.+ ...  .-..-+++++..|++.||++|++-+|++.
T Consensus       221 L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p--~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  221 LIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP--KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCHHHHHHhccCCceeeeecCCCCCccchhhhcc--cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                  222222111     1111111110 011  11235678999999999999999988874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=352.66  Aligned_cols=257  Identities=19%  Similarity=0.243  Sum_probs=209.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ++.+||+|+|++|++|+....+     +.+|||++.+..  ....++.+.+|-.+|.+| .||.||+|+-.|++....|+
T Consensus        77 Fg~~lGeGSYStV~~A~~~~t~-----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   77 FGKILGEGSYSTVVLAREKATG-----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhheeccccceeEEEeeecCCC-----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            5788999999999999998876     899999997752  223346678899999999 89999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |+||+++|+|.++|+..+.     |++.....++.||+.||+|||+   .+||||||||+|||||+||++||+|||.|+.
T Consensus       152 vLe~A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEecCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999998764     8999999999999999999999   8999999999999999999999999999999


Q ss_pred             CCCCCcccccceee-ecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          503 LPGTSKVTKNETIV-TSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      +............. .........+||..|.+||++. ....+..+|+|+|||+||.|+.|++||.+...     ...++
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFq  297 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQ  297 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHH
Confidence            87654321111110 0111124578999999999955 47889999999999999999999999975322     23445


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++..-...+++.+.+...             +|+.+.|..||.+|++..++-+
T Consensus       298 kI~~l~y~fp~~fp~~a~-------------dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 KIQALDYEFPEGFPEDAR-------------DLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHhcccCCCCCCHHHH-------------HHHHHHHccCccccccHHHHhh
Confidence            555555566666665443             3666799999999999988754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=347.49  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=197.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC--ceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND--EKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv  423 (642)
                      ..+.||+|+||.||++...+.+     ...|||.+....... .+.+.+|+.+|++++|||||+++|.....+  ..++.
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g-----~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTG-----ELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             hhccccCccceEEEEEEecCCC-----cceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            4678999999999999998853     789999987653322 477899999999999999999999866555  58899


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEeccccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~  502 (642)
                      |||+++|+|.+++...+.    .|++..+.++.+||++||+|||+   ++|+||||||+|||++. ++.+||+|||+++.
T Consensus        95 mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            999999999999987653    39999999999999999999999   89999999999999999 79999999999987


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ......         .........||+.|||||+...+.....++||||+||++.||+||+.||...    .....++-.
T Consensus       168 ~~~~~~---------~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~  234 (313)
T KOG0198|consen  168 LESKGT---------KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLL  234 (313)
T ss_pred             cccccc---------cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHH
Confidence            653110         1111224679999999999654333345999999999999999999999752    112222222


Q ss_pred             HHhcc--CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          583 AFRER--RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       583 ~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .....  +.+++.+++..             .+++.+|++.||++|||+.++++.
T Consensus       235 ig~~~~~P~ip~~ls~~a-------------~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  235 IGREDSLPEIPDSLSDEA-------------KDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             HhccCCCCCCCcccCHHH-------------HHHHHHHhhcCcccCcCHHHHhhC
Confidence            22222  23444444433             346777999999999999999864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-43  Score=385.02  Aligned_cols=262  Identities=26%  Similarity=0.399  Sum_probs=212.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|.||.||+|...+-.+......||||.+++..+....++|.+|+.+|++++|||||+++|.|.+....++++|
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence            46899999999999999987665544678999999987666667999999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          426 FIRNGSLYAALHAGPSDS--LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      ||++|||..+|++.+...  ...++-...+.++.|||+|+.||++   +++|||||..+|+||++...+||+|||+|+.+
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            999999999998863221  2358899999999999999999999   89999999999999999999999999999966


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ....++.....          ..-...|||||.+.. +.++.|+|||||||+|||++| |..||.+..+.     +....
T Consensus       853 y~~~yyr~~~~----------a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v~~~  916 (1025)
T KOG1095|consen  853 YDKDYYRKHGE----------AMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EVLLD  916 (1025)
T ss_pred             hhchheeccCc----------cccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HHHHH
Confidence            55444332211          012346999999665 889999999999999999999 99999764432     11221


Q ss_pred             HHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          583 AFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       583 ~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ...+. -+.+             ..+-..++++|..||+.+|++||++..+++.+..+
T Consensus       917 ~~~ggRL~~P-------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  917 VLEGGRLDPP-------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             HHhCCccCCC-------------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            22222 1111             12334567899999999999999999999988776

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.8e-43  Score=353.38  Aligned_cols=243  Identities=21%  Similarity=0.348  Sum_probs=207.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||||+.+.+.     +.||+|.+.+... .+..+.+.+|++|+++++|||||.++++|++..+.++|.|
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~-----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTI-----QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             HHHhcCCccceeeecccccce-----eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            357999999999999988776     8999999987643 3345789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+.| +|+.+|.+.+     .++++.+..|+.++..||.|||+   .+|+|||+||.|||++..+.+|+||||+|+.+..
T Consensus        82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9987 9999998765     39999999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ..+.+.|||.|||||+ ..++.|+..+|+||+|||+||+++|++||..     ..+.+.++.+..
T Consensus       153 ~t~------------vltsikGtPlYmAPEl-v~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I~~  214 (808)
T KOG0597|consen  153 NTS------------VLTSIKGTPLYMAPEL-VEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSILK  214 (808)
T ss_pred             Cce------------eeeeccCcccccCHHH-HcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHHhc
Confidence            311            1225689999999998 4468999999999999999999999999973     456777887777


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++...+...++.+             ..+....+.+||.+|.+-.+++.
T Consensus       215 d~v~~p~~~S~~f-------------~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 DPVKPPSTASSSF-------------VNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCCCcccccHHH-------------HHHHHHHhhcChhhcccHHHHhc
Confidence            6655444444443             34555689999999999888763

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=338.08  Aligned_cols=260  Identities=20%  Similarity=0.297  Sum_probs=208.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...+||.|..++||+|+....+     ..||||++.-.........+.+|+..|+.++||||++++..|..+.+.|+||.
T Consensus        30 L~e~IG~G~sa~V~~A~c~p~~-----e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   30 LQEVIGVGASAVVYLARCIPTN-----EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             EEEEEeccceeEeeeeeecccC-----CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3578999999999999987765     89999999876555556889999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||.+||+.++++..-..   .+++..+..|.+++++||.|||.   ++.||||||+.|||||++|.+||+|||.+..+..
T Consensus       105 fMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999877654   39999999999999999999999   8999999999999999999999999998877665


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccc-cccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEA-RIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....  .    .  .....+||+.|||||+ ......|+.|+||||||++..||++|..||...    ..+....... 
T Consensus       179 ~G~R~--~----~--rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~----pPmkvLl~tL-  245 (516)
T KOG0582|consen  179 SGDRQ--V----T--RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY----PPMKVLLLTL-  245 (516)
T ss_pred             cCcee--e----E--eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC----ChHHHHHHHh-
Confidence            43110  0    1  1135689999999998 334467999999999999999999999999742    2233333333 


Q ss_pred             hccCCCcc--ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSE--VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~--~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +..++...  ..+.+-     ....-..+.+++-.|++.||++|||+.++++
T Consensus       246 qn~pp~~~t~~~~~d~-----~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  246 QNDPPTLLTSGLDKDE-----DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCCCCCcccccCChHH-----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            33332122  112111     1122236677888899999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-41  Score=354.57  Aligned_cols=265  Identities=25%  Similarity=0.352  Sum_probs=200.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC-ceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND-EKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lv  423 (642)
                      ..+.||+|+||.||+|.............||||+++........+.+.+|+.++.++ +|||||+++++|...+ ..++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI   90 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence            357899999999999986432222233689999997654333446799999999999 8999999999987654 57899


Q ss_pred             EeeccCCcHHHHHhcCCCC---------------------------------------------------------CCCC
Q 006522          424 SDFIRNGSLYAALHAGPSD---------------------------------------------------------SLPP  446 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~  446 (642)
                      |||+++|+|.+++......                                                         ...+
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            9999999999999753210                                                         0135


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCccccc
Q 006522          447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA  526 (642)
Q Consensus       447 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (642)
                      +++..+..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+++.........          ......
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~----------~~~~~~  237 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----------RKGSAR  237 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh----------cccCCC
Confidence            8899999999999999999999   899999999999999999999999999998654321110          011234


Q ss_pred             CCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhccC-CCccccChhhhhchhH
Q 006522          527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHA  604 (642)
Q Consensus       527 gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~  604 (642)
                      ++..|+|||++. +..++.++|||||||++|||+| |+.||.+.....    .+......... ..+...+         
T Consensus       238 ~~~~y~aPE~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~---------  303 (338)
T cd05102         238 LPLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTRMRAPENAT---------  303 (338)
T ss_pred             CCccccCcHHhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCCCCCCCCCC---------
Confidence            567799999854 4678999999999999999997 999997543221    11121111111 1111112         


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          605 KRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       605 ~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                          ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       304 ----~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 ----PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                235678999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=350.70  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=203.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC----CccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCce
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG----DATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEK  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~  420 (642)
                      ....||+|+||.|+.+.....+     ..||+|.+...    ......+.+.+|+.++++++ ||||+++++++......
T Consensus        21 ~~~~lG~GsfgkV~~a~~~~t~-----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   21 LGRTLGSGSFGKVKLAKHRLTG-----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             eeeeecCCCCeeEEEeeeccCC-----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            3578999999999999988765     89999977653    11122356778999999998 99999999999999999


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC-CCeEEecccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGL  499 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGl  499 (642)
                      |+||||+.+|+|++++...+     .+.+....++++|++.|++|||+   .+|+||||||+|||+|.+ +.+||+|||+
T Consensus        96 ~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999998843     38889999999999999999999   899999999999999999 9999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES  578 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~  578 (642)
                      +......            .......+||+.|+|||++.... ..+.++||||+||+||.|++|+.||++     .....
T Consensus       168 s~~~~~~------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-----~~~~~  230 (370)
T KOG0583|consen  168 SAISPGE------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-----SNVPN  230 (370)
T ss_pred             ccccCCC------------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-----ccHHH
Confidence            9876311            11223678999999999966644 335899999999999999999999986     23444


Q ss_pred             HHHHHHhccCCCcccc-ChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          579 LVRKAFRERRPLSEVI-DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       579 ~~~~~~~~~~~~~~~~-d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      ..+........++..+ ++++             ..++.+|+..||.+|+++.|++
T Consensus       231 l~~ki~~~~~~~p~~~~S~~~-------------~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  231 LYRKIRKGEFKIPSYLLSPEA-------------RSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHhcCCccCCCCcCCHHH-------------HHHHHHHcCCCcccCCCHHHHh
Confidence            5555666666666666 5544             3477779999999999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-43  Score=355.95  Aligned_cols=256  Identities=26%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .++.||+|+||+||+|.+..+        ||||.+.... .....+.|..|+..+++-+|.||+=+.|||..+.. .+|.
T Consensus       396 l~~rIGsGsFGtV~Rg~whGd--------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHGD--------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             ccceeccccccceeecccccc--------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            468899999999999998764        9999998763 23456899999999999999999999999998877 9999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      .+|+|-+|+.+||....    .|...+.++|++|||+||.|||.   ++|||||||+.||++.+++++||+|||++..-.
T Consensus       467 qwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             hhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            99999999999997663    48899999999999999999999   899999999999999999999999999986422


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .-          ..........|..-|||||++...  ..|+..+||||||||+|||+||..||.. ...+..+..    
T Consensus       540 ~w----------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifm----  604 (678)
T KOG0193|consen  540 RW----------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFM----  604 (678)
T ss_pred             ee----------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEE----
Confidence            11          011122245677889999986542  4589999999999999999999999983 222211111    


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      . ...     .+.|++...  ...+-.++.+|+..||..++++||.+.+|+.+|+.+.
T Consensus       605 V-GrG-----~l~pd~s~~--~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  605 V-GRG-----YLMPDLSKI--RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             e-ccc-----ccCccchhh--hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            0 111     011111111  1234456778899999999999999999999888774

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=350.98  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      -..||+|+.|.||.+......     +.||||++....... .+-+.+|+.+|+..+|+|||++++.|...++.+.||||
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~-----~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTK-----QEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhccccccceeeeeeccCC-----ceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            357999999999999987775     889999998754433 26688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |++|+|.|.+....      +++.++..|++++++||+|||.   ++|+|||||.+|||++.++.+||+|||++..+...
T Consensus       352 m~ggsLTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR------MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             cCCCchhhhhhccc------ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999997543      8999999999999999999999   89999999999999999999999999999877654


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ...+.+||++|||||+.. ...|++|.||||+|++++||+-|++||..    +..+..+..-....
T Consensus       423 ~~------------KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng  485 (550)
T KOG0578|consen  423 QS------------KRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNG  485 (550)
T ss_pred             cC------------ccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcC
Confidence            21            223678999999999944 47899999999999999999999999974    22233332222222


Q ss_pred             cCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+.  ..+.+++.+.+             +..+||+.|+++|+++.|+++
T Consensus       486 ~P~lk~~~klS~~~kd-------------FL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 TPKLKNPEKLSPELKD-------------FLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCCcCCccccCHHHHH-------------HHHHHhhcchhcCCCHHHHhc
Confidence            221  24445555544             566699999999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-41  Score=350.56  Aligned_cols=244  Identities=22%  Similarity=0.322  Sum_probs=211.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      +..||+|+.|.|..|+...++     +.+|||++.+..  .......+++||-+|+-++||||+++|+.+++..+.|+|.
T Consensus        17 gkTLG~Gstg~vrlakh~~TG-----qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETG-----QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cccccCCCCceehhhhccccc-----ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            567999999999999998876     899999997652  1222356889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|.|++++..++     ++++....++++||+.|+.|+|.   .+|+||||||+|+|||..+.+||+|||+|..-.
T Consensus        92 Eyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            9999999999998766     48999999999999999999999   799999999999999999999999999997643


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .+             ....+.||++.|.|||+..+....+.++||||.|||||.|+||+.||++     +++..++.+..
T Consensus       164 ~g-------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~  225 (786)
T KOG0588|consen  164 PG-------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQ  225 (786)
T ss_pred             CC-------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHH
Confidence            22             2233679999999999966655567999999999999999999999983     46778888888


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++...++..+.++..+             |+.+++..||+.|.|++||.+
T Consensus       226 ~G~f~MPs~Is~eaQd-------------LLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  226 RGVFEMPSNISSEAQD-------------LLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cCcccCCCcCCHHHHH-------------HHHHHhccCccccccHHHHhh
Confidence            8888788778776654             666699999999999999976

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.9e-41  Score=339.57  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=203.8

Q ss_pred             ccccHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHHHHhcccCCCeeeEEE
Q 006522          335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVEAIARVQHPNIVRLKA  412 (642)
Q Consensus       335 ~~~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~  412 (642)
                      ..++.+++.......+|+|++|.||+|... +      +.||||+++.....  ...+.|.+|+.+|++++|||||+++|
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~-~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFN-N------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEEC-C------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            345667776666788999999999999984 3      79999999765322  22477889999999999999999999


Q ss_pred             EEEe----CCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC
Q 006522          413 FYYA----NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD  488 (642)
Q Consensus       413 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  488 (642)
                      ++.+    ....++||||+++|+|.+++....     .++|....+++.|++.||.|||+.  .+++||||||+||++++
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~  158 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTE  158 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECC
Confidence            9987    346789999999999999997643     389999999999999999999972  37889999999999999


Q ss_pred             CCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCcccccc-CCCCCcccchHHHHHHHHHHHhCCCCCC
Q 006522          489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-GSKFTQKCDVYSFGIVLLEILTGRLPDA  567 (642)
Q Consensus       489 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDV~S~Gvvl~el~tG~~P~~  567 (642)
                      ++.+||+|||+++......               ....|+..|+|||++.. ...++.++|||||||++|||+||+.||.
T Consensus       159 ~~~~kl~dfg~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        159 NYKLKIICHGLEKILSSPP---------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             CCcEEEcccchHhhhcccc---------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            9999999999988653221               12356778999998543 1578999999999999999999999997


Q ss_pred             CCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          568 GPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       568 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....     ..+............  ++..         ....+.+++.+||+.||++|||++|+++.|+.++
T Consensus       224 ~~~~-----~~~~~~i~~~~~~~~--~~~~---------~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        224 NLTT-----KEIYDLIINKNNSLK--LPLD---------CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCH-----HHHHHHHHhcCCCCC--CCCc---------CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            5321     222232222211111  1111         1123556888999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-41  Score=312.08  Aligned_cols=259  Identities=18%  Similarity=0.270  Sum_probs=202.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...+|+|.||.||+|++..++     +.||||+++.....+. .....|||+.|+.++|+||+.++++|-..+...+|+|
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~-----~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETG-----KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCC-----cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467999999999999998876     8999999987643322 2668899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||+. +|+..++....    .++..++..++.++++|++|||+   +.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus        82 fm~t-dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             eccc-cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            9987 99999987653    58999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .+..+.|.+|+|||.+.+.+.|+...||||.|||+.||+-|.+-|.+. .+-..+..+++. +.
T Consensus       154 p~~~------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~-LG  219 (318)
T KOG0659|consen  154 PNRI------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRA-LG  219 (318)
T ss_pred             CCcc------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHH-cC
Confidence            4221            112256788999999888889999999999999999999987666543 222223222221 11


Q ss_pred             ccCCCccccChhhhhch-----h----------HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEI-----H----------AKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~-----~----------~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .+   .+...|++....     .          -.......++++..++..||.+|+++.|++++
T Consensus       220 TP---~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  220 TP---TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CC---CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11   111111111000     0          01123456899999999999999999998863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=317.40  Aligned_cols=225  Identities=18%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....||.|+||.|..++.+.++     ..+|+|++.+..  ...+++...+|..+|+.+.||.++++++.|.+.+..|||
T Consensus        48 ~~~tlGtGSFGrV~LVr~k~~g-----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   48 RLKTLGTGSFGRVHLVREKHSG-----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             heeeeccCccceEEEEEEccCC-----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4578999999999999998876     899999998753  234557788999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||++||.|+.+++..++     +++.....++.||+.||+|||+   ..|++|||||+|||||.+|.+||.|||+|+.+
T Consensus       123 meyv~GGElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EeccCCccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            999999999999998664     8999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ...               +-+.||||.|+|||++.. ..++.++|.|||||++|||+.|.+||.....     ....+++
T Consensus       195 ~~r---------------T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI  253 (355)
T KOG0616|consen  195 SGR---------------TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKI  253 (355)
T ss_pred             cCc---------------EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHH
Confidence            543               125789999999999554 8899999999999999999999999985332     4566677


Q ss_pred             HhccCCCccccChhhhhchhH
Q 006522          584 FRERRPLSEVIDPALVKEIHA  604 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~  604 (642)
                      ......++..+++.+.+.+..
T Consensus       254 ~~~~v~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  254 LEGKVKFPSYFSSDAKDLLKK  274 (355)
T ss_pred             HhCcccCCcccCHHHHHHHHH
Confidence            777777788888877664433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=343.70  Aligned_cols=239  Identities=26%  Similarity=0.401  Sum_probs=193.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      -+.+|.|+.|.||.|++..       ..||||+++.-.        +.+|+-|++|+||||+.+.|+|......++||||
T Consensus       129 LeWlGSGaQGAVF~Grl~n-------etVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHN-------ETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhccCcccceeeeeccC-------ceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            3689999999999999887       689999986422        3578889999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |..|-|+.+|+...     +++-...+.|..+||.||.|||.   ..|||||||+-||||..+..+||+|||.++...+.
T Consensus       194 Ca~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             cccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence            99999999998765     37778889999999999999999   79999999999999999999999999999876543


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      .             .....+||..|||||++. ....++|+||||||||||||+||..||.+.+...     ++...   
T Consensus       266 S-------------TkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGV---  323 (904)
T KOG4721|consen  266 S-------------TKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGV---  323 (904)
T ss_pred             h-------------hhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEec---
Confidence            1             012568999999999955 4889999999999999999999999997533321     11100   


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .-..        ........+...+.-|+..||+..|..||++++++..|+-
T Consensus       324 GsNs--------L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  324 GSNS--------LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             cCCc--------ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            0000        0001111222344457788999999999999999988864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=337.45  Aligned_cols=262  Identities=23%  Similarity=0.345  Sum_probs=207.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|.||.|..+....+      ..||||.++........++|.+|+++|.+++|||||+++|.|..++..++|+|
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGP------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhhhhcCcccceeEEEEecCc------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            468999999999999998875      89999999987655556899999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||++|+|.+++..+....   +.-...++|+.|||.||+||.+   .++||||+.++|+|+|.++++||+|||+++.+-.
T Consensus       616 YmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999998875321   3445667899999999999999   7999999999999999999999999999997655


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCCcccHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t--G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ..++....          ..+-+..|||||.++. +++++++|||+|||++||+++  .+.||....++  ...+-....
T Consensus       690 g~yy~vqg----------r~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~  756 (807)
T KOG1094|consen  690 GDYYRVQG----------RAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEF  756 (807)
T ss_pred             CCceeeec----------ceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhh
Confidence            44333221          1234567999999776 799999999999999999876  78898754332  122222222


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ++.... ...+.       ...-+-.++++++++||..|.++||+++++...|++..
T Consensus       757 ~~~~~~-~~~l~-------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  757 FRDQGR-QVVLS-------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             cCCCCc-ceecc-------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            222221 11111       01123346778999999999999999999999888753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.6e-40  Score=348.06  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=200.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ..+.||+|+||.||+|.............||||+++........+.+.+|+.+++.+ +|||||+++++|...+..++||
T Consensus        39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~  118 (375)
T cd05104          39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT  118 (375)
T ss_pred             hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence            468899999999999975432222333789999997654333446789999999999 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCC--------------------------------------------------------------
Q 006522          425 DFIRNGSLYAALHAGPSD--------------------------------------------------------------  442 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~--------------------------------------------------------------  442 (642)
                      ||+++|+|.++++.....                                                              
T Consensus       119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (375)
T cd05104         119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD  198 (375)
T ss_pred             hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence            999999999999753210                                                              


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccce
Q 006522          443 --------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET  514 (642)
Q Consensus       443 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~  514 (642)
                              ....++|..+.+++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+++..........   
T Consensus       199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~---  272 (375)
T cd05104         199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV---  272 (375)
T ss_pred             cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc---
Confidence                    01248899999999999999999999   8999999999999999999999999999986543321100   


Q ss_pred             eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhccCC-Ccc
Q 006522          515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP-LSE  592 (642)
Q Consensus       515 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~~~-~~~  592 (642)
                             .....++..|+|||++. +..++.++|||||||++|||+| |..||.....+. .....+.   ..... .+.
T Consensus       273 -------~~~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~---~~~~~~~~~  340 (375)
T cd05104         273 -------KGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIK---EGYRMLSPE  340 (375)
T ss_pred             -------cCCCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHH---hCccCCCCC
Confidence                   01223456799999854 4778999999999999999998 889987543221 1222221   11111 111


Q ss_pred             ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          593 VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       593 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ..+             .++.+++.+||+.||++||++.||++.|++.
T Consensus       341 ~~~-------------~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         341 CAP-------------SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCC-------------HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            111             2456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.7e-40  Score=335.93  Aligned_cols=267  Identities=25%  Similarity=0.388  Sum_probs=198.1

Q ss_pred             ccccCccCCceeEEEEecCCCC-----------CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSG-----------MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY  415 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~  415 (642)
                      ...||+|+||.||++....+..           .+....||+|.+..........+|.+|++++.+++||||+++++++.
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            4679999999999998754321           12336799999976543334468999999999999999999999999


Q ss_pred             eCCceEEEEeeccCCcHHHHHhcCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 006522          416 ANDEKLLISDFIRNGSLYAALHAGPSD--------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS  481 (642)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  481 (642)
                      ..+..++||||+++|+|.+++......              ....++|..+.+++.||+.||+|||+   .+|+||||||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp  166 (304)
T cd05096          90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLAT  166 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcch
Confidence            999999999999999999998653211              11347899999999999999999999   8999999999


Q ss_pred             CCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh
Q 006522          482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT  561 (642)
Q Consensus       482 ~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t  561 (642)
                      +|||+++++.+||+|||+++.+.......      .    .....++..|+|||++.. ..++.++|||||||++|||++
T Consensus       167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~----~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         167 RNCLVGENLTIKIADFGMSRNLYAGDYYR------I----QGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             hheEEcCCccEEECCCccceecccCceeE------e----cCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHH
Confidence            99999999999999999997653321100      0    012345678999998554 678999999999999999997


Q ss_pred             --CCCCCCCCCCCcccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          562 --GRLPDAGPENDGKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       562 --G~~P~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                        +..||.....  ......+....... ........+         .....+.+++.+||+.||++|||+.||.+.|++
T Consensus       236 ~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         236 LCKEQPYGELTD--EQVIENAGEFFRDQGRQVYLFRPP---------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             ccCCCCCCcCCH--HHHHHHHHHHhhhccccccccCCC---------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence              5667764322  11222222221111 100000011         111345679999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.3e-40  Score=347.11  Aligned_cols=264  Identities=23%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ..+.||+|+||.||+++....+.......||||+++........+.+.+|+++++++ +|||||+++++|...+..++||
T Consensus        42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~  121 (374)
T cd05106          42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT  121 (374)
T ss_pred             ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence            468899999999999987544333344689999998654444446789999999999 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCC---------------------------------------------------------------
Q 006522          425 DFIRNGSLYAALHAGPS---------------------------------------------------------------  441 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  441 (642)
                      ||+++|+|.++++....                                                               
T Consensus       122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (374)
T cd05106         122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE  201 (374)
T ss_pred             hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence            99999999999864321                                                               


Q ss_pred             --CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecC
Q 006522          442 --DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG  519 (642)
Q Consensus       442 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~  519 (642)
                        ....++++..+.+|+.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++........      . . 
T Consensus       202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~------~-~-  270 (374)
T cd05106         202 DTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY------V-V-  270 (374)
T ss_pred             ccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce------e-e-
Confidence              011358899999999999999999999   89999999999999999999999999999765432110      0 0 


Q ss_pred             CCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhh
Q 006522          520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPAL  598 (642)
Q Consensus       520 ~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l  598 (642)
                        .....++..|||||++. +..++.++|||||||++|||++ |+.||....... .+........  ....+..++   
T Consensus       271 --~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~--~~~~~~~~~---  341 (374)
T cd05106         271 --KGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY--QMSRPDFAP---  341 (374)
T ss_pred             --ccCCCCccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc--CccCCCCCC---
Confidence              01223456799999854 4678999999999999999998 999997543211 1111111110  111111122   


Q ss_pred             hhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       599 ~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                                .++.+++.+||+.||++|||+.||+++|+++
T Consensus       342 ----------~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         342 ----------PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ----------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      2355688889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=345.36  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..||+|+||.||+|.+....+... ..||||..+..  ......++|.+|+++|++++|||||+++|++......++|||
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~-~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE  241 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKV-VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME  241 (474)
T ss_pred             ceeecccccEEEEEEEEecCCcee-eeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence            789999999999999987643211 22999999852  334556899999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      +|.||+|.++|+....    .++..+++.++.++|+||+|||+   .++|||||..+|+|++.++.+||+|||+++.-..
T Consensus       242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            9999999999988664    38999999999999999999999   8999999999999999999999999999876431


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .   ....         ....-...|+|||.+.. ..|+.++|||||||++||+++ |..||.+...     .+...+..
T Consensus       315 ~---~~~~---------~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-----~~v~~kI~  376 (474)
T KOG0194|consen  315 Y---VMKK---------FLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-----YEVKAKIV  376 (474)
T ss_pred             e---eecc---------ccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCH-----HHHHHHHH
Confidence            1   0000         01123456999999665 689999999999999999999 8999986432     22333332


Q ss_pred             hccCCC-ccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          585 RERRPL-SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~~~~~-~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ....+. ...-.|.            .+..++..||..+|++||+|.++.+.|+.+..
T Consensus       377 ~~~~r~~~~~~~p~------------~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  377 KNGYRMPIPSKTPK------------ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             hcCccCCCCCCCHH------------HHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            222211 1112222            23345668999999999999999999998753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-40  Score=315.01  Aligned_cols=258  Identities=20%  Similarity=0.270  Sum_probs=200.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      -+.|++|.||.||+|+++.+.     ..||+|+++-...... --.-+|||.+|.+++|||||.+.++....  +.+|+|
T Consensus        81 lnrI~EGtyGiVYRakdk~t~-----eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTD-----EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HhhcccCcceeEEEeccCCcc-----eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            477999999999999999887     8999999986533221 13457999999999999999999987654  579999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      ||||+. ||..++..-.    .++...+...++.|+++|++|||.   +.|+|||||++|+|+...|.+||+|||+||.+
T Consensus       156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            999998 9999998655    358899999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....            ..+..+.|.+|+|||.+++...|+++.||||+|||+.||+++++-|.+...     ...+.++
T Consensus       228 gsp~k------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-----~dQl~~I  290 (419)
T KOG0663|consen  228 GSPLK------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-----IDQLDKI  290 (419)
T ss_pred             cCCcc------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-----HHHHHHH
Confidence            65421            122456788999999988888899999999999999999999988876332     1222222


Q ss_pred             HhccCCCccccChhhhh-------------------chhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVK-------------------EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~-------------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++.-..-.+.+.|.+..                   .+....-...-+++....+..||++|-|+.|.++
T Consensus       291 f~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  291 FKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            22211112222222111                   0000001145678999999999999999999874

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-39  Score=326.99  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=197.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||+|+......  ....||+|.++........+.|.+|+.++++++||||+++++++...+..++|||
T Consensus         9 ~~~~ig~G~fg~V~~~~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   86 (266)
T cd05064           9 IERILGTGRFGELCRGCLKLPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE   86 (266)
T ss_pred             EeeeecccCCCeEEEEEEecCCC--ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence            45789999999999998754321  2278999999875444444679999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+|++|||.+.....
T Consensus        87 ~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          87 YMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             eCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999976432    48999999999999999999999   8999999999999999999999999998765321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...           .......++..|+|||++. +..++.++|||||||++||+++ |+.||.....     ...++...
T Consensus       160 ~~~-----------~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~  222 (266)
T cd05064         160 EAI-----------YTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAVE  222 (266)
T ss_pred             cch-----------hcccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHH
Confidence            110           0011223456799999854 4788999999999999999775 9999975322     12222221


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ... .+.+..+             ...+.+++.+||+.+|++||++.|+.+.|+++
T Consensus       223 ~~~~~~~~~~~-------------~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 DGFRLPAPRNC-------------PNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCCC-------------CHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111 1111111             12356688899999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-40  Score=341.25  Aligned_cols=242  Identities=20%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      +||+|+||.||++....++     +.||+|+++...  .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   76 (323)
T cd05571           2 LLGKGTFGKVILVREKATG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeC
Confidence            6899999999999987765     899999987542  222346788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        77 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          77 ANGGELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            99999999997643     48999999999999999999999   89999999999999999999999999998753221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      .            .......||+.|+|||++. +..++.++||||+||++|||+||+.||....     ...........
T Consensus       149 ~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~~~~~~~~~  210 (323)
T cd05571         149 G------------ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILME  210 (323)
T ss_pred             C------------CcccceecCccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcC
Confidence            1            0111346889999999854 4778999999999999999999999997422     22233333333


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ...++..+++             ++.+++.+||+.||++||     ++.|+++
T Consensus       211 ~~~~p~~~~~-------------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 EIRFPRTLSP-------------EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCCCH-------------HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3333333333             244578889999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=338.98  Aligned_cols=238  Identities=22%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|+||.||++....++     +.||+|.+....  .......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQ-----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            699999999999987765     789999987531  2233467889999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus        76 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          76 NGGELFHHLQREG-----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            9999999997643     38999999999999999999999   899999999999999999999999999987532221


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            ......||+.|+|||++. +..++.++||||+||++|||+||+.||...     ......+......
T Consensus       148 ~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~~  209 (312)
T cd05585         148 D------------KTNTFCGTPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQEP  209 (312)
T ss_pred             C------------ccccccCCcccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcCC
Confidence            0            112346889999999854 477899999999999999999999999742     2334444444444


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT  631 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e  631 (642)
                      ..++..+++.             +.+++.+||+.||++||++.+
T Consensus       210 ~~~~~~~~~~-------------~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         210 LRFPDGFDRD-------------AKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             CCCCCcCCHH-------------HHHHHHHHcCCCHHHcCCCCC
Confidence            3334444433             345778899999999986433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-40  Score=322.58  Aligned_cols=243  Identities=21%  Similarity=0.333  Sum_probs=201.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|.||.|-+++....+     +.||||.+++..  +....-.+.+||+||+.++||||+.+++.|++.+.+.+||
T Consensus        58 ~etLGkGTYGKVk~A~e~~sg-----R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   58 TETLGKGTYGKVKLAYEHKSG-----REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             HHHhcCCcccceeehhhccCC-----cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            457999999999999986654     899999998762  2333456899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||..+|.|+|++.+.+.     |++.....+++||.+|+.|+|.   ++++|||||.+|||+|.++++||+|||++-.+.
T Consensus       133 EYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999988764     9999999999999999999999   899999999999999999999999999997765


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...             -.++.||++.|.+||+..+...-++..|-||+||+||.|+.|..||++     .+...+++++.
T Consensus       205 ~~k-------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lvrQIs  266 (668)
T KOG0611|consen  205 DKK-------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLVRQIS  266 (668)
T ss_pred             ccc-------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHHHHhh
Confidence            432             123679999999999855433447899999999999999999999985     34455666665


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++.+.-++  .|            ....-++.+++..+|++|-|+.||..
T Consensus       267 ~GaYrEP~--~P------------SdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  267 RGAYREPE--TP------------SDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             cccccCCC--CC------------chHHHHHHHHHhcCcccchhHHHHhh
Confidence            54332111  11            11233888999999999999999875

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=336.54  Aligned_cols=244  Identities=24%  Similarity=0.410  Sum_probs=200.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ..||+|+||.||+|.+....     +.||+|++.-......++++.+|+.++++++++||.++|+.+..+...+++||||
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~-----k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTK-----KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             hhccccccceeeeeeecccc-----ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            68999999999999998886     8999999988766666789999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      .+|++.+.+....     .+++....-|++++..|+.|||+   .+.+|||||+.|||+..+|.+|++|||.+-.+..+.
T Consensus        94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999998654     24777778899999999999999   799999999999999999999999999998775542


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            .....+||+.|||||++. ...|+.|+||||+|++.+||++|.+|+.......     .+   +-  
T Consensus       166 ~------------rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----vl---fl--  222 (467)
T KOG0201|consen  166 K------------RRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----VL---FL--  222 (467)
T ss_pred             h------------ccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----EE---Ee--
Confidence            1            123678999999999965 5789999999999999999999999997543310     00   00  


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                        ++....|.+....     ...+.+++-.|++.||+.||++.++++
T Consensus       223 --Ipk~~PP~L~~~~-----S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 --IPKSAPPRLDGDF-----SPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --ccCCCCCcccccc-----CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              1111112222111     123445677799999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-39  Score=342.78  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=202.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ..+.||+|+||.||+|.............||||++.........+.|.+|++++++++ |||||+++++|...+..++||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT  120 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence            3578999999999999875443333346899999976544444478999999999995 999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCC--------------------------------------------------------------
Q 006522          425 DFIRNGSLYAALHAGPSD--------------------------------------------------------------  442 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~--------------------------------------------------------------  442 (642)
                      ||+++|+|.++++.....                                                              
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (400)
T cd05105         121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY  200 (400)
T ss_pred             EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence            999999999998753210                                                              


Q ss_pred             -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeE
Q 006522          443 -----------------------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC  493 (642)
Q Consensus       443 -----------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  493 (642)
                                                   ....+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k  277 (400)
T cd05105         201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK  277 (400)
T ss_pred             hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence                                         01248899999999999999999999   8999999999999999999999


Q ss_pred             EecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND  572 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~  572 (642)
                      |+|||+++.........          ......++..|+|||.+. +..++.++|||||||++|||++ |..||.....+
T Consensus       278 L~DfGla~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         278 ICDFGLARDIMHDSNYV----------SKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEeCCcceecccccccc----------ccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999998654321100          011234667899999854 4678999999999999999997 99998753222


Q ss_pred             cccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          573 GKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      .    .......... .+....             ....+.+++.+||+.||++||++.+|+++|+++.+
T Consensus       347 ~----~~~~~~~~~~~~~~~~~-------------~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 S----TFYNKIKSGYRMAKPDH-------------ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H----HHHHHHhcCCCCCCCcc-------------CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1    1111111111 111111             11345678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-39  Score=329.83  Aligned_cols=249  Identities=21%  Similarity=0.226  Sum_probs=193.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++....++     +.||||.+....  .......+.+|+.++++++|+||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCC-----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            467999999999999987665     899999987542  1222356789999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus        80 e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            99999999988865432   248999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....||..|+|||++. +..++.++|||||||++|||+||+.||....... ..........
T Consensus       154 ~~~~-------------~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~  218 (285)
T cd05631         154 EGET-------------VRGRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVK  218 (285)
T ss_pred             CCCe-------------ecCCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhh
Confidence            2210             11346788999999855 4788999999999999999999999997543211 1111111111


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~  634 (642)
                      .........+++             .+.+++.+||+.||++||+     +.|+++
T Consensus       219 ~~~~~~~~~~s~-------------~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 EDQEEYSEKFSE-------------DAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccccCCccCCH-------------HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            111111112222             3456888899999999997     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.8e-39  Score=326.27  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=203.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.............|++|.+..........+|.+|+.++++++||||+++++++...+..+++|||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   89 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY   89 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence            46799999999999998765444445789999997654444446799999999999999999999999998899999999


Q ss_pred             ccCCcHHHHHhcCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          427 IRNGSLYAALHAGPSDS-----------LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +++|+|.+++.......           ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEEC
Confidence            99999999997643211           1358899999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGK  574 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~  574 (642)
                      |||+++.........          ......+++.|+|||.+.. ..++.++|||||||++|||+| |..||.+...   
T Consensus       167 dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---  232 (283)
T cd05048         167 DFGLSRDIYSADYYR----------VQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---  232 (283)
T ss_pred             CCcceeecccccccc----------ccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999997653321100          0112345678999998554 678999999999999999998 9999975322   


Q ss_pred             cHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          575 GLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       575 ~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                        .+.......... +.+..             ...++.+++.+||+.||++||++.||++.|+++
T Consensus       233 --~~~~~~i~~~~~~~~~~~-------------~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 --QEVIEMIRSRQLLPCPED-------------CPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --HHHHHHHHcCCcCCCccc-------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence              122222221111 11111             123456788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.8e-39  Score=336.15  Aligned_cols=242  Identities=22%  Similarity=0.308  Sum_probs=193.4

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      +||+|+||.||++.....+     +.||+|.+....  .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~   76 (323)
T cd05595           2 LLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   76 (323)
T ss_pred             eeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeC
Confidence            6899999999999987664     899999997541  222346678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          77 ANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            99999999987543     48999999999999999999999   89999999999999999999999999998753221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......||+.|+|||++. +..++.++|||||||++|||+||+.||.....     ..........
T Consensus       149 ~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~~~  210 (323)
T cd05595         149 GA------------TMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILME  210 (323)
T ss_pred             CC------------ccccccCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcC
Confidence            10            011346888999999854 46789999999999999999999999974321     2233333333


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ...++..+++.             +.+++.+||+.||++||     ++.++++
T Consensus       211 ~~~~p~~~~~~-------------~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 EIRFPRTLSPE-------------AKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCCCHH-------------HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            33333333433             34577789999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-39  Score=336.31  Aligned_cols=243  Identities=20%  Similarity=0.274  Sum_probs=194.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +.||+|+||.||++.....+     +.||+|.+....  .......+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            36899999999999987665     899999997542  22334678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        76 y~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          76 YVNGGELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             CCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            999999999987543     48999999999999999999999   8999999999999999999999999999875322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ..........
T Consensus       148 ~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~~~~  209 (328)
T cd05593         148 DAA------------TMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILM  209 (328)
T ss_pred             ccc------------ccccccCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHHhcc
Confidence            110            011346889999999854 4678999999999999999999999997432     2233333333


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ....++..+++.             +.+++.+||+.||++||     ++.|+++
T Consensus       210 ~~~~~p~~~~~~-------------~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         210 EDIKFPRTLSAD-------------AKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCccCCCCCCHH-------------HHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            333333333332             34577889999999997     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=336.98  Aligned_cols=252  Identities=24%  Similarity=0.438  Sum_probs=207.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||-|.||.||.|++++..     ..||||.+++.  ...+++|+.|+.+|+.++|||+|+|+|.|......|+|.|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkys-----lTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccc-----eeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            4678999999999999999886     89999999864  3456999999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||.+|+|.++|++..+.   .++--..+.++.||+.||+||..   +.+|||||..+|+|+.++..+||+|||+++.+..
T Consensus       344 fM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             cccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999999987653   36667888999999999999998   8999999999999999999999999999999877


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      +.+...      .     ...-...|.|||.+.. ..++.|+|||+|||+|||+.| |-.||.+.+-  .....++++.+
T Consensus       418 DTYTAH------A-----GAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--SqVY~LLEkgy  483 (1157)
T KOG4278|consen  418 DTYTAH------A-----GAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYGLLEKGY  483 (1157)
T ss_pred             Cceecc------c-----CccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccH--HHHHHHHhccc
Confidence            643211      1     1123456999998555 778999999999999999999 8899875321  12223333333


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      +...+  +             .+..++++||+.||++.|.+||+++|+-+.++.|
T Consensus       484 RM~~P--e-------------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  484 RMDGP--E-------------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cccCC--C-------------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            33222  1             2334577899999999999999999999999876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-39  Score=337.48  Aligned_cols=241  Identities=17%  Similarity=0.269  Sum_probs=195.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ..+.||+|+||.||+|.....+     +.||||.+....  .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        22 ~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         22 MGETLGTGSFGRVRIAKHKGTG-----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             EEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            3578999999999999987765     789999987542  222346789999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            99999999999997653     38889999999999999999999   89999999999999999999999999998765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....               ....||+.|+|||++. +..++.++|||||||++|||+||+.||.+..     .....+..
T Consensus       169 ~~~~---------------~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i  227 (329)
T PTZ00263        169 PDRT---------------FTLCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEKI  227 (329)
T ss_pred             CCCc---------------ceecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHHH
Confidence            3221               1246888999999854 4678999999999999999999999997422     12233333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVS  633 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~  633 (642)
                      ......++..+++.             +.+++.+||+.||++||+     +.|++
T Consensus       228 ~~~~~~~p~~~~~~-------------~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        228 LAGRLKFPNWFDGR-------------ARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             hcCCcCCCCCCCHH-------------HHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            33333333333332             345888899999999997     56665

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-40  Score=320.80  Aligned_cols=259  Identities=21%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc-----e
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE-----K  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-----~  420 (642)
                      ..+++|.|+||.||+|......     ..||||+........     .+|+++|++++|||||++.-+|....+     .
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~-----~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETE-----EEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCC-----ceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            3578999999999999998875     899999987654322     379999999999999999999876432     3


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC-CCeEEecccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGL  499 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGl  499 (642)
                      .+|||||+. +|++.++...... ..++...+.-++.||.+||+|||+   .+|+||||||.|+|+|.+ |.+||||||.
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS  172 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS  172 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence            489999998 9999998532111 236667788899999999999999   899999999999999976 9999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      |+.+.....             ......|..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.+... ...+..+
T Consensus       173 AK~L~~~ep-------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eI  238 (364)
T KOG0658|consen  173 AKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEI  238 (364)
T ss_pred             ceeeccCCC-------------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHH
Confidence            998764421             11334567899999988878899999999999999999999999987332 2233333


Q ss_pred             HHHHHhcc---------CCCccccChhhhhch----hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRER---------RPLSEVIDPALVKEI----HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~---------~~~~~~~d~~l~~~~----~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++ .+..+         ....+.-.|.+....    .......+.++++.+++..+|.+|.++.|++.
T Consensus       239 ik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  239 IK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            32 21110         000111112221111    11123346788999999999999999999874

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-38  Score=319.47  Aligned_cols=247  Identities=22%  Similarity=0.393  Sum_probs=195.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....+      ..+|+|.+......  .++|.+|++++++++||||+++++++...+..++||||
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~------~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQ------IKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             eeEecCCcCceEEEEEeccC------ceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            45799999999999988765      68999988754322  36789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++....    .++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||.++.....
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          81 MENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             CCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            999999999976432    38999999999999999999999   89999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...        .   .....++..|+|||+.. +..++.++||||||+++|||+| |+.||....     ....+.....
T Consensus       154 ~~~--------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~  216 (256)
T cd05114         154 EYT--------S---SSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISR  216 (256)
T ss_pred             cee--------c---cCCCCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC
Confidence            110        0   01223456799999854 4678999999999999999999 899986432     2223333322


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ..+..    .+...        ...+.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~~----~~~~~--------~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         217 GFRLY----RPKLA--------SMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCC----CCCCC--------CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            22211    11110        124677999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-39  Score=328.56  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=195.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      -..||+|+||.||.|+.++++     ..+|+|++++..  ...+++.++.|-.+|...++|+||+|+..|++.+..||||
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg-----~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTG-----EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             heeeccccceeEEEEEEccCC-----cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            478999999999999998886     899999998863  2345678899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||++|||+..+|...+     .|++.....++.+++.|++-+|.   .++|||||||+|+|||..|++||+||||+.-+.
T Consensus       221 EylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999999998765     39999999999999999999999   899999999999999999999999999996443


Q ss_pred             CCCcccc---------------cceeee----cC----------------CCcccccCCCcccCccccccCCCCCcccch
Q 006522          505 GTSKVTK---------------NETIVT----SG----------------TGSRISAISNVYLAPEARIYGSKFTQKCDV  549 (642)
Q Consensus       505 ~~~~~~~---------------~~~~~~----~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV  549 (642)
                      .......               ......    ..                ......+|||-|||||++.. ..|+..+|.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDw  371 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDW  371 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccH
Confidence            2111000               000000    00                00114689999999999665 779999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC
Q 006522          550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR  628 (642)
Q Consensus       550 ~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs  628 (642)
                      ||+|||+|||+.|.+||......+ ....++.....-..|  +..+.           ..++.+++.+|+. ||++|.-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~fP--~~~~~-----------s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLKFP--EEVDL-----------SDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhccCC--CcCcc-----------cHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999998643321 112222211111111  11111           1345678888888 9999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=321.94  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=194.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHh--cccCCCeeeEEEEEEeCC----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIA--RVQHPNIVRLKAFYYAND----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~H~nIv~l~~~~~~~~----~~  420 (642)
                      ..++|+|+||.||||.+..       +.||||++...+.    ..|..|-+|.+  .++|+||++++++-....    +.
T Consensus       215 ~eli~~Grfg~V~KaqL~~-------~~VAVKifp~~~k----qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDN-------RLVAVKIFPEQEK----QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             HHHhhcCccceeehhhccC-------ceeEEEecCHHHH----HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            4679999999999999887       7999999975432    56777777665  458999999999877655    78


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeeeCCCCCeEE
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS------PRKYVHGNIKSTKILLDDELHPCI  494 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl  494 (642)
                      +||+||.++|+|.++|..+-      ++|....+|+.-+++||+|||+.-      .++|+|||||++|||+.+|+++.|
T Consensus       284 wLVt~fh~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            99999999999999998754      899999999999999999999843      247999999999999999999999


Q ss_pred             ecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCC-----cccchHHHHHHHHHHHhCCCCCC-C
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT-----QKCDVYSFGIVLLEILTGRLPDA-G  568 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~sDV~S~Gvvl~el~tG~~P~~-~  568 (642)
                      +|||+|..+......          .....-+||.+|||||++.+.-.+.     .+.||||+|.|||||+++-.-++ +
T Consensus       358 aDFGLAl~~~p~~~~----------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~  427 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQ----------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG  427 (534)
T ss_pred             eccceeEEecCCCCC----------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence            999999887644211          1112358999999999854322222     47899999999999999643332 1


Q ss_pred             C-----------CCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          569 P-----------ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       569 ~-----------~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      +           -.....+.+......+++..      |.+.+.......+..+.+.+-.||+.||+.|.|+.-|.+++.
T Consensus       428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R------P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  428 PVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR------PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             CCCcccCchhHHhcCCCCHHHHHHHHHhhccC------CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            1           11112233333333333221      111111122234556777888999999999999999999888


Q ss_pred             hhh
Q 006522          638 RVK  640 (642)
Q Consensus       638 ~l~  640 (642)
                      ++.
T Consensus       502 ~l~  504 (534)
T KOG3653|consen  502 ELM  504 (534)
T ss_pred             HHh
Confidence            774

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=331.63  Aligned_cols=241  Identities=20%  Similarity=0.243  Sum_probs=194.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     +.||+|++....  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISE-----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            467999999999999988665     889999986532  1223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...+     .+++.....++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            9999999999997643     38899999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               .....||+.|+|||++. +..++.++|||||||++|||+||+.||....     .........
T Consensus       153 ~~---------------~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~i~  211 (291)
T cd05612         153 DR---------------TWTLCGTPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEKIL  211 (291)
T ss_pred             CC---------------cccccCChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence            22               11345788999999854 4678999999999999999999999997532     223333333


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~  634 (642)
                      .....++..+++.             +.+++.+||+.||.+||+     +.|+++
T Consensus       212 ~~~~~~~~~~~~~-------------~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         212 AGKLEFPRHLDLY-------------AKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             hCCcCCCccCCHH-------------HHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            3333333333332             345888899999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.7e-39  Score=326.18  Aligned_cols=261  Identities=17%  Similarity=0.230  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|.++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCC-----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            467999999999999987665     789999987543333336788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++ +|.+++.....    .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~~-~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LDS-DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCc-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            975 99999875432    47899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|++.|+|||++.....++.++||||+||++|||+||+.||...... ..+.... .....
T Consensus       157 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~-~~~~~  222 (288)
T cd07871         157 TK------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIF-RLLGT  222 (288)
T ss_pred             Cc------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HHhCC
Confidence            10            0112356788999998665567899999999999999999999999753221 1111111 11110


Q ss_pred             cCC--Cccc---------cChhhhhch---hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRP--LSEV---------IDPALVKEI---HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--~~~~---------~d~~l~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...  ....         ..+......   .......++.+++.+|++.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000  0000         000000000   00001235678999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-39  Score=298.27  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=201.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .++.||+|.||.||.++.+++.     -.||+|++.+..  ......++.+|++|-+.|+||||.++|+||.+....||+
T Consensus        26 igr~LgkgkFG~vYlarekks~-----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSL-----FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             ccccccCCccccEeEeeeccCC-----cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4688999999999999998876     799999997652  122237889999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      +||.++|+++..|.+....   .+++.....++.|+|.||.|+|.   ++||||||||+|+|++..+..|++|||.+-..
T Consensus       101 lEya~~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEecCCchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            9999999999999865542   48888889999999999999999   89999999999999999999999999987543


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      +.              ....+.+||.-|.+||. ..+..++...|+|++||+.||++.|.+||....     ..+..+++
T Consensus       175 p~--------------~kR~tlcgt~dyl~pEm-v~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-----~~etYkrI  234 (281)
T KOG0580|consen  175 PS--------------NKRKTLCGTLDYLPPEM-VEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-----HSETYKRI  234 (281)
T ss_pred             CC--------------CCceeeecccccCCHhh-cCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-----hHHHHHHH
Confidence            21              12336789999999998 556889999999999999999999999997543     12223333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..-+..++..+..             .+.+++.+|+..+|.+|.+..|+++
T Consensus       235 ~k~~~~~p~~is~-------------~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  235 RKVDLKFPSTISG-------------GAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHccccCCcccCh-------------hHHHHHHHHhccCccccccHHHHhh
Confidence            3323223333333             2345888899999999999999875

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.9e-39  Score=329.59  Aligned_cols=262  Identities=18%  Similarity=0.228  Sum_probs=193.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.....+     +.||||.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNG-----KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCC-----CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            467999999999999987654     789999987654333335678999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      ++ ++|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          85 VH-TDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CC-cCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            96 688888875432    48889999999999999999999   89999999999999999999999999998754321


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......||+.|+|||++.....++.++||||+||++|||+||+.||.+.......+..... ....
T Consensus       157 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~  223 (303)
T cd07869         157 SH------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL-VLGT  223 (303)
T ss_pred             Cc------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhCC
Confidence            10            0113457888999998655456889999999999999999999999754321111111111 1100


Q ss_pred             cCC--C-----ccccChh---------hhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRP--L-----SEVIDPA---------LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--~-----~~~~d~~---------l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...  .     ....++.         +............+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000  0     0000000         0000000001134668999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-39  Score=330.48  Aligned_cols=247  Identities=20%  Similarity=0.315  Sum_probs=207.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc-eEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDE-KLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~  424 (642)
                      .+.+|+|+||.++.++.+...     +.+++|.+.-.... ...+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~-----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDD-----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhcCccccchhhhhhhccCC-----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            467999999999999888776     78999998765322 223578899999999999999999999999988 99999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      +|++||++.+.+.+.+.   ..++++++.+|+.|++.|+.|||+   ..|+|||||+.||++..+..+||+|||+|+.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999987663   259999999999999999999998   899999999999999999999999999999886


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ...+.+||+.||.||. ..+..|+.|+||||+||++|||++-+.+|..     .++...+.+..
T Consensus       158 ~~~~------------~a~tvvGTp~YmcPEi-l~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----~~m~~Li~ki~  219 (426)
T KOG0589|consen  158 PEDS------------LASTVVGTPYYMCPEI-LSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----SNMSELILKIN  219 (426)
T ss_pred             Cchh------------hhheecCCCcccCHHH-hCCCCCCccCcchhhcchHHHHHhcccccCc-----cchHHHHHHHh
Confidence            5421            1225689999999998 5558999999999999999999999999974     34566666666


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      +.. .+++.....++..             ++..|+..+|+.||++.+++.+
T Consensus       220 ~~~~~Plp~~ys~el~~-------------lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRS-------------LVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHH-------------HHHHHhhcCCccCCCHHHHhhC
Confidence            554 4445555554433             5666999999999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-39  Score=323.08  Aligned_cols=254  Identities=30%  Similarity=0.503  Sum_probs=191.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||.|.||.||+|.... ........|+||.++........++|.+|++.+++++||||++++|++...+..++|+||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4679999999999999983 122334889999997654444458899999999999999999999999988889999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++|+....   ..+++..+..|+.|||+||+|||+   .+++|+||+++||++++++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999998722   249999999999999999999999   89999999999999999999999999999876322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .....          .....+...|+|||.+.. ..++.++||||||+++|||+| |+.||...     ....+......
T Consensus       157 ~~~~~----------~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~  220 (259)
T PF07714_consen  157 SKYKN----------DSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQ  220 (259)
T ss_dssp             SSEEE----------STTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHT
T ss_pred             ccccc----------cccccccccccccccccc-cccccccccccccccccccccccccccccc-----ccccccccccc
Confidence            21100          012234567999998544 668999999999999999999 78888643     22333333322


Q ss_pred             ccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          586 ERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       586 ~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      ... +....++             ..+.+++..||+.||++||+|.|+++.|
T Consensus       221 ~~~~~~~~~~~-------------~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 GQRLPIPDNCP-------------KDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TEETTSBTTSB-------------HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccceeccchh-------------HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            221 1111122             2345688889999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-38  Score=328.41  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=197.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....+ ......||+|.++........++|.+|+.+++.++||||++++|+|... ..++|+|
T Consensus        11 ~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e   88 (316)
T cd05108          11 KIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ   88 (316)
T ss_pred             eeeeeecCCCceEEEEEEecCC-CccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeee
Confidence            3478999999999999875542 1222469999987654444457899999999999999999999999864 5789999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.++++....    .+++..++.++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++....
T Consensus        89 ~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          89 LMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             cCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            9999999999986542    48899999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....       .   .....++..|+|||++. +..++.++|||||||++|||+| |+.||.+...     ..+.. ..
T Consensus       162 ~~~~~-------~---~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~~~~-~~  224 (316)
T cd05108         162 DEKEY-------H---AEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISS-IL  224 (316)
T ss_pred             CCcce-------e---ccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH-HH
Confidence            32110       0   01123456799999854 4778999999999999999998 9999875321     12211 12


Q ss_pred             hccC--CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RERR--PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....  +.....+             ..+.+++.+||+.+|++||++.+++..|..+.
T Consensus       225 ~~~~~~~~~~~~~-------------~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         225 EKGERLPQPPICT-------------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             hCCCCCCCCCCCC-------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111  1111111             23566889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.5e-38  Score=322.77  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=202.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|......+......+++|.+.........+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            46799999999999998654444445789999987654444457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC
Q 006522          427 IRNGSLYAALHAGPS-------------------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD  487 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  487 (642)
                      +.+|+|.+++.....                   ....++++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEc
Confidence            999999999865321                   112358999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCC
Q 006522          488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPD  566 (642)
Q Consensus       488 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~  566 (642)
                      +++.+||+|||+++.........          ......++..|+|||... +..++.++||||||+++|||+| |+.||
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYV----------KRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             CCCcEEeccccccccccCccchh----------cccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            99999999999987653322110          011223456799999854 4678999999999999999999 99998


Q ss_pred             CCCCCCcccHHHHHHHHHhc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          567 AGPENDGKGLESLVRKAFRE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       567 ~~~~~~~~~l~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      .+..     ...++...... ..+.....             ...+.+++.+||+.+|++||++.|+++.|+++-
T Consensus       231 ~~~~-----~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         231 PGIA-----PERLFNLLKTGYRMERPENC-------------SEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CCCC-----HHHHHHHHhCCCCCCCCCCC-------------CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            6432     12222221111 11111111             124567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-38  Score=331.15  Aligned_cols=264  Identities=23%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeC-CceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAN-DEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~~~~lv~  424 (642)
                      .+.||+|+||.||+|...........+.||+|+++........+.+.+|+.++.++ +|+||++++++|... ...+++|
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~   91 (337)
T cd05054          12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   91 (337)
T ss_pred             hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence            57899999999999986554333444799999997654333346788999999999 899999999988765 4678999


Q ss_pred             eeccCCcHHHHHhcCCCC--------------------------------------------------------CCCCCC
Q 006522          425 DFIRNGSLYAALHAGPSD--------------------------------------------------------SLPPLP  448 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l~  448 (642)
                      ||+++|+|.+++......                                                        ...+++
T Consensus        92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (337)
T cd05054          92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT  171 (337)
T ss_pred             ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence            999999999998653210                                                        012589


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCC
Q 006522          449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS  528 (642)
Q Consensus       449 ~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt  528 (642)
                      |..+.+++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++.+.......          ......++
T Consensus       172 ~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~----------~~~~~~~~  238 (337)
T cd05054         172 LEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----------RKGDARLP  238 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------hccCCCCC
Confidence            99999999999999999999   899999999999999999999999999998764322110          01123456


Q ss_pred             CcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHH
Q 006522          529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ  607 (642)
Q Consensus       529 ~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  607 (642)
                      ..|+|||++.. ..++.++|||||||++|||+| |+.||.+..... .+.    ........  ... +.        ..
T Consensus       239 ~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~--~~~-~~--------~~  301 (337)
T cd05054         239 LKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFC----RRLKEGTR--MRA-PE--------YA  301 (337)
T ss_pred             ccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHH----HHHhccCC--CCC-Cc--------cC
Confidence            67999998544 789999999999999999998 999997532221 111    11111111  000 10        11


Q ss_pred             HHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          608 VLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       608 ~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ..++.+++.+||+.+|++||++.|+++.|+.+-
T Consensus       302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            134677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=334.90  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      .-.+||+|.||+|+.+..+..+     +.+|||.+++..  ..+.++....|..|+... +||.++.++.+|++.++.|+
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~-----e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTN-----EYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCC-----cEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            4579999999999999998876     899999999873  234568888999998888 69999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+.|||+..+.+..      .|++.....++.+|+.||+|||+   ++||+||||.+|||||.+|.+||+|||+++.
T Consensus       447 vmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            99999999955544432      39999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .-..            +..+.+.+||+.|||||++. +..|+.++|.|||||+||||++|+.||.+.+.     .+....
T Consensus       518 ~m~~------------g~~TsTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----ee~Fds  579 (694)
T KOG0694|consen  518 GMGQ------------GDRTSTFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----EEVFDS  579 (694)
T ss_pred             cCCC------------CCccccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH
Confidence            4321            12233689999999999954 58999999999999999999999999986433     344555


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      +..+....+..++.             +.+.++.+.+..+|++|..+
T Consensus       580 I~~d~~~yP~~ls~-------------ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 IVNDEVRYPRFLSK-------------EAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HhcCCCCCCCcccH-------------HHHHHHHHHhccCcccccCC
Confidence            55544443433333             44568888999999999876

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.3e-39  Score=334.34  Aligned_cols=243  Identities=19%  Similarity=0.241  Sum_probs=193.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....||+|+||.||+|.......    ..||+|++....  .....+.+.+|+.+++.++|||||++++++...+..++|
T Consensus        34 ~~~~ig~G~~g~Vy~a~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         34 FIRTLGTGSFGRVILATYKNEDF----PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             EEEEEeecCCeEEEEEEEECCCC----eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            35689999999999998654321    589999986532  222346788999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999997654     38999999999999999999999   89999999999999999999999999999765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ...               .....||+.|+|||++. +..++.++|||||||++|||+||+.||.....     ....+..
T Consensus       182 ~~~---------------~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i  240 (340)
T PTZ00426        182 DTR---------------TYTLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKI  240 (340)
T ss_pred             CCC---------------cceecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHH
Confidence            321               11346888999999854 46789999999999999999999999975321     2223333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ......++..+++.             +.+++.+|++.||++|+     +++|+++
T Consensus       241 ~~~~~~~p~~~~~~-------------~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        241 LEGIIYFPKFLDNN-------------CKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             hcCCCCCCCCCCHH-------------HHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            33332233333332             34578889999999995     7888764

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.3e-39  Score=331.29  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=193.5

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC---ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      +.||+|+||.||+++...+..  ..+.||||.++...   .......+.+|+.++++++||||+++++++..++..|+||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGAD--TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCC--CCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            468999999999998754321  22789999987531   1222356789999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          80 EYLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             eCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            9999999999997643     37888999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...            .......||+.|+|||++.. ..++.++|||||||++|||+||+.||....     .........
T Consensus       152 ~~~------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~  213 (323)
T cd05584         152 HEG------------TVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKIL  213 (323)
T ss_pred             cCC------------CcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHH
Confidence            211            01123468899999998544 678899999999999999999999997532     223334444


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      .....++..+++.             +.+++.+||+.||++||     ++.++++
T Consensus       214 ~~~~~~~~~~~~~-------------~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         214 KGKLNLPPYLTPE-------------ARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cCCCCCCCCCCHH-------------HHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            4433333333332             34588889999999999     6777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=319.34  Aligned_cols=252  Identities=21%  Similarity=0.285  Sum_probs=193.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-------------ccHHHHHHHHHHHhcccCCCeeeEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-------------WRFKDFESEVEAIARVQHPNIVRLKAF  413 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~  413 (642)
                      ...||+|.||.|-+++....+     +.||+|++.+....             ...+...+||.+|++++|||||+|+++
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~-----~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDG-----KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hhhhcCCccceEEEEeecCCC-----cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            457999999999999988776     89999999764211             123578999999999999999999999


Q ss_pred             EEeC--CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          414 YYAN--DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       414 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      ..+.  +..|||+|||..|.+...=    .. .+.+++.+..+|++++..||+|||.   ++||||||||+|+||+++|+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p----~d-~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP----PD-KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC----CC-cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            8875  5789999999998875321    11 1239999999999999999999999   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC---CCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS---KFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      +||+|||.+..............       ....+||+.|||||....+.   ..+.+.||||+||+||-|+.|+.||.+
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~-------L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQ-------LSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEeeccceeeecccCCccccHHH-------HhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999987644321111111       11358999999999855522   346789999999999999999999975


Q ss_pred             CCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       569 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .     .......++......+++.  ++         ....+-+++.++|.+||++|.+..||..
T Consensus       322 ~-----~~~~l~~KIvn~pL~fP~~--pe---------~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  322 D-----FELELFDKIVNDPLEFPEN--PE---------INEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             c-----hHHHHHHHHhcCcccCCCc--cc---------ccHHHHHHHHHHhhcChhheeehhhhee
Confidence            2     3345555555544332221  11         1223456889999999999999988754

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.9e-38  Score=320.31  Aligned_cols=262  Identities=23%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||++.............+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   87 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            3567999999999999875533333347799999876432 234679999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          426 FIRNGSLYAALHAGPS--------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      |+++|+|.+++.....        .....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccC
Confidence            9999999999975432        112358999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGL  576 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l  576 (642)
                      |+++.........       .   .....++..|+|||++. +..++.++|||||||++|||+| |+.||.....     
T Consensus       165 g~~~~~~~~~~~~-------~---~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-----  228 (288)
T cd05093         165 GMSRDVYSTDYYR-------V---GGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----  228 (288)
T ss_pred             CccccccCCceee-------c---CCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9987654321100       0   01223567799999854 4678999999999999999999 9999864322     


Q ss_pred             HHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          577 ESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       577 ~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ............ .....++             ..+.+++.+||+.||.+|||+.|+.+.|+++.
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~-------------~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         229 NEVIECITQGRVLQRPRTCP-------------KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHHHHHcCCcCCCCCCCC-------------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            122222222211 1111111             24567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-38  Score=330.29  Aligned_cols=196  Identities=22%  Similarity=0.375  Sum_probs=168.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..+|+|.+.........+++.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            467999999999999988765     789999987653333346799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          85 MDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999997643     388999999999999999999972  36999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      .              .....||..|+|||++. +..++.++|||||||++|||+||+.||...
T Consensus       158 ~--------------~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 M--------------ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             c--------------cccCCCCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            1              11345788999999854 467899999999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.3e-38  Score=333.92  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ....||+|+||.||+|...........+.||||+++........+.+.+|+++|.++. |||||+++++|...+..++||
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~  120 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT  120 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence            4678999999999999976433333347899999986544333467899999999997 999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCC---------------------------------------------------------------
Q 006522          425 DFIRNGSLYAALHAGPS---------------------------------------------------------------  441 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~---------------------------------------------------------------  441 (642)
                      ||+++|+|.++++....                                                               
T Consensus       121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (401)
T cd05107         121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK  200 (401)
T ss_pred             eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence            99999999999975421                                                               


Q ss_pred             ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          442 ------------------------------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       442 ------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                                                    .....++|...++|+.|++.||+|||+   .+++||||||+|||+++++.
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~  277 (401)
T cd05107         201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKL  277 (401)
T ss_pred             hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCE
Confidence                                          011347888999999999999999998   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.........          ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||....
T Consensus       278 ~kL~DfGla~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         278 VKICDFGLARDIMRDSNYI----------SKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EEEEecCcceecccccccc----------cCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999998653321100          0112346778999998544 678999999999999999998 899986532


Q ss_pred             CCcccHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          571 NDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ...    ..........+ +.+..++             ..+.+++.+||+.+|++||+++|+++.|+++
T Consensus       347 ~~~----~~~~~~~~~~~~~~p~~~~-------------~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNE----QFYNAIKRGYRMAKPAHAS-------------DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chH----HHHHHHHcCCCCCCCCCCC-------------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            211    11111111111 1111111             2456688889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=333.56  Aligned_cols=244  Identities=22%  Similarity=0.331  Sum_probs=189.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++.....+     +.||||.+.........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTG-----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCC-----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            467999999999999987654     799999997654433447789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+..         ..++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus       154 ~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        154 MDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             CCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            9999986432         25667888999999999999999   89999999999999999999999999999865432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..            ......||..|+|||++..    +...+.++|||||||++|||++|+.||.....  .........
T Consensus       222 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~  287 (353)
T PLN00034        222 MD------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCA  287 (353)
T ss_pred             cc------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHH
Confidence            11            0113468889999998532    23345689999999999999999999973222  122222222


Q ss_pred             HHhc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .... .......++             .++.+++.+||+.||++||++.|+++
T Consensus       288 ~~~~~~~~~~~~~~-------------~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        288 ICMSQPPEAPATAS-------------REFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HhccCCCCCCCccC-------------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2111 111111222             23556888899999999999999986

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-38  Score=329.75  Aligned_cols=237  Identities=18%  Similarity=0.264  Sum_probs=189.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||+++...++     +.||||.+.+..  .....+.+..|..++..+ +||||+++++++...+..++|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E   76 (320)
T cd05590           2 VLGKGSFGKVMLARLKESG-----RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME   76 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc
Confidence            6899999999999987765     799999987531  223346778899999877 79999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        77 y~~~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          77 FVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             CCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            999999999987653     38999999999999999999999   8999999999999999999999999999875321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ..........
T Consensus       149 ~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~  210 (320)
T cd05590         149 NG------------KTTSTFCGTPDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILN  210 (320)
T ss_pred             CC------------CcccccccCccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhc
Confidence            11            0111346889999999854 4678999999999999999999999997532     2333344433


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      .....+..+++             .+.+++.+|++.||++||++
T Consensus       211 ~~~~~~~~~~~-------------~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         211 DEVVYPTWLSQ-------------DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHcccCHHHCCCC
Confidence            33333333333             34557888999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.7e-38  Score=316.03  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=198.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|++|.||++...+.+     +.|++|.+.....  ..+++.+|++++++++||||+++++++...+..++|||
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             EeeecCCcccceEEEEEEecCC-----ceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            3467999999999999987654     7899999875432  24779999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          83 FMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             eCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999999976433   248999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....           ......++..|+|||+.. +..++.++|||||||++|||+| |..||....     .........
T Consensus       157 ~~~~-----------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~  219 (263)
T cd05052         157 DTYT-----------AHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE  219 (263)
T ss_pred             ceee-----------ccCCCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH
Confidence            2110           000123356799999854 4778999999999999999998 999986432     222222222


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. .....+.++             ..+.+++.+||+.+|++||++.|++++|+.+
T Consensus       220 ~~~~~~~~~~~~-------------~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 KGYRMERPEGCP-------------PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCCC-------------HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11 111111111             2456688899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-38  Score=318.27  Aligned_cols=261  Identities=21%  Similarity=0.353  Sum_probs=198.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||++.............||+|.+..........+|.+|+.++++++||||+++++++......++|||
T Consensus        10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e   89 (277)
T cd05062          10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME   89 (277)
T ss_pred             eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence            34679999999999998754322223378999998754433334678999999999999999999999999899999999


Q ss_pred             eccCCcHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          426 FIRNGSLYAALHAGPSD-----SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |+++|+|.++++.....     ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~  166 (277)
T cd05062          90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCc
Confidence            99999999999754321     11347889999999999999999999   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL  579 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~  579 (642)
                      +.........       .   .....++..|+|||++. +..++.++|||||||++|||+| |..||.....     ...
T Consensus       167 ~~~~~~~~~~-------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~~~  230 (277)
T cd05062         167 RDIYETDYYR-------K---GGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQV  230 (277)
T ss_pred             cccCCcceee-------c---CCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH
Confidence            7654321110       0   01224567799999854 4678999999999999999999 7888864321     222


Q ss_pred             HHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          580 VRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       580 ~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .+....... ......             ...+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVMEGGLLDKPDNC-------------PDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCcCCCCCCC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            222222111 111111             1245678999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.8e-39  Score=332.84  Aligned_cols=243  Identities=20%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .||+|+||.||++.....+     +.||+|.+....  .......+.+|++++.+++||||+++++++...+..++||||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~   76 (325)
T cd05594           2 LLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY   76 (325)
T ss_pred             eeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeC
Confidence            6899999999999987654     899999997542  222346778899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          77 ANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            99999999887543     489999999999999999999962  58999999999999999999999999998753221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ...........
T Consensus       150 ~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~~~~i~~~  211 (325)
T cd05594         150 GA------------TMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFELILME  211 (325)
T ss_pred             Cc------------ccccccCCcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCC-----HHHHHHHHhcC
Confidence            10            011346889999999854 4678999999999999999999999997432     22333333333


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ...++..+++.             +.+++.+||+.||++|+     ++.++++
T Consensus       212 ~~~~p~~~~~~-------------~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 EIRFPRTLSPE-------------AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCCCCHH-------------HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            33333334433             34577889999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.7e-38  Score=320.60  Aligned_cols=258  Identities=21%  Similarity=0.368  Sum_probs=195.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|.....+. .....+++|.+.........+++..|+.++++++||||+++++++. ....++++||
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~   89 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL   89 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCC-ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence            4689999999999998765421 1123588888865433333467888999999999999999999875 4567899999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++....    .++|..+..|+.||+.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          90 SPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             CCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            999999999976542    48999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....          ......++..|+|||.+.. ..++.++|||||||++||++| |+.||.+...  ..+..++    .
T Consensus       163 ~~~~----------~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~----~  225 (279)
T cd05111         163 DKKY----------FYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLL----E  225 (279)
T ss_pred             Cccc----------ccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----H
Confidence            1100          0112346678999998544 678999999999999999998 9999975321  1122222    2


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ......   .+..        ....+.+++.+||..||++|||+.|+++.|..+..
T Consensus       226 ~~~~~~---~~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         226 KGERLA---QPQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCcCC---CCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            111111   1111        11234568889999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-38  Score=331.17  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=194.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC---ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...||+|+||.||+++...+.  ...+.||+|.+.+..   .....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGH--DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            467999999999999875432  122789999987531   222336688999999999 59999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          83 ILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999997643     38999999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ......           .......||..|+|||++.....++.++|||||||++|||+||+.||...... .........
T Consensus       155 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~  222 (332)
T cd05614         155 FLSEEK-----------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRR  222 (332)
T ss_pred             ccccCC-----------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHH
Confidence            432211           01113468899999998654345789999999999999999999999753221 122233333


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ......++...+++.             +.+++.+||+.||++||     ++.++++
T Consensus       223 ~~~~~~~~~~~~~~~-------------~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILKCDPPFPSFIGPE-------------AQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HhcCCCCCCCCCCHH-------------HHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            333333333333333             34577889999999999     6667654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.6e-38  Score=320.94  Aligned_cols=249  Identities=18%  Similarity=0.247  Sum_probs=191.2

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|+||.||++.....+     +.||+|.+.....  ....+.+..|++++++++||||+++.+++...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATG-----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCC-----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            699999999999987664     7999999875422  222366788999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++|+|.+++...... ...+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++......
T Consensus        76 ~~g~L~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          76 NGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             CCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            999999888643221 2358999999999999999999999   899999999999999999999999999987654321


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....... .............
T Consensus       152 ~------------~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~  217 (280)
T cd05608         152 S------------KTKGYAGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDS  217 (280)
T ss_pred             c------------cccccCCCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccC
Confidence            1            011346788999999855 4778999999999999999999999997532211 1112222222221


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ....+.++             ..+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~~-------------~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 VTYPDKFS-------------PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCcccCC-------------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11111122             2345688889999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-38  Score=329.67  Aligned_cols=243  Identities=17%  Similarity=0.283  Sum_probs=189.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ++||+|+||.||++....++     +.||+|.++...  .....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            36899999999999988765     789999997642  222335678899998877 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        76 E~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~  147 (329)
T cd05618          76 EYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  147 (329)
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence            9999999999887543     38999999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---cccHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND---GKGLESLVR  581 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~---~~~l~~~~~  581 (642)
                      ...            .......||..|+|||++. +..++.++|||||||++|||+||+.||......   ......++.
T Consensus       148 ~~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~  214 (329)
T cd05618         148 RPG------------DTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  214 (329)
T ss_pred             CCC------------CccccccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH
Confidence            211            0112346889999999854 477899999999999999999999999632211   111222222


Q ss_pred             H-HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          582 K-AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       582 ~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      . .......++..+++             .+.+++.+||+.||++||+.
T Consensus       215 ~~i~~~~~~~p~~~~~-------------~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         215 QVILEKQIRIPRSLSV-------------KAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHhcCCCCCCCCCCH-------------HHHHHHHHHhcCCHHHcCCC
Confidence            2 22222222322222             34568888999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.9e-38  Score=318.67  Aligned_cols=260  Identities=20%  Similarity=0.257  Sum_probs=191.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||+|....+.   ....+++|.++..........|.+|+.++++++||||+++++++.+....++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGY---TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCC---CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            5899999999999875432   1267999998765433333578999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.++++..........++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999976543222346788888999999999999999   8999999999999999999999999999875432211


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccC------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYG------SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~  581 (642)
                      .          .......++..|+|||++...      ..++.++|||||||++|||++ |+.||.......  ....  
T Consensus       156 ~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~--  221 (269)
T cd05087         156 Y----------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY--  221 (269)
T ss_pred             e----------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH--
Confidence            0          001133567789999985421      135789999999999999996 999997532211  1111  


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ......   ....++.+....     ...+.+++..|| .+|++|||++||+..|+
T Consensus       222 ~~~~~~---~~~~~~~~~~~~-----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         222 TVREQQ---LKLPKPRLKLPL-----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Hhhccc---CCCCCCccCCCC-----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111   111122211111     113445777898 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-38  Score=327.37  Aligned_cols=241  Identities=20%  Similarity=0.308  Sum_probs=188.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||+|.....+     +.||+|.++...  .....+.+..|..++... +||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e   76 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTN-----EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME   76 (316)
T ss_pred             eeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence            6899999999999987664     789999987531  122235566777777654 89999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~~~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          77 YLNGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            999999999997643     38899999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......||+.|+|||++. +..++.++|||||||++|||++|+.||.+...     .........
T Consensus       149 ~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~  210 (316)
T cd05592         149 GE------------GKASTFCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILN  210 (316)
T ss_pred             CC------------CccccccCCccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc
Confidence            21            0111346889999999854 46789999999999999999999999975321     233333333


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR-TVS  633 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~  633 (642)
                      ....++..+++.             +.+++.+||+.||++||++. ++.
T Consensus       211 ~~~~~~~~~~~~-------------~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         211 DRPHFPRWISKE-------------AKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCCCCHH-------------HHHHHHHHccCCHHHcCCChHHHH
Confidence            333333333322             34577889999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-38  Score=318.45  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=201.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|.............||||.++........+.|.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   89 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY   89 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence            46799999999999987654323334789999997654443447899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          427 IRNGSLYAALHAGPS---------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      +++|+|.++++..+.         .....+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+||+||
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~  166 (280)
T cd05049          90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDF  166 (280)
T ss_pred             CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCc
Confidence            999999999976532         112358999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGL  576 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l  576 (642)
                      |+++.........       .   .....++..|+|||++. +..++.++|||||||++|||++ |+.||.....     
T Consensus       167 g~~~~~~~~~~~~-------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----  230 (280)
T cd05049         167 GMSRDVYTTDYYR-------V---GGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----  230 (280)
T ss_pred             ccceecccCccee-------c---CCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence            9987653321100       0   01223467799999854 4778999999999999999999 9999865322     


Q ss_pred             HHHHHHHHhccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          577 ESLVRKAFRERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       577 ~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ...+......... ....++             ..+.+++.+||+.||++||++.|+++.|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         231 EEVIECITQGRLLQRPRTCP-------------SEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHHHcCCcCCCCCCCC-------------HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2222222222111 111111             245678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=343.73  Aligned_cols=251  Identities=20%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|++|.||++....+.+    ..||+|.+.... ......+.+|+.++++++|||||++++++...+..++|||
T Consensus        71 ~~~~lg~G~~g~vy~a~~~~~~~----~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         71 LTTLVGRNPTTAAFVATRGSDPK----EKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             EEEEEEeCCCcEEEEEEEcCCCC----eEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            45789999999999998766521    678888765433 2233567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.++++..... ..++++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       146 ~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             CCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            99999999988653221 2358999999999999999999999   8999999999999999999999999999987543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....          ......+||+.|+|||++. +..++.++|||||||++|||+||+.||....     ..........
T Consensus       222 ~~~~----------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~~~~~~~~~~  285 (478)
T PTZ00267        222 SVSL----------DVASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGPS-----QREIMQQVLY  285 (478)
T ss_pred             cccc----------ccccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh
Confidence            2110          0112456899999999854 4778999999999999999999999997422     2233333332


Q ss_pred             ccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ... +.+..+++             .+.+++.+||+.||++||++.+++.
T Consensus       286 ~~~~~~~~~~s~-------------~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 GKYDPFPCPVSS-------------GMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCCCccCCH-------------HHHHHHHHHhccChhhCcCHHHHHh
Confidence            221 12222222             3456888899999999999999864

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-38  Score=329.65  Aligned_cols=246  Identities=17%  Similarity=0.286  Sum_probs=191.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +||+|+||.||++.....+     +.||||.++...  .....+.+.+|..++.++ +||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e   76 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTR-----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             eEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe
Confidence            6899999999999987765     899999997642  222335688999999998 79999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++...+     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~~~~g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          77 FVSGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            999999999887543     38999999999999999999999   8999999999999999999999999999874321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---cccHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND---GKGLESLVRK  582 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~---~~~l~~~~~~  582 (642)
                      ..            .......||+.|+|||++. +..++.++|||||||++|||+||+.||+.....   ......+...
T Consensus       149 ~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~  215 (329)
T cd05588         149 PG------------DTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ  215 (329)
T ss_pred             CC------------CccccccCCccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH
Confidence            11            0111346889999999854 477899999999999999999999999642211   1112222222


Q ss_pred             -HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC------HHHHH
Q 006522          583 -AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR------MRTVS  633 (642)
Q Consensus       583 -~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs------~~ev~  633 (642)
                       .......++..+++             ++.+++.+|++.||++||+      +.|++
T Consensus       216 ~~~~~~~~~p~~~~~-------------~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         216 VILEKQIRIPRSLSV-------------KASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             HHHcCCCCCCCCCCH-------------HHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence             22222222333332             3456888899999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-38  Score=314.38  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=200.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....++  ....||||.++.........+|.+|+.++++++||||+++++++...+..++|||
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           8 IEKVIGGGEFGEVCRGRLKLPGK--KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             eeeEecCCccceEEEEEEccCCC--CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            35789999999999999865421  1268999998765444444789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          86 YMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             cCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999976442    48999999999999999999999   8999999999999999999999999999987642


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....     .     .....++..|+|||.+. +..++.++||||||+++|||++ |..||.....     ........
T Consensus       159 ~~~~~-----~-----~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~  222 (266)
T cd05033         159 SEATY-----T-----TKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVE  222 (266)
T ss_pred             cccce-----e-----ccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHH
Confidence            21100     0     01223456799999854 4678999999999999999998 9999864221     12222221


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ... .+.....             ...+.+++.+||+.+|++||++.|+++.|+++
T Consensus       223 ~~~~~~~~~~~-------------~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DGYRLPPPMDC-------------PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cCCCCCCCCCC-------------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111 1111111             12456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-38  Score=323.63  Aligned_cols=261  Identities=18%  Similarity=0.235  Sum_probs=192.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||+++...++     +.||||++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             EEEecccCCEEEEEEEECCCC-----cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            467899999999999987765     7899999876432 2234678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++++.+..+....     ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99987776554322     248999999999999999999999   8999999999999999999999999999987543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH-
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF-  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~-  584 (642)
                      ....           ......||+.|+|||++. +..++.++||||+||++|||++|+.||....... .+.. +.... 
T Consensus       153 ~~~~-----------~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~-~~~~~~  218 (287)
T cd07848         153 GSNA-----------NYTEYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFT-IQKVLG  218 (287)
T ss_pred             cccc-----------cccccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhC
Confidence            2110           111346788899999854 4678999999999999999999999997533211 1111 11100 


Q ss_pred             ----------hccCCCccccChhhhhchh-----HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 ----------RERRPLSEVIDPALVKEIH-----AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ----------~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                                ...........+.......     .......+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                      0000000000000000000     0011235788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-38  Score=328.81  Aligned_cols=242  Identities=17%  Similarity=0.249  Sum_probs=191.8

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +||+|+||.||+|+...++     +.||+|.++...  .....+.+..|.+++..+ +||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E   76 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME   76 (321)
T ss_pred             ccccCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe
Confidence            6899999999999987654     799999987531  222336678899999876 89999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          77 YVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999987643     38899999999999999999999   8999999999999999999999999999875322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ..........
T Consensus       149 ~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~  210 (321)
T cd05591         149 NGV------------TTTTFCGTPDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILH  210 (321)
T ss_pred             CCc------------cccccccCccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHc
Confidence            110            111346888999999854 4678999999999999999999999997532     2233333333


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-------CHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-------RMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-------s~~ev~~  634 (642)
                      .....+..+++             ++.+++.+||+.||++||       ++.++++
T Consensus       211 ~~~~~p~~~~~-------------~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         211 DDVLYPVWLSK-------------EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            33222222332             345678889999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.4e-38  Score=315.17  Aligned_cols=249  Identities=26%  Similarity=0.415  Sum_probs=196.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||+|....+      ..||+|.+.....  ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNS------TKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             eeecCCcCCceEEEEEecCC------ceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            46799999999999997665      6799999865332  237899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        83 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          83 MAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999976432   248899999999999999999999   89999999999999999999999999999865432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||+.. +..++.++|||||||++|||+| |+.||.....     .........
T Consensus       157 ~~~-----------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~~  219 (261)
T cd05072         157 EYT-----------AREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDVMSALQR  219 (261)
T ss_pred             cee-----------ccCCCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHHHHHHHc
Confidence            110           011223556799999854 4678899999999999999999 9999964321     111222111


Q ss_pred             cc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. .+....+             ..++.+++.+||+.+|++||+++++.+.|+.+
T Consensus       220 ~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         220 GYRMPRMENC-------------PDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCCCCCC-------------CHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11 1111111             12456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-38  Score=318.87  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=188.0

Q ss_pred             ccCccCCceeEEEEecCCC-------------------CCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeee
Q 006522          349 VVGKSKNGIMYKVVVGRGS-------------------GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR  409 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  409 (642)
                      .||+|+||.||+|.....+                   ..+....|++|.+..... ...++|.+|+.++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            5899999999999864321                   122335689999865422 22367889999999999999999


Q ss_pred             EEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC
Q 006522          410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE  489 (642)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  489 (642)
                      ++++|......++||||+++|+|.+++.....    .+++..+..++.||++||+|||+   .+|+||||||+||+++..
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence            99999999999999999999999999875432    48899999999999999999999   899999999999999754


Q ss_pred             C-------CeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHH-h
Q 006522          490 L-------HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEIL-T  561 (642)
Q Consensus       490 ~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~-t  561 (642)
                      +       .+|++|||++.......                ...++..|+|||.+.....++.++|||||||++|||+ +
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~----------------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSRE----------------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             CcccCccceeeecCCcccccccccc----------------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            3       37999999876432110                1245667999998655466899999999999999995 6


Q ss_pred             CCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          562 GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       562 G~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      |+.||......  ....    ........++...             ..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 g~~p~~~~~~~--~~~~----~~~~~~~~~~~~~-------------~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPS--EKER----FYEKKHRLPEPSC-------------KELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChH--HHHH----HHHhccCCCCCCC-------------hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            99998753221  1111    1122222222111             13566888999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.6e-38  Score=312.81  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=193.4

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||++.....+     +.+|+|.+...........|.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   76 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADN-----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ   76 (252)
T ss_pred             ccCcccCccEEEEEEecCC-----ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence            5899999999999987654     78999988754333344779999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +++|.+++....    ..++|..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        77 ~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  149 (252)
T cd05084          77 GGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY  149 (252)
T ss_pred             CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence            999999997543    248999999999999999999999   8999999999999999999999999999875432210


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhc-
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRE-  586 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~-  586 (642)
                      ..       ..   ....++..|+|||.+.. ..++.++|||||||++|||++ |..||.....     .......... 
T Consensus       150 ~~-------~~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~~~~  213 (252)
T cd05084         150 AS-------TG---GMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQGV  213 (252)
T ss_pred             cc-------cC---CCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCC
Confidence            00       00   01123456999998544 678999999999999999998 8888864221     1111111111 


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ..+.....             ...+.+++.+||+.+|++|||+.|+.++|++
T Consensus       214 ~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         214 RLPCPELC-------------PDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCCCcccC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11111111             1245678899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.1e-38  Score=318.84  Aligned_cols=262  Identities=24%  Similarity=0.364  Sum_probs=201.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.............+++|.+..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY   88 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence            467999999999999875543333346799999875432 2236789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          427 IRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +++++|.+++..+...           ....++|..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEEC
Confidence            9999999999764321           11248999999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGK  574 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~  574 (642)
                      |||+++.........       .   .....++..|+|||++. +..++.++|||||||++|||+| |+.||.....   
T Consensus       166 dfg~a~~~~~~~~~~-------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---  231 (291)
T cd05094         166 DFGMSRDVYSTDYYR-------V---GGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---  231 (291)
T ss_pred             CCCcccccCCCceee-------c---CCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999997654321100       0   01234567799999854 4778999999999999999999 9999864322   


Q ss_pred             cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       575 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                        ...++........  .. ..         .....+.+++.+||+.+|++||++.+|+++|+++.
T Consensus       232 --~~~~~~~~~~~~~--~~-~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         232 --TEVIECITQGRVL--ER-PR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             --HHHHHHHhCCCCC--CC-Cc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              1222222222111  10 00         01134567999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=300.23  Aligned_cols=244  Identities=19%  Similarity=0.269  Sum_probs=193.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ..++||+|.|+.||++....++     +.+|+|++.... .....+++.+|+.|.+.++|||||++.+.+.+....|+|+
T Consensus        15 l~e~igkG~FSvVrRc~~~~tg-----~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   15 VKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             HHHHHccCchHHHHHHHhccch-----HHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            3468999999999999888776     556666554321 1123478899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC---CCCCeEEecccccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGFGLNR  501 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~  501 (642)
                      |+|+||+|..-+-.+.     ..++...-.+++||+.||+|+|.   ++|||||+||+|+++.   ..--+|++|||+|.
T Consensus        90 e~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999987665442     37888899999999999999999   8999999999999994   34568999999999


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .+....             .-...+|||+|||||+ .....|+..+|||+.|||||-|+.|..||.+.+.     ..+.+
T Consensus       162 ~l~~g~-------------~~~G~~GtP~fmaPEv-vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rlye  222 (355)
T KOG0033|consen  162 EVNDGE-------------AWHGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYE  222 (355)
T ss_pred             EeCCcc-------------ccccccCCCcccCHHH-hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHHHH
Confidence            876321             1124689999999999 4458899999999999999999999999986322     33344


Q ss_pred             HHHhccCC----CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRERRP----LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~----~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++......    ..+.+.++             .-+++.+++..||.+|.|+.|.++
T Consensus       223 ~I~~g~yd~~~~~w~~is~~-------------Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVTPE-------------AKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHhccccCCCCcccCcCCHH-------------HHHHHHHHhccChhhhccHHHHhC
Confidence            44433322    23333333             334788899999999999988764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=308.92  Aligned_cols=259  Identities=20%  Similarity=0.268  Sum_probs=196.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-----CCce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-----NDEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~  420 (642)
                      ...||+|+||.|..+....++     ..||+|++... ......++-.||+.+|+.++|+|||.+++.+..     -+..
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~-----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTG-----EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             cccccCcceeeEEEEEEcCCC-----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            357999999999999998886     89999999854 333334788999999999999999999999876     2368


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |+|+|+|+. ||.+.++.+.     .|+......++.|+++||.|+|+   .+|+||||||+|++++.+...||+|||+|
T Consensus       102 YiV~elMet-DL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  102 YLVFELMET-DLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             EEehhHHhh-HHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence            999999965 9999998754     38889999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +......          ....-+..+.|.+|.|||+......|+.+.||||.|||+.||++|++-|.+.+.-     ..+
T Consensus       173 R~~~~~~----------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-----~Ql  237 (359)
T KOG0660|consen  173 RYLDKFF----------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-----HQL  237 (359)
T ss_pred             eeccccC----------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-----HHH
Confidence            9875430          0001124567889999999888889999999999999999999999988763221     111


Q ss_pred             HHHHhccCCCcc-----ccChhhhhchhH-------------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRPLSE-----VIDPALVKEIHA-------------KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~-----~~d~~l~~~~~~-------------~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .....--+...+     +-++....-+..             ....-.++++..++|..||.+|+|++|+++
T Consensus       238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111110000000     000000000000             001134677888999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-38  Score=333.04  Aligned_cols=255  Identities=18%  Similarity=0.239  Sum_probs=188.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++.....+     +.||+|....       ..+.+|++++++++|||||++++++......++|+||
T Consensus        97 ~~~lg~G~~g~V~~~~d~~~~-----~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         97 LETFTPGAEGFAFACIDNKTC-----EHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             EEEEcCCCCeEEEEEEECCCC-----CEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            467999999999999998775     7899997532       4567999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +. ++|.+++....     .+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       165 ~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        165 YK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             CC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            95 69999886543     38899999999999999999999   89999999999999999999999999998753221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCc------ccHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG------KGLESLV  580 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~------~~l~~~~  580 (642)
                      .           ........||+.|+|||++. +..++.++|||||||++|||+||+.||.......      ..+...+
T Consensus       236 ~-----------~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~  303 (391)
T PHA03212        236 N-----------ANKYYGWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII  303 (391)
T ss_pred             c-----------ccccccccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence            1           00112346899999999854 4678999999999999999999998875432110      1111111


Q ss_pred             HHHHhccCCCcc----ccChhh-------------hhch-hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRPLSE----VIDPAL-------------VKEI-HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~----~~d~~l-------------~~~~-~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +...........    .++...             .... .......++.+++.+||+.||++|||+.|+++
T Consensus       304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            111000000000    000000             0000 00011235678999999999999999999984

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.8e-38  Score=327.52  Aligned_cols=197  Identities=21%  Similarity=0.380  Sum_probs=168.0

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||++....++     ..+|+|.+.........+.+.+|++++++++||||++++++|...+..++|||
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            3467999999999999987664     78999988764333334679999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++.....++.|++.||+|||+.  .+|+||||||+|||+++++.+||+|||+++....
T Consensus        84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999997543     388899999999999999999972  3699999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ..              .....|+..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus       157 ~~--------------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 SM--------------ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hc--------------cccCCCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            10              11335788899999854 467899999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=312.98  Aligned_cols=251  Identities=25%  Similarity=0.460  Sum_probs=197.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|++|.||++....+      +.||+|.++....  ..++|.+|+.++++++||||+++++++...+..++|||
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068          10 LLRKLGAGQFGEVWEGLWNNT------TPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             eEEEecccCCccEEEEEecCC------eEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            357899999999999997655      7899999876432  23779999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++.....   ..++|..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        82 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          82 LMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999976442   248999999999999999999999   8999999999999999999999999999987652


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....           ......+..|+|||+.. +..++.++|||||||++|||+| |+.||.+...     ........
T Consensus       156 ~~~~~-----------~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~  218 (261)
T cd05068         156 DIYEA-----------REGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQVD  218 (261)
T ss_pred             Ccccc-----------cCCCcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH
Confidence            21100           00112235699999854 4778999999999999999999 9999964321     11222221


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      . .....  ..+.         ....+.+++.+|++.+|++||++.++++.|+++
T Consensus       219 ~-~~~~~--~~~~---------~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         219 Q-GYRMP--CPPG---------CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             c-CCCCC--CCCc---------CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            1 11110  0111         113466789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=329.25  Aligned_cols=248  Identities=16%  Similarity=0.191  Sum_probs=195.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|.....+     +.||||++....  .....+.+.+|++++.+++||||+++++++...+..++||
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTG-----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            467999999999999988764     789999997542  1223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            9999999999997543     38899999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.....     ........
T Consensus       153 ~~---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~  211 (333)
T cd05600         153 TY---------------ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWENLK  211 (333)
T ss_pred             cc---------------cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHHHH
Confidence            21               113468889999998554 6889999999999999999999999975322     12222211


Q ss_pred             hccCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          585 RERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       585 ~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .....  .+...++.       .....++.+++.+||..+|++||++.|+++.
T Consensus       212 ~~~~~~~~~~~~~~~-------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         212 YWKETLQRPVYDDPR-------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             hccccccCCCCCccc-------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            11110  01111110       0112345678889999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4e-38  Score=319.01  Aligned_cols=247  Identities=21%  Similarity=0.252  Sum_probs=190.8

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|+||.||++.....+     +.+|+|.+.....  ....+.+..|++++++++||||+++++++......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTG-----KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCC-----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            699999999999987765     8999999865321  112245667999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++.......
T Consensus        76 ~g~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          76 NGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             CCCCHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            99999998865443   248999999999999999999999   899999999999999999999999999987654321


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .             .....|+..|+|||++.. ..++.++||||+||++|||++|+.||...... .......+......
T Consensus       150 ~-------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~  214 (277)
T cd05607         150 T-------------ITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE  214 (277)
T ss_pred             e-------------eeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc
Confidence            0             012357888999998554 56899999999999999999999999753221 11122222222211


Q ss_pred             CCC-ccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          588 RPL-SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       588 ~~~-~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ... ...++             .++.+++.+||+.||++||+++|+++.
T Consensus       215 ~~~~~~~~~-------------~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         215 VKFEHQNFT-------------EESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccccccCC-------------HHHHHHHHHHhccCHhhCCCCccchhh
Confidence            110 01111             235678889999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-37  Score=317.18  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....+......+.||+|+++........+.|.+|+.++++++||||+++++++...+..++++||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~   89 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY   89 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence            46789999999999988654333344789999998654333346789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          427 IRNGSLYAALHAGPS-----------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +++++|.+++.....           .....+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEec
Confidence            999999999863211           011348899999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGK  574 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~  574 (642)
                      |||+++.........          ......+++.|+|||.+.. ..++.++|||||||++|||+| |..||.+..    
T Consensus       167 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----  231 (283)
T cd05091         167 DLGLFREVYAADYYK----------LMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----  231 (283)
T ss_pred             ccccccccccchhee----------eccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----
Confidence            999988654321100          0012245677999998554 678999999999999999998 888886422    


Q ss_pred             cHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          575 GLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       575 ~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                       ...+......... +..+..             ...+.+++..||+.+|++||+++||+..|+.
T Consensus       232 -~~~~~~~i~~~~~~~~~~~~-------------~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         232 -NQDVIEMIRNRQVLPCPDDC-------------PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHHHHcCCcCCCCCCC-------------CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1233333322221 111111             1235568899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=314.07  Aligned_cols=255  Identities=23%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ++||+|+||.||+|...+++.   ...+++|.++........+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCC---eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            368999999999999876531   1467889887543333346789999999999 899999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          427 IRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +++|+|.++++.....           ....+++.++..++.|++.||+|||+   .+++||||||+||++++++.+|++
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEEC
Confidence            9999999999764321           11248999999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGK  574 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~  574 (642)
                      |||+++......          .   ......+..|+|||++. ...++.++|||||||++|||+| |..||.....   
T Consensus       155 dfgl~~~~~~~~----------~---~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---  217 (270)
T cd05047         155 DFGLSRGQEVYV----------K---KTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---  217 (270)
T ss_pred             CCCCccccchhh----------h---ccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence            999986322110          0   00112345699999854 4678999999999999999997 9999964321   


Q ss_pred             cHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          575 GLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       575 ~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                        ........... ......+             ...+.+++.+||+.+|.+|||+.|++..|+++-
T Consensus       218 --~~~~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         218 --AELYEKLPQGYRLEKPLNC-------------DDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --HHHHHHHhCCCCCCCCCcC-------------CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence              22222221111 1111111             124567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.8e-38  Score=317.04  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=189.7

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||+|....+   .....+++|.+...........|.+|+.+++.++||||+++++++...+..++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecC---CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            589999999999976543   12267999988755433334678999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.+++...........++.....++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999999977543222335788889999999999999999   8999999999999999999999999999865432211


Q ss_pred             ccccceeeecCCCcccccCCCcccCcccccc------CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIY------GSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~  581 (642)
                      ..       .   .....++..|+|||+...      ...++.++|||||||++|||++ |..||......     ....
T Consensus       156 ~~-------~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~  220 (269)
T cd05042         156 YI-------T---KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-----QVLK  220 (269)
T ss_pred             ee-------c---cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHH
Confidence            00       0   012345667999998432      2356889999999999999999 78888643221     1112


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      .......  .....+.+....     ...+.+++..|| .||++|||++||++.|.
T Consensus       221 ~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         221 QVVREQD--IKLPKPQLDLKY-----SDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHhhccC--ccCCCCcccccC-----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2121111  111111111111     123344677788 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.7e-39  Score=297.76  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc---cc----cHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA---TW----RFKDFESEVEAIARV-QHPNIVRLKAFYYAND  418 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~----~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~  418 (642)
                      .+++|.|..++|.++..+.++     +..|+|++.....   ..    -.+.-.+|+.||+++ .||||+++.++|+++.
T Consensus        22 keilgrgvss~vrRci~k~t~-----~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETG-----KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             HHHhcccchhhhhhhhhcccc-----cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            468999999999999888876     7889998865421   11    124457899999999 7999999999999999


Q ss_pred             ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          419 EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      ..++|+|.|+.|.|+|+|...-     .++++...+|++|+..|++|||.   ..||||||||+|||+|++.++||+|||
T Consensus        97 F~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            9999999999999999998654     38999999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG  573 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~  573 (642)
                      +++.+....             ..+..||||+|.|||.+..     ...|+...|+||.|||||.|+.|.+||...    
T Consensus       169 Fa~~l~~Ge-------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----  231 (411)
T KOG0599|consen  169 FACQLEPGE-------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----  231 (411)
T ss_pred             eeeccCCch-------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----
Confidence            999876542             2346799999999997432     356889999999999999999999999742    


Q ss_pred             ccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       574 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +. .-.++.+..+..   +.-+|++.+ +     .....+++.+|++.||.+|.|++|+++
T Consensus       232 kQ-mlMLR~ImeGky---qF~speWad-i-----s~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  232 KQ-MLMLRMIMEGKY---QFRSPEWAD-I-----SATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HH-HHHHHHHHhccc---ccCCcchhh-c-----cccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11 112233333332   233444422 1     124556899999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-37  Score=318.13  Aligned_cols=264  Identities=24%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ....||+|+||.||++.............+|+|.+..........++.+|++++.++ +||||+++++++...+..++||
T Consensus        16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~   95 (293)
T cd05053          16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV   95 (293)
T ss_pred             EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEE
Confidence            356899999999999987654333344789999987654333446789999999999 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeE
Q 006522          425 DFIRNGSLYAALHAGPS-----------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC  493 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  493 (642)
                      ||+++|+|.++++....           .....+++..+++++.|++.||+|||+   .+|+||||||+||++++++.+|
T Consensus        96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~k  172 (293)
T cd05053          96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMK  172 (293)
T ss_pred             EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEE
Confidence            99999999999975321           112458999999999999999999999   8999999999999999999999


Q ss_pred             EecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND  572 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~  572 (642)
                      |+|||+++.+........      .    ....++..|+|||+.. +..++.++|||||||++|||++ |..||....  
T Consensus       173 L~Dfg~~~~~~~~~~~~~------~----~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  239 (293)
T cd05053         173 IADFGLARDIHHIDYYRK------T----TNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  239 (293)
T ss_pred             eCccccccccccccceec------c----CCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCCC--
Confidence            999999987643221100      0    0123456799999844 4678999999999999999998 999986422  


Q ss_pred             cccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                         ..+...........  . ...         .....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       240 ---~~~~~~~~~~~~~~--~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         240 ---VEELFKLLKEGYRM--E-KPQ---------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHHHHHHcCCcC--C-CCC---------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               12222222211110  0 000         11234667999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.8e-39  Score=330.91  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      +.||+|+||.||+++...+..  ..+.||+|++..... ......+.+|++++++++||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPD--AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            468999999999998753321  127899999975421 12235678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        80 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          80 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99999999997543     48999999999999999999999   89999999999999999999999999998764322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ...........
T Consensus       152 ~~------------~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~  213 (318)
T cd05582         152 EK------------KAYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKA  213 (318)
T ss_pred             CC------------ceecccCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcC
Confidence            10            111346888999999854 4678999999999999999999999997532     12233333333


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT  631 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e  631 (642)
                      ...++..+++.             +.+++.+||+.||++||++.+
T Consensus       214 ~~~~p~~~~~~-------------~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 KLGMPQFLSPE-------------AQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCCHH-------------HHHHHHHHhhcCHhHcCCCCC
Confidence            33333333333             345778899999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.5e-38  Score=320.49  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=196.9

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ....||+|+||.||+|.....+   ....+++|.++........+.|.+|++++.++ +||||+++++++...+..++||
T Consensus        11 ~~~~lg~G~~g~V~~a~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088          11 FQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             eeeeecCCCCceEEEEEEccCC---ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            3467999999999999986542   12467888876543333446789999999999 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeE
Q 006522          425 DFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC  493 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  493 (642)
                      ||+++|+|.++++.....           ....+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence            999999999999765321           11358999999999999999999999   8999999999999999999999


Q ss_pred             EecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND  572 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~  572 (642)
                      |+|||+++......             ......++..|+|||++. +..++.++|||||||++|||+| |..||..... 
T Consensus       165 l~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  229 (303)
T cd05088         165 IADFGLSRGQEVYV-------------KKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  229 (303)
T ss_pred             eCccccCcccchhh-------------hcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCCh-
Confidence            99999986422110             000122355699999854 4668999999999999999998 9999964322 


Q ss_pred             cccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          573 GKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                          .+......... ......++             ..+.+++.+||+.+|++||++.++++.|+++.+
T Consensus       230 ----~~~~~~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         230 ----AELYEKLPQGYRLEKPLNCD-------------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             ----HHHHHHHhcCCcCCCCCCCC-------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                12222221111 01111111             235678999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-38  Score=324.47  Aligned_cols=241  Identities=20%  Similarity=0.298  Sum_probs=189.1

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||+|....++     +.||||.++...  .....+.+..|..++... +||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e   76 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME   76 (316)
T ss_pred             eeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe
Confidence            6899999999999987765     789999987641  122235677888888765 99999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        77 y~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          77 YLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            999999999997543     38899999999999999999999   8999999999999999999999999999875321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......||..|+|||++. +..++.++|||||||++|||+||+.||....     .....+....
T Consensus       149 ~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~~  210 (316)
T cd05619         149 GDA------------KTCTFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIRM  210 (316)
T ss_pred             CCC------------ceeeecCCccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh
Confidence            110            011346788999999854 4678999999999999999999999997532     1222332222


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR-TVS  633 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~  633 (642)
                      .....+..++.             .+.+++.+||+.||++||++. ++.
T Consensus       211 ~~~~~~~~~~~-------------~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         211 DNPCYPRWLTR-------------EAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCCCCCccCCH-------------HHHHHHHHHhccCHhhcCCChHHHH
Confidence            22222222222             345688889999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-38  Score=325.44  Aligned_cols=242  Identities=19%  Similarity=0.277  Sum_probs=192.1

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||+++...++     +.||||.+++..  .......+.+|++++..+ +||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e   76 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTD-----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME   76 (318)
T ss_pred             eeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc
Confidence            6899999999999987764     789999997541  222336678899999888 79999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++....
T Consensus        77 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          77 YVNGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            999999999987653     38999999999999999999999   8999999999999999999999999999865321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......||+.|+|||++. +..++.++|||||||++|||+||+.||....     ..........
T Consensus       149 ~~------------~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~  210 (318)
T cd05570         149 GG------------VTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILE  210 (318)
T ss_pred             CC------------CcccceecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHc
Confidence            11            0111345788999999854 4778999999999999999999999997432     2223333332


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM-----RTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~-----~ev~~  634 (642)
                      .....+..++             ..+.+++.+||+.||++||++     .++++
T Consensus       211 ~~~~~~~~~~-------------~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         211 DEVRYPRWLS-------------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCCCCcCC-------------HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2222222222             234568889999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-37  Score=312.24  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=199.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....++.  ...+++|.++........+++..|++++++++||||+++++++...+..++|||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRK--EVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE   86 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCC--ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence            357899999999999998754321  258999998765333334779999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++.....    .+++.++..++.|++.||+|||+   .+++||||||+||++++++.+|++|||++.....
T Consensus        87 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          87 YMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             cCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999976432    48999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ......      .   ......+..|+|||++.. ..++.++|||||||++|||+| |+.||.....     ..+.....
T Consensus       160 ~~~~~~------~---~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~  224 (268)
T cd05063         160 DPEGTY------T---TSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAIN  224 (268)
T ss_pred             ccccce------e---ccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHh
Confidence            211100      0   001123456999998554 678999999999999999998 9999964321     22222222


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. ..+....             ....+.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 ~~~~~~~~~~-------------~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DGFRLPAPMD-------------CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCCCCCCCCC-------------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11 1111111             113456799999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.6e-38  Score=323.97  Aligned_cols=242  Identities=20%  Similarity=0.266  Sum_probs=189.8

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      +.||+|+||.||+++....+     +.||+|.++...  .....+.+..|..++... +||||+++++++...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKG-----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            36899999999999987765     789999997542  122335677888888765 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        76 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05620          76 EFLNGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV  147 (316)
T ss_pred             CCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence            9999999999987643     38899999999999999999999   899999999999999999999999999986432


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...            .......||+.|+|||++. +..++.++||||+||++|||++|+.||....     .....+...
T Consensus       148 ~~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~~~~~  209 (316)
T cd05620         148 FGD------------NRASTFCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELFESIR  209 (316)
T ss_pred             cCC------------CceeccCCCcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHH
Confidence            111            0111346889999999854 4778999999999999999999999997432     123333333


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH-HHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR-TVS  633 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~-ev~  633 (642)
                      ......+..+++.             +.+++.+||+.||++||++. ++.
T Consensus       210 ~~~~~~~~~~~~~-------------~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         210 VDTPHYPRWITKE-------------SKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             hCCCCCCCCCCHH-------------HHHHHHHHccCCHHHcCCChHHHH
Confidence            3332233333332             34577889999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-38  Score=327.77  Aligned_cols=238  Identities=23%  Similarity=0.287  Sum_probs=187.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHH-HHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVE-AIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||++....++     +.||+|++....  .....+++.+|.. +++.++||||+++++++...+..++|||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e   76 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADG-----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD   76 (323)
T ss_pred             eeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence            6899999999999987765     899999987532  1122245556655 5678899999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          77 YVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             CCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            999999999997643     48899999999999999999999   8999999999999999999999999999875322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......||+.|+|||++. +..++.++|||||||++|||+||+.||...     ...........
T Consensus       149 ~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~  210 (323)
T cd05575         149 HSK------------TTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILN  210 (323)
T ss_pred             CCC------------ccccccCChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHc
Confidence            110            111346888999999854 477899999999999999999999999743     22333444433


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      ....+...+++             .+.+++.+|++.||++||+++
T Consensus       211 ~~~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 KPLRLKPNISV-------------SARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHhhcCHHhCCCCC
Confidence            33222222222             345588889999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.7e-37  Score=310.28  Aligned_cols=258  Identities=21%  Similarity=0.353  Sum_probs=194.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-CCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-NDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~  426 (642)
                      +.||+|+||.||+|......  .....||+|++.........+.+.+|+.+++.++||||+++++++.. ++..++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCC--CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            36899999999999875432  12268999998654433345788999999999999999999998764 4568999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +.+|+|.+++.....    .+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          79 MKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            999999999976432    36788889999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG-RLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG-~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....        ........++..|+|||+... ..++.++|||||||++|||+|| ..||....     ..........
T Consensus       152 ~~~~--------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~~~  217 (262)
T cd05058         152 EYYS--------VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYLLQ  217 (262)
T ss_pred             ccee--------ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHhc
Confidence            1100        000112345667999998544 6789999999999999999995 55564321     1222332222


Q ss_pred             ccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          586 ERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       586 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      .... ....+.             ..+.+++..||+.+|++||++.|+++.|+++..
T Consensus       218 ~~~~~~~~~~~-------------~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 GRRLLQPEYCP-------------DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCCcCC-------------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            2211 111111             245678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-37  Score=312.83  Aligned_cols=259  Identities=23%  Similarity=0.418  Sum_probs=194.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC------Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  419 (642)
                      ...||+|+||.||+|.....+.   ...+|+|.++... .....+.|.+|++++++++||||+++++++...      ..
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~---~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDS---ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccCcccCceEEEeEEccCCC---eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4679999999999999866531   2479999887542 223347889999999999999999999987542      24


Q ss_pred             eEEEEeeccCCcHHHHHhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          420 KLLISDFIRNGSLYAALHAGP-SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      .++||||+++|+|.+++.... ......+++.....++.|++.||+|||+   .+|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885332 1122358999999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~  577 (642)
                      +++.........       .   .....+++.|+|||+.. +..++.++|||||||++|||++ |+.||.....     .
T Consensus       158 ~~~~~~~~~~~~-------~---~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~  221 (272)
T cd05075         158 LSKKIYNGDYYR-------Q---GRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----S  221 (272)
T ss_pred             cccccCccccee-------c---CCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence            998764332100       0   11223566799999854 4678999999999999999999 8899865221     1


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ............ .  ..+..         ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus       222 ~~~~~~~~~~~~-~--~~~~~---------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         222 EIYDYLRQGNRL-K--QPPDC---------LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHHcCCCC-C--CCCCC---------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222222221111 0  01111         12356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=340.66  Aligned_cols=264  Identities=22%  Similarity=0.366  Sum_probs=211.4

Q ss_pred             HHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc
Q 006522          340 EDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE  419 (642)
Q Consensus       340 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  419 (642)
                      +|.......+||+|+||+||+|.+--. +.....+||+|.+.+........++++|+-+|++++|||+++++|+|.... 
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            444445678999999999999977544 334446899999987765555689999999999999999999999999876 


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      ..||.+||+.|+|.++++.++.    ++--...+.|..|||+||.|||+   ++++||||..+|||+.+-..+||.|||+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecch
Confidence            8899999999999999998765    37778999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLES  578 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~  578 (642)
                      ++.+..+.......          ...-.+.|||-|.+.. ..|+.++|||||||++||++| |..||++...+  .+..
T Consensus       845 a~ll~~d~~ey~~~----------~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~d  911 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAP----------GGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPD  911 (1177)
T ss_pred             hhccCccccccccc----------ccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhH
Confidence            99987664322211          1223456999998554 889999999999999999999 99999875432  2333


Q ss_pred             HHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      .++...+  .+-++             -+...++.++.+||..|++.||+++++.+.+.++-
T Consensus       912 lle~geR--LsqPp-------------iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  912 LLEKGER--LSQPP-------------ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             HHhcccc--CCCCC-------------CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            3332211  11111             23345677899999999999999999999988874

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=311.17  Aligned_cols=246  Identities=22%  Similarity=0.373  Sum_probs=192.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||++....+      ..+|+|.+......  ..+|.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~------~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGK------IDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             hhhhhccCCCceEEEeEecCC------ccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            456799999999999987654      68999998754322  2678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++.....    .++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        80 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          80 YMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             cCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999999976442    48999999999999999999999   8999999999999999999999999999876532


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....        .   .....++..|+|||... +..++.++|||||||++|||+| |+.||.....     ........
T Consensus       153 ~~~~--------~---~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~  215 (256)
T cd05059         153 DQYT--------S---SQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEVVESVS  215 (256)
T ss_pred             cccc--------c---cCCCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHHH
Confidence            2100        0   00112345699999854 4678999999999999999999 8999864322     11222221


Q ss_pred             hccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          585 RERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       585 ~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      .... ..+...             ..++.+++.+||+.+|++|||+.|+++.|
T Consensus       216 ~~~~~~~~~~~-------------~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         216 AGYRLYRPKLA-------------PTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCcCCCCCCC-------------CHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1111 111111             12456789999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-37  Score=310.12  Aligned_cols=251  Identities=20%  Similarity=0.325  Sum_probs=191.9

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccC
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN  429 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  429 (642)
                      ||+|+||.||+|......   ....||+|.+.........+.|.+|+.++++++||||+++++++. .+..++||||+++
T Consensus         3 ig~G~~g~v~~~~~~~~~---~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRK---KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             cCCCCcccEEEEEEecCC---CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            899999999999765321   116799999876544434467999999999999999999999885 4578999999999


Q ss_pred             CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcc
Q 006522          430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV  509 (642)
Q Consensus       430 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~  509 (642)
                      |+|.+++.....    .+++..+.+++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        79 ~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          79 GPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            999999975432    48999999999999999999999   89999999999999999999999999998765432211


Q ss_pred             cccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhccC
Q 006522          510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR  588 (642)
Q Consensus       510 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~~  588 (642)
                      ..      .   .....++..|+|||.... ..++.++|||||||++||+++ |+.||.....     ..+.........
T Consensus       152 ~~------~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~  216 (257)
T cd05115         152 YK------A---RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSFIEQGKR  216 (257)
T ss_pred             ee------c---cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCCCC
Confidence            00      0   011223567999998543 678999999999999999996 9999975322     122222221111


Q ss_pred             -CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          589 -PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       589 -~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                       ..+...             ..++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~-------------~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAEC-------------PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             111111             12455688889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-37  Score=311.18  Aligned_cols=246  Identities=22%  Similarity=0.389  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....      ..+|+|.+.....  ..++|.+|+.++.+++||||+++++++...+..++||||
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~------~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             eeEecCcccceEEEEEecCC------CcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            45799999999999987654      5799999875432  236799999999999999999999999988899999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    .++|..++.++.||+.||+|||+   .+++|+||||+||++++++.+||+|||.++.....
T Consensus        81 ~~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          81 MSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             CCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            999999999976432    48999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...        .   .....++..|+|||.... ..++.++|||||||++|||+| |+.||.....     .........
T Consensus       154 ~~~--------~---~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~  216 (256)
T cd05113         154 EYT--------S---SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEKVSQ  216 (256)
T ss_pred             cee--------e---cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHhc
Confidence            110        0   011234567999998543 678999999999999999999 9999864321     122222222


Q ss_pred             ccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          586 ERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       586 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ..+. .....             ...+.+++.+||+.+|++||++.++++.|+
T Consensus       217 ~~~~~~~~~~-------------~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         217 GLRLYRPHLA-------------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCCC-------------CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            2211 11111             134567889999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=344.74  Aligned_cols=262  Identities=16%  Similarity=0.193  Sum_probs=200.9

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEE-EEeC------
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAF-YYAN------  417 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~-~~~~------  417 (642)
                      ..++|.+|||+.||.|.+..++     ..+|+|++-.. +....+...+||++|++|+ |+|||.+++. ....      
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4578999999999999998875     89999999876 4445688999999999995 9999999993 3221      


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      -+.+|.||||++|.|-|++..+...   .|++.++++|+.|+++|+++||... ++|||||||-+||||+.++..|||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence            2678999999999999999876554   3999999999999999999999854 68999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCcccc--ccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR--IYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      |.+...........+......   .-...-|+.|+|||++  ..+..+++|+||||+||+||.|+....||+....-   
T Consensus       191 GSatt~~~~~~~~~e~~~ve~---eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEE---EIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHH---HHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            988643322110000000000   0012357789999973  34567899999999999999999999999753221   


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                        .++    ...+.++..           ......+.+|+..||+.||.+||++.+|++.+-+|+
T Consensus       265 --aIl----ng~Y~~P~~-----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  265 --AIL----NGNYSFPPF-----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             --eEE----eccccCCCC-----------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence              111    112221111           123345667999999999999999999999998875

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-37  Score=308.62  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=193.0

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      +||+|+||.||++....+      ..+|+|.+...........|.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~ig~g~~g~vy~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDK------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             ccCCCCCceEEEEEecCC------cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            689999999999987654      78999998765433333578999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.+++.....    .+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        76 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          76 GGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence            9999999875432    48999999999999999999999   8999999999999999999999999999875432210


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .           ......++..|+|||+.. ...++.++|||||||++||+++ |..||.....     ........ ..
T Consensus       149 ~-----------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~~-~~  210 (250)
T cd05085         149 S-----------SSGLKQIPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQVE-KG  210 (250)
T ss_pred             c-----------cCCCCCCcccccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHH-cC
Confidence            0           001123356799999854 4678999999999999999998 9999964321     11112111 11


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      .. .. ....         ....+.+++.+|++.+|++||++.|++++|.
T Consensus       211 ~~-~~-~~~~---------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YR-MS-CPQK---------CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CC-CC-CCCC---------CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11 00 0111         1134667899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-37  Score=304.00  Aligned_cols=265  Identities=19%  Similarity=0.274  Sum_probs=198.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCC-eeeEEEEEEeCC------c
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPN-IVRLKAFYYAND------E  419 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~  419 (642)
                      +.||+|+||+||+|+....+     +.||+|+++-.... ..-....+|+.++++++|+| ||++++++...+      .
T Consensus        17 eklGeGtyg~Vykar~~~~g-----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTG-----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHhCCCCceEEEEEEEecCC-----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45999999999999998876     89999999876332 22256789999999999999 999999999877      7


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++|+||+.. +|.+++....... ..++-..+..++.||++||+|||+   ++|+||||||.|||++++|.+||+|||+
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            8899999976 9999998765321 236668899999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      |+...-...            .....++|.+|+|||++.....|++..||||+|||+.||++++.-|.+... ...+..+
T Consensus       167 Ara~~ip~~------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~I  233 (323)
T KOG0594|consen  167 ARAFSIPMR------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRI  233 (323)
T ss_pred             HHHhcCCcc------------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHH
Confidence            996542211            122446788899999988767899999999999999999999988876433 2222222


Q ss_pred             HHHHHhcc-CCCcccc-----Chhhhh-----chhHH--HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          580 VRKAFRER-RPLSEVI-----DPALVK-----EIHAK--RQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       580 ~~~~~~~~-~~~~~~~-----d~~l~~-----~~~~~--~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .+..-... ...+...     ++....     .....  .-.....+++.+|++.+|++|.|++.+++.
T Consensus       234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22111110 0001110     000000     00000  001356789999999999999999999875

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.1e-37  Score=314.81  Aligned_cols=259  Identities=26%  Similarity=0.433  Sum_probs=197.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.....+ ......|++|.+...........|.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   88 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY   88 (283)
T ss_pred             eeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence            467999999999999863221 1123789999998654444447789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEE
Q 006522          427 IRNGSLYAALHAGPSD------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI  494 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl  494 (642)
                      +++|+|.+++......            ....+++.+...++.|++.||+|||+   ++++||||||+||++++++.+||
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEe
Confidence            9999999998643210            11248899999999999999999999   89999999999999999999999


Q ss_pred             ecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCc
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG  573 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~  573 (642)
                      +|||+++.........          ......++..|+|||++.. ..++.++|||||||++|||+| |..||.+...  
T Consensus       166 ~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05090         166 SDLGLSREIYSADYYR----------VQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--  232 (283)
T ss_pred             ccccccccccCCccee----------cccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999998654321100          0112335667999998543 678999999999999999999 9999864321  


Q ss_pred             ccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          574 KGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       574 ~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                         ........... .+....+++             ++.+++.+||+.||++||++.++.+.|..
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~-------------~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ---QEVIEMVRKRQLLPCSEDCPP-------------RMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHHHcCCcCCCCCCCCH-------------HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               12222221111 111222222             34568888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.6e-38  Score=333.18  Aligned_cols=256  Identities=19%  Similarity=0.261  Sum_probs=190.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|.....+     +.||+|++....  .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTH-----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            467999999999999987765     899999997642  2223467899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          81 DYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            9999999999997643     38889999999999999999999   899999999999999999999999999986542


Q ss_pred             CCCcccc--cc---------------------------------eeeecCCCcccccCCCcccCccccccCCCCCcccch
Q 006522          505 GTSKVTK--NE---------------------------------TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV  549 (642)
Q Consensus       505 ~~~~~~~--~~---------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV  549 (642)
                      .......  ..                                 ............+||+.|+|||++. +..++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~Di  231 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDW  231 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccce
Confidence            1110000  00                                 0000000012357999999999854 4678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh--ccCCCc--cccChhhhhchhHHHHHHHHHHHHHh--cCCCCC
Q 006522          550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR--ERRPLS--EVIDPALVKEIHAKRQVLATFHIALN--CTELDP  623 (642)
Q Consensus       550 ~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~--~~~~~~--~~~d~~l~~~~~~~~~~~~~~~l~~~--Cl~~dP  623 (642)
                      |||||++|||+||+.||......     ........  .....+  ..++++             +.+++.+  |+..+|
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~s~~-------------~~dli~~ll~~~~~~  293 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPT-----ETQLKVINWENTLHIPPQVKLSPE-------------AVDLITKLCCSAEER  293 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHH-----HHHHHHHccccccCCCCCCCCCHH-------------HHHHHHHHccCcccc
Confidence            99999999999999999753321     11111111  111111  112332             2334433  677788


Q ss_pred             CCCCCHHHHHH
Q 006522          624 EFRPRMRTVSE  634 (642)
Q Consensus       624 ~~RPs~~ev~~  634 (642)
                      ..||++.|+++
T Consensus       294 ~~R~~~~~~l~  304 (381)
T cd05626         294 LGRNGADDIKA  304 (381)
T ss_pred             cCCCCHHHHhc
Confidence            88999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7e-38  Score=324.84  Aligned_cols=244  Identities=17%  Similarity=0.296  Sum_probs=190.8

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      +.||+|+||.||++....++     +.||+|+++...  .....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKND-----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            36899999999999988765     899999998642  222346688999999988 6999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        76 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~  147 (327)
T cd05617          76 EYVNGGDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL  147 (327)
T ss_pred             eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence            9999999999887543     38999999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC-cccHHHHH-HH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND-GKGLESLV-RK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~-~~~l~~~~-~~  582 (642)
                      ....            ......||+.|+|||++. +..++.++|||||||++|||+||+.||...... ......+. ..
T Consensus       148 ~~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  214 (327)
T cd05617         148 GPGD------------TTSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV  214 (327)
T ss_pred             CCCC------------ceecccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH
Confidence            1110            111346889999999854 478899999999999999999999999643221 11122222 22


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      .......++..+++.             +.+++.+||+.||++||++.
T Consensus       215 ~~~~~~~~p~~~~~~-------------~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         215 ILEKPIRIPRFLSVK-------------ASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             HHhCCCCCCCCCCHH-------------HHHHHHHHhccCHHHcCCCC
Confidence            222222233333332             34578889999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.6e-38  Score=324.35  Aligned_cols=238  Identities=22%  Similarity=0.333  Sum_probs=186.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHH---hcccCCCeeeEEEEEEeCCceE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAI---ARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      ...||+|+||.||++.....+     +.||||.++...  .....+.+.+|+.++   ++++||||+++++++...+..+
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTG-----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            357999999999999987654     899999997542  122235666776655   5678999999999999999999


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +||||+++|+|..+++..      .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        79 lv~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          79 FVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             EEEcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999888642      38999999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ......            .......||+.|+|||.+. +..++.++|||||||++|||++|+.||....     ......
T Consensus       150 ~~~~~~------------~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~~~~  211 (324)
T cd05589         150 EGMGFG------------DRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEEVFD  211 (324)
T ss_pred             cCCCCC------------CcccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence            532211            0111346888999999854 4778999999999999999999999997532     122333


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      .........+..+++             .+.+++.+||+.||++||++
T Consensus       212 ~i~~~~~~~p~~~~~-------------~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         212 SIVNDEVRYPRFLSR-------------EAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             HHHhCCCCCCCCCCH-------------HHHHHHHHHhhcCHhHcCCC
Confidence            333333222333333             23458888999999999953

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-37  Score=318.86  Aligned_cols=259  Identities=23%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ..+.||+|+||.||++.............||||.++........+.+.+|+++++++ +||||+++++++...+..++||
T Consensus        39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  118 (302)
T cd05055          39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT  118 (302)
T ss_pred             EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence            467899999999999986443223334689999987654443446789999999999 8999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.++++....   ..+++.++..++.|++.||+|||+   .+|+|+||||+||+++.++.+|++|||+++...
T Consensus       119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            99999999999976432   238999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......      ..    ....++..|+|||.+.. ..++.++||||+||++|||+| |+.||.......     .....
T Consensus       193 ~~~~~~------~~----~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-----~~~~~  256 (302)
T cd05055         193 NDSNYV------VK----GNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-----KFYKL  256 (302)
T ss_pred             CCCcee------ec----CCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-----HHHHH
Confidence            331100      00    12235667999998544 678999999999999999998 999987533211     11111


Q ss_pred             HhccCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          584 FRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       584 ~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ......  .....+             .++.+++.+||+.+|++||++.|+++.|+++
T Consensus       257 ~~~~~~~~~~~~~~-------------~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         257 IKEGYRMAQPEHAP-------------AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHcCCcCCCCCCCC-------------HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111111  111111             2456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=323.56  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             hcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          345 ASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       345 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ....+||.|-||.||+|...... .+..-.||||..+........+.|+.|+.+|+.++|||||+++|.|.+ ...++||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            35689999999999999986652 222357999999886555556899999999999999999999999986 4689999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |.++-|.|..+|+....    .|+......++.||+.||+|||+   .++|||||..+|||+.....+|++|||+++.+.
T Consensus       470 EL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             ecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999987664    48889999999999999999999   899999999999999999999999999999987


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      +..++...           ...-+..|||||.+.. ++++.++|||-|||++||++. |..||.+-.+.+..    ..-.
T Consensus       543 d~~yYkaS-----------~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----~~iE  606 (974)
T KOG4257|consen  543 DDAYYKAS-----------RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----GHIE  606 (974)
T ss_pred             ccchhhcc-----------ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceE----EEec
Confidence            76544321           1123456999998655 789999999999999999997 99999876553211    1111


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ..++.|.++...|.+.             .++-+||..||.+||.+.|+...|..+..
T Consensus       607 nGeRlP~P~nCPp~LY-------------slmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALY-------------SLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCCCChHHH-------------HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            2344555666666554             47777999999999999999999988753

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=311.45  Aligned_cols=259  Identities=23%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE------  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------  419 (642)
                      .+.||+|+||.||+|....+.+  ....||+|+++.... ....+.+.+|++.+++++||||+++++++...+.      
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDG--SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCC--CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            4679999999999999865421  227899999876422 2234678999999999999999999999876554      


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSD-SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      .++||||+++|+|.+++...... ....+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence            78999999999999998654321 12358999999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~  577 (642)
                      +++.........          ......++..|+|||+. .+..++.++|||||||++|||++ |..||.+...     .
T Consensus       159 ~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~  222 (273)
T cd05035         159 LSKKIYSGDYYR----------QGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----H  222 (273)
T ss_pred             ceeecccccccc----------ccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence            998764332110          00112345679999985 44678999999999999999999 8899865322     1


Q ss_pred             HHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          578 SLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       578 ~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      +.......... .....             ....+.+++.+||+.||++||++.|+++.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         223 EIYDYLRHGNRLKQPED-------------CLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHHcCCCCCCCcC-------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            22222222111 11111             123467788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-37  Score=312.07  Aligned_cols=245  Identities=20%  Similarity=0.314  Sum_probs=187.6

Q ss_pred             ccCccCCceeEEEEecCCC-------CCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceE
Q 006522          349 VVGKSKNGIMYKVVVGRGS-------GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      .||+|+||.||+|+.....       .......|++|.+..... .....|.+|+.++++++||||+++++++......+
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            5899999999999864321       112235689998765432 22367889999999999999999999999999999


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC-------eEE
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH-------PCI  494 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl  494 (642)
                      +||||+++|+|..+++....    .+++..+.+++.||++||+|||+   .+|+||||||+|||++.++.       +|+
T Consensus        81 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999998875432    48999999999999999999999   89999999999999987654       899


Q ss_pred             ecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCCc
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEIL-TGRLPDAGPENDG  573 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~-tG~~P~~~~~~~~  573 (642)
                      +|||++......                ....++..|+|||.+..+..++.++|||||||++|||+ +|+.|+.....  
T Consensus       154 ~d~g~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--  215 (262)
T cd05077         154 SDPGIPITVLSR----------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--  215 (262)
T ss_pred             CCCCCCccccCc----------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--
Confidence            999998654221                12346677999998654567899999999999999998 58888764221  


Q ss_pred             ccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       574 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                         ... .........   ...+          ....+.+++.+||+.||++||++.|+++.+
T Consensus       216 ---~~~-~~~~~~~~~---~~~~----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         216 ---AEK-ERFYEGQCM---LVTP----------SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---hHH-HHHHhcCcc---CCCC----------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence               111 111111111   1111          012456789999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-37  Score=314.01  Aligned_cols=258  Identities=17%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|+...++     +.||||.+....  .......|.+|++++++++||||+++++++...+..++|+
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDR-----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCC-----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            457999999999999987665     799999876432  2223367899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...... ...+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999988643221 1348899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......|+..|+|||.+.. ..++.++||||||+++|||+||+.||.....   ....+.....
T Consensus       158 ~~~~------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~  221 (267)
T cd08228         158 SKTT------------AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIE  221 (267)
T ss_pred             chhH------------HHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHh
Confidence            3210            0112356778999998544 6788999999999999999999999864322   2223332222


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....+  ....         ......+.+++.+||+.+|++||++.||++.|++++
T Consensus       222 ~~~~~--~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         222 QCDYP--PLPT---------EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             cCCCC--CCCh---------hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            11111  1100         011234667888999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=314.28  Aligned_cols=261  Identities=22%  Similarity=0.363  Sum_probs=201.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||++.............||+|.+...........+.+|+.++++++||||+++++++......++|||
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   89 (277)
T cd05032          10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME   89 (277)
T ss_pred             EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence            35789999999999999876443333478999998765433344678999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          426 FIRNGSLYAALHAGPSD-----SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |+++|+|.+++......     ....++|..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccc
Confidence            99999999999754321     11247899999999999999999999   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL  579 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~  579 (642)
                      +.+.......          ......++..|+|||.... ..++.++|||||||++||++| |+.||.....     ...
T Consensus       167 ~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~  230 (277)
T cd05032         167 RDIYETDYYR----------KGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEV  230 (277)
T ss_pred             hhhccCcccc----------cCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHH
Confidence            7654332110          0112345678999998543 678999999999999999998 9999864221     222


Q ss_pred             HHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          580 VRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       580 ~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .+...... ...+...             ...+.+++.+||+.+|++|||+.|+++.|++
T Consensus       231 ~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         231 LKFVIDGGHLDLPENC-------------PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHhcCCCCCCCCCC-------------CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            22222111 1111111             1345678999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-37  Score=324.43  Aligned_cols=259  Identities=20%  Similarity=0.269  Sum_probs=189.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  420 (642)
                      ...||+|+||.||+|.....+     ..||||++.... ......++.+|++++++++||||+++++++...+     ..
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTG-----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCC-----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            467999999999999987665     899999987532 2222357889999999999999999999986533     47


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+. ++|.+++....     .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccc
Confidence            99999995 69999987543     38999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCcccccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      +........         ........||+.|+|||++.. ...++.++|||||||++|||+||+.||.+....  .....
T Consensus       151 ~~~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~  219 (338)
T cd07859         151 RVAFNDTPT---------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDL  219 (338)
T ss_pred             cccccccCc---------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHH
Confidence            764322110         001123468889999998433 256889999999999999999999999753221  11111


Q ss_pred             HHHHHhccCCCccccC-------------------hhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVID-------------------PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d-------------------~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +........  .+...                   ..+....  ......+.+++.+||+.||++|||+.|+++
T Consensus       220 ~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         220 ITDLLGTPS--PETISRVRNEKARRYLSSMRKKQPVPFSQKF--PNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHhCCCC--HHHHHHhhhhhHHHHHHhhcccCCCchHHhc--CCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            111110000  00000                   0000000  001124567999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.8e-38  Score=323.48  Aligned_cols=205  Identities=19%  Similarity=0.318  Sum_probs=162.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      .+..||+|+||.||+|....+.   ..+.||+|.+......   ..+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~---~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07868           5 EGCKVGRGTYGHVYKAKRKDGK---DDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   78 (317)
T ss_pred             cccccccCCCeEEEEEEEccCC---CCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence            3567999999999999875431   1178999998754322   5678999999999999999999998653  467899


Q ss_pred             EeeccCCcHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----CCCCCeEEe
Q 006522          424 SDFIRNGSLYAALHAGPS----DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL----DDELHPCIS  495 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~  495 (642)
                      |||+.+ +|.+++.....    .....+++..+..++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            999865 89888764321    112358999999999999999999999   899999999999999    466899999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      |||+++........         ........||+.|+|||++.....++.++||||+||++|||+||+.||...
T Consensus       155 DfG~a~~~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         155 DMGFARLFNSPLKP---------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ecCceeccCCCCcc---------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99999875432110         011123567889999998665456899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.4e-38  Score=325.58  Aligned_cols=241  Identities=22%  Similarity=0.253  Sum_probs=186.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHH-HHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVE-AIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||++....++     +.||+|++....  .......+..|.. +++.++||||+++++++...+..++|||
T Consensus         2 ~lg~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEE-----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD   76 (325)
T ss_pred             eeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe
Confidence            6899999999999987765     789999987532  1112234455554 5678899999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        77 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          77 YINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            999999999997643     37788888999999999999999   8999999999999999999999999999875322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......||+.|+|||++. +..++.++||||+||++|||++|+.||....     ..........
T Consensus       149 ~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~  210 (325)
T cd05602         149 HN------------GTTSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNILN  210 (325)
T ss_pred             CC------------CCcccccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHHHHHHHh
Confidence            11            0112346889999999854 4778999999999999999999999997432     2233333333


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      ........+++             .+.+++.+|++.||.+||++.+.+
T Consensus       211 ~~~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         211 KPLQLKPNITN-------------SARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCcCCCCCCCH-------------HHHHHHHHHcccCHHHCCCCCCCH
Confidence            32222222332             234577789999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3e-37  Score=315.85  Aligned_cols=268  Identities=24%  Similarity=0.356  Sum_probs=200.3

Q ss_pred             ccccCccCCceeEEEEecCCCC-----------CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSG-----------MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY  415 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~  415 (642)
                      ...||+|+||.||++.....++           ......||+|.+.........+.|.+|++++++++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4679999999999998866432           12346799999986544444578999999999999999999999999


Q ss_pred             eCCceEEEEeeccCCcHHHHHhcCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC
Q 006522          416 ANDEKLLISDFIRNGSLYAALHAGPSDS------LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE  489 (642)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  489 (642)
                      ..+..++||||+++++|.+++.......      ...+++..+..++.|++.||+|||+   .+++||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCC
Confidence            9999999999999999999997654211      1258999999999999999999999   899999999999999999


Q ss_pred             CCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCC
Q 006522          490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDA  567 (642)
Q Consensus       490 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t--G~~P~~  567 (642)
                      +.++|+|||+++.........          ......++..|+|||+... ..++.++|||||||++|||++  |..||.
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYR----------VQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             CceEEccccceeecccCccee----------ecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            999999999987654321100          0112345678999998554 678999999999999999998  677775


Q ss_pred             CCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          568 GPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       568 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ....  ......................+        .....++.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         236 HLTD--QQVIENAGHFFRDDGRQIYLPRP--------PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CcCh--HHHHHHHHhccccccccccCCCc--------cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            4221  11111111111111000000000        0011356789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-37  Score=308.21  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=195.4

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||+|......+  ....+|+|.+.........+++.+|++++++++|||||++++++. .+..++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSG--KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             ccCccCceeEEEeEeeccCC--CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            68999999999998655432  226899999986544334478999999999999999999999876 456899999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.+++....     .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999997654     38999999999999999999999   8999999999999999999999999999886543221


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      ..         .......++..|+|||... +..++.++|||||||++|||+| |+.||.....  ..+...+   ....
T Consensus       151 ~~---------~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~---~~~~  215 (257)
T cd05060         151 YY---------RATTAGRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML---ESGE  215 (257)
T ss_pred             cc---------ccccCccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH---HcCC
Confidence            10         0001122345799999854 4678999999999999999998 9999965321  1222222   1111


Q ss_pred             C-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          588 R-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       588 ~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      . +....++             ..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~-------------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECP-------------QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCC-------------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            1 1111111             24567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=317.06  Aligned_cols=249  Identities=23%  Similarity=0.258  Sum_probs=192.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||||.+.....  ......+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCC-----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            467999999999999987654     8999999875321  122356788999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++...
T Consensus        80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             eccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999998875432   248999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....|+..|+|||++. +..++.++||||+||++|||++|+.||.+.... .....+.....
T Consensus       154 ~~~~-------------~~~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~  218 (285)
T cd05605         154 EGET-------------IRGRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVK  218 (285)
T ss_pred             CCCc-------------cccccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhh
Confidence            2210             11235788899999854 467899999999999999999999999753221 11111111111


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      .........++             ..+.+++.+||+.||++||     +++++++
T Consensus       219 ~~~~~~~~~~~-------------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         219 EDQEEYSEKFS-------------EAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hcccccCcccC-------------HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            11111111122             2345688889999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-37  Score=309.01  Aligned_cols=250  Identities=21%  Similarity=0.326  Sum_probs=191.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      .||+|+||.||+|......   ....+|+|+++.... ....+++.+|+.++++++||||+++++++. .+..++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK---SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCC---CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            5899999999999754221   117899999875432 223477899999999999999999999885 45678999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+   ++|+||||||+||++++++.+||+|||+++......
T Consensus        78 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          78 ELGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999999997543     38999999999999999999999   899999999999999999999999999998764332


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ....      .   .....++..|+|||.+. ...++.++|||||||++|||+| |+.||.....     ..+.......
T Consensus       150 ~~~~------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~i~~~  214 (257)
T cd05116         150 NYYK------A---KTHGKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQMIESG  214 (257)
T ss_pred             Ceee------e---cCCCCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCC
Confidence            1100      0   01123456799999854 4678899999999999999998 9999975321     1222222221


Q ss_pred             -cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          587 -RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       587 -~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                       ..+.+..+++             ++.+++.+||+.||++||++.+|++.|+.
T Consensus       215 ~~~~~~~~~~~-------------~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         215 ERMECPQRCPP-------------EMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             1122222222             34568888999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-37  Score=321.94  Aligned_cols=264  Identities=23%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC-ceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND-EKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-~~~lv  423 (642)
                      ....||+|+||.||+|...........+.||||+++..........+.+|+.++.++ +|||||++++++...+ ..++|
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI   90 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence            457899999999999986433223334789999997654333346788999999999 7899999999887654 67899


Q ss_pred             EeeccCCcHHHHHhcCCCC-------------------------------------------------------------
Q 006522          424 SDFIRNGSLYAALHAGPSD-------------------------------------------------------------  442 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~-------------------------------------------------------------  442 (642)
                      |||+++|+|.++++.....                                                             
T Consensus        91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T cd05103          91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED  170 (343)
T ss_pred             EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence            9999999999999753210                                                             


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCC
Q 006522          443 -SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG  521 (642)
Q Consensus       443 -~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~  521 (642)
                       ....++|..+..++.||++||+|||+   .+|+||||||+||++++++.+||+|||+++..........          
T Consensus       171 ~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~----------  237 (343)
T cd05103         171 LYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR----------  237 (343)
T ss_pred             hhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh----------
Confidence             01247899999999999999999999   8999999999999999999999999999976533211100          


Q ss_pred             cccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhc-cCCCccccChhhh
Q 006522          522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRE-RRPLSEVIDPALV  599 (642)
Q Consensus       522 ~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~d~~l~  599 (642)
                      .....++..|+|||.+. +..++.++|||||||++|||++ |..||.......    ......... ....+...++   
T Consensus       238 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---  309 (343)
T cd05103         238 KGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKEGTRMRAPDYTTP---  309 (343)
T ss_pred             cCCCCCCcceECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHHHHhccCCCCCCCCCCH---
Confidence            01223456799999854 4678999999999999999997 999987533221    111111111 1111222222   


Q ss_pred             hchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       600 ~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                                ++.+++..||+.||++||++.|+++.|+.+.
T Consensus       310 ----------~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         310 ----------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ----------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      3567888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-37  Score=322.66  Aligned_cols=239  Identities=18%  Similarity=0.260  Sum_probs=189.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccC-CCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQH-PNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv  423 (642)
                      ...||+|+||.||+|.....+     +.||||++....  .....+.+..|++++..++| ++|+++++++...+..|+|
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            467999999999999987764     789999987531  22234678899999999976 4688899999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          80 MEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            99999999999997543     38899999999999999999999   89999999999999999999999999998643


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....            .......||+.|+|||++. +..++.++||||+||++|||+||+.||....     ........
T Consensus       152 ~~~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~i  213 (324)
T cd05587         152 IFGG------------KTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDELFQSI  213 (324)
T ss_pred             CCCC------------CceeeecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Confidence            2111            0112346889999999854 4678999999999999999999999997532     12233333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      ......++..+++             ++.+++.+||+.||++|++.
T Consensus       214 ~~~~~~~~~~~~~-------------~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         214 MEHNVSYPKSLSK-------------EAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HcCCCCCCCCCCH-------------HHHHHHHHHhhcCHHHcCCC
Confidence            3333333333332             34568888999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-37  Score=315.83  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+||+|+||.||+|+...++.   ...+++|.++........+.|.+|++++.++ +||||+++++++...+..++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGL---KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCC---cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            4679999999999999876531   1357888887533333346789999999999 79999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEE
Q 006522          426 FIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI  494 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl  494 (642)
                      |+++|+|.++++.....           ....+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence            99999999999764321           11248999999999999999999999   89999999999999999999999


Q ss_pred             ecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCc
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG  573 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~  573 (642)
                      +|||++.......          .   ......+..|+|||+.. ...++.++|||||||++|||+| |+.||.....  
T Consensus       161 ~dfg~~~~~~~~~----------~---~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--  224 (297)
T cd05089         161 ADFGLSRGEEVYV----------K---KTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--  224 (297)
T ss_pred             CCcCCCcccccee----------c---cCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999986432110          0   00112245699999854 3678999999999999999998 9999975322  


Q ss_pred             ccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          574 KGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       574 ~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                         ........... ......++             ..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         225 ---AELYEKLPQGYRMEKPRNCD-------------DEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             ---HHHHHHHhcCCCCCCCCCCC-------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               22222222211 11111122             23456888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.6e-38  Score=328.96  Aligned_cols=250  Identities=18%  Similarity=0.219  Sum_probs=192.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....||+|+||.||++....++     +.||+|.+....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          47 VIKVIGRGAFGEVQLVRHKSSK-----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             EEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            3578999999999999987765     799999986531  122235678999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++...      .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         122 MEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998653      27888889999999999999999   89999999999999999999999999998765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      .....           .......||+.|+|||++...   ..++.++|||||||++|||+||+.||....     .....
T Consensus       193 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~  256 (370)
T cd05596         193 DANGM-----------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTY  256 (370)
T ss_pred             cCCCc-----------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HHHHH
Confidence            42211           011134689999999985432   247899999999999999999999997532     22223


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF--RPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~  634 (642)
                      .........+.   .|...      .....+.+++.+|++.+|++  ||++.|+++
T Consensus       257 ~~i~~~~~~~~---~~~~~------~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         257 SKIMDHKNSLT---FPDDI------EISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHcCCCcCC---CCCcC------CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            33322211110   00000      01123456888899999987  999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.5e-37  Score=311.37  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||+|......+......|++|.............|.+|+.++++++|+||+++++++...+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            46799999999999998763222233789999887544333346799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC---CeEEecccccc
Q 006522          427 IRNGSLYAALHAGPSD--SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL---HPCISGFGLNR  501 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~  501 (642)
                      +++|+|.+++......  ....++|..++.++.||+.||+|||+   .+++||||||+||+++.++   .+||+|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcccc
Confidence            9999999999765421  12358999999999999999999999   8999999999999998654   69999999998


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~  580 (642)
                      ..........          ......+..|+|||++. +..++.++|||||||++|||+| |+.||.....     ....
T Consensus       168 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~  231 (277)
T cd05036         168 DIYRASYYRK----------GGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVM  231 (277)
T ss_pred             ccCCccceec----------CCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            7633211000          00112345699999854 4679999999999999999997 9999975322     1222


Q ss_pred             HHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          581 RKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       581 ~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ........ ..+..+             ...+.+++.+||+.+|++||++.+|++.|++
T Consensus       232 ~~~~~~~~~~~~~~~-------------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 EFVTGGGRLDPPKGC-------------PGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHcCCcCCCCCCC-------------CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            22221111 111111             1245678899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-37  Score=322.53  Aligned_cols=239  Identities=18%  Similarity=0.270  Sum_probs=189.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ...||+|+||.||+|....++     +.||+|.+.+..  .....+.+..|..++..+ +|++|+++++++...+..++|
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            467999999999999987765     799999987642  122335677888888887 689999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        80 ~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          80 MEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             EcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            99999999999987643     38899999999999999999999   89999999999999999999999999998753


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....            .......||+.|+|||++. +..++.++|||||||++|||+||+.||.....     .......
T Consensus       152 ~~~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~i  213 (323)
T cd05616         152 MWDG------------VTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSI  213 (323)
T ss_pred             CCCC------------CccccCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            2211            0112346889999999855 47789999999999999999999999975321     2233333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      .......+..+++             ++.+++.+|++.||++|++.
T Consensus       214 ~~~~~~~p~~~s~-------------~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         214 MEHNVAYPKSMSK-------------EAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HhCCCCCCCcCCH-------------HHHHHHHHHcccCHHhcCCC
Confidence            3333222222222             34568888999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-37  Score=312.20  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=196.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|.....+. .....||+|.+.........+++.+|+.+++.++||||+++++++.. ...++++||
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~   89 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL   89 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence            4689999999999998654421 11246899998765444445788999999999999999999999975 457899999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++....    .+++..++.++.|++.||+|||+   ++|+||||||+||++++++.+||+|||+++.....
T Consensus        90 ~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          90 MPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             CCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            999999999976432    48999999999999999999999   89999999999999999999999999999876432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....       .   .....++..|+|||... +..++.++|||||||++|||+| |..||.....  ..+..++...  
T Consensus       163 ~~~~-------~---~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~--  227 (279)
T cd05109         163 ETEY-------H---ADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKG--  227 (279)
T ss_pred             ccee-------e---cCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC--
Confidence            1100       0   01123456799999854 4678999999999999999998 8999864321  1122222211  


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ...+.....             ...+.+++.+||+.||++||++.|+++.|+.+..
T Consensus       228 ~~~~~~~~~-------------~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ERLPQPPIC-------------TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CcCCCCccC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111111111             1245668889999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-37  Score=316.59  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             cccccCccCCceeEEEEecCC--CCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRG--SGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ....||+|+||.||++.....  ........||+|.+.........+++.+|+.+++.+ +||||+++++++......++
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   98 (304)
T cd05101          19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   98 (304)
T ss_pred             ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence            457899999999999975321  111223689999987643333447789999999999 89999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          423 ISDFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      ||||+++|+|.+++......           ....++|.++..++.||++||+|||+   .+++||||||+||++++++.
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~  175 (304)
T cd05101          99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNV  175 (304)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCc
Confidence            99999999999999764321           11358899999999999999999999   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.........          ......++..|+|||+.. +..++.++|||||||++|||+| |..||... 
T Consensus       176 ~kl~D~g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-  243 (304)
T cd05101         176 MKIADFGLARDVNNIDYYK----------KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-  243 (304)
T ss_pred             EEECCCccceecccccccc----------cccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence            9999999998664321110          011223556799999854 3678999999999999999998 78888642 


Q ss_pred             CCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          571 NDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                          ....+.......... ..  ..         .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       244 ----~~~~~~~~~~~~~~~-~~--~~---------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         244 ----PVEELFKLLKEGHRM-DK--PA---------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ----CHHHHHHHHHcCCcC-CC--CC---------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                223333333222111 00  00         11234566889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.5e-38  Score=325.55  Aligned_cols=242  Identities=23%  Similarity=0.272  Sum_probs=187.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHH-HHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVE-AIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|+||.||++....++     +.+|+|++....  .....+.+.+|.. +++.++||||+++++++...+..++|||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e   76 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDG-----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD   76 (325)
T ss_pred             ceeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc
Confidence            6899999999999987665     899999987541  1122245666665 4677899999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        77 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          77 FVNGGELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            999999999887543     48999999999999999999999   8999999999999999999999999999875321


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......||+.|+|||++. +..++.++|||||||++|||++|+.||....     .....+....
T Consensus       149 ~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~~~~  210 (325)
T cd05604         149 QS------------DTTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDNILH  210 (325)
T ss_pred             CC------------CCcccccCChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHHHHc
Confidence            11            0112346889999999854 4778999999999999999999999997532     2233333333


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .........+             ..+.+++.+|++.+|++||++++.++
T Consensus       211 ~~~~~~~~~~-------------~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         211 KPLVLRPGAS-------------LTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCccCCCCCC-------------HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            2221111122             23456888899999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-37  Score=314.69  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             ccccCccCCceeEEEEecCCCC---------CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSG---------MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  417 (642)
                      .+.||+|+||.||+++......         .+....||+|.++..........|.+|++++++++||||+++++++...
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   89 (295)
T cd05097          10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD   89 (295)
T ss_pred             hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            4679999999999998754321         1233579999987653333446799999999999999999999999999


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSD-------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL  490 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  490 (642)
                      +..++||||+++++|.+++......       ....++|..+..++.|++.||+|||+   .+++||||||+||++++++
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~  166 (295)
T cd05097          90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHY  166 (295)
T ss_pred             CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCC
Confidence            9999999999999999999654211       11247899999999999999999999   8999999999999999999


Q ss_pred             CeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCCC
Q 006522          491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDAG  568 (642)
Q Consensus       491 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t--G~~P~~~  568 (642)
                      .+||+|||+++........      . .   .....++..|+|||+... ..++.++|||||||++|||+|  |..||..
T Consensus       167 ~~kl~dfg~~~~~~~~~~~------~-~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         167 TIKIADFGMSRNLYSGDYY------R-I---QGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             cEEecccccccccccCcce------e-c---cCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999998765322110      0 0   012244667999998554 678999999999999999998  6677764


Q ss_pred             CCCCcccHHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          569 PENDGKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       569 ~~~~~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ...  .............. ........+.         ....+.+++.+||+.||++||+|.+|++.|++
T Consensus       236 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         236 LSD--EQVIENTGEFFRNQGRQIYLSQTPL---------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             cCh--HHHHHHHHHhhhhccccccCCCCCC---------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            322  11111111111111 0000000110         11356779999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=316.97  Aligned_cols=271  Identities=23%  Similarity=0.350  Sum_probs=195.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~  424 (642)
                      ...||+|+||+||.+...... ......||+|.++........+.|.+|++++++++||||+++++++...  ...++||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM   87 (283)
T ss_pred             ceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence            467999999999887643211 1122689999987653333347789999999999999999999998764  3578999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...      .++|.++..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus        88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999753      38999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .......         ......++..|+|||... +..++.++|||||||++|||+||..|+.......   ........
T Consensus       159 ~~~~~~~---------~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~  225 (283)
T cd05080         159 EGHEYYR---------VREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQ  225 (283)
T ss_pred             Ccchhhc---------cCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccc
Confidence            3221100         001223456699999854 4678999999999999999999999986432211   00000000


Q ss_pred             hcc--CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          585 RER--RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ...  ..+.+.++...... .......++.+++..||+.+|++|||++++++.|+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~  283 (283)
T cd05080         226 GQMTVVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH  283 (283)
T ss_pred             cccchhhhhhhhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence            000  00000000000000 000112456779999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.4e-38  Score=323.64  Aligned_cols=239  Identities=19%  Similarity=0.262  Sum_probs=186.2

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHH-HHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVE-AIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ++||+|+||.||+++...++     +.||+|.+....  .......+.+|.. +++.++||||+++++++...+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDG-----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            36899999999999987765     899999987532  1122245556654 578899999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+.+....     .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        76 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          76 DYVNGGELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            9999999999886543     37888999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......||+.|+|||++. +..++.++|||||||++|||+||+.||....     .........
T Consensus       148 ~~~~------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~  209 (321)
T cd05603         148 EPEE------------TTSTFCGTPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNIL  209 (321)
T ss_pred             CCCC------------ccccccCCcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHh
Confidence            2110            111346888999999854 4678999999999999999999999997532     233333333


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      .....++...+             ..+.+++.+|++.||++||+..
T Consensus       210 ~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         210 HKPLQLPGGKT-------------VAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             cCCCCCCCCCC-------------HHHHHHHHHHccCCHhhcCCCC
Confidence            33222221111             2355688889999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=337.33  Aligned_cols=250  Identities=21%  Similarity=0.286  Sum_probs=195.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-------  418 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------  418 (642)
                      .+.||+|+||.||+++....+     +.||||.+.... .......+.+|+.++..++|+||+++++.+...+       
T Consensus        37 ~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         37 SRVLGSGATGTVLCAKRVSDG-----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             EEEEecCCCEEEEEEEEcCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            568999999999999987654     899999987542 2233467889999999999999999988776432       


Q ss_pred             -ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          419 -EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       419 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                       ..++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEec
Confidence             367999999999999999764332 2358999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++.+......          .......||+.|+|||++. +..++.++|||||||++|||+||+.||...     ...
T Consensus       188 Gls~~~~~~~~~----------~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~~~  251 (496)
T PTZ00283        188 GFSKMYAATVSD----------DVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGE-----NME  251 (496)
T ss_pred             ccCeeccccccc----------cccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----CHH
Confidence            999865432110          0112456899999999854 467899999999999999999999999742     233


Q ss_pred             HHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+........ +++..+++             ++.+++.+||+.||++||++.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-------------~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        252 EVMHKTLAGRYDPLPPSISP-------------EMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             HHHHHHhcCCCCCCCCCCCH-------------HHHHHHHHHcccChhhCcCHHHHHh
Confidence            34444333221 22222222             3456888899999999999999876

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-37  Score=308.96  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=198.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....++  ....+|+|.++........+.|.+|+.++++++||||+++++++...+..++|||
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           8 IEKVIGAGEFGEVCSGRLKLPGK--REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eeeeecccCCCceEEEEEecCCC--CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            35789999999999998754321  1158999998765433345789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++....
T Consensus        86 ~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          86 YMENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             cCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999976532    48999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....     . .   .....++..|+|||++.. ..++.++|||||||++||+++ |+.||.....     ........
T Consensus       159 ~~~~~-----~-~---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~~~~~~  223 (267)
T cd05066         159 DPEAA-----Y-T---TRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDVIKAIE  223 (267)
T ss_pred             cccee-----e-e---cCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHHHHHHh
Confidence            21100     0 0   011223457999998543 678999999999999999887 9999865322     11222221


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ... .+....++             ..+.+++.+||+.+|++||+|.++++.|+++
T Consensus       224 ~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 EGYRLPAPMDCP-------------AALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCcCCCCCCCC-------------HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111 11111111             2345688899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=330.99  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=202.9

Q ss_pred             ccHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe
Q 006522          337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA  416 (642)
Q Consensus       337 ~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~  416 (642)
                      ++++--.....-++|+|.||+||.|++..+.     ..+|||-+...++. ..+-+..||.+-++++|.|||+++|.+.+
T Consensus       570 feYeyde~~ervVLGKGTYG~VYA~RD~~tq-----vrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~se  643 (1226)
T KOG4279|consen  570 FEYEYDESNERVVLGKGTYGTVYAARDMDTQ-----VRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSE  643 (1226)
T ss_pred             EEeeecCCCceEEeecCceeEEEeeccccce-----eEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCC
Confidence            4444334445679999999999999998886     78999999876443 23567889999999999999999999999


Q ss_pred             CCceEEEEeeccCCcHHHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC-CCCCeE
Q 006522          417 NDEKLLISDFIRNGSLYAALHAGPSDSLPPL--PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD-DELHPC  493 (642)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k  493 (642)
                      ++..-+.||.++||+|.++|+..=    .|+  ++.+.-.+.+||++||.|||+   +.|||||||-+|||++ -.|.+|
T Consensus       644 nGf~kIFMEqVPGGSLSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlK  716 (1226)
T KOG4279|consen  644 NGFFKIFMEQVPGGSLSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLK  716 (1226)
T ss_pred             CCeEEEEeecCCCCcHHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEE
Confidence            999999999999999999998643    346  788889999999999999999   8999999999999996 579999


Q ss_pred             EecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~  572 (642)
                      |+|||.++.+..-.            .-+.+..||..|||||++..| +.|+.++|||||||++.||.||++||......
T Consensus       717 ISDFGTsKRLAgin------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp  784 (1226)
T KOG4279|consen  717 ISDFGTSKRLAGIN------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP  784 (1226)
T ss_pred             ecccccchhhccCC------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence            99999998765321            112245789999999997664 46999999999999999999999999754332


Q ss_pred             cccHHHHHHHH-HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          573 GKGLESLVRKA-FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       573 ~~~l~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                         -...++.. +...+++++.++             .++-.++++|..+||.+||++.++++
T Consensus       785 ---qAAMFkVGmyKvHP~iPeels-------------aeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  785 ---QAAMFKVGMYKVHPPIPEELS-------------AEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ---hHhhhhhcceecCCCCcHHHH-------------HHHHHHHHHHcCCCcccCccHHHhcc
Confidence               12222222 122222222222             23445899999999999999999875

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.1e-37  Score=308.34  Aligned_cols=259  Identities=17%  Similarity=0.253  Sum_probs=188.6

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||++....+..   ...+++|.+.........+.|.+|+.+++.++||||++++++|......++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCC---cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            58999999999997654421   246777877654433344789999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.++++..... ...+++.....++.||+.||+|||+   .+++||||||+|||++.++.+||+|||++........
T Consensus        79 ~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          79 LGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            99999999865322 1246777888999999999999999   8999999999999999999999999999764321110


Q ss_pred             ccccceeeecCCCcccccCCCcccCcccccc------CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIY------GSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~  581 (642)
                      .          .......++..|+|||+...      ...++.++|||||||++|||++ |..||.....     .....
T Consensus       155 ~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~  219 (268)
T cd05086         155 I----------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLN  219 (268)
T ss_pred             h----------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence            0          00113356778999998532      1245789999999999999997 5667754221     12222


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      .......  ....++.+.....     ..+.+++..|| .+|++||+++||++.|.
T Consensus       220 ~~~~~~~--~~~~~~~~~~~~~-----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         220 HVIKDQQ--VKLFKPQLELPYS-----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHhhcc--cccCCCccCCCCc-----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222211  1222232221111     23455777799 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.5e-37  Score=308.45  Aligned_cols=250  Identities=28%  Similarity=0.480  Sum_probs=199.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|....+      ..+++|.+...... ...++.+|+.++++++||||+++++++...+..++|||
T Consensus        10 ~~~~ig~g~~~~vy~~~~~~~------~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148          10 LERKLGSGYFGEVWEGLWKNR------VRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HhhhhccCCCccEEEeEecCC------CcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            356799999999999998875      78999998765332 23678999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.++++....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||.+.....
T Consensus        83 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999999999986543   248999999999999999999999   8999999999999999999999999999976543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            .....++..|+|||.... ..++.++||||||+++|||++ |+.||.....     ........
T Consensus       157 ~~~~------------~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~  218 (261)
T cd05148         157 DVYL------------SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYDQIT  218 (261)
T ss_pred             cccc------------ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHH
Confidence            2110            002234567999998544 678999999999999999998 8999965321     12222222


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. ..+.....+             ..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         219 AGYRMPCPAKCP-------------QEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             hCCcCCCCCCCC-------------HHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            21 111111111             2356788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.4e-37  Score=311.31  Aligned_cols=264  Identities=19%  Similarity=0.256  Sum_probs=201.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-CCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-NDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~  424 (642)
                      ..++||+|+||.||+|...... ......|++|++.........+.+.+|+.++++++||||+++++++.. ....++++
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   88 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLY   88 (280)
T ss_pred             EeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEE
Confidence            3578999999999999987621 111278999998765444455788999999999999999999999876 46789999


Q ss_pred             eeccCCcHHHHHhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          425 DFIRNGSLYAALHAGPSD---SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      ||+++|+|.+++......   ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++
T Consensus        89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~  165 (280)
T cd05043          89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR  165 (280)
T ss_pred             EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence            999999999999764321   11358999999999999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~  580 (642)
                      .+........          .....++..|+|||++. +..++.++|||||||++||+++ |+.||....  .   ..+.
T Consensus       166 ~~~~~~~~~~----------~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~---~~~~  229 (280)
T cd05043         166 DLFPMDYHCL----------GDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEID--P---FEMA  229 (280)
T ss_pred             cccCCceEEe----------CCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--H---HHHH
Confidence            6543321100          01223456799999854 4678999999999999999999 999997532  1   1222


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      ...... ......  ..         ....+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       230 ~~~~~~-~~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         230 AYLKDG-YRLAQP--IN---------CPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHcC-CCCCCC--Cc---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222111 111110  00         01245678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-37  Score=312.57  Aligned_cols=246  Identities=19%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             ccCccCCceeEEEEecCCCC--CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSG--MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .||+|+||.||+|.....+.  ......|++|.+.... ....+.|.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            58999999999998765421  1223568888876532 22336788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC--------eEEeccc
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH--------PCISGFG  498 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DfG  498 (642)
                      +++|+|.++++....    .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.        +|++|||
T Consensus        81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            999999999986543    48999999999999999999999   89999999999999987765        5899999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR-LPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~-~P~~~~~~~~~~l~  577 (642)
                      ++......                ....++..|+|||++.....++.++|||||||++|||++|. .|+.....     .
T Consensus       154 ~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~  212 (258)
T cd05078         154 ISITVLPK----------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----Q  212 (258)
T ss_pred             cccccCCc----------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----H
Confidence            87654321                12346677999998665456899999999999999999985 55543211     1


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ... ........++....             .++.+++.+||+.||++|||++|+++.|+
T Consensus       213 ~~~-~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         213 KKL-QFYEDRHQLPAPKW-------------TELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHH-HHHHccccCCCCCc-------------HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111 11122222222222             23567888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8e-37  Score=306.89  Aligned_cols=249  Identities=25%  Similarity=0.418  Sum_probs=193.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....+      ..||+|.+......  .++|.+|++++++++||||+++++++. .+..++||||
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071          11 EVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             eeecCCCCCCcEEEEEecCC------ceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            45789999999999987665      56999999764332  367899999999999999999999874 4568999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||.++.....
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          82 MSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999976432   248999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||+.. +..++.++|||||||++|||+| |+.||.....     .........
T Consensus       156 ~~~-----------~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~~~~~~~~~  218 (262)
T cd05071         156 EYT-----------ARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVER  218 (262)
T ss_pred             ccc-----------cccCCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----HHHHHHHhc
Confidence            110           001223566799999844 4678999999999999999999 8888864321     111222211


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. ...  ..+         .....+.+++.+|++.||++||++.++++.|+..
T Consensus       219 ~~-~~~--~~~---------~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 GY-RMP--CPP---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CC-CCC--Ccc---------ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            11 100  111         1123456799999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9e-37  Score=311.03  Aligned_cols=261  Identities=21%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|...+.........||+|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            46899999999999986542222223689999987654333345788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          427 IRNGSLYAALHAGPSD-----SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +++|+|.++++.....     .....++..+..++.|++.||+|||+   ++|+||||||+||++++++.+|++|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCccc
Confidence            9999999999753321     12346788899999999999999999   899999999999999999999999999988


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~  580 (642)
                      .........       .   .....++..|+|||.... ..++.++|||||||++|||++ |+.||.....     ....
T Consensus       168 ~~~~~~~~~-------~---~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~~  231 (288)
T cd05061         168 DIYETDYYR-------K---GGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVL  231 (288)
T ss_pred             ccccccccc-------c---cCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH
Confidence            654322100       0   012234567999998544 678999999999999999999 7888864322     2222


Q ss_pred             HHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          581 RKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       581 ~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ........ ......             ...+.+++.+||+.||++|||+.|+++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGYLDQPDNC-------------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCCCCCCCCC-------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            22222111 111111             13466788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-37  Score=316.56  Aligned_cols=261  Identities=16%  Similarity=0.238  Sum_probs=192.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+++....+     ..||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             EEEecccCCEEEEEEEecCCC-----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            467999999999999987664     789999987653333335688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++ +|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            975 89888875432    38899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......+|..|+|||++.....++.++||||+||++|||+||+.||...... ..+.. +......
T Consensus       158 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~-~~~~~~~  223 (309)
T cd07872         158 TK------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHL-IFRLLGT  223 (309)
T ss_pred             cc------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHHhCC
Confidence            10            0112356788999998655567899999999999999999999999754321 11111 1111110


Q ss_pred             cCC--CccccC------hhhhhc----h--hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRP--LSEVID------PALVKE----I--HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--~~~~~d------~~l~~~----~--~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...  .....+      ......    .  .......++.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000  000000      000000    0  00001234568999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-37  Score=330.33  Aligned_cols=258  Identities=18%  Similarity=0.214  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     +.||||....       ..+.+|+++|++++|||||++++++...+..++||||
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~-----~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYP-----QRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCC-----CEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999988765     7899996432       3467899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +. ++|.+++.....    .++|.++..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       242 ~~-~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            95 699998875432    49999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC---cc---cHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND---GK---GLESLV  580 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~---~~---~l~~~~  580 (642)
                      ...          .......||..|+|||++. +..++.++|||||||++|||++|..|+......   ..   .+...+
T Consensus       314 ~~~----------~~~~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i  382 (461)
T PHA03211        314 WST----------PFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII  382 (461)
T ss_pred             ccc----------ccccccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence            110          0011346899999999954 467899999999999999999988775432211   11   122222


Q ss_pred             HHHHhccCCCccccChhhhhchhHH------------------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAK------------------RQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~------------------~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      +........+.......+.......                  .....+.+++.+||+.||++|||+.|+++.
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            2111100011111111111100000                  001246679999999999999999999863

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.5e-37  Score=306.35  Aligned_cols=247  Identities=28%  Similarity=0.480  Sum_probs=193.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....+      ..+|+|.+......  .++|.+|+.++++++|+||+++++++. .+..++||||
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~------~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070          11 IKKLGNGQFGEVWMGTWNGN------TKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hheeccccCceEEEEEecCC------ceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            46799999999999987765      67999998764332  267999999999999999999999875 4568999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.++++....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          82 MSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            999999999976432   248999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||+.. +..++.++||||||+++|||++ |+.||.+...     .........
T Consensus       156 ~~~-----------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~  218 (260)
T cd05070         156 EYT-----------ARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQVER  218 (260)
T ss_pred             ccc-----------cccCCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc
Confidence            110           001123455799999854 4678999999999999999999 8999965321     122222221


Q ss_pred             c-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          586 E-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       586 ~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      . ..+.....             ...+.+++.+|++.+|++|||++++.+.|+.
T Consensus       219 ~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYRMPCPQDC-------------PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCcC-------------CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1 11111111             1245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.8e-37  Score=314.44  Aligned_cols=264  Identities=23%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             cccccCccCCceeEEEEecCCCCC--CCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGM--GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ..+.||+|+||.||++........  .....+|+|.++.........++.+|+++++++ +||||+++++++...+..++
T Consensus        22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (307)
T cd05098          22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV  101 (307)
T ss_pred             EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            457899999999999986442211  122579999998643333346788999999999 89999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          423 ISDFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      ||||+++|+|.+++......           ....++|.++++++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus       102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~  178 (307)
T cd05098         102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNV  178 (307)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCCc
Confidence            99999999999999765321           11358999999999999999999998   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.........          ......++..|+|||++. +..++.++|||||||++|||++ |..||... 
T Consensus       179 ~kL~dfg~a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-  246 (307)
T cd05098         179 MKIADFGLARDIHHIDYYK----------KTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-  246 (307)
T ss_pred             EEECCCcccccccccchhh----------ccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-
Confidence            9999999987653221100          000122345799999854 4678999999999999999998 88888642 


Q ss_pred             CCcccHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          571 NDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                          .............. .....+             ..++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       247 ----~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         247 ----PVEELFKLLKEGHRMDKPSNC-------------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ----CHHHHHHHHHcCCCCCCCCcC-------------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                12222222222111 111111             1245568889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=324.50  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=205.9

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..++||+|.||+|++|.+...+  +....||||.++.........+|++|+.+|.+|+|||+|+|||...+ ....||||
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~ps--gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPS--GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCC--CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3578999999999999988743  44578999999876544456899999999999999999999999987 67889999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      .++.|+|.+.|++...   ..|.......++.|||.||.||.+   +++|||||..+|+|+.....+||+||||.+-+..
T Consensus       191 LaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999998332   358888889999999999999999   8999999999999999999999999999999887


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...++....         .......|.|||.+.. ..++.++|||+|||++|||+| |+.||.+..  +   .++++.+-
T Consensus       265 ned~Yvm~p---------~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g---~qIL~~iD  329 (1039)
T KOG0199|consen  265 NEDMYVMAP---------QRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--G---IQILKNID  329 (1039)
T ss_pred             CCcceEecC---------CCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCC--H---HHHHHhcc
Confidence            655442111         2233456999999554 899999999999999999999 899997632  2   22222221


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                       ++..+           ...+.+.+.+++++..||..+|++|||+..+.+.+-.
T Consensus       330 -~~erL-----------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 -AGERL-----------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -ccccC-----------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence             11111           1112355677889999999999999999999865533

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=328.29  Aligned_cols=259  Identities=19%  Similarity=0.276  Sum_probs=192.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++.....+     +.||||++....  .....+.+.+|+.++..++||||+++++++...+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTG-----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            467999999999999987765     789999997532  1223366889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999997643     38999999999999999999999   899999999999999999999999999997653


Q ss_pred             CCCcccccceee--------------------------ecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHH
Q 006522          505 GTSKVTKNETIV--------------------------TSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLE  558 (642)
Q Consensus       505 ~~~~~~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~e  558 (642)
                      ............                          .........+||+.|+|||++. +..++.++|||||||++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHH
Confidence            321100000000                          0000011346999999999854 4778999999999999999


Q ss_pred             HHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHH
Q 006522          559 ILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR---MRTVSE  634 (642)
Q Consensus       559 l~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs---~~ev~~  634 (642)
                      |++|+.||.....     .............+...-+..+         ...+.+++.+|+. +|.+|++   +.|+++
T Consensus       232 l~~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~---------s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         232 MLVGYPPFCSDNP-----QETYRKIINWKETLQFPDEVPL---------SPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hhcCCCCCCCCCH-----HHHHHHHHcCCCccCCCCCCCC---------CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999975321     2222222221111100000000         1133456677886 8999998   887765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-37  Score=326.62  Aligned_cols=248  Identities=18%  Similarity=0.234  Sum_probs=188.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     +.+|+|.+.+..  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQ-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            467999999999999988765     899999986531  1222356889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...      .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       123 Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         123 EYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             cCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999653      27888999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .....           ......||+.|+|||++...   ..++.++||||+||++|||+||+.||....     ......
T Consensus       194 ~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~~~~  257 (370)
T cd05621         194 ETGMV-----------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVGTYS  257 (370)
T ss_pred             cCCce-----------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence            32110           11245689999999985432   237889999999999999999999997532     222233


Q ss_pred             HHHhccCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 006522          582 KAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF--RPRMRTVSES  635 (642)
Q Consensus       582 ~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~~  635 (642)
                      ........  +++..  .+         ...+.+++..|+..++.+  ||++.|+++.
T Consensus       258 ~i~~~~~~~~~p~~~--~~---------s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 KIMDHKNSLNFPEDV--EI---------SKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHhCCcccCCCCcc--cC---------CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            33222111  11110  00         112334666778755543  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.7e-37  Score=311.14  Aligned_cols=258  Identities=19%  Similarity=0.295  Sum_probs=199.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|++|.||++....++     ..++||.+....  ......+|.+|+.++++++||||+++++++..++..++||
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCC-----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            467999999999999986554     789999886532  2223367899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++...... ...++|..+..++.||++||+|||+   .+++|+||||+||+++.++.++++|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            999999999998743221 1358999999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......|+..|+|||+.. +..++.++||||||+++|||++|..||.....+   .....+...
T Consensus       158 ~~~~------------~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~  221 (267)
T cd08229         158 SKTT------------AAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE  221 (267)
T ss_pred             cCCc------------ccccccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh
Confidence            3211            011235778899999854 467889999999999999999999999653221   222222221


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....+  .. .+        ......+.+++.+||+.||++||||.+|++.++++.
T Consensus       222 ~~~~~--~~-~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 QCDYP--PL-PS--------DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cCCCC--CC-Cc--------ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            11111  00 00        011224556888999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-37  Score=325.36  Aligned_cols=208  Identities=22%  Similarity=0.297  Sum_probs=170.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++.....+     +.||+|++.+..  .......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTG-----HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            467999999999999987664     799999997532  1223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            9999999999997643     48999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCcccccc----------ee-------------eecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh
Q 006522          505 GTSKVTKNE----------TI-------------VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT  561 (642)
Q Consensus       505 ~~~~~~~~~----------~~-------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t  561 (642)
                      .........          ..             ..........+||+.|+|||++. +..++.++|||||||++|||++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHh
Confidence            321100000          00             00000012357999999999854 4778999999999999999999


Q ss_pred             CCCCCCC
Q 006522          562 GRLPDAG  568 (642)
Q Consensus       562 G~~P~~~  568 (642)
                      |+.||.+
T Consensus       232 G~~Pf~~  238 (363)
T cd05628         232 GYPPFCS  238 (363)
T ss_pred             CCCCCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-38  Score=326.09  Aligned_cols=244  Identities=21%  Similarity=0.345  Sum_probs=199.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEe---cCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc--e
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL---TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE--K  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~---~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~  420 (642)
                      +..+||+|+|-+||||.+...+     ..||=-.+   +........++|..|+++|+.|+|||||+++.++.+...  .
T Consensus        44 ~~evLGrGafKtVYka~De~~g-----iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEG-----IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             hhhhcccccceeeeeccccccc-----hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            4568999999999999997664     44542222   122333445889999999999999999999999998665  7


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEecccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGL  499 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGl  499 (642)
                      -+|.|.|..|+|+.|+++++.     ++.+....|++||++||.|||++. ++|||||||.+||+++. .|.+||+|+||
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeeecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence            799999999999999998765     777899999999999999999977 69999999999999975 59999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      |.......              ...+.|||.|||||++.  ..|++.+||||||++++||+|+..||..    ..+-.++
T Consensus       193 Atl~r~s~--------------aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQI  252 (632)
T KOG0584|consen  193 ATLLRKSH--------------AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQI  252 (632)
T ss_pred             HHHhhccc--------------cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHH
Confidence            98875431              12468999999999743  6899999999999999999999999964    4556777


Q ss_pred             HHHHHhccCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .++...+..|  +..+-||++..             ++.+|+.. ..+|||+.|++.
T Consensus       253 YKKV~SGiKP~sl~kV~dPevr~-------------fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  253 YKKVTSGIKPAALSKVKDPEVRE-------------FIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHcCCCHHHhhccCCHHHHH-------------HHHHHhcC-chhccCHHHHhh
Confidence            7777766554  34444565544             66679999 999999999985

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.9e-37  Score=313.31  Aligned_cols=261  Identities=20%  Similarity=0.281  Sum_probs=186.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcc---cCCCeeeEEEEEEe-----C
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARV---QHPNIVRLKAFYYA-----N  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~  417 (642)
                      ...||+|+||.||+|.....++    +.||+|.++.... ......+.+|+.+++++   +||||++++++|..     .
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCC----eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            4579999999999998743211    7899999875422 22225667788887766   69999999999863     3


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      ...++||||+. ++|.+++.....   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            46899999996 599999976433   248999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++......             ......||+.|+|||.+. +..++.++|||||||++|||++|+.||.+.... ..+.
T Consensus       155 g~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~  219 (290)
T cd07862         155 GLARIYSFQM-------------ALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLG  219 (290)
T ss_pred             cceEeccCCc-------------ccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHH
Confidence            9987653221             111346788999999854 467899999999999999999999999753321 1111


Q ss_pred             HHHHHHHhccC--CCc-------cccChhhhhchhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRERR--PLS-------EVIDPALVKEIHA--KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~--~~~-------~~~d~~l~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+... ....  ...       ..+.+.-......  ......+.+++.+|++.||++|||+.|+++
T Consensus       220 ~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         220 KILDVI-GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHh-CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            211111 0000  000       0000000000000  001134567999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.6e-38  Score=325.80  Aligned_cols=250  Identities=19%  Similarity=0.248  Sum_probs=193.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||+|+++....  ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATG-----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            467999999999999987765     7999999976421  223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            99999999999976532    48999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCcccccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      .....           ......||+.|+|||++..     ...++.++|||||||++|||+||+.||.....     ...
T Consensus       154 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~  217 (330)
T cd05601         154 ANKMV-----------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKT  217 (330)
T ss_pred             CCCce-----------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHH
Confidence            32110           0113467889999998542     35678999999999999999999999975322     222


Q ss_pred             HHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ............-.-++.+         ...+.+++..|++ +|++||++.++++
T Consensus       218 ~~~i~~~~~~~~~~~~~~~---------~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         218 YNNIMNFQRFLKFPEDPKV---------SSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHcCCCccCCCCCCCC---------CHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            2222221111000000111         1234557777997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=293.74  Aligned_cols=270  Identities=20%  Similarity=0.258  Sum_probs=202.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ce
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EK  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  420 (642)
                      ..+.+|+|||..||.+....+.     +.+|+|++.-.. .+..+..++|++..++++||||++++++...+.     +.
T Consensus        25 i~~~LgeGGfsfv~LV~~~s~~-----~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   25 IQRLLGEGGFSFVDLVKGLSTG-----HLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             EeeeecCCCceeeeeecccCcc-----cchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3568999999999999855544     789999997654 334588999999999999999999998875433     58


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |++++|...|+|.+.+......+ ..+++.+.+.|+.+|++||.+||+.. ++++||||||.|||+.+++.+++.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence            99999999999999997654432 35999999999999999999999955 36999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES  578 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~  578 (642)
                      ....-.............   -..-..|..|+|||.+.-  +...++++|||||||+||+|+.|..||+.....+..+.-
T Consensus       177 ~~a~i~i~~~~~a~~lQe---~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQE---WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cccceEeechHHHHHHHH---HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            765432211111100000   012345777999998543  345789999999999999999999999865444433322


Q ss_pred             HHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      .+..             +.+. ..........+.+++.+|++.||.+||+..|++..++.+.
T Consensus       254 Av~n-------------~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  254 AVQN-------------AQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eeec-------------cccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1111             1110 0001112345677899999999999999999999998763

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-38  Score=330.59  Aligned_cols=255  Identities=19%  Similarity=0.250  Sum_probs=189.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++.....+     +.||||.+.+..  .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTG-----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            467999999999999987765     899999986532  2223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999999999997543     38899999999999999999999   899999999999999999999999999997432


Q ss_pred             CCCcccc-----cceeee------------------------------cCCCcccccCCCcccCccccccCCCCCcccch
Q 006522          505 GTSKVTK-----NETIVT------------------------------SGTGSRISAISNVYLAPEARIYGSKFTQKCDV  549 (642)
Q Consensus       505 ~~~~~~~-----~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV  549 (642)
                      .......     ......                              ........+||+.|+|||++. +..++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di  231 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDW  231 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceee
Confidence            2110000     000000                              000011246999999999854 4778999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc--CCCcc--ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCC
Q 006522          550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER--RPLSE--VIDPALVKEIHAKRQVLATFHIALNCTELDPEF  625 (642)
Q Consensus       550 ~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~--~~~~~--~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~  625 (642)
                      |||||++|||+||+.||.....     ...........  ..+++  .++             ..+.+++.+|+. +|.+
T Consensus       232 wSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~~p~~~~~s-------------~~~~dli~~lL~-~~~~  292 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENS-----HETYRKIINWRETLYFPDDIHLS-------------VEAEDLIRRLIT-NAEN  292 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCH-----HHHHHHHHccCCccCCCCCCCCC-------------HHHHHHHHHHhc-CHhh
Confidence            9999999999999999975322     12222222111  11111  111             234457777887 6666


Q ss_pred             C---CCHHHHHH
Q 006522          626 R---PRMRTVSE  634 (642)
Q Consensus       626 R---Ps~~ev~~  634 (642)
                      |   +++.|+++
T Consensus       293 r~~r~~~~~~l~  304 (377)
T cd05629         293 RLGRGGAHEIKS  304 (377)
T ss_pred             cCCCCCHHHHhc
Confidence            5   58888875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.5e-37  Score=309.51  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=197.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.............+++|.+..... ...+.|.+|++++++++|+||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEY   88 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEec
Confidence            467999999999999765432223337899998876432 2346899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEec
Q 006522          427 IRNGSLYAALHAGPSD----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG  496 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D  496 (642)
                      +++|+|.++++.....          ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECC
Confidence            9999999999765321          11248999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCccc
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKG  575 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~  575 (642)
                      ||+++.........       .   .....+++.|+|||+.. +..++.++|||||||++|||+| |+.||.....    
T Consensus       166 fg~~~~~~~~~~~~-------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  230 (280)
T cd05092         166 FGMSRDIYSTDYYR-------V---GGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----  230 (280)
T ss_pred             CCceeEcCCCceee-------c---CCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH----
Confidence            99987654321100       0   01223456799999854 4678999999999999999999 9999864221    


Q ss_pred             HHHHHHHHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          576 LESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       576 l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                       ........... ......+++             .+.+++.+||+.||++||++.||.+.|++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~-------------~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         231 -TEAIECITQGRELERPRTCPP-------------EVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HHHHHHHHcCccCCCCCCCCH-------------HHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             11222221111 111111222             34568888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.6e-37  Score=319.53  Aligned_cols=204  Identities=19%  Similarity=0.323  Sum_probs=162.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe--CCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~  424 (642)
                      +..||+|+||.||+|+...+.   ....||+|.+......   ..+.+|++++++++||||+++++++..  ....++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~---~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGK---DEKEYALKQIEGTGIS---MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCC---ccceEEEEEecCCCCc---HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            467999999999999976532   1278999998754322   567899999999999999999999864  45678999


Q ss_pred             eeccCCcHHHHHhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----CCCCCeEEec
Q 006522          425 DFIRNGSLYAALHAGPS----DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL----DDELHPCISG  496 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~D  496 (642)
                      ||+++ +|.+++.....    .....+++..+..++.||+.||+|||+   .+|+||||||+||++    ++++.+||+|
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            99875 88888753321    112358999999999999999999999   899999999999999    5678999999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ||+++........         ........||+.|+|||++.....++.++|||||||++|||+||+.||...
T Consensus       156 fG~a~~~~~~~~~---------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         156 MGFARLFNSPLKP---------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccceeccCCCccc---------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9999876432110         001123467889999998665456899999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.9e-37  Score=307.49  Aligned_cols=259  Identities=26%  Similarity=0.425  Sum_probs=198.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....+..  ...||||.++........++|..|+.++++++||||+++++++...+..++|||
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           8 IEEVIGAGEFGEVCRGRLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             EEeEecCCCCCeEEEEEEecCCCC--ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            457899999999999998765321  157999998765444445789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++....
T Consensus        86 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          86 FMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             cCCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999976532    48999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .......     .  .......+..|+|||++. +..++.++|||||||++||+++ |..||.....     ........
T Consensus       159 ~~~~~~~-----~--~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i~  225 (269)
T cd05065         159 DTSDPTY-----T--SSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIE  225 (269)
T ss_pred             Ccccccc-----c--cccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHHH
Confidence            2211000     0  000111245699999854 4678999999999999999987 9999864321     12222221


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .. ..+.....             ...+.+++.+||+.+|++||++.+++..|+++
T Consensus       226 ~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDYRLPPPMDC-------------PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCcCCCcccC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11 11111111             12345688899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-36  Score=311.93  Aligned_cols=268  Identities=22%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             ccccCccCCceeEEEEecCCC-----------CCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGS-----------GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY  415 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~  415 (642)
                      ...||+|+||.||++......           ..+....||+|.+..........+|.+|++++++++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            457999999999998654321           112236799999976533333468999999999999999999999999


Q ss_pred             eCCceEEEEeeccCCcHHHHHhcCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC
Q 006522          416 ANDEKLLISDFIRNGSLYAALHAGPSDS------LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE  489 (642)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  489 (642)
                      ..+..++||||+++|+|.+++.......      ...+++.++..++.|++.||+|||+   .+++||||||+||+++++
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcCC
Confidence            9999999999999999999997654221      1247889999999999999999999   899999999999999999


Q ss_pred             CCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh--CCCCCC
Q 006522          490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDA  567 (642)
Q Consensus       490 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t--G~~P~~  567 (642)
                      +.+||+|||+++.+.......          ......++..|+|||.... ..++.++|||||||++|||+|  |..||.
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYR----------IQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             CCEEeccCcccccccCCccee----------ccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            999999999987653321100          0001234567999998544 678999999999999999998  778886


Q ss_pred             CCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          568 GPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       568 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .....  ...............  ....+..      ......+.+++.+||+.||++||++.||++.|++
T Consensus       236 ~~~~~--~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         236 QLSDE--QVIENTGEFFRDQGR--QVYLPKP------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ccChH--HHHHHHHHHHhhccc--cccCCCC------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            43221  111111111111100  0000000      0011345679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.5e-37  Score=331.23  Aligned_cols=258  Identities=19%  Similarity=0.272  Sum_probs=186.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--------
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--------  417 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------  417 (642)
                      ....||+|+||.||+|.....+     +.||||++....     ....+|+.+|++++|||||++++++...        
T Consensus        70 ~~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         70 LGNIIGNGSFGVVYEAICIDTS-----EKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             EeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3578999999999999987654     789999886532     2345799999999999999999987542        


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-CeEEec
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISG  496 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~D  496 (642)
                      ...++||||+++ +|.+++...... ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeec
Confidence            135689999985 787777543211 1358999999999999999999999   8999999999999998654 799999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      ||+++.+....             ......||+.|+|||++.....++.++|||||||++|||+||..||.+.... ..+
T Consensus       215 FGla~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~  280 (440)
T PTZ00036        215 FGSAKNLLAGQ-------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQL  280 (440)
T ss_pred             cccchhccCCC-------------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHH
Confidence            99998654221             1113467889999998665457899999999999999999999999753321 112


Q ss_pred             HHHHHHHHhcc---------C-----CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          577 ESLVRKAFRER---------R-----PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       577 ~~~~~~~~~~~---------~-----~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...++. ....         .     .++......+..... .....++.+++.+||+.||.+|||+.|+++
T Consensus       281 ~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p-~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        281 VRIIQV-LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFP-KGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHH-hCCCCHHHHHHhchhhhcccCCccCchhHHHHhc-cCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            222111 0000         0     000001111111000 011245778999999999999999999884

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-37  Score=329.89  Aligned_cols=209  Identities=21%  Similarity=0.282  Sum_probs=169.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||+|.....+     +.||+|.+....  .....+.+.+|+.++++++|||||++++++...+..++||
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTK-----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            467999999999999987765     799999987542  1223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          81 DYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            9999999999997643     38889999999999999999999   899999999999999999999999999986432


Q ss_pred             CCCcccc--c---------------------------------ceeeecCCCcccccCCCcccCccccccCCCCCcccch
Q 006522          505 GTSKVTK--N---------------------------------ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV  549 (642)
Q Consensus       505 ~~~~~~~--~---------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV  549 (642)
                      .......  .                                 .............+||+.|+|||++. +..++.++||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~Di  231 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW  231 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeE
Confidence            1100000  0                                 00000000112357999999999855 4778999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC
Q 006522          550 YSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       550 ~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ||+||++|||+||+.||...
T Consensus       232 wSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             EechHHHHHHHhCCCCCCCC
Confidence            99999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=320.09  Aligned_cols=242  Identities=22%  Similarity=0.344  Sum_probs=198.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..||.|+||.||-+++..+.     .+||||++.-...  .....+++.|+..|.+++|||+|.+.|||......+||||
T Consensus        32 rEIGHGSFGAVYfArd~~n~-----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHhcCCccceeEEeeccCcc-----ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            56899999999999998887     8999999975422  2233789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||-| |-.|++.-++.    ++.+..+..|+.+.+.||+|||+   .+.||||||..|||+.+.|.+|++|||.|..+..
T Consensus       107 YClG-SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHhc-cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            9964 88888876653    58999999999999999999999   7899999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .                ...+|||+|||||+++.  .+.|+-|+||||+||++.||.-.++|+..+..    +..+....
T Consensus       179 A----------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIA  238 (948)
T KOG0577|consen  179 A----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA  238 (948)
T ss_pred             h----------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHH
Confidence            3                25789999999998654  47899999999999999999999999875432    22222222


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      -.+.+.        +.    ..+....+..++-.|++.-|++|||..+++.
T Consensus       239 QNesPt--------Lq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  239 QNESPT--------LQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             hcCCCC--------CC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            222222        21    2234456777899999999999999988765

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-36  Score=304.59  Aligned_cols=247  Identities=27%  Similarity=0.439  Sum_probs=191.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....+      ..+|+|.+.....  ..+.|.+|+.++++++|||++++++++. .+..++||||
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~------~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCC------ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            35799999999999987665      5689998865432  2367899999999999999999999875 4568999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++....   ..++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          82 MGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999976432   248999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||+.. +..++.++|||||||++|||+| |+.||.+...     .........
T Consensus       156 ~~~-----------~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~  218 (260)
T cd05069         156 EYT-----------ARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----REVLEQVER  218 (260)
T ss_pred             ccc-----------ccCCCccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc
Confidence            110           001223456799999844 4678999999999999999999 9999875322     112222211


Q ss_pred             ccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          586 ERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       586 ~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ... +....+             ...+.+++.+||+.||++||+++++.+.|++
T Consensus       219 ~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 GYRMPCPQGC-------------PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCCCccc-------------CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111 111111             1245668889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-36  Score=315.59  Aligned_cols=264  Identities=24%  Similarity=0.350  Sum_probs=201.0

Q ss_pred             cccccCccCCceeEEEEecCCCC--CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSG--MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ....||+|+||.||++.......  ......||+|.++........+++.+|+++++++ +||||++++++|...+..++
T Consensus        16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (334)
T cd05100          16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV   95 (334)
T ss_pred             ecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence            45789999999999998643221  1222579999887643333457899999999999 89999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          423 ISDFIRNGSLYAALHAGPS-----------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      ||||+++|+|.+++.....           .....++|.+++.++.|++.||+|||+   .+++||||||+||++++++.
T Consensus        96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~~  172 (334)
T cd05100          96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNV  172 (334)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCc
Confidence            9999999999999976431           112358999999999999999999999   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.........          ......++..|+|||++.. ..++.++|||||||++|||++ |..||....
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         173 MKIADFGLARDVHNIDYYK----------KTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             EEECCcccceecccccccc----------cccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999987654321100          0011234567999998544 678999999999999999999 888886432


Q ss_pred             CCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          571 NDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                           ...+..........  +. ..         .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       242 -----~~~~~~~~~~~~~~--~~-~~---------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 -----VEELFKLLKEGHRM--DK-PA---------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             -----HHHHHHHHHcCCCC--CC-CC---------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence                 23333332222111  11 00         01124567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.5e-37  Score=309.33  Aligned_cols=246  Identities=21%  Similarity=0.340  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     +.||+|.+.........++|.+|++++++++||||+++++++...+..++||||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTR-----RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            357999999999999987654     789999987643333446799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|..+.         .+++.....++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            9999997542         27888999999999999999999   89999999999999999999999999998764322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc--HHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG--LESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~--l~~~~~~~~  584 (642)
                      .              .....||..|+|||++.. ..++.++|||||||++|||+||+.||.........  .........
T Consensus       149 ~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  213 (279)
T cd06619         149 I--------------AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV  213 (279)
T ss_pred             c--------------ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh
Confidence            1              113467888999998554 67899999999999999999999999753221111  111111111


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ....+  .....         ....++.+++.+||+.+|++||+++|+++.
T Consensus       214 ~~~~~--~~~~~---------~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         214 DEDPP--VLPVG---------QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ccCCC--CCCCC---------cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11111  00000         011235668889999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-36  Score=309.77  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=197.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.............||+|.+.........++|.+|+.++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY   89 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence            46789999999999987532111122789999987654433447799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC
Q 006522          427 IRNGSLYAALHAGPS-----------------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE  489 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  489 (642)
                      +++|+|.+++.....                 .....+++..++.++.|++.||+|||+   .+++||||||+||+++++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~  166 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGEN  166 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCC
Confidence            999999999975321                 112348899999999999999999999   899999999999999999


Q ss_pred             CCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 006522          490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG  568 (642)
Q Consensus       490 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~  568 (642)
                      +.+||+|||+++.+........          ......+..|+|||... +..++.++|||||||++|||++ |..||.+
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         167 MVVKIADFGLSRNIYSADYYKA----------SENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             CceEECccccceecccCccccc----------cCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999876533211000          00122355699999854 4678999999999999999998 8888864


Q ss_pred             CCCCcccHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          569 PENDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       569 ~~~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ..     ............. +..+.+             ..++.+++.+||+.||++|||+.|+++.|++
T Consensus       236 ~~-----~~~~~~~~~~~~~~~~~~~~-------------~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MA-----HEEVIYYVRDGNVLSCPDNC-------------PLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CC-----HHHHHHHHhcCCCCCCCCCC-------------CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            22     1233332222211 111111             1346679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.5e-37  Score=318.22  Aligned_cols=240  Identities=18%  Similarity=0.264  Sum_probs=189.8

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l  422 (642)
                      ....||+|+||.||++....++     +.||+|.+....  .....+.+..|..++..+. |++|+++++++...+..++
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           4 FLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             EEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            3468999999999999987665     799999987531  2223466888999998885 5778889999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+++|+|.+++....     .+++.++..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.
T Consensus        79 v~Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            999999999999997643     38999999999999999999999   8999999999999999999999999999875


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .....            .......||+.|+|||++. +..++.++||||+||++|||+||+.||....     .....+.
T Consensus       151 ~~~~~------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~~~~~  212 (323)
T cd05615         151 HMVDG------------VTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----EDELFQS  212 (323)
T ss_pred             cCCCC------------ccccCccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            32211            0112346889999999854 4678999999999999999999999997532     1233333


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      ........+..+++             .+.+++.+|++.+|.+|++.
T Consensus       213 i~~~~~~~p~~~~~-------------~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IMEHNVSYPKSLSK-------------EAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHhCCCCCCccCCH-------------HHHHHHHHHcccCHhhCCCC
Confidence            33333322322222             34568888999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=308.72  Aligned_cols=267  Identities=26%  Similarity=0.414  Sum_probs=192.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~  424 (642)
                      ...||+|+||.||++....-. ......||+|.+..... ...+.|.+|++++++++||||+++++++...  ...++||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            467999999999999753210 11127899999876432 2347889999999999999999999988654  4678999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....    .++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus        87 e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          87 EYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            99999999999975432    48999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .......      .   .....++..|+|||+.. +..++.++|||||||++|||++|..|+......      +.+.. 
T Consensus       160 ~~~~~~~------~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~-  222 (284)
T cd05081         160 QDKEYYK------V---REPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMM-  222 (284)
T ss_pred             CCCccee------e---cCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhc-
Confidence            3321100      0   00112345699999854 467899999999999999999988775432111      00000 


Q ss_pred             hccCCCccccChhhhhch-------hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RERRPLSEVIDPALVKEI-------HAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~-------~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ..... .......+....       ........+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus       223 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         223 GNDKQ-GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             ccccc-cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            00000 000000000000       00011134677999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-37  Score=324.35  Aligned_cols=258  Identities=18%  Similarity=0.282  Sum_probs=191.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  420 (642)
                      .+.||+|+||.||++....++     +.||||++.... .....+++.+|+++++.++||||+++++++...+     ..
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCC-----CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            467999999999999987654     889999987542 2223467889999999999999999999998776     78


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |+|+||+. ++|.+.+....     .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccce
Confidence            99999997 58888886533     48999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +.......           .......+|..|+|||++.....++.++||||+||++|||+||+.||...... ..+ ..+
T Consensus       151 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~-~~i  217 (372)
T cd07853         151 RVEEPDES-----------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQL-DLI  217 (372)
T ss_pred             eecccCcc-----------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHH-HHH
Confidence            76432211           01112356788999998665456899999999999999999999999753221 111 111


Q ss_pred             HHHHh-------------------ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFR-------------------ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~-------------------~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .....                   ......... +.+.. . ......++.+++.+|++.||++|||+.|+++
T Consensus       218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~-~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSL-PVLYT-L-SSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCch-HHhcc-c-CCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            10000                   000000000 00000 0 0011235678999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-36  Score=304.34  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=196.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|++|.||++....++     +.|++|.+.... .....+++.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADK-----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCC-----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            467999999999999987665     889999986532 22334778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.++++....   ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          80 YAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             eCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            9999999999986532   258999999999999999999999   8999999999999999999999999999886543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....|+..|+|||+... ..++.++|||||||++|||+||+.||.....     .........
T Consensus       154 ~~~~------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~  215 (256)
T cd08529         154 NTNF------------ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIR  215 (256)
T ss_pred             ccch------------hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc
Confidence            2110            112356778999998554 6789999999999999999999999974321     222222222


Q ss_pred             ccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ... +....++             ..+.+++.+||+.+|++||++.++++
T Consensus       216 ~~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         216 GVFPPVSQMYS-------------QQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCCccccC-------------HHHHHHHHHHccCCcccCcCHHHHhh
Confidence            211 1111222             24566888999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=307.43  Aligned_cols=263  Identities=22%  Similarity=0.329  Sum_probs=200.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhc--ccCCCeeeEEEEEEeCC----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIAR--VQHPNIVRLKAFYYAND----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~  420 (642)
                      .+.||+|.||.||+|.+..       ..||||++...+.    +.+.+|.+|.+.  |+|+||..+++.-..++    +.
T Consensus       216 ~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             EEEecCccccceeeccccC-------CceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            4789999999999999876       5799999986543    556677777654  49999999998876543    68


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE-----YSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      +||.||.++|||+|+|...      .++.+..++++.-+|.||+|||.     +..+.|.|||||+.|||+..++.+.|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            9999999999999999864      38889999999999999999996     344679999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCC-----cccchHHHHHHHHHHHhC--------
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT-----QKCDVYSFGIVLLEILTG--------  562 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~sDV~S~Gvvl~el~tG--------  562 (642)
                      |+|||-........        ........+||.+|||||++...-...     ..+||||||.|+||++-+        
T Consensus       359 DLGLAv~h~~~t~~--------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDT--------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             eceeeEEecccCCc--------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            99999765544211        222334568999999999965432221     478999999999999863        


Q ss_pred             --CCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          563 --RLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       563 --~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                        +.||.+....+....+..+..--++  +.+.++..+    +..+.+..+.++|..||..+|..|-|+--+-+.|.++.
T Consensus       431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~--~RP~ipnrW----~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSFEEMRKVVCVQK--LRPNIPNRW----KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             hhcCCcccCCCCCCCHHHHhcceeecc--cCCCCCccc----ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence              4677765544444443322211111  122223322    33566778889999999999999999988888887764

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-36  Score=304.80  Aligned_cols=254  Identities=23%  Similarity=0.377  Sum_probs=197.3

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|++|.||+|.+...+  +....||+|.+.........++|.+|+.++++++||||+++++++.. ...++||||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCC--CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            6899999999999986632  22257999999876443445789999999999999999999999988 88999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +|+|.+++.....   ..++|.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            9999999986542   258999999999999999999999   8999999999999999999999999999987643221


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      ...      .   .....++..|+|||+.. +..++.++|||||||++|||+| |+.||.....     .+..+......
T Consensus       153 ~~~------~---~~~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~  217 (257)
T cd05040         153 HYV------M---EEHLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILKKIDKEG  217 (257)
T ss_pred             cee------c---ccCCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcC
Confidence            110      0   01234667899999844 4678999999999999999999 9999864221     22222222111


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ....   .+.        .....+.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~---~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ERLE---RPE--------ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CcCC---CCc--------cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1100   000        01134567889999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-38  Score=327.55  Aligned_cols=255  Identities=20%  Similarity=0.294  Sum_probs=195.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|.....+     +.||||+++...  .....+.+.+|++++..++||||+++++++...+..++||
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTG-----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            467999999999999988654     899999997542  1233467899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            9999999999998652     48999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCcccc-----------------cceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 006522          505 GTSKVTK-----------------NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA  567 (642)
Q Consensus       505 ~~~~~~~-----------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~  567 (642)
                      .......                 ...............||+.|+|||++.. ..++.++|||||||++|||+||+.||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCC
Confidence            4320000                 0000000111224568999999998554 688999999999999999999999997


Q ss_pred             CCCCCcccHHHHHHHHHh--ccCCCcc--ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 006522          568 GPENDGKGLESLVRKAFR--ERRPLSE--VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-MRTVSE  634 (642)
Q Consensus       568 ~~~~~~~~l~~~~~~~~~--~~~~~~~--~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~ev~~  634 (642)
                      ....     .........  .....+.  .+++             .+.+++.+|+. ||++||+ +.|+++
T Consensus       232 ~~~~-----~~~~~~i~~~~~~~~~p~~~~~~~-------------~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         232 SDTL-----QETYNKIINWKESLRFPPDPPVSP-------------EAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCH-----HHHHHHHhccCCcccCCCCCCCCH-------------HHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            5331     222222222  1111111  1122             34457778997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-36  Score=305.66  Aligned_cols=258  Identities=19%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|++|.||+|....++     +.||+|.++..  ......+.+.+|++++++++|+||+++++++...+..++||
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDG-----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCC-----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            467999999999999998554     78999988643  22223478999999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...... ...+++.++..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||+++...
T Consensus        82 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            999999999998653221 2358999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......++..|+|||.+. +..++.++|||||||++|||++|+.||.....   ..........
T Consensus       158 ~~~~------------~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~  221 (267)
T cd08224         158 SKTT------------AAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE  221 (267)
T ss_pred             CCCc------------ccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhh
Confidence            2210            011234677899999854 46789999999999999999999999864332   2233332222


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....+  ....         ......+.+++.+||+.+|++||++.+|+++|++++
T Consensus       222 ~~~~~--~~~~---------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYP--PLPA---------DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCC--CCCh---------hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            21111  1000         011224567888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-36  Score=310.10  Aligned_cols=249  Identities=23%  Similarity=0.246  Sum_probs=191.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||+|.+.....  ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATG-----KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCC-----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            357999999999999987765     8999999865421  112255788999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....   ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++....
T Consensus        80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          80 TIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999998875432   249999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...             ......|+..|+|||++. +..++.++|||||||++|||+||+.||...... .....+.....
T Consensus       154 ~~~-------------~~~~~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~  218 (285)
T cd05632         154 EGE-------------SIRGRVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVL  218 (285)
T ss_pred             CCC-------------cccCCCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhh
Confidence            221             011346788999999854 467899999999999999999999999753221 11111111111


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~  634 (642)
                      .........++             ..+.+++.+|++.||++||+     +.|+++
T Consensus       219 ~~~~~~~~~~~-------------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         219 ETEEVYSAKFS-------------EEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccccccCccCC-------------HHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            11111111111             23456888999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-36  Score=306.15  Aligned_cols=256  Identities=21%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||+|......  +....|++|...........+.|.+|+.++++++||||+++++++.. +..++|||
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056          10 LGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             eeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            3578999999999999875542  22257999988765434444789999999999999999999998875 56789999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++....
T Consensus        87 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          87 LAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             cCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999976432    48999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....           .....++..|+|||.+. ...++.++|||||||++||+++ |+.||......     .......
T Consensus       160 ~~~~~-----------~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~  222 (270)
T cd05056         160 ESYYK-----------ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRIE  222 (270)
T ss_pred             cccee-----------cCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH
Confidence            31110           00123445799999854 4678999999999999999996 99999754321     1111111


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      .. ..+....++             ..+.+++.+|+..+|++|||+.++++.|++++.
T Consensus       223 ~~~~~~~~~~~~-------------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         223 NGERLPMPPNCP-------------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             cCCcCCCCCCCC-------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11 111112122             235568888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.3e-37  Score=341.03  Aligned_cols=269  Identities=20%  Similarity=0.221  Sum_probs=197.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||+|+....+     +.||+|++.....  ....++|.+|++++++++||||+++++++...+..++||
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg-----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCS-----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCC-----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            467999999999999987764     8999999975422  222367999999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          425 DFIRNGSLYAALHAGPSD------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      ||+++|+|.+++......      ....+++..++.++.||++||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998642110      11346788899999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccce------eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 006522          499 LNRLLPGTSKVTKNET------IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       499 la~~~~~~~~~~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~  572 (642)
                      +++.............      ............||+.|||||+.. +..++.++|||||||++|||+||+.||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9987632111000000      000001112356999999999854 467899999999999999999999999752221


Q ss_pred             cccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHhh
Q 006522          573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-RMRTVSESLDRV  639 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-s~~ev~~~L~~l  639 (642)
                      .  .  ..........    ...+.       ......+.+++.+|++.||++|| +++++.+.|+..
T Consensus       238 k--i--~~~~~i~~P~----~~~p~-------~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        238 K--I--SYRDVILSPI----EVAPY-------REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             h--h--hhhhhccChh----hcccc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1  1  0111110000    00000       00112345688899999999996 677787877765

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=323.00  Aligned_cols=237  Identities=21%  Similarity=0.309  Sum_probs=184.1

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc---cCCCeeeEEEEEEeCCceEEEE
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV---QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ||+|+||.||+++....+     +.||||++....  .......+..|..++.+.   +||||+++++++...+..++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTR-----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCC-----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            699999999999987765     899999986531  112224556677777665   6999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        76 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          76 DYMSGGELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             cCCCCChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            9999999999987543     38999999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......||..|+|||++.....++.++||||+||++|||+||+.||....     .....+...
T Consensus       148 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-----~~~~~~~i~  210 (330)
T cd05586         148 TDNK------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-----TQQMYRNIA  210 (330)
T ss_pred             CCCC------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-----HHHHHHHHH
Confidence            2110            11234688999999986554568999999999999999999999997532     223333333


Q ss_pred             hccCCCcc-ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          585 RERRPLSE-VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       585 ~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      .....++. .+++             .+.+++.+||+.||++||++
T Consensus       211 ~~~~~~~~~~~~~-------------~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         211 FGKVRFPKNVLSD-------------EGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             cCCCCCCCccCCH-------------HHHHHHHHHcCCCHHHCCCC
Confidence            22222111 1222             23457888999999999954

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-36  Score=311.31  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=197.0

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||++....++. .....||+|.+..........++.+|+.++++++||||+++++++... ..++++|
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGE-TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eccccccCCCccEEEEEEecCCC-cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            34679999999999998765532 122468999887654433345789999999999999999999998764 4679999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++....
T Consensus        89 ~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          89 LMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             hcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            9999999999976542    48999999999999999999999   8999999999999999999999999999986643


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....          ......++..|+|||++. +..++.++|||||||++|||+| |+.||.+...  .....++... 
T Consensus       162 ~~~~~----------~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-  227 (303)
T cd05110         162 DEKEY----------NADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKG-  227 (303)
T ss_pred             ccccc----------ccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC-
Confidence            21110          011223466799999854 4778999999999999999998 9999864321  1122222110 


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                       ...+.....             ...+.+++..||..+|++||++.|+++.|+++.+
T Consensus       228 -~~~~~~~~~-------------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         228 -ERLPQPPIC-------------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -CCCCCCCCC-------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             111111111             1245678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-36  Score=303.02  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=191.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-CCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-NDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~  424 (642)
                      ....||+|+||.||++....       ..|++|.++....   .+.|.+|+.++++++|+||+++++++.. .+..++||
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082          10 LLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             eeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            35789999999999997653       6789998865322   3678999999999999999999998654 45789999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.++++....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+|++|||+++...
T Consensus        80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             ECCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            99999999999976543   248999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ...               ....++..|+|||+.. +..++.++|||||||++|||++ |+.||...     .........
T Consensus       154 ~~~---------------~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~  212 (256)
T cd05082         154 STQ---------------DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV  212 (256)
T ss_pred             ccC---------------CCCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH
Confidence            211               0123345699999854 4678999999999999999998 99998642     222333222


Q ss_pred             HhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          584 FRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       584 ~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ..... ...+.++             ..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       213 ~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 EKGYKMDAPDGCP-------------PVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             hcCCCCCCCCCCC-------------HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            22111 1111111             2345688899999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=315.40  Aligned_cols=246  Identities=20%  Similarity=0.277  Sum_probs=199.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ...||+|.||.||++....++     +.+|+|.+.+....  ...+.+.+|+.+|+++. |||||.+++.|.+.+..++|
T Consensus        40 ~~~lG~G~Fg~v~~~~~~~tg-----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   40 GRELGRGQFGVVYLCREKSTG-----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             hhhhCCCCceEEEEEEecCCC-----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            478999999999999998865     89999999876332  23468999999999998 99999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC----CCCeEEecccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD----ELHPCISGFGL  499 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DfGl  499 (642)
                      ||++.||.|++.+...      .+++.....++.|++.|+.|||+   .+|+||||||+|+|+..    ++.+|++|||+
T Consensus       115 mEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999875      18999999999999999999999   89999999999999953    35799999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      +.......             .....+||+.|+|||+.. ...|+..+||||.||++|.|++|..||.+......     
T Consensus       186 a~~~~~~~-------------~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-----  246 (382)
T KOG0032|consen  186 AKFIKPGE-------------RLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-----  246 (382)
T ss_pred             ceEccCCc-------------eEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-----
Confidence            98765421             122568999999999944 37899999999999999999999999987544322     


Q ss_pred             HHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..........+.....+.+         ...+-+++..++..||.+|+|+.++++
T Consensus       247 ~~~i~~~~~~f~~~~w~~i---------s~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  247 FLAILRGDFDFTSEPWDDI---------SESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHcCCCCCCCCCcccc---------CHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1133333222111111111         123445888899999999999999986

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.4e-37  Score=327.40  Aligned_cols=209  Identities=21%  Similarity=0.285  Sum_probs=168.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||||.+.+..  .....+.+.+|++++++++||||+++++.+...+..++||
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTN-----ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCC-----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            467999999999999987764     899999986532  1223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++...+     .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+.
T Consensus        81 E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            9999999999997643     38889999999999999999999   899999999999999999999999999986432


Q ss_pred             CCCccc---c-----cc-----------------------eeeecCCCcccccCCCcccCccccccCCCCCcccchHHHH
Q 006522          505 GTSKVT---K-----NE-----------------------TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG  553 (642)
Q Consensus       505 ~~~~~~---~-----~~-----------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~G  553 (642)
                      ......   .     ..                       .............||+.|||||++. +..++.++||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG  231 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVG  231 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeecc
Confidence            110000   0     00                       0000000112357999999999854 47789999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 006522          554 IVLLEILTGRLPDAGP  569 (642)
Q Consensus       554 vvl~el~tG~~P~~~~  569 (642)
                      |++|||+||+.||...
T Consensus       232 vilyell~G~~Pf~~~  247 (376)
T cd05598         232 VILYEMLVGQPPFLAD  247 (376)
T ss_pred             ceeeehhhCCCCCCCC
Confidence            9999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=303.28  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=200.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      +.||+|+||.||++......  .....|++|.+.........+.+.+|++++++++|+||+++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            36899999999999987641  1127899999987644334578999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          428 RNGSLYAALHAGPSD----SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      ++++|.+++......    ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||.++..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999875211    01359999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .......          ......++..|+|||.+.. ..++.++||||+||++|||++ |+.||....     .......
T Consensus       156 ~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~  219 (262)
T cd00192         156 YDDDYYR----------KKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEY  219 (262)
T ss_pred             ccccccc----------cccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Confidence            5432100          0113346778999998554 578999999999999999999 699997542     1222222


Q ss_pred             HHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          583 AFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       583 ~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ..... ......++             .++.+++.+||+.+|++|||+.|+++.|+
T Consensus       220 ~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         220 LRKGYRLPKPEYCP-------------DELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHcCCCCCCCccCC-------------hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            22211 11112222             24566888899999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=305.98  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..+.||+|+||.||+|.....+ ......+|+|.+..........++.+|+.++++++||||+++++++.. ...++|||
T Consensus        11 ~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   88 (279)
T cd05057          11 KIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ   88 (279)
T ss_pred             EcceecCCCCccEEEEEEecCC-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence            3578999999999999976542 222357999988765444444788999999999999999999999987 78899999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        89 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          89 LMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             cCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            9999999999976543    38999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....       .   .....++..|+|||... ...++.++|||||||++||++| |+.||.....     ..+.....
T Consensus       162 ~~~~~-------~---~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~  225 (279)
T cd05057         162 DEKEY-------H---AEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLE  225 (279)
T ss_pred             cccce-------e---cCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHh
Confidence            21110       0   00122356799999854 4678999999999999999999 9999975321     22222222


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ... .+.+...+             ..+.+++.+||..+|++||++.++++.|+++.
T Consensus       226 ~~~~~~~~~~~~-------------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         226 KGERLPQPPICT-------------IDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CCCCCCCCCCCC-------------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111 11111112             23456888899999999999999999999873

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-36  Score=304.68  Aligned_cols=244  Identities=23%  Similarity=0.365  Sum_probs=189.3

Q ss_pred             ccCccCCceeEEEEecCCCC-----CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          349 VVGKSKNGIMYKVVVGRGSG-----MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .||+|+||.||++.......     ......+++|.+......  ...|.+|+.++++++||||+++++++.. +..++|
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            68999999999999976531     222346888877654332  4789999999999999999999999988 788999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-------CeEEec
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-------HPCISG  496 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~D  496 (642)
                      |||+++|+|.+++.....    .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++       .+||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999986542    48999999999999999999999   8999999999999999887       799999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcc
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGK  574 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~  574 (642)
                      ||+++.....                ....++..|+|||++... ..++.++|||||||++|||++ |..||......  
T Consensus       152 fg~a~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--  213 (259)
T cd05037         152 PGIPITVLSR----------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--  213 (259)
T ss_pred             CCcccccccc----------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--
Confidence            9998764321                022345569999985543 368899999999999999999 57777643211  


Q ss_pred             cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       575 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                         .+... +........   +.          ...+.+++.+||..+|.+|||+.|+++.|+
T Consensus       214 ---~~~~~-~~~~~~~~~---~~----------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         214 ---EKERF-YQDQHRLPM---PD----------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---hHHHH-HhcCCCCCC---CC----------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               11111 111111010   00          035667899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.9e-36  Score=310.22  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=199.4

Q ss_pred             cccccCccCCceeEEEEecCCCC--CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSG--MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ..+.||+|+||.||++.......  ......+|+|.++.........++.+|+++++++ +||||+++++++...+..++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            45789999999999998643211  1223679999988654444456789999999999 69999999999999889999


Q ss_pred             EEeeccCCcHHHHHhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          423 ISDFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      ||||+++|+|.+++......           ....++|..+.+++.|++.||+|||+   .+++||||||+||++++++.
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~  172 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNV  172 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCc
Confidence            99999999999999764321           12358999999999999999999999   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.........          ......++..|+|||++. +..++.++|||||||++|||+| |..||....
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         173 MKIADFGLARGVHDIDYYK----------KTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             EEEcccccccccccccccc----------ccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999998654321100          000112345699999854 4678999999999999999999 899986422


Q ss_pred             CCcccHHHHHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          571 NDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                           ............. .....+             ..++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       242 -----~~~~~~~~~~~~~~~~~~~~-------------~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         242 -----VEELFKLLREGHRMDKPSNC-------------THELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -----HHHHHHHHHcCCCCCCCCCC-------------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 1222222221111 111111             124556889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-36  Score=298.45  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=202.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      -..||.|.-|+||.+.+....     ..+|+|++.+..  ......+...|-+||+.++||.+++||+.|+.+...++||
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~-----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTN-----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCC-----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            357999999999999998876     899999998762  2233467888999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |||+||+|..+.+.+...   .+++..+..++.+|+.||+|||-   .|||.|||||+|||+-++|++.|+||-|+....
T Consensus       157 eyCpGGdL~~LrqkQp~~---~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGK---RFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             ecCCCccHHHHHhhCCCC---ccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999999876553   59999999999999999999999   899999999999999999999999999887653


Q ss_pred             CCCcccc---------------------------cce---------------e--eecCCCcccccCCCcccCccccccC
Q 006522          505 GTSKVTK---------------------------NET---------------I--VTSGTGSRISAISNVYLAPEARIYG  540 (642)
Q Consensus       505 ~~~~~~~---------------------------~~~---------------~--~~~~~~~~~~~gt~~y~aPE~~~~~  540 (642)
                      .......                           ...               .  ...+..+...+||-.|.|||+ +.+
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv-I~G  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV-IRG  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee-eec
Confidence            2111000                           000               0  112233456789999999999 455


Q ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCC
Q 006522          541 SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTE  620 (642)
Q Consensus       541 ~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~  620 (642)
                      ...+.++|.|+|||++|||+.|+.||.+..+..     -+..+......+++.-           .-...+-+|+.+.|.
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-----Tl~NIv~~~l~Fp~~~-----------~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-----TLRNIVGQPLKFPEEP-----------EVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-----hHHHHhcCCCcCCCCC-----------cchhHHHHHHHHHhc
Confidence            889999999999999999999999998765532     2333333332222211           112345568899999


Q ss_pred             CCCCCCCC----HHHH
Q 006522          621 LDPEFRPR----MRTV  632 (642)
Q Consensus       621 ~dP~~RPs----~~ev  632 (642)
                      +||++|.-    +.||
T Consensus       374 KdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEI  389 (459)
T ss_pred             cChhhhhccccchHHh
Confidence            99999987    5555

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-36  Score=307.33  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=196.9

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      ....||+|+||.||.+..... +......||+|.++........+.+.+|++++++++||||+++++++...  ...++|
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             hceecCCCCceeEEEEEEccC-CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            346799999999999975421 11222789999987654444457899999999999999999999999875  568899


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++++|.+++.....    .++|..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++..
T Consensus        87 ~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          87 MEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            999999999999975432    48999999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----------Cc
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN----------DG  573 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~----------~~  573 (642)
                      .......       .  ......++..|+|||+... ..++.++|||||||++|||+|++.|+.....          ..
T Consensus       160 ~~~~~~~-------~--~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05079         160 ETDKEYY-------T--VKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ  229 (284)
T ss_pred             ccCccce-------e--ecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence            4321110       0  0112345667999998554 6789999999999999999998876532211          00


Q ss_pred             ccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       574 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ......+... ....... . .    .     .....+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       230 ~~~~~~~~~~-~~~~~~~-~-~----~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVRVL-EEGKRLP-R-P----P-----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHHHH-HcCccCC-C-C----C-----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111111 1111100 0 0    0     0123567799999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-36  Score=309.51  Aligned_cols=248  Identities=22%  Similarity=0.241  Sum_probs=192.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||||.+.....  ....+.+.+|+.++++++|+||+++++.+...+..++||
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCC-----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            357999999999999988765     8999999875422  122256788999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....   ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++....
T Consensus        80 e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            99999999999865433   248999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....|+..|+|||++.. ..++.++|||||||++|||++|+.||.......  .........
T Consensus       154 ~~~~-------------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--~~~~~~~~~  217 (285)
T cd05630         154 EGQT-------------IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLV  217 (285)
T ss_pred             CCcc-------------ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--hHHHHHhhh
Confidence            2210             112367889999999554 678999999999999999999999997533211  011111111


Q ss_pred             hc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 006522          585 RE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       585 ~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~  634 (642)
                      .. .......+++             .+.+++..||+.||++|||     +.|+++
T Consensus       218 ~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 KEVQEEYSEKFSP-------------DARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhhhhcCccCCH-------------HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            10 1111122222             3456888899999999999     778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-36  Score=302.64  Aligned_cols=247  Identities=28%  Similarity=0.447  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....+      +.||+|.+......  .++|.+|+.++++++||||+++++++. .+..++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             eeeeccCccceEEeeecCCC------ceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            46799999999999997765      78999998764432  378999999999999999999999864 5678999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          82 MENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999876443   248999999999999999999998   89999999999999999999999999998765422


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||++. ...++.++|||||||++||++| |+.||.....     .........
T Consensus       156 ~~~-----------~~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~  218 (260)
T cd05067         156 EYT-----------AREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNLER  218 (260)
T ss_pred             Ccc-----------cccCCcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHc
Confidence            110           001223456799999854 4678899999999999999999 9999975321     122222211


Q ss_pred             cc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .. .+.....             ..++.+++.+||+.+|++||+++++.+.|+.
T Consensus       219 ~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 GYRMPRPDNC-------------PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCC-------------CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11 1111111             1246678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-36  Score=306.44  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=196.0

Q ss_pred             cccCccCCceeEEEEecCCCC-CCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSG-MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      +.||+|+||.||+|....... ......+++|.+...........|.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998765321 1223679999887654333447899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-----CeEEecccc
Q 006522          427 IRNGSLYAALHAGPSD--SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-----HPCISGFGL  499 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DfGl  499 (642)
                      +++|+|.++++.....  ....++|.++..++.|++.||+|||+   .+++|+||||+||+++.+.     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999754321  12348999999999999999999998   8999999999999999877     899999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLES  578 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~  578 (642)
                      ++..........          .....++..|+|||++. +..++.++|||||||++|||+| |+.||.....     ..
T Consensus       158 ~~~~~~~~~~~~----------~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~  221 (269)
T cd05044         158 ARDIYKSDYYRK----------EGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QE  221 (269)
T ss_pred             cccccccccccc----------CcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HH
Confidence            876543211100          00223456799999854 4678999999999999999998 9999864321     11


Q ss_pred             HHHHHHhccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          579 LVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       579 ~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .......... .....+             ...+.+++.+||+.+|++||++.++++.|++
T Consensus       222 ~~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         222 VLQHVTAGGRLQKPENC-------------PDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHHhcCCccCCcccc-------------hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            2221111111 111111             1245678899999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.9e-37  Score=321.93  Aligned_cols=251  Identities=18%  Similarity=0.213  Sum_probs=188.9

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....||+|+||.||++....++     +.+|+|.+....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        47 i~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          47 VVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             EEEEEeecCCeEEEEEEECCCC-----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            3578999999999999988775     899999986431  122235678999999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++...      .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         122 MEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            9999999999998653      27888899999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      ......           ......||+.|+|||++...   ..++.++|||||||++|||++|+.||....     .....
T Consensus       193 ~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~~~~  256 (371)
T cd05622         193 NKEGMV-----------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVGTY  256 (371)
T ss_pred             CcCCcc-----------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-----HHHHH
Confidence            432110           11235689999999985432   237899999999999999999999997532     22233


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF--RPRMRTVSES  635 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~--RPs~~ev~~~  635 (642)
                      ...........-...+.+         ...+.+++..|+..++.+  ||++.|+++.
T Consensus       257 ~~i~~~~~~~~~~~~~~~---------s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         257 SKIMNHKNSLTFPDDNDI---------SKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHHcCCCcccCCCcCCC---------CHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            333322111100000111         112345777788743332  6788888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.5e-36  Score=301.10  Aligned_cols=247  Identities=22%  Similarity=0.387  Sum_probs=194.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....+      ..+|+|.+......  ..+|.+|++++++++||||+++++++......++||||
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~------~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEK------RKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             EeeecCcccceEEEEEEeCC------CeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            46799999999999988655      67999998754332  26789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          81 MEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             CCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            999999999976442    48899999999999999999999   79999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......++..|+|||... +..++.++|||||||++|||++ |+.||.....     .........
T Consensus       154 ~~~-----------~~~~~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~  216 (256)
T cd05112         154 QYT-----------SSTGTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINA  216 (256)
T ss_pred             ccc-----------ccCCCccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhC
Confidence            100           001123456799999854 4678999999999999999998 9999864221     222222211


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ....    ..+..        ....+.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~----~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         217 GFRL----YKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCC----CCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            1111    11111        1134677999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-36  Score=307.03  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe--CCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~  424 (642)
                      ...||+|+||.||++...... ....+.+|||.+.........+.|.+|++++++++||||+++++++..  ....++||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM   87 (284)
T ss_pred             heeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence            367999999999999875431 112278999999865443234789999999999999999999999987  55789999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++.....    .++|..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        88 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          88 EYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             ecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999976542    48999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc----------
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK----------  574 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~----------  574 (642)
                      .......         ......++..|+|||.... ..++.++||||||+++|||+||+.|+........          
T Consensus       161 ~~~~~~~---------~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  230 (284)
T cd05038         161 EDKDYYY---------VKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM  230 (284)
T ss_pred             cCCccee---------ccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence            3211100         0001234456999998544 6788999999999999999999999865332211          


Q ss_pred             cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       575 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ....+.... ........  .         .....++.+++.+||+.+|++||+|.||+++|++++
T Consensus       231 ~~~~~~~~~-~~~~~~~~--~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         231 IVTRLLELL-KEGERLPR--P---------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             cHHHHHHHH-HcCCcCCC--C---------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            011111111 11111000  0         011135678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.6e-36  Score=315.01  Aligned_cols=205  Identities=24%  Similarity=0.306  Sum_probs=165.2

Q ss_pred             cccCcc--CCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          348 YVVGKS--KNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       348 ~~lg~g--~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+||+|  +|++||++....++     +.||+|++..... ....+.+.+|+++++.++|||||+++++|..++..++||
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTG-----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhccccccceEEEEEEeecccC-----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            578999  67899999988775     8999999976432 223356778999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++..+...   .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++++||+......
T Consensus        79 e~~~~~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          79 SFMAYGSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             eccCCCcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            999999999999754322   48999999999999999999999   899999999999999999999999998655432


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      ........     .........++..|+|||++... ..++.++|||||||++|||+||+.||..
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         153 NHGQRLRV-----VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccc-----cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            21110000     00001123456779999986543 4588999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.7e-37  Score=308.33  Aligned_cols=250  Identities=20%  Similarity=0.268  Sum_probs=191.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....++     +.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTG-----ELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hheeecCCCeEEEEEEECCCC-----eEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            467899999999999986654     7899999875432 2236688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.++++...     ++++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          88 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999987543     48999999999999999999999   89999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARI--YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..            ......|+..|+|||.+.  ....++.++|||||||++|||+||+.||.......    ... ...
T Consensus       160 ~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~----~~~-~~~  222 (267)
T cd06646         160 IA------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALF-LMS  222 (267)
T ss_pred             cc------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh----hhe-eee
Confidence            10            011235778899999853  23457889999999999999999999986432111    000 000


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..........++        ......+.+++.+||+.+|++||+++++++.
T Consensus       223 ~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         223 KSNFQPPKLKDK--------TKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             cCCCCCCCCccc--------cccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            000000000000        0111346678999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.1e-36  Score=309.99  Aligned_cols=260  Identities=21%  Similarity=0.335  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++.....+     ..+|+|.+.........+++.+|++++.+++||||++++++|..++..++||||
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSG-----LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCC-----eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            467999999999999987664     789999887543333346788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.++++...     .+++..+..++.|+++||+|||+.  .+++||||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            99999999997643     488999999999999999999972  47999999999999999999999999998654321


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      .              .....|+..|+|||.. .+..++.++|||||||++|||+||+.||.....  .....+.......
T Consensus       154 ~--------------~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~  216 (308)
T cd06615         154 M--------------ANSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSE  216 (308)
T ss_pred             c--------------cccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCcccc
Confidence            0              1134577889999985 446789999999999999999999999864321  1111111100000


Q ss_pred             cCC--------CccccCh------hhhhc--------hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RRP--------LSEVIDP------ALVKE--------IHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~~--------~~~~~d~------~l~~~--------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ...        ....-++      ++.+.        .........+.+++.+||+.+|++||++.|+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000        0000000      00000        0000012346789999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=303.19  Aligned_cols=249  Identities=21%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc----cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA----TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  422 (642)
                      .+.||+|++|.||++....++     +.|++|.+.....    ....+.+.+|++++++++||||+++++++...+..++
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~-----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTG-----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cceecCCCceEEEEEEEcCCC-----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            578999999999999987654     7899998865421    1223578899999999999999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |+||+++++|.+++....     .+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            999999999999987543     48889999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ......         .........|+..|+|||++.. ..++.++||||+||++|||++|+.||.....    .......
T Consensus       154 ~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~  219 (263)
T cd06625         154 LQTICS---------SGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKI  219 (263)
T ss_pred             cccccc---------ccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHH
Confidence            532210         0001113456778999999554 6689999999999999999999999964321    1111111


Q ss_pred             HHh-ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          583 AFR-ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       583 ~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ... ....++..+++             .+.+++.+||+.+|++|||+.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTNPQLPSHVSP-------------DARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCCCCCCccCCH-------------HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            111 11112222222             34568888999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.9e-36  Score=302.89  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..+++|.++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSD-----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCC-----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            467999999999999987664     789999986543333457888999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..+++.....++.|++.||.|||+   .+|+|+||||+||++++++.++++|||+++.....
T Consensus        80 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          80 CDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            999999999875432   248899999999999999999999   89999999999999999999999999998765332


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|+..|+|||+.. +..++.++||||||+++|+|++|+.||....     ...........
T Consensus       154 ~~------------~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~  215 (255)
T cd08219         154 GA------------YACTYVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQG  215 (255)
T ss_pred             cc------------ccccccCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcC
Confidence            11            011345778899999854 4678999999999999999999999997422     22222222222


Q ss_pred             cC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .. +++..++             ..+.+++.+||+.||++||++.|++..
T Consensus       216 ~~~~~~~~~~-------------~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         216 SYKPLPSHYS-------------YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCCcccC-------------HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11 1111121             234568889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-36  Score=309.05  Aligned_cols=245  Identities=19%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||+++....+     ..|++|.+...... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCC-----cEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            356899999999999976554     78999998764332 237789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++.++..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 ~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999998642      37899999999999999999999   89999999999999999999999999998764322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|++.|+|||.+. +..++.++|||||||++|||+||+.||......    ..+.......
T Consensus       170 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~~~~~~~~~~  232 (296)
T cd06654         170 QS------------KRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATNG  232 (296)
T ss_pred             cc------------ccCcccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----HhHHHHhcCC
Confidence            10            011235778899999854 467889999999999999999999999753321    1111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+.   .-.+.        .....+.+++.+||..+|++||++.|+++
T Consensus       233 ~~~---~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         233 TPE---LQNPE--------KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCC---CCCcc--------ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            111   00110        01123556889999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-36  Score=299.96  Aligned_cols=245  Identities=26%  Similarity=0.454  Sum_probs=195.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|++|.||++... +      +.||+|.++....  ..+++.+|+.++++++|+||+++++++...+..++|||
T Consensus        10 ~~~~ig~g~~g~v~~~~~~-~------~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039          10 LGATIGKGEFGDVMLGDYR-G------QKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             ceeeeecCCCceEEEEEec-C------cEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            3578999999999999875 2      6899999986543  34789999999999999999999999999899999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++.....   ..++|..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.++....
T Consensus        81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          81 YMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            9999999999976543   248999999999999999999999   8999999999999999999999999999876532


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...               ...++..|+|||+.. ...++.++||||||+++||+++ |+.||....     .........
T Consensus       155 ~~~---------------~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~  213 (256)
T cd05039         155 GQD---------------SGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPHVE  213 (256)
T ss_pred             ccc---------------cCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHHHh
Confidence            210               112345699999854 4678899999999999999998 999986432     112222111


Q ss_pred             hccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          585 RERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       585 ~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      .... .....+             ...+.+++.+||+.+|++||++.|++++|+.+
T Consensus       214 ~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         214 KGYRMEAPEGC-------------PPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             cCCCCCCccCC-------------CHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            1111 111111             13456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=301.73  Aligned_cols=248  Identities=28%  Similarity=0.464  Sum_probs=196.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....+      +.|+||.+......  .+++.+|+.++++++||||+++++++......++||||
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             eeeeccCcceEEEEEEEcCC------ceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            46799999999999997655      67999998764332  37899999999999999999999999988899999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++.....   ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+|++|||+++.....
T Consensus        83 ~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          83 MSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             cCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999976542   248999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....           .....++..|+|||.+. +..++.++||||+||++||++| |+.||.+...     .........
T Consensus       157 ~~~~-----------~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~  219 (261)
T cd05034         157 EYTA-----------REGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQVER  219 (261)
T ss_pred             hhhh-----------hhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc
Confidence            1000           00112345699999854 4678999999999999999999 9999964321     122222222


Q ss_pred             c-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          586 E-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       586 ~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      . ..+.....             ...+.+++.+|++.+|++||+++++.+.|+.
T Consensus       220 ~~~~~~~~~~-------------~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         220 GYRMPRPPNC-------------PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCC-------------CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1 11111111             1245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-36  Score=299.35  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=194.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|++|.||++....+      +.|++|.+.........+.|.+|++++++++||||+++++++......++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~------~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGN------TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             ccccCCCceEEEEEEeCC------CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            689999999999998774      89999998765443344789999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCc
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~  508 (642)
                      +++|.+++.....    .+++..+..++.+++.||+|||+   ++++||||||+||+++.++.+||+|||+++.......
T Consensus        76 ~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          76 GGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            9999999976432    48899999999999999999999   8999999999999999999999999999876542211


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHhc-
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRE-  586 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~-  586 (642)
                      ..          ......++..|+|||.+. +..++.++|||||||++|||+| |..||.....     .......... 
T Consensus       149 ~~----------~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~~~~  212 (251)
T cd05041         149 TV----------SDGLKQIPIKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESGY  212 (251)
T ss_pred             ee----------ccccCcceeccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHhcCC
Confidence            00          001122345699999854 4678999999999999999999 8888864321     1111111111 


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ..+..+..             ...+.+++.+||+.+|++||++.|+++.|+.
T Consensus       213 ~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         213 RMPAPQLC-------------PEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCCCCccC-------------CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            11111111             1246678999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-36  Score=316.71  Aligned_cols=193  Identities=21%  Similarity=0.301  Sum_probs=160.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      ...||+|+||.||++.....+     +.||||.+.... .....+.+.+|+.++++++||||+++++++...+      .
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLG-----INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCC-----ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            468999999999999987654     899999987542 2223467889999999999999999999987543      4


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++ +|.+.++.       .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus       101 ~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence            6999999975 67776642       27889999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ++......             ......||+.|+|||++. +..++.++||||+||++|||+||+.||.+.
T Consensus       170 a~~~~~~~-------------~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTNF-------------MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccCc-------------cCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            87543221             111346788899999854 477899999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-36  Score=321.31  Aligned_cols=259  Identities=19%  Similarity=0.268  Sum_probs=189.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++......   ..+.|++|.+...      +.+.+|++++++++|||||++++++......++||||
T Consensus        97 ~~~Lg~G~~g~Vy~~~~~~~~---~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         97 LSSLTPGSEGEVFVCTKHGDE---QRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             EEeecCCCCeEEEEEEEcCCc---cceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            467999999999999764321   2278999988653      3456899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +. ++|.+++....     .+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       168 ~~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        168 YK-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             cC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            96 68999884332     49999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCc--ccHHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG--KGLESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~--~~l~~~~~~~~  584 (642)
                      ...          .......||+.|+|||++. +..++.++|||||||++|||++|+.||.+.....  ..+...++...
T Consensus       239 ~~~----------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        239 PDT----------PQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             ccc----------ccccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            110          0111346889999999854 4678999999999999999999999997643321  11111111110


Q ss_pred             hccCCCccccChhhhh-----------------chhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVK-----------------EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~-----------------~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .....+.......+..                 .+........+.+++.+|+..||++|||+.|++.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000000000000                 0000011234567889999999999999999986

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-36  Score=306.66  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=198.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++....++     +.||+|.+.........+++.+|+++++.++||||+++++++...+..++||||
T Consensus        10 ~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620          10 ISDLGAGNGGSVSKVKHIPTG-----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHcCCCCCeEEEEEEEcCCC-----cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            467999999999999987654     789999887654443447899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++...+     ++++..+..++.+++.||.|||+.  .+++||||||+||++++++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            99999999987643     489999999999999999999962  47999999999999999999999999998654221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC------cccHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND------GKGLESLV  580 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~------~~~l~~~~  580 (642)
                      .              .....|+..|+|||++.. ..++.++|||||||++||++||+.||......      ...+..++
T Consensus       158 ~--------------~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd06620         158 I--------------ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL  222 (284)
T ss_pred             c--------------cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence            0              113457888999998554 67889999999999999999999999754321      11122333


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      ........+.   +..        ......+.+++.+||+.||++||++.|+++..
T Consensus       223 ~~~~~~~~~~---~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         223 QQIVQEPPPR---LPS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             HHHhhccCCC---CCc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            3333222110   000        01123466788999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-36  Score=309.50  Aligned_cols=261  Identities=17%  Similarity=0.232  Sum_probs=192.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     +.||+|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCC-----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            357999999999999987654     789999987553333335678999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      ++ ++|.+++.....    .+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        86 ~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            97 599999876432    48899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ...            .....+++.|+|||.+.....++.++|||||||++|||+||+.||......  .....+......
T Consensus       158 ~~~------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~  223 (301)
T cd07873         158 TKT------------YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGT  223 (301)
T ss_pred             CCc------------ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCC
Confidence            100            012245678999998655456889999999999999999999999753221  111111111100


Q ss_pred             cC--CCccccC---------hhhhhch---hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RR--PLSEVID---------PALVKEI---HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~--~~~~~~d---------~~l~~~~---~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..  ......+         +......   ........+.+++.+|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00  0000000         0000000   00001224567999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-36  Score=303.03  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....++     ..|++|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~-----~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQ-----VRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             eEEEecCCceEEEEeEecCCC-----cEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            457999999999999987664     78999988764332 336889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEecccccccC
Q 006522          427 IRNGSLYAALHAGPSDSLPPL--PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRLL  503 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~  503 (642)
                      +++++|.+++.....    ++  ++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.+||+|||++...
T Consensus        87 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          87 VPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             CCCCCHHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999976432    24  788889999999999999999   89999999999999976 679999999998765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .....            ......|+..|+|||++... ..++.++|||||||++|||++|+.||.......  ...+...
T Consensus       160 ~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~  225 (268)
T cd06624         160 AGINP------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVG  225 (268)
T ss_pred             ccCCC------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhh
Confidence            32210            01123467789999985442 347899999999999999999999986432211  1111111


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .......++..+++             ++.+++.+||+.+|++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         226 MFKIHPEIPESLSA-------------EAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhccCCCCCcccCH-------------HHHHHHHHHcCCCchhCCCHHHHHh
Confidence            11111112222222             3456788899999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.1e-36  Score=303.39  Aligned_cols=247  Identities=19%  Similarity=0.283  Sum_probs=190.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeC------Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~~  419 (642)
                      ...||+|+||.||+|.....+     +.||+|.+......  ...+.+|+.++.++ +||||+++++++...      ..
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCC-----cEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            357999999999999987765     89999998754322  36788999999999 799999999998763      35


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++|+|.+++.....   ..++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            7899999999999999986432   248999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      ++.......            ......|+..|+|||++..    ...++.++|||||||++|||++|+.||.....    
T Consensus       158 ~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~----  221 (272)
T cd06637         158 SAQLDRTVG------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----  221 (272)
T ss_pred             ceecccccc------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH----
Confidence            876532210            1113467888999998542    23578899999999999999999999964221    


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..... ......  .....+..         ....+.+++.+||+.+|.+|||+.|+++
T Consensus       222 ~~~~~-~~~~~~--~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         222 MRALF-LIPRNP--APRLKSKK---------WSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHHH-HHhcCC--CCCCCCCC---------cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11111 111111  11111111         1124567899999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.5e-36  Score=303.67  Aligned_cols=259  Identities=22%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++........+..+.|++|.+.........++|.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY   89 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence            35689999999999998776555566889999987654433347899999999999999999999999998999999999


Q ss_pred             ccCCcHHHHHhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          427 IRNGSLYAALHAGPSDS----LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      +++|+|.+++.......    ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++++|||+++.
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~  166 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKD  166 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccc
Confidence            99999999997654221    1258999999999999999999999   8999999999999999999999999999875


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~  581 (642)
                      .......           ......++..|+|||.+.. ..++.++|||||||++|||++ |..||.....     ...+.
T Consensus       167 ~~~~~~~-----------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~~~~  229 (275)
T cd05046         167 VYNSEYY-----------KLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLN  229 (275)
T ss_pred             cCccccc-----------ccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HHHHH
Confidence            4322110           0112244567999998543 567899999999999999999 8889864321     12222


Q ss_pred             HHHhccCC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          582 KAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       582 ~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      ........  ....++             ..+.+++.+||+.+|++||++.|++..|++
T Consensus       230 ~~~~~~~~~~~~~~~~-------------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         230 RLQAGKLELPVPEGCP-------------SRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHHcCCcCCCCCCCCC-------------HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            22211111  111111             245668899999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.6e-36  Score=303.68  Aligned_cols=248  Identities=21%  Similarity=0.305  Sum_probs=192.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..+++|.+..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643          10 IGELGDGAFGKVYKAQNKETG-----VLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HhhcccCCCeEEEEEEECCCC-----eEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            356999999999999987764     7889999865432 2347789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++....    .++++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          84 CAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            99999999886533    248999999999999999999999   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..            ......++..|+|||++.    .+..++.++|||||||++|||++|+.||.....     ...+..
T Consensus       157 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~  219 (282)
T cd06643         157 IQ------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLLK  219 (282)
T ss_pred             cc------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHHH
Confidence            10            011335778899999853    234577899999999999999999999864321     112222


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+  ....+..        ....+.+++.+||+.||.+||++.++++
T Consensus       220 ~~~~~~~--~~~~~~~--------~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         220 IAKSEPP--TLAQPSR--------WSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HhhcCCC--CCCCccc--------cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2222111  1111110        1124567889999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.2e-36  Score=304.28  Aligned_cols=262  Identities=19%  Similarity=0.251  Sum_probs=191.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||+|+...++     ..||+|.++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             eeEecccCceEEEEEEECCCC-----cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            356899999999999987654     7899999875422 2233678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++ ++|.+++......  ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        80 ~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          80 FLS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             cCC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            997 6899888654321  358999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......+++.|+|||++.....++.++|||||||++|||+||+.||...... .......+....
T Consensus       154 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~  220 (285)
T cd07861         154 PVR------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGT  220 (285)
T ss_pred             Ccc------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            210            0012245678999998655456789999999999999999999999753221 011111110000


Q ss_pred             cc-------C-------CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ER-------R-------PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~-------~-------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..       .       .........+....  .....++.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         221 PTEDVWPGVTSLPDYKNTFPKWKKGSLRSAV--KNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CChhhhhcchhhHHHHhhccccCcchhHHhc--CCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00       0       00000000000000  001234567999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.8e-36  Score=299.81  Aligned_cols=249  Identities=27%  Similarity=0.471  Sum_probs=193.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++....+      ..+++|.+.....  ..+.|.+|++++++++|+||+++++++.. ...+++|||
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~------~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             EeEecCccceEEEEEEecCC------ccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            46799999999999987665      6799998875432  23678999999999999999999999887 778999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||.++.....
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          82 MAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             CCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999976432   248899999999999999999998   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....           .....++..|+|||++.. ..++.++|||||||++||++| |+.||.....     ....... .
T Consensus       156 ~~~~-----------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~-~  217 (260)
T cd05073         156 EYTA-----------REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRAL-E  217 (260)
T ss_pred             Cccc-----------ccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHH-h
Confidence            1100           011234567999998544 678999999999999999999 9999974321     1111111 1


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      ..... +. ..         ....++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       218 ~~~~~-~~-~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         218 RGYRM-PR-PE---------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCCCC-CC-cc---------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            11111 00 00         1112466788999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6e-37  Score=319.01  Aligned_cols=193  Identities=23%  Similarity=0.362  Sum_probs=166.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-C-----CCeeeEEEEEEeCCce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-H-----PNIVRLKAFYYANDEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~  420 (642)
                      .++||+|.||.|.+|++..++     +.||||+++.....  ..+-..|+.+|..++ |     -|+|++++||...++.
T Consensus       191 ~e~LGkGtFGQVvk~~d~~T~-----e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  191 LEVLGKGSFGQVVKAYDHKTG-----EIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEecccccceeEEEEecCCC-----cEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            478999999999999999876     89999999875432  366778999999997 5     3799999999999999


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC--CCCeEEeccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD--ELHPCISGFG  498 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DfG  498 (642)
                      +||+|.+.. +|+++++...-.   +|+......|+.||+.||.+||+   .+|||+||||+||||.+  ...+||+|||
T Consensus       264 ciVfELL~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence            999999976 999999877643   49999999999999999999999   89999999999999964  3479999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      .|........               ...-+..|+|||++++ ..|+.+.||||||||+.||+||.+-|.+.
T Consensus       337 SSc~~~q~vy---------------tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  337 SSCFESQRVY---------------TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cccccCCcce---------------eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCC
Confidence            9987655422               1233567999999765 89999999999999999999998777764

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=297.74  Aligned_cols=245  Identities=20%  Similarity=0.350  Sum_probs=201.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      -..+|+|+||.||++..+..+     .++|+|++....+   .+++..|+.+|++++.|+||++||.|......++||||
T Consensus        38 ~~KLGEGSYGSV~KAIH~EsG-----~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   38 VGKLGEGSYGSVHKAIHRESG-----HVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHhcCCcchHHHHHHHhccC-----cEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            356899999999999988876     8999999875433   37889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |-.|+..+.++.+..    +|++..+..+.+..++||+|||.   .+-||||||..|||++.+|.+|++|||.|..+.++
T Consensus       110 CGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  110 CGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             cCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            999999999987654    59999999999999999999999   67899999999999999999999999999876543


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      -            .....+.||+.|||||++.. -.|++++||||+|++..||.-|++||.+...-    ..++  ....
T Consensus       183 M------------AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----RAIF--MIPT  243 (502)
T KOG0574|consen  183 M------------AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----RAIF--MIPT  243 (502)
T ss_pred             H------------HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccc----ceeE--eccC
Confidence            1            12235679999999999554 78999999999999999999999999763321    0000  0011


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+|      |.+   -..++...++-+++..|+-..|++|-|+.++++
T Consensus       244 ~PP------PTF---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  244 KPP------PTF---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCC------CCC---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            111      111   123345567788999999999999999988765

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-36  Score=316.92  Aligned_cols=257  Identities=18%  Similarity=0.259  Sum_probs=188.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      .+.||+|+||.||+++....+     +.||||++.... .....+.+.+|+.+++.++||||+++++++....      .
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCC-----ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            467999999999999987654     789999997642 2223467889999999999999999999986543      4


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++ +|.+.+..       .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        97 ~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             eEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence            6999999975 77777642       37889999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++......             ......||..|+|||++. +..++.++|||||||++|||++|+.||.+.... ......
T Consensus       166 ~~~~~~~~-------------~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~  230 (355)
T cd07874         166 ARTAGTSF-------------MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKV  230 (355)
T ss_pred             cccCCCcc-------------ccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            97643221             011346788899999854 467899999999999999999999999753211 011111


Q ss_pred             HH------------------HHHhccCCCccccChhhh-hch------hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VR------------------KAFRERRPLSEVIDPALV-KEI------HAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~------------------~~~~~~~~~~~~~d~~l~-~~~------~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +.                  ..............+... ...      ........+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            11                  000000000000000000 000      00011245678999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.8e-36  Score=316.06  Aligned_cols=193  Identities=19%  Similarity=0.294  Sum_probs=161.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC------Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  419 (642)
                      ...||+|+||.||+++....+     +.||||++.... .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCC-----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            468999999999999987665     789999997542 223346788999999999999999999988643      24


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++ +|.+.+..       .+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             EEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            7999999975 78777742       37889999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ++......             ......||..|+|||++. +..++.++|||||||++|||+||+.||...
T Consensus       173 a~~~~~~~-------------~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         173 ARTAGTSF-------------MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccccCCCC-------------cccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            97643221             111346788899999854 477899999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-36  Score=337.33  Aligned_cols=251  Identities=18%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      ...||+|+||.||++......     ..||+|.+.... .......|.+|+.++++++|||||+++++|...  ...|+|
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg-----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQ-----EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCC-----eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            467999999999999988765     789999987542 222346789999999999999999999998654  468999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCceecCCCCCCeeeCC-----------
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSP----RKYVHGNIKSTKILLDD-----------  488 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlkp~NILl~~-----------  488 (642)
                      |||+++|+|.++|...... ...+++..++.|+.||+.||+|||+...    .+||||||||+|||++.           
T Consensus        93 MEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999753221 1359999999999999999999998431    35999999999999964           


Q ss_pred             ------CCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCcccccc-CCCCCcccchHHHHHHHHHHHh
Q 006522          489 ------ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-GSKFTQKCDVYSFGIVLLEILT  561 (642)
Q Consensus       489 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~sDV~S~Gvvl~el~t  561 (642)
                            ...+||+|||+++.+....             ......||+.|+|||++.. ...++.++||||||||+|||+|
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s-------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES-------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc-------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                  3458999999997653221             1123468899999998643 2458899999999999999999


Q ss_pred             CCCCCCCCCCCcccHHHHHHHHHhccCCCc-cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          562 GRLPDAGPENDGKGLESLVRKAFRERRPLS-EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       562 G~~P~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      |+.||....    ....++...... ..++ ...+             ..+.+|+..||+.+|.+||++.|++.
T Consensus       239 Gk~PF~~~~----~~~qli~~lk~~-p~lpi~~~S-------------~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        239 GKTPFHKAN----NFSQLISELKRG-PDLPIKGKS-------------KELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCCcCC----cHHHHHHHHhcC-CCCCcCCCC-------------HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999997432    223333322221 1111 1111             23556888899999999999999983

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-36  Score=314.97  Aligned_cols=251  Identities=20%  Similarity=0.277  Sum_probs=187.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeC------Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  419 (642)
                      ...||+|+||.||++....++     +.||||++..... ....+.+.+|+.++++++||||+++++++...      ..
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             heecccCCCeEEEEEEECCCC-----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            367999999999999987665     7899999875422 22336678999999999999999999988643      35


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++++|++ +++|.+++...      .+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        95 ~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             EEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence            68999988 77999887532      38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++.....               .....||..|+|||++.....++.++||||+||++|||++|+.||.+...     ...
T Consensus       165 ~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~  224 (343)
T cd07878         165 ARQADDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQ  224 (343)
T ss_pred             ceecCCC---------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            8764322               11335788899999865545789999999999999999999999975321     111


Q ss_pred             HHHHHhc-cCCCccc---cCh----------------hhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRE-RRPLSEV---IDP----------------ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~-~~~~~~~---~d~----------------~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +...... ..+..+.   +..                .+.....  .....+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFR--GANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhcc--CCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111110 0000000   000                0000000  00123568999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7e-36  Score=302.87  Aligned_cols=244  Identities=21%  Similarity=0.239  Sum_probs=184.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHh---cccCCCeeeEEEEEEeCCceEEE
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIA---RVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~---~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      +||+|+||.||++.....+     +.+|+|.+.....  ......+.+|..++.   ..+||||+.+++++...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCC-----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            4899999999999987654     7999998875422  111133445554443   34799999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+|++|||++...
T Consensus        76 ~e~~~~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            99999999999987543     48999999999999999999999   89999999999999999999999999998654


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....              .....|+..|+|||....+..++.++||||+||++|||+||+.||......  .........
T Consensus       148 ~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~  211 (279)
T cd05633         148 SKKK--------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMT  211 (279)
T ss_pred             cccC--------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--CHHHHHHHh
Confidence            3211              112357888999998654456899999999999999999999999753322  111111111


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ......+.+.+++             ++.+++.+||+.||++||     +++|+++
T Consensus       212 ~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         212 LTVNVELPDSFSP-------------ELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             hcCCcCCccccCH-------------HHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            1111122222222             344577889999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-37  Score=283.37  Aligned_cols=254  Identities=22%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             ccHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEE
Q 006522          337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYY  415 (642)
Q Consensus       337 ~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~  415 (642)
                      .++.|+.  .-..+|.|..|.|++......+     +.+|||.+......+..++++..+.++.+-+ .|.||+.+|||.
T Consensus        89 ~dindl~--~l~dlGsGtcG~V~k~~~rs~~-----~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   89 ADINDLE--NLGDLGSGTCGQVWKMRFRSTG-----HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             cChHHhh--hHHhhcCCCccceEEEEEcccc-----eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3555553  3456899999999999998876     8999999998876666788999999887774 899999999999


Q ss_pred             eCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      .+...++.||.|.. .+..+++.-.    .++++...-++...+.+||.||.+.  .+|+|||+||+|||+|+.|.+|+|
T Consensus       162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEee
Confidence            99999999999854 6666665543    2588888889999999999999874  689999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG  573 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~  573 (642)
                      |||++-.+.++..             ....+|.+.|||||.+.-  ...|+.++|||||||.++||+||+.||.+...+-
T Consensus       235 DFGIsGrlvdSkA-------------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF  301 (391)
T KOG0983|consen  235 DFGISGRLVDSKA-------------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF  301 (391)
T ss_pred             cccccceeecccc-------------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH
Confidence            9999977654421             113567888999997543  2468999999999999999999999998755443


Q ss_pred             ccHHHHHHHHHhccCC-Ccc--ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          574 KGLESLVRKAFRERRP-LSE--VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       574 ~~l~~~~~~~~~~~~~-~~~--~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..    +.+...+.+| ++.  -++|             .+.++...|+..|+.+||...++++
T Consensus       302 e~----ltkvln~ePP~L~~~~gFSp-------------~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  302 EV----LTKVLNEEPPLLPGHMGFSP-------------DFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HH----HHHHHhcCCCCCCcccCcCH-------------HHHHHHHHHhhcCcccCcchHHHhc
Confidence            22    2333333222 111  1333             3445777799999999999988875

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=315.64  Aligned_cols=199  Identities=22%  Similarity=0.311  Sum_probs=167.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+++....+     +.||+|.+.+..  .....+.|.+|+.++..++|+||+++++++...+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTG-----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            467999999999999988765     899999987531  1222366889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            99999999999975432    38899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .....           ......||+.|+|||++..    ...++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         154 ADGTV-----------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCCc-----------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            32110           1112468899999998542    24578899999999999999999999974

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=306.30  Aligned_cols=262  Identities=17%  Similarity=0.235  Sum_probs=192.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....++     +.||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTG-----QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCC-----cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            467999999999999987654     789999987643332235677899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +.+ +|.+++.....    .+++.....++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++.....
T Consensus        85 ~~~-~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LDT-DLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CCC-CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            985 99999876542    48999999999999999999999   89999999999999999999999999998653211


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..         .   .....++..|+|||+......++.++||||+||++|||++|+.||.........+....+ ....
T Consensus       157 ~~---------~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~  223 (291)
T cd07844         157 SK---------T---YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR-VLGT  223 (291)
T ss_pred             Cc---------c---ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-hcCC
Confidence            10         0   011235677999998655456889999999999999999999999754321111111111 0000


Q ss_pred             cCC--------C--------ccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRP--------L--------SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--------~--------~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+        .        .......+............+.+++.+|++.+|++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000        0        00000111000000111245678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-35  Score=298.77  Aligned_cols=250  Identities=22%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--------ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--------WRFKDFESEVEAIARVQHPNIVRLKAFYYAND  418 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~  418 (642)
                      ...||+|++|.||+|.....+     +.+|+|.+......        ...+.+.+|+.++++++||||+++++++...+
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSG-----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD   79 (267)
T ss_pred             cceeecCCCeEEEEEEecCCC-----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence            457999999999999986654     78999988654221        12256889999999999999999999999999


Q ss_pred             ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          419 EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      ..++||||+++++|.+++....     .+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccC
Confidence            9999999999999999997643     38899999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES  578 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~  578 (642)
                      .++..........      .........|+..|+|||.+. +..++.++||||+||++|||+||+.||.....    ...
T Consensus       152 ~~~~~~~~~~~~~------~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~  220 (267)
T cd06628         152 ISKKLEANSLSTK------TNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQA  220 (267)
T ss_pred             CCcccccccccCC------ccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HHH
Confidence            9987653211100      000111335778899999854 46788999999999999999999999975321    111


Q ss_pred             HHHHHHhc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          579 LVRKAFRE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       579 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                       +...... .......++             ..+.+++.+||+.||++||++.|+++
T Consensus       221 -~~~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         221 -IFKIGENASPEIPSNIS-------------SEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -HHHHhccCCCcCCcccC-------------HHHHHHHHHHccCCchhCcCHHHHhh
Confidence             1111111 111111111             23456888899999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5e-36  Score=303.72  Aligned_cols=244  Identities=23%  Similarity=0.388  Sum_probs=192.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|....++     ..||+|.+.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCC-----eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            356899999999999887654     789999987554334447899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.+|++|||+++.....
T Consensus        84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          84 LGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            9999999998642      38899999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|+..|+|||++. +..++.++|||||||++|||+||+.|+......     .........
T Consensus       155 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~~  216 (277)
T cd06642         155 QI------------KRNTFVGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFLIPKN  216 (277)
T ss_pred             ch------------hhhcccCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhhhhcC
Confidence            10            011234677899999854 467899999999999999999999998643211     111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..       +.+..     .....+.+++.+||+.+|++||+|.|+++
T Consensus       217 ~~-------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 SP-------PTLEG-----QYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CC-------CCCCc-----ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            11       11111     11234567889999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-36  Score=315.53  Aligned_cols=187  Identities=22%  Similarity=0.317  Sum_probs=157.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||+|......     ..||+|....       .....|+.++++++|||||++++++...+..++|||
T Consensus        70 ~~~~lg~G~~g~Vy~~~~~~~~-----~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         70 VIKTLTPGSEGRVFVATKPGQP-----DPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             EEEEecCCCCeEEEEEEECCCC-----ceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3568999999999999987664     7899997543       223569999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+. |+|.+++....    ..++|..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       138 ~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        138 HYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             ccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            995 69999887543    248999999999999999999999   8999999999999999999999999999875322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCC
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD  566 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~  566 (642)
                      ..             ......||..|+|||++.. ..++.++|||||||++|||+++..|+
T Consensus       210 ~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 AP-------------AFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             Cc-------------ccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11             0113457889999998554 67899999999999999999966554

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-36  Score=318.16  Aligned_cols=208  Identities=21%  Similarity=0.311  Sum_probs=169.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++.....+     +.||+|.+....  .......+.+|+.++.+++||||+++++++...+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTG-----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            467999999999999987765     899999997532  2223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            9999999999997643     38899999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCccccccee-----------------------eecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh
Q 006522          505 GTSKVTKNETI-----------------------VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT  561 (642)
Q Consensus       505 ~~~~~~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t  561 (642)
                      ...........                       ..........+||+.|+|||++. +..++.++|||||||++|||+|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeeccc
Confidence            22110000000                       00000111347999999999854 4778999999999999999999


Q ss_pred             CCCCCCC
Q 006522          562 GRLPDAG  568 (642)
Q Consensus       562 G~~P~~~  568 (642)
                      |+.||..
T Consensus       232 G~~Pf~~  238 (360)
T cd05627         232 GYPPFCS  238 (360)
T ss_pred             CCCCCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.7e-36  Score=301.55  Aligned_cols=249  Identities=20%  Similarity=0.304  Sum_probs=191.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     +.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        14 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645          14 IQRIGSGTYGDVYKARNVNTG-----ELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHhCCCCCeEEEEEEEcCCC-----cEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            467999999999999987665     7899999876432 2235688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...+     .+++.+...++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          88 CGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999987543     38999999999999999999999   89999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARI--YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..            ......|+..|+|||++.  ....++.++||||+||++|||++|+.||......    ..... ..
T Consensus       160 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~~~~-~~  222 (267)
T cd06645         160 IA------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALFL-MT  222 (267)
T ss_pred             cc------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hhHHh-hh
Confidence            10            011345788899999853  2345789999999999999999999998643211    11111 11


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..... .......    .   .....+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~-~~~~~~~----~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         223 KSNFQ-PPKLKDK----M---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccCCC-CCccccc----C---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11110 1111000    0   00123557899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=303.90  Aligned_cols=245  Identities=18%  Similarity=0.232  Sum_probs=201.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|.|.+|-.++..-.+     ..||||++.+..- ......+.+|+..|+-++|||||++|++.......|||+|
T Consensus        23 ekTlG~GHFAVVKLArHVFTG-----ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   23 EKTLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             hhhhcCCceehhhhhhhhccc-----ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            357999999999999887665     8999999988632 2223678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee-CCCCCeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL-DDELHPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DfGla~~~~  504 (642)
                      .-.+|+|+++|.++..    .+.+....+++.||+.|+.|+|.   ..+|||||||+||.+ ..-|-+|+.|||++-.+.
T Consensus        98 LGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             ecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            9999999999988765    39999999999999999999999   789999999999876 567899999999986654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..             ......+|+..|.|||++++.....++.||||+|||||-|++|+.||..+...+ .    +..+.
T Consensus       171 PG-------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-T----LTmIm  232 (864)
T KOG4717|consen  171 PG-------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-T----LTMIM  232 (864)
T ss_pred             Cc-------------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-h----hhhhh
Confidence            33             223367899999999998775555689999999999999999999998654322 2    22233


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .-.+.++..++.+.             -+++..++..||++|-+.+||+.
T Consensus       233 DCKYtvPshvS~eC-------------rdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 DCKYTVPSHVSKEC-------------RDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccccCchhhhHHH-------------HHHHHHHHhcCchhhccHHHHhc
Confidence            44455555555444             34777799999999999999874

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.5e-36  Score=325.59  Aligned_cols=255  Identities=16%  Similarity=0.215  Sum_probs=184.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCC------CeeeEEEEEEeC-Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHP------NIVRLKAFYYAN-DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~-~~  419 (642)
                      ...||+|+||.||+++....+     +.||||+++....  ..+++..|++++.+++|.      +++++++++... ..
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRK-----EYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCC-----eEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            468999999999999987664     8899999975322  125567788888877654      589999998865 46


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC---------
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL---------  490 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---------  490 (642)
                      .++|||++ +++|.+++...+     .+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++         
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccc
Confidence            78999988 779999987643     489999999999999999999972  3899999999999998765         


Q ss_pred             -------CeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCC
Q 006522          491 -------HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR  563 (642)
Q Consensus       491 -------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~  563 (642)
                             .+||+|||.+......               ....+||+.|+|||++. +..++.++|||||||++|||+||+
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~~~---------------~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDERHS---------------RTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             ccCCCCceEEECCCCccccCccc---------------cccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCC
Confidence                   4999999987542211               12457889999999955 478999999999999999999999


Q ss_pred             CCCCCCCCCcccHHHHHHHHHh--------------------ccCCCccccChhhhhch------hHHHHHHHHHHHHHh
Q 006522          564 LPDAGPENDGKGLESLVRKAFR--------------------ERRPLSEVIDPALVKEI------HAKRQVLATFHIALN  617 (642)
Q Consensus       564 ~P~~~~~~~~~~l~~~~~~~~~--------------------~~~~~~~~~d~~l~~~~------~~~~~~~~~~~l~~~  617 (642)
                      .||++....  .....+.....                    ....+....++......      ........+.+|+.+
T Consensus       343 ~pf~~~~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        343 LLYDTHDNL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCChH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            999754321  11111111100                    00000011111110000      000112356789999


Q ss_pred             cCCCCCCCCCCHHHHHH
Q 006522          618 CTELDPEFRPRMRTVSE  634 (642)
Q Consensus       618 Cl~~dP~~RPs~~ev~~  634 (642)
                      ||+.||++|||++|+++
T Consensus       421 mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        421 LLHYDRQKRLNARQMTT  437 (467)
T ss_pred             hCCcChhhCCCHHHHhc
Confidence            99999999999999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-36  Score=315.59  Aligned_cols=199  Identities=22%  Similarity=0.306  Sum_probs=167.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     +.+|+|.+.+..  .......|.+|+.++..++|+||+++++++...+..++||
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            467999999999999987765     789999986431  1222355889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.++++....    .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ey~~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            99999999999976432    48999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      ....           .......||+.|+|||++..    ...++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         154 EDGT-----------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             cCCc-----------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            2211           01113468999999998542    34678999999999999999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-35  Score=298.15  Aligned_cols=261  Identities=21%  Similarity=0.425  Sum_probs=194.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      .+.||+|+||.||+|......+.  .+.||||++.... .....+++.+|++++++++||||+++++++....      .
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGS--FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCC--ceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45799999999999987653221  2789999987542 2333477899999999999999999999887542      2


Q ss_pred             eEEEEeeccCCcHHHHHhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPS-DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      .++++||+++|+|.+++..... .....+++.....++.|++.||+|||+   .+|+||||||+||++++++.+|++|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence            4789999999999988754321 112248899999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~  577 (642)
                      +++.........          ......++..|++||... ...++.++|||||||++|||++ |+.||.....     .
T Consensus       159 ~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~  222 (273)
T cd05074         159 LSKKIYSGDYYR----------QGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----S  222 (273)
T ss_pred             ccccccCCccee----------cCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----H
Confidence            988654321100          001223456799999854 4678899999999999999999 8888864321     1


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ........... ..  ..+         .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus       223 ~~~~~~~~~~~-~~--~~~---------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         223 EIYNYLIKGNR-LK--QPP---------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             HHHHHHHcCCc-CC--CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            22221111111 11  001         01135667999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.1e-37  Score=289.28  Aligned_cols=275  Identities=19%  Similarity=0.244  Sum_probs=203.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEe-CCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYA-NDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~  424 (642)
                      ...||+|.||.||++...++.+.. .+.+|+|+++...+... -....||+.+++.++|||||.+...+.+ +...++++
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f  107 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF  107 (438)
T ss_pred             cceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence            457999999999999877664321 25899999987633322 2667899999999999999999999988 66789999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC----CCeEEeccccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE----LHPCISGFGLN  500 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DfGla  500 (642)
                      ||.+. ||.+.|+-++......++-.....|+.||+.|+.|||+   +-|+||||||.|||+..+    |.+||+|||++
T Consensus       108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            99998 99999987765544578999999999999999999999   789999999999999776    99999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc----cH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK----GL  576 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~----~l  576 (642)
                      +.+.......         .....++.|.+|+|||.+++...||.+.||||.|||..||+|-++-|.+.+..-.    .-
T Consensus       184 R~~~~plkpl---------~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  184 RLFNNPLKPL---------ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             HHhhcccccc---------ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            9876543211         1122456688999999988888899999999999999999999888876433211    11


Q ss_pred             HHHHHHHHhccCCCccccChhhhh------chhH-------------HH-----HHHHHHHHHHhcCCCCCCCCCCHHHH
Q 006522          577 ESLVRKAFRERRPLSEVIDPALVK------EIHA-------------KR-----QVLATFHIALNCTELDPEFRPRMRTV  632 (642)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~------~~~~-------------~~-----~~~~~~~l~~~Cl~~dP~~RPs~~ev  632 (642)
                      ...+.+++.--..-.+...|.+.+      .+..             --     .....+++..+++..||.+|.|+.++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence            122222222111101111111111      0000             00     01236789999999999999999998


Q ss_pred             HHH
Q 006522          633 SES  635 (642)
Q Consensus       633 ~~~  635 (642)
                      ++.
T Consensus       335 leh  337 (438)
T KOG0666|consen  335 LEH  337 (438)
T ss_pred             hcc
Confidence            763

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-35  Score=299.76  Aligned_cols=245  Identities=22%  Similarity=0.376  Sum_probs=194.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.....+     ..||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCC-----EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            356999999999999987654     899999987654334457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++...      ++++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++++|||++......
T Consensus        84 ~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          84 LGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            9999999998642      38889999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||++. +..++.++|||||||++|||+||+.||......     .........
T Consensus       155 ~~------------~~~~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~~~  216 (277)
T cd06640         155 QI------------KRNTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFLIPKN  216 (277)
T ss_pred             cc------------ccccccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhhhhcC
Confidence            10            011234677899999854 467899999999999999999999998753221     111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..       +.+.     ......+.+++.+||+.+|++||++.|++..
T Consensus       217 ~~-------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NP-------PTLT-----GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CC-------CCCc-----hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11       1111     1122346678999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-35  Score=301.29  Aligned_cols=248  Identities=20%  Similarity=0.304  Sum_probs=191.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.....+     +.+++|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hheecCCCCeEEEEEEECCCC-----ceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            456999999999999987765     789999987643 23347789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|..++.....    .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        91 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          91 CPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             CCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            999999988865432    48999999999999999999999   89999999999999999999999999988653221


Q ss_pred             CcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..            ......++..|+|||++..    ...++.++|||||||++|||+||+.||.....     ......
T Consensus       164 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~  226 (292)
T cd06644         164 LQ------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLK  226 (292)
T ss_pred             cc------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHH
Confidence            10            0112346778999998542    24468899999999999999999999864221     122222


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+  ....+.        ....++.+++.+||+.+|++||++.|+++
T Consensus       227 ~~~~~~~--~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 IAKSEPP--TLSQPS--------KWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HhcCCCc--cCCCCc--------ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            2221111  111110        11124567889999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=299.00  Aligned_cols=245  Identities=22%  Similarity=0.340  Sum_probs=194.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||.|++|.||++....++     ..|++|.+...........+.+|++++++++|+||+++++++......++|+||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTN-----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCC-----eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            356899999999999987654     899999987654344446789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      ++++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            9999999999754      48999999999999999999999   89999999999999999999999999999876533


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||++.. ..++.++|||||||++|||+||+.||.....     ..........
T Consensus       152 ~~------------~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~  213 (274)
T cd06609         152 MS------------KRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLIPKN  213 (274)
T ss_pred             cc------------ccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHhhhc
Confidence            10            0113356778999998554 5689999999999999999999999975321     1111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+  ...+..         ....+.+++.+||..+|++||+++++++
T Consensus       214 ~~~--~~~~~~---------~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 NPP--SLEGNK---------FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCC--CCcccc---------cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111  110000         1123556888899999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-36  Score=303.66  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=187.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcc---cCCCeeeEEEEEEeC-----
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARV---QHPNIVRLKAFYYAN-----  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----  417 (642)
                      ...||+|+||.||++....++     +.||+|.++..... .....+.+|+++++++   +||||+++++++...     
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            356999999999999988765     89999998754221 1124566788877766   699999999998753     


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      ...++||||+++ +|.+++.....   ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcc
Confidence            357899999975 89998875432   248999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++......             ......||..|+|||++.. ..++.++||||+||++|||++|+.||..... ...+.
T Consensus       153 g~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~  217 (288)
T cd07863         153 GLARIYSCQM-------------ALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLG  217 (288)
T ss_pred             CccccccCcc-------------cCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHH
Confidence            9987653221             0113456788999998544 6789999999999999999999999865322 11122


Q ss_pred             HHHHHHHhc---cCC----C-ccccChhhhhchhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRE---RRP----L-SEVIDPALVKEIHA--KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~---~~~----~-~~~~d~~l~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .........   ..+    . ...+.+........  ......+.+++.+|++.||++|||+.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            221111000   000    0 00000000000000  011234568999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-35  Score=302.90  Aligned_cols=263  Identities=16%  Similarity=0.167  Sum_probs=190.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|.....+     ..|++|++...........+.+|++++++++|+||+++++++...+..++||||
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870          10 LEKLGEGSYATVYKGISRING-----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCC-----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            357999999999999987654     789999987653333335678999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +. +++.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          85 MH-TDLAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             cc-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            96 688777754332    37888899999999999999999   79999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH--
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF--  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~--  584 (642)
                      ..            ......++..|+|||.+.....++.++|||||||++|||+||+.||.........+...+....  
T Consensus       157 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         157 SQ------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             CC------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence            11            0112345778999998654456788999999999999999999999754321111111110000  


Q ss_pred             ---------hccCCCcccc----ChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 ---------RERRPLSEVI----DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ---------~~~~~~~~~~----d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                               .......+..    .+.+............+.+++.+|++.||++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                     0000000000    0000000000011235667899999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-35  Score=302.66  Aligned_cols=242  Identities=17%  Similarity=0.281  Sum_probs=191.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||.|++|.||++.....+     +.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATG-----QEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCC-----cEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            357999999999999876654     7899999875432 2347789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          98 LAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             cCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999998642      38999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||.+. +..++.++|||||||++|||+||+.||......    .. .......
T Consensus       169 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~-~~~~~~~  230 (296)
T cd06655         169 QS------------KRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RA-LYLIATN  230 (296)
T ss_pred             cc------------cCCCcCCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH-HHHHHhc
Confidence            11            011235777899999854 467889999999999999999999999753221    11 1111111


Q ss_pred             cC-C--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RR-P--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~-~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. .  ....++             ..+.+++.+||..||++||++.+++.
T Consensus       231 ~~~~~~~~~~~~-------------~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 GTPELQNPEKLS-------------PIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCcccCC-------------HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11 1  011111             13456888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6e-36  Score=304.26  Aligned_cols=262  Identities=15%  Similarity=0.181  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||+|.....+     +.||+|+++.... ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g-----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             EEEecccCCeEEEEEEECCCC-----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            356899999999999987664     7899999875422 2223567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++ ++|.+++.....    .+++..+..++.||++||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          80 YCD-QDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             cCC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            997 588888765432    48999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......++..|+|||++.....++.++|||||||++|||+||..|+.........+....+ ...
T Consensus       152 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~  218 (284)
T cd07839         152 PVR------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLG  218 (284)
T ss_pred             CCC------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH-HhC
Confidence            210            0112345778999998655455789999999999999999999997543221111111111 000


Q ss_pred             cc-----------CC--CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ER-----------RP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~-----------~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..           ..  ....................++.+++.+||+.||.+|||+.|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00           00  000000000000000011235567999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-35  Score=302.08  Aligned_cols=250  Identities=20%  Similarity=0.340  Sum_probs=192.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     +.||+|.++.........++.+|+.++.+++||||+++++++...+..++||||
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTG-----VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            467999999999999987554     789999887543333347899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++.....  ...+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            999999999876421  12589999999999999999999962  48999999999999999999999999998765322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-----SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .              .....++..|+|||.+...     ..++.++|||||||++|||+||+.||.....  ........
T Consensus       157 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~  220 (286)
T cd06622         157 L--------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLS  220 (286)
T ss_pred             c--------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHH
Confidence            1              1123467789999985332     2358899999999999999999999965322  11122222


Q ss_pred             HHHhcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...... ..+...++             ..+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         221 AIVDGDPPTLPSGYS-------------DDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHhhcCCCCCCcccC-------------HHHHHHHHHHcccCcccCCCHHHHhc
Confidence            222111 11111122             23456888899999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=332.48  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=207.7

Q ss_pred             cccccCccCCceeEEEEecCCCCC--CCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGM--GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ..+.+|+|.||.|++|....-...  .....||||.++........+.+..|+++|..+ +|+|||.++|+|..++..++
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~  379 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV  379 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence            445999999999999987644322  235789999999875556668999999999999 79999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC
Q 006522          423 ISDFIRNGSLYAALHAGP---------SDSL--PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH  491 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  491 (642)
                      |+||++.|+|.++++..+         ....  ..++....+.++.|||.||+||++   .+++||||..+|||+.++..
T Consensus       380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCE
Confidence            999999999999998876         1111  138899999999999999999999   89999999999999999999


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPE  570 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~  570 (642)
                      +||+|||+++.......+.....   .     . .-...|||||.+.. ..|+.|+|||||||+||||+| |..||.+..
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~---~-----~-~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSS---A-----G-TLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             EEEccccceeccCCCCceEecCC---C-----C-ccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999997654433221100   0     0 02345999999655 889999999999999999999 999997622


Q ss_pred             CCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          571 NDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       571 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      . ...+.++++...+...  ++.             +..+++++|..||+.+|++||++.|+++.++.+
T Consensus       527 ~-~~~l~~~l~~G~r~~~--P~~-------------c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 P-TEELLEFLKEGNRMEQ--PEH-------------CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             c-HHHHHHHHhcCCCCCC--CCC-------------CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1 1122223333222222  122             234566799999999999999999999999874

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-35  Score=298.48  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=191.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-----cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-----TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      ...||+|+||.||+|....+      ..+|+|.+.....     ....+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~------~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQG------QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             cceEeccCCeEEEEEEEcCC------CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence            46799999999999987654      7899998865321     122356889999999999999999999999999999


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +||||+++++|.+++....     ++++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++
T Consensus        79 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          79 IFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            9999999999999997643     38899999999999999999999   789999999999999999999999999987


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ..........      .........|+..|+|||++. +..++.++|||||||++|||+||+.||.....    ......
T Consensus       151 ~~~~~~~~~~------~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~  219 (265)
T cd06631         151 RLAWVGLHGT------HSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFY  219 (265)
T ss_pred             hhhhcccccc------ccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHH
Confidence            6532111000      000112345788899999854 46788999999999999999999999974322    111111


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                       ....... ...+...         ....+.+++.+||+.+|++||++.|+++
T Consensus       220 -~~~~~~~-~~~~~~~---------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 -IGAHRGL-MPRLPDS---------FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -hhhccCC-CCCCCCC---------CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1111111 1111111         1123566888999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-35  Score=297.49  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=186.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc----cccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--Cce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA----TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  420 (642)
                      ...||+|+||.||++.....+     +.|++|++.....    ....+.+.+|+.++++++||||+++++++...  ...
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTG-----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCC-----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            468999999999999987654     7899998864321    12336788999999999999999999998763  567


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++++||+++++|.+++....     .+++.....++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            89999999999999997543     38899999999999999999998   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +........         ........++..|+|||++. +..++.++|||||||++|||+||+.||.....    ... +
T Consensus       154 ~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~-~  218 (266)
T cd06651         154 KRLQTICMS---------GTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAA-I  218 (266)
T ss_pred             ccccccccc---------CCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHH-H
Confidence            765321100         00111335778899999854 46789999999999999999999999974321    111 1


Q ss_pred             HHHHhcc--CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRER--RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .......  ..++..+++             .+.++ ++||..+|++||+++||++
T Consensus       219 ~~~~~~~~~~~~~~~~~~-------------~~~~l-i~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         219 FKIATQPTNPQLPSHISE-------------HARDF-LGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHhcCCCCCCCchhcCH-------------HHHHH-HHHhcCChhhCcCHHHHhc
Confidence            1111111  111111111             11223 3688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-35  Score=299.58  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=193.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++.....+     +.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             eeeecccCCeEEEEEEECCCC-----cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            357899999999999987654     8899999865422 2223668899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++++.|..++....     .++|..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            999988888765432     38999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......++..|+|||++.....++.++|||||||++|||+||+.||.+....+ .+.. ......
T Consensus       153 ~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~-~~~~~~  218 (286)
T cd07847         153 PGD------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYL-IRKTLG  218 (286)
T ss_pred             Ccc------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhC
Confidence            211            01123456779999986554567899999999999999999999997543211 1111 111110


Q ss_pred             cc----------CCC-ccccChhhh--hchh--HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ER----------RPL-SEVIDPALV--KEIH--AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~----------~~~-~~~~d~~l~--~~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..          ... .....+...  ....  .......+.+++.+||+.+|++||++.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00          000 000000000  0000  0011245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-35  Score=294.53  Aligned_cols=246  Identities=21%  Similarity=0.325  Sum_probs=192.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-ceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~  424 (642)
                      .+.||+|++|.||++....++     +.|++|.+..... ....+.+.+|++++++++|+||+++++.+...+ ..++||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDG-----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCC-----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            467899999999999987765     7899999875422 233467889999999999999999999886544 578999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++.....   ..+++.++..++.|++.|++|||+   .+++||||||+||+++.++.++|+|||+++...
T Consensus        80 e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             cccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            99999999999976432   248999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......+++.|+|||++.. ..++.++||||+||++|||+||+.||....     .........
T Consensus       154 ~~~~------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~  215 (257)
T cd08223         154 NQCD------------MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRII  215 (257)
T ss_pred             ccCC------------ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHH
Confidence            2210            1113456788999998544 678899999999999999999999987422     223333222


Q ss_pred             hccC-CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .... .....++             ..+.+++.+||+.+|++||++.|+++
T Consensus       216 ~~~~~~~~~~~~-------------~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         216 EGKLPPMPKDYS-------------PELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             hcCCCCCccccC-------------HHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2221 1111122             24567888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-36  Score=301.09  Aligned_cols=252  Identities=26%  Similarity=0.405  Sum_probs=196.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++.....+     +.+|+|.+........ .....+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNG-----QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTT-----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             eEEEEeCCCEEEEEEEECCCC-----eEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            468999999999999998876     7999999987644322 1334569999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++....     .+++..+..++.|+++||+|||+   .+++||||||+||++++++.++|+|||.+.....
T Consensus        79 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             ccccccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999999999998322     48999999999999999999999   8999999999999999999999999999875411


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..            .......++..|+|||+...+..++.++||||+|+++|+|++|..||...  ..............
T Consensus       151 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~~  216 (260)
T PF00069_consen  151 NN------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKILK  216 (260)
T ss_dssp             TT------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHHH
T ss_pred             cc------------cccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhccc
Confidence            10            11124467888999998553578899999999999999999999999754  11112222222211


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....      ....   ........+.+++.+||+.||++||++.++++
T Consensus       217 ~~~~------~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  217 RPLP------SSSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             THHH------HHTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccc------cccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1100      0000   00000146778999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.6e-36  Score=305.61  Aligned_cols=246  Identities=20%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..||||.+..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTG-----KQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCC-----CEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            356899999999999887654     7899999865432 2346789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||++......
T Consensus       101 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658         101 LEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            9999999988542      38899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|+..|+|||... +..++.++|||||||++|||++|+.||.....     ..........
T Consensus       172 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~  233 (292)
T cd06658         172 VP------------KRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQAMRRIRDN  233 (292)
T ss_pred             cc------------cCceeecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc
Confidence            10            011235778899999854 46789999999999999999999999974321     1111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..+  ...+..        .....+.+++.+||..||++|||+.|+++.
T Consensus       234 ~~~--~~~~~~--------~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 LPP--RVKDSH--------KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCC--cccccc--------ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  000000        011234457888999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-35  Score=294.65  Aligned_cols=243  Identities=23%  Similarity=0.375  Sum_probs=188.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ....||+|+||.||++... +      +.||+|.++....   .+.+.+|+.++++++||||+++++++... ..++|||
T Consensus        10 ~~~~lg~g~~g~v~~~~~~-~------~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEYT-G------QKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             eeeeeccCCCCceEecccC-C------CceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            3578999999999998643 2      6799999865322   26789999999999999999999998654 5799999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        79 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          79 LMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             CCCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999976543   248999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               .....+..|+|||++. +..++.++|||||||++|||++ |+.||.....     ........
T Consensus       153 ~~---------------~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~  211 (254)
T cd05083         153 GV---------------DNSKLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVE  211 (254)
T ss_pred             cC---------------CCCCCCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHh
Confidence            10               0112345699999854 4678999999999999999998 9999864321     22222221


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .. .. .+. .+.         ....+.+++.+||+.+|++||++.++++.|++
T Consensus       212 ~~-~~-~~~-~~~---------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         212 KG-YR-MEP-PEG---------CPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CC-CC-CCC-CCc---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            11 11 110 000         11245578899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=299.94  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=194.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc---CCCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ---HPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .+.||+|+||.||+|.....+     +.|++|.+.........+++.+|+.++++++   ||||+++++++......++|
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTG-----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhheeccCCceEEEEEEcCCC-----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            357999999999999986654     7999999876544444577899999999997   99999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++++|.++++..      .+++.....++.|++.||.|||+   .+|+||||+|+||++++++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          81 MEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            9999999999998653      38999999999999999999999   89999999999999999999999999998766


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....            ......|+..|+|||.+..+..++.++|||||||++|||++|+.||.....     .......
T Consensus       152 ~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~~  214 (277)
T cd06917         152 NQNSS------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMMLI  214 (277)
T ss_pred             CCCcc------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhcc
Confidence            43310            011235778899999865555678999999999999999999999975322     1111111


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .... +      +.+...    .....+.+++.+||+.||++||++.|+++
T Consensus       215 ~~~~-~------~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 PKSK-P------PRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccCC-C------CCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1110 0      111110    01234667889999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.8e-36  Score=304.92  Aligned_cols=244  Identities=19%  Similarity=0.278  Sum_probs=190.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ..||+|+||.||++.....+     +.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSG-----RQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCC-----CEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            36899999999999987654     78999998654332 3367889999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++...      .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus       101 ~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         101 QGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             CCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999987542      38899999999999999999999   899999999999999999999999999987543221


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            ......|+..|+|||++. +..++.++|||||||++|||++|+.||.....     ...........
T Consensus       172 ~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~  233 (297)
T cd06659         172 P------------KRKSLVGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDSP  233 (297)
T ss_pred             c------------cccceecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhccC
Confidence            0            111345778899999854 46789999999999999999999999974321     11112111111


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+... ..+.         ....+.+++.+||+.+|++||++.|+++
T Consensus       234 ~~~~~-~~~~---------~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         234 PPKLK-NAHK---------ISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCcc-ccCC---------CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            11000 0000         0123456888999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-35  Score=301.07  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=189.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEe-----CCce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYA-----NDEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~~  420 (642)
                      ...||+|+||.||++.....+     +.+|+|.+......  ..++.+|+.+++++ +||||+++++++..     .+..
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNG-----SKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCC-----ceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            367999999999999987765     78999987653222  26788999999999 79999999998853     3468


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+++|+|.++++..... ...+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCce
Confidence            9999999999999988643211 1348899999999999999999999   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      +.......            ......|+..|+|||++..    ...++.++||||+||++|||+||+.||.....    .
T Consensus       172 ~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~----~  235 (286)
T cd06638         172 AQLTSTRL------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP----M  235 (286)
T ss_pred             eecccCCC------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch----h
Confidence            76532210            1113457888999998542    24478899999999999999999999875321    1


Q ss_pred             HHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..+.. ......  ....++..        ....+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~-~~~~~~--~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 RALFK-IPRNPP--PTLHQPEL--------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHhh-ccccCC--CcccCCCC--------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11111 111111  11112211        11245678999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=300.38  Aligned_cols=248  Identities=20%  Similarity=0.309  Sum_probs=192.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++.....+     ..+|+|.+..... ...+.|.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611          10 IGELGDGAFGKVYKAQHKETG-----LFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             HHHhcCCCCceEEEEEEcCCC-----cEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356899999999999987654     7899999875432 2347899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++.....    .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          84 CDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             cCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            999999999876432    48999999999999999999999   89999999999999999999999999988654322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..            ......++..|+|||.+..    ...++.++|||||||++|||++|+.||.....     ......
T Consensus       157 ~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~~~~  219 (280)
T cd06611         157 LQ------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRVLLK  219 (280)
T ss_pred             cc------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHHHHH
Confidence            10            1113357788999998542    24467899999999999999999999975321     122222


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+  ....+.        .....+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~--~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         220 ILKSEPP--TLDQPS--------KWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HhcCCCC--CcCCcc--------cCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            2222111  000010        01123556888999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.2e-36  Score=312.95  Aligned_cols=199  Identities=22%  Similarity=0.295  Sum_probs=167.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||+++....+     +.||+|.+.+..  .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTE-----RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            467999999999999987765     789999986531  1222356888999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....    .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999976432    48899999999999999999999   899999999999999999999999999997654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG----SKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .....           ......||+.|+|||++...    ..++.++|||||||++|||+||+.||..
T Consensus       154 ~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         154 QDGTV-----------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCce-----------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            32110           01134688999999985431    3578899999999999999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-35  Score=293.00  Aligned_cols=248  Identities=21%  Similarity=0.280  Sum_probs=196.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .++||+|+||.||.+.....+     ..+++|.+.... .....+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDD-----SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             eeEecccCCceEEEEEEcCCC-----cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            468999999999999987765     789999886542 23334778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....   ..+++.++..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          80 YANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             ecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            9999999999976532   248999999999999999999999   7999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......|++.|+|||+.. +..++.++||||||+++|||++|+.||....     ..........
T Consensus       154 ~~~------------~~~~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~~  215 (256)
T cd08221         154 EYS------------MAETVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATN-----PLNLVVKIVQ  215 (256)
T ss_pred             ccc------------cccccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHc
Confidence            311            011345778899999854 3668899999999999999999999986422     2233333332


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ....  . ..+.         ....+.+++.+||+.+|++||++.|+++.
T Consensus       216 ~~~~--~-~~~~---------~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 GNYT--P-VVSV---------YSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCC--C-Cccc---------cCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            2211  1 1110         11235568888999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-35  Score=297.93  Aligned_cols=257  Identities=22%  Similarity=0.290  Sum_probs=194.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~  424 (642)
                      .+.||.|++|.||++.....+     +.+|+|.+.........+++.+|++++++++||||++++++|...  +..++||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTG-----MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             EEEeccCCceEEEEEEECCCC-----eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            467899999999999997654     899999987654433447799999999999999999999998754  3689999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++...... ...+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999987643221 1348899999999999999999999   899999999999999999999999999986543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....              ....++..|+|||... +..++.++||||+||++|||+||+.||...........+......
T Consensus       157 ~~~~--------------~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (287)
T cd06621         157 NSLA--------------GTFTGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV  221 (287)
T ss_pred             cccc--------------ccccCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence            2210              0224566799999854 467899999999999999999999999764321112222222222


Q ss_pred             hccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....+ +.......       ......+.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         222 NMPNPELKDEPGNG-------IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCchhhccCCCCC-------CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            21111 11111000       011234678999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.3e-36  Score=303.94  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=192.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++....++     +.||+|++...... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETG-----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCC-----CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            467999999999999987654     88999998754322 233678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.++.....     .++|..+..++.||++||+|||+   .+++||||+|+||++++++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            999999988776432     38999999999999999999999   8999999999999999999999999999876533


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......++..|+|||+......++.++|||||||++|||+||+.||.....    ...+ .....
T Consensus       153 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~-~~~~~  215 (286)
T cd07846         153 PGE------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQL-YHIIK  215 (286)
T ss_pred             Ccc------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHH-HHHHH
Confidence            211            011234677899999865545678899999999999999999999864321    1111 11110


Q ss_pred             ccCCCc--------------cccChhhhhchh----HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLS--------------EVIDPALVKEIH----AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~--------------~~~d~~l~~~~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....+.              ....+.......    .......+.+++.+||+.+|++||++.|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000              000000000000    0011245778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-35  Score=299.42  Aligned_cols=261  Identities=18%  Similarity=0.259  Sum_probs=191.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++.....+     +.|+||.+..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             eeeecCCCceEEEEEEECCCC-----CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            357899999999999987654     7899999875422 2223578899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+. ++|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        80 ~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          80 FLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             ccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            996 689999876443   248999999999999999999999   8999999999999999999999999999876532


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....++..|+|||++.....++.++|||||||++|||+||+.||..... ........+....
T Consensus       153 ~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~  219 (284)
T cd07860         153 PVRT------------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGT  219 (284)
T ss_pred             Cccc------------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            2100            01224567899999865544568899999999999999999999975322 1111111111100


Q ss_pred             ccC--------------CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERR--------------PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~--------------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...              .........+....  ......+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         220 PDEVVWPGVTSLPDYKPSFPKWARQDFSKVV--PPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CChhhhhhhhHHHHHHhhcccccccCHHHHc--ccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000              00000000000000  001134567999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-35  Score=297.25  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=191.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc---------cccHHHHHHHHHHHhcccCCCeeeEEEEEEeC
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA---------TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~  417 (642)
                      .+.||+|++|.||+|.....+     +.||+|.++....         ....+.+.+|+.++++++||||+++++++...
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   80 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTG-----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE   80 (272)
T ss_pred             cceecccCceEEEEEeecCCC-----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence            467999999999999976654     7899998764211         01125688899999999999999999999999


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      +..++||||+++|+|.++++...     .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeec
Confidence            99999999999999999997653     48999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      |+++........          .......|+..|+|||.+.... .++.++||||||+++||+++|+.||.....    .
T Consensus       153 ~~~~~~~~~~~~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~  218 (272)
T cd06629         153 GISKKSDDIYDN----------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----I  218 (272)
T ss_pred             cccccccccccc----------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----H
Confidence            998764322100          0111345778899999855432 478999999999999999999999964221    1


Q ss_pred             HHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...........   ...+.+.....     ....+.+++.+||+.+|++||++.||++
T Consensus       219 ~~~~~~~~~~~---~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         219 AAMFKLGNKRS---APPIPPDVSMN-----LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHHhhcccc---CCcCCcccccc-----CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            22221111111   11111111111     1234566888999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-35  Score=295.42  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=193.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....++     ..+++|.+.....   .+++.+|++++++++||||+++++++......++++||
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETG-----QVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCC-----cEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            457999999999999988754     7899999875432   47899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++....    ..++|..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++......
T Consensus        80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999997543    248999999999999999999999   89999999999999999999999999998865432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||++. +..++.++|||||||++|||+||+.||.......     ........
T Consensus       153 ~~------------~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~~~~~  214 (256)
T cd06612         153 MA------------KRNTVIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFMIPNK  214 (256)
T ss_pred             cc------------ccccccCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhhhccC
Confidence            10            011234677899999854 4678999999999999999999999997532211     01111000


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..  ...-.+        ......+.+++.+||+.||++|||+.|+++
T Consensus       215 ~~--~~~~~~--------~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PP--PTLSDP--------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CC--CCCCch--------hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00  000000        011134667889999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=311.49  Aligned_cols=247  Identities=20%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ..||.|+||.||++..+..+     ...|-|.+.. ......++|+-||+||+.++||+||++++.|+..+..+++.|||
T Consensus        38 GELGDGAFGKVyKA~nket~-----~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETK-----LLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             hhhcCccchhhhhhhcccch-----hhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45899999999999988763     3445555543 44455689999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      .||-...++-.-+.    +|++.++..+++|++.||.|||+   +.|||||||..|||+.-+|.++++|||.+...... 
T Consensus       112 ~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-  183 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-  183 (1187)
T ss_pred             CCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-
Confidence            99999988876553    59999999999999999999999   89999999999999999999999999987543221 


Q ss_pred             cccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                                 ........|||+|||||+...    ...|+.++||||||++|.||..+.+|...-    ..+..+++..
T Consensus       184 -----------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----npMRVllKia  248 (1187)
T KOG0579|consen  184 -----------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIA  248 (1187)
T ss_pred             -----------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----chHHHHHHHh
Confidence                       112235689999999998443    367999999999999999999999997531    1123333333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+++.   .+-|        ......+-++..+|+..||+.||++.++++
T Consensus       249 KSePPT---LlqP--------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  249 KSEPPT---LLQP--------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hcCCCc---ccCc--------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            233222   2222        234456677889999999999999999875

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-35  Score=302.93  Aligned_cols=245  Identities=19%  Similarity=0.308  Sum_probs=191.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||++.....+     ..||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATG-----QEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCC-----CEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            467999999999999976554     78999998764332 236788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            9999999998642      37899999999999999999999   89999999999999999999999999998765332


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......+++.|+|||... +..++.++|||||||++|+|+||+.||........    ... ....
T Consensus       169 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----~~~-~~~~  230 (297)
T cd06656         169 QS------------KRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYL-IATN  230 (297)
T ss_pred             cc------------CcCcccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----eee-eccC
Confidence            11            011235677899999854 46788999999999999999999999975332111    000 0111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+  ....+.        .....+.+++.+||+.+|++||++.|+++
T Consensus       231 ~~~--~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 GTP--ELQNPE--------RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCC--CCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110  111111        01123456888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.2e-35  Score=297.65  Aligned_cols=257  Identities=18%  Similarity=0.228  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      ...||+|+||.||++.....+     +.||+|+++............+|+.++.++. ||||+++++++.+.  +..++|
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTG-----KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             EeeccccccceEEEEEEcCCC-----cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            356899999999999987654     7899999876432222244567999999995 99999999999987  889999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||++ |+|.+.+.....    .++|..+..++.|++.||+|||+   .+++||||||+||+++. +.+||+|||+++..
T Consensus        79 ~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          79 FELMD-MNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EecCC-ccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            99997 588888875432    48999999999999999999999   89999999999999999 99999999999765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....             .....++..|+|||+...+..++.++||||+||++|||++|+.||.....  ..........
T Consensus       150 ~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~  214 (282)
T cd07831         150 YSKPP-------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDV  214 (282)
T ss_pred             ccCCC-------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHH
Confidence            43211             01234677899999755556678999999999999999999999975322  1111111111


Q ss_pred             Hhc-----------cCC----CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRE-----------RRP----LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~-----------~~~----~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...           ...    .+......+...  .......+.+++.+||+.+|++||++.|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKL--LPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCCCCHHHHHhhcccccccccCcccccccHHHH--cccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            100           000    000000000000  0112356788999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-35  Score=293.48  Aligned_cols=246  Identities=22%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.+|++....++     +.|++|.+.... .....+++.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDG-----KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCC-----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            467999999999999987765     789999986532 22233688999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++.....   ..+++.++..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          80 YCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999999976432   248899999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....|+..|+|||+.. +..++.++|||||||++|||+||+.||...     .....+.....
T Consensus       154 ~~~~------------~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~~  215 (256)
T cd08218         154 TVEL------------ARTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLVLKIIR  215 (256)
T ss_pred             chhh------------hhhccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHHHHHhc
Confidence            2110            11234677899999854 467889999999999999999999998642     12233333332


Q ss_pred             ccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...+ ....+             ...+.+++.+||+.+|++||++.||++
T Consensus       216 ~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         216 GSYPPVSSHY-------------SYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCCCcccC-------------CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2211 11111             123566888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.4e-35  Score=292.33  Aligned_cols=245  Identities=21%  Similarity=0.355  Sum_probs=193.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++.....+     ..+|+|.+.... .....+.+.+|++++++++||||+++++.+...+..++|||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQ-----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             EEEecccCceEEEEEEEcCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            467999999999999987654     889999987542 22334789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC-CCeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~~~  504 (642)
                      |+++++|.+++.....   ..+++..+..++.|++.||+|||+   .+++||||||+||+++++ ..+|++|||.++...
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          80 YAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             cCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            9999999999976542   248999999999999999999999   899999999999999854 468999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....|+..|+|||... +..++.++||||||+++|+|++|+.||.....     ........
T Consensus       154 ~~~~-------------~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~  214 (256)
T cd08220         154 SKSK-------------AYTVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIM  214 (256)
T ss_pred             CCcc-------------ccccccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHH
Confidence            3210             11235677899999854 46788999999999999999999999965322     22232222


Q ss_pred             hcc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ... .++.+.+++             .+.+++.+||+.+|++|||+.|+++
T Consensus       215 ~~~~~~~~~~~~~-------------~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         215 SGTFAPISDRYSP-------------DLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             hcCCCCCCCCcCH-------------HHHHHHHHHccCChhhCCCHHHHhh
Confidence            221 112222222             3456888899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.4e-35  Score=298.86  Aligned_cols=240  Identities=19%  Similarity=0.296  Sum_probs=192.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|++|.||++.....+     +.+|+|.+....  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSG-----KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            467999999999999987754     889999987532  2223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++....     .+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            9999999999997653     48999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               .....|++.|+|||.+.. ...+.++||||||+++|||+||+.||....     .....+...
T Consensus       153 ~~---------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~  211 (290)
T cd05580         153 GR---------------TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEKIL  211 (290)
T ss_pred             CC---------------CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHh
Confidence            22               113357788999998544 578899999999999999999999997532     122223333


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVS  633 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~  633 (642)
                      .....++..+++.             +.+++.+||..||.+||     +++|++
T Consensus       212 ~~~~~~~~~~~~~-------------l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         212 EGKVRFPSFFSPD-------------AKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             cCCccCCccCCHH-------------HHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            3333333333333             34577889999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.9e-35  Score=295.39  Aligned_cols=244  Identities=22%  Similarity=0.386  Sum_probs=192.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|...........+.|.+|+.++++++||||+++++++..++..++||||
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             heeEeecCCeEEEEEEECCCC-----cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            456999999999999876654     899999987554444447789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++..+..++.|++.|+.|||+   .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        84 ~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          84 LGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            9999999998642      38899999999999999999999   89999999999999999999999999998765332


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||... +..++.++|||||||++|||+||..||.....     ..........
T Consensus       155 ~~------------~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~  216 (277)
T cd06641         155 QI------------KRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLIPKN  216 (277)
T ss_pred             hh------------hhccccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHHhcC
Confidence            10            011234677899999854 46788999999999999999999999864221     1222222111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+   .++..         ....+.+++.+||+.+|++||++.|+++
T Consensus       217 ~~~---~~~~~---------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         217 NPP---TLEGN---------YSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCC---CCCcc---------cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            111   11111         1123456888899999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.4e-35  Score=292.61  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=192.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc----cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA----TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  422 (642)
                      .+.||+|++|.||+|.....+     ..|++|.+.....    ....+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDG-----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             cceeeecCCceEEEEEEcCCC-----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence            467999999999999987544     7899998865431    2234678999999999999999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |+||+++++|.+++....     .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        80 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          80 FLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            999999999999997543     38899999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .....             ......|+..|+|||.+.....++.++|+|||||++|||++|+.||....    ........
T Consensus       152 ~~~~~-------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~~~~  214 (258)
T cd06632         152 VVEFS-------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAVFKI  214 (258)
T ss_pred             ccccc-------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHHHHH
Confidence            53321             01134577889999986543338899999999999999999999996532    11111111


Q ss_pred             HH-hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AF-RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. .....+...+++             .+.+++.+||+.+|++||++.|++.
T Consensus       215 ~~~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRSKELPPIPDHLSD-------------EAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HhcccCCCcCCCcCH-------------HHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11 111111222222             3345788899999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.3e-35  Score=296.30  Aligned_cols=244  Identities=20%  Similarity=0.219  Sum_probs=185.6

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHH---HHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVE---AIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      +||+|+||.||++.....+     +.||+|.+......  .....+..|..   .++..+||||+++++++...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCC-----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            4899999999999887654     79999998754211  11123444443   44445899999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus        76 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            99999999999886542     49999999999999999999999   89999999999999999999999999998754


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....              .....|+..|+|||++..+..++.++||||+||++|||++|+.||.......  ........
T Consensus       148 ~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~--~~~~~~~~  211 (278)
T cd05606         148 SKKK--------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMT  211 (278)
T ss_pred             CccC--------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc--hHHHHHHh
Confidence            3211              1133578889999986554568999999999999999999999997542211  11111212


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      ......++..++             ..+.+++.+|+..+|++||     ++.|+++
T Consensus       212 ~~~~~~~~~~~s-------------~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         212 LTMAVELPDSFS-------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             hccCCCCCCcCC-------------HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            111222222222             2345678889999999999     8988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.3e-35  Score=299.36  Aligned_cols=243  Identities=22%  Similarity=0.346  Sum_probs=189.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     +.||+|.+....  .....+++.+|++++++++||||++++++|...+..++||
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            367999999999999987654     789999886432  2223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||++ |++.+.+.....    .+++..+..++.|++.||.|||+   .+|+||||+|+||++++++.+||+|||++....
T Consensus        95 e~~~-g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9997 578777764332    48999999999999999999999   899999999999999999999999999986543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..                ....++..|+|||++..  ...++.++||||||+++|||+||+.||.....     ......
T Consensus       167 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~~~~  225 (307)
T cd06607         167 PA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH  225 (307)
T ss_pred             CC----------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHHHHH
Confidence            21                12346678999998542  35688999999999999999999999864321     111111


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+  . +.+        ......+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~~~~~--~-~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         226 IAQNDSP--T-LSS--------NDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HhcCCCC--C-CCc--------hhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            1111111  0 100        112234677889999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.9e-35  Score=296.69  Aligned_cols=260  Identities=20%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||+|....++     +.|++|++..... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETG-----ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             EeecccCCCcEEEEEEECCCC-----ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            467899999999999987654     7899999876532 2234679999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+ +++|.+++....    .++++.++..++.||++||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          80 YM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            99 999999987644    248999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           .......|+..|+|||.+.....++.++||||+||++|||+||+.||..... ...+. .+.....
T Consensus       152 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~-~~~~~~~  218 (286)
T cd07832         152 EEP-----------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLA-IVFRTLG  218 (286)
T ss_pred             CCC-----------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHH-HHHHHcC
Confidence            211           0011235778899999866545678999999999999999999877764321 11111 1111110


Q ss_pred             ccCC-----Ccc------ccCh-----hhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRP-----LSE------VIDP-----ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~-----~~~------~~d~-----~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....     ..+      ...+     .+.. .. ......+.+++.+|++.+|++||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         219 TPNEETWPGLTSLPDYNKITFPESKPIPLEE-IF-PDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCChHHHhhccCcchhhcccCCCCCcchHHH-hC-CCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000     000      0000     0000 00 012256788999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=298.90  Aligned_cols=262  Identities=20%  Similarity=0.286  Sum_probs=194.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++....++     +.|++|.++.... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCC-----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            467999999999999987764     7999999875422 2234778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++++.+..+.....     .+++..+..++.||+.||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            999877766554322     38999999999999999999999   8999999999999999999999999999877644


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           .......++..|+|||++.....++.++||||||+++|||++|+.||....... .+.. ......
T Consensus       153 ~~~-----------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~-~~~~~~  219 (288)
T cd07833         153 RPA-----------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYL-IQKCLG  219 (288)
T ss_pred             Ccc-----------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhC
Confidence            321           011133567789999996653378999999999999999999999997532211 1111 111000


Q ss_pred             c-----------cC-----CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 E-----------RR-----PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~-----------~~-----~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .           ..     ...+..++.............++.+++.+||+.+|++||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0           00     0011111111100000111356788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9e-35  Score=290.93  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=198.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||.|+||.||++......+ .....||+|.+.........+.+..|+.++.+++|+||+++++++...+..+++|||
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             cceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            4578999999999999876421 233789999997654433457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++......   .+++.++..++.|++.||+|||+   .+++||||||+||++++++.++++|||+++.....
T Consensus        83 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       83 MEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             cCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999764421   28999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHHHHHHh
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .....           ....++..|+|||.. .+..++.++||||+|+++|||++ |+.||...     ......+....
T Consensus       157 ~~~~~-----------~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~  219 (258)
T smart00219      157 DYYKK-----------KGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLEYLKK  219 (258)
T ss_pred             ccccc-----------ccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhc
Confidence            11110           012256789999985 44778999999999999999999 78888642     12223333222


Q ss_pred             ccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          586 ERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       586 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      .... ....             ...++.+++.+|++.||++|||+.|+++.|
T Consensus       220 ~~~~~~~~~-------------~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYRLPKPEN-------------CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCCc-------------CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            2211 1111             112466688999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-35  Score=294.89  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=192.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-----cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-----TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      ...||+|++|.||++....++     +.||+|.+.....     ....+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~-----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTG-----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             cceecCcCceEEEEEEEcCCC-----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence            467999999999999876654     7899999875321     112467899999999999999999999999999999


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-CeEEeccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLN  500 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla  500 (642)
                      +||||+++++|.+++....     ++++..+..++.|++.||+|||+   .+++||||||+||+++.++ .+||+|||.+
T Consensus        80 ~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             EEEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            9999999999999997543     48899999999999999999999   8999999999999998775 5999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      ..........        ........|+..|+|||.+. +..++.++||||+||++|||++|+.||......  ......
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~  220 (268)
T cd06630         152 ARLAAKGTGA--------GEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALI  220 (268)
T ss_pred             cccccccccC--------CccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHH
Confidence            7764331100        00111345778899999854 467899999999999999999999999643221  111222


Q ss_pred             HHHHhc--cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRE--RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......  .....+.++             ..+.+++.+|++.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 FKIASATTAPSIPEHLS-------------PGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHhccCCCCCCchhhC-------------HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111111  111111222             23456888899999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=294.86  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=194.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...+|+|++|.||++....++     +.+++|.+...... ..+.+.+|++++++++||||+++++++...+..+++|||
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATG-----ELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             EEEecCCCceEEEEeEecCCC-----CEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            467899999999999987654     78999998765333 347899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++.....    .+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          82 CGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999999876522    48999999999999999999999   89999999999999999999999999998765422


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..            ......++..|+|||.....  ..++.++|||||||++|||+||+.||......    .... ...
T Consensus       155 ~~------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----~~~~-~~~  217 (262)
T cd06613         155 IA------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----RALF-LIS  217 (262)
T ss_pred             hh------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHH-HHH
Confidence            10            01123567789999985432  26888999999999999999999999753211    1111 111


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...........        ......++.+++.+||+.+|++|||+.|++.
T Consensus       218 ~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         218 KSNFPPPKLKD--------KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hccCCCccccc--------hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11100000000        1112235678999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-35  Score=292.89  Aligned_cols=258  Identities=21%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||.|++|.||+|....++     ..+++|++...........+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNN-----EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCC-----cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            467999999999999977654     789999987654333557899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.++++.....  ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999764321  248999999999999999999999   89999999999999999999999999998776543


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      .....        .......|+..|+|||++.....++.++|||||||++|||++|+.||......     .........
T Consensus       156 ~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~  222 (267)
T cd06610         156 GDRTR--------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQN  222 (267)
T ss_pred             ccccc--------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcC
Confidence            21110        01123457888999998665447899999999999999999999999753221     112222222


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+   .+....    ........+.+++.+||+.||++||++.|+++
T Consensus       223 ~~~---~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DPP---SLETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCC---CcCCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111   011000    00011234567889999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.7e-35  Score=297.25  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=190.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC-----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND-----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~-----~~  420 (642)
                      ...||+|+||.||++....++     +.+|+|.+.....  ..+.+.+|+.++.++ +||||+++++++...+     ..
T Consensus        27 ~~~l~~g~~~~vy~~~~~~~~-----~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          27 IETIGKGTYGKVYKVTNKKDG-----SLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             EEEeecCCCeEEEEEEECCCC-----CEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            357999999999999987665     7899999865432  236788999999999 8999999999997643     57


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+++|+|.++++..... ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence            9999999999999998643211 1248999999999999999999999   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS----KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      +.......            ......|+..|+|||++....    .++.++|||||||++|||++|+.||.....    .
T Consensus       176 ~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~----~  239 (291)
T cd06639         176 AQLTSTRL------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP----V  239 (291)
T ss_pred             hhcccccc------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH----H
Confidence            76543211            011235677899999854322    368899999999999999999999974321    1


Q ss_pred             HHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. +........  ....++.        .....+.+++.+||+.+|++||++.|+++
T Consensus       240 ~~-~~~~~~~~~--~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 KT-LFKIPRNPP--PTLLHPE--------KWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HH-HHHHhcCCC--CCCCccc--------ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 111111111  1111111        11234677999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=303.15  Aligned_cols=272  Identities=19%  Similarity=0.241  Sum_probs=194.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l  422 (642)
                      ...||+|++|.||+|....+   +....||+|.+....  .....+.+.+|+.++++++||||+++++++...  +..++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           5 EGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             EEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            35699999999999998762   112899999998632  112236778999999999999999999999988  78999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC----CCCeEEeccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD----ELHPCISGFG  498 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DfG  498 (642)
                      ||||+++ +|.+.+..........+++..+..++.|++.||+|||+   .+|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 78777755433222358999999999999999999999   89999999999999999    9999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc----
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK----  574 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~----  574 (642)
                      +++........         ........++..|+|||++.....++.++|||||||++|||++|+.||........    
T Consensus       158 ~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         158 LARLFNAPLKP---------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             cccccCCCccc---------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            99875433210         00111345778899999865545688999999999999999999999976443320    


Q ss_pred             ----cHHHHHHHHHhc----------cCCCcc--------ccC-hhhhhchhH-HHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          575 ----GLESLVRKAFRE----------RRPLSE--------VID-PALVKEIHA-KRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       575 ----~l~~~~~~~~~~----------~~~~~~--------~~d-~~l~~~~~~-~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                          .+..++......          ......        ... ..+...... .....++.+++.+|++.||++|||+.
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                011111100000          000000        000 000000000 01224678899999999999999999


Q ss_pred             HHHH
Q 006522          631 TVSE  634 (642)
Q Consensus       631 ev~~  634 (642)
                      |+++
T Consensus       309 eil~  312 (316)
T cd07842         309 EALE  312 (316)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-36  Score=307.49  Aligned_cols=244  Identities=20%  Similarity=0.269  Sum_probs=202.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|.|+.|..++....+     ..||+|.+++..- ......+.+|+++|..++|||||+++.+.......|+|||
T Consensus        61 ~~tig~g~f~~V~La~~~~t~-----~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTG-----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             eeeeccceeEEEEeeEecCCC-----ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            467999999999999988775     8999999988632 2233558899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+.+|.+++++..+++     +.+.....++.|+.+|++|||+   +.|+|||||++||||+.++.+||+|||++..+..
T Consensus       136 ya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             eccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999998775     4457788899999999999999   8999999999999999999999999999987653


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .             ....+.+|++.|.|||++......++.+|+||+|+++|-|+.|..||++.     .+...-.+...
T Consensus       208 ~-------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-----~lk~Lr~rvl~  269 (596)
T KOG0586|consen  208 G-------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-----NLKELRPRVLR  269 (596)
T ss_pred             c-------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-----ccccccchhee
Confidence            3             12336789999999999776666789999999999999999999999853     33334444444


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....++..++-+.             -+++++.+-.+|.+|++++++.+
T Consensus       270 gk~rIp~~ms~dc-------------e~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 GKYRIPFYMSCDC-------------EDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeecccceeechh-------------HHHHHHhhccCccccCCHHHhhh
Confidence            4444444444333             34677789999999999999875

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.5e-35  Score=299.39  Aligned_cols=263  Identities=17%  Similarity=0.225  Sum_probs=195.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++.....+     +.|++|.+.....  ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETR-----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCC-----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            467999999999999987765     7899999876432  223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|++|||+++...
T Consensus        81 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            9999999999997543     48999999999999999999999   899999999999999999999999999987422


Q ss_pred             CCCcccccc--e-eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          505 GTSKVTKNE--T-IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       505 ~~~~~~~~~--~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .........  . ............++..|+|||.+.. ..++.++|||||||++|||+||+.||.+..     ...+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~~~~~~  226 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----PEELFG  226 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence            111000000  0 0000001112356788999998554 678999999999999999999999997432     223333


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .........+.. ++.         ....+.+++.+||+.||++||++.++.+.|+.
T Consensus       227 ~~~~~~~~~~~~-~~~---------~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         227 QVISDDIEWPEG-DEA---------LPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHhcccCCCCc-ccc---------CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            332222111110 000         11234568889999999999997666666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4e-35  Score=294.98  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=198.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||++.....+     +.+++|++.........+++.+|++++++++||||+++++++...+..++|+||
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTG-----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCC-----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            457999999999999998654     889999987764444457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++....    ..+++.....++.|++.||+|||+.  .+++||||||+||++++++.+||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999997653    2488999999999999999999983  58999999999999999999999999998654321


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..              ....++..|+|||+.. +..++.++||||||+++|+|++|+.||.............++.....
T Consensus       155 ~~--------------~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         155 LA--------------KTFVGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             Hh--------------hcccCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence            10              0135667899999854 46889999999999999999999999975433223333444433332


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+.   +...        .....+.+++.+||..+|++|||+.|++.
T Consensus       220 ~~~~---~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 PPPR---LPSG--------KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCC---CChh--------hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            2211   0000        01123556888899999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=312.43  Aligned_cols=201  Identities=25%  Similarity=0.331  Sum_probs=172.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC------Cce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~  420 (642)
                      ...||+|+||.||+++.+..+     ..||||.++........+...+|+++|++++|||||++++.-...      ...
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG-----~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETG-----RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             hhhhcCCccceeeeecccccc-----cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            467999999999999977765     899999998876555568889999999999999999999876543      367


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC----CCCCeEEec
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD----DELHPCISG  496 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~----~~~~~kl~D  496 (642)
                      .+|||||.+|||+..|.+-...  ..|++.+.+.+..+++.||.|||+   ++|+||||||.||++-    ....-||+|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeec
Confidence            8999999999999999865432  459999999999999999999999   8999999999999983    334579999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE  570 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~  570 (642)
                      ||.||.+.+..             .-+..+||..|.+||.+.....|+..+|.|||||++||++||..||-...
T Consensus       168 fG~Arel~d~s-------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  168 FGAARELDDNS-------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccccccCCCCC-------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99999887653             12367899999999986544789999999999999999999999997543

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.6e-35  Score=295.53  Aligned_cols=243  Identities=23%  Similarity=0.278  Sum_probs=187.2

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|+||.||++.....+     +.+|+|.+....  .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATG-----KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCC-----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            689999999999877654     789999986532  1222356788999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++.....   ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++.......
T Consensus        76 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          76 NGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             CCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            99999999976543   248999999999999999999999   899999999999999999999999999987653211


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .             .....++..|+|||+... ..++.++||||+||++|+|++|+.||...... ..............
T Consensus       150 ~-------------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~  214 (277)
T cd05577         150 K-------------IKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMA  214 (277)
T ss_pred             c-------------cccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHhcccccc
Confidence            0             112346678999998554 56889999999999999999999999754321 11112222111112


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT  631 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e  631 (642)
                      ......+++             .+.+++.+||+.||++||+.+|
T Consensus       215 ~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         215 VEYPDKFSP-------------EAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCccCCH-------------HHHHHHHHHccCChhHccCCCc
Confidence            122222333             3345788899999999994443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4e-35  Score=298.00  Aligned_cols=250  Identities=19%  Similarity=0.306  Sum_probs=187.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHH-HhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEA-IARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||++....++     +.||+|+++.........++..|+.+ ++..+||||+++++++..++..++|||
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTG-----TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCC-----cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            357899999999999987654     89999998765333233566677775 556699999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPR-KYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |++ |+|.+++....... ..+++..+..++.||+.||+|||+   + +++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 68988886543222 359999999999999999999998   5 89999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ...             ......|+..|+|||.+...   ..++.++|||||||++|||++|+.||......   .. ...
T Consensus       156 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~-~~~  218 (283)
T cd06617         156 DSV-------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQ-QLK  218 (283)
T ss_pred             ccc-------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HH-HHH
Confidence            211             01123467789999975431   34688999999999999999999999642221   11 122


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .......+  ......         ....+.+++.+||..+|++||++.|+++
T Consensus       219 ~~~~~~~~--~~~~~~---------~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 QVVEEPSP--QLPAEK---------FSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHhcCCC--CCCccc---------cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22221111  110000         1124566888999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.1e-35  Score=292.83  Aligned_cols=248  Identities=20%  Similarity=0.288  Sum_probs=187.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC----ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--Cce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD----ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~  420 (642)
                      .+.||+|+||.||++.....+     +.|++|.+....    .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTG-----RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCC-----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            568999999999999987765     799999886431    112346788999999999999999999998764  457


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+++|+|.+++....     .+++....+++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            89999999999999987543     37889999999999999999999   89999999999999999999999999998


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +........         ........|+..|+|||.+. +..++.++|||||||++|||++|+.||....    ..... 
T Consensus       154 ~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~~-  218 (265)
T cd06652         154 KRLQTICLS---------GTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAAI-  218 (265)
T ss_pred             ccccccccc---------ccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHHH-
Confidence            765322100         00111345778899999854 4678999999999999999999999996421    11222 


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ........  ...+.+.         ....+.+++.+|+. +|++||++.|+++
T Consensus       219 ~~~~~~~~--~~~~~~~---------~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         219 FKIATQPT--NPVLPPH---------VSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHhcCCC--CCCCchh---------hCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            11111111  1111111         11234557777884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.8e-35  Score=291.68  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=192.3

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|++|.||+++....+     +.+++|.+.....  ....+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKN-----RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCC-----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            689999999999987654     8999999875422  233467999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++....     .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        76 ~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~  147 (262)
T cd05572          76 LGGELWTILRDRG-----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ  147 (262)
T ss_pred             CCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence            9999999997643     38899999999999999999999   899999999999999999999999999988664321


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh--
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR--  585 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~--  585 (642)
                                   ......++..|++||.+. +..++.++|+||+|+++|||++|+.||.....+   ..........  
T Consensus       148 -------------~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~  210 (262)
T cd05572         148 -------------KTWTFCGTPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---PMEIYNDILKGN  210 (262)
T ss_pred             -------------ccccccCCcCccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---HHHHHHHHhccC
Confidence                         011235677899999854 467899999999999999999999999764321   2223333321  


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-----~~ev~~  634 (642)
                      .....+...+             ..+.+++.+||+.+|++||+     ++|+++
T Consensus       211 ~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         211 GKLEFPNYID-------------KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCCCcccC-------------HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1111122222             24566888899999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-35  Score=298.91  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=189.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||++.....+     +.+|+|.+...........+.+|+.++.++. ||||+++++++...+..+++||
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSG-----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCC-----CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            467999999999999987765     8999999876543334467899999999996 9999999999999899999999


Q ss_pred             eccCCcHHHHH---hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          426 FIRNGSLYAAL---HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~gsL~~~l---~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |+.. ++.++.   .....   ..+++.....++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLK---SVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             cccC-CHHHHHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            9864 554433   22221   3489999999999999999999972  4899999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      ......             .....|+..|+|||++...  ..++.++|||||||++|||++|+.||....    .....+
T Consensus       158 ~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~  220 (288)
T cd06616         158 LVDSIA-------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQL  220 (288)
T ss_pred             hccCCc-------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHH
Confidence            532210             0123467789999986543  368999999999999999999999996432    111222


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ........+   .+.+...     .....++.+++.+||+.+|++|||+.||++
T Consensus       221 ~~~~~~~~~---~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         221 TQVVKGDPP---ILSNSEE-----REFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             hhhcCCCCC---cCCCcCC-----CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222211111   1111100     012235677899999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-34  Score=294.85  Aligned_cols=262  Identities=17%  Similarity=0.259  Sum_probs=195.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||+|....++     ..||||.++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTG-----EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             eeeeccCCceEEEEEEECCCC-----eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            467899999999999987654     789999997654443446788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++ +|.+++......  ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+|++|||+++.....
T Consensus        80 ~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          80 MDK-DLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             CCc-cHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            985 899988765432  358999999999999999999998   89999999999999999999999999998754322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH--
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF--  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~--  584 (642)
                      ..            ......++..|++||++.....++.++|||||||++|||+||+.||.+..... ......+...  
T Consensus       154 ~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~  220 (284)
T cd07836         154 VN------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTP  220 (284)
T ss_pred             cc------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            10            01123457789999986554567899999999999999999999997543221 1111111100  


Q ss_pred             --------hccC----CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 --------RERR----PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 --------~~~~----~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                              ....    ..+...+... ... .......+.+++.+|++.||.+||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         221 TESTWPGISQLPEYKPTFPRYPPQDL-QQL-FPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ChhhHHHHhcCchhcccccCCChHHH-HHH-hhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    0000    0000000000 000 0011245678999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-34  Score=298.91  Aligned_cols=261  Identities=22%  Similarity=0.270  Sum_probs=187.0

Q ss_pred             CCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccCCcH
Q 006522          354 KNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL  432 (642)
Q Consensus       354 ~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (642)
                      ++|.||.+.....+     +.||||++... ......+.+.+|++++++++||||+++++++...+..+++|||+++|+|
T Consensus        12 ~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTN-----TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCC-----CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            34445555544433     89999998764 2334457899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCccccc
Q 006522          433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN  512 (642)
Q Consensus       433 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  512 (642)
                      .+++......   .+++.....++.|+++||+|||+   .+|+||||||+||+++.++.+|++|||.+............
T Consensus        87 ~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          87 EDLLKTHFPE---GLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999865332   38899999999999999999999   89999999999999999999999999988765432211100


Q ss_pred             ceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCC--
Q 006522          513 ETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP--  589 (642)
Q Consensus       513 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~--  589 (642)
                      ..     .......++..|+|||++... ..++.++|||||||++|||++|+.||......    .............  
T Consensus       161 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~  231 (314)
T cd08216         161 VH-----DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLL  231 (314)
T ss_pred             cc-----cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCcccc
Confidence            00     011134567789999985442 35789999999999999999999999753221    1111111100000  


Q ss_pred             -----------Ccc----ccChhh---hhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          590 -----------LSE----VIDPAL---VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       590 -----------~~~----~~d~~l---~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                                 ...    ..++..   ...........++.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                       000    000000   000011122346778999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-34  Score=292.15  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=192.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC---------ccccHHHHHHHHHHHhc-ccCCCeeeEEEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---------ATWRFKDFESEVEAIAR-VQHPNIVRLKAFYYA  416 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~  416 (642)
                      ...||+|+||.||++....+.+    +.+|+|.+....         ......++.+|+.++.+ ++||||+++++++..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~----~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQ----NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCC----ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4579999999999999877211    789999876421         12233567889998875 799999999999999


Q ss_pred             CCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEec
Q 006522          417 NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG  496 (642)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D  496 (642)
                      .+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.  .+++|+||||+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542211 13489999999999999999999952  5799999999999999999999999


Q ss_pred             ccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       497 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      ||++.......             ......|+..|+|||... +..++.++||||||+++|||++|+.||....     .
T Consensus       158 fg~~~~~~~~~-------------~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~  218 (269)
T cd08528         158 FGLAKQKQPES-------------KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----M  218 (269)
T ss_pred             ccceeeccccc-------------ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccC-----H
Confidence            99987654321             011345677899999855 4678999999999999999999999986421     1


Q ss_pred             HHHHHHHHhccC-CCcc-ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          577 ESLVRKAFRERR-PLSE-VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       577 ~~~~~~~~~~~~-~~~~-~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      ............ +... ..+             ..+.+++.+||+.||++||++.|+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~-------------~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         219 LSLATKIVEAVYEPLPEGMYS-------------EDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHHHHhhccCCcCCcccCC-------------HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            222222222111 1111 111             23556888999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-34  Score=290.06  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||++....++     +.|++|.++..... ...+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTG-----ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCC-----cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            367999999999999987654     78999998765332 345789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++....     .+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus        80 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          80 YCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             cCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999997643     37889999999999999999999   8999999999999999999999999999887644


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS--KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......        .......++..|+|||++....  .++.++||||||+++||+++|+.||......    .......
T Consensus       152 ~~~~~~--------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~~~  219 (264)
T cd06626         152 NTTTMG--------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHV  219 (264)
T ss_pred             CCCccc--------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHHHH
Confidence            321110        0011245677899999855422  2789999999999999999999999643221    1111111


Q ss_pred             Hhc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ... ...++...           .....+.+++.+||+.+|++||++.|++.
T Consensus       220 ~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         220 GAGHKPPIPDSL-----------QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             hcCCCCCCCccc-----------ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111 11111111           00123456888999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.8e-35  Score=299.21  Aligned_cols=260  Identities=18%  Similarity=0.254  Sum_probs=193.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc----ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT----WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...||+|++|.||+|.....+     +.|+||.+......    .....+..|++++++++|+||+++++++...+..++
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETG-----RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             eeeeeeccccEEEEEEECCCC-----cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence            457999999999999987654     79999999765322    123567789999999999999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+ +|+|.+++....    ..+++..+..++.||++||+|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        80 v~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            99999 899999997643    248999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .......            .....++..|+|||.+.....++.++|||||||++|||++|..||..... ...+......
T Consensus       152 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~  218 (298)
T cd07841         152 FGSPNRK------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEA  218 (298)
T ss_pred             ccCCCcc------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHH
Confidence            5432110            01223566799999865545678999999999999999999877764322 1111111111


Q ss_pred             HHhccC--------CCcccc------ChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          583 AFRERR--------PLSEVI------DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       583 ~~~~~~--------~~~~~~------d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                       .....        ......      ......  ........+.+++.+||+.||++|||+.|+++.
T Consensus       219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         219 -LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ--IFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             -cCCCchhhhhhcccccccccccccCCcchhh--hcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000        000000      000000  001123467789999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-34  Score=296.67  Aligned_cols=264  Identities=16%  Similarity=0.187  Sum_probs=191.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCc-----
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDE-----  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~-----  419 (642)
                      .+.||+|+||.||++....++     +.||+|.+..... ....+.+.+|+.+++++ +||||+++++++...+.     
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~-----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             eeEecccCCeEEEEEEECCCC-----cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            467999999999999987665     7999998865422 22236788999999999 56999999999987665     


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEeccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFG  498 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfG  498 (642)
                      .|+||||+++ +|.+++..........+++..+..++.||+.||+|||+   .+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 89998876443222358999999999999999999999   89999999999999998 8999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES  578 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~  578 (642)
                      +++.......            ......+++.|+|||++.....++.++|||||||++|||+||..||.+.... ..+..
T Consensus       157 ~~~~~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~  223 (295)
T cd07837         157 LGRAFSIPVK------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLH  223 (295)
T ss_pred             cceecCCCcc------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Confidence            9875432210            0112245677999998655456799999999999999999999999753221 11111


Q ss_pred             HHHHHHhccC-CCccc------------cChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          579 LVRKAFRERR-PLSEV------------IDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       579 ~~~~~~~~~~-~~~~~------------~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .......... .....            ....+...  ......++.+++.+||+.||++||++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRA--VPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHhCCCChhhCcchhhccchhhcCcccchhHHHh--ccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1110000000 00000            00000000  0012245678999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.5e-35  Score=296.89  Aligned_cols=262  Identities=18%  Similarity=0.249  Sum_probs=191.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      ...||+|+||.||+|.....+     +.+++|.++..... .....+.+|+.++++++||||+++++++...  +..++|
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTG-----EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCC-----cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            467999999999999987654     78999999754322 2225678899999999999999999999887  789999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++ +|.+++.....    .+++..+..++.||+.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcCc-CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            999974 99999876442    48999999999999999999999   89999999999999999999999999998865


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....            ......++..|+|||.+.....++.++||||+||++|||++|+.||...... ..+.......
T Consensus       157 ~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~  223 (293)
T cd07843         157 GSPLK------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLL  223 (293)
T ss_pred             cCCcc------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            43210            0112345678999998655445789999999999999999999999753221 1111111000


Q ss_pred             H----------hcc-----CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 F----------RER-----RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~----------~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .          ...     ..........+............+.+++..||+.+|++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0          000     00000000011000000001234667999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=294.27  Aligned_cols=261  Identities=18%  Similarity=0.251  Sum_probs=191.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++....++     +.|++|++...... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTG-----EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCC-----CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            357899999999999987654     78999998754322 223678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |++ ++|.+++.....   ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||+++....
T Consensus        79 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          79 FLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             ccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            995 699999876542   248999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....++..|+|||++.....++.++|||||||++|||+||+.||...... ..+....+....
T Consensus       152 ~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~  218 (283)
T cd07835         152 PVRT------------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGT  218 (283)
T ss_pred             Cccc------------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            2100            012245677999998655455789999999999999999999999753221 111111111000


Q ss_pred             ccC--------------CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERR--------------PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~--------------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...              .......+.....  .......+.+++.+||+.||++||+++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         219 PDEDVWPGVTSLPDYKPTFPKWARQDLSKV--VPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CChHHhhhhhhchhhhhhcccccccchhhh--cCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000              0000000000000  0001135678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-35  Score=300.07  Aligned_cols=249  Identities=17%  Similarity=0.240  Sum_probs=189.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      -..||+||.+.||++...+.      ..+|+|++... .+.....-|..|+..|.+| .|.+||++++|-..++..||||
T Consensus       366 lk~iG~GGSSkV~kV~~s~~------~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  366 LKQIGSGGSSKVFKVLNSDK------QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             HHhhcCCCcceeeeeecCCC------cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            46799999999999987766      67888877543 3334457799999999999 6999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||-+. ||..+|+++...   ...| .+..+..|++.|+.++|.   .+|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus       440 E~Gd~-DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             ecccc-cHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            98755 999999887653   2445 677899999999999999   89999999999999974 689999999999876


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG----------SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK  574 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~  574 (642)
                      .+..          ..-...-+||+.||+||.+...          -+++.++||||+|||||+|+.|+.||..      
T Consensus       511 ~DTT----------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~------  574 (677)
T KOG0596|consen  511 PDTT----------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ------  574 (677)
T ss_pred             cccc----------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH------
Confidence            6531          1122245899999999975431          1367899999999999999999999963      


Q ss_pred             cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       575 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                       +...+.+.       ..+.||...-+......-.+++++|..||..||++||+..|+++
T Consensus       575 -~~n~~aKl-------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  575 -IINQIAKL-------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -HHHHHHHH-------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             11111111       11222211001111111233788999999999999999999885

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=307.74  Aligned_cols=263  Identities=17%  Similarity=0.251  Sum_probs=190.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ceE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EKL  421 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  421 (642)
                      ...||+|+||.||+|.....+     +.||+|.+..........++.+|+.++++++||||+++++++....     ..+
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTG-----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCC-----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            468999999999999987654     7899999875433333467889999999999999999999876543     579


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +|+||+++ +|.+++...      .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        85 lv~e~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          85 IVQELMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEehhccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence            99999975 888887643      38999999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .........         .......||..|+|||.+.....++.++||||+||++|||+||+.||.+...  ......+.
T Consensus       155 ~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~  223 (336)
T cd07849         155 IADPEHDHT---------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLIL  223 (336)
T ss_pred             ecccccccc---------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            654321100         0111346788899999855545689999999999999999999999965321  11111111


Q ss_pred             HHHhccCC--CccccChhhhhc---------hh----HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          582 KAFRERRP--LSEVIDPALVKE---------IH----AKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       582 ~~~~~~~~--~~~~~d~~l~~~---------~~----~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .......+  .....+......         ..    ......++.+++.+||+.||++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11110000  000000000000         00    00112456789999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=298.29  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=196.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|++|.||++.....+     +.+|+|.+......  ...+.+.+|++++++++||||+++++++......++||
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTG-----KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCC-----cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            457999999999999987754     89999999765322  23467899999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++.....   ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            99999999999875432   248999999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCcccccce-----------------eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 006522          505 GTSKVTKNET-----------------IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA  567 (642)
Q Consensus       505 ~~~~~~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~  567 (642)
                      ..........                 ............||..|+|||+.. +..++.++|||||||++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            3211100000                 000011112346888999999854 4678999999999999999999999997


Q ss_pred             CCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHH
Q 006522          568 GPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR----MRTVSE  634 (642)
Q Consensus       568 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs----~~ev~~  634 (642)
                      .....     .................           .....+.+++.+||+.||++||+    +.|++.
T Consensus       234 ~~~~~-----~~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         234 GSNRD-----ETFSNILKKEVTFPGSP-----------PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCchH-----HHHHHHhcCCccCCCcc-----------ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            54321     11222222221111110           01234567888999999999999    666554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-34  Score=290.99  Aligned_cols=235  Identities=19%  Similarity=0.297  Sum_probs=181.9

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEeecc
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      +|+|+||.||++....++     ..+|+|.+.......      .|+.....+ +||||+++++++...+..++||||++
T Consensus        24 lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~   92 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK   92 (267)
T ss_pred             ecCCCceEEEEEEEcCCC-----cEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence            699999999999987765     789999986532211      122222222 79999999999999999999999999


Q ss_pred             CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-CeEEecccccccCCCCC
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRLLPGTS  507 (642)
Q Consensus       429 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~~~~  507 (642)
                      +|+|.+++....     .++|..+..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||+++......
T Consensus        93 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  164 (267)
T PHA03390         93 DGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS  164 (267)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence            999999997653     48999999999999999999999   8999999999999999988 99999999987543221


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                                      ...++..|+|||++. +..++.++|||||||++|||+||+.||.....+......+.... ...
T Consensus       165 ----------------~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~  226 (267)
T PHA03390        165 ----------------CYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK  226 (267)
T ss_pred             ----------------cCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc
Confidence                            234677899999854 46789999999999999999999999985443332333333322 222


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-MRTVSE  634 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs-~~ev~~  634 (642)
                      .+....+++             .+.+++.+||+.+|.+||+ ++|+++
T Consensus       227 ~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 LPFIKNVSK-------------NANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCcccccCH-------------HHHHHHHHHhccChhhCCchHHHHhc
Confidence            222222333             3455777899999999996 688874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=294.04  Aligned_cols=261  Identities=19%  Similarity=0.276  Sum_probs=194.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      ...||+|++|.||+|.....+     +.+|+|++.... .....+.+.+|++++++++|||++++++++...  +..++|
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTG-----ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCC-----eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            357899999999999988754     899999998753 223336788999999999999999999999988  789999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++ +|.+++....    ..+++..+..++.||+.||+|||+   .+++|+||||+||++++++.+||+|||++...
T Consensus        79 ~e~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          79 FEYMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             eccccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999975 9999887543    248999999999999999999999   89999999999999999999999999998766


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....           .......++..|+|||.+.....++.++||||||+++|||+||+.||..... ...+.. +...
T Consensus       151 ~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~-~~~~  217 (287)
T cd07840         151 TKRNS-----------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEK-IFEL  217 (287)
T ss_pred             cCCCc-----------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH-HHHH
Confidence            43321           0011234567799999765545678999999999999999999999975332 111111 1111


Q ss_pred             HhccC----C-C-----------ccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERR----P-L-----------SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~----~-~-----------~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .....    + .           .......+... ........+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF-FKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hCCCchhhccccccchhhhhccccccchhHHHHH-hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            10000    0 0           00000111000 00011356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-34  Score=294.17  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=192.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++.....+     +.+++|++..... ...+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTG-----RQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCC-----CEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            468999999999999976654     7899998865332 2236788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++...      .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+......
T Consensus        98 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          98 LEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             cCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999998762      38899999999999999999999   89999999999999999999999999987654322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|+..|+|||... +..++.++|||||||++|||++|+.||....     .....+.....
T Consensus       169 ~~------------~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~~~~~~~~~~  230 (285)
T cd06648         169 VP------------RRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PLQAMKRIRDN  230 (285)
T ss_pred             Cc------------ccccccCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HHHHHHHHHhc
Confidence            10            011235778899999854 3678999999999999999999999986422     12222222222


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+...  .+.        .....+.+++.+||+.+|++||++.|+++
T Consensus       231 ~~~~~~--~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         231 LPPKLK--NLH--------KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCCc--ccc--------cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            111100  000        01124667899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.6e-34  Score=298.48  Aligned_cols=265  Identities=25%  Similarity=0.285  Sum_probs=190.3

Q ss_pred             ccCcc--CCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKS--KNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g--~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|  +||+||++.....+     +.||+|.+.... .....+.+.+|+.+++.++||||++++++|...+..++|+|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e   79 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTG-----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP   79 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCC-----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence            45555  89999999987654     899999987543 22334778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+.+|+|.+++......   .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|++||+.+.....
T Consensus        80 ~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          80 FMAYGSANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             cccCCCHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            99999999999865432   48899999999999999999998   8999999999999999999999999986543322


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ......  .   .........++..|+|||++..+ ..++.++|||||||++|||++|+.||.......    .......
T Consensus       154 ~~~~~~--~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~  224 (328)
T cd08226         154 NGQKAK--V---VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLK  224 (328)
T ss_pred             cCcccc--c---cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHhc
Confidence            110000  0   00000112345669999986543 347899999999999999999999997532211    1111110


Q ss_pred             hccC-CCc---------------------------------cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          585 RERR-PLS---------------------------------EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       585 ~~~~-~~~---------------------------------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      .... +..                                 ...+..+.. .........+.+++.+||+.||++|||+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~  303 (328)
T cd08226         225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSAS  303 (328)
T ss_pred             CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence            0000 000                                 000000000 01122345678999999999999999999


Q ss_pred             HHHH
Q 006522          631 TVSE  634 (642)
Q Consensus       631 ev~~  634 (642)
                      |+++
T Consensus       304 e~l~  307 (328)
T cd08226         304 SLLS  307 (328)
T ss_pred             HHhh
Confidence            9974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=296.29  Aligned_cols=243  Identities=23%  Similarity=0.251  Sum_probs=192.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .++||+|+||.||-+....++     +.+|+|++.+..  ........+.|-.+|.+++.+.||.+-..|++.+..++|+
T Consensus       190 ~RvlGkGGFGEV~acqvraTG-----KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATG-----KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             eEEEecccccceeEEEEecch-----hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            478999999999999998876     788888876541  1112255788999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ..|.||||.-+|...+.   +.+++...+.++.+|+.||++||.   .+||.|||||+|||||++|+++|+|.|+|..+.
T Consensus       265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            99999999999887664   459999999999999999999999   899999999999999999999999999998876


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH-HHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE-SLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~-~~~~~~  583 (642)
                      ....             -+..+||.+|||||++.. ..|+...|.||+||++|||+.|+.||.....  +.-. +.-+..
T Consensus       339 ~g~~-------------~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--Kvk~eEvdrr~  402 (591)
T KOG0986|consen  339 EGKP-------------IRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--KVKREEVDRRT  402 (591)
T ss_pred             CCCc-------------cccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhh--hhhHHHHHHHH
Confidence            5421             124589999999999555 6699999999999999999999999964222  1111 122222


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM  629 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~  629 (642)
                      ......+++-++++.             -++....+..||++|.--
T Consensus       403 ~~~~~ey~~kFS~ea-------------kslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEA-------------KSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             hcchhhcccccCHHH-------------HHHHHHHHccCHHHhccC
Confidence            222222333344333             235555788999998643

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-34  Score=295.14  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=190.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||+++...++     ..||+|.+.....  ....+++.+|++++++++|||++++++++...+..++||
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            467999999999999987654     7899999875422  223367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||++ |+|.+.+.....    +++|.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++....
T Consensus       105 e~~~-g~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         105 EYCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             eCCC-CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            9997 588888765432    48999999999999999999999   899999999999999999999999999886543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARI--YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..                ....|+..|+|||++.  ....++.++|||||||++|||++|+.||.....     ......
T Consensus       177 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~~  235 (317)
T cd06635         177 PA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH  235 (317)
T ss_pred             Cc----------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH
Confidence            21                1235677899999853  235688999999999999999999999865321     111122


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      ......+..  ...         .....+.+++.+||+.+|++||++.|+++.+
T Consensus       236 ~~~~~~~~~--~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         236 IAQNESPTL--QSN---------EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             HHhccCCCC--CCc---------cccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            222211100  000         0112355688899999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.3e-34  Score=294.06  Aligned_cols=247  Identities=19%  Similarity=0.297  Sum_probs=188.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEe------CCc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYA------NDE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~------~~~  419 (642)
                      ...+|+|+||.||+|.....+     +.+|+|.+.....  ...++..|+.++.++ +||||+++++++..      .+.
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~-----~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCC-----cEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            357999999999999987664     7899999865432  236788999999999 79999999999863      356


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++|+|.+++.....   ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.++|+|||+
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~  167 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGV  167 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence            8999999999999999976443   248888999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      ++.......            ......|+..|+|||.+..    ...++.++|||||||++|||+||+.||.....    
T Consensus       168 ~~~~~~~~~------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~----  231 (282)
T cd06636         168 SAQLDRTVG------------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP----  231 (282)
T ss_pred             hhhhhcccc------------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH----
Confidence            875432110            0113457888999998542    24578899999999999999999999964321    


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...... ......  ... .+        ......+.+++.+||+.||.+||++.|+++
T Consensus       232 ~~~~~~-~~~~~~--~~~-~~--------~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         232 MRALFL-IPRNPP--PKL-KS--------KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             Hhhhhh-HhhCCC--CCC-cc--------cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            111111 111110  110 00        011234667899999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-34  Score=288.80  Aligned_cols=251  Identities=19%  Similarity=0.267  Sum_probs=192.9

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLIS  424 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~  424 (642)
                      ..+|+|+||.||++....++     ..+++|.+.... .....+++..|++++++++||||+++++++...  ...+++|
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             eeeccCCCeEEEEeeecCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            57899999999999987765     789999987542 223346788999999999999999999988653  4578999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS--PRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||+++++|.+++...... ..++++..++.++.|++.||+|||..+  ..+++|+||||+||++++++.+||+|||+++.
T Consensus        81 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999764221 235999999999999999999999321  27999999999999999999999999999887


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .......            .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||....     .....+.
T Consensus       160 ~~~~~~~------------~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~  221 (265)
T cd08217         160 LGHDSSF------------AKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASK  221 (265)
T ss_pred             ccCCccc------------ccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHH
Confidence            6433110            112356788999998544 668899999999999999999999997532     1222222


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......   ..+.+.         ....+.+++.+|++.+|++||++.||++
T Consensus       222 ~~~~~~---~~~~~~---------~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         222 IKEGKF---RRIPYR---------YSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HhcCCC---CCCccc---------cCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            221111   111111         1134567888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-35  Score=318.39  Aligned_cols=270  Identities=16%  Similarity=0.200  Sum_probs=179.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCC--------------CeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGA--------------PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKA  412 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~  412 (642)
                      ...||+|+||.||++......+...              ...++.|.+..  .......+.+|+.+|++++|||||++++
T Consensus       153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~  230 (501)
T PHA03210        153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA--GSRAAIQLENEILALGRLNHENILKIEE  230 (501)
T ss_pred             EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc--chHHHHHHHHHHHHHHhCCCCCcCcEeE
Confidence            4689999999999987654321000              00111222221  1122367889999999999999999999


Q ss_pred             EEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCe
Q 006522          413 FYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP  492 (642)
Q Consensus       413 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  492 (642)
                      ++...+..|+|+|++. ++|.+++..................|+.||+.||+|||+   .+|+||||||+|||++.++.+
T Consensus       231 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~v  306 (501)
T PHA03210        231 ILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKI  306 (501)
T ss_pred             EEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence            9999999999999985 588888765432211223456677899999999999999   899999999999999999999


Q ss_pred             EEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-
Q 006522          493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN-  571 (642)
Q Consensus       493 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~-  571 (642)
                      ||+|||+++.+......           ......||..|+|||++. +..++.++|||||||++|||++|..++..... 
T Consensus       307 kL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        307 VLGDFGTAMPFEKEREA-----------FDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             EEEeCCCceecCccccc-----------ccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            99999999876432110           111346889999999854 47789999999999999999998865432211 


Q ss_pred             C-cccHHHHHHHHHhccCCCccc-------cC--------hhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          572 D-GKGLESLVRKAFRERRPLSEV-------ID--------PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       572 ~-~~~l~~~~~~~~~~~~~~~~~-------~d--------~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      . ...+...+.........+++.       ++        ..+...+........+.+++.+|++.||++|||+.|+++
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1 111111111110000000000       00        000000000001124566788999999999999999986

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=288.55  Aligned_cols=244  Identities=19%  Similarity=0.243  Sum_probs=184.6

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHH-hcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAI-ARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .||+|++|.||+|.....+     +.||||.+.....  ......+..|..++ ...+|+||+++++++...+..++|+|
T Consensus         3 ~l~~g~~~~v~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (260)
T cd05611           3 PISKGAFGSVYLAKKRSTG-----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME   77 (260)
T ss_pred             cCCcCCCeeEEEEEecCCC-----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe
Confidence            5899999999999987654     7899999875421  11223455565554 45589999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++....     ++++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++....
T Consensus        78 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          78 YLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             ccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            999999999997543     48899999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .                ....++..|+|||.... ..++.++||||||+++|||+||..||.....     .........
T Consensus       150 ~----------------~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~  207 (260)
T cd05611         150 N----------------KKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILS  207 (260)
T ss_pred             c----------------ccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHh
Confidence            1                12346677999998554 5589999999999999999999999964322     222222222


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                      ..........+.         ....+.+++.+||+.+|++||++.++.+.|
T Consensus       208 ~~~~~~~~~~~~---------~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         208 RRINWPEEVKEF---------CSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccCCCCccccc---------CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            111111111110         112456788899999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=334.88  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=199.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +..||.|.||.||.+...+.+     ...|||-++-.+ .....+...+|..++..++|||+|+++|+-..++..++.||
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tG-----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTG-----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             ccccCCcceeeeEEeecCCcc-----chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            689999999999999988876     788888776542 23334677899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      ||++|+|.+.+...+.     .++.....+..|++.|++|||+   .+||||||||.||+||.+|.+|++|||.|..+..
T Consensus      1315 yC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999976543     5666777789999999999999   8999999999999999999999999999987765


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ...        +.+..-....||+.|||||++.+.  ....-++||||+|||+.||+||+.||...+++   ..-..+..
T Consensus      1387 ~~~--------~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~ 1455 (1509)
T KOG4645|consen 1387 NAQ--------TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVA 1455 (1509)
T ss_pred             chh--------cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHh
Confidence            421        112223356899999999996542  34567899999999999999999999754442   22222333


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....+++++-++++-.             +++-.|+..||++|.++.|+++
T Consensus      1456 ~gh~Pq~P~~ls~~g~-------------dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGR-------------DFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ccCCCCCchhhhHhHH-------------HHHHHHHhcCchhhhHHHHHHH
Confidence            3344455555554433             3666699999999999887765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=293.91  Aligned_cols=259  Identities=20%  Similarity=0.328  Sum_probs=193.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|++|.||+|.....+     +.|++|++.............+|+..+++++ ||||+++++++...+..++|||
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             heeeccCCceEEEEEEECCCC-----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            457899999999999987654     7899999876533222244567999999998 9999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+ +|+|.+++.....   ..++|..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++....
T Consensus        79 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          79 YM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             cC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            99 8899999876542   248999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...             .....++..|+|||++.....++.++||||||+++|||+||+.||....... .... ......
T Consensus       152 ~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~  216 (283)
T cd07830         152 RPP-------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLG  216 (283)
T ss_pred             CCC-------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcC
Confidence            211             1123467789999986555668999999999999999999999996542211 0100 000000


Q ss_pred             c----------------cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 E----------------RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~----------------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .                ...+.......+....  ......+.+++.+||+.+|++||+++|++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI--PNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CCChhhhhhHhhhhccccccccccccccHHHHc--ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0                0000000001010000  011245778999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-34  Score=293.47  Aligned_cols=244  Identities=20%  Similarity=0.288  Sum_probs=189.4

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ..||+|+||.||++.....+     ..||+|.+..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSG-----KLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCC-----eEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            57899999999999887654     8999998865332 23467899999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++...      .+++.....++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus       100 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657         100 EGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            999999987542      37899999999999999999999   899999999999999999999999999886543221


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            ......|+..|+|||... +..++.++||||+||++|||++|+.||.....  ......+.......
T Consensus       171 ~------------~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~~~  235 (292)
T cd06657         171 P------------RRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPPK  235 (292)
T ss_pred             c------------cccccccCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCCcc
Confidence            0            011335778899999854 46788999999999999999999999864221  11111111111110


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+++             .+.+++.+||+.+|.+||++.|+++
T Consensus       236 ~~~~~~~~~-------------~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 LKNLHKVSP-------------SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCcccCCH-------------HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            000111122             2445788899999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=295.96  Aligned_cols=246  Identities=19%  Similarity=0.300  Sum_probs=191.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     +.|++|.+..... ...+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATG-----QEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCC-----CEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            467999999999999876554     7899999865322 2236789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++|+|.+++...      .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          98 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999999753      37889999999999999999999   89999999999999999999999999988755332


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......|++.|+|||.+.. ..++.++|||||||++||+++|+.||.......     .+......
T Consensus       169 ~~------------~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-----~~~~~~~~  230 (293)
T cd06647         169 QS------------KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATN  230 (293)
T ss_pred             cc------------ccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-----heeehhcC
Confidence            11            0112357788999998544 678899999999999999999999997533211     01111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..+  ....+.        .....+.+++.+||+.+|++||++.+++..
T Consensus       231 ~~~--~~~~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTP--ELQNPE--------KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCC--CCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111  000000        011234568889999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=294.23  Aligned_cols=260  Identities=16%  Similarity=0.180  Sum_probs=179.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccH----------HHHHHHHHHHhcccCCCeeeEEEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF----------KDFESEVEAIARVQHPNIVRLKAFYYA  416 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~H~nIv~l~~~~~~  416 (642)
                      .+.||+|+||.||+|....+...  ...+++|...........          .....+...+..++|+||+++++++..
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~--~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   94 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCI--NNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF   94 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCccc--ccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence            46899999999999998665211  145666654322211100          112334455667799999999998766


Q ss_pred             CC----ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCe
Q 006522          417 ND----EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP  492 (642)
Q Consensus       417 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  492 (642)
                      ..    ..++++|++.. ++.+.+....     ..++..+..|+.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         95 KRCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             ecCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence            54    34678887754 6766665432     25778889999999999999999   899999999999999999999


Q ss_pred             EEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 006522          493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       493 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~  572 (642)
                      +|+|||+++.+.........     .........||+.|+|||+.. +..++.++|||||||++|||+||+.||......
T Consensus       166 ~l~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEY-----SKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             EEEEcCCceeeccCCccccc-----ccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999876432211100     001112346899999999854 477899999999999999999999999764332


Q ss_pred             cccHH----HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          573 GKGLE----SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       573 ~~~l~----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      .....    .+..+........ .             .....+.+++..|++.+|++||++.++.+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEGKIKI-K-------------NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHhhhhhhcc-C-------------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            21111    1111111111000 0             01234667888899999999999999998763

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=289.97  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=191.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------~  419 (642)
                      ...||+|++|.||+|.....+     +.+++|.+......  .++|.+|+.+++++ +|+||+++++++....      .
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTG-----QLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCC-----cEEEEEEEecCchh--HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            467999999999999987654     78999998764332  37799999999999 7999999999997654      4


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+++++|.+++...... ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            89999999999999998754311 1358999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      +........            ......|+..|+|||++..    ...++.++|||||||++|||+||+.||.....    
T Consensus       160 ~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----  223 (275)
T cd06608         160 SAQLDSTLG------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP----  223 (275)
T ss_pred             ceecccchh------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch----
Confidence            876432210            0113457788999997532    23467899999999999999999999964221    


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. ..........  .....+        ......+.+++.+||..||++|||+.|+++
T Consensus       224 ~~-~~~~~~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         224 MR-ALFKIPRNPP--PTLKSP--------ENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HH-HHHHhhccCC--CCCCch--------hhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11 1111111111  111111        112235667899999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-34  Score=295.64  Aligned_cols=265  Identities=17%  Similarity=0.217  Sum_probs=189.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDE------  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------  419 (642)
                      ...||+|+||.||++.....+     +.||||.+...... .....+.+|++++++++||||+++++++...+.      
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTK-----QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCC-----cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            467999999999999987654     89999988654222 222456789999999999999999999876543      


Q ss_pred             --eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          420 --KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       420 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                        .++||||+.+ +|.+.+.....    .+++.++..++.||+.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence              4999999975 88888865432    48999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |++..........        ........++..|+|||.+.....++.++||||||+++|||+||+.||.....  ....
T Consensus       164 g~~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~  233 (310)
T cd07865         164 GLARAFSLSKNSK--------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQL  233 (310)
T ss_pred             CCcccccCCcccC--------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            9998654332110        00011234677899999865544578899999999999999999999875322  1112


Q ss_pred             HHHHHHHhccCC--CccccC--------------hhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRERRP--LSEVID--------------PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~~--~~~~~d--------------~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+........+  .+...+              ...............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            222221111000  000000              000000000011234568999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.2e-35  Score=291.18  Aligned_cols=245  Identities=19%  Similarity=0.248  Sum_probs=193.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||.|+||.||++.....+     +.||+|.+....  .....+.+.+|++++++++||||+++++++...+..++|+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTK-----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             EEEeccCCCceEEEEEEccCC-----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            467999999999999987654     789999997542  2234578999999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++++|.+++....     ++++.....++.|+++||.|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          80 DLLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             eCCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            9999999999997642     48899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...             ......|+..|+|||.... ..++.++||||+|+++|+|++|+.||......  ..........
T Consensus       152 ~~~-------------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~  215 (258)
T cd05578         152 PDT-------------LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE  215 (258)
T ss_pred             CCc-------------cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc
Confidence            321             0113346777999998544 66899999999999999999999999754332  1122222211


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH--HHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM--RTVS  633 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~--~ev~  633 (642)
                      ......+..++             ..+.+++.+||+.||.+||++  +|++
T Consensus       216 ~~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         216 TADVLYPATWS-------------TEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccccCcccCc-------------HHHHHHHHHHccCChhHcCCccHHHHh
Confidence            12222222222             345568888999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=277.75  Aligned_cols=247  Identities=18%  Similarity=0.301  Sum_probs=194.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeC----Cce
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAN----DEK  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~  420 (642)
                      +..+||-|-.|.|..++.+.++     ..+|+|++.+.      ...++|+++--+. .|||||.+++.|.+.    ...
T Consensus        66 s~qvLG~GinGkV~~C~~k~T~-----ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   66 SWQVLGAGINGKVVQCVHKRTQ-----EKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhhhccccCCceEEEEeccch-----hhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4578999999999999998876     78999999764      4456899887666 799999999998753    356


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC---CCCCeEEecc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGF  497 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~Df  497 (642)
                      .+|||.|+||.|+..+.+++..   .+++.+...|++||+.|+.|||+   ..|.||||||+|+|..   .+-.+||+||
T Consensus       135 LiVmE~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             EeeeecccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence            8999999999999999987753   59999999999999999999999   8999999999999995   4678999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+|+......             ...+.+-|++|.|||+ ++..+|+...|+||+||++|-|++|.+||......  .+.
T Consensus       209 GFAK~t~~~~-------------~L~TPc~TPyYvaPev-lg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--ais  272 (400)
T KOG0604|consen  209 GFAKETQEPG-------------DLMTPCFTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AIS  272 (400)
T ss_pred             ccccccCCCc-------------cccCCcccccccCHHH-hCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCC
Confidence            9998754221             1225678999999999 55578999999999999999999999999865442  122


Q ss_pred             HHHHH-HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRK-AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .=.+. +......++   +|++.      .-.+...++++..|..+|.+|.|+.|+++
T Consensus       273 pgMk~rI~~gqy~FP---~pEWs------~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  273 PGMKRRIRTGQYEFP---EPEWS------CVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hhHHhHhhccCccCC---ChhHh------HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            22222 222222221   23221      11234556888999999999999999875

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-34  Score=287.96  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++....++     ..+|+|.+..... ....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDS-----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCC-----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            467999999999999997765     7899999865421 1233678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-CeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~~~  504 (642)
                      |+++++|.+++.....   ..++|..+..++.|+++||+|||+   .+++|+||||+||++++++ .+|++|||.+....
T Consensus        80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          80 YCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            9999999999976433   248999999999999999999999   8999999999999998875 46999999987654


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......|++.|+|||+... ..++.++|||||||++|||++|+.||...     .....+....
T Consensus       154 ~~~~------------~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~  215 (257)
T cd08225         154 DSME------------LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKIC  215 (257)
T ss_pred             CCcc------------cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHh
Confidence            3211            0112357788999998543 67889999999999999999999998642     2233333332


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....   ..+.+..         ...+.+++.+||+.+|++|||+.|+++
T Consensus       216 ~~~~---~~~~~~~---------~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         216 QGYF---APISPNF---------SRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             cccC---CCCCCCC---------CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2221   1111111         124566888999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-37  Score=283.22  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=194.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..||.|+||+|+|-..+..+     +..|||+++........++++.|.+...+- +.||||+++|.+...+..++.||.
T Consensus        70 g~iG~G~fG~V~KM~hk~sg-----~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSG-----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHhcCCcchhhhhhhcCccC-----cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            46899999999999888776     899999999876555568899999876555 799999999999999999999999


Q ss_pred             ccCCcHHHHH---hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          427 IRNGSLYAAL---HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       427 ~~~gsL~~~l---~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |.- ||..+.   +....   ..+++...-+|..-...||.||.+.  ..|||||+||+|||+|..|.+|+||||++-.+
T Consensus       145 Md~-SlDklYk~vy~vq~---~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQK---SRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHh---ccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            954 765443   22222   2488888888999999999999875  68999999999999999999999999999776


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..+..             .+.-+|...|||||.+..... |+-+|||||+|++|||+.||+.||..-.    +..+.+..
T Consensus       219 v~SiA-------------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~----svfeql~~  281 (361)
T KOG1006|consen  219 VDSIA-------------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD----SVFEQLCQ  281 (361)
T ss_pred             HHHHH-------------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH----HHHHHHHH
Confidence            54321             113467778999998655444 8999999999999999999999987522    23444444


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...+.++   .+....    ...+....+..++-.|+-.|-..||+..++.+
T Consensus       282 Vv~gdpp---~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  282 VVIGDPP---ILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHcCCCC---eecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            4444433   222111    11223456777888899999999999988754

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.5e-34  Score=296.71  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=190.8

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCC--ceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND--EKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--~~~l  422 (642)
                      ...||+|+||.||+|....++     +.+|+|++.... .......+.+|+.+++++ +||||++++++|...+  ..++
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTK-----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCC-----eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            467999999999999987654     789999886531 222235678899999999 9999999999987543  5799


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||++ ++|.+++...      .++|..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        87 v~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          87 VFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             Eecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            999997 5999988753      38899999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ........       .........|+..|+|||.+.....++.++|||||||++|||+||+.||....... ........
T Consensus       157 ~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~  228 (337)
T cd07852         157 LSELEENP-------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEV  228 (337)
T ss_pred             cccccccc-------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            64332110       00011134578889999986655668899999999999999999999996532211 01110000


Q ss_pred             HHhccCCCcc------------ccC-------hhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          583 AFRERRPLSE------------VID-------PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       583 ~~~~~~~~~~------------~~d-------~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                         ...+..+            .++       .......  ......+.+++.+||+.||++|||+.++++.
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 ---IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL--PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             ---hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc--cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               0000000            000       0000000  0012456789999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-34  Score=289.01  Aligned_cols=254  Identities=19%  Similarity=0.296  Sum_probs=193.2

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|+||.||+++....+     +.+++|.+.....  ....+.+.+|++++++++||||+++++.+......++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTG-----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCC-----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            689999999999988654     7899999875422  233477899999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++....     .+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||++.......
T Consensus        76 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~  147 (265)
T cd05579          76 PGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR  147 (265)
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence            9999999997643     38999999999999999999999   899999999999999999999999999987543221


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      ......    .........++..|+|||.... ...+.++||||||+++||++||+.||....     ............
T Consensus       148 ~~~~~~----~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  217 (265)
T cd05579         148 QINLND----DEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILNGK  217 (265)
T ss_pred             cccccc----ccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC
Confidence            100000    0001113456778999998544 568899999999999999999999997432     122233322222


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      .+......           ....+.+++.+||+.+|++|||+.++.+.|+
T Consensus       218 ~~~~~~~~-----------~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 IEWPEDVE-----------VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCCCcccc-----------CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            22111110           0134566888899999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.4e-34  Score=291.46  Aligned_cols=260  Identities=18%  Similarity=0.241  Sum_probs=188.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||+|.....+     +.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCC-----cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            457899999999999987654     7899999865422 2223678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~  504 (642)
                      |++ ++|.+++.....   ..+++.....++.||+.||+|||+   .+++||||||+||+++. ++.+||+|||+++...
T Consensus        82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            996 588888765432   236788889999999999999999   89999999999999985 5679999999997543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            ......++..|+|||++.....++.++||||+||++|||+||+.||...... ..+..... ..
T Consensus       155 ~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~-~~  220 (294)
T PLN00009        155 IPVR------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFR-IL  220 (294)
T ss_pred             CCcc------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-Hh
Confidence            2210            0012345678999998655456789999999999999999999999753221 11111111 00


Q ss_pred             hccC-CC--------------ccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          585 RERR-PL--------------SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~-~~--------------~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .... ..              .......+...  ......++.+++.+|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATV--VPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCCChhhccccccchhhhhhcccCCCCCHHHh--CcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000 00              00000000000  0011234677999999999999999999985

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.7e-35  Score=319.73  Aligned_cols=258  Identities=22%  Similarity=0.307  Sum_probs=187.2

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-----------
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-----------  416 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----------  416 (642)
                      .+||+||||.|||++.+-++     +.+|||++.-.........+.+|+.++++|+|||||+++..+.+           
T Consensus       485 ~lLGkGGFG~VvkVRNKlDG-----r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDG-----REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             HHhcCCCCceEEEEeecccc-----hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            68999999999999998876     89999999876544445788999999999999999999854210           


Q ss_pred             --------------------------------------------C-----------------------------------
Q 006522          417 --------------------------------------------N-----------------------------------  417 (642)
Q Consensus       417 --------------------------------------------~-----------------------------------  417 (642)
                                                                  .                                   
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                        0                                   


Q ss_pred             -----------------------------CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 006522          418 -----------------------------DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE  468 (642)
Q Consensus       418 -----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  468 (642)
                                                   ...|+=||||+.-.++++++++....    .-...++++++|+.||+|+|+
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHh
Confidence                                         11378899999977777777654321    246678999999999999999


Q ss_pred             cCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC---CCc---ccccceeeecCCCcccccCCCcccCccccccCC-
Q 006522          469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG---TSK---VTKNETIVTSGTGSRISAISNVYLAPEARIYGS-  541 (642)
Q Consensus       469 ~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~---~~~---~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-  541 (642)
                         ++||||||||.||++|++..+||+|||+|+....   ...   ...+..........+..+||..|+|||++.... 
T Consensus       716 ---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 ---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             ---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence               8999999999999999999999999999987321   100   001111111111234578999999999866544 


Q ss_pred             -CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCc-cccChhhhhchhHHHHHHHHHHHHHhcC
Q 006522          542 -KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS-EVIDPALVKEIHAKRQVLATFHIALNCT  619 (642)
Q Consensus       542 -~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~l~~~Cl  619 (642)
                       .|+.|+|+||+|||++||+.   ||...    ..-...+.......-|.+ ...++...          .-.+++.+++
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~~~f~~~~~~----------~e~slI~~Ll  855 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEPADFFDPEHP----------EEASLIRWLL  855 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCCcccccccch----------HHHHHHHHHh
Confidence             69999999999999999995   66542    122233333322222211 11233221          2245889999


Q ss_pred             CCCCCCCCCHHHHHH
Q 006522          620 ELDPEFRPRMRTVSE  634 (642)
Q Consensus       620 ~~dP~~RPs~~ev~~  634 (642)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.9e-34  Score=293.34  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=189.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      .+.||+|+||.||++.....+     ..||+|.++..... .....+.+|+.++++++|+||+++++++...  +..++|
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSG-----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            467999999999999987654     78999998754221 1224567899999999999999999999765  468999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++ +|.+++....    ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        87 ~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          87 MEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999975 8988887543    248999999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......            .....++..|+|||.+.....++.++||||+||++|||++|+.||.....  ......+...
T Consensus       159 ~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~  224 (309)
T cd07845         159 GLPAKP------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQL  224 (309)
T ss_pred             CCccCC------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHh
Confidence            432100            01123466799999865545688999999999999999999999975322  1111111111


Q ss_pred             HhccC-CCc---------cc--cChhhhhchhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FRERR-PLS---------EV--IDPALVKEIHA--KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~-~~~---------~~--~d~~l~~~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..... ...         ..  +...-......  ......+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            10000 000         00  00000000000  001245668999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3e-34  Score=294.54  Aligned_cols=260  Identities=21%  Similarity=0.288  Sum_probs=190.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-------  418 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------  418 (642)
                      ...||+|+||.||+|.....+     +.||+|.++.... ......+.+|++++++++||||+++++++...+       
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTG-----ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             eeeecccCCEEEEEEEECCCC-----cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            467999999999999997754     7899999875422 222356788999999999999999999987654       


Q ss_pred             ---ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          419 ---EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       419 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                         ..++|+||+++ ++.+.+....    ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence               78999999986 7777776542    248999999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      |||++.........           ......++..|+|||.+.....++.++|||||||++|||++|+.||.....  ..
T Consensus       159 dfg~~~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~  225 (302)
T cd07864         159 DFGLARLYNSEESR-----------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LA  225 (302)
T ss_pred             cccccccccCCccc-----------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HH
Confidence            99998866433210           001123456799999865545678999999999999999999999974321  11


Q ss_pred             HHHHHHHHHhccCC--Ccccc--------Ch------hhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          576 LESLVRKAFRERRP--LSEVI--------DP------ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~--~~~~~--------d~------~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ....+........+  .+...        ++      .+.....  .....+.+++..||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS--FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC--CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11112221111100  00000        00      0000000  01235678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.1e-34  Score=291.40  Aligned_cols=257  Identities=21%  Similarity=0.280  Sum_probs=195.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc---cccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA---TWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...||+|++|.||++.......  ..+.||||.+++...   ....+.+.+|++++.++ +||||+++++.+......++
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHD--AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             EEEeccCCCceEEEEEEecccc--CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            4679999999999998653221  127899999875321   22236788999999999 69999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+++|+|.+++....     .+++.....++.|+++||+|||+   .+++||||||+||+++.++.++|+|||+++.
T Consensus        83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          83 ILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999987543     38899999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .......           ......|+..|+|||...... ..+.++||||||+++|||+||+.||..... ......+.+
T Consensus       155 ~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~  222 (288)
T cd05583         155 FLAEEEE-----------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISR  222 (288)
T ss_pred             ccccccc-----------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHH
Confidence            5432110           011235677899999854322 368899999999999999999999964222 112233333


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~  638 (642)
                      .......+.+..+++.             +.+++.+||+.||++|||+.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~~~-------------l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 RILKSKPPFPKTMSAE-------------ARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHccCCCCCcccCHH-------------HHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            3333333333333332             3457888999999999999888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8e-34  Score=289.60  Aligned_cols=253  Identities=19%  Similarity=0.272  Sum_probs=191.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC---ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...||+|+||.||++....+...  ...||+|++....   .....+.+.+|++++.++ +|+||+++++++..+...++
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~--g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDS--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCC--CceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            45789999999999987542211  1789999987532   122236788999999999 69999999999999989999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+++++|.+++....     ++++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.
T Consensus        83 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          83 ILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999997643     48889999999999999999999   8999999999999999999999999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .......           ......|+..|+|||..... ..++.++||||||+++|||+||+.||..... ......+..
T Consensus       155 ~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~  222 (290)
T cd05613         155 FHEDEVE-----------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISR  222 (290)
T ss_pred             ccccccc-----------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHH
Confidence            5332110           01123577889999985432 3467899999999999999999999964222 222333444


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP-----s~~ev~~  634 (642)
                      .......+.+..+++             .+.+++.+||+.||++||     +..++++
T Consensus       223 ~~~~~~~~~~~~~~~-------------~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 RILKSEPPYPQEMSA-------------LAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HhhccCCCCCccCCH-------------HHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            333333333333333             234578889999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-34  Score=299.47  Aligned_cols=262  Identities=19%  Similarity=0.293  Sum_probs=191.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeC----CceE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN----DEKL  421 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~~~~  421 (642)
                      ...||+|++|.||++.....+     ..||+|++..... ....+.+.+|+.++++++||||+++++++...    ...+
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSG-----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCC-----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            357999999999999988765     7999999876422 23346788999999999999999999988643    4679


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +||||+. |+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++
T Consensus        85 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            9999996 59999986543     38999999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ........        .........|+..|+|||.+.....++.++|||||||++|||++|+.||......  .....+.
T Consensus       156 ~~~~~~~~--------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~  225 (334)
T cd07855         156 GLSSSPTE--------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLIL  225 (334)
T ss_pred             eecccCcC--------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHH
Confidence            65432111        0000113467788999998655456899999999999999999999999753221  1111111


Q ss_pred             HHHhccCCCccccC----hhhhhc---------h--h--HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          582 KAFRERRPLSEVID----PALVKE---------I--H--AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d----~~l~~~---------~--~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .....  +..+..+    ..+...         .  .  .......+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~g~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         226 SVLGS--PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHhCC--ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11000  0000000    000000         0  0  0011345778999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-33  Score=283.80  Aligned_cols=251  Identities=21%  Similarity=0.360  Sum_probs=198.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|++|.||++.....+     +.|+||++.........+.+.+|+.++.+++|+||+++++++...+..++||||
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~-----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTG-----KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCC-----cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468999999999999998754     899999987754433447899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++....     .+++..+..++.|+++||+|||+.  .+++||||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999997652     489999999999999999999973  48999999999999999999999999998765433


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ....            ....++..|+|||.... ..++.++||||||+++|||+||+.||.....  .............
T Consensus       154 ~~~~------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~  218 (264)
T cd06623         154 LDQC------------NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDG  218 (264)
T ss_pred             CCcc------------cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcC
Confidence            2110            12346677999998544 6788999999999999999999999975432  1222333333222


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..+   .++...        ....+.+++.+||+.+|++||++.|+++.
T Consensus       219 ~~~---~~~~~~--------~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 PPP---SLPAEE--------FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCC---CCCccc--------CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111   111110        11345668888999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=287.45  Aligned_cols=246  Identities=21%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...+|+|++|.||++.....+     ..+++|.+.....  ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATG-----KEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCC-----cEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            357899999999999988654     7899999976543  347889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++....    ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          97 MDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             cCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999998754    249999999999999999999999   89999999999999999999999999988654322


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||.+. +..++.++|||||||++|||+||+.||.....    . .........
T Consensus       170 ~~------------~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~-~~~~~~~~~  231 (286)
T cd06614         170 KS------------KRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----L-RALFLITTK  231 (286)
T ss_pred             hh------------hhccccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHHHhc
Confidence            10            011234667899999854 46789999999999999999999999864221    1 111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..  ....++.        .....+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~--~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 GI--PPLKNPE--------KWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CC--CCCcchh--------hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11  1111111        01124556889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.8e-34  Score=301.33  Aligned_cols=193  Identities=20%  Similarity=0.306  Sum_probs=160.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      ...||+|+||.||++.....+     +.||+|.+.... .....+++.+|+.++++++||||+++++++....      .
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTG-----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCC-----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            467999999999999987765     899999986532 2223367788999999999999999999987543      4


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+. ++|.+.+..       .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        96 ~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             EEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            699999996 488888753       27888999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      ++.......             .....++..|+|||.+. +..++.++|||||||++|+|++|+.||...
T Consensus       165 ~~~~~~~~~-------------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         165 ARTAGTSFM-------------MTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ceeCCCCCC-------------CCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            976533210             11235677899999854 477899999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=275.88  Aligned_cols=269  Identities=18%  Similarity=0.257  Sum_probs=202.0

Q ss_pred             cHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEe
Q 006522          338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYA  416 (642)
Q Consensus       338 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~  416 (642)
                      .++++.+-+.++||+|+++.|-.++.-.++     +.+|||++.+.. .....++.+|++++.+. .|+||+.++++|++
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~-----~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTG-----KEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccc-----hhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            356777778899999999999988876655     899999998763 33447889999999999 69999999999999


Q ss_pred             CCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC---CCeE
Q 006522          417 NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE---LHPC  493 (642)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~k  493 (642)
                      +...|||||-|.||+|..+|+++..     +++....++.++||.||.|||.   ++|.||||||+|||-.+-   --+|
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence            9999999999999999999988764     8999999999999999999999   899999999999998543   3489


Q ss_pred             EecccccccCCCCCcccccceeeecCCCcccccCCCcccCcccc---cc-CCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR---IY-GSKFTQKCDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~-~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      |+||-+..-........     ........+.+|+..|||||+.   .. ...|+.+.|.||+|||||-|+.|..||.+.
T Consensus       220 iCDfDLgSg~k~~~~~s-----pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCS-----PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             eeccccccccccCCCCC-----CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            99998775433221111     0111122356899999999972   11 246899999999999999999999999875


Q ss_pred             CCCcc----------cHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          570 ENDGK----------GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       570 ~~~~~----------~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      -..+-          .-..+++.+..+...+++   .++.. +     ..+..+++...+..|+.+|.++.++++
T Consensus       295 Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd---kdWah-I-----S~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  295 CGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD---KDWAH-I-----SSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCcCCccCCCccHHHHHHHHHHHhccCCcCCh---hhhHH-h-----hHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            43211          122233333333333322   22211 1     123345666677799999998888765

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-34  Score=292.06  Aligned_cols=251  Identities=21%  Similarity=0.339  Sum_probs=189.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ....||+|++|.||++.....+     +.||||+++.........++.+|+.++.+. +||||+++++++......++||
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTG-----HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCC-----eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4578999999999999988754     899999997654333346677888877777 4999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+++ ++.+++.....    .+++..+..++.|+++||+|||+.  .+|+||||||+||++++++.+||+|||++....
T Consensus        94 e~~~~-~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          94 ELMST-CLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eccCc-CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99854 77777655332    589999999999999999999972  489999999999999999999999999987653


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ....             .....++..|+|||.+...   ..++.++||||||+++|||++|+.||......    .....
T Consensus       167 ~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~  229 (296)
T cd06618         167 DSKA-------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FEVLT  229 (296)
T ss_pred             CCCc-------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HHHHH
Confidence            2211             0122466789999985432   23788999999999999999999999642221    12222


Q ss_pred             HHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .......+...  ...        ....++.+++.+||+.||++||++.++++.
T Consensus       230 ~~~~~~~~~~~--~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEEPPSLP--PNE--------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCCCCCCC--CCC--------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22222211110  000        011245678899999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.2e-34  Score=297.23  Aligned_cols=270  Identities=17%  Similarity=0.179  Sum_probs=193.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc-------------cHHHHHHHHHHHhcccCCCeeeEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-------------RFKDFESEVEAIARVQHPNIVRLKAF  413 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~H~nIv~l~~~  413 (642)
                      ...||+|+||.||++.....+     +.||||.++......             ....+.+|++++++++||||++++++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             hhcccCCCceeEEEEEECCCC-----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            467999999999999987654     899999987542211             01257899999999999999999999


Q ss_pred             EEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeE
Q 006522          414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC  493 (642)
Q Consensus       414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  493 (642)
                      +...+..++||||+. |+|.+++....     .+++.....++.|++.||+|||+   .+++||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence            999999999999997 59999986543     38899999999999999999999   8999999999999999999999


Q ss_pred             EecccccccCCCCCcccccce--eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 006522          494 ISGFGLNRLLPGTSKVTKNET--IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN  571 (642)
Q Consensus       494 l~DfGla~~~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~  571 (642)
                      |+|||+++.............  ............++..|+|||.+.....++.++||||+||++|||+||+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999986642211100000  000001111234677899999865545578999999999999999999999975432


Q ss_pred             CcccHHHHHHHHHhccCC--Cc------------cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          572 DGKGLESLVRKAFRERRP--LS------------EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       572 ~~~~l~~~~~~~~~~~~~--~~------------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      . ..+ ..+.........  ..            ....+......  ......+.+++.+||+.+|++||++.|++.
T Consensus       240 ~-~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 I-DQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF--PNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H-HHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhC--cCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1 111 111111111000  00            00001110000  011245678999999999999999999985

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-33  Score=289.79  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=188.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|....++     ..|++|.+.....  ....+.+.+|++++++++|||++++++++...+..++||
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTN-----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            356999999999999987654     7899999865422  223357889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+. |++.+++....    .++++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus       101 e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633         101 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             ecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            9996 58888876543    248999999999999999999999   899999999999999999999999999875422


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARI--YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..                ....|+..|+|||++.  ....++.++|||||||++|||++|..||.....     ......
T Consensus       173 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~  231 (313)
T cd06633         173 PA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH  231 (313)
T ss_pred             CC----------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHH
Confidence            11                1235677899999853  235678899999999999999999999875321     112222


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......  .....+.+         ...+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~--~~~~~~~~---------~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         232 IAQNDS--PTLQSNEW---------TDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHhcCC--CCCCcccc---------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222111  11111111         123456888999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.2e-34  Score=297.33  Aligned_cols=265  Identities=17%  Similarity=0.239  Sum_probs=192.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC-----Cce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN-----DEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~  420 (642)
                      ...||+|+||.||++.....+     +.||||.+.... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETN-----EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCC-----CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            457999999999999987654     899999987542 222235678899999999999999999988654     247


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+. ++|.+++....     .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            99999996 68999887543     48999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +.......            ......++..|+|||.+.....++.++|||||||++|||++|+.||.+....  ......
T Consensus       156 ~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~  221 (337)
T cd07858         156 RTTSEKGD------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLI  221 (337)
T ss_pred             cccCCCcc------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHH
Confidence            76543210            0112346778999998655456889999999999999999999999753211  111111


Q ss_pred             HHHHhccCC--CccccChhhhhc-------------hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhh
Q 006522          581 RKAFRERRP--LSEVIDPALVKE-------------IHAKRQVLATFHIALNCTELDPEFRPRMRTVSES--LDRV  639 (642)
Q Consensus       581 ~~~~~~~~~--~~~~~d~~l~~~-------------~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~l  639 (642)
                      ........+  .....++.....             ........++.+++.+||+.+|++|||+.|+++.  ++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            111100000  000000000000             0000122456789999999999999999999865  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=279.60  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=195.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.+|++.....+     +.|++|.+...... ...+.+.+|++++++++|||++++++++...+..++|||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETG-----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCC-----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            467999999999999887654     78999999765321 334789999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++....     .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          80 YAENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             cCCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            999999999997652     48999999999999999999999   8999999999999999999999999999986643


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....++..|+|||.... ..++.++||||+|+++|+|++|+.||....    ...........
T Consensus       152 ~~~~------------~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~  214 (254)
T cd06627         152 VSKD------------DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIVQD  214 (254)
T ss_pred             Cccc------------ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcc
Confidence            3210            113356778999998544 558899999999999999999999987432    12222222212


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ........+++             .+.+++.+||+.+|++||++.|++.
T Consensus       215 ~~~~~~~~~~~-------------~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISP-------------ELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHHhCChhhCcCHHHHhc
Confidence            22222222222             3446888899999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-33  Score=289.23  Aligned_cols=244  Identities=20%  Similarity=0.344  Sum_probs=188.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|++|.||+|....++     ..+++|.+...  ......+++.+|++++++++|+|++++++++...+..++||
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCC-----cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            457999999999999987654     78999988643  22223467889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+. |++.+.+.....    ++++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        95 e~~~-~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          95 EYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EccC-CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            9996 688888764432    48999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccc--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARI--YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..                ....++..|+|||.+.  ....++.++|||||||++|||++|+.||.....     ......
T Consensus       167 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~  225 (308)
T cd06634         167 PA----------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYH  225 (308)
T ss_pred             Cc----------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHHHHH
Confidence            21                1234677899999853  234578899999999999999999999864321     111111


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ......+  .....         .....+.+++.+||+.+|++||++.++++.
T Consensus       226 ~~~~~~~--~~~~~---------~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         226 IAQNESP--ALQSG---------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HhhcCCC--CcCcc---------cccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            1111111  10000         111234568889999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=281.76  Aligned_cols=249  Identities=19%  Similarity=0.272  Sum_probs=188.0

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC----ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--Cc
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD----ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DE  419 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~  419 (642)
                      ..+.||+|++|.||++.....+     +.|++|.+....    .....+.+.+|++++++++||||+++++++...  ..
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTG-----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCC-----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence            3568999999999999987654     789999875321    122346789999999999999999999998765  35


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++|+||+++++|.+++....     .+++.....++.|++.||.|||+   .+++||||||+||+++.++.++|+|||+
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccc
Confidence            789999999999999987543     37889999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++.......         .........++..|+|||++.. ..++.++|||||||++|||++|+.||.....    ....
T Consensus       153 ~~~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~  218 (264)
T cd06653         153 SKRIQTICM---------SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAI  218 (264)
T ss_pred             ccccccccc---------cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHH
Confidence            986532110         0001113457788999998544 6788999999999999999999999964321    2222


Q ss_pred             HHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                       ........  ...+.+.+.         ..+.+++..||+ +|..||+..++++
T Consensus       219 -~~~~~~~~--~~~~p~~~~---------~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         219 -FKIATQPT--KPMLPDGVS---------DACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -HHHHcCCC--CCCCCcccC---------HHHHHHHHHHhc-CcccCccHHHHhc
Confidence             22221111  111121111         234557788999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-33  Score=279.58  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=195.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--CceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv  423 (642)
                      .+.||+|++|.||+|....++     +.|++|.+..... ....+.+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTG-----ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             eeEeeecCceEEEEEEECCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            367999999999999988654     8999999876532 23347899999999999999999999999988  889999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      +||+++++|.+++....     .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            99999999999997653     48999999999999999999999   89999999999999999999999999998876


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......          .......++..|+|||.... ...+.++||||||+++|+|++|+.||.....    ........
T Consensus       152 ~~~~~~----------~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~  216 (260)
T cd06606         152 GDIETG----------EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKI  216 (260)
T ss_pred             cccccc----------ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhc
Confidence            543210          00113456778999998544 5689999999999999999999999975431    11111111


Q ss_pred             Hh--ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          584 FR--ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..  ....+...+             ...+.+++.+|++.+|++||++.|++.
T Consensus       217 ~~~~~~~~~~~~~-------------~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         217 GSSGEPPEIPEHL-------------SEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCCCcCCCccc-------------CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11  111111112             134566888999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-33  Score=291.20  Aligned_cols=270  Identities=19%  Similarity=0.238  Sum_probs=191.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYAND-------  418 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------  418 (642)
                      ...||+|++|.||+|.....+     +.+++|++...... .....+.+|++++++++||||+++++++....       
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTG-----RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            467999999999999987665     78999988654221 12256789999999999999999999876543       


Q ss_pred             -ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          419 -EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       419 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                       ..++|+||+.+ ++.+.+....    ..+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+||
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence             46999999975 7887776533    248999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++............. ...........+++.|+|||.+.....++.++|||||||++|||++|+.||.+.... ....
T Consensus       160 g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~  237 (311)
T cd07866         160 GLARPYDGPPPNPKGGG-GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLH  237 (311)
T ss_pred             ccchhccCCCcccccCC-cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence            99986543321111000 001111223467888999998655456899999999999999999999999753221 1111


Q ss_pred             HHHHHHHhccCC--------Cc--------cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRERRP--------LS--------EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~~--------~~--------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .... ......+        +.        ....+.+....  ......+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFK-LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHH-HhCCCChhhchhhhhcccccccccCCCCCccHHHHc--ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111 1100000        00        00111111000  011245778999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-35  Score=275.88  Aligned_cols=238  Identities=21%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      .-.+||+|.||.|-.++.+..+     +.+|+|++++.-  ....+..-+.|-++|+..+||.+..+...|+..+..++|
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~-----k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATG-----KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             HHHHhcCCccceEEEEeecccC-----ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            3578999999999999988776     899999998762  222334557899999999999999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+.||.|+-+|...+     .+++.....+-.+|..||.|||+   ++||.||||.+|.|+|.+|++||+|||+++.-
T Consensus       247 MeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999998887654     38888888999999999999999   89999999999999999999999999999863


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      -..            +......+|||.|.|||++ ....|+.+.|.|.+||++|||++|+.||...+.     ..+..-+
T Consensus       319 I~~------------g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLI  380 (516)
T KOG0690|consen  319 IKY------------GDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELI  380 (516)
T ss_pred             ccc------------cceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHH
Confidence            222            1122367999999999995 458899999999999999999999999985332     2344444


Q ss_pred             HhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP  627 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  627 (642)
                      ..+...++..++|+...             +.--.+..||.+|.
T Consensus       381 l~ed~kFPr~ls~eAkt-------------LLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMEDLKFPRTLSPEAKT-------------LLSGLLKKDPKKRL  411 (516)
T ss_pred             HhhhccCCccCCHHHHH-------------HHHHHhhcChHhhc
Confidence            44444456666666544             33347889999994

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=285.16  Aligned_cols=258  Identities=19%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..||+|++|.||++....++     +.+++|.+...... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTG-----EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             eeeecCCCceEEEEEcCCCC-----cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            56899999999999987654     88999998765322 2346788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++ +|.+++....    ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||.+......
T Consensus        80 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          80 MDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             cCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            975 8998887643    248999999999999999999999   89999999999999999999999999998766433


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||.......++.++||||+|+++|+|+||+.||...... ..+..... ....
T Consensus       152 ~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~-~~~~  217 (283)
T cd05118         152 VR------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFR-TLGT  217 (283)
T ss_pred             cc------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-HcCC
Confidence            10            0012346677999998655447899999999999999999999999653321 11111111 0000


Q ss_pred             cC----------------CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RR----------------PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~----------------~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..                ......+.....  .......++.+++.+||+.||.+||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPK--LFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CchHhcccchhhhhhhhhhhccccccCHHH--hhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00                000000000000  00122356778999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.9e-33  Score=276.40  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=194.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....++     +.+++|++..... ...+.+.+|++++++++||||+++++++...+..++++||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTG-----KEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             eeeeccCCceEEEEEEECCCC-----cEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            357999999999999987654     7899999976543 2347899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++....    ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||.+......
T Consensus        79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999999997653    248999999999999999999999   89999999999999999999999999998765433


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..             .....++..|+|||.... ..++.++||||||+++|+|++|+.||.....     ..........
T Consensus       152 ~~-------------~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~  212 (253)
T cd05122         152 KA-------------RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATN  212 (253)
T ss_pred             cc-------------ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhc
Confidence            11             113456778999998544 5688999999999999999999999874321     1111111111


Q ss_pred             cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..  ....++..        ....+.+++.+||+.||++|||+.|+++
T Consensus       213 ~~--~~~~~~~~--------~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         213 GP--PGLRNPEK--------WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CC--CCcCcccc--------cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11  11111100        0134667888999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-33  Score=292.17  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=187.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      ...||+|+||.||+|.....+     +.||||++..... ......+.+|+.++++++||||+++++++....      .
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTG-----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCC-----cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            478999999999999976554     7899999875422 222356889999999999999999999987543      4


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++|+||+.. +|.+++.       ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        95 ~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             EEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            5899999975 7777652       138899999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++......               ....++..|+|||.+.....++.++|||||||++|||++|+.||.....     ...
T Consensus       164 ~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~  223 (342)
T cd07879         164 ARHADAEM---------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQ  223 (342)
T ss_pred             CcCCCCCC---------------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence            87543211               1234567799999865545688999999999999999999999975321     111


Q ss_pred             HHHHHhc-cCCCccc-------------------cChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HH
Q 006522          580 VRKAFRE-RRPLSEV-------------------IDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES--LD  637 (642)
Q Consensus       580 ~~~~~~~-~~~~~~~-------------------~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~  637 (642)
                      +...... +.+..+.                   ....+....  ......+.+++.+||+.||++||++.|++..  ++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~  301 (342)
T cd07879         224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF--PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD  301 (342)
T ss_pred             HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh--cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence            1111110 0000000                   000000000  0011346789999999999999999999843  55


Q ss_pred             hhh
Q 006522          638 RVK  640 (642)
Q Consensus       638 ~l~  640 (642)
                      .++
T Consensus       302 ~~~  304 (342)
T cd07879         302 SFR  304 (342)
T ss_pred             hcc
Confidence            443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-33  Score=292.28  Aligned_cols=253  Identities=19%  Similarity=0.245  Sum_probs=186.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------c
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~  419 (642)
                      ...||+|+||.||++.....+     ..||||++..... ....+.+.+|++++++++||||+++++++....      .
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            467999999999999977654     7899999865322 222356889999999999999999999987653      3


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++||||+ +++|.+++...      .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|++|||+
T Consensus        95 ~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             EEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            58999999 77999888642      38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++......               ....+++.|+|||.+.....++.++||||+||++|++++|+.||......     ..
T Consensus       165 ~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-----~~  224 (343)
T cd07880         165 ARQTDSEM---------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-----DQ  224 (343)
T ss_pred             ccccccCc---------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence            87543211               12345778999998654356889999999999999999999999753221     11


Q ss_pred             HHHHHhccCCCccccChhhh--------h--------chh--HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALV--------K--------EIH--AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~--------~--------~~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..............+...+.        .        ...  .......+.+++.+|++.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111110000000000000        0        000  0011224678999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.5e-33  Score=290.47  Aligned_cols=266  Identities=20%  Similarity=0.231  Sum_probs=187.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeC----Cce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAN----DEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~~  420 (642)
                      ...||+|+||.||++......   ....||+|++.... .....+.+.+|++++.++ +||||+++++++...    ...
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETS---EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCC---cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            467999999999999987651   01789999987532 222236788999999999 599999999976543    357


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++++||+. ++|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            88899886 59999986543     48999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +........        .........||..|+|||+......++.++||||+||++|+|++|+.||......  ......
T Consensus       153 ~~~~~~~~~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~  222 (332)
T cd07857         153 RGFSENPGE--------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQI  222 (332)
T ss_pred             eeccccccc--------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHH
Confidence            865432111        0001113467889999998555456899999999999999999999998753211  011110


Q ss_pred             HHHHhccCC--CccccChhhhh-----------chhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRP--LSEVIDPALVK-----------EIHA--KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~--~~~~~d~~l~~-----------~~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .........  .....++....           ....  ......+.+++.+|++.||++|||+.|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000  00000000000           0000  001235678999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-33  Score=293.57  Aligned_cols=257  Identities=19%  Similarity=0.256  Sum_probs=185.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC------Cc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~  419 (642)
                      ...||+|+||.||++....++     +.||+|++.... .....+.+.+|+.++++++||||+++++++...      ..
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCC-----eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            357999999999999987654     899999987542 222236788999999999999999999988643      34


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .+++++++ +++|.+++...      .+++..+..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        97 ~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~  166 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL  166 (345)
T ss_pred             EEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccc
Confidence            67888876 78999888643      38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++.....               .....++..|+|||.......++.++|||||||++|||++|+.||..... ...+...
T Consensus       167 ~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~  230 (345)
T cd07877         167 ARHTDDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLI  230 (345)
T ss_pred             ccccccc---------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence            8754221               11235677899999855435678999999999999999999999964322 1111111


Q ss_pred             HHHHHhccCCCccccChhhhhch-hH-------------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALVKEI-HA-------------KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~~~-~~-------------~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+............+........ ..             ......+.+++.+|++.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            11110000000000000000000 00             001234678999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.7e-33  Score=288.73  Aligned_cols=257  Identities=19%  Similarity=0.268  Sum_probs=187.4

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEe-CCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-NDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     +.||+|++.... .....+.+.+|++++++++||||++++++|.. ....++|+
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTG-----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             EEeecccCCeEEEEEEECCCC-----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            468999999999999987665     899999886532 22233678899999999999999999999876 45789999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||+ +++|.++++..      .+++.....++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus        90 e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          90 ELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             ehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            998 56999888642      37888889999999999999999   899999999999999999999999999987532


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               .....++..|+|||.+..+..++.++|||||||++|||+||+.||......  .....+....
T Consensus       160 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~~~~~~  222 (328)
T cd07856         160 PQ---------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSIITDLL  222 (328)
T ss_pred             CC---------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh
Confidence            21               012345677999998655467899999999999999999999999753221  1111111111


Q ss_pred             hccCC--CccccChh-------hhh--chhHH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          585 RERRP--LSEVIDPA-------LVK--EIHAK----RQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       585 ~~~~~--~~~~~d~~-------l~~--~~~~~----~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .....  .....+..       +..  .....    .....+.+++.+|++.+|++||++.+++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000  00000000       000  00000    012456778999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=280.31  Aligned_cols=259  Identities=19%  Similarity=0.262  Sum_probs=189.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhcc---cCCCeeeEEEEEEeCCc---
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARV---QHPNIVRLKAFYYANDE---  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~---  419 (642)
                      .+.||+|+||.||++.....+     +.+|+|+++..... .....+.+|+.++.++   +||||+++++++...+.   
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             EEEecccCceEEEEEEECCCC-----CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            467899999999999987643     79999999754222 2225567788877766   59999999999998776   


Q ss_pred             --eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          420 --KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       420 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                        .+++|||+.+ +|.+++.....   ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+||
T Consensus        79 ~~~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          79 LKLTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             ceeEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEecc
Confidence              8999999975 89998875432   248999999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |++........             .....++..|+|||++.. ..++.++|||||||++|||+||+.||..... ...+.
T Consensus       152 g~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~  216 (287)
T cd07838         152 GLARIYSFEMA-------------LTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLD  216 (287)
T ss_pred             CcceeccCCcc-------------cccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHH
Confidence            99876533211             012245678999998544 6789999999999999999999999875322 11122


Q ss_pred             HHHHHHHhc---cCCCc---------cccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRE---RRPLS---------EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~---~~~~~---------~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+.......   ..+..         .........  ....-...+.+++.+||+.||++||++.|++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS--FVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHcCCCChHhcCCCcccchhhcccccccchhh--hhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            222111000   00000         000000000  00112245678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.7e-33  Score=291.45  Aligned_cols=258  Identities=20%  Similarity=0.304  Sum_probs=186.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC---------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN---------  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------  417 (642)
                      ...||.|+||.||+|.....+     +.||+|.+..... ...+.+.+|++++++++||||+++++++...         
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~-----~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCD-----KRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCC-----cEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            467999999999999987765     7999999866433 3347788999999999999999999876654         


Q ss_pred             -----CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC-CCCC
Q 006522          418 -----DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD-DELH  491 (642)
Q Consensus       418 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~  491 (642)
                           ...++||||++ ++|.+++...      .+++.....++.||+.||+|||+   .+|+||||||+||+++ +++.
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCce
Confidence                 35789999997 5999888642      38899999999999999999999   8999999999999997 4567


Q ss_pred             eEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 006522          492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN  571 (642)
Q Consensus       492 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~  571 (642)
                      +|++|||+++.........         .......++..|+|||.+..+..++.++|||||||++|||++|+.||.....
T Consensus       154 ~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHK---------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             EEECCcccceecCCccccc---------cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8999999987653221100         0011235677899999855556688999999999999999999999975322


Q ss_pred             CcccHHHHHHHHHhccC-CCc-------cccChhhh------hc-hh--HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          572 DGKGLESLVRKAFRERR-PLS-------EVIDPALV------KE-IH--AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       572 ~~~~l~~~~~~~~~~~~-~~~-------~~~d~~l~------~~-~~--~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .    . .........+ ...       ..+.....      .. ..  ......++.+++.+||+.||++|||+.|+++
T Consensus       225 ~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 L----E-QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             H----H-HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1    1 1111110000 000       00000000      00 00  0011235668999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-33  Score=276.73  Aligned_cols=238  Identities=22%  Similarity=0.337  Sum_probs=190.4

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeec
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ||+|++|.||++.....+     +.+++|.+.....  ......+..|++++++++||||+++++.+..++..++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTG-----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCC-----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            689999999999987644     7899999876532  223467899999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCC
Q 006522          428 RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS  507 (642)
Q Consensus       428 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~  507 (642)
                      ++++|.+++....     .+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        76 ~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  147 (250)
T cd05123          76 PGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG  147 (250)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence            9999999997653     38999999999999999999999   899999999999999999999999999987654321


Q ss_pred             cccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhcc
Q 006522          508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      .            ......++..|+|||.... ...+.++|+||||+++||+++|+.||.....     ....+......
T Consensus       148 ~------------~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~  209 (250)
T cd05123         148 S------------RTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP  209 (250)
T ss_pred             C------------cccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC
Confidence            0            0113456778999998543 6678999999999999999999999964322     23333333333


Q ss_pred             CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHH
Q 006522          588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT  631 (642)
Q Consensus       588 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~e  631 (642)
                      .++...++.             .+.+++.+||..||++||++.+
T Consensus       210 ~~~~~~~~~-------------~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 LRFPEFLSP-------------EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCH-------------HHHHHHHHHhcCCHhhCCCccc
Confidence            333333322             3456888899999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-33  Score=293.09  Aligned_cols=253  Identities=18%  Similarity=0.257  Sum_probs=189.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE------  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------  419 (642)
                      ...||+|++|.||+|....++     ..||||++.... .....+.+.+|+.++++++||||+++++++...+.      
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTG-----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             EEEeccCCceEEEEEEECCCC-----cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            467999999999999997765     789999986532 22233667889999999999999999998876654      


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGl  499 (642)
                      .++|+||+ +++|.+++...      .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        95 ~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             EEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence            89999998 66999998752      38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHH
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      +......               .....++..|+|||.......++.++||||+||++|||+||+.||.....     ...
T Consensus       165 ~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-----~~~  224 (343)
T cd07851         165 ARHTDDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-----IDQ  224 (343)
T ss_pred             ccccccc---------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHH
Confidence            8765322               11235677899999855434678999999999999999999999975322     111


Q ss_pred             HHHHHhccCCCccccChhhhh-----c-----------hhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          580 VRKAFRERRPLSEVIDPALVK-----E-----------IHA--KRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~~~~~~~~~~~~d~~l~~-----~-----------~~~--~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +...........+.+...+..     .           ...  .....++.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            111111110000000000000     0           000  011346778999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=291.27  Aligned_cols=265  Identities=18%  Similarity=0.257  Sum_probs=196.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~  420 (642)
                      ...||+|++|.||+|.....+     +.|++|++..... ....+.+.+|+.++++++||||+++++++...+     ..
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTG-----RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCC-----cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            467999999999999987654     7899999876432 333478999999999999999999999998775     78


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      |+||||+++ +|.+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++|+|||++
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEEecchhh-hHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            999999984 8999987543     48999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      .........         ........++..|+|||.+.....++.++||||||+++|+|+||+.||.....     ....
T Consensus       151 ~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~  216 (330)
T cd07834         151 RGVDPDEDE---------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQL  216 (330)
T ss_pred             Eeecccccc---------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHH
Confidence            876443210         00111335677899999866544789999999999999999999999975432     1111


Q ss_pred             HHHHhccC-CCccc----cChhhhhchh-------------HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhh
Q 006522          581 RKAFRERR-PLSEV----IDPALVKEIH-------------AKRQVLATFHIALNCTELDPEFRPRMRTVSES--LDRV  639 (642)
Q Consensus       581 ~~~~~~~~-~~~~~----~d~~l~~~~~-------------~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~--L~~l  639 (642)
                      +....... +..+.    ..........             .......+.+++.+||+.+|++||++.+++..  ++.+
T Consensus       217 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         217 NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            11111100 00000    0000000000             00012356789999999999999999999873  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.6e-33  Score=278.26  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|++|.+|++.....+     +.+++|.+.... ......++.+|++++++++|+||+++++++......++|||
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDN-----QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             eeeecCCCceeEEEEEECCCC-----CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            467899999999999877654     789999987542 22334678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++...... ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+|++|||+++....
T Consensus        80 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          80 YAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            99999999998763321 1358999999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..              .....++..|++||... +..++.++|+||+|+++|||++|+.||.....     .........
T Consensus       156 ~~--------------~~~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~  215 (256)
T cd08530         156 NM--------------AKTQIGTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQR  215 (256)
T ss_pred             CC--------------cccccCCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhc
Confidence            21              11234677899999854 46788999999999999999999999975321     222222221


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ...  . .+..         .....+.+++.+|++.+|++||++.|+++
T Consensus       216 ~~~--~-~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 GKY--P-PIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCC--C-CCch---------hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111  1 1111         11234667889999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-32  Score=275.01  Aligned_cols=248  Identities=22%  Similarity=0.356  Sum_probs=196.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|++|.||++....++     ..+++|++..... ....+.+.+|++++++++|||++++++.+...+..++|+|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDG-----KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCC-----cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            357899999999999987654     7899999876532 2334678999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      |+++++|.+++...... ...+++..+..++.+++.||+|||+   .+++|+||+|+||++++++.++|+|||.+.....
T Consensus        80 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          80 YADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             ecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            99999999999765311 1359999999999999999999999   7999999999999999999999999999876543


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......|++.|+|||.... ..++.++||||+|+++|+|++|+.||....     ..........
T Consensus       156 ~~~------------~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~  217 (258)
T cd08215         156 TVD------------LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILK  217 (258)
T ss_pred             Ccc------------eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhc
Confidence            210            0112356778999998544 678899999999999999999999986432     2233333322


Q ss_pred             cc-CCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. .++...++             ..+.+++.+||+.+|++||++.|+++
T Consensus       218 ~~~~~~~~~~~-------------~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 GQYPPIPSQYS-------------SELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCCC-------------HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            21 11111111             24556888999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=279.72  Aligned_cols=258  Identities=19%  Similarity=0.288  Sum_probs=192.8

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..||+|++|.||++.....+     +.+++|.+.... .....+.+..|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTG-----EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             hcccccCcceEEEeeecCCC-----cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            56899999999999988754     899999998653 222236788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      ++ ++|.+++....    ..+++..+..++.|++.||+|||+   .+|+||||+|+||++++++.+||+|||+++.....
T Consensus        80 ~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          80 CD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             cC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            98 59999998653    248999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhc
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+.... .....
T Consensus       152 ~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~-~~~~~  217 (282)
T cd07829         152 LR------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIF-QILGT  217 (282)
T ss_pred             cc------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH-HHhCC
Confidence            11            0012234567999998665447899999999999999999999999653221 1111111 00000


Q ss_pred             c--------CC-------CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          587 R--------RP-------LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~--------~~-------~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .        ..       .............  ......+.+++.+||+.||++||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CcHHHHHhhcccccccccccccCccchHHhc--ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0        00       0000000000000  001245788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.9e-33  Score=281.97  Aligned_cols=256  Identities=19%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ...||+|++|.||++....++     +.|++|.+....  .....+.+.+|++++.+++ ||||+++++++...+..++|
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETN-----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCC-----CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            457899999999999987654     889999987532  1222367889999999998 99999999999999999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++++|.+++....     .+++..+..|+.|++.||+|||+   .+++|+||||+||+++.++.++++|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            99999999999997653     49999999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCcccccce--------eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCccc
Q 006522          504 PGTSKVTKNET--------IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG  575 (642)
Q Consensus       504 ~~~~~~~~~~~--------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~  575 (642)
                      ...........        ............++..|+|||.... ..++.++||||+|++++|+++|+.||.....    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----  227 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----  227 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence            54321100000        0000011123457788999998544 6688999999999999999999999975321    


Q ss_pred             HHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHH
Q 006522          576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM----RTVSE  634 (642)
Q Consensus       576 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~----~ev~~  634 (642)
                       ....+........++..+++             .+.+++.+||+.+|.+||++    .|+++
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~-------------~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 -YLTFQKILKLEYSFPPNFPP-------------DAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHHHHhcCCCCCCccCH-------------HHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             22222332323333333322             34568888999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=279.29  Aligned_cols=256  Identities=21%  Similarity=0.254  Sum_probs=194.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc------ccHHHHHHHHHHHhcccCCCeeeEEEEEEeC-Cce
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT------WRFKDFESEVEAIARVQHPNIVRLKAFYYAN-DEK  420 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~  420 (642)
                      .+||+|||+.||++.+-...     +.||||+-.....+      ...+...+|..|-+.++||.||++|+||.-+ +..
T Consensus       469 hLLGrGGFSEVyKAFDl~Eq-----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQ-----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHhccccHHHHHHhcccchh-----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            68999999999999987765     78999986433221      1235678999999999999999999999754 578


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC---CCCCeEEecc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGF  497 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~Df  497 (642)
                      +-|+|||+|.+|+-+|+.++.     +++.....|+.||+.||.||.+.. .+|||-||||.||||.   ..|.+||.||
T Consensus       544 CTVLEYceGNDLDFYLKQhkl-----mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHKL-----MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eeeeeecCCCchhHHHHhhhh-----hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            899999999999999988764     889999999999999999999865 6999999999999994   4689999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcc
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK  574 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~  574 (642)
                      |+++++.++++........+     ...+||.+|.+||.+.-+   .+++.|+||||.|||+|..+.|+.||....... 
T Consensus       618 GLSKIMdddSy~~vdGmeLT-----SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-  691 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELT-----SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-  691 (775)
T ss_pred             chhhhccCCccCcccceeee-----cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-
Confidence            99999987765433322222     246799999999987654   457899999999999999999999996532211 


Q ss_pred             cHHHHH--HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          575 GLESLV--RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       575 ~l~~~~--~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      ++.+.-  .+...-..|....++++.             -.++.+|+++.-++|....++.
T Consensus       692 dILqeNTIlkAtEVqFP~KPvVsseA-------------kaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 DILQENTILKATEVQFPPKPVVSSEA-------------KAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHhhhchhcceeccCCCCCccCHHH-------------HHHHHHHHHhhhhhhhhHHHHc
Confidence            111110  001111122233344333             3477789988888887766654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.8e-33  Score=277.98  Aligned_cols=248  Identities=21%  Similarity=0.308  Sum_probs=185.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC---C-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG---D-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~---~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...||+|+||.||++......     ..+++|.++..   . ......++.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAV-----AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             eeeecCCCCceEEEEEecCCC-----CcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence            457999999999999876653     33444444321   1 11222467789999999999999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+++++|.+++...... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++ +.+||+|||+++.
T Consensus        80 v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceee
Confidence            99999999999998753221 1359999999999999999999999   89999999999999975 5699999999876


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .......            .....|+..|+|||... +..++.++||||||+++|+|++|..||...     ........
T Consensus       155 ~~~~~~~------------~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~~  216 (260)
T cd08222         155 LMGSCDL------------ATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVLR  216 (260)
T ss_pred             cCCCccc------------ccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHH
Confidence            5432110            11234677899999854 467888999999999999999999998632     12223333


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ......+   .+..         .....+.+++.+||+.+|++||++.|+++
T Consensus       217 ~~~~~~~---~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         217 IVEGPTP---SLPE---------TYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHcCCCC---CCcc---------hhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            2222111   1111         11124566889999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-32  Score=308.22  Aligned_cols=143  Identities=22%  Similarity=0.323  Sum_probs=127.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc--cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|+....+     +.||||+++....  ......+.+|+.++..++||||+++++++...+..|+||
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~-----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNS-----KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCC-----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            467999999999999988654     7999999975422  222367889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||+++++|.++++...     .+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            9999999999997643     38889999999999999999999   7999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8e-33  Score=273.44  Aligned_cols=221  Identities=21%  Similarity=0.256  Sum_probs=172.6

Q ss_pred             cCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccCCcH
Q 006522          353 SKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL  432 (642)
Q Consensus       353 g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (642)
                      |.+|.||++++..++     +.+|+|++....      .+.+|...+....||||+++++++...+..++||||+++|+|
T Consensus         4 g~~~~v~~~~~~~~~-----~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQ-----QTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCC-----cEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            889999999998776     789999997642      233455556666899999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCccccc
Q 006522          433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN  512 (642)
Q Consensus       433 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~  512 (642)
                      .+++....     .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++++|||.+.......     
T Consensus        73 ~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----  139 (237)
T cd05576          73 WSHISKFL-----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----  139 (237)
T ss_pred             HHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence            99997643     38999999999999999999999   899999999999999999999999999876543221     


Q ss_pred             ceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCcc
Q 006522          513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE  592 (642)
Q Consensus       513 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~  592 (642)
                                ....++..|+|||... +..++.++||||+||++|||++|+.|+.......       .  ......++.
T Consensus       140 ----------~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~--~~~~~~~~~  199 (237)
T cd05576         140 ----------DGEAVENMYCAPEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N--THTTLNIPE  199 (237)
T ss_pred             ----------ccCCcCccccCCcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c--cccccCCcc
Confidence                      0123456699999843 4678899999999999999999998875321100       0  000001122


Q ss_pred             ccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          593 VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       593 ~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      .+++             .+.+++.+|++.||++||++.
T Consensus       200 ~~~~-------------~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         200 WVSE-------------EARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             cCCH-------------HHHHHHHHHccCCHHHhcCCC
Confidence            2222             345688889999999999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-33  Score=269.03  Aligned_cols=265  Identities=18%  Similarity=0.264  Sum_probs=211.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC-CceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN-DEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~  424 (642)
                      ...++-+|.||.||.|.+.+.......+.|.||.++...++-++..++.|...+..+.|||+..+.+.+.+. +..+.+|
T Consensus       288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y  367 (563)
T KOG1024|consen  288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY  367 (563)
T ss_pred             chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence            357888999999999988776555566789999998877777778899999999999999999999998765 5789999


Q ss_pred             eeccCCcHHHHHhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          425 DFIRNGSLYAALHAGPSD---SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      .++.-|+|..+|...+..   ....++-.+.+.++.|++.|++|||.   .+|||.||..+|++||+...+||+|=.++|
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhcc
Confidence            999999999999843321   12347778889999999999999999   899999999999999999999999999999


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~~~~  580 (642)
                      .+...++....+.          ...+..||+||.+.. ..|+.++|||||||+||||+| |+.||...+  ...+..++
T Consensus       445 DLFP~DYhcLGDn----------EnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~~yl  511 (563)
T KOG1024|consen  445 DLFPGDYHCLGDN----------ENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEMEHYL  511 (563)
T ss_pred             ccCcccccccCCC----------CCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHHHHH
Confidence            8876654432221          122346999998554 789999999999999999999 999997532  22233333


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      +..++-..|    +           .+..+++.+|..||..+|++||++.+++.-|.+...
T Consensus       512 kdGyRlaQP----~-----------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  512 KDGYRLAQP----F-----------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             hccceecCC----C-----------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            333322222    1           233467789999999999999999999999988643

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-35  Score=266.96  Aligned_cols=265  Identities=19%  Similarity=0.257  Sum_probs=196.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeC--------
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--------  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------  417 (642)
                      ...+|+|.||.||+++.++++     +.||+|++--.. ....-...++|+.+|..++|+|++.+++.|...        
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~-----kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTG-----KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCcc-----chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            467999999999999998876     778888764321 111225678999999999999999999988653        


Q ss_pred             CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecc
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~Df  497 (642)
                      ...|+||++|+. +|..+|.....    .++...+.+++.++..||.|+|+   ..|+|||+|++|+||+.++.+||+||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence            247999999998 99999975532    38889999999999999999999   89999999999999999999999999


Q ss_pred             cccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++.+......        ...+.+..+.|.+|.+||.+++.+.|+++.|||.-|||+.||.||.+-+.+....  ...
T Consensus       169 Glar~fs~~~n~--------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq--qql  238 (376)
T KOG0669|consen  169 GLARAFSTSKNV--------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ--QQL  238 (376)
T ss_pred             ccccceeccccc--------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH--HHH
Confidence            999876544321        1222345667899999999888889999999999999999999999888763321  112


Q ss_pred             HHHHHHHhc----cCC------CccccChh-hhhch-hH-HHHH------HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRE----RRP------LSEVIDPA-LVKEI-HA-KRQV------LATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~----~~~------~~~~~d~~-l~~~~-~~-~~~~------~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ..+......    .+|      +.+.+.-+ +.+.. .. ...+      ...++++-..+..||.+|+++.+++.
T Consensus       239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            222222111    111      11111000 11000 00 1112      26778999999999999999998875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=276.13  Aligned_cols=238  Identities=19%  Similarity=0.296  Sum_probs=187.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      +-.+||+|+||.|..+..+...     ..+|||++++.-  ....++--+.|-++|+.- +-|.+|+++.+|+..+..|+
T Consensus       353 Fl~VlGKGSFGKVlLaerkgtd-----ELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  353 FLMVLGKGSFGKVLLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             eEEEeccCccceeeeecccCcc-----hhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            4579999999999999876654     789999998751  112224445677777766 67899999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      ||||+.||+|.-.+++.+.     +-+..++.++.+||-||-|||+   ++||.||||.+||+||.+|++||+|||+++.
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999999987664     6667889999999999999999   8999999999999999999999999999985


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ---            .+..+.+.+||+-|+|||++.. +.|+..+|.|||||+||||+.|+.||++.+.     .+..+.
T Consensus       500 ni~------------~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-----~elF~a  561 (683)
T KOG0696|consen  500 NIF------------DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQA  561 (683)
T ss_pred             ccc------------CCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH
Confidence            321            2223346799999999999666 8999999999999999999999999987443     334444


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP  627 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  627 (642)
                      +.......+..++.             +.+.+....+...|.+|.
T Consensus       562 I~ehnvsyPKslSk-------------EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  562 IMEHNVSYPKSLSK-------------EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHccCcCcccccH-------------HHHHHHHHHhhcCCcccc
Confidence            44443333333332             233455556777888774

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=291.99  Aligned_cols=248  Identities=22%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEe-----CCce
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYA-----NDEK  420 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-----~~~~  420 (642)
                      ..+||+|.+|.||+++..+.+     +..|+|++....+.+  ++++.|.++++.. +|||++.++|+|..     +++.
T Consensus        24 ~evig~Gtygkv~k~k~~~~~-----~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTG-----QLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             EEEEeeccceeEEEEeeeecC-----ceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            468999999999999988775     788888887654433  7788999999888 79999999999975     4689


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      +||||||.+||..|+++....   ..+.|..+..|+++++.|+.+||.   ..++|||+|-.|||++.++.+|++|||++
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeee
Confidence            999999999999999987653   359999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcccccceeeecCCCcccccCCCcccCccccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccH
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG----SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL  576 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l  576 (642)
                      ..+..+            .....+..||+.|||||++...    ..|+.++|+||+|++..||.-|.+|+.++..     
T Consensus       171 aQldsT------------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----  233 (953)
T KOG0587|consen  171 AQLDST------------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----  233 (953)
T ss_pred             eeeecc------------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----
Confidence            876533            2233467899999999986553    3467899999999999999999999876432     


Q ss_pred             HHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       577 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                         ++..+.-.+.    =.|.+   ........++.+++..|+..|-++||++.++++
T Consensus       234 ---mraLF~IpRN----PPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 ---MRALFLIPRN----PPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---hhhhccCCCC----CCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               1112221111    11222   123445677889999999999999999988764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=281.71  Aligned_cols=243  Identities=19%  Similarity=0.293  Sum_probs=188.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .++||+|.||+||-|..++.+     +.||||.+.+-. ...+..+++.|+.||.+++||.||.+...|+..+..+.|||
T Consensus       569 devLGSGQFG~VYgg~hRktG-----rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTG-----RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccC-----ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            489999999999999998876     899999998752 22333778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC---CCCeEEeccccccc
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD---ELHPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DfGla~~  502 (642)
                      -+.| |..+.+-.....   .|++.....+..||+.||.|||.   ++|+|+||||+|||+.+   .-.+||||||.|++
T Consensus       644 Kl~G-DMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  644 KLHG-DMLEMILSSEKG---RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             hhcc-hHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceee
Confidence            9955 666665443332   38999999999999999999999   89999999999999953   45799999999999


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      +.+...             .+..+||+.|.|||++.. ..|+..-|+||.|||+|--++|..||..    +.++.+.++.
T Consensus       717 IgEksF-------------RrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQN  778 (888)
T KOG4236|consen  717 IGEKSF-------------RRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQN  778 (888)
T ss_pred             cchhhh-------------hhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCC----ccchhHHhhc
Confidence            875531             236789999999999654 7899999999999999999999999964    3344444443


Q ss_pred             HHh-ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 006522          583 AFR-ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV  632 (642)
Q Consensus       583 ~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev  632 (642)
                      ... -+..-...+++.             .++++...++..=++|-|....
T Consensus       779 AaFMyPp~PW~eis~~-------------AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  779 AAFMYPPNPWSEISPE-------------AIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             cccccCCCchhhcCHH-------------HHHHHHHHHHHHHHHhcchHhh
Confidence            321 111112233333             3445555666666666665443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=245.60  Aligned_cols=226  Identities=19%  Similarity=0.274  Sum_probs=176.0

Q ss_pred             ccHHHHHhhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEE
Q 006522          337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY  415 (642)
Q Consensus       337 ~~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~  415 (642)
                      +++.+-.......||+|++|.|-+-++...+     +..|||++...-.....++.++|+.+..+. ..|.+|.++|.+.
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg-----~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSG-----TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCC-----eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            4443333345678999999999998887765     899999998775444557888999876655 8999999999999


Q ss_pred             eCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      .....++.||.|.- ||..+..+--..+ ..+++...-+|+..|.+||.|||+.  ..+||||+||+|||++.+|++|+|
T Consensus       116 regdvwIcME~M~t-Sldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  116 REGDVWICMELMDT-SLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             ccccEEEeHHHhhh-hHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEc
Confidence            99999999999965 8876654322111 2488899999999999999999995  579999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCC
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG---SKFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~  572 (642)
                      |||++-.+.++..             .+...|...|||||.+..+   ..|+-|+||||+|+++.||.+++.||+.-.. 
T Consensus       192 DFGIsG~L~dSiA-------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t-  257 (282)
T KOG0984|consen  192 DFGISGYLVDSIA-------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT-  257 (282)
T ss_pred             ccccceeehhhhH-------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC-
Confidence            9999977654321             1123566779999975432   3689999999999999999999999975333 


Q ss_pred             cccHHHHHHHHHhccC
Q 006522          573 GKGLESLVRKAFRERR  588 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~  588 (642)
                         -.+.+++...+..
T Consensus       258 ---pF~qLkqvVeep~  270 (282)
T KOG0984|consen  258 ---PFQQLKQVVEEPS  270 (282)
T ss_pred             ---HHHHHHHHhcCCC
Confidence               2344455554443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-32  Score=238.38  Aligned_cols=197  Identities=20%  Similarity=0.285  Sum_probs=166.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      +.||+|.+|+||+++..+..     ..||+|+++-.++.+. -....+|+.+++.++|.|||++++...++...-+|+||
T Consensus         8 ekigegtygtvfkarn~~t~-----eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             HhhcCCcceeeEecccCCcc-----ceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            56999999999999987765     8999999986543332 36789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |.. +|..+...-.+    .++.+....++.|+++||.|+|+   ..+.|||+||.|.|++.+|+.|++|||+++.+.-.
T Consensus        83 cdq-dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hhH-HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            976 88888765443    38889999999999999999999   89999999999999999999999999999876432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP  569 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~  569 (642)
                      ..            -....+.|.+|.+|.++.+..-|++..|+||-|||+.|+.. |++-|.+.
T Consensus       155 vr------------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  155 VR------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             eE------------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            11            01133567889999997776779999999999999999997 66666653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-32  Score=283.48  Aligned_cols=233  Identities=23%  Similarity=0.344  Sum_probs=185.0

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..+|.|+|+++-.+......     +..+||++.+...     +-.+|+.++.+. +||||+++.+.+.+..+.|+|||+
T Consensus       328 ~~~~~gs~s~~~~~~~~~t~-----~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  328 EELGEGSFSAVKYCESSPTD-----QEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             cccCCCCccceeeeeccccc-----cchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            44899999999999887776     8899999987622     223678777766 799999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee-CCCCCeEEecccccccCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL-DDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DfGla~~~~~  505 (642)
                      +.+|-+.+.+.....     +. ..+..|+.+|+.|+.|||+   ++||||||||+|||+ ++.++++|+|||.++....
T Consensus       398 l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999888876542     23 6777899999999999999   899999999999999 5899999999999988754


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .-               ...+-|..|.|||+.. ...|++++|+||+|++||||+||+.||.....+    .++.... .
T Consensus       469 ~~---------------~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i-~  527 (612)
T KOG0603|consen  469 SC---------------DTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRI-Q  527 (612)
T ss_pred             hh---------------cccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhh-c
Confidence            31               1234567799999955 588999999999999999999999999865443    1222222 1


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .. ...+.++..             +.+|+..||+.||.+||+|.++..
T Consensus       528 ~~-~~s~~vS~~-------------AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 MP-KFSECVSDE-------------AKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CC-ccccccCHH-------------HHHHHHHhccCChhhCcChhhhcc
Confidence            11 122333333             345777799999999999999853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.4e-33  Score=270.04  Aligned_cols=255  Identities=18%  Similarity=0.277  Sum_probs=196.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-C-CC----eeeEEEEEEeCCceE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-H-PN----IVRLKAFYYANDEKL  421 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----Iv~l~~~~~~~~~~~  421 (642)
                      ..+|+|.||.|-++++....     ..||||+++.....  .+..+-|++++.++. + |+    +|.+.+||.-.++.+
T Consensus        95 ~~lGeGtFGkV~ec~D~~~~-----~~vAlKIik~V~kY--reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   95 DLLGEGTFGKVVECWDRETK-----EHVALKIIKNVDKY--REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             hhhcCCcccceEEEeecCCC-----ceehHHHHHHHHHH--hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            57899999999999998874     89999999875443  367788999999993 2 33    889999999999999


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC--------------
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD--------------  487 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--------------  487 (642)
                      +|+|.+ |-|+++++..+..   .+++...+..|+.|++++++|||+   .+++|-||||+|||+.              
T Consensus       168 ivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence            999988 5599999987654   469999999999999999999999   8999999999999982              


Q ss_pred             ------CCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh
Q 006522          488 ------DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT  561 (642)
Q Consensus       488 ------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t  561 (642)
                            .+..+||.|||.|+...+..               ...+.|..|+|||++++ -.++.++||||+||||+|++|
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h---------------s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH---------------STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc---------------ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeec
Confidence                  13468999999998754432               13456778999999765 899999999999999999999


Q ss_pred             CCCCCCCCCCCcccHHHHHHHHHhccCC------------------Cc------------cccChhhhhchhHHHHHHHH
Q 006522          562 GRLPDAGPENDGKGLESLVRKAFRERRP------------------LS------------EVIDPALVKEIHAKRQVLAT  611 (642)
Q Consensus       562 G~~P~~~~~~~~~~l~~~~~~~~~~~~~------------------~~------------~~~d~~l~~~~~~~~~~~~~  611 (642)
                      |..-|.+.++.+. + ...+.+....+.                  .+            +...|.-........+..++
T Consensus       305 G~~LFqtHen~EH-L-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  305 GETLFQTHENLEH-L-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             cceecccCCcHHH-H-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            9999987553321 1 222222221000                  00            00111111111224566789


Q ss_pred             HHHHHhcCCCCCCCCCCHHHHHH
Q 006522          612 FHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       612 ~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ++|+.+++..||.+|+|++|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            99999999999999999999875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.5e-33  Score=300.82  Aligned_cols=198  Identities=23%  Similarity=0.308  Sum_probs=172.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      -.+||+|+||.|..++.+..+     +++|+|++.+-..-  ....-|..|-.+|.--+.+-||.++-.|++.++.|+||
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~-----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTE-----KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HHHhcccccceeEEEEeeccc-----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            478999999999999998887     89999999873211  11256889999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      |||+||||-.++....     ++++.....++.+|.-||+-||+   .|+|||||||+|||||.+|++||+|||.+-.+.
T Consensus       155 dY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             ecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            9999999999998665     38999999999999999999999   899999999999999999999999999987776


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCcccccc---C-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY---G-SKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .+...           .+...+|||-|++||++..   + +.|+..+|.||+||++|||+.|..||+.
T Consensus       227 ~dG~V-----------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  227 ADGTV-----------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CCCcE-----------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            54321           2236689999999998543   2 5789999999999999999999999974

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.5e-31  Score=291.73  Aligned_cols=263  Identities=16%  Similarity=0.151  Sum_probs=164.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEE------EEeCCc
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAF------YYANDE  419 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~~~~~  419 (642)
                      ..+.||+|+||.||+|++..+.. .....||||++......   +.+..|  .+....+.+++.+...      +....+
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            35789999999999999977611 12278999988653221   212111  1222223333322221      234567


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 006522          420 KLLISDFIRNGSLYAALHAGPSD---------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI  484 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  484 (642)
                      .++||||+++++|.++++.....               ......+..+..|+.|++.||+|||+   .+|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence            89999999999999999754310               00011234456799999999999999   8999999999999


Q ss_pred             eeCC-CCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCC---------------------C
Q 006522          485 LLDD-ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS---------------------K  542 (642)
Q Consensus       485 Ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~  542 (642)
                      |+++ ++.+||+|||+++.+......           ......+|+.|||||.+....                     .
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~-----------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINY-----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             EEeCCCCcEEEEeCCCcccccccccc-----------CCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            9985 689999999999865432111           112346788999999643211                     2


Q ss_pred             CCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCC-------ccccChhhhhchhH-HHHHHHHHHH
Q 006522          543 FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPL-------SEVIDPALVKEIHA-KRQVLATFHI  614 (642)
Q Consensus       543 ~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~d~~l~~~~~~-~~~~~~~~~l  614 (642)
                      ++.++|||||||++|||+++..|++.      .+..+.+.........       .....+++...... ........+|
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHH
Confidence            44567999999999999998776542      1111111111111000       00011111100000 0011234579


Q ss_pred             HHhcCCCCCCCCCCHHHHHH
Q 006522          615 ALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       615 ~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      +.+|++.||++|||++|+++
T Consensus       430 i~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHccCCcccCCCHHHHhC
Confidence            99999999999999999986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-31  Score=274.30  Aligned_cols=212  Identities=21%  Similarity=0.276  Sum_probs=173.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc--ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      ...||-|+||.|..+...++.     ..+|.|.+++.+.-  .++.....|-.||+.-+.+.||+||-.|++++..|+||
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~-----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTR-----ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             EeeecccccceeEEEeecchh-----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            468999999999999988775     78999999876432  23356778999999999999999999999999999999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCC
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||++|||+..+|.+.+.     |.+.....++.++..|+++.|.   .++|||||||+|||||.+|++||.||||+.-+.
T Consensus       709 dYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             eccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence            99999999999987653     8888888899999999999999   899999999999999999999999999986542


Q ss_pred             CC--C-ccccccee---------------------------eecCCCcccccCCCcccCccccccCCCCCcccchHHHHH
Q 006522          505 GT--S-KVTKNETI---------------------------VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI  554 (642)
Q Consensus       505 ~~--~-~~~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gv  554 (642)
                      -+  . ++......                           .+........+||+.|+|||++.. ..++..+|.||.||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGV  859 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhH
Confidence            11  1 11100000                           001111135689999999999665 78999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCC
Q 006522          555 VLLEILTGRLPDAGPEND  572 (642)
Q Consensus       555 vl~el~tG~~P~~~~~~~  572 (642)
                      |||||+.|+.||......
T Consensus       860 il~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHHHHhhCCCCccCCCCC
Confidence            999999999999765443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.9e-30  Score=256.55  Aligned_cols=240  Identities=24%  Similarity=0.376  Sum_probs=189.5

Q ss_pred             CCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccCCcHH
Q 006522          354 KNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY  433 (642)
Q Consensus       354 ~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  433 (642)
                      +||.||++.....+     +.+++|++.........+.+.+|++.+++++|+||+++++++......++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTG-----KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence            58999999997743     7899999976543322488999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccc
Q 006522          434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE  513 (642)
Q Consensus       434 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~  513 (642)
                      +++....     .+++..+..++.+++.+++|||+   .+++|+||+|+||++++++.++++|||.+.......      
T Consensus        76 ~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------  141 (244)
T smart00220       76 DLLKKRG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------  141 (244)
T ss_pred             HHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc------
Confidence            9987643     28899999999999999999999   799999999999999999999999999988764331      


Q ss_pred             eeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccc
Q 006522          514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEV  593 (642)
Q Consensus       514 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~  593 (642)
                             ......++..|++||... +..++.++||||+|+++|+|++|..||....    ......+............
T Consensus       142 -------~~~~~~~~~~~~~pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~  209 (244)
T smart00220      142 -------LLTTFVGTPEYMAPEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKKIGKPKPPFPPP  209 (244)
T ss_pred             -------ccccccCCcCCCCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHhccCCCCccc
Confidence                   111334667799999854 4678889999999999999999999986421    1222233222222111100


Q ss_pred             cChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          594 IDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       594 ~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                       ...         ...++.+++.+|+..+|++||++.++++
T Consensus       210 -~~~---------~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 -EWK---------ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -ccc---------CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             000         1135667899999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=273.78  Aligned_cols=238  Identities=18%  Similarity=0.214  Sum_probs=191.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ..||-|+||.|-.+......     ..+|+|.+++.  -+..+.+.+..|-.||...+.|.||++|..|.+....|++||
T Consensus       426 aTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhcccCccceEEEEEecccc-----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            56899999999999887763     35888888775  234455788899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      -|-||.|...|++++.     |+..+...++..+.+|++|||+   .+||.|||||+|.++|.+|-+||.|||+|+.+..
T Consensus       501 aClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999998765     7788888999999999999999   8999999999999999999999999999998765


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...             +-+.+||+.|.|||+++. ...+.++|.||+|+++|||+||.+||.+.+. -..+..+++..- 
T Consensus       573 g~K-------------TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid-  636 (732)
T KOG0614|consen  573 GRK-------------TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGID-  636 (732)
T ss_pred             CCc-------------eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhh-
Confidence            432             225789999999999776 7789999999999999999999999986432 111111111111 


Q ss_pred             ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCC
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR  628 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs  628 (642)
                       ...++..+             .....+++.+.+..+|.+|.-
T Consensus       637 -~i~~Pr~I-------------~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 -KIEFPRRI-------------TKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -hhhccccc-------------chhHHHHHHHHHhcCcHhhhc
Confidence             01111111             123456777788889999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.8e-30  Score=277.67  Aligned_cols=263  Identities=15%  Similarity=0.142  Sum_probs=174.2

Q ss_pred             cccccCccCCceeEEEEecCCCC-----------CCCCeEEEEEEecCCCccc-------------cHHHHHHHHHHHhc
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSG-----------MGAPTVVAVRRLTEGDATW-------------RFKDFESEVEAIAR  401 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~  401 (642)
                      ..+.||+|+||.||+|.......           ....+.||||++.......             ..+.+..|+.++.+
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~  228 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK  228 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence            35789999999999997633211           1122679999986532211             01234457788888


Q ss_pred             ccCCCe-----eeEEEEEEe--------CCceEEEEeeccCCcHHHHHhcCCCC-------------------CCCCCCH
Q 006522          402 VQHPNI-----VRLKAFYYA--------NDEKLLISDFIRNGSLYAALHAGPSD-------------------SLPPLPW  449 (642)
Q Consensus       402 l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~  449 (642)
                      ++|.++     +++++||..        .+..++||||+++|+|.++++.....                   ....++|
T Consensus       229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence            877654     677888754        35689999999999999999753210                   0123578


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCC
Q 006522          450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN  529 (642)
Q Consensus       450 ~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  529 (642)
                      ..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++........           ......+|+
T Consensus       309 ~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----------~~~~g~~tp  374 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----------NPLYGMLDP  374 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----------CccccCCCc
Confidence            8899999999999999999   89999999999999999999999999999765322110           001223477


Q ss_pred             cccCccccccCC---------------------CCCcccchHHHHHHHHHHHhCCC-CCCCCCCCc-------ccHHHHH
Q 006522          530 VYLAPEARIYGS---------------------KFTQKCDVYSFGIVLLEILTGRL-PDAGPENDG-------KGLESLV  580 (642)
Q Consensus       530 ~y~aPE~~~~~~---------------------~~~~~sDV~S~Gvvl~el~tG~~-P~~~~~~~~-------~~l~~~~  580 (642)
                      .|+|||.+....                     ....+.||||+||++|||++|.. |+.....-.       .++..|.
T Consensus       375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r  454 (507)
T PLN03224        375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR  454 (507)
T ss_pred             ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence            899999854321                     11235799999999999999875 664321110       1111111


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP---EFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP---~~RPs~~ev~~  634 (642)
                       .......      +-...+.     ......+++.+++..+|   .+|+|+.|+++
T Consensus       455 -~~~~~~~------~~~~~d~-----~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 -MYKGQKY------DFSLLDR-----NKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             -hhcccCC------Ccccccc-----cChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence             1111111      1111111     11234567778888765   68999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=249.24  Aligned_cols=243  Identities=18%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l  422 (642)
                      .-.+||+|+|..|..+++.++.     +.+|+|++++.  .+.+.+.-...|-.+..+- +||.+|.++.+|+.....++
T Consensus       254 ll~vigrgsyakvl~~~~~~t~-----qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTD-----QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             eeeeecCcchhhhhheehcccc-----eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3578999999999999998886     89999999876  2333345566788777766 89999999999999999999


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |.||++||+|.-++++.+     .|+++....+..+|..||.|||+   ++||.||||.+|||+|..|++|+.|+|+++.
T Consensus       329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence            999999999987776654     39999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC--CCCCcccHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG--PENDGKGLESLV  580 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~--~~~~~~~l~~~~  580 (642)
                      --..            +-.+.+.+||+.|+|||+ +.+..|+...|.|++||+++||+.|+.||+-  +.+.+.+...++
T Consensus       401 ~l~~------------gd~tstfcgtpnyiapei-lrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl  467 (593)
T KOG0695|consen  401 GLGP------------GDTTSTFCGTPNYIAPEI-LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL  467 (593)
T ss_pred             CCCC------------CcccccccCCCcccchhh-hcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence            4322            112236799999999998 5568999999999999999999999999973  333344444444


Q ss_pred             HHHHhc-cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC
Q 006522          581 RKAFRE-RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP  627 (642)
Q Consensus       581 ~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  627 (642)
                      -+..-+ ...++..++-             +...+...-++.||.+|.
T Consensus       468 fqvilekqiriprslsv-------------kas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  468 FQVILEKQIRIPRSLSV-------------KASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHhhhcccccceeeh-------------hhHHHHHHhhcCCcHHhc
Confidence            333322 2222222221             222344557888998884

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.7e-30  Score=235.77  Aligned_cols=253  Identities=14%  Similarity=0.196  Sum_probs=194.9

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCC--ceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAND--EKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv  423 (642)
                      .+.+|+|.++.||.|......     ..++||.++....    +.+.+|+.||..++ |||||++++...+..  ...||
T Consensus        43 vrk~GRGKYSEVFeg~~~~~~-----eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   43 VRKVGRGKYSEVFEGINITNN-----EKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             HHHHcCccHhhHhcccccCCC-----ceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            357899999999999876665     7899999986432    67889999999996 999999999998765  46799


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEeccccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~  502 (642)
                      +||+.+-+...+..        .|+-..+..++.|+++||.|+|+   .||+|||+||.|+++|. .-..+++|+|+|..
T Consensus       114 FE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            99999987766553        26667888999999999999999   89999999999999995 56799999999988


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      +.....             ....+.+..|.-||.+..-+.|+..-|+|||||++.+|+..+.||.........+..+++.
T Consensus       183 YHp~~e-------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  183 YHPGKE-------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             cCCCce-------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            754422             2234556678999987776789999999999999999999999998655555555544432


Q ss_pred             HHh-------ccCCCccccChhhhhch------------hHHH---HHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFR-------ERRPLSEVIDPALVKEI------------HAKR---QVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~-------~~~~~~~~~d~~l~~~~------------~~~~---~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .-.       ...  .-.+||++.+.+            ....   ..-++++++-+.+..|.++|||++|++.
T Consensus       250 LGt~el~~Yl~KY--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  250 LGTDELYAYLNKY--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             hChHHHHHHHHHH--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            110       011  111344433211            1110   1246788999999999999999999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=278.56  Aligned_cols=246  Identities=23%  Similarity=0.294  Sum_probs=183.3

Q ss_pred             cccccCccCCc-eeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNG-IMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g-~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ..+++|.|+.| .||+|...+       +.||||++-....    .-..+||..|..- +|||||++++.-+++...|+.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye~-------R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYEG-------REVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeCC-------ceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            45789999887 679998776       7999999865321    3457899999888 799999999998888999999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-----CCCeEEeccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-----ELHPCISGFG  498 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DfG  498 (642)
                      .|.|.. +|.+++....... ....-...+.+..|+++||+|||+   .+||||||||.||||+.     ..+++|+|||
T Consensus       582 lELC~~-sL~dlie~~~~d~-~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  582 LELCAC-SLQDLIESSGLDV-EMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             ehHhhh-hHHHHHhccccch-hhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999977 9999998752111 111113446788999999999999   79999999999999964     3679999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG-RLPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG-~~P~~~~~~~~~~l~  577 (642)
                      +++.+..+.....         ......||.+|+|||++.. ..-+.++||+|+|||+|+.+|| ..||.+.....    
T Consensus       657 lsKkl~~~~sS~~---------r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----  722 (903)
T KOG1027|consen  657 LSKKLAGGKSSFS---------RLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----  722 (903)
T ss_pred             cccccCCCcchhh---------cccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhh----
Confidence            9998876532111         1225678999999999554 5667799999999999999995 99996532211    


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                        . .+......+... .+       ..++  ++.+|+-++++++|..||++.+|+.
T Consensus       723 --~-NIl~~~~~L~~L-~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  723 --A-NILTGNYTLVHL-EP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             --h-hhhcCccceeee-cc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence              1 112222221111 00       0111  5567889999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-31  Score=246.29  Aligned_cols=261  Identities=17%  Similarity=0.266  Sum_probs=188.9

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC-----ceE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND-----EKL  421 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~  421 (642)
                      +-||-|+||+||.+.+..++     +.||+|++..... -...+.+.+|+++|..++|.||...++..+-..     ++|
T Consensus        59 RPIGYGAFGVVWsVTDPRdg-----rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSG-----KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CcccccceeEEEeccCCCCc-----cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            56899999999999998876     8899999876421 122378899999999999999999999887643     578


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      .|.|.|.. +|...+-.-     .+++-..+.-+..||++||.|||+   .+|.||||||.|.|++.+...||||||+++
T Consensus       134 V~TELmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccc
Confidence            89998865 887777542     358888888899999999999999   899999999999999999999999999998


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .-..+....           .+..+.|.+|+|||++.+.+.|+.+.||||.|||+.||+.++.-|.....- . -.+.+.
T Consensus       205 vee~d~~~h-----------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-q-QL~lIt  271 (449)
T KOG0664|consen  205 TWDQRDRLN-----------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-E-QLQMII  271 (449)
T ss_pred             ccchhhhhh-----------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-H-HHHHHH
Confidence            755442211           112345678999999888788999999999999999999988877643211 0 011111


Q ss_pred             HHH------------hc------cCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          582 KAF------------RE------RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       582 ~~~------------~~------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      ..+            .+      +.+....--+.+.........-.+.+.+.+..+..||++|.+..+.+..
T Consensus       272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            100            00      0000000001111111111223445667788899999999998887653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=234.62  Aligned_cols=189  Identities=20%  Similarity=0.293  Sum_probs=150.9

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCC------ceE
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------EKL  421 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~  421 (642)
                      .+|.|.- .|-.+.+.-..     +.||+|++... ......++..+|...+..+.|+||++++.+|.-..      +.|
T Consensus        24 p~~~g~~-~v~~a~D~v~~-----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y   97 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLG-----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY   97 (369)
T ss_pred             ccCCCCc-eEEecchhhcc-----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence            4555555 34444443332     78999987654 22222377789999999999999999999987543      579


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +|||||.. +|.+.++-       .++.++..+|..|++.|+.|||+   .+|+||||||+||++..+..+||.|||+|+
T Consensus        98 ~v~e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   98 LVMELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            99999965 99999872       27788999999999999999999   899999999999999999999999999997


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      ....+             ..-+..+.|..|.|||++.+ ..+.+.+||||.||++.||++|+.-|.+
T Consensus       167 ~e~~~-------------~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  167 TEDTD-------------FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             ccCcc-------------cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecC
Confidence            54322             01124567788999999776 4599999999999999999999988875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.7e-27  Score=229.59  Aligned_cols=213  Identities=25%  Similarity=0.440  Sum_probs=179.1

Q ss_pred             cCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccC
Q 006522          350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN  429 (642)
Q Consensus       350 lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~  429 (642)
                      ||+|.+|.||++....++     +.+++|.+.........+.+.+|++.+++++|++|+++++++......++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTG-----KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCC-----cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence            689999999999997643     889999998654321347799999999999999999999999999999999999999


Q ss_pred             CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEecccccccCCCCCc
Q 006522          430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       430 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~~~~~  508 (642)
                      ++|.+++....    ..+++..+..++.+++++++|||+   .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus        76 ~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~  148 (215)
T cd00180          76 GSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS  148 (215)
T ss_pred             CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence            99999997653    248899999999999999999999   79999999999999999 89999999999876543311


Q ss_pred             ccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccC
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR  588 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~  588 (642)
                                  ......+...|++||........+.++|+|++|+++++|                             
T Consensus       149 ------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------  187 (215)
T cd00180         149 ------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------  187 (215)
T ss_pred             ------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------
Confidence                        011234566799999854422778999999999999999                             


Q ss_pred             CCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       589 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                                          ..+.+++..|++.+|++||++.++++.
T Consensus       188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                244567888999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=254.67  Aligned_cols=195  Identities=19%  Similarity=0.282  Sum_probs=165.7

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC---ccc----cHHHHHHHHHHHhccc---CCCeeeEEEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---ATW----RFKDFESEVEAIARVQ---HPNIVRLKAFYYA  416 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~----~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~  416 (642)
                      -..+|+|+||.|+.+.++...     ..|+||.+.+..   +.+    ..-.+-.||+||..++   |+||++++++|++
T Consensus       566 lq~lG~GAyGkV~lai~K~n~-----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENN-----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             eeeccccccceEEEeeecccc-----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            468999999999999998875     899999998752   111    1123557999999997   9999999999999


Q ss_pred             CCceEEEEee-ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          417 NDEKLLISDF-IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       417 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      ++..||+||- -++-+|++++..+.+     +++.....|++||+.|+++||+   ++|||||||-+||.+|.+|-+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence            9999999995 467799999987653     8999999999999999999999   899999999999999999999999


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      |||.+......              .....+||..|.|||++.+....+..-|||++|++||.++....||..
T Consensus       713 dfgsaa~~ksg--------------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSG--------------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcCC--------------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99988654322              223568999999999965545557888999999999999999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-27  Score=235.83  Aligned_cols=127  Identities=16%  Similarity=0.272  Sum_probs=109.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc-----CC---CeeeEEEEEEeC-
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-----HP---NIVRLKAFYYAN-  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~---nIv~l~~~~~~~-  417 (642)
                      ...||.|-|++||.+++..+.     +.||+|+.+....  ..+..+.||++|++++     |+   +||+|+++|... 
T Consensus        83 ~rKLGWGHFSTVWLawDtq~~-----r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   83 QRKLGWGHFSTVWLAWDTQNK-----RYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             EEeccccccceeEEEeeccCC-----eEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            367999999999999999886     8999999986432  3377889999999993     33   599999999864 


Q ss_pred             ---CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 006522          418 ---DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL  486 (642)
Q Consensus       418 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  486 (642)
                         .+.+||+|++ |-+|..+|......   .++...+..|++||+.||.|||+.|  +|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence               4789999998 55999999877654   4888999999999999999999985  89999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=4e-28  Score=240.03  Aligned_cols=272  Identities=19%  Similarity=0.264  Sum_probs=198.6

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|.|++||++.+...  ......||+|.+......   .++.+|+++|..+ .+.||+++.+++..+++..+|+|
T Consensus        41 v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hccccccchhhhhhhhHhhh--ccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            47899999999999998772  122389999999876554   6688999999999 69999999999999999999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-CCCeEEecccccccCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRLLP  504 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DfGla~~~~  504 (642)
                      |++.-+..+++..        ++...+..+++.+..||+|+|.   ++||||||||+|+|.+. -+.-.|.|||+|....
T Consensus       116 ~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             ccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence            9999999988864        6678899999999999999999   89999999999999974 4677899999998321


Q ss_pred             CCCc-----c-------c-------ccce----------e---eecCCCcccccCCCcccCccccccCCCCCcccchHHH
Q 006522          505 GTSK-----V-------T-------KNET----------I---VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF  552 (642)
Q Consensus       505 ~~~~-----~-------~-------~~~~----------~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~  552 (642)
                      ....     .       .       ....          .   ..........+||++|.|||++..-..-++++||||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            1100     0       0       0000          0   0011111246799999999997766778999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcccHHHHHH--------HHHh-ccC-CCcc---------------ccC-hhhhh------
Q 006522          553 GIVLLEILTGRLPDAGPENDGKGLESLVR--------KAFR-ERR-PLSE---------------VID-PALVK------  600 (642)
Q Consensus       553 Gvvl~el~tG~~P~~~~~~~~~~l~~~~~--------~~~~-~~~-~~~~---------------~~d-~~l~~------  600 (642)
                      |||++.+++++.||.....+...+.+++.        +... .+. .+.+               .++ ..+..      
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            99999999999999877666544444431        1100 000 0000               010 00000      


Q ss_pred             --chhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          601 --EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       601 --~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                        ..........++++..+|+..||.+|.|++|.+.
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              0000011236789999999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-28  Score=224.97  Aligned_cols=249  Identities=19%  Similarity=0.247  Sum_probs=184.4

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEE-EEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKA-FYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~-~~~~~~~~~lv  423 (642)
                      ....+|+|.||.+..+.++...     +.+++|.+......  .++|.+|...--.| .|.||+.-|+ .|+..+..+++
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~-----t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSK-----TRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCc-----eEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3568999999999999988876     89999998875443  38999999877666 6899997765 56777888899


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee--CCCCCeEEecccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL--DDELHPCISGFGLNR  501 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DfGla~  501 (642)
                      +||++.|||.+-+...+      +-+....+++.|+++||.|||+   ..+||||||.+|||+  .+..++|+||||+.+
T Consensus       101 qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             eccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccccc
Confidence            99999999999887643      6778889999999999999999   899999999999999  245689999999987


Q ss_pred             cCCCCCcccccceeeecCCCcccccCCCcccCcccccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHH
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~  577 (642)
                      ........               ..-+..|-+||....    .-...+.+|||.||+++|.++||..||......+....
T Consensus       172 k~g~tV~~---------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~  236 (378)
T KOG1345|consen  172 KVGTTVKY---------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYW  236 (378)
T ss_pred             ccCceehh---------------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHH
Confidence            65432111               111234889986332    12357899999999999999999999987666666677


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~  635 (642)
                      .|.+...+....+++.+.+-     .     .++.++-.+-+..+|++|=...++..+
T Consensus       237 ~~~~w~~rk~~~~P~~F~~f-----s-----~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  237 EWEQWLKRKNPALPKKFNPF-----S-----EKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHHHHhcccCccCchhhccc-----C-----HHHHHHHHHhcCCcccccchhHHHHHH
Confidence            77665544443333332221     1     122334445677788777444444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.3e-26  Score=226.47  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=168.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|++|.||++....++     +.+++|.+.........+.+.+|++.+.+++|+|++++++++......++++||
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTG-----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCC-----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            467899999999999998744     789999998653322347899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      +++++|.+++.....    .+++.....++.+++.++.|||+   .+++|+|++|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       79 CEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            999999999976542    17889999999999999999999   79999999999999999999999999998876433


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      ..           .......++..|++||.......++.++||||||++++||++|+.||+.
T Consensus       152 ~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LA-----------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-----------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            10           0011234566799999853446778899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-28  Score=249.09  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=191.1

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      -..+|.|.+|.|||+++...+     +..|||.++-... ..+.-..+|+-+++..+|||||.++|.+...+..+++|||
T Consensus        20 lqrvgsgTygdvyKaRd~~s~-----elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSG-----ELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             eeeecCCcccchhhhcccccC-----chhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357899999999999998876     7899999876432 2235667899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      |.+|+|.+..+..+     ++++.++..++++..+||+|||+   .+-+|||||-.|||+.+.+.+|++|||.+..+...
T Consensus        94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999887643     69999999999999999999999   78899999999999999999999999998765432


Q ss_pred             CcccccceeeecCCCcccccCCCcccCcccccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHH
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .            ..+....||++|||||+..-  .+.|+.++|||+.|+...|+---+.|..+-    ..+......- 
T Consensus       166 i------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hpmr~l~LmT-  228 (829)
T KOG0576|consen  166 I------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HPMRALFLMT-  228 (829)
T ss_pred             h------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----chHHHHHHhh-
Confidence            1            12235679999999997432  357899999999999999999888885421    1111111100 


Q ss_pred             hccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      ....     -.|.+.+.   ......+-+++..|+-.+|++||+++.++
T Consensus       229 kS~~-----qpp~lkDk---~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  229 KSGF-----QPPTLKDK---TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             ccCC-----CCCcccCC---ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            1111     11222221   11223445678889999999999987654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.3e-27  Score=270.63  Aligned_cols=207  Identities=14%  Similarity=0.107  Sum_probs=137.4

Q ss_pred             hcccC-CCeeeEEEEE-------EeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006522          400 ARVQH-PNIVRLKAFY-------YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSP  471 (642)
Q Consensus       400 ~~l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  471 (642)
                      +.++| +||++++++|       ...+..+.++||+ +++|+++|....    ..+++.+++.|+.||++||+|||+   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---   98 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHS---   98 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHh---
Confidence            34456 6888898888       2334567888987 559999997532    249999999999999999999999   


Q ss_pred             CCceecCCCCCCeeeCCCC-------------------CeEEecccccccCCCCCcc--cccceeee--cCCCcccccCC
Q 006522          472 RKYVHGNIKSTKILLDDEL-------------------HPCISGFGLNRLLPGTSKV--TKNETIVT--SGTGSRISAIS  528 (642)
Q Consensus       472 ~~iiHrDlkp~NILl~~~~-------------------~~kl~DfGla~~~~~~~~~--~~~~~~~~--~~~~~~~~~gt  528 (642)
                      ++|+||||||+||||+..+                   .+|++|||+++........  ........  .........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            8999999999999996544                   4555555555432111000  00000000  00011124689


Q ss_pred             CcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHH
Q 006522          529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQV  608 (642)
Q Consensus       529 ~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  608 (642)
                      +.|||||++.. ..++.++|||||||+||||++|..|+....       ..........      +.+....      ..
T Consensus       179 ~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~------~~  238 (793)
T PLN00181        179 SWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHRV------LPPQILL------NW  238 (793)
T ss_pred             cceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHhh------cChhhhh------cC
Confidence            99999998554 778999999999999999999988864211       1111111111      1111100      11


Q ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          609 LATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       609 ~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .+...++.+||+.+|.+||+|.|+++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhh
Confidence            22346778899999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=6e-26  Score=213.36  Aligned_cols=170  Identities=21%  Similarity=0.204  Sum_probs=124.1

Q ss_pred             CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcc
Q 006522          430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV  509 (642)
Q Consensus       430 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~  509 (642)
                      |+|.++++..+.    +++|.++..|+.||++||+|||+   .+      ||+||+++.++.+|+  ||+++.....   
T Consensus         1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---   62 (176)
T smart00750        1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE---   62 (176)
T ss_pred             CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc---
Confidence            789999986432    49999999999999999999999   44      999999999999999  9998765322   


Q ss_pred             cccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCC
Q 006522          510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP  589 (642)
Q Consensus       510 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~  589 (642)
                                    ...||+.|||||++. +..++.++|||||||++|||+||+.||.......    ...........+
T Consensus        63 --------------~~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~  123 (176)
T smart00750       63 --------------QSRVDPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELS----AILEILLNGMPA  123 (176)
T ss_pred             --------------cCCCcccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhc----HHHHHHHHHhcc
Confidence                          125778899999955 4778999999999999999999999996533222    222222211111


Q ss_pred             CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhh
Q 006522          590 LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       590 ~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  640 (642)
                      ... .+...   ........++.+++.+||+.+|++||++.|+++.+..+.
T Consensus       124 ~~~-~~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      124 DDP-RDRSN---LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             CCc-ccccc---HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            000 00000   000111125788999999999999999999999887663

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=6.2e-27  Score=235.28  Aligned_cols=271  Identities=18%  Similarity=0.205  Sum_probs=200.1

Q ss_pred             CccccHHHHHhhc---ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc------C
Q 006522          334 GFSLELEDLLRAS---AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ------H  404 (642)
Q Consensus       334 ~~~~~~~~~~~~~---~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H  404 (642)
                      .++..+.|++..-   ....|+|-|++|.+|.+...+     ..||||++.......  +.=++|++||++|+      -
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~-----~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG-----QEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCC-----CeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhh
Confidence            3455666666543   345789999999999877654     699999998754322  55678999999995      3


Q ss_pred             CCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 006522          405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI  484 (642)
Q Consensus       405 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  484 (642)
                      -|+++++..|...++.+||+|-+.- +|.++|...+.+.  .|....+..++.|+.-||..|..   .+|+|.||||.||
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNi  567 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNI  567 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccce
Confidence            4799999999999999999998855 9999998876653  48888999999999999999998   7999999999999


Q ss_pred             eeCCC-CCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCC
Q 006522          485 LLDDE-LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR  563 (642)
Q Consensus       485 Ll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~  563 (642)
                      |+++. ..+||||||.|..+....-.              ....+..|.|||++++ ..|+...|+||.||+||||+||+
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~eneit--------------PYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENEIT--------------PYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             EeccCcceeeeccCcccccccccccc--------------HHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccc
Confidence            99864 56899999999876544210              1223456999999664 89999999999999999999999


Q ss_pred             CCCCCCCCCcccHHHHHHHH--------HhccCCCccccChhh--------------------------------hhc--
Q 006522          564 LPDAGPENDGKGLESLVRKA--------FRERRPLSEVIDPAL--------------------------------VKE--  601 (642)
Q Consensus       564 ~P~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~d~~l--------------------------------~~~--  601 (642)
                      .-|.+..+..  +..+....        ++...-..+.+|..+                                ...  
T Consensus       633 IlFpG~TNN~--MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~  710 (752)
T KOG0670|consen  633 ILFPGRTNNQ--MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQR  710 (752)
T ss_pred             eecCCCCcHH--HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCC
Confidence            9998765532  22222111        111100111111111                                110  


Q ss_pred             --hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          602 --IHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       602 --~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                        -.....+..+-+|.-.|+..||++|.|..+++.
T Consensus       711 ~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  711 LPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             CCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence              011235567788999999999999999998764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=216.07  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=183.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc-HHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..|.+...|..|+|++...       .+++|++...+...+ -++|..|.-.|+-+.||||..++|.|..+....++..|
T Consensus       196 tkl~e~hsgelwrgrwqgn-------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGN-------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhccCCCcccccccccCc-------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            4566788899999988764       466677655433222 27899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe--cccccccCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS--GFGLNRLLP  504 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~--DfGla~~~~  504 (642)
                      |+.|+|+..||+...-   ..+..+.++++.+||+|++|||+.. +-|..--|.+..+++|++.+++|+  |--++.+..
T Consensus       269 mp~gslynvlhe~t~v---vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe~  344 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV  344 (448)
T ss_pred             ccchHHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeecc
Confidence            9999999999987542   4677899999999999999999975 345556789999999999998875  322221110


Q ss_pred             CCCcccccceeeecCCCcccccCCCcccCccccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                                         ...-++.||+||.+.....  --.++|+|||.+++|||.|.+.||.+-..-+..+...++.
T Consensus       345 -------------------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg  405 (448)
T KOG0195|consen  345 -------------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG  405 (448)
T ss_pred             -------------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc
Confidence                               1123567999998654322  2358899999999999999999998654433222211111


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                       +  +..++.-+++.             +.+++.-|++.||.+||.+..|+-.||+++.
T Consensus       406 -l--rv~ippgis~h-------------m~klm~icmnedpgkrpkfdmivpilekm~~  448 (448)
T KOG0195|consen  406 -L--RVHIPPGISRH-------------MNKLMNICMNEDPGKRPKFDMIVPILEKMIL  448 (448)
T ss_pred             -c--cccCCCCccHH-------------HHHHHHHHhcCCCCcCCCcceehhhHHHhcC
Confidence             1  11233333333             3346666999999999999999999999863

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=5.5e-24  Score=252.43  Aligned_cols=181  Identities=34%  Similarity=0.648  Sum_probs=125.7

Q ss_pred             ccCCchHhHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCceeeEecC-CCEeEEEcCCCCccccCCccccCCCCCCEEEc
Q 006522           18 LCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIR-NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSL   96 (642)
Q Consensus        18 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~~c~w~gv~c~~-~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~L   96 (642)
                      .+.....|..||++||+++. +|.+.+.+|+.. .+||.|.||+|.. ++|+.|+|++|+++|.+|+.+..+++|+.|+|
T Consensus        23 ~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L  100 (968)
T PLN00113         23 FSMLHAEELELLLSFKSSIN-DPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL  100 (968)
T ss_pred             ccCCCHHHHHHHHHHHHhCC-CCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence            34446689999999999995 777788999754 5689999999974 68999999999999999999999999999999


Q ss_pred             cCCCCCCccccccc-cCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceeeccccccc
Q 006522           97 ASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS  175 (642)
Q Consensus        97 s~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~  175 (642)
                      ++|+++|.+|..+. ++++|++|+|++|+++|.+|.  ..+++|++|+|++|.+++.+|..+..+++|+ .|+|++|.+.
T Consensus       101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~-~L~L~~n~l~  177 (968)
T PLN00113        101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLK-VLDLGGNVLV  177 (968)
T ss_pred             CCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCC-EEECccCccc
Confidence            99999988988766 777777777777776655553  2344444444444444444444444444444 4444444444


Q ss_pred             ccCCcccCCCCCCcEEEeecCCCCCCcC
Q 006522          176 GQIPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       176 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p  203 (642)
                      +.+|..++++++|++|+|++|.+++.+|
T Consensus       178 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p  205 (968)
T PLN00113        178 GKIPNSLTNLTSLEFLTLASNQLVGQIP  205 (968)
T ss_pred             ccCChhhhhCcCCCeeeccCCCCcCcCC
Confidence            4444444444444444444444444433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=6.9e-23  Score=210.36  Aligned_cols=165  Identities=16%  Similarity=0.132  Sum_probs=122.0

Q ss_pred             cccccCccCCceeEEEEecC-CCCCCCCeEEEEEEecCCC----ccccHHHHHHHHHHHhcccCCCeee-EEEEEEeCCc
Q 006522          346 SAYVVGKSKNGIMYKVVVGR-GSGMGAPTVVAVRRLTEGD----ATWRFKDFESEVEAIARVQHPNIVR-LKAFYYANDE  419 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~-~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~  419 (642)
                      ....||+|+||.||+|+... ++     ..||||++....    .....+.|.+|+++|++++|+|||+ +++    .+.
T Consensus        22 ~~~~IG~G~fg~Vy~a~~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~   92 (365)
T PRK09188         22 ETAVLKRDVFSTVERGYFAGDPG-----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK   92 (365)
T ss_pred             EccEEeecCcEEEEEEEEcCCCC-----eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence            35689999999999998765 32     678999875331    1222467999999999999999985 443    246


Q ss_pred             eEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeeeCCCCCeEEeccc
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI-KSTKILLDDELHPCISGFG  498 (642)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DfG  498 (642)
                      .++||||+++++|... ..        ..   ...++.|+++||+|||+   .+|+|||| ||+|||++.++.+||+|||
T Consensus        93 ~~LVmE~~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            8999999999999732 11        10   14678999999999999   89999999 9999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccc
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI  538 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  538 (642)
                      +++.+..........    ....-+...+++.|+|||++.
T Consensus       158 lA~~~~~~~~~~~~~----~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        158 LASVFRRRGALYRIA----AYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             cceecccCcchhhhh----hhhhhhhhhccCccCCcccCC
Confidence            999775432111100    000012456778899999843

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1e-20  Score=195.71  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc--cHHHHHHHHHHHhcccCC-CeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW--RFKDFESEVEAIARVQHP-NIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv  423 (642)
                      ...+|.|+||.||++...        ..+++|.+.......  ....|.+|+.+++.+.|+ +|+++.+++......+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~   76 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV   76 (384)
T ss_pred             EEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence            356889999999999977        578888887664332  357899999999999988 799999999777778999


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC-CeEEeccccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~  502 (642)
                      ++|+.++++.+++......  ..++......++.|++.++.|+|+   .+++|||+||+||+++... .++++|||.++.
T Consensus        77 ~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          77 MEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            9999999999777654321  248889999999999999999999   7899999999999999988 799999999985


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      ...........      .......||..|+|||.....  ..++...|+||+|++++++++|..||...... .......
T Consensus       152 ~~~~~~~~~~~------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~  224 (384)
T COG0515         152 LPDPGSTSSIP------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTL  224 (384)
T ss_pred             cCCCCcccccc------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHH
Confidence            54332111000      012356788999999985542  47889999999999999999999997653321 0112222


Q ss_pred             HHHHhccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          581 RKAFRERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      ........+ ......+...     ......+.+++..|+..+|..|.++.+...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         225 KIILELPTPSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HHHHhcCCcccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            222222211 1111111100     111234556888899999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.6e-23  Score=225.62  Aligned_cols=261  Identities=18%  Similarity=0.191  Sum_probs=184.9

Q ss_pred             hcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC-CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEE
Q 006522          345 ASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       345 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....++|.|++|.++.+........+..+.+.+| .... ........+..|..+-.+++|||++..+..+++....+-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            3568999999998888887776544444455544 2122 1122223367788889999999999888888777777777


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      |||+++ ||+.++....     .+.-..+-.+++|+..|++|+|+   .+|.|||+|++|+++..++.+||+|||.+...
T Consensus       400 mE~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceee
Confidence            999999 9999997652     26677888999999999999999   89999999999999999999999999998765


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ......        ........+|+..|+|||++.. ..|+ ...||||.||++..|++|+.||..+.......   ...
T Consensus       471 ~~~~e~--------~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~  538 (601)
T KOG0590|consen  471 RYPWEK--------NIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTN  538 (601)
T ss_pred             ccCcch--------hhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccch---hhh
Confidence            432110        0011225678889999999665 5554 56799999999999999999997655433221   000


Q ss_pred             HHhccCCCccccC-hhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 006522          583 AFRERRPLSEVID-PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d-~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~  634 (642)
                      .......  .... ..+..     .--.+.-.++.++++.||.+|.|+.+|++
T Consensus       539 ~~~~~~~--~~~~~~~~~~-----~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  539 NYSDQRN--IFEGPNRLLS-----LLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccc--cccChHHHHH-----hchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000000  0000 00111     11123345888999999999999999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=4.3e-20  Score=190.49  Aligned_cols=264  Identities=18%  Similarity=0.201  Sum_probs=185.3

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccC----CCeeeEEEEE-EeCCce
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH----PNIVRLKAFY-YANDEK  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~  420 (642)
                      ....||+|+||.||.|......    ...+|+|.......... ..+..|+.++..+.+    +++..+++.. ......
T Consensus        22 i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   22 LGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             EeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            3568999999999999987763    26788888776533322 267789999998873    5889999998 477788


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC-----CCeEEe
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-----LHPCIS  495 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~  495 (642)
                      ++||+.+ |.+|.++......   ..++-.+...|+.|++.+|.+||+   .+++||||||+|+++...     ..+.+.
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence            9999977 7799998865542   348999999999999999999999   899999999999999754     469999


Q ss_pred             cccccccCC--CCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCc
Q 006522          496 GFGLNRLLP--GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG  573 (642)
Q Consensus       496 DfGla~~~~--~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~  573 (642)
                      |||+++...  ......    ............||..|.++.+.. +...+.+.|+||++.++.|+..|..||.......
T Consensus       170 DfGlar~~~~~~~~~~~----~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGN----LRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             ecCCCccccccCCCCcc----cccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            999998332  221100    000111112345999999999854 4788999999999999999999999996543321


Q ss_pred             ccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 006522          574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       574 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  639 (642)
                      . ... +......... ..     ...  ...   ..+.++...+-..+...+|....+...|+..
T Consensus       245 ~-~~~-~~~~~~~~~~-~~-----~~~--~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  245 L-KSK-FEKDPRKLLT-DR-----FGD--LKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             h-HHH-HHHHhhhhcc-cc-----ccC--CCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            1 111 1111111110 00     000  001   1223344445557899999999888887654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=3.1e-21  Score=201.33  Aligned_cols=217  Identities=24%  Similarity=0.348  Sum_probs=162.1

Q ss_pred             HhcccCCCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCc-eec
Q 006522          399 IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY-VHG  477 (642)
Q Consensus       399 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-iHr  477 (642)
                      |+.+.|.|+.+++|.+.+....+.|.+||..|+|.|.+.....    .++|.....+.++|++||+|+|.   .+| .|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHN---SPIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence            4678999999999999999999999999999999999987443    49999999999999999999998   444 999


Q ss_pred             CCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC--C----CCCcccchHH
Q 006522          478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--S----KFTQKCDVYS  551 (642)
Q Consensus       478 Dlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~----~~~~~sDV~S  551 (642)
                      .++++|+++|....+|++|||+..............          ...-...|.|||.+...  .    ..+.+.||||
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~----------~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs  143 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHH----------PIRKALLWTAPELLRGALSQSLESALTQKGDIYS  143 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccc----------hhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence            999999999999999999999987764311000000          11112349999985431  1    1477899999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHh-ccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 006522          552 FGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR-ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR  630 (642)
Q Consensus       552 ~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~  630 (642)
                      ||++++|+++.+.||+........ .+.+..... ...+    +-|.+....   +....+..++..||..+|++||+++
T Consensus       144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~~~~~~----~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKKGGSNP----FRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             HHHHHHHHHhccCccccccccCCh-HHHHHHHHhcCCCC----cCcchhhhh---hcchHHHHHHHHhcccChhhCccHH
Confidence            999999999999999875444332 333333333 2222    222222111   1122577899999999999999999


Q ss_pred             HHHHHHHhhh
Q 006522          631 TVSESLDRVK  640 (642)
Q Consensus       631 ev~~~L~~l~  640 (642)
                      +|-..++.+.
T Consensus       216 ~i~~~~~~~~  225 (484)
T KOG1023|consen  216 QIRSKLLTIN  225 (484)
T ss_pred             HHHhhhhhhc
Confidence            9988887653

>PLN03150 hypothetical protein; Provisional

Probab=99.84  E-value=2.2e-20  Score=207.70  Aligned_cols=134  Identities=34%  Similarity=0.543  Sum_probs=94.9

Q ss_pred             CCchHhHHHHHHHHHhcccCCCCCCCCCCCCCCC---CCCceeeEecC------CCEeEEEcCCCCccccCCccccCCCC
Q 006522           20 FSLNQDGLALLALKAAIAQDPTRALDSWSESDST---PCHWSGIHCIR------NRVTSLYLPNRNLTGYMPSELGLLNS   90 (642)
Q Consensus        20 ~~~~~~~~~l~~~~~~~~~~~~~~~~~w~~~~~~---~c~w~gv~c~~------~~v~~l~l~~~~l~g~~p~~l~~l~~   90 (642)
                      .....|..||+.+|+++. ++.  ..+|++ ++|   .|.|.||.|..      ..|+.|+|++|++.|.+|+.++.|++
T Consensus       368 ~t~~~~~~aL~~~k~~~~-~~~--~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~  443 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLG-LPL--RFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH  443 (623)
T ss_pred             ccCchHHHHHHHHHHhcC-Ccc--cCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence            345578999999999985 433  248964 232   12799999952      13677777777777777777777777


Q ss_pred             CCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHh
Q 006522           91 LTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFL  157 (642)
Q Consensus        91 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  157 (642)
                      |+.|+|++|+|.|.+|..+..+++|+.|+|++|+++|.+|+.+.+|++|+.|+|++|.|+|.+|..+
T Consensus       444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l  510 (623)
T PLN03150        444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL  510 (623)
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence            7777777777777777777777777777777777777777777777777777777777766666554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=1.2e-20  Score=178.28  Aligned_cols=139  Identities=13%  Similarity=0.164  Sum_probs=106.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc-c-------HHH-----------------HHHHHHHHhcc
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-R-------FKD-----------------FESEVEAIARV  402 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-------~~~-----------------~~~E~~~l~~l  402 (642)
                      ..||+|++|.||+|...++      +.||||+++...... .       ..+                 ..+|++++.++
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g------~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05147           3 GCISTGKEANVYHATTANG------EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL   76 (190)
T ss_pred             CccccccceEEEEEECCCC------CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            5799999999999998754      899999997542110 0       012                 23599999999


Q ss_pred             cCCCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCC
Q 006522          403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI-HEYSPRKYVHGNIKS  481 (642)
Q Consensus       403 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp  481 (642)
                      .|+++.....+..  ...++||||++++++.......     .++++.....++.|++.+|+|+ |+   .+|+||||||
T Consensus        77 ~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP  146 (190)
T cd05147          77 VTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSE  146 (190)
T ss_pred             HHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCH
Confidence            8887644333322  2348999999998776543222     1488899999999999999999 57   7999999999


Q ss_pred             CCeeeCCCCCeEEecccccccC
Q 006522          482 TKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       482 ~NILl~~~~~~kl~DfGla~~~  503 (642)
                      +||+++ ++.++|+|||+|...
T Consensus       147 ~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         147 YNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHEEEE-CCcEEEEEccccccC
Confidence            999998 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.4e-22  Score=205.52  Aligned_cols=191  Identities=26%  Similarity=0.316  Sum_probs=156.5

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-ccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      ++|+|.||.|+.+....+..  +...+|.|.+++.... ........|-.++..++ ||.+|++...++.+...+++++|
T Consensus         1 vlg~g~~gkvfLvrk~~g~d--a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGAD--AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhcccc--ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            47899999999877655432  2367888877665211 11124456888888886 99999999999999999999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      ..+|+|...+.....     +++.....+...+|-|++++|+   .+|+|||+|++||+++.+|++|+.|||+++..-..
T Consensus        79 ~rgg~lft~l~~~~~-----f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVM-----FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             cccchhhhccccCCc-----hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            999999988876543     6677777788889999999999   89999999999999999999999999999876433


Q ss_pred             CcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .                ..+||..|||||+..   ....++|.||||++++||+||..||..
T Consensus       151 ~----------------~~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  151 K----------------IACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             h----------------hcccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            1                227888999999843   467899999999999999999999974

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=3.2e-20  Score=173.11  Aligned_cols=194  Identities=15%  Similarity=0.142  Sum_probs=137.3

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc---cHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEE
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW---RFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l  422 (642)
                      ...|++|+||+||.+... +      ..++.+.+.......   ....|.+|+++|++++ |++|++++++    +..++
T Consensus         7 ~~~l~~~~f~~v~~~~~~-~------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l   75 (218)
T PRK12274          7 NEPLKSDTFGRILLVRGG-E------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL   75 (218)
T ss_pred             ceeecCCCcceEEEeecC-C------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence            467999999999976652 2      677777776543211   1135889999999994 5889999886    45799


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeeeCCCCCeEEecccccc
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI-KSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DfGla~  501 (642)
                      +|||++|.+|.+.+..            ....++.|++.+|.|+|+   .+|+|||| ||+|||++.++.++|+|||++.
T Consensus        76 vmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         76 DRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             EEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            9999999998754321            113578899999999999   89999999 7999999999999999999998


Q ss_pred             cCCCCCccc---ccceeeecCCCcccccCCCcccCccccccCCCCC-cccchHHHHHHHHHHHhCCCCCCC
Q 006522          502 LLPGTSKVT---KNETIVTSGTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       502 ~~~~~~~~~---~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      .........   ........-  ..-...++.|++|+....-...+ .+.+.++.|+-+|.++||..++.+
T Consensus       141 ~~~~~~~~~r~L~~rDl~~ll--k~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLL--KHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHH--HHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            654332110   000000000  00122566788887522212233 567889999999999999998764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=7e-20  Score=168.27  Aligned_cols=258  Identities=18%  Similarity=0.201  Sum_probs=184.0

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccC-CCeeeEEEEEEeCCceEEEEe
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH-PNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||.|+||.+|.+..-..+     ..||+|.-+.....   .++..|..+...++| ..|..+..|..+.+.-.+|||
T Consensus        20 vrkiGsGSFGdIy~~~~i~~g-----e~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   20 VRKIGSGSFGDIYLGISITSG-----EEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             EEeecCCchhheeeeeeccCC-----ceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            367999999999999876665     89999987764333   567789999999965 667788888888899999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC---CCCCeEEeccccccc
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DfGla~~  502 (642)
                      .. |.||.++..-..+    .++..+.+-++-|++.-++|+|.   +++|||||||+|+|..   ....+.++|||+|+.
T Consensus        92 LL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence            88 7899999875543    38889999999999999999999   8999999999999995   346788999999998


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      +.+......-     .-...+...||..|.+-..... ..-+.+.|+=|+|.+|...--|..||.+.....+  .+-.++
T Consensus       164 y~d~~t~~HI-----pyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKyEk  235 (341)
T KOG1163|consen  164 YRDIRTRQHI-----PYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKYEK  235 (341)
T ss_pred             hccccccccC-----ccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHHHH
Confidence            7544221110     1112235678999988776443 5567889999999999999999999987544321  111122


Q ss_pred             HHhccCC-CccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          583 AFRERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       583 ~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                      +....-. ..+.    +.+...     .++.-.+.-|-..--++-|...-+-+.+.
T Consensus       236 I~EkK~s~~ie~----LC~G~P-----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  236 ISEKKMSTPIEV----LCKGFP-----AEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHHhhcCCCHHH----HhCCCc-----HHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            2111110 0111    112111     23444556677777777777655554443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4e-20  Score=176.49  Aligned_cols=165  Identities=12%  Similarity=0.143  Sum_probs=126.2

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc--cHHH------HHHHHHHHhcccCCCeeeEEEEEEeC-
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW--RFKD------FESEVEAIARVQHPNIVRLKAFYYAN-  417 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~H~nIv~l~~~~~~~-  417 (642)
                      .+++|.|+||.||.+.. .+      ..+|+|.+.......  ....      +.+|+..+.+++||+|..+.+++... 
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~------~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DY------GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             EEEecCCCceEEEEEec-CC------CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            58999999999999655 33      579999997653221  1122      68999999999999999999987643 


Q ss_pred             -------CceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC
Q 006522          418 -------DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL  490 (642)
Q Consensus       418 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  490 (642)
                             ...++||||++|.+|.++..         ++.    ....+++.+|..+|+   .+++|||+||+||+++.++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence                   35789999999999988732         222    345699999999999   8999999999999999988


Q ss_pred             CeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHH
Q 006522          491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEIL  560 (642)
Q Consensus       491 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~  560 (642)
                       ++++|||..+......                         |-+.+.....++.++|+||||+++.-..
T Consensus       173 -i~liDfg~~~~~~e~~-------------------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRK-------------------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchh-------------------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence             9999999876543221                         1111223356778999999999976554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=4.6e-19  Score=170.19  Aligned_cols=204  Identities=15%  Similarity=0.201  Sum_probs=164.7

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~  424 (642)
                      -+..||+|.||+.+.|..--.+     ..||||.-......   .++..|....+.| ..+.|..++-|..+.-+-.||+
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nn-----e~VAIKfEPrkS~A---PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNN-----EPVAIKFEPRKSEA---PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             eccccccCcceeeecccccccC-----ceEEEEeccccCCc---chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            4678999999999999866554     89999986554332   5667788888877 5689999888888888889999


Q ss_pred             eeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-----CCCeEEecccc
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-----ELHPCISGFGL  499 (642)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DfGl  499 (642)
                      |.+ |.||.|+..-.++    .|+.+++..||.|++.-++|+|+   +.+|.|||||+|+||..     ...+.+.|||+
T Consensus       104 dLL-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhh-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            988 7899998876654    39999999999999999999999   89999999999999953     35689999999


Q ss_pred             cccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN  571 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~  571 (642)
                      |+.+.+.........     .......||..||+-...++ +.-+.+-|+=|+|-++...+-|..||.+-..
T Consensus       176 AK~YrDp~TkqHIPY-----rE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPY-----REHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hhhhcCccccccCcc-----ccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            998865532221111     11124568999999998664 7788999999999999999999999987554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-20  Score=205.89  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=175.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHH--HhcccCCCeeeEEEEEEeCCceEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEA--IARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ....+|.+.|=.|.++++.+|       .|+||++-+.+..-..+.|.++++-  ...++|||++++.-+-......|||
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG-------~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREG-------LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             eecccCchhhhhhhhccCCCc-------eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence            356799999999999999887       4888988776544444555544433  4455999999988776677778899


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccC
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      =+|..+ +|+|.|..+.     .+...+..-|+.|++.||.-+|.   .+|+|+|||.+|||+..-.-+.|+||..-|..
T Consensus       100 Rqyvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCc
Confidence            999977 9999997543     47777888899999999999999   89999999999999999999999999755432


Q ss_pred             CCCCcccccceeeecCCCcccccCCCcccCccccccCC----------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCC
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS----------KFTQKCDVYSFGIVLLEILT-GRLPDAGPEND  572 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~  572 (642)
                      --..+....-..-....+.+.     -|+|||.+....          ..+++.||||.||++.||++ |++||.     
T Consensus       171 YLPeDNPadf~fFFDTSrRRt-----CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----  240 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRT-----CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----  240 (1431)
T ss_pred             cCCCCCcccceEEEecCCcee-----eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----
Confidence            111110101111111111112     299999865522          15678999999999999998 788885     


Q ss_pred             cccHHHHHHHHHhccCCCccccChh-hhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 006522          573 GKGLESLVRKAFRERRPLSEVIDPA-LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD  637 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L~  637 (642)
                         +.+........      ..+++ +.+.+.+    ..+-.+++.+++.||.+|.++++.++.-.
T Consensus       241 ---LSQL~aYr~~~------~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  241 ---LSQLLAYRSGN------ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             ---HHHHHhHhccC------ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence               23333222111      11221 1111111    13445788899999999999999987643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.4e-19  Score=168.38  Aligned_cols=140  Identities=19%  Similarity=0.264  Sum_probs=109.5

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc-c------------------------HHHHHHHHHHHhcc
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-R------------------------FKDFESEVEAIARV  402 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l  402 (642)
                      ..||+|++|.||+|...++      +.||||+++...... .                        ...+.+|.+.+.++
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   76 (190)
T cd05145           3 GCISTGKEANVYHARTGDG------EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL   76 (190)
T ss_pred             ceeecCCCcEEEEEEcCCC------CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            4689999999999998744      899999988652110 0                        12346899999999


Q ss_pred             cCCCeeeEEEEEEeCCceEEEEeeccCCcHHHH-HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 006522          403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA-LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS  481 (642)
Q Consensus       403 ~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  481 (642)
                      +|++|.....+...  ..++||||++++++... +...      .++......++.|++.++.|+|+.  .+|+||||||
T Consensus        77 ~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP  146 (190)
T cd05145          77 YEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSE  146 (190)
T ss_pred             HhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCh
Confidence            99988655444433  35899999998865443 3321      367788999999999999999973  4899999999


Q ss_pred             CCeeeCCCCCeEEecccccccCC
Q 006522          482 TKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       482 ~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      +||+++ ++.++|+|||+++...
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecC
Confidence            999999 7899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=8.8e-19  Score=167.02  Aligned_cols=135  Identities=14%  Similarity=0.133  Sum_probs=104.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-----cCCCeeeEEEEEEeCC--
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-----QHPNIVRLKAFYYAND--  418 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~--  418 (642)
                      ....||+|+||.||.  ....      ...+||++...... ..+++.+|+.+++++     +||||++++|++.++.  
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~------~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPED------AQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CcceecCCCceEEEE--CCCC------cCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            357899999999995  4333      22368887654222 337899999999999     5799999999999874  


Q ss_pred             -ceE-EEEee--ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCCeeeCC----C
Q 006522          419 -EKL-LISDF--IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL-MYIHEYSPRKYVHGNIKSTKILLDD----E  489 (642)
Q Consensus       419 -~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlkp~NILl~~----~  489 (642)
                       ..+ +|+||  +++|+|.+++....      +++.  ..++.|++.++ +|||+   .+|+||||||+|||++.    +
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCC
Confidence             333 78999  66899999996532      5545  35678888888 99999   89999999999999973    3


Q ss_pred             CCeEEeccccc
Q 006522          490 LHPCISGFGLN  500 (642)
Q Consensus       490 ~~~kl~DfGla  500 (642)
                      ..++|+||+.+
T Consensus       146 ~~~~LiDg~G~  156 (210)
T PRK10345        146 VIPVVCDNIGE  156 (210)
T ss_pred             CcEEEEECCCC
Confidence            48999995433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.7e-18  Score=169.94  Aligned_cols=202  Identities=19%  Similarity=0.196  Sum_probs=135.6

Q ss_pred             cCCCeeeEEEEEEe---------------------------CCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHH
Q 006522          403 QHPNIVRLKAFYYA---------------------------NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI  455 (642)
Q Consensus       403 ~H~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  455 (642)
                      +|||||++.++|.+                           +...|+||.-++. +|.+++..+.      .+...+.-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence            69999999998754                           1246899998876 9999997654      444566778


Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCeee--CCCC--CeEEecccccccCCCCCcccccceeeecCCCcccccCCCcc
Q 006522          456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILL--DDEL--HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY  531 (642)
Q Consensus       456 ~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  531 (642)
                      ..|+++|+.|||.   ++|.|||+|++|||+  |+|.  ...|+|||++--.....-.......      .-...|...-
T Consensus       347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~------~Vd~GGNa~l  417 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD------EVDLGGNAKL  417 (598)
T ss_pred             HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc------cccCCCccee
Confidence            9999999999999   899999999999998  4443  4679999987543221100000000      0012344458


Q ss_pred             cCccccccCCCC-----CcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHH
Q 006522          532 LAPEARIYGSKF-----TQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKR  606 (642)
Q Consensus       532 ~aPE~~~~~~~~-----~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  606 (642)
                      ||||+.......     =.|+|.|+.|.+.||+++...||.....   ...+.....-.+-+++++.+.|.+..      
T Consensus       418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~r~Yqe~qLPalp~~vpp~~rq------  488 (598)
T KOG4158|consen  418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDTRTYQESQLPALPSRVPPVARQ------  488 (598)
T ss_pred             cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heechhhhhhhhCCCCcccCChHHHH------
Confidence            999984432111     2589999999999999999999986322   11111111112233455666665543      


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 006522          607 QVLATFHIALNCTELDPEFRPRMRTVSESL  636 (642)
Q Consensus       607 ~~~~~~~l~~~Cl~~dP~~RPs~~ev~~~L  636 (642)
                             ++...++.||.+|++..-..+.|
T Consensus       489 -------lV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  489 -------LVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -------HHHHHhcCCccccCCccHHHhHH
Confidence                   55668999999999976655544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.72  E-value=1e-17  Score=164.77  Aligned_cols=199  Identities=21%  Similarity=0.281  Sum_probs=130.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC--ccccHHHHHHHHHHHhcccC----------CCeeeEEEE
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQH----------PNIVRLKAF  413 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H----------~nIv~l~~~  413 (642)
                      .+..||.|+++.||.+.+..++     +.+|||......  .....+++.+|.-....+.+          -.++--++.
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~-----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETG-----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTT-----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EccccccCCceEEEEEEEccCC-----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            3578999999999999998876     899999876442  23345777777765555432          122222222


Q ss_pred             EE---------eCC--------ceEEEEeeccCCcHHHHHhc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006522          414 YY---------AND--------EKLLISDFIRNGSLYAALHA---GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK  473 (642)
Q Consensus       414 ~~---------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  473 (642)
                      ..         ...        ..+++|+-+. +||.+++..   .... ...+....++.+..|+++.+++||+   .+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~---~G  165 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHS---YG  165 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhh---cc
Confidence            22         111        2367788774 589887642   2211 1235556778888999999999999   89


Q ss_pred             ceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccC-------CCCCcc
Q 006522          474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-------SKFTQK  546 (642)
Q Consensus       474 iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~  546 (642)
                      ++|+||||+|++++.+|.+.|+||+.........         .      ....+..|.+||.....       -.++.+
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~  230 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------R------CSEFPVAFTPPELESCAGQFGQNNAPYTFA  230 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---------E------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeecCcee---------e------ccCCCcccCChhhhhhhcccCcccceeeec
Confidence            9999999999999999999999998665432210         0      01233568999974331       247899


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCC
Q 006522          547 CDVYSFGIVLLEILTGRLPDAGP  569 (642)
Q Consensus       547 sDV~S~Gvvl~el~tG~~P~~~~  569 (642)
                      .|.|++|+++|.|.+|+.||...
T Consensus       231 ~DaW~LG~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  231 TDAWQLGITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             HHHHHHHHHHHHHHHSS-STCCC
T ss_pred             cCHHHHHHHHHHHHHccCCCCCC
Confidence            99999999999999999999854

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=8.9e-17  Score=155.68  Aligned_cols=135  Identities=12%  Similarity=0.257  Sum_probs=112.0

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc-------ccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCce
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-------WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK  420 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  420 (642)
                      ..||+|++|.||+|... +      ..+++|+.......       .....+.+|++++..++|++|+....++...+..
T Consensus         2 ~~l~~G~~~~vy~~~~~-~------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-G------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEeeC-C------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            46899999999999873 2      56888876543211       1124678999999999999998888888788889


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||++|++|.+++...        .+ .+..++.+++.+|.++|+   .+++|||++|.||+++ ++.++|+|||++
T Consensus        75 ~lv~e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence            9999999999999998642        12 778999999999999999   8999999999999999 789999999987


Q ss_pred             cc
Q 006522          501 RL  502 (642)
Q Consensus       501 ~~  502 (642)
                      +.
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            64

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=8.3e-17  Score=154.35  Aligned_cols=131  Identities=16%  Similarity=0.298  Sum_probs=106.2

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-------cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceE
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-------TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      +||+|++|.||++... +      ..+++|.......       ....+++.+|++++.+++|+++.....++...+..+
T Consensus         1 ~ig~G~~~~vy~~~~~-~------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-G------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeecC-C------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            4899999999999843 2      5788887543211       112356789999999999988766666666777789


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +||||++|++|.+.+....            ..++.+++.+|.+||+   .+++|||+||.||+++ ++.+++.|||+++
T Consensus        74 lv~e~~~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            9999999999999875421            1789999999999999   8999999999999999 7899999999876


Q ss_pred             c
Q 006522          502 L  502 (642)
Q Consensus       502 ~  502 (642)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            4

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=9.4e-17  Score=157.04  Aligned_cols=139  Identities=16%  Similarity=0.192  Sum_probs=105.4

Q ss_pred             ccccCccCCceeEEEE-ecCCCCCCCCeEEEEEEecCCCccc-----------------------cHHHHHHHHHHHhcc
Q 006522          347 AYVVGKSKNGIMYKVV-VGRGSGMGAPTVVAVRRLTEGDATW-----------------------RFKDFESEVEAIARV  402 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~-~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l  402 (642)
                      ...||+|++|.||+|. ....+     +.||||.++......                       ....+.+|++++.++
T Consensus        33 ~~~Lg~G~~g~Vy~a~~~~~~g-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       33 GGCISTGKEANVYHALDFDGSG-----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             CCeeccCcceeEEEEEecCCCC-----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4689999999999998 33332     899999987542100                       012357899999999


Q ss_pred             cCCC--eeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCC
Q 006522          403 QHPN--IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK-YVHGNI  479 (642)
Q Consensus       403 ~H~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiHrDl  479 (642)
                      .+..  +.+++++    ...++||||+++++|........     .+.......++.|++.+++|||+   .+ |+||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di  175 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDL  175 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence            7633  3444443    23589999999988876543221     25556678899999999999999   78 999999


Q ss_pred             CCCCeeeCCCCCeEEecccccccC
Q 006522          480 KSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       480 kp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999988653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=9.9e-17  Score=176.78  Aligned_cols=135  Identities=14%  Similarity=0.234  Sum_probs=108.1

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-----ccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCce
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-----ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK  420 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~  420 (642)
                      ..+.||+|+||.||++......     ..+.++..+...     .....+++.+|++++.+++|++|+....++...+..
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-----~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-----AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-----ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3578999999999998875542     222222111111     111235688999999999999999988888888888


Q ss_pred             EEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccc
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla  500 (642)
                      ++||||+++++|.+++.             ....++.|++++|.|||+   .+++|||+||+|||+ +++.++|+|||++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            99999999999999875             346799999999999999   899999999999999 5789999999998


Q ss_pred             cc
Q 006522          501 RL  502 (642)
Q Consensus       501 ~~  502 (642)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            64

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=5.8e-17  Score=181.00  Aligned_cols=191  Identities=17%  Similarity=0.261  Sum_probs=150.3

Q ss_pred             hcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhccc---CCCeeeEEEEEEeCCceE
Q 006522          345 ASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ---HPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       345 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~  421 (642)
                      .....+|+|+||.||+|...++      +.||+|+-+.....    +|..-.+++.||+   -+-|..+..++.-.+.-+
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~------~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNG------KLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             EEEeeeccccceEEEEeecCCC------cEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3457899999999999999885      89999998765443    2333345556665   234555555566677889


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeC-------CCCCeEE
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD-------DELHPCI  494 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-------~~~~~kl  494 (642)
                      +|+||.+.|+|.+++...     ..++|...+.+..|+++-+++||.   .+|||+||||+|+||.       +...++|
T Consensus       771 lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             eeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            999999999999999833     248999999999999999999999   8999999999999993       3567999


Q ss_pred             ecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL  564 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~  564 (642)
                      +|||.+-.+.--.          .++.....++|-.+-.+|. ..++.++..+|.|.+..+++-|+.|+.
T Consensus       843 IDfG~siDm~lfp----------~~~~F~~~~~td~f~C~EM-~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFP----------DGTKFKAVWHTDLFDCIEM-REGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcC----------CCcEEeeeeccccchhHHH-hcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999886543211          1112234567788999998 566899999999999999999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=5.8e-17  Score=177.30  Aligned_cols=215  Identities=20%  Similarity=0.268  Sum_probs=140.2

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEe
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +.+++..|++|.||.++++...     +.+|.|+-++.       -+.+-  ++.....|.+|                 
T Consensus        87 ~IklisngAygavylvrh~~tr-----qrfa~kiNkq~-------lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKETR-----QRFAMKINKQN-------LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             eeEeeccCCCCceeeeeccccc-----cchhhcccccc-------hhhhc--cccccCCccee-----------------
Confidence            4567888999999999988775     67787543321       11111  34444555554                 


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                          ||-...+..-+     +++-..        +.+++|||+   .+|+|||+||+|.+|..-|++|+.|||+++..-.
T Consensus       136 ----gDc~tllk~~g-----~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG-----PLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ----chhhhhcccCC-----CCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                45544444322     233222        778999999   8999999999999999999999999999975422


Q ss_pred             CCcccc-cce--eeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHH
Q 006522          506 TSKVTK-NET--IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       506 ~~~~~~-~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ...... ...  ..+........+||+.|+|||++.. +.|+..+|.|++|+|+||.+.|..||++...     .+++..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtp-----eelfg~  269 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQ  269 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCH-----HHHHhh
Confidence            111100 000  0011112235789999999999665 7899999999999999999999999986433     233333


Q ss_pred             HHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCC
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP  627 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RP  627 (642)
                      ...+....++- |..+..+         +-+++...++.+|..|-
T Consensus       270 visd~i~wpE~-dea~p~E---------a~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEWPEE-DEALPPE---------AQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhcccccc-CcCCCHH---------HHHHHHHHHHhChHhhc
Confidence            33333333333 3333221         22355667888888884

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=4.8e-16  Score=148.79  Aligned_cols=135  Identities=15%  Similarity=0.181  Sum_probs=105.5

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc---------------------ccHHHHHHHHHHHhcccC
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT---------------------WRFKDFESEVEAIARVQH  404 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~H  404 (642)
                      ..+.||+|+||.||++....+      +.||||++......                     .....+.+|+.++.++.|
T Consensus        19 ~~~~i~~G~~g~Vy~~~~~~g------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          19 LGNQIGVGKESDVYLALDPDG------NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             cCCccccCcceEEEEEEcCCC------CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            357899999999999988655      79999987643210                     001236789999999988


Q ss_pred             CC--eeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 006522          405 PN--IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST  482 (642)
Q Consensus       405 ~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~  482 (642)
                      ++  +.+.++    ....++||||+++++|.+....           .....++.+++.++.++|+   .+|+||||||+
T Consensus        93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~  154 (198)
T cd05144          93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEF  154 (198)
T ss_pred             cCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcc
Confidence            74  444444    2456899999999998765421           2345788999999999999   89999999999


Q ss_pred             CeeeCCCCCeEEecccccccCC
Q 006522          483 KILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       483 NILl~~~~~~kl~DfGla~~~~  504 (642)
                      ||++++++.++|+|||.+....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=5.1e-17  Score=166.47  Aligned_cols=179  Identities=18%  Similarity=0.315  Sum_probs=128.2

Q ss_pred             ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          419 EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                      ..|+.|++|+..+|.+||......  ...+|...+.++.|++.|++|      ++.+|||+||.||....+..+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            478999999999999999765432  347788999999999999999      479999999999999999999999999


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCCcccHH
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE  577 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~~~~~~~~~l~  577 (642)
                      +.........      ........+...||..||+||.+ .+..|+.|+||||+|++|+|+++ -..++...        
T Consensus       402 l~ts~~~~~~------~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------  466 (516)
T KOG1033|consen  402 LVTSQDKDET------VAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLIQFSTQFERI--------  466 (516)
T ss_pred             heeecccCCc------ccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------
Confidence            9877655431      00011112245799999999994 45899999999999999999998 33333210        


Q ss_pred             HHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV  632 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev  632 (642)
                      ..... .+     ...++|....+...      -..+..+++...|.+||++.++
T Consensus       467 ~t~~d-~r-----~g~ip~~~~~d~p~------e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  467 ATLTD-IR-----DGIIPPEFLQDYPE------EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             Hhhhh-hh-----cCCCChHHhhcCcH------HHHHHHHhcCCCcccCchHHHH
Confidence            00000 11     22333333322211      2347788999999999955544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=3.3e-17  Score=179.66  Aligned_cols=252  Identities=21%  Similarity=0.224  Sum_probs=182.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCC-ccccHHHHHHHHHHHhccc-CCCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      .-||+|+|+.+-........    ...+|+|.+.... .....+....|..+-..+. |+|++++++.....+..+++.+
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~----~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDP----ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccchhhhhhhcCCC----cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            34889999988877664442    1567777776543 2223355566888888886 9999999999999999999999


Q ss_pred             eccCCcHHHHH-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCCeeeCCCC-CeEEeccccccc
Q 006522          426 FIRNGSLYAAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIH-EYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~gsL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DfGla~~  502 (642)
                      |..+|++++.+ +....    ..+......+..|+..++.|+| +   .++.|||+||+|.+++..+ ..|++|||+|..
T Consensus       102 ~s~g~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccccccccccccCCcc----CCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999988 43321    2455667789999999999999 6   7999999999999999999 999999999987


Q ss_pred             CCC-CCcccccceeeecCCCcccccC-CCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 006522          503 LPG-TSKVTKNETIVTSGTGSRISAI-SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       503 ~~~-~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +.. ...          .......+| ++.|+|||.........+..|+||.|+++.-+++|..|++.+.........|.
T Consensus       175 ~~~~~g~----------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~  244 (601)
T KOG0590|consen  175 YRNKNGA----------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK  244 (601)
T ss_pred             ccccCCc----------ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence            654 211          111123466 88999999866544567899999999999999999999987655443334443


Q ss_pred             HHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      ............-++..             ..++..+++..+|..|.+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~-------------~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  245 SNKGRFTQLPWNSISDQ-------------AHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccccCccccCChh-------------hhhcccccccCCchhcccccccc
Confidence            33211111112222222             23345557878899998877654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=5.5e-15  Score=144.88  Aligned_cols=138  Identities=20%  Similarity=0.216  Sum_probs=107.2

Q ss_pred             hcccccC-ccCCceeEEEEecCCCCCCCCeEEEEEEecCCC------------ccccHHHHHHHHHHHhcccCCCe--ee
Q 006522          345 ASAYVVG-KSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD------------ATWRFKDFESEVEAIARVQHPNI--VR  409 (642)
Q Consensus       345 ~~~~~lg-~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~H~nI--v~  409 (642)
                      ..++++| .|+.|+||.+....       ..++||+.....            .......+.+|++++.+++|++|  ++
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~~-------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~  106 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTPG-------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPR  106 (239)
T ss_pred             hcCceeecCCCCccEEEEEeCC-------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCce
Confidence            4568898 89999999998863       578888775321            01223568899999999998875  67


Q ss_pred             EEEEEEeCC----ceEEEEeeccC-CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 006522          410 LKAFYYAND----EKLLISDFIRN-GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI  484 (642)
Q Consensus       410 l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  484 (642)
                      .+++.....    ..++||||+++ .+|.+++...      +++..    .+.+++.+|.+||+   .+|+||||||+||
T Consensus       107 pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NI  173 (239)
T PRK01723        107 PIAARVVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNI  173 (239)
T ss_pred             eEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhE
Confidence            777755432    23599999997 6999888642      24433    36789999999999   8999999999999


Q ss_pred             eeCCCCCeEEeccccccc
Q 006522          485 LLDDELHPCISGFGLNRL  502 (642)
Q Consensus       485 Ll~~~~~~kl~DfGla~~  502 (642)
                      |++.++.++|+|||.++.
T Consensus       174 Lv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        174 LLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EEcCCCCEEEEECCCccc
Confidence            999988999999998764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.61  E-value=2.6e-17  Score=143.80  Aligned_cols=152  Identities=28%  Similarity=0.423  Sum_probs=135.9

Q ss_pred             CCCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEe
Q 006522           64 RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLD  143 (642)
Q Consensus        64 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  143 (642)
                      .+.+|.|.|++|.++ .+|+.+..|.+|+.|++++|++. .+|..++.++.|+.|+++-|++. .+|..|+.++.|+.||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            357899999999999 67889999999999999999997 58999999999999999999998 8999999999999999


Q ss_pred             cccccCC-CcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCC
Q 006522          144 LSSNLLN-GSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       144 Ls~N~l~-~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  220 (642)
                      |++|+++ ..+|..|..+..|. .|+|++|.|. .+|..++++++|+.|.+..|.|-..+-.++.+..+..+-+.||.
T Consensus       109 ltynnl~e~~lpgnff~m~tlr-alyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLR-ALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             ccccccccccCCcchhHHHHHH-HHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccce
Confidence            9999996 56899999999999 8999999997 78889999999999999999987665566667777777778875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.59  E-value=9.5e-15  Score=133.04  Aligned_cols=133  Identities=17%  Similarity=0.149  Sum_probs=112.1

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccC--CCeeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH--PNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e  425 (642)
                      +.+|+|.++.||++....       ..+++|.......   ...+.+|+.++..++|  .+++++++++...+..+++||
T Consensus         4 ~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e   73 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME   73 (155)
T ss_pred             eecccccccceEEEEecC-------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence            468999999999999754       5789998866433   3678999999999976  589999998888888999999


Q ss_pred             eccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccccccc
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~  502 (642)
                      |++++.+..+            ++.....++.+++++++++|.....+++|+|+||+||++++.+.+++.|||.++.
T Consensus        74 ~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9998776543            4466778899999999999985434799999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=3e-14  Score=135.06  Aligned_cols=137  Identities=20%  Similarity=0.264  Sum_probs=97.3

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc-cHHH----------------------HHHHHHHHhcccC
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-RFKD----------------------FESEVEAIARVQH  404 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~H  404 (642)
                      ..||+|+||.||++....+      ..||||++....... ....                      ...|.+.+.++.+
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~------~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~   76 (187)
T cd05119           3 GPIGTGKEADVYLALDGDG------EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE   76 (187)
T ss_pred             cccccccceeEEEEECCCC------CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence            5789999999999998744      789999987542111 0011                      1356677777754


Q ss_pred             CC--eeeEEEEEEeCCceEEEEeeccCCcHHHH-HhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 006522          405 PN--IVRLKAFYYANDEKLLISDFIRNGSLYAA-LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS  481 (642)
Q Consensus       405 ~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  481 (642)
                      ..  +.+.+++    ...++||||++++.+... +....      .. .....++.+++.++.++|..  .+|+||||||
T Consensus        77 ~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p  143 (187)
T cd05119          77 AGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSE  143 (187)
T ss_pred             cCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCCh
Confidence            43  4444443    346899999999654321 11110      11 45678999999999999973  5899999999


Q ss_pred             CCeeeCCCCCeEEecccccccCC
Q 006522          482 TKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       482 ~NILl~~~~~~kl~DfGla~~~~  504 (642)
                      +||+++ ++.++++|||.+....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhEEEE-CCcEEEEECccccccc
Confidence            999999 8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.53  E-value=1.4e-16  Score=139.18  Aligned_cols=138  Identities=24%  Similarity=0.359  Sum_probs=127.5

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCccc-ccCcccccCCCCcCeEec
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC-GPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L  144 (642)
                      .+..|++.+|++. .+|.+++.|+.|+.|+++-|++. ..|..|+.++.|+.|||..|+++ ..+|..|..|+.|+.|+|
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl  134 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL  134 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence            5678899999998 57899999999999999999997 79999999999999999999997 467999999999999999


Q ss_pred             ccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccc
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSL  208 (642)
Q Consensus       145 s~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  208 (642)
                      +.|.|. .+|..++++++|+ .|.+..|.+- ++|.+++.+++|++|++.+|.|+-.+|.++.+
T Consensus       135 ~dndfe-~lp~dvg~lt~lq-il~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l  195 (264)
T KOG0617|consen  135 GDNDFE-ILPPDVGKLTNLQ-ILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANL  195 (264)
T ss_pred             cCCCcc-cCChhhhhhccee-EEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhh
Confidence            999999 8999999999999 9999999997 78999999999999999999999888866543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.45  E-value=2.4e-14  Score=141.10  Aligned_cols=160  Identities=22%  Similarity=0.256  Sum_probs=117.2

Q ss_pred             CCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccC-CcccccCccccc---------
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAH-NSFCGPIPDRIK---------  134 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~---------  134 (642)
                      ...+.|+|..|+++...|.+|+.+++|+.||||+|+|+.+-|.+|.++.+|..|-+-+ |+|+...-..|.         
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3568899999999988889999999999999999999998899998888777665544 766532222232         


Q ss_pred             --------------------------------------------------------------------------------
Q 006522          135 --------------------------------------------------------------------------------  134 (642)
Q Consensus       135 --------------------------------------------------------------------------------  134 (642)
                                                                                                      
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence                                                                                            


Q ss_pred             ---------------------------------------------CCCCcCeEecccccCCCcchhHhhhhccccceeec
Q 006522          135 ---------------------------------------------TLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNL  169 (642)
Q Consensus       135 ---------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l  169 (642)
                                                                   +|++|+.|+|++|.+++.-+.+|..+..++ .|.|
T Consensus       227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~-eL~L  305 (498)
T KOG4237|consen  227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQ-ELYL  305 (498)
T ss_pred             chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhh-hhhc
Confidence                                                         223566677777777666666666666666 6667


Q ss_pred             ccccccccCCcccCCCCCCcEEEeecCCCCCCcCccc-cccccCCcccCCCCCCCCC
Q 006522          170 SFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVG-SLLNQGPTAFSGNPGLCGF  225 (642)
Q Consensus       170 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~~~~  225 (642)
                      ..|+|...-...|.++..|++|+|.+|+|+-.-|... .+..+..+.+.+||+.|..
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence            7776665555567778888888888888887766432 2334566677889988864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=1.7e-13  Score=132.18  Aligned_cols=160  Identities=19%  Similarity=0.324  Sum_probs=116.2

Q ss_pred             HHHHHhcccCCCeeeEEEEEEeCC-----ceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 006522          395 EVEAIARVQHPNIVRLKAFYYAND-----EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY  469 (642)
Q Consensus       395 E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  469 (642)
                      =..-+-++.|.|||+++.|+.+..     ...++.|||+.|++.++|++..+.. ..+....-.+|+-||..||.|||+.
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            345567778999999999986543     4689999999999999998765432 2367777789999999999999984


Q ss_pred             CCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccch
Q 006522          470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV  549 (642)
Q Consensus       470 ~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV  549 (642)
                       .++|+|+++..+-|.+..++-+|+.----.. .....  ..     +.........+-++|.|||+-. ....+.++||
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~--~~-----~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dI  265 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSV--NS-----TREAEKSVNTSLPGFSAPESGT-TTNTTGASDI  265 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEecccCccc-cchhh--hh-----hhHhhhhccccCCccccCCcCc-ccccccchhh
Confidence             4799999999999999999888875321110 00000  00     0000111233556799999732 2566789999


Q ss_pred             HHHHHHHHHHHhCCCC
Q 006522          550 YSFGIVLLEILTGRLP  565 (642)
Q Consensus       550 ~S~Gvvl~el~tG~~P  565 (642)
                      |+||...+||..+..-
T Consensus       266 y~fgmcAlemailEiq  281 (458)
T KOG1266|consen  266 YKFGMCALEMAILEIQ  281 (458)
T ss_pred             hhhhHHHHHHHHheec
Confidence            9999999999988753

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.43  E-value=1.5e-14  Score=148.64  Aligned_cols=146  Identities=26%  Similarity=0.252  Sum_probs=98.4

Q ss_pred             CCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcc
Q 006522           74 NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSL  153 (642)
Q Consensus        74 ~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  153 (642)
                      .|+++..-...|..+.++++|+|+.|+++..--..+++|+.|+.|+||+|.+....++.+....+|++||||+|+++...
T Consensus       254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~  333 (873)
T KOG4194|consen  254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLD  333 (873)
T ss_pred             hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCC
Confidence            33333333445556667777777777777666666777777777777777777777777777777888888888877666


Q ss_pred             hhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCcc----ccccccCCcccCCCC
Q 006522          154 PEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV----GSLLNQGPTAFSGNP  220 (642)
Q Consensus       154 p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~----~~~~~~~~~~~~~n~  220 (642)
                      +.+|..|.+|+ +|+|++|.++..--..|..+++|+.|||++|.|++.+.+.    ..+..+..+.+.||.
T Consensus       334 ~~sf~~L~~Le-~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  334 EGSFRVLSQLE-ELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ  403 (873)
T ss_pred             hhHHHHHHHhh-hhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence            77777777777 7777777777655566777777777777777777666542    123334444455553

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.42  E-value=1.4e-14  Score=149.85  Aligned_cols=151  Identities=32%  Similarity=0.383  Sum_probs=75.1

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCccc-ccCcccccCCCCcCeEec
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC-GPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L  144 (642)
                      +++.|-|...+|. .+|++++.|.+|+.|.+++|+|.. +-.++..|+.|+.+++.+|+|. .-+|..+..|..|+.|||
T Consensus        33 ~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDL  110 (1255)
T KOG0444|consen   33 QMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDL  110 (1255)
T ss_pred             heeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeec
Confidence            4555555555544 345555555555555555555542 3334455555555555555543 224444555555555555


Q ss_pred             ccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCC
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       145 s~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  220 (642)
                      |+|+|. ..|..+...+++. .|+||+|+|..++-..|.+++.|-.||||+|.|...+|+...+..+..+.+++||
T Consensus       111 ShNqL~-EvP~~LE~AKn~i-VLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  111 SHNQLR-EVPTNLEYAKNSI-VLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             chhhhh-hcchhhhhhcCcE-EEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCCh
Confidence            555554 4455554444444 5555555554322233445555555555555555555544444444444444443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.40  E-value=2e-14  Score=141.68  Aligned_cols=152  Identities=32%  Similarity=0.432  Sum_probs=131.4

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEE-EccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEec
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRL-SLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  144 (642)
                      -|+.++++.|++. .+|..+..+..+.+. .+++|.+ +.+|..+..+++|..|+|++|-+. .+|..++.+..|+.|||
T Consensus       389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~Lnl  465 (565)
T KOG0472|consen  389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNL  465 (565)
T ss_pred             ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecc
Confidence            4899999999998 568777777776654 5555555 578889999999999999999998 79999999999999999


Q ss_pred             ccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCCCC
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL  222 (642)
Q Consensus       145 s~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  222 (642)
                      |.|+|. .+|..+..+..++ .+-.++||+....|+.+.+|.+|.+|||.+|.|...+|.++.+.++..+.+.|||+.
T Consensus       466 S~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  466 SFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             cccccc-cchHHHhhHHHHH-HHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            999998 8999988888887 777778999866666699999999999999999999999999999999999999853

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=1.4e-12  Score=139.05  Aligned_cols=141  Identities=18%  Similarity=0.227  Sum_probs=101.9

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcccc---------------------------------------
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR---------------------------------------  388 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------  388 (642)
                      ..||.|++|.||+|++.+|      +.||||+.+......-                                       
T Consensus       123 ~plasaSigQVh~A~l~~G------~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDG------KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             cceeeeehhheEEEEecCC------CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            5799999999999999877      8999999865421000                                       


Q ss_pred             HHHHHHHHHHHhccc-----CCCeeeEEEEEE-eCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH-
Q 006522          389 FKDFESEVEAIARVQ-----HPNIVRLKAFYY-ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR-  461 (642)
Q Consensus       389 ~~~~~~E~~~l~~l~-----H~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-  461 (642)
                      .-+|.+|+..+.+++     +++| .+-..+. .....++||||++|++|.++.......    .   .+..++..++. 
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~---~~~~ia~~~~~~  268 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG----L---DRKALAENLARS  268 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcC----C---CHHHHHHHHHHH
Confidence            013566777777663     3443 3323332 234679999999999998876532211    2   23456666666 


Q ss_pred             HHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       462 gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      .+..+|.   .+++|+|+||.||++++++.+++.|||++..+..
T Consensus       269 ~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            4678888   7999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.39  E-value=8.2e-15  Score=144.41  Aligned_cols=146  Identities=26%  Similarity=0.361  Sum_probs=120.0

Q ss_pred             EeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEeccc
Q 006522           67 VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSS  146 (642)
Q Consensus        67 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  146 (642)
                      ++.+++.+|.+....|..+ +++.|+.||...|-+. .+|++++.+.+|.-|||.+|++. .+| .|.+++.|.+|+++.
T Consensus       162 l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~  237 (565)
T KOG0472|consen  162 LSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGE  237 (565)
T ss_pred             HHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcc
Confidence            4456666666664444333 3777888888888774 68888888888888888888887 566 788888888899988


Q ss_pred             ccCCCcchhHhh-hhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCC
Q 006522          147 NLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       147 N~l~~~~p~~~~-~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  220 (642)
                      |+++ .+|.... +++.+. .|||.+|++. ..|+.+.-+.+|+.||+|+|.|++.++.++.+ .+..+.+.|||
T Consensus       238 N~i~-~lpae~~~~L~~l~-vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  238 NQIE-MLPAEHLKHLNSLL-VLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             cHHH-hhHHHHhcccccce-eeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            8888 7777665 899998 9999999998 78999999999999999999999999988777 67788889998

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.37  E-value=6.5e-14  Score=144.93  Aligned_cols=79  Identities=34%  Similarity=0.450  Sum_probs=40.8

Q ss_pred             cccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCcccccc
Q 006522          130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLL  209 (642)
Q Consensus       130 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  209 (642)
                      |..+..|.+|..+|||.|+|. .+|+.+..+.+|. .|+||+|+|+ .+....+...+|++|+||.|+|+..+..+..+.
T Consensus       215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lr-rLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~  291 (1255)
T KOG0444|consen  215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLR-RLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLT  291 (1255)
T ss_pred             CCchhhhhhhhhccccccCCC-cchHHHhhhhhhh-eeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhH
Confidence            334444445555555555555 4555555555555 5666666555 333334445556666666666664433333444


Q ss_pred             cc
Q 006522          210 NQ  211 (642)
Q Consensus       210 ~~  211 (642)
                      ++
T Consensus       292 kL  293 (1255)
T KOG0444|consen  292 KL  293 (1255)
T ss_pred             HH
Confidence            43

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.37  E-value=3.4e-13  Score=138.93  Aligned_cols=151  Identities=23%  Similarity=0.301  Sum_probs=114.9

Q ss_pred             CCCCCCceeeEecC----------------CCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCc
Q 006522           51 DSTPCHWSGIHCIR----------------NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN  114 (642)
Q Consensus        51 ~~~~c~w~gv~c~~----------------~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  114 (642)
                      .+|+|.-.-..|..                ..+..|+|++|.|+..-+..|-+|++|+.++|.+|.|+ .||.......+
T Consensus        48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sgh  126 (873)
T KOG4194|consen   48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGH  126 (873)
T ss_pred             CcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccc
Confidence            35666666667753                34567999999999888889999999999999999997 58865555666


Q ss_pred             cceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEee
Q 006522          115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLR  194 (642)
Q Consensus       115 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~  194 (642)
                      |+.|+|.+|.++..-.+.+.-++.|+.||||.|.++-.--.+|..-.+++ +|+|++|.|+..-...|.++.+|.+|.|+
T Consensus       127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~-~L~La~N~It~l~~~~F~~lnsL~tlkLs  205 (873)
T KOG4194|consen  127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIK-KLNLASNRITTLETGHFDSLNSLLTLKLS  205 (873)
T ss_pred             eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCce-EEeeccccccccccccccccchheeeecc
Confidence            99999999998877777888888888888888888733333444445666 77777777776666677777777777777


Q ss_pred             cCCCCCCcC
Q 006522          195 NNNLSGEIP  203 (642)
Q Consensus       195 ~N~l~~~~p  203 (642)
                      +|.++-.++
T Consensus       206 rNrittLp~  214 (873)
T KOG4194|consen  206 RNRITTLPQ  214 (873)
T ss_pred             cCcccccCH
Confidence            777776544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=2.8e-11  Score=112.66  Aligned_cols=129  Identities=19%  Similarity=0.191  Sum_probs=94.7

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCee-eEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV-RLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~  426 (642)
                      ..++.|.++.||++... +      ..+++|........  ...+.+|+.++..+.+.+++ +++.+.  ....++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~-~------~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-N------KKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEEC-C------eEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            35788999999999865 2      67999987654321  14567899999999765554 444443  3346899999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS--PRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      +++.++.+.    .         .....++.+++++|+.||+..  +..++|+|++|.||+++ ++.+++.|||.+.
T Consensus        73 i~G~~l~~~----~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          73 IEGSELLTE----D---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cCCCccccc----c---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999887643    0         011346788999999999832  12369999999999999 6689999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN03150 hypothetical protein; Provisional

Probab=99.27  E-value=1.3e-11  Score=137.85  Aligned_cols=116  Identities=36%  Similarity=0.675  Sum_probs=99.5

Q ss_pred             cceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEee
Q 006522          115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLR  194 (642)
Q Consensus       115 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~  194 (642)
                      ++.|+|++|.++|.+|..+..|++|+.|+|++|.|+|.+|..+..++.|+ .|+|++|+|+|.+|+.++++++|+.|+|+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~-~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC-EEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            77899999999999999999999999999999999999999999999999 99999999999999999999999999999


Q ss_pred             cCCCCCCcCcccc--ccccCCcccCCCCCCCCCCCCCCC
Q 006522          195 NNNLSGEIPQVGS--LLNQGPTAFSGNPGLCGFPLQSPC  231 (642)
Q Consensus       195 ~N~l~~~~p~~~~--~~~~~~~~~~~n~~~~~~~~~~~c  231 (642)
                      +|+|+|.+|....  ..+.....+.+|+++|+.|....|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            9999999985321  123445678999999986643344

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=2.3e-11  Score=127.74  Aligned_cols=259  Identities=17%  Similarity=0.161  Sum_probs=171.9

Q ss_pred             cHHHHHhhcccccCc--cCCceeEEEEecCCCCCCCCeEEEEEEecCCCc-cccHHHHHHHHHHHhcc-cCCCeeeEEEE
Q 006522          338 ELEDLLRASAYVVGK--SKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARV-QHPNIVRLKAF  413 (642)
Q Consensus       338 ~~~~~~~~~~~~lg~--g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~  413 (642)
                      +..+-......-+|.  |.+|.+|.+....   ......+|+|+-+..-. .....+=.+|+....++ .|+|.|+.+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            333333345567888  9999999998732   11227888888443311 11112234677777777 69999998888


Q ss_pred             EEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCCeeeCCC
Q 006522          414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR----GLMYIHEYSPRKYVHGNIKSTKILLDDE  489 (642)
Q Consensus       414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlkp~NILl~~~  489 (642)
                      +...+..++-.|++. .+|.++.+....    .++....+.+..+..+    |+.++|+   ..++|-|+||.||.+..+
T Consensus       187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  187 WEGSGILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             cccCCcceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccc
Confidence            888899999999885 688888876543    2555666666666666    9999999   899999999999999988


Q ss_pred             -CCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          490 -LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       490 -~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                       ...++.|||+...+............       -..-|...|++||. .. ..++..+|+||+|.+..|..++......
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~-------~r~~~~~~Y~~ke~-~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVS-------KRPEGDCIYAAKEL-LN-GLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeee-------ecCCCCceEeChhh-hc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence             99999999998877654322111100       01134556999997 33 6789999999999999999998776543


Q ss_pred             CCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Q 006522          569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS  633 (642)
Q Consensus       569 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~Cl~~dP~~RPs~~ev~  633 (642)
                      .....     |.+     .+...  +-.++.+...     .++-.....+++.+|..|++.+++.
T Consensus       330 g~~~~-----W~~-----~r~~~--ip~e~~~~~s-----~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  330 GKNSS-----WSQ-----LRQGY--IPLEFCEGGS-----SSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             CCCCC-----ccc-----ccccc--CchhhhcCcc-----hhhhhHHHHhcCcchhhhhHHHHHh
Confidence            21111     111     00000  1111111111     1112255668899999999887654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.22  E-value=1.8e-12  Score=140.54  Aligned_cols=153  Identities=30%  Similarity=0.371  Sum_probs=122.5

Q ss_pred             CEeEEEcCCCCccccCCcccc-------------------------CCCCCCEEEccCCCCCCccccccccCCccceeec
Q 006522           66 RVTSLYLPNRNLTGYMPSELG-------------------------LLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL  120 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~-------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  120 (642)
                      .+.+|+|..|+|....+..+.                         .++.|+.|+|.+|.|+...-+.+.+...|+.|+|
T Consensus       311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL  390 (1081)
T KOG0618|consen  311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL  390 (1081)
T ss_pred             eeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence            477888888887643221111                         1344677888888888776667888999999999


Q ss_pred             cCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCC
Q 006522          121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       121 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  200 (642)
                      ++|+|.......+.++..|++|+||+|.|+ .+|..+..+..|+ +|...+|++. ..| .+..++.|+.+|+|.|+|+-
T Consensus       391 syNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~-tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  391 SYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH-TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             cccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH-HHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            999998544456788999999999999999 8999999999999 9999999998 566 88999999999999999985


Q ss_pred             -CcCccccccccCCcccCCCCCC
Q 006522          201 -EIPQVGSLLNQGPTAFSGNPGL  222 (642)
Q Consensus       201 -~~p~~~~~~~~~~~~~~~n~~~  222 (642)
                       .+|.....+++..++++||.++
T Consensus       467 ~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  467 VTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhhhhhCCCcccceeeccCCccc
Confidence             3443333367888999999863

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=3.7e-10  Score=119.85  Aligned_cols=228  Identities=16%  Similarity=0.181  Sum_probs=147.3

Q ss_pred             eEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHH
Q 006522          373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR  452 (642)
Q Consensus       373 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~  452 (642)
                      ..|.|...+.... .......+-++-|+.++||||+++++.+......|+|+|-+.  -|..++.+.        .....
T Consensus        38 ~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~~~v  106 (690)
T KOG1243|consen   38 GPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GKEEV  106 (690)
T ss_pred             CceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HHHHH
Confidence            6777777765544 333567788899999999999999999999999999999874  577777643        23455


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCccc
Q 006522          453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYL  532 (642)
Q Consensus       453 ~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  532 (642)
                      ...+.||+.||.|||..  .+++|++|.-+.|++++.|+-||++|-++...........            ...--..|.
T Consensus       107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~------------~~~~~~s~~  172 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK------------SLYLIESFD  172 (690)
T ss_pred             HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc------------cchhhhccc
Confidence            66789999999999976  4799999999999999999999999988765443321000            000011266


Q ss_pred             CccccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCCcccHHHHHHHHHhccCCCccccChhhhhchhHHHHHHHHH
Q 006522          533 APEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF  612 (642)
Q Consensus       533 aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~  612 (642)
                      .|+.+.. .  +-..|.|-|||+++|++.|..+-.........+.+.....+....-..+..            ... .+
T Consensus       173 ~P~~~~~-s--~~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~------------r~n-~~  236 (690)
T KOG1243|consen  173 DPEEIDP-S--EWSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGATELK------------RPN-KL  236 (690)
T ss_pred             ChhhcCc-c--ccchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhcccccc------------ccc-hh
Confidence            6764221 1  135699999999999999943321111111111111111110000000000            001 34


Q ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHHhhhc
Q 006522          613 HIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       613 ~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  641 (642)
                      +++..|....+-.|=.+-+++..|++++.
T Consensus       237 ~~~~~~~~~~gff~n~fvd~~~fLeel~l  265 (690)
T KOG1243|consen  237 RFILECRLLGGFFRNDFVDTLLFLEELRL  265 (690)
T ss_pred             hHHHHHHhccccccchHHHHHHHHHhccc
Confidence            56666777777777778888888877753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=9e-11  Score=126.60  Aligned_cols=143  Identities=11%  Similarity=0.119  Sum_probs=95.6

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCcc---------------------------------ccH-----
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT---------------------------------WRF-----  389 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------~~~-----  389 (642)
                      ..+|.|++|.||+|++.+++     +.||||+.+.....                                 +..     
T Consensus       125 ~PlasaSiaQVh~A~l~~~G-----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNG-----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hhhcCCCccEEEEEEECCCC-----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            57999999999999998732     89999999754110                                 000     


Q ss_pred             -HHHHHHHHHHhccc----CCCeeeEEEEEEe-CCceEEEEeeccCCcHHHH--HhcCCCCCCCCCCHHHHHHHHHHHHH
Q 006522          390 -KDFESEVEAIARVQ----HPNIVRLKAFYYA-NDEKLLISDFIRNGSLYAA--LHAGPSDSLPPLPWEARLKIAQGTAR  461 (642)
Q Consensus       390 -~~~~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~  461 (642)
                       -+|.+|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+++.+.  +...+.+ ...+.......++.|+  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-MKLLAERGVEVFFTQV--  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-HHHHHHHHHHHHHHHH--
Confidence             12556666666663    4444554444443 4568899999999999875  3322211 0112222233333333  


Q ss_pred             HHHHHHhcCCCCceecCCCCCCeeeCCCC----CeEEecccccccCCCC
Q 006522          462 GLMYIHEYSPRKYVHGNIKSTKILLDDEL----HPCISGFGLNRLLPGT  506 (642)
Q Consensus       462 gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DfGla~~~~~~  506 (642)
                           +.   .+++|+|+||.||+++.++    .+++.|||+...+...
T Consensus       277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 33   6899999999999999888    9999999999877543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=3.4e-10  Score=106.03  Aligned_cols=142  Identities=15%  Similarity=0.128  Sum_probs=99.1

Q ss_pred             cccCccCCceeEEEEecCCC-CCCCCeEEEEEEecCCCc-----------c----------ccHHHH----HHHHHHHhc
Q 006522          348 YVVGKSKNGIMYKVVVGRGS-GMGAPTVVAVRRLTEGDA-----------T----------WRFKDF----ESEVEAIAR  401 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~-~~~~~~~vavK~~~~~~~-----------~----------~~~~~~----~~E~~~l~~  401 (642)
                      ..||.|.-+.||.|...++. +......+|||..+....           .          ...+.+    .+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46889999999999865421 111236899998754210           0          001223    389999999


Q ss_pred             cc--CCCeeeEEEEEEeCCceEEEEeeccCCcHHH-HHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceec
Q 006522          402 VQ--HPNIVRLKAFYYANDEKLLISDFIRNGSLYA-ALHAGPSDSLPPLPWEARLKIAQGTARGLMYI-HEYSPRKYVHG  477 (642)
Q Consensus       402 l~--H~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHr  477 (642)
                      +.  .-++.+.+++    ...++||||+.++.+.. .+...      .++..+...+..+++.+|.+| |.   .+++|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            94  3566677764    56789999997754422 22221      245556677889999999999 77   799999


Q ss_pred             CCCCCCeeeCCCCCeEEecccccccC
Q 006522          478 NIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       478 Dlkp~NILl~~~~~~kl~DfGla~~~  503 (642)
                      ||++.||+++ ++.+.++|||.+-..
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999997 467999999977543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.13  E-value=2.7e-12  Score=132.24  Aligned_cols=131  Identities=29%  Similarity=0.421  Sum_probs=77.1

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecc
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  145 (642)
                      .+|.|||+.|+++ .+|..+..|+ |+.|.+++|+++ .+|..++.+..|..||.+.|++. .+|..++.+.+|+.|++.
T Consensus       122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr  197 (722)
T KOG0532|consen  122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR  197 (722)
T ss_pred             HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence            3445555555555 3444454443 555555555553 45555555555555555555555 455555555555555555


Q ss_pred             cccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCc
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ  204 (642)
Q Consensus       146 ~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  204 (642)
                      .|++. .+|+.+..|+ |. .||+|+|+++ .+|-.|.+|+.|++|.|.+|.|+.++-+
T Consensus       198 Rn~l~-~lp~El~~Lp-Li-~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq  252 (722)
T KOG0532|consen  198 RNHLE-DLPEELCSLP-LI-RLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ  252 (722)
T ss_pred             hhhhh-hCCHHHhCCc-ee-eeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence            55555 4555555444 33 5777777776 6677777777777777777777755443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=3.9e-10  Score=109.91  Aligned_cols=142  Identities=17%  Similarity=0.235  Sum_probs=109.2

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccC--CCeeeEEEEEEeCC---ceEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH--PNIVRLKAFYYAND---EKLL  422 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~---~~~l  422 (642)
                      ..++.|..+.+|++...++      ..+++|............++.+|+++++.+++  .++.+++.+.....   ..++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g------~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~   77 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGG------RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY   77 (223)
T ss_pred             eecCCCccceEEEEEecCC------cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence            3578899999999988664      67899987654322123678899999999965  44677777776543   5689


Q ss_pred             EEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS--------------------------------  470 (642)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------  470 (642)
                      ||||+++.++.+.+..      ..++..++..++.+++++|.+||+..                                
T Consensus        78 v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          78 VMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             EEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            9999999888776532      13777888889999999999998621                                


Q ss_pred             ---------------------CCCceecCCCCCCeeeCC--CCCeEEecccccc
Q 006522          471 ---------------------PRKYVHGNIKSTKILLDD--ELHPCISGFGLNR  501 (642)
Q Consensus       471 ---------------------~~~iiHrDlkp~NILl~~--~~~~kl~DfGla~  501 (642)
                                           ...++|+|++|.||+++.  ++.+.|.||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                                 235799999999999998  6678999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=5.1e-11  Score=125.20  Aligned_cols=190  Identities=21%  Similarity=0.235  Sum_probs=142.3

Q ss_pred             ccccCccCCceeEEEEec-CCCCCCCCeEEEEEEecCCCccccH-HHHHHHHHHHhcc-cCCCeeeEEEEEEeCCceEEE
Q 006522          347 AYVVGKSKNGIMYKVVVG-RGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~-~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv  423 (642)
                      ...||.+.|+.|+++... .+.     ..+++|.+.+....... ..-..|+.+...+ .|.+++++...+...+..|+=
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~-----~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGD-----CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             eEEccCCccccceeeeecCCCC-----ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            356889999999998755 333     78999988765322211 2235677777666 699999988888888888899


Q ss_pred             EeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCC-CCeEEeccccccc
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DfGla~~  502 (642)
                      -||++++++...+.-.     ..++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..++.|||++..
T Consensus       345 ~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             hhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            9999999987766322     137778889999999999999998   899999999999999875 8889999998864


Q ss_pred             CCCCCcccccceeeecCCCcccccCCCccc-CccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYL-APEARIYGSKFTQKCDVYSFGIVLLEILTGRL  564 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~  564 (642)
                      +.-...               ......+++ ..|.+.....+..+.|++|||.-+.|.+|+..
T Consensus       417 ~~~~~~---------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  417 LAFSSG---------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cceecc---------------cccccccccccchhhccccccccccccccccccccccccCcc
Confidence            221100               111222344 35555666778899999999999999999864

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.07  E-value=1.7e-10  Score=128.85  Aligned_cols=115  Identities=26%  Similarity=0.360  Sum_probs=56.9

Q ss_pred             CCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceee
Q 006522           89 NSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLN  168 (642)
Q Consensus        89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~  168 (642)
                      .+|+.|+|++|+|++ +|..   .++|+.|++++|+|++ +|..   +.+|+.|+|++|.|+ .+|...   +.|+ .|+
T Consensus       342 ~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~-~Ld  408 (788)
T PRK15387        342 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVLP---SELK-ELM  408 (788)
T ss_pred             cccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCcc---cCCC-EEE
Confidence            367777777777764 5532   2345556666666653 4432   234555566655555 234322   2344 555


Q ss_pred             cccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCC
Q 006522          169 LSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       169 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~  220 (642)
                      +++|+|++ +|..+   .+|+.|+|++|+|+..+..+..+.++..+.+++|+
T Consensus       409 LS~N~Lss-IP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~  456 (788)
T PRK15387        409 VSGNRLTS-LPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNP  456 (788)
T ss_pred             ccCCcCCC-CCcch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCC
Confidence            55555553 34322   23445555555555322222333344444455554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.06  E-value=1.5e-11  Score=126.87  Aligned_cols=148  Identities=30%  Similarity=0.422  Sum_probs=129.2

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecc
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  145 (642)
                      .+..+.|.+|.+. .+|..+++|..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.|
T Consensus        99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s  174 (722)
T KOG0532|consen   99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS  174 (722)
T ss_pred             HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence            3566778888887 78999999999999999999998 6899999998 999999999998 799999999999999999


Q ss_pred             cccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCCC
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPG  221 (642)
Q Consensus       146 ~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~  221 (642)
                      .|++. .+|..++.+..|+ .|++..|++. .+|+++..|+ |..||+|+|+++-.+-.+..+..+..+.+..||.
T Consensus       175 ~nei~-slpsql~~l~slr-~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL  246 (722)
T KOG0532|consen  175 KNEIQ-SLPSQLGYLTSLR-DLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL  246 (722)
T ss_pred             hhhhh-hchHHhhhHHHHH-HHHHhhhhhh-hCCHHHhCCc-eeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence            99999 8999999999999 9999999998 6777777776 8999999999996544444556666777888873

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.1e-09  Score=97.10  Aligned_cols=131  Identities=18%  Similarity=0.292  Sum_probs=98.1

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEE-ecCCCc------cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceE
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRR-LTEGDA------TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~-~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~  421 (642)
                      ++++|+-..+|.+....       ..+++|. +.+.-.      .-..++-.+|+.++.+++--.|..-.=|..+.+...
T Consensus         3 ~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~   75 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL   75 (204)
T ss_pred             hhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence            57889889999886533       2344443 333211      112245678999999997655555555677788889


Q ss_pred             EEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      ++|||++|..|.+.+...            +..++..+-.-+.-||.   .+|+|+||.++||++..+. +.++|||++.
T Consensus        76 I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          76 IVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             EEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccc
Confidence            999999999999898753            24677777788888999   8999999999999998764 9999999986


Q ss_pred             c
Q 006522          502 L  502 (642)
Q Consensus       502 ~  502 (642)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            3

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.03  E-value=3.4e-10  Score=126.52  Aligned_cols=134  Identities=25%  Similarity=0.360  Sum_probs=88.0

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCcccc---cccc--------------CCccceeeccCCccccc
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPA---NLFN--------------ATNLVYLDLAHNSFCGP  128 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~--------------l~~L~~L~L~~N~l~~~  128 (642)
                      .++.|+|++|+++. +|.   .+++|+.|+|++|+|++ +|.   .+..              ..+|++|+|++|+|++ 
T Consensus       283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~-  356 (788)
T PRK15387        283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLAS-  356 (788)
T ss_pred             hcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCC-
Confidence            45566677776663 333   23567777777777765 332   1111              1368888888888884 


Q ss_pred             CcccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccc
Q 006522          129 IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSL  208 (642)
Q Consensus       129 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  208 (642)
                      +|..   ..+|+.|++++|+|+ .+|...   ..|. .|++++|+|++ +|..   .++|+.|++++|+|++ +|..  .
T Consensus       357 LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~-~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l--~  421 (788)
T PRK15387        357 LPTL---PSELYKLWAYNNRLT-SLPALP---SGLK-ELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML--P  421 (788)
T ss_pred             CCCC---Ccccceehhhccccc-cCcccc---cccc-eEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc--h
Confidence            5543   356778888889888 466543   4577 89999999985 5544   3578999999999996 5532  2


Q ss_pred             cccCCcccCCCC
Q 006522          209 LNQGPTAFSGNP  220 (642)
Q Consensus       209 ~~~~~~~~~~n~  220 (642)
                      .++..+.+.+|.
T Consensus       422 ~~L~~L~Ls~Nq  433 (788)
T PRK15387        422 SGLLSLSVYRNQ  433 (788)
T ss_pred             hhhhhhhhccCc
Confidence            334455666665

>PLN03210 Resistant to P

Probab=99.02  E-value=9.4e-10  Score=131.85  Aligned_cols=162  Identities=23%  Similarity=0.277  Sum_probs=90.9

Q ss_pred             ceeeEecCCCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCC
Q 006522           57 WSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTL  136 (642)
Q Consensus        57 w~gv~c~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  136 (642)
                      |.|+.+. .+++.|+|++++..+.+| .++.+++|+.|+|++|.....+|..+.++++|+.|+|++|...+.+|..+ ++
T Consensus       627 ~~~~~~l-~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        627 WDGVHSL-TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             ccccccC-CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            4444332 245666666655444454 35666666666666665545666666666666666666654444555543 44


Q ss_pred             CCcCeEecccccCCCc--------------------chhHh------------------------------hhhccccce
Q 006522          137 KNLTHLDLSSNLLNGS--------------------LPEFL------------------------------LDLRALTGT  166 (642)
Q Consensus       137 ~~L~~L~Ls~N~l~~~--------------------~p~~~------------------------------~~l~~l~~~  166 (642)
                      ++|+.|+|++|...+.                    +|..+                              ...++|+ .
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~-~  782 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT-R  782 (1153)
T ss_pred             CCCCEEeCCCCCCccccccccCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccch-h
Confidence            4555555444432222                    22211                              0112455 6


Q ss_pred             eecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccccCCcccCCCCCC
Q 006522          167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL  222 (642)
Q Consensus       167 l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~  222 (642)
                      |+|++|+..+.+|..++++++|+.|+|++|..-+.+|....+.++..+.++++..+
T Consensus       783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L  838 (1153)
T PLN03210        783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRL  838 (1153)
T ss_pred             eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcc
Confidence            66677766667777777888888888877654445564444555556666665443

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.02  E-value=8.6e-10  Score=123.98  Aligned_cols=125  Identities=30%  Similarity=0.442  Sum_probs=95.8

Q ss_pred             EecCCCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcC
Q 006522           61 HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLT  140 (642)
Q Consensus        61 ~c~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  140 (642)
                      .|.....+.|+|++++++. +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+
T Consensus       174 ~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~  244 (754)
T PRK15370        174 DCLKNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQ  244 (754)
T ss_pred             hhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--cccc
Confidence            4555678899999999884 566553  57899999999998 4776654  58999999999988 5676543  4788


Q ss_pred             eEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCC
Q 006522          141 HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       141 ~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  201 (642)
                      .|+|++|++. .+|..+.  +.|+ .|++++|+|+ .+|..+.  ++|+.|+|++|+|++.
T Consensus       245 ~L~Ls~N~L~-~LP~~l~--s~L~-~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L  298 (754)
T PRK15370        245 EMELSINRIT-ELPERLP--SALQ-SLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL  298 (754)
T ss_pred             EEECcCCccC-cCChhHh--CCCC-EEECcCCccC-ccccccC--CCCcEEECCCCccccC
Confidence            9999999988 6777664  4677 8889999888 4666553  4788899999988864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.01  E-value=4.2e-11  Score=114.19  Aligned_cols=131  Identities=28%  Similarity=0.382  Sum_probs=104.5

Q ss_pred             ccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhcc
Q 006522           83 SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRA  162 (642)
Q Consensus        83 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  162 (642)
                      ..+...+.|+.||||+|.++ .+.....-+|.++.|++|+|.+.. + ..+..|++|++||||+|.++ .+..+-..|-+
T Consensus       278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN  353 (490)
T KOG1259|consen  278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN  353 (490)
T ss_pred             EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence            33445678999999999997 577788888999999999999983 3 34889999999999999998 66666677888


Q ss_pred             ccceeecccccccccCCcccCCCCCCcEEEeecCCCCC--CcCccccccccCCcccCCCC
Q 006522          163 LTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG--EIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       163 l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~~~~~~~~n~  220 (642)
                      .+ +|.|+.|.+.. + ..++.+-+|..||+++|+|..  .+-.+++++.+....+.+||
T Consensus       354 IK-tL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP  410 (490)
T KOG1259|consen  354 IK-TLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP  410 (490)
T ss_pred             Ee-eeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence            88 99999998852 2 356777889999999999974  34455666666667778887

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.00  E-value=3.5e-11  Score=130.79  Aligned_cols=126  Identities=34%  Similarity=0.440  Sum_probs=111.1

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCcccc-ccccCCccceeeccCCcccccCcccccCCCCcCeEec
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPA-NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  144 (642)
                      .+..|+|.+|.|+...=+.|.+..+|+.|+|++|+|. .+|. .+.++..|+.|+||+|+|+ .+|..+.++..|+.|..
T Consensus       360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            5778899999999888788999999999999999997 5665 4669999999999999999 78999999999999999


Q ss_pred             ccccCCCcchhHhhhhccccceeeccccccccc-CCcccCCCCCCcEEEeecCC
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ-IPEMYGHFPVMVSLDLRNNN  197 (642)
Q Consensus       145 s~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~  197 (642)
                      .+|++. .+| .+..+++|+ .+|+|.|+++.. +|... ..++|++|||++|.
T Consensus       438 hsN~l~-~fP-e~~~l~qL~-~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLK-VLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCCcee-ech-hhhhcCcce-EEecccchhhhhhhhhhC-CCcccceeeccCCc
Confidence            999999 888 788999999 999999999844 44433 33799999999997

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.98  E-value=6.5e-10  Score=124.93  Aligned_cols=123  Identities=28%  Similarity=0.457  Sum_probs=87.7

Q ss_pred             cCCCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeE
Q 006522           63 IRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHL  142 (642)
Q Consensus        63 ~~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  142 (642)
                      .+..++.|+|++|+++. +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|++. .+|..+.  ++|+.|
T Consensus       197 Ip~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L  267 (754)
T PRK15370        197 IPEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL  267 (754)
T ss_pred             cccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE
Confidence            34578899999999984 566554  58999999999997 4676553  46888888888887 5676553  478888


Q ss_pred             ecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCC
Q 006522          143 DLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       143 ~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  201 (642)
                      +|++|+|+ .+|..+.  .+|+ .|++++|+|++ +|..+.  ++|+.|++++|+|+..
T Consensus       268 ~Ls~N~L~-~LP~~l~--~sL~-~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L  319 (754)
T PRK15370        268 DLFHNKIS-CLPENLP--EELR-YLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL  319 (754)
T ss_pred             ECcCCccC-ccccccC--CCCc-EEECCCCcccc-Ccccch--hhHHHHHhcCCccccC
Confidence            88888887 5666543  3566 78888888874 444332  3567777777777753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=2.5e-08  Score=98.96  Aligned_cols=142  Identities=13%  Similarity=0.069  Sum_probs=98.8

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccH----------HHHHHHHHHHhcccCC--CeeeEEEEEE
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF----------KDFESEVEAIARVQHP--NIVRLKAFYY  415 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~H~--nIv~l~~~~~  415 (642)
                      +++-......|+++... |      +.+.||+..........          ..+.+|...+.++...  .+.+.+++..
T Consensus        28 e~v~~~~~rrvvr~~~~-g------~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e  100 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-G------KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGE  100 (268)
T ss_pred             cEEecCCCceEEEEEEC-C------EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEE
Confidence            34443333446666543 3      67999977443211111          2478999999888433  3444555654


Q ss_pred             e-----CCceEEEEeeccCC-cHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCC-
Q 006522          416 A-----NDEKLLISDFIRNG-SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-  488 (642)
Q Consensus       416 ~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-  488 (642)
                      .     ....++|+|++++- +|.+++.....   .+.+...+..++.+++..+.-||.   .+|+|+|++++|||++. 
T Consensus       101 ~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~  174 (268)
T PRK15123        101 RGSNPATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLP  174 (268)
T ss_pred             ecCCCccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEecc
Confidence            3     22478999999986 79998854321   124556778899999999999999   89999999999999975 


Q ss_pred             ------CCCeEEeccccccc
Q 006522          489 ------ELHPCISGFGLNRL  502 (642)
Q Consensus       489 ------~~~~kl~DfGla~~  502 (642)
                            +..+.++||+.++.
T Consensus       175 ~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        175 FPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             ccCCCCCceEEEEECCcccc
Confidence                  57899999997753

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.93  E-value=3.9e-10  Score=116.55  Aligned_cols=135  Identities=24%  Similarity=0.296  Sum_probs=87.1

Q ss_pred             CCEeEEEcCCCCccccCCccccCCCC---CCEEEccCCCCCC----ccccccccC-CccceeeccCCccccc----Cccc
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNS---LTRLSLASNNFSK----PIPANLFNA-TNLVYLDLAHNSFCGP----IPDR  132 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~p~~l~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~  132 (642)
                      ..++.|+|++|.+.+..+..+..+..   |+.|++++|++++    .+...+..+ ++|+.|+|++|.+++.    ++..
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            36777777777777655555555555   7777887777763    223344455 7777778877777732    3334


Q ss_pred             ccCCCCcCeEecccccCCCc----chhHhhhhccccceeeccccccccc----CCcccCCCCCCcEEEeecCCCCC
Q 006522          133 IKTLKNLTHLDLSSNLLNGS----LPEFLLDLRALTGTLNLSFNQFSGQ----IPEMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       133 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~l~~~l~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~  200 (642)
                      +..+.+|+.|+|++|.+++.    ++..+..++.|+ .|++++|.+++.    ++..+..+++|+.|++++|.+++
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~-~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE-VLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCC-EEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            55666777777777777642    333444455677 777777777532    33445566777777777777764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=5e-10  Score=123.80  Aligned_cols=208  Identities=18%  Similarity=0.213  Sum_probs=135.6

Q ss_pred             ccCccCCceeEEEEecCCCCCCCCeEEEEEEecCC--CccccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCceEEEEee
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       349 ~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~  426 (642)
                      -+-+|.++.++-+.-...+     ...+.|.....  -...+.+...++-.++-..+||-+++..--+-.....+||++|
T Consensus       811 p~qS~sp~ss~p~~pa~sg-----h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~  885 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSG-----HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY  885 (1205)
T ss_pred             cccCCCCcccccCCccccc-----cccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence            4556777777765544332     11222222111  1111123344454455445677777655544456678999999


Q ss_pred             ccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                      ..+++|...++..+.     .+.+........+..+++|||.   ..+.|||+||.|++...++..+++|||........
T Consensus       886 ~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  886 LNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hccCCchhhhhcCCC-----cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence            999999999987652     3333444555667889999998   56999999999999999999999999954433211


Q ss_pred             Cccc---------------ccceeeecC----CCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 006522          507 SKVT---------------KNETIVTSG----TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA  567 (642)
Q Consensus       507 ~~~~---------------~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~  567 (642)
                      ....               .........    .......||+.|.+||... +......+|.|+.|++++|.++|..||.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0000               000000000    1123567899999999855 4778889999999999999999999997


Q ss_pred             CCC
Q 006522          568 GPE  570 (642)
Q Consensus       568 ~~~  570 (642)
                      ...
T Consensus      1037 a~t 1039 (1205)
T KOG0606|consen 1037 AET 1039 (1205)
T ss_pred             Ccc
Confidence            543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.92  E-value=1.9e-10  Score=109.84  Aligned_cols=131  Identities=28%  Similarity=0.350  Sum_probs=109.2

Q ss_pred             CEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecc
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  145 (642)
                      -++.|||++|.++ .+..+..-++.++.|++|+|.+.. +- .+..|++|+.||||+|.++ .+..+-.+|-+.+.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            3688999999998 567888899999999999999973 33 4889999999999999998 455666788999999999


Q ss_pred             cccCCCcchhHhhhhccccceeeccccccccc-CCcccCCCCCCcEEEeecCCCCCCcC
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ-IPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       146 ~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p  203 (642)
                      .|.+..  -+.+..|=+|. .|++++|+|... --..+++++.|++|.|.+|.|++.+.
T Consensus       361 ~N~iE~--LSGL~KLYSLv-nLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLV-NLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhHhh--hhhhHhhhhhe-eccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            999862  24566777788 899999999732 13468999999999999999998654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=1e-09  Score=82.76  Aligned_cols=61  Identities=38%  Similarity=0.501  Sum_probs=46.4

Q ss_pred             CCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccC
Q 006522           89 NSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLL  149 (642)
Q Consensus        89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  149 (642)
                      ++|+.|+|++|+|+...+..|.++++|++|+|++|+++...|..|.++++|++|+|++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677888888888755445667788888888888888777677778888888888888765

...

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.90  E-value=4.1e-10  Score=116.37  Aligned_cols=154  Identities=25%  Similarity=0.225  Sum_probs=105.3

Q ss_pred             CEeEEEcCCCCccc------cCCccccCCCCCCEEEccCCCCCCccccccccCCc---cceeeccCCcccc----cCccc
Q 006522           66 RVTSLYLPNRNLTG------YMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN---LVYLDLAHNSFCG----PIPDR  132 (642)
Q Consensus        66 ~v~~l~l~~~~l~g------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~  132 (642)
                      .++.|+++++.+.+      .++..+..+++|+.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...
T Consensus        52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~  131 (319)
T cd00116          52 SLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKG  131 (319)
T ss_pred             CceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHH
Confidence            47788888877762      24456777888899999988887766666666655   8999998888873    33344


Q ss_pred             ccCC-CCcCeEecccccCCCc----chhHhhhhccccceeecccccccc----cCCcccCCCCCCcEEEeecCCCCCCcC
Q 006522          133 IKTL-KNLTHLDLSSNLLNGS----LPEFLLDLRALTGTLNLSFNQFSG----QIPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       133 ~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~l~~~l~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p  203 (642)
                      +..+ ++|+.|+|++|.+++.    ++..+..+..|+ .|++++|.+++    .++..+..+++|+.|+|++|.+++...
T Consensus       132 l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  210 (319)
T cd00116         132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK-ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA  210 (319)
T ss_pred             HHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcC-EEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence            5566 8889999999988843    334455566788 88888888874    234445566788889999888874322


Q ss_pred             c-----cccccccCCcccCCCC
Q 006522          204 Q-----VGSLLNQGPTAFSGNP  220 (642)
Q Consensus       204 ~-----~~~~~~~~~~~~~~n~  220 (642)
                      .     +..+.++..+.+++|+
T Consensus       211 ~~l~~~~~~~~~L~~L~ls~n~  232 (319)
T cd00116         211 SALAETLASLKSLEVLNLGDNN  232 (319)
T ss_pred             HHHHHHhcccCCCCEEecCCCc
Confidence            1     1223344555555553

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.90  E-value=1.4e-09  Score=99.84  Aligned_cols=109  Identities=32%  Similarity=0.354  Sum_probs=35.2

Q ss_pred             cCCCCCCEEEccCCCCCCccccccc-cCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHh-hhhccc
Q 006522           86 GLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFL-LDLRAL  163 (642)
Q Consensus        86 ~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~l  163 (642)
                      .+...++.|+|++|.|+. | +.+. .+.+|+.|+|++|.++. ++ .+..+++|+.|+|++|+++ .+++.+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            344567777777777763 3 2454 46777777777777774 32 4666777788888888877 343333 356777


Q ss_pred             cceeecccccccccC-CcccCCCCCCcEEEeecCCCCC
Q 006522          164 TGTLNLSFNQFSGQI-PEMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       164 ~~~l~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~  200 (642)
                      + .|++++|+|...- -..++.+++|+.|+|.+|.++.
T Consensus        91 ~-~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   91 Q-ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             C-EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            7 7778888776321 1345667788888888887763

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.89  E-value=8.4e-10  Score=101.37  Aligned_cols=120  Identities=29%  Similarity=0.397  Sum_probs=51.0

Q ss_pred             CEeEEEcCCCCccccCCcccc-CCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccc-cCCCCcCeEe
Q 006522           66 RVTSLYLPNRNLTGYMPSELG-LLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLD  143 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~  143 (642)
                      +++.|+|++|.++- + +.++ .+.+|+.|+||+|.++. ++ .+..++.|+.|+|++|+++. +++.+ ..+++|++|+
T Consensus        20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence            56889999999984 3 4566 58999999999999985 44 58889999999999999995 54444 4699999999


Q ss_pred             cccccCCCcc-hhHhhhhccccceeecccccccccCCc----ccCCCCCCcEEE
Q 006522          144 LSSNLLNGSL-PEFLLDLRALTGTLNLSFNQFSGQIPE----MYGHFPVMVSLD  192 (642)
Q Consensus       144 Ls~N~l~~~~-p~~~~~l~~l~~~l~l~~N~l~~~~p~----~~~~l~~L~~L~  192 (642)
                      |++|++...- -..+..++.|+ .|+|.+|+++.. +.    .+..+|+|+.||
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~-~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLR-VLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT---EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             CcCCcCCChHHhHHHHcCCCcc-eeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            9999997421 14567889999 999999999843 32    345677888776

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=2.4e-08  Score=89.80  Aligned_cols=142  Identities=13%  Similarity=0.219  Sum_probs=100.5

Q ss_pred             ccccCccCCceeEEEEecCCCCCCCCeEEEEEE-ecCCCc------cccHHHHHHHHHHHhcccCCCeeeEEEEEEeCCc
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRR-LTEGDA------TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE  419 (642)
Q Consensus       347 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~-~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~  419 (642)
                      -.++-+|+-+.|+++....       +...||. ..+...      .-..++-.+|+.++.+++--.|.--.=++.+...
T Consensus        12 l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~   84 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG   84 (229)
T ss_pred             ceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC
Confidence            3567889988999887665       3444443 333211      1122567789999999975555544456667777


Q ss_pred             eEEEEeeccC-CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCC---CeEEe
Q 006522          420 KLLISDFIRN-GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL---HPCIS  495 (642)
Q Consensus       420 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~  495 (642)
                      -.++|||+++ -++.+++.......   -.......+++.|-+.+.-||.   ..|+|+||..+||++..++   .+.+.
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lI  158 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILI  158 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEE
Confidence            7899999976 47888887654321   2222336788999999999999   8999999999999996543   45799


Q ss_pred             cccccc
Q 006522          496 GFGLNR  501 (642)
Q Consensus       496 DfGla~  501 (642)
                      |||++.
T Consensus       159 dfgls~  164 (229)
T KOG3087|consen  159 DFGLSS  164 (229)
T ss_pred             eecchh
Confidence            999975

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.86  E-value=2.4e-09  Score=74.02  Aligned_cols=41  Identities=51%  Similarity=0.991  Sum_probs=31.3

Q ss_pred             hHhHHHHHHHHHhcccCCCCCCCCCCCCC-CCCCCceeeEec
Q 006522           23 NQDGLALLALKAAIAQDPTRALDSWSESD-STPCHWSGIHCI   63 (642)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~~~~~~w~~~~-~~~c~w~gv~c~   63 (642)
                      ++|++||++||+++..+|.+.+.+|+... .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            57999999999999877778899999874 789999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PLN03210 Resistant to P

Probab=98.85  E-value=1.2e-08  Score=122.47  Aligned_cols=134  Identities=22%  Similarity=0.257  Sum_probs=91.0

Q ss_pred             CCCEeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEe
Q 006522           64 RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLD  143 (642)
Q Consensus        64 ~~~v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  143 (642)
                      +..++.|++.++.+. .+|..+ .+.+|+.|+|++|++. .+|..+..+++|++|+|++|...+.+|. +..+++|+.|+
T Consensus       588 p~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~  663 (1153)
T PLN03210        588 PPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLK  663 (1153)
T ss_pred             CcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEE
Confidence            345666777666654 455555 4577777777777775 4666677777777777777665556664 66777777777


Q ss_pred             cccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcC
Q 006522          144 LSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       144 Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  203 (642)
                      |++|.....+|..+..+++|+ .|++++|...+.+|..+ ++++|+.|+|++|...+.+|
T Consensus       664 L~~c~~L~~lp~si~~L~~L~-~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p  721 (1153)
T PLN03210        664 LSDCSSLVELPSSIQYLNKLE-DLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP  721 (1153)
T ss_pred             ecCCCCccccchhhhccCCCC-EEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence            777766567777777777777 77777765445666554 56777777777766555555

syringae 6; Provisional

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.83  E-value=3.7e-08  Score=101.55  Aligned_cols=172  Identities=22%  Similarity=0.290  Sum_probs=127.6

Q ss_pred             CCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCCeeeEEEEEEe----CCceEEEEeeccC
Q 006522          354 KNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA----NDEKLLISDFIRN  429 (642)
Q Consensus       354 ~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~  429 (642)
                      -..+.||++...++     ..+++|+++..... .......-+++.+++.|+|||++.+.|..    +...++||+|.++
T Consensus       288 ~~~Ttyk~~s~~DG-----~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~  361 (655)
T KOG3741|consen  288 FSITTYKATSNVDG-----NAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS  361 (655)
T ss_pred             ccceeEeeeeccCC-----ceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence            34578999887765     88999999432111 11122345778999999999999998873    3468899999985


Q ss_pred             -CcHHHHHhcCCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEeccc
Q 006522          430 -GSLYAALHAGPSDS----------LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG  498 (642)
Q Consensus       430 -gsL~~~l~~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfG  498 (642)
                       ++|+++-.......          ....+++..+.++.|+..||.++|+   .|+.-+-|.+.+||++.+.+++|+..|
T Consensus       362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~  438 (655)
T KOG3741|consen  362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCG  438 (655)
T ss_pred             CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEeccc
Confidence             57877764432211          2347889999999999999999999   789889999999999999999999998


Q ss_pred             ccccCCCCCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCC
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL  564 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~  564 (642)
                      +...+..+.                        .  |. +.   --.+-|.=.||.+++.|.||..
T Consensus       439 i~Dvl~~d~------------------------~--~~-le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  439 IMDVLQEDP------------------------T--EP-LE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ceeeecCCC------------------------C--cc-hh---HHhhhhHHHHHHHHHHHhhccc
Confidence            765544331                        0  11 11   1235688899999999999954

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.80  E-value=2.3e-09  Score=114.30  Aligned_cols=128  Identities=37%  Similarity=0.540  Sum_probs=88.6

Q ss_pred             CEeEEEcCCCCccccCCccccCCC-CCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEec
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLN-SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  144 (642)
                      .++.|++.+|+++ .+|+..+.+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|++
T Consensus       117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence            5788889888888 5677777774 8999999999986 56667888899999999999988 56666667888888888


Q ss_pred             ccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCC
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       145 s~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  199 (642)
                      ++|+++ .+|.....+..|. .+.+++|++. ..+..+.++.++..|.+++|++.
T Consensus       194 s~N~i~-~l~~~~~~~~~L~-~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~  245 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALE-ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE  245 (394)
T ss_pred             cCCccc-cCchhhhhhhhhh-hhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence            888888 6666544444455 5666666322 23333344444444444444443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=4.6e-08  Score=91.43  Aligned_cols=126  Identities=18%  Similarity=0.271  Sum_probs=82.0

Q ss_pred             eeEEEEecCCCCCCCCeEEEEEEecCCCccc-------------------------cHHHHHHHHHHHhcccCC--Ceee
Q 006522          357 IMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-------------------------RFKDFESEVEAIARVQHP--NIVR  409 (642)
Q Consensus       357 ~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~~l~H~--nIv~  409 (642)
                      .||.|...++      ..+|||..+......                         ......+|.+.|.++..-  ++.+
T Consensus         1 ~Vy~~~~~~~------~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~   74 (188)
T PF01163_consen    1 DVYHAIDPDG------EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK   74 (188)
T ss_dssp             EEEEEEECTT------EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred             CEEEEECCCC------CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence            3888888777      799999876531100                         113467899999999755  5666


Q ss_pred             EEEEEEeCCceEEEEeecc--CCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCceecCCCCCCeee
Q 006522          410 LKAFYYANDEKLLISDFIR--NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI-HEYSPRKYVHGNIKSTKILL  486 (642)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl  486 (642)
                      .+++.    ...+||||++  |..+..+....       ++......++.+++..+..+ |.   .+|+|+||.+.||++
T Consensus        75 p~~~~----~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv  140 (188)
T PF01163_consen   75 PYDYN----RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILV  140 (188)
T ss_dssp             EEEEE----TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEE
T ss_pred             EEEEe----CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEe
Confidence            66542    4579999998  54554433221       11234567788888866665 67   799999999999999


Q ss_pred             CCCCCeEEecccccccC
Q 006522          487 DDELHPCISGFGLNRLL  503 (642)
Q Consensus       487 ~~~~~~kl~DfGla~~~  503 (642)
                      +++ .+.++|||.+...
T Consensus       141 ~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  141 DDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             ETT-CEEE--GTTEEET
T ss_pred             ecc-eEEEEecCcceec
Confidence            987 9999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.76  E-value=4.7e-09  Score=79.16  Aligned_cols=59  Identities=41%  Similarity=0.503  Sum_probs=30.7

Q ss_pred             ccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhHhhhhccccceeeccccc
Q 006522          114 NLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQ  173 (642)
Q Consensus       114 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~  173 (642)
                      +|++|+|++|+++...+..|.++++|++|+|++|.++...|..|..+++|+ .|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~-~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLR-YLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTES-EEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCC-EEeCcCCc
Confidence            455556665555544444555555555555555555544444444444444 44444443

...

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.73  E-value=2.5e-09  Score=106.18  Aligned_cols=137  Identities=23%  Similarity=0.252  Sum_probs=113.0

Q ss_pred             CCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEeccc-ccCCCcchhHhhhhccccceee
Q 006522           90 SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSS-NLLNGSLPEFLLDLRALTGTLN  168 (642)
Q Consensus        90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~l~~~l~  168 (642)
                      .-+.|+|..|+|+-..|..|..+++|+.||||+|+|+-+-|++|.+|.+|..|-+-+ |+|+...-..|..|..++ .|.
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slq-rLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQ-RLL  146 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHH-HHh
Confidence            567899999999977777889999999999999999999999999999987776665 999955556788999999 899


Q ss_pred             cccccccccCCcccCCCCCCcEEEeecCCCCCCcC-ccccccccCCcccCCCCCCCCCCC
Q 006522          169 LSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP-QVGSLLNQGPTAFSGNPGLCGFPL  227 (642)
Q Consensus       169 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~~~~~~~~n~~~~~~~~  227 (642)
                      +.-|++.-...+.|..+++|..|.+..|.+.-..- .+..+..++..-...||+.|...+
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL  206 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL  206 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence            99999998888999999999999999999874332 223444556666778888876543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.69  E-value=1.2e-08  Score=108.67  Aligned_cols=161  Identities=32%  Similarity=0.344  Sum_probs=114.5

Q ss_pred             CCceeeEecCCCEe---EEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCC-ccceeeccCCcccccCc
Q 006522           55 CHWSGIHCIRNRVT---SLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNAT-NLVYLDLAHNSFCGPIP  130 (642)
Q Consensus        55 c~w~gv~c~~~~v~---~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p  130 (642)
                      +.+.+..+......   .++++.+.+... ...+..++.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|
T Consensus        80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~  156 (394)
T COG4886          80 ISSLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP  156 (394)
T ss_pred             cccccccccccCCCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh
Confidence            34444444433344   477777777533 344566688899999999997 4776777774 8999999999998 566


Q ss_pred             ccccCCCCcCeEecccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcCccccccc
Q 006522          131 DRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN  210 (642)
Q Consensus       131 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  210 (642)
                      ..+..+++|+.|++++|+++ .+|...+.++.|. .|++++|+++ .+|........|++|.+++|.+...+.....+.+
T Consensus       157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~-~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~  233 (394)
T COG4886         157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN-NLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKN  233 (394)
T ss_pred             hhhhccccccccccCCchhh-hhhhhhhhhhhhh-heeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhccc
Confidence            77888999999999999998 6777666778888 8999999998 6666655666788999999964444444444445


Q ss_pred             cCCcccCCCCC
Q 006522          211 QGPTAFSGNPG  221 (642)
Q Consensus       211 ~~~~~~~~n~~  221 (642)
                      +......+|..
T Consensus       234 l~~l~l~~n~~  244 (394)
T COG4886         234 LSGLELSNNKL  244 (394)
T ss_pred             ccccccCCcee
Confidence            44444555543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=6.2e-07  Score=90.41  Aligned_cols=197  Identities=16%  Similarity=0.233  Sum_probs=126.6

Q ss_pred             cccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcc-cCCCeeeEEEEEE------eCC
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY------AND  418 (642)
Q Consensus       346 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~------~~~  418 (642)
                      .+.-+|+|+.+.+|..-...+        .+-|+.........    .+-++.|... .||-+-.=+.|=+      ...
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d--------~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD--------QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCccccCCccceeeecchhhc--------hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence            356789999999997654433        33455554422211    1233344444 6775443122211      112


Q ss_pred             c-eEEEEeeccCCc-HHHHHhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEe
Q 006522          419 E-KLLISDFIRNGS-LYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS  495 (642)
Q Consensus       419 ~-~~lv~e~~~~gs-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~  495 (642)
                      . .-+.|..+++-. ..+++.. .++...+...|...++.++.+|.+.+-||.   .+.+-+|+.++|+|+.+++.+.+.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEE
Confidence            2 456777665532 2233321 223345678999999999999999999999   788999999999999999999998


Q ss_pred             cccccccCCCCCcccccceeeecCCCcccccCCCcccCccccc----cCCCCCcccchHHHHHHHHHHHhC-CCCCCCCC
Q 006522          496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVLLEILTG-RLPDAGPE  570 (642)
Q Consensus       496 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~sDV~S~Gvvl~el~tG-~~P~~~~~  570 (642)
                      |=-.-... .            .++.....+|...|.+||.-.    .+-.-+...|-|-+||++++++.| +.||.+..
T Consensus       160 dsDsfqi~-~------------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         160 DSDSFQIN-A------------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             cccceeec-c------------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            73211110 0            111122346788899999622    123457789999999999999986 99998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=8.6e-07  Score=85.09  Aligned_cols=105  Identities=17%  Similarity=0.211  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHhccc--CCCeeeEEEEEEeCC----ceEEEEeeccCC-cHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 006522          390 KDFESEVEAIARVQ--HPNIVRLKAFYYAND----EKLLISDFIRNG-SLYAALHAGPSDSLPPLPWEARLKIAQGTARG  462 (642)
Q Consensus       390 ~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~g  462 (642)
                      ..+.+|...+.++.  .=.+.+.+++.....    ..++|+|++++- +|.+++.....     .+...+..++.+++..
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHH
Confidence            56788998888884  334556677766533    358999999984 79999876332     4446678899999999


Q ss_pred             HHHHHhcCCCCceecCCCCCCeeeCCCC---CeEEeccccccc
Q 006522          463 LMYIHEYSPRKYVHGNIKSTKILLDDEL---HPCISGFGLNRL  502 (642)
Q Consensus       463 L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DfGla~~  502 (642)
                      ++-||.   .+|+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   8999999999999998877   899999987664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.58  E-value=3.2e-07  Score=88.09  Aligned_cols=134  Identities=19%  Similarity=0.250  Sum_probs=93.0

Q ss_pred             hhcccccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc---------------------cHHHHHHHHHHHhcc
Q 006522          344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW---------------------RFKDFESEVEAIARV  402 (642)
Q Consensus       344 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~E~~~l~~l  402 (642)
                      .+.++.||-|.-+.||.|...++      ..+|||.=+....+.                     ......+|.++|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g------~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKG------RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HhhccccccCccceEEEEECCCC------CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            34579999999999999999987      788888644321100                     123467899999999


Q ss_pred             cCC--CeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 006522          403 QHP--NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK  480 (642)
Q Consensus       403 ~H~--nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  480 (642)
                      .-.  .|.+.+++    +...+||||++|-.|+..--          +....-.|+..|+.-+.-.-.   .+|||+|+.
T Consensus       167 ~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~---~GiVHGDlS  229 (304)
T COG0478         167 YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYR---RGIVHGDLS  229 (304)
T ss_pred             hhcCCCCCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHH---cCccccCCc
Confidence            644  67766655    45689999999866654321          112222333333333333324   699999999


Q ss_pred             CCCeeeCCCCCeEEeccccc
Q 006522          481 STKILLDDELHPCISGFGLN  500 (642)
Q Consensus       481 p~NILl~~~~~~kl~DfGla  500 (642)
                      +=||+++++|.+.++||--+
T Consensus       230 efNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             hheEEEecCCCEEEEeCccc
Confidence            99999999999999999543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=3.1e-08  Score=105.95  Aligned_cols=106  Identities=25%  Similarity=0.343  Sum_probs=75.3

Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCCCcccccceeeecCCCcccccCCCcccCcc
Q 006522          456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE  535 (642)
Q Consensus       456 ~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  535 (642)
                      +.+++.|+.|+|..  .++||++|.|++|.++..+..||+.|+.+........+.....   .........-..-|.|||
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~y---d~~lp~~~~~~~~f~apE  179 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEY---DPPLPLLLQPHLNFLAPE  179 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccC---CCCCChhhccCcccccch
Confidence            34456999999985  7899999999999999999999999998866554322111110   000011122234599999


Q ss_pred             ccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 006522          536 ARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDA  567 (642)
Q Consensus       536 ~~~~~~~~~~~sDV~S~Gvvl~el~t-G~~P~~  567 (642)
                      ++.. ...+.++|+||+||++|.+.. |+.-+.
T Consensus       180 ~~~~-~~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  180 YLLG-TTNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             hhcc-ccccccccceeeeeEEEEEecCCcchhh
Confidence            9554 677899999999999999995 444443

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=6.8e-06  Score=77.36  Aligned_cols=137  Identities=15%  Similarity=0.110  Sum_probs=100.3

Q ss_pred             CccCCceeEEEEecCCCCCCCCeEEEEEEecCC-Cc----cccHHHHHHHHHHHhcccC--CCeeeEEEEEE-eC----C
Q 006522          351 GKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DA----TWRFKDFESEVEAIARVQH--PNIVRLKAFYY-AN----D  418 (642)
Q Consensus       351 g~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-~~----~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~-~~----~  418 (642)
                      |+||-+.|++.....       +.+-+|+-... ..    ......|.+|+..+.++..  -.+.+.. ++. ..    -
T Consensus        27 ~rgG~SgV~r~~~~g-------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~   98 (216)
T PRK09902         27 RRNGMSGVQCVERNG-------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEW   98 (216)
T ss_pred             CCCCcceEEEEEeCC-------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCce
Confidence            567888888876554       35888886522 11    2234789999999999953  3344544 332 21    1


Q ss_pred             ceEEEEeeccC-CcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCC--eEEe
Q 006522          419 EKLLISDFIRN-GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH--PCIS  495 (642)
Q Consensus       419 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~  495 (642)
                      ..+||+|-+.+ -||.+++.....   .+.+...+..+..+|++.++-||.   .++.|+|+-+.||+++.++.  ++++
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEE
Confidence            36799997763 489998865432   236777888999999999999999   89999999999999986666  9999


Q ss_pred             cccccc
Q 006522          496 GFGLNR  501 (642)
Q Consensus       496 DfGla~  501 (642)
                      ||--++
T Consensus       173 DlEk~r  178 (216)
T PRK09902        173 DLEKSR  178 (216)
T ss_pred             Ehhccc
Confidence            997654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=2.7e-08  Score=84.63  Aligned_cols=130  Identities=25%  Similarity=0.305  Sum_probs=88.0

Q ss_pred             eEEEcCCCCccccCCc---cccCCCCCCEEEccCCCCCCcccccccc-CCccceeeccCCcccccCcccccCCCCcCeEe
Q 006522           68 TSLYLPNRNLTGYMPS---ELGLLNSLTRLSLASNNFSKPIPANLFN-ATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLD  143 (642)
Q Consensus        68 ~~l~l~~~~l~g~~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  143 (642)
                      -.++|+++.|. .+++   .+.....|+..+|++|.|. .+|+.|.. .+.++.|+|++|+++ .+|..+..++.|+.|+
T Consensus        30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            34566666654 3343   3444556667788888886 46666653 457888888888888 6777788888888888


Q ss_pred             cccccCCCcchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCCCcC
Q 006522          144 LSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       144 Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  203 (642)
                      ++.|.|. ..|..+..|.++. .|+..+|.+. .+|-.+-.-+..-..++.+|.+.+.-|
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~-~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLD-MLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             cccCccc-cchHHHHHHHhHH-HhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            8888888 6777777788887 8888888776 344332222222334457777777666

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.41  E-value=1.9e-08  Score=85.49  Aligned_cols=104  Identities=27%  Similarity=0.404  Sum_probs=54.6

Q ss_pred             CCEEEccCCCCCCccccccc---cCCccceeeccCCcccccCcccc-cCCCCcCeEecccccCCCcchhHhhhhccccce
Q 006522           91 LTRLSLASNNFSKPIPANLF---NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT  166 (642)
Q Consensus        91 L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~l~~~  166 (642)
                      +..|+|+++.|- .++....   ....|+..+|++|.|.. +|+.| ...+.++.|+|++|.++ .+|..+..++.|+ .
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr-~  104 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR-S  104 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh-h
Confidence            445555655552 3444333   23344445666666653 33333 23445666666666665 5555566666666 5


Q ss_pred             eecccccccccCCcccCCCCCCcEEEeecCCCC
Q 006522          167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       167 l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  199 (642)
                      ++++.|.|. ..|..+..+.+|..|+..+|.+.
T Consensus       105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            666666665 33444444555555555555544

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.40  E-value=6.2e-09  Score=110.56  Aligned_cols=128  Identities=30%  Similarity=0.384  Sum_probs=97.9

Q ss_pred             CCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcccccCCCCcCeEecccccCCCcchhH-hhhhcccccee
Q 006522           89 NSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEF-LLDLRALTGTL  167 (642)
Q Consensus        89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~l~~~l  167 (642)
                      ..|.+.+.+.|.|. .+...+.-++.|+.|||++|+++..  +.+..|+.|++|||++|.|. .+|.. ...+. |. .|
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~-~L  237 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQ-LL  237 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-he-ee
Confidence            35777888899986 5677788889999999999999854  37889999999999999998 55532 22233 66 89


Q ss_pred             ecccccccccCCcccCCCCCCcEEEeecCCCCCCc--CccccccccCCcccCCCCCCCC
Q 006522          168 NLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEI--PQVGSLLNQGPTAFSGNPGLCG  224 (642)
Q Consensus       168 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~~~~~~~~~~~n~~~~~  224 (642)
                      ++++|.++..  ..+.+|.+|+.|||++|-|++.-  -.+..+..+..+++.|||--|.
T Consensus       238 ~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  238 NLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             eecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9999998743  34678899999999999998632  2234455566788999996664

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.40  E-value=8.7e-08  Score=96.67  Aligned_cols=133  Identities=23%  Similarity=0.191  Sum_probs=73.0

Q ss_pred             CEeEEEcCCCCccccC--CccccCCCCCCEEEccCCCCCCcccccc-ccCCccceeeccCCcccc-cCcccccCCCCcCe
Q 006522           66 RVTSLYLPNRNLTGYM--PSELGLLNSLTRLSLASNNFSKPIPANL-FNATNLVYLDLAHNSFCG-PIPDRIKTLKNLTH  141 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~  141 (642)
                      .|+.|||+.|=+..+-  -.-...|++|+.|+||.|+|.-...... ..+++|+.|.|+.+.|+- .+-.....+++|+.
T Consensus       147 ~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~  226 (505)
T KOG3207|consen  147 NVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEV  226 (505)
T ss_pred             cceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHH
Confidence            5788888888776442  2344567888888888888763332222 245666677776666652 11122334566666


Q ss_pred             EecccccCCCcchhHhhhhccccceeecccccccccC-CcccCCCCCCcEEEeecCCCC
Q 006522          142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI-PEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       142 L~Ls~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~  199 (642)
                      |+|.+|...+.--....-++.|+ .|+|++|++-... -...+.++.|..|+++.+.++
T Consensus       227 L~L~~N~~~~~~~~~~~i~~~L~-~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  227 LYLEANEIILIKATSTKILQTLQ-ELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             hhhhcccccceecchhhhhhHHh-hccccCCcccccccccccccccchhhhhccccCcc
Confidence            66666642222222223344555 6666666654221 123455566666666666554

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.25  E-value=2.2e-07  Score=93.85  Aligned_cols=133  Identities=24%  Similarity=0.233  Sum_probs=89.0

Q ss_pred             CEeEEEcCCCCccccCC--ccccCCCCCCEEEccCCCCCCccc--cccccCCccceeeccCCcccccCcccc-cCCCCcC
Q 006522           66 RVTSLYLPNRNLTGYMP--SELGLLNSLTRLSLASNNFSKPIP--ANLFNATNLVYLDLAHNSFCGPIPDRI-KTLKNLT  140 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~p--~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~  140 (642)
                      .++.+.|.+....- ++  .....+++++.||||.|-|+...|  .-...|++|+.|+|+.|++.-...+.. ..++.|+
T Consensus       122 kL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK  200 (505)
T KOG3207|consen  122 KLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK  200 (505)
T ss_pred             hhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence            56666776665542 22  356678889999999998875433  224578899999999998874333322 2467888


Q ss_pred             eEecccccCCC-cchhHhhhhccccceeecccccccccCCcccCCCCCCcEEEeecCCCCC
Q 006522          141 HLDLSSNLLNG-SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       141 ~L~Ls~N~l~~-~~p~~~~~l~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  200 (642)
                      .|.|+.+.|+- .+-..+...++|. .|+|..|..-+.-.....-+..|++|||++|++-.
T Consensus       201 ~L~l~~CGls~k~V~~~~~~fPsl~-~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~  260 (505)
T KOG3207|consen  201 QLVLNSCGLSWKDVQWILLTFPSLE-VLYLEANEIILIKATSTKILQTLQELDLSNNNLID  260 (505)
T ss_pred             eEEeccCCCCHHHHHHHHHhCCcHH-HhhhhcccccceecchhhhhhHHhhccccCCcccc
Confidence            89999888872 1223345567777 88888885332333344456678889999888753

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=7.3e-06  Score=88.28  Aligned_cols=150  Identities=17%  Similarity=0.272  Sum_probs=101.5

Q ss_pred             cHHHHHhhcc-cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc-----------------------------
Q 006522          338 ELEDLLRASA-YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW-----------------------------  387 (642)
Q Consensus       338 ~~~~~~~~~~-~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------  387 (642)
                      .++++...+. .-++.++-|.||+|++.+|      +.||||+.+..-...                             
T Consensus       120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG------~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~  193 (517)
T COG0661         120 PIEELFSEFEPEPIASASIAQVHRAVLKSG------EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE  193 (517)
T ss_pred             CHHHHHHHcCCCchhhhhHhhheeEEecCC------CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence            4556655554 7888999999999999997      899999987642111                             


Q ss_pred             cH----------HHHHHHHHHHhccc-----CCCeeeEEEEEE-eCCceEEEEeeccCCcHHHHH--hcCCCCCCCCCCH
Q 006522          388 RF----------KDFESEVEAIARVQ-----HPNIVRLKAFYY-ANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPW  449 (642)
Q Consensus       388 ~~----------~~~~~E~~~l~~l~-----H~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~l~~  449 (642)
                      .+          -++.+|+..+.+++     .++|. +=..|+ -.....|+|||++|-.+.+..  ...+      ++ 
T Consensus       194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g------~d-  265 (517)
T COG0661         194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG------ID-  265 (517)
T ss_pred             HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhcC------CC-
Confidence            00          12566777777763     34433 323333 346789999999999998884  3322      33 


Q ss_pred             HHHHHHHHHHHHH-HHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCCC
Q 006522          450 EARLKIAQGTARG-LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       450 ~~~~~i~~~ia~g-L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~~  506 (642)
                        +..++..++++ +..+=.   .+++|.|..|.||+++.++++-+.|||+...+.+.
T Consensus       266 --~k~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         266 --RKELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --HHHHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              23333333332 111212   48999999999999999999999999998776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.17  E-value=3e-05  Score=75.37  Aligned_cols=138  Identities=14%  Similarity=0.153  Sum_probs=83.0

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCC--eeeEEEEEEeCCceEEEEe
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPN--IVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e  425 (642)
                      ..||+|..+.+|+.   .+      ..+++|......   ......+|.++++.+..-.  +.+.+++....+...+|||
T Consensus         7 ~~i~~G~t~~~y~~---~~------~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KT------GKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe---cC------CCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            45799999999983   12      346678776432   2255789999999986443  4667777777777789999


Q ss_pred             eccCCc-HHHH---------------------HhcCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-C
Q 006522          426 FIRNGS-LYAA---------------------LHAGPSDSLPPLPWEARLK-IAQ----------GTAR-GLMYIHEY-S  470 (642)
Q Consensus       426 ~~~~gs-L~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~~-~  470 (642)
                      +++|.+ +.+.                     +|.-...   ......... +-.          .+.. ...+|... .
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999863 2111                     2221110   011111100 100          0111 12222211 1


Q ss_pred             CCCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          471 PRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       471 ~~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      ...++|+|+.|.||++++++ +.|.||+.+.
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            23578999999999999888 9999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.16  E-value=3.4e-08  Score=105.15  Aligned_cols=125  Identities=30%  Similarity=0.377  Sum_probs=84.4

Q ss_pred             EeEEEcCCCCccccCCccccCCCCCCEEEccCCCCCCccccccccCCccceeeccCCcccccCcc-cccCCCCcCeEecc
Q 006522           67 VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPD-RIKTLKNLTHLDLS  145 (642)
Q Consensus        67 v~~l~l~~~~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls  145 (642)
                      +...+.+.|.|. .+..++.-++.|+.|||++|+++..-  .+..|+.|++|||+.|+|. .+|. ....+. |+.|+|+
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence            344555666665 45667777888888888888887532  6778888888888888887 3443 223344 8888888


Q ss_pred             cccCCCcchhHhhhhccccceeecccccccccC-CcccCCCCCCcEEEeecCCCC
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI-PEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       146 ~N~l~~~~p~~~~~l~~l~~~l~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~  199 (642)
                      +|.++. + ..+.+|++|. .||+++|-|++-- -..+..|..|..|+|.+|.|-
T Consensus       241 nN~l~t-L-~gie~LksL~-~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTT-L-RGIENLKSLY-GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHh-h-hhHHhhhhhh-ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            888762 2 2456777777 7888888776431 122445666777888888774

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.12  E-value=6.6e-07  Score=94.78  Aligned_cols=183  Identities=18%  Similarity=0.106  Sum_probs=131.0

Q ss_pred             cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccccHHHHHHHHHHHhcccCCC-eeeEEEEEEeCCceEEEEee
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPN-IVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~  426 (642)
                      .-.++++.+.+||.+....      +...++.+...      ....-++++|.+++||| .++.++-+..++..+++++|
T Consensus       248 h~fvK~altknpKkRptae------klL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAE------KLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHhcCCCccCCChh------hheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            4567899999999876665      44446655432      34456889999999999 77777777777888999999


Q ss_pred             ccCC-cHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeeCCCCCeEEecccccccCCC
Q 006522          427 IRNG-SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       427 ~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DfGla~~~~~  505 (642)
                      +..| +-......    ....+...+...+.+.-.++++|+|+   -.-+|||    ||+..+ ...|..||+....+..
T Consensus       316 ~s~~rs~~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~  383 (829)
T KOG0576|consen  316 CSTGRSSALEMTV----SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTR  383 (829)
T ss_pred             hcCCccccccCCh----hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCc
Confidence            9887 22111110    11124444556677778899999998   3458999    777765 6789999998876654


Q ss_pred             CCcccccceeeecCCCcccccCCCcccCccccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG  568 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~sDV~S~Gvvl~el~tG~~P~~~  568 (642)
                      ..             ..+...+++.++|||+.. ...+..+.|+||.|+-..++.-|-.|-..
T Consensus       384 ~~-------------~~~t~~~~~~~~~pev~~-~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  384 TM-------------KPRTAIGTPEPLAPEVIQ-ENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cc-------------ccccCCCCCCCCCchhhc-ccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            31             122456788999999844 47888999999999877788778777543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.1e-05  Score=75.84  Aligned_cols=103  Identities=16%  Similarity=0.176  Sum_probs=81.2

Q ss_pred             HHHHHHHhcccC-CCeeeEEEEEEeCCceEEEEeeccCCcHHHHHhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006522          393 ESEVEAIARVQH-PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSP  471 (642)
Q Consensus       393 ~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  471 (642)
                      ..|.-+|+.+.+ +++.+++|+|-    .++|.||...+++.+.-..  ......-+|..|.+||.++++.+.++++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            358888999976 69999999993    4779999998776532100  0000126899999999999999999988555


Q ss_pred             CCceecCCCCCCeeeCCCCCeEEecccccc
Q 006522          472 RKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       472 ~~iiHrDlkp~NILl~~~~~~kl~DfGla~  501 (642)
                      ..+.-.|++++|+-+++++++|+.|..-..
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            568899999999999999999999987554

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.07  E-value=4e-06  Score=57.97  Aligned_cols=36  Identities=33%  Similarity=0.550  Sum_probs=15.2

Q ss_pred             CCCEEEccCCCCCCccccccccCCccceeeccCCccc
Q 006522           90 SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC  126 (642)
Q Consensus        90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  126 (642)
                      +|++|+|++|+|+ .+|+.+.+|++|+.|+|++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            3444444444444 23434444444444444444443

...

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=2.4e-05  Score=84.08  Aligned_cols=150  Identities=13%  Similarity=0.204  Sum_probs=98.2

Q ss_pred             ccHHHHHhhcc-cccCccCCceeEEEEecCCCCCCCCeEEEEEEecCCCccc----------------------------
Q 006522          337 LELEDLLRASA-YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW----------------------------  387 (642)
Q Consensus       337 ~~~~~~~~~~~-~~lg~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------  387 (642)
                      -.++++...+. .-||.-+.|.||+++++.|      ..||||+-+..-...                            
T Consensus       155 ~~ie~if~~f~~~piaaASlaQVhrA~L~~G------~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lv  228 (538)
T KOG1235|consen  155 APIEDIFSEFDEEPIAAASLAQVHRARLKNG------EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLV  228 (538)
T ss_pred             CCHHHHHHhcCcchhhhcchhheEEEEecCC------CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHH
Confidence            45666666554 7899999999999999997      899999977642111                            


Q ss_pred             --------cHHHHHHHHHHHhcc----cCCC---eeeEEEEEEe-CCceEEEEeeccCCcHHHHH--hcCCCCCCCCCCH
Q 006522          388 --------RFKDFESEVEAIARV----QHPN---IVRLKAFYYA-NDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPW  449 (642)
Q Consensus       388 --------~~~~~~~E~~~l~~l----~H~n---Iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~l~~  449 (642)
                              ..-+|.+|++-..++    +|-+   =|.+=..+++ .....|+||||+|..+.|.-  ...+      ++-
T Consensus       229 dE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~  302 (538)
T KOG1235|consen  229 DEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISP  302 (538)
T ss_pred             HHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC------CCH
Confidence                    001356777666555    3555   1112222332 24689999999998876653  3332      333


Q ss_pred             HHHHHHHHHHHHHHHH--HHhcCCCCceecCCCCCCeeeC----CCCCeEEecccccccCCC
Q 006522          450 EARLKIAQGTARGLMY--IHEYSPRKYVHGNIKSTKILLD----DELHPCISGFGLNRLLPG  505 (642)
Q Consensus       450 ~~~~~i~~~ia~gL~y--LH~~~~~~iiHrDlkp~NILl~----~~~~~kl~DfGla~~~~~  505 (642)
                      .   .|+..+.++...  ++    .|++|+|-.|.||++.    .+..+.+-|||+......
T Consensus       303 ~---~i~~~l~~~~~~qIf~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  303 H---DILNKLVEAYLEQIFK----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             H---HHHHHHHHHHHHHHHh----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3   333333333222  22    4799999999999998    478899999999876654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	642
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-31
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-14
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-06
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-06
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-06
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-06
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-06
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-06
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-06
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-06
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-06
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  131 bits (330), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 93/292 (31%), Positives = 154/292 (52%), Gaps = 24/292 (8%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+   G +YK  +  G      T+VAV+RL E         F++EVE I+   H N++
Sbjct: 45  ILGRGGFGKVYKGRLADG------TLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLL 98
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           RL+ F     E+LL+  ++ NGS+ + L   P +S PPL W  R +IA G+ARGL Y+H+
Sbjct: 99  RLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHD 157
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
           +   K +H ++K+  ILLD+E    +  FGL +L+       K+  +  +  G+ I  I+
Sbjct: 158 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-----YKDXHVXXAVRGT-IGHIA 211
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG-RLPDAG--PENDGKGLESLVRKAFR 585
             YL+        K ++K DV+ +G++LLE++TG R  D      +D   L   V+   +
Sbjct: 212 PEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           E++ L  ++D  L +  +   +V     +AL CT+  P  RP+M  V   L+
Sbjct: 266 EKK-LEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  129 bits (324), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 91/292 (31%), Positives = 149/292 (51%), Gaps = 24/292 (8%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+   G +YK  +  G       +VAV+RL E         F++EVE I+   H N++
Sbjct: 37  ILGRGGFGKVYKGRLADG------XLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           RL+ F     E+LL+  ++ NGS+ + L   P +S PPL W  R +IA G+ARGL Y+H+
Sbjct: 91  RLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
           +   K +H ++K+  ILLD+E    +  FGL +L+         +  V       I  I+
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------DYKDXHVXXAVRGXIGHIA 203
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG-RLPDAG--PENDGKGLESLVRKAFR 585
             YL+        K ++K DV+ +G++LLE++TG R  D      +D   L   V+   +
Sbjct: 204 PEYLST------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           E++ L  ++D  L +  +   +V     +AL CT+  P  RP+M  V   L+
Sbjct: 258 EKK-LEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 140/293 (47%), Gaps = 30/293 (10%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWR--FKDFESEVEAIARVQHPN 406
           +G+   G++YK       G    T VAV++L    D T     + F+ E++ +A+ QH N
Sbjct: 39  MGEGGFGVVYK-------GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L  F    D+  L+  ++ NGSL   L     D  PPL W  R KIAQG A G+ ++
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC--LDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE     ++H +IKS  ILLD+     IS FGL R          +E    +   SRI  
Sbjct: 150 HE---NHHIHRDIKSANILLDEAFTAKISDFGLAR---------ASEKFAQTVMXSRIVG 197
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
            +  Y+APEA     + T K D+YSFG+VLLEI+TG LP      + + L  +  +   E
Sbjct: 198 -TTAYMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIEDE 253
Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            + + + ID  +         V A + +A  C       RP ++ V + L  +
Sbjct: 254 EKTIEDYIDKKMNDA--DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 139/293 (47%), Gaps = 30/293 (10%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWR--FKDFESEVEAIARVQHPN 406
           +G+   G++YK       G    T VAV++L    D T     + F+ E++ +A+ QH N
Sbjct: 39  MGEGGFGVVYK-------GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L  F    D+  L+  ++ NGSL   L     D  PPL W  R KIAQG A G+ ++
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC--LDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE     ++H +IKS  ILLD+     IS FGL R          +E    +    RI  
Sbjct: 150 HE---NHHIHRDIKSANILLDEAFTAKISDFGLAR---------ASEKFAQTVMXXRIVG 197
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
            +  Y+APEA     + T K D+YSFG+VLLEI+TG LP      + + L  +  +   E
Sbjct: 198 -TTAYMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIEDE 253
Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            + + + ID  +         V A + +A  C       RP ++ V + L  +
Sbjct: 254 EKTIEDYIDKKMNDA--DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 140/293 (47%), Gaps = 30/293 (10%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWR--FKDFESEVEAIARVQHPN 406
           +G+   G++YK       G    T VAV++L    D T     + F+ E++ +A+ QH N
Sbjct: 33  MGEGGFGVVYK-------GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 85
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L  F    D+  L+  ++ NGSL   L     D  PPL W  R KIAQG A G+ ++
Sbjct: 86  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC--LDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE     ++H +IKS  ILLD+     IS FGL R     ++      IV  GT +    
Sbjct: 144 HE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIV--GTTA---- 194
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
               Y+APEA     + T K D+YSFG+VLLEI+TG LP      + + L  +  +   E
Sbjct: 195 ----YMAPEA--LRGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEEIEDE 247
Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            + + + ID  +         V A + +A  C       RP ++ V + L  +
Sbjct: 248 EKTIEDYIDKKMNDA--DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 80/215 (37%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 351 GKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-DATWR--FKDFESEVEAIARVQHPNI 407
           G+   G++YK       G    T VAV++L    D T     + F+ E++  A+ QH N+
Sbjct: 31  GEGGFGVVYK-------GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENL 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V L  F    D+  L+  +  NGSL   L     D  PPL W  R KIAQG A G+ ++H
Sbjct: 84  VELLGFSSDGDDLCLVYVYXPNGSLLDRLSC--LDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           E     ++H +IKS  ILLD+     IS FGL R          +E        SRI   
Sbjct: 142 E---NHHIHRDIKSANILLDEAFTAKISDFGLAR---------ASEKFAQXVXXSRIVG- 188
Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
           +  Y APEA     + T K D+YSFG+VLLEI+TG
Sbjct: 189 TTAYXAPEA--LRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 158/313 (50%), Gaps = 34/313 (10%)
Query: 333 EGFSLELEDLLRAS-----AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW 387
           E + + L DL  A+      +++G    G +YK V+  G+       VA++R T  +++ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK------VALKRRTP-ESSQ 77
Query: 388 RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             ++FE+E+E ++  +HP++V L  F    +E +LI  ++ NG+L   L+     ++  +
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM-SM 136
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
            WE RL+I  G ARGL Y+H    R  +H ++KS  ILLD+   P I+ FG+++   GT 
Sbjct: 137 SWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTE 191
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA 567
               +   V  GT          Y+ PE  I G + T+K DVYSFG+VL E+L  R   A
Sbjct: 192 LDQTHLXXVVKGTLG--------YIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCAR--SA 240
Query: 568 GPENDGKGLESLVRKAFRERR--PLSEVIDPALVKEIHAKRQVLATF-HIALNCTELDPE 624
             ++  + + +L   A        L +++DP L  +I  + + L  F   A+ C  L  E
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI--RPESLRKFGDTAVKCLALSSE 298
Query: 625 FRPRMRTVSESLD 637
            RP M  V   L+
Sbjct: 299 DRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 97/313 (30%), Positives = 158/313 (50%), Gaps = 34/313 (10%)
Query: 333 EGFSLELEDLLRAS-----AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW 387
           E + + L DL  A+      +++G    G +YK V+  G+       VA++R T  +++ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK------VALKRRTP-ESSQ 77
Query: 388 RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             ++FE+E+E ++  +HP++V L  F    +E +LI  ++ NG+L   L+     ++  +
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM-SM 136
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
            WE RL+I  G ARGL Y+H    R  +H ++KS  ILLD+   P I+ FG+++   GT 
Sbjct: 137 SWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTE 191
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA 567
               +   V  GT          Y+ PE  I G + T+K DVYSFG+VL E+L  R   A
Sbjct: 192 LGQTHLXXVVKGTLG--------YIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCAR--SA 240
Query: 568 GPENDGKGLESLVRKAFRERR--PLSEVIDPALVKEIHAKRQVLATF-HIALNCTELDPE 624
             ++  + + +L   A        L +++DP L  +I  + + L  F   A+ C  L  E
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI--RPESLRKFGDTAVKCLALSSE 298
Query: 625 FRPRMRTVSESLD 637
            RP M  V   L+
Sbjct: 299 DRPSMGDVLWKLE 311

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 41/301 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+GK   G   KV   R +G     V+ ++ L   D   + + F  EV+ +  ++HPN++
Sbjct: 17  VLGKGCFGQAIKVT-HRETG----EVMVMKELIRFDEETQ-RTFLKEVKVMRCLEHPNVL 70
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +     Y +     I+++I+ G+L   + +  S      PW  R+  A+  A G+ Y+H 
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHS 126
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE---TIVTSGTGSRIS 525
            +    +H ++ S   L+ +  +  ++ FGL RL+    + T+ E   ++       R +
Sbjct: 127 MN---IIHRDLNSHNCLVRENKNVVVADFGLARLM--VDEKTQPEGLRSLKKPDRKKRYT 181
Query: 526 AISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL---PDAGPENDGKGLESLVR 581
            + N Y +APE  I G  + +K DV+SFGIVL EI+ GR+   PD  P     GL     
Sbjct: 182 VVGNPYWMAPEM-INGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNV--- 236
Query: 582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL 641
           + F +R        P+              F I + C +LDPE RP    +   L+ +++
Sbjct: 237 RGFLDRY-CPPNCPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 642 Q 642
Sbjct: 283 H 283

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 34  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 90
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H N+++  IL+ D L  
Sbjct: 91  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANILVSDTLSC 144
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 145 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 192
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 193 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 246

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 124/263 (47%), Gaps = 43/263 (16%)
Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           R +  +V +   G   +V +G  +G    T VAV+ L +G  +     F +E   + ++Q
Sbjct: 21  RETLKLVERLGAGQFGEVWMGYYNGH---TKVAVKSLKQGSMS--PDAFLAEANLMKQLQ 75
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           H  +VRL A     +   +I++++ NGSL   L    + S   L     L +A   A G+
Sbjct: 76  HQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGM 131
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            +I E   R Y+H ++++  IL+ D L   I+ FGL RL      +  NE     G    
Sbjct: 132 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARL------IEDNEXTAREGAKFP 182
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-------------- 568
           I      + APEA  YG+ FT K DV+SFGI+L EI+T GR+P  G              
Sbjct: 183 IK-----WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 236
Query: 569 ----PENDGKGLESLVRKAFRER 587
               P+N  + L  L+R  ++ER
Sbjct: 237 RMVRPDNCPEELYQLMRLCWKER 259

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 46  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 102
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 103 VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 156
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 157 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 204
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 205 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 44  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 100
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 101 VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 154
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 155 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 202
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 203 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 256

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 38  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 94
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 95  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 149 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 196
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 48  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 104
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 105 VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 158
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 159 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 206
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 207 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 260

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 40  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 96
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 97  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 150
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 151 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 198
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 199 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 252

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 39  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 95
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 96  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 149
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 150 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 197
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 198 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 251

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 43  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 99
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 100 VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 153
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 154 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 201
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 202 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 255

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 44  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 100
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 101 VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 154
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 155 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 202
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 203 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 38  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 94
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 95  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 149 KIADFGLARL------IEDNEXTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 196
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 38  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 94
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 95  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 149 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 196
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 33  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 89
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 90  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 143
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL      +  NE     G    I      + APEA  YG+ FT K DV+SF
Sbjct: 144 KIADFGLARL------IEDNEYTAREGAKFPIK-----WTAPEAINYGT-FTIKSDVWSF 191
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 192 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 245

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 375 VAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VAV+ L E D    R  +F  EV  + R++HPNIV             ++++++  GSLY
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             LH   S +   L    RL +A   A+G+ Y+H  +P   VH N+KS  +L+D +    
Sbjct: 123 RLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVK 179
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +  FGL+RL        K  T ++S +    +A +  ++APE  +      +K DVYSFG
Sbjct: 180 VCDFGLSRL--------KASTFLSSKS----AAGTPEWMAPEV-LRDEPSNEKSDVYSFG 226
Query: 554 IVLLEILTGRLP 565
           ++L E+ T + P
Sbjct: 227 VILWELATLQQP 238

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 141/295 (47%), Gaps = 42/295 (14%)
Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           R S  ++ +  NG   +V +G  +G    T VA++ L  G  T   + F  E + + +++
Sbjct: 8   RESLQLIKRLGNGQFGEVWMGTWNG---NTKVAIKTLKPG--TMSPESFLEEAQIMKKLK 62
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           H  +V+L A   + +   ++++++  GSL   L  G   +L  LP    + +A   A G+
Sbjct: 63  HDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALK-LP--NLVDMAAQVAAGM 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            YI   +   Y+H +++S  IL+ + L   I+ FGL RL      +  NE     G    
Sbjct: 119 AYIERMN---YIHRDLRSANILVGNGLICKIADFGLARL------IEDNEXTARQGAKFP 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRK 582
           I      + APEA +YG +FT K DV+SFGI+L E++T GR+P  G  N+ + LE  V +
Sbjct: 170 IK-----WTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPG-MNNREVLEQ-VER 221
Query: 583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            +R   P               +   ++   + ++C + DPE RP    +   L+
Sbjct: 222 GYRMPCP---------------QDCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 139/295 (47%), Gaps = 41/295 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G  + G   +V  GR    G   + VA++ L  G    + ++F SE   + + +HPNI
Sbjct: 21  VIGAGEFG---EVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           +RL+     +   +++++F+ NG+L  +  L+ G    +        + + +G A G+ Y
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI------QLVGMLRGIASGMRY 131
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E S   YVH ++ +  IL++  L   +S FGL+R L   S    ++   TS  G +I 
Sbjct: 132 LAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS----SDPTYTSSLGGKIP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
                + APEA I   KFT   D +S+GIV+ E+++ G  P     N  + + + + + +
Sbjct: 185 I---RWTAPEA-IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN--QDVINAIEQDY 238
Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           R   P      P     +H          + L+C + D   RPR   V  +LD++
Sbjct: 239 RLPPP------PDCPTSLH---------QLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 50/263 (19%)
Query: 385 ATWRFKD--------------FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A WR KD              F  E+  ++RV HPNIV+L  +    +   L+ ++   G
Sbjct: 28  AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL--YGACLNPVCLVMEYAEGG 85
Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           SLY  LH   ++ LP       +      ++G+ Y+H   P+  +H ++K   +LL    
Sbjct: 86  SLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---- 139
Query: 491 HPCISGFGLNRLLP-GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              ++G  + ++   GT+     +T +T+  GS        ++APE    GS +++KCDV
Sbjct: 140 ---VAGGTVLKICDFGTA--CDIQTHMTNNKGS------AAWMAPEV-FEGSNYSEKCDV 187
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           +S+GI+L E++T R P           + +   AFR    +     P L+K +    + L
Sbjct: 188 FSWGIILWEVITRRKP----------FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 237
Query: 610 ATFHIALNCTELDPEFRPRMRTV 632
            T      C   DP  RP M  +
Sbjct: 238 MT-----RCWSKDPSQRPSMEEI 255

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 50/263 (19%)
Query: 385 ATWRFKD--------------FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A WR KD              F  E+  ++RV HPNIV+L  +    +   L+ ++   G
Sbjct: 27  AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL--YGACLNPVCLVMEYAEGG 84
Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           SLY  LH   ++ LP       +      ++G+ Y+H   P+  +H ++K   +LL    
Sbjct: 85  SLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---- 138
Query: 491 HPCISGFGLNRLLP-GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              ++G  + ++   GT+     +T +T+  GS        ++APE    GS +++KCDV
Sbjct: 139 ---VAGGTVLKICDFGTA--CDIQTHMTNNKGS------AAWMAPEV-FEGSNYSEKCDV 186
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           +S+GI+L E++T R P           + +   AFR    +     P L+K +    + L
Sbjct: 187 FSWGIILWEVITRRKP----------FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236
Query: 610 ATFHIALNCTELDPEFRPRMRTV 632
            T      C   DP  RP M  +
Sbjct: 237 MT-----RCWSKDPSQRPSMEEI 254

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 37/270 (13%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           + VA++ L  G    + ++F SE   + + +HPNI+RL+     +   +++++F+ NG+L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 433 --YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
             +  L+ G    +        + + +G A G+ Y+ E S   YVH ++ +  IL++  L
Sbjct: 105 DSFLRLNDGQFTVI------QLVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNL 155
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R L   S    ++   TS  G +I      + APEA I   KFT   D +
Sbjct: 156 VCKVSDFGLSRFLEENS----SDPTETSSLGGKIPI---RWTAPEA-IAFRKFTSASDAW 207
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           S+GIV+ E+++ G  P     N  + + + + + +R   P      P     +H      
Sbjct: 208 SYGIVMWEVMSFGERPYWDMSN--QDVINAIEQDYRLPPP------PDCPTSLH------ 253
Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLDRV 639
               + L+C + D   RPR   V  +LD++
Sbjct: 254 ---QLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 40/234 (17%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L +G  +     F +E   + ++QH  +VRL A     +   +I++++ NGSL
Sbjct: 38  TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSL 94
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    + S   L     L +A   A G+ +I E   R Y+H ++++  IL+ D L  
Sbjct: 95  VDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I+ FGL RL+             T+  G++       + APEA  YG+ FT K DV+SF
Sbjct: 149 KIADFGLARLIEDAEX--------TAREGAKFPI---KWTAPEAINYGT-FTIKSDVWSF 196
Query: 553 GIVLLEILT-GRLPDAG------------------PENDGKGLESLVRKAFRER 587
           GI+L EI+T GR+P  G                  P+N  + L  L+R  ++ER
Sbjct: 197 GILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 33/266 (12%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPN++ L+     +   ++I++F+ NGSL +
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L                + + +G A G+ Y+ + +   YVH ++ +  IL++  L   +
Sbjct: 124 FLRQNDGQ----FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 176
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R L   +    ++   TS  G +I      + APEA  Y  KFT   DV+S+GI
Sbjct: 177 SDFGLSRFLEDDT----SDPTYTSALGGKIPI---RWTAPEAIQY-RKFTSASDVWSYGI 228
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           V+ E+++ G  P     N  + + + + + +R   P+     P+            A   
Sbjct: 229 VMWEVMSYGERPYWDMTN--QDVINAIEQDYRLPPPMDC---PS------------ALHQ 271
Query: 614 IALNCTELDPEFRPRMRTVSESLDRV 639
           + L+C + D   RP+   +  +LD++
Sbjct: 272 LMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 318 TDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTV-VA 376
           T EE G+ G+       F+ E+E        ++G   +G   +V  GR    G   V VA
Sbjct: 31  TYEEPGRAGR------SFTREIEASRIHIEKIIGSGDSG---EVCYGRLRVPGQRDVPVA 81
Query: 377 VRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL--YA 434
           ++ L  G    + +DF SE   + +  HPNI+RL+         +++++++ NGSL  + 
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
             H G    +        + + +G   G+ Y+ +     YVH ++ +  +L+D  L   +
Sbjct: 142 RTHDGQFTIM------QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R+L        +     + TG +I      + APEA I    F+   DV+SFG+
Sbjct: 193 SDFGLSRVL------EDDPDAAXTTTGGKIPI---RWTAPEA-IAFRTFSSASDVWSFGV 242
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           V+ E+L  G  P     N  + + S V + +R          PA +   HA  Q++    
Sbjct: 243 VMWEVLAYGERPYWNMTN--RDVISSVEEGYRL---------PAPMGCPHALHQLM---- 287
Query: 614 IALNCTELDPEFRPRMRTVSESLD 637
             L+C   D   RPR   +   LD
Sbjct: 288 --LDCWHKDRAQRPRFSQIVSVLD 309

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 86/324 (26%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 318 TDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTV-VA 376
           T EE G+ G+       F+ E+E        ++G   +G   +V  GR    G   V VA
Sbjct: 31  TYEEPGRAGR------SFTREIEASRIHIEKIIGSGDSG---EVCYGRLRVPGQRDVPVA 81
Query: 377 VRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL--YA 434
           ++ L  G    + +DF SE   + +  HPNI+RL+         +++++++ NGSL  + 
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
             H G    +        + + +G   G+ Y+ +     YVH ++ +  +L+D  L   +
Sbjct: 142 RTHDGQFTIM------QLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R+L        +     + TG +I      + APEA I    F+   DV+SFG+
Sbjct: 193 SDFGLSRVL------EDDPDAAYTTTGGKIPI---RWTAPEA-IAFRTFSSASDVWSFGV 242
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           V+ E+L  G  P     N  + + S V + +R          PA +   HA  Q++    
Sbjct: 243 VMWEVLAYGERPYWNMTN--RDVISSVEEGYRL---------PAPMGCPHALHQLM---- 287
Query: 614 IALNCTELDPEFRPRMRTVSESLD 637
             L+C   D   RPR   +   LD
Sbjct: 288 --LDCWHKDRAQRPRFSQIVSVLD 309

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPN++ L+     +   ++I++F+ NGSL +
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L                + + +G A G+ Y+ + +   YVH  + +  IL++  L   +
Sbjct: 98  FLRQNDGQ----FTVIQLVGMLRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKV 150
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL+R L   +    ++   TS  G +I      + APEA  Y  KFT   DV+S+GI
Sbjct: 151 SDFGLSRFLEDDT----SDPTYTSALGGKIPI---RWTAPEAIQY-RKFTSASDVWSYGI 202
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           V+ E+++ G  P     N  + + + + + +R   P+     P+            A   
Sbjct: 203 VMWEVMSYGERPYWDMTN--QDVINAIEQDYRLPPPMD---CPS------------ALHQ 245
Query: 614 IALNCTELDPEFRPRMRTVSESLDRV 639
           + L+C + D   RP+   +  +LD++
Sbjct: 246 LMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 43/268 (16%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ +  G  +   + F +E   +  +QH  +V+L A     +   +I++F+  GSL
Sbjct: 40  TKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSL 96
Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ +I +   R Y+H ++++  IL+   L
Sbjct: 97  LDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 148
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +GS FT K DV+
Sbjct: 149 VCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGS-FTIKSDVW 196
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           SFGI+L+EI+T GR+P  G  N  + + +L R  +R  RP +        +E+       
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNP-EVIRALER-GYRMPRPEN------CPEEL------- 241
Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLD 637
             ++I + C +  PE RP    +   LD
Sbjct: 242 --YNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 134 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 180
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 181 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 230
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 231 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 275
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 276 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 124/268 (46%), Gaps = 43/268 (16%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ +  G  +   + F +E   +  +QH  +V+L A     +   +I++F+  GSL
Sbjct: 213 TKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSL 269
Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ +I +   R Y+H ++++  IL+   L
Sbjct: 270 LDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 321
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +GS FT K DV+
Sbjct: 322 VCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGS-FTIKSDVW 369
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           SFGI+L+EI+T GR+P  G  N  + + +L R  +R  RP  E     L           
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNP-EVIRALER-GYRMPRP--ENCPEEL----------- 414
Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLD 637
             ++I + C +  PE RP    +   LD
Sbjct: 415 --YNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 124 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 170
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 171 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 220
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 221 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 265
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 266 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLGRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 375 VAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VAV+ L E D    R  +F  EV  + R++HPNIV             ++++++  GSLY
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             LH   S +   L    RL +A   A+G+ Y+H  +P   VH ++KS  +L+D +    
Sbjct: 123 RLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVK 179
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +  FGL+RL              +    S+ +A +  ++APE  +      +K DVYSFG
Sbjct: 180 VCDFGLSRLK------------ASXFLXSKXAAGTPEWMAPEV-LRDEPSNEKSDVYSFG 226
Query: 554 IVLLEILTGRLP 565
           ++L E+ T + P
Sbjct: 227 VILWELATLQQP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 106
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 107 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 153
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 154 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 203
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 204 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 248
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 249 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLARVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 3/138 (2%)
Query: 111 NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHXXXXXXXXXXXXPEFLLDLRALTGTLNLS 170
           N  ++++LD+++N   G IP  I ++  L              P+ + DLR L   L+LS
Sbjct: 627 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLS 685
Query: 171 FNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSP 230
            N+  G+IP+      ++  +DL NNNLSG IP++G      P  F  NPGLCG+PL  P
Sbjct: 686 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--P 743
Query: 231 CPEPENPKVHANPEVEDG 248
             +P N   +A+ +   G
Sbjct: 744 RCDPSNADGYAHHQRSHG 761

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 98/192 (51%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 44  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 102
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   HA   D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 103 LRDYLQAHAERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 203
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 204 WSFGVVLYELFT 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   +VH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++ + NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 140/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G+ +   + F
Sbjct: 173 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGNMS--PEAF 227
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 228 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--- 283
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 284 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLGRL------IE 332
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 333 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 386
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 387 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 429
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 430 EYLQAFLE 437

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 69/131 (52%), Gaps = 3/131 (2%)
Query: 111 NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHXXXXXXXXXXXXPEFLLDLRALTGTLNLS 170
           N  ++++LD+++N   G IP  I ++  L              P+ + DLR L   L+LS
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLS 688
Query: 171 FNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSP 230
            N+  G+IP+      ++  +DL NNNLSG IP++G      P  F  NPGLCG+PL  P
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--P 746
Query: 231 CPEPENPKVHA 241
             +P N   +A
Sbjct: 747 RCDPSNADGYA 757

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 42  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 100
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H N+ +  IL+++E
Sbjct: 101 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRNLATRNILVENE 151
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 152 NRVKIGDFGLTKVLPQDKEYYK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 201
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 202 WSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +F+  GS
Sbjct: 44  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGS 102
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 103 LREYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 203
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 204 WSFGVVLYELFT 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 47/272 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPNI+ L+         ++I++++ NGSL A
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             + R  + Q      G   G+ Y+ + S   YVH ++ +  IL++ 
Sbjct: 105 FLRKN----------DGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNS 151
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FG++R+L         E    +   +R   I   + APEA  Y  KFT   D
Sbjct: 152 NLVCKVSDFGMSRVL---------EDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASD 201
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ 607
           V+S+GIV+ E+++ G  P     N        V KA  E   L   +D            
Sbjct: 202 VWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEEGYRLPPPMDCP---------- 245
Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +A   + L+C + +   RP+   +   LD++
Sbjct: 246 -IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 47/272 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPNI+ L+         ++I++++ NGSL A
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             + R  + Q      G   G+ Y+ + S   YVH ++ +  IL++ 
Sbjct: 99  FLRKN----------DGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNS 145
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FG++R+L         E    +   +R   I   + APEA  Y  KFT   D
Sbjct: 146 NLVCKVSDFGMSRVL---------EDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASD 195
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ 607
           V+S+GIV+ E+++ G  P     N        V KA  E   L   +D            
Sbjct: 196 VWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEEGYRLPPPMDCP---------- 239
Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +A   + L+C + +   RP+   +   LD++
Sbjct: 240 -IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++ + NGSL +
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 106
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+   S   YVH ++ +  IL++ 
Sbjct: 107 FLRKH----------DAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 153
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 154 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 203
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 204 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 248
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 249 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++ +++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 20/228 (8%)
Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFES 394
           F+ E+         V+G  + G +YK ++   SG      VA++ L  G    +  DF  
Sbjct: 37  FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLG 95
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSD-SLPPLPWEARL 453
           E   + +  H NI+RL+         ++I++++ NG+L   L     + S+  L     +
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-----V 150
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
            + +G A G+ Y+   +   YVH ++ +  IL++  L   +S FGL+R+L    +     
Sbjct: 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA---- 203
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
           T  TSG       I   + APEA  Y  KFT   DV+SFGIV+ E++T
Sbjct: 204 TYTTSG-----GKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMT 245

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++ +  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLAAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 46  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 104
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 105 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 155
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 156 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 205
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 206 WSFGVVLYELFT 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 59  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 117
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 218
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 219 WSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 44  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 102
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 103 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 154 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 203
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 204 WSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 47  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 105
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 106 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 156
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 157 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 206
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 207 WSFGVVLYELFT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 39  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 97
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 98  LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 148
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 149 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 198
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 199 WSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 72  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 181
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 182 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 231
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 232 WSFGVVLYELFT 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 255 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 309
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--- 365
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 366 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 414
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 415 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 469 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 511
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 512 EYLQAFLE 519

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 41  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 200
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 201 WSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 59  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 117
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 169 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 218
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 219 WSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 48  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 106
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 107 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 157
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 158 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 207
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 208 WSFGVVLYELFT 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 40  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 98
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 99  LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 149
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 150 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 199
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 200 WSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 41  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 151 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 200
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 201 WSFGVVLYELFT 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++ +++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEXTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 45  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 103
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 104 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 154
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 155 NRVKIGDFGLTKVLPQDKEXXK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 204
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 205 WSFGVVLYELFT 216

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 46/297 (15%)
Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F  E + + +++
Sbjct: 8   RESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAFLQEAQVMKKLR 62
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWEARLKIAQGTAR 461
           H  +V+L A   + +   ++++++  GSL   L    G    LP L     + +A   A 
Sbjct: 63  HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIAS 116
Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      +  NE     G  
Sbjct: 117 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IEDNEYTARQGAK 167
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
             I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G  N  + +   V
Sbjct: 168 FPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 219
Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            + +R   P      P   + +H          +   C   DPE RP    +   L+
Sbjct: 220 ERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFIRNGS 431
           VVAV++L         +DFE E+E +  +QH NIV+ K   Y+   +   LI +++  GS
Sbjct: 41  VVAVKKLQHSTEE-HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 432 L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L  Y   H    D +  L + +++       +G+ Y+     ++Y+H ++ +  IL+++E
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQI------CKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL ++LP   +  K    V     S I      + APE+ +  SKF+   DV
Sbjct: 151 NRVKIGDFGLTKVLPQDKEFFK----VKEPGESPI-----FWYAPES-LTESKFSVASDV 200
Query: 550 YSFGIVLLEILT 561
           +SFG+VL E+ T
Sbjct: 201 WSFGVVLYELFT 212

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++ +++  GSL   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  G L   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 226
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--- 282
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 283 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 331
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 332 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 386 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 428
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 429 EYLQAFLE 436

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 46/297 (15%)
Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F  E + + +++
Sbjct: 6   RESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAFLQEAQVMKKLR 60
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTAR 461
           H  +V+L A   + +   ++++++  GSL   L    G    LP L     + +A   A 
Sbjct: 61  HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIAS 114
Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      +  NE     G  
Sbjct: 115 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IEDNEYTARQGAK 165
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
             I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G  N  + +   V
Sbjct: 166 FPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 217
Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            + +R   P      P   + +H          +   C   DPE RP    +   L+
Sbjct: 218 ERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 226
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--- 282
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 283 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 331
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 332 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 386 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 428
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 429 EYLQAFLE 436

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 57
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--- 113
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + ++   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 114 --VDMSAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 162
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 163 DNEWTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 216
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 217 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 259
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 260 EYLQAFLE 267

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 341 DLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIA 400
           ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F  E + + 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAFLQEAQVMK 58
Query: 401 RVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQG 458
           +++H  +V+L A   + +   ++++++  GSL   L    G    LP L     + +A  
Sbjct: 59  KLRHEKLVQLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQ 112
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      +  NE     
Sbjct: 113 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IEDNEXTARQ 163
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
           G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G  N
Sbjct: 164 GAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN 211

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L  G  T   + F  E   +  +QH  +VRL A     +   +I++++  GSL
Sbjct: 38  TKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL 95
Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ YI     + Y+H ++++  +L+ + L
Sbjct: 96  LDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESL 147
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +G  FT K DV+
Sbjct: 148 MCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGC-FTIKSDVW 195
Query: 551 SFGIVLLEILT-GRLPDAGPEN 571
           SFGI+L EI+T G++P  G  N
Sbjct: 196 SFGILLYEIVTYGKIPYPGRTN 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ L  G  T   + F  E   +  +QH  +VRL A     +   +I++F+  GSL
Sbjct: 37  TKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSL 94
Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ YI     + Y+H ++++  +L+ + L
Sbjct: 95  LDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESL 146
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+      +  NE     G    I      + APEA  +G  FT K +V+
Sbjct: 147 MCKIADFGLARV------IEDNEYTAREGAKFPIK-----WTAPEAINFGC-FTIKSNVW 194
Query: 551 SFGIVLLEILT-GRLPDAGPEN 571
           SFGI+L EI+T G++P  G  N
Sbjct: 195 SFGILLYEIVTYGKIPYPGRTN 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 49/273 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++ + NGSL +
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             +A+  + Q      G A G+ Y+ +      VH ++ +  IL++ 
Sbjct: 136 FLRKH----------DAQFTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINS 182
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FGL+R+L         E    +   +R   I   + +PEA  Y  KFT   D
Sbjct: 183 NLVCKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASD 232
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKR 606
           V+S+GIVL E+++ G  P     N        V KA  E   L   +D PA         
Sbjct: 233 VWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYRLPPPMDCPA--------- 277
Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              A + + L+C + D   RP+   +   LD++
Sbjct: 278 ---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 139/308 (45%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 57
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++++++  GSL   L    G    LP L   
Sbjct: 58  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--- 113
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + ++   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 114 --VDMSAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 162
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 163 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 216
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 217 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 259
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 260 EYLQAFLE 267

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 117/272 (43%), Gaps = 47/272 (17%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF SE   + +  HPNI+ L+         ++I++++ NGSL A
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ------GTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
            L             + R  + Q      G   G+ Y+ + S    VH ++ +  IL++ 
Sbjct: 120 FLRKN----------DGRFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNS 166
Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCD 548
            L   +S FG++R+L         E    +   +R   I   + APEA  Y  KFT   D
Sbjct: 167 NLVCKVSDFGMSRVL---------EDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASD 216
Query: 549 VYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ 607
           V+S+GIV+ E+++ G  P     N        V KA  E   L   +D            
Sbjct: 217 VWSYGIVMWEVMSYGERPYWDMSNQD------VIKAIEEGYRLPPPMDCP---------- 260
Query: 608 VLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +A   + L+C + +   RP+   +   LD++
Sbjct: 261 -IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 138/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 226
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++ +++  GSL   L    G    LP L   
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL--- 282
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 283 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 331
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 332 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   +PE RP  
Sbjct: 386 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKEPEERPTF 428
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 429 EYLQAFLE 436

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 46/308 (14%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + +  ++ R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAF 60
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--GPSDSLPPLPWE 450
             E + + +++H  +V+L A   + +   ++ +++  G L   L    G    LP L   
Sbjct: 61  LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQL--- 116
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + +A   A G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      + 
Sbjct: 117 --VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IE 165
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
            NE     G    I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G 
Sbjct: 166 DNEYTARQGAKFPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGM 219
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
            N  + +   V + +R   P      P   + +H          +   C   DPE RP  
Sbjct: 220 VN--REVLDQVERGYRMPCP------PECPESLH---------DLMCQCWRKDPEERPTF 262
Query: 630 RTVSESLD 637
             +   L+
Sbjct: 263 EYLQAFLE 270

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 110/230 (47%), Gaps = 25/230 (10%)
Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTV-VAVRRLTEGDATWRFKDFE 393
           F+ EL+        V+G  + G   +V  GR    G   V VA++ L  G    + +DF 
Sbjct: 36  FAKELDASCIKIERVIGAGEFG---EVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFL 92
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEA 451
            E   + +  HPN+V L+         +++ +F+ NG+L A L  H G    +       
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI------Q 146
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            + + +G A G+ Y+ +     YVH ++ +  IL++  L   +S FGL+R+      +  
Sbjct: 147 LVGMLRGIAAGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV------IED 197
Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
           +   V + TG +I      + APEA  Y  KFT   DV+S+GIV+ E+++
Sbjct: 198 DPEAVYTTTGGKIPV---RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMS 243

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 29/231 (12%)
Query: 344 RASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ 403
           R S  +  K   G   +V +G  +G    T VA++ L  G  T   + F  E + + +++
Sbjct: 10  RESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPG--TMSPEAFLQEAQVMKKLR 64
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTAR 461
           H  +V+L A   + +   ++++++  GSL   L    G    LP L     + +A   A 
Sbjct: 65  HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIAS 118
Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ Y+   +   YVH ++++  IL+ + L   ++ FGL RL      +  NE     G  
Sbjct: 119 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL------IEDNEYTARQGAK 169
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
             I      + APEA +YG +FT K DV+SFGI+L E+ T GR+P  G  N
Sbjct: 170 FPIK-----WTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVN 214

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 332 DEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFK 390
           D  +  E+E      +  +G    G +YK   G+  G      VAV+ L   D T  +F+
Sbjct: 26  DSSYYWEIEASEVMLSTRIGSGSFGTVYK---GKWHG-----DVAVKILKVVDPTPEQFQ 77
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
            F +EV  + + +H NI+     Y   D   +++ +    SLY  LH   +         
Sbjct: 78  AFRNEVAVLRKTRHVNILLFMG-YMTKDNLAIVTQWCEGSSLYKHLHVQETK----FQMF 132
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             + IA+ TA+G+ Y+H    +  +H ++KS  I L + L   I  FGL  +    S   
Sbjct: 133 QLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 511 KNETIVTSGTGSRISAISNVYLAPEA-RIYGSK-FTQKCDVYSFGIVLLEILTGRLP 565
           +    V   TGS +      ++APE  R+  +  F+ + DVYS+GIVL E++TG LP
Sbjct: 190 Q----VEQPTGSVL------WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 119/270 (44%), Gaps = 43/270 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L  G    + +DF  E   + +  HPNI+ L+     +   +++++++ NGSL  
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 435 ALHAGPSDSLPPLPWEARLKIAQ--GTARGLMYIHEY-SPRKYVHGNIKSTKILLDDELH 491
            L             + +  + Q  G  RG+    +Y S   YVH ++ +  IL++  L 
Sbjct: 113 FLKKN----------DGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLV 162
Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYS 551
             +S FGL+R+L         E    +   +R   I   + APEA I   KFT   DV+S
Sbjct: 163 CKVSDFGLSRVL---------EDDPEAAYTTRGGKIPIRWTAPEA-IAFRKFTSASDVWS 212
Query: 552 FGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVL 609
           +GIV+ E+++ G  P     N        V KA  E   L   +D PA            
Sbjct: 213 YGIVMWEVVSYGERPYWEMTNQD------VIKAVEEGYRLPSPMDCPA------------ 254
Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           A + + L+C + +   RP+   +   LD++
Sbjct: 255 ALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 53/268 (19%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T VAV+ +  G  +   + F +E   +  +QH  +V+L A     +   +I++F+  GSL
Sbjct: 207 TKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSL 263
Query: 433 YAALHA--GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
              L +  G    LP L     +  +   A G+ +I +   R Y+H ++++  IL+   L
Sbjct: 264 LDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASL 315
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I+ FGL R+                  G++       + APEA  +GS FT K DV+
Sbjct: 316 VCKIADFGLARV------------------GAKFPI---KWTAPEAINFGS-FTIKSDVW 353
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           SFGI+L+EI+T GR+P  G  N  + + +L R  +R  RP  E     L           
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNP-EVIRALER-GYRMPRP--ENCPEEL----------- 398
Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLD 637
             ++I + C +  PE RP    +   LD
Sbjct: 399 --YNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 29/204 (14%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
            V A R   + D +   ++   E +  A ++HPNI+ L+          L+ +F R G L
Sbjct: 34  AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L       +PP   +  +  A   ARG+ Y+H+ +    +H ++KS+ IL+  ++  
Sbjct: 94  NRVLSG---KRIPP---DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147
Query: 493 C--------ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT 544
                    I+ FGL R    T+K++              +A +  ++APE  I  S F+
Sbjct: 148 GDLSNKILKITDFGLAREWHRTTKMS--------------AAGAYAWMAPEV-IRASMFS 192
Query: 545 QKCDVYSFGIVLLEILTGRLPDAG 568
           +  DV+S+G++L E+LTG +P  G
Sbjct: 193 KGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA------TWRFKDFESEVEAIARVQ 403
           +GK   G+++K     G  +   +VVA++ L  GD+        +F++F+ EV  ++ + 
Sbjct: 27  IGKGGFGLVHK-----GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           HPNIV+L    +  +   ++ +F+  G LY  L     D   P+ W  +L++    A G+
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIALGI 135
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y+   +P   VH +++S  I L            L+   P  +KV  + ++      S 
Sbjct: 136 EYMQNQNP-PIVHRDLRSPNIFLQ----------SLDENAPVCAKVA-DFSLSQQSVHSV 183
Query: 524 ISAISNV-YLAPEARIYGSK---FTQKCDVYSFGIVLLEILTGRLP 565
              + N  ++APE    G++   +T+K D YSF ++L  ILTG  P
Sbjct: 184 SGLLGNFQWMAPET--IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 116/238 (48%), Gaps = 29/238 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 20  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   Y    +  +++ +    SLY  LHA  +        +  + IA+ TARG+ Y+H 
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH- 125
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++    I  FGL  +    S   + E +  SG        S
Sbjct: 126 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 173
Query: 529 NVYLAPEA-RIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
            +++APE  R+  S  ++ + DVY+FGIVL E++TG+LP +   N  + +E + R + 
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 37/227 (16%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA------TWRFKDFESEVEAIARVQ 403
           +GK   G+++K     G  +   +VVA++ L  GD+        +F++F+ EV  ++ + 
Sbjct: 27  IGKGGFGLVHK-----GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           HPNIV+L    +  +   ++ +F+  G LY  L     D   P+ W  +L++    A G+
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIALGI 135
Query: 464 MYIHEYSPRKYVHGNIKSTKILLD--DELHPC---ISGFGLNRLLPGTSKVTKNETIVTS 518
            Y+   +P   VH +++S  I L   DE  P    ++ FGL          ++      S
Sbjct: 136 EYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----------SQQSVHSVS 184
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           G       ++   +  E   Y    T+K D YSF ++L  ILTG  P
Sbjct: 185 GLLGNFQWMAPETIGAEEESY----TEKADTYSFAMILYTILTGEGP 227

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 132/296 (44%), Gaps = 46/296 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + V  G  +  P  VA++ L E        +F  E   +A + HP++
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIP--VAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSD--SLPPLPWEARLKIAQGTARGLMY 465
           VRL     +   +L ++  + +G L   +H    +  S   L W  ++      A+G+MY
Sbjct: 80  VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E   R+ VH ++ +  +L+    H  I+ FGL RLL G  K         +  G ++ 
Sbjct: 133 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-------EYNADGGKMP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDAGPENDGKGLESLVRKA 583
                ++A E  I+  KFT + DV+S+G+ + E++T  G+  D  P  +   +  L+ K 
Sbjct: 183 I---KWMALEC-IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            R  +P    ID                + + + C  +D + RP+ + ++    R+
Sbjct: 236 ERLPQPPICTID---------------VYMVMVKCWMIDADSRPKFKELAAEFSRM 276

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 109/230 (47%), Gaps = 43/230 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA------TWRFKDFESEVEAIARVQ 403
           +GK   G+++K     G  +   +VVA++ L  GD+        +F++F+ EV  ++ + 
Sbjct: 27  IGKGGFGLVHK-----GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           HPNIV+L    +  +   ++ +F+  G LY  L     D   P+ W  +L++    A G+
Sbjct: 82  HPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRL----LDKAHPIKWSVKLRLMLDIALGI 135
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y+   +P   VH +++S  I L            L+   P  +KV    T     +   
Sbjct: 136 EYMQNQNP-PIVHRDLRSPNIFLQS----------LDENAPVCAKVADFGT-----SQQS 179
Query: 524 ISAISNV-----YLAPEARIYGSK---FTQKCDVYSFGIVLLEILTGRLP 565
           + ++S +     ++APE    G++   +T+K D YSF ++L  ILTG  P
Sbjct: 180 VHSVSGLLGNFQWMAPET--IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L E   + R +DF+ E E +  +QH +IVR           L++ +++R+G L 
Sbjct: 73  LVAVKALKEASESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 434 ---------AALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTK 483
                    A L AG  D  P PL     L +A   A G++Y+   +   +VH ++ +  
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 188
Query: 484 ILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
            L+   L   I  FG++R +  T              G R + +   ++ PE+ +Y  KF
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYSTDYYR---------VGGR-TMLPIRWMPPESILY-RKF 237
Query: 544 TQKCDVYSFGIVLLEILT-GRLP 565
           T + DV+SFG+VL EI T G+ P
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 375 VAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VAV+ L     T  + + F++EV  + + +H NI+ L   Y    +  +++ +    SLY
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLY 107
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             LHA    S      +  + IA+ TARG+ Y+H    +  +H ++KS  I L ++    
Sbjct: 108 HHLHA----SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVK 160
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA-RIYGSK-FTQKCDVYS 551
           I  FGL          T+      S    ++S  S +++APE  R+  S  ++ + DVY+
Sbjct: 161 IGDFGL---------ATEKSRWSGSHQFEQLSG-SILWMAPEVIRMQDSNPYSFQSDVYA 210
Query: 552 FGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
           FGIVL E++TG+LP +   N  + +E + R + 
Sbjct: 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 46/296 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + V  G  +  P  VA++ L E        +F  E   +A + HP++
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIP--VAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           VRL     +   +L ++  + +G L  Y   H     S   L W  ++      A+G+MY
Sbjct: 103 VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 155
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E   R+ VH ++ +  +L+    H  I+ FGL RLL G  K         +  G ++ 
Sbjct: 156 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK-------EYNADGGKMP 205
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT--GRLPDAGPENDGKGLESLVRKA 583
                ++A E  I+  KFT + DV+S+G+ + E++T  G+  D  P  +   +  L+ K 
Sbjct: 206 I---KWMALEC-IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEKG 258
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            R  +P    ID                + + + C  +D + RP+ + ++    R+
Sbjct: 259 ERLPQPPICTID---------------VYMVMVKCWMIDADSRPKFKELAAEFSRM 299

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L +     R KDF  E E +  +QH +IV+        D  +++ +++++G L 
Sbjct: 45  LVAVKTLKDASDNAR-KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 434 AALHAGPSDSL------PP--LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             L A   D++      PP  L     L IAQ  A G++Y+   + + +VH ++ +   L
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCL 160
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           + + L   I  FG++R +  T              G  +  I   ++ PE+ +Y  KFT 
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTDYYRVG--------GHTMLPIR--WMPPESIMY-RKFTT 209
Query: 546 KCDVYSFGIVLLEILT-GRLP 565
           + DV+S G+VL EI T G+ P
Sbjct: 210 ESDVWSLGVVLWEIFTYGKQP 230

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L E   + R +DF+ E E +  +QH +IVR           L++ +++R+G L 
Sbjct: 50  LVAVKALKEASESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 434 ---------AALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTK 483
                    A L AG  D  P PL     L +A   A G++Y+   +   +VH ++ +  
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 165
Query: 484 ILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
            L+   L   I  FG++R +  T              G R + +   ++ PE+ +Y  KF
Sbjct: 166 CLVGQGLVVKIGDFGMSRDIYSTDYYR---------VGGR-TMLPIRWMPPESILY-RKF 214
Query: 544 TQKCDVYSFGIVLLEILT-GRLP 565
           T + DV+SFG+VL EI T G+ P
Sbjct: 215 TTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 29/235 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 32  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
               +  A  +  +++ +    SLY  LHA  +        +  + IA+ TARG+ Y+H 
Sbjct: 84  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLH- 137
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++    I  FGL          T+      S    ++S  S
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGL---------ATEKSRWSGSHQFEQLSG-S 185
Query: 529 NVYLAPEA-RIYGSK-FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR 581
            +++APE  R+  S  ++ + DVY+FGIVL E++TG+LP +   N  + +E + R
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L E   + R +DF+ E E +  +QH +IVR           L++ +++R+G L 
Sbjct: 44  LVAVKALKEASESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 434 ---------AALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTK 483
                    A L AG  D  P PL     L +A   A G++Y+   +   +VH ++ +  
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRN 159
Query: 484 ILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
            L+   L   I  FG++R +  T              G R + +   ++ PE+ +Y  KF
Sbjct: 160 CLVGQGLVVKIGDFGMSRDIYSTDYYR---------VGGR-TMLPIRWMPPESILY-RKF 208
Query: 544 TQKCDVYSFGIVLLEILT-GRLP 565
           T + DV+SFG+VL EI T G+ P
Sbjct: 209 TTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 115/238 (48%), Gaps = 30/238 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD---FESEVEAIARVQHP 405
           V+G+   G ++  +V + SG  A  + A++ L +  AT + +D    + E + +  V HP
Sbjct: 31  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK--ATLKVRDRVRTKMERDILVEVNHP 86
Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            IV+L   +    +  LI DF+R G L+  L    S  +     + +  +A+  A  L +
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAE-LALALDH 141
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +H       ++ ++K   ILLD+E H  ++ FGL++      +   +E    S  G+   
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT--- 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                Y+APE  +     TQ  D +SFG+++ E+LTG LP  G   D K   +++ KA
Sbjct: 190 ---VEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKA 241

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 115/238 (48%), Gaps = 30/238 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD---FESEVEAIARVQHP 405
           V+G+   G ++  +V + SG  A  + A++ L +  AT + +D    + E + +  V HP
Sbjct: 31  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK--ATLKVRDRVRTKMERDILVEVNHP 86
Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            IV+L   +    +  LI DF+R G L+  L    S  +     + +  +A+  A  L +
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAE-LALALDH 141
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +H       ++ ++K   ILLD+E H  ++ FGL++      +   +E    S  G+   
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT--- 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                Y+APE  +     TQ  D +SFG+++ E+LTG LP  G   D K   +++ KA
Sbjct: 190 ---VEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKA 241

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 115/238 (48%), Gaps = 30/238 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD---FESEVEAIARVQHP 405
           V+G+   G ++  +V + SG  A  + A++ L +  AT + +D    + E + +  V HP
Sbjct: 32  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLKK--ATLKVRDRVRTKMERDILVEVNHP 87
Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            IV+L   +    +  LI DF+R G L+  L    S  +     + +  +A+  A  L +
Sbjct: 88  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAE-LALALDH 142
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +H       ++ ++K   ILLD+E H  ++ FGL++      +   +E    S  G+   
Sbjct: 143 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT--- 190
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                Y+APE  +     TQ  D +SFG+++ E+LTG LP  G   D K   +++ KA
Sbjct: 191 ---VEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMILKA 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 21  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 73  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 126
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 174
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 16  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 68  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 121
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 169
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 21  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 73  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 126
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 174
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 18  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 70  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 124 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 171
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 44  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 150
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
            S    +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 197
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 43  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 95  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 149
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
            S    +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 150 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 196
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 59/317 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+ + G + K       G    T VAV+ L E  +    +D  SE   + +V HP++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALH----AGPSDSLP---------------PLPWE 450
           L      +   LLI ++ + GSL   L      GP                     L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             +  A   ++G+ Y+ E    K VH ++ +  IL+ +     IS FGL+R       V 
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT---GRLPDA 567
           + ++ V    G     I   ++A E+ ++   +T + DV+SFG++L EI+T      P  
Sbjct: 202 EEDSYVKRSQGR----IPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 568 GPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
            PE     L +L++   R  RP   SE                   + + L C + +P+ 
Sbjct: 257 PPER----LFNLLKTGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDK 295
Query: 626 RPRMRTVSESLDRVKLQ 642
           RP    +S+ L+++ ++
Sbjct: 296 RPVFADISKDLEKMMVK 312

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 59/317 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+ + G + K       G    T VAV+ L E  +    +D  SE   + +V HP++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALH----AGPSDSLP---------------PLPWE 450
           L      +   LLI ++ + GSL   L      GP                     L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             +  A   ++G+ Y+ E    K VH ++ +  IL+ +     IS FGL+R       V 
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT---GRLPDA 567
           + ++ V    G     I   ++A E+ ++   +T + DV+SFG++L EI+T      P  
Sbjct: 202 EEDSXVKRSQGR----IPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 568 GPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
            PE     L +L++   R  RP   SE                   + + L C + +P+ 
Sbjct: 257 PPER----LFNLLKTGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDK 295
Query: 626 RPRMRTVSESLDRVKLQ 642
           RP    +S+ L+++ ++
Sbjct: 296 RPVFADISKDLEKMMVK 312

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 16  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 68  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 121
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL          T+      S    ++S  S
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGL---------ATEKSRWSGSHQFEQLSG-S 169
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 36  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 88  LFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 142
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
            S    +H ++KS  I L ++L   I  FGL          T+      S    ++S  S
Sbjct: 143 KS---IIHRDLKSNNIFLHEDLTVKIGDFGL---------ATEKSRWSGSHQFEQLSG-S 189
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 44  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   Y    +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA 150
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
            S    +H ++KS  I L ++L   I  FGL          T+      S    ++S  S
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGL---------ATEKSRWSGSHQFEQLSG-S 197
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 132/317 (41%), Gaps = 59/317 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+ + G + K       G    T VAV+ L E  +    +D  SE   + +V HP++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALH----AGPSDSLP---------------PLPWE 450
           L      +   LLI ++ + GSL   L      GP                     L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             +  A   ++G+ Y+ E S    VH ++ +  IL+ +     IS FGL+R       V 
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR------DVY 201
Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT---GRLPDA 567
           + ++ V    G     I   ++A E+ ++   +T + DV+SFG++L EI+T      P  
Sbjct: 202 EEDSXVKRSQGR----IPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 568 GPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
            PE     L +L++   R  RP   SE                   + + L C + +P+ 
Sbjct: 257 PPER----LFNLLKTGHRMERPDNCSE-----------------EMYRLMLQCWKQEPDK 295
Query: 626 RPRMRTVSESLDRVKLQ 642
           RP    +S+ L+++ ++
Sbjct: 296 RPVFADISKDLEKMMVK 312

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIV 408
           +G    G +YK   G+  G      VAV+ L     T  + + F++EV  + + +H NI+
Sbjct: 16  IGSGSFGTVYK---GKWHG-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
               +  A  +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H 
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH- 121
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  I L ++L   I  FGL  +    S   + E +  SG        S
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SG--------S 169
Query: 529 NVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
            +++APE      K  ++ + DVY+FGIVL E++TG+LP +   N
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T+VAV+ L E  +     DF+ E   +A   +PNIV+L           L+ +++  G L
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 433 YAALHAGPSDSL-------------------PPLPWEARLKIAQGTARGLMYIHEYSPRK 473
              L +    ++                   PPL    +L IA+  A G+ Y+ E   RK
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RK 194
Query: 474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLA 533
           +VH ++ +   L+ + +   I+ FGL+R       +   +     G      AI   ++ 
Sbjct: 195 FVHRDLATRNCLVGENMVVKIADFGLSR------NIYSADYYKADGN----DAIPIRWMP 244
Query: 534 PEARIYGSKFTQKCDVYSFGIVLLEILT 561
           PE+ I+ +++T + DV+++G+VL EI +
Sbjct: 245 PES-IFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ L +     R KDF+ E E +  +QH +IV+        D  +++ +++++G L 
Sbjct: 47  LVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 434 AALHAGPSDSLPPLPWEAR-----------LKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
             L A   D++  +  + R           L IA   A G++Y+   + + +VH ++ + 
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATR 162
Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
             L+   L   I  FG++R       V   +     G     + +   ++ PE+ +Y  K
Sbjct: 163 NCLVGANLLVKIGDFGMSR------DVYSTDYYRVGGH----TMLPIRWMPPESIMY-RK 211
Query: 543 FTQKCDVYSFGIVLLEILT-GRLP 565
           FT + DV+SFG++L EI T G+ P
Sbjct: 212 FTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 370 GAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEK-----LLI 423
           G    VAV+ +   +++ R  ++F SE   +    HPN++RL         +     ++I
Sbjct: 60  GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 424 SDFIRNGSL-----YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGN 478
             F++ G L     Y+ L  GP      +P +  LK     A G+ Y+   S R ++H +
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKH----IPLQTLLKFMVDIALGMEYL---SNRNFLHRD 172
Query: 479 IKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI 538
           + +   +L D++  C++ FGL++ +       +           RI+ +   ++A E+ +
Sbjct: 173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG----------RIAKMPVKWIAIES-L 221
Query: 539 YGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
               +T K DV++FG+ + EI T G  P  G +N    +   +    R ++P  + +D  
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGHRLKQP-EDCLD-- 276
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                         + I  +C   DP  RP    +   L+++
Sbjct: 277 ------------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 41/237 (17%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGD------------ATWRFKD---FESEVEAIARVQHPN 406
           V+G+GS      V  VR++T  D            AT + +D    + E + +A V HP 
Sbjct: 35  VLGQGS---FGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V+L   +    +  LI DF+R G L+  L    S  +     + +  +A+  A GL ++
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAE-LALGLDHL 146
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H       ++ ++K   ILLD+E H  ++ FGL++      +   +E    S  G     
Sbjct: 147 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK------EAIDHEKKAYSFCG----- 192
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
            +  Y+APE  +     +   D +S+G+++ E+LTG LP  G   D K   +L+ KA
Sbjct: 193 -TVEYMAPEV-VNRQGHSHSADWWSYGVLMFEMLTGSLPFQG--KDRKETMTLILKA 245

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L 
Sbjct: 247 TVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L       +  +     L +A   +  + Y+ +   + ++H N+ +   L+ +     
Sbjct: 305 DYLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVK 358
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           ++ FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG
Sbjct: 359 VADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFG 406
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           ++L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 407 VLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 441

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 15/195 (7%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++R+          +   E++A+++  HPNIV     +   DE  L+   +  GS+  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 435 ALH---AGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
            +    A        L       I +    GL Y+H+      +H ++K+  ILL ++  
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 492 PCISGFGLNRLLPGTSKVTKNETIVT-SGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
             I+ FG++  L     +T+N+   T  GT          ++APE       +  K D++
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGT--------PCWMAPEVMEQVRGYDFKADIW 211
Query: 551 SFGIVLLEILTGRLP 565
           SFGI  +E+ TG  P
Sbjct: 212 SFGITAIELATGAAP 226

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L 
Sbjct: 286 TVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L       +  +     L +A   +  + Y+ +   + ++H N+ +   L+ +     
Sbjct: 344 DYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVK 397
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           ++ FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG
Sbjct: 398 VADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFG 445
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           ++L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 446 VLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 480

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 84/194 (43%), Gaps = 13/194 (6%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++R+          +   E++A+++  HPNIV     +   DE  L+   +  GS+  
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 435 ALH---AGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
            +    A        L       I +    GL Y+H+      +H ++K+  ILL ++  
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYS 551
             I+ FG++  L     +T+N+         +    +  ++APE       +  K D++S
Sbjct: 155 VQIADFGVSAFLATGGDITRNKV-------RKTFVGTPCWMAPEVMEQVRGYDFKADIWS 207
Query: 552 FGIVLLEILTGRLP 565
           FGI  +E+ TG  P
Sbjct: 208 FGITAIELATGAAP 221

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 39  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 96
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 97  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 151 ADFGLSRLMTGDT--------FTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 198
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 199 LLWEIATYGMSPYPGI--DPSQVYELLEKDYRMERP 232

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 39  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 96
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 97  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 151 ADFGLSRLMTGDTX--------TAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 198
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 199 LLWEIATYGMSPYPGI--DPSQVYELLEKDYRMERP 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G  + G +Y+ V  + S       VAV+ L E   T   ++F  E   +  ++HPN+V+
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           +I++F+  G+L   L       +  +     L +A   +  + Y+ + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK- 134
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             + ++H ++ +   L+ +     ++ FGL+RL+ G +         T+  G++      
Sbjct: 135 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--------TAHAGAKFPI--- 181
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APE+  Y +KF+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  R
Sbjct: 182 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMER 238
Query: 589 P 589
           P
Sbjct: 239 P 239

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G  + G +Y+ V  + S       VAV+ L E   T   ++F  E   +  ++HPN+V+
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           +I++F+  G+L   L       +  +     L +A   +  + Y+ + 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK- 134
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             + ++H ++ +   L+ +     ++ FGL+RL+ G +         T+  G++      
Sbjct: 135 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI--- 181
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APE+  Y +KF+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  R
Sbjct: 182 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMER 238
Query: 589 P 589
           P
Sbjct: 239 P 239

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 46  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 104 YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 158 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 205
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 206 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 239

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 27/267 (10%)
Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFI 427
           G   +VAV+ L EG        ++ E+E +  + H +IV+ K       EK   L+ +++
Sbjct: 35  GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   +     L  AQ    G+ Y+H    + Y+H  + +  +L
Sbjct: 95  PLGSL--------RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVL 143
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           LD++    I  FGL + +P   +  +    V     S +      + APE  +   KF  
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPV-----FWYAPEC-LKECKFYY 193
Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
             DV+SFG+ L E+LT    +  P      L    +      R L+E+++    +     
Sbjct: 194 ASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR-LTELLERG-ERLPRPD 251
Query: 606 RQVLATFHIALNCTELDPEFRPRMRTV 632
           R     +H+  NC E +  FRP  + +
Sbjct: 252 RCPCEIYHLMKNCWETEASFRPTFQNL 278

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 27/267 (10%)
Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFI 427
           G   +VAV+ L EG        ++ E+E +  + H +IV+ K       EK   L+ +++
Sbjct: 36  GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   +     L  AQ    G+ Y+H    + Y+H  + +  +L
Sbjct: 96  PLGSL--------RDYLPRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVL 144
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           LD++    I  FGL + +P   +  +    V     S +      + APE  +   KF  
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPV-----FWYAPEC-LKECKFYY 194
Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
             DV+SFG+ L E+LT    +  P      L    +      R L+E+++    +     
Sbjct: 195 ASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLR-LTELLERG-ERLPRPD 252
Query: 606 RQVLATFHIALNCTELDPEFRPRMRTV 632
           R     +H+  NC E +  FRP  + +
Sbjct: 253 RCPCEIYHLMKNCWETEASFRPTFQNL 279

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 41  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 99  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 153 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 200
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 201 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 41  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 99  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 153 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 200
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 201 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL 422
           V  G        VAV+ L E   T   ++F  E   +  ++HPN+V+L           +
Sbjct: 29  VYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
           I++F+  G+L   L       +  +     L +A   +  + Y+ +   + ++H ++ + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAAR 140
Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
             L+ +     ++ FGL+RL+ G +         T+  G++       + APE+  Y +K
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NK 188
Query: 543 FTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           F+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 126/282 (44%), Gaps = 46/282 (16%)
Query: 370 GAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK------LL 422
           G+   VAV+ L  +  A+   ++F  E   +    HP++ +L      +  K      ++
Sbjct: 49  GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108
Query: 423 ISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           I  F+++G L+A L A      P  LP +  ++     A G+ Y+   S R ++H ++ +
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAA 165
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV---YLAPEARI 538
              +L +++  C++ FGL+R              + SG   R    S +   +LA E+ +
Sbjct: 166 RNCMLAEDMTVCVADFGLSR-------------KIYSGDYYRQGCASKLPVKWLALES-L 211
Query: 539 YGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
             + +T   DV++FG+ + EI+T G+ P AG EN    + + +    R ++P      P 
Sbjct: 212 ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIGGNRLKQP------PE 263
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            ++E+         + +   C   DP+ RP    +   L+ +
Sbjct: 264 CMEEV---------YDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G  + G +Y+ V  + S       VAV+ L E   T   ++F  E   +  ++HPN+V+
Sbjct: 25  LGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           +I++F+  G+L   L       +  +     L +A   +  + Y+ + 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK- 133
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             + ++H ++ +   L+ +     ++ FGL+RL+ G +         T+  G++      
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI--- 180
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APE+  Y +KF+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  R
Sbjct: 181 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMER 237
Query: 589 P 589
           P
Sbjct: 238 P 238

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 28/241 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G  + G +Y+ V  + S       VAV+ L E   T   ++F  E   +  ++HPN+V+
Sbjct: 34  LGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQ 86
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           +I++F+  G+L   L       +  +     L +A   +  + Y+ + 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK- 142
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             + ++H ++ +   L+ +     ++ FGL+RL+ G +         T+  G++      
Sbjct: 143 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI--- 189
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APE+  Y +KF+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  R
Sbjct: 190 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMER 246
Query: 589 P 589
           P
Sbjct: 247 P 247

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 46  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 104 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 157
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 158 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 205
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 206 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 239

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 41  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 99  YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 153 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 200
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 201 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 43  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 101 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 155 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 202
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 203 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 236

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLISDFIRNGSL 432
           VAV+ L          D + E+E +  + H NIV+ K     +  +   LI +F+ +GSL
Sbjct: 53  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 112
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    +     +  + +LK A    +G+ Y+     R+YVH ++ +  +L++ E   
Sbjct: 113 KEYLPKNKNK----INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQV 165
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I  FGL + +    +  K    V     S +      + APE  +  SKF    DV+SF
Sbjct: 166 KIGDFGLTKAI----ETDKEXXTVKDDRDSPV-----FWYAPEC-LMQSKFYIASDVWSF 215
Query: 553 GIVLLEILTGRLPDAGP 569
           G+ L E+LT    D+ P
Sbjct: 216 GVTLHELLTYCDSDSSP 232

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 43  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 101 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 155 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 202
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 203 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 236

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN--DEKLLISDFIRNGSL 432
           VAV+ L          D + E+E +  + H NIV+ K     +  +   LI +F+ +GSL
Sbjct: 41  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 100
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    +     +  + +LK A    +G+ Y+     R+YVH ++ +  +L++ E   
Sbjct: 101 KEYLPKNKNK----INLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQV 153
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            I  FGL + +    +  K    V     S +      + APE  +  SKF    DV+SF
Sbjct: 154 KIGDFGLTKAI----ETDKEXXTVKDDRDSPV-----FWYAPEC-LMQSKFYIASDVWSF 203
Query: 553 GIVLLEILTGRLPDAGP 569
           G+ L E+LT    D+ P
Sbjct: 204 GVTLHELLTYCDSDSSP 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 42  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 99
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 100 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 153
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 154 ADFGLSRLMTGDT--------YTAPAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 201
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 202 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 235

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I++F+  G+L  
Sbjct: 43  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 101 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 154
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 155 ADFGLSRLMTGDT--------YTAPAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 202
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 203 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 236

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +G A   FK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQGKA---FKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSY--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +G A   FK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQGKA---FKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I +F+  G+L  
Sbjct: 39  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 96
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 97  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 150
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 151 ADFGLSRLMTGDTX--------TAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 198
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 199 LLWEIATYGMSPYPGI--DPSQVYELLEKDYRMERP 232

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +G A   FK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQGKA---FKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSY--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I +F+  G+L  
Sbjct: 41  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 99  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 153 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 200
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 201 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 28/241 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G  + G +Y+ V  + S       VAV+ L E   T   ++F  E   +  ++HPN+V+
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L           +I +F+  G+L   L       +  +     L +A   +  + Y+ + 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEK- 134
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             + ++H ++ +   L+ +     ++ FGL+RL+ G +         T+  G++      
Sbjct: 135 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKFPI--- 181
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            + APE+  Y +KF+ K DV++FG++L EI T G  P  G   D   +  L+ K +R  R
Sbjct: 182 KWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMER 238
Query: 589 P 589
           P
Sbjct: 239 P 239

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I +F+  G+L  
Sbjct: 42  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 99
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 100 YLRECNRQEVNAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 153
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 154 ADFGLSRLMTGDTX--------TAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 201
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 202 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 235

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           +I +F+  G+L  
Sbjct: 41  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L       +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 99  YLRECNRQEVSAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 152
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y +KF+ K DV++FG+
Sbjct: 153 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAY-NKFSIKSDVWAFGV 200
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  RP
Sbjct: 201 LLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERP 234

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 366 GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEKLLI 423
           G   GA  +VAV++L       + +DF+ E++ +  +    IV+ +   Y     E  L+
Sbjct: 32  GDNTGA--LVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLV 88
Query: 424 SDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
            +++ +G L  +   H    D+   L + +++       +G+ Y+     R+ VH ++ +
Sbjct: 89  MEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYL---GSRRCVHRDLAA 139
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             IL++ E H  I+ FGL +LLP    + K+  +V     S I      + APE+ +  +
Sbjct: 140 RNILVESEAHVKIADFGLAKLLP----LDKDXXVVREPGQSPI-----FWYAPES-LSDN 189
Query: 542 KFTQKCDVYSFGIVLLEILT 561
            F+++ DV+SFG+VL E+ T
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 28  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 77
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 135
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 136 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 183
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 184 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 110
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 168
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 215
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 216 -----XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 35  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 84
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 142
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 143 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 190
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 191 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 31  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 80
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 138
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 139 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 186
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 187 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 39  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 88
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 146
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 194
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 195 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 39  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 88
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 146
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 193
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 194 -----XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 46  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 95
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 153
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 154 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 201
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 202 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSX--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 110
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 168
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 215
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 216 -----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 63  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 112
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 170
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 217
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 218 -----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 40  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 89
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 147
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 148 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSY--- 195
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 196 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 55  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 104
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 162
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 209
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 210 -----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 76
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 134
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH +      H +IK   +LLD D     +  FG         ++ + E  V+    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG------SAKQLVRGEPNVSY--- 182
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           +G + E  ++   +  V+G    G++++  +           VA++++ +     RFK+ 
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE------VAIKKVLQDK---RFKNR 81
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPP 446
           E ++  I  V+HPN+V LKAF+Y+N +K       L+ +++      A+ H        P
Sbjct: 82  ELQIMRI--VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139
Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP-G 505
           +    +L + Q   R L YIH        H +IK   +LLD          G+ +L+  G
Sbjct: 140 M-LLIKLYMYQ-LLRSLAYIHSIG---ICHRDIKPQNLLLD-------PPSGVLKLIDFG 187
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
           ++K      I+ +G  +     S  Y APE     + +T   D++S G V+ E++ G+
Sbjct: 188 SAK------ILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 65  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 114
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 172
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSY-------- 220
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 221 ------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 32  VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 81
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 139
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 140 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS--------- 186
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 187 -----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +     +     VA++++ +     RFK+   E++ + ++ H NIV
Sbjct: 106 VIGNGSFGVVYQAKLCDSGEL-----VAIKKVLQDK---RFKN--RELQIMRKLDHCNIV 155
Query: 409 RLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +    P+ +  +L + Q   R 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKLYMYQ-LFRS 213
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           L YIH +      H +IK   +LLD +   L  C  G    +L+ G   V+         
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSY-------- 261
Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                   S  Y APE     + +T   DV+S G VL E+L G+
Sbjct: 262 ------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +     P IV     +Y++ E  +  + +  GSL   L          +P E   K
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-----IPEEILGK 118
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           ++    RGL Y+ E    + +H ++K + IL++      +  FG++  L         ++
Sbjct: 119 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDS 168
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
           +  S  G+R       Y+APE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K
Sbjct: 169 MANSFVGTR------SYMAPE-RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPP--DAK 219
Query: 575 GLESL 579
            LE++
Sbjct: 220 ELEAI 224

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSL--PPLPWEARLKIAQGTARGLMYIHEYSPRK 473
            + E    S F  + SL        SD     P+  E  +  +   ARG+ ++   S RK
Sbjct: 163 TSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFL---SSRK 219
Query: 474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLA 533
            +H ++ +  ILL +     I  FGL R       + KN   V  G     + +   ++A
Sbjct: 220 CIHRDLAARNILLSENNVVKICDFGLAR------DIYKNPDYVRKGD----TRLPLKWMA 269
Query: 534 PEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
           PE+ I+   ++ K DV+S+G++L EI + G  P  G + D +   S +R+  R R P  E
Sbjct: 270 PES-IFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMD-EDFCSRLREGMRMRAP--E 325
Query: 593 VIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
              P +             + I L+C   DP+ RPR   + E L
Sbjct: 326 YSTPEI-------------YQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/264 (21%), Positives = 111/264 (42%), Gaps = 39/264 (14%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ + EG  +    +F  E + + ++ HP +V+            +++++I NG L  
Sbjct: 35  VAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L +      P    E    + +G A            +++H ++ +   L+D +L   +
Sbjct: 93  YLRSHGKGLEPSQLLEMCYDVCEGMAF-------LESHQFIHRDLAARNCLVDRDLCVKV 145
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R       V  ++ + + GT   +      + APE   Y  K++ K DV++FGI
Sbjct: 146 SDFGMTRY------VLDDQYVSSVGTKFPVK-----WSAPEVFHY-FKYSSKSDVWAFGI 193
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFH 613
           ++ E+ + G++P     N    L+  V +  R  RP             H     +  + 
Sbjct: 194 LMWEVFSLGKMPYDLYTNSEVVLK--VSQGHRLYRP-------------HLASDTI--YQ 236
Query: 614 IALNCTELDPEFRPRMRTVSESLD 637
           I  +C    PE RP  + +  S++
Sbjct: 237 IMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 366 GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLI 423
           G   GA  +VAV++L       + +DF+ E++ +  +    IV+ +   Y    +   L+
Sbjct: 36  GDNTGA--LVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 92
Query: 424 SDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
            +++ +G L  +   H    D+   L + +++       +G+ Y+     R+ VH ++ +
Sbjct: 93  MEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYL---GSRRCVHRDLAA 143
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             IL++ E H  I+ FGL +LLP    + K+  +V     S I      + APE+ +  +
Sbjct: 144 RNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPI-----FWYAPES-LSDN 193
Query: 542 KFTQKCDVYSFGIVLLEILT 561
            F+++ DV+SFG+VL E+ T
Sbjct: 194 IFSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 366 GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLI 423
           G   GA  +VAV++L       + +DF+ E++ +  +    IV+ +   Y    +   L+
Sbjct: 35  GDNTGA--LVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 91
Query: 424 SDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
            +++ +G L  +   H    D+   L + +++       +G+ Y+     R+ VH ++ +
Sbjct: 92  MEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYL---GSRRCVHRDLAA 142
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             IL++ E H  I+ FGL +LLP    + K+  +V     S I      + APE+ +  +
Sbjct: 143 RNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPI-----FWYAPES-LSDN 192
Query: 542 KFTQKCDVYSFGIVLLEILT 561
            F+++ DV+SFG+VL E+ T
Sbjct: 193 IFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 366 GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLI 423
           G   GA  +VAV++L       + +DF+ E++ +  +    IV+ +   Y    +   L+
Sbjct: 48  GDNTGA--LVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104
Query: 424 SDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
            +++ +G L  +   H    D+   L + +++       +G+ Y+     R+ VH ++ +
Sbjct: 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYL---GSRRCVHRDLAA 155
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             IL++ E H  I+ FGL +LLP    + K+  +V     S I      + APE+ +  +
Sbjct: 156 RNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPI-----FWYAPES-LSDN 205
Query: 542 KFTQKCDVYSFGIVLLEILT 561
            F+++ DV+SFG+VL E+ T
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 82  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 185 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 238 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 271

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 104
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 105 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 157
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 158 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 207
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 208 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 260
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 261 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 294

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 118/260 (45%), Gaps = 31/260 (11%)
Query: 319 DEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVR 378
           DE++ ++ + F+  +    EL+D        +G    G+++KV   + SG+     V  R
Sbjct: 45  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMAR 98
Query: 379 RLTEGDATWRFKD-FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALH 437
           +L   +     ++    E++ +     P IV     +Y++ E  +  + +  GSL   L 
Sbjct: 99  KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 158
Query: 438 AGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF 497
                    +P +   K++    +GL Y+ E    K +H ++K + IL++      +  F
Sbjct: 159 KAGR-----IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF 211
Query: 498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLL 557
           G++  L         +++  S  G+R       Y++PE R+ G+ ++ + D++S G+ L+
Sbjct: 212 GVSGQL--------IDSMANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLV 256
Query: 558 EILTGRLPDAGPENDGKGLE 577
           E+  GR P   P  D K LE
Sbjct: 257 EMAVGRYPIPPP--DAKELE 274

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 236 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 269

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 83  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 135
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 185
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 186 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 238
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 239 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 85
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 86  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 138
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 139 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 188
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 189 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 241
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 242 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 275

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 87  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 139
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 190 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 242
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 243 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 276

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 83  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 135
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 185
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 186 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 238
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 239 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 272

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
           V+G+   G   +V+  R    G     A++R+ E  +    +DF  E+E + ++  HPNI
Sbjct: 29  VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 408 VRLK-----------AFYYANDEKLLISDFIRNGSLYAA--LHAGPSDSLPPLPWEARLK 454
           + L            A  YA    LL  DF+R   +       A  + +   L  +  L 
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            A   ARG+ Y+   S ++++H N+ +  IL+ +     I+ FGL+R           + 
Sbjct: 144 FAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR----------GQE 190
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
           +    T  R+      ++A E+  Y S +T   DV+S+G++L EI++ G  P  G
Sbjct: 191 VYVKKTMGRLPV---RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 236 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 269

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 44/268 (16%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLY 433
           VAV+ + + DAT   + F +E   + +++H N+V+L          L ++++++  GSL 
Sbjct: 47  VAVKCI-KNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L    S     L  +  LK +      + Y+       +VH ++ +  +L+ ++    
Sbjct: 104 DYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 157
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +S FGL +           E   T  TG     +   + APEA +   KF+ K DV+SFG
Sbjct: 158 VSDFGLTK-----------EASSTQDTGK----LPVKWTAPEA-LREKKFSTKSDVWSFG 201
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           I+L EI + GR+P   P    K +   V K ++   P  +   PA+             +
Sbjct: 202 ILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAP--DGCPPAV-------------Y 244
Query: 613 HIALNCTELDPEFRPRMRTVSESLDRVK 640
            +  NC  LD   RP    + E L+ +K
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFI 427
           G   +VAV+ L           ++ E++ +  + H +I++ K       EK   L+ +++
Sbjct: 41  GTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   +     L  AQ    G+ Y+H    + Y+H N+ +  +L
Sbjct: 101 PLGSL--------RDYLPRHSIGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVL 149
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           LD++    I  FGL + +P   +  +    V     S +      + APE  +   KF  
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPV-----FWYAPEC-LKEYKFYY 199
Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
             DV+SFG+ L E+LT       P      L  + +      R L+E+++    +     
Sbjct: 200 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERG-ERLPRPD 257
Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           +     +H+  NC E +  FRP    +   L  V
Sbjct: 258 KCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VAV+ L E   T   ++F  E   +  ++HPN+V+L           ++++++  G+L  
Sbjct: 60  VAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLD 117
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L     + +  +     L +A   +  + Y+ +   + ++H ++ +   L+ +     +
Sbjct: 118 YLRECNREEVTAV---VLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHVVKV 171
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           + FGL+RL+ G +         T+  G++       + APE+  Y + F+ K DV++FG+
Sbjct: 172 ADFGLSRLMTGDT--------YTAHAGAKFPI---KWTAPESLAYNT-FSIKSDVWAFGV 219
Query: 555 VLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP 589
           +L EI T G  P  G   D   +  L+ K +R  +P
Sbjct: 220 LLWEIATYGMSPYPGI--DLSQVYDLLEKGYRMEQP 253

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 44/268 (16%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLY 433
           VAV+ + + DAT   + F +E   + +++H N+V+L          L ++++++  GSL 
Sbjct: 32  VAVKCI-KNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L    S     L  +  LK +      + Y+       +VH ++ +  +L+ ++    
Sbjct: 89  DYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 142
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +S FGL +           E   T  TG     +   + APEA +   KF+ K DV+SFG
Sbjct: 143 VSDFGLTK-----------EASSTQDTGK----LPVKWTAPEA-LREKKFSTKSDVWSFG 186
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           I+L EI + GR+P   P    K +   V K ++   P  +   PA+             +
Sbjct: 187 ILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAP--DGCPPAV-------------Y 229
Query: 613 HIALNCTELDPEFRPRMRTVSESLDRVK 640
            +  NC  LD   RP    + E L+ +K
Sbjct: 230 EVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 125/287 (43%), Gaps = 46/287 (16%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 74  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 126
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 176
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 177 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 229
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
            R  +P    ID                + I + C  +D + RP+ R
Sbjct: 230 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFR 261

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--LLISDFI 427
           G   +VAV+ L           ++ E++ +  + H +I++ K       EK   L+ +++
Sbjct: 41  GTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   +     L  AQ    G+ Y+H    + Y+H N+ +  +L
Sbjct: 101 PLGSL--------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVL 149
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           LD++    I  FGL + +P   +  +    V     S +      + APE  +   KF  
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPV-----FWYAPEC-LKEYKFYY 199
Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
             DV+SFG+ L E+LT       P      L  + +      R L+E+++    +     
Sbjct: 200 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERG-ERLPRPD 257
Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           +     +H+  NC E +  FRP    +   L  V
Sbjct: 258 KCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G ++K V +  G  +  P  + V     G  +  F+     + AI  + H +I
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIGSLDHAHI 95
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           VRL      +  +L ++ ++  GSL  +   H G       L W  ++      A+G+ Y
Sbjct: 96  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYY 148
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E+     VH N+ +  +LL       ++ FG+  LLP   K      ++ S   + I 
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QLLYSEAKTPIK 200
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
                ++A E+  +G K+T + DV+S+G+ + E++T G  P AG       +  L+ K  
Sbjct: 201 -----WMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGE 252
Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           R  +P    ID                + + + C  +D   RP  + ++    R+
Sbjct: 253 RLAQPQICTID---------------VYMVMVKCWMIDENIRPTFKELANEFTRM 292

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 84  CRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 136
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 186
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 187 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 239
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 240 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+  +G   KV   +       +V+A  ++ +  +    +D+  E++ +A   HPNIV
Sbjct: 41  IIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 409 R-LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           + L AFYY N+  +LI +F   G++ A +         PL       + + T   L Y+H
Sbjct: 98  KLLDAFYYENNLWILI-EFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH 152
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           +    K +H ++K+  IL   +    ++ FG++          KN    T     R S I
Sbjct: 153 D---NKIIHRDLKAGNILFTLDGDIKLADFGVS---------AKN----TRTIQRRDSFI 196
Query: 528 SNVY-LAPEARIYGSK----FTQKCDVYSFGIVLLEI 559
              Y +APE  +  +     +  K DV+S GI L+E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+  +G   KV   +       +V+A  ++ +  +    +D+  E++ +A   HPNIV
Sbjct: 41  IIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 409 R-LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           + L AFYY N+  +LI +F   G++ A +         PL       + + T   L Y+H
Sbjct: 98  KLLDAFYYENNLWILI-EFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH 152
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           +    K +H ++K+  IL   +    ++ FG++     T  + + ++ +  GT       
Sbjct: 153 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFI--GTP------ 199
Query: 528 SNVYLAPEARIYGSK----FTQKCDVYSFGIVLLEI 559
              ++APE  +  +     +  K DV+S GI L+E+
Sbjct: 200 --YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 126/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L++   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 82  CRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 185 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 238 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 271

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 81  CRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 133
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 183
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 184 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 236
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 237 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 270

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 236 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 269

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 76
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A G+ Y
Sbjct: 77  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNY 129
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 130 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 179
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 180 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 232
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
            R  +P    ID                + I + C  +D + RP+ R
Sbjct: 233 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFR 264

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 83  CRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 135
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 185
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 186 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 238
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 239 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 272

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 119/263 (45%), Gaps = 31/263 (11%)
Query: 316 LVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVV 375
           L  DE++ ++ + F+  +    EL+D        +G    G+++KV   + SG+     V
Sbjct: 7   LELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----V 60
Query: 376 AVRRLTEGDATWRFKD-FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
             R+L   +     ++    E++ +     P IV     +Y++ E  +  + +  GSL  
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L          +P +   K++    +GL Y+ E    K +H ++K + IL++      +
Sbjct: 121 VLKKAGR-----IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 173
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
             FG++  L         +++  S  G+R       Y++PE R+ G+ ++ + D++S G+
Sbjct: 174 CDFGVSGQLI--------DSMANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGL 218
Query: 555 VLLEILTGRLPDAGPENDGKGLE 577
            L+E+  GR P   P  D K LE
Sbjct: 219 SLVEMAVGRYPIPPP--DAKELE 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 83  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 135
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 185
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 186 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 238
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I   C  +D + RP+ R +
Sbjct: 239 ERLPQPPICTID---------------VYMIMRKCWMIDADSRPKFREL 272

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 89
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 90  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 142
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 143 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 192
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 193 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 245
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I   C  +D + RP+ R +
Sbjct: 246 ERLPQPPICTID---------------VYMIMRKCWMIDADSRPKFREL 279

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G ++K V +  G  +  P  + V     G  +  F+     + AI  + H +I
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--FQAVTDHMLAIGSLDHAHI 77
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           VRL      +  +L ++ ++  GSL  +   H G       L W  ++      A+G+ Y
Sbjct: 78  VRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYY 130
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + E+     VH N+ +  +LL       ++ FG+  LLP   K      ++ S   + I 
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-----QLLYSEAKTPIK 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
                ++A E+ I+  K+T + DV+S+G+ + E++T G  P AG       +  L+ K  
Sbjct: 183 -----WMALES-IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGE 234
Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           R  +P    ID                + + + C  +D   RP  + ++    R+
Sbjct: 235 RLAQPQICTID---------------VYMVMVKCWMIDENIRPTFKELANEFTRM 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 46/236 (19%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-----DATWRFKDFESEVEAIARVQH 404
           +GK   GI++K +  R +G     VVAV+++ +      DA   F++     E      H
Sbjct: 17  LGKGAYGIVWKSI-DRRTG----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSG---H 68
Query: 405 PNIVRLKAFYYANDEK--LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
            NIV L     A++++   L+ D++    L+A + A   + L P+    +  +     + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA---NILEPV---HKQYVVYQLIKV 121
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN---------- 512
           + Y+H       +H ++K + ILL+ E H  ++ FGL+R      +VT N          
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 513 -----ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                + I+T    +R       Y APE  +  +K+T+  D++S G +L EIL G+
Sbjct: 179 NFDDDQPILTDYVATRW------YRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 81  CRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 133
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 183
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 184 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 236
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 237 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 270

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA+  L E  +    K+   E   +A V +P++
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIMELREATSPKANKEILDEAYVMASVDNPHV 113
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 114 CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 166
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 167 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 216
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 217 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 269
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
            R  +P    ID                + I + C  +D + RP+ R
Sbjct: 270 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFR 301

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 347 AYVVGKSKNGIMYKVVVGRGSGMGAPTV-----------VAVRRL----TEGDATWRFKD 391
           ++++GK  N   YK+V   G G G  TV           VA++ +     E + T   K 
Sbjct: 2   SHMIGKIINE-RYKIVDKLGGG-GMSTVYLAEDTILNIKVAIKAIFIPPREKEET--LKR 57
Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           FE EV   +++ H NIV +      +D   L+ ++I   +L   +     +S  PL  + 
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDT 112
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            +        G+ + H+    + VH +IK   IL+D      I  FG+ + L  TS    
Sbjct: 113 AINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           N  + T             Y +PE +  G    +  D+YS GIVL E+L G  P
Sbjct: 170 NHVLGTVQ-----------YFSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+  +G   KV   +       +V+A  ++ +  +    +D+  E++ +A   HPNIV
Sbjct: 41  IIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 97
Query: 409 R-LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           + L AFYY N+  +LI +F   G++ A +         PL       + + T   L Y+H
Sbjct: 98  KLLDAFYYENNLWILI-EFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH 152
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           +    K +H ++K+  IL   +    ++ FG++     T  + + +  +  GT       
Sbjct: 153 D---NKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFI--GTP------ 199
Query: 528 SNVYLAPEARIYGSK----FTQKCDVYSFGIVLLEI 559
              ++APE  +  +     +  K DV+S GI L+E+
Sbjct: 200 --YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 44/268 (16%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLY 433
           VAV+ + + DAT   + F +E   + +++H N+V+L          L ++++++  GSL 
Sbjct: 38  VAVKCI-KNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 94
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L    S     L  +  LK +      + Y+       +VH ++ +  +L+ ++    
Sbjct: 95  DYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 148
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +S FGL +           E   T  TG     +   + APEA +  + F+ K DV+SFG
Sbjct: 149 VSDFGLTK-----------EASSTQDTGK----LPVKWTAPEA-LREAAFSTKSDVWSFG 192
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           I+L EI + GR+P   P    K +   V K ++   P  +   PA+             +
Sbjct: 193 ILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDAP--DGCPPAV-------------Y 235
Query: 613 HIALNCTELDPEFRPRMRTVSESLDRVK 640
            +  NC  LD   RP    + E L+ +K
Sbjct: 236 EVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 124/287 (43%), Gaps = 46/287 (16%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
            R  +P    ID                + I   C  +D + RP+ R
Sbjct: 236 ERLPQPPICTID---------------VYMIMRKCWMIDADSRPKFR 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
           V+G+   G   +V+  R    G     A++R+ E  +    +DF  E+E + ++  HPNI
Sbjct: 32  VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 408 VRLK-----------AFYYANDEKLLISDFIRNGSLYAA--LHAGPSDSLPPLPWEARLK 454
           + L            A  YA    LL  DF+R   +       A  + +   L  +  L 
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            A   ARG+ Y+   S ++++H ++ +  IL+ +     I+ FGL+R           + 
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQE 193
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
           +    T  R+      ++A E+  Y S +T   DV+S+G++L EI++ G  P  G
Sbjct: 194 VYVKKTMGRLPV---RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPT-VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+ + G +YK  +  G   G  T  VA++ L +       ++F  E    AR+QHPN+V
Sbjct: 34  LGEDRFGKVYKGHLF-GPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAAL-------HAGPSD-------SLPPLPWEARLK 454
            L      +    +I  +  +G L+  L         G +D       +L P  +   + 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF---VH 149
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           +    A G+ Y+   S    VH ++ +  +L+ D+L+  IS  GL R      +V   + 
Sbjct: 150 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR------EVYAADY 200
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG 573
               G     S +   ++APEA +YG KF+   D++S+G+VL E+ + G  P  G  N  
Sbjct: 201 YKLLGN----SLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255
Query: 574 KGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                 V +  R R+ L    D PA V            + + + C    P  RPR + +
Sbjct: 256 ------VVEMIRNRQVLPCPDDCPAWV------------YALMIECWNEFPSRRPRFKDI 297
Query: 633 SESL 636
              L
Sbjct: 298 HSRL 301

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
           V+G+   G   +V+  R    G     A++R+ E  +    +DF  E+E + ++  HPNI
Sbjct: 22  VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 408 VRLK-----------AFYYANDEKLLISDFIRNGSLYAA--LHAGPSDSLPPLPWEARLK 454
           + L            A  YA    LL  DF+R   +       A  + +   L  +  L 
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            A   ARG+ Y+   S ++++H ++ +  IL+ +     I+ FGL+R           + 
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQE 183
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
           +    T  R+      ++A E+  Y S +T   DV+S+G++L EI++ G  P  G
Sbjct: 184 VYVKKTMGRLPV---RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPT-VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+ + G +YK  +  G   G  T  VA++ L +       ++F  E    AR+QHPN+V
Sbjct: 17  LGEDRFGKVYKGHLF-GPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAAL-------HAGPSD-------SLPPLPWEARLK 454
            L      +    +I  +  +G L+  L         G +D       +L P  +   + 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF---VH 132
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           +    A G+ Y+   S    VH ++ +  +L+ D+L+  IS  GL R      +V   + 
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR------EVYAADY 183
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG 573
               G     S +   ++APEA +YG KF+   D++S+G+VL E+ + G  P  G  N  
Sbjct: 184 YKLLGN----SLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238
Query: 574 KGLESLVRKAFRERRPLSEVID-PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                 V +  R R+ L    D PA V            + + + C    P  RPR + +
Sbjct: 239 ------VVEMIRNRQVLPCPDDCPAWV------------YALMIECWNEFPSRRPRFKDI 280
Query: 633 SESL 636
              L
Sbjct: 281 HSRL 284

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 122/282 (43%), Gaps = 42/282 (14%)
Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEK 420
           + +G   G   VV V ++ +  +T + +DF  E   +    HPN++ +     +      
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
            LI+ ++  GSLY  LH G +  +        +K A   ARG+ ++H   P    H  + 
Sbjct: 85  TLITHWMPYGSLYNVLHEGTNFVVDQ---SQAVKFALDMARGMAFLHTLEPLIPRHA-LN 140
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           S  +++D+++               T++++  +   +  +  R+ A +  ++APEA    
Sbjct: 141 SRSVMIDEDM---------------TARISMADVKFSFQSPGRMYAPA--WVAPEALQKK 183
Query: 541 SKFTQK--CDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPAL 598
            + T +   D++SF ++L E++T  +P A    D   +E  ++ A    RP    I P +
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFA----DLSNMEIGMKVALEGLRP---TIPPGI 236
Query: 599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
              +    ++         C   DP  RP+   +   L++++
Sbjct: 237 SPHVSKLMKI---------CMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 127/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I+++ H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 98  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 158 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 209
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 210 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 258
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 259 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 301
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 302 EDRPNFAIILERIE 315

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+     G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 236 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 269

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+     G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 87  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 139
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 190 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 242
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 243 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 276

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT-EGDATWRFKDFESEVEAIARVQHPNI 407
           V+GK    +M  V + R    G    V VRR+  E  +       + E+       HPNI
Sbjct: 16  VIGKGFEDLM-TVNLARYKPTGE--YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 72
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V  +A + A++E  +++ F+  GS    +     D +  L   A   I QG  + L YIH
Sbjct: 73  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---AIAYILQGVLKALDYIH 129
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI--- 524
                 YVH ++K++ IL+  +    +SG            +  N ++++ G   R+   
Sbjct: 130 HMG---YVHRSVKASHILISVDGKVYLSG------------LRSNLSMISHGQRQRVVHD 174
Query: 525 ----SAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLP 565
               S     +L+PE      + +  K D+YS GI   E+  G +P
Sbjct: 175 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 220

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 97
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 158 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 209
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 210 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 258
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 259 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 301
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 302 EDRPNFAIILERIE 315

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 30/226 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT-EGDATWRFKDFESEVEAIARVQHPNI 407
           V+GK    +M  V + R    G    V VRR+  E  +       + E+       HPNI
Sbjct: 32  VIGKGFEDLM-TVNLARYKPTGE--YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V  +A + A++E  +++ F+  GS    +     D +  L   A   I QG  + L YIH
Sbjct: 89  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---AIAYILQGVLKALDYIH 145
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI--- 524
                 YVH ++K++ IL+  +    +SG            +  N ++++ G   R+   
Sbjct: 146 HMG---YVHRSVKASHILISVDGKVYLSG------------LRSNLSMISHGQRQRVVHD 190
Query: 525 ----SAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLP 565
               S     +L+PE      + +  K D+YS GI   E+  G +P
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 80  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 132
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 183 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 235
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 236 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 269

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 32/203 (15%)
Query: 364 GRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI 423
           GR   M       V RL + + T        E   ++ V HP I+R+   +    +  +I
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHT------NDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84
Query: 424 SDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
            D+I  G L++ L    S   P P+   A+   A+     L Y+H    +  ++ ++K  
Sbjct: 85  MDYIEGGELFSLLRK--SQRFPNPV---AKFYAAE-VCLALEYLHS---KDIIYRDLKPE 135
Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
            ILLD   H  I+ FG  + +P         T    GT          Y+APE  +    
Sbjct: 136 NILLDKNGHIKITDFGFAKYVPDV-------TYXLCGTPD--------YIAPEV-VSTKP 179
Query: 543 FTQKCDVYSFGIVLLEILTGRLP 565
           + +  D +SFGI++ E+L G  P
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 143 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 194
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 195 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 243
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 244 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 286
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 287 EDRPNFAIILERIE 300

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I+++ H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 84  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 144 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 195
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K             + +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 196 RASYYRKGGC----------AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 244
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 245 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 287
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 288 EDRPNFAIILERIE 301

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 31/195 (15%)
Query: 393 ESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
           E EV ++  ++H NI++     K     + +  LI+ F   GSL   L A        + 
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VS 119
Query: 449 WEARLKIAQGTARGLMYIHEYSPR-------KYVHGNIKSTKILLDDELHPCISGFGLNR 501
           W     IA+  ARGL Y+HE  P           H +IKS  +LL + L  CI+ FGL  
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA- 178
Query: 502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ----KCDVYSFGIVLL 557
            L   +  +  +T    GT          Y+APE       F +    + D+Y+ G+VL 
Sbjct: 179 -LKFEAGKSAGDTHGQVGT--------RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 558 EILTGRLPDAGPEND 572
           E+ +      GP ++
Sbjct: 230 ELASRCTAADGPVDE 244

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 44/268 (16%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLY 433
           VAV+ + + DAT   + F +E   + +++H N+V+L          L ++++++  GSL 
Sbjct: 219 VAVKCI-KNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L    S     L  +  LK +      + Y+       +VH ++ +  +L+ ++    
Sbjct: 276 DYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 329
Query: 494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFG 553
           +S FGL +           E   T  TG     +   + APEA +   KF+ K DV+SFG
Sbjct: 330 VSDFGLTK-----------EASSTQDTGK----LPVKWTAPEA-LREKKFSTKSDVWSFG 373
Query: 554 IVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF 612
           I+L EI + GR+P   P    K +   V K ++   P  +   PA+             +
Sbjct: 374 ILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAP--DGCPPAV-------------Y 416
Query: 613 HIALNCTELDPEFRPRMRTVSESLDRVK 640
            +  NC  LD   RP    + E L+ ++
Sbjct: 417 DVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E E + ++ HP +V+L           L+++F+ +G L  
Sbjct: 35  VAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E      +H ++ +   L+ +     +
Sbjct: 93  YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 145
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 146 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 193
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 194 LMWEVFSEGKIP 205

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 143 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 194
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 195 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 243
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 244 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 286
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 287 EDRPNFAIILERIE 300

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 87  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 139
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 190 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 242
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 243 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 276

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 51  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 109 YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 157
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 158 VVKVSDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 205
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 264 ERPTFKILLS 273

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---LPWEA 451
           EV  +A ++HPNIV+ +  +  N    ++ D+   G L+  ++A           L W  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
           ++ +A      L ++H+   RK +H +IKS  I L  +    +  FG+ R+L  T ++  
Sbjct: 133 QICLA------LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-- 181
Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
                     +R    +  YL+PE       +  K D+++ G VL E+ T
Sbjct: 182 ----------ARACIGTPYYLSPEI-CENKPYNNKSDIWALGCVLYELCT 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 349 VVGKS-KNGIMYKVVVGRGSGMGAP-----TVVAVRRLTEGDATWR-FKDFESEVEAIAR 401
           V+GK    G   +VV+    G+        T VAV+ L + DAT +   D  SE+E +  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 89
Query: 402 V-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA----GPSDSLPP-------LPW 449
           + +H NI+ L      +    +I ++   G+L   L A    G   S  P       L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           +  +  A   ARG+ Y+   + +K +H ++ +  +L+ ++    I+ FGL R +      
Sbjct: 150 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXX 206
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
            K        T  R+      ++APEA ++   +T + DV+SFG++L EI T      G 
Sbjct: 207 KKT-------TNGRLPV---KWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTL----GGS 251
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ----VLATFHIALNCTELDPEF 625
              G  +E L +                L+KE H   +        + +  +C    P  
Sbjct: 252 PYPGVPVEELFK----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 295
Query: 626 RPRMRTVSESLDRV 639
           RP  + + E LDR+
Sbjct: 296 RPTFKQLVEDLDRI 309

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E E + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 34  VAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E S    +H ++ +   L+ +     +
Sbjct: 92  YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGENQVIKV 144
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 145 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 192
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 193 LMWEVFSEGKIP 204

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 51  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 109 YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 157
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 158 VVKVSDFGLSRY------VLDDEE--TSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 205
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 264 ERPTFKILLS 273

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 40  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 99
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 100 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 159
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 160 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 211
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 212 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 260
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 261 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 303
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 304 EDRPNFAIILERIE 317

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 125/314 (39%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 15  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 74
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 75  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 134
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 135 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 186
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K             + +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 187 RASYYRKGGC----------AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 235
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 236 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 278
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 279 EDRPNFAIILERIE 292

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 30  IGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHE 468
               Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H 
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS 137
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H +IK+  +LL +     ++ FG+   L  T ++ +N  + T           
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNXFVGTP---------- 183
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P +           P+N+   LE 
Sbjct: 184 -FWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 241
Query: 579 LVRKAFRERRPLSEVIDPALVKE 601
                    +PL E ++  L KE
Sbjct: 242 ------NYSKPLKEFVEACLNKE 258

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESE 395
           +EL+D        +G    G+++KV   + SG+     V  R+L   +     ++    E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMARKLIHLEIKPAIRNQIIRE 54
Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
           ++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K+
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKV 109
Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +    +GL Y+ E    K +H ++K + IL++      +  FG++  L         +++
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSM 159
Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
             S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K 
Sbjct: 160 ANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKE 210
Query: 576 LE 577
           LE
Sbjct: 211 LE 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 102 TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G   S  P       L  +  +  A   ARG+ Y+   + +K +H ++
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 217
Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 266
Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 267 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 317
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 318 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 38  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM 97
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 157
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 158 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 209
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 210 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 258
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 259 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 301
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 302 EDRPNFAIILERIE 315

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 30  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 89
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 90  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 149
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 150 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 201
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 202 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 250
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 251 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 293
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 294 EDRPNFAIILERIE 307

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 76/314 (24%), Positives = 125/314 (39%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 144 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 195
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K             + +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 196 RASYYRKGGC----------AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 244
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 245 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 287
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 288 EDRPNFAIILERIE 301

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESE 395
           +EL+D        +G    G+++KV   + SG+     V  R+L   +     ++    E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMARKLIHLEIKPAIRNQIIRE 54
Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
           ++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K+
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKV 109
Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +    +GL Y+ E    K +H ++K + IL++      +  FG++  L         +++
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSM 159
Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
             S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K 
Sbjct: 160 ANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKE 210
Query: 576 LE 577
           LE
Sbjct: 211 LE 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 36  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 93
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 94  YLREMRHRFQTQQL--------LEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQG 142
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 143 VVKVSDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 190
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 249 ERPTFKILLS 258

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 29/183 (15%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLPWEAR 452
           +E+  +  + HPNI++L   +       L+++F   G L+  + +    D          
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---- 150
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSKV 509
             I +    G+ Y+H+++    VH +IK   ILL+++   L+  I  FGL+       K+
Sbjct: 151 --IMKQILSGICYLHKHNI---VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
                        R    +  Y+APE  +   K+ +KCDV+S G+++  +L G  P  G 
Sbjct: 206 -------------RDRLGTAYYIAPE--VLKKKYNEKCDVWSCGVIMYILLCG-YPPFGG 249
Query: 570 END 572
           +ND
Sbjct: 250 QND 252

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 36  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 93
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 94  YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 142
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E      T SR S     +  PE  +Y SKF+ K D++
Sbjct: 143 VVKVSDFGLSRY------VLDDEY-----TSSRGSKFPVRWSPPEVLMY-SKFSSKSDIW 190
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 248
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 249 ERPTFKILLS 258

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 99/230 (43%), Gaps = 34/230 (14%)
Query: 343 LRASAYVVGKSKN-GIMYKVVVGRGSGMGAPTVVAV---RRLTEGDATWRFKDFESEVEA 398
           ++   Y++G +   G   KV VG+    G    V +   +++   D   + +    E++ 
Sbjct: 13  VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQN 69
Query: 399 IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           +   +HP+I++L        +  ++ +++  G L+  +          L  +   ++ Q 
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQ 124
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
              G+ Y H +     VH ++K   +LLD  ++  I+ FGL+ ++             + 
Sbjct: 125 ILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-------------SD 168
Query: 519 GTGSRISAISNVYLAPEA---RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           G   R S  S  Y APE    R+Y      + D++S G++L  +L G LP
Sbjct: 169 GEFLRXSCGSPNYAAPEVISGRLYAGP---EVDIWSSGVILYALLCGTLP 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 31  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 89  YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 137
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 138 VVKVSDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 185
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 243
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 244 ERPTFKILLS 253

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 35  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 92
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 93  YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 141
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 142 VVKVSDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 189
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 247
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 248 ERPTFKILLS 257

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 41  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 100
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 101 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 160
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK- 511
           L +A+  A G  Y+ E     ++H +I +   LL                 PG  +V K 
Sbjct: 161 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---------------CPGPGRVAKI 202
Query: 512 -----NETIVTSGTGSR--ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
                   I  +G   +   + +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 203 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 261
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 262 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 304
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 305 EDRPNFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 125/314 (39%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 123
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK- 511
           L +A+  A G  Y+ E     ++H +I +   LL                 PG  +V K 
Sbjct: 184 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---------------CPGPGRVAKI 225
Query: 512 -----NETIVTSGTGSR--ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
                   I  +G   +   + +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 284
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 285 MPY--PSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 327
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 328 EDRPNFAIILERIE 341

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 50  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 109
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 110 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 169
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--------ISGFGLNRLLP 504
           L +A+  A G  Y+ E     ++H +I +   LL      C        I  FG+ R + 
Sbjct: 170 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT-----CPGPGRVAKIGDFGMARDIY 221
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
             S   K         G  +  +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 222 RASYYRKG--------GCAMLPVK--WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 270
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 271 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 313
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 314 EDRPNFAIILERIE 327

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    +F  E + +  + H  +V+L           +I++++ NG L  
Sbjct: 42  VAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 99
Query: 435 AL----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L    H   +  L        L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 100 YLREMRHRFQTQQL--------LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQG 148
Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R       V  +E   TS  GS+       +  PE  +Y SKF+ K D++
Sbjct: 149 VVKVSDFGLSRY------VLDDE--YTSSVGSKFPV---RWSPPEVLMY-SKFSSKSDIW 196
Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQ 607
           +FG+++ EI + G++P     N        + +  R  RP   SE +   +    H K  
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETA--EHIAQGLRLYRPHLASEKVYTIMYSCWHEKAD 254
Query: 608 VLATFHIALN 617
              TF I L+
Sbjct: 255 ERPTFKILLS 264

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+     G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 87  CRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 139
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FGL +LL    K    E       G ++ 
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE-------GGKVP 189
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 190 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 242
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 243 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 276

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 44/220 (20%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E+E  A + HPNI+RL  ++Y      LI ++   G LY  L    +        +    
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT-----FDEQRTAT 127
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           I +  A  LMY H    +K +H +IK   +LL  +    I+ FG +   P   + T   T
Sbjct: 128 IMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGT 184
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP-DAGPENDG 573
           +               YL PE  I G    +K D++  G++  E+L G  P ++   N+ 
Sbjct: 185 L--------------DYLPPEM-IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNET 229
Query: 574 ----------------KGLESLVRKAFR----ERRPLSEV 593
                            G + L+ K  R    ER PL++V
Sbjct: 230 YRRIVKVDLKFPASVPTGAQDLISKLLRHNPSERLPLAQV 269

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 35  IGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 89
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHE 468
               Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H 
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS 142
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H +IK+  +LL +     ++ FG+   L  T ++ +N  + T           
Sbjct: 143 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTP---------- 188
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P +           P+N+   LE 
Sbjct: 189 -FWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 246
Query: 579 LVRKAFRERRPLSEVIDPALVKE 601
                    +PL E ++  L KE
Sbjct: 247 ------NYSKPLKEFVEACLNKE 263

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  + LI   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 82  CRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 185 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 238 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 271

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    + +   T+ + T   K F  EV  +  + HPNIV+L         
Sbjct: 30  KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKT 88
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             LI ++   G +  Y   H    +       EAR K  Q     + Y H+   ++ VH 
Sbjct: 89  LYLIMEYASGGEVFDYLVAHGRMKEK------EARSKFRQ-IVSAVQYCHQ---KRIVHR 138
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV--YLAPE 535
           ++K+  +LLD +++  I+ FG +           NE  V    G ++ A      Y APE
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS-----------NEFTV----GGKLDAFCGAPPYAAPE 183
Query: 536 ARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
               G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 184 L-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  + LI   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 84  CRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 136
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 186
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 187 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 239
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I + C  +D + RP+ R +
Sbjct: 240 ERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFREL 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 15  IGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHE 468
               Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H 
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H +IK+  +LL +     ++ FG+   L  T ++ +N  + T           
Sbjct: 123 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTP---------- 168
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P +           P+N+   LE 
Sbjct: 169 -FWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 226
Query: 579 LVRKAFRERRPLSEVIDPALVKE 601
                    +PL E ++  L KE
Sbjct: 227 ------NYSKPLKEFVEACLNKE 243

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 99/246 (40%), Gaps = 53/246 (21%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF--ESEVEAIARVQHPN 406
           ++G+ + G +YK     GS    P  V V            ++F  E  +  +  ++H N
Sbjct: 20  LIGRGRYGAVYK-----GSLDERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDN 68
Query: 407 IVRLKAFYYANDEK---------LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQ 457
           I R    +   DE+         LL+ ++  NGSL   L    SD      W +  ++A 
Sbjct: 69  IAR----FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD------WVSSCRLAH 118
Query: 458 GTARGLMYIHEYSPR------KYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
              RGL Y+H   PR         H ++ S  +L+ ++    IS FGL+  L G   V  
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 512 NETIVTSGTGSRISAISNV-YLAPEA-------RIYGSKFTQKCDVYSFGIVLLEILTGR 563
            E        + IS +  + Y+APE        R   S   Q  D+Y+ G++  EI   R
Sbjct: 179 GEE-----DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ-VDMYALGLIYWEIFM-R 231
Query: 564 LPDAGP 569
             D  P
Sbjct: 232 CTDLFP 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++   P + +
Sbjct: 15  IGKGSFGEVFKGIDNR-----TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHE 468
               Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H 
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H +IK+  +LL +     ++ FG+   L  T ++ +N  + T           
Sbjct: 123 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNXFVGTP---------- 168
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLES 578
             ++APE  I  S +  K D++S GI  +E+  G  P +           P+N+   LE 
Sbjct: 169 -FWMAPEV-IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 226
Query: 579 LVRKAFRERRPLSEVIDPALVKE 601
                    +PL E ++  L KE
Sbjct: 227 ------NYSKPLKEFVEACLNKE 243

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESE 395
           +EL+D        +G    G+++KV   + SG+     V  R+L   +     ++    E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMARKLIHLEIKPAIRNQIIRE 54
Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
           ++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K+
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKV 109
Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +    +GL Y+ E    K +H ++K + IL++      +  FG++  L         +++
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DSM 159
Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
             S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K 
Sbjct: 160 ANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKE 210
Query: 576 LE 577
           LE
Sbjct: 211 LE 212

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 109/242 (45%), Gaps = 31/242 (12%)
Query: 337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESE 395
           +EL+D        +G    G+++KV   + SG+     V  R+L   +     ++    E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMARKLIHLEIKPAIRNQIIRE 54
Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
           ++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K+
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKV 109
Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +    +GL Y+ E    K +H ++K + IL++      +  FG++  L         +++
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DSM 159
Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
             S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  D K 
Sbjct: 160 ANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKE 210
Query: 576 LE 577
           LE
Sbjct: 211 LE 212

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 78/314 (24%), Positives = 131/314 (41%), Gaps = 58/314 (18%)
Query: 349 VVGKS-KNGIMYKVVVGRGSGMGAP-----TVVAVRRLTEGDATWR-FKDFESEVEAIAR 401
           V+GK    G   +VV+    G+        T VAV+ L + DAT +   D  SE+E +  
Sbjct: 20  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 78
Query: 402 V-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA----GPSDSLPP-------LPW 449
           + +H NI+ L      +    +I ++   G+L   L A    G   S  P       L  
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           +  +  A   ARG+ Y+   + +K +H ++ +  +L+ ++    I+ FGL R +      
Sbjct: 139 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
            K        T  R+      ++APEA ++   +T + DV+SFG++L EI T      G 
Sbjct: 196 KKT-------TNGRLPV---KWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTL----GGS 240
Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ----VLATFHIALNCTELDPEF 625
              G  +E L +                L+KE H   +        + +  +C    P  
Sbjct: 241 PYPGVPVEELFK----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 284
Query: 626 RPRMRTVSESLDRV 639
           RP  + + E LDR+
Sbjct: 285 RPTFKQLVEDLDRI 298

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G   S  P       L  +  +  A   ARG+ Y+   + +K +H ++
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 225
Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 226 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 276
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 277 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 85/192 (44%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +    DF  E E + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 54  VAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 111
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E      +H ++ +   L+ +     +
Sbjct: 112 YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 164
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 165 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 212
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 213 LMWEVFSEGKIP 224

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 53  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 111
Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G   S  P       L  +  +  A   ARG+ Y+   + +K +H ++
Sbjct: 112 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 168
Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 169 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 217
Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 218 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 268
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 269 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G   S  P       L  +  +  A   ARG+ Y+   + +K +H ++
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 176
Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 177 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 225
Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 226 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 276
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 277 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L I+  +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 82  CRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 185 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I   C  +D + RP+ R +
Sbjct: 238 ERLPQPPICTID---------------VYMIMRKCWMIDADSRPKFREL 271

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 123/314 (39%), Gaps = 50/314 (15%)
Query: 338 ELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFES 394
           +L+++ R +  ++    +G   +V  G+ SGM    +P  VAV+ L E  +     DF  
Sbjct: 24  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 83
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLP-PLPWEAR 452
           E   I++  H NIVR       +  + ++ + +  G L + L    P  S P  L     
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 143
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           L +A+  A G  Y+ E     ++H +I +   LL                 PG  +V K 
Sbjct: 144 LHVARDIACGCQYLEE---NHFIHRDIAARNCLLT---------------CPGPGRVAKI 185
Query: 513 ETIVTSGTGSRIS--------AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GR 563
                +    R S         +   ++ PEA + G  FT K D +SFG++L EI + G 
Sbjct: 186 GDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGY 244
Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
           +P   P    + +   V    R        +DP        K      + I   C +  P
Sbjct: 245 MP--YPSKSNQEVLEFVTSGGR--------MDP-------PKNCPGPVYRIMTQCWQHQP 287
Query: 624 EFRPRMRTVSESLD 637
           E RP    + E ++
Sbjct: 288 EDRPNFAIILERIE 301

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E E + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 34  VAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 91
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E      +H ++ +   L+ +     +
Sbjct: 92  YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 144
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 145 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 192
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 193 LMWEVFSEGKIP 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 337 LELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESE 395
           +EL+D        +G    G+++KV   + SG+     V  R+L   +     ++    E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVS-HKPSGL-----VMARKLIHLEIKPAIRNQIIRE 54
Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
           ++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K+
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKV 109
Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +    +GL Y+ E    K +H ++K + IL++      +  FG++  L         +++
Sbjct: 110 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSM 159
Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
             S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P+
Sbjct: 160 ANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNG 430
           T VAV+ L + DAT +   D  SE+E +  + +H NI+ L      +    +I ++   G
Sbjct: 54  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 112
Query: 431 SLYAALHA----GPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNI 479
           +L   L A    G   S  P       L  +  +  A   ARG+ Y+   + +K +H ++
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDL 169
Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
            +  +L+ ++    I+ FGL R +       K        T  R+      ++APEA ++
Sbjct: 170 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKT-------TNGRLPV---KWMAPEA-LF 218
Query: 540 GSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVIDPA 597
              +T + DV+SFG++L EI T G  P  G P  +   L  L+++  R  +P +      
Sbjct: 219 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFKLLKEGHRMDKPSN------ 269
Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              E+         + +  +C    P  RP  + + E LDR+
Sbjct: 270 CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E E + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 37  VAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E      +H ++ +   L+ +     +
Sbjct: 95  YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 147
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 148 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 195
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 196 LMWEVFSEGKIP 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 46/296 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V  P +
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIP--VAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  +L ++  +  G L  +   + G   S   L W  ++      A+G+ Y
Sbjct: 82  SRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +    + VH ++ +  +L+    H  I+ FGL RLL        +ET   +  G    
Sbjct: 135 LEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL------DIDETEYHADGGK--- 182
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
            +   ++A E+ I   +FT + DV+S+G+ + E++T G  P D  P    + +  L+ K 
Sbjct: 183 -VPIKWMALES-ILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            R  +P    ID                + I + C  +D E RPR R +     R+
Sbjct: 238 ERLPQPPICTID---------------VYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 98
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 152
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 153 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 196
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 197 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ + EG  +   +DF  E E + ++ HP +V+L           L+ +F+ +G L  
Sbjct: 32  VAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L             E  L +      G+ Y+ E      +H ++ +   L+ +     +
Sbjct: 90  YLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKV 142
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FG+ R +             TS TG++       + +PE   + S+++ K DV+SFG+
Sbjct: 143 SDFGMTRFVLDDQ--------YTSSTGTKFPV---KWASPEVFSF-SRYSSKSDVWSFGV 190
Query: 555 VLLEILT-GRLP 565
           ++ E+ + G++P
Sbjct: 191 LMWEVFSEGKIP 202

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G +Y  L       L     +         A  L Y H  
Sbjct: 78  LYGYFHDATRVYLILEYAPRGEVYKELQ-----KLSKFDEQRTATYITELANALSYCHS- 131
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 175
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 176 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A  ++  + L + D   R    E E+  +  ++HP+I++L     + DE +++ ++  N 
Sbjct: 33  ALKIINKKVLAKSDMQGRI---EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 89
Query: 431 SL-YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
              Y       S+       EAR +  Q     + Y H +   K VH ++K   +LLD+ 
Sbjct: 90  LFDYIVQRDKMSEQ------EAR-RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH 139
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ-KCD 548
           L+  I+ FGL+              I+T G   + S  S  Y APE  I G  +   + D
Sbjct: 140 LNVKIADFGLS-------------NIMTDGNFLKTSCGSPNYAAPEV-ISGKLYAGPEVD 185
Query: 549 VYSFGIVLLEILTGRLP 565
           V+S G++L  +L  RLP
Sbjct: 186 VWSCGVILYVMLCRRLP 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 73
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 127
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T       SGT         
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT------LSGTLD------- 172
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 173 -YLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A  ++  + L + D   R    E E+  +  ++HP+I++L     + DE +++ ++  N 
Sbjct: 43  ALKIINKKVLAKSDMQGRI---EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 99
Query: 431 SL-YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
              Y       S+       EAR +  Q     + Y H +   K VH ++K   +LLD+ 
Sbjct: 100 LFDYIVQRDKMSEQ------EAR-RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH 149
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ-KCD 548
           L+  I+ FGL+              I+T G   + S  S  Y APE  I G  +   + D
Sbjct: 150 LNVKIADFGLS-------------NIMTDGNFLKTSCGSPNYAAPEV-ISGKLYAGPEVD 195
Query: 549 VYSFGIVLLEILTGRLP 565
           V+S G++L  +L  RLP
Sbjct: 196 VWSCGVILYVMLCRRLP 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A  ++  + L + D   R    E E+  +  ++HP+I++L     + DE +++ ++  N 
Sbjct: 37  ALKIINKKVLAKSDMQGRI---EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 93
Query: 431 SL-YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
              Y       S+       EAR +  Q     + Y H +   K VH ++K   +LLD+ 
Sbjct: 94  LFDYIVQRDKMSEQ------EAR-RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH 143
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ-KCD 548
           L+  I+ FGL+              I+T G   + S  S  Y APE  I G  +   + D
Sbjct: 144 LNVKIADFGLS-------------NIMTDGNFLKTSCGSPNYAAPEV-ISGKLYAGPEVD 189
Query: 549 VYSFGIVLLEILTGRLP 565
           V+S G++L  +L  RLP
Sbjct: 190 VWSCGVILYVMLCRRLP 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A  ++  + L + D   R    E E+  +  ++HP+I++L     + DE +++ ++  N 
Sbjct: 42  ALKIINKKVLAKSDMQGRI---EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNE 98
Query: 431 SL-YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
              Y       S+       EAR +  Q     + Y H +   K VH ++K   +LLD+ 
Sbjct: 99  LFDYIVQRDKMSEQ------EAR-RFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEH 148
Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ-KCD 548
           L+  I+ FGL+              I+T G   + S  S  Y APE  I G  +   + D
Sbjct: 149 LNVKIADFGLS-------------NIMTDGNFLKTSCGSPNYAAPEV-ISGKLYAGPEVD 194
Query: 549 VYSFGIVLLEILTGRLP 565
           V+S G++L  +L  RLP
Sbjct: 195 VWSCGVILYVMLCRRLP 211

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G +YK     G       VVA++ +   +A    +D + E+  +++   P I R
Sbjct: 27  IGKGSFGEVYK-----GIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 81
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
               Y  + +  +I +++  GS    L  GP      L       I +   +GL Y+H  
Sbjct: 82  YFGSYLKSTKLWIIMEYLGGGSALDLLKPGP------LEETYIATILREILKGLDYLH-- 133
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
           S RK +H +IK+  +LL ++    ++ FG+   L  T ++ +N  + T            
Sbjct: 134 SERK-IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNXFVGTP----------- 180
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLESL 579
            ++APE  I  S +  K D++S GI  +E+  G  P++           P+N    LE  
Sbjct: 181 FWMAPEV-IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ 239
Query: 580 VRKAFRE 586
             K F+E
Sbjct: 240 HSKPFKE 246

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 89
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 90  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCH-- 142
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 143 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 187
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 188 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 131
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 175
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 176 DYLPPEX-IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 64/317 (20%)
Query: 349 VVGKS-KNGIMYKVVVGRGSGMGAP-----TVVAVRRLTEGDATWR-FKDFESEVEAIAR 401
           V+GK    G   +VV+    G+        T VAV+ L + DAT +   D  SE+E +  
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 74
Query: 402 V-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--------------GPSDSLPP 446
           + +H NI+ L      +    +I ++   G+L   L A               P + L  
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
              +  +  A   ARG+ Y+   + +K +H ++ +  +L+ ++    I+ FGL R +   
Sbjct: 135 ---KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
               K        T  R+      ++APEA ++   +T + DV+SFG++L EI T     
Sbjct: 189 DYYKKT-------TNGRLPV---KWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTL---- 233
Query: 567 AGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ----VLATFHIALNCTELD 622
            G    G  +E L +                L+KE H   +        + +  +C    
Sbjct: 234 GGSPYPGVPVEELFK----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAV 277
Query: 623 PEFRPRMRTVSESLDRV 639
           P  RP  + + E LDR+
Sbjct: 278 PSQRPTFKQLVEDLDRI 294

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGD--------ATWRFKDFES---EVEAIARVQHPNI 407
           Y +V   G G     +    R+T+ +        A+ + KD  +   EVE + ++ HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           ++L      +    ++ +    G L+  +      S          +I +    G+ Y+H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH 138
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +++    VH ++K   ILL+ +   C   I  FGL+      +K+             RI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----------DRI 184
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
              +  Y+APE  +    + +KCDV+S G++L  +L+G  P  G
Sbjct: 185 G--TAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 74
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 128
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 129 --KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL-------------- 172
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 173 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 64/317 (20%)
Query: 349 VVGKS-KNGIMYKVVVGRGSGMGAP-----TVVAVRRLTEGDATWR-FKDFESEVEAIAR 401
           V+GK    G   +VV+    G+        T VAV+ L + DAT +   D  SE+E +  
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKM 89
Query: 402 V-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA--------------GPSDSLPP 446
           + +H NI+ L      +    +I ++   G+L   L A               P + L  
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
              +  +  A   ARG+ Y+   + +K +H ++ +  +L+ ++    I+ FGL R +   
Sbjct: 150 ---KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
               K        T  R+      ++APEA ++   +T + DV+SFG++L EI T     
Sbjct: 204 DYYKKT-------TNGRLPV---KWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTL---- 248
Query: 567 AGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQ----VLATFHIALNCTELD 622
            G    G  +E L +                L+KE H   +        + +  +C    
Sbjct: 249 GGSPYPGVPVEELFK----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAV 292
Query: 623 PEFRPRMRTVSESLDRV 639
           P  RP  + + E LDR+
Sbjct: 293 PSQRPTFKQLVEDLDRI 309

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 106/247 (42%), Gaps = 37/247 (14%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK   G ++K +  R        VVA++ +   +A    +D + E+  +++     + +
Sbjct: 31  IGKGSFGEVFKGIDNR-----TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTK 85
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
               Y    +  +I +++  GS    L AGP D            + +   +GL Y+H  
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF------QIATMLKEILKGLDYLHS- 138
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
              K +H +IK+  +LL ++    ++ FG+   L  T ++ +N  + T            
Sbjct: 139 --EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-QIKRNTFVGTP----------- 184
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG----------PENDGKGLESL 579
            ++APE  I  S +  K D++S GI  +E+  G  P++           P+N+   L   
Sbjct: 185 FWMAPEV-IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGD 243
Query: 580 VRKAFRE 586
             K+F+E
Sbjct: 244 FTKSFKE 250

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 349 VVGKSKNGIMYK-VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           V+G    G +YK + +  G  +  P  VA++ L E  +    K+   E   +A V +P++
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 408 VRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            RL      +  + LI   +  G L  Y   H     S   L W  ++      A+G+ Y
Sbjct: 82  CRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNY 134
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           + +   R+ VH ++ +  +L+    H  I+ FG  +LL    K    E       G ++ 
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE-------GGKVP 184
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP-DAGPENDGKGLESLVRKA 583
                ++A E+ I    +T + DV+S+G+ + E++T G  P D  P ++   + S++ K 
Sbjct: 185 I---KWMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKG 237
Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            R  +P    ID                + I   C  +D + RP+ R +
Sbjct: 238 ERLPQPPICTID---------------VYMIMRKCWMIDADSRPKFREL 271

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 37/247 (14%)
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
            +  E+E+E +  + HPNI+++   +       ++ +    G L   + +  +     L 
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG-KALS 122
Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCIS--GFGLNRLLPG 505
                ++ +     L Y H    +  VH ++K   IL  D   H  I    FGL  L   
Sbjct: 123 EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-- 177
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                K++   T+  G+ +      Y+APE  ++    T KCD++S G+V+  +LTG LP
Sbjct: 178 -----KSDEHSTNAAGTAL------YMAPE--VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
Query: 566 DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
             G       LE + +KA  +    +    P   + +   +Q+L            DPE 
Sbjct: 225 FTGT-----SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK----------DPER 269
Query: 626 RPRMRTV 632
           RP    V
Sbjct: 270 RPSAAQV 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 29/223 (13%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           V K  +G   +V++ R         + + R T    +   K  E EV  +  + HPNI++
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMK 100
Query: 410 LKAFYYANDEKLLISDFIRNGSLY-AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           L  F+       L+ +  + G L+   +H    + +     +A + I Q    G+ Y+H+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----DAAVIIKQ-VLSGVTYLHK 154
Query: 469 YSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           ++    VH ++K   +LL+ +       I  FGL+ +     K+ +       GT     
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER-----LGTA---- 202
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
                Y+APE  +   K+ +KCDV+S G++L  +L G  P  G
Sbjct: 203 ----YYIAPE--VLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 39/236 (16%)
Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G   KV + R    G    V +   T+ + T   K F  EV  +  + HPNIV+L     
Sbjct: 26  GNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIE 84
Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA--RGLMYIHEYSPRK 473
                 L+ ++   G ++  L A             R+K  +  A  R ++   +Y  +K
Sbjct: 85  TEKTLYLVMEYASGGEVFDYLVA-----------HGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 474 Y-VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI--SNV 530
           Y VH ++K+  +LLD +++  I+ FG +           NE  V    G+++     S  
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFS-----------NEFTV----GNKLDTFCGSPP 178
Query: 531 YLAPEARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
           Y APE    G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 179 YAAPEL-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 228

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 131
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 175
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 176 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 32/238 (13%)
Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFES 394
           F+++  D++R     +GK K G +Y     +   + A  V+   +L +     + +    
Sbjct: 11  FTIDDFDIVRP----LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR---R 63
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA-GPSDSLPPLPWEARL 453
           E+E  + ++HPNI+R+  +++      L+ +F   G LY  L   G  D       +   
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE------QRSA 117
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
              +  A  L Y HE   RK +H +IK   +L+  +    I+ FG +   P   +     
Sbjct: 118 TFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----- 169
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
                    R    +  YL PE  I G    +K D++  G++  E L G  P   P +
Sbjct: 170 ---------RXMCGTLDYLPPEM-IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGK 127
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           ++    +GL Y+ E    K +H ++K + IL++      +  FG++  L         ++
Sbjct: 128 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DS 177
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +  S  G+R       Y++PE R+ G+ ++ + D++S G+ L+E+  GR P
Sbjct: 178 MANSFVGTR------SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 42/275 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+
Sbjct: 61  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 432 LYAALHAGPSDSLPPLP---------WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
           L   L +  ++ +P  P          E  +  +   A+G+ ++   + RK +H ++ + 
Sbjct: 121 LSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAAR 177
Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
            ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+   
Sbjct: 178 NILLSEKNVVKICDFGLAR------DIXKDPDXVRKGD----ARLPLKWMAPET-IFDRV 226
Query: 543 FTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKE 601
           +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +   
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM--- 280
Query: 602 IHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                     +   L+C   +P  RP    + E L
Sbjct: 281 ----------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 343 LRASAYVVGKSKN-GIMYKVVVGRGSGMGAPTVVAV---RRLTEGDATWRFKDFESEVEA 398
           ++   YV+G +   G   KV +G     G    V +   +++   D   + K    E++ 
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQN 64
Query: 399 IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIA 456
           +   +HP+I++L        +  ++ +++  G L  Y   H    +       EAR ++ 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE------MEAR-RLF 117
Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           Q     + Y H +     VH ++K   +LLD  ++  I+ FGL+ ++             
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------------- 161
Query: 517 TSGTGSRISAISNVYLAPEA---RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           + G   R S  S  Y APE    R+Y      + D++S G++L  +L G LP
Sbjct: 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGP---EVDIWSCGVILYALLCGTLP 210

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGD--------ATWRFKDFES---EVEAIARVQHPNI 407
           Y +V   G G     +    R+T+ +        A+ + KD  +   EVE + ++ HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           ++L      +    ++ +    G L+  +      S          +I +    G+ Y+H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH 138
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +++    VH ++K   ILL+ +   C   I  FGL+      +K+             RI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----------DRI 184
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
              +  Y+APE  +    + +KCDV+S G++L  +L+G  P  G
Sbjct: 185 G--TAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGD--------ATWRFKDFES---EVEAIARVQHPNI 407
           Y +V   G G     +    R+T+ +        A+ + KD  +   EVE + ++ HPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           ++L      +    ++ +    G L+  +      S          +I +    G+ Y+H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH 138
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +++    VH ++K   ILL+ +   C   I  FGL+      +K+             RI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----------DRI 184
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG 568
              +  Y+APE  +    + +KCDV+S G++L  +L+G  P  G
Sbjct: 185 G--TAYYIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    + +   T+ + T   K F  EV  +  + HPNIV+L         
Sbjct: 27  KVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKT 85
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             LI ++   G +  Y   H    +       EAR K  Q     + Y H+   ++ VH 
Sbjct: 86  LYLIMEYASGGEVFDYLVAHGRMKEK------EARSKFRQ-IVSAVQYCHQ---KRIVHR 135
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI--SNVYLAPE 535
           ++K+  +LLD +++  I+ FG +           NE  V    G ++     S  Y APE
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS-----------NEFTV----GGKLDTFCGSPPYAAPE 180
Query: 536 ARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
               G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 181 L-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 225

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 71
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 72  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 125
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 126 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 169
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 170 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 29  KVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 87
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             L+ ++   G +  Y   H    +       EAR K  Q     + Y H+   +  VH 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEK------EARAKFRQ-IVSAVQYCHQ---KFIVHR 137
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV--YLAPE 535
           ++K+  +LLD +++  I+ FG +           NE       G+++ A      Y APE
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS-----------NEFTF----GNKLDAFCGAPPYAAPE 182
Query: 536 ARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
               G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 183 L-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 104 PIPANLFNATNLVYLDLAH----NSFCGPIPDRIKTLKNLTHXXXXXXXXXXXXPEFLLD 159
           PIP++L    NL YL+  +    N+  GPIP  I  L  L +            P+FL  
Sbjct: 67  PIPSSL---ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 160 LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
           ++ L  TL+ S+N  SG +P      P +V +    N +SG IP
Sbjct: 124 IKTLV-TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 35/61 (57%)
Query: 167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFP 226
           L+L  N+  G +P+       + SL++  NNL GEIPQ G+L     +A++ N  LCG P
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 227 L 227
           L
Sbjct: 309 L 309

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 76
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 130
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 131 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 174
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 175 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 47  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 106
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH N+ +   +
Sbjct: 107 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCM 163
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 164 VAHDFTVKIGDFGMTRDIYETDYYRK------GGKG----LLPVRWMAPESLKDGV-FTT 212
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 213 SSDMWSFGVVLWEITS 228

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 40/272 (14%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 433 YAALHAGPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
              L +  ++ +P        L  E  +  +   A+G+ ++   + RK +H ++ +  IL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           L ++    I  FGL R       + K+   V  G     + +   ++APE  I+   +T 
Sbjct: 177 LSEKNVVKIXDFGLAR------DIYKDPDYVRKGD----ARLPLKWMAPET-IFDRVYTI 225
Query: 546 KCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHA 604
           + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +      
Sbjct: 226 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRL-KEGTRMRAP--DYTTPEM------ 276
Query: 605 KRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                  +   L+C   +P  RP    + E L
Sbjct: 277 -------YQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 22  KVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 80
Query: 420 KLLISDFIRNGSLYAALHAGPSDSLPPLPW----EARLKIAQGTARGLMYIHEYSPRKYV 475
             L+ ++   G ++        D L    W    EAR K  Q     + Y H+   +  V
Sbjct: 81  LYLVMEYASGGEVF--------DYLVAHGWMKEKEARAKFRQ-IVSAVQYCHQ---KFIV 128
Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE 535
           H ++K+  +LLD +++  I+ FG +           NE   T G        S  Y APE
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFS-----------NE--FTFGNKLDTFCGSPPYAAPE 175
Query: 536 ARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
               G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 176 L-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    E+E  + ++HPNI+R
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNILR 79
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +  +++      L+ +F   G LY  L   G  D       +      +  A  L Y HE
Sbjct: 80  MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEELADALHYCHE 133
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              RK +H +IK   +L+  +    I+ FG +   P   +              R    +
Sbjct: 134 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--------------RXMCGT 176
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             YL PE  I G    +K D++  G++  E L G  P   P +
Sbjct: 177 LDYLPPEM-IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 46  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH N+ +   +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCM 162
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRK------GGKG----LLPVRWMAPESLKDGV-FTT 211
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 212 SSDMWSFGVVLWEITS 227

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 40/272 (14%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 433 YAALHAGPSDSLPP-------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
              L +  ++ +P        L  E  +  +   A+G+ ++   + RK +H ++ +  IL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           L ++    I  FGL R       + K+   V  G     + +   ++APE  I+   +T 
Sbjct: 177 LSEKNVVKICDFGLAR------DIYKDPDYVRKGD----ARLPLKWMAPET-IFDRVYTI 225
Query: 546 KCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHA 604
           + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +      
Sbjct: 226 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM------ 276
Query: 605 KRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                  +   L+C   +P  RP    + E L
Sbjct: 277 -------YQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY-ANDEKL-LISDFI 427
           G   +VAV+ L           ++ E++ +  + H +I++ K     A    L L+ +++
Sbjct: 58  GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 428 RNGSLYAALHAGPSDSLP--PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             GSL         D LP   +     L  AQ    G+ Y+H    + Y+H ++ +  +L
Sbjct: 118 PLGSL--------RDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVL 166
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           LD++    I  FGL + +P   +  +    V     S +      + APE  +   KF  
Sbjct: 167 LDNDRLVKIGDFGLAKAVPEGHEXYR----VREDGDSPV-----FWYAPEC-LKEYKFYY 216
Query: 546 KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA--LVKEIH 603
             DV+SFG+ L E+LT       P      L  + +      R L+E+++    L +   
Sbjct: 217 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDK 275
Query: 604 AKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
              +V   +H+  NC E +  FRP    +   L  V
Sbjct: 276 CPAEV---YHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 43  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 102
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 103 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 159
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 160 VAHDFTVKIGDFGMTRDIXETDXXRKG------GKG----LLPVRWMAPESLKDGV-FTT 208
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 209 SSDMWSFGVVLWEITS 224

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 56/257 (21%)
Query: 340 EDLLRASAYVVGKSKNG--IMYKVVVGRGS------GMGAPTVVAV-------RRLTEGD 384
           +D+       VG S +G  + + + +GRGS      G+   T V V       R+LT+ +
Sbjct: 9   DDIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 68
Query: 385 ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-------LISDFIRNGSLYAALH 437
              RFK+   E E +  +QHPNIVR   FY + +  +       L+++   +G+L   L 
Sbjct: 69  RQ-RFKE---EAEXLKGLQHPNIVR---FYDSWESTVKGKKCIVLVTELXTSGTLKTYLK 121
Query: 438 AGPSDSLPPL-PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG 496
                 +  L  W       +   +GL ++H  +P   +H ++K   I         I+G
Sbjct: 122 RFKVXKIKVLRSW------CRQILKGLQFLHTRTP-PIIHRDLKCDNIF--------ITG 166
Query: 497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV--YLAPEARIYGSKFTQKCDVYSFGI 554
                  P  S    +  + T    S   A+     + APE   Y  K+ +  DVY+FG 
Sbjct: 167 -------PTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEX--YEEKYDESVDVYAFGX 217
Query: 555 VLLEILTGRLPDAGPEN 571
             LE  T   P +  +N
Sbjct: 218 CXLEXATSEYPYSECQN 234

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 46  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 162
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRKG------GKG----LLPVRWMAPESLKDGV-FTT 211
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 212 SSDMWSFGVVLWEITS 227

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 131
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 132 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 181
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 182 MYDKEXXSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           EVE  + ++HPNI+RL  +++ +    LI ++   G++Y  L       L     +    
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-----QKLSKFDEQRTAT 112
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                A  L Y H    +K +H +IK   +LL       I+ FG +   P + +     T
Sbjct: 113 YITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGT 169
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +               YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 170 L--------------DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 46  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 162
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 163 VAHDFTVKIGDFGMTRDIXETDXXRK------GGKG----LLPVRWMAPESLKDGV-FTT 211
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 212 SSDMWSFGVVLWEITS 227

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G +Y  L       L     +         A  L Y H  
Sbjct: 78  LYGYFHDATRVYLILEYAPRGEVYKEL-----QKLSKFDEQRTATYITELANALSYCHS- 131
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTL-------------- 175
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 176 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN 417
           Y V +   +G G+ +   V+ L E  AT +      EV+ + +V  HPNI++LK  Y  N
Sbjct: 32  YAVKIIDVTGGGSFSAEEVQELRE--ATLK------EVDILRKVSGHPNIIQLKDTYETN 83
Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
               L+ D ++ G L+  L    ++ +     E R KI +     +  +H+ +    VH 
Sbjct: 84  TFFFLVFDLMKKGELFDYL----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHR 135
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K   ILLDD+++  ++ FG +  L    K+ +       GT S        YLAPE  
Sbjct: 136 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPS--------YLAPEI- 181
Query: 538 IYGSK------FTQKCDVYSFGIVLLEILTGRLP 565
           I  S       + ++ D++S G+++  +L G  P
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 343 LRASAYVVGKSKN-GIMYKVVVGRGSGMGAPTVVAV---RRLTEGDATWRFKDFESEVEA 398
           ++   YV+G +   G   KV +G     G    V +   +++   D   + K    E++ 
Sbjct: 8   VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQN 64
Query: 399 IARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIA 456
           +   +HP+I++L        +  ++ +++  G L  Y   H    +       EAR ++ 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE------MEAR-RLF 117
Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           Q     + Y H +     VH ++K   +LLD  ++  I+ FGL+ ++             
Sbjct: 118 QQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------------- 161
Query: 517 TSGTGSRISAISNVYLAPEA---RIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           + G   R S  S  Y APE    R+Y      + D++S G++L  +L G LP
Sbjct: 162 SDGEFLRDSCGSPNYAAPEVISGRLYAGP---EVDIWSCGVILYALLCGTLP 210

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN 417
           Y V +   +G G+ +   V+ L E  AT +      EV+ + +V  HPNI++LK  Y  N
Sbjct: 45  YAVKIIDVTGGGSFSAEEVQELRE--ATLK------EVDILRKVSGHPNIIQLKDTYETN 96
Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
               L+ D ++ G L+  L    ++ +     E R KI +     +  +H+ +    VH 
Sbjct: 97  TFFFLVFDLMKKGELFDYL----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHR 148
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K   ILLDD+++  ++ FG +  L    K+ +       GT S        YLAPE  
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPS--------YLAPEI- 194
Query: 538 IYGSK------FTQKCDVYSFGIVLLEILTGRLP 565
           I  S       + ++ D++S G+++  +L G  P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 73
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 127
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL-------------- 171
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 172 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 29  KVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 87
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             L+ ++   G +  Y   H    +       EAR K  Q     + Y H+   +  VH 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEK------EARAKFRQ-IVSAVQYCHQ---KFIVHR 137
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K+  +LLD +++  I+ FG +           NE   T G        S  Y APE  
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS-----------NE--FTFGNKLDTFCGSPPYAAPEL- 183
Query: 538 IYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
             G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 29  KVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 87
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             L+ ++   G +  Y   H    +       EAR K  Q     + Y H+   +  VH 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEK------EARAKFRQ-IVSAVQYCHQ---KFIVHR 137
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K+  +LLD +++  I+ FG +           NE   T G        S  Y APE  
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS-----------NE--FTFGNKLDTFCGSPPYAAPEL- 183
Query: 538 IYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
             G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I++F + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 432 LYAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           L   L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ 
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 166
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  ILL ++    I  FGL R       + K+   V  G       +   ++APE  I+ 
Sbjct: 167 ARNILLSEKNVVKICDFGLAR------DIXKDPDXVRKGDAR----LPLKWMAPET-IFD 215
Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
             +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P + 
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM- 271
Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                       +   L+C   +P  RP    + E L
Sbjct: 272 ------------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           EVE  + ++HPNI+RL  +++      LI ++   G++Y  L       L     +    
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTAT 109
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                A  L Y H    ++ +H +IK   +LL       I+ FG +   P + + T   T
Sbjct: 110 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 166
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +               YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 167 L--------------DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 118/291 (40%), Gaps = 40/291 (13%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 49  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 108
Query: 412 AFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-----PLPWEARLKIAQGTARGLMYI 466
                    L+I+++   G L   L       L      PL     L  +   A+G+ ++
Sbjct: 109 GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL 168
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
              + +  +H ++ +  +LL +     I  FGL R       +  +   +  G       
Sbjct: 169 ---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVKGNAR---- 215
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR 585
           +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   + K    LV+  ++
Sbjct: 216 LPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVKDGYQ 273
Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             +P      P   K I++  Q          C  L+P  RP  + +   L
Sbjct: 274 MAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQICSFL 309

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 44/277 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I++F + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 432 LYAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           L   L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ 
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 166
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+ 
Sbjct: 167 ARNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGD----ARLPLKWMAPET-IFD 215
Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
             +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P + 
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM- 271
Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                       +   L+C   +P  RP    + E L
Sbjct: 272 ------------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I++F + G+
Sbjct: 50  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGN 109
Query: 432 LYAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           L   L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ 
Sbjct: 110 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 166
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  ILL ++    I  FGL R       + K+   V  G       +   ++APE  I+ 
Sbjct: 167 ARNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGDAR----LPLKWMAPET-IFD 215
Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
             +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P + 
Sbjct: 216 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM- 271
Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                       +   L+C   +P  RP    + E L
Sbjct: 272 ------------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN 417
           Y V +   +G G+ +   V+ L E  AT +      EV+ + +V  HPNI++LK  Y  N
Sbjct: 45  YAVKIIDVTGGGSFSAEEVQELRE--ATLK------EVDILRKVSGHPNIIQLKDTYETN 96
Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
               L+ D ++ G L+  L    ++ +     E R KI +     +  +H+ +    VH 
Sbjct: 97  TFFFLVFDLMKKGELFDYL----TEKVTLSEKETR-KIMRALLEVICALHKLN---IVHR 148
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K   ILLDD+++  ++ FG +  L    K+         GT S        YLAPE  
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-----VCGTPS--------YLAPEI- 194
Query: 538 IYGSK------FTQKCDVYSFGIVLLEILTGRLP 565
           I  S       + ++ D++S G+++  +L G  P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 51/303 (16%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHA------GPSDSLPPLPWEAR-----LKIAQG 458
           L      +    +I ++   G+L   L A        S  +  +P E       +     
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K       
Sbjct: 166 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT------ 216
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGL 576
            T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +   L
Sbjct: 217 -TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 268
Query: 577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             L+++  R  +P +         E+         + +  +C    P  RP  + + E L
Sbjct: 269 FKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 637 DRV 639
           DR+
Sbjct: 314 DRI 316

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 18  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 137 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG------GKG-- 185
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 186 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 220

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 29  KVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 87
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             L+ ++   G +  Y   H    +       EAR K  Q     + Y H+   +  VH 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEK------EARAKFRQ-IVSAVQYCHQ---KFIVHR 137
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K+  +LLD +++  I+ FG +           NE   T G        S  Y APE  
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS-----------NE--FTFGNKLDTFCGSPPYAAPEL- 183
Query: 538 IYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
             G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 132
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 133 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 182
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 183 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 43/276 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+
Sbjct: 60  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 119
Query: 432 LYAALHAGPSDSLPP----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           L   L +  ++ +P           L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 120 LSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+  
Sbjct: 177 RNILLSEKNVVKICDFGLAR------DIXKDPDXVRKGD----ARLPLKWMAPET-IFDR 225
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 280
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 281 -----------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G +YK +  + +G     +VA++++  E D     ++   E+  + +   P++V
Sbjct: 37  LGEGSYGSVYKAI-HKETGQ----IVAIKQVPVESD----LQEIIKEISIMQQCDSPHVV 87
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +    Y+ N +  ++ ++   GS+   +          L  +    I Q T +GL Y+H 
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHF 143
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               + +H +IK+  ILL+ E H  ++ FG+   L  T  + K   ++  GT        
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVI--GTP------- 189
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA 567
             ++APE  I    +    D++S GI  +E+  G+ P A
Sbjct: 190 -FWMAPEV-IQEIGYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 46  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 162
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T+   K       G G     +   ++APE+   G  FT 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETAYYRKG------GKG----LLPVRWMAPESLKDGV-FTT 211
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 212 SSDMWSFGVVLWEITS 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 97/238 (40%), Gaps = 26/238 (10%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIAR-VQHPNI 407
           V+GK   G   KV++ R         V V +          K   SE   + + V+HP +
Sbjct: 45  VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V L   +   D+   + D+I  G L+  L        P     AR   A+  A  L Y+H
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAE-IASALGYLH 156
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
             +    V+ ++K   ILLD + H  ++ FGL +           E I  + T S     
Sbjct: 157 SLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-----------ENIEHNSTTSTFCGT 202
Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
              YLAPE  ++   + +  D +  G VL E+L G LP     N  +  ++++ K  +
Sbjct: 203 PE-YLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRNTAEMYDNILNKPLQ 257

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 27  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG------GKG-- 194
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 195 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 33  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 92
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 93  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 150
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 151 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 200
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 201 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 45  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 104
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 105 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 161
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 162 VAHDFTVKIGDFGMTRDIYETDYYRK------GGKG----LLPVRWMAPESLKDGV-FTT 210
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 211 SSDMWSFGVVLWEITS 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 27/238 (11%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           V K  +G   +V++ +    GA   + + + +    T        EV  + ++ HPNI++
Sbjct: 26  VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  F+       L+ +  R G L+  +      S      +A + I +    G  Y+H++
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS----EVDAAV-IMKQVLSGTTYLHKH 140
Query: 470 SPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           +    VH ++K   +LL+ +       I  FGL+       K+ +       GT      
Sbjct: 141 N---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-----LGTA----- 187
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
               Y+APE  +   K+ +KCDV+S G++L  +L G  P  G + D + L+ + +  F
Sbjct: 188 ---YYIAPE--VLRKKYDEKCDVWSCGVILYILLCG-YPPFGGQTDQEILKRVEKGKF 239

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 31/240 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           V K  +G   +V++ +    GA   + + + +    T        EV  + ++ HPNI++
Sbjct: 9   VKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 410 LKAFYYANDEKLLISDFIRNGSLY--AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           L  F+       L+ +  R G L+    L    S+    +       I +    G  Y+H
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVLSGTTYLH 121
Query: 468 EYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +++    VH ++K   +LL+ +       I  FGL+       K+ +       GT    
Sbjct: 122 KHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER-----LGTA--- 170
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
                 Y+APE  +   K+ +KCDV+S G++L  +L G  P  G + D + L+ + +  F
Sbjct: 171 -----YYIAPE--VLRKKYDEKCDVWSCGVILYILLCG-YPPFGGQTDQEILKRVEKGKF 222

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 131
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 132 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 181
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 182 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 127
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 128 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 177
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 178 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 130
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 131 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 180
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 181 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           EV+ + ++ HPNI++L  F+       L+ +    G L+  + +    S          +
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----R 153
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTK 511
           I +    G+ Y+H+    K VH ++K   +LL+ +       I  FGL+     + K+  
Sbjct: 154 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-- 208
Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
            + I T+            Y+APE  ++G+ + +KCDV+S G++L  +L+G
Sbjct: 209 KDKIGTA-----------YYIAPEV-LHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 129
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 130 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 179
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 180 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 132
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 133 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 182
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 183 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 34  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 93
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 94  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 151
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 152 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 201
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 202 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           EV+ + ++ HPNI++L  F+       L+ +    G L+  + +    S          +
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-----R 154
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGTSKVTK 511
           I +    G+ Y+H+    K VH ++K   +LL+ +       I  FGL+     + K+  
Sbjct: 155 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-- 209
Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
            + I T+            Y+APE  ++G+ + +KCDV+S G++L  +L+G
Sbjct: 210 KDKIGTA-----------YYIAPEV-LHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 77
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 131
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 132 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-------------- 175
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 176 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 33/233 (14%)
Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G   KV + R    G    V +   T+ +++   K F  EV     + HPNIV+L     
Sbjct: 25  GNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFEVIE 83
Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
                 L+ ++   G ++  L A           EAR K  Q     + Y H+   +  V
Sbjct: 84  TEKTLYLVXEYASGGEVFDYLVAHGRXK----EKEARAKFRQ-IVSAVQYCHQ---KFIV 135
Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV--YLA 533
           H ++K+  +LLD + +  I+ FG +           NE       G+++ A      Y A
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFS-----------NEFTF----GNKLDAFCGAPPYAA 180
Query: 534 PEARIYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
           PE    G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 181 PEL-FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 7   ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 67  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 124
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ Y+   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 125 --KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 174
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 175 MYDKEYYSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 98
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 152
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 153 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL-------------- 196
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 197 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
           + G+   +   +   V++ T+ ++  R      EV+ + ++ HPNI++L  F+       
Sbjct: 49  ITGQECAVKVISKRQVKQKTDKESLLR------EVQLLKQLDHPNIMKLYEFFEDKGYFY 102
Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           L+ +    G L+  + +    S          +I +    G+ Y+H+    K VH ++K 
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITYMHK---NKIVHRDLKP 154
Query: 482 TKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI 538
             +LL+ +       I  FGL+     + K+   + I T+            Y+APE  +
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTA-----------YYIAPEV-L 200
Query: 539 YGSKFTQKCDVYSFGIVLLEILTG 562
           +G+ + +KCDV+S G++L  +L+G
Sbjct: 201 HGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
           E E+  +  ++HP+I++L        + +++ ++   G L+  +          +  +  
Sbjct: 57  EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR-----MTEDEG 110
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
            +  Q     + Y H +   K VH ++K   +LLDD L+  I+ FGL+            
Sbjct: 111 RRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS------------ 155
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ-KCDVYSFGIVLLEILTGRLP 565
             I+T G   + S  S  Y APE  I G  +   + DV+S GIVL  +L GRLP
Sbjct: 156 -NIMTDGNFLKTSCGSPNYAAPEV-INGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 40/291 (13%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 412 AFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-----PLPWEARLKIAQGTARGLMYI 466
                    L+I+++   G L   L       L      PL     L  +   A+G+ ++
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL 176
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
              + +  +H ++ +  +LL +     I  FGL R       +  +   +  G     + 
Sbjct: 177 ---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVKGN----AR 223
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR 585
           +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   + K    LV+  ++
Sbjct: 224 LPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVKDGYQ 281
Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             +P      P   K I++  Q          C  L+P  RP  + +   L
Sbjct: 282 MAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQICSFL 317

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 44/276 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 433 YAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
              L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+  
Sbjct: 177 RNILLSEKNVVKICDFGLAR------DIXKDPDXVRKGD----ARLPLKWMAPET-IFDR 225
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 280
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 281 -----------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 33  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 92
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 93  LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 149 CTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 203
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 204 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 254
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 255 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 296
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 297 VEDLDRI 303

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 73
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 127
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 128 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-------------- 171
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 172 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 371 APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNG 430
           A T VAV+ + E  +     +F +E   +      ++VRL          L++ + + +G
Sbjct: 46  AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 431 SLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
            L + L      A  +   PP   +  +++A   A G+ Y++    +K+VH ++ +   +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCM 162
Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +  +    I  FG+ R +  T    K       G G     +   ++APE+   G  FT 
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETDYYRKG------GKG----LLPVRWMAPESLKDGV-FTT 211
Query: 546 KCDVYSFGIVLLEILT 561
             D++SFG+VL EI +
Sbjct: 212 SSDMWSFGVVLWEITS 227

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 35  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 94
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 95  LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 151 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 205
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 206 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 256
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 257 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 298
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 299 VEDLDRI 305

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 44/277 (15%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGS 431
            VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+
Sbjct: 61  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 120
Query: 432 LYAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           L   L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ 
Sbjct: 121 LSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLA 177
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+ 
Sbjct: 178 ARNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGD----ARLPLKWMAPET-IFD 226
Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
             +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P + 
Sbjct: 227 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM- 282
Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                       +   L+C   +P  RP    + E L
Sbjct: 283 ------------YQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 38  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 97
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 98  LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 154 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 208
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 209 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 259
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 260 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 301
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 302 VEDLDRI 308

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 74
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 128
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 129 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL-------------- 172
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 173 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 30/236 (12%)
Query: 332 DEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD 391
           +E  + +  ++LRA    +GK   G +  V       M A   +  ++  E +     ++
Sbjct: 9   NEDVNFDHFEILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV---RN 61
Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
              E++ +  ++HP +V L   +   ++  ++ D +  G L   L             E 
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK------EE 115
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            +K+       +M +     ++ +H ++K   ILLD+  H  I+ F +  +LP       
Sbjct: 116 TVKLF--ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP------- 166
Query: 512 NETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            ET +T+  G++       Y+APE  +   G+ ++   D +S G+   E+L GR P
Sbjct: 167 RETQITTMAGTK------PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 33  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA-----GPSDSLPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +       +  L P      +++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 200
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 201 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK 454
           E++ +     P IV     +Y++ E  +  + +  GSL   L          +P +   K
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGK 111
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           ++    +GL Y+ E    K +H ++K + IL++      +  FG++  L        NE 
Sbjct: 112 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEF 166
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   GT S        Y++PE R+ G+ ++ + D++S G+ L+E+  GR P
Sbjct: 167 V---GTRS--------YMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 44/276 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 433 YAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
              L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G       +   ++APE  I+  
Sbjct: 177 RNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGDAR----LPLKWMAPET-IFDR 225
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 280
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 281 -----------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 44/276 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 433 YAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
              L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G       +   ++APE  I+  
Sbjct: 177 RNILLSEKNVVKICDFGLAR------DIYKDPDXVRKGDAR----LPLKWMAPET-IFDR 225
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 280
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 281 -----------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR---REVEIQSHLRHPNILR 76
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCHS- 130
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL-------------- 174
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G  P
Sbjct: 175 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 44/276 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 433 YAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
              L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 213
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G     + +   ++APE  I+  
Sbjct: 214 RNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGD----ARLPLKWMAPET-IFDR 262
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 263 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 317
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 318 -----------YQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIH 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 33  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 200
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 201 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 235

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 44/276 (15%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRL-KAFYYANDEKLLISDFIRNGSL 432
           VAV+ L EG      +   SE++ +  +  H N+V L  A        ++I +F + G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 433 YAALHAGPSDSLPP-----------LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
              L +  ++ +P            L  E  +  +   A+G+ ++   + RK +H ++ +
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             ILL ++    I  FGL R       + K+   V  G       +   ++APE  I+  
Sbjct: 168 RNILLSEKNVVKICDFGLAR------DIXKDPDXVRKGDAR----LPLKWMAPET-IFDR 216
Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+SFG++L EI + G  P  G + D +    L ++  R R P  +   P +  
Sbjct: 217 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTRMRAP--DYTTPEM-- 271
Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                      +   L+C   +P  RP    + E L
Sbjct: 272 -----------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T+VAV+   E         F  E   + +  HPNIVRL           ++ + ++ G  
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    +     L  +  L++    A G+ Y+     +  +H ++ +   L+ ++   
Sbjct: 200 LTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVL 252
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            IS FG++R         + + +  +  G R   +   + APEA  YG +++ + DV+SF
Sbjct: 253 KISDFGMSR--------EEADGVXAASGGLRQVPVK--WTAPEALNYG-RYSSESDVWSF 301
Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
           GI+L E  + G  P   P    +     V K    R P  E+   A+             
Sbjct: 302 GILLWETFSLGASPY--PNLSNQQTREFVEKG--GRLPCPELCPDAV------------- 344
Query: 612 FHIALNCTELDPEFRPRMRTVSESLDRVK 640
           F +   C   +P  RP   T+ + L  ++
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
           + G+   +   +   V++ T+ ++  R      EV+ + ++ HPNI++L  F+       
Sbjct: 55  ITGQECAVKVISKRQVKQKTDKESLLR------EVQLLKQLDHPNIMKLYEFFEDKGYFY 108
Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           L+ +    G L+  + +    S          +I +    G+ Y+H+    K VH ++K 
Sbjct: 109 LVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITYMHK---NKIVHRDLKP 160
Query: 482 TKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI 538
             +LL+ +       I  FGL+     + K+   + I T+            Y+APE  +
Sbjct: 161 ENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTA-----------YYIAPEV-L 206
Query: 539 YGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
           +G+ + +KCDV+S G++L  +L+G  P  G 
Sbjct: 207 HGT-YDEKCDVWSTGVILYILLSGCPPFNGA 236

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE 419
           KV + R    G    V +   T+ +++   K F  EV  +  + HPNIV+L         
Sbjct: 29  KVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKT 87
Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             L+ ++   G +  Y   H    +       EAR K  Q     + Y H+   +  VH 
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEK------EARAKFRQ-IVSAVQYCHQ---KFIVHR 137
Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++K+  +LLD +++  I+ FG +           NE   T G        S  Y APE  
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS-----------NE--FTFGNKLDEFCGSPPYAAPEL- 183
Query: 538 IYGSKFTQ-KCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
             G K+   + DV+S G++L  +++G LP      DG+ L+ L  +  R
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLP-----FDGQNLKELRERVLR 227

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 125/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +        N  
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-------NNID 211
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
              + T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 212 YYKNTTNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 40/219 (18%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEV----EAIARVQ-----------HPN 406
           V+GRGS       V + RL + D  +  K  + E+    E I  VQ           HP 
Sbjct: 16  VIGRGSY----AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L + +        + +++  G L    H      LP     AR   A+  +  L Y+
Sbjct: 72  LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE--HARFYSAE-ISLALNYL 126
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE   R  ++ ++K   +LLD E H  ++ +G+ +           E +    T S    
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----------EGLRPGDTTSXFCG 172
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             N Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 173 TPN-YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 108/238 (45%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 133
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 134 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 183
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            + K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 184 MLDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 23  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA-----GPSDSLPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +       +  L P      +++A   A G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 142 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 190
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 191 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 225

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
           T+VAV+   E         F  E   + +  HPNIVRL           ++ + ++ G  
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L    +     L  +  L++    A G+ Y+     +  +H ++ +   L+ ++   
Sbjct: 200 LTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVL 252
Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            IS FG++R         + + +  +  G R   +   + APEA  YG +++ + DV+SF
Sbjct: 253 KISDFGMSR--------EEADGVYAASGGLRQVPVK--WTAPEALNYG-RYSSESDVWSF 301
Query: 553 GIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLAT 611
           GI+L E  + G  P   P    +     V K    R P  E+   A+             
Sbjct: 302 GILLWETFSLGASPY--PNLSNQQTREFVEKG--GRLPCPELCPDAV------------- 344
Query: 612 FHIALNCTELDPEFRPRMRTVSESLDRVK 640
           F +   C   +P  RP   T+ + L  ++
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 15/169 (8%)
Query: 404 HPNIVRLKAFYY----ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
           HPNI+RL A+      A  E  L+  F + G+L+  +     D    L  +  L +  G 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER-LKDKGNFLTEDQILWLLLGI 143
Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFG-LNRLLPGTSKVTKNETIVTS 518
            RGL  IH    + Y H ++K T ILL DE  P +   G +N+           + +   
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE--GSRQALTLQ 198
Query: 519 GTGSRISAISNVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLP 565
              ++   IS  Y APE     S     ++ DV+S G VL  ++ G  P
Sbjct: 199 DWAAQRCTIS--YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 151
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 262
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 263 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 314 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 355
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 356 VEDLDRI 362

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L +G      ++   E + + ++ +P IVRL     A +  +L+ +    G L+ 
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK 424
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L  G  + +P        ++    + G+ Y+ E   + +VH N+ +  +LL +  +  I
Sbjct: 425 FL-VGKREEIPV---SNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKI 477
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL++ L        +++  T+ +  +       + APE  I   KF+ + DV+S+G+
Sbjct: 478 SDFGLSKALGA------DDSYYTARSAGKWPL---KWYAPEC-INFRKFSSRSDVWSYGV 527
Query: 555 VLLEILT 561
            + E L+
Sbjct: 528 TMWEALS 534

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 72
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 126
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 127 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL-------------- 170
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 171 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIT 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I ++   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 44/221 (19%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEV----EAIARVQ-----------HPN 406
           V+GRGS       V + RL + D  +  K  + E+    E I  VQ           HP 
Sbjct: 27  VIGRGS----YAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 82
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L + +        + +++  G L    H      LP     AR   A+  +  L Y+
Sbjct: 83  LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE--HARFYSAE-ISLALNYL 137
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR--LLPGTSKVTKNETIVTSGTGSRI 524
           HE   R  ++ ++K   +LLD E H  ++ +G+ +  L PG              T S  
Sbjct: 138 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------------TTSXF 181
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
               N Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 182 CGTPN-YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 20  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 139 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 187
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 188 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 40/219 (18%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEV----EAIARVQ-----------HPN 406
           V+GRGS       V + RL + D  +  K  + E+    E I  VQ           HP 
Sbjct: 12  VIGRGSY----AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 67
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L + +        + +++  G L    H      LP     AR   A+  +  L Y+
Sbjct: 68  LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEE--HARFYSAE-ISLALNYL 122
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           HE   R  ++ ++K   +LLD E H  ++ +G+ +           E +    T S    
Sbjct: 123 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----------EGLRPGDTTSXFCG 168
Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             N Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 169 TPN-YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 24  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 143 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 191
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 192 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 226

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 34/250 (13%)
Query: 317 VTDEEEGQKGKFFIIDEGFSLELEDLLRASAYV-VGKSKNGIMYKVVVGRGSGMGAPTVV 375
           V   E+ +     ++D+G     +  L   +YV +G+   GI   V + R    G    V
Sbjct: 24  VVTHEQFKAALRMVVDQG-----DPRLLLDSYVKIGEGSTGI---VCLAREKHSGRQVAV 75
Query: 376 AVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA 435
            +  L +     R +   +EV  +   QH N+V +   Y   +E  ++ +F++ G+L   
Sbjct: 76  KMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132
Query: 436 LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS 495
           +      S   L  E    + +   + L Y+H    +  +H +IKS  ILL  +    +S
Sbjct: 133 V------SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLS 183
Query: 496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIV 555
            FG    +  +  V K + +V  GT          ++APE  I  S +  + D++S GI+
Sbjct: 184 DFGFCAQI--SKDVPKRKXLV--GT--------PYWMAPEV-ISRSLYATEVDIWSLGIM 230
Query: 556 LLEILTGRLP 565
           ++E++ G  P
Sbjct: 231 VIEMVDGEPP 240

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 26  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 193
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 194 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 27  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 146 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 194
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 195 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 26  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 145 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 193
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 194 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 228

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            + V  GT          Y++PE     S  ++  D+++ G ++ +++ G  P
Sbjct: 192 NSFV--GTAQ--------YVSPELLTEKSA-SKSSDLWALGCIIYQLVAGLPP 233

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/314 (22%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRR----LTEGDATWRFKDFESEVEAIARVQH 404
           V+GK   G   KV++ R    G    V V +    L + D        E  + ++AR  H
Sbjct: 30  VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT--EKRILSLAR-NH 83
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI-AQGTARGL 463
           P + +L   +   D    + +F+  G L    H   S        EAR +  A      L
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD----EARARFYAAEIISAL 137
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
           M++H+   +  ++ ++K   +LLD E H  ++ FG+ +           E I    T + 
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----------EGICNGVTTAT 183
Query: 524 ISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL- 579
                + Y+APE     +YG       D ++ G++L E+L G  P    EN+    E++ 
Sbjct: 184 FCGTPD-YIAPEILQEMLYGPA----VDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAIL 237
Query: 580 ----------------VRKAFRERRP------LSEVIDPALVKEIHAKRQVLATFHIALN 617
                           + K+F  + P      L++  + A+++    K    A     LN
Sbjct: 238 NDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ----LN 293
Query: 618 CTELDPEFRPRMRT 631
             +++P FRPR+++
Sbjct: 294 HRQIEPPFRPRIKS 307

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 15  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 65
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 121
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 122 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 172
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 173 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 75
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHS- 129
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + +     T+              
Sbjct: 130 --KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL-------------- 173
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 174 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 55  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K       G G  
Sbjct: 174 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK------GGKG-- 222
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 223 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 257

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 130
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 131 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 180
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 181 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 20  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 80  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 137
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 138 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 187
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 188 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK K G +Y     +   + A  V+   +L +     + +    EVE  + ++HPNI+R
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR---REVEIQSHLRHPNILR 76
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           L  +++      LI ++   G++Y  L       L     +         A  L Y H  
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCHS- 130
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             ++ +H +IK   +LL       I+ FG +   P + + T   T+              
Sbjct: 131 --KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTL-------------- 174
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            YL PE  I G    +K D++S G++  E L G  P
Sbjct: 175 DYLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 18  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 68
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 124
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 125 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 175
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 176 -------YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+GK   GI+Y      G  +     +A++ + E D+ +  +    E+     ++H NIV
Sbjct: 29  VLGKGTYGIVYA-----GRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIV 82
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA--GP-SDSLPPLPWEARLKIAQGTARGLMY 465
           +    +  N    +  + +  GSL A L +  GP  D+   + +  +  +      GL Y
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKY 137
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +H+    + VH +IK   +L++       IS FG ++ L G +  T+  T    GT    
Sbjct: 138 LHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQ-- 188
Query: 525 SAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLP 565
                 Y+APE    G + + +  D++S G  ++E+ TG+ P
Sbjct: 189 ------YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 133
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 134 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 183
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 184 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 18  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 68
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 124
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 125 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 175
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 176 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 12  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 62
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 119 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 170 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
              V  GT          Y++PE     S   +  D+++ G ++ +++ G LP     N+
Sbjct: 192 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAG-LPPFRAGNE 239
Query: 573 GKGLESLVR 581
           G     +++
Sbjct: 240 GLIFAKIIK 248

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 238
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 239 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 296 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 565 P 565
           P
Sbjct: 343 P 343

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
              V  GT          Y++PE     S   +  D+++ G ++ +++ G LP     N+
Sbjct: 192 NXFV--GTAQ--------YVSPELLTEKSA-XKSSDLWALGCIIYQLVAG-LPPFRAGNE 239
Query: 573 GKGLESLVR 581
           G     +++
Sbjct: 240 GLIFAKIIK 248

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 132
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 133 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 182
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 183 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 132
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 133 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 182
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 183 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 54/285 (18%)
Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGS 431
             VAV+ L +        D  SE+E +  + +H NI+ L      +    +I  +   G+
Sbjct: 68  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGN 127
Query: 432 LYAALHAGPSDSLPP---------------LPWEARLKIAQGTARGLMYIHEYSPRKYVH 476
           L   L A      PP               + ++  +      ARG+ Y+   + +K +H
Sbjct: 128 LREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 180
Query: 477 GNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA 536
            ++ +  +L+ +     I+ FGL R +       K        T  R+      ++APEA
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-------TNGRLPV---KWMAPEA 230
Query: 537 RIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PENDGKGLESLVRKAFRERRPLSEVI 594
            ++   +T + DV+SFG+++ EI T G  P  G P  +   L  L+++  R  +P +   
Sbjct: 231 -LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFKLLKEGHRMDKPAN--- 283
Query: 595 DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                 E+         + +  +C    P  RP  + + E LDR+
Sbjct: 284 ---CTNEL---------YMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 10  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 60
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 167
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 83  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 141
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 142 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 192
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            + V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 193 NSFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 59/307 (19%)
Query: 356 GIMYKVVVGRGSGMGA-----PTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVR 409
           G   +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP---------------LPWEARLK 454
           L      +    +I  +   G+L   L A      PP               + ++  + 
Sbjct: 106 LLGACTQDGPLYVIVAYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
                ARG+ Y+   + +K +H ++ +  +L+ +     I+ FGL R +       K   
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT-- 216
Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG-PEND 572
                T  R+      ++APEA ++   +T + DV+SFG+++ EI T G  P  G P  +
Sbjct: 217 -----TNGRLPV---KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              L  L+++  R  +P +         E+         + +  +C    P  RP  + +
Sbjct: 268 ---LFKLLKEGHRMDKPAN------CTNEL---------YMMMRDCWHAVPSQRPTFKQL 309
Query: 633 SESLDRV 639
            E LDR+
Sbjct: 310 VEDLDRI 316

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+GK   GI+Y      G  +     +A++ + E D+ +  +    E+     ++H NIV
Sbjct: 15  VLGKGTYGIVYA-----GRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA--GP-SDSLPPLPWEARLKIAQGTARGLMY 465
           +    +  N    +  + +  GSL A L +  GP  D+   + +  +  +      GL Y
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKY 123
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +H+    + VH +IK   +L++       IS FG ++ L G +  T+  T    GT    
Sbjct: 124 LHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQ-- 174
Query: 525 SAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGRLP 565
                 Y+APE    G + + +  D++S G  ++E+ TG+ P
Sbjct: 175 ------YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 10  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 60
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 167
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 25/177 (14%)
Query: 393 ESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
           + E+ A+   + HPNIV+L   ++      L+ + +  G L+  +      S     +  
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-- 110
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE---LHPCISGFGLNRLLPGTSK 508
              I +     + ++H+      VH ++K   +L  DE   L   I  FG  RL P  ++
Sbjct: 111 ---IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             K                   Y APE  +  + + + CD++S G++L  +L+G++P
Sbjct: 165 PLKTPCFTLH------------YAAPEL-LNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 15  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 65
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 121
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 122 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 172
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 173 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 13  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 63
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 119
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 120 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 170
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 171 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEV----EAIARVQ-----------HPN 406
           V+GRGS       V + RL + D  +  +  + E+    E I  VQ           HP 
Sbjct: 59  VIGRGS----YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +V L + +        + +++  G L    H      LP     AR   A+  +  L Y+
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPE--EHARFYSAE-ISLALNYL 169
Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR--LLPGTSKVTKNETIVTSGTGSRI 524
           HE   R  ++ ++K   +LLD E H  ++ +G+ +  L PG +      T    GT +  
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------TSTFCGTPN-- 218
Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 219 ------YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 252
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 253 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 310 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 356
Query: 565 P 565
           P
Sbjct: 357 P 357

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 13  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 63
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 119
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 120 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 170
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 171 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 341 DLLRASAYVV-GKSKNGIMYKVVVGRG-----------SGMGAPTVVAVRRLTEGDATWR 388
           +L++A  +VV G S   + +  V+GRG              G     AV+ L        
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYAND-EKLLISDFIRNGSLYAALHAGPSDSLPPL 447
              F +E   +    HPN++ L      ++   L++  ++++G L   +     +  P +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTV 191
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +      A+G+ ++   + +K+VH ++ +   +LD++    ++ FGL R      
Sbjct: 192 --KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----D 241
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              K    V + TG+++      ++A E+ +   KFT K DV+SFG++L E++T   P
Sbjct: 242 MYDKEFDSVHNKTGAKLPV---KWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 79  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 137
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 138 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 188
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            + V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 189 NSFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 13  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 63
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 119
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 120 -FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 170
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 171 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 12  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 62
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 119 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 170 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 119
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 120 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 177 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 223
Query: 565 P 565
           P
Sbjct: 224 P 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ Q    GL
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ----GL 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 SFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 12  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 62
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 119 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 170 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 10  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 60
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 167
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +VG+  +G   KV   +    GA   +A  ++ E  +    +D+  E+E +A   HP IV
Sbjct: 15  IVGELGDGAFGKVYKAKNKETGA---LAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 71
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L   YY + +  ++ +F   G++ A +         P        + +     L ++H 
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP----QIQVVCRQMLEALNFLHS 127
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              ++ +H ++K+  +L+  E    ++ FG++          KN          R S I 
Sbjct: 128 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVS---------AKN----LKTLQKRDSFIG 171
Query: 529 NVY-LAPEA----RIYGSKFTQKCDVYSFGIVLLEI 559
             Y +APE      +  + +  K D++S GI L+E+
Sbjct: 172 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 113
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 114 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 171 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 565 P 565
           P
Sbjct: 218 P 218

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 10  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 60
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 167
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 12  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 62
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 119 -FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 170 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 75  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 126
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKTFCGTPEYLAP 174
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 175 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 53/304 (17%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 42  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 101
Query: 412 AFYYANDEKLLISDFIRNGSLY------AALHAGPS----------DSLPPLPWEAR--L 453
                    L+I+++   G L       A    GPS          D     P E R  L
Sbjct: 102 GACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLL 161
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             +   A+G+ ++   + +  +H ++ +  +LL +     I  FGL R       +  + 
Sbjct: 162 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDS 212
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEND 572
             +  G     + +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   +
Sbjct: 213 NYIVKGN----ARLPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 267
Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            K    LV+  ++  +P      P   K I++  Q          C  L+P  RP  + +
Sbjct: 268 SK-FYKLVKDGYQMAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQI 311
Query: 633 SESL 636
              L
Sbjct: 312 CSFL 315

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 113
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 114 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 171 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 565 P 565
           P
Sbjct: 218 P 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAP-TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +G+   G++Y+ V  +G     P T VA++ + E  +     +F +E   +      ++V
Sbjct: 20  LGQGSFGMVYEGV-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDS-----LPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +   +      L P      +++A   A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +    + ++    I  FG+ R +  T    K       G G  
Sbjct: 139 AYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG------GKG-- 187
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT 561
              +   +++PE+   G  FT   DV+SFG+VL EI T
Sbjct: 188 --LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIAT 222

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/170 (21%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           +HP +  +   +   +    + +++  G L   + +     L    +      A     G
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-----YAAEIILG 131
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L ++H    +  V+ ++K   ILLD + H  I+ FG+ +           E ++     +
Sbjct: 132 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----------ENMLGDAKTN 177
Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                 + Y+APE  + G K+    D +SFG++L E+L G+ P  G + +
Sbjct: 178 EFCGTPD-YIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 75  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 126
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKXFCGTPEYLAP 174
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 175 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 229

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 113
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 114 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 171 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 565 P 565
           P
Sbjct: 218 P 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 391 DFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           + E+E+E + ++ HP I+++K F+ A D  +++ + +  G L+  +             E
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLK------E 112
Query: 451 ARLKIA-QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           A  K+        + Y+HE      +H ++K   +LL  +   C   I+ FG +++L  T
Sbjct: 113 ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRL 564
           S +             R    +  YLAPE  +    + + +  D +S G++L   L+G  
Sbjct: 170 SLM-------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 216
Query: 565 P 565
           P
Sbjct: 217 P 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 75  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 126
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKTFCGTPEYLAP 174
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 175 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 75  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 126
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKXFCGTPEYLAP 174
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 175 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 229

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 24/238 (10%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI-AQGTARGLMYIHEYSPRK 473
             +D    + ++   G L+  L      S   +  E R +         L Y+H    R 
Sbjct: 75  QTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEIVSALEYLH---SRD 125
Query: 474 YVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLA 533
            V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLA
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKXFCGTPEYLA 173
Query: 534 PEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           PE  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 174 PEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 229

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 18  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 77
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 78  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 129
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKTFCGTPEYLAP 177
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 178 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 80  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 139 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 190 NAFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 231

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 22/237 (9%)
Query: 355 NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY 414
            G   KV++ R    G    + + R     A        +E   +   +HP +  LK  +
Sbjct: 20  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 79
Query: 415 YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +D    + ++   G L+  L    S         AR   A+     L Y+H    R  
Sbjct: 80  QTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAE-IVSALEYLH---SRDV 131
Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           V+ +IK   ++LD + H  I+ FGL +              ++ G   +    +  YLAP
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGATMKXFCGTPEYLAP 179
Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           E  +  + + +  D +  G+V+ E++ GRLP    +++ +  E ++ +  R  R LS
Sbjct: 180 EV-LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEIRFPRTLS 234

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 58  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 116
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 117 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 168 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 85/181 (46%), Gaps = 35/181 (19%)
Query: 394 SEVEAIARVQHPNIVRL-KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP---PLPW 449
            E+  + ++ HPN+V+L +     N++ L +        ++  ++ GP   +P   PL  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYM--------VFELVNQGPVMEVPTLKPLSE 136
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           +      Q   +G+ Y+H    +K +H +IK + +L+ ++ H  I+ FG++    G+  +
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEILTGRL 564
             N    T GT +        ++APE+     +I+  K     DV++ G+ L   + G+ 
Sbjct: 194 LSN----TVGTPA--------FMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQC 238
Query: 565 P 565
           P
Sbjct: 239 P 239

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 57  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 115
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 116 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 166
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 167 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 208

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 80  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 139 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 190 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 231

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 121
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 169
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 170 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 28/216 (12%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           +VG+  +G   KV   +    GA   +A  ++ E  +    +D+  E+E +A   HP IV
Sbjct: 23  IVGELGDGAFGKVYKAKNKETGA---LAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L   YY + +  ++ +F   G++ A +         P        + +     L ++H 
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP----QIQVVCRQMLEALNFLHS 135
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              ++ +H ++K+  +L+  E    ++ FG++          KN          R S I 
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVS---------AKN----LKTLQKRDSFIG 179
Query: 529 NVY-LAPEA----RIYGSKFTQKCDVYSFGIVLLEI 559
             Y +APE      +  + +  K D++S GI L+E+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAI----------ARVQHPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+            A + H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 87  ERDVMSRLDHPFFVKL-YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 145
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 146 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 196
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 197 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 80  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 139 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 190 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 80  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 139 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 190 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 231

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 192 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 59  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 117
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 118 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 168
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 169 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 210

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 83  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 141
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 142 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 192
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 193 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 234

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+ +  L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL---TEGDATWRFKDFESEVEAIARVQHPN 406
           +G+   G++YK    R    G    +   RL   TEG  +   +    E+  +  + HPN
Sbjct: 11  IGEGTYGVVYK---ARNKLTGEVVALXKIRLDTETEGVPSTAIR----EISLLKELNHPN 63
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGLMY 465
           IV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A    +
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 118
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
            H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT        
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW------ 168
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 60  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 118
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 119 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 169
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 170 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 211

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL---TEGDATWRFKDFESEVEAIARVQHPN 406
           +G+   G++YK    R    G    +   RL   TEG  +   +    E+  +  + HPN
Sbjct: 10  IGEGTYGVVYK---ARNKLTGEVVALXKIRLDTETEGVPSTAIR----EISLLKELNHPN 62
Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGLMY 465
           IV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A    +
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA----F 117
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
            H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT        
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW------ 167
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 11  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 61
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+    L   + A     +P PL      ++ QG A   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 118 -FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 168
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 169 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 192 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 32/204 (15%)
Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
           + G+   +   +   V++ T+ ++  R      EV+ + ++ HPNI +L  F+       
Sbjct: 49  ITGQECAVKVISKRQVKQKTDKESLLR------EVQLLKQLDHPNIXKLYEFFEDKGYFY 102
Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           L+ +    G L+  + +    S          +I +    G+ Y H+    K VH ++K 
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSEVDAA-----RIIRQVLSGITYXHK---NKIVHRDLKP 154
Query: 482 TKILLDDELHPC---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI 538
             +LL+ +       I  FGL+     + K    + I T+            Y+APE  +
Sbjct: 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKX--KDKIGTA-----------YYIAPEV-L 200
Query: 539 YGSKFTQKCDVYSFGIVLLEILTG 562
           +G+ + +KCDV+S G++L  +L+G
Sbjct: 201 HGT-YDEKCDVWSTGVILYILLSG 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/170 (21%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 403 QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           +HP +  +   +   +    + +++  G L   + +     L    + A   I      G
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-----G 130
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           L ++H    +  V+ ++K   ILLD + H  I+ FG+ +           E ++     +
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK-----------ENMLGDAKTN 176
Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                 + Y+APE  + G K+    D +SFG++L E+L G+ P  G + +
Sbjct: 177 XFCGTPD-YIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 82  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 140
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 141 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 192 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 12  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 62
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+ +  L   + A     +P PL      ++ QG A   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 119 -FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 169
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 170 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 394 SEVEAIARVQHPNIVRLKAFYY------------ANDEKLLIS-DFIRNGSLYAALHAGP 440
           SEV  +A + H  +VR  A +                  L I  ++  NG+LY  +H+  
Sbjct: 51  SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 441 SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN 500
            +      W    ++ +     L YIH    +  +H ++K   I +D+  +  I  FGL 
Sbjct: 111 LNQQRDEYW----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 501 RLLPGTSKVTKNETIVTSGTGSRI-SAI-SNVYLAPEARIYGSKFTQKCDVYSFGIVLLE 558
           + +  +  + K ++    G+   + SAI + +Y+A E       + +K D+YS GI+  E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 559 IL 560
           ++
Sbjct: 224 MI 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 89/187 (47%), Gaps = 18/187 (9%)
Query: 375 VAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYA 434
           VA++ L +G      ++   E + + ++ +P IVRL     A +  +L+ +    G L+ 
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK 98
Query: 435 ALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
            L  G  + +P        ++    + G+ Y+ E   + +VH ++ +  +LL +  +  I
Sbjct: 99  FL-VGKREEIPV---SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKI 151
Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGI 554
           S FGL++ L        +++  T+ +  +       + APE  I   KF+ + DV+S+G+
Sbjct: 152 SDFGLSKALGA------DDSYYTARSAGKWPL---KWYAPEC-INFRKFSSRSDVWSYGV 201
Query: 555 VLLEILT 561
            + E L+
Sbjct: 202 TMWEALS 208

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 64  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 122
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 123 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 173
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 174 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 215

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 85  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 143
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 144 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 194
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 195 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLIS-DFIRNGSLYAALHA-GPSDSLPPLPWEAR 452
           E + ++R+ HP  V+L  F + +DEKL     + +NG L   +   G  D      + A 
Sbjct: 79  ERDVMSRLDHPFFVKL-YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 137
Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
           +         L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 138 I------VSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 188
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              V  GT          Y++PE     S   +  D+++ G ++ +++ G  P
Sbjct: 189 NXFV--GTAQ--------YVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPP 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           VGK + G ++     RGS  G    VAV+  +  D    F+  E+E+     ++H NI+ 
Sbjct: 45  VGKGRYGEVW-----RGSWQGEN--VAVKIFSSRDEKSWFR--ETELYNTVMLRHENILG 95
Query: 410 LKAF----YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
             A      +++ +  LI+ +   GSLY  L     D++      + L+I    A GL +
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV------SCLRIVLSIASGLAH 149
Query: 466 IH-----EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           +H             H ++KS  IL+      CI+  GL         V  +++      
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL--------AVMHSQSTNQLDV 201
Query: 521 GSRISAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEI 559
           G+     +  Y+APE      ++      ++ D+++FG+VL E+
Sbjct: 202 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +GK + G      V  G   G    V V   TE +A+W F+  E+E+     ++H NI+ 
Sbjct: 45  IGKGRYG-----EVWMGKWRGEKVAVKVFFTTE-EASW-FR--ETEIYQTVLMRHENIL- 94
Query: 410 LKAFYYAN-------DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
              F  A+        +  LI+D+  NGSLY  L +   D+      ++ LK+A  +  G
Sbjct: 95  --GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA------KSMLKLAYSSVSG 146
Query: 463 LMYIHE--YSPR---KYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
           L ++H   +S +      H ++KS  IL+      CI+  GL        K   +   V 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL------AVKFISDTNEVD 200
Query: 518 SGTGSRISAISNVYLAPEA------RIYGSKFTQKCDVYSFGIVLLEI 559
               +R+   +  Y+ PE       R +   +    D+YSFG++L E+
Sbjct: 201 IPPNTRVG--TKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEV 245

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VA++ + +     +    E+E+  + +++HPNIV L   Y +     LI   +  G L+
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL---LDDEL 490
             +     +       +A   I Q     + Y+H+      VH ++K   +L   LD++ 
Sbjct: 105 DRI----VEKGFYTERDASRLIFQ-VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDS 156
Query: 491 HPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              IS FGL+++  PG        +++++  G      +  Y+APE  +    +++  D 
Sbjct: 157 KIMISDFGLSKMEDPG--------SVLSTACG------TPGYVAPEV-LAQKPYSKAVDC 201
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVI 594
           +S G++   +L G  P    END K  E +++  +    P  + I
Sbjct: 202 WSIGVIAYILLCG-YPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 123
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMXGTL----- 171
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 172 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMCGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+ +  L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMXGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           VGK + G ++     RGS  G    VAV+  +  D    F+  E+E+     ++H NI+ 
Sbjct: 16  VGKGRYGEVW-----RGSWQGEN--VAVKIFSSRDEKSWFR--ETELYNTVMLRHENILG 66
Query: 410 LKAF----YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
             A      +++ +  LI+ +   GSLY  L     D++      + L+I    A GL +
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV------SCLRIVLSIASGLAH 120
Query: 466 IH-----EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           +H             H ++KS  IL+      CI+  GL         V  +++      
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL--------AVMHSQSTNQLDV 172
Query: 521 GSRISAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEI 559
           G+     +  Y+APE      ++      ++ D+++FG+VL E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           VGK + G ++     RGS  G    VAV+  +  D    F+  E+E+     ++H NI+ 
Sbjct: 16  VGKGRYGEVW-----RGSWQGEN--VAVKIFSSRDEKSWFR--ETELYNTVMLRHENILG 66
Query: 410 LKAF----YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
             A      +++ +  LI+ +   GSLY  L     D++      + L+I    A GL +
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV------SCLRIVLSIASGLAH 120
Query: 466 IH-----EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           +H             H ++KS  IL+      CI+  GL         V  +++      
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL--------AVMHSQSTNQLDV 172
Query: 521 GSRISAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEI 559
           G+     +  Y+APE      ++      ++ D+++FG+VL E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 13  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 63
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ +F+ +  L   + A     +P PL      ++ QG A   
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA--- 119
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 120 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 170
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 171 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMXGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMXGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ----------HPNIV 408
           + +V   G G      +AV R+TE     +  D +  V+    ++          H N+V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +   P   +P    +A+    Q  A G++Y+H 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEP--DAQRFFHQLMA-GVVYLHG 122
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +     +    E ++    G+      
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVF----RYNNRERLLNKMXGTL----- 170
Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             Y+APE         +  DV+S GIVL  +L G LP   P +
Sbjct: 171 -PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 44/295 (14%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 412 AFYYANDEKLLISDFIRNGSLY-------AALHAGPSDSLPPLPWEAR--LKIAQGTARG 462
                    L+I+++   G L          L   P+ ++       R  L  +   A+G
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQG 176
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + ++   + +  +H ++ +  +LL +     I  FGL R       +  +   +  G   
Sbjct: 177 MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVKGNAR 227
Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR 581
               +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   + K    LV+
Sbjct: 228 ----LPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVK 281
Query: 582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             ++  +P      P   K I++  Q          C  L+P  RP  + +   L
Sbjct: 282 DGYQMAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQICSFL 321

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VA++ + +     +    E+E+  + +++HPNIV L   Y +     LI   +  G L+
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL---LDDEL 490
             +     +       +A   I Q     + Y+H+      VH ++K   +L   LD++ 
Sbjct: 105 DRI----VEKGFYTERDASRLIFQ-VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDS 156
Query: 491 HPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              IS FGL+++  PG        +++++  G      +  Y+APE  +    +++  D 
Sbjct: 157 KIMISDFGLSKMEDPG--------SVLSTACG------TPGYVAPEV-LAQKPYSKAVDC 201
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP 589
           +S G++   +L G  P    END K  E +++  +    P
Sbjct: 202 WSIGVIAYILLCG-YPPFYDENDAKLFEQILKAEYEFDSP 240

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/217 (19%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFE-SEVEAIARVQHPNIV 408
           +G+   G+++K    R +G     +VA+++  E +     K     E+  + +++HPN+V
Sbjct: 11  IGEGSYGVVFKCR-NRDTGQ----IVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAA---LHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            L   +       L+ ++  +  L+         P   +  + W+        T + + +
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNF 117
Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
            H+++    +H ++K   IL+       +  FG  RLL G S    +E            
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE------------ 162
Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
             +  Y +PE  +  +++    DV++ G V  E+L+G
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           P + +L + +   D    + +++  G L Y     G       + + A + I      GL
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GL 133
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++H+   R  ++ ++K   ++LD E H  I+ FG+ +              +  G  +R
Sbjct: 134 FFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK------------EHMMDGVTTR 178
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
               +  Y+APE   Y   + +  D +++G++L E+L G+ P  G + D
Sbjct: 179 EFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 226

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 44/295 (14%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 412 AFYYANDEKLLISDFIRNGSLY-------AALHAGPSDSLPPLPWEAR--LKIAQGTARG 462
                    L+I+++   G L          L   P+ ++       R  L  +   A+G
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176
Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + ++   + +  +H ++ +  +LL +     I  FGL R       +  +   +  G   
Sbjct: 177 MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVKGNAR 227
Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVR 581
               +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   + K    LV+
Sbjct: 228 ----LPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVK 281
Query: 582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             ++  +P      P   K I++  Q          C  L+P  RP  + +   L
Sbjct: 282 DGYQMAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQICSFL 321

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VA++ + +     +    E+E+  + +++HPNIV L   Y +     LI   +  G L+
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL---LDDEL 490
             +     +       +A   I Q     + Y+H+      VH ++K   +L   LD++ 
Sbjct: 105 DRI----VEKGFYTERDASRLIFQ-VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDS 156
Query: 491 HPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              IS FGL+++  PG        +++++  G      +  Y+APE  +    +++  D 
Sbjct: 157 KIMISDFGLSKMEDPG--------SVLSTACG------TPGYVAPEV-LAQKPYSKAVDC 201
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP 589
           +S G++   +L G  P    END K  E +++  +    P
Sbjct: 202 WSIGVIAYILLCG-YPPFYDENDAKLFEQILKAEYEFDSP 240

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VA++ + +     +    E+E+  + +++HPNIV L   Y +     LI   +  G L+
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL---LDDEL 490
             +     +       +A   I Q     + Y+H+      VH ++K   +L   LD++ 
Sbjct: 105 DRI----VEKGFYTERDASRLIFQ-VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDS 156
Query: 491 HPCISGFGLNRLL-PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
              IS FGL+++  PG        +++++  G      +  Y+APE  +    +++  D 
Sbjct: 157 KIMISDFGLSKMEDPG--------SVLSTACG------TPGYVAPEV-LAQKPYSKAVDC 201
Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP 589
           +S G++   +L G  P    END K  E +++  +    P
Sbjct: 202 WSIGVIAYILLCG-YPPFYDENDAKLFEQILKAEYEFDSP 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 18/219 (8%)
Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++GK + G +Y    GR  G  A  ++ + R  E     + K F+ EV A  + +H N+V
Sbjct: 40  LIGKGRFGQVYH---GRWHGEVAIRLIDIERDNED----QLKAFKREVMAYRQTRHENVV 92
Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                  +     +I+   +  +LY+ +     D+   L      +IAQ   +G+ Y+H 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +  +H ++KS  +  D+     I+ FGL   + G  +  + E  +    G       
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFS-ISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 529 NVY--LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            +   L+P+       F++  DV++ G +  E+     P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 43/194 (22%)
Query: 393 ESEVEAIARVQHPNIVRLKA----FYY---ANDEKLLISDF----IRNGS------LYAA 435
           E EV+A+A++ H NIV        F Y    +D+ L  SD+     +N S      L+  
Sbjct: 53  EREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQ 112
Query: 436 LHAGPSDSLPPLPWEAR---------LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           +      +L     + R         L++ +   +G+ YIH    +K +H ++K + I L
Sbjct: 113 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFL 169
Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
            D     I  FGL   L    K T+++  +              Y++PE +I    + ++
Sbjct: 170 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR-------------YMSPE-QISSQDYGKE 215
Query: 547 CDVYSFGIVLLEIL 560
            D+Y+ G++L E+L
Sbjct: 216 VDLYALGLILAELL 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 10  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 60
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ + +    L   + A     +P PL      ++ QG A   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 117 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLW---- 167
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 168 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 38/259 (14%)
Query: 384 DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSD 442
           DA  R  D   E++ + ++ HPN+++  A +  ++E  ++ +    G L   + H     
Sbjct: 72  DAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 443 SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL 502
            L  +P     K        L ++H    R+ +H +IK   + +       +   GL R 
Sbjct: 131 RL--IPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
              +SK T   ++V  GT          Y++PE RI+ + +  K D++S G +L E+   
Sbjct: 186 F--SSKTTAAHSLV--GTP--------YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 563 RLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK--RQVLATFHIALNCTE 620
           + P  G   D   L SL +K       + +   P L  + +++  RQ++        C  
Sbjct: 233 QSPFYG---DKMNLYSLCKK-------IEQCDYPPLPSDHYSEELRQLVNM------CIN 276
Query: 621 LDPEFRPRMRTVSESLDRV 639
            DPE RP +  V +   R+
Sbjct: 277 PDPEKRPDVTYVYDVAKRM 295

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 42/282 (14%)
Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEK 420
           + +G   G   VV V ++ +  +T + +DF  E   +    HPN++ +     +      
Sbjct: 26  LWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84
Query: 421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
            LI+ +   GSLY  LH G +  +        +K A   ARG  ++H   P    H  + 
Sbjct: 85  TLITHWXPYGSLYNVLHEGTNFVVDQ---SQAVKFALDXARGXAFLHTLEPLIPRHA-LN 140
Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           S  + +D++                T++++  +   +  +  R  A +  ++APEA    
Sbjct: 141 SRSVXIDED---------------XTARISXADVKFSFQSPGRXYAPA--WVAPEALQKK 183
Query: 541 SKFTQK--CDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPAL 598
            + T +   D +SF ++L E++T  +P A   N   G     + A    RP    I P +
Sbjct: 184 PEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIG----XKVALEGLRP---TIPPGI 236
Query: 599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
              +    ++         C   DP  RP+   +   L++ +
Sbjct: 237 SPHVSKLXKI---------CXNEDPAKRPKFDXIVPILEKXQ 269

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           VGK + G +++       G+     VAV+  +  D    F+  E+E+     ++H NI+ 
Sbjct: 16  VGKGRYGEVWR-------GLWHGESVAVKIFSSRDEQSWFR--ETEIYNTVLLRHDNILG 66
Query: 410 LKAFYY----ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
             A       ++ +  LI+ +  +GSLY  L      +L P      L++A   A GL +
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQ---RQTLEP---HLALRLAVSAACGLAH 120
Query: 466 IH-----EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           +H             H + KS  +L+   L  CI+  GL  +       ++    +  G 
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMH------SQGSDYLDIGN 174
Query: 521 GSRISAISNVYLAPEARIYGSKFTQKC-------DVYSFGIVLLEI 559
             R+   +  Y+APE  +   +    C       D+++FG+VL EI
Sbjct: 175 NPRVG--TKRYMAPE--VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 20/172 (11%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 255
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +            
Sbjct: 256 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------------ 300
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             +  G   +    +  YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 301 EGIKDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 28/181 (15%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            ARG+ Y+ E   +K+VH ++ +   +LD+     ++ FGL R       +   E    S
Sbjct: 133 VARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLAR------DILDREY--YS 181
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES 578
               R + +   + A E+ +   +FT K DV+SFG++L E+LT   P   P       + 
Sbjct: 182 VQQHRHARLPVKWTALES-LQTYRFTTKSDVWSFGVLLWELLTRGAP---PYRHIDPFDL 237
Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
               A   R P  E    +L             + +   C E DP  RP  R +   +++
Sbjct: 238 THFLAQGRRLPQPEYCPDSL-------------YQVMQQCWEADPAVRPTFRVLVGEVEQ 284
Query: 639 V 639
           +
Sbjct: 285 I 285

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           +G+   G++YK    R    G   VVA++++     TEG  +   +    E+  +  + H
Sbjct: 14  IGEGTYGVVYK---ARNKLTGE--VVALKKIRLDTETEGVPSTAIR----EISLLKELNH 64
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-PLPWEARLKIAQGTARGL 463
           PNIV+L    +  ++  L+ + + +  L   + A     +P PL      ++ QG A   
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--- 120
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            + H +   + +H ++K   +L++ E    ++ FGL R   G    T    +VT      
Sbjct: 121 -FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLW---- 171
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                  Y APE  +    ++   D++S G +  E++T R
Sbjct: 172 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 33/238 (13%)
Query: 342 LLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT-----------EGDATWRFK 390
           LL+A ++ V     G  Y+++   G+G       A RRLT             D     K
Sbjct: 41  LLKARSFDV-TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK 99
Query: 391 DFESEVEAIARVQHPNIVRLKAFY-----YANDEKLLISDFIRNGSLYAALHAGPSDSLP 445
               E++ +   +H NI+ +K        Y   + + +   +    L+  +H     S  
Sbjct: 100 RTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH-----SSQ 154
Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG 505
           PL  E          RGL Y+H     + +H ++K + +L+++     I  FG+ R L  
Sbjct: 155 PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL-- 209
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
            +   +++  +T    +R       Y APE  +   ++TQ  D++S G +  E+L  R
Sbjct: 210 CTSPAEHQYFMTEYVATRW------YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 22/172 (12%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +EV  +    H N+V + + Y   DE  ++ +F+  G+L   +     +       E   
Sbjct: 91  NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIA 144
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
            +     R L Y+H    +  +H +IKS  ILL  +    +S FG    +  + +V K +
Sbjct: 145 TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRK 199
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            +V  GT          ++APE  I    +  + D++S GI+++E++ G  P
Sbjct: 200 XLV--GT--------PYWMAPEV-ISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 20/172 (11%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 252
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +            
Sbjct: 253 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------------ 297
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             +  G   +    +  YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 298 EGIKDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 24/182 (13%)
Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEK----LLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV + A   A         ++ +++   +L   +H     +  P+
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 113
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT- 506
             +  +++     + L + H+      +H ++K   I++       +  FG+ R +  + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           + VT+   ++  GT          YL+PE +  G     + DVYS G VL E+LTG  P 
Sbjct: 171 NSVTQTAAVI--GTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 567 AG 568
            G
Sbjct: 220 TG 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 34/197 (17%)
Query: 393 ESEVEAIARVQHPNIVRLKAFYYAND----EKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
           E E+ +   ++H N+++  A          E  LI+ F   GSL   L          + 
Sbjct: 57  EREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI------IT 110
Query: 449 WEARLKIAQGTARGLMYIHEYSPR--------KYVHGNIKSTKILLDDELHPCISGFGLN 500
           W     +A+  +RGL Y+HE  P            H + KS  +LL  +L   ++ FGL 
Sbjct: 111 WNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170
Query: 501 -RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ----KCDVYSFGIV 555
            R  PG      +  +     G+R       Y+APE       F +    + D+Y+ G+V
Sbjct: 171 VRFEPGKPPGDTHGQV-----GTR------RYMAPEVLEGAINFQRDAFLRIDMYAMGLV 219
Query: 556 LLEILTGRLPDAGPEND 572
           L E+++      GP ++
Sbjct: 220 LWELVSRCKAADGPVDE 236

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 392 FESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV +    +A   A     ++ +++   +L   +H     +  P+
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 113
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT- 506
             +  +++     + L + H+      +H ++K   I++       +  FG+ R +  + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           + VT+   ++  GT          YL+PE +  G     + DVYS G VL E+LTG  P 
Sbjct: 171 NSVTQTAAVI--GTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 567 AGPEND 572
            G   D
Sbjct: 220 TGDSPD 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 27/200 (13%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ +  G A    ++ + E+     ++HPNIVR K          +I ++   G LY
Sbjct: 47  LVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104
Query: 434 AAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
             + +AG          EAR    Q  + G+ Y H     +  H ++K    LLD    P
Sbjct: 105 ERICNAGRFSE-----DEARFFFQQLLS-GVSYCHSM---QICHRDLKLENTLLDGSPAP 155
Query: 493 --CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I  FG ++     S V  ++   T GT +        Y+APE  +      +  DV+
Sbjct: 156 RLKICDFGYSK-----SSVLHSQPKSTVGTPA--------YIAPEVLLRQEYDGKIADVW 202
Query: 551 SFGIVLLEILTGRLPDAGPE 570
           S G+ L  +L G  P   PE
Sbjct: 203 SCGVTLYVMLVGAYPFEDPE 222

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 33/238 (13%)
Query: 342 LLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLT-----------EGDATWRFK 390
           LL+A ++ V     G  Y+++   G+G       A RRLT             D     K
Sbjct: 40  LLKARSFDV-TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK 98
Query: 391 DFESEVEAIARVQHPNIVRLKAFY-----YANDEKLLISDFIRNGSLYAALHAGPSDSLP 445
               E++ +   +H NI+ +K        Y   + + +   +    L+  +H     S  
Sbjct: 99  RTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH-----SSQ 153
Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG 505
           PL  E          RGL Y+H     + +H ++K + +L+++     I  FG+ R L  
Sbjct: 154 PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL-- 208
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
            +   +++  +T    +R       Y APE  +   ++TQ  D++S G +  E+L  R
Sbjct: 209 CTSPAEHQYFMTEYVATRW------YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 356 GIMYKVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLK 411
           G   KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L 
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 412 AFYYANDEKLLISDFIRNGSLYAALH----AGPSDSLPP-------LPWEARLKIAQGTA 460
                    L+I+++   G L   L      G   S  P       L     L  +   A
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVA 176
Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           +G+ ++   + +  +H ++ +  +LL +     I  FGL R       +  +   +  G 
Sbjct: 177 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR------DIMNDSNYIVKGN 227
Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL 579
               + +   ++APE+ I+   +T + DV+S+GI+L EI + G  P  G   + K    L
Sbjct: 228 ----ARLPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKL 281
Query: 580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           V+  ++  +P      P   K I++  Q          C  L+P  RP  + +   L
Sbjct: 282 VKDGYQMAQP---AFAP---KNIYSIMQA---------CWALEPTHRPTFQQICSFL 323

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 390 KDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
           +D   E+E + R  QHPNI+ LK  Y       L+++ +R G L   +      S     
Sbjct: 65  RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS----E 120
Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH--PC--ISGFGLNRLLP 504
            EA   +     + + Y+H    +  VH ++K + IL  DE     C  I  FG  + L 
Sbjct: 121 REASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
                 +N  ++T          +  ++APE  +    + + CD++S GI+L  +L G  
Sbjct: 177 A-----ENGLLMT-------PCYTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYT 223
Query: 565 PDA-GPEN 571
           P A GP +
Sbjct: 224 PFANGPSD 231

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 159 IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 212
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHAQ 266
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
                +H +IKS  ILL  +    +S FG    +  + +V + + +V  GT         
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLV--GT--------P 311
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            ++APE  I    +  + D++S GI+++E++ G  P
Sbjct: 312 YWMAPEL-ISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           VG+   G++YK    +G       +VA++R+      EG  +   +    E+  +  + H
Sbjct: 29  VGEGTYGVVYKAKDSQGR------IVALKRIRLDAEDEGIPSTAIR----EISLLKELHH 78
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL---HAGPSDSLPPLPWEARLKIAQGTAR 461
           PNIV L    ++     L+ +F+    L   L     G  DS      + ++ + Q   R
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS------QIKIYLYQ-LLR 130
Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ + H++   + +H ++K   +L++ +    ++ FGL R   G    +    +VT    
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLW-- 184
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                    Y AP+  +   K++   D++S G +  E++TG+
Sbjct: 185 ---------YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 390 KDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
           +D   E+E + R  QHPNI+ LK  Y       L+++ +R G L   +      S     
Sbjct: 65  RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFS----E 120
Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH--PC--ISGFGLNRLLP 504
            EA   +     + + Y+H    +  VH ++K + IL  DE     C  I  FG  + L 
Sbjct: 121 REASF-VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
                 +N  ++T          +  ++APE  +    + + CD++S GI+L  +L G  
Sbjct: 177 A-----ENGLLMT-------PCYTANFVAPEV-LKRQGYDEGCDIWSLGILLYTMLAGYT 223
Query: 565 PDA-GPEN 571
           P A GP +
Sbjct: 224 PFANGPSD 231

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 392 FESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV +    +A   A     ++ +++   +L   +H     +  P+
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 113
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
             +  +++     + L + H+      +H ++K   IL+       +  FG+ R +   S
Sbjct: 114 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANILISATNAVKVVDFGIARAI-ADS 169
Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDA 567
             +  +T    GT          YL+PE +  G     + DVYS G VL E+LTG  P  
Sbjct: 170 GNSVXQTAAVIGTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
Query: 568 G 568
           G
Sbjct: 221 G 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 392 FESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV +    +A   A     ++ +++   +L   +H     +  P+
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 113
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT- 506
             +  +++     + L + H+      +H ++K   I++       +  FG+ R +  + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           + VT+   ++  GT          YL+PE +  G     + DVYS G VL E+LTG  P 
Sbjct: 171 NSVTQTAAVI--GTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 567 AG 568
            G
Sbjct: 220 TG 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-----TEGDATWRFKDFESEVEAIARVQH 404
           VG+   G++YK    +G       +VA++R+      EG  +   +    E+  +  + H
Sbjct: 29  VGEGTYGVVYKAKDSQGR------IVALKRIRLDAEDEGIPSTAIR----EISLLKELHH 78
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAAL---HAGPSDSLPPLPWEARLKIAQGTAR 461
           PNIV L    ++     L+ +F+    L   L     G  DS      + ++ + Q   R
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS------QIKIYLYQ-LLR 130
Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           G+ + H++   + +H ++K   +L++ +    ++ FGL R   G    +    +VT    
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLW-- 184
Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                    Y AP+  +   K++   D++S G +  E++TG+
Sbjct: 185 ---------YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 82  IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 135
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHA- 188
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IKS  ILL  +    +S FG    +  + +V + + +V +        IS 
Sbjct: 189 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISR 244
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   PE            D++S GI+++E++ G  P
Sbjct: 245 LPYGPE-----------VDIWSLGIMVIEMVDGEPP 269

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 20/172 (11%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 114
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +           E
Sbjct: 115 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------E 160
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            I    T          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 161 GIKDGATMKXFCGTPE-YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 20/172 (11%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 112
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +           E
Sbjct: 113 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------E 158
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            I    T          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 159 GIKDGATMKXFCGTPE-YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 392 FESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV +    +A   A     ++ +++   +L   +H     +  P+
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 113
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT- 506
             +  +++     + L + H+      +H ++K   I++       +  FG+ R +  + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           + VT+   ++  GT          YL+PE +  G     + DVYS G VL E+LTG  P 
Sbjct: 171 NSVTQTAAVI--GTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 219
Query: 567 AG 568
            G
Sbjct: 220 TG 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 20/172 (11%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E   +   +HP +  LK  +  +D    + ++   G L+  L      S       AR 
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARF 113
Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
             A+     L Y+H  S +  V+ ++K   ++LD + H  I+ FGL +           E
Sbjct: 114 YGAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----------E 159
Query: 514 TIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            I    T          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 160 GIKDGATMKXFCGTPE-YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
           RGL YIH       +H ++K + + ++++    I GFGL R        T +E  +T   
Sbjct: 136 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARH-------TDDE--MTGYV 183
Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
            +R       Y APE  +    + Q  D++S G ++ E+LTGR
Sbjct: 184 ATRW------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYA----------------NDEKLLIS-DFIRNGSLYAAL 436
           SEV  +A + H  +VR    YYA                    L I  ++  N +LY  +
Sbjct: 51  SEVMLLASLNHQYVVR----YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 437 HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG 496
           H+   +      W    ++ +     L YIH    +  +H ++K   I +D+  +  I  
Sbjct: 107 HSENLNQQRDEYW----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159
Query: 497 FGLNRLLPGTSKVTKNETIVTSGTGSRI-SAI-SNVYLAPEARIYGSKFTQKCDVYSFGI 554
           FGL + +  +  + K ++    G+   + SAI + +Y+A E       + +K D+YS GI
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 555 VLLEIL 560
           +  E++
Sbjct: 220 IFFEMI 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 23/169 (13%)
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           P + +L + +   D    + +++  G L Y     G       + + A + I      GL
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------GL 455
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++     +  ++ ++K   ++LD E H  I+ FG+ +              +  G  ++
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------------ENIWDGVTTK 500
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
               +  Y+APE   Y   + +  D ++FG++L E+L G+ P  G + D
Sbjct: 501 XFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 44/270 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDF-----------ESEVEAIARVQHPN 406
           Y+V+   G+G        +RR ++G    W+  D+            SEV  +  ++HPN
Sbjct: 8   YEVLYTIGTG-SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 407 IVRLKAFYY------ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           IVR    YY       N    ++ ++   G L + +  G  +    L  E  L++     
Sbjct: 67  IVR----YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 461 RGLMYIHEYSP--RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
             L   H  S      +H ++K   + LD + +  +  FGL R+L   +   K  T V  
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-- 177
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG---PENDGKG 575
           GT          Y++PE ++    + +K D++S G +L E+     P       E  GK 
Sbjct: 178 GTP--------YYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 576 LESLVRKA-FRERRPLSEVIDPAL-VKEIH 603
            E   R+  +R    L+E+I   L +K+ H
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYH 258

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 392 FESEVEAIARVQHPNIVRL----KAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F  E +  A + HP IV +    +A   A     ++ +++   +L   +H     +  P+
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPM 130
Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT- 506
             +  +++     + L + H+      +H ++K   I++       +  FG+ R +  + 
Sbjct: 131 TPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
           + VT+   ++  GT          YL+PE +  G     + DVYS G VL E+LTG  P 
Sbjct: 188 NSVTQTAAVI--GTAQ--------YLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPF 236
Query: 567 AG 568
            G
Sbjct: 237 TG 238

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 84  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 138
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 139 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 189
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 190 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 244 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 286
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 287 FTELKAQLSTI 297

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 39  IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 92
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHA- 145
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IKS  ILL  +    +S FG    +  + +V + + +V +        IS 
Sbjct: 146 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISR 201
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   PE            D++S GI+++E++ G  P
Sbjct: 202 LPYGPE-----------VDIWSLGIMVIEMVDGEPP 226

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 59  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 114 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 164
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 165 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 219 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 261
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 262 FTELKAQLSTI 272

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 115
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 116 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 166
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 167 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 221 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 263
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 264 FTELKAQLSTI 274

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT +        ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPA--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 23/169 (13%)
Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSL-YAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           P + +L + +   D    + +++  G L Y     G       + + A + I      GL
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI------GL 134
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++     +  ++ ++K   ++LD E H  I+ FG+ +              +  G  ++
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------------ENIWDGVTTK 179
Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
               +  Y+APE   Y   + +  D ++FG++L E+L G+ P  G + D
Sbjct: 180 XFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 110
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 161
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 162 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 216 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 258
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 259 FTELKAQLSTI 269

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 53  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 107
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 108 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 158
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 159 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 213 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 255
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 256 FTELKAQLSTI 266

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 44/270 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDF-----------ESEVEAIARVQHPN 406
           Y+V+   G+G        +RR ++G    W+  D+            SEV  +  ++HPN
Sbjct: 8   YEVLYTIGTG-SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 407 IVRLKAFYY------ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           IVR    YY       N    ++ ++   G L + +  G  +    L  E  L++     
Sbjct: 67  IVR----YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 461 RGLMYIHEYSP--RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
             L   H  S      +H ++K   + LD + +  +  FGL R+L        +E     
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL------NHDEDFAKE 175
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG---PENDGKG 575
             G      +  Y++PE ++    + +K D++S G +L E+     P       E  GK 
Sbjct: 176 FVG------TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 576 LESLVRKA-FRERRPLSEVIDPAL-VKEIH 603
            E   R+  +R    L+E+I   L +K+ H
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYH 258

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 22/182 (12%)
Query: 394 SEVEAIARVQHPNIVRLKAFYY------------ANDEKLLIS-DFIRNGSLYAALHAGP 440
           SEV  +A + H  +VR  A +                  L I  ++  N +LY  +H+  
Sbjct: 51  SEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN 110
Query: 441 SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN 500
            +      W    ++ +     L YIH    +  +H N+K   I +D+  +  I  FGL 
Sbjct: 111 LNQQRDEYW----RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLA 163
Query: 501 RLLPGTSKVTKNETIVTSGTGSRI-SAISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLE 558
           + +  +  + K ++    G+   + SAI    Y+A E       + +K D YS GI+  E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
Query: 559 IL 560
            +
Sbjct: 224 XI 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 37  IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 90
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHA- 143
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IKS  ILL  +    +S FG    +  + +V + + +V +        IS 
Sbjct: 144 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISR 199
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   PE            D++S GI+++E++ G  P
Sbjct: 200 LPYGPE-----------VDIWSLGIMVIEMVDGEPP 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 26/167 (15%)
Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           HP+I+ L   Y ++    L+ D +R G L+  L    ++ +     E R  I +     +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETR-SIMRSLLEAV 213
Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++H       VH ++K   ILLDD +   +S FG +  L    K+   E   T G    
Sbjct: 214 SFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPG---- 264
Query: 524 ISAISNVYLAPEARIYGSKFT-----QKCDVYSFGIVLLEILTGRLP 565
                  YLAPE        T     ++ D+++ G++L  +L G  P
Sbjct: 265 -------YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS----LDL 110
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 161
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 162 -EDSTXXKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 216 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 258
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 259 FTELKAQLSTI 269

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A+G+ ++   + +  +H ++ +  ILL       I  FGL R +       KN++    
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHI-------KNDSNYVV 226
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
              +R+      ++APE+ I+   +T + DV+S+GI L E+ + G  P  G   D K   
Sbjct: 227 KGNARLPV---KWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 281
Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            ++++ FR   P             HA  ++   + I   C + DP  RP  + + + ++
Sbjct: 282 KMIKEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIE 326
Query: 638 R 638
           +
Sbjct: 327 K 327

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 56  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 110
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 111 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 161
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 162 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 216 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 258
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 259 FTELKAQLSTI 269

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 56/251 (22%), Positives = 98/251 (39%), Gaps = 38/251 (15%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           + F  E   + +  HP+IV+L      N    +I +    G L + L          L  
Sbjct: 58  EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS----LDL 112
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            + +  A   +  L Y+     +++VH +I +  +L+       +  FGL+R +      
Sbjct: 113 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ 163
Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
            ++ T   +  G     +   ++APE+ I   +FT   DV+ FG+ + EIL  G  P  G
Sbjct: 164 -EDSTYYKASKGK----LPIKWMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217
Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +N+    + + R    ER P+     P L             + +   C   DP  RPR
Sbjct: 218 VKNN----DVIGRIENGERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPR 260
Query: 629 MRTVSESLDRV 639
              +   L  +
Sbjct: 261 FTELKAQLSTI 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 44/270 (16%)
Query: 359 YKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDF-----------ESEVEAIARVQHPN 406
           Y+V+   G+G        +RR ++G    W+  D+            SEV  +  ++HPN
Sbjct: 8   YEVLYTIGTG-SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 407 IVRLKAFYY------ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
           IVR    YY       N    ++ ++   G L + +  G  +    L  E  L++     
Sbjct: 67  IVR----YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLT 121
Query: 461 RGLMYIHEYSP--RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
             L   H  S      +H ++K   + LD + +  +  FGL R+L   +   K       
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK----AFV 177
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG---PENDGKG 575
           GT          Y++PE ++    + +K D++S G +L E+     P       E  GK 
Sbjct: 178 GTP--------YYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 576 LESLVRKA-FRERRPLSEVIDPAL-VKEIH 603
            E   R+  +R    L+E+I   L +K+ H
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYH 258

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 112
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 113 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 168
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 169 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 215
Query: 566 DAG 568
             G
Sbjct: 216 FLG 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 108/243 (44%), Gaps = 25/243 (10%)
Query: 333 EGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDF 392
           + FS   ED+ +    V+G+  +  +   +      +      AV+ + +     R + F
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCI-----NLITSQEYAVKIIEKQPGHIRSRVF 58
Query: 393 ESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
             EVE + + Q H N++ L  F+   D   L+ + +R GS+ + +H     +      EA
Sbjct: 59  R-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----ELEA 113
Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD--DELHPC-ISGFGLN---RLLPG 505
            + + Q  A  L ++H    +   H ++K   IL +  +++ P  I  FGL    +L   
Sbjct: 114 SV-VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGD 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            S ++  E +   G+   ++       + EA IY     ++CD++S G++L  +L+G  P
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY----DKRCDLWSLGVILYILLSGYPP 225
Query: 566 DAG 568
             G
Sbjct: 226 FVG 228

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 32  IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 85
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHA- 138
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IKS  ILL  +    +S FG    +  + +V + + +V +        IS 
Sbjct: 139 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISR 194
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   PE            D++S GI+++E++ G  P
Sbjct: 195 LPYGPE-----------VDIWSLGIMVIEMVDGEPP 219

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 112
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 113 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 168
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 169 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 215
Query: 566 DAG 568
             G
Sbjct: 216 FLG 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVR 409
           +G+   GI+    V R SG     +VAV+++       R   F +EV  +   QH N+V 
Sbjct: 28  IGEGSTGIVCIATV-RSSG----KLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVE 81
Query: 410 LKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           +   Y   DE  ++ +F+  G+L   +     +       E    +     + L  +H  
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLQALSVLHA- 134
Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN 529
             +  +H +IKS  ILL  +    +S FG    +  + +V + + +V +        IS 
Sbjct: 135 --QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISR 190
Query: 530 VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   PE            D++S GI+++E++ G  P
Sbjct: 191 LPYGPE-----------VDIWSLGIMVIEMVDGEPP 215

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/173 (21%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E+  +   ++PNIV     Y   DE  ++ +++  GSL   +     D       E ++
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQI 119
Query: 454 -KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
             + +   + L ++H     + +H NIKS  ILL  +    ++ FG        +++T  
Sbjct: 120 AAVCRECLQALEFLHS---NQVIHRNIKSDNILLGMDGSVKLTDFGF------CAQITPE 170
Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           ++  ++  G+        ++APE  +    +  K D++S GI+ +E++ G  P
Sbjct: 171 QSKRSTMVGTP------YWMAPEV-VTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 97/239 (40%), Gaps = 32/239 (13%)
Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G   +VV+      G   + AV+ + +     +    E+E+  + +++H NIV L+  Y 
Sbjct: 33  GAFSEVVLAEEKATG--KLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYE 90
Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
           + +   L+   +  G L+  +      +      +A   I Q     + Y+H       V
Sbjct: 91  SPNHLYLVMQLVSGGELFDRIVEKGFYTEK----DASTLIRQ-VLDAVYYLHRMG---IV 142
Query: 476 HGNIKSTKILL---DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-- 530
           H ++K   +L    D+E    IS FGL+++                G G  +S       
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSKM---------------EGKGDVMSTACGTPG 187
Query: 531 YLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP 589
           Y+APE  +    +++  D +S G++   +L G  P    END K  E +++  +    P
Sbjct: 188 YVAPEV-LAQKPYSKAVDCWSIGVIAYILLCG-YPPFYDENDSKLFEQILKAEYEFDSP 244

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A+G+ ++   + +  +H ++ +  ILL       I  FGL R +       KN++    
Sbjct: 177 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-------KNDSNYVV 226
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
              +R+      ++APE+ I+   +T + DV+S+GI L E+ + G  P  G   D K   
Sbjct: 227 KGNARLPV---KWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 281
Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            ++++ FR   P             HA  ++   + I   C + DP  RP  + + + ++
Sbjct: 282 KMIKEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIE 326
Query: 638 R 638
           +
Sbjct: 327 K 327

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A+G+ ++   + +  +H ++ +  ILL       I  FGL R +       KN++    
Sbjct: 170 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-------KNDSNYVV 219
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
              +R+      ++APE+ I+   +T + DV+S+GI L E+ + G  P  G   D K   
Sbjct: 220 KGNARLPV---KWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 274
Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            ++++ FR   P             HA  ++   + I   C + DP  RP  + + + ++
Sbjct: 275 KMIKEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIE 319
Query: 638 R 638
           +
Sbjct: 320 K 320

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+  L    S     L  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTE 113
Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP----CISGFGLNRLLPG 505
           E   +  +    G+ Y+H     +  H ++K   I+L D   P     I  FGL   +  
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 NE     GT          ++APE   Y      + D++S G++   +L+G  P
Sbjct: 170 ----FGNEFKNIFGTPE--------FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASP 216
Query: 566 DAG 568
             G
Sbjct: 217 FLG 219

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A+G+ ++   + +  +H ++ +  ILL       I  FGL R +       KN++    
Sbjct: 172 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-------KNDSNYVV 221
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
              +R+      ++APE+ I+   +T + DV+S+GI L E+ + G  P  G   D K   
Sbjct: 222 KGNARLPV---KWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 276
Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            ++++ FR   P             HA  ++   + I   C + DP  RP  + + + ++
Sbjct: 277 KMIKEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIE 321
Query: 638 R 638
           +
Sbjct: 322 K 322

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 20/123 (16%)
Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
           +P E   KI   T + L ++ E    K +H +IK + ILLD   +  +  FG++  L  +
Sbjct: 122 IPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ----KCDVYSFGIVLLEILTG 562
              T++        G R       Y+APE RI  S   Q    + DV+S GI L E+ TG
Sbjct: 180 IAKTRD-------AGCR------PYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 563 RLP 565
           R P
Sbjct: 226 RFP 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 27/200 (13%)
Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +VAV+ +  G+     ++ + E+     ++HPNIVR K          ++ ++   G L+
Sbjct: 46  LVAVKYIERGEKI--DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 103
Query: 434 AAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
             + +AG          EAR    Q  + G+ Y H     +  H ++K    LLD    P
Sbjct: 104 ERICNAGRFSE-----DEARFFFQQLIS-GVSYCHAM---QVCHRDLKLENTLLDGSPAP 154
Query: 493 --CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I  FG ++     S V  ++   T GT +        Y+APE  +      +  DV+
Sbjct: 155 RLKICAFGYSK-----SSVLHSQPKSTVGTPA--------YIAPEVLLKKEYDGKVADVW 201
Query: 551 SFGIVLLEILTGRLPDAGPE 570
           S G+ L  +L G  P   PE
Sbjct: 202 SCGVTLYVMLVGAYPFEDPE 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 81/181 (44%), Gaps = 31/181 (17%)
Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
            A+G+ ++   + +  +H ++ +  ILL       I  FGL R +       KN++    
Sbjct: 154 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-------KNDSNYVV 203
Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE 577
              +R+      ++APE+ I+   +T + DV+S+GI L E+ + G  P  G   D K   
Sbjct: 204 KGNARLPV---KWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 258
Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            ++++ FR   P             HA  ++   + I   C + DP  RP  + + + ++
Sbjct: 259 KMIKEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 638 R 638
           +
Sbjct: 304 K 304

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	642
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-71
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-64
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-60
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-51
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-49
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-47
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-48
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-45
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-37
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-09
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-25
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-11
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-19
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-18
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-18
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-17
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-13
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-17
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-06
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-16
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-16
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-07
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-08
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-14
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-05
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-09
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-13
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-13
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-07
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-13
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-12
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-10
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-12
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-12
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-10
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-11
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-10
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-07
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-04
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-10
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-05
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-09
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-09
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-09
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-08
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-06
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-08
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-08
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-08
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-07
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-07
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-06
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-07
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-06
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-06
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-05
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-05
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-05
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-05
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-04
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  232 bits (594), Expect = 3e-71
 Identities = 100/317 (31%), Positives = 160/317 (50%), Gaps = 43/317 (13%)

Query: 335 FSLELEDLLRA-----SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF 389
           FSL   +L  A     +  ++G+   G +YK  +  G      T+VAV+RL E       
Sbjct: 20  FSLR--ELQVASDNFSNKNILGRGGFGKVYKGRLADG------TLVAVKRLKEERTQGGE 71

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
             F++EVE I+   H N++RL+ F     E+LL+  ++ NGS+ + L     +S PPL W
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDW 130

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
             R +IA G+ARGL Y+H++   K +H ++K+  ILLD+E    +  FGL +L+      
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY---- 186

Query: 510 TKNETIVTS---GT-GSRISAISNVYLAPEARIYGS--KFTQKCDVYSFGIVLLEILTGR 563
              +T VT+   GT G         ++APE   Y S  K ++K DV+ +G++LLE++TG+
Sbjct: 187 --KDTHVTTAVRGTIG---------HIAPE---YLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 564 LP---DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTE 620
                     +D   L   V+   +E++ L  ++D  L        +V     +AL CT+
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYK-DEEVEQLIQVALLCTQ 290

Query: 621 LDPEFRPRMRTVSESLD 637
             P  RP+M  V   L+
Sbjct: 291 SSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  213 bits (544), Expect = 3e-64
 Identities = 89/278 (32%), Positives = 132/278 (47%), Gaps = 39/278 (14%)

Query: 373 TVVAVRRLTEGDATWRF---KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN 429
           T VAV++L            + F+ E++ +A+ QH N+V L  F    D+  L+  ++ N
Sbjct: 55  TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114

Query: 430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           GSL   L     D  PPL W  R KIAQG A G+ ++HE     ++H +IKS  ILLD+ 
Sbjct: 115 GSLLDRLSC--LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTS---GT-GSRISAISNVYLAPEARIYGSKFTQ 545
               IS FGL R     ++     T++TS   GT           Y+APEA + G + T 
Sbjct: 170 FTAKISDFGLARASEKFAQ-----TVMTSRIVGTTA---------YMAPEA-LRG-EITP 213

Query: 546 KCDVYSFGIVLLEILTGRLP-DAGPENDGKGLESLV---RKAFRERRPLSEVIDPALVKE 601
           K D+YSFG+VLLEI+TG    D   E      + L+    +   E + + + ID  +   
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREP-----QLLLDIKEEIEDEEKTIEDYIDKKM--N 266

Query: 602 IHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                 V A + +A  C       RP ++ V + L  +
Sbjct: 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  203 bits (520), Expect = 1e-60
 Identities = 94/311 (30%), Positives = 147/311 (47%), Gaps = 44/311 (14%)

Query: 339 LEDLLRA-----SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFE 393
           L DL  A       +++G    G +YK V+  G        VA++R T   +    ++FE
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG------AKVALKRRTPESSQ-GIEEFE 83

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E+E ++  +HP++V L  F    +E +LI  ++ NG+L   L+ G       + WE RL
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY-GSDLPTMSMSWEQRL 142

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK--VTK 511
           +I  G ARGL Y+H    R  +H ++KS  ILLD+   P I+ FG+++      +  ++ 
Sbjct: 143 EICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS- 198

Query: 512 NETIVTSGT-GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP-DAGP 569
             T+V  GT G         Y+ PE  I G + T+K DVYSFG+VL E+L  R       
Sbjct: 199 --TVV-KGTLG---------YIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSL 245

Query: 570 ENDGKGLESLVR--KAFRERRPLSEVIDPALVKEIHAK--RQVLATFHIALNCTELDPEF 625
               + + +L            L +++DP L  +I  +  R+       A+ C  L  E 
Sbjct: 246 P---REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD---TAVKCLALSSED 299

Query: 626 RPRMRTVSESL 636
           RP M  V   L
Sbjct: 300 RPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  177 bits (452), Expect = 8e-51
 Identities = 71/312 (22%), Positives = 116/312 (37%), Gaps = 47/312 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNI 407
           V  + + G ++K  +           VAV+     D  +W+    E EV ++  ++H NI
Sbjct: 31  VKARGRFGCVWKAQL-LN------EYVAVKIFPIQDKQSWQN---EYEVYSLPGMKHENI 80

Query: 408 VRLKAF----YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           ++           + +  LI+ F   GSL   L A        + W     IA+  ARGL
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGL 134

Query: 464 MYIHEYSPR-------KYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
            Y+HE  P           H +IKS  +LL + L  CI+ FGL                V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 517 TSGTGSRISAISNVYLAPE----ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
             GT  R       Y+APE    A  +      + D+Y+ G+VL E+ +      GP ++
Sbjct: 195 --GT-RR-------YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 573 GK-GLESLV--RKAFRERRPL--SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                E  +    +  + + +   +   P L         +         C + D E R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 628 RMRTVSESLDRV 639
               V E + ++
Sbjct: 305 SAGCVGERITQM 316

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  173 bits (441), Expect = 3e-49
 Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 36/221 (16%)

Query: 23  NQDGLALLALKAAIAQDPTRALDSWSES-DSTPCHWSGIHCIR----NRVTSLYLPNRNL 77
            QD  ALL +K  +       L SW  + D     W G+ C       RV +L L   NL
Sbjct: 5   PQDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 78  ---------------------------TGYMPSELGLLNSLTRLSLASNNFSKPIPANLF 110
                                       G +P  +  L  L  L +   N S  IP  L 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 111 NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS 170
               LV LD ++N+  G +P  I +L NL  +    N ++G++P+       L  ++ +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182

Query: 171 FNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ-VGSLLN 210
            N+ +G+IP  + +   +  +DL  N L G+     GS  N
Sbjct: 183 RNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKN 222

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  166 bits (423), Expect = 8e-47
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 5/165 (3%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTR-LSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             +      ++G +P   G  + L   ++++ N  +  IP    N  NL ++DL+ N   
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
           G       + KN   + L+ N L   L + +   + L   L+L  N+  G +P+      
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLN-GLDLRNNRIYGTLPQGLTQLK 268

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPC 231
            + SL++  NNL GEIPQ G+L     +A++ N  LCG PL   C
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  180 bits (458), Expect = 3e-48
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 14  FPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLP 73
           F A    SL ++   L++ K  +  D    L  WS S+  PC + G+ C  ++VTS+ L 
Sbjct: 2   FQASPSQSLYREIHQLISFKDVL-PDKN-LLPDWS-SNKNPCTFDGVTCRDDKVTSIDLS 58

Query: 74  NRNLT---GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIP 130
           ++ L      + S L  L  L  L L++++ +  +      + +L  LDL+ NS  GP+ 
Sbjct: 59  SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT 117

Query: 131 DR--IKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPE---MYGH 184
               + +   L  L++SSN L+        L L +L   L+LS N  SG       +   
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE-VLDLSANSISGANVVGWVLSDG 176

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLN 210
              +  L +  N +SG++  V   +N
Sbjct: 177 CGELKHLAISGNKISGDVD-VSRCVN 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  171 bits (436), Expect = 2e-45
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 1/179 (0%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
               +            G    +L  L++    ++ S  +         N  ++++LD++
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
           +N   G IP  I ++  L  L+L  N ++GS+P+ + DLR L   L+LS N+  G+IP+ 
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL-NILDLSSNKLDGRIPQA 699

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVH 240
                ++  +DL NNNLSG IP++G      P  F  NPGLCG+PL    P   +   H
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  145 bits (369), Expect = 8e-37
 Identities = 49/143 (34%), Positives = 70/143 (48%), Gaps = 1/143 (0%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
              +N +  LYL N   TG +P  L   + L  L L+ N  S  IP++L + + L  L L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
             N   G IP  +  +K L  L L  N L G +P  L +   L   ++LS N+ +G+IP+
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN-WISLSNNRLTGEIPK 508

Query: 181 MYGHFPVMVSLDLRNNNLSGEIP 203
             G    +  L L NN+ SG IP
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIP 531

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  145 bits (368), Expect = 1e-36
 Identities = 52/140 (37%), Positives = 67/140 (47%), Gaps = 4/140 (2%)

Query: 68  TSLYLPNRNLTGYMPSELG-LLNSLTRLSLASNNFSKPIPANLFN--ATNLVYLDLAHNS 124
             L L     +G +P  L  L  SL  L L+SNNFS PI  NL       L  L L +N 
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
           F G IP  +     L  L LS N L+G++P  L  L  L   L L  N   G+IP+   +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWLNMLEGEIPQELMY 464

Query: 185 FPVMVSLDLRNNNLSGEIPQ 204
              + +L L  N+L+GEIP 
Sbjct: 465 VKTLETLILDFNDLTGEIPS 484

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (359), Expect = 2e-35
 Identities = 52/141 (36%), Positives = 72/141 (51%), Gaps = 5/141 (3%)

Query: 68  TSLYLPNRNLTGYMPSE-LGLLNSLTRLSLASNNFSKPIPANLFNAT-NLVYLDLAHNSF 125
            SL L + N +G +P + L  +  L  L L+ N FS  +P +L N + +L+ LDL+ N+F
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 126 CGPIPDRI--KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
            GPI   +       L  L L +N   G +P  L +   L  +L+LSFN  SG IP   G
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV-SLHLSFNYLSGTIPSSLG 439

Query: 184 HFPVMVSLDLRNNNLSGEIPQ 204
               +  L L  N L GEIPQ
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQ 460

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  139 bits (352), Expect = 1e-34
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 8/155 (5%)

Query: 50  SDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANL 109
           S +    W         +  L +    ++G +   +    +L  L ++SNNFS  IP  L
Sbjct: 164 SGANVVGWVLSDGCGE-LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-L 219

Query: 110 FNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNL 169
            + + L +LD++ N   G     I T   L  L++SSN   G +P     L++L   L+L
Sbjct: 220 GDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQ-YLSL 276

Query: 170 SFNQFSGQIP-EMYGHFPVMVSLDLRNNNLSGEIP 203
           + N+F+G+IP  + G    +  LDL  N+  G +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  133 bits (336), Expect = 1e-32
 Identities = 54/140 (38%), Positives = 73/140 (52%), Gaps = 6/140 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L + +    G +P     L SL  LSLA N F+  IP  L      L  LDL+ N F 
Sbjct: 250 KLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
           G +P    +   L  L LSSN  +G LP + LL +R L   L+LSFN+FSG++PE   + 
Sbjct: 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK-VLDLSFNEFSGELPESLTNL 366

Query: 186 PV-MVSLDLRNNNLSGEIPQ 204
              +++LDL +NN SG I  
Sbjct: 367 SASLLTLDLSSNNFSGPILP 386

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  131 bits (332), Expect = 4e-32
 Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 5/136 (3%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    L G +P EL  + +L  L L  N+ +  IP+ L N TNL ++ L++N   G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            IP  I  L+NL  L LS+N  +G++P  L D R+L   L+L+ N F+G IP        
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI-WLDLNTNLFNGTIPAAMFKQ-- 561

Query: 188 MVSLDLRNNNLSGEIP 203
             S  +  N ++G+  
Sbjct: 562 --SGKIAANFIAGKRY 575

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (330), Expect = 7e-32
 Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 22/165 (13%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L L   +LTG +PS L    +L  +SL++N  +  IP  +    NL  L L++NSF G
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS----------------- 170
            IP  +   ++L  LDL++NL NG++P  +           ++                 
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 171 ----FNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP-QVGSLLN 210
                 +F G   E           ++ +    G       +  +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (404), Expect = 4e-44
 Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 41/270 (15%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGS 431
             VA++++         K F  E+  ++RV HPNIV+    Y A    + L+ ++   GS
Sbjct: 32  KDVAIKQIESESER---KAFIVELRQLSRVNHPNIVK---LYGACLNPVCLVMEYAEGGS 85

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
           LY  LH   ++ LP       +      ++G+ Y+H   P+  +H ++K   +LL     
Sbjct: 86  LYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143

Query: 492 PC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              I  FG    +         +T +T+  GS        ++APE    GS +++KCDV+
Sbjct: 144 VLKICDFGTACDI---------QTHMTNNKGS------AAWMAPEV-FEGSNYSEKCDVF 187

Query: 551 SFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLA 610
           S+GI+L E++T R P          +   V      R PL + +   +   +        
Sbjct: 188 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTRPPLIKNLPKPIESLMTR------ 239

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDRVK 640
                  C   DP  RP M  + + +  + 
Sbjct: 240 -------CWSKDPSQRPSMEEIVKIMTHLM 262

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  157 bits (400), Expect = 1e-43
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 31/291 (10%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+GK   G   KV   R +G     V+ ++ L   D   + + F  EV+ +  ++HPN++
Sbjct: 17  VLGKGCFGQAIKVTH-RETGE----VMVMKELIRFDEETQ-RTFLKEVKVMRCLEHPNVL 70

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +     Y +     I+++I+ G+L   +           PW  R+  A+  A G+ Y+H 
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                 +H ++ S   L+ +  +  ++ FGL RL+       +    +      +   + 
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 529 NVYL--APEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
                 APE  I G  + +K DV+SFGIVL EI+     D            L  + F  
Sbjct: 184 GNPYWMAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRGFL- 240

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
            R       P+              F I + C +LDPE RP    +   L+
Sbjct: 241 DRYCPPNCPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLE 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  152 bits (385), Expect = 5e-42
 Identities = 63/279 (22%), Positives = 109/279 (39%), Gaps = 50/279 (17%)

Query: 373 TVVAVRRLTEG---DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRN 429
             VAV+        D +   ++   E +  A ++HPNI+ L+          L+ +F R 
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90

Query: 430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           G L   L          +P +  +  A   ARG+ Y+H+ +    +H ++KS+ IL+  +
Sbjct: 91  GPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144

Query: 490 LHPC--------ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
           +           I+ FGL R          + T   S  G+        ++APE  I  S
Sbjct: 145 VENGDLSNKILKITDFGLARE--------WHRTTKMSAAGAY------AWMAPEV-IRAS 189

Query: 542 KFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP-LSEVIDPALVK 600
            F++  DV+S+G++L E+LTG +P  G +     L      A  +    +         K
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVAMNKLALPIPSTCPEPFAK 245

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                        +  +C   DP  RP    + + L  +
Sbjct: 246 -------------LMEDCWNPDPHSRPSFTNILDQLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  149 bits (378), Expect = 8e-41
 Identities = 62/268 (23%), Positives = 112/268 (41%), Gaps = 35/268 (13%)

Query: 375 VAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSL 432
           VAV+ L     T  + + F++EV  + + +H NI+      Y+   +L +++ +    SL
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQLAIVTQWCEGSSL 106

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
           Y  LH     S      +  + IA+ TARG+ Y+H    +  +H ++KS  I L ++   
Sbjct: 107 YHHLH----ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA--RIYGSKFTQKCDVY 550
            I  FGL                    +GS +      ++APE       + ++ + DVY
Sbjct: 160 KIGDFGLATE----KSRWSGSHQFEQLSGSIL------WMAPEVIRMQDSNPYSFQSDVY 209

Query: 551 SFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLA 610
           +FGIVL E++TG+LP +   N  + +E + R       P    +     K +        
Sbjct: 210 AFGIVLYELMTGQLPYSNINNRDQIIEMVGRG---SLSPDLSKVRSNCPKRMK------- 259

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDR 638
              +   C +   + RP    +   ++ 
Sbjct: 260 --RLMAECLKKKRDERPSFPRILAEIEE 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  149 bits (379), Expect = 1e-40
 Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 35/269 (13%)

Query: 373 TVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
           + VAV+ L E D    R  +F  EV  + R++HPNIV             ++++++  GS
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
           LY  LH   S +   L    RL +A   A+G+ Y+H  +P   VH N+KS  +L+D +  
Sbjct: 121 LYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYT 177

Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYS 551
             +  FGL+RL   T   +K+      GT          ++APE  +      +K DVYS
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSAA----GTPE--------WMAPEV-LRDEPSNEKSDVYS 224

Query: 552 FGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP-LSEVIDPALVKEIHAKRQVLA 610
           FG++L E+ T + P           + +    F+ +R  +   ++P +   I        
Sbjct: 225 FGVILWELATLQQPWGNLNP----AQVVAAVGFKCKRLEIPRNLNPQVAAIIE------- 273

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDRV 639
                  C   +P  RP   T+ + L  +
Sbjct: 274 ------GCWTNEPWKRPSFATIMDLLRPL 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  141 bits (358), Expect = 4e-38
 Identities = 64/279 (22%), Positives = 112/279 (40%), Gaps = 50/279 (17%)

Query: 373 TVVAVRRL------TEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF 426
           +VVA++ L       E +   +F++F+ EV  ++ + HPNIV+L      ++   ++ +F
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEF 102

Query: 427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           +  G LY  L     D   P+ W  +L++    A G+ Y+   +P   VH +++S  I L
Sbjct: 103 VPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFL 157

Query: 487 DDELHPC-----ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA-RIYG 540
                       ++ FGL++    +          +   G+        ++APE      
Sbjct: 158 QSLDENAPVCAKVADFGLSQQSVHSV---------SGLLGN------FQWMAPETIGAEE 202

Query: 541 SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP-LSEVIDPALV 599
             +T+K D YSF ++L  ILTG  P            +++       RP + E   P L 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--REEGLRPTIPEDCPPRLR 260

Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
             I               C   DP+ RP    + + L  
Sbjct: 261 NVIEL-------------CWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  141 bits (357), Expect = 5e-38
 Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 46/277 (16%)

Query: 373 TVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL--ISDFIRN 429
             + V+ L   D + R  +DF  E   +    HPN++ +     +        I+ ++  
Sbjct: 34  NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93

Query: 430 GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           GSLY  LH G +     +     +K A   ARG+ ++H   P       + S  +++D++
Sbjct: 94  GSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDED 149

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK---FTQK 546
           +   IS   +        ++            +        ++APEA +         + 
Sbjct: 150 MTARISMADVKFSFQSPGRM---------YAPA--------WVAPEA-LQKKPEDTNRRS 191

Query: 547 CDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRP-LSEVIDPALVKEIHAK 605
            D++SF ++L E++T  +P A   N    +E  ++ A    RP +   I P + K +   
Sbjct: 192 ADMWSFAVLLWELVTREVPFADLSN----MEIGMKVALEGLRPTIPPGISPHVSKLMKI- 246

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKLQ 642
                       C   DP  RP+   +   L++++ +
Sbjct: 247 ------------CMNEDPAKRPKFDMIVPILEKMQDK 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (353), Expect = 4e-37
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 54/282 (19%)

Query: 375 VAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           VA+R +        + K F+ EV A  + +H N+V       +     +I+   +  +LY
Sbjct: 58  VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
           + +     D+   L      +IAQ   +G+ Y+H    +  +H ++KS  +  D+     
Sbjct: 118 SVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN--GKV 168

Query: 494 -ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE--------ARIYGSKFT 544
            I+ FGL  +        + E  +    G         +LAPE               F+
Sbjct: 169 VITDFGLFSISGVLQ-AGRREDKLRIQNGW------LCHLAPEIIRQLSPDTEEDKLPFS 221

Query: 545 QKCDVYSFGIVLLEILTGRLPDAGPEND------GKGLESLVRKAFRERRPLSEVIDPAL 598
           +  DV++ G +  E+     P      +      G G+          +  LS++     
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM----------KPNLSQIGMGKE 271

Query: 599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
           + +            I L C   + E RP    + + L+++ 
Sbjct: 272 ISD------------ILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  136 bits (344), Expect = 9e-36
 Identities = 64/301 (21%), Positives = 105/301 (34%), Gaps = 57/301 (18%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVE--AIARVQHPNIVRL-----KAFYYANDEKLLISD 425
             VAV+  +  +     ++F +E     +  ++H NI R      +       E LL+ +
Sbjct: 37  RPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92

Query: 426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPR------KYVHGNI 479
           +  NGSL   L            W +  ++A    RGL Y+H   PR         H ++
Sbjct: 93  YYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDL 146

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV--TSGTGSRISAISNVYLAPE-- 535
            S  +L+ ++    IS FGL+  L G   V   E      S  G+        Y+APE  
Sbjct: 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR------YMAPEVL 200

Query: 536 ----ARIYGSKFTQKCDVYSFGIVLLEIL---TGRLPDAGPE-----------NDGKGLE 577
                        ++ D+Y+ G++  EI    T   P                N     +
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED 260

Query: 578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
             V  +  ++RP      P   KE     + L       +C + D E R   +   E + 
Sbjct: 261 MQVLVSREKQRP---KF-PEAWKENSLAVRSLK--ETIEDCWDQDAEARLTAQXAEERMA 314

Query: 638 R 638
            
Sbjct: 315 E 315

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (330), Expect = 4e-34
 Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 38/217 (17%)

Query: 373 TVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-------NDEKLLIS 424
             VAV+  +  D  +W     E+E+     ++H NI+    F  +       + +  LI+
Sbjct: 32  ENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILG---FIASDMTSRHSSTQLWLIT 85

Query: 425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY-----VHGNI 479
            +   GSLY  L          L   + L+I    A GL ++H             H ++
Sbjct: 86  HYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---- 535
           KS  IL+      CI+  GL  +   ++   + +       G++       Y+APE    
Sbjct: 140 KSKNILVKKNGQCCIADLGLAVMHSQST--NQLDVGNNPRVGTKR------YMAPEVLDE 191

Query: 536 -ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
             ++      ++ D+++FG+VL E+    + +   E+
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 8e-34
 Identities = 63/302 (20%), Positives = 102/302 (33%), Gaps = 70/302 (23%)

Query: 373 TVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK--------LLI 423
             VAV+     + A+W     E+E+     ++H NI+     + A D K         LI
Sbjct: 61  EKVAVKVFFTTEEASWFR---ETEIYQTVLMRHENILG----FIAADIKGTGSWTQLYLI 113

Query: 424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY-----VHGN 478
           +D+  NGSLY  L +        L  ++ LK+A  +  GL ++H             H +
Sbjct: 114 TDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167

Query: 479 IKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE--- 535
           +KS  IL+      CI+  GL       +           GT  R       Y+ PE   
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT-KR-------YMPPEVLD 219

Query: 536 --ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK----------- 582
                   +     D+YSFG++L E+    +     E        LV             
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279

Query: 583 AFRERRP------LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             ++ RP       S+     + K +               C   +P  R     V ++L
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTE-------------CWAHNPASRLTALRVKKTL 326

Query: 637 DR 638
            +
Sbjct: 327 AK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (320), Expect = 2e-32
 Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 38/217 (17%)

Query: 373 TVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYA-------NDEKLLIS 424
             VAV+  +  +  +W     E+E+     ++H NI+    F  A         +  L+S
Sbjct: 66  EEVAVKIFSSREERSWFR---EAEIYQTVMLRHENILG---FIAADNKDNGTWTQLWLVS 119

Query: 425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY-----VHGNI 479
           D+  +GSL+  L+         +  E  +K+A  TA GL ++H             H ++
Sbjct: 120 DYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173

Query: 480 KSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---- 535
           KS  IL+      CI+  GL       +     +       G++       Y+APE    
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTI--DIAPNHRVGTKR------YMAPEVLDD 225

Query: 536 -ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
              +   +  ++ D+Y+ G+V  EI          E+
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (290), Expect = 4e-27
 Identities = 26/141 (18%), Positives = 43/141 (30%), Gaps = 2/141 (1%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
               +L L    L             L  L L+             + ++L  L L  N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF-SGQIPEMYG 183
                      L +L  L      L       +  L+ L   LN++ N   S ++PE + 
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQSFKLPEYFS 146

Query: 184 HFPVMVSLDLRNNNLSGEIPQ 204
           +   +  LDL +N +      
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCT 167

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (289), Expect = 5e-27
 Identities = 32/140 (22%), Positives = 53/140 (37%), Gaps = 4/140 (2%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L L    +   M S    L  L  L    +N  +    ++F +  NL+YLD++H    
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSL-PEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
                    L +L  L ++ N    +  P+   +LR LT  L+LS  Q     P  +   
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSL 493

Query: 186 PVMVSLDLRNNNLSGEIPQV 205
             +  L++ +NN        
Sbjct: 494 SSLQVLNMSHNNFFSLDTFP 513

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  114 bits (287), Expect = 1e-26
 Identities = 40/165 (24%), Positives = 55/165 (33%), Gaps = 5/165 (3%)

Query: 68  TSLYLPNRNLTGYMP-SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             L   + NL      S    L +L  L ++  +            ++L  L +A NSF 
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 127 GPI-PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
               PD    L+NLT LDLS   L    P     L +L   LN+S N F       Y   
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCL 517

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAF--SGNPGLCGFPLQ 228
             +  LD   N++     Q              + N   C    Q
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  107 bits (270), Expect = 1e-24
 Identities = 31/148 (20%), Positives = 50/148 (33%), Gaps = 6/148 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    +          L+ L+ L L  N             ++L  L     +   
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNG-SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
                I  LK L  L+++ NL+    LPE+  +L  L   L+LS N+             
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE-HLDLSSNKIQSIYCTDLRVLH 173

Query: 187 ----VMVSLDLRNNNLSGEIPQVGSLLN 210
               + +SLDL  N ++   P     + 
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIR 201

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  105 bits (263), Expect = 7e-24
 Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 5/139 (3%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI 133
             N    +P    L  S   L L+ N        + F+   L  LDL+            
Sbjct: 16  ELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72

Query: 134 KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDL 193
           ++L +L+ L L+ N +          L +L   L       +       GH   +  L++
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQ-KLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 194 RNNNL-SGEIPQVGSLLNQ 211
            +N + S ++P+  S L  
Sbjct: 132 AHNLIQSFKLPEYFSNLTN 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 31/141 (21%), Positives = 49/141 (34%), Gaps = 10/141 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN--SF 125
             L L N             L SL RL+  SN           +  +L +LDL+ N  SF
Sbjct: 307 QHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSF 361

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIP-EMYGH 184
            G          +L +LDLS N +      F L L  L   L+   +         ++  
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNF-LGLEQLE-HLDFQHSNLKQMSEFSVFLS 419

Query: 185 FPVMVSLDLRNNNLSGEIPQV 205
              ++ LD+ + +       +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGI 440

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 34/142 (23%), Positives = 50/142 (35%), Gaps = 8/142 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK-PIPANLFNATNLVYLDLAHNSFC 126
             L     NL       +G L +L  L++A N      +P    N TNL +LDL+ N   
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 127 GPIPDRIKTLKNLT----HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE-M 181
                 ++ L  +      LDLS N +N   P    ++R L   L L  N  S  + +  
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LH-KLTLRNNFDSLNVMKTC 220

Query: 182 YGHFPVMVSLDLRNNNLSGEIP 203
                 +    L       E  
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGN 242

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.6 bits (176), Expect = 4e-13
 Identities = 22/161 (13%), Positives = 42/161 (26%), Gaps = 14/161 (8%)

Query: 50  SDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANL 109
                     +H +     SL L    +    P     +  L +L+L +N  S  +    
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTC 220

Query: 110 FNA-TNLVYLDLAHNSFCGPI---PDRIKTLKNLTHLDLSSNLLN------GSLPEFLLD 159
                 L    L    F             L+ L +L +    L         + +    
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280

Query: 160 LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
           L  ++ + +L            + +      L+L N     
Sbjct: 281 LTNVS-SFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 21/108 (19%), Positives = 42/108 (38%), Gaps = 5/108 (4%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFN-ATNLVYLDLAHNS 124
            +  L + + N           LNSL  L  + N+        L +  ++L +L+L  N 
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

Query: 125 F-CG-PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS 170
           F C       ++ +K+   L +    +  + P     +  L  +LN++
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVL--SLNIT 600

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  111 bits (279), Expect = 5e-27
 Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 54/298 (18%)

Query: 360 KVVVGR--GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
            V + R    G     +VAV++L       + +DF+ E++ +  +    IV+ +   Y  
Sbjct: 38  SVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96

Query: 418 DEK--LLISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +   L+ +++ +G L   L           L     L  +    +G+ Y+     R+ 
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS---RRC 148

Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           VH ++ +  IL++ E H  I+ FGL +LLP    + K+  +V     S I      + AP
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPIF-----WYAP 199

Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEV 593
           E+      F+++ DV+SFG+VL E+ T      +      + +        R+   LS +
Sbjct: 200 ESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-----RDVPALSRL 253

Query: 594 IDPALVK-------------EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           ++  L++             E+H          +   C    P+ RP    +   LD 
Sbjct: 254 LE--LLEEGQRLPAPPACPAEVH---------ELMKLCWAPSPQDRPSFSALGPQLDM 300

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  113 bits (286), Expect = 1e-26
 Identities = 30/207 (14%), Positives = 59/207 (28%), Gaps = 20/207 (9%)

Query: 21  SLNQDGLALLALKAAIAQDP-------TRALDSWSESDSTPCHWSGIHCI----RNRVTS 69
              +D LAL  +  A+           T+   +W+ +      W     +      RVT 
Sbjct: 27  EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSNGRVTG 85

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP----IPANLFNATNLVYLDLAHNSF 125
           L L     +G +P  +G L  L  L+L S+          P  +    +          +
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 126 CGPIPDRIK--TLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                D        +L    ++S+    S+ +        T  +    N  +  + +   
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT-QIGQLSNNITF-VSKAVM 203

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLN 210
               +    + N+    E         
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENE 230

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (277), Expect = 2e-25
 Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 25/185 (13%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFS-------KPIPANLFNATNLVYLDL 120
           +S+ L N  ++ +        + L+ ++L  N  +       K    N  N   L  +DL
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495

Query: 121 AHNSFCGPIPDRIK--TLKNLTHLDLSSNLLNGSLPEFLLDLRALTG-----TLNLSFNQ 173
             N     + D  +  TL  L  +DLS N  +   P   L+   L G       +   N+
Sbjct: 496 RFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553

Query: 174 FSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGS---LLNQGPTAFSGNPGLCGFPLQSP 230
              + PE     P +  L + +N++     ++     +L+        NP      L   
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLD-----IKDNP-NISIDLSYV 607

Query: 231 CPEPE 235
           CP  E
Sbjct: 608 CPYIE 612

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (272), Expect = 8e-25
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 12/153 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L      L G +P   G    L  L+LA N  ++ IPAN       +  L  AHN   
Sbjct: 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK 390

Query: 127 G-PIPDRIKTLKNLTHLDLSSNLLNG-------SLPEFLLDLRALTGTLNLSFNQFSGQI 178
             P     K++  ++ +D S N +          L         ++ ++NLS NQ S   
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS-SINLSNNQISKFP 449

Query: 179 PEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
            E++     + S++L  N L+          N+
Sbjct: 450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  107 bits (268), Expect = 2e-24
 Identities = 27/154 (17%), Positives = 57/154 (37%), Gaps = 13/154 (8%)

Query: 68  TSLYLPNRNL-TGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             +Y+   NL T  + + L  +  L  L    N     +PA   +   L  L+LA+N   
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQIT 366

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSG-------Q 177
               +     + + +L  + N L   +P       +  ++  ++ S+N+           
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS-AIDFSYNEIGSVDGKNFDP 424

Query: 178 IPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
           +         + S++L NN +S    ++ S  + 
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  101 bits (254), Expect = 1e-22
 Identities = 23/171 (13%), Positives = 57/171 (33%), Gaps = 30/171 (17%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA--------------- 112
           T +   + N+T  +   +  L  L +  + ++ F        +                 
Sbjct: 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244

Query: 113 ----TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG--- 165
                +L  +++ +      +P  +K L  +  ++++ N    S  +   D +AL     
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI-SGEQLKDDWQALADAPV 303

Query: 166 -----TLNLSFNQF-SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
                 + + +N   +  +         +  L+   N L G++P  GS + 
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIK 354

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  101 bits (253), Expect = 2e-22
 Identities = 26/159 (16%), Positives = 57/159 (35%), Gaps = 17/159 (10%)

Query: 68  TSLYLPNRNLTGYMPS-ELGLLNSLTRLSLASNNFSK-------PIPANLFNATNLVYLD 119
            +L   +  L       +   ++ ++ +  + N           P+    F   N+  ++
Sbjct: 380 ENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSIN 439

Query: 120 LAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG-------SLPEFLLDLRALTGTLNLSFN 172
           L++N       +   T   L+ ++L  N+L            E   +   LT +++L FN
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT-SIDLRFN 498

Query: 173 QFSGQIPEM-YGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           + +    +      P +V +DL  N+ S    Q  +   
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSST 537

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.7 bits (249), Expect = 5e-22
 Identities = 22/166 (13%), Positives = 51/166 (30%), Gaps = 30/166 (18%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            +    + +      +     +    T++   SNN +  +   +   T L    + ++ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 126 CGP-------------------IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
                                    +   LK+LT +++ +      LP FL  L  +   
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ-L 277

Query: 167 LNLSFNQF--------SGQIPEMYGHFPVMVSLDLRNNNL-SGEIP 203
           +N++ N+           Q          +  + +  NNL +  + 
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 96.3 bits (240), Expect = 5e-21
 Identities = 30/164 (18%), Positives = 55/164 (33%), Gaps = 18/164 (10%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF--NATNLVYLDLAH 122
           N +T +    +N              LT + L  N  +K +  +        LV +DL++
Sbjct: 467 NMLTEI---PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSY 522

Query: 123 NSFCGPIPDRIKTLKNLTHLDLSSNL------LNGSLPEFLLDLRALTGTLNLSFNQFSG 176
           NSF    P +      L    + +             PE +    +LT  L +  N    
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT-QLQIGSNDIRK 580

Query: 177 QIPEMYGHFPVMVSLDLRNNNLSG-EIPQVGSLLNQGPTAFSGN 219
            + E     P +  LD+++N     ++  V   +  G      +
Sbjct: 581 -VNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 92.8 bits (231), Expect = 7e-20
 Identities = 26/140 (18%), Positives = 45/140 (32%), Gaps = 14/140 (10%)

Query: 68  TSLYLPNRNLTGYMPSELGLLN--SLTRLSLASNNFSKPIPANLFNATNLVYL------D 119
           TS+ L    LT  +  +        L  + L+ N+FSK  P    N++ L         D
Sbjct: 491 TSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548

Query: 120 LAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIP 179
              N      P+ I    +LT L + SN +     +   ++      L++  N       
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNIS----VLDIKDNPNISIDL 604

Query: 180 EMYGHFPVMVSLDLRNNNLS 199
                +       L  +   
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.6 bits (189), Expect = 1e-14
 Identities = 20/196 (10%), Positives = 47/196 (23%), Gaps = 31/196 (15%)

Query: 20  FSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTG 79
            + +      L+  A   +D     + W   +       G                    
Sbjct: 12  LTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGT----------------- 54

Query: 80  YMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNL 139
                     +    +   + +      +L +   +  L L      G +PD I  L  L
Sbjct: 55  -------QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107

Query: 140 THLDLSSNLLNG----SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG--HFPVMVSLDL 193
             L L S+          P+ +    +           +     +      F  ++   +
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDE-QKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166

Query: 194 RNNNLSGEIPQVGSLL 209
            ++     I +   + 
Sbjct: 167 NSDPQQKSIKKSSRIT 182

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (271), Expect = 3e-26
 Identities = 65/299 (21%), Positives = 108/299 (36%), Gaps = 53/299 (17%)

Query: 360 KVVVGR--GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           KV + R    G      VAV+ L          D + E+E +  + H NIV+ K     +
Sbjct: 36  KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95

Query: 418 DEK--LLISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
                 LI +F+ +GSL   L       +L        LK A    +G+ Y+     R+Y
Sbjct: 96  GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYLGS---RQY 147

Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLA 533
           VH ++ +  +L++ E    I  FGL + +        ++   T            V + A
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIE------TDKEYYTVKDDRDSP----VFWYA 197

Query: 534 PEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLES------------LV 580
           PE  +   KF    DV+SFG+ L E+LT      +      K +               +
Sbjct: 198 PECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           ++  R   P      P    E++          +   C E  P  R   + + E  + +
Sbjct: 257 KEGKRLPCP------PNCPDEVY---------QLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (269), Expect = 5e-26
 Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 57/300 (19%)

Query: 360 KVVVGR--GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
            V + R          VVAV++L         +DFE E+E +  +QH NIV+ K   Y+ 
Sbjct: 25  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSLQHDNIVKYKGVCYSA 83

Query: 418 DEK--LLISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +   LI +++  GSL   L           L     L+      +G+ Y+     ++Y
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT---KRY 135

Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           +H ++ +  IL+++E    I  FGL ++LP      +++             I   + AP
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLP------QDKEFFKVKEPGESP-IF--WYAP 186

Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILT----------------GRLPDAGPENDGKGLES 578
           E+     KF+   DV+SFG+VL E+ T                G             L  
Sbjct: 187 ESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--FHLIE 243

Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           L++   R  RP           EI+          I   C   +   RP  R ++  +D+
Sbjct: 244 LLKNNGRLPRP------DGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQ 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 8e-26
 Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 57/300 (19%)

Query: 360 KVVVGR--GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
            V + R          VVAV++L         +DFE E+E +  +QH NIV+ K   Y+ 
Sbjct: 56  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 418 DEK--LLISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKY 474
             +   LI +++  GSL   L           L     L+      +G+ Y+     ++Y
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLGT---KRY 166

Query: 475 VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
           +H ++ +  IL+++E    I  FGL ++LP      +++             I   + AP
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLP------QDKEYYKVKEPGESP-IF--WYAP 217

Query: 535 EARIYGSKFTQKCDVYSFGIVLLEILT----------------GRLPDAGPENDGKGLES 578
           E+     KF+   DV+SFG+VL E+ T                G             L  
Sbjct: 218 ESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--FHLIE 274

Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           L++   R  RP           EI+          I   C   +   RP  R ++  +D+
Sbjct: 275 LLKNNGRLPRP------DGCPDEIY---------MIMTECWNNNVNQRPSFRDLALRVDQ 319

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 45/279 (16%)

Query: 365 RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKL 421
              G      VA++ L E  +    K+   E   +A V +P++ RL              
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL----LGICLTSTVQ 92

Query: 422 LISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           LI+  +  G L   +     +     L     L      A+G+ Y+ +   R+ VH ++ 
Sbjct: 93  LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLED---RRLVHRDLA 144

Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  +L+    H  I+ FGL +LL    K            G ++  I   ++A E+ ++ 
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYH-------AEGGKV-PIK--WMALESILHR 194

Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
             +T + DV+S+G+ + E++T G  P  G       + S++ K  R  +P      P   
Sbjct: 195 -IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP------PICT 245

Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
            +++          I   C  +D + RP+ R +     +
Sbjct: 246 IDVY---------MIMRKCWMIDADSRPKFRELIIEFSK 275

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  105 bits (263), Expect = 5e-25
 Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 51/296 (17%)

Query: 360 KVVVGR--GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN 417
           KV +     +  G   +VAV+ L           ++ E++ +  + H +I++ K      
Sbjct: 46  KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105

Query: 418 DEK--LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
                 L+ +++  GSL   L    S  L  L     L  AQ    G+ Y+H    + Y+
Sbjct: 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQL-----LLFAQQICEGMAYLHA---QHYI 156

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE 535
           H ++ +  +LLD++    I  FGL + +P           V     S +      + APE
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPVF-----WYAPE 207

Query: 536 ARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLES------------LVRK 582
                 KF    DV+SFG+ L E+LT      + P    + +              L+ +
Sbjct: 208 CLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
             R  RP           E++         H+  NC E +  FRP    +   L  
Sbjct: 267 GERLPRP------DKCPAEVY---------HLMKNCWETEASFRPTFENLIPILKT 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (266), Expect = 6e-25
 Identities = 59/281 (20%), Positives = 104/281 (37%), Gaps = 40/281 (14%)

Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL 422
           V  G      T+VAV+   E         F  E   + +  HPNIVRL           +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189

Query: 423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
           + + ++ G     L          L  +  L++    A G+ Y+     +  +H ++ + 
Sbjct: 190 VMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAAR 242

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK 542
             L+ ++    IS FG++R           + +  +  G R   +   + APEA  YG +
Sbjct: 243 NCLVTEKNVLKISDFGMSREE--------ADGVYAASGGLRQVPVK--WTAPEALNYG-R 291

Query: 543 FTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESL--VRKAFRERRPLSEVIDPALV 599
           ++ + DV+SFGI+L E  + G  P     N     ++   V K  R   P          
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFVEKGGRLPCP------ELCP 341

Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
             +           +   C   +P  RP   T+ + L  ++
Sbjct: 342 DAVFR---------LMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  108 bits (271), Expect = 1e-24
 Identities = 34/145 (23%), Positives = 48/145 (33%), Gaps = 1/145 (0%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
           +T L L +  L     +     + LT L +  N  SK  P        L  L+L HN   
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
                      NLT L L SN +        +  + L  TL+LS N  S           
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI-TLDLSHNGLSSTKLGTQVQLE 145

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQ 211
            +  L L NN +     +   +   
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFAN 170

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (265), Expect = 6e-24
 Identities = 38/148 (25%), Positives = 52/148 (35%), Gaps = 3/148 (2%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L +  L+           +LT L L SN+  K          NL+ LDL+HN    
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFL--LDLRALTGTLNLSFNQFSGQIPEMYGHF 185
                   L+NL  L LS+N +     E L      +L   L LS NQ     P  +   
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK-KLELSSNQIKEFSPGCFHAI 194

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGP 213
             +  L L N  L   + +   L     
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANT 222

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  105 bits (263), Expect = 9e-24
 Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 4/153 (2%)

Query: 50  SDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANL 109
           S  T  + + +    + +  L L    ++         L  L  L L  N   + +    
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425

Query: 110 F-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG--SLPEFLLDLRALTGT 166
           +    N+  + L++N +     +    + +L  L L    L    S P     LR LT  
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT-I 484

Query: 167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
           L+LS N  +    +M      +  LDL++NNL+
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  103 bits (259), Expect = 3e-23
 Identities = 40/148 (27%), Positives = 55/148 (37%), Gaps = 11/148 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK--PIPANLFNATNLVYLDLAHNSF 125
             +YL          +   L+ SL RL L           P+      NL  LDL++N+ 
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLN--------GSLPEFLLDLRALTGTLNLSFNQFSGQ 177
                D ++ L+ L  LDL  N L         G    FL  L  L   LNL  N F   
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH-ILNLESNGFDEI 551

Query: 178 IPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
             E++     +  +DL  NNL+     V
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASV 579

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (254), Expect = 1e-22
 Identities = 33/155 (21%), Positives = 53/155 (34%), Gaps = 14/155 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
                 +  LT  +P    L  ++T L+L  N   +   AN    + L  LD+  N+   
Sbjct: 7   EVADCSHLKLTQ-VPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P+  + L  L  L+L  N L+    +       LT  L+L  N         +     
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLT-ELHLMSNSIQKIKNNPFVKQKN 122

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +++LDL +N LS                      L
Sbjct: 123 LITLDLSHNGLSSTKLG----------TQVQLENL 147

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (250), Expect = 4e-22
 Identities = 36/144 (25%), Positives = 53/144 (36%), Gaps = 6/144 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANL--FNATNLVYLDLAHNSF 125
            +L L +  L+         L +L  L L++N         L  F  ++L  L+L+ N  
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG--TLNLSFNQFSGQIPEMYG 183
               P     +  L  L L++  L  SL E L    A T    L+LS +Q S      + 
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 184 HFPVM--VSLDLRNNNLSGEIPQV 205
                    LDL  NNL+      
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDS 267

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 96.6 bits (241), Expect = 6e-21
 Identities = 31/170 (18%), Positives = 57/170 (33%), Gaps = 12/170 (7%)

Query: 52  STPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLN--SLTRLSLASNNFSKPIPANL 109
            +      +      + +L L N  L+    +    L   +LT L L+ NN +     + 
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

Query: 110 FNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSL---------PEFLLDL 160
                L Y  L +N+        +  L N+ +L+L  +    S+               L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 161 RALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           + L   LN+  N   G    M+     +  L L N+  S       + ++
Sbjct: 329 KCLE-HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 8e-21
 Identities = 31/153 (20%), Positives = 56/153 (36%), Gaps = 8/153 (5%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLN--SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
            +  L L N  +      EL +    SL +L L+SN   +  P        L  L L + 
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 124 SFCGPIPDRIK---TLKNLTHLDLSSNLLNGSLPEFL--LDLRALTGTLNLSFNQFSGQI 178
                + +++       ++ +L LS++ L+ +       L    LT  L+LS+N  +   
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT-MLDLSYNNLNVVG 264

Query: 179 PEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
            + +   P +    L  NN+          L  
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 1e-20
 Identities = 33/160 (20%), Positives = 59/160 (36%), Gaps = 14/160 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFS-KPIPANLF---NATNLVYLDLAHN 123
             L + + ++ G   +    L +L  LSL+++  S + +    F     + L  L+L  N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPEMY 182
                  D    L +L  LDL  N +   L  +    L  +   + LS+N++       +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF-EIYLSYNKYLQLTRNSF 450

Query: 183 GHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
              P +  L LR   L          ++  P+ F     L
Sbjct: 451 ALVPSLQRLMLRRVALKN--------VDSSPSPFQPLRNL 482

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 27/112 (24%), Positives = 40/112 (35%), Gaps = 2/112 (1%)

Query: 71  YLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIP 130
            L      G     L  L+ L  L+L SN F +       +   L  +DL  N+      
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 131 DRIKTLKNLTHLDLSSNLLNGSLPE-FLLDLRALTGTLNLSFNQFSGQIPEM 181
                  +L  L+L  NL+     + F    R LT  L++ FN F      +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT-ELDMRFNPFDCTCESI 628

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 20/135 (14%), Positives = 36/135 (26%), Gaps = 9/135 (6%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            +  L L +             L  L  + L  NN +    +   N  +L  L+L  N  
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596

Query: 126 CGPIPDRIKT-LKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
                       +NLT LD+  N  + +       +      +N +             +
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHYLCN 652

Query: 185 FPVMVSLDLRNNNLS 199
            P           + 
Sbjct: 653 TP----PHYHGFPVR 663

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/284 (19%), Positives = 114/284 (40%), Gaps = 46/284 (16%)

Query: 361 VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---N 417
           V  G          VA++ L +G      ++   E + + ++ +P IVRL          
Sbjct: 26  VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL----IGVCQA 81

Query: 418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
           +  +L+ +    G L+  L     +    +P     ++    + G+ Y+ E   + +VH 
Sbjct: 82  EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE---KNFVHR 134

Query: 478 NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           ++ +  +LL +  +  IS FGL++ L        +++  T+ +  +   +   + APE  
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALG------ADDSYYTARSAGKWP-LK--WYAPECI 185

Query: 538 IYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVI 594
            +  KF+ + DV+S+G+ + E L+ G+ P    +      E  + + +  R   P     
Sbjct: 186 NFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKRMECP----- 235

Query: 595 DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
            P    E++          +  +C     E RP   TV + +  
Sbjct: 236 -PECPPELY---------ALMSDCWIYKWEDRPDFLTVEQRMRA 269

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  106 bits (266), Expect = 3e-24
 Identities = 64/336 (19%), Positives = 132/336 (39%), Gaps = 57/336 (16%)

Query: 309 EKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSG 368
           + +      +D EE +  K F+  +   +   +L        G    G + +   G    
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL--------GCGNFGSVRQ---GVYRM 359

Query: 369 MGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISD 425
                 VA++ L +G      ++   E + + ++ +P IVRL          +  +L+ +
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL----IGVCQAEALMLVME 415

Query: 426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
               G L+  L     +    +P     ++    + G+ Y+ E   + +VH N+ +  +L
Sbjct: 416 MAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVL 468

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           L +  +  IS FGL++ L        +++  T+ +  +   +   + APE   +  KF+ 
Sbjct: 469 LVNRHYAKISDFGLSKALG------ADDSYYTARSAGKW-PLK--WYAPECINFR-KFSS 518

Query: 546 KCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKEI 602
           + DV+S+G+ + E L+ G+ P    +      E  + + +  R   P      P    E+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKRMECP------PECPPEL 568

Query: 603 HAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           +A         +  +C     E RP   TV + +  
Sbjct: 569 YA---------LMSDCWIYKWEDRPDFLTVEQRMRA 595

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  105 bits (263), Expect = 5e-24
 Identities = 62/279 (22%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 363 VGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL 422
           V  G        VAV+ L E       ++F  E   +  ++HPN+V+L           +
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293

Query: 423 ISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           I++F+  G+L  Y         S   L     L +A   +  + Y+ +   + ++H N+ 
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAMEYLEK---KNFIHRNLA 345

Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +   L+ +     ++ FGL+RL+             T+  G++   I   + APE+  Y 
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLM--------TGDTYTAHAGAKF-PIK--WTAPESLAYN 394

Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
            KF+ K DV++FG++L EI T G  P  G +     +  L+ K +R  RP          
Sbjct: 395 -KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRMERP------EGCP 445

Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           ++++          +   C + +P  RP    + ++ + 
Sbjct: 446 EKVY---------ELMRACWQWNPSDRPSFAEIHQAFET 475

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (254), Expect = 5e-24
 Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 44/283 (15%)

Query: 361 VVVGRGSGMGAPTVVAVRRLTEG-DATWRFKDFESEVEAIARVQHPNIVRLKAFYYA--- 416
           V  G          VAV+ L    +      +  +E   + ++ +P IVR+         
Sbjct: 33  VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM----IGICE 88

Query: 417 NDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVH 476
            +  +L+ +    G L   L          +     +++    + G+ Y+ E     +VH
Sbjct: 89  AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVH 140

Query: 477 GNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA 536
            ++ +  +LL  + +  IS FGL++ L        +E    + T  +   +   + APE 
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALR------ADENYYKAQTHGKWP-VK--WYAPEC 191

Query: 537 RIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVID 595
             Y  KF+ K DV+SFG+++ E  + G+ P  G +     + +++ K  R   P      
Sbjct: 192 INYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCP------ 242

Query: 596 PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
               +E++          +   C   D E RP    V   L  
Sbjct: 243 AGCPREMYD---------LMNLCWTYDVENRPGFAAVELRLRN 276

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (256), Expect = 5e-24
 Identities = 55/280 (19%), Positives = 107/280 (38%), Gaps = 45/280 (16%)

Query: 365 RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKL 421
              G      V ++ + +      F+     + AI  + H +IVRL              
Sbjct: 35  IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL----LGLCPGSSLQ 90

Query: 422 LISDFIRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
           L++ ++  GSL   +     +     L     L      A+G+ Y+ E      VH N+ 
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYYLEE---HGMVHRNLA 142

Query: 481 STKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG 540
           +  +LL       ++ FG+  LLP        +      + ++   I   ++A E+  +G
Sbjct: 143 ARNVLLKSPSQVQVADFGVADLLP-------PDDKQLLYSEAKT-PIK--WMALESIHFG 192

Query: 541 SKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
            K+T + DV+S+G+ + E++T G  P AG       +  L+ K  R  +P          
Sbjct: 193 -KYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGERLAQP------QICT 243

Query: 600 KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            +++          + + C  +D   RP  + ++    R+
Sbjct: 244 IDVY---------MVMVKCWMIDENIRPTFKELANEFTRM 274

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  100 bits (252), Expect = 1e-23
 Identities = 58/277 (20%), Positives = 102/277 (36%), Gaps = 43/277 (15%)

Query: 370 GAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLIS 424
           G    VAV+ L            DF  EV A+  + H N++RL    Y         +++
Sbjct: 44  GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL----YGVVLTPPMKMVT 99

Query: 425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI 484
           +    GSL   L                 + A   A G+ Y+     ++++H ++ +  +
Sbjct: 100 ELAPLGSLLDRLR-KHQGHFLL---GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNL 152

Query: 485 LLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFT 544
           LL       I  FGL R LP       N+         ++   +  + APE+      F+
Sbjct: 153 LLATRDLVKIGDFGLMRALPQ------NDDHYVMQEHRKVP-FA--WCAPESLKTR-TFS 202

Query: 545 QKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIH 603
              D + FG+ L E+ T G+ P  G     + L  + ++  R  RP          ++I+
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGERLPRP------EDCPQDIY 255

Query: 604 AKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
                    ++ + C    PE RP    + + L   +
Sbjct: 256 ---------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 283

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  101 bits (253), Expect = 1e-23
 Identities = 57/278 (20%), Positives = 111/278 (39%), Gaps = 43/278 (15%)

Query: 365 RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKL 421
              G      VA++ L E  +    K+   E   +A V +P++ RL              
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL----LGICLTSTVQ 92

Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           LI+  +  G L   +     +    +  +  L      A+G+ Y+ +   R+ VH ++ +
Sbjct: 93  LITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAA 145

Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
             +L+    H  I+ FGL +LL    K            G ++  I   ++A E+ ++  
Sbjct: 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYH-------AEGGKV-PIK--WMALESILHR- 194

Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
            +T + DV+S+G+ + E++T G  P  G       + S++ K  R  +P      P    
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLPQP------PICTI 246

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           +++          I + C  +D + RP+ R +     +
Sbjct: 247 DVY---------MIMVKCWMIDADSRPKFRELIIEFSK 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 53/277 (19%), Positives = 100/277 (36%), Gaps = 52/277 (18%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDF 426
                VA++      +    + F  E   + +  HP+IV+L          +   +I + 
Sbjct: 41  NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL----IGVITENPVWIIMEL 96

Query: 427 IRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
              G L + L     S  L  L     +  A   +  L Y+     +++VH +I +  +L
Sbjct: 97  CTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES---KRFVHRDIAARNVL 148

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEARIYGSKFT 544
           +       +  FGL+R +         ++     +  ++     + ++APE+  +  +FT
Sbjct: 149 VSSNDCVKLGDFGLSRYM--------EDSTYYKASKGKLP----IKWMAPESINFR-RFT 195

Query: 545 QKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKE 601
              DV+ FG+ + EIL  G  P  G +N+    +    +    R   P      P     
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPMP------PNCPPT 245

Query: 602 IHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           ++          +   C   DP  RPR   +   L  
Sbjct: 246 LY---------SLMTKCWAYDPSRRPRFTELKAQLST 273

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 52/282 (18%), Positives = 100/282 (35%), Gaps = 52/282 (18%)

Query: 366 GSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD 425
             G    T V ++ L +    +  + F      ++++ H ++V         DE +L+ +
Sbjct: 34  DYGQLHETEVLLKVLDKAHRNYS-ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92

Query: 426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
           F++ GSL   L          +    +L++A+  A  + ++ E      +HGN+ +  IL
Sbjct: 93  FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNIL 145

Query: 486 LDDELHPC--------ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           L  E            +S  G++  +           +       RI      ++ PE  
Sbjct: 146 LIREEDRKTGNPPFIKLSDPGISITV-----------LPKDILQERIP-----WVPPECI 189

Query: 538 IYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDP 596
                     D +SFG  L EI + G  P +  ++  K          +   P       
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQFYEDRHQLPAP-----KA 242

Query: 597 ALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           A   E+          ++  NC + +P+ RP  R +   L+ 
Sbjct: 243 A---ELA---------NLINNCMDYEPDHRPSFRAIIRDLNS 272

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 64/294 (21%), Positives = 102/294 (34%), Gaps = 47/294 (15%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G +Y+  V       +P  VAV+ L E  +     DF  E   I++  H NIVR      
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103

Query: 416 ANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK 473
            +  + ++ + +  G L + L            L     L +A+  A G  Y+       
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENH 160

Query: 474 YVHGNIKSTKILLD---DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV 530
           ++H +I +   LL          I  FG+ R       + +       G           
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCA--------- 205

Query: 531 YL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
            L      PEA + G  FT K D +SFG++L EI + G +P     N  + +   V    
Sbjct: 206 MLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 262

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           R   P            ++          I   C +  PE RP    + E ++ 
Sbjct: 263 RMDPP------KNCPGPVY---------RIMTQCWQHQPEDRPNFAIILERIEY 301

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 41/270 (15%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
             VA++ L  G    + +DF SE   + +  HPNI+RL+         +++++++ NGSL
Sbjct: 78  VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
              L                + + +G   G+ Y+ +     YVH ++ +  +L+D  L  
Sbjct: 138 DTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVC 190

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEARIYGSKFTQKCDVYS 551
            +S FGL+R+      +  +     + TG +I     + + APEA  +   F+   DV+S
Sbjct: 191 KVSDFGLSRV------LEDDPDAAYTTTGGKIP----IRWTAPEAIAFR-TFSSASDVWS 239

Query: 552 FGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKEIHAKRQV 608
           FG+V+ E+L  G  P     N     +  S V + +R   P            +H     
Sbjct: 240 FGVVMWEVLAYGERPYWNMTNR----DVISSVEEGYRLPAP------MGCPHALH----- 284

Query: 609 LATFHIALNCTELDPEFRPRMRTVSESLDR 638
                + L+C   D   RPR   +   LD 
Sbjct: 285 ----QLMLDCWHKDRAQRPRFSQIVSVLDA 310

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 39/290 (13%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G++Y+ V          T VA++ + E  +     +F +E   +      ++VRL     
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98

Query: 416 ANDEKLLISDFIRNGSLYAAL-----HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS 470
                L+I + +  G L + L         +  L P      +++A   A G+ Y++   
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 156

Query: 471 PRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV 530
             K+VH ++ +   ++ ++    I  FG+ R +               G    +     V
Sbjct: 157 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------YETDYYRKGGKGLLP----V 204

Query: 531 -YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            +++PE+   G  FT   DV+SFG+VL EI T    P  G  N+   +   V +     +
Sbjct: 205 RWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVMEGGLLDK 261

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           P             +    +   F +   C + +P+ RP    +  S+  
Sbjct: 262 PD------------NCPDML---FELMRMCWQYNPKMRPSFLEIISSIKE 296

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 41/278 (14%)

Query: 365 RGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS 424
           + S       VA++ L  G    +  DF  E   + +  H NI+RL+         ++I+
Sbjct: 66  KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125

Query: 425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI 484
           +++ NG+L   L                + + +G A G+ Y+       YVH ++ +  I
Sbjct: 126 EYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNI 178

Query: 485 LLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEARIYGSKF 543
           L++  L   +S FGL+R+L        +     + +G +I     + + APEA  Y  KF
Sbjct: 179 LVNSNLVCKVSDFGLSRVL------EDDPEATYTTSGGKIP----IRWTAPEAISYR-KF 227

Query: 544 TQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVK 600
           T   DV+SFGIV+ E++T G  P     N     E    +   FR   P           
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAINDGFRLPTP------MDCPS 277

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
            I+          + + C + +   RP+   +   LD+
Sbjct: 278 AIY---------QLMMQCWQQERARRPKFADIVSILDK 306

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 64/294 (21%), Positives = 103/294 (35%), Gaps = 47/294 (15%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G +Y+  V       +P  VAV+ L E  +     DF  E   I++  H NIVR      
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144

Query: 416 ANDEKLLISDFIRNGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRK 473
            +  + ++ + +  G L + L            L     L +A+  A G  Y+       
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENH 201

Query: 474 YVHGNIKSTKILLD---DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV 530
           ++H +I +   LL          I  FG+ R       + +       G           
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCA--------- 246

Query: 531 YL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
            L      PEA + G  FT K D +SFG++L EI + G +P     N  + +   V    
Sbjct: 247 MLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSGG 303

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           R   P  +     +             + I   C +  PE RP    + E ++ 
Sbjct: 304 RMDPP--KNCPGPV-------------YRIMTQCWQHQPEDRPNFAIILERIEY 342

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 38/278 (13%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL 421
            V  G        VAV+ L E       ++F  E   +  ++HPN+V+L           
Sbjct: 28  EVYEGVWKKYSLTVAVKTLKED-TMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85

Query: 422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKS 481
           +I++F+  G+L   L       +        L +A   +  + Y+     + ++H ++ +
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQISSAMEYL---EKKNFIHRDLAA 139

Query: 482 TKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS 541
              L+ +     ++ FGL+RL+             T+  G++   I   + APE+  Y  
Sbjct: 140 RNCLVGENHLVKVADFGLSRLM--------TGDTYTAHAGAKF-PIK--WTAPESLAYN- 187

Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
           KF+ K DV++FG++L EI T G  P  G +     +  L+ K +R  RP          +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRMERP------EGCPE 239

Query: 601 EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           +++          +   C + +P  RP    + ++ + 
Sbjct: 240 KVY---------ELMRACWQWNPSDRPSFAEIHQAFET 268

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 54/269 (20%), Positives = 107/269 (39%), Gaps = 41/269 (15%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
              VA++ + EG  +   +DF  E E + ++ HP +V+L           L+++F+ +G 
Sbjct: 32  KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89

Query: 432 LYAALHAGPSD-SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           L   L       +   L     L +      G+ Y+ E      +H ++ +   L+ +  
Sbjct: 90  LSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQ 141

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FG+ R +         +   TS TG++   +   + +PE   +  +++ K DV+
Sbjct: 142 VIKVSDFGMTRFV--------LDDQYTSSTGTKF-PVK--WASPEVFSFS-RYSSKSDVW 189

Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           SFG+++ E+ + G++P     N    +   +   FR  +P            ++      
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRLYKP------RLASTHVY------ 235

Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLDR 638
               I  +C    PE RP    +   L  
Sbjct: 236 ---QIMNHCWRERPEDRPAFSRLLRQLAE 261

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 4e-22
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 39/269 (14%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
             VA++ L  G    + +DF  E   + +  HPNI+RL+     +   +++++++ NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
            + L                + + +G A G+ Y+ +     YVH ++ +  IL++  L  
Sbjct: 134 DSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVC 186

Query: 493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSF 552
            +S FGL R+L        +     +  G +I      + +PEA  Y  KFT   DV+S+
Sbjct: 187 KVSDFGLGRVL------EDDPEAAYTTRGGKIPI---RWTSPEAIAYR-KFTSASDVWSY 236

Query: 553 GIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           GIVL E+++ G  P     N     +    V + +R   P            ++      
Sbjct: 237 GIVLWEVMSYGERPYWEMSNQ----DVIKAVDEGYRLPPP------MDCPAALY------ 280

Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLDR 638
               + L+C + D   RP+   +   LD+
Sbjct: 281 ---QLMLDCWQKDRNNRPKFEQIVSILDK 306

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 68/302 (22%), Positives = 118/302 (39%), Gaps = 64/302 (21%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA 416
           KV +     +       +VAV+ L E   + R +DF+ E E +  +QH +IVR       
Sbjct: 56  KVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTMLQHQHIVRFFGVCTE 114

Query: 417 NDEKLLISDFIRNGSL----------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
               L++ +++R+G L             L  G   +  PL     L +A   A G++Y+
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                  +VH ++ +   L+   L   I  FG++R +        +      G  + +  
Sbjct: 175 AG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-------STDYYRVGGRTMLP- 223

Query: 527 ISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
              + ++ PE+ +Y  KFT + DV+SFG+VL EI T G+ P     N             
Sbjct: 224 ---IRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------------ 267

Query: 585 RERRPLSEVIDPALVKEIHAKRQVL--------ATFHIALNCTELDPEFRPRMRTVSESL 636
                  E ID   + +     + L          + I   C + +P+ R  ++ V   L
Sbjct: 268 -------EAID--CITQ----GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

Query: 637 DR 638
             
Sbjct: 315 QA 316

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.9 bits (244), Expect = 8e-22
 Identities = 74/273 (27%), Positives = 124/273 (45%), Gaps = 49/273 (17%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDFIR 428
            T VAV+ +  G  +   + F +E   +  +QH  +V+L    +A    +   +I++F+ 
Sbjct: 212 HTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKL----HAVVTKEPIYIITEFMA 265

Query: 429 NGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
            GSL   L    G    LP L     +  +   A G+ +I +   R Y+H ++++  IL+
Sbjct: 266 KGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILV 317

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
              L   I+ FGL R++         +   T+  G++   I     APEA  +G  FT K
Sbjct: 318 SASLVCKIADFGLARVI--------EDNEYTAREGAKF-PIKW--TAPEAINFG-SFTIK 365

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+SFGI+L+EI+T GR+P  G  N    +   + + +R  RP          +E++  
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPRP------ENCPEELY-- 415

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
                  +I + C +  PE RP    +   LD 
Sbjct: 416 -------NIMMRCWKNRPEERPTFEYIQSVLDD 441

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.8 bits (246), Expect = 1e-21
 Identities = 51/273 (18%), Positives = 97/273 (35%), Gaps = 44/273 (16%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDF 426
                VA++      +    + F  E   + +  HP+IV+L          +   +I + 
Sbjct: 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL----IGVITENPVWIIMEL 471

Query: 427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
              G L + L          L   + +  A   +  L Y+     +++VH +I +  +L+
Sbjct: 472 CTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLV 524

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
                  +  FGL+R +         ++     +  ++      ++APE+  +  +FT  
Sbjct: 525 SSNDCVKLGDFGLSRYM--------EDSTYYKASKGKLPI---KWMAPESINFR-RFTSA 572

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+ FG+ + EIL  G  P  G +N    +   +    R   P      P     ++  
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGERLPMP------PNCPPTLY-- 622

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
                   +   C   DP  RPR   +   L  
Sbjct: 623 -------SLMTKCWAYDPSRRPRFTELKAQLST 648

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 55/276 (19%), Positives = 100/276 (36%), Gaps = 50/276 (18%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDF 426
           G    VAV+   +       + F SE   +  + HP+IV+L          +   +I + 
Sbjct: 38  GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMEL 93

Query: 427 IRNGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
              G L   L     S  +  L     +  +    + + Y+        VH +I    IL
Sbjct: 94  YPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYLES---INCVHRDIAVRNIL 145

Query: 486 LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQ 545
           +       +  FGL+R +         +      + +R+  I   +++PE+  +  +FT 
Sbjct: 146 VASPECVKLGDFGLSRYI--------EDEDYYKASVTRL-PIK--WMSPESINFR-RFTT 193

Query: 546 KCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SLVRKAFRERRPLSEVIDPALVKEI 602
             DV+ F + + EIL+ G+ P    EN     +   ++ K  R  +P            +
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEKGDRLPKP------DLCPPVL 243

Query: 603 HAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           +          +   C + DP  RPR   +  SL  
Sbjct: 244 Y---------TLMTRCWDYDPSDRPRFTELVCSLSD 270

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 27/140 (19%), Positives = 51/140 (36%), Gaps = 4/140 (2%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L L + N    M +    L  L  L    +   +    + F +   L+YLD+++ +  
Sbjct: 379 RHLDL-SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437

Query: 127 GPIPDRIKTLKNLTHLDLSSN-LLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
                    L +L  L ++ N   + +L     +   LT  L+LS  Q       ++   
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT-FLDLSKCQLEQISWGVFDTL 496

Query: 186 PVMVSLDLRNNNLSGEIPQV 205
             +  L++ +NNL       
Sbjct: 497 HRLQLLNMSHNNLLFLDSSH 516

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.7 bits (236), Expect = 2e-20
 Identities = 32/144 (22%), Positives = 43/144 (29%), Gaps = 3/144 (2%)

Query: 82  PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI-KTLKNLT 140
            S    L  L  L ++  N            T+L  L +A NSF       +     NLT
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 141 HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
            LDLS   L          L  L   LN+S N         Y     + +LD   N +  
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535

Query: 201 EIPQVGSLLNQGPT-AFSGNPGLC 223
               +            + N   C
Sbjct: 536 SKGILQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.7 bits (236), Expect = 2e-20
 Identities = 26/155 (16%), Positives = 52/155 (33%), Gaps = 13/155 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +    ++ L+  +P    + +S   + L+ N        +  N + L +LDL+      
Sbjct: 14  ITYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                   L +L++L L+ N +    P     L +L   L     + +       G    
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE-NLVAVETKLASLESFPIGQLIT 129

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +  L++ +N +              P  FS    L
Sbjct: 130 LKKLNVAHNFIHSCKL---------PAYFSNLTNL 155

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 25/146 (17%), Positives = 43/146 (29%), Gaps = 2/146 (1%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             ++ L    L           + L  L L+                +L  L L  N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSG-QIPEMYGHF 185
              P     L +L +L      L       +  L  L   LN++ N     ++P  + + 
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK-KLNVAHNFIHSCKLPAYFSNL 152

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQ 211
             +V +DL  N +          L +
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRE 178

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 3/103 (2%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDR 132
           N      + +      +LT L L+     + I   +F     L  L+++HN+        
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

Query: 133 IKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
              L +L+ LD S N +  S        ++L    NL+ N  +
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLA-FFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 30/139 (21%), Positives = 53/139 (38%), Gaps = 8/139 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK-PIPANLFNATNLVYLDLAHNSFC 126
            +L      L       +G L +L +L++A N      +PA   N TNLV++DL++N   
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166

Query: 127 GPIPDRIKTLKNLT----HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM- 181
               + ++ L+        LD+S N ++  + +       L   L L  N  S  I +  
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLH-ELTLRGNFNSSNIMKTC 224

Query: 182 YGHFPVMVSLDLRNNNLSG 200
             +   +    L       
Sbjct: 225 LQNLAGLHVHRLILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 27/149 (18%), Positives = 44/149 (29%), Gaps = 10/149 (6%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
              +    L   N       +   L +++ +SLA  +       ++        L +   
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRC 317

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                 P     L  L  L L+ N  + S     + L +L+  L+LS N  S      Y 
Sbjct: 318 QLKQ-FPT--LDLPFLKSLTLTMNKGSISFK--KVALPSLS-YLDLSRNALSFSGCCSYS 371

Query: 184 HF--PVMVSLDLRNNNLSGEIPQVGSLLN 210
                 +  LDL  N           L  
Sbjct: 372 DLGTNSLRHLDLSFNGAIIMSANFMGLEE 400

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 17/85 (20%), Positives = 31/85 (36%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            +T L L    L          L+ L  L+++ NN      ++     +L  LD + N  
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLN 150
                      K+L   +L++N + 
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 23/136 (16%), Positives = 43/136 (31%), Gaps = 18/136 (13%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFS-----KPIPANLFN---ATNLVYLDLAHNSF 125
           N N +  M + L  L  L    L    F      +    ++        +    L + + 
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                 +   L N++ + L+   +   L +       +    +L++   Q   Q P    
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQ----SLSIIRCQLK-QFPT--L 325

Query: 184 HFPVMVSLDLRNNNLS 199
             P + SL L  N  S
Sbjct: 326 DLPFLKSLTLTMNKGS 341

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 59/281 (20%), Positives = 120/281 (42%), Gaps = 45/281 (16%)

Query: 370 GAPTVVAVRRLTEGDATWR-FKDFESEVEAIARVQHPNIVRL-----KAFYYANDEKLLI 423
           G    VAV+ +   +++ R  ++F SE   +    HPN++RL     +       + ++I
Sbjct: 60  GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119

Query: 424 SDFIRNGSLYAAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKST 482
             F++ G L+  L ++        +P +  LK     A G+ Y+   S R ++H ++ + 
Sbjct: 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAAR 176

Query: 483 KILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEARIYGS 541
             +L D++  C++ FGL++ +        +      G  +++     V ++A E+     
Sbjct: 177 NCMLRDDMTVCVADFGLSKKI-------YSGDYYRQGRIAKMP----VKWIAIESLADR- 224

Query: 542 KFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPL--SEVIDPAL 598
            +T K DV++FG+ + EI T G  P  G +N    +   +    R ++P    + +    
Sbjct: 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGHRLKQPEDCLDEL---- 278

Query: 599 VKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                        + I  +C   DP  RP    +   L+++
Sbjct: 279 -------------YEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 60/291 (20%), Positives = 120/291 (41%), Gaps = 43/291 (14%)

Query: 360 KVVVGRGSGM-GAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRL------K 411
            V   +     G+   VAV+ L          ++F  E   +    HP++ +L       
Sbjct: 38  SVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97

Query: 412 AFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS 470
                    ++I  F+++G L+A L  +   ++   LP +  ++     A G+ Y+   S
Sbjct: 98  RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---S 154

Query: 471 PRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV 530
            R ++H ++ +   +L +++  C++ FGL+R +        +      G  S++     V
Sbjct: 155 SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-------YSGDYYRQGCASKLP----V 203

Query: 531 -YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERR 588
            +LA E+      +T   DV++FG+ + EI+T G+ P AG EN    + + +    R ++
Sbjct: 204 KWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIGGNRLKQ 260

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           P                 +V   + +   C   DP+ RP    +   L+ +
Sbjct: 261 P------------PECMEEV---YDLMYQCWSADPKQRPSFTCLRMELENI 296

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 57/299 (19%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA 416
           KV +     +       +VAV+ L +     R KDF+ E E +  +QH +IV+       
Sbjct: 30  KVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVKFYGVCGD 88

Query: 417 NDEKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            D  +++ +++++G L              +   P  +   L     L IA   A G++Y
Sbjct: 89  GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS--- 522
           +   + + +VH ++ +   L+   L   I  FG++R       V   +     G      
Sbjct: 149 L---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDYYRVGGHTMLPI 199

Query: 523 RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLE--SL 579
           R       ++ PE+ +Y  KFT + DV+SFG++L EI T G+ P     N     E    
Sbjct: 200 R-------WMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIEC 247

Query: 580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           + +     RP          KE++          + L C + +P+ R  ++ + + L  
Sbjct: 248 ITQGRVLERP------RVCPKEVY---------DVMLGCWQREPQQRLNIKEIYKILHA 291

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 57/310 (18%), Positives = 120/310 (38%), Gaps = 50/310 (16%)

Query: 345 ASAYVVGKSKNGIMYKVVVGRGS-GM----------GAPTVVAVRRLTEGDATWRFKDFE 393
               ++   +       V+G+G  G+                A++ L+      + + F 
Sbjct: 11  VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL 70

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDE-KLLISDFIRNGSLYAALHA-GPSDSLPPLPWEA 451
            E   +  + HPN++ L       +    ++  ++ +G L   + +   + ++  L    
Sbjct: 71  REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---- 126

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
            +      ARG+ Y+   + +K+VH ++ +   +LD+     ++ FGL R +     + +
Sbjct: 127 -ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-----LDR 177

Query: 512 NETIVTSGTGSRISAISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
               V     +R+     V + A E+     +FT K DV+SFG++L E+LT G  P    
Sbjct: 178 EYYSVQQHRHARLP----VKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHI 232

Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
           +     L   + +  R  +P            ++          +   C E DP  RP  
Sbjct: 233 DP--FDLTHFLAQGRRLPQP------EYCPDSLY---------QVMQQCWEADPAVRPTF 275

Query: 630 RTVSESLDRV 639
           R +   ++++
Sbjct: 276 RVLVGEVEQI 285

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 53/295 (17%)

Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND 418
           +V+  R    G     A++R+ E  +    +DF  E+E + ++  HPNI+ L        
Sbjct: 40  QVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99

Query: 419 EKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
              L  ++  +G+L                A  + +   L  +  L  A   ARG+ Y+ 
Sbjct: 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL- 158

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
             S ++++H ++ +  IL+ +     I+ FGL+R           + +    T  R+   
Sbjct: 159 --SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYVKKTMGRLP-- 204

Query: 528 SNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR 585
             V ++A E+  Y   +T   DV+S+G++L EI++ G  P  G       L   + + +R
Sbjct: 205 --VRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQGYR 259

Query: 586 ERRPL--SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
             +PL   + +                 + +   C    P  RP    +  SL+R
Sbjct: 260 LEKPLNCDDEV-----------------YDLMRQCWREKPYERPSFAQILVSLNR 297

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 50/273 (18%), Positives = 102/273 (37%), Gaps = 37/273 (13%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL-ISDFIR 428
           G     AV+ L           F +E   +    HPN++ L      ++   L +  +++
Sbjct: 51  GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110

Query: 429 NGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
           +G L   +     + ++  L     +      A+G+ Y+     +K+VH ++ +   +LD
Sbjct: 111 HGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLD 162

Query: 488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKC 547
           ++    ++ FGL R +         +    S      + +   ++A E+     KFT K 
Sbjct: 163 EKFTVKVADFGLARDM--------YDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKS 213

Query: 548 DVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKR 606
           DV+SFG++L E++T G  P          +   + +  R  +P            ++   
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQP------EYCPDPLY--- 262

Query: 607 QVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                  + L C     E RP    +   +  +
Sbjct: 263 ------EVMLKCWHPKAEMRPSFSELVSRISAI 289

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 49/273 (17%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDFIR 428
            T VAV+ L +G  +     F +E   + ++QH  +VRL    YA    +   +I++++ 
Sbjct: 37  HTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRL----YAVVTQEPIYIITEYME 90

Query: 429 NGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
           NGSL   L   +G   ++  L     L +A   A G+ +I E   R Y+H ++++  IL+
Sbjct: 91  NGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEE---RNYIHRDLRAANILV 142

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
            D L   I+ FGL RL+         +   T+  G++   I   + APEA  YG  FT K
Sbjct: 143 SDTLSCKIADFGLARLI--------EDNEYTAREGAKF-PIK--WTAPEAINYG-TFTIK 190

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+SFGI+L EI+T GR+P  G  N    +   + + +R  RP          +E++  
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYRMVRP------DNCPEELY-- 240

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
                   +   C +  PE RP    +   L+ 
Sbjct: 241 -------QLMRLCWKERPEDRPTFDYLRSVLED 266

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 95.6 bits (238), Expect = 5e-21
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 49/273 (17%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDFIR 428
            T VA++ L  G  +   + F  E + + +++H  +V+L    YA    +   ++++++ 
Sbjct: 208 TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQL----YAVVSEEPIYIVTEYMS 261

Query: 429 NGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
            GSL   L    G    LP L     + +A   A G+ Y+       YVH ++++  IL+
Sbjct: 262 KGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVER---MNYVHRDLRAANILV 313

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
            + L   ++ FGL RL+         +   T+  G++   I   + APEA +YG +FT K
Sbjct: 314 GENLVCKVADFGLARLI--------EDNEYTARQGAKF-PIK--WTAPEAALYG-RFTIK 361

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+SFGI+L E+ T GR+P  G  N  + +   V + +R   P      P  + +    
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCPPEC---PESLHD---- 412

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
                   +   C   +PE RP    +   L+ 
Sbjct: 413 --------LMCQCWRKEPEERPTFEYLQAFLED 437

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 94.4 bits (235), Expect = 5e-21
 Identities = 53/274 (19%), Positives = 107/274 (39%), Gaps = 39/274 (14%)

Query: 370 GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLL-ISDFIR 428
           G     AV+ L           F +E   +    HPN++ L      ++   L +  +++
Sbjct: 115 GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174

Query: 429 NGSLYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD 487
           +G L   +     + ++  L     +      A+G+ ++     +K+VH ++ +   +LD
Sbjct: 175 HGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLD 226

Query: 488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV-YLAPEARIYGSKFTQK 546
           ++    ++ FGL R +       K    V + TG+++     V ++A E+     KFT K
Sbjct: 227 EKFTVKVADFGLARDM-----YDKEFDSVHNKTGAKLP----VKWMALESLQTQ-KFTTK 276

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+SFG++L E++T G  P          +   + +  R  +P            ++  
Sbjct: 277 SDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGRRLLQP------EYCPDPLY-- 326

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
                   + L C     E RP    +   +  +
Sbjct: 327 -------EVMLKCWHPKAEMRPSFSELVSRISAI 353

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 50/298 (16%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY 415
           KVV     G+    A   VAV+ L         +   SE++ ++ +  H NIV L     
Sbjct: 38  KVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97

Query: 416 ANDEKLLISDFIRNGSL-------------YAALHAGPSDSLPPLPWEARLKIAQGTARG 462
                L+I+++   G L                  A   D    L  E  L  +   A+G
Sbjct: 98  IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 157

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + ++   + +  +H ++ +  ILL       I  FGL R +       KN++       +
Sbjct: 158 MAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-------KNDSNYVVKGNA 207

Query: 523 RISAISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
           R+     V ++APE+      +T + DV+S+GI L E+ + G  P  G   D K  + ++
Sbjct: 208 RLP----VKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK-MI 261

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           ++ FR   P             HA  ++   + I   C + DP  RP  + + + +++
Sbjct: 262 KEGFRMLSPE------------HAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 304

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 95.5 bits (238), Expect = 1e-20
 Identities = 32/156 (20%), Positives = 46/156 (29%), Gaps = 10/156 (6%)

Query: 50  SDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANL 109
           S    C         N+       N  L   +P    L NS   L  + N          
Sbjct: 3   SSDQKCI----EKEVNKT--YNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTF 53

Query: 110 FNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNL 169
               NL +LDL          D  ++   L  L L++N L       L   +AL   L  
Sbjct: 54  SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK-HLFF 112

Query: 170 SFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
                S        +   + SL L +N++S      
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 27/139 (19%), Positives = 41/139 (29%), Gaps = 3/139 (2%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
              L      L     +    L +LT L L        I  + F +   L  L L  N  
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHRLDTLVLTANPL 93

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
                  +   K L HL      ++      L + + L  +L L  N  S          
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE-SLYLGSNHISSIKLPKGFPT 152

Query: 186 PVMVSLDLRNNNLSGEIPQ 204
             +  LD +NN +     +
Sbjct: 153 EKLKVLDFQNNAIHYLSKE 171

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 1e-19
 Identities = 36/158 (22%), Positives = 61/158 (38%), Gaps = 7/158 (4%)

Query: 68  TSLYLPNRNLTGYMP-SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             L L    L      S    L+ L  L+L+ +               L +L+L  N F 
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 127 GPI---PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                  + ++TL  L  L LS   L+         L+ +   ++LS N+ +    E   
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALS 521

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPT-AFSGNP 220
           H   +  L+L +N++S  +P +  +L+Q  T     NP
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNP 558

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 1e-19
 Identities = 36/136 (26%), Positives = 53/136 (38%), Gaps = 5/136 (3%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPI---PANLFNATNLVYLDLAHNS 124
             L L +  L          L +L  L+L  N+F K       +L     L  L L+   
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
                     +LK + H+DLS N L  S  E L  L+ +   LNL+ N  S  +P +   
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY--LNLASNHISIILPSLLPI 545

Query: 185 FPVMVSLDLRNNNLSG 200
                +++LR N L  
Sbjct: 546 LSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 29/149 (19%), Positives = 47/149 (31%), Gaps = 7/149 (4%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
                 V S+ L          +     + L  L L + + S+ +P+ L   + L  L L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVL 308

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSL-PEFLLDLRALTGTLNLSFNQFSGQIP 179
           + N F            +LTHL +  N     L    L +L  L   L+LS +       
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR-ELDLSHDDIE-TSD 366

Query: 180 EMYGHFPVMVSL---DLRNNNLSGEIPQV 205
                   +  L   +L  N       + 
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.7 bits (223), Expect = 6e-19
 Identities = 31/143 (21%), Positives = 54/143 (37%), Gaps = 5/143 (3%)

Query: 66  RVTSLYL-PNRNLTGYMPSELGLLNSLTRLSLASNNFSK--PIPANLFNATNLVYLDLAH 122
            +T L +  N          L  L +L  L L+ ++          L N ++L  L+L++
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSY 385

Query: 123 NSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPE-FLLDLRALTGTLNLSFNQFSGQIPEM 181
           N       +  K    L  LDL+   L     +    +L  L   LNLS +       ++
Sbjct: 386 NEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK-VLNLSHSLLDISSEQL 444

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQ 204
           +   P +  L+L+ N+      Q
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQ 467

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.5 bits (220), Expect = 1e-18
 Identities = 30/162 (18%), Positives = 51/162 (31%), Gaps = 17/162 (10%)

Query: 66  RVTSLYLPNRNLTGYMPSELGL--LNSLTRLSLASNNFSKPIPANLFN---ATNLVYLDL 120
              SL          +   L    + SL   +    +    I   +F      ++  ++L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESINL 261

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
             + F     +       L  LDL++  L+  LP  L+ L  L   L LS N+F      
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-KLVLSANKFENLCQI 319

Query: 181 MYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
              +FP +  L ++ N    E+                   L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELG---------TGCLENLENL 352

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 86.6 bits (215), Expect = 6e-18
 Identities = 30/144 (20%), Positives = 45/144 (31%), Gaps = 2/144 (1%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L L    L     + L    +L  L       S      L N   L  L L  N    
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG-TLNLSFNQFSGQIPEMYGHFP 186
               +    + L  LD  +N ++    E +  L+  T  +LNL+ N  +G I        
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSA 202

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLN 210
           V  SL+         I +      
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNST 226

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 23/176 (13%), Positives = 51/176 (28%), Gaps = 21/176 (11%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNL--VYLDLAHN 123
            + SLYL + +++     +      L  L   +N        ++ +      + L+L  N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFL--LDLRALTGTLNLSFNQFSGQIPEM 181
              G I            L+         + + L    +++L               P +
Sbjct: 190 DIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW-LGTFEDMDDEDISPAV 247

Query: 182 YGHFPVM--VSLDLRNNNLSGEIPQV-------------GSLLNQGPTAFSGNPGL 222
           +     M   S++L+ +                       + L++ P+   G   L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTL 303

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.9 bits (156), Expect = 9e-11
 Identities = 21/134 (15%), Positives = 45/134 (33%), Gaps = 6/134 (4%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
           R+  L L   +L+         L  +  + L+ N  +        +    +YL+LA N  
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHI 535

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
              +P  +  L     ++L  N L+ +                 +  +       +  + 
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDCT-----CSNIYFLEWYKENMQKLEDTEDTLCENP 590

Query: 186 PVMVSLDLRNNNLS 199
           P++  + L +  LS
Sbjct: 591 PLLRGVRLSDVTLS 604

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 41/267 (15%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL 432
             VAV+ + EG  +    +F  E + + ++ HP +V+            +++++I NG L
Sbjct: 33  YDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90

Query: 433 YAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
              L + G       L     L++      G+ ++      +++H ++ +   L+D +L 
Sbjct: 91  LNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLC 142

Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYS 551
             +S FG+ R +         +    S  G++   +   + APE   Y  K++ K DV++
Sbjct: 143 VKVSDFGMTRYV--------LDDQYVSSVGTKF-PVK--WSAPEVFHYF-KYSSKSDVWA 190

Query: 552 FGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLA 610
           FGI++ E+ + G++P     N    +   V +  R  RP            I+       
Sbjct: 191 FGILMWEVFSLGKMPYDLYTN--SEVVLKVSQGHRLYRP------HLASDTIY------- 235

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLD 637
              I  +C    PE RP  + +  S++
Sbjct: 236 --QIMYSCWHELPEKRPTFQQLLSSIE 260

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.7 bits (238), Expect = 1e-20
 Identities = 31/208 (14%), Positives = 64/208 (30%), Gaps = 25/208 (12%)

Query: 24  QDGLALLALKAAI----------AQDPTRALDSWSESDSTPCHWSGIHCI----RNRVTS 69
           +D  AL A+  A+            + T    +W+ +      W     +      RVT 
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKE-LDMWGDQPGVDLDNNGRVTG 327

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPA-NLFNATNLVYLDLAHNSFCGP 128
           L L      G +P  +G L  L  LS  +++ +           T  +  +  H      
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387

Query: 129 IPDRIKTLKNLTHLDLSSNLLNGSL------PEFLLDLRALTGTLNLSFNQFSGQIPEMY 182
               +   + L   DL  + +N +        +  + L+     +    N+ +  I +  
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ--IGNLTNRITF-ISKAI 444

Query: 183 GHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
                +  +   N+  + +   V     
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDWEDA 472

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 93.8 bits (233), Expect = 5e-20
 Identities = 20/164 (12%), Positives = 48/164 (29%), Gaps = 31/164 (18%)

Query: 76  NLTGYMPSELGLLNSLTRLSLASNNFS-------------------KPIPANLFNATNLV 116
           N   ++   +  L  L  +  A++ F+                   +    +  N  +L 
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494

Query: 117 YLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG---------SLPEFLLDLRALTGTL 167
            ++L +      +PD +  L  L  L+++ N              L +       +    
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ-IF 553

Query: 168 NLSFNQFSGQIPEMY-GHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
            + +N                +  LD  +N +   +   G+ + 
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVK 596

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.3 bits (224), Expect = 6e-19
 Identities = 24/156 (15%), Positives = 55/156 (35%), Gaps = 20/156 (12%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGL--LNSLTRLSLASNNFSK-----PIPANLFNATNLVY 117
           ++V  L   +  L   +P+      +  +  +  + N             + +   N   
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677

Query: 118 LDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLL-------NGSLPEFLLDLRALTGTLNLS 170
           + L++N       +   T   ++ + LS+NL+                +   LT T++L 
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT-TIDLR 736

Query: 171 FNQFSGQIPE--MYGHFPVMVSLDLRNNNLSGEIPQ 204
           FN+ +  + +       P + ++D+  N  S   P 
Sbjct: 737 FNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPT 770

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.9 bits (223), Expect = 9e-19
 Identities = 30/173 (17%), Positives = 57/173 (32%), Gaps = 31/173 (17%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            +    +        +  +  +    T++   +N  +  I   +   T L  +  A++ F
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPF 460

Query: 126 CGP-------------------IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
                                        LK+LT ++L +      LP+FL DL  L  +
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ-S 519

Query: 167 LNLSFNQFSG---------QIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           LN++ N+            ++ +     P +    +  NNL  E P   SL  
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 24/153 (15%), Positives = 48/153 (31%), Gaps = 14/153 (9%)

Query: 68  TSLYLPNRNLTGYMPS-ELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
              Y+   NL  +  S  L  +  L  L    N     + A       L  L L +N   
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVKLTDLKLDYNQIE 608

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSGQIPEMYG 183
             IP+        +  L  S N L   +P       +  +  +++ S+N+   +   +  
Sbjct: 609 E-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG-SVDFSYNKIGSEGRNISC 665

Query: 184 HFPV-----MVSLDLRNNNLSGEIPQVGSLLNQ 211
                      ++ L  N +     ++ +  + 
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 6e-16
 Identities = 27/141 (19%), Positives = 47/141 (33%), Gaps = 16/141 (11%)

Query: 68  TSLYLPNRNLTGYMPSELGL--LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAH--- 122
           T++ L    LT  +  +     L  L+ + ++ N FS   P    N++ L    + H   
Sbjct: 731 TTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788

Query: 123 ---NSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQI 178
              N      P  I T  +L  L + SN +   + E L   L      L+++ N      
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLY----ILDIADNPNISID 843

Query: 179 PEMYGHFPVMVSLDLRNNNLS 199
                 +       L  +   
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 15/136 (11%), Positives = 38/136 (27%), Gaps = 2/136 (1%)

Query: 76  NLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKT 135
               Y+     L      L   +  +      N  ++ N    +   + +       +  
Sbjct: 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDN 321

Query: 136 LKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRN 195
              +T L L+     G +P+ +  L  L   L+   +  +                + R 
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELK-VLSFGTHSETVSGRLFGDEELTPDMSEERK 380

Query: 196 NNLSGEIPQVGSLLNQ 211
           + +     ++    +Q
Sbjct: 381 HRIRMHYKKMFLDYDQ 396

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 62/299 (20%), Positives = 118/299 (39%), Gaps = 51/299 (17%)

Query: 360 KVVVGRGSGM-----GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAF 413
           +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ L   
Sbjct: 50  QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109

Query: 414 YYANDEKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARG 462
              +    +I ++   G+L               +         + ++  +      ARG
Sbjct: 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + Y+   + +K +H ++ +  +L+ +     I+ FGL R +        N       T  
Sbjct: 170 MEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-------NNIDYYKKTTNG 219

Query: 523 RISAISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
           R+     V ++APEA      +T + DV+SFG+++ EI T G  P  G     + L  L+
Sbjct: 220 RLP----VKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFKLL 272

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           ++  R  +P             +   ++   + +  +C    P  RP  + + E LDR+
Sbjct: 273 KEGHRMDKPA------------NCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 50/269 (18%), Positives = 110/269 (40%), Gaps = 41/269 (15%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
              VA++ + EG +     +F  E + +  + H  +V+L           +I++++ NG 
Sbjct: 48  QYDVAIKMIKEG-SMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105

Query: 432 LYAALHA-GPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           L   L           L     L++ +     + Y+     ++++H ++ +   L++D+ 
Sbjct: 106 LLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQG 157

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +S FGL+R +         +   TS  GS+   +   +  PE  +Y  KF+ K D++
Sbjct: 158 VVKVSDFGLSRYV--------LDDEYTSSVGSKF-PVR--WSPPEVLMYS-KFSSKSDIW 205

Query: 551 SFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVL 609
           +FG+++ EI + G++P     N        + +  R  RP          ++++      
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTN--SETAEHIAQGLRLYRP------HLASEKVY------ 251

Query: 610 ATFHIALNCTELDPEFRPRMRTVSESLDR 638
               I  +C     + RP  + +  ++  
Sbjct: 252 ---TIMYSCWHEKADERPTFKILLSNILD 277

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 59/270 (21%), Positives = 107/270 (39%), Gaps = 48/270 (17%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGS 431
             VAV+ +   DAT   + F +E   + +++H N+V+L          L ++++++  GS
Sbjct: 217 NKVAVKCIKN-DATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273

Query: 432 LYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE 489
           L   L            L     LK +      + Y+       +VH ++ +  +L+ ++
Sbjct: 274 LVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSED 325

Query: 490 LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               +S FGL +               ++    ++  +   + APEA     KF+ K DV
Sbjct: 326 NVAKVSDFGLTK------------EASSTQDTGKL-PVK--WTAPEALREK-KFSTKSDV 369

Query: 550 YSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQV 608
           +SFGI+L EI + GR+P        K +   V K ++   P            ++     
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDAP------DGCPPAVY----- 416

Query: 609 LATFHIALNCTELDPEFRPRMRTVSESLDR 638
                +  NC  LD   RP    + E L+ 
Sbjct: 417 ----DVMKNCWHLDAATRPTFLQLREQLEH 442

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 93.8 bits (233), Expect = 3e-20
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 49/273 (17%)

Query: 372 PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA---NDEKLLISDFIR 428
            T VA++ L  G  +   + F  E + + +++H  +V+L    YA    +   ++++++ 
Sbjct: 291 TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQL----YAVVSEEPIYIVTEYMS 344

Query: 429 NGSLYAAL--HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
            GSL   L    G    LP L     + +A   A G+ Y+       YVH ++++  IL+
Sbjct: 345 KGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVER---MNYVHRDLRAANILV 396

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQK 546
            + L   ++ FGL RL+         +   T+  G++   I   + APEA +YG +FT K
Sbjct: 397 GENLVCKVADFGLARLI--------EDNEYTARQGAKF-PIK--WTAPEAALYG-RFTIK 444

Query: 547 CDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAK 605
            DV+SFGI+L E+ T GR+P  G  N  + +   V + +R   P      P   + +H  
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMPCP------PECPESLH-- 494

Query: 606 RQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
                   +   C   +PE RP    +   L+ 
Sbjct: 495 -------DLMCQCWRKEPEERPTFEYLQAFLED 520

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 63/307 (20%), Positives = 111/307 (36%), Gaps = 69/307 (22%)

Query: 360 KVVVGRGSGM-----GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAF 413
           +VV+    G+          VAV+ L +        D  SE+E +  + +H NI+ L   
Sbjct: 96  QVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155

Query: 414 YYANDEKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARG 462
              +    +I ++   G+L               +         + ++  +      ARG
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215

Query: 463 LMYIHEYSPRKYVHG-----NIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
           + Y+     +K +H      N+     L+ +     I+ FGL R +        N     
Sbjct: 216 MEYLAS---QKCIHRDLAARNV-----LVTENNVMKIADFGLARDI-------NNIDYYK 260

Query: 518 SGTGSRISAISNVYL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
             T  R        L     APEA      +T + DV+SFG+++ EI T G  P  G   
Sbjct: 261 KTTNGR--------LPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311

Query: 572 DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT 631
             + L  L+++  R  +P             +   ++   + +  +C    P  RP  + 
Sbjct: 312 --EELFKLLKEGHRMDKPA------------NCTNEL---YMMMRDCWHAVPSQRPTFKQ 354

Query: 632 VSESLDR 638
           + E LDR
Sbjct: 355 LVEDLDR 361

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 44/268 (16%)

Query: 373 TVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI-SDFIRNGS 431
             VAV+ +         + F +E   + +++H N+V+L          L I ++++  GS
Sbjct: 45  NKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
           L   L +     L     +  LK +      + Y+       +VH ++ +  +L+ ++  
Sbjct: 102 LVDYLRSRGRSVLGG---DCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNV 155

Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYS 551
             +S FGL +               ++    ++  +   + APEA     KF+ K DV+S
Sbjct: 156 AKVSDFGLTKE------------ASSTQDTGKL-PVK--WTAPEALREK-KFSTKSDVWS 199

Query: 552 FGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLA 610
           FGI+L EI + GR+P        K +   V K ++   P            ++       
Sbjct: 200 FGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGYKMDAP------DGCPPAVY------- 244

Query: 611 TFHIALNCTELDPEFRPRMRTVSESLDR 638
              +  NC  LD   RP    + E L+ 
Sbjct: 245 --EVMKNCWHLDAAMRPSFLQLREQLEH 270

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 59/303 (19%)

Query: 360 KVVVGRGSGM-----GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAF 413
           +VV+    G+        T VAV+ L          D  SE+E +  + +H NI+ L   
Sbjct: 84  QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143

Query: 414 YYANDEKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARG 462
              +    +I ++   G+L               +    +    L  +  +  A   ARG
Sbjct: 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARG 203

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + Y+   + +K +H ++ +  +L+ ++    I+ FGL R +        +       T  
Sbjct: 204 MEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-------HHIDYYKKTTNG 253

Query: 523 RISAISNVYL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGL 576
           R        L     APEA      +T + DV+SFG++L EI T G  P  G     + L
Sbjct: 254 R--------LPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL 302

Query: 577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             L+++  R  +P             +   ++   + +  +C    P  RP  + + E L
Sbjct: 303 FKLLKEGHRMDKPS------------NCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDL 347

Query: 637 DRV 639
           DR+
Sbjct: 348 DRI 350

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 63/293 (21%), Positives = 107/293 (36%), Gaps = 46/293 (15%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA 416
           KV  G   G         VA++ L +       ++F  E    AR+QHPN+V L      
Sbjct: 24  KVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 83

Query: 417 NDEKLLISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           +    +I  +  +G L                         L     + +    A G+ Y
Sbjct: 84  DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 143

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +   S    VH ++ +  +L+ D+L+  IS  GL R +                  S + 
Sbjct: 144 L---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-------YAADYYKLLGNSLL- 192

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF 584
            I   ++APEA +YG KF+   D++S+G+VL E+ + G  P  G  N  + +  ++R   
Sbjct: 193 PIR--WMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMIRNRQ 247

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
               P            ++          + + C    P  RPR + +   L 
Sbjct: 248 VLPCP------DDCPAWVY---------ALMIECWNEFPSRRPRFKDIHSRLR 285

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 31/249 (12%), Positives = 78/249 (31%), Gaps = 26/249 (10%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+     +Y+   G  +         ++     +  W F      +E +        +
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-WEFYIGTQLMERLKPSMQHMFM 130

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +  + +   +  +L+ +    G+L  A++   +     +P    +  A      +  +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 469 YSPRKYVHGNIKSTKILLDDELHP-----------CISGFGLNRLLPGTSKVTKNETIVT 517
               + +HG+IK    +L +                +   G +  +    K+    TI T
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM----KLFPKGTIFT 243

Query: 518 SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE 577
           +   +        +   E  +    +  + D +     +  +L G       E      E
Sbjct: 244 AKCETSG------FQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 578 SLVRKAFRE 586
            L R+    
Sbjct: 297 GLFRRLPHL 305

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 64/307 (20%), Positives = 118/307 (38%), Gaps = 59/307 (19%)

Query: 340 EDLLRASAYVVGKSKNG--IMYKVVVGRGS------GMGAPT--VVAVRRLTEGDATWR- 388
           +D+       VG S +G  + + + +GRGS      G+   T   VA   L +   T   
Sbjct: 9   DDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 68

Query: 389 FKDFESEVEAIARVQHPNIVRLKAFYYANDEK----LLISDFIRNGSLYAALHAGPSDSL 444
            + F+ E E +  +QHPNIVR    + +  +     +L+++ + +G+L   L        
Sbjct: 69  RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RF 123

Query: 445 PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLL 503
             +  +      +   +GL ++H  +P   +H ++K   I +        I   GL  L 
Sbjct: 124 KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
             +                  + I     +APE  +Y  K+ +  DVY+FG+ +LE+ T 
Sbjct: 183 RASF---------------AKAVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATS 225

Query: 563 RLPDAGPENDGKGLESLVRKAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTE 620
             P +    + +    + R+     +P    +V  P + KEI               C  
Sbjct: 226 EYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIPEV-KEIIEG------------CIR 268

Query: 621 LDPEFRP 627
            + + R 
Sbjct: 269 QNKDERY 275

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 46/298 (15%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFY 414
           G + +              VAV+ L EG      +   SE++ +  +  H N+V L    
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100

Query: 415 YANDEKL-LISDFIRNGSL-----------YAALHAGPSDSLPPLPWEARLKIAQGTARG 462
                 L +I +F + G+L                A        L  E  +  +   A+G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           + ++   + RK +H ++ +  ILL ++    I  FGL R +         +        +
Sbjct: 161 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------YKDPDYVRKGDA 210

Query: 523 RISAISNV-YLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
           R+     + ++APE       +T + DV+SFG++L EI + G  P  G + D +     +
Sbjct: 211 RLP----LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-RL 264

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           ++  R R P             +   ++   +   L+C   +P  RP    + E L  
Sbjct: 265 KEGTRMRAPD------------YTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGN 307

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 64/308 (20%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA 416
           KVV      +      T VAV+ L E  +    +D  SE   + +V HP++++L      
Sbjct: 38  KVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97

Query: 417 NDEKLLISDFIRNGSL-------------------YAALHAGPSDSLPPLPWEARLKIAQ 457
           +   LLI ++ + GSL                        +        L     +  A 
Sbjct: 98  DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
             ++G+ Y+   +  K VH ++ +  IL+ +     IS FGL+R +         E    
Sbjct: 158 QISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-------YEEDSYV 207

Query: 518 SGTGSRISAISNVYL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
             +  R        +     A E+      +T + DV+SFG++L EI+T G  P  G   
Sbjct: 208 KRSQGR--------IPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 572 DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT 631
             + L +L++   R  RP             +   ++   + + L C + +P+ RP    
Sbjct: 259 --ERLFNLLKTGHRMERPD------------NCSEEM---YRLMLQCWKQEPDKRPVFAD 301

Query: 632 VSESLDRV 639
           +S+ L+++
Sbjct: 302 ISKDLEKM 309

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 60/285 (21%), Positives = 112/285 (39%), Gaps = 57/285 (20%)

Query: 359 YKVV--VGRGSGMGAPTVVAVRRLTEG-----------DATWRFK-DFESEVEAIARVQH 404
           Y  +  +G GS  G    + V+   +G             + + + +   EV  +A ++H
Sbjct: 26  YVRLQKIGEGS-FG--KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR-LKIAQGTARGL 463
           PNIV+ +  +  N    ++ D+   G L+  ++A           E + L         L
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ----EDQILDWFVQICLAL 138

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++H+   RK +H +IKS  I L  +    +  FG+ R+L  T ++ +    +  GT   
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI--GTPY- 190

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                  YL+PE       +  K D+++ G VL E+ T +        +   +++LV K 
Sbjct: 191 -------YLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHA-----FEAGSMKNLVLKI 237

Query: 584 FRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                 P+S      L       R +++         + +P  RP
Sbjct: 238 ISGSFPPVSLHYSYDL-------RSLVS------QLFKRNPRDRP 269

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 60/305 (19%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYA 416
           +V   R  G+      T+VAV+ L E  +     DF+ E   +A   +PNIV+L      
Sbjct: 62  RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121

Query: 417 NDEKLLISDFIRNGSL-------------------YAALHAGPSDSLPPLPWEARLKIAQ 457
                L+ +++  G L                    +      S   PPL    +L IA+
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
             A G+ Y+ E   RK+VH ++ +   L+ + +   I+ FGL+R       +   +    
Sbjct: 182 QVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSADYYKA 232

Query: 518 SGTGS---RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG 573
            G  +   R       ++ PE+  Y  ++T + DV+++G+VL EI + G  P  G  ++ 
Sbjct: 233 DGNDAIPIR-------WMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283

Query: 574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS 633
             +   VR       P             +   ++   +++   C    P  RP   ++ 
Sbjct: 284 -EVIYYVRDGNILACPE------------NCPLEL---YNLMRLCWSKLPADRPSFCSIH 327

Query: 634 ESLDR 638
             L R
Sbjct: 328 RILQR 332

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 63/298 (21%), Positives = 112/298 (37%), Gaps = 54/298 (18%)

Query: 360 KVVVGRGSGMG---APTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY 415
           KVV     G+G   A   VAV+ L         +   SE++ ++ + QH NIV L     
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120

Query: 416 ANDEKLLISDFIRNGSL---------YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
                L+I+++   G L                 + +         L  +   A+G+ ++
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                +  +H ++ +  +LL +     I  FGL R +        N++       +R   
Sbjct: 181 AS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-------MNDSNYIVKGNAR--- 227

Query: 527 ISNVYL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLV 580
                L     APE+      +T + DV+S+GI+L EI + G  P  G   + K  + LV
Sbjct: 228 -----LPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-LV 280

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           +  ++  +P              A + +   + I   C  L+P  RP  + +   L  
Sbjct: 281 KDGYQMAQPA------------FAPKNI---YSIMQACWALEPTHRPTFQQICSFLQE 323

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 12/157 (7%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
             +    +L L +  L    P +   L+ L  +++ +    + +P  +     L  L LA
Sbjct: 78  ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLA 135

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG--------TLNLSFNQ 173
            N     +P  I +L  L  L + +      LPE L    A           +L L +  
Sbjct: 136 RNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG 194

Query: 174 FSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
               +P    +   + SL +RN+ LS   P +  L  
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPK 230

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 28/153 (18%), Positives = 50/153 (32%), Gaps = 10/153 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            SL L    +   +P+ +  L +L  L + ++  S  +   + +   L  LDL   +   
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR 243

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P        L  L L       +LP  +  L  L   L+L       ++P +    P 
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPA 302

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP 220
              + +  +  +        L    P A    P
Sbjct: 303 NCIILVPPHLQA-------QLDQHRPVARPAEP 328

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 22/145 (15%), Positives = 38/145 (26%), Gaps = 26/145 (17%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI------------------ 129
            +    L    +   +P    L         D                            
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70

Query: 130 -PDRIK--TLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
             D ++  T      L+L S  L    P+    L  L   + +       ++P+    F 
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ-HMTIDAAGLM-ELPDTMQQFA 127

Query: 187 VMVSLDLRNNNLSGEIPQ-VGSLLN 210
            + +L L  N L   +P  + SL  
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNR 151

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 61/290 (21%)

Query: 359 YKVV--VGRGSGMGAPTV-----------VAVRRLTE---GDATWRFKDFESEVEAIARV 402
           YK+V  +G G GM   TV           VA++ +            + FE EV   +++
Sbjct: 13  YKIVDKLGGG-GMS--TVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQL 68

Query: 403 QHPNIVRLKAFYYANDEKL--LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
            H NIV +       ++    L+ ++I   +L   + +       PL  +  +       
Sbjct: 69  SHQNIVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQIL 121

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
            G+ + H+    + VH +IK   IL+D      I  FG+ + L  TS +T+   ++  GT
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVL--GT 175

Query: 521 GSRISAISNVYLAPE-ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
                     Y +PE A+  G    +  D+YS GIVL E+L G  P      +G+   S+
Sbjct: 176 VQ--------YFSPEQAK--GEATDECTDIYSIGIVLYEMLVGEPP-----FNGETAVSI 220

Query: 580 VRKAFRERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
             K  ++  P ++  +   + + +           + L  TE D   R +
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQSLSN---------VILRATEKDKANRYK 261

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 65/307 (21%), Positives = 111/307 (36%), Gaps = 63/307 (20%)

Query: 360 KVVVGRGSGM---GAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYY 415
           KV+     G+   G    VAV+ L E   +   +   SE++ + ++  H NIV L     
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 416 ANDEKLLISDFIRNGSL------------------YAALHAGPSDSLPPLPWEARLKIAQ 457
            +    LI ++   G L                           + L  L +E  L  A 
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
             A+G+ ++     +  VH ++ +  +L+       I  FGL R       +  +     
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------DIMSDSNY-V 229

Query: 518 SGTGSRISAISNVYL-----APEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN 571
               +R        L     APE+   G  +T K DV+S+GI+L EI + G  P  G   
Sbjct: 230 VRGNAR--------LPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280

Query: 572 DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRT 631
           D    + L++  F+  +P             +A  ++   + I  +C   D   RP    
Sbjct: 281 DANFYK-LIQNGFKMDQPF------------YATEEI---YIIMQSCWAFDSRKRPSFPN 324

Query: 632 VSESLDR 638
           ++  L  
Sbjct: 325 LTSFLGC 331

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 49/268 (18%), Positives = 90/268 (33%), Gaps = 53/268 (19%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFY------------YANDEKL-LISDFIRNGSLYAAL 436
               SEV  +A + H  +VR  A +                  L +  ++  NG+LY  +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106

Query: 437 HAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISG 496
           H+           +   ++ +     L YIH    +  +H ++K   I +D+  +  I  
Sbjct: 107 HSENL----NQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159

Query: 497 FGLNRLLPGTSKVTKNETIVTSGTGSRISAISNV----YLAPE----ARIYGSKFTQKCD 548
           FGL + +  +  + K ++    G+   ++  S +    Y+A E       Y     +K D
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLT--SAIGTAMYVATEVLDGTGHYN----EKID 213

Query: 549 VYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQV 608
           +YS GI+  E++               L+ L   +        +       K I      
Sbjct: 214 MYSLGIIFFEMIYPFSTG---MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR----- 265

Query: 609 LATFHIALNCTELDPEFRPRMRTVSESL 636
                      + DP  RP        L
Sbjct: 266 --------LLIDHDPNKRP---GARTLL 282

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 36/221 (16%)

Query: 359 YKV--VVGRGSGMGA---------PTVVAVRRLTE---GDATWRFKDFESEVEAIARVQH 404
           Y++  +VGRG GMG            +VA++ ++E    D  +R +  + E     R+Q 
Sbjct: 36  YRLRRLVGRG-GMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQE 93

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
           P++V +  F   + +  +    I    L A L         PL     + I +     L 
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALD 148

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
             H        H ++K   IL+  +    +  FG+        K+T+    V  GT    
Sbjct: 149 AAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTV--GTLY-- 200

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 Y+APE R   S  T + D+Y+   VL E LTG  P
Sbjct: 201 ------YMAPE-RFSESHATYRADIYALTCVLYECLTGSPP 234

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 60/303 (19%)

Query: 359 YKVV--VGRGS-GMGAPTVVAVRRLTEG--------------DATWRFKDFESEVEAIAR 401
           +++   +GRG        V     L +G              DA  R  D   E++ + +
Sbjct: 34  FRIEKKIGRGQFS----EVYRAACLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQ 88

Query: 402 VQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR 461
           + HPN+++  A +  ++E  ++ +    G L   +          +P     K       
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTVWKYFVQLCS 147

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTG 521
            L ++H    R+ +H +IK   + +       +   GL R    +SK T   ++V  GT 
Sbjct: 148 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV--GTP 200

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR 581
                    Y++PE RI+ + +  K D++S G +L E+   + P  G   D   L SL +
Sbjct: 201 Y--------YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLYSLCK 248

Query: 582 KAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           K  +   P   S+     L       RQ++        C   DPE RP    V+   D  
Sbjct: 249 KIEQCDYPPLPSDHYSEEL-------RQLVN------MCINPDPEKRP---DVTYVYDVA 292

Query: 640 KLQ 642
           K  
Sbjct: 293 KRM 295

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 32/134 (23%), Positives = 53/134 (39%), Gaps = 4/134 (2%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L L    +   M S    L  L  L    +N  +    ++F +  NL+YLD++H    
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSL-PEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
                    L +L  L ++ N    +  P+   +LR LT  L+LS  Q     P  +   
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSL 493

Query: 186 PVMVSLDLRNNNLS 199
             +  L++ +N L 
Sbjct: 494 SSLQVLNMASNQLK 507

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 29/147 (19%), Positives = 49/147 (33%), Gaps = 4/147 (2%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
             +L L    L             L  L L+       I    + + ++L  L L  N  
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF-SGQIPEMYGH 184
                     L +L  L      L       +  L+ L   LN++ N   S ++PE + +
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQSFKLPEYFSN 147

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
              +  LDL +N +         +L+Q
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 26/146 (17%), Positives = 46/146 (31%), Gaps = 10/146 (6%)

Query: 54  PCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNAT 113
           PC       +     +      N    +P    L  S   L L+ N        + F+  
Sbjct: 2   PCV-----EVVPN-ITYQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFP 52

Query: 114 NLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQ 173
            L  LDL+            ++L +L+ L L+ N +          L +L   L      
Sbjct: 53  ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ-KLVAVETN 111

Query: 174 FSGQIPEMYGHFPVMVSLDLRNNNLS 199
            +       GH   +  L++ +N + 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.4 bits (191), Expect = 4e-15
 Identities = 31/125 (24%), Positives = 49/125 (39%), Gaps = 4/125 (3%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLS 145
           L +L  L ++  +        +F   ++L  L +A NSF       I   L+NLT LDLS
Sbjct: 420 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
              L    P     L +L   LN++ NQ       ++     +  + L  N      P++
Sbjct: 479 QCQLEQLSPTAFNSLSSLQ-VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

Query: 206 GSLLN 210
             L  
Sbjct: 538 DYLSR 542

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 4/110 (3%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             L + + +           L+SL  L +A N+F +    ++F    NL +LDL+     
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFS 175
              P    +L +L  L+++SN L  S+P+ + D L +L   + L  N + 
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQ-KIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 33/137 (24%), Positives = 50/137 (36%), Gaps = 9/137 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNF-SKPIPANLFNATNLVYLDLAHNSFC 126
             L     NL       +G L +L  L++A N   S  +P    N TNL +LDL+ N   
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162

Query: 127 GPIPDRIKTLKNLT----HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY 182
                 ++ L  +      LDLS N +N  +         L   L L  N  S  + +  
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLH-KLTLRNNFDSLNVMK-- 218

Query: 183 GHFPVMVSLDLRNNNLS 199
                +  L++    L 
Sbjct: 219 TCIQGLAGLEVHRLVLG 235

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 9/116 (7%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN--SFCGPIPDRIKTLKNLTHLDLS 145
           L SL RL+  SN           +  +L +LDL+ N  SF G          +L +LDLS
Sbjct: 324 LKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY--GHFPVMVSLDLRNNNLS 199
            N +  ++    L L  L   L+   +    Q+ E         ++ LD+ + +  
Sbjct: 382 FNGVI-TMSSNFLGLEQLE-HLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR 434

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 29/170 (17%), Positives = 56/170 (32%), Gaps = 13/170 (7%)

Query: 68  TSLYLPNRNLT-GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNL----VYLDLAH 122
             L + +  +    +P     L +L  L L+SN        +L     +    + LDL+ 
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 123 NSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF--SGQIPE 180
           N     I         L  L L +N  + ++ +  +   A      L   +F   G + +
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 181 M-YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQS 229
                   + +L +    L+     +   L+     F+    +  F L S
Sbjct: 246 FDKSALEGLCNLTIEEFRLA----YLDYYLDDIIDLFNCLTNVSSFSLVS 291

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.8 bits (114), Expect = 9e-06
 Identities = 33/157 (21%), Positives = 50/157 (31%), Gaps = 19/157 (12%)

Query: 69  SLYLPNRNLTGYMPSELGLLNSLT--RLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF 125
             +    NL  +  S L  L +LT     LA  ++      +LFN  TN+    L   + 
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
              + D         HL+L +          L  L+     L  + N+      E+    
Sbjct: 295 -ERVKDFSY-NFGWQHLELVNCKFGQFPTLKLKSLK----RLTFTSNKGGNAFSEV--DL 346

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           P +  LDL  N L        S       +  G   L
Sbjct: 347 PSLEFLDLSRNGL--------SFKGCCSQSDFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 26/168 (15%), Positives = 45/168 (26%), Gaps = 34/168 (20%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLA---SNNFSKPIPANLFNATNLVYLDLA 121
             +  L L +  +     ++L +L+ +  L+L+   S N    I    F    L  L L 
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208

Query: 122 HNSFCGPIPDR-IKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG-----TLNLSFNQFS 175
           +N     +    I+ L  L    L              D  AL G               
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

Query: 176 GQIPEMYGHFPVMVS-------------------------LDLRNNNL 198
             + ++   F  + +                         L+L N   
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 63/304 (20%), Positives = 111/304 (36%), Gaps = 59/304 (19%)

Query: 359 YKVV--VGRGSGMGAPTVVAVRRLTEG-------------DATWRFKDFESEVEAIARVQ 403
           Y+V+  +G GS  G      +RR ++G                 + +   SEV  +  ++
Sbjct: 8   YEVLYTIGTGS-YG--RCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63

Query: 404 HPNIVRLK-AFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR 461
           HPNIVR         +  L ++ ++   G L + +  G  +    L  E  L++      
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTL 122

Query: 462 GLMYIHEYSPRKY--VHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
            L   H  S   +  +H ++K   + LD + +  +  FGL R+L   +   K  T V  G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV--G 178

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
           T          Y++PE ++    + +K D++S G +L E+     P           + L
Sbjct: 179 TPY--------YMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKEL 224

Query: 580 VRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
             K    + R +       L + I                  L    RP   +V E L+ 
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITR-------------MLNLKDYHRP---SVEEILEN 268

Query: 639 VKLQ 642
             + 
Sbjct: 269 PLIL 272

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 11/135 (8%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
           NR     + + +L   + S      ++  L L+ N  S+   A+L   T L  L+L+ N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
               +   +++L  L  LDL++N +   L        ++  TL+ + N  S ++      
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYVQ-ELLV----GPSIE-TLHAANNNIS-RVSC--SR 118

Query: 185 FPVMVSLDLRNNNLS 199
                ++ L NN ++
Sbjct: 119 GQGKKNIYLANNKIT 133

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 28/139 (20%), Positives = 53/139 (38%), Gaps = 9/139 (6%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            + +L+  N N++               + LA+N  +     +    + + YLDL  N  
Sbjct: 100 SIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 126 CG-PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
                 +   +   L HL+L  N +   +   ++    L  TL+LS N+ +  +   +  
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQS 212

Query: 185 FPVMVSLDLRNNNLSGEIP 203
              +  + LRNN L   I 
Sbjct: 213 AAGVTWISLRNNKLV-LIE 230

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 76.4 bits (188), Expect = 7e-15
 Identities = 26/118 (22%), Positives = 47/118 (39%), Gaps = 9/118 (7%)

Query: 86  GLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS 145
              N      +  ++  + + +   +A N+  LDL+ N         +     L  L+LS
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
           SN+L     +    L  L  TL+L+ N    ++       P + +L   NNN+S  + 
Sbjct: 67  SNVLY-ETLDL-ESLSTLR-TLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVS 115

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 21/133 (15%), Positives = 45/133 (33%), Gaps = 8/133 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    +   +  ++ +   L  L L+SN  +  +     +A  + ++ L +N    
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL 228

Query: 128 PIPDRIKTLKNLTHLDLSSNLLN-GSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
            I   ++  +NL H DL  N  + G+L +F    + +     ++         +      
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV---QTVAKQTVKKLTGQNEEECT 284

Query: 187 VMVSLDLRNNNLS 199
           V            
Sbjct: 285 VPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 32/171 (18%), Positives = 51/171 (29%), Gaps = 30/171 (17%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF-C 126
            +L L +  L  +M  E      +T +SL +N     I   L  + NL + DL  N F C
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251

Query: 127 GPIPD------RIKTL----------------KNLTHLDLSSNLLNGSLPEFLLDLRALT 164
           G + D      R++T+                   T     +         F   L AL 
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311

Query: 165 ----GTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
                 L+   ++    +     +      +D         I QV      
Sbjct: 312 RKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQA 361

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 2/82 (2%)

Query: 129 IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVM 188
           I +  +         ++ + L  +L         +   L+LS N  S         F  +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVK-ELDLSGNPLSQISAADLAPFTKL 60

Query: 189 VSLDLRNNNLSGEIPQVGSLLN 210
             L+L +N L  E   + SL  
Sbjct: 61  ELLNLSSNVLY-ETLDLESLST 81

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 22/166 (13%), Positives = 42/166 (25%), Gaps = 29/166 (17%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
             VT + L N  L   +   L    +L    L  N F      + F + N     +A  +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQT 271

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT------------------ 166
                    +     T     +         F   L AL                     
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331

Query: 167 ---------LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
                    ++    Q+   I ++       ++L+ +   L  ++ 
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 18/143 (12%), Positives = 37/143 (25%), Gaps = 8/143 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASN-------NFSKPIPANLFNATNLVYLDL 120
           T   L +              + L  L    +       + ++ +     N      +D 
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ-IP 179
               +   I       +    L+     L+  +         L GTL  +  Q   Q   
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHAT 403

Query: 180 EMYGHFPVMVSLDLRNNNLSGEI 202
           E      ++ ++  R   +  E 
Sbjct: 404 EEQSPLQLLRAIVKRYEEMYVEQ 426

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 6/134 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L + N + T Y  + +  L++L RL +   + +     NL   T+L  LD++H++   
Sbjct: 69  KDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            I  +I TL  +  +DLS N     +   L  L  L  +LN+ F+            FP 
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK-SLNIQFDGVHDYRG--IEDFPK 182

Query: 188 MVSLDLRNNNLSGE 201
           +  L   +  + G+
Sbjct: 183 LNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 29/125 (23%), Positives = 51/125 (40%), Gaps = 9/125 (7%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPD--RIKTLKNLTHLDLS 145
           +NSLT ++LA+ N +  +   +  A N+  L + +        +   I  L NL  L + 
Sbjct: 43  MNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIH----ATNYNPISGLSNLERLRIM 96

Query: 146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
              +       L  L +LT  L++S +     I       P + S+DL  N    +I  +
Sbjct: 97  GKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL 155

Query: 206 GSLLN 210
            +L  
Sbjct: 156 KTLPE 160

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 30/145 (20%), Positives = 52/145 (35%), Gaps = 6/145 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK-PIPANLFNATNLVYLDLAHNSFC 126
            ++YL N  +T     + G  + +  L L  N            ++  L +L+L +N   
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
             +  ++     L  LDLSSN L   +         +T  ++L  N+    I +      
Sbjct: 183 D-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISLRNNKLV-LIEKALRFSQ 237

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQ 211
            +   DLR N       +     NQ
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQ 262

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 30/159 (18%), Positives = 58/159 (36%), Gaps = 23/159 (14%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHN 123
           NR     + + +L   + S      ++  L L+ N  S+ I A      T L  L+L+ N
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSN 68

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                  D +++L  L  LDL++N +   L        ++  TL+ + N  S ++     
Sbjct: 69  VLYE-TLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIE-TLHAANNNIS-RVSC--S 117

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
                 ++ L NN ++  +                   +
Sbjct: 118 RGQGKKNIYLANNKIT-MLR---------DLDEGCRSRV 146

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 28/139 (20%), Positives = 52/139 (37%), Gaps = 9/139 (6%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            + +L+  N N++               + LA+N  +     +    + + YLDL  N  
Sbjct: 100 SIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 126 CG-PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
                 +   +   L HL+L  N +   +    +    L  TL+LS N+ +  +   +  
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLK-TLDLSSNKLA-FMGPEFQS 212

Query: 185 FPVMVSLDLRNNNLSGEIP 203
              +  + LRNN L   I 
Sbjct: 213 AAGVTWISLRNNKLV-LIE 230

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 9/116 (7%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
            N      +  ++  + + +   +A N+  LDL+ N         +     L  L+LSSN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 148 LLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
           +L     +    L  L  TL+L+ N    ++       P + +L   NNN+S  + 
Sbjct: 69  VLY-ETLDL-ESLSTLR-TLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVS 115

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 23/98 (23%), Positives = 38/98 (38%), Gaps = 4/98 (4%)

Query: 111 NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS 170
           N        +  +S    +    ++  N+  LDLS N L+      L     L   LNLS
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE-LLNLS 66

Query: 171 FNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSL 208
            N    +  ++      + +LDL NN +  E+    S+
Sbjct: 67  SNVLY-ETLDL-ESLSTLRTLDLNNNYVQ-ELLVGPSI 101

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 22/137 (16%), Positives = 50/137 (36%), Gaps = 9/137 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    +   +  ++     L  L L+SN  +  +     +A  + ++ L +N    
Sbjct: 172 EHLNLQYNFIYD-VKGQVVFAK-LKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-V 227

Query: 128 PIPDRIKTLKNLTHLDLSSNLLN-GSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
            I   ++  +NL H DL  N  + G+L +F    + +     ++      ++        
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ---TVAKQTVK-KLTGQNEEEC 283

Query: 187 VMVSLDLRNNNLSGEIP 203
            + +L         ++P
Sbjct: 284 TVPTLGHYGAYCCEDLP 300

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 2/82 (2%)

Query: 129 IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVM 188
           I +  +         ++ + L  +L         +   L+LS N  S         F  +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVK-ELDLSGNPLSQISAADLAPFTKL 60

Query: 189 VSLDLRNNNLSGEIPQVGSLLN 210
             L+L +N L  E   + SL  
Sbjct: 61  ELLNLSSNVLY-ETLDLESLST 81

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 25/120 (20%), Positives = 40/120 (33%), Gaps = 25/120 (20%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF-C 126
            +L L +  L  +M  E      +T +SL +N     I   L  + NL + DL  N F C
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251

Query: 127 GPIPDRIKTLKNLTHLDLSSN-------LLNGSLPE---------------FLLDLRALT 164
           G + D     + +  +   +            ++P                F   L AL 
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 29/136 (21%), Positives = 55/136 (40%), Gaps = 9/136 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
                    +T    + +  +  L  L + +N  +   P  L N + L +L++  N    
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +K L  L  L++ SN ++      L +L  L  +L L+ NQ   +  E+ G    
Sbjct: 258 INA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLN-SLFLNNNQLGNEDMEVIGGLTN 312

Query: 188 MVSLDLRNNNLSGEIP 203
           + +L L  N+++   P
Sbjct: 313 LTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 81.4 bits (202), Expect = 7e-17
 Identities = 33/143 (23%), Positives = 56/143 (39%), Gaps = 11/143 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    +T    S L  L  LT L + +N  +      L N TNL  L L  ++   
Sbjct: 69  EYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISD 124

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P  +  L  +  L+L +N    S    L ++  L   L ++ ++    +  +  +   
Sbjct: 125 ISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLN-YLTVTESKVKD-VTPI-ANLTD 178

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           + SL L  N +   I  + SL +
Sbjct: 179 LYSLSLNYNQIED-ISPLASLTS 200

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 9/132 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            SL + N  +T    S L  L+ LT L + +N  S      + + T L  L++  N    
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD 279

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +  L  L  L L++N L     E +  L  LT TL LS N  +  I  +      
Sbjct: 280 ISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT-TLFLSQNHITD-IRPL-ASLSK 334

Query: 188 MVSLDLRNNNLS 199
           M S D  N  + 
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 29/143 (20%), Positives = 54/143 (37%), Gaps = 11/143 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            SL L   +      S L  +  L  L++  +      P  + N T+L  L L +N    
Sbjct: 135 YSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P  + +L +L +     N +    P  + ++  L  +L +  N+ +   P    +   
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN-SLKIGNNKITDLSP--LANLSQ 244

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           +  L++  N +S  I  V  L  
Sbjct: 245 LTWLEIGTNQISD-INAVKDLTK 266

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 29/143 (20%), Positives = 53/143 (37%), Gaps = 12/143 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L      +    P     L    R  L   + +  +        ++  L +A      
Sbjct: 3   ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-A 57

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            I   I+ L NL +L+L+ N +    P  L +L  LT  L +  N+ +  I  +  +   
Sbjct: 58  SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLT-NLYIGTNKIT-DISAL-QNLTN 111

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           +  L L  +N+S  I  + +L  
Sbjct: 112 LRELYLNEDNISD-ISPLANLTK 133

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 84.3 bits (208), Expect = 4e-17
 Identities = 47/213 (22%), Positives = 77/213 (36%), Gaps = 31/213 (14%)

Query: 393 ESEVEAIARVQHPNIVRLKAFY------YANDEKLLISDFIRNGSLYAALHA-GPSDSLP 445
             E++ + ++ HPN+V  +           ND  LL  ++   G L   L+       L 
Sbjct: 60  CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119

Query: 446 PLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRL 502
                 R  ++   +  L Y+HE    + +H ++K   I+L          I   G  + 
Sbjct: 120 EG--PIRTLLSD-ISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173

Query: 503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG 562
           L      T     V    G+        YLAPE  +   K+T   D +SFG +  E +TG
Sbjct: 174 LDQGELCT---EFV----GTL------QYLAPEL-LEQKKYTVTVDYWSFGTLAFECITG 219

Query: 563 RLPDAGPENDGKGLESLVRKAFRERRPLSEVID 595
             P   P          VR+   E   + + + 
Sbjct: 220 FRP-FLPNWQPVQWHGKVREKSNEHIVVYDDLT 251

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 56/298 (18%), Positives = 100/298 (33%), Gaps = 69/298 (23%)

Query: 359 YKVV--VGRGSGMGAPTVVAVRRLTEGDA------TWRFKDFESEVEAIARVQHPNIVRL 410
           +K +  +G G   G   V   +   +G         +  +  E EV+A+A++ H NIV  
Sbjct: 13  FKEIELIGSGG-FG--QVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHY 69

Query: 411 KAFYYANDEKLLISDFIR----------------NGSLYAALHAGPSDSLPPLPWEARLK 454
              +   D     S                     G+L   +     + L        L+
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK---VLALE 126

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           + +   +G+ YIH    +K ++ ++K + I L D     I  FGL   L    K T    
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT---R 180

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
               GT          Y++PE  I    + ++ D+Y+ G++L E+L           +  
Sbjct: 181 SK--GTLR--------YMSPEQ-ISSQDYGKEVDLYALGLILAELLHV----CDTAFETS 225

Query: 575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              + +R        +S++ D      +                    PE RP    +
Sbjct: 226 KFFTDLRD-----GIISDIFDKKEKTLLQ-------------KLLSKKPEDRPNTSEI 265

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 28/184 (15%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHA----GPSDSL 444
            DF++E++ I  +++   +  +     N +++ +I +++ N S+            + + 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 445 PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP 504
                  +  I         YIH  + +   H ++K + IL+D      +S FG      
Sbjct: 147 FIPIQVIKCIIKS-VLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE----- 198

Query: 505 GTSKVTKNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT--QKCDVYSFGIVLLEILT 561
             S+   ++ I  S GT          ++ PE            K D++S GI L  +  
Sbjct: 199 --SEYMVDKKIKGSRGTYE--------FMPPEF-FSNESSYNGAKVDIWSLGICLYVMFY 247

Query: 562 GRLP 565
             +P
Sbjct: 248 NVVP 251

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 84.1 bits (208), Expect = 5e-17
 Identities = 36/137 (26%), Positives = 53/137 (38%), Gaps = 5/137 (3%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
              L L    +     S    L  L  L L S      I    F N  NL  LDL  +  
Sbjct: 26  TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSL--PEFLLDLRALTGTLNLSFNQFSG-QIPEMY 182
               PD  + L +L  L L    L+ ++    +  +L+ALT  L+LS NQ     +   +
Sbjct: 86  YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT-RLDLSKNQIRSLYLHPSF 144

Query: 183 GHFPVMVSLDLRNNNLS 199
           G    + S+D  +N + 
Sbjct: 145 GKLNSLKSIDFSSNQIF 161

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 36/153 (23%), Positives = 53/153 (34%), Gaps = 19/153 (12%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDR 132
             NLT  +P    +LN+  RL L+ N     + A+ F     L  L+L        I   
Sbjct: 13  FCNLT-QVPQ---VLNTTERLLLSFNYIRT-VTASSFPFLEQLQLLELGSQYTPLTIDKE 67

Query: 133 I-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI--PEMYGHFPVMV 189
             + L NL  LDL S+ +    P+    L  L   L L F   S  +     + +   + 
Sbjct: 68  AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF-ELRLYFCGLSDAVLKDGYFRNLKALT 126

Query: 190 SLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            LDL  N +                +F     L
Sbjct: 127 RLDLSKNQIRSLYL---------HPSFGKLNSL 150

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 47/254 (18%), Positives = 77/254 (30%), Gaps = 23/254 (9%)

Query: 68  TSLYLPNRNLTGYMPSEL-GLLNSLTRLSLASNNFSKP----IPANLF-NATNLVYLDLA 121
             L L     +     +      SL +L L  N         +  ++F   ++L  L L 
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
           HN      P     L  L  L L+SN L   L    L    L   L++S NQ     P+ 
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLE-ILDISRNQLLAPNPD- 544

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVG--SLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKV 239
              F  +  LD+ +N    E       + LN      +G P         P         
Sbjct: 545 --VFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADI--YCVYPDSFSGVSLF 600

Query: 240 HANPEVEDGPQNPKNTNFGYSGDVKDRGRNGSVVVSVISGVSVVVGVVSVSVWLFRRKRR 299
             + E  D  +  K+  F             +V +++     + V       ++  +  +
Sbjct: 601 SLSTEGCDEEEVLKSLKFSLFIVC-------TVTLTLFLMTILTVTKFRGFCFICYKTAQ 653

Query: 300 AREGKMGKEEKTND 313
               K   +    D
Sbjct: 654 RLVFKDHPQGTEPD 667

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.4 bits (175), Expect = 5e-13
 Identities = 32/137 (23%), Positives = 49/137 (35%), Gaps = 8/137 (5%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAH 122
           R+ V  L L +  +          L  L  L+LA N  +K I    F    NL  L+L++
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINK-IADEAFYGLDNLQVLNLSY 323

Query: 123 NSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY 182
           N            L  + ++DL  N +     +    L  L  TL+L  N  +       
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ-TLDLRDNALT-----TI 377

Query: 183 GHFPVMVSLDLRNNNLS 199
              P +  + L  N L 
Sbjct: 378 HFIPSIPDIFLSGNKLV 394

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.7 bits (168), Expect = 3e-12
 Identities = 34/173 (19%), Positives = 54/173 (31%), Gaps = 12/173 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK-PIPANLF-NATNLVYLDLAHNSF 125
             L L +  +    P     L  L  L L     S   +    F N   L  LDL+ N  
Sbjct: 76  RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135

Query: 126 -CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT-GTLNLSFNQFSGQIPEMYG 183
               +      L +L  +D SSN +       L  L+  T    +L+ N    ++   +G
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195

Query: 184 HFP------VMVSLDLRNNNLSGEIPQVGSLLNQG--PTAFSGNPGLCGFPLQ 228
                    V+  LD+  N  + +I    S         +      + G    
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 33/150 (22%), Positives = 52/150 (34%), Gaps = 17/150 (11%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
            +  L L    +          L++L  L+L+ N   + + ++ F     + Y+DL  N 
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE-LYSSNFYGLPKVAYIDLQKNH 349

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLN-----GSLPEFLLDLRALTG---------TLNLS 170
                    K L+ L  LDL  N L       S+P+  L    L            ++LS
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLS 409

Query: 171 FNQFSG-QIPEMYGHFPVMVSLDLRNNNLS 199
            N+     I       P +  L L  N  S
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFS 439

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 25/154 (16%), Positives = 50/154 (32%), Gaps = 22/154 (14%)

Query: 68  TSLYLPNRNLTGYM--PSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
             L L    L+  +        L +LTRL L+ N          F    +L  +D + N 
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159

Query: 125 FCGPIPDRIKTL--KNLTHLDLSSNLLNGSLPE-FLLDLRALTG----TLNLSFNQFSGQ 177
                   ++ L  K L+   L++N L   +   +   +          L++S N ++  
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219

Query: 178 IPEMYGHF------------PVMVSLDLRNNNLS 199
           I   + +               ++      +N+ 
Sbjct: 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 35/165 (21%), Positives = 57/165 (34%), Gaps = 9/165 (5%)

Query: 48  SESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPA 107
             +  T   W     + + +  LYL +  L    P     L +L  LSL SN  +  +  
Sbjct: 464 QLAWETELCWDVFEGLSH-LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSH 521

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGS--LPEFLLDLRALTG 165
           N     NL  LD++ N    P PD      +L+ LD++ N       L  F+  L     
Sbjct: 522 NDL-PANLEILDISRNQLLAPNPD---VFVSLSVLDITHNKFICECELSTFINWLNHTNV 577

Query: 166 TLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           T+           P+ +    +  SL     +    +  +   L 
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLF-SLSTEGCDEEEVLKSLKFSLF 621

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 27/173 (15%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAAL-HAGPSDSLPPLPWEARL 453
           EVE  + ++HPNI+RL  +++      LI ++   G++Y  L      D           
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTAT 113

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
            I +  A  L Y H    ++ +H +IK   +LL       I+ FG        S    + 
Sbjct: 114 YITE-LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGW-------SVHAPSS 162

Query: 514 TIVTS-GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 GT          YL PE  I G    +K D++S G++  E L G+ P
Sbjct: 163 RRTDLCGTLD--------YLPPEM-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 82.3 bits (203), Expect = 6e-17
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 21/199 (10%)

Query: 373 TVVAVRRLT-EGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
             V VRR+  E  +       + E+       HPNIV  +A + A++E  +++ F+  GS
Sbjct: 53  EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 112

Query: 432 LYAALHAGPSDSLPPLPWEARLKIA---QGTARGLMYIHEYSPRKYVHGNIKSTKILLDD 488
               +     D +     E    IA   QG  + L YIH      YVH ++K++ IL+  
Sbjct: 113 AKDLICTHFMDGMN----EL--AIAYILQGVLKALDYIHH---MGYVHRSVKASHILISV 163

Query: 489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY-LAPE-ARIYGSKFTQK 546
           +    +SG   N  +   S   +   +      S    +  +  L+PE  +     +  K
Sbjct: 164 DGKVYLSGLRSNLSM--ISHGQRQRVVHDFPKYS----VKVLPWLSPEVLQQNLQGYDAK 217

Query: 547 CDVYSFGIVLLEILTGRLP 565
            D+YS GI   E+  G +P
Sbjct: 218 SDIYSVGITACELANGHVP 236

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 80.3 bits (199), Expect = 7e-17
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 27/173 (15%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAAL-HAGPSDSLPPLPWEAR 452
           E+E  + ++HPNI+R+   Y+ + +++ L+ +F   G LY  L   G  D        + 
Sbjct: 64  EIEIQSHLRHPNILRMY-NYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-----EQRSA 117

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
             + +  A  L Y HE   RK +H +IK   +L+  +    I+ FG +   P   + T  
Sbjct: 118 TFMEE-LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-- 171

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                 GT          YL PE  I G    +K D++  G++  E L G  P
Sbjct: 172 ----MCGTLD--------YLPPEM-IEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.8 bits (200), Expect = 7e-17
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 80/302 (26%)

Query: 359 YKVV--VGRGSGMGAPTV-----------VAVRRLTE---GDATWRFKDFESEVEAIARV 402
           Y++   +G G GM    V           VAV+ L      D ++  + F  E +  A +
Sbjct: 14  YELGEILGFG-GMS--EVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAAL 69

Query: 403 QHPNIV----------RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
            HP IV                Y      ++ +++   +L   +H        P+  +  
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTE-----GPMTPKRA 118

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR-LLPGTSKVTK 511
           +++     + L + H+      +H ++K   I++       +  FG+ R +    + VT+
Sbjct: 119 IEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 512 NETIVTSGTGSRISAISNVYLAPE-ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
              ++  GT          YL+PE AR  G     + DVYS G VL E+LTG  P  G  
Sbjct: 176 TAAVI--GTAQ--------YLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPPFTG-- 221

Query: 571 NDGKGLESLVRKAFR----ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFR 626
                 +S V  A++    +  P S      L  ++ A         + L     +PE R
Sbjct: 222 ------DSPVSVAYQHVREDPIPPSA-RHEGLSADLDA---------VVLKALAKNPENR 265

Query: 627 PR 628
            +
Sbjct: 266 YQ 267

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 32/157 (20%), Positives = 50/157 (31%), Gaps = 13/157 (8%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIP----ANLFNATNLVY 117
            ++  +  L +   +   +   ++ +  +L+ L L+ N                   L  
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205

Query: 118 LDLAHNSFC---GPIPDRIKTLKNLTHLDLSSNLLNGSLPE-FLLDLRALTGTLNLSFNQ 173
           L L +       G           L  LDLS N L  +           L  +LNLSF  
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN-SLNLSFTG 264

Query: 174 FSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
              Q+P+  G    +  LDL  N L    P    L  
Sbjct: 265 LK-QVPK--GLPAKLSVLDLSYNRLD-RNPSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 29/120 (24%), Positives = 43/120 (35%), Gaps = 10/120 (8%)

Query: 85  LGLLNSLTRLSLASNNF---SKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKT-LKNLT 140
                +L  L+L +      S    A       L  LDL+HNS               L 
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256

Query: 141 HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
            L+LS   L   +P+ L     L+  L+LS+N+     P      P + +L L+ N    
Sbjct: 257 SLNLSFTGLK-QVPKGLP--AKLS-VLDLSYNRLDR-NPSP-DELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 7/103 (6%)

Query: 75  RNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI 133
              +G   +       L  L L+ N+      A      + L  L+L+       +P  +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL 272

Query: 134 KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSG 176
                L+ LDLS N L+   P    +L  +   L+L  N F  
Sbjct: 273 --PAKLSVLDLSYNRLD-RNP-SPDELPQVG-NLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 36/186 (19%), Positives = 62/186 (33%), Gaps = 21/186 (11%)

Query: 50  SDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLN-----------SLTRLSLAS 98
           SD  P   S  +C+      LY   R+L   +       +           SL RL++ +
Sbjct: 18  SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRA 77

Query: 99  NNFSKPIPAN---LFNATNLVYLDLAHNSFCGPIPDRI--KTLKNLTHLDLSSNLLNGSL 153
                 I      +   + L  L L +    G  P  +   T  +L  L+L +       
Sbjct: 78  ARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-R 136

Query: 154 PEFLLDLRALTGT----LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLL 209
             +L +L+         L+++         E    FP + +LDL +N   GE   + +L 
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196

Query: 210 NQGPTA 215
                 
Sbjct: 197 PLKFPT 202

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 34/162 (20%), Positives = 51/162 (31%), Gaps = 11/162 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
           T L L + NLT    + L     L  + L+ N   K I  + F     L  L +++N   
Sbjct: 229 TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRL- 284

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
             +    + +  L  LDLS N L   +         L   L L  N     +        
Sbjct: 285 VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV-TLKL--STHH 339

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQ 228
            + +L L +N+            N    A       C    Q
Sbjct: 340 TLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQ 380

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 30/156 (19%), Positives = 55/156 (35%), Gaps = 17/156 (10%)

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGP 128
           +++  +    Y   E   LN+   ++  ++   K +PA L  +   +  L+L        
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEE- 83

Query: 129 IPDRI-KTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMYGHFP 186
           I          +  L +  N +   LP  +  ++  LT  L L  N  S     ++ + P
Sbjct: 84  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT-VLVLERNDLSSLPRGIFHNTP 141

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            + +L + NNNL   I             F     L
Sbjct: 142 KLTTLSMSNNNLE-RIE---------DDTFQATTSL 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 7/138 (5%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN 123
           N    +   N  +     + L     +  L+L      + I    F  A  +  L +  N
Sbjct: 45  NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFN 103

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEM 181
           +    +P  + + +  LT L L  N L+ SLP  +  +   LT TL++S N       + 
Sbjct: 104 AI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT-TLSMSNNNLERIEDDT 160

Query: 182 YGHFPVMVSLDLRNNNLS 199
           +     + +L L +N L+
Sbjct: 161 FQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 24/155 (15%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T+L + N NL            SL  L L+SN  +  +  +L    +L + ++++N    
Sbjct: 144 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVSYNLL-- 198

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +     +  LD S N +N       ++L      L L  N  +     +  ++P 
Sbjct: 199 ---STLAIPIAVEELDASHNSINVVRGPVNVELT----ILKLQHNNLT-DTAWL-LNYPG 249

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +V +DL  N L  +I             F     L
Sbjct: 250 LVEVDLSYNELE-KIM---------YHPFVKMQRL 274

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 19/141 (13%), Positives = 41/141 (29%), Gaps = 11/141 (7%)

Query: 82  PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTH 141
            S L        + +                 N   +   +++        + + + +  
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73

Query: 142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE 201
           L+L+   +             +   L + FN      P ++ + P++  L L  N+LS  
Sbjct: 74  LNLNDLQIEEIDTYAFAYAHTIQ-KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131

Query: 202 IPQVGSLLNQGPTAFSGNPGL 222
           +P            F   P L
Sbjct: 132 LP---------RGIFHNTPKL 143

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 19/118 (16%), Positives = 35/118 (29%), Gaps = 11/118 (9%)

Query: 105 IPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT 164
           I +NL        + +   +          TL N   +   ++ +       L   R + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 165 GTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             LNL+  Q        + +   +  L +  N +   +P         P  F   P L
Sbjct: 73  -LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP---------PHVFQNVPLL 119

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 42/143 (29%), Positives = 56/143 (39%), Gaps = 12/143 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L L    L       L  L +LT L LA+N  S   P  L   T L  L L  N    
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN 279

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P  +  L  LT+L+L+ N L       + +L+ LT  L L FN  S   P        
Sbjct: 280 ISP--LAGLTALTNLELNENQLED--ISPISNLKNLT-YLTLYFNNISDISP--VSSLTK 332

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           +  L   NN +S  +  + +L N
Sbjct: 333 LQRLFFYNNKVSD-VSSLANLTN 354

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 12/144 (8%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
                L   N+T         L+ +T L              +    NL  ++ ++N   
Sbjct: 26  KMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT 81

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
              P  +K L  L  + +++N +       L +L  LT  L L  NQ +   P    +  
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLT-GLTLFNNQITDIDP--LKNLT 134

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLN 210
            +  L+L +N +S  I  +  L +
Sbjct: 135 NLNRLELSSNTISD-ISALSGLTS 157

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.5 bits (194), Expect = 2e-15
 Identities = 40/143 (27%), Positives = 55/143 (38%), Gaps = 13/143 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L   N  +T      L  L +L RL ++SN  S    + L   TNL  L   +N    
Sbjct: 159 QQLSFGN-QVTD--LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD 213

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P  +  L NL  L L+ N L       L  L  LT  L+L+ NQ S  +  +      
Sbjct: 214 ITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLT-DLDLANNQISN-LAPL-SGLTK 266

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           +  L L  N +S  I  +  L  
Sbjct: 267 LTELKLGANQISN-ISPLAGLTA 288

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.5 bits (181), Expect = 6e-14
 Identities = 34/136 (25%), Positives = 58/136 (42%), Gaps = 12/136 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             + + N  +     + L  L +LT L+L +N  +   P  L N TNL  L+L+ N+   
Sbjct: 93  VDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +  L +L  L   + + +    + L +L  L   L++S N+ S  I  +      
Sbjct: 149 ISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLE-RLDISSNKVSD-ISVL-AKLTN 200

Query: 188 MVSLDLRNNNLSGEIP 203
           + SL   NN +S   P
Sbjct: 201 LESLIATNNQISDITP 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.0 bits (172), Expect = 9e-13
 Identities = 28/138 (20%), Positives = 51/138 (36%), Gaps = 10/138 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L+  N  ++    S L  L ++  LS   N  S   P  L N T +  L L   ++  
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNG-SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
              +      N++  +   N+      P  + D  + T   ++++N  S    E+   F 
Sbjct: 390 APVN---YKANVSIPNTVKNVTGALIAPATISDGGSYT-EPDITWNLPS-YTNEVSYTFS 444

Query: 187 VMVSLDLRNNNLSGEIPQ 204
             V++       SG + Q
Sbjct: 445 QPVTIGKGTTTFSGTVTQ 462

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.3 bits (108), Expect = 5e-05
 Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 6/78 (7%)

Query: 133 IKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLD 192
              L       L    +  ++     DL  +T TL          I  +  +   +  ++
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVT-TLQADRLGIKS-IDGV-EYLNNLTQIN 74

Query: 193 LRNNNLSGEIPQVGSLLN 210
             NN L+  I  + +L  
Sbjct: 75  FSNNQLTD-ITPLKNLTK 91

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 29/163 (17%), Positives = 58/163 (35%), Gaps = 27/163 (16%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
            C+  +   L L N  L+  +P        L  L  + N+ ++ +P    +  +L+  + 
Sbjct: 67  DCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLTE-LPELPQSLKSLLVDNN 121

Query: 121 AHNSFCGPIP---------------DRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG 165
              +     P                 ++    L  +D+ +N L   LP+    L     
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---- 176

Query: 166 TLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSL 208
            +    NQ   ++PE+  + P + ++   NN+L        SL
Sbjct: 177 FIAAGNNQLE-ELPEL-QNLPFLTAIYADNNSLKKLPDLPLSL 217

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 30/172 (17%), Positives = 56/172 (32%), Gaps = 41/172 (23%)

Query: 68  TSLYLPNRNLTGYMPSELG-------------LLNSLTRLSLASNNFSKPIPANLFNATN 114
           T  Y          P   G             L      L L +   S  +P       +
Sbjct: 37  TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPELP---PH 92

Query: 115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG----------------SLPEFLL 158
           L  L  + NS    +P+  ++LK+L   + +   L+                  LPE   
Sbjct: 93  LESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPEL-Q 150

Query: 159 DLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           +   L   +++  N    ++P++      +  +   NN L  E+P++ +L  
Sbjct: 151 NSSFLK-IIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPELQNLPF 196

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 30/141 (21%), Positives = 52/141 (36%), Gaps = 14/141 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             +   N  L      EL  L  LT +   +N+  K +P       +L  +   +N    
Sbjct: 176 EFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNIL-- 227

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                ++ L  LT +   +NLL  +LP+    L      LN+  N  +  +PE+      
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE----ALNVRDNYLT-DLPELPQSLTF 281

Query: 188 MVSLDLRNNNLSGEIPQVGSL 208
           +   +   + LS   P +  L
Sbjct: 282 LDVSENIFSGLSELPPNLYYL 302

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 25/140 (17%), Positives = 47/140 (33%), Gaps = 21/140 (15%)

Query: 82  PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTL----- 136
           P  +     L      S+N ++ +P    N  +      A + +    P           
Sbjct: 5   PRNVSNTF-LQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 137 --------KNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVM 188
                   +    L+L++  L+ SLPE    L     +L  S N  + ++PE+      +
Sbjct: 63  SRLRDCLDRQAHELELNNLGLS-SLPELPPHLE----SLVASCNSLT-ELPELPQSLKSL 116

Query: 189 VSLDLRNNNLSGEIPQVGSL 208
           +  +     LS   P +  L
Sbjct: 117 LVDNNNLKALSDLPPLLEYL 136

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 22/136 (16%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L + +  LT  +P       SLT L ++ N FS  +        NL YL+ + N    
Sbjct: 260 EALNVRDNYLTD-LPELPQ---SLTFLDVSENIFSG-LSELP---PNLYYLNASSNEIRS 311

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            + D      +L  L++S+N L   LP     L      L  SFN  + ++PE+  +   
Sbjct: 312 -LCD---LPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPELPQN--- 358

Query: 188 MVSLDLRNNNLSGEIP 203
           +  L +  N L  E P
Sbjct: 359 LKQLHVEYNPLR-EFP 373

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 28/136 (20%), Positives = 50/136 (36%), Gaps = 23/136 (16%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L   +  +     S   L  SL  L++++N   + +PA       L  L  + N    
Sbjct: 300 YYLNASSNEIR----SLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLAE 351

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +P+     +NL  L +  N L    P+    +       +L  N    ++PE+  +   
Sbjct: 352 -VPE---LPQNLKQLHVEYNPLR-EFPDIPESVE------DLRMNSHLAEVPELPQN--- 397

Query: 188 MVSLDLRNNNLSGEIP 203
           +  L +  N L  E P
Sbjct: 398 LKQLHVETNPLR-EFP 412

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 16/108 (14%), Positives = 30/108 (27%), Gaps = 14/108 (12%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L++    L    P     +  L       N+    +P       NL  L +  N    
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELP---QNLKQLHVETNPLRE 410

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
             PD     +++  L ++S  +     EF  +            +   
Sbjct: 411 -FPD---IPESVEDLRMNSERVV-DPYEFAHETTDKLEDDVFEHHHHH 453

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 37/230 (16%), Positives = 70/230 (30%), Gaps = 31/230 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFI------ 427
           V+ +R L       + K     +     V+ P   ++        +  ++S F       
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188

Query: 428 -RNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL 486
               +    L +  S     L   ARL++     R L  +H       VH  ++   I+L
Sbjct: 189 SNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244

Query: 487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE----ARIYGSK 542
           D      ++GF       G S V+          G   +       A       + + + 
Sbjct: 245 DQRGGVFLTGFEHLVRD-GASAVSP--------IGRGFAPPE--TTAERMLPFGQHHPTL 293

Query: 543 FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
            T   D ++ G+ +  I    LP+                 FR  + + +
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLPNTDDA-----ALGGSEWIFRSCKNIPQ 338

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 36/226 (15%)

Query: 392 FESEVEAIARVQHPNIVRLKAFY--YANDEKLLISDFIRNGSLYAALHA-GPSDSLPPLP 448
              E E + ++ H NIV+L A         K+LI +F   GSLY  L     +  LP   
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES- 112

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL----DDELHPCISGFGLNRLLP 504
            E  + +      G+ ++ E      VH NIK   I+     D +    ++ FG      
Sbjct: 113 -EFLIVLRD-VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA----- 162

Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPE-------ARIYGSKFTQKCDVYSFGIVLL 557
             ++  +++    S  G+        YL P+        + +  K+    D++S G+   
Sbjct: 163 --ARELEDDEQFVSLYGTEE------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214

Query: 558 EILTGRLP---DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
              TG LP     GP  + + +  ++           +  +   + 
Sbjct: 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 80.7 bits (199), Expect = 4e-16
 Identities = 37/175 (21%), Positives = 55/175 (31%), Gaps = 15/175 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
           T L L + NLT    + L     L  + L+ N   K I  + F     L  L +++N   
Sbjct: 235 TILKLQHNNLT--DTAWLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRL- 290

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
             +    + +  L  LDLS N L   +         L   L L  N     +        
Sbjct: 291 VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV-TLKL--STHH 345

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSP----CPEPENP 237
            + +L L +N+            N    A       C    Q      C E + P
Sbjct: 346 TLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 7/138 (5%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN 123
           N    +   N  +     + L     +  L+L      + I    F  A  +  L +  N
Sbjct: 51  NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFN 109

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEM 181
           +    +P  + + +  LT L L  N L+ SLP  +  +   LT TL++S N       + 
Sbjct: 110 AI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT-TLSMSNNNLERIEDDT 166

Query: 182 YGHFPVMVSLDLRNNNLS 199
           +     + +L L +N L+
Sbjct: 167 FQATTSLQNLQLSSNRLT 184

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 72.7 bits (178), Expect = 2e-13
 Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 17/138 (12%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLS 145
           LN+   ++  ++   K +PA L  +   +  L+L        I          +  L + 
Sbjct: 50  LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMG 107

Query: 146 SNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ 204
            N +   LP  +  ++  LT  L L  N  S     ++ + P + +L + NNNL   I  
Sbjct: 108 FNAIR-YLPPHVFQNVPLLT-VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIE- 163

Query: 205 VGSLLNQGPTAFSGNPGL 222
                      F     L
Sbjct: 164 --------DDTFQATTSL 173

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 24/155 (15%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T+L + N NL            SL  L L+SN  +  +  +L    +L + ++++N    
Sbjct: 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLI--PSLFHANVSYNLL-- 204

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +     +  LD S N +N       ++L      L L  N  +     +  ++P 
Sbjct: 205 ---STLAIPIAVEELDASHNSINVVRGPVNVELT----ILKLQHNNLT-DTAWL-LNYPG 255

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +V +DL  N L  +I             F     L
Sbjct: 256 LVEVDLSYNELE-KIM---------YHPFVKMQRL 280

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.8 bits (155), Expect = 9e-11
 Identities = 20/152 (13%), Positives = 46/152 (30%), Gaps = 13/152 (8%)

Query: 72  LPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPD 131
            P +     + S L        + +                 N   +   +++       
Sbjct: 10  KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69

Query: 132 RIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVS 190
            + + + +  L+L+   +   +  +       +   L + FN      P ++ + P++  
Sbjct: 70  LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ-KLYMGFNAIRYLPPHVFQNVPLLTV 127

Query: 191 LDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           L L  N+LS  +P            F   P L
Sbjct: 128 LVLERNDLS-SLP---------RGIFHNTPKL 149

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 30/164 (18%), Positives = 49/164 (29%), Gaps = 11/164 (6%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
            +  + L    L   M      +  L RL +++N     +         L  LDL+HN  
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
              +         L +L L  N +  +L   L     L   L LS N +          F
Sbjct: 314 LH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK-NLTLSHNDWDC-NSLRAL-F 366

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQS 229
             +    + + +   +I      L  G      +       LQ 
Sbjct: 367 RNVARPAVDDADQHCKIDY---QLEHGLCCKESDKPYLDRLLQY 407

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 52/314 (16%), Positives = 106/314 (33%), Gaps = 66/314 (21%)

Query: 359 YKVV--VGRGSGMGAPTVVAVRRLTEG-----------DATWRFKDFESEVEAIARVQHP 405
           ++ +  +GRG G G   V   +   +            +     +    EV+A+A+++HP
Sbjct: 7   FEPIQCLGRG-GFG--VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 406 NIVRLK-AFYYANDEKLLISD------FI-----RNGSLYAALHAGPSDSLPPLPWEARL 453
            IVR   A+   N  + L         +I     R  +L   ++     ++        L
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE 513
            I    A  + ++H    +  +H ++K + I    +    +  FGL   +    +     
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT-- 176

Query: 514 TIVTSGTGSRISAISNV----YLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
             V +   +       V    Y++PE +I+G+ ++ K D++S G++L E+L        P
Sbjct: 177 --VLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY-------P 226

Query: 570 ENDGKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
            +        +      +  PL     P     +                    P  RP 
Sbjct: 227 FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD-------------MLSPSPMERP- 272

Query: 629 MRTVSESLDRVKLQ 642
                  ++    +
Sbjct: 273 --EAINIIENAVFE 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 79.5 bits (196), Expect = 6e-16
 Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 36/225 (16%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKL--LISDFIRNGSLYAALHA-GPSDSLPPLPW 449
             E E + ++ H NIV+L A       +   LI +F   GSLY  L     +  LP    
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-- 112

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL----DDELHPCISGFGLNRLLPG 505
           E  + +      G+ ++ E      VH NIK   I+     D +    ++ FG       
Sbjct: 113 EFLIVLRD-VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA------ 162

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPE-------ARIYGSKFTQKCDVYSFGIVLLE 558
            ++  +++    S  G+        YL P+        + +  K+    D++S G+    
Sbjct: 163 -ARELEDDEQFVSLYGTEE------YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215

Query: 559 ILTGRLP---DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVK 600
             TG LP     GP  + + +  ++           +  +   + 
Sbjct: 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.9 bits (194), Expect = 8e-16
 Identities = 35/215 (16%), Positives = 65/215 (30%), Gaps = 39/215 (18%)

Query: 392 FESEVEAIARVQHPNIVRLKA----FYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
           F    + +   Q   ++R++      +  +   L         +    L +  S     L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSL 203

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
              ARL++     R L  +H       VH  ++   I+LD      ++GF          
Sbjct: 204 VHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEH-------- 252

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPE----------ARIYGSKFTQKCDVYSFGIVLL 557
            V     +V+S +          +  PE           R   +  T   D ++ G+V+ 
Sbjct: 253 LVRDGARVVSSVS--------RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 558 EILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
            I    LP                  FR  + + +
Sbjct: 305 WIWCADLPI-----TKDAALGGSEWIFRSCKNIPQ 334

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 56/263 (21%), Positives = 103/263 (39%), Gaps = 50/263 (19%)

Query: 324 QKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG 383
           Q G   I  + +  E+ DL       +G    G ++K+   +        V+AV+++   
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLG--EMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRS 61

Query: 384 DATWRFKDFESEVEAIAR-VQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALH--AGP 440
                 K    +++ + +    P IV+    +           FI N  ++ A+      
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQ---CFGT---------FITNTDVFIAMELMGTC 109

Query: 441 SDSL-----PPLPWEARL-KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI 494
           ++ L      P+P E  L K+     + L Y+        +H ++K + ILLD+     +
Sbjct: 110 AEKLKKRMQGPIP-ERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKL 166

Query: 495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI-----YGSKFTQKCDV 549
             FG++  L       K+ +    G  +        Y+APE RI         +  + DV
Sbjct: 167 CDFGISGRL--VDDKAKDRSA---GCAA--------YMAPE-RIDPPDPTKPDYDIRADV 212

Query: 550 YSFGIVLLEILTGRLPDAGPEND 572
           +S GI L+E+ TG+ P    + D
Sbjct: 213 WSLGISLVELATGQFPYKNCKTD 235

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 24/161 (14%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN--S 124
           T +   ++ LT  +P+  G+ +S TRL L SN     +P  +F   T L  L L+ N  S
Sbjct: 10  TEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLS 65

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
           F G          +L +LDLS N +  ++    L L  L   L+   +    Q+ E +  
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLK-QMSE-FSV 121

Query: 185 FPVMVSL---DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           F  + +L   D+ + +                  F+G   L
Sbjct: 122 FLSLRNLIYLDISHTHTR-VAF---------NGIFNGLSSL 152

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 32/115 (27%), Positives = 47/115 (40%), Gaps = 6/115 (5%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLS 145
           L +L  L ++  +        +F   ++L  L +A NSF       I   L+NLT LDLS
Sbjct: 125 LRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 146 SNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
              L   L     + L +L   LN+S N F       Y     +  LD   N++ 
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 36/141 (25%), Positives = 53/141 (37%), Gaps = 7/141 (4%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFS-KPIPANLF-NATNLVYLDLAHNS 124
            T L L +  L          L  LT+LSL+SN  S K   +      T+L YLDL+ N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSGQIPEMY 182
               +      L+ L HLD   + L   + E    L LR L   L++S          ++
Sbjct: 90  VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI-YLDISHTHTRVAFNGIF 146

Query: 183 GHFPVMVSLDLRNNNLSGEIP 203
                +  L +  N+      
Sbjct: 147 NGLSSLEVLKMAGNSFQENFL 167

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 7/112 (6%)

Query: 68  TSLYLP-NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF 125
             L +  N     ++P     L +LT L L+     + +    FN+ ++L  L+++HN+F
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNF 211

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD--LRALTGTLNLSFNQFS 175
                   K L +L  LD S N +  +  +  L     +L   LNL+ N F+
Sbjct: 212 FSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLA-FLNLTQNDFA 261

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 60/276 (21%), Positives = 97/276 (35%), Gaps = 53/276 (19%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFK-DFESEVEAIARV-QHPNIVRLKAF 413
           G ++KV   +  G     + AV+R        + +    +EV +  +V QHP  VRL+  
Sbjct: 71  GEVFKVR-SKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125

Query: 414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK--IAQGTARGLMYIHEYSP 471
           +       L ++     SL     A  +     LP EA++   +   T   L ++H    
Sbjct: 126 WEEGGILYLQTELC-GPSLQQHCEAWGA----SLP-EAQVWGYLRD-TLLALAHLHS--- 175

Query: 472 RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY 531
           +  VH ++K   I L       +  FGL   L         E     G           Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAGAGEVQE--GDPR--------Y 222

Query: 532 LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           +APE  +    +    DV+S G+ +LE+         P   G+G + L +         +
Sbjct: 223 MAPE--LLQGSYGTAADVFSLGLTILEVACNMEL---PHG-GEGWQQLRQGYLPP--EFT 274

Query: 592 EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
             +   L       R VL          E DP+ R 
Sbjct: 275 AGLSSEL-------RSVLV------MMLEPDPKLRA 297

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 61/262 (23%), Positives = 116/262 (44%), Gaps = 43/262 (16%)

Query: 319 DEEEGQKGKFFIIDEG--FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVA 376
           DE++ ++ + F+  +     L+ +D  + S   +G    G+++KV   + SG     V+A
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKDDDFEKIS--ELGAGNGGVVFKVSH-KPSG----LVMA 62

Query: 377 VR--RLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFY--YANDEKLLIS-DFIRNGS 431
            +   L    A         E++ +     P IV    FY  + +D ++ I  + +  GS
Sbjct: 63  RKLIHLEIKPAI--RNQIIRELQVLHECNSPYIVG---FYGAFYSDGEISICMEHMDGGS 117

Query: 432 LYAALHAGPSDSLPPLPWEARL-KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
           L   L          +P E  L K++    +GL Y+      K +H ++K + IL++   
Sbjct: 118 LDQVLKKAG-----RIP-EQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              +  FG++  L  +       + V  GT S        Y++PE R+ G+ ++ + D++
Sbjct: 170 EIKLCDFGVSGQLIDS----MANSFV--GTRS--------YMSPE-RLQGTHYSVQSDIW 214

Query: 551 SFGIVLLEILTGRLPDAGPEND 572
           S G+ L+E+  GR P   P+  
Sbjct: 215 SMGLSLVEMAVGRYPIPPPDAK 236

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 16/157 (10%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
                 +R+ T  +PS  GL  ++  L L+ N  +     +L    NL  L L  +    
Sbjct: 8   GVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-N 63

Query: 128 PIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSG-QIPEMYGHF 185
            I      +L +L HLDLS N L+     +   L +L   LNL  N +    +  ++ + 
Sbjct: 64  TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK-YLNLMGNPYQTLGVTSLFPNL 122

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             + +L + N     EI             F+G   L
Sbjct: 123 TNLQTLRIGNVETFSEIR---------RIDFAGLTSL 150

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.5 bits (191), Expect = 5e-15
 Identities = 32/139 (23%), Positives = 59/139 (42%), Gaps = 9/139 (6%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
           +  L++P   L   + +   LL  + R+++ ++     +P +   +  +L +LDL+ N  
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLM 346

Query: 126 ---CGPIPDRIKTLKNLTHLDLSSNLLN--GSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
                          +L  L LS N L       E LL L+ LT +L++S N F   +P+
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT-SLDISRNTFH-PMPD 404

Query: 181 MYGHFPVMVSLDLRNNNLS 199
                  M  L+L +  + 
Sbjct: 405 SCQWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.5 bits (191), Expect = 5e-15
 Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 29/159 (18%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
           +N + S+      L          L +LT L ++ N F   +P +      + +L+L+  
Sbjct: 370 QNHLRSMQKTGEILLT--------LKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSST 420

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG 183
                +   I   + L  LD+S+N L+ S   FL  L+     L +S N+    +P+   
Sbjct: 421 GI-RVVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQ----ELYISRNKLK-TLPD-AS 470

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            FPV++ + +  N L   +P            F     L
Sbjct: 471 LFPVLLVMKISRNQLK-SVP---------DGIFDRLTSL 499

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 5/136 (3%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
           + SL L    +T     +L    +L  L L S+  +  I  + F +  +L +LDL+ N  
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHL 86

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNG-SLPEFLLDLRALTGTLNLSFNQFSGQIPEMY-G 183
                     L +L +L+L  N      +     +L  L  TL +   +   +I  +   
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ-TLRIGNVETFSEIRRIDFA 145

Query: 184 HFPVMVSLDLRNNNLS 199
               +  L+++  +L 
Sbjct: 146 GLTSLNELEIKALSLR 161

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.0 bits (182), Expect = 6e-14
 Identities = 29/131 (22%), Positives = 49/131 (37%), Gaps = 11/131 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           TSL + +RN    MP        +  L+L+S      +   +     L  LD+++N+   
Sbjct: 390 TSLDI-SRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNL-D 444

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                   L  L  L +S N L  +LP+  L    L   + +S NQ       ++     
Sbjct: 445 SFSLF---LPRLQELYISRNKLK-TLPDASL-FPVLL-VMKISRNQLKSVPDGIFDRLTS 498

Query: 188 MVSLDLRNNNL 198
           +  + L  N  
Sbjct: 499 LQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 19/127 (14%), Positives = 43/127 (33%), Gaps = 7/127 (5%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           LN L   + + ++    +         +  L +        +      L+ +  + + ++
Sbjct: 263 LNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320

Query: 148 LLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSL---DLRNNNLSGEIPQ 204
            +      F   L++L   L+LS N    +  +         SL    L  N+L   + +
Sbjct: 321 KVFLVPCSFSQHLKSLE-FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQK 378

Query: 205 VGSLLNQ 211
            G +L  
Sbjct: 379 TGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 18/163 (11%), Positives = 55/163 (33%), Gaps = 13/163 (7%)

Query: 68  TSLYLPNRN-LTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF 125
            +L + N    +     +   L SL  L + + +      +    +  ++ +L L  +  
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSES 184

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNG------SLPEFLLDLRALTGTLNLSFNQFSGQIP 179
              +      L ++ +L+L    L         + E    ++ L    ++  ++   ++ 
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL 244

Query: 180 EMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           ++  +   +  ++  +  L+G    +G          S    +
Sbjct: 245 KLLRYILELSEVEFDDCTLNG----LGDFNPSESDVVSELGKV 283

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 6/87 (6%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
            CI   +  L + N NL       L     L  L ++ N     +P        L+ + +
Sbjct: 427 TCIPQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLKT-LPDASL-FPVLLVMKI 480

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           + N            L +L  + L +N
Sbjct: 481 SRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 23/171 (13%), Positives = 49/171 (28%), Gaps = 25/171 (14%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP----------IPANLFNATN 114
           + V  L L + NL  +  S L +    + +   +   S            +   +   + 
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 115 LVYLDLAHNSFCGPIPDRIKTLK--------NLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
           + + D   N      P     +          +  L +    L   L      L  +   
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK-R 314

Query: 167 LNLSFNQFSGQIPEMYGHFPVMVS---LDLRNNNLSGEIPQVGSLLNQGPT 214
           + +  ++    +P        + S   LDL  N +  E  +  +     P+
Sbjct: 315 ITVENSKVF-LVPC--SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 28/205 (13%), Positives = 52/205 (25%), Gaps = 24/205 (11%)

Query: 392 FESEVEAIARVQHPNIVRLKAFY--YANDEKLLISDFIR--NGSLYAALHAGPSDSLPPL 447
                +A+A    P   +L      YA    LL+          L++ L           
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR-GDE 191

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
              A   +     R    +     +  VHG+     + +  +    +             
Sbjct: 192 GILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSA-------- 240

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPE-ARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
                  +   GT    S++   Y   E      + FT   + +  G+ +  +    LP 
Sbjct: 241 -------LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293

Query: 567 AGPENDGKGLESLVRKAFRERRPLS 591
                  KG              L+
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLA 318

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 35/166 (21%), Positives = 57/166 (34%), Gaps = 17/166 (10%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L + N  LT  +P        L  ++  +N  +  +P      T+L  L + +N    
Sbjct: 123 KHLDVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELP---TSLEVLSVRNNQLTF 174

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEF---LLDLRALTGTLNLSFNQFSGQIPEMYGH 184
            +P+     ++L  LD+S+NLL  SLP                    N+ +  IPE    
Sbjct: 175 -LPE---LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSP 230
                ++ L +N LS  I +  S     P              Q  
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 22/148 (14%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
           C+ N+ + L L   NL+  +P  L     +T L +  N     +P       +L YLD  
Sbjct: 56  CLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LPELP---ASLEYLDAC 108

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
            N     +P+      +L HLD+ +N L   LPE    L      +N   NQ +  +PE+
Sbjct: 109 DNRL-STLPELPA---SLKHLDVDNNQLT-MLPELPALLE----YINADNNQLT-MLPEL 158

Query: 182 YGHFPVMVSLDLRNNNLSGEIP-QVGSL 208
                 +  L +RNN L+  +P    SL
Sbjct: 159 PTS---LEVLSVRNNQLT-FLPELPESL 182

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 15/128 (11%)

Query: 81  MPSELGLLNSLTRLSLASNNFSKPIPANLFNA----TNLVYLDLAHNSFCGPIPDRIKTL 136
           M   L + N+ +    +  N      A+ F+A              N     + + +  +
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58

Query: 137 KNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNN 196
              + L L+   L+ SLP+ L     +T  L ++ N     +PE+      +  LD  +N
Sbjct: 59  NQFSELQLNRLNLS-SLPDNL--PPQIT-VLEITQNALI-SLPELPAS---LEYLDACDN 110

Query: 197 NLSGEIPQ 204
            LS  +P+
Sbjct: 111 RLS-TLPE 117

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 47/182 (25%), Positives = 71/182 (39%), Gaps = 23/182 (12%)

Query: 395 EVEAIARVQHPNIVRLKAFYY----ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           E +      HPNI+RL A+      A  E  L+  F + G+L+  +          L  E
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NFLT-E 133

Query: 451 AR-LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL----PG 505
            + L +  G  RGL  IH    + Y H ++K T ILL DE  P +   G          G
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGR 563
           + +    +              +  Y APE  +        ++ DV+S G VL  ++ G 
Sbjct: 191 SRQALTLQDWAAQRC-------TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

Query: 564 LP 565
            P
Sbjct: 244 GP 245

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 35/242 (14%)

Query: 332 DEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD 391
           ++ +    EDL       +G+   G + K+V  + SG     ++AV+R+         K 
Sbjct: 14  EQHWDFTAEDLKDLG--EIGRGAYGSVNKMVH-KPSG----QIMAVKRIRSTVDEKEQKQ 66

Query: 392 FESEVEAIAR-VQHPNIVRLKAFY--YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
              +++ + R    P IV+   FY     +    I   + + S         S     +P
Sbjct: 67  LLMDLDVVMRSSDCPYIVQ---FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123

Query: 449 WEARL-KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
            E  L KI   T + L ++      K +H +IK + ILLD   +  +  FG++  L    
Sbjct: 124 -EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VD 178

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVLLEILTGR 563
            + K       G           Y+APE RI        +  + DV+S GI L E+ TGR
Sbjct: 179 SIAKTRDA---GCRP--------YMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

Query: 564 LP 565
            P
Sbjct: 227 FP 228

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 38/157 (24%), Positives = 55/157 (35%), Gaps = 15/157 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             L L   NLT      L  L+ L  L L   N +  I    F     L  L+++H  + 
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYL 213

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMYGHF 185
             +        NLT L ++   L  ++P   +  L  L   LNLS+N  S     M    
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLR-FLNLSYNPISTIEGSMLHEL 271

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             +  + L    L+  +          P AF G   L
Sbjct: 272 LRLQEIQLVGGQLA-VVE---------PYAFRGLNYL 298

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 43/163 (26%), Positives = 55/163 (33%), Gaps = 23/163 (14%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
               L L    +      E      L  L L  N  S  +    F N  NL  L L  N 
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNR 91

Query: 125 FCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMY 182
               IP  +   L NLT LD+S N +   L +++  DL  L  +L +  N     I    
Sbjct: 92  L-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLK-SLEVGDNDLV-YISH-- 145

Query: 183 GHF---PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             F     +  L L   NL+  IP           A S   GL
Sbjct: 146 RAFSGLNSLEQLTLEKCNLT-SIP---------TEALSHLHGL 178

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 21/165 (12%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLD 119
            C   +  ++    +     +P   G+      L L  N     +  + F +  +L  L+
Sbjct: 8   EC-SAQDRAVLCHRKRFVA-VPE--GIPTETRLLDLGKNRIKT-LNQDEFASFPHLEELE 62

Query: 120 LAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQ 177
           L  N     +       L NL  L L SN L   +P  +   L  LT  L++S N+    
Sbjct: 63  LNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLT-KLDISENKIVIL 119

Query: 178 IPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +  M+     + SL++ +N+L   I            AFSG   L
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YIS---------HRAFSGLNSL 154

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 27/162 (16%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAH 122
            N +  +   +R  +G        LNSL +L+L   N +  IP     +   L+ L L H
Sbjct: 137 DNDLVYI--SHRAFSG--------LNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRH 185

Query: 123 NSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE- 180
            +    I D   K L  L  L++S      ++    L    LT +L+++    +  +P  
Sbjct: 186 LNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYL 242

Query: 181 MYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
              H   +  L+L  N +S  I           +       L
Sbjct: 243 AVRHLVYLRFLNLSYNPIS-TIE---------GSMLHELLRL 274

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 28/148 (18%), Positives = 55/148 (37%), Gaps = 9/148 (6%)

Query: 54  PCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NA 112
              +  ++    R+  L + +      M        +LT LS+   N +  +P     + 
Sbjct: 193 DYSFKRLY----RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHL 247

Query: 113 TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSF 171
             L +L+L++N         +  L  L  + L    L   +  +    L  L   LN+S 
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLR-VLNVSG 305

Query: 172 NQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
           NQ +     ++     + +L L +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 39/167 (23%), Positives = 55/167 (32%), Gaps = 23/167 (13%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLD 119
            C      +   P + L   +P   G+  +  R+ L  N  S  +PA  F    NL  L 
Sbjct: 7   VCYNEPKVTTSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISH-VPAASFRACRNLTILW 62

Query: 120 LAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQI 178
           L  N            L  L  LDLS N    S+       L  L  TL+L       ++
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH-TLHLDRCGLQ-EL 120

Query: 179 PEMYGHFPVMVSL---DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
               G F  + +L    L++N L   +P            F     L
Sbjct: 121 GP--GLFRGLAALQYLYLQDNALQ-ALP---------DDTFRDLGNL 155

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 39/161 (24%), Positives = 56/161 (34%), Gaps = 22/161 (13%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             ++L    ++    +      +LT L L SN  ++ I A  F     L  LDL+ N+  
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDNAQL 93

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +       L  L  L L    L   L   L   L AL   L L  N     +P+    
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ-YLYLQDNALQ-ALPD--DT 148

Query: 185 FPVMVSL---DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           F  + +L    L  N +S  +P           AF G   L
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVP---------ERAFRGLHSL 179

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 45/166 (27%), Positives = 63/166 (37%), Gaps = 18/166 (10%)

Query: 68  TSLYLP-NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
             L L  N  L    P+    L  L  L L      + +   LF     L YL L  N+ 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNAL 141

Query: 126 CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYG 183
              +PD   + L NLTHL L  N ++ S+PE     L +L   L L  N+ +   P  + 
Sbjct: 142 QA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLD-RLLLHQNRVAHVHPHAFR 198

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQS 229
               +++L L  NNLS  +P           A +    L    L  
Sbjct: 199 DLGRLMTLYLFANNLS-ALP---------TEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 32/133 (24%), Positives = 45/133 (33%), Gaps = 5/133 (3%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
            +L+L    L    P     L +L  L L  N     +P + F +  NL +L L  N   
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHF 185
                  + L +L  L L  N +   +       L  L  TL L  N  S    E     
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLM-TLYLFANNLSALPTEALAPL 224

Query: 186 PVMVSLDLRNNNL 198
             +  L L +N  
Sbjct: 225 RALQYLRLNDNPW 237

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 30/147 (20%), Positives = 50/147 (34%), Gaps = 20/147 (13%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA 121
           C+ N    L +    LT  +P  L     +T L +  NN +  +PA       L  L+++
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPALP---PELRTLEVS 89

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
            N     +P     L  L+            LP     L      L +  NQ +  +P +
Sbjct: 90  GNQL-TSLPVLPPGLLELSIFSNPLT----HLPALPSGLC----KLWIFGNQLT-SLPVL 139

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVGSL 208
                 +  L + +N L+        L
Sbjct: 140 PPG---LQELSVSDNQLASLPALPSEL 163

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 18/144 (12%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L + +  L   +P+       L +L   +N  +  +PA     + L  L ++ N    
Sbjct: 184 QELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS 235

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +P        L  L +S N L  SLP     L     +L++  NQ + ++PE   H   
Sbjct: 236 -LPV---LPSELKELMVSGNRLT-SLPMLPSGLL----SLSVYRNQLT-RLPESLIHLSS 285

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQ 211
             +++L  N LS    Q    +  
Sbjct: 286 ETTVNLEGNPLSERTLQALREITS 309

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.1 bits (156), Expect = 8e-11
 Identities = 32/153 (20%), Positives = 52/153 (33%), Gaps = 34/153 (22%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L++    LT   P        L  LS++ N  +  +PA     + L  L   +N    
Sbjct: 124 CKLWIFGNQLTSL-PVLPP---GLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS 175

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT----------------GTLNLSF 171
            +P        L  L +S N L  SLP    +L  L                   L +S 
Sbjct: 176 -LPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSG 230

Query: 172 NQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ 204
           N+ +  +P +      +  L +  N L+  +P 
Sbjct: 231 NRLT-SLPVLPSE---LKELMVSGNRLT-SLPM 258

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 17/111 (15%), Positives = 36/111 (32%), Gaps = 10/111 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L +    LT  +P        L  LS+  N  ++ +P +L + ++   ++L  N    
Sbjct: 244 KELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGN---- 294

Query: 128 PIPDRIKTL-KNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQ 177
           P+ +R     + +T     S  +           R        + +     
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 24/176 (13%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP-WE 450
            ++EV+   +++HP+I+ L  ++  ++   L+ +   NG +   L         P    E
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENE 113

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
           AR  + Q    G++Y+H       +H ++  + +LL   ++  I+ FGL   L       
Sbjct: 114 ARHFMHQ-IITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK-----M 164

Query: 511 KNETIVTS-GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            +E   T  GT        N Y++PE     S    + DV+S G +   +L GR P
Sbjct: 165 PHEKHYTLCGT-------PN-YISPEI-ATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 15/137 (10%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
            N + S  + N    G        +  L+ + +A  N +  IP  L    +L  L L  N
Sbjct: 154 TNPLKSSGIENGAFQG--------MKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGN 202

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY 182
                +     K L NL  L LS N ++      L +   L   L+L+ N+   ++P   
Sbjct: 203 KI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLV-KVPGGL 259

Query: 183 GHFPVMVSLDLRNNNLS 199
                +  + L NNN+S
Sbjct: 260 ADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 28/162 (17%), Positives = 66/162 (40%), Gaps = 23/162 (14%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
           ++  LYL    L   +P    +  +L  L +  N  +K +  ++F     ++ ++L  N 
Sbjct: 101 KLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNP 156

Query: 125 F-CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY 182
                I +   + +K L+++ ++   +  ++P+ L    +LT  L+L  N+ + ++    
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT-ELHLDGNKIT-KVDAAS 211

Query: 183 -GHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLC 223
                 +  L L  N++S  +            + +  P L 
Sbjct: 212 LKGLNNLAKLGLSFNSIS-AVD---------NGSLANTPHLR 243

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 38/158 (24%), Positives = 55/158 (34%), Gaps = 21/158 (13%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             +   +  L   +P    L      L L +N  ++ I    F N  NL  L L +N   
Sbjct: 34  RVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS 89

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
             I       L  L  L LS N L   LPE +   + L   L +  N+ +     ++   
Sbjct: 90  K-ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQ-ELRVHENEITKVRKSVFNGL 144

Query: 186 PVMVSLDLRNNNL-SGEIPQVGSLLNQGPTAFSGNPGL 222
             M+ ++L  N L S  I            AF G   L
Sbjct: 145 NQMIVVELGTNPLKSSGIE---------NGAFQGMKKL 173

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 37/167 (22%), Positives = 58/167 (34%), Gaps = 26/167 (15%)

Query: 55  CHWSGIHCIRNR-----------VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK 103
           CH   + C                  L L N  +T     +   L +L  L L +N  SK
Sbjct: 31  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90

Query: 104 PIPANLF-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLR 161
            I    F     L  L L+ N     +P+  K  K L  L +  N +   + + +   L 
Sbjct: 91  -ISPGAFAPLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEIT-KVRKSVFNGLN 145

Query: 162 ALTGTLNLSFNQF-SGQIPEMYGHF---PVMVSLDLRNNNLSGEIPQ 204
            +   + L  N   S  I    G F     +  + + + N++  IPQ
Sbjct: 146 QMI-VVELGTNPLKSSGIEN--GAFQGMKKLSYIRIADTNIT-TIPQ 188

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 19/158 (12%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNF-SKPIPANLF-NATNLVYLDLAHNSF 125
             L +    +T    S    LN +  + L +N   S  I    F     L Y+ +A  + 
Sbjct: 124 QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
              IP       +LT L L  N +   +    L  L  L   L LSFN  S        +
Sbjct: 184 TT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLA-KLGLSFNSISAVDNGSLAN 238

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            P +  L L NN L  ++          P   + +  +
Sbjct: 239 TPHLRELHLNNNKLV-KV----------PGGLADHKYI 265

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 19/115 (16%), Positives = 35/115 (30%), Gaps = 14/115 (12%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN---- 123
             L L   +++      L     L  L L +N   K +P  L +   +  + L +N    
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 277

Query: 124 ----SFCGPIPDRIKTLKNLTHLDLSSN-LLNGSLPEFLLD-LRALTGTLNLSFN 172
                FC P         + + + L SN +    +       +      + L   
Sbjct: 278 IGSNDFCPPGY--NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA-AVQLGNY 329

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 60/292 (20%), Positives = 105/292 (35%), Gaps = 64/292 (21%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFK-DFESEVEAIARV-QHPNIVRLKAF 413
           G ++K V  R  G     + A++R  +  A    + +   EV A A + QH ++VR    
Sbjct: 25  GSVFKCV-KRLDGC----IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR---- 75

Query: 414 YY---ANDEKLLI-SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEY 469
           Y+   A D+ +LI +++   GSL  A+       +          +     RGL YIH  
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVGRGLRYIHS- 133

Query: 470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT-----------KNETIVTS 518
                VH +IK + I +     P  +    +     ++KV             +   V  
Sbjct: 134 --MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 519 GTGSRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGR-LPDAGPENDGKGL 576
           G  SR       +LA E  +  +     K D+++  + ++       LP  G +      
Sbjct: 192 GD-SR-------FLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------ 236

Query: 577 ESLVRKAFRERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                +  + R P + +V+            ++L            DPE RP
Sbjct: 237 ---WHEIRQGRLPRIPQVLSQEF-------TELLKV------MIHPDPERRP 272

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 54/286 (18%), Positives = 96/286 (33%), Gaps = 54/286 (18%)

Query: 362 VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEK 420
           +V RG        VAV+R+        F   + EV+ +    +HPN++R          +
Sbjct: 40  IVYRGMFDNRD--VAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93

Query: 421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIK 480
            +  +     +L   +       L   P    + + Q T  GL ++H       VH ++K
Sbjct: 94  YIAIELCA-ATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLHS---LNIVHRDLK 145

Query: 481 STKILL-----DDELHPCISGFGL-NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAP 534
              IL+       ++   IS FGL  +L  G    ++   +   GT          ++AP
Sbjct: 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP--GTEG--------WIAP 195

Query: 535 E--ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSE 592
           E  +       T   D++S G V   +++      G     +    L   +     P   
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 593 VIDPA--LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
               A  L++                    +DP+ RP   +    L
Sbjct: 256 EDVIARELIE----------------KMIAMDPQKRP---SAKHVL 282

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 49/264 (18%), Positives = 85/264 (32%), Gaps = 58/264 (21%)

Query: 359 YKV--VVGRGSGMGAPTV------------VAVRRL-TEGDATWRFKDFESEVEAIARVQ 403
           Y+V   +  G G+G   +            V ++ L   GDA  +     +E + +A V 
Sbjct: 82  YEVKGCIAHG-GLG--WIYLALDRNVNGRPVVLKGLVHSGDAEAQ-AMAMAERQFLAEVV 137

Query: 404 HPNIVRLKAFYYANDEKLLISDFI-----RNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           HP+IV++  F    D       +I        SL  +           LP    +     
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLE 190

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
               L Y+H       V+ ++K   I+L +E    +   G    +     +         
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-------- 238

Query: 519 GTGSRISAISNVYLAPE-ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE 577
           GT          + APE  R   +  T   D+Y+ G  L  +        G   DG   +
Sbjct: 239 GTPG--------FQAPEIVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED 287

Query: 578 SLVRKAFRERRPLSEVIDPALVKE 601
             V    +       ++  A+  +
Sbjct: 288 DPV---LKTYDSYGRLLRRAIDPD 308

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 32/140 (22%), Positives = 51/140 (36%), Gaps = 9/140 (6%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF 125
            T L +    ++    S++  L+ L  L ++ N     +  ++F     L YLDL+HN  
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKL 81

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSGQIPEMYG 183
              I        NL HLDLS N  + +LP      ++  L   L LS             
Sbjct: 82  -VKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLK-FLGLSTTHLEKSSVLPIA 136

Query: 184 HFPVMVSLDLRNNNLSGEIP 203
           H  +   L +       +  
Sbjct: 137 HLNISKVLLVLGETYGEKED 156

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 34/147 (23%), Positives = 55/147 (37%), Gaps = 12/147 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             +      L  ++P    L    T L+++ N  S+   +++ + + L  L ++HN    
Sbjct: 3   FLVDRSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                 K  + L +LDLS N L   +         L   L+LSFN F   +P     F  
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLK-HLDLSFNAFD-ALPIC-KEFGN 113

Query: 188 MVSL---DLRNNNLSGEIPQVGSLLNQ 211
           M  L    L   +L        + LN 
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNI 140

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 26/116 (22%), Positives = 48/116 (41%), Gaps = 8/116 (6%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF--CGPIPDRIKTLKNLTHLDLS 145
           ++    L  ++N  +  +  N  + T L  L L  N       I +    +K+L  LD+S
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382

Query: 146 SNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMV-SLDLRNNNLS 199
            N ++    +      ++L  +LN+S N  +  I       P  +  LDL +N + 
Sbjct: 383 QNSVSYDEKKGDCSWTKSLL-SLNMSSNILTDTIF---RCLPPRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 19/148 (12%), Positives = 48/148 (32%), Gaps = 10/148 (6%)

Query: 58  SGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLV 116
                    ++   + +            + +++   +   +  ++ +     +  +  +
Sbjct: 269 DYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFL 327

Query: 117 YLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG--TLNLSFNQF 174
           +LD ++N     + +    L  L  L L  N L   L +       +     L++S N  
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386

Query: 175 SGQIPEMYGHFPVMVS---LDLRNNNLS 199
                E  G      S   L++ +N L+
Sbjct: 387 --SYDEKKGDCSWTKSLLSLNMSSNILT 412

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 32/208 (15%), Positives = 66/208 (31%), Gaps = 7/208 (3%)

Query: 1   MLLPLLFFALLLLFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGI 60
            +  L    +  +     C         L                +W+            
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLD 119
                 ++++ L  +            L +L+   + S+ F  P  + ++   +N+   +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP-QSYIYEIFSNMNIKN 306

Query: 120 LAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIP 179
              +            +    HLD S+NLL  ++ E    L  L  TL L  NQ   ++ 
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQMNQLK-ELS 364

Query: 180 EMYGHFPVMVS---LDLRNNNLSGEIPQ 204
           ++      M S   LD+  N++S +  +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKK 392

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 27/109 (24%), Positives = 49/109 (44%), Gaps = 7/109 (6%)

Query: 68  TSLYLPNRNLT-GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             L +   +++      +     SL  L+++SN  +  I   L     +  LDL  N   
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
             IP ++  L+ L  L+++SN L  S+P+ + D L +L   + L  N +
Sbjct: 435 S-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ-KIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 29/214 (13%), Positives = 61/214 (28%), Gaps = 13/214 (6%)

Query: 1   MLLPLLFFALLLLFPAPLCFSLNQDGLALLALK----AAIAQDPTRALDSWSESDSTPCH 56
            +  L    +LL+         + +GL     +              +   S        
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 57  WSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLV 116
            S I C+       Y  +  L     +      +L  +    N+F + +   L   T + 
Sbjct: 194 LSNIKCVLEDNKCSYFLS-ILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVW 250

Query: 117 YLDLAHNSFCGPIPDRI-----KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSF 171
           Y  +++    G +  R       +LK L+   + S++              +    N + 
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN-IKNFTV 309

Query: 172 NQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV 205
           +                + LD  NN L+  + + 
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 52/263 (19%)

Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFES 394
             ++ +DL       +G+   G++ K+     SG     ++AV+R+     +   K    
Sbjct: 2   MEVKADDLEPIM--ELGRGAYGVVEKMRH-VPSG----QIMAVKRIRATVNSQEQKRLLM 54

Query: 395 EVEAIAR-VQHPNIVRLKAFYYANDEKLLISDFIRNGSLY----------AALHAGPSDS 443
           +++   R V  P  V    FY A           R G ++             +    D 
Sbjct: 55  DLDISMRTVDCPFTVT---FYGA---------LFREGDVWICMELMDTSLDKFYKQVIDK 102

Query: 444 LPPLPWEARL-KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL 502
              +P E  L KIA    + L ++H  S    +H ++K + +L++      +  FG++  
Sbjct: 103 GQTIP-EDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159

Query: 503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVLLE 558
           L     V K+      G           Y+APE RI        ++ K D++S GI ++E
Sbjct: 160 L--VDDVAKD-IDA--GCKP--------YMAPE-RINPELNQKGYSVKSDIWSLGITMIE 205

Query: 559 ILTGRLPDAGPENDGKGLESLVR 581
           +   R P        + L+ +V 
Sbjct: 206 LAILRFPYDSWGTPFQQLKQVVE 228

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 46/188 (24%), Positives = 74/188 (39%), Gaps = 15/188 (7%)

Query: 17  PLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRN 76
              F     G  + +L  + + +   +    +  D     + G+    + V +  L    
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE--ASGVKTCDLSKSK 286

Query: 77  LTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-K 134
           +   + S       L +L+LA N  +K I  N F   T+L+ L+L+ N   G I  R+ +
Sbjct: 287 IFALLKSVFSHFTDLEQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFE 344

Query: 135 TLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSL-- 191
            L  L  LDLS N +  +L +     L  L   L L  NQ    +P+  G F  + SL  
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLK-ELALDTNQLKS-VPD--GIFDRLTSLQK 399

Query: 192 -DLRNNNL 198
             L  N  
Sbjct: 400 IWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 28/133 (21%), Positives = 49/133 (36%), Gaps = 16/133 (12%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDR 132
           NR L   +P    L   +  + L+ N+ ++ +    F    +L +L +   +    I + 
Sbjct: 19  NRGLHQ-VPE---LPAHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNN 73

Query: 133 I-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF-SGQIPEMYGHFPVMV 189
             + L +L  L L  N     L     + L  L   L L+        +      F  + 
Sbjct: 74  TFRGLSSLIILKLDYNQF-LQLETGAFNGLANLE-VLTLTQCNLDGAVLSG--NFFKPLT 129

Query: 190 SL---DLRNNNLS 199
           SL    LR+NN+ 
Sbjct: 130 SLEMLVLRDNNIK 142

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 30/115 (26%), Positives = 50/115 (43%), Gaps = 9/115 (7%)

Query: 89  NSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSS 146
           + +    L+ +     +  ++F + T+L  L LA N     I D     L +L  L+LS 
Sbjct: 275 SGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQ 332

Query: 147 NLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPE-MYGHFPVMVSLDLRNNNLS 199
           N L GS+   + + L  L   L+LS+N     + +  +   P +  L L  N L 
Sbjct: 333 NFL-GSIDSRMFENLDKLE-VLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 26/181 (14%), Positives = 44/181 (24%), Gaps = 37/181 (20%)

Query: 68  TSLYLPNRNLTGYMPSEL-GLLNSLTRLSLASNNFSKPIPANLF---NATNLVYLDLAHN 123
             L L + N+    P+     +     L L  N     I           +   L L+  
Sbjct: 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSI 190

Query: 124 --------SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
                                 ++T LDLS N    S+ +   D  A T   +L  +   
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 176 GQIPEMYG--------------HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPG 221
                                     + + DL  + +   +           + FS    
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL---------KSVFSHFTD 300

Query: 222 L 222
           L
Sbjct: 301 L 301

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 36/157 (22%), Positives = 57/157 (36%), Gaps = 16/157 (10%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L+L N  +          + SL RL L      + I    F    NL YL+L   +  
Sbjct: 150 RELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSFNQFSGQIPEMYGHF 185
             +P+ +  L  L  L++S N     +       L +L   L +  +Q S      +   
Sbjct: 210 D-MPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLK-KLWVMNSQVSLIERNAFDGL 265

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             +V L+L +NNLS  +P            F+    L
Sbjct: 266 ASLVELNLAHNNLS-SLP---------HDLFTPLRYL 292

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 40/161 (24%), Positives = 57/161 (35%), Gaps = 19/161 (11%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN 123
           N+ + +    R L+  +P   G+ ++   L+L  NN    I A+ F +  +L  L L  N
Sbjct: 54  NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRN 109

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE-M 181
           S    I       L +L  L+L  N L          L  L   L L  N     IP   
Sbjct: 110 SI-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLR-ELWLRNNPIE-SIPSYA 166

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           +   P ++ LDL        I            AF G   L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYIS---------EGAFEGLFNL 198

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 4/132 (3%)

Query: 68  TSLYLPNRNLTGYMPSE-LGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             L L       Y+       L +L  L+L   N    +P  L     L  L+++ N F 
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFP 231

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
              P     L +L  L + ++ ++         L +L   LNL+ N  S    +++    
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV-ELNLAHNNLSSLPHDLFTPLR 290

Query: 187 VMVSLDLRNNNL 198
            +V L L +N  
Sbjct: 291 YLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 29/156 (18%), Positives = 52/156 (33%), Gaps = 23/156 (14%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
               L L   N+          L+ L  L L  N+  + I    F    +L  L+L  N 
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN- 133

Query: 125 FCGPIPDRIKT--------LKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLS-FNQF 174
                   +          L  L  L L +N +  S+P +    + +L   L+L    + 
Sbjct: 134 -------WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLM-RLDLGELKKL 184

Query: 175 SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
                  +     +  L+L   N+  ++P +  L+ 
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVG 219

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 2/83 (2%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
            +  L +   +     P     L+SL +L + ++  S  I  N F    +LV L+LAHN+
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNN 277

Query: 125 FCGPIPDRIKTLKNLTHLDLSSN 147
                 D    L+ L  L L  N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHN 300

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 70.2 bits (172), Expect = 7e-13
 Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 7/159 (4%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L+L N  +          + SL RL L        I    F   +NL YL+LA  +  
Sbjct: 139 KELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
             IP+ +  L  L  LDLS N L+   P     L  L   L +  +Q        + +  
Sbjct: 199 E-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ-KLWMIQSQIQVIERNAFDNLQ 255

Query: 187 VMVSLDLRNNNLSGEIPQ--VGSLLNQGPTAFSGNPGLC 223
            +V ++L +NNL+  +P      L +        NP  C
Sbjct: 256 SLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 38/167 (22%), Positives = 54/167 (32%), Gaps = 31/167 (18%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN 123
           N+ + +    +NL   +P   G+  +   L+L  N     I  N F +  +L  L L+ N
Sbjct: 43  NQFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRN 98

Query: 124 --------SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
                   +F G        L NL  L+L  N L        + L  L   L L  N   
Sbjct: 99  HIRTIEIGAFNG--------LANLNTLELFDNRLTTIPNGAFVYLSKLK-ELWLRNNPIE 149

Query: 176 GQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
                 +   P +  LDL        I            AF G   L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYIS---------EGAFEGLSNL 187

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 40/155 (25%), Positives = 58/155 (37%), Gaps = 15/155 (9%)

Query: 63  IRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLA 121
           I      L L    +     +    L  L  L L+ N+    I    F    NL  L+L 
Sbjct: 62  ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELF 120

Query: 122 HNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLS-FNQFSGQI 178
            N     IP+     L  L  L L +N +  S+P +    + +L   L+L    + S  I
Sbjct: 121 DNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR-RLDLGELKRLS-YI 176

Query: 179 PEMYGHF---PVMVSLDLRNNNLSGEIPQVGSLLN 210
            E  G F     +  L+L   NL  EIP +  L+ 
Sbjct: 177 SE--GAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 37/201 (18%)

Query: 442 DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR 501
                L  E  +  +   A+G+ ++   + RK +H ++ +  ILL ++    I  FGL R
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 502 LLPGTSKVTKNETIVTSGTGS---RISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLE 558
                  + K+   V  G      +       ++APE  I+   +T + DV+SFG++L E
Sbjct: 242 ------DIYKDPDYVRKGDARLPLK-------WMAPET-IFDRVYTIQSDVWSFGVLLWE 287

Query: 559 ILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALN 617
           I + G  P  G + D +     +++  R R P             +   ++   +   L+
Sbjct: 288 IFSLGASPYPGVKIDEE-FCRRLKEGTRMRAPD------------YTTPEM---YQTMLD 331

Query: 618 CTELDPEFRPRMRTVSESLDR 638
           C   +P  RP    + E L  
Sbjct: 332 CWHGEPSQRPTFSELVEHLGN 352

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 41/176 (23%), Positives = 70/176 (39%), Gaps = 25/176 (14%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
              E+     + H ++V    F+  ND   ++ +  R  SL          +L     EA
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR--RKALT--EPEA 143

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL--PGTSKV 509
           R  + Q    G  Y+H     + +H ++K   + L+++L   I  FGL   +   G  K 
Sbjct: 144 RYYLRQ-IVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                    GT        N Y+APE  +     + + DV+S G ++  +L G+ P
Sbjct: 200 V------LCGT-------PN-YIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 25/176 (14%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEA 451
              E+     + H ++V    F+  ND   ++ +  R  SL        + + P    EA
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EA 117

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL--PGTSKV 509
           R  + Q    G  Y+H     + +H ++K   + L+++L   I  FGL   +   G  K 
Sbjct: 118 RYYLRQ-IVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                    GT        N Y+APE  +     + + DV+S G ++  +L G+ P
Sbjct: 174 V------LCGT-------PN-YIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 50/287 (17%), Positives = 104/287 (36%), Gaps = 41/287 (14%)

Query: 355 NGIMYKV--VVGRGS------GMGAPT-VVAVRRLT-EGDATWRFKDFESEVEAIARVQH 404
            G +Y +   +G G        +     + A++ +  E         + +E+  + ++Q 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 405 PN--IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
            +  I+RL  +   +    ++ +   N  L + L      S+ P  WE +          
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDP--WERKSYWKN-MLEA 120

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGS 522
           +  IH+      VH ++K    L+ D     +  FG+   +   +     ++ V  GT +
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV--GTVN 174

Query: 523 RIS--AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV 580
            +   AI ++  + E     SK + K DV+S G +L  +  G+ P     N    L +++
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                      ++ +  L   +               C + DP+ R 
Sbjct: 235 DP--NHEIEFPDIPEKDLQDVLK-------------CCLKRDPKQRI 266

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 32/160 (20%), Positives = 56/160 (35%), Gaps = 22/160 (13%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNS 124
           ++  LY+   +L   +P    L +SL  L +  N   K +P  +F    N+  +++  N 
Sbjct: 103 KLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNP 158

Query: 125 F-CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY- 182
                          L +L +S   L   +P+ L     L   L+L  N+    I     
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN-ELHLDHNKIQ-AIELEDL 213

Query: 183 GHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             +  +  L L +N +   I            + S  P L
Sbjct: 214 LRYSKLYRLGLGHNQIR-MIE---------NGSLSFLPTL 243

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 27/134 (20%), Positives = 51/134 (38%), Gaps = 11/134 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             +   +  L   +P    +    T L L +N+ S+ +  + F    +L  L L +N   
Sbjct: 36  RVVQCSDLGLK-AVPK--EISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKIS 91

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
             I ++    L+ L  L +S N L   +P  L    +L   L +  N+       ++   
Sbjct: 92  K-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV-ELRIHDNRIRKVPKGVFSGL 146

Query: 186 PVMVSLDLRNNNLS 199
             M  +++  N L 
Sbjct: 147 RNMNCIEMGGNPLE 160

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 11/139 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLN-SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
             + +    L              L  L ++    +  IP +L     L  L L HN   
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKI- 205

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             I          L  L L  N +   +    L  L  L   L+L  N+ S ++P     
Sbjct: 206 QAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLR-ELHLDNNKLS-RVPAGLPD 262

Query: 185 FPVMVSLDLRNNNLSGEIP 203
             ++  + L  NN++ ++ 
Sbjct: 263 LKLLQVVYLHTNNIT-KVG 280

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 33/165 (20%), Positives = 52/165 (31%), Gaps = 23/165 (13%)

Query: 55  CHWSGIHCIRNR-----------VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK 103
           CH   + C                T L L N +++     +   L  L  L L +N  SK
Sbjct: 33  CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92

Query: 104 PIPANLF-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRA 162
            I    F     L  L ++ N     IP       +L  L +  N +          LR 
Sbjct: 93  -IHEKAFSPLRKLQKLYISKNHLVE-IPPN--LPSSLVELRIHDNRIRKVPKGVFSGLRN 148

Query: 163 LTGTLNLSFNQF-SGQIPEMYGHFPVM--VSLDLRNNNLSGEIPQ 204
           +   + +  N   +       G F  +    L +    L+  IP+
Sbjct: 149 MN-CIEMGGNPLENSGFEP--GAFDGLKLNYLRISEAKLT-GIPK 189

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 24/139 (17%), Positives = 43/139 (30%), Gaps = 14/139 (10%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L+L +  +      +L   + L RL L  N     I          L  L L +N   
Sbjct: 196 NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS 254

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPE-------FLLDLRALTGTLNLSFNQFSGQI- 178
             +P  +  LK L  + L +N +   +         F +        ++L  N       
Sbjct: 255 R-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN-GISLFNNPVPYWEV 311

Query: 179 -PEMYGHFPVMVSLDLRNN 196
            P  +      +++   N 
Sbjct: 312 QPATFRCVTDRLAIQFGNY 330

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 48/240 (20%), Positives = 87/240 (36%), Gaps = 33/240 (13%)

Query: 336 SLELEDLLRASAYVVGKSKNGIMYKVVVGRGS------GMGAPT--VVAVRRLTEGDATW 387
            + L + L+   Y   +  + + ++  VGRGS           T    AV+++       
Sbjct: 39  GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR- 97

Query: 388 RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
                  E+ A A +  P IV L           +  + +  GSL   +          L
Sbjct: 98  -----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-----CL 147

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGT 506
           P +  L        GL Y+H    R+ +HG++K+  +LL  +     +  FG        
Sbjct: 148 PEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFG-------H 197

Query: 507 SKVTKNETIVTSGTGSRISAISNVY-LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           +   + + +  S   +          +APE  + G     K D++S   ++L +L G  P
Sbjct: 198 ALCLQPDGLGKSLL-TGDYIPGTETHMAPEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 44/224 (19%)

Query: 360 KVVVGRGS------GMGAPT--VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLK 411
           +VV+G+G+      G        +A++ + E D+    +    E+     ++H NIV+  
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQ-- 83

Query: 412 AFYY---ANDEKLLIS-DFIRNGSLYAALHA--GPSDSLPPLPWEARLKIAQGTARGLMY 465
             Y    + +  + I  + +  GSL A L +  GP                Q    GL Y
Sbjct: 84  --YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IGFYTKQ-ILEGLKY 137

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           +H+    + VH +IK   +L++       IS FG ++      ++        + TG+  
Sbjct: 138 LHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSK------RLAGINPCTETFTGT-- 186

Query: 525 SAISNVY-LAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLP 565
                +  +APE  I      + +  D++S G  ++E+ TG+ P
Sbjct: 187 -----LQYMAPEI-IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 40/215 (18%), Positives = 83/215 (38%), Gaps = 20/215 (9%)

Query: 390 KDFESEVEAIARVQHPN--IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             + +E+  + ++Q  +  I+RL  +   +    ++ +   N  L + L      S+ P 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDP- 154

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-ELHPCISGFGLNRLLPGT 506
            WE +          +  IH+      VH ++K    L+ D  L   +  FG+   +   
Sbjct: 155 -WERKSYWKN-MLEAVHTIHQ---HGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPD 207

Query: 507 SKVTKNETIVTSGTGSRIS--AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           +     ++ V  G  + +   AI ++  + E     SK + K DV+S G +L  +  G+ 
Sbjct: 208 TTSVVKDSQV--GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

Query: 565 PDAGPENDGKGLESLVRKAFRERRPLSEVIDPALV 599
           P     N    L +++           ++ +  L 
Sbjct: 266 PFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQ 298

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 38/188 (20%), Positives = 72/188 (38%), Gaps = 32/188 (17%)

Query: 390 KDFESEVEAIARVQHPN--IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             + +E+  + ++Q  +  I+RL  +   +    ++ +   N  L + L      S+ P 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDP- 126

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
            WE +          +  IH+      VH ++K    L+ D     +  FG+   +   +
Sbjct: 127 -WERKSYWKN-MLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEA----------RIYGSKFTQKCDVYSFGIVLL 557
                ++ V  GT +        Y+ PEA              SK + K DV+S G +L 
Sbjct: 181 TSVVKDSQV--GTVN--------YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 558 EILTGRLP 565
            +  G+ P
Sbjct: 231 YMTYGKTP 238

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 32/213 (15%)

Query: 362 VVGRGS------GMGAPT--VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAF 413
            +G+GS      G+   T  VVA++ +   +A    +D + E+  +++   P + +    
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLK-IAQGTARGLMYIHEYSPR 472
           Y  + +  +I +++  GS    L  GP D       E ++  I +   +GL Y+H     
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHS---E 138

Query: 473 KYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYL 532
           K +H +IK+  +LL +     ++ FG+   L  T    K  T V  GT          ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFV--GT--------PFWM 186

Query: 533 APEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           APE  I  S +  K D++S GI  +E+  G  P
Sbjct: 187 APEV-IKQSAYDSKADIWSLGITAIELARGEPP 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 28/189 (14%), Positives = 60/189 (31%), Gaps = 35/189 (18%)

Query: 51  DSTPCH---WSGIHCIRNRVTS----------LYLPNRNLTGYMPSELGLLNSLTRLSLA 97
            S PC              +            L L   +L          L +++R+ ++
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63

Query: 98  SNNFSKPIPANLFNA-TNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPE 155
            +   + + ++ F   + + ++++ +      I     K L  L  L + +  L    P+
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122

Query: 156 --FLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVS----LDLRNNNLSGEIPQVGSLL 209
              +         L ++ N +   IP     F  + +    L L NN  +  +       
Sbjct: 123 LTKVYSTDIFF-ILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFT-SVQ------ 172

Query: 210 NQGPTAFSG 218
                AF+G
Sbjct: 173 ---GYAFNG 178

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 24/145 (16%), Positives = 47/145 (32%), Gaps = 31/145 (21%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDR--IKTLKNLTHLDL 144
           L+ +T + + +      I  +       L +L + +       PD   + +      L++
Sbjct: 79  LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEI 137

Query: 145 SSNLLNGSLPEFLLD-LRALTGTLNLSFNQ--------FSG---------------QIPE 180
           + N    S+P      L   T TL L  N         F+G                I +
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDK 197

Query: 181 M--YGHFPVMVSLDLRNNNLSGEIP 203
               G +     LD+   +++  +P
Sbjct: 198 DAFGGVYSGPSLLDVSQTSVT-ALP 221

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 23/134 (17%), Positives = 42/134 (31%), Gaps = 10/134 (7%)

Query: 68  TSLYLPNRNLTGYMPSE--LGLLNSLTRLSLASNNFSKPIPANLFN--ATNLVYLDLAHN 123
             L + N  L    P    +   +    L +  N +   IP N F       + L L +N
Sbjct: 108 KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMY 182
            F   +         L  + L+ N     + +     + +    L++S    +  +P   
Sbjct: 167 GFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS-- 222

Query: 183 GHFPVMVSLDLRNN 196
                +  L  RN 
Sbjct: 223 KGLEHLKELIARNT 236

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 37/291 (12%), Positives = 75/291 (25%), Gaps = 78/291 (26%)

Query: 362 VVGRGSGMGAPTV-----------VAVRRL-TEGDATWRFKD-FESEVEAIARVQHPNIV 408
             G                     VA+  +  +G           S    ++R+  P + 
Sbjct: 38  FHGGV-PPL--QFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           R+    +     L+++++IR GSL       PS      P  A ++  Q  A      H 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS------PVGA-IRAMQSLAAAADAAHR 147

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                        +++ +  +    ++                                 
Sbjct: 148 ---AGVALSIDHPSRVRVSIDGDVVLAYPA------------------------------ 174

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
              +             + D+   G  L  +L  R P         GL    R    +  
Sbjct: 175 --TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLAPAERDTAGQPI 223

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
             +++ D  +  +I A         +A    + D   R    T+   + + 
Sbjct: 224 EPADI-DRDIPFQISA---------VAARSVQGDGGIRSAS-TLLNLMQQA 263

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 37/146 (25%), Positives = 55/146 (37%), Gaps = 16/146 (10%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
             +TSL   N ++T    + +  L  LT+L   SNN +     +L   TNL YL    N 
Sbjct: 42  ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNK 96

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
               +   +  L  LT+L+  +N L   L   +     LT  LN + N  + +I     H
Sbjct: 97  LTN-LD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT-YLNCARNTLT-EID--VSH 146

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLN 210
              +  LD   N        V     
Sbjct: 147 NTQLTELDCHLNKKI-TKLDVTPQTQ 171

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 24/132 (18%), Positives = 43/132 (32%), Gaps = 15/132 (11%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T L             ++     LT L  + N  ++   +       L  L+   N+   
Sbjct: 151 TELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITELDVSQN---KLLNRLNCDTNNITK 205

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +   +     LT LD SSN L   +   +  L  LT   + S N  + ++         
Sbjct: 206 -LD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT-YFDCSVNPLT-ELDV--STLSK 255

Query: 188 MVSLDLRNNNLS 199
           + +L     +L 
Sbjct: 256 LTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 28/139 (20%), Positives = 54/139 (38%), Gaps = 22/139 (15%)

Query: 71  YLPNRNLTGYMPSELGL----------LNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
           + P+ N    + +   +          L +LT L   +++ +  +   +   T L  L  
Sbjct: 14  WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLIC 71

Query: 121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE 180
             N+    +   +    NLT+L   SN L  +L   +  L  LT  LN   N+ + ++  
Sbjct: 72  TSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLT-YLNCDTNKLT-KLDV 123

Query: 181 MYGHFPVMVSLDLRNNNLS 199
                P++  L+   N L+
Sbjct: 124 --SQNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 19/143 (13%), Positives = 41/143 (28%), Gaps = 14/143 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T+L+    +L      +L     L           K +  ++ + T L  LD        
Sbjct: 257 TTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI-T 310

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +   +     L +L L++  L   L   +     L  +L+            + G  P 
Sbjct: 311 ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLK-SLSCVNAHIQ-DFSSV-GKIPA 362

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           + +             +  +  +
Sbjct: 363 LNNNFEAEGQTITMPKETLTNNS 385

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 15/132 (11%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T L      LT     ++     LT L    N     +   +   T L  LD + N    
Sbjct: 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +   +   K L  L+  +N +   L   L     LT  L+ S N+ + +I         
Sbjct: 185 -LD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLT-FLDCSSNKLT-EIDV--TPLTQ 234

Query: 188 MVSLDLRNNNLS 199
           +   D   N L+
Sbjct: 235 LTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 25/143 (17%), Positives = 47/143 (32%), Gaps = 16/143 (11%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T        LT     ++  L+ LT L     +  +    +L + T L+Y          
Sbjct: 236 TYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIK 289

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +   +     L  LD  +  +   L   L     L   L L+  + + ++     H   
Sbjct: 290 ELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLV-YLYLNNTELT-ELD--VSHNTK 340

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           + SL   N ++  +   VG +  
Sbjct: 341 LKSLSCVNAHIQ-DFSSVGKIPA 362

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 28/132 (21%), Positives = 50/132 (37%), Gaps = 15/132 (11%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T L   + N+T     +L    +LT L+  SN  +      L   T L YL+   N    
Sbjct: 67  TKLICTSNNITTL---DLSQNTNLTYLACDSNKLTNLDVTPL---TKLTYLNCDTNKL-T 119

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
            +   +     LT+L+ + N L   +   +     LT  L+   N+   ++         
Sbjct: 120 KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLT-ELDCHLNKKITKLDV--TPQTQ 171

Query: 188 MVSLDLRNNNLS 199
           + +LD   N ++
Sbjct: 172 LTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 25/178 (14%), Positives = 46/178 (25%), Gaps = 35/178 (19%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L      +T     +L     L  L L +   ++ +  +  + T L  L   +     
Sbjct: 300 YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-LDVS--HNTKLKSLSCVNAHIQD 353

Query: 128 PIPDRIKTLKNLTHLDLSSN-------------LLNGSLPEFLLDLRALTGTLNLSFNQF 174
                +  +  L +   +                L  ++   LLD       +       
Sbjct: 354 -FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV 411

Query: 175 SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCP 232
             Q            +  +   NLS + P V         A  G       P ++P P
Sbjct: 412 YDQA-----------TNTITWENLSTDNPAVTYTFTSENGAIVGTV---TTPFEAPQP 455

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 16/146 (10%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
                L  +++T         LNS+ ++   +++    +   +    N+  L L  N   
Sbjct: 23  TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNK-- 76

Query: 127 GPIPD--RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
             + D   +  LKNL  L L  N +   L   L DL+ L  +L+L  N  S  I  +  H
Sbjct: 77  --LTDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK-SLSLEHNGIS-DINGL-VH 129

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLN 210
            P + SL L NN ++ +I  +  L  
Sbjct: 130 LPQLESLYLGNNKIT-DITVLSRLTK 154

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 45/155 (29%), Positives = 64/155 (41%), Gaps = 17/155 (10%)

Query: 58  SGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVY 117
            GI  + N VT L+L    LT   P  L  L +L  L L  N     +  +L +   L  
Sbjct: 59  QGIQYLPN-VTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113

Query: 118 LDLAHNSFCGPIPD--RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
           L L HN     I D   +  L  L  L L +N +  +    L  L  L  TL+L  NQ S
Sbjct: 114 LSLEHN----GISDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLD-TLSLEDNQIS 166

Query: 176 GQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
             I  +      + +L L  N++S ++  +  L N
Sbjct: 167 -DIVPL-AGLTKLQNLYLSKNHIS-DLRALAGLKN 198

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 41/192 (21%), Positives = 59/192 (30%), Gaps = 17/192 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            SLYL N  +T    + L  L  L  LSL  N  S  I   L   T L  L L+ N    
Sbjct: 134 ESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKN---- 185

Query: 128 PIPD--RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
            I D   +  LKNL  L+L S            +L     T+  +        PE+    
Sbjct: 186 HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN-TVKNTDGSL--VTPEIISDD 242

Query: 186 PVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCPEPENPKVHANPEV 245
                 +++ +    E     S +   P           F  +   P  E   V  + + 
Sbjct: 243 GDYEKPNVKWHLP--EFTNEVSFIFYQPVTIGKAKAR--FHGRVTQPLKEVYTVSYDVDG 298

Query: 246 EDGPQNPKNTNF 257
                  +    
Sbjct: 299 TVIKTKVEAGTR 310

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 41.2 bits (96), Expect = 9e-04
 Identities = 10/78 (12%), Positives = 26/78 (33%), Gaps = 6/78 (7%)

Query: 133 IKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLD 192
                     +L    +         +L ++   +  + +     +  +  + P +  L 
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSID-QIIANNSDIK-SVQGI-QYLPNVTKLF 71

Query: 193 LRNNNLSGEIPQVGSLLN 210
           L  N L+ +I  + +L N
Sbjct: 72  LNGNKLT-DIKPLTNLKN 88

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 19/141 (13%), Positives = 45/141 (31%), Gaps = 14/141 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L +   +L  Y P  L  + +++ L L        +        +++  L+L      
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLD 235

Query: 127 GP--------IPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI 178
                       + +       ++ ++   L   + + L  +  L   L  S NQ    +
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL-ELEFSRNQLKS-V 292

Query: 179 PE-MYGHFPVMVSLDLRNNNL 198
           P+ ++     +  + L  N  
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 23/163 (14%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF 125
           V SL L N  +T    S+L    +L  L L SN  +  I  + F++  +L +LDL++N  
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYL 112

Query: 126 CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPE--FLLDLRALTGTLNLSFNQFSGQIPEMY 182
              +     K L +LT L+L  N    +L E      L  L      + + F+ +I    
Sbjct: 113 SN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT-KIQR-- 167

Query: 183 GHFPVMVSL---DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
             F  +  L   ++  ++L              P +      +
Sbjct: 168 KDFAGLTFLEELEIDASDLQ-SYE---------PKSLKSIQNV 200

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 22/160 (13%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
                 + +L   +PS  GL  ++  L L++N  +  I  +      NL  L L  N   
Sbjct: 34  GICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGI- 88

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPE--MY 182
             I +    +L +L HLDLS N L  +L       L +LT  LNL  N +   + E  ++
Sbjct: 89  NTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLT-FLNLLGNPYK-TLGETSLF 145

Query: 183 GHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            H   +  L + N +   +I             F+G   L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQ---------RKDFAGLTFL 176

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 16/126 (12%), Positives = 40/126 (31%), Gaps = 13/126 (10%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSS 146
           L  L  L + +++           +  N+ +L L        +   +    ++  L+L  
Sbjct: 173 LTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231

Query: 147 NLLNG----SLPEF----LLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNL 198
             L+      L       L+        + ++      Q+ ++      ++ L+   N L
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFR-NVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 199 SGEIPQ 204
              +P 
Sbjct: 290 KS-VPD 294

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
             +G+   G +YK +  + +G     +VA++++         ++   E+  + +   P++
Sbjct: 35  EKLGEGSYGSVYKAIH-KETGQ----IVAIKQV---PVESDLQEIIKEISIMQQCDSPHV 86

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V+    Y+ N +  ++ ++   GS+   +          L  +    I Q T +GL Y+H
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLH 142

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
                + +H +IK+  ILL+ E H  ++ FG+   L  T  + K  T++  GT       
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDTMAKRNTVI--GT------- 188

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              ++APE  I    +    D++S GI  +E+  G+ P
Sbjct: 189 -PFWMAPEV-IQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 9/151 (5%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
           R   L                    +  L LA  + +     +L     + +LDL+HN  
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRL 475

Query: 126 CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMY--G 183
              +P  +  L+ L  L  S N L  ++   + +L  L   L L  N+   Q   +    
Sbjct: 476 RA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ-ELLLCNNRLQ-QSAAIQPLV 530

Query: 184 HFPVMVSLDLRNNNLSGEIPQVGSLLNQGPT 214
             P +V L+L+ N+L  E      L    P+
Sbjct: 531 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 561

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 38/143 (26%), Positives = 55/143 (38%), Gaps = 23/143 (16%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCG-PIPDRIKTLKNLTHLDLS 145
           L+SL +L     N +  +      +   L  L++AHN      +P+    L NL HLDLS
Sbjct: 99  LSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 146 SNLLNGSLPEFLLD----LRALTGTLNLSFNQFSGQIPEMYGHFPVM--VSLDLRNNNLS 199
           SN +  S+    L     +  L  +L+LS N  +  I    G F  +    L L  N L 
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP--GAFKEIRLKELALDTNQLK 213

Query: 200 GEIPQVGSLLNQGPTAFSGNPGL 222
             +P            F     L
Sbjct: 214 -SVP---------DGIFDRLTSL 226

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 31/152 (20%), Positives = 50/152 (32%), Gaps = 19/152 (12%)

Query: 74  NRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDR 132
             N    +P    L  S   L L+ N     + +  F +   L  LDL+       I D 
Sbjct: 16  ELNFYK-IPD--NLPFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEI-QTIEDG 70

Query: 133 I-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVS 190
             ++L +L+ L L+ N +  SL       L +L   L       +       GH   +  
Sbjct: 71  AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQ-KLVAVETNLASLENFPIGHLKTLKE 128

Query: 191 LDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
           L++ +N +                 FS    L
Sbjct: 129 LNVAHNLIQ-SFKLPE--------YFSNLTNL 151

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 33/135 (24%), Positives = 47/135 (34%), Gaps = 9/135 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             L     NL       +G L +L  L++A N          F N TNL +LDL+ N   
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI- 161

Query: 127 GPIPDRI-KTLKNLT----HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
             I     + L  +      LDLS N +N  +         L   L L  NQ       +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK-ELALDTNQLKSVPDGI 219

Query: 182 YGHFPVMVSLDLRNN 196
           +     +  + L  N
Sbjct: 220 FDRLTSLQKIWLHTN 234

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 33/144 (22%), Positives = 55/144 (38%), Gaps = 12/144 (8%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
              +     N+T         L+ +T LS      +  I   +    NL+ L+L  N   
Sbjct: 21  AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT 76

Query: 127 GPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP 186
              P  +K L  +T L+LS N L       +  L+++  TL+L+  Q +   P       
Sbjct: 77  DLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIK-TLDLTSTQITDVTPL--AGLS 129

Query: 187 VMVSLDLRNNNLSGEIPQVGSLLN 210
            +  L L  N ++  I  +  L N
Sbjct: 130 NLQVLYLDLNQIT-NISPLAGLTN 152

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 12/143 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T L L    L     S +  L S+  L L S   +   P  L   +NL  L L  N    
Sbjct: 88  TELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN 143

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
             P  +  L NL +L + +  ++  L   L +L  LT TL    N+ S  I  +    P 
Sbjct: 144 ISP--LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLT-TLKADDNKIS-DISPL-ASLPN 196

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           ++ + L+NN +S ++  + +  N
Sbjct: 197 LIEVHLKNNQIS-DVSPLANTSN 218

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 16/103 (15%), Positives = 35/103 (33%), Gaps = 8/103 (7%)

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTL 167
                 N + +    ++    +      L  +T L      +  ++ E +  L  L   L
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLI-GL 68

Query: 168 NLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
            L  NQ +  +  +  +   +  L+L  N L   +  +  L +
Sbjct: 69  ELKDNQIT-DLAPL-KNLTKITELELSGNPLK-NVSAIAGLQS 108

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 6/108 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
             L + N  ++    + L  L+ LT L    N  S  I   L +  NL+ + L +N    
Sbjct: 154 QYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD 209

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
             P  +    NL  + L++  +      +  +L         S    +
Sbjct: 210 VSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA 255

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 27/143 (18%), Positives = 56/143 (39%), Gaps = 18/143 (12%)

Query: 426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKIL 485
             R  +L   ++   S           L I    A  + ++H    +  +H ++K + I 
Sbjct: 142 LCRKENLKDWMNRRCSLEDRE--HGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIF 196

Query: 486 LDDELHPCISGFGLNRLL------PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY 539
              +    +  FGL   +                   T   G+++      Y++PE +I+
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL------YMSPE-QIH 249

Query: 540 GSKFTQKCDVYSFGIVLLEILTG 562
           G+ ++ K D++S G++L E+L  
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYS 272

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 47/228 (20%), Positives = 80/228 (35%), Gaps = 41/228 (17%)

Query: 361 VVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDE 419
            VV +GS  G P  VAV+R+              E++ +     HPN++R       +  
Sbjct: 30  TVVFQGSFQGRP--VAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83

Query: 420 KLLISDFIRNGSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHG 477
             +  +   N +L           ++L        + + +  A G+ ++H     K +H 
Sbjct: 84  LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHR 139

Query: 478 NIKSTKILLDDELHPC-------------ISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           ++K   IL+                    IS FGL + L       +      SGT    
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG-- 197

Query: 525 SAISNVYLAPE------ARIYGSKFTQKCDVYSFGIVLLEILT-GRLP 565
                 + APE            + T+  D++S G V   IL+ G+ P
Sbjct: 198 ------WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 45/162 (27%), Positives = 59/162 (36%), Gaps = 27/162 (16%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF--NATNLVYLDLAHNSF 125
             L    + L   +P    L +    L L+ NN S+ + A       TNL  L L+HN  
Sbjct: 21  NILSCSKQQLPN-VPQ--SLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHL 76

Query: 126 CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYG 183
              I       + NL +LDLSSN L+ +L EFL   L+AL   L L  N     +     
Sbjct: 77  -NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALE-VLLLYNNHIV-VVDR--N 130

Query: 184 HFPVMVSL---DLRNNNLSGEIPQVGSLLNQGPTAFSGNPGL 222
            F  M  L    L  N +S   P                  L
Sbjct: 131 AFEDMAQLQKLYLSQNQIS-RFP---------VELIKDGNKL 162

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 33/137 (24%), Positives = 51/137 (37%), Gaps = 11/137 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
            SL L + +L          + +L  L L+SN+    +   LF +   L  L L +N   
Sbjct: 67  HSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV 125

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD----LRALTGTLNLSFNQFSGQIPEM 181
             +     + +  L  L LS N ++   P  L+     L  L   L+LS N+        
Sbjct: 126 V-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM-LLDLSSNKLKKLPLTD 182

Query: 182 YGHFPVMVSLDLR-NNN 197
               P  V   L  +NN
Sbjct: 183 LQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 27/93 (29%), Positives = 34/93 (36%), Gaps = 8/93 (8%)

Query: 88  LNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI----KTLKNLTHL 142
           L +L  L L +N+    +  N F +   L  L L+ N      P  +      L  L  L
Sbjct: 111 LQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLL 168

Query: 143 DLSSNLLNGSLPEFLLDLRALT-GTLNLSFNQF 174
           DLSSN L       L  L A     L L  N  
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 362 VVGRGS------GMGAPT--VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAF 413
           V+G G+         AP    VA++R+          +   E++A+++  HPNIV     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 414 YYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA---QGTARGLMYIHEYS 470
           +   DE  L+   +  GS+   +    +             IA   +    GL Y+H+  
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-- 139

Query: 471 PRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNE---TIVTSGTGSRISAI 527
               +H ++K+  ILL ++    I+ FG++  L     +T+N+   T V  GT       
Sbjct: 140 -NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV--GT------- 189

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              ++APE       +  K D++SFGI  +E+ TG  P
Sbjct: 190 -PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 42/138 (30%), Positives = 56/138 (40%), Gaps = 13/138 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             L L +  L+         L  L  L L  N     +PA +F    NL  L +  N   
Sbjct: 40  KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ 98

Query: 127 GPIPDRIKT-LKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +P  +   L NL  L L  N L  SLP  + D L  LT  L+L +N+    +P+  G 
Sbjct: 99  A-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLT-YLSLGYNELQ-SLPK--GV 152

Query: 185 FPVMVSL---DLRNNNLS 199
           F  + SL    L NN L 
Sbjct: 153 FDKLTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 39/135 (28%), Positives = 55/135 (40%), Gaps = 7/135 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             LYL +  L          L +L  L +  N     +P  +F+   NL  L L  N   
Sbjct: 64  RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL- 121

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +P R+  +L  LT+L L  N L  SLP+ + D L +L   L L  NQ        +  
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK-ELRLYNNQLKRVPEGAFDK 179

Query: 185 FPVMVSLDLRNNNLS 199
              + +L L NN L 
Sbjct: 180 LTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 33/108 (30%), Positives = 42/108 (38%), Gaps = 7/108 (6%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             L L    L    P     L  LT LSL  N     +P  +F+  T+L  L L +N   
Sbjct: 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL- 169

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFN 172
             +P+     L  L  L L +N L   +PE   D L  L   L L  N
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLK-MLQLQEN 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 63.0 bits (154), Expect = 7e-11
 Identities = 42/173 (24%), Positives = 80/173 (46%), Gaps = 21/173 (12%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
            E + ++R+ HP  V+L  F + +DEKL     + +NG L   +    S          R
Sbjct: 79  RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET----CTR 133

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
              A+  +  L Y+H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  + 
Sbjct: 134 FYTAEIVS-ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            + V  GT          Y++PE  +      +  D+++ G ++ +++ G  P
Sbjct: 190 NSFV--GTAQ--------YVSPEL-LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 36/134 (26%), Positives = 52/134 (38%), Gaps = 13/134 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
            +L L +  L   +P     L +LT L ++ N  +  +P         L  L L  N   
Sbjct: 80  GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNEL- 136

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +P  +      L  L L++N L   LP  LL+ L  L  TL L  N     IP+  G 
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD-TLLLQENSLYT-IPK--GF 191

Query: 185 F--PVMVSLDLRNN 196
           F   ++    L  N
Sbjct: 192 FGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 39/137 (28%), Positives = 51/137 (37%), Gaps = 17/137 (12%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
             +    RNLT  +P    L    T L L+ N              T L  L+L      
Sbjct: 13  LEVNCDKRNLTA-LPP--DLPKDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT 68

Query: 127 G-PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
              +      L  L  LDLS N L  SLP     L ALT  L++SFN+ +  +P   G  
Sbjct: 69  KLQVDGT---LPVLGTLDLSHNQLQ-SLPLLGQTLPALT-VLDVSFNRLT-SLPL--GAL 120

Query: 186 PVMVS---LDLRNNNLS 199
             +     L L+ N L 
Sbjct: 121 RGLGELQELYLKGNELK 137

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 37/177 (20%), Positives = 81/177 (45%), Gaps = 29/177 (16%)

Query: 395 EVEAIARVQHPNIVRLK-AFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLP-WEA 451
           E+  + ++ HPN+V+L       N++ L ++ + +  G +       P      L   +A
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP------LSEDQA 139

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
           R    Q   +G+ Y+H    +K +H +IK + +L+ ++ H  I+ FG++    G+  +  
Sbjct: 140 R-FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFT---QKCDVYSFGIVLLEILTGRLP 565
           N            +  +  ++APE+ +  ++     +  DV++ G+ L   + G+ P
Sbjct: 196 N------------TVGTPAFMAPES-LSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 63.8 bits (155), Expect = 9e-11
 Identities = 43/171 (25%), Positives = 67/171 (39%), Gaps = 26/171 (15%)

Query: 397 EAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKI 455
             ++    P IV +  + +   +KL  I D +  G L+  L      S      + R   
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYA 298

Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           A+    GL ++H    R  V+ ++K   ILLD+  H  IS  GL       +     +  
Sbjct: 299 AE-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL-------ACDFSKKKP 347

Query: 516 VTS-GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             S GT          Y+APE    G  +    D +S G +L ++L G  P
Sbjct: 348 HASVGTHG--------YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 49/219 (22%), Positives = 98/219 (44%), Gaps = 34/219 (15%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRR--LTEGDATWRFKDFESEVEAIARVQHPNI 407
           +G+  +G +Y  +    +G      VA+R+  L +     + +   +E+  +   ++PNI
Sbjct: 28  IGQGASGTVYTAMD-VATGQ----EVAIRQMNLQQQP---KKELIINEILVMRENKNPNI 79

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL-KIAQGTARGLMYI 466
           V     Y   DE  ++ +++  GSL   +     D       E ++  + +   + L ++
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAVCRECLQALEFL 132

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H     + +H +IKS  ILL  +    ++ FG    +  T + +K  T+V  GT      
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMV--GT------ 179

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
               ++APE  +    +  K D++S GI+ +E++ G  P
Sbjct: 180 --PYWMAPEV-VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 42/187 (22%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           ++  +E+  +  + HPNI++L   +       L+++F   G L+        + +     
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF--------EQI----- 137

Query: 450 EARLKIAQGTARGLM--------YIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFG 498
             R K  +  A  +M        Y+H+      VH +IK   ILL   +  L+  I  FG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLE 558
           L       S     +  +    G+        Y+APE  +   K+ +KCDV+S G+++  
Sbjct: 195 L-------SSFFSKDYKLRDRLGTAY------YIAPE--VLKKKYNEKCDVWSCGVIMYI 239

Query: 559 ILTGRLP 565
           +L G  P
Sbjct: 240 LLCGYPP 246

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 47/226 (20%), Positives = 87/226 (38%), Gaps = 42/226 (18%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAV-----RRLTEGDATWRFKDFESEVEAIARVQ 403
            +G    G +      + + +      A+       ++             EV  +  + 
Sbjct: 44  KLGSGAYGEVLLCR-DKVTHV----ERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLD 94

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR-LKIAQGTARG 462
           HPNI++L  F+       L+ +  + G L+  +      +      E     I +    G
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN------EVDAAVIIKQVLSG 148

Query: 463 LMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           + Y+H+      VH ++K   +LL   + +    I  FGL       S V +N+  +   
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGL-------SAVFENQKKMKER 198

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            G+        Y+APE  +   K+ +KCDV+S G++L  +L G  P
Sbjct: 199 LGTAY------YIAPE--VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 350 VGKSKNGIMYKVVVGRGSGMGAPTVVAVRR--LTEGDATWRFKDFESEVEAIARVQHPNI 407
           +G+   GI+      + SG      VAV+   L +     R +   +EV  +   QH N+
Sbjct: 53  IGEGSTGIVCLARE-KHSG----RQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNV 104

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL-KIAQGTARGLMYI 466
           V +   Y   +E  ++ +F++ G+L   +     +       E ++  + +   + L Y+
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-------EEQIATVCEAVLQALAYL 157

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H    +  +H +IKS  ILL  +    +S FG    +  +  V K +++V  GT      
Sbjct: 158 HA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLV--GT------ 204

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
               ++APE  I  S +  + D++S GI+++E++ G  P
Sbjct: 205 --PYWMAPEV-ISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 27/140 (19%), Positives = 46/140 (32%), Gaps = 10/140 (7%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFC 126
                    +T  +PS   L  +   L          I    F    +L  ++++ N   
Sbjct: 12  RVFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 67

Query: 127 GPIPDRI-KTLKNLTHLDLS-SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE-MYG 183
             I   +   L  L  + +  +N L    PE   +L  L   L +S       +P+    
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ-YLLISNTGIK-HLPDVHKI 125

Query: 184 HFPVMVSLDLRNNNLSGEIP 203
           H    V LD+++N     I 
Sbjct: 126 HSLQKVLLDIQDNINIHTIE 145

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 25/113 (22%), Positives = 46/113 (40%), Gaps = 9/113 (7%)

Query: 86  GLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDL 144
           GL      L L  N   + I  + FN T L  L+L+ N+    +P+ +         LD+
Sbjct: 151 GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 209

Query: 145 SSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNN 196
           S   ++ SLP + L+ L+ L    +    +   ++P +      ++   L   
Sbjct: 210 SRTRIH-SLPSYGLENLKKLR-ARSTYNLK---KLPTLE-KLVALMEASLTYP 256

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 30/181 (16%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +    EV+ + ++ HPNI++L  F+       L+ +    G L+  + +    S      
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS------ 124

Query: 450 E--ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLP 504
           E  A  +I +    G+ Y+H+    K VH ++K   +LL     + +  I  FGL     
Sbjct: 125 EVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL----- 175

Query: 505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
             S   +    +    G+        Y+APE  +    + +KCDV+S G++L  +L+G  
Sbjct: 176 --STHFEASKKMKDKIGTAY------YIAPE--VLHGTYDEKCDVWSTGVILYILLSGCP 225

Query: 565 P 565
           P
Sbjct: 226 P 226

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 32/146 (21%), Positives = 51/146 (34%), Gaps = 17/146 (11%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFC 126
                L  +++T         L+ +   +  ++N    +   +   TNL  L L+HN   
Sbjct: 21  AVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQ-- 74

Query: 127 GPIPD--RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGH 184
             I D   +K L  L  L ++ N L          L      L L  N+       +  H
Sbjct: 75  --ISDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLS----RLFLDNNELR-DTDSL-IH 126

Query: 185 FPVMVSLDLRNNNLSGEIPQVGSLLN 210
              +  L +RNN L   I  +G L  
Sbjct: 127 LKNLEILSIRNNKLK-SIVMLGFLSK 151

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 6/103 (5%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           + L+L N  L       L  L +L  LS+ +N     I   L   + L  LDL  N    
Sbjct: 109 SRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN 164

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS 170
                +  LK +  +DL+         ++  +L       +  
Sbjct: 165 TGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPD 205

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 11/94 (11%)

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTL 167
                 N V  +L   S    +    K L  + + +  ++ +  SL   +     L   L
Sbjct: 14  PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK-EL 68

Query: 168 NLSFNQFSGQIPEMYG--HFPVMVSLDLRNNNLS 199
           +LS N    QI ++        +  L +  N L 
Sbjct: 69  HLSHN----QISDLSPLKDLTKLEELSVNRNRLK 98

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 14/149 (9%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
              S         + +   NRNLT ++P    L      LSL+ N+ S+    ++   + 
Sbjct: 21  IVGSMTPFSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSE 77

Query: 115 LVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQ 173
           L  L L+HN     +   +    ++L +LD+S N L  ++    +   +L   L+LSFN 
Sbjct: 78  LRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRL-QNISCCPMA--SLR-HLDLSFND 132

Query: 174 FSGQIPEMYGHFPVMVSL---DLRNNNLS 199
           F   +P     F  +  L    L      
Sbjct: 133 FD-VLPV-CKEFGNLTKLTFLGLSAAKFR 159

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 32/153 (20%), Positives = 50/153 (32%), Gaps = 13/153 (8%)

Query: 58  SGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVY 117
             ++ +   +    L   +            +S T L+   N F+  +         L  
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381

Query: 118 LDLAHNSF--CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS 175
           L L  N       +    K + +L  LD+S N LN    +           LNLS N  +
Sbjct: 382 LILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 176 GQIPEMYGHFPVMVS----LDLRNNNLSGEIPQ 204
           G        F  +      LDL NN +   IP+
Sbjct: 442 G------SVFRCLPPKVKVLDLHNNRIM-SIPK 467

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 26/113 (23%), Positives = 36/113 (31%), Gaps = 5/113 (4%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF-CGPIPDRIKTLKNLTHLDLSS 146
              L  L ++ N     I        +L +LDL+ N F   P+      L  LT L LS+
Sbjct: 99  NQDLEYLDVSHNRLQN-ISCCPM--ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155

Query: 147 NLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV-SLDLRNNNL 198
                     +  L      L+L      G   E        V  L    N+L
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 29/133 (21%), Positives = 54/133 (40%), Gaps = 14/133 (10%)

Query: 44  LDSWSESDSTPCHWSGIHCIRNRVTSL-YLPNRNLTGYMPSELGLLNSLTRLSLASNNFS 102
           L ++ +      + S +  +   + SL                    S+  L+L+SN  +
Sbjct: 389 LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA-------WAESILVLNLSSNMLT 441

Query: 103 KPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LR 161
             +   L     +  LDL +N     IP  +  L+ L  L+++SN L  S+P+ + D L 
Sbjct: 442 GSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497

Query: 162 ALTGTLNLSFNQF 174
           +L   + L  N +
Sbjct: 498 SLQ-YIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 20/158 (12%), Positives = 47/158 (29%), Gaps = 10/158 (6%)

Query: 62  CIRNRVTSLYLPNRNLTGYMPSELGLL---NSLTRLSLASNNFSKPIPANLFNATN---- 114
                + ++ L +   T     +L        +  L++ +   ++ I    F  +     
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALK 305

Query: 115 -LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQ 173
            L+   + +  F             +    LS +              + T  LN + N 
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT-FLNFTQNV 364

Query: 174 FSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQ 211
           F+  + +       + +L L+ N L     +V  +   
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKN 401

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 39/184 (21%), Positives = 82/184 (44%), Gaps = 33/184 (17%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAAL--HAGPSDSLPP 446
            + E+E+E + ++ HP I+++K F+  + E   ++ + +  G L+  +  +    ++   
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEA--- 239

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLL 503
                +L   Q     + Y+HE      +H ++K   +LL  +   C   I+ FG     
Sbjct: 240 ---TCKLYFYQ-MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH---- 288

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILT 561
              SK+    +++ +  G+        YLAPE    +  + + +  D +S G++L   L+
Sbjct: 289 ---SKILGETSLMRTLCGTP------TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

Query: 562 GRLP 565
           G  P
Sbjct: 340 GYPP 343

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 36/195 (18%)

Query: 393 ESEVEAIARVQHPNIVRLKAFY--YANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPW 449
             EV  +  + HPNIV+L   +     ++ L LI ++   G ++  L A     +     
Sbjct: 62  FREVRIMKILNHPNIVKL---FEVIETEKTLYLIMEYASGGEVFDYLVA--HGRMKEK-- 114

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           EAR K  Q     + Y H+   ++ VH ++K+  +LLD +++  I+ FG       +++ 
Sbjct: 115 EARSKFRQ-IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGF------SNEF 164

Query: 510 TKNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLPDA 567
           T    +    G        +  Y APE    G K+   + DV+S G++L  +++G LP  
Sbjct: 165 TVGGKLDAFCG--------APPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLP-- 213

Query: 568 GPENDGKGLESLVRK 582
               DG+ L+ L  +
Sbjct: 214 ---FDGQNLKELRER 225

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 42/137 (30%), Positives = 55/137 (40%), Gaps = 13/137 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             L L +  L     +    L  LT L+L  N     + A +F+  T L  L LA+N   
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL- 95

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +P  +   L  L  L L  N L  SLP  + D L  L   L L+ NQ    IP   G 
Sbjct: 96  ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK-ELRLNTNQLQ-SIPA--GA 150

Query: 185 F---PVMVSLDLRNNNL 198
           F     + +L L  N L
Sbjct: 151 FDKLTNLQTLSLSTNQL 167

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 32/113 (28%), Positives = 44/113 (38%), Gaps = 11/113 (9%)

Query: 92  TRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLN 150
            +L L S   +    A     T L +L+L +N     +   +   L  L  L L++N L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96

Query: 151 GSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVS---LDLRNNNLS 199
            SLP  + D L  L   L L  NQ    +P   G F  +     L L  N L 
Sbjct: 97  -SLPLGVFDHLTQLD-KLYLGGNQLKS-LPS--GVFDRLTKLKELRLNTNQLQ 144

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 28/116 (24%), Positives = 48/116 (41%), Gaps = 13/116 (11%)

Query: 90  SLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSN 147
           ++T + L  N     IP   F     L  +DL++N     +     + L++L  L L  N
Sbjct: 33  TITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN 90

Query: 148 LLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHF---PVMVSLDLRNNNLS 199
            +   LP+ L + L +L   L L+ N+ +  +      F     +  L L +N L 
Sbjct: 91  KIT-ELPKSLFEGLFSLQ-LLLLNANKIN-CLRV--DAFQDLHNLNLLSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 6e-07
 Identities = 30/113 (26%), Positives = 47/113 (41%), Gaps = 7/113 (6%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHN 123
            ++  + L N  ++   P     L SL  L L  N     +P +LF    +L  L L  N
Sbjct: 56  KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNAN 114

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
                +     + L NL  L L  N L  ++ +     LRA+  T++L+ N F
Sbjct: 115 KI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ-TMHLAQNPF 164

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 26/133 (19%), Positives = 45/133 (33%), Gaps = 21/133 (15%)

Query: 90  SLTRLSLASNNFS----KPIPANLFNATNLVYLDLAHNSF----CGPIPDRIKTLKNLTH 141
           S+   SL  +  +    K + A L    ++  + L+ N+        + + I + K+L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 142 LDLSSNLLNGSLPEFLLDLRALTG---------TLNLSFNQFSGQ----IPEMYGHFPVM 188
            + S         E    LR L           T+ LS N F       + +       +
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 189 VSLDLRNNNLSGE 201
             L L NN L  +
Sbjct: 125 EHLYLHNNGLGPQ 137

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 27/135 (20%), Positives = 45/135 (33%), Gaps = 21/135 (15%)

Query: 85  LGLLNSLTRLSLASNNF-----SKPIPANLFNATNLVYLDLAHNSF----CGPIPDRIKT 135
                 L  + +  N          +   L     L  LDL  N+F       +   +K+
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 136 LKNLTHLDLSSNLLNG----SLPEFLLDL--RALTGTLNLSFNQFSGQ-----IPEMYGH 184
             NL  L L+  LL+     ++ +    L    L  TL L +N+            +   
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ-TLRLQYNEIELDAVRTLKTVIDEK 301

Query: 185 FPVMVSLDLRNNNLS 199
            P ++ L+L  N  S
Sbjct: 302 MPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 21/150 (14%), Positives = 42/150 (28%), Gaps = 32/150 (21%)

Query: 83  SELGLLNSLTRLSLASNNFS----KPIPANLFNATNLVYLDLAHNSF----------CGP 128
           + L   +S+  + L+ N       + +  N+ +  +L   + +                 
Sbjct: 26  AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL 85

Query: 129 IPDRIKTLKNLTHLDLSSNLL--NG--SLPEFLLDLRALTGTLNLSFNQFS--------- 175
           +   +     L  + LS N         L +FL     L   L L  N            
Sbjct: 86  LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE-HLYLHNNGLGPQAGAKIAR 144

Query: 176 ----GQIPEMYGHFPVMVSLDLRNNNLSGE 201
                 + +   + P + S+    N L   
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENG 174

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 25/143 (17%), Positives = 44/143 (30%), Gaps = 27/143 (18%)

Query: 85  LGLLNSLTRLSLASNNFS----KPIPANLFNATNLVYLDLAHNSF-------------CG 127
           L     L  + L+ N F     +P+   L   T L +L L +N                 
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNG----SLPEFLLDLRALTGTLNLSFNQFSGQ-----I 178
            +  + K    L  +    N L         +     R L  T+ +  N    +     +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLL 208

Query: 179 PEMYGHFPVMVSLDLRNNNLSGE 201
            E   +   +  LDL++N  +  
Sbjct: 209 LEGLAYCQELKVLDLQDNTFTHL 231

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 19/167 (11%)

Query: 400 ARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           A+V    IV L  + +     L L+   +  G +   ++    D+       A    AQ 
Sbjct: 240 AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ- 297

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
              GL ++H+   R  ++ ++K   +LLDD+ +  IS  GL   L      TK       
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA-- 350

Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           GT          ++APE  + G ++    D ++ G+ L E++  R P
Sbjct: 351 GTPG--------FMAPEL-LLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 42/256 (16%), Positives = 81/256 (31%), Gaps = 52/256 (20%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMG-APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
            +G+   G++   +    +    A  ++   ++ + +     +  ++EV  + ++ HPNI
Sbjct: 33  AIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPK-DVERIKTEVRLMKKLHHPNI 90

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLY------------AALHAGPSDSLPPLPWEARLKI 455
            RL   Y       L+ +    G L                       + P P      I
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 456 AQGT---------------ARGLM--------YIHEYSPRKYVHGNIKSTKILL--DDEL 490
                                 +M        Y+H    +   H +IK    L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSF 207

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEA-RIYGSKFTQKCDV 549
              +  FGL++     +          +GT          ++APE        +  KCD 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY--------FVAPEVLNTTNESYGPKCDA 259

Query: 550 YSFGIVLLEILTGRLP 565
           +S G++L  +L G +P
Sbjct: 260 WSAGVLLHLLLMGAVP 275

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 51/226 (22%), Positives = 87/226 (38%), Gaps = 42/226 (18%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAV-----RRLTEGDATWRFKDFESEVEAIARVQ 403
           ++GK   G + K    R +        AV           D          EVE + ++ 
Sbjct: 29  MLGKGSFGEVLKCK-DRITQQ----EYAVKVINKASAKNKD----TSTILREVELLKKLD 79

Query: 404 HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR-LKIAQGTARG 462
           HPNI++L      +    ++ +    G L+  +      S      E    +I +    G
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------EHDAARIIKQVFSG 133

Query: 463 LMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           + Y+H+      VH ++K   ILL   + +    I  FGL       S   +  T +   
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL-------STCFQQNTKMKDR 183

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            G+        Y+APE  +    + +KCDV+S G++L  +L+G  P
Sbjct: 184 IGTAY------YIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 26/169 (15%)

Query: 400 ARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
            +V    +V L  + Y   + L L+   +  G L   ++       P     A    A+ 
Sbjct: 239 EKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVFYAAE- 294

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK-VTKNETIVT 517
              GL  +H     + V+ ++K   ILLDD  H  IS  GL       +  V + +TI  
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKG 344

Query: 518 S-GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             GT          Y+APE  +   ++T   D ++ G +L E++ G+ P
Sbjct: 345 RVGTVG--------YMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQSP 384

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 44/181 (24%), Positives = 69/181 (38%), Gaps = 28/181 (15%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLP 448
           F  E + +       I  L    YA  +D  L L+ D+   G L         +   P  
Sbjct: 121 FREERDVLVNGDSKWITTLH---YAFQDDNNLYLVMDYYVGGDLLT--LLSKFEDRLPEE 175

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
             AR  +A+     +  +H+     YVH +IK   IL+D   H  ++ FG    L     
Sbjct: 176 M-ARFYLAE-MVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPE----ARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           V  +   V  GT          Y++PE          ++  +CD +S G+ + E+L G  
Sbjct: 231 VQSS-VAV--GTPD--------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

Query: 565 P 565
           P
Sbjct: 280 P 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 28/170 (16%)

Query: 400 ARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
              +HP +  LK + +   ++L  + ++   G L+  L      S       AR   A+ 
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAE- 256

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK--VTKNETIV 516
               L Y+H  S +  V+ ++K   ++LD + H  I+ FGL        K  +    T+ 
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGL-------CKEGIKDGATMK 307

Query: 517 T-SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T  GT          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 308 TFCGTPE--------YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 38/183 (20%), Positives = 79/183 (43%), Gaps = 25/183 (13%)

Query: 388 RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPL 447
             +D+  E+E +A   HP IV+L   YY + +  ++ +F   G++ A +          L
Sbjct: 59  ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GL 114

Query: 448 PWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTS 507
                  + +     L ++H    ++ +H ++K+  +L+  E    ++ FG++       
Sbjct: 115 TEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LK 169

Query: 508 KVTKNETIVTSGTGSRISAISNVY-LAPE----ARIYGSKFTQKCDVYSFGIVLLEILTG 562
            + K ++ +  GT          Y +APE      +  + +  K D++S GI L+E+   
Sbjct: 170 TLQKRDSFI--GTP---------YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

Query: 563 RLP 565
             P
Sbjct: 219 EPP 221

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 29/180 (16%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLP 448
           F  E + +A    P +V+L   +YA  +D  L ++ +++  G L   +         P  
Sbjct: 116 FWEERDIMAFANSPWVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEK 168

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
           W AR   A+     L  IH      ++H ++K   +LLD   H  ++ FG    +     
Sbjct: 169 W-ARFYTAEVVL-ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           V  + T V  GT          Y++PE   ++     + ++CD +S G+ L E+L G  P
Sbjct: 224 VRCD-TAV--GTPD--------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 26/122 (21%), Positives = 39/122 (31%), Gaps = 15/122 (12%)

Query: 55  CHW-SGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NA 112
            H  SG+ C R+                   L    +LT L + +    + +        
Sbjct: 7   PHGSSGLRCTRDGALD-----------SLHHLPGAENLTELYIENQQHLQHLELRDLRGL 55

Query: 113 TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFN 172
             L  L +  +      PD       L+ L+LS N L  SL    +   +L   L LS N
Sbjct: 56  GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGN 113

Query: 173 QF 174
             
Sbjct: 114 PL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 4e-07
 Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 2/96 (2%)

Query: 129 IPDRIKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
               +   +NLT L + +      L    L  L  L   L +  +      P+ +   P 
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVKSGLRFVAPDAFHFTPR 81

Query: 188 MVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLC 223
           +  L+L  N L     +    L+      SGNP  C
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 39/143 (27%), Positives = 57/143 (39%), Gaps = 12/143 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
           T L+L    LT   P  L  L +L  L L  N     +  +L +   L  L L HN    
Sbjct: 71  TKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD 126

Query: 128 PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPV 187
                +  L  L  L L +N +  +    L  L  L  TL+L  NQ S  I  +      
Sbjct: 127 ING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLD-TLSLEDNQIS-DIVPL-AGLTK 179

Query: 188 MVSLDLRNNNLSGEIPQVGSLLN 210
           + +L L  N++S ++  +  L N
Sbjct: 180 LQNLYLSKNHIS-DLRALAGLKN 201

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 13/133 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            SL L +  ++    + L  L  L  L L +N  +      L   T L  L L  N    
Sbjct: 115 KSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN---- 166

Query: 128 PIPD--RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
            I D   +  L  L +L LS N ++  L   L  L+ L   L L   +   +      + 
Sbjct: 167 QISDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLD-VLELFSQECLNKPINHQSNL 223

Query: 186 PVMVSLDLRNNNL 198
            V  ++   + +L
Sbjct: 224 VVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 21/121 (17%), Positives = 45/121 (37%), Gaps = 17/121 (14%)

Query: 83  SELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPD--RIKTLKNLT 140
                     + +L   + +  +        ++  +   ++     I     I+ L N+T
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD----IKSVQGIQYLPNVT 71

Query: 141 HLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYG--HFPVMVSLDLRNNNL 198
            L L+ N L   + + L +L+ L   L L  N    ++ ++        + SL L +N +
Sbjct: 72  KLFLNGNKLT-DI-KPLANLKNLG-WLFLDEN----KVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 199 S 199
           S
Sbjct: 125 S 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 24/131 (18%), Positives = 40/131 (30%), Gaps = 24/131 (18%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG 127
            +L L +  ++      L  L  L  L L+ N+ S  +   L    NL  L+L       
Sbjct: 159 DTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214

Query: 128 PIPDRIKTLKNLTHLDLSSNLL--------NGSL--PEFLLDLRALTGTLNLSFNQ---- 173
              +    L     +  +   L        +G    P     L   T  ++  F Q    
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 274

Query: 174 ------FSGQI 178
                 F G++
Sbjct: 275 GKAKARFHGRV 285

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 28/178 (15%)

Query: 395 EVEAIARVQHPNIVRLK-AFYYANDEKL-LISDFIRNGS--LYAALHAGPSDSLPPLPWE 450
           E++ + R++H N+++L    Y    +K+ ++ ++   G   +  ++        P    +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPV--CQ 110

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
           A     Q    GL Y+H    +  VH +IK   +LL       IS  G+   L       
Sbjct: 111 AHGYFCQ-LIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH---PFA 163

Query: 511 KNETIVTS-GTGSRISAISNVYLAPEARIYGSKF--TQKCDVYSFGIVLLEILTGRLP 565
            ++T  TS G        S  +  PE    G       K D++S G+ L  I TG  P
Sbjct: 164 ADDTCRTSQG--------SPAFQPPEI-ANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 56.4 bits (137), Expect = 8e-09
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 53/226 (23%)

Query: 362 VVGRGS-GMGAPTVVAVRRLTEGDATWRF------KDF---ESEVEAIA------RVQHP 405
           V+G+GS G     V  V++++  DA   +      K        V           V HP
Sbjct: 31  VLGQGSFG----KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86

Query: 406 NIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
            IV+L    YA   + KL LI DF+R G L+  L      +      + +  +A+  A  
Sbjct: 87  FIVKLH---YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----DVKFYLAE-LALA 138

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS---G 519
           L ++H       ++ ++K   ILLD+E H  ++ FGL       SK + +         G
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL-------SKESIDHEKKAYSFCG 188

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T          Y+APE  +     TQ  D +SFG+++ E+LTG LP
Sbjct: 189 TVE--------YMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 42/183 (22%), Positives = 67/183 (36%), Gaps = 30/183 (16%)

Query: 392 FESEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLP 448
           F  E + +       I +L   ++A  ++  L L+ ++   G L   L         P  
Sbjct: 108 FREERDVLVNGDRRWITQL---HFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAE 162

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
             AR  +A+     +  +H      YVH +IK   ILLD   H  ++ FG    L     
Sbjct: 163 M-ARFYLAE-IVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 509 VTKNETIVTSGTGSRISAISNVYLAPE------ARIYGSKFTQKCDVYSFGIVLLEILTG 562
           V      V  GT          YL+PE             +  +CD ++ G+   E+  G
Sbjct: 218 VRSL-VAV--GTPD--------YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

Query: 563 RLP 565
           + P
Sbjct: 267 QTP 269

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 37/179 (20%), Positives = 78/179 (43%), Gaps = 26/179 (14%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEK-------LLISDFIRNGSLYAALHAGPSDSLPP 446
             ++ +A + HPNIV+L++++Y   E+        ++ +++   +L+          + P
Sbjct: 68  QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAP 126

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPG 505
            P   ++ + Q   R +  +H  S     H +IK   +L+++      +  FG  + L  
Sbjct: 127 PPILIKVFLFQ-LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGR 563
           +        I +     R       Y APE  I+G++ +T   D++S G +  E++ G 
Sbjct: 185 SEPNV--AYICS-----RY------YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 37/181 (20%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWE 450
            E++ +  ++HP +V L    Y+  ++E + ++ D +  G L    H   +        E
Sbjct: 64  KELQIMQGLEHPFLVNLW---YSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFK----E 114

Query: 451 ARLK--IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK 508
             +K  I +     L Y+     ++ +H ++K   ILLD+  H  I+ F +       + 
Sbjct: 115 ETVKLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNI-------AA 163

Query: 509 VTKNETIVTS--GTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           +   ET +T+  GT          Y+APE  +   G+ ++   D +S G+   E+L GR 
Sbjct: 164 MLPRETQITTMAGTKP--------YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

Query: 565 P 565
           P
Sbjct: 216 P 216

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 35/158 (22%), Positives = 57/158 (36%), Gaps = 21/158 (13%)

Query: 65  NRVTSLYLPNRNLT----GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-----TNL 115
            +   + L +  LT      + S L +  +L  L+L SN         +          +
Sbjct: 28  QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87

Query: 116 VYLDLAHNSF----CGPIPDRIKTLKNLTHLDLSSNLLNGS----LPEFLLDLRALTGTL 167
             L L +       CG +   ++TL  L  L LS NLL  +    L E LLD +     L
Sbjct: 88  QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147

Query: 168 NLSFNQFSGQ----IPEMYGHFPVMVSLDLRNNNLSGE 201
            L +   S      +  +    P    L + NN+++  
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 30/158 (18%), Positives = 53/158 (33%), Gaps = 23/158 (14%)

Query: 66  RVTSLYLPNRNLT----GYMPSELGLLNSLTRLSLASNNFS----KPIPANL-FNATNLV 116
           R+  L L   +L+      + S L        L++++N+ +    + +   L  +   L 
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 117 YLDLAHNSF----CGPIPDRIKTLKNLTHLDLSSNLLNGS----LPEFLLD-LRALTGTL 167
            L L         C  +   + +  +L  L L SN L       L   LL     L  TL
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR-TL 261

Query: 168 NLSFNQFSGQ----IPEMYGHFPVMVSLDLRNNNLSGE 201
            +     + +    +  +      +  L L  N L  E
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 31/158 (19%), Positives = 56/158 (35%), Gaps = 23/158 (14%)

Query: 66  RVTSLYLPNRNLT----GYMPSELGLLNSLTRLSLASNNFSKP-----IPANLFNATNLV 116
           ++ +L L +  +T      +   +    SL  L+L SN           P  L  ++ L 
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259

Query: 117 YLDLAHNSF----CGPIPDRIKTLKNLTHLDLSSNLLNGS----LPEFLLD-LRALTGTL 167
            L +         CG +   ++  ++L  L L+ N L       L E LL+    L  +L
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE-SL 318

Query: 168 NLSFNQFSGQ----IPEMYGHFPVMVSLDLRNNNLSGE 201
            +    F+         +      ++ L + NN L   
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 31/133 (23%), Positives = 43/133 (32%), Gaps = 19/133 (14%)

Query: 85  LGLLNSLTRLSLASNNFS----KPIPANLFNA-TNLVYLDLAHNSF----CGPIPDRIKT 135
           L    SL  LSLA N       + +   L      L  L +   SF    C      +  
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 136 LKNLTHLDLSSNLLNGS----LPEFLLD-LRALTGTLNLSFNQFSGQ----IPEMYGHFP 186
            + L  L +S+N L  +    L + L      L   L L+    S      +        
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR-VLWLADCDVSDSSCSSLAATLLANH 398

Query: 187 VMVSLDLRNNNLS 199
            +  LDL NN L 
Sbjct: 399 SLRELDLSNNCLG 411

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 25/151 (16%), Positives = 54/151 (35%), Gaps = 25/151 (16%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NAT 113
           C  + + C   ++             +P    +      L L +N F+      +F    
Sbjct: 11  CEGTTVDCSNQKLNK-----------IPE--HIPQYTAELRLNNNEFTVLEATGIFKKLP 57

Query: 114 NLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSF 171
            L  ++ ++N     I +   +    +  + L+SN L  ++   +   L +L  TL L  
Sbjct: 58  QLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLK-TLMLRS 114

Query: 172 NQFSGQIPEMYGHF---PVMVSLDLRNNNLS 199
           N+ +  +      F     +  L L +N ++
Sbjct: 115 NRIT-CVGN--DSFIGLSSVRLLSLYDNQIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 20/84 (23%), Positives = 33/84 (39%), Gaps = 4/84 (4%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNS 124
            V  + L +  L          L SL  L L SN  +  +  + F   +++  L L  N 
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQ 140

Query: 125 FCGPIPDRI-KTLKNLTHLDLSSN 147
               +      TL +L+ L+L +N
Sbjct: 141 I-TTVAPGAFDTLHSLSTLNLLAN 163

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 41/181 (22%), Positives = 74/181 (40%), Gaps = 26/181 (14%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           +  E+E+E +  + HPNI+++   +       ++ +    G L   + +  +        
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGT 506
                + Q     L Y H    +  VH ++K   IL           I  FGL       
Sbjct: 125 YVAELMKQ-MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGL------- 173

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           +++ K++   T+  G+ +      Y+APE   R        KCD++S G+V+  +LTG L
Sbjct: 174 AELFKSDEHSTNAAGTAL------YMAPEVFKRDVT----FKCDIWSAGVVMYFLLTGCL 223

Query: 565 P 565
           P
Sbjct: 224 P 224

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 13/186 (6%)

Query: 390 KDFESEVEAIARVQ-HPNIVRLKAFYYANDEK-------LLISDFIRNGSLYAALHAGPS 441
           +    EV  + ++  HPNIV+  +      E+        L+   +  G L   L    S
Sbjct: 70  RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129

Query: 442 DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR 501
               PL  +  LKI   T R + ++H   P   +H ++K   +LL ++    +  FG   
Sbjct: 130 RG--PLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

Query: 502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE-ARIYGSK-FTQKCDVYSFGIVLLEI 559
            +      + +               + +Y  PE   +Y +    +K D+++ G +L  +
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 560 LTGRLP 565
              + P
Sbjct: 247 CFRQHP 252

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 54.5 bits (132), Expect = 3e-08
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 40/198 (20%)

Query: 395 EVEAIARVQHPNIVRLKAFY--YANDEKL-LISDFIRNGSL--YAALHAGPSDSLPPLPW 449
           E++ +   +HP+I++L   Y   +      ++ +++  G L  Y   H    +       
Sbjct: 61  EIQNLKLFRHPHIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM------ 111

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           EAR    Q     + Y H       VH ++K   +LLD  ++  I+ FGL+ ++      
Sbjct: 112 EARRLFQQ-ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM------ 161

Query: 510 TKNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLPDA 567
           +  E + TS G        S  Y APE  I G  +   + D++S G++L  +L G LP  
Sbjct: 162 SDGEFLRTSCG--------SPNYAAPEV-ISGRLYAGPEVDIWSCGVILYALLCGTLP-- 210

Query: 568 GPENDGKGLESLVRKAFR 585
               D + + +L +K   
Sbjct: 211 ---FDDEHVPTLFKKIRG 225

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 8/111 (7%)

Query: 67  VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
           VT LYL + N    +P EL     LT + L++N  S  +    F N T L+ L L++N  
Sbjct: 33  VTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRL 90

Query: 126 CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
              IP R    LK+L  L L  N ++  +PE   + L AL+  L +  N  
Sbjct: 91  -RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS-HLAIGANPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 6e-06
 Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 13/104 (12%)

Query: 105 IPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRAL 163
           +P  +    ++  L L  N F   +P  +   K+LT +DLS+N ++ +L       +  L
Sbjct: 25  LPKGI--PRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 164 TGTLNLSFNQFSGQIPEMYGHFPVMVSL---DLRNNNLSGEIPQ 204
             TL LS+N+    IP     F  + SL    L  N++S  +P+
Sbjct: 81  L-TLILSYNRLR-CIPP--RTFDGLKSLRLLSLHGNDIS-VVPE 119

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 31/189 (16%)

Query: 389 FKDFESEVEAIARV-QHPNIVR-----LKAFYYANDEKL-LISDFIRNGSLYAALHAGPS 441
            ++ + E+  + +   H NI       +K      D++L L+ +F   GS+   +     
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123

Query: 442 DSLPPLPWEARLK-IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN 500
           ++L     E  +  I +   RGL ++H+    K +H +IK   +LL +     +  FG++
Sbjct: 124 NTLK----EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE----ARIYGSKFTQKCDVYSFGIVL 556
             L     V +  T +  GT          ++APE         + +  K D++S GI  
Sbjct: 177 AQL--DRTVGRRNTFI--GTPY--------WMAPEVIACDENPDATYDFKSDLWSLGITA 224

Query: 557 LEILTGRLP 565
           +E+  G  P
Sbjct: 225 IEMAEGAPP 233

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 27/177 (15%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLP 448
           E++ + ++ H NIVRL+ F+Y++ EK       L+ D++   ++Y               
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPV 155

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTS 507
              +L + Q   R L YIH        H +IK   +LLD +     +  FG  + L    
Sbjct: 156 IYVKLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF-TQKCDVYSFGIVLLEILTGR 563
                  I +     R       Y APE  I+G+   T   DV+S G VL E+L G+
Sbjct: 212 PNV--SYICS-----RY------YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 35/154 (22%), Positives = 57/154 (37%), Gaps = 24/154 (15%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSF 125
               L+     +   M + L  L +   L+L++NN  K I ++L    NL  L L  N  
Sbjct: 26  EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRN-- 80

Query: 126 CGPIPDRIKTLKN-------LTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQI 178
                  IK ++N       L  L +S N +  SL   +  L  L   L +S N+ +   
Sbjct: 81  ------LIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR-VLYMSNNKIT-NW 130

Query: 179 PEMY--GHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
            E+        +  L L  N L  +  +  +   
Sbjct: 131 GEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 7/111 (6%)

Query: 91  LTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCG--PIPDRIKTLKNLTHLDLSSNL 148
           + + +   +            AT    ++L H        +   + TLK   HL LS+N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNN 59

Query: 149 LNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
           +       L  +  L   L+L  N    +I  +      +  L +  N ++
Sbjct: 60  I--EKISSLSGMENLR-ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 54.5 bits (132), Expect = 4e-08
 Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 33/172 (19%)

Query: 400 ARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA 456
              +HP +  LK   YA    ++L  + ++   G L+  L      +       AR   A
Sbjct: 60  QNTRHPFLTALK---YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE----RARFYGA 112

Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           +     L Y+H    R  V+ +IK   ++LD + H  I+ FGL        K   ++   
Sbjct: 113 E-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL-------CKEGISDGAT 161

Query: 517 TS---GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
                GT          YLAPE  +  + + +  D +  G+V+ E++ GRLP
Sbjct: 162 MKTFCGTPE--------YLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 32/110 (29%), Positives = 44/110 (40%), Gaps = 5/110 (4%)

Query: 65  NRVTSLYLPNRNLT-GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
           + V  L L N     G +         L  LS  +   +  I ANL     L  L+L+ N
Sbjct: 17  SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSDN 74

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLNG-SLPEFLLDLRALTGTLNLSFN 172
              G +    +   NLTHL+LS N +   S  E L  L  L  +L+L   
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK-SLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 4/83 (4%)

Query: 117 YLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSG 176
            LD + ++  G +       + L  L   +  L  S+   L  L  L   L LS N+ SG
Sbjct: 23  VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLK-KLELSDNRVSG 78

Query: 177 QIPEMYGHFPVMVSLDLRNNNLS 199
            +  +    P +  L+L  N + 
Sbjct: 79  GLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 22/83 (26%), Positives = 33/83 (39%), Gaps = 4/83 (4%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP-IPANLFNATNLVYLDLAHN 123
           N++  L L +  ++G +        +LT L+L+ N          L    NL  LDL + 
Sbjct: 64  NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

Query: 124 SFCGPIPDR---IKTLKNLTHLD 143
                   R    K L  LT+LD
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYLD 146

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 43/196 (21%), Positives = 81/196 (41%), Gaps = 28/196 (14%)

Query: 374 VVAVRR--LTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGS 431
           VVA+++   +   +  +++D   EV  + +++HPN ++ +  Y       L+ ++   GS
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGS 139

Query: 432 LYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELH 491
               L         PL       +  G  +GL Y+H       +H ++K+  ILL +   
Sbjct: 140 ASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGL 192

Query: 492 PCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDV 549
             +  FG        S +    + V  GT          ++APE    +   ++  K DV
Sbjct: 193 VKLGDFGS------ASIMAPANSFV--GT--------PYWMAPEVILAMDEGQYDGKVDV 236

Query: 550 YSFGIVLLEILTGRLP 565
           +S GI  +E+   + P
Sbjct: 237 WSLGITCIELAERKPP 252

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 27/198 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           +V V + T        +D + E      ++HP+IV L   Y ++    ++ +F+    L 
Sbjct: 56  IVDVAKFT-SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             +              A   + Q     L Y H+      +H ++K   +LL  + +  
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQ-ILEALRYCHD---NNIIHRDVKPHCVLLASKENSA 170

Query: 494 ---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKC 547
              + GFG+   L  +  V      V  GT          ++APE      YG    +  
Sbjct: 171 PVKLGGFGVAIQLGESGLVAG--GRV--GTPH--------FMAPEVVKREPYG----KPV 214

Query: 548 DVYSFGIVLLEILTGRLP 565
           DV+  G++L  +L+G LP
Sbjct: 215 DVWGCGVILFILLSGCLP 232

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 53.4 bits (129), Expect = 8e-08
 Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 30/181 (16%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
                EVE + ++ HPNI++L      +    ++ +    G L+  +      S      
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---- 121

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGT 506
           +A   I Q    G+ Y+H+      VH ++K   ILL   + +    I  FGL+      
Sbjct: 122 DAARIIKQ-VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           +K+      +  GT          Y+APE     Y     +KCDV+S G++L  +L+G  
Sbjct: 178 TKMK---DRI--GTAY--------YIAPEVLRGTYD----EKCDVWSAGVILYILLSGTP 220

Query: 565 P 565
           P
Sbjct: 221 P 221

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 53.4 bits (129), Expect = 9e-08
 Identities = 46/190 (24%), Positives = 82/190 (43%), Gaps = 45/190 (23%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKL---LIS-----DFI-RNGSLYAALHAGP 440
            + E+E+E + ++ HP I+++K F+ A D  +   L+      D +  N  L  A     
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEA----- 114

Query: 441 SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGF 497
                      +L   Q     + Y+HE      +H ++K   +LL  +   C   I+ F
Sbjct: 115 ---------TCKLYFYQ-MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161

Query: 498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIV 555
           G +++L  TS +    T+   GT +        YLAPE    +  + + +  D +S G++
Sbjct: 162 GHSKILGETSLMR---TLC--GTPT--------YLAPEVLVSVGTAGYNRAVDCWSLGVI 208

Query: 556 LLEILTGRLP 565
           L   L+G  P
Sbjct: 209 LFICLSGYPP 218

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 34/177 (19%), Positives = 71/177 (40%), Gaps = 28/177 (15%)

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGS-LYAALHAGPSDSLPPLPWE 450
             E+  ++RV+H NI+++    + N     L+ +   +G  L+A +   P    P     
Sbjct: 77  TLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----L 131

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
           A     Q     + Y+     +  +H +IK   I++ ++    +  FG        + + 
Sbjct: 132 ASYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS------AAYLE 181

Query: 511 KNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLP 565
           + +   T  GT          Y APE  + G+ +   + +++S G+ L  ++    P
Sbjct: 182 RGKLFYTFCGTIE--------YCAPEV-LMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 33/172 (19%)

Query: 400 ARVQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA 456
             V+HP IV L    YA     KL LI +++  G L+  L              A   +A
Sbjct: 76  EEVKHPFIVDLI---YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TACFYLA 128

Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           +  +  L ++H+   +  ++ ++K   I+L+ + H  ++ FGL        K + ++  V
Sbjct: 129 E-ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL-------CKESIHDGTV 177

Query: 517 TS---GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           T    GT          Y+APE  +  S   +  D +S G ++ ++LTG  P
Sbjct: 178 THTFCGTIE--------YMAPEI-LMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 27/177 (15%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKL------LISDFIRNGSLYAALHAGPSDSLPPLP 448
           E++ +  V+HPN+V LKAF+Y+N +K       L+ +++   ++Y A             
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTS 507
              +L + Q   R L YIH        H +IK   +LLD       +  FG  ++L    
Sbjct: 141 LLIKLYMYQ-LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

Query: 508 KVTKNETIVTSGTGSRISAISNVYLAPEARIYGSK-FTQKCDVYSFGIVLLEILTGR 563
                  I +     R       Y APE  I+G+  +T   D++S G V+ E++ G+
Sbjct: 197 PNV--SYICS-----RY------YRAPEL-IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 27/203 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            +  R+          ++ E EV  + +V H N++ L   Y    + +LI + +  G L+
Sbjct: 44  FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L    S S      EA   I Q    G+ Y+H    +K  H ++K   I+L D+  P 
Sbjct: 104 DFLAQKESLSEE----EATSFIKQ-ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155

Query: 494 ----ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               +  FGL   +    +      I   GT          ++APE  +       + D+
Sbjct: 156 PHIKLIDFGLAHEIEDGVEFK---NIF--GTPE--------FVAPEI-VNYEPLGLEADM 201

Query: 550 YSFGIVLLEILTGRLPDAGPEND 572
           +S G++   +L+G  P  G +  
Sbjct: 202 WSIGVITYILLSGASPFLG-DTK 223

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 2e-07
 Identities = 25/213 (11%), Positives = 55/213 (25%), Gaps = 26/213 (12%)

Query: 13  LFPAPLCFSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPCHWSGIHCIRNRVTSLYL 72
           +      +           +     +        W + D      S I      ++ +  
Sbjct: 112 ITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ--VDLSPVLD 169

Query: 73  PNRNLTGYMPSELGLL-------NSLTRLSLASNNFSKPIPANLFNA--TNLVYLDL--- 120
               L          L        +L  L + S      +  ++  +   NL  L L   
Sbjct: 170 AMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVG 229

Query: 121 AHNSFCGPIPDRI------KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTG--TLNLSFN 172
             +       +            NL  L +        + E  L+   L    T+++S  
Sbjct: 230 VEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289

Query: 173 QFSG----QIPEMYGHFPVMVSLDLRNNNLSGE 201
             +      + +       +  ++++ N LS E
Sbjct: 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 8e-06
 Identities = 27/144 (18%), Positives = 54/144 (37%), Gaps = 17/144 (11%)

Query: 64  RNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-------TNLV 116
              + S  LP+  +   + S+L  L  L  L +   ++      N+F          NL 
Sbjct: 197 SLEIISGGLPDSVVEDILGSDLPNLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 117 YLDLAHNSFCGPIPDRI---KTLKNLTHLDLSSNLLNGSLPEFLLD----LRALTGTLNL 169
           +L +        + +       L  L  +D+S+ +L       LLD    ++ L   +N+
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK-FINM 314

Query: 170 SFNQFSGQ-IPEMYGHFPVMVSLD 192
            +N  S +   E+    P+ + + 
Sbjct: 315 KYNYLSDEMKKELQKSLPMKIDVS 338

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 27/195 (13%)

Query: 377 VRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAA 435
               +  +     +    EV+ + +V  HPNI++LK  Y  N    L+ D ++ G L+  
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 114

Query: 436 LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCIS 495
           L    + S      E R  +       +  +H+      VH ++K   ILLDD+++  ++
Sbjct: 115 LTEKVTLSEK----ETRKIMRA-LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166

Query: 496 GFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE-----ARIYGSKFTQKCDVY 550
            FG +  L    K+     +   GT S        YLAPE            + ++ D++
Sbjct: 167 DFGFSCQLDPGEKLR---EVC--GTPS--------YLAPEIIECSMNDNHPGYGKEVDMW 213

Query: 551 SFGIVLLEILTGRLP 565
           S G+++  +L G  P
Sbjct: 214 STGVIMYTLLAGSPP 228

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 33/111 (29%), Positives = 46/111 (41%), Gaps = 7/111 (6%)

Query: 65  NRVTSLYLPNRNLT-GYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN 123
             V  L L N     G +        +L  LSL +      + +NL     L  L+L+ N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSEN 81

Query: 124 SFCGPIPDRIKTLKNLTHLDLSSNLLN--GSLPEFLLDLRALTGTLNLSFN 172
              G +    + L NLTHL+LS N L    +L E L  L  L  +L+L   
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLK-SLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 25/92 (27%), Positives = 34/92 (36%), Gaps = 5/92 (5%)

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTL 167
                  LV LD   ++  G I        NL  L L +  L  S+   L  L  L   L
Sbjct: 22  TPAAVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLK-KL 76

Query: 168 NLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
            LS N+  G +  +    P +  L+L  N L 
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 39.7 bits (93), Expect = 7e-04
 Identities = 21/82 (25%), Positives = 30/82 (36%), Gaps = 4/82 (4%)

Query: 66  RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP-IPANLFNATNLVYLDLAHNS 124
           ++  L L    + G +      L +LT L+L+ N          L     L  LDL +  
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE 131

Query: 125 FCGPIPDR---IKTLKNLTHLD 143
                  R    K L  LT+LD
Sbjct: 132 VTNLNDYRESVFKLLPQLTYLD 153

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 44/135 (32%), Positives = 62/135 (45%), Gaps = 13/135 (9%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
           T L L   +L          L SLT+L L  N     +P  +FN  T+L YL+L+ N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQL- 88

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGH 184
             +P+ +   L  L  L L++N L  SLP+ + D L  L   L L  NQ    +P+  G 
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK-DLRLYQNQLKS-VPD--GV 143

Query: 185 FPVMVSLD---LRNN 196
           F  + SL    L +N
Sbjct: 144 FDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 34/113 (30%), Positives = 49/113 (43%), Gaps = 7/113 (6%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHN 123
             +T LYL    L          L SLT L+L++N     +P  +F+  T L  L L  N
Sbjct: 52  TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTN 110

Query: 124 SFCGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
                +PD +   L  L  L L  N L  S+P+ + D L +L   + L  N +
Sbjct: 111 QL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQ-YIWLHDNPW 160

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 40/195 (20%)

Query: 395 EVEAIARVQHPNIVRLKAFY--YANDEKL-LISDFIRNGSL--YAALHAGPSDSLPPLPW 449
           E++ +   +HP+I++L   Y   +    + ++ +++  G L  Y   +    +       
Sbjct: 66  EIQNLKLFRHPHIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------ 116

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           E+R    Q  + G+ Y H       VH ++K   +LLD  ++  I+ FGL+ ++      
Sbjct: 117 ESRRLFQQILS-GVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM------ 166

Query: 510 TKNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLPDA 567
           +  E + TS G        S  Y APE  I G  +   + D++S G++L  +L G LP  
Sbjct: 167 SDGEFLRTSCG--------SPNYAAPEV-ISGRLYAGPEVDIWSSGVILYALLCGTLP-- 215

Query: 568 GPENDGKGLESLVRK 582
               D   + +L +K
Sbjct: 216 ---FDDDHVPTLFKK 227

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 51.0 bits (123), Expect = 4e-07
 Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 26/175 (14%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSL--YAALHAGPSDSLPPLPWEA 451
           E+     + H N+V+    +        L  ++   G L        G  +       +A
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------DA 107

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
           +    Q  A G++Y+H        H +IK   +LLD+  +  IS FGL  +    ++   
Sbjct: 108 QRFFHQLMA-GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLP 565
                  GT          Y+APE  +   +F  +  DV+S GIVL  +L G LP
Sbjct: 164 LNK--MCGTLP--------YVAPEL-LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 27/203 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            +  R+          ++ E EV  + +V HPNI+ L   Y    + +LI + +  G L+
Sbjct: 44  FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L     +SL     EA   I Q    G+ Y+H    +K  H ++K   I+L D+  P 
Sbjct: 104 DFLAQ--KESLSEE--EATSFIKQ-ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155

Query: 494 ----ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               +  FGL   +    +      I   GT          ++APE  +       + D+
Sbjct: 156 PHIKLIDFGLAHEIEDGVEFK---NIF--GTPE--------FVAPEI-VNYEPLGLEADM 201

Query: 550 YSFGIVLLEILTGRLPDAGPEND 572
           +S G++   +L+G  P  G +  
Sbjct: 202 WSIGVITYILLSGASPFLG-DTK 223

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 42/134 (31%), Positives = 55/134 (41%), Gaps = 12/134 (8%)

Query: 68  TSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFC 126
             LYL +  +T   P     L +L  L L SN     +P  +F++ T L  LDL  N   
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQL- 100

Query: 127 GPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHF 185
             +P  +   L +L  L +  N L   LP  +  L  LT  L L  NQ    IP   G F
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT-HLALDQNQLK-SIPH--GAF 155

Query: 186 PVMVSLD---LRNN 196
             + SL    L  N
Sbjct: 156 DRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 12/112 (10%)

Query: 92  TRLSLASNNFSKPIPANLFNA-TNLVYLDLAHN---SFCGPIPDRIKTLKNLTHLDLSSN 147
             L L  N  +K +   +F++  NL  L L  N   +    + D    L  LT LDL +N
Sbjct: 43  QILYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGALPVGVFDS---LTQLTVLDLGTN 98

Query: 148 LLNGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNL 198
            L   LP  + D L  L   L +  N+ +  +P        +  L L  N L
Sbjct: 99  QLT-VLPSAVFDRLVHLK-ELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 49.9 bits (120), Expect = 8e-07
 Identities = 35/181 (19%), Positives = 69/181 (38%), Gaps = 30/181 (16%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
             F+ E+E +  + HPNI+RL   +  N +  L+ +    G L+  +             
Sbjct: 51  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES---- 106

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGT 506
           +A   +       + Y H+       H ++K    L      +    +  FGL       
Sbjct: 107 DAARIMKD-VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGL------- 155

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRL 564
           +   K   ++ +  G+        Y++P+    +YG     +CD +S G+++  +L G  
Sbjct: 156 AARFKPGKMMRTKVGTPY------YVSPQVLEGLYG----PECDEWSAGVMMYVLLCGYP 205

Query: 565 P 565
           P
Sbjct: 206 P 206

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 49.9 bits (120), Expect = 9e-07
 Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 29/195 (14%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           ++  ++L+  D    F+  E E     ++QHPNIVRL           L+ D +  G L+
Sbjct: 38  IINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             + A    S      +A   I Q     + Y H       VH N+K   +LL  +    
Sbjct: 94  EDIVAREFYSEA----DASHCIQQ-ILESIAYCHS---NGIVHRNLKPENLLLASKAKGA 145

Query: 494 ---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVY 550
              ++ FGL   +  +            GT          YL+PE  +    +++  D++
Sbjct: 146 AVKLADFGLAIEVNDSEAWH---GFA--GTPG--------YLSPEV-LKKDPYSKPVDIW 191

Query: 551 SFGIVLLEILTGRLP 565
           + G++L  +L G  P
Sbjct: 192 ACGVILYILLVGYPP 206

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 55/205 (26%)

Query: 395 EVEAIARVQHPNIVRL-------KAFY----YANDEKLLISDFI-RNGSLYAALHAGPSD 442
           E+  +  ++HP+I++L               YA  E   + D+I     +          
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGE---LFDYIVEKKRMT--------- 106

Query: 443 SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL 502
                  E R    Q     + Y H     K VH ++K   +LLDD L+  I+ FGL+ +
Sbjct: 107 -----EDEGRRFFQQ-IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157

Query: 503 LPGTSKVTKNETIVTS-GTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEIL 560
           +      T    + TS G        S  Y APE  I G  +   + DV+S GIVL  +L
Sbjct: 158 M------TDGNFLKTSCG--------SPNYAAPEV-INGKLYAGPEVDVWSCGIVLYVML 202

Query: 561 TGRLPDAGPENDGKGLESLVRKAFR 585
            GRLP      D + + +L +K   
Sbjct: 203 VGRLP-----FDDEFIPNLFKKVNS 222

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 46/198 (23%), Positives = 74/198 (37%), Gaps = 35/198 (17%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           ++  ++L+  D    F+  E E     ++QHPNIVRL           L+ D +  G L+
Sbjct: 61  IINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDEL 490
             + A    S      +A   I Q     + Y H       VH N+K   +LL       
Sbjct: 117 EDIVAREFYSEA----DASHCIQQ-ILESIAYCHS---NGIVHRNLKPENLLLASKAKGA 168

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKC 547
              ++ FGL   +  +            GT          YL+PE      Y     +  
Sbjct: 169 AVKLADFGLAIEVNDSEAWH---GFA--GTPG--------YLSPEVLKKDPYS----KPV 211

Query: 548 DVYSFGIVLLEILTGRLP 565
           D+++ G++L  +L G  P
Sbjct: 212 DIWACGVILYILLVGYPP 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 26/175 (14%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSL--YAALHAGPSDSLPPLPWEA 451
           E+     + H N+V+    +        L  ++   G L        G  +       +A
Sbjct: 55  EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------DA 107

Query: 452 RLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTK 511
           +    Q  A G++Y+H        H +IK   +LLD+  +  IS FGL  +    ++   
Sbjct: 108 QRFFHQLMA-GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 512 NETIVTSGTGSRISAISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLP 565
              +   GT          Y+APE  +   +F  +  DV+S GIVL  +L G LP
Sbjct: 164 LNKMC--GTLP--------YVAPEL-LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 25/93 (26%), Positives = 35/93 (37%), Gaps = 4/93 (4%)

Query: 107 ANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
           A   NA     LDL        I +   TL     +D S N +   L +    LR L  T
Sbjct: 13  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLK-T 68

Query: 167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
           L ++ N+       +    P +  L L NN+L 
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 9/110 (8%)

Query: 66  RVTSLYLPNRNLTGYMPSELG-LLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
           R   L L    +   +   LG  L+    +   S+N  + +         L  L + +N 
Sbjct: 20  RDRELDLRGYKIP--VIENLGATLDQFDAIDF-SDNEIRKL-DGFPLLRRLKTLLVNNNR 75

Query: 125 FCGPIPDRIKTLKNLTHLDLSSNLLN--GSLPEFLLDLRALTGTLNLSFN 172
            C       + L +LT L L++N L   G L + L  L++LT  L +  N
Sbjct: 76  ICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLT-YLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 39.6 bits (93), Expect = 9e-04
 Identities = 18/84 (21%), Positives = 30/84 (35%), Gaps = 6/84 (7%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP-IPANLFNATNLVYLDLAHN 123
            R+ +L + N  +          L  LT L L +N+  +      L +  +L YL +  N
Sbjct: 64  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

Query: 124 SFCGPIPD-R---IKTLKNLTHLD 143
                    R   I  +  +  LD
Sbjct: 124 PVTN-KKHYRLYVIYKVPQVRVLD 146

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 46/178 (25%), Positives = 66/178 (37%), Gaps = 33/178 (18%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSL--YAALHAGPSDSLPPLPWEAR 452
           E+     ++HPNIVR K          +I ++   G L          S+       EAR
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED------EAR 119

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC--ISGFGLNRLLPGTSKVT 510
               Q  + G+ Y H     +  H ++K    LLD    P   I  FG        SK +
Sbjct: 120 FFFQQLLS-GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGY-------SKSS 168

Query: 511 KNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              +   S  G+        Y+APE    + Y  K     DV+S G+ L  +L G  P
Sbjct: 169 VLHSQPKSTVGTP------AYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYP 217

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 36/193 (18%)

Query: 390 KDFESEVEAIAR-VQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA-GP-SDSLPP 446
           +D   E+E + R  QHPNI+ LK  Y       ++++ ++ G L   +      S+    
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER--- 116

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC----ISGFGLNRL 502
              EA   +     + + Y+H    +  VH ++K + IL  DE        I  FG  + 
Sbjct: 117 ---EAS-AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEI 559
           L   + +    T     T +        ++APE    + Y       CD++S G++L  +
Sbjct: 170 LRAENGLLM--TPC--YTAN--------FVAPEVLERQGYD----AACDIWSLGVLLYTM 213

Query: 560 LTGRLPDAGPEND 572
           LTG  P A   +D
Sbjct: 214 LTGYTPFANGPDD 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 46/198 (23%), Positives = 76/198 (38%), Gaps = 34/198 (17%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
           ++  ++L+  D     +  E E      ++HPNIVRL           LI D +  G L+
Sbjct: 43  IINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDEL 490
             + A    S      +A   I Q     +++ H+      VH N+K   +LL       
Sbjct: 99  EDIVAREYYSEA----DASHCIQQ-ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGA 150

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKC 547
              ++ FGL   + G  +          GT          YL+PE      YG    +  
Sbjct: 151 AVKLADFGLAIEVEGEQQAWF--GFA--GTPG--------YLSPEVLRKDPYG----KPV 194

Query: 548 DVYSFGIVLLEILTGRLP 565
           D+++ G++L  +L G  P
Sbjct: 195 DLWACGVILYILLVGYPP 212

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 44/206 (21%), Positives = 75/206 (36%), Gaps = 53/206 (25%)

Query: 379 RLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALH 437
           RL+        +    E   + +V  HP+I+ L   Y ++    L+ D +R G L+  L 
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL- 191

Query: 438 AGPSDSLPPLPWEARLKIAQGT-----ARGLM--------YIHEYSPRKYVHGNIKSTKI 484
                              +        R +M        ++H       VH ++K   I
Sbjct: 192 -----------------TEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENI 231

Query: 485 LLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE-----ARIY 539
           LLDD +   +S FG +  L    K+     +   GT          YLAPE         
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLR---ELC--GTPG--------YLAPEILKCSMDET 278

Query: 540 GSKFTQKCDVYSFGIVLLEILTGRLP 565
              + ++ D+++ G++L  +L G  P
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPP 304

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 31/168 (18%)

Query: 403 QHPNIVRLK-AFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
            HP + +L   F     ++L  + +F+  G L   +              AR   A+   
Sbjct: 82  NHPFLTQLFCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----RARFYAAE-II 134

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS-- 518
             LM++H+   +  ++ ++K   +LLD E H  ++ FG+        K      + T+  
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM-------CKEGICNGVTTATF 184

Query: 519 -GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            GT          Y+APE  +    +    D ++ G++L E+L G  P
Sbjct: 185 CGTPD--------YIAPEI-LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 29/168 (17%)

Query: 402 VQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
             HP +V L    +  + +L  + +++  G L   +              AR   A+  +
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAE-IS 163

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS-- 518
             L Y+HE   R  ++ ++K   +LLD E H  ++ +G+        K        TS  
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTSTF 213

Query: 519 -GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            GT +        Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 214 CGTPN--------YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 29/167 (17%)

Query: 403 QHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTAR 461
           + P + +L    +   ++L  + +++  G L   +        P     A    A+  A 
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-IAI 453

Query: 462 GLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS--- 518
           GL ++     +  ++ ++K   ++LD E H  I+ FG+        K    + + T    
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-------CKENIWDGVTTKTFC 503

Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           GT          Y+APE  I    + +  D ++FG++L E+L G+ P
Sbjct: 504 GTPD--------YIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 37/172 (21%)

Query: 402 VQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           V+HP +V L    ++    +KL  + D+I  G L+  L        P     AR   A+ 
Sbjct: 96  VKHPFLVGLH---FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAE- 147

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK--VTKNETIV 516
            A  L Y+H       V+ ++K   ILLD + H  ++ FGL        K  +  N T  
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL-------CKENIEHNST-- 195

Query: 517 TS---GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
           TS   GT          YLAPE  ++   + +  D +  G VL E+L G  P
Sbjct: 196 TSTFCGTPE--------YLAPEV-LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.9 bits (112), Expect = 3e-06
 Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 8/111 (7%)

Query: 68  TSLYLPNRNLTGYMPSEL-GLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLDLAHNSF 125
           T L L +  L       L G L  L +L L  N  +  I  N F  A+++  L L  N  
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90

Query: 126 CGPIPDRI-KTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
              I +++   L  L  L+L  N ++  +     + L +LT +LNL+ N F
Sbjct: 91  -KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLT-SLNLASNPF 138

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 29/168 (17%)

Query: 402 VQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTA 460
             HP +V L    +  + +L  + +++  G L   +              AR   A+  +
Sbjct: 67  SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAE-IS 120

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS-- 518
             L Y+HE   R  ++ ++K   +LLD E H  ++ +G+        K        TS  
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM-------CKEGLRPGDTTSTF 170

Query: 519 -GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            GT +        Y+APE  + G  +    D ++ G+++ E++ GR P
Sbjct: 171 CGTPN--------YIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 47.9 bits (115), Expect = 4e-06
 Identities = 45/194 (23%), Positives = 80/194 (41%), Gaps = 33/194 (17%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            +  RRL+        ++ E EV  +  ++HPNI+ L   +    + +LI + +  G L+
Sbjct: 37  FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC 493
             L     +SL     EA   + Q    G+ Y+H    ++  H ++K   I+L D+  P 
Sbjct: 97  DFLAE--KESLTED--EATQFLKQ-ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPN 148

Query: 494 ----ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQK 546
               +  FG+   +   ++      I   GT          ++APE       G     +
Sbjct: 149 PRIKLIDFGIAHKIEAGNEFK---NIF--GTPE--------FVAPEIVNYEPLG----LE 191

Query: 547 CDVYSFGIVLLEIL 560
            D++S G V+  IL
Sbjct: 192 ADMWSIG-VITYIL 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 43/220 (19%), Positives = 70/220 (31%), Gaps = 41/220 (18%)

Query: 360 KVVVGRGSGMGAPTVVAV-----RRLTEGDATWRFKDFESEVEAIARV----QHPNIVRL 410
            V  G          VA+      R+              EV  + +V     HP ++RL
Sbjct: 46  TVFAGHRLTDRLQ--VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 411 KAFYYANDEKLLISDFIRNGS-L--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
             ++   +  +L+ +       L  Y        +        +R          + + H
Sbjct: 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG------PSR-CFFGQVVAAIQHCH 156

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
               R  VH +IK   IL+D       +  FG   LL               GT      
Sbjct: 157 S---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD------FDGT------ 201

Query: 527 ISNVYLAPEARIYGSKFT-QKCDVYSFGIVLLEILTGRLP 565
              VY  PE  I   ++      V+S GI+L +++ G +P
Sbjct: 202 --RVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 33/170 (19%)

Query: 402 VQHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
            +HP +  +          E L  + +++  G L   + +     L      A    A+ 
Sbjct: 75  WEHPFLTHMF---CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAAE- 126

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
              GL ++H    +  V+ ++K   ILLD + H  I+ FG+        K        T+
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM-------CKENMLGDAKTN 176

Query: 519 ---GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              GT          Y+APE  + G K+    D +SFG++L E+L G+ P
Sbjct: 177 TFCGTPD--------YIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 34/183 (18%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
              E+E+  + +++H NIV L+  Y +     L+   +  G L+  +      +      
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK---- 106

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGT 506
           +A L I Q     + Y+HE      VH ++K   +L    ++     I+ FGL       
Sbjct: 107 DASLVIQQ-VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGL------- 155

Query: 507 SKVTKNETIVTS-GTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTG 562
           SK+ +N  + T+ GT          Y+APE    + Y     +  D +S G++   +L G
Sbjct: 156 SKMEQNGIMSTACGTPG--------YVAPEVLAQKPYS----KAVDCWSIGVITYILLCG 203

Query: 563 RLP 565
             P
Sbjct: 204 YPP 206

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 47.7 bits (114), Expect = 6e-06
 Identities = 38/203 (18%), Positives = 70/203 (34%), Gaps = 37/203 (18%)

Query: 375 VAV-----RRLTEGDATWRFKDFESEVEAIARVQH--PNIVRLKAFYYANDEKLLISDFI 427
           VA+      R+++            EV  + +V      ++RL  ++   D  +LI +  
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130

Query: 428 RN-GSL--YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKI 484
                L  +        +        AR          + + H       +H +IK   I
Sbjct: 131 EPVQDLFDFITERGALQEE------LAR-SFFWQVLEAVRHCHN---CGVLHRDIKDENI 180

Query: 485 LLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
           L+D       +  FG          + K+        G+R      VY  PE  I   ++
Sbjct: 181 LIDLNRGELKLIDFGS-------GALLKDTVYTDF-DGTR------VYSPPEW-IRYHRY 225

Query: 544 T-QKCDVYSFGIVLLEILTGRLP 565
             +   V+S GI+L +++ G +P
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIP 248

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 38/230 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMG-APTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
            +G    G++++V   R +G   A   V     ++       +    E++ ++ ++HP +
Sbjct: 164 ELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESD------KETVRKEIQTMSVLRHPTL 216

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V L   +  ++E ++I +F+  G L+  + A   + +     EA   + Q   +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSED--EAVEYMRQ-VCKGLCHMH 272

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCI--SGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           E     YVH ++K   I+   +    +    FGL   L     V      VT+GT     
Sbjct: 273 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-----VTTGTAE--- 321

Query: 526 AISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                + APE    +  G       D++S G++   +L+G  P  G END
Sbjct: 322 -----FAAPEVAEGKPVG----YYTDMWSVGVLSYILLSGLSPFGG-END 361

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 47.2 bits (113), Expect = 8e-06
 Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 27/203 (13%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLY 433
            +  RR          +D E EV  +  +QHPN++ L   Y    + +LI + +  G L+
Sbjct: 43  FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102

Query: 434 AALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP- 492
             L     +SL     EA   + Q    G+ Y+H     +  H ++K   I+L D   P 
Sbjct: 103 DFLAE--KESLTEE--EATEFLKQ-ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPK 154

Query: 493 ---CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FGL   +   ++      I   GT          ++APE  +       + D+
Sbjct: 155 PRIKIIDFGLAHKIDFGNEFK---NIF--GTPE--------FVAPEI-VNYEPLGLEADM 200

Query: 550 YSFGIVLLEILTGRLPDAGPEND 572
           +S G++   +L+G  P  G +  
Sbjct: 201 WSIGVITYILLSGASPFLG-DTK 222

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 35/188 (18%), Positives = 69/188 (36%), Gaps = 37/188 (19%)

Query: 390 KDFESEVEAIARVQ-HPNIVRLKAFY----YANDEKLLISDFIRNGSLYAALHAGPSDSL 444
                EV+   +    P+IV +   Y    +     L+I + +  G L++ +      + 
Sbjct: 66  PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125

Query: 445 PPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNR 501
                EA  +I +     + ++H        H ++K   +L    + +    ++ FG   
Sbjct: 126 TER--EAA-EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF-- 177

Query: 502 LLPGTSKVTKNETIVTS-GTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLL 557
                +K T    + T   T          Y+APE      Y     + CD++S G+++ 
Sbjct: 178 -----AKETTQNALQTPCYTPY--------YVAPEVLGPEKYD----KSCDMWSLGVIMY 220

Query: 558 EILTGRLP 565
            +L G  P
Sbjct: 221 ILLCGFPP 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 26/173 (15%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
           +E   +  V  P +V+L+ F + ++  L ++ +++  G +++ L      S P     AR
Sbjct: 90  NEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP----HAR 144

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
              AQ       Y+H       ++ ++K   +L+D + +  ++ FG        +K  K 
Sbjct: 145 FYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF-------AKRVKG 193

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
            T    GT           LAPE  I    + +  D ++ G+++ E+  G  P
Sbjct: 194 RTWTLCGTPE--------ALAPEI-ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 37/169 (21%), Positives = 70/169 (41%), Gaps = 31/169 (18%)

Query: 402 VQHPNIVRLK-AFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
            + P + +L   F     ++L  + +++  G L   +        P     A    A+  
Sbjct: 78  GKPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAE-I 130

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS- 518
           A GL ++     +  ++ ++K   ++LD E H  I+ FG+        K    + + T  
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM-------CKENIWDGVTTKT 180

Query: 519 --GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             GT          Y+APE  I    + +  D ++FG++L E+L G+ P
Sbjct: 181 FCGTPD--------YIAPEI-IAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 46.4 bits (111), Expect = 2e-05
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 32/176 (18%)

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAAL-HAG--PSDSLPPLPW 449
            E   ++ V HP I+R+    + + +++ +I D+I  G L++ L  +   P+        
Sbjct: 55  DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP------- 106

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
            A+   A+     L Y+H    +  ++ ++K   ILLD   H  I+ FG        +K 
Sbjct: 107 VAKFYAAE-VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGF-------AKY 155

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
             + T    GT          Y+APE  +    + +  D +SFGI++ E+L G  P
Sbjct: 156 VPDVTYTLCGTPD--------YIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 49/242 (20%), Positives = 94/242 (38%), Gaps = 34/242 (14%)

Query: 343 LRASAYVVGKSKNGIMYKVVVGR--GSGMGAPTVVAVRRLTEGDATWRF-------KDFE 393
           L    ++ G +++ +     V    G G  +      ++ T+     +        K   
Sbjct: 37  LVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR 96

Query: 394 SEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
           +E+  + R+ HPNI++LK  +    E  L+ + +  G L+  +      S      +A  
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER----DAAD 152

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGTSKVT 510
            + Q     + Y+HE      VH ++K   +L      +    I+ FGL++++     + 
Sbjct: 153 AVKQ-ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPE 570
              T+   GT          Y APE  + G  +  + D++S GI+   +L G  P     
Sbjct: 209 ---TVC--GTPG--------YCAPEI-LRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

Query: 571 ND 572
            D
Sbjct: 255 GD 256

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 31/193 (16%)

Query: 390 KDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLP 448
            + + E+ A+   + HPNIV+L   ++      L+ + +  G L+  +      S     
Sbjct: 50  ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS----E 105

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPG 505
            EA   I +     + ++H+      VH ++K   +L  DE       I  FG  RL P 
Sbjct: 106 TEAS-YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTG 562
            ++  K  T     T          Y APE      Y     + CD++S G++L  +L+G
Sbjct: 162 DNQPLK--TPC--FTLH--------YAAPELLNQNGYD----ESCDLWSLGVILYTMLSG 205

Query: 563 RLPDAGPENDGKG 575
           ++P    +     
Sbjct: 206 QVPFQSHDRSLTC 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 29/206 (14%), Positives = 66/206 (32%), Gaps = 53/206 (25%)

Query: 395 EVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR-- 452
           E++ +  + H NI++L  ++Y   ++        +            ++           
Sbjct: 50  ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109

Query: 453 ----------------------LKIAQG------------TARGLMYIHEYSPRKYVHGN 478
                                 ++  +               R + +IH        H +
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRD 166

Query: 479 IKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEAR 537
           IK   +L++ + +   +  FG  + L  +        I +     R       Y APE  
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--AYICS-----RF------YRAPELM 213

Query: 538 IYGSKFTQKCDVYSFGIVLLEILTGR 563
           +  +++T   D++S G V  E++ G+
Sbjct: 214 LGATEYTPSIDLWSIGCVFGELILGK 239

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 39/111 (35%), Positives = 49/111 (44%), Gaps = 13/111 (11%)

Query: 92  TRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSFCGPIPDRI-KTLKNLTHLDLSSNLL 149
           TRL L SN     +P  +F+  T L  L L+ N     +PD +   L  LT L L  N L
Sbjct: 31  TRLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKL 88

Query: 150 NGSLPEFLLD-LRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLD---LRNN 196
             SLP  + D L  L   L L  NQ    +P+  G F  + SL    L  N
Sbjct: 89  Q-SLPNGVFDKLTQLK-ELALDTNQLKS-VPD--GIFDRLTSLQKIWLHTN 134

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 33/189 (17%)

Query: 391 DFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
               EVE + + Q H N++ L  F+   D   L+ + +R GS+ + +H     +      
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN----EL 111

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC---ISGFGLNRLLPGT 506
           EA   + Q  A  L ++H    +   H ++K   IL +         I  F L       
Sbjct: 112 EAS-VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL------- 160

Query: 507 SKVTKNETIVTSGTGSRISAI--SNVYLAPE--------ARIYGSKFTQKCDVYSFGIVL 556
               K     +  +   +     S  Y+APE        A IY     ++CD++S G++L
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD----KRCDLWSLGVIL 216

Query: 557 LEILTGRLP 565
             +L+G  P
Sbjct: 217 YILLSGYPP 225

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 44/200 (22%)

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
            G+ ++H       +H ++K + I++  +    I  FGL R    +  +T    +VT   
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--PYVVT--- 189

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG------------ 568
             R       Y APE  I G  + +  D++S G ++ E++ G +   G            
Sbjct: 190 --RY------YRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240

Query: 569 -----PENDGKGLESLVRK-----AFRERRPLSEVIDPALVKEIHAKRQVLATFHIAL-- 616
                     K L+  VR               ++    L        ++ A+    L  
Sbjct: 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300

Query: 617 NCTELDPEFRPRMRTVSESL 636
               +D   R    +V E+L
Sbjct: 301 KMLVIDASKRI---SVDEAL 317

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 37/200 (18%), Positives = 71/200 (35%), Gaps = 44/200 (22%)

Query: 461 RGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGT 520
            G+ ++H       +H ++K + I++  +    I  FGL R    +  +T    +VT   
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT--PYVVT--- 226

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAG------------ 568
             R       Y APE  I G  + +  D++S G ++ E++  ++   G            
Sbjct: 227 --RY------YRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277

Query: 569 -----PENDGKGLESLVRK-----AFRERRPLSEVIDPALVKEIHAKRQVLATFHIAL-- 616
                     K L+  VR               ++   +L        ++ A+    L  
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337

Query: 617 NCTELDPEFRPRMRTVSESL 636
               +DP  R    +V ++L
Sbjct: 338 KMLVIDPAKRI---SVDDAL 354

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 26/186 (13%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHA-GPSDSLPPLP 448
              ++E+  + ++ HP ++ L   +    E +LI +F+  G L+  + A     S     
Sbjct: 93  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA--- 149

Query: 449 WEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL-DDELHPC-ISGFGLNRLLPGT 506
            E    + Q    GL ++HE      VH +IK   I+    +     I  FGL   L   
Sbjct: 150 -EVINYMRQ-ACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD 566
             V      VT+ T          + APE  +         D+++ G++   +L+G  P 
Sbjct: 205 EIVK-----VTTATAE--------FAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

Query: 567 AGPEND 572
           AG E+D
Sbjct: 251 AG-EDD 255

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 38/173 (21%)

Query: 403 QHPNIVRLKAFYYA--NDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
           Q P +V L   +YA   + KL LI D+I  G L+  L      +      E ++ + +  
Sbjct: 117 QSPFLVTL---HYAFQTETKLHLILDYINGGELFTHLSQRERFTEH----EVQIYVGE-I 168

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV-TKNETIVTS 518
              L ++H+      ++ +IK   ILLD   H  ++ FGL       SK    +ET    
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL-------SKEFVADETERAY 218

Query: 519 ---GTGSRISAISNVYLAPE---ARIYGSKFTQKCDVYSFGIVLLEILTGRLP 565
              GT          Y+AP+       G    +  D +S G+++ E+LTG  P
Sbjct: 219 DFCGTIE--------YMAPDIVRGGDSG--HDKAVDWWSLGVLMYELLTGASP 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 37/191 (19%), Positives = 73/191 (38%), Gaps = 29/191 (15%)

Query: 374 VVAVRRLTEGDATWRFKDFESEVEAIARVQH-PNIVRLKAFYYANDEKLLISDFIRNGSL 432
            +  RR  +        +   E+  +   +  P ++ L   Y    E +LI ++   G +
Sbjct: 61  FLKKRRRGQDCR----AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116

Query: 433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP 492
           ++      ++ +     +    I Q    G+ Y+H+      VH ++K   ILL      
Sbjct: 117 FSLCLPELAEMVSEN--DVIRLIKQ-ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPL 170

Query: 493 C---ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDV 549
               I  FG++R +    ++     I+  GT          YLAPE  +     T   D+
Sbjct: 171 GDIKIVDFGMSRKIGHACELR---EIM--GTPE--------YLAPEI-LNYDPITTATDM 216

Query: 550 YSFGIVLLEIL 560
           ++ G ++  +L
Sbjct: 217 WNIG-IIAYML 226

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 39/189 (20%), Positives = 83/189 (43%), Gaps = 32/189 (16%)

Query: 390 KDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPW 449
           ++ ++E+  + ++ H N+++L   + + ++ +L+ +++  G L+  +     +S      
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTEL 187

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL----DDELHPCISGFGLNRLLPG 505
           +  L + Q    G+ ++H+      +H ++K   IL       ++   I  FGL R    
Sbjct: 188 DTILFMKQ-ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIK--IIDFGLARRYKP 241

Query: 506 TSKVTKNETIVTSGTGSRISAISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGR 563
             K+      V  GT          +LAPE     + S      D++S G++   +L+G 
Sbjct: 242 REKLK-----VNFGTPE--------FLAPEVVNYDFVSF---PTDMWSVGVIAYMLLSGL 285

Query: 564 LPDAGPEND 572
            P  G +ND
Sbjct: 286 SPFLG-DND 293

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 4e-04
 Identities = 43/364 (11%), Positives = 93/364 (25%), Gaps = 114/364 (31%)

Query: 311 TNDAVLVTDEEEGQKGKFFIIDE---GFSL-ELEDLLRASAYVVGKSKNGIMYKVVVGRG 366
           T     VTD           +D      +  E++ LL      +      +  +V+    
Sbjct: 272 TRFKQ-VTDFLSAATTTHISLDHHSMTLTPDEVKSLL---LKYLDCRPQDLPREVL---- 323

Query: 367 SGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL--LIS 424
                P  +++                     IA      +     + + N +KL  +I 
Sbjct: 324 --TTNPRRLSI---------------------IAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 425 DFIRN------GSLYAALHAGPSDSLPPLP-----W------EARLKIAQGTARGLMYIH 467
             +          ++  L   P  +  P       W      +  + + +     L+   
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 468 EYSPRKYVHGNIKSTKILLDDE--LH-PCISGFGLNRLLPGTSKVTKNET---------- 514
                  +       K+ L++E  LH   +  + + +       +               
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480

Query: 515 IVTSGTGSRISAISNVYL-----------------APEA--------RIYGSKFTQKCDV 549
           +       R++    V+L                 A  +        + Y          
Sbjct: 481 LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPK 540

Query: 550 YSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKE-----IHA 604
           Y     L+  +   LP           E+L+          ++++  AL+ E       A
Sbjct: 541 YE---RLVNAILDFLPKIE--------ENLICS------KYTDLLRIALMAEDEAIFEEA 583

Query: 605 KRQV 608
            +QV
Sbjct: 584 HKQV 587

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 34/144 (23%), Positives = 54/144 (37%), Gaps = 16/144 (11%)

Query: 58  SGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNA-TNLV 116
                         L  +++T    ++  L NS+ ++   +N+  K +         N+ 
Sbjct: 15  DDAFA---ETIKANLKKKSVTD-AVTQNEL-NSIDQIIA-NNSDIKSVQG--IQYLPNVR 66

Query: 117 YLDLAHNSFCG-PIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLD-LRALTGTLNLSFNQF 174
           YL L  N             L NLT+L L+ N L  SLP  + D L  L   L L  NQ 
Sbjct: 67  YLALGGNKLHDISALKE---LTNLTYLILTGNQLQ-SLPNGVFDKLTNLK-ELVLVENQL 121

Query: 175 SGQIPEMYGHFPVMVSLDLRNNNL 198
                 ++     +  L+L +N L
Sbjct: 122 QSLPDGVFDKLTNLTYLNLAHNQL 145

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 26/127 (20%), Positives = 48/127 (37%), Gaps = 18/127 (14%)

Query: 90  SLTRLSLASNNFSKPIPANLFNA-----TNLVYLDLAHNSF----CGPIPDRIKTL-KNL 139
           S+T L+L  N+        L         N+  L+L  N+     C  +   + ++  ++
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV 198

Query: 140 THLDLSSNLLNGS----LPEFLLDLRALTGTLNLSFNQFSGQ----IPEMYGHFPVMVSL 191
           T LDLS+NLL       L      +     +LNL  N   G     +  +      + ++
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTV 258

Query: 192 DLRNNNL 198
            L  + +
Sbjct: 259 YLDYDIV 265

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 28/167 (16%), Positives = 49/167 (29%), Gaps = 40/167 (23%)

Query: 431 SLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL 490
            L   +          LP     KI Q   +GL Y+H  +  + +H +IK   ILL    
Sbjct: 130 HLLKWIIKSNYQ---GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE 184

Query: 491 HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISN--------------------- 529
                          +     + + V++   +  + + N                     
Sbjct: 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC 244

Query: 530 -------------VYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                         Y + E  I GS +    D++S   +  E+ TG 
Sbjct: 245 WVHKHFTEDIQTRQYRSLEVLI-GSGYNTPADIWSTACMAFELATGD 290

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	642
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-41
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-40
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-37
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-36
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-35
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-33
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-33
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-29
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-27
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-27
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-24
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-24
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-23
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-23
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-17
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.001
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 8e-44
 Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 41/295 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNI 407
            +G    G +YK              VAV+ L        + + F++EV  + + +H NI
Sbjct: 15  RIGSGSFGTVYKGKWHGD--------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           +    +     +  +++ +    SLY  LH   +           + IA+ TA+G+ Y+H
Sbjct: 67  LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLH 121

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
               +  +H ++KS  I L ++L   I  FGL  +    S   + E +   G+       
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL----- 171

Query: 528 SNVYLAPEARIYGSK--FTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
              ++APE      K  ++ + DVY+FGIVL E++TG+LP +   N  + +  + R    
Sbjct: 172 ---WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--- 225

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
              P    +     K +           +   C +   + RP    +  S++ + 
Sbjct: 226 YLSPDLSKVRSNCPKAMK---------RLMAECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-42
 Identities = 60/312 (19%), Positives = 112/312 (35%), Gaps = 41/312 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +GK + G +++   G+  G      VAV+  +  +   R    E+E+     ++H NI+
Sbjct: 10  SIGKGRFGEVWR---GKWRG----EEVAVKIFSSREE--RSWFREAEIYQTVMLRHENIL 60

Query: 409 RLKAFYYANDEKL----LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
              A    ++       L+SD+  +GSL+  L+         +  E  +K+A  TA GL 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLA 114

Query: 465 YIHE-----YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
           ++H             H ++KS  IL+      CI+  GL       +           G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 520 TGSRISAISNVYLAPEA-----RIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
           T          Y+APE       +   +  ++ D+Y+ G+V  EI          E+   
Sbjct: 175 T--------KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226

Query: 575 GLESLVRKAFRE----RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
               LV          +    + + P +     +   +     I   C   +   R    
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286

Query: 631 TVSESLDRVKLQ 642
            + ++L ++  Q
Sbjct: 287 RIKKTLSQLSQQ 298

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-41
 Identities = 72/311 (23%), Positives = 129/311 (41%), Gaps = 57/311 (18%)

Query: 334 GFSLELED--LLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD 391
           G++L +++  LL+     +GK + G +      RG        VAV+ +         + 
Sbjct: 1   GWALNMKELKLLQ----TIGKGEFGDVMLGDY-RG------NKVAVKCIKNDATA---QA 46

Query: 392 FESEVEAIARVQHPNIVRLKAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWE 450
           F +E   + +++H N+V+L          L ++++++  GSL   L    S     L  +
Sbjct: 47  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGD 103

Query: 451 ARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVT 510
             LK +      + Y+       +VH ++ +  +L+ ++    +S FGL +    T    
Sbjct: 104 CLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160

Query: 511 KNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGP 569
           K               +   + APEA +   KF+ K DV+SFGI+L EI + GR+P   P
Sbjct: 161 K---------------LPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPY--P 202

Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
               K +   V K ++   P  +   PA+ +             +  NC  LD   RP  
Sbjct: 203 RIPLKDVVPRVEKGYKMDAP--DGCPPAVYE-------------VMKNCWHLDAAMRPSF 247

Query: 630 RTVSESLDRVK 640
             + E L+ +K
Sbjct: 248 LQLREQLEHIK 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 6e-41
 Identities = 60/309 (19%), Positives = 110/309 (35%), Gaps = 49/309 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+   G +++            T+VAV+ L E  +     DF+ E   +A   +PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAG-------------------PSDSLPPLPW 449
           +L           L+ +++  G L   L +                     S   PPL  
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
             +L IA+  A G+ Y+ E    K+VH ++ +   L+ + +   I+ FGL+R +      
Sbjct: 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP 569
             +                 +   P   I+ +++T + DV+++G+VL EI +  L     
Sbjct: 197 KADGNDAIP-----------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 570 ENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRM 629
               + +  +            E     L              ++   C    P  RP  
Sbjct: 246 MAHEEVIYYVRDG---NILACPENCPLELY-------------NLMRLCWSKLPADRPSF 289

Query: 630 RTVSESLDR 638
            ++   L R
Sbjct: 290 CSIHRILQR 298

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 7e-41
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 43/289 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G  + G ++             T VAV+ L +G  +     F +E   + ++QH  +V
Sbjct: 20  RLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLV 71

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           RL A     +   +I++++ NGSL   L          L     L +A   A G+ +I E
Sbjct: 72  RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              R Y+H ++++  IL+ D L   I+ FGL RL+       +                 
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK--------- 175

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             + APEA I    FT K DV+SFGI+L EI+T       P      +   + + +R  R
Sbjct: 176 --WTAPEA-INYGTFTIKSDVWSFGILLTEIVTHGRI-PYPGMTNPEVIQNLERGYRMVR 231

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           P  +     L               +   C +  PE RP    +   L+
Sbjct: 232 P--DNCPEELY-------------QLMRLCWKERPEDRPTFDYLRSVLE 265

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 63/309 (20%), Positives = 107/309 (34%), Gaps = 50/309 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
           V+G    G +        S  G    VAV+ L E   +   +   SE++ + ++  H NI
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHA------------------GPSDSLPPLPW 449
           V L      +    LI ++   G L   L +                     + L  L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 450 EARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKV 509
           E  L  A   A+G+ ++     +  VH ++ +  +L+       I  FGL R +   S  
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 510 TKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAG 568
                                ++APE  ++   +T K DV+S+GI+L EI + G  P  G
Sbjct: 221 VVRGNARLPVK----------WMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 569 PENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR 628
                     L++  F+  +P        +               I  +C   D   RP 
Sbjct: 270 -IPVDANFYKLIQNGFKMDQP--FYATEEIY-------------IIMQSCWAFDSRKRPS 313

Query: 629 MRTVSESLD 637
              ++  L 
Sbjct: 314 FPNLTSFLG 322

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-40
 Identities = 52/291 (17%), Positives = 107/291 (36%), Gaps = 43/291 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G  + G+++               VA++ + EG  +   +DF  E E + ++ HP +V
Sbjct: 12  EIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLV 63

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L           L+ +F+ +G L   L             E  L +      G+ Y+ E
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                 +H ++ +   L+ +     +S FG+ R +      +   T              
Sbjct: 120 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--------- 167

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             + +PE     S+++ K DV+SFG+++ E+ +         ++ + +E  +   FR  +
Sbjct: 168 --WASPEV-FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-DISTGFRLYK 223

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           P   +    +               I  +C +  PE RP    +   L  +
Sbjct: 224 P--RLASTHVY-------------QIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (369), Expect = 5e-40
 Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 35/292 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G  + G +    +           VA++ L  G    + +DF SE   + +  HPN++
Sbjct: 33  VIGAGEFGEVCSGHLKLPGKREI--FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 90

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L+     +   ++I++F+ NGSL + L      +         + + +G A G+ Y+  
Sbjct: 91  HLEGVVTKSTPVMIITEFMENGSLDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLA- 145

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                YVH ++ +  IL++  L   +S FGL+R L        ++T   + T +    I 
Sbjct: 146 --DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE-------DDTSDPTYTSALGGKIP 196

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER 587
             + APEA I   KFT   DV+S+GIV+ E+++ G  P     N  + + + + + +R  
Sbjct: 197 IRWTAPEA-IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQDYRLP 253

Query: 588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
            P+      AL               + L+C + D   RP+   +  +LD++
Sbjct: 254 PPMD--CPSALH-------------QLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-40
 Identities = 58/316 (18%), Positives = 113/316 (35%), Gaps = 44/316 (13%)

Query: 336 SLELEDLLRASAYVVGKSKNGIMYKVVVGRGS-----------GMGAPTVVAVRRLTEGD 384
           +L  E +      V+G S   + +  V+GRG              G     AV+ L    
Sbjct: 8   ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67

Query: 385 ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEK-LLISDFIRNGSLYAALHAGPSDS 443
                  F +E   +    HPN++ L      ++   L++  ++++G L   +       
Sbjct: 68  DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--- 124

Query: 444 LPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL 503
                 +  +      A+G+ ++     +K+VH ++ +   +LD++    ++ FGL R +
Sbjct: 125 -HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180

Query: 504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR 563
                 + +                  ++A E+ +   KFT K DV+SFG++L E++T  
Sbjct: 181 YDKEFDSVHNKTGAKLPVK--------WMALES-LQTQKFTTKSDVWSFGVLLWELMTRG 231

Query: 564 LPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDP 623
                P         +     + RR L     P  + E            + L C     
Sbjct: 232 ----APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE------------VMLKCWHPKA 275

Query: 624 EFRPRMRTVSESLDRV 639
           E RP    +   +  +
Sbjct: 276 EMRPSFSELVSRISAI 291

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 6e-39
 Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 34/290 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G  + G +YK ++ + S       VA++ L  G    +  DF  E   + +  H NI+
Sbjct: 14  VIGAGEFGEVYKGML-KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           RL+         ++I++++ NG+L   L     +          + + +G A G+ Y+  
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                YVH ++ +  IL++  L   +S FGL+R+L    + T   +              
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------- 178

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             + APEA I   KFT   DV+SFGIV+ E++T         ++ + ++++       R 
Sbjct: 179 --WTAPEA-ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRL 232

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR 638
           P       A+               + + C + +   RP+   +   LD+
Sbjct: 233 PTPMDCPSAIY-------------QLMMQCWQQERARRPKFADIVSILDK 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-39
 Identities = 60/294 (20%), Positives = 111/294 (37%), Gaps = 29/294 (9%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G    G+++KV   + SG     V+A + +              E++ +     P IV
Sbjct: 13  ELGAGNGGVVFKVSH-KPSG----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                +Y++ E  +  + +  GSL   L          +P +   K++    +GL Y+  
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR- 121

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               K +H ++K + IL++      +  FG++  L         +++  S  G+R     
Sbjct: 122 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------DSMANSFVGTRS---- 168

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGP--ENDGKGLESLVRKAFRE 586
             Y++PE R+ G+ ++ + D++S G+ L+E+  GR P   P  +         V     E
Sbjct: 169 --YMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
             P        L       R  +A F +        P   P      E  D V 
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 58/311 (18%), Positives = 115/311 (36%), Gaps = 47/311 (15%)

Query: 327 KFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT 386
           K F+  +   +   +L        G    G + + V  R         VA++ L +G   
Sbjct: 2   KLFLKRDNLLIADIEL--------GCGNFGSVRQGVY-RMRKKQ--IDVAIKVLKQGTEK 50

Query: 387 WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPP 446
              ++   E + + ++ +P IVRL       +  +L+ +    G L+  L          
Sbjct: 51  ADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV----GKREE 105

Query: 447 LPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT 506
           +P     ++    + G+ Y+     + +VH ++ +  +LL +  +  IS FGL++ L   
Sbjct: 106 IPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162

Query: 507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP 565
                  +                + APE  I   KF+ + DV+S+G+ + E L+ G+ P
Sbjct: 163 DSYYTARSAGKWPLK---------WYAPEC-INFRKFSSRSDVWSYGVTMWEALSYGQKP 212

Query: 566 DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEF 625
               +  G  + + + +   +R        P L               +  +C     E 
Sbjct: 213 Y--KKMKGPEVMAFIEQG--KRMECPPECPPELY-------------ALMSDCWIYKWED 255

Query: 626 RPRMRTVSESL 636
           RP   TV + +
Sbjct: 256 RPDFLTVEQRM 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-38
 Identities = 56/304 (18%), Positives = 100/304 (32%), Gaps = 43/304 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
            +G    G + +          A   VAV+ L         +   SE++ ++ +  H NI
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALH-------------AGPSDSLPPLPWEARLK 454
           V L          L+I+++   G L   L              A   D    L  E  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            +   A+G+ ++     +  +H ++ +  ILL       I  FGL R +   S       
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
                          V       I+   +T + DV+S+GI L E+ +             
Sbjct: 207 ARLP-----------VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

Query: 575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE 634
               ++++ FR   P  E     +               I   C + DP  RP  + + +
Sbjct: 256 KFYKMIKEGFRMLSP--EHAPAEMY-------------DIMKTCWDADPLKRPTFKQIVQ 300

Query: 635 SLDR 638
            +++
Sbjct: 301 LIEK 304

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-38
 Identities = 58/279 (20%), Positives = 101/279 (36%), Gaps = 38/279 (13%)

Query: 360 KVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD-FESEVEAIARVQHPNIVRLKAFYYAND 418
            V  G          VAV+ L         KD   +E   + ++ +P IVR+       +
Sbjct: 22  TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE 80

Query: 419 EKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGN 478
             +L+ +    G L   L          +  +  +++    + G+ Y+       +VH +
Sbjct: 81  SWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRD 132

Query: 479 IKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARI 538
           + +  +LL  + +  IS FGL++ L       K +T                + APE  I
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK---------WYAPE-CI 182

Query: 539 YGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPA 597
              KF+ K DV+SFG+++ E  + G+ P  G    G  + +++ K   ER          
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--MKGSEVTAMLEKG--ERMGCPAGCPRE 238

Query: 598 LVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           +               +   C   D E RP    V   L
Sbjct: 239 MY-------------DLMNLCWTYDVENRPGFAAVELRL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-37
 Identities = 47/289 (16%), Positives = 109/289 (37%), Gaps = 45/289 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G  + G++                VA++ + EG  +    +F  E + +  + H  +V
Sbjct: 11  ELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 62

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L           +I++++ NG L   L             +  L++ +     + Y+  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE- 117

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              ++++H ++ +   L++D+    +S FGL+R +      +   +              
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR--------- 166

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER 587
             +  PE  +  SKF+ K D+++FG+++ EI + G++P     N        + +  R  
Sbjct: 167 --WSPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRLY 221

Query: 588 RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
           RP   +    +               I  +C     + RP  + +  ++
Sbjct: 222 RP--HLASEKVY-------------TIMYSCWHEKADERPTFKILLSNI 255

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 48/303 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNI 407
           V+G+   G + K    R    G     A++R+ E  +    +DF  E+E + ++  HPNI
Sbjct: 17  VIGEGNFGQVLK---ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALH-----------AGPSDSLPPLPWEARLKIA 456
           + L           L  ++  +G+L   L            A  + +   L  +  L  A
Sbjct: 74  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
              ARG+ Y+ +   ++++H ++ +  IL+ +     I+ FGL       S+  +     
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL-------SRGQEVYVKK 183

Query: 517 TSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGL 576
           T G           ++A E  +  S +T   DV+S+G++L EI++      G    G   
Sbjct: 184 TMGRLPV------RWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLG----GTPYCGMTC 232

Query: 577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
             L  K  +  R    +     V +            +   C    P  RP    +  SL
Sbjct: 233 AELYEKLPQGYRLEKPLNCDDEVYD------------LMRQCWREKPYERPSFAQILVSL 280

Query: 637 DRV 639
           +R+
Sbjct: 281 NRM 283

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 9e-37
 Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 43/289 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+   G ++             T VA++ L  G  +   + F  E + + +++H  +V
Sbjct: 24  KLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 75

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L A     +   ++++++  GSL   L     ++   L     + +A   A G+ Y+  
Sbjct: 76  QLYAVVS-EEPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVE- 130

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                YVH ++++  IL+ + L   ++ FGL RL+       +                 
Sbjct: 131 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK--------- 179

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             + APEA     +FT K DV+SFGI+L E+ T       P       E L +     R 
Sbjct: 180 --WTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRM 233

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLD 637
           P       +L               +   C   +PE RP    +   L+
Sbjct: 234 PCPPECPESLH-------------DLMCQCWRKEPEERPTFEYLQAFLE 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 58/291 (19%), Positives = 117/291 (40%), Gaps = 41/291 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G  + G +Y+ V  +         VAV+ L E       ++F  E   +  ++HPN+V
Sbjct: 24  KLGGGQYGEVYEGVW-KKYS----LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLV 76

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L           +I++F+  G+L   L          +     L +A   +  + Y+ +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK 133

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              + ++H ++ +   L+ +     ++ FGL+RL+ G +                     
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------- 181

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             + APE+ +  +KF+ K DV++FG++L EI T  +    P  D   +  L+ K +R  R
Sbjct: 182 --WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMER 237

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           P  E     +               +   C + +P  RP    + ++ + +
Sbjct: 238 P--EGCPEKVY-------------ELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 5e-36
 Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 42/304 (13%)

Query: 342 LLRASAY----VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVE 397
           +L+ + +    V+G    G +YK +     G      VA++ L E  +    K+   E  
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLW-IPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 398 AIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQ 457
            +A V +P++ RL           LI+  +  G L   +     +    +  +  L    
Sbjct: 64  VMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCV 118

Query: 458 GTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVT 517
             A+G+ Y+     R+ VH ++ +  +L+    H  I+ FGL +LL    K    E    
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 518 SGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGL 576
                        ++A E+ I    +T + DV+S+G+ + E++T G  P  G       +
Sbjct: 176 PIK----------WMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEI 222

Query: 577 ESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
            S++ K   ER P   +    +             + I + C  +D + RP+ R +    
Sbjct: 223 SSILEK--GERLPQPPICTIDV-------------YMIMVKCWMIDADSRPKFRELIIEF 267

Query: 637 DRVK 640
            ++ 
Sbjct: 268 SKMA 271

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-36
 Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 52/300 (17%)

Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDF 392
           ++LE  ++ R     +GK K G +Y     + S      ++A++ L +            
Sbjct: 3   WALEDFEIGR----PLGKGKFGNVYLARE-KQSK----FILALKVLFKAQLEKAGVEHQL 53

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
             EVE  + ++HPNI+RL  +++      LI ++   G++Y  L       L     +  
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRT 108

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
                  A  L Y H    ++ +H +IK   +LL       I+ FG +   P + + T  
Sbjct: 109 ATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
            T+               YL PE  I G    +K D++S G++  E L G+ P      +
Sbjct: 166 GTL--------------DYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----FE 205

Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
               +   ++  R      + +                   +     + +P  RP +R V
Sbjct: 206 ANTYQETYKRISRVEFTFPDFVTEGAR-------------DLISRLLKHNPSQRPMLREV 252

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-35
 Identities = 56/289 (19%), Positives = 100/289 (34%), Gaps = 41/289 (14%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFK-DFESEVEAIARVQHPNI 407
            +G    G   K+   +  G     ++  + L  G  T   K    SEV  +  ++HPNI
Sbjct: 11  TIGTGSYGRCQKIRR-KSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 408 VRL-KAFYYANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           VR         +  L ++ ++   G L + +  G  +    L  E  L++       L  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKE 124

Query: 466 IHEYSP--RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            H  S      +H ++K   + LD + +  +  FGL R+L   +   K            
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-------- 176

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
               +  Y++PE  +    + +K D++S G +L E+     P        K L   +R+ 
Sbjct: 177 ----TPYYMSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREG 229

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
             + R +       L               I      L    RP +  +
Sbjct: 230 --KFRRIPYRYSDELN-------------EIITRMLNLKDYHRPSVEEI 263

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 55/300 (18%)

Query: 350 VGKSKNG--IMYKVVVGRGSGMGA---------PTVVAVRRLTEGDATWRFKD-FESEVE 397
           VG S +G  + + + +GRG                 VA   L +   T   +  F+ E E
Sbjct: 2   VGMSNDGRFLKFDIEIGRG-SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60

Query: 398 AIARVQHPNIVRLKAFYYANDEK----LLISDFIRNGSLYAALHAGPSDSLPPLPWEARL 453
            +  +QHPNIVR    + +  +     +L+++ + +G+L   L          +  +   
Sbjct: 61  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLR 115

Query: 454 KIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRLLPGTSKVTKN 512
              +   +GL ++H  +P   +H ++K   I +        I   GL  L   +      
Sbjct: 116 SWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAK 171

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
             I T             ++APE  +Y  K+ +  DVY+FG+ +LE+ T   P +  +N 
Sbjct: 172 AVIGTPE-----------FMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN- 217

Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                 + R+     +P S   D   + E+           I   C   + + R  ++ +
Sbjct: 218 ---AAQIYRRVTSGVKPAS--FDKVAIPEVK---------EIIEGCIRQNKDERYSIKDL 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-35
 Identities = 57/295 (19%), Positives = 100/295 (33%), Gaps = 39/295 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR--FKDFESEVEAIARVQHPN 406
            +G    G++ +      SG      VAV+ L     +      DF  EV A+  + H N
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           ++RL           ++++    GSL   L                 + A   A G+ Y+
Sbjct: 73  LIRLYGVVL-TPPMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                ++++H ++ +  +LL       I  FGL R LP        +             
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-VP------ 177

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR 585
                      +    F+   D + FG+ L E+ T G+ P  G  N  + L  + ++  R
Sbjct: 178 ---FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGER 233

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK 640
             RP  E     +              ++ + C    PE RP    + + L   +
Sbjct: 234 LPRP--EDCPQDIY-------------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 55/291 (18%), Positives = 107/291 (36%), Gaps = 38/291 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+ + G +++ +            VA++      +    + F  E   + +  HP+IV
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +L       +   +I +    G L + L          L   + +  A   +  L Y+  
Sbjct: 72  KLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES 126

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              +++VH +I +  +L+       +  FGL+R +  ++    ++  +            
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------- 174

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             ++APE+ I   +FT   DV+ FG+ + EIL   +    P    K  + + R    ER 
Sbjct: 175 --WMAPES-INFRRFTSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGERL 228

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           P+     P L               +   C   DP  RPR   +   L  +
Sbjct: 229 PMPPNCPPTLY-------------SLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 4e-35
 Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 38/284 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+   G +   V  R +       VAV+ +    A    ++ + E+     + H N+V
Sbjct: 12  TLGEGAYGEVQLAVN-RVTE----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
           +        + + L  ++   G L+  +          +P     +       G++Y+H 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG 121

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
                  H +IK   +LLD+  +  IS FGL  +    ++      +   GT        
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC--GTLP------ 170

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             Y+APE         +  DV+S GIVL  +L G LP   P +  +       K  +   
Sbjct: 171 --YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYL 226

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              + ID A +  +H                  +P  R  +  +
Sbjct: 227 NPWKKIDSAPLALLHK-------------ILVENPSARITIPDI 257

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-35
 Identities = 55/293 (18%), Positives = 111/293 (37%), Gaps = 35/293 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+   G++Y+ V          T VA++ + E  +     +F +E   +      ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHA-----GPSDSLPPLPWEARLKIAQGTARGL 463
           RL          L+I + +  G L + L +       +  L P      +++A   A G+
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            Y++     K+VH ++ +   ++ ++    I  FG+ R +  T    K    +       
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 200

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                  +++PE+ +    FT   DV+SFG+VL EI T         ++ + L  ++   
Sbjct: 201 -------WMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG- 251

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                   +     L             F +   C + +P+ RP    +  S+
Sbjct: 252 --GLLDKPDNCPDML-------------FELMRMCWQYNPKMRPSFLEIISSI 289

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (330), Expect = 1e-34
 Identities = 48/288 (16%), Positives = 100/288 (34%), Gaps = 49/288 (17%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL--TEGDATWRFKDFESEVEAIARVQHPN 406
            +G    G +Y       +      VVA++++  +   +  +++D   EV  + +++HPN
Sbjct: 22  EIGHGSFGAVYFAR-DVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
            ++ +  Y       L+ ++    +              PL       +  G  +GL Y+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYL 131

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H       +H ++K+  ILL +     +  FG   ++   +             G+    
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----------VGTPY-- 176

Query: 527 ISNVYLAPE--ARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
               ++APE    +   ++  K DV+S GI  +E+   + P          + +L   A 
Sbjct: 177 ----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ 228

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
            E   L         +                +C +  P+ RP    +
Sbjct: 229 NESPALQSGHWSEYFRN------------FVDSCLQKIPQDRPTSEVL 264

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 56/304 (18%), Positives = 108/304 (35%), Gaps = 42/304 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIAR-VQHPNI 407
            +G+   G + +              VAV+ L EG      +   SE++ +     H N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 408 VRLKAFYYANDEKLLI-SDFIRNGSLYAALHAGPSDSLP-----------PLPWEARLKI 455
           V L          L++  +F + G+L   L +  ++ +P            L  E  +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 456 AQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETI 515
           +   A+G+ ++     RK +H ++ +  ILL ++    I  FGL R +       +    
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 516 VTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG 575
                         +       I+   +T + DV+SFG++L EI +            + 
Sbjct: 197 RLP-----------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245

Query: 576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES 635
               +++  R R P  +   P + +               L+C   +P  RP    + E 
Sbjct: 246 FCRRLKEGTRMRAP--DYTTPEMYQ-------------TMLDCWHGEPSQRPTFSELVEH 290

Query: 636 LDRV 639
           L  +
Sbjct: 291 LGNL 294

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 5e-33
 Identities = 50/281 (17%), Positives = 97/281 (34%), Gaps = 41/281 (14%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G   KV   +        + A + +         +D+  E++ +A   HPNIV+L   +Y
Sbjct: 23  GAFGKVYKAQNKETS--VLAAAKVIDTKSEEEL-EDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 416 ANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYV 475
             +   ++ +F   G++ A +     +   PL       + + T   L Y+H+    K +
Sbjct: 80  YENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 476 HGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPE 535
           H ++K+  IL   +    ++ FG++     T +         S  G+        ++APE
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR------DSFIGTPY------WMAPE 180

Query: 536 A----RIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
                      +  K DV+S GI L+E+     P    E +   +   + K+        
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--HELNPMRVLLKIAKSEPPTLAQP 238

Query: 592 EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                                     C E + + R     +
Sbjct: 239 SRWSSNFK-------------DFLKKCLEKNVDARWTTSQL 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 50/284 (17%), Positives = 107/284 (37%), Gaps = 43/284 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+  +G +Y  +    +G      VA+R++       + +   +E+  +   ++PNIV
Sbjct: 27  KIGQGASGTVYTAM-DVATG----QEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNIV 80

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
                Y   DE  ++ +++  GSL   +                  + +   + L ++H 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHS 134

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
               + +H +IKS  ILL  +    ++ FG         ++T  ++  ++  G+      
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QITPEQSKRSTMVGTPY---- 181

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
             ++APE  +    +  K D++S GI+ +E++ G  P    EN  + L  +         
Sbjct: 182 --WMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNG-TPEL 236

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              E +                       C ++D E R   + +
Sbjct: 237 QNPEKLSAIFR-------------DFLNRCLDMDVEKRGSAKEL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 3e-32
 Identities = 63/306 (20%), Positives = 110/306 (35%), Gaps = 46/306 (15%)

Query: 349 VVGKSKNGIMYKV--VVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHP 405
            +G+   G +     +          T VAV+ L          D  SE+E +  + +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLP-----------PLPWEARLK 454
           NI+ L      +    +I ++   G+L   L A     L             L  +  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
            A   ARG+ Y+     +K +H ++ +  +L+ ++    I+ FGL R +       K   
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDG 573
                          V       ++   +T + DV+SFG++L EI T G  P  G   + 
Sbjct: 197 GRLP-----------VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244

Query: 574 KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVS 633
             L  L+++  R  +P        L               +  +C    P  RP  + + 
Sbjct: 245 -ELFKLLKEGHRMDKP--SNCTNELY-------------MMMRDCWHAVPSQRPTFKQLV 288

Query: 634 ESLDRV 639
           E LDR+
Sbjct: 289 EDLDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 50/286 (17%), Positives = 102/286 (35%), Gaps = 43/286 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G    G++++V   R +G       A + +     + + +    E++ ++ ++HP +V
Sbjct: 33  ELGTGAFGVVHRVTE-RATG----NNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPTLV 86

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   +  ++E ++I +F+  G L+  +     D    +  +  ++  +   +GL ++HE
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 469 YSPRKYVHGNIKSTKILLDDEL--HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                YVH ++K   I+   +      +  FGL   L     V                 
Sbjct: 143 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE--------- 190

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
               + APE    G       D++S G++   +L+G  P  G END + L ++    +  
Sbjct: 191 ----FAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNM 244

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                  I                           DP  R  +   
Sbjct: 245 DDSAFSGISEDGK-------------DFIRKLLLADPNTRMTIHQA 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  118 bits (296), Expect = 6e-30
 Identities = 54/287 (18%), Positives = 107/287 (37%), Gaps = 44/287 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G      +      + +      +VA++ + +     +    E+E+  + +++HPNIV
Sbjct: 16  VLGTGAFSEVILAE-DKRTQ----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   Y +     LI   +  G L+  +                 ++       + Y+H+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHD 125

Query: 469 YSPRKYVHGNIKSTKILL---DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
                 VH ++K   +L    D++    IS FGL       SK+    +++++  G+   
Sbjct: 126 L---GIVHRDLKPENLLYYSLDEDSKIMISDFGL-------SKMEDPGSVLSTACGTPG- 174

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
                Y+APE  +    +++  D +S G++   +L G  P    END K  E +++  + 
Sbjct: 175 -----YVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYE 227

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
              P  + I  +                   +  E DPE R      
Sbjct: 228 FDSPYWDDISDSAK-------------DFIRHLMEKDPEKRFTCEQA 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  117 bits (295), Expect = 2e-29
 Identities = 51/286 (17%), Positives = 103/286 (36%), Gaps = 43/286 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G    G++++ V  + +G     V   + +       +    ++E+  + ++ HP ++
Sbjct: 36  ELGSGAFGVVHRCVE-KATG----RVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKLI 89

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   +    E +LI +F+  G L+  + A        +     +   +    GL ++HE
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHE 145

Query: 469 YSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                 VH +IK   I+ +        I  FGL   L            VT+ T      
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-----VKVTTATAE---- 193

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
               + APE  +         D+++ G++   +L+G  P AG E+D + L+++ R  +  
Sbjct: 194 ----FAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEF 247

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                  + P                    N  + +P  R  +   
Sbjct: 248 DEDAFSSVSPEAK-------------DFIKNLLQKEPRKRLTVHDA 280

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 4e-29
 Identities = 41/281 (14%), Positives = 94/281 (33%), Gaps = 44/281 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW--RFKDFESEVEAIARVQHPN 406
           ++G+     +        +        A++ L +       +      E + ++R+ HP 
Sbjct: 15  ILGEGSFSTVVLAR-ELATS----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
            V+L   +  +++      + +NG L   +       +                  L Y+
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYL 124

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H    +  +H ++K   ILL++++H  I+ FG  ++L   SK  +  + V +        
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ------ 175

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
               Y++PE  +      +  D+++ G ++ +++ G  P             + +K  + 
Sbjct: 176 ----YVSPEL-LTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKL 225

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
                E   P                 +      LD   R 
Sbjct: 226 EYDFPEKFFPKAR-------------DLVEKLLVLDATKRL 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  111 bits (279), Expect = 5e-28
 Identities = 58/289 (20%), Positives = 102/289 (35%), Gaps = 37/289 (12%)

Query: 356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYY 415
           G M +V + R   +     V V R         +  F  E +  A + HP IV +     
Sbjct: 18  GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77

Query: 416 ANDEKL----LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSP 471
           A         ++ +++   +L   +H     +  P+  +  +++     + L + H+   
Sbjct: 78  AETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQ--- 129

Query: 472 RKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVY 531
              +H ++K   I++       +  FG+ R +  +         V  GT          Y
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQ--------Y 180

Query: 532 LAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLS 591
           L+PE +  G     + DVYS G VL E+LTG  P  G ++        VR+         
Sbjct: 181 LSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARH 238

Query: 592 EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-MRTVSESLDRV 639
           E +   L               + L     +PE R +    +   L RV
Sbjct: 239 EGLSADLD-------------AVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 53/282 (18%), Positives = 91/282 (32%), Gaps = 37/282 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           ++G+   G +Y         M A   +  +R+          +    +  ++    P IV
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            +   ++  D+   I D +  G L+  L                   A     GL ++H 
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN 125

Query: 469 YSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAIS 528
              R  V+ ++K   ILLD+  H  IS  GL          +K +   + GT        
Sbjct: 126 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDF------SKKKPHASVGT-------- 168

Query: 529 NVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERR 588
           + Y+APE    G  +    D +S G +L ++L G  P     +  K    + R       
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAV 226

Query: 589 PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
            L +   P L   +                 + D   R    
Sbjct: 227 ELPDSFSPELRSLLEG-------------LLQRDVNRRLGCL 255

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 3e-27
 Identities = 44/290 (15%), Positives = 93/290 (32%), Gaps = 47/290 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G+ + GI+++ V    S          + +            + E+  +   +H NI+
Sbjct: 12  DLGRGEFGIVHRCV-ETSSK----KTYMAKFVKVKGTDQVL--VKKEISILNIARHRNIL 64

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   + + +E ++I +FI    ++  ++         L     +         L ++H 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHS 120

Query: 469 YSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
                  H +I+   I+          I  FG  R L          T            
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT------------ 165

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
            +  Y APE        +   D++S G ++  +L+G  P    E + + +E+++   +  
Sbjct: 166 -APEYYAPEV-HQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTF 222

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESL 636
                + I    +                      + + R    T SE+L
Sbjct: 223 DEEAFKEISIEAM-------------DFVDRLLVKERKSRM---TASEAL 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  108 bits (271), Expect = 6e-27
 Identities = 48/293 (16%), Positives = 106/293 (36%), Gaps = 44/293 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD--------FESEVEAIA 400
           ++G+  + ++ + +  + +        AV+ +          +           EV+ + 
Sbjct: 10  ILGRGVSSVVRRCIH-KPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 401 RVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
           +V  HPNI++LK  Y  N    L+ D ++ G L+  L          L  +   KI +  
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRAL 119

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSG 519
              +  +H+      VH ++K   ILLDD+++  ++ FG +  L    K+ +       G
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCG 171

Query: 520 TGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL 579
           T    S ++   +          + ++ D++S G+++  +L G  P          L  +
Sbjct: 172 T---PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMI 227

Query: 580 VRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
           +   ++   P  +     +               +      + P+ R      
Sbjct: 228 MSGNYQFGSPEWDDYSDTVK-------------DLVSRFLVVQPQKRYTAEEA 267

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 7e-25
 Identities = 68/307 (22%), Positives = 110/307 (35%), Gaps = 49/307 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
           V+G    G++Y+  +   SG     +VA++++ +       +    E++ + ++ H NIV
Sbjct: 27  VIGNGSFGVVYQAKL-CDSG----ELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIV 76

Query: 409 RLKAFYYANDEK------LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARG 462
           RL+ F+Y++ EK       L+ D++       A H   +     LP            R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRS 134

Query: 463 LMYIHEYSPRKYVHGNIKSTKILLDDELHPC-ISGFGLNRLLPGTSKVTKNETIVTSGTG 521
           L YIH        H +IK   +LLD +     +  FG  + L               G  
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-------------VRGEP 178

Query: 522 SRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG------KG 575
           +     S  Y APE     + +T   DV+S G VL E+L G+    G           K 
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

Query: 576 LESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATF-----HIALNCTELDPEFRPRMR 630
           L +  R+  RE  P         +K     +            +     E  P  R    
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL--- 295

Query: 631 TVSESLD 637
           T  E+  
Sbjct: 296 TPLEACA 302

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-24
 Identities = 46/282 (16%), Positives = 98/282 (34%), Gaps = 47/282 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR--FKDFESEVEAIARV-QHP 405
           ++GK   G ++     + +        A++ L +         +    E   ++   +HP
Sbjct: 9   MLGKGSFGKVFLAEF-KKTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 406 NIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
            +  +   +   +    + +++  G L   + +                 A     GL +
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQF 118

Query: 466 IHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           +H    +  V+ ++K   ILLD + H  I+ FG+ +      +    +    +  G+   
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGT--- 166

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR 585
                Y+APE  + G K+    D +SFG++L E+L G+ P       G+  E L      
Sbjct: 167 ---PDYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSP-----FHGQDEEELFHSIRM 217

Query: 586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP 627
           +       ++                  + +     +PE R 
Sbjct: 218 DNPFYPRWLEKEAK-------------DLLVKLFVREPEKRL 246

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 42/295 (14%), Positives = 85/295 (28%), Gaps = 41/295 (13%)

Query: 359 YKV--VVGRGSGMGA---------PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           Y++   +G G   G             VA++         +      E +    +Q    
Sbjct: 9   YRLGRKIGSG-SFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVG 64

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           +    +  A  +  ++   +   SL    +            +  L +A      + YIH
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH 120

Query: 468 EYSPRKYVHGNIKSTKIL---LDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
               + ++H ++K    L           I  FGL +                       
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL---- 173

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
              +  Y +      G + +++ D+ S G VL+    G LP  G +   K  +   R + 
Sbjct: 174 -TGTARYASINT-HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 230

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           ++     EV+      E                C  L  + +P    + +    +
Sbjct: 231 KKMSTPIEVLCKGYPSEFA---------TYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (252), Expect = 2e-24
 Identities = 42/299 (14%), Positives = 86/299 (28%), Gaps = 47/299 (15%)

Query: 359 YKV--VVGRGSGMGA---------PTVVAVRRLTEGDATWRFKDFESEVEAIARVQH-PN 406
           YKV   +G G   G             VA++         + +D   E      +     
Sbjct: 7   YKVGRRIGEG-SFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCTG 62

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           I  +  F       +L+ D +           G          +     A+     +  I
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSI 117

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHP-----CISGFGLNRLL-PGTSKVTKNETIVTSGT 520
           HE   +  V+ +IK    L+            +  FG+ +      +K         + +
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 521 GSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV 580
           G+        Y++      G + +++ D+ + G V +  L G LP  G +      +   
Sbjct: 175 GTAR------YMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYE 226

Query: 581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV 639
           R   +++      +     +E +                 L  +  P    +     +V
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFY---------KYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-24
 Identities = 45/229 (19%), Positives = 80/229 (34%), Gaps = 34/229 (14%)

Query: 359 YKV--VVGRGSGMGA---------PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI 407
           Y     +G G   G             VA+++++  +     +    E++ + R +H NI
Sbjct: 10  YTNLSYIGEG-AYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68

Query: 408 VRLKAFY----YANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           + +            + + +   +    LY  L          L  +          RGL
Sbjct: 69  IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGL 122

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            YIH       +H ++K + +LL+      I  FGL R+       T   T   +     
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW-- 177

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                  Y APE  +    +T+  D++S G +L E+L+ R    G    
Sbjct: 178 -------YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 7e-24
 Identities = 53/301 (17%), Positives = 96/301 (31%), Gaps = 53/301 (17%)

Query: 335 FSLELEDLLRASAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR--FKDF 392
           +SL+   +LR     +G    G ++ +   R +G       A++ L +         +  
Sbjct: 1   YSLQDFQILR----TLGTGSFGRVHLIR-SRHNG----RYYAMKVLKKEIVVRLKQVEHT 51

Query: 393 ESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEAR 452
             E   ++ V HP I+R+   +    +  +I D+I  G L++ L           P    
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVA 106

Query: 453 LKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKN 512
              A      L Y+H    +  ++ ++K   ILLD   H  I+ FG  + +P  +     
Sbjct: 107 KFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG 163

Query: 513 ETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND 572
                             Y+APE  +    + +  D +SFGI++ E+L G  P       
Sbjct: 164 TPD---------------YIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTP-----FY 202

Query: 573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                    K            +  +   +                   D   R      
Sbjct: 203 DSNTMKTYEKILNAELRFPPFFNEDVKDLLS-------------RLITRDLSQRLGNLQN 249

Query: 633 S 633
            
Sbjct: 250 G 250

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-23
 Identities = 52/299 (17%), Positives = 102/299 (34%), Gaps = 46/299 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPNI 407
            +G+   G++YK    + +G     VVA++++     T         E+  +  + HPNI
Sbjct: 9   KIGEGTYGVVYKAR-NKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V+L    +  ++  L+ +F+               +L  +P            +GL + H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
                + +H ++K   +L++ E    ++ FGL R      +   +E +            
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW--------- 167

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER 587
              Y APE  +    ++   D++S G +  E++T R    G           + + FR  
Sbjct: 168 ---YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-----IDQLFRIFRTL 219

Query: 588 RPLSEVIDPALVKEIHAKRQVLATFHIALN----------------CTELDPEFRPRMR 630
               EV+ P +      K           +                    DP  R   +
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 1e-23
 Identities = 48/288 (16%), Positives = 93/288 (32%), Gaps = 40/288 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIV 408
            +G  +  ++ K          A   +  RR          +D E EV  +  +QHPN++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHE 468
            L   Y    + +LI + +  G L+  L          L  E   +  +    G+ Y+H 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS 131

Query: 469 YSPRKYVHGNIKSTKILLDDE----LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
               +  H ++K   I+L D         I  FGL   +   ++                
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------------ 176

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
              +  ++APE  +       + D++S G++   +L+G  P  G +   + L ++    +
Sbjct: 177 -FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNY 233

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
                                                DP+ R  ++  
Sbjct: 234 EFEDEYFSNTSALAK-------------DFIRRLLVKDPKKRMTIQDS 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 98.4 bits (244), Expect = 2e-23
 Identities = 51/301 (16%), Positives = 101/301 (33%), Gaps = 41/301 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL-TEGDATWRFKDFESEVEAIARVQHPNI 407
            +G+   G++YK     G         A++++  E +          E+  +  ++H NI
Sbjct: 9   KIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           V+L    +     +L+ + +                   L              G+ Y H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH 117

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
           +   R+ +H ++K   +L++ E    I+ FGL R      +   +E +            
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW--------- 165

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG------KGLESLVR 581
              Y AP+  +   K++   D++S G +  E++ G     G           + L +   
Sbjct: 166 ---YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 582 KAFRERRPLSEVIDPALVKEIHAKRQVLATF-----HIALNCTELDPEFRPRMRTVSESL 636
           K +     L +      V E       L         +     +LDP  R    T  ++L
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQAL 279

Query: 637 D 637
           +
Sbjct: 280 E 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 3e-23
 Identities = 54/282 (19%), Positives = 93/282 (32%), Gaps = 48/282 (17%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ--HPN 406
           ++G    G +Y  +    +   A   V   R+++            EV  + +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           ++RL  ++   D  +LI +                     L  E            + + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHC 126

Query: 467 HEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRIS 525
           H       +H +IK   IL+D +     +  FG   LL         +T+ T   G+R  
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------KDTVYTDFDGTR-- 173

Query: 526 AISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKG---------- 575
               VY  PE   Y     +   V+S GI+L +++ G +P    E   +G          
Sbjct: 174 ----VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229

Query: 576 -LESLVRKAFR---ERRP----------LSEVIDPALVKEIH 603
             + L+R         RP          + +V+ P    EIH
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 55/294 (18%), Positives = 105/294 (35%), Gaps = 45/294 (15%)

Query: 354 KNGIM--YKV---VVGRGSGMGAPTVVAVRRLTEGD--ATWRFKD---FESEVEAIARV- 402
           KN I+  YKV   V+G G   G   V+ +      +  A    +D      EVE   R  
Sbjct: 6   KNAIIDDYKVTSQVLGLG-ING--KVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS 62

Query: 403 QHPNIVRLKAFY---YANDEKL-LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQG 458
           Q P+IVR+   Y   YA  + L ++ + +  G L++ +                 +I + 
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKS 119

Query: 459 TARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTS 518
               + Y+H        H ++K   +L   +    I          G +K T +   +T+
Sbjct: 120 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF----GFAKETTSHNSLTT 172

Query: 519 GTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES 578
              +        Y+APE  +   K+ + CD++S G+++  +L G  P     +       
Sbjct: 173 PCYTPY------YVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPG 224

Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTV 632
           +  +    +          + +E+           +  N  + +P  R  +   
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVK---------MLIRNLLKTEPTQRMTITEF 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 2e-22
 Identities = 51/311 (16%), Positives = 99/311 (31%), Gaps = 40/311 (12%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRL----TEGDATWRFKDFESEVEAIARVQH 404
            +G+   G ++K    +  G      VA++R+     E           + +  +   +H
Sbjct: 14  EIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLY-AALHAGPSDSLPPLPWEARLKIAQGTARGL 463
           PN+VRL      +         +    +             P +P E    +     RGL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 464 MYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSR 523
            ++H     + VH ++K   IL+       ++ FGL       +++   +  +TS   + 
Sbjct: 130 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL-------ARIYSFQMALTSVVVTL 179

Query: 524 ISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA 583
                  Y APE  +  S +    D++S G +  E+   +    G  +  +  + L    
Sbjct: 180 ------WYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232

Query: 584 FRERRPLSEVIDPALVKEIHAKRQVLATF---------HIALNCTELDPEFRPRMRTVSE 634
                     +            Q +  F          + L C   +P  R    +   
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

Query: 635 -----SLDRVK 640
                 L+R K
Sbjct: 293 HPYFQDLERCK 303

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 2e-22
 Identities = 51/284 (17%), Positives = 92/284 (32%), Gaps = 46/284 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR--FKDFESEVEAIARVQHPN 406
           ++GK   G +  V   + +G       A++ L +     +       +E   +   +HP 
Sbjct: 12  LLGKGTFGKVILVR-EKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           +  LK  +  +D    + ++   G L+  L             E            L Y+
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYL 121

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H    R  V+ +IK   ++LD + H  I+ FGL +         K       GT      
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GT------ 168

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
                      +  + + +  D +  G+V+ E++ GRLP        +  E L      E
Sbjct: 169 ---PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELILME 220

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
                  + P   K + A               + DP+ R    
Sbjct: 221 EIRFPRTLSPEA-KSLLAG------------LLKKDPKQRLGGG 251

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 4e-22
 Identities = 50/303 (16%), Positives = 104/303 (34%), Gaps = 42/303 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWR----FKDFESEVEAIARVQH 404
            +G+ +   +YK    + +      +VA++++  G  +       +    E++ +  + H
Sbjct: 5   FLGEGQFATVYKARD-KNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
           PNI+ L   +       L+ DF+                   L           T +GL 
Sbjct: 60  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLE 114

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           Y+H+      +H ++K   +LLD+     ++ FGL +     ++      +VT       
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRW----- 165

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG------KGLES 578
                 Y APE       +    D+++ G +L E+L       G  +        + L +
Sbjct: 166 ------YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219

Query: 579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALN----CTELDPEFRPRMRTVSE 634
              + + +   L + +       I       A     L+        +P  R    T ++
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQ 276

Query: 635 SLD 637
           +L 
Sbjct: 277 ALK 279

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 1e-20
 Identities = 43/224 (19%), Positives = 81/224 (36%), Gaps = 25/224 (11%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPNI 407
            VG    G +   V GR         VA+++L     +  F K    E+  +  ++H N+
Sbjct: 25  PVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           + L   +  ++     +DF                    L  +    +     +GL YIH
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIH 138

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
                  +H ++K   + ++++    I  FGL R                          
Sbjct: 139 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW------------ 183

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPEN 571
              Y APE  +   ++TQ  D++S G ++ E++TG+    G ++
Sbjct: 184 ---YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 2e-20
 Identities = 48/286 (16%), Positives = 92/286 (32%), Gaps = 38/286 (13%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKD---FESEVEAIARVQH- 404
           V+G    G ++ V    G   G   + A++ L +     + K      +E + +  ++  
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTG--KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 405 PNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
           P +V L   +    +  LI D+I  G L+  L                          L 
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALE 143

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           ++H+      ++ +IK   ILLD   H  ++ FGL++           +   T       
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY---- 196

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF 584
                       R   S   +  D +S G+++ E+LTG  P    + +      + R+  
Sbjct: 197 ------MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRIL 249

Query: 585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
           +   P  + +                   +       DP+ R    
Sbjct: 250 KSEPPYPQEMSALAK-------------DLIQRLLMKDPKKRLGCG 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 90.2 bits (223), Expect = 3e-20
 Identities = 46/324 (14%), Positives = 104/324 (32%), Gaps = 53/324 (16%)

Query: 306 GKEEKTNDAVLVTDEEEGQKGKFFIIDEGFSLELEDLLRASAYVVGKSKNGIMYKVVVGR 365
           G E+++    L   +E+  K           L+  D ++     +G    G +  V   +
Sbjct: 9   GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGRVMLVK-HK 63

Query: 366 GSGMGAPTVVAVRRLTEGDATW--RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI 423
            SG       A++ L +       + +   +E   +  V  P +V+L+  +  N    ++
Sbjct: 64  ESG----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTK 483
            +++  G +++ L       +           A        Y+H       ++ ++K   
Sbjct: 120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPEN 171

Query: 484 ILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKF 543
           +L+D + +  ++ FG  + + G +                        LAPE  I    +
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---------------EALAPE-IILSKGY 215

Query: 544 TQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIH 603
            +  D ++ G+++ E+  G  P             +  K    +          L     
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRFPSHFSSDL----- 265

Query: 604 AKRQVLATFHIALNCTELDPEFRP 627
                     +  N  ++D   R 
Sbjct: 266 --------KDLLRNLLQVDLTKRF 281

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 9e-20
 Identities = 48/307 (15%), Positives = 97/307 (31%), Gaps = 37/307 (12%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPNI 407
            +G+   G ++K    R +G      VA++++   +    F      E++ +  ++H N+
Sbjct: 17  KIGQGTFGEVFKARH-RKTG----QKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 408 VRLKAFYYANDEKLLISD---FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLM 464
           V L                  ++        L    S+ L         ++ Q    GL 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 131

Query: 465 YIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
           YIH     K +H ++K+  +L+  +    ++ FGL R          N       T    
Sbjct: 132 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW-- 186

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG----------- 573
                 Y  PE  +    +    D++  G ++ E+ T      G                
Sbjct: 187 ------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 574 ---KGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR 630
              +   ++      E+  L +     +   + A  +      +      LDP  R    
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI--- 297

Query: 631 TVSESLD 637
              ++L+
Sbjct: 298 DSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.7 bits (216), Expect = 1e-19
 Identities = 50/306 (16%), Positives = 103/306 (33%), Gaps = 49/306 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPNI 407
            +G+   G ++K    R +      +VA++R+   D           E+  +  ++H NI
Sbjct: 9   KIGEGTYGTVFKAKN-RETH----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 408 VRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIH 467
           VRL    +++ +  L+ +F                       E          +GL + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCH 118

Query: 468 EYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAI 527
               R  +H ++K   +L++      ++ FGL R      +    E +            
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------------ 163

Query: 528 SNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRER 587
           +  Y  P+       ++   D++S G +  E+         P   G  ++  +++ FR  
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR----PLFPGNDVDDQLKRIFRLL 219

Query: 588 RPLSEVIDPALVKEIHAKRQVLATFHIAL----------------NCTELDPEFRPRMRT 631
              +E   P++ K    K   +     +L                N  + +P  R    +
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---S 276

Query: 632 VSESLD 637
             E+L 
Sbjct: 277 AEEALQ 282

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.0 bits (206), Expect = 2e-18
 Identities = 64/188 (34%), Positives = 85/188 (45%), Gaps = 13/188 (6%)

Query: 18  LCFSLNQDGLALLALKAAIAQDPTRALDSWSES-DSTPCHWSGIHCIRN----RVTSLYL 72
           LC    QD  ALL +K  +  +PT  L SW  + D     W G+ C  +    RV +L L
Sbjct: 2   LC--NPQDKQALLQIKKDL-GNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDL 57

Query: 73  PNRNLTGYM--PSELGLLNSLTRLSLASN-NFSKPIPANLFNATNLVYLDLAHNSFCGPI 129
              NL      PS L  L  L  L +    N   PIP  +   T L YL + H +  G I
Sbjct: 58  SGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMV 189
           PD +  +K L  LD S N L+G+LP  +  L  L G      N+ SG IP+ YG F  + 
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI-TFDGNRISGAIPDSYGSFSKLF 176

Query: 190 SLDLRNNN 197
           +    + N
Sbjct: 177 TSMTISRN 184

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.4 bits (194), Expect = 9e-17
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 1/64 (1%)

Query: 168 NLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPL 227
           +L  N+  G +P+       + SL++  NNL GEIPQ G+L     +A++ N  LCG PL
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309

Query: 228 QSPC 231
              C
Sbjct: 310 -PAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.4 bits (155), Expect = 9e-12
 Identities = 21/108 (19%), Positives = 40/108 (37%), Gaps = 1/108 (0%)

Query: 47  WSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIP 106
              S +     + +    ++ T      +N   +   ++GL  +L  L L +N     +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261

Query: 107 ANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLP 154
             L     L  L+++ N+ CG IP     L+       ++N      P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (196), Expect = 8e-17
 Identities = 52/280 (18%), Positives = 93/280 (33%), Gaps = 33/280 (11%)

Query: 359 YKVV--VGRGSGMGA---------PTVVAVRRLTEGDATWRF-KDFESEVEAIARVQHPN 406
           Y+ +  VG G   G+            VAV++L+    +    K    E+  +  ++H N
Sbjct: 20  YQNLSPVGSG-AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 407 IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYI 466
           ++ L   +         +D      L  A                +  I Q   RGL YI
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYI 137

Query: 467 HEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISA 526
           H       +H ++K + + ++++    I  FGL R                         
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----------- 183

Query: 527 ISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE 586
               Y APE  +    + Q  D++S G ++ E+LTGR    G  +    L+ ++R     
Sbjct: 184 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTP 238

Query: 587 RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFR 626
              L + I     +        +   + A      +P   
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 78.7 bits (193), Expect = 2e-16
 Identities = 33/237 (13%), Positives = 76/237 (32%), Gaps = 37/237 (15%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNI 407
            +G+ K   +++ +    +       V V+ L         K  + E++ +  ++  PNI
Sbjct: 42  KLGRGKYSEVFEAI-NITNN----EKVVVKILKPVKK----KKIKREIKILENLRGGPNI 92

Query: 408 VRLKAFYYANDEKL--LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMY 465
           + L         +   L+ + + N                 L             + L Y
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDY 144

Query: 466 IHEYSPRKYVHGNIKSTKILLDDE-LHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRI 524
            H       +H ++K   +++D E     +  +GL       ++             SR 
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------AEFYHPGQEYNVRVASRY 194

Query: 525 SAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR 581
                 +  PE  +    +    D++S G +L  ++  + P     ++   L  + +
Sbjct: 195 ------FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.7 bits (190), Expect = 6e-16
 Identities = 44/182 (24%), Positives = 59/182 (32%), Gaps = 31/182 (17%)

Query: 44  LDSWSESDSTPCHWSGI--HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNF 101
           L +     +T    S I    I   +  L L    L       L  L +LT L LA+N  
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253

Query: 102 SKPIPANLFNATNLVYLDLAHNSFCGPIP--------------------DRIKTLKNLTH 141
           S   P  L   T L  L L  N      P                      I  LKNLT+
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311

Query: 142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE 201
           L L  N ++   P  +  L  L   L  + N+ S        +   +  L   +N +S  
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366

Query: 202 IP 203
            P
Sbjct: 367 TP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 70.4 bits (171), Expect = 2e-13
 Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 6/93 (6%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
                       +T L L   N++    S +  L  L RL  A+N  S    ++L N TN
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVS--DVSSLANLTN 352

Query: 115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           + +L   HN      P  +  L  +T L L+  
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 62.7 bits (151), Expect = 4e-11
 Identities = 28/118 (23%), Positives = 42/118 (35%), Gaps = 7/118 (5%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
              S I  +        L          S +  L +LT L+L  NN S   P  + + T 
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFN 172
           L  L  A+N         +  L N+  L    N ++   P  L +L  +T  L L+  
Sbjct: 331 LQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRIT-QLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 15/62 (24%), Positives = 30/62 (48%), Gaps = 4/62 (6%)

Query: 65  NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNS 124
           ++VT+L      +       +  LN+LT+++ ++N  +   P  L N T LV + + +N 
Sbjct: 44  DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 99

Query: 125 FC 126
             
Sbjct: 100 IA 101

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.002
 Identities = 13/112 (11%), Positives = 28/112 (25%), Gaps = 33/112 (29%)

Query: 96  LASNNFSKPIPAN-LF---NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG 151
           L S   ++  P N +F        +   L   +    +      L  +T L      +  
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 57

Query: 152 SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
                   +  +                    +   +  ++  NN L+   P
Sbjct: 58  -------SIDGV-------------------EYLNNLTQINFSNNQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.4 bits (88), Expect = 0.002
 Identities = 13/67 (19%), Positives = 23/67 (34%), Gaps = 4/67 (5%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           L    +  L   N +  +     +   +  L            D ++ L NLT ++ S+N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76

Query: 148 LLNGSLP 154
            L    P
Sbjct: 77  QLTDITP 83

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 70.5 bits (171), Expect = 7e-14
 Identities = 32/156 (20%), Positives = 52/156 (33%), Gaps = 17/156 (10%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
           CH   + C    +  +           P +L        L L +N  ++    +  N  N
Sbjct: 10  CHLRVVQCSDLGLEKV-----------PKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56

Query: 115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF 174
           L  L L +N      P     L  L  L LS N L   LPE    +      L +  N+ 
Sbjct: 57  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE---KMPKTLQELRVHENEI 112

Query: 175 SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN 210
           +     ++     M+ ++L  N L     + G+   
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 148

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.8 bits (133), Expect = 4e-09
 Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 11/162 (6%)

Query: 44  LDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK 103
           ++  +    +    +G      +++ + + + N+T       GL  SLT L L  N  +K
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITK 185

Query: 104 PIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRAL 163
              A+L    NL  L L+ NS        +    +L  L L++N L    P  L D + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYI 244

Query: 164 TGTLNLSFNQFSG------QIPEMYGHFPVMVSLDLRNNNLS 199
              + L  N  S         P           + L +N + 
Sbjct: 245 Q-VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.1 bits (173), Expect = 8e-14
 Identities = 47/302 (15%), Positives = 103/302 (34%), Gaps = 37/302 (12%)

Query: 350 VGKSKNGIM--YKVV--VGRGSGMGA---------PTVVAVRRLTEGDATWRF-KDFESE 395
           VG S   ++  Y+ +  +G G   G             VA+++L+         K    E
Sbjct: 8   VGDSTFTVLKRYQNLKPIGSG-AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66

Query: 396 VEAIARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSL-PPLPWEARLK 454
           +  +  V H NI+ L   +        + +F     +   + A     +   L  E    
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123

Query: 455 IAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNET 514
           +      G+ ++H       +H ++K + I++  +    I  FGL       ++      
Sbjct: 124 LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL-------ARTAGTSF 173

Query: 515 IVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGK 574
           ++T    +R       Y APE  I G  + +  D++S G ++ E++  ++   G  +   
Sbjct: 174 MMTPYVVTRY------YRAPE-VILGMGYKENVDIWSVGCIMGEMVRHKILFPG-RDYID 225

Query: 575 GLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE 634
               ++ +         + + P +   +  + +        L    L P      +  + 
Sbjct: 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 285

Query: 635 SL 636
             
Sbjct: 286 QA 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 64.3 bits (155), Expect = 1e-11
 Identities = 37/237 (15%), Positives = 75/237 (31%), Gaps = 37/237 (15%)

Query: 359 YKVV--VGRGSGMGA---------PTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPN- 406
           Y +V  +G G               T VA++ +         +  E E++ + RV   + 
Sbjct: 15  YILVRKLGWG-HFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADN 71

Query: 407 ----------IVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIA 456
                     I++L   +       +    +        L          +P     +I+
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 457 QGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSKVTKNETIV 516
           +    GL Y+H       +H +IK   +L++    P      +     G +         
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ-IKIADLGNACWYDEHYTN 188

Query: 517 TSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDG 573
           +  T          Y +PE  + G+ +    D++S   ++ E++TG       E   
Sbjct: 189 SIQTRE--------YRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (151), Expect = 2e-11
 Identities = 34/172 (19%), Positives = 47/172 (27%), Gaps = 1/172 (0%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
                      R+ +L+L    L    P     L +L  L L  N           +  N
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154

Query: 115 LVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF 174
           L +L L  N          + L +L  L L  N +    P    DL  L     L  N  
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL-YLFANNL 213

Query: 175 SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFP 226
           S    E       +  L L +N    +               S +   C  P
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (129), Expect = 1e-08
 Identities = 38/184 (20%), Positives = 59/184 (32%), Gaps = 2/184 (1%)

Query: 47  WSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIP 106
              +       +    +          N  L    P+    L  L  L L      +  P
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122

Query: 107 ANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
                   L YL L  N+      D  + L NLTHL L  N ++         L +L   
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-R 181

Query: 167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPT-AFSGNPGLCGF 225
           L L  N+ +   P  +     +++L L  NNLS    +  + L        + NP +C  
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241

Query: 226 PLQS 229
             + 
Sbjct: 242 RARP 245

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.5 bits (124), Expect = 6e-08
 Identities = 32/175 (18%), Positives = 43/175 (24%), Gaps = 30/175 (17%)

Query: 54  PCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNAT 113
           PC      C      +   P + L   +P  +    +  R+ L  N  S    A+     
Sbjct: 1   PCP-GACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACR 56

Query: 114 NLVYLDLAHNSFCGPI-------------------------PDRIKTLKNLTHLDLSSNL 148
           NL  L L  N                               P     L  L  L L    
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 149 LNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
           L    P     L AL     L  N       + +     +  L L  N +S    
Sbjct: 117 LQELGPGLFRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (112), Expect = 1e-06
 Identities = 29/125 (23%), Positives = 37/125 (29%), Gaps = 8/125 (6%)

Query: 55  CHWSGIHCIRNRVTSL---YLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFN 111
              S        + SL    L    +    P     L  L  L L +NN S      L  
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 112 ATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSF 171
              L YL L  N +      R      L     SS+ +  SLP+ L           L+ 
Sbjct: 224 LRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAGRD----LKRLAA 278

Query: 172 NQFSG 176
           N   G
Sbjct: 279 NDLQG 283

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.8 bits (138), Expect = 1e-09
 Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 4/102 (3%)

Query: 92  TRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNG 151
             L L   N    +   L +   ++      +    P+ +     + + H+DLS++++  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60

Query: 152 -SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLD 192
            +L   L     L   L+L   + S  I         +V L+
Sbjct: 61  STLHGILSQCSKLQ-NLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 26/122 (21%), Positives = 43/122 (35%), Gaps = 7/122 (5%)

Query: 94  LSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSL 153
           L LA  + +  +  +L     + +LDL+HN      P     L  L  L++     N   
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56

Query: 154 PEFLLDLRALTGTLNLSFNQF-SGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQG 212
               +        L L  N+       +     P +V L+L+ N+L  E      L    
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 213 PT 214
           P+
Sbjct: 117 PS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 6e-07
 Identities = 22/117 (18%), Positives = 33/117 (28%), Gaps = 27/117 (23%)

Query: 70  LYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLV------------- 116
           L+L +++LT      L  L  +T L L+ N      P  L     L              
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 117 ---------YLDLAHNSF-CGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRAL 163
                     L L +N          + +   L  L+L  N L          L  +
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 12/55 (21%), Positives = 21/55 (38%), Gaps = 4/55 (7%)

Query: 92  TRLSLASNNFSK-PIPANLFNATNLVYLDLAHNSFCGP---IPDRIKTLKNLTHL 142
             L L +N   +      L +   LV L+L  NS C          + L +++ +
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.5 bits (137), Expect = 2e-09
 Identities = 20/110 (18%), Positives = 37/110 (33%), Gaps = 9/110 (8%)

Query: 54  PCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNAT 113
                 I    + +          +  + S   L  SL  L++++N   + +PA      
Sbjct: 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---P 304

Query: 114 NLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRAL 163
            L  L  + N     +P+     +NL  L +  N L    P+    +  L
Sbjct: 305 RLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 1e-07
 Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 11/90 (12%)

Query: 122 HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEM 181
            N+    I        +L  L++S+N L   LP     L      L  SFN  + ++PE+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPEL 322

Query: 182 YGHFPVMVSLDLRNNNLSGEIPQV-GSLLN 210
             +   +  L +  N L  E P +  S+ +
Sbjct: 323 PQN---LKQLHVEYNPLR-EFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 13/67 (19%), Positives = 26/67 (38%), Gaps = 8/67 (11%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL 120
            C+  +   L L N  L+  +P        L  L  + N+ ++ +P       +L  L +
Sbjct: 34  DCLDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSLTE-LPELP---QSLKSLLV 85

Query: 121 AHNSFCG 127
            +N+   
Sbjct: 86  DNNNLKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 14/64 (21%), Positives = 22/64 (34%), Gaps = 9/64 (14%)

Query: 113 TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFN 172
                L+L +      +P+      +L  L  S N L   LPE    L+    +L +  N
Sbjct: 38  RQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELPQSLK----SLLVDNN 88

Query: 173 QFSG 176
               
Sbjct: 89  NLKA 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.7 bits (137), Expect = 2e-09
 Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 6/92 (6%)

Query: 114 NLVYLDLAHNSFC-GPIPDRIKTLKNLTHLDLSSNLLNG----SLPEFLLDLRALTGTLN 168
           ++  LD+           + +  L+    + L    L       +   L    AL   LN
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA-ELN 61

Query: 169 LSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSG 200
           L  N+                S  ++  +L  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (136), Expect = 3e-09
 Identities = 20/102 (19%), Positives = 35/102 (34%), Gaps = 14/102 (13%)

Query: 106 PANLFNATNLVYLDLAHNSF----CGPIPDRIKTLKNLTHLDLSSNLLNGS----LPEFL 157
                  + L  L LA        C  +   +    +L  LDLS+N L  +    L E +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 158 LDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
                L   L L    +S ++ +       + +L+    +L 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 1e-08
 Identities = 17/108 (15%), Positives = 28/108 (25%), Gaps = 9/108 (8%)

Query: 90  SLTRLSLASNNFSKPIPANLFNA-TNLVYLDLAHNSF----CGPIPDRIKTLKNLTHLDL 144
            +  L +     S    A L         + L         C  I   ++    L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 145 SSNLLNG----SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVM 188
            SN L       + + L         L+L     +G    +       
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 110

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (129), Expect = 2e-08
 Identities = 14/72 (19%), Positives = 25/72 (34%), Gaps = 6/72 (8%)

Query: 138 NLTHLDLSSNLLNGS-LPEFLLDLRALTGTLNLSFNQFSGQ----IPEMYGHFPVMVSLD 192
           ++  LD+    L+ +   E L  L+     + L     +      I       P +  L+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQ-VVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 193 LRNNNLSGEIPQ 204
           LR+N L      
Sbjct: 62  LRSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 2e-08
 Identities = 18/117 (15%), Positives = 40/117 (34%), Gaps = 9/117 (7%)

Query: 54  PCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFS----KPIPANL 109
                    +  ++++  L +  +           + L  L LA  + S      + A L
Sbjct: 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 393

Query: 110 FNATNLVYLDLAHNSFCGPIPDRI-KTLKN----LTHLDLSSNLLNGSLPEFLLDLR 161
               +L  LDL++N        ++ ++++     L  L L     +  + + L  L 
Sbjct: 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (121), Expect = 2e-07
 Identities = 20/110 (18%), Positives = 40/110 (36%), Gaps = 10/110 (9%)

Query: 47  WSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTG----YMPSELGLLNSLTRLSLASNNFS 102
             E         G+    + +  L+L + +++      + + L   +SL  L L++N   
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 103 KPIPANLFNA-----TNLVYLDLAHNSFCGPIPDRIKTL-KNLTHLDLSS 146
                 L  +       L  L L    +   + DR++ L K+   L + S
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 10/91 (10%)

Query: 67  VTSLYLPNRNLTGYMPSEL-GLLNSLTRLSLASNNFS----KPIPANLFNATNLVYLDLA 121
           + SL +    L+    +EL  LL     + L     +    K I + L     L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 122 HNSFCGPIPDRI-----KTLKNLTHLDLSSN 147
            N         +          +  L L + 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 2e-06
 Identities = 11/60 (18%), Positives = 21/60 (35%), Gaps = 3/60 (5%)

Query: 88  LNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSN 147
           + S   ++    N +  +P +L    +   L L+ N         +     LT L+L   
Sbjct: 9   VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 3e-05
 Identities = 30/131 (22%), Positives = 43/131 (32%), Gaps = 2/131 (1%)

Query: 44  LDSWSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSK 103
           L +   S +       +      +T L +    LT      L  L  L  L L  N    
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 104 PIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRAL 163
             P  L     L  L LA+N+        +  L+NL  L L  N L  ++P+       L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 164 TGTLNLSFNQF 174
                L  N +
Sbjct: 198 P-FAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 19/68 (27%), Positives = 25/68 (36%), Gaps = 6/68 (8%)

Query: 62  CIRNRVTSL---YLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYL 118
           C  ++V S        RNLT  +P +L      T L L+ N       A L   T L  L
Sbjct: 4   CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 119 DLAHNSFC 126
           +L      
Sbjct: 61  NLDRAELT 68

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 32/183 (17%), Positives = 51/183 (27%), Gaps = 24/183 (13%)

Query: 63  IRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAH 122
           +    T L+L    L  +  + L     LT+L+L  +               L  LDL+H
Sbjct: 29  LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSH 86

Query: 123 NSFCGPIPDRIKTLKNLTHLDLSSNLLN----------------------GSLPEFLLDL 160
           N                      + L +                       +LP  LL  
Sbjct: 87  NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146

Query: 161 RALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP 220
                 L+L+ N  +     +      + +L L+ N+L                   GNP
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNP 206

Query: 221 GLC 223
            LC
Sbjct: 207 WLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 15/72 (20%), Positives = 27/72 (37%), Gaps = 4/72 (5%)

Query: 111 NATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS 170
              + + ++    +    +P  +   K+ T L LS NLL       L+    LT  LNL 
Sbjct: 8   KVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT-QLNLD 63

Query: 171 FNQFSGQIPEMY 182
             + +    +  
Sbjct: 64  RAELTKLQVDGT 75

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.002
 Identities = 12/66 (18%), Positives = 22/66 (33%), Gaps = 4/66 (6%)

Query: 132 RIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSL 191
            +  + +   ++     L  +LP    DL   T  L+LS N            +  +  L
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 192 DLRNNN 197
           +L    
Sbjct: 61  NLDRAE 66

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.6 bits (111), Expect = 3e-06
 Identities = 16/110 (14%), Positives = 33/110 (30%), Gaps = 11/110 (10%)

Query: 90  SLTRLSLASNNFS----KPIPANLFNATNLVYLDLAHNSF----CGPIPDRIKTLKNLTH 141
           S+   SL  +  +    K + A L    ++  + L+ N+        + + I + K+L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 142 LDLSSN---LLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVM 188
            + S      +   +PE L  L                           +
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 113

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 14/96 (14%), Positives = 28/96 (29%), Gaps = 12/96 (12%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELG------LLNSLTRLSLASNNFSKPIPAN 108
              +        +  L L +  L+    + +           L  L L  N         
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 109 LFNA-----TNLVYLDLAHNSFCGPIPDRIKTLKNL 139
           L         +L++L+L  N F     D +  ++ +
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.9 bits (108), Expect = 3e-06
 Identities = 18/162 (11%), Positives = 46/162 (28%), Gaps = 27/162 (16%)

Query: 349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRF---------KDFESEVEAI 399
           ++G+ K   ++     +           V+    G  +++            F       
Sbjct: 7   LMGEGKESAVFNCYSEKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 400 ARVQHPNIVRLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGT 459
           AR +   + +L+           +            +    +  L  +  E   ++    
Sbjct: 61  ARNEFRALQKLQGLA--------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112

Query: 460 ARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR 501
              +   +    R  VHG++    +L+ +E    I  F  + 
Sbjct: 113 LEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 1e-05
 Identities = 21/126 (16%), Positives = 40/126 (31%), Gaps = 6/126 (4%)

Query: 81  MPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLT 140
           +   +      ++ +L           +L      V L+   +     +    + +  L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELL 68

Query: 141 HLDLSSNLLNG--SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNL 198
            L+LS+N L     +   +     L   LNLS N+   +          +  L L  N+L
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLK-ILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 199 SGEIPQ 204
           S     
Sbjct: 128 SDTFRD 133

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 2e-05
 Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 3/117 (2%)

Query: 113 TNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLL-DLRALTGTLNLSF 171
                L    +         +   +NLT L + +      L    L  L  L   L +  
Sbjct: 8   HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVK 65

Query: 172 NQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQ 228
           +      P+ +   P +  L+L  N L     +    L+      SGNP  C   L+
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 4e-04
 Identities = 17/101 (16%), Positives = 29/101 (28%), Gaps = 3/101 (2%)

Query: 61  HCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLF-NATNLVYLD 119
            C  +  + L              L    +LT L + +    + +          L  L 
Sbjct: 4   ACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 120 LAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDL 160
           +  +      PD       L+ L+LS N    SL    +  
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFN-ALESLSWKTVQG 102

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 5e-05
 Identities = 24/93 (25%), Positives = 34/93 (36%), Gaps = 4/93 (4%)

Query: 107 ANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGT 166
           A   NA     LDL        I +   TL     +D S N +     +    LR L  T
Sbjct: 12  AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLK-T 67

Query: 167 LNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS 199
           L ++ N+       +    P +  L L NN+L 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 8e-05
 Identities = 11/75 (14%), Positives = 20/75 (26%), Gaps = 13/75 (17%)

Query: 55  CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATN 114
           C      C  ++VT +           PS   L  +   L                   +
Sbjct: 8   CSNRVFLCQESKVTEI-----------PS--DLPRNAIELRFVLTKLRVIQKGAFSGFGD 54

Query: 115 LVYLDLAHNSFCGPI 129
           L  ++++ N     I
Sbjct: 55  LEKIEISQNDVLEVI 69

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 1e-04
 Identities = 13/108 (12%), Positives = 26/108 (24%), Gaps = 3/108 (2%)

Query: 47  WSESDSTPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIP 106
               +      +    +      L+L    +                    +NN  +   
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194

Query: 107 ANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLP 154
                A+  V LD++           ++ LK L      +      LP
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKKLP 239

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 6/66 (9%)

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTL 167
            L N + L  L    N      P  + +L NL  + L +N ++   P  L +   L   +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLF-IV 222

Query: 168 NLSFNQ 173
            L+ NQ
Sbjct: 223 TLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 4e-04
 Identities = 17/78 (21%), Positives = 31/78 (39%), Gaps = 6/78 (7%)

Query: 47  WSESDSTPCHWSGIHCIRN--RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKP 104
                      S +  + N  ++T+L   +  ++    S L  L +L  + L +N  S  
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDV 210

Query: 105 IPANLFNATNLVYLDLAH 122
            P  L N +NL  + L +
Sbjct: 211 SP--LANTSNLFIVTLTN 226

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 27/161 (16%), Positives = 43/161 (26%), Gaps = 14/161 (8%)

Query: 55  CHWSGIHCIRNRVTS-----------LYLP-NRNLTGYMPSELGLLNSLTRLSLASNNFS 102
           C  + + C    +             L L  N           G L  L +L L  N  +
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 103 KPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRA 162
              P     A+++  L L  N            L  L  L+L  N ++  +P     L +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 163 LTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP 203
           L  T     +        +      +    L         P
Sbjct: 128 L--TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 13/39 (33%), Positives = 16/39 (41%), Gaps = 2/39 (5%)

Query: 108 NLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSS 146
            L   T L  L L+ N         +  LKNL  L+L S
Sbjct: 173 PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFS 209

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	642
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.86
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.85
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.84
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.79
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.79
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.79
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.69
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.63
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.58
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.57
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.57
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.57
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.53
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.53
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.49
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.47
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.44
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.33
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.25
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.2
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.09
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.99
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.97
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.86
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.77
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.74
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.21
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.84
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.76
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.18
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.76
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.89

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=373.31  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=206.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++.....+..  ...||||++.........+.|.+|+++|++++|||||+++|+|...+..++||||
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey  108 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKR--EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF  108 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---C--CEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEEECCCCE--EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEE
T ss_conf             56980278829999999579978--8999999978445989999999999999857998886189999628877999972


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      |++|+|.+++.....    .++|.++..|+.|||+||+|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       109 ~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         109 MENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             CCCCCCEEEECCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf             279853002104567----99999999999999998898852---79835761504489889991998884431575677


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             8654453025328886555679830285323248888963306779999999994-999999999995317899999985
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....       .........||..|+|||.... ..++.++|||||||++|||+| |+.||.+..     ..+.......
T Consensus       182 ~~~~-------~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~~~~~~i~~  248 (299)
T d1jpaa_         182 TSDP-------TYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQDVINAIEQ  248 (299)
T ss_dssp             ---------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHT
T ss_pred             CCCC-------EEEECCCCCCCCCCCCHHHHHC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHC
T ss_conf             7765-------3650256668830038788836-9978612144535789999867999999999-----9999999973


Q ss_pred             CC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             15-98753338455411047999999999998637789999999789999998542
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                      .. .+....++             ..+.+++.+||+.||++||||.+|++.|+++.
T Consensus       249 ~~~~~~~~~~~-------------~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         249 DYRLPPPMDCP-------------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             TCCCCCCTTCC-------------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             78899974226-------------99999999975879768929999999999984

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.87  Aligned_cols=251  Identities=20%  Similarity=0.338  Sum_probs=202.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....+      ..||||++......  .++|.+|++++.+++|||||+++|+|...+..++||||
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTT------EEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEECCC------CEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf             88982088829999998899------99999998788676--89999999999966899756535243159933799983


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    .++|..+..|+.|||.||+|||+   ++|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             CCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCC
T ss_conf             699918997520134----78899999999999998776531---64310443153266668877686553210023688


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ...           ......||..|+|||++.. ..++.++|||||||++|||+|+..|+...    ....+........
T Consensus       155 ~~~-----------~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~----~~~~~~~~~i~~~  218 (263)
T d1sm2a_         155 QYT-----------SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTG  218 (263)
T ss_dssp             ---------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCS----CCHHHHHHHHHHT
T ss_pred             CCE-----------EECCEECCCCCCCHHHHCC-CCCCCHHHHCCHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHHC
T ss_conf             733-----------5043001766678578607-99984033210599999998789888778----9999999999806


Q ss_pred             CC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             59-87533384554110479999999999986377899999997899999985424
Q 006522          587 RR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       587 ~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      .. ..++.+++             ++.+++.+||+.||++||||++|++.|++|++
T Consensus       219 ~~~~~p~~~~~-------------~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         219 FRLYKPRLAST-------------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCCCCCTTSCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             88899543679-------------99999999765797689199999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=366.43  Aligned_cols=253  Identities=22%  Similarity=0.375  Sum_probs=203.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||||++.....  ..++|.+|+++|++++|||||+++|+|.+.+..++||||
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGT-----EEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEECCCC-----EEEEEEEECCCCC--HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf             659820888089999999999-----6999999777610--399999999999867999882677527457854787631


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..++|..+..|+.|||.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        95 ~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          95 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             CCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf             467606777530355---415799999999999997888987---89305760457689989992898324454653788


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ....           .....|+..|+|||++.. ..++.++|||||||++|||+||..|+....    ...+........
T Consensus       169 ~~~~-----------~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----~~~~~~~~i~~~  232 (287)
T d1opja_         169 TYTA-----------HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELLEKD  232 (287)
T ss_dssp             SSEE-----------ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----CHHHHHHHHHTT
T ss_pred             CCEE-----------ECCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHCC
T ss_conf             7221-----------035566546669278727-999810430217899999986799887742----599999998558


Q ss_pred             -CCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             -5987533384554110479999999999986377899999997899999985424
Q 006522          587 -RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       587 -~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                       ..+..+.+++             .+.+++.+||+.||++||||.++++.|+.+..
T Consensus       233 ~~~~~~~~~~~-------------~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         233 YRMERPEGCPE-------------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCCCCCHH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             88888743309-------------99999999757797689399999999999987

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.28  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=198.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             30027557761189993589999997299999912898-32108999999999861568971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++...        ..||||+++... .....+.|.+|+.++.+++|||||+++|++.+ +..++|||
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEEEECCCCEEEEEEEC--------CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             889830788589999999--------989999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      |+++|+|.++++....    .++|..+..|+.|||+||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 y~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             CCCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf             5899888999852357----89999999999999999888750---9995161478997981899788750022133355


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             98654453025328886555679830285323248--8889633067799999999949999999999953178999999
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG--SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ....          .......||+.|||||++...  ..++.++|||||||++|||+||+.||.+...    ........
T Consensus       157 ~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~~~~~~  222 (276)
T d1uwha_         157 WSGS----------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMV  222 (276)
T ss_dssp             -------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHH
T ss_pred             CCCC----------CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHH
T ss_conf             6776----------312566557431799999505689999531516359999999978899899896----99999999


Q ss_pred             HHCCC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             85159-87533384554110479999999999986377899999997899999985424
Q 006522          584 FRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       584 ~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      ..... +....+.+.         ....+.+++.+||+.||++||||.++++.|+.++.
T Consensus       223 ~~~~~~p~~~~~~~~---------~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         223 GRGYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             HHTSCCCCGGGSCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HCCCCCCCCHHCCCC---------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             658889860003655---------54999999999758897689299999999999997

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.50  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             CCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEECC
Q ss_conf             02755776118999358999999729999991289832108999999999861568971148899995891489995056
Q 006522          349 VVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDFIR  428 (642)
Q Consensus       349 ~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  428 (642)
                      .||+|+||.||+|.....+.   ...||||.++........++|.+|+++|.+++|||||+++|+|.+ +..++||||++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~   91 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG   91 (285)
T ss_dssp             EEECCTTEEEEEEEEC---C---CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             EEECCCCEEEEEEEEECCCC---CEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEECC
T ss_conf             87306080999999960897---689999998820397899999999999986799888068656036-80799998078


Q ss_pred             CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             99688887239999999999999999999999999998703999951058899991238999808911255334799986
Q 006522          429 NGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGTSK  508 (642)
Q Consensus       429 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~~~  508 (642)
                      +|+|.+++.....    .+++..+..|+.|||.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        92 ~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          92 GGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             TEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             CCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCC
T ss_conf             9968997521256----99999999999999998789986---8810576764660454688542033134211554343


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             54453025328886555679830285323248888963306779999999994-99999999999531789999998515
Q 006522          509 VTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFRER  587 (642)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~~~  587 (642)
                      ..         .......||..|+|||++.. ..++.++|||||||++|||+| |+.||.+...     .+.........
T Consensus       165 ~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~i~~~~  229 (285)
T d1u59a_         165 YY---------TARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGK  229 (285)
T ss_dssp             EE---------CCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTC
T ss_pred             CC---------CCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHCCC
T ss_conf             21---------13562113743358688727-99995412322017899999389999999799-----99999998189


Q ss_pred             -CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -9875333845541104799999999999863778999999978999999854
Q 006522          588 -RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       588 -~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                       .+.++.+++             .+.+++.+||+.+|++||||.+|++.|+.+
T Consensus       230 ~~~~p~~~~~-------------~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 RMECPPECPP-------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCCCTTCCH-------------HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9999976789-------------999999997577976890999999999999

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.57  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             CCCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCCEEEEE
Q ss_conf             130027557761189993589999997299999912898321089999999998615-6897114889999589148999
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       346 ~~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ....||+|+||.||++.............||+|.+...........+.+|+.++.++ +|||||++++++.+.+..++||
T Consensus        41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (325)
T d1rjba_          41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF  120 (325)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             70198307881999999857885542049999996633587899999999999997158996868778886299589999


Q ss_pred             EECCCCCHHHHHHCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEE
Q ss_conf             505699688887239999------------------99999999999999999999999870399995105889999123
Q 006522          425 DFIRNGSLYAALHAGPSD------------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILL  486 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILl  486 (642)
                      ||+++|+|.++++.....                  ....++|..++.|+.|||+||+|||+   ++|+||||||+|||+
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill  197 (325)
T d1rjba_         121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV  197 (325)
T ss_dssp             ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred             ECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHCCCC
T ss_conf             72799959999986257775102210000122200125778999999999999999999973---990505270321443


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCC
Q ss_conf             899980891125533479998654453025328886555679830285323248888963306779999999994-9999
Q 006522          487 DDELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLP  565 (642)
Q Consensus       487 d~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P  565 (642)
                      +.++.+||+|||+|+..........          .....||..|||||++.. ..++.++|||||||++|||+| |+.|
T Consensus       198 ~~~~~~Kl~DFGla~~~~~~~~~~~----------~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~P  266 (325)
T d1rjba_         198 THGKVVKICDFGLARDIMSDSNYVV----------RGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP  266 (325)
T ss_dssp             ETTTEEEECCCGGGSCGGGCTTSEE----------ETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCCCEEEEEECCCCCCCCCCCCEEE----------ECCCCCCCCCCCHHHHCC-CCCCCCEECCCHHHHHHHHHHCCCCC
T ss_conf             4598289851422220457786156----------234357876578388727-99996330300039999998389999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             9999999531789999998515987533384554110479999999999986377899999997899999985
Q 006522          566 DAGPENDGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDR  638 (642)
Q Consensus       566 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~  638 (642)
                      |.+.... ..+...+....  +.+....+++             .+.+++.+||+.||++||||.||++.|..
T Consensus       267 f~~~~~~-~~~~~~~~~~~--~~~~p~~~~~-------------~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         267 YPGIPVD-ANFYKLIQNGF--KMDQPFYATE-------------EIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             STTCCCS-HHHHHHHHTTC--CCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCHH-HHHHHHHHCCC--CCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             9998989-99999985699--8998876789-------------99999999758896689399999999748

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.38  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=204.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      .++||+|+||.||+|....+++ .....||||++..........+|.+|++++.+++|||||+++|++.+.+..++||||
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~   90 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY   90 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EEEEEECCCEEEEEEEEECCCC-EEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
T ss_conf             1598117790999999968998-787999999988445968999999999999856898783236778338803899972


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +.+|++.+.+.....    .++|..+++|+.|||.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        91 ~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          91 MENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             CTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             CCCCCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf             135740222102345----42089999999999985412121---23425765644278889984998455103003578


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ....         .......||..|+|||++.. ..++.++|||||||++|||+||..|+....    ...+..+.....
T Consensus       164 ~~~~---------~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~~~i~~~  229 (283)
T d1mqba_         164 PEAT---------YTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAINDG  229 (283)
T ss_dssp             -------------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTT
T ss_pred             CCCC---------EEECCCCCCCCCCCHHHHCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCC----CHHHHHHHHHCC
T ss_conf             7652---------67426777734348888704-999973556344898999996798865568----999999998635


Q ss_pred             CC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             59-8753338455411047999999999998637789999999789999998542
Q 006522          587 RR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       587 ~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                      .+ +....+.             ..+.+++.+||+.+|++||||.+|++.|+++.
T Consensus       230 ~~~~~~~~~~-------------~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         230 FRLPTPMDCP-------------SAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             CCCCCCTTCB-------------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHH-------------HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             7899850457-------------99999999977679768939999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.96  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=197.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....+      ..||||++......  .+.|.+|++++.+++|||||+++|++. .+..++||||
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey   88 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             EEEEECCCCCEEEEEEECCC------CEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEEEE
T ss_conf             67981079828999999999------99999998647688--899999999998679998857873104-5976999995


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   .+++|..+++|+.|||+||.|||+   ++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        89 ~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          89 MENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf             789828888751478---988788999999999999999974---89546756422515620244042341014773588


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ...           ......|+..|+|||++.. ..++.++|||||||++|||+||..|+....    ...+........
T Consensus       163 ~~~-----------~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~i~~~  226 (272)
T d1qpca_         163 EYT-----------AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQNLERG  226 (272)
T ss_dssp             CEE-----------CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHHTT
T ss_pred             CCC-----------CCCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHHC
T ss_conf             644-----------2035677444458289837-999824564525799999996898888888----999999999706


Q ss_pred             CC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             59-875333845541104799999999999863778999999978999999854
Q 006522          587 RR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       587 ~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      .. ...+.+.+             .+.+++.+||+.||++||||.+|++.|+.+
T Consensus       227 ~~~~~p~~~~~-------------~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 YRMVRPDNCPE-------------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             88889655719-------------999999997588976893999999986113

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.28  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=198.5

Q ss_pred             CCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             0027557761189993589999997299999912898-321089999999998615689711488999958914899950
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       348 ~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ..||+|+||.||+|......   ..+.||||+++... .....+.|.+|+++|++++|||||+++|+|.. +..++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK---VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS---SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCCCCCCCEEEEEEEECCCC---CCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEEC
T ss_conf             78345878299999981697---38599999988010898999999999999986799898527777505-977999974


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.++++...     +++|..+++|+.|||.||+|||+   ++|+||||||+|||++.++.+|++|||+++.+...
T Consensus        89 ~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          89 AELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             CTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCC
T ss_conf             78896899975225-----78999999999999999766874---79556777611310235675123413453313432


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             8654453025328886555679830285323248888963306779999999994-999999999995317899999985
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .....         ......||..|+|||.+.. ..++.++|||||||++|||+| |+.||.+..     ..+.......
T Consensus       161 ~~~~~---------~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~~~~~i~~  225 (277)
T d1xbba_         161 ENYYK---------AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSEVTAMLEK  225 (277)
T ss_dssp             CSEEE---------C----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHT
T ss_pred             CCCCC---------CCCCCCCCCEECCCHHHCC-CCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHC
T ss_conf             34432---------2445677842039166537-9998434430340313289658999999989-----9999999982


Q ss_pred             CC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             15-9875333845541104799999999999863778999999978999999854
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      .. .+.+..+++             .+.+++.+||+.||++||||.+|+++|+..
T Consensus       226 ~~~~~~p~~~~~-------------~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 GERMGCPAGCPR-------------EMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TCCCCCCTTCCH-------------HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             899999865679-------------999999997588976890989999985288

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.35  Aligned_cols=248  Identities=20%  Similarity=0.259  Sum_probs=196.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++....++     ..||+|++.........+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf             989721748099999999999-----799999984566412799999999999857998884696540467436798864


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++....     .+++..+..|+.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        85 ~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          85 CSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             58980899975379-----99999999999999999999997---59835754689978878998798323142240468


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ...          ......+||+.|||||++.....++.++||||+||++|||+||+.||..........    ......
T Consensus       157 ~~~----------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----~~~~~~  222 (271)
T d1nvra_         157 NRE----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEK  222 (271)
T ss_dssp             TEE----------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH----HHHHTT
T ss_pred             CCC----------CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHHCC
T ss_conf             865----------311132557474287286189999971016173799999982997888898599999----998638


Q ss_pred             CCC--CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             598--753338455411047999999999998637789999999789999
Q 006522          587 RRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ...  ....+++             .+.+++.+|++.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~s~-------------~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         223 KTYLNPWKKIDS-------------APLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             CTTSTTGGGSCH-------------HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             887886446999-------------9999999976799668909999961

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=357.06  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=206.9

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.............||||++.........++|.+|++++++++||||++++++|...+..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~   97 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY   97 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEEEEEEE
T ss_conf             67982078839999998887657788299999988210857999999999999966899765524666059803899981


Q ss_pred             CCCCCHHHHHHCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC
Q ss_conf             5699688887239999-------------------999999999999999999999998703999951058899991238
Q 006522          427 IRNGSLYAALHAGPSD-------------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD  487 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld  487 (642)
                      +++|+|.++++.....                   ....++|..+++|+.|+|.||+|||+   ++++||||||+|||+|
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld  174 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG  174 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             CCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEEEEECCCCEEEC
T ss_conf             5899299999852755421000011100121034678898999999999999998554135---7868548840116898


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCC
Q ss_conf             9998089112553347999865445302532888655567983028532324888896330677999999999499-999
Q 006522          488 DELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR-LPD  566 (642)
Q Consensus       488 ~~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~-~P~  566 (642)
                      .++.+||+|||+|+.+.......          ......|+..|+|||.+.. ..++.++|||||||++|||++|. .||
T Consensus       175 ~~~~~Kl~DFGls~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         175 ENMVVKIADFGLSRNIYSADYYK----------ADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC--------------CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCEEECCCHHHEECCCCCCCC----------CCCCCCCCCCCCCHHHHCC-CCCCHHHHHCCCHHHHHHHHCCCCCCC
T ss_conf             99928983314421136776411----------1577776767679899726-889805630252362999980689999


Q ss_pred             CCCCCCCCCHHHHHHHHHHCCC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             9999995317899999985159-87533384554110479999999999986377899999997899999985424
Q 006522          567 AGPENDGKGLESLVRKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       567 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      .+.     ...+.......... +..+.+.+             ++.+++.+||+.+|++||||.||+++|++|.+
T Consensus       244 ~~~-----~~~e~~~~v~~~~~~~~p~~~~~-------------~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         244 YGM-----AHEEVIYYVRDGNILACPENCPL-------------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTS-----CHHHHHHHHHTTCCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCC-----CHHHHHHHHHCCCCCCCCCCCHH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             998-----99999999973997888732529-------------99999999748896579399999999998429

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.95  Aligned_cols=260  Identities=20%  Similarity=0.327  Sum_probs=205.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CCEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958-91489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN-DEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e  425 (642)
                      .++||+|+||+||+|.+..+++.  ...||||+++........++|.+|+++|++++|||||+++|++... ...++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGK--KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             CEEEEECCCEEEEEEEEECCCCE--EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             66981368809999999779987--9999999988436978999999999999867899986786789806994389998


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      ||++|+|.+++.....    .+++..++.++.|+|.||.|+|+   ++|+||||||+|||+++++.+||+|||+++.+..
T Consensus       110 ~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             CCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             EEECCCHHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCC
T ss_conf             7406741442101345----40489999999998876520033---6762577668757677999889910652322556


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             98654453025328886555679830285323248888963306779999999994999999999995317899999985
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      .....        ........||..|+|||+... ..++.++||||||+++|||+||+.||......    .++......
T Consensus       183 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~i~~  249 (311)
T d1r0pa_         183 KEFDS--------VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLLQ  249 (311)
T ss_dssp             TTCCC--------TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT
T ss_pred             CCCCC--------CEECCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHC
T ss_conf             65553--------100256555645567688743-79997457466199999999789999888999----999999980


Q ss_pred             CCCC-CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             1598-7533384554110479999999999986377899999997899999985424
Q 006522          586 ERRP-LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       586 ~~~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      ..++ .++.+.             ..+.+++.+||+.||++||+|.||++.|+++..
T Consensus       250 g~~~~~p~~~~-------------~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         250 GRRLLQPEYCP-------------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCCCCCTTCC-------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCC-------------HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             89889964475-------------999999999768897689399999999999997

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.19  Aligned_cols=242  Identities=18%  Similarity=0.283  Sum_probs=195.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..||+|.+...... ..+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTC-----CEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEECCCCCEEEEEEECCCC-----CEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf             789812858299999998999-----89999998430172-799999999999867999880585779889998999970


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++...      .+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        99 ~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             3798089886415------99999999999999999999998---79722677688868878996864251564132136


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ..            ......||..|+|||++.. ..++.++||||+||++|||+||+.||.+..     ...........
T Consensus       170 ~~------------~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~~~~~  231 (293)
T d1yhwa1         170 QS------------KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLRALYLIATN  231 (293)
T ss_dssp             TC------------CBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHHHHHH
T ss_pred             CC------------CCCCCCCCCCCCCHHHHCC-CCCCCHHCEEHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHC
T ss_conf             66------------4444444777368266447-998801203137299999804889989979-----99999999857


Q ss_pred             CC-C--CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             59-8--753338455411047999999999998637789999999789999
Q 006522          587 RR-P--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~-~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .. .  ..+.+++             .+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~s~-------------~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GTPELQNPEKLSA-------------IFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSCCCSSGGGSCH-------------HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9998888553799-------------9999999986699668909999964

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.22  Aligned_cols=259  Identities=20%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|+++..........+.+|+.+|++++|||||+++++|.+.++.++||||
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTT-----EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             789712778099999998999-----699999987540978999999999999867999999499999989999999976


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++...+     .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        86 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          86 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             79986899874249-----999999999999999999999985--99971445779946878998999548776256788


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                                    .....+||..|+|||++.. ..++.++||||+||++|||+||+.||.+.........  .......
T Consensus       159 --------------~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~  221 (322)
T d1s9ja_         159 --------------MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEG  221 (322)
T ss_dssp             --------------TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C------
T ss_pred             --------------CCCCCCCCCCCCCCHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHHCC
T ss_conf             --------------6211137714119468758-9989488899899999999988899899887899999--9887517


Q ss_pred             CC----C--------C-CCCCCH----HHHHCHH-----------HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             59----8--------7-533384----5541104-----------7999999999998637789999999789999
Q 006522          587 RR----P--------L-SEVIDP----ALVKEIH-----------AKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       587 ~~----~--------~-~~~~d~----~l~~~~~-----------~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ..    .        . ....+.    .......           ......++.+++.+|+..||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             7545774212333221111222354134778876650268766764448999999999986899467908999960

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.13  Aligned_cols=242  Identities=22%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             30027557761189993589999997299999912898--3210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++....++     ..||+|.+....  .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEECCCCCEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             889851778589999998999-----499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECC
T ss_conf             5047985898875048-----99999999999999999999998---894652202344146689987115556335448


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...              .....||..|+|||++.. ..++.++||||+||++|||+||+.||.+.     ...+......
T Consensus       158 ~~~--------------~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~  217 (263)
T d2j4za1         158 SSR--------------RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRIS  217 (263)
T ss_dssp             CCC--------------CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHH
T ss_pred             CCC--------------CCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH
T ss_conf             885--------------235578876349999758-99893144046759999983299998889-----9999999997


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51598753338455411047999999999998637789999999789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      +....+.+.++++             +.+++.+|++.||++|||+.|+++
T Consensus       218 ~~~~~~p~~~s~~-------------~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         218 RVEFTFPDFVTEG-------------ARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTCCCCCTTSCHH-------------HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCCHH-------------HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             1899998668999-------------999999976479768909999971

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.88  Aligned_cols=248  Identities=19%  Similarity=0.342  Sum_probs=202.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||++....+      ..||||.++.....  .++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~------~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTT------EEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             EEEEECCCCEEEEEEEECCC------CEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf             68982078839999998899------89999998747577--89999999999966898601588998507816999970


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    .+++..+.+|+.|+|+||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          81 MANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CTTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             CCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC
T ss_conf             489938886410246----77689999999999999998754---68434665413588769984798861442023578


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             8654453025328886555679830285323248888963306779999999994-999999999995317899999985
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...           ......||..|+|||.+.. ..++.++||||||+++|||+| |+.||....     ..+.......
T Consensus       154 ~~~-----------~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~~~~~i~~  216 (258)
T d1k2pa_         154 EYT-----------SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSETAEHIAQ  216 (258)
T ss_dssp             SCC-----------CCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHHHHHHHHT
T ss_pred             CCE-----------EECCCCCCCCCCCCHHHCC-CCCCCCEEECCCCHHHHHHHHCCCCCCCCCC-----HHHHHHHHHH
T ss_conf             722-----------5246578877578078637-9988521033643246739755999988999-----9999999980


Q ss_pred             CC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             15-9875333845541104799999999999863778999999978999999854
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      .. ...++...+             ++.+++.+||+.||++|||+.++++.|.+|
T Consensus       217 ~~~~~~p~~~~~-------------~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         217 GLRLYRPHLASE-------------KVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCCCCCCTTCCH-------------HHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             797899654659-------------999999997668976893999999874188

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.14  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      .+.||+|+||.||+|.....+ ......||+|++.........++|.+|++++++++|||||+++|+|.+. ..++++||
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~   91 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL   91 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             EEEEECCCCEEEEEEEECCCC-CEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEEEE
T ss_conf             319820899299999995899-8898999999965134979999999999999867998881589999619-83699984


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +.+|+|.+++.....    .++|..+++|+.|||.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        92 ~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          92 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             CTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             CCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf             268740101113345----79999999999999999999987---69504762120311679987586025522233544


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             8654453025328886555679830285323248888963306779999999994-999999999995317899999985
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....          ......||..|+|||++.. ..++.++|||||||++|||+| |+.||.+...  ..+...+...  
T Consensus       165 ~~~~----------~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~--  229 (317)
T d1xkka_         165 EKEY----------HAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG--  229 (317)
T ss_dssp             CC------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHT--
T ss_pred             CCCC----------CCCCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHCC--
T ss_conf             4532----------2365105864467088746-99983565440799999999779999999998--9999999759--


Q ss_pred             CCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             1598753338455411047999999999998637789999999789999998542
Q 006522          586 ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                      .+.+..+.+++             .+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       230 ~~~~~p~~~~~-------------~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         230 ERLPQPPICTI-------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CCCCCCTTBCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             98999855689-------------9999999847899346919999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=350.66  Aligned_cols=243  Identities=19%  Similarity=0.315  Sum_probs=194.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC--CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             300275577611899935899999972999999128983--210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      .+.||+|+||.||++....++     ..||||.+.....  ....+.+.+|+++|.+++|||||++++++.+.+..++||
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTT-----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             279701888099999998999-----399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|+|..++....     ++++..+..|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        95 E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCC
T ss_conf             8069994578997379-----99999999999999999999986---897666788421798799978984436533467


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             99865445302532888655567983028532324--8888963306779999999994999999999995317899999
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY--GSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..                ....||+.|||||++..  ...++.++|||||||++|||++|+.||.+..     ..+....
T Consensus       167 ~~----------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~-----~~~~~~~  225 (309)
T d1u5ra_         167 PA----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYH  225 (309)
T ss_dssp             SB----------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HHHHHHH
T ss_pred             CC----------------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH
T ss_conf             78----------------73134766368899834678886721454558999999987889999979-----9999999


Q ss_pred             HHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9851598753338455411047999999999998637789999999789999
Q 006522          583 AFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ......+  ...+..+         ...+.+++.+||+.||++|||+.++++
T Consensus       226 i~~~~~~--~~~~~~~---------s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         226 IAQNESP--ALQSGHW---------SEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHSCCC--CCSCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCC--CCCCCCC---------CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9828999--8887888---------999999999977379657918999971

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=350.34  Aligned_cols=247  Identities=19%  Similarity=0.267  Sum_probs=197.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|.+...........+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        14 ~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_          14 RDVLGTGAFSEVILAEDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             EEESBSGGGGGEEEEEETTTC-----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             889940658399999999999-----899999981577312899999999999867998999198999989988898852


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC---CCCCEEEECCCCCCCC
Q ss_conf             5699688887239999999999999999999999999998703999951058899991238---9998089112553347
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGFGLNRLL  503 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld---~~~~~ki~DfGla~~~  503 (642)
                      +++|+|.+++....     .+++..+..|+.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+..
T Consensus        89 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          89 VSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf             68984888653036-----78878999999999999875241---30556870463001104688824998315435872


Q ss_pred             CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             99986544530253288865556798302853232488889633067799999999949999999999953178999999
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....             ....+||..|+|||++.. ..++.++||||+||++|||+||+.||.+..     ..+.....
T Consensus       161 ~~~~~-------------~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~~~~~~i  221 (307)
T d1a06a_         161 DPGSV-------------LSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DAKLFEQI  221 (307)
T ss_dssp             -------------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHH
T ss_pred             CCCCE-------------EEEEEECCCCCCCHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHH
T ss_conf             58970-------------440032842259188737-999807873451599999985979999989-----99999998


Q ss_pred             HHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             851598753338455411047999999999998637789999999789999
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ............+.+    .     ..+.+++.+|++.||++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~----s-----~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         222 LKAEYEFDSPYWDDI----S-----DSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HTTCCCCCTTTTTTS----C-----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HCCCCCCCCCCCCCC----C-----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             616877787666678----9-----99999999976089757918999862

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=349.08  Aligned_cols=247  Identities=17%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..||||++...... ..+.+.+|+.+|.+++|||||++++++.+.+..++||||
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g-----~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTT-----EEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECCCCHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             889840768199999988999-----89999998452431-699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC--CCCCEEEECCCCCCCCC
Q ss_conf             5699688887239999999999999999999999999998703999951058899991238--99980891125533479
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLP  504 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld--~~~~~ki~DfGla~~~~  504 (642)
                      |++|+|.+++.....    .+++..+..|+.||+.||+|||+   .+|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       105 ~~gg~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         105 MSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCSCBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECC
T ss_conf             799889999976237----89999999999999999999975---69760001546736416889869995452104425


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....||..|||||++.. ..++.++||||+||++|||+||+.||.+.     ...+..+...
T Consensus       178 ~~~~-------------~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~i~  238 (350)
T d1koaa2         178 PKQS-------------VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRNVK  238 (350)
T ss_dssp             TTSC-------------EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             CCCC-------------CCEECCCCCCCCHHHHCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             6543-------------200068624218899758-99872676554659999998598998997-----9999999998


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51598753338455411047999999999998637789999999789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ...........+.+    .     ..+.+++.+|+..||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~----s-----~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         239 SCDWNMDDSAFSGI----S-----EDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HTCCCSCCGGGGGC----C-----HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HCCCCCCCCCCCCC----C-----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             47889894223589----9-----99999999975689667908999862

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.53  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=198.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|....+      ..||||++......  .+.|.+|+.++.+++|||||+++|+|. .+..++||||
T Consensus        22 ~~~iG~G~fg~Vy~~~~~~~------~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          22 EVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             EEEEEECCCEEEEEEEECCC------CEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEE
T ss_conf             46993079809999999999------99999998804488--899999999998666678868999982-3975999994


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....   ..++|..++.|+.|||.||+|||+   ++|+||||||+|||+|.++.+||+|||+++.+...
T Consensus        93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             CCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf             479943542000035---530599999999999999998754---11433531230799989992998442555425688


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf             86544530253288865556798302853232488889633067799999999949999999999953178999999851
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFRE  586 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~~  586 (642)
                      ...           ......||..|+|||++.. ..++.++||||||+++|||+||..|+.....    ..+........
T Consensus       167 ~~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----~~~~~~~i~~~  230 (285)
T d1fmka3         167 EYT-----------ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERG  230 (285)
T ss_dssp             --------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTT
T ss_pred             CCE-----------EECCCCCCCCCCCHHHHHC-CCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC----HHHHHHHHHHC
T ss_conf             733-----------5245455665458089837-9989177413235899999868999998888----99999999826


Q ss_pred             -CCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             -59875333845541104799999999999863778999999978999999854
Q 006522          587 -RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       587 -~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                       ..+..+.+++             ++.+++.+||+.||++||+|.+|+++|+..
T Consensus       231 ~~~~~~~~~~~-------------~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         231 YRMPCPPECPE-------------SLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             CCCCCCTTSCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             89999832379-------------999999997566975891999999987666

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.03  Aligned_cols=245  Identities=20%  Similarity=0.303  Sum_probs=195.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|++..... ...+.|.+|+++|++++|||||++++++.+.+..++||||
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEECCCCEEEEEEECCCC-----EEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             479930778199999999999-----3999999872899-9999999999999867999988498898009958999962


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    ++++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 ~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          91 CAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             CCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC
T ss_conf             799818899986289----99999999999999999999998---89887140700314878999899716123035778


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             86544530253288865556798302853232----48888963306779999999994999999999995317899999
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARI----YGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ..            ......||..|+|||++.    .+..++.++||||+||++|||+||+.||.+...     .+....
T Consensus       164 ~~------------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~~~~  226 (288)
T d2jfla1         164 IQ------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRVLLK  226 (288)
T ss_dssp             HH------------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHHHH
T ss_pred             CC------------CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH
T ss_conf             64------------1001025626479999832025788888066578789999998208899999899-----999999


Q ss_pred             HHHCCCCC---CCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             98515987---53338455411047999999999998637789999999789999
Q 006522          583 AFRERRPL---SEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~~---~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ......+.   ...+++             .+.+++.+||+.||++|||+.|+++
T Consensus       227 i~~~~~~~~~~~~~~s~-------------~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         227 IAKSEPPTLAQPSRWSS-------------NFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCCCCCSSGGGSCH-------------HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHCCCCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             97079987776566999-------------9999999976699668919999962

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.39  Aligned_cols=264  Identities=22%  Similarity=0.329  Sum_probs=204.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECC-CEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615-6897114889999589-148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYAND-EKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lv~  424 (642)
                      ...||+|+||.||++...........+.||||++.........+.+.+|...+.++ +|+|||.+++++...+ ..++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
T ss_conf             44984167839999998677755578399999986001717899999999998861499849974115404797579999


Q ss_pred             EECCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEE
Q ss_conf             505699688887239999-----------999999999999999999999998703999951058899991238999808
Q 006522          425 DFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPC  493 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~k  493 (642)
                      ||+++|+|.++++.....           ....++|..++.|+.|||+||+|||+   ++|+||||||+|||++.++.+|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEE
T ss_pred             EECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEE
T ss_conf             8458992999998536666653222023321468999999999999999998873---7971786773106577998289


Q ss_pred             EECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCC
Q ss_conf             9112553347999865445302532888655567983028532324888896330677999999999499-999999999
Q 006522          494 ISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR-LPDAGPEND  572 (642)
Q Consensus       494 i~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~-~P~~~~~~~  572 (642)
                      |+|||+|+........          .......||..|+|||++.. ..++.++|||||||++|||+||. .||......
T Consensus       175 l~DFGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         175 ICDFGLARDIYKDPDY----------VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             ECC------CCSCTTS----------CCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ECCCCCHHHCCCCCCC----------CCCCCEEECCCCCCHHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH
T ss_conf             8457520011356652----------22475166721020368646-889966322136789999986889999899989


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             53178999999851598753338455411047999999999998637789999999789999998542
Q 006522          573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                       ..+...+...  ......+.+++             .+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       244 -~~~~~~~~~~--~~~~~~~~~~~-------------~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 -EEFCRRLKEG--TRMRAPDYTTP-------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             -HHHHHHHHHT--CCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHCC--CCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             -9999999638--98888865789-------------9999999976779667919999999997998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.33  Aligned_cols=246  Identities=17%  Similarity=0.244  Sum_probs=200.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             30027557761189993589999997299999912898--3210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     ..||||.+....  .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             889850879099999998999-----799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|+|.+++...+     .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+|+.+.
T Consensus        88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECC
T ss_conf             7048987777653159-----99999999999999999976216---508847677412366888538860321024225


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      .....          .......||..|+|||++.. ..++.++||||+||++|||+||+.||.+.     +.........
T Consensus       160 ~~~~~----------~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~i~  223 (288)
T d1uu3a_         160 PESKQ----------ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQKII  223 (288)
T ss_dssp             --------------------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             CCCCC----------CCCCCCCCCCCCCCCEEECC-CCCCCCCCEEHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             67764----------33355567755258440026-89896662304569999980388998995-----9999999997


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51598753338455411047999999999998637789999999789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .....+.+.++++             +.+++.+|++.||++|||+.|+..
T Consensus       224 ~~~~~~p~~~s~~-------------~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         224 KLEYDFPEKFFPK-------------ARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTCCCCCTTCCHH-------------HHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCCCCCCCCCHH-------------HHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             1899998547999-------------999999985579768919789737

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.17  Aligned_cols=255  Identities=20%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+.  ....||||.++........+.|.+|+.++++++|||||+++|++. .+..++||||
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~   88 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPEN--PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL   88 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             EEEEEECCCCEEEEEEEECCCC--EEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEEE
T ss_conf             7799307882999999936996--449999999365668799999999999998689999856988995-3747999984


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389998089112553347999
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPGT  506 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~~  506 (642)
                      +++|+|.+++.....    .+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        89 ~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          89 CTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             CTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             CCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf             069807765422478----99999999999999877523022---67441410265532067896787650342133677


Q ss_pred             CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             8654453025328886555679830285323248888963306779999999994-999999999995317899999985
Q 006522          507 SKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ..           .......||..|+|||++.. ..++.++|||||||++|||+| |+.||.+...  ..+.   .....
T Consensus       162 ~~-----------~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~---~~i~~  224 (273)
T d1mp8a_         162 TY-----------YKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVI---GRIEN  224 (273)
T ss_dssp             --------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHH---HHHHT
T ss_pred             CC-----------EECCCEECCCCCCHHHHHCC-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHH---HHHHC
T ss_conf             62-----------33054005831032667516-99887452444247899998269999888999--9999---99981


Q ss_pred             CC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             15-987533384554110479999999999986377899999997899999985424
Q 006522          586 ER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       586 ~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      .. .+....+++             .+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus       225 ~~~~~~~~~~~~-------------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         225 GERLPMPPNCPP-------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             TCCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             899989877799-------------99999999768797689299999999999977

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.67  Aligned_cols=243  Identities=21%  Similarity=0.341  Sum_probs=191.1

Q ss_pred             CCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE----CCCEEE
Q ss_conf             0027557761189993589999997299999912898-32108999999999861568971148899995----891489
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-ATWRFKDFESEVEAIARVQHPNIVRLKAFYYA----NDEKLL  422 (642)
Q Consensus       348 ~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~l  422 (642)
                      ..||+|+||.||++....++     ..||+|.+.... .....+.|.+|+++|++++|||||++++++.+    ....++
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~-----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEECCCCCEEEEEEECCCC-----EEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf             69700828499999999999-----5999999851227989999999999999857999850699998403345888999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC-CCCCEEEECCCCCC
Q ss_conf             99505699688887239999999999999999999999999998703999951058899991238-99980891125533
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD-DELHPCISGFGLNR  501 (642)
Q Consensus       423 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld-~~~~~ki~DfGla~  501 (642)
                      ||||+++|+|.+++....     .+++..+..|+.||+.||+|||+.. ++|+||||||+|||++ +++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf             995789894899975135-----5469999999999999999999789-9799687674351166799988980057654


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf             47999865445302532888655567983028532324888896330677999999999499999999999531789999
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      ......              .....||+.|+|||++.  ..++.++|||||||++|||+||+.||....    ......+
T Consensus       164 ~~~~~~--------------~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~~~~~~  223 (270)
T d1t4ha_         164 LKRASF--------------AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYR  223 (270)
T ss_dssp             GCCTTS--------------BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHH
T ss_pred             ECCCCC--------------CCCCCCCCCCCCHHHHC--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCC----CHHHHHH
T ss_conf             236876--------------67755381300898847--899986711007999999987889998765----5999999


Q ss_pred             HHHHCCCC--CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             99851598--753338455411047999999999998637789999999789999
Q 006522          582 KAFRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .......+  +...+++             ++.+++.+||+.||++|||+.|+++
T Consensus       224 ~i~~~~~~~~~~~~~~~-------------~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         224 RVTSGVKPASFDKVAIP-------------EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHTTTCCCGGGGGCCCH-------------HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHCCCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99738998656755789-------------9999999976379758929999967

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.30  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615-68971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++....++.   ...||||++.........+.|.+|+++|.++ +|||||+++|+|.+.+..++|||
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGL---RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTE---EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEECCCCEEEEEEECCCCE---EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
T ss_conf             7798207882899999989996---9999999978233857999999999999862289988367888841873699998


Q ss_pred             ECCCCCHHHHHHCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEE
Q ss_conf             0569968888723999-----------99999999999999999999999987039999510588999912389998089
Q 006522          426 FIRNGSLYAALHAGPS-----------DSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCI  494 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki  494 (642)
                      |+++|+|.++++....           .....++|..+++++.|||.||.|+|+   ++|+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred             ECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCEEE
T ss_conf             028986999986403555551231012345789999999999999999876630---89545550520489868876387


Q ss_pred             ECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCC
Q ss_conf             1125533479998654453025328886555679830285323248888963306779999999994999-999999995
Q 006522          495 SGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRL-PDAGPENDG  573 (642)
Q Consensus       495 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~-P~~~~~~~~  573 (642)
                      +|||+++......             ......||..|+|||.+.. ..++.++|||||||++|||+||.. ||.+.    
T Consensus       169 ~DfG~a~~~~~~~-------------~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~----  230 (309)
T d1fvra_         169 ADFGLSRGQEVYV-------------KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----  230 (309)
T ss_dssp             CCTTCEESSCEEC-------------CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTC----
T ss_pred             CCCCCCCCCCCCC-------------CCCCEECCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHHCCCCCCCCC----
T ss_conf             4344322444223-------------4553013775555387526-999962215313889999983689999999----


Q ss_pred             CCHHHHHHHHHHCC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             31789999998515-987533384554110479999999999986377899999997899999985424
Q 006522          574 KGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       574 ~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                       ...+......... .+....+++             ++.+++.+||+.||++||||.+|++.|+++.+
T Consensus       231 -~~~~~~~~i~~~~~~~~~~~~~~-------------~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         231 -TCAELYEKLPQGYRLEKPLNCDD-------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             -CHHHHHHHGGGTCCCCCCTTBCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CHHHHHHHHHHCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -99999999982688888766789-------------99999999767896689499999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=345.97  Aligned_cols=247  Identities=18%  Similarity=0.249  Sum_probs=197.8

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++.....+     ..||+|.+...... ..+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECCCCHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             899931778299999998999-----79999998872646-799999999999867997989199999989999999982


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC--CCCCEEEECCCCCCCCC
Q ss_conf             5699688887239999999999999999999999999998703999951058899991238--99980891125533479
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD--DELHPCISGFGLNRLLP  504 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld--~~~~~ki~DfGla~~~~  504 (642)
                      +++|+|.+++.....    ++++..+..|+.||+.||+|||+   .+|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       108 ~~gg~L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         108 LSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCCBHHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCCCHHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf             899808888986389----98999999999999999999997---79265131445531134678848995256303437


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....|+..|+|||++.. ..++.++||||+||++|||+||+.||.+.     ..........
T Consensus       181 ~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~~~i~  241 (352)
T d1koba_         181 PDEI-------------VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVK  241 (352)
T ss_dssp             TTSC-------------EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHHHHHHHHH
T ss_pred             CCCC-------------EEECCCCCCCCCHHHHCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             8872-------------010047645348999747-99897633389899999999688998997-----9999999998


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51598753338455411047999999999998637789999999789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ...........+.+.         ..+.+++.+|++.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~s---------~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         242 RCDWEFDEDAFSSVS---------PEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HCCCCCCSSTTTTSC---------HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HCCCCCCCCCCCCCC---------HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             478898930024799---------99999999975699668918999960

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.24  Aligned_cols=266  Identities=22%  Similarity=0.283  Sum_probs=196.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----CEEE
Q ss_conf             300275577611899935899999972999999128983210899999999986156897114889999589----1489
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND----EKLL  422 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  422 (642)
                      .+.||+|+||.||+|.. .+      ..||||+++....  ....+..|+..+.+++|||||+++|+|...+    ..++
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g------~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RG------EEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TT------EEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             EEEEEECCCEEEEEEEE-CC------EEEEEEEECCCCH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             88982078819999999-99------8999999872004--679999999999627998683268899837986048999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCEECCCCCCCEEECCCCCEEEECC
Q ss_conf             995056996888872399999999999999999999999999987039-----999510588999912389998089112
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS-----PRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       423 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrdlk~~NILld~~~~~ki~Df  497 (642)
                      |||||++|+|.++++..      .++|..+++++.|+|.||+|+|+..     .++|+||||||+|||++.++.+||+||
T Consensus        79 v~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEECCCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEEC
T ss_conf             99646698989998658------999899999999999999998876652046898661531731357868877688763


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             55334799986544530253288865556798302853232488-----8896330677999999999499999999999
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGS-----KFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DV~SfGviL~el~tG~~P~~~~~~~  572 (642)
                      |+++........        .........||..|+|||++....     .++.++|||||||++|||+||..|+......
T Consensus       153 Gl~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~  224 (303)
T d1vjya_         153 GLAVRHDSATDT--------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  224 (303)
T ss_dssp             TTCEEEETTTTE--------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred             CCCCCCCCCCCC--------EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             866234677762--------001355250354767822105654546777675012201599999996289988766311


Q ss_pred             ----------CCCHHHHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             ----------531789999998515987533384554110479999999999986377899999997899999985424
Q 006522          573 ----------GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       573 ----------~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                                ........ ......     ...|.+............+.+++.+||+.||++||||.||++.|+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         225 QLPYYDLVPSDPSVEEMR-KVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCTTTTTSCSSCCHHHHH-HHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHCCCCCCHHHHHH-HHHHCC-----CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             241012255643099999-987502-----4688877655776899999999999760698589599999999998888

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.17  Aligned_cols=263  Identities=21%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615-68971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||++.............||||+++..........|.+|+.++.++ +|||||+++|+|.+.+..++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf             54982068829999998066447788699999987424877999999999998762699988789989831997899997


Q ss_pred             ECCCCCHHHHHHCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCE
Q ss_conf             05699688887239999-------------99999999999999999999999870399995105889999123899980
Q 006522          426 FIRNGSLYAALHAGPSD-------------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP  492 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~  492 (642)
                      |+++|+|.++++.....             ....+++..+..|+.|||+||+|||+   ++++||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred             CCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCC
T ss_conf             37998799999853566544444533222334588999999999999999998875---792666241021000025752


Q ss_pred             EEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf             8911255334799986544530253288865556798302853232488889633067799999999949-999999999
Q 006522          493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTG-RLPDAGPEN  571 (642)
Q Consensus       493 ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG-~~P~~~~~~  571 (642)
                      |++|||+++.........          ......||..|+|||++.. ..++.++|||||||++|||+|+ ++|+... .
T Consensus       185 ki~DfG~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~  252 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYV----------VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGM-P  252 (311)
T ss_dssp             EECCCGGGSCTTSCTTSE----------ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-C
T ss_pred             CCCCCCHHEECCCCCCCE----------EEEECCCCHHHCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-C
T ss_conf             102340102336788615----------8620135968767788617-999974001025899999985899887789-9


Q ss_pred             CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             95317899999985159875333845541104799999999999863778999999978999999854
Q 006522          572 DGKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       572 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      ....+...+....  +....+.+++             .+.+++.+||+.||++||||.+++++|+++
T Consensus       253 ~~~~~~~~i~~~~--~~~~~~~~~~-------------~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 VDSKFYKMIKEGF--RMLSPEHAPA-------------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SSHHHHHHHHHTC--CCCCCTTSCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCC--CCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             8999999986689--8898543659-------------999999997577965792999999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=345.04  Aligned_cols=246  Identities=21%  Similarity=0.235  Sum_probs=193.9

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHH---HHHHHHCCCCCCEEEEEEEEEECCCEE
Q ss_conf             30027557761189993589999997299999912898--3210899999---999986156897114889999589148
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFES---EVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~  421 (642)
                      .+.||+|+||.||++....++     ..||+|.+....  .......+.+   |+.+++.++|||||++++++.+.+..+
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             018842889099999999999-----799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99950569968888723999999999999999999999999999870399995105889999123899980891125533
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       422 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                      +||||+++|+|.+++....     .+++..+..|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf             9999148983899987325-----53278999999999999999997---796220444221678588967982201023


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf             47999865445302532888655567983028532324888896330677999999999499999999999531789999
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .+....              .....||..|+|||++..+..++.++||||+||++|||+||+.||......  ......+
T Consensus       156 ~~~~~~--------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~  219 (364)
T d1omwa3         156 DFSKKK--------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDR  219 (364)
T ss_dssp             ECSSSC--------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHH
T ss_pred             ECCCCC--------------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH
T ss_conf             337886--------------433113455421687603899984410467789999998599988889989--9999998


Q ss_pred             HHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             99851598753338455411047999999999998637789999999-----789999
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~  634 (642)
                      ..........+.+++++             .+++.+|++.||++|||     +.++++
T Consensus       220 ~~~~~~~~~~~~~s~~~-------------~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 MTLTMAVELPDSFSPEL-------------RSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSSSCCCCCCSSSCHHH-------------HHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HCCCCCCCCCCCCCHHH-------------HHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             60468887887789999-------------9999998566988808874357999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.40  Aligned_cols=251  Identities=20%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CCCEEEE
Q ss_conf             300275577611899935899999972999999128983-2108999999999861568971148899995--8914899
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYA--NDEKLLI  423 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv  423 (642)
                      .+.||+|+||.||++....++     ..||+|.+..... ....+.+.+|++++.+++|||||++++++.+  .+..++|
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTC-----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             679830889199999999999-----799999987465797999999999999997789998248999991789989999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             95056996888872399999999999999999999999999987039--9995105889999123899980891125533
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS--PRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       424 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                      |||+++|+|.+++...... ...+++..++.|+.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EECCCCCCHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             9568999389999851545-789999999999999999999999716778878858676542574788857980010003


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf             47999865445302532888655567983028532324888896330677999999999499999999999531789999
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      .+.....            ......||+.|+|||++. +..++.++|||||||++|||+||+.||.+.     ...+...
T Consensus       163 ~~~~~~~------------~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~~~~  224 (269)
T d2java1         163 ILNHDTS------------FAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKELAG  224 (269)
T ss_dssp             HC-----------------------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHH
T ss_pred             ECCCCCC------------CCCCCCCCCCCCCHHHHC-CCCCCHHHHHHHHCHHHHHHHHCCCCCCCC-----CHHHHHH
T ss_conf             2245777------------556677882327999983-999993898875278999980188998998-----9999999


Q ss_pred             HHHHCCC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9985159-8753338455411047999999999998637789999999789999
Q 006522          582 KAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       582 ~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ....... .+...+++             ++.+++.+||+.||++|||+.|+++
T Consensus       225 ~i~~~~~~~~~~~~s~-------------~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         225 KIREGKFRRIPYRYSD-------------ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHTCCCCCCTTSCH-------------HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHCCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             9971899889743599-------------9999999976799557918999972

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.93  Aligned_cols=244  Identities=22%  Similarity=0.285  Sum_probs=200.9

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             30027557761189993589999997299999912898--3210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++.....+     ..||+|++.+..  .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf             889831768499999998999-----899999981565449799999999999998679998877876403564211100


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|+|.+++....     .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf             0357986055553256-----77599999999999652113431---596224647778476589988882056520035


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....            .....+||+.|+|||++.. ..++.++||||+||++|||+||+.||.+.     +.....+...
T Consensus       157 ~~~~------------~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~~~~~~~i~  218 (337)
T d1o6la_         157 SDGA------------TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHERLFELIL  218 (337)
T ss_dssp             CTTC------------CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             CCCC------------CCCCCEECHHHHHHHHCCC-CCCCHHHCCCCHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             6786------------2055100889966665048-98883331022306788998789999996-----9999999985


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             51598753338455411047999999999998637789999999-----789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~  634 (642)
                      .....++..+++++             .+++..|++.||.+||+     +.++++
T Consensus       219 ~~~~~~p~~~s~~~-------------~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 MEEIRFPRTLSPEA-------------KSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HCCCCCCTTSCHHH-------------HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCCCCCCHHH-------------HHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             28998986689999-------------9999866638934422565234999972

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=339.55  Aligned_cols=241  Identities=20%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCC--CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             3002755776118999358999999729999991289--83210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     ..||||++...  ......+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEECCCCCEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             889720768089999998999-----799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|+|.+++.....     +++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EECCCCCCCCCCCCCCC-----CCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEEC
T ss_conf             50378632234322221-----1100799999999876554124---767705568105038689988983175216712


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...               ...+||..|+|||++. +..++.++||||+||++|||+||+.||.+.     ...+......
T Consensus       156 ~~~---------------~~~~Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~  214 (316)
T d1fota_         156 DVT---------------YTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEKIL  214 (316)
T ss_dssp             SCB---------------CCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHH
T ss_pred             CCC---------------CCCCCCCCCCCHHHHC-CCCCCCHHHCCCCCHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             456---------------4345763435999983-899980430465333689997598999996-----9999999997


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             5159875333845541104799999999999863778999999-----9789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~  634 (642)
                      .....+...+++++             .+++.+|+..||.+|+     |+.++++
T Consensus       215 ~~~~~~p~~~s~~~-------------~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         215 NAELRFPPFFNEDV-------------KDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HCCCCCCTTSCHHH-------------HHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCCCCHHH-------------HHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             08988997789999-------------9999999544997666431021999981

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.72  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=206.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCC--CCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCCEEEE
Q ss_conf             300275577611899935899--99997299999912898321089999999998615-689711488999958914899
Q 006522          347 AYVVGKSKNGIMYKVVVGRGS--GMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  423 (642)
                      .+.||+|+||.||++......  .......||||+++.........++.+|...+.++ +|||||+++++|.+.+..++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCCEEEEE
T ss_conf             00985167828999998578755566754999999881128688999999999999813999697346522018868999


Q ss_pred             EEECCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCE
Q ss_conf             9505699688887239999-----------99999999999999999999999870399995105889999123899980
Q 006522          424 SDFIRNGSLYAALHAGPSD-----------SLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHP  492 (642)
Q Consensus       424 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~  492 (642)
                      |||+++|+|.+++......           ....+++..++.++.|||.||+|||+   .+|+||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCE
T ss_pred             EECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCEEECCCCCE
T ss_conf             97369990999998606776432223345743467999999999999999987663---797863022102245478976


Q ss_pred             EEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf             891125533479998654453025328886555679830285323248888963306779999999994-9999999999
Q 006522          493 CISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPEN  571 (642)
Q Consensus       493 ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~  571 (642)
                      ||+|||+++.......          ........|+..|+|||.+.. ..++.++|||||||++|||+| |+.||.+.. 
T Consensus       175 kl~dfg~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-  242 (299)
T d1fgka_         175 KIADFGLARDIHHIDY----------YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  242 (299)
T ss_dssp             EECSTTCCCCGGGCCT----------TCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             EECCCHHHCCCCCCCC----------CCCCCCCCCCHHHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC-
T ss_conf             7622111011355555----------431466788846632667517-9888255547758888874017989899999-


Q ss_pred             CCCCHHHHHHHHHHCC-CCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             9531789999998515-98753338455411047999999999998637789999999789999998542
Q 006522          572 DGKGLESLVRKAFRER-RPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       572 ~~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                          ..+......... .+....+.+             .+.+++.+||+.||++|||+.||++.|++|.
T Consensus       243 ----~~~~~~~i~~~~~~~~p~~~~~-------------~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         243 ----VEELFKLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----HHHHHHHHHTTCCCCCCSSCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHCCCCCCCCCCCHH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             ----9999999972888898743529-------------9999999976679767939999999998886

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.97  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=196.3

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC-----CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEE
Q ss_conf             30027557761189993589999997299999912898-----3210899999999986156897114889999589148
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD-----ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKL  421 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  421 (642)
                      ...||+|+||.||++.....+     ..||||.+....     .....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             279811789599999999999-----899999987566321340689999999999998679989993889999799899


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC----CEEEECC
Q ss_conf             999505699688887239999999999999999999999999998703999951058899991238999----8089112
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL----HPCISGF  497 (642)
Q Consensus       422 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~----~~ki~Df  497 (642)
                      +||||+++|+|.+++....     .+++..+..|+.|++.||+|||+   .+|+||||||+|||++.++    .+|++||
T Consensus        90 iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEECCCCCCCCCHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf             9998677864310010356-----42155789999999999876662---542211333012798258986664696433


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf             55334799986544530253288865556798302853232488889633067799999999949999999999953178
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++.......             .....|+..|+|||++.. ..++.++||||+||++|||+||+.||.+..     ..
T Consensus       162 G~a~~~~~~~~-------------~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~  222 (293)
T d1jksa_         162 GLAHKIDFGNE-------------FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDT-----KQ  222 (293)
T ss_dssp             TTCEECTTSCB-------------CSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH
T ss_pred             HHHHHCCCCCC-------------CCCCCCCCCCCCHHHHCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCC-----HH
T ss_conf             44210577763-------------122477774309999818-999976652214099999970889988999-----99


Q ss_pred             HHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             999999851598753338455411047999999999998637789999999789999
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      +.................+.    .     ...+.+++.+||+.||++|||+.|+++
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~----~-----s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         223 ETLANVSAVNYEFEDEYFSN----T-----SALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHHTTCCCCCHHHHTT----S-----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHCCCCCCCHHCCC----C-----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99999981688887010478----8-----999999999986389668919999961

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.84  Aligned_cols=246  Identities=25%  Similarity=0.419  Sum_probs=197.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CCEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958-91489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAN-DEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e  425 (642)
                      .+.||+|+||.||++... +      ..||||+++....   .+.|.+|++++++++|||||+++|+|.+. +..++|||
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~------~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-G------NKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-T------EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             EEEEECCCCEEEEEEEEC-C------EEEEEEEECCHHH---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             579820798089999999-9------0999999885777---99999999999867898985498788723892899996


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      |+++|+|.+++.....   .+++|..+++|+.|||.||+|||+   .+|+||||||+|||++.++.+|++|||+++....
T Consensus        82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCC
T ss_conf             3699989999874578---888999999999999852321133---7655366656760146899776324560034478


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             98654453025328886555679830285323248888963306779999999994-99999999999531789999998
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ..               ....++..|+|||++.. ..++.++||||||+++|||+| |+.|+...  ....+...+... 
T Consensus       156 ~~---------------~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~-  216 (262)
T d1byga_         156 TQ---------------DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKG-  216 (262)
T ss_dssp             ---------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTT-
T ss_pred             CC---------------CCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHCC-
T ss_conf             77---------------65566646778178727-988858877757999999997899999999--999999999808-


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             515987533384554110479999999999986377899999997899999985424
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                       .+.+..+.+++             ++.+++.+||+.||.+||||.+++++|++|+.
T Consensus       217 -~~~~~~~~~~~-------------~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         217 -YKMDAPDGCPP-------------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -CCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -99999765799-------------99999999756697689399999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.97  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||+|.............||||+++..........|.+|+.++.+++|||||+++|+|...+..++||||
T Consensus        25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~  104 (308)
T d1p4oa_          25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  104 (308)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEEEE
T ss_conf             35982078818999998786447789689999987012868999999999999976999884125478428810677760


Q ss_pred             CCCCCHHHHHHCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             56996888872399-----9999999999999999999999999870399995105889999123899980891125533
Q 006522          427 IRNGSLYAALHAGP-----SDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       427 ~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                      +++|+|.+++....     ......++|..+.+|+.|+|+||.|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             CCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEEEEEECCCCE
T ss_conf             48998899987503321134446887999999999999999998764---796543286775403599649994245420


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHH
Q ss_conf             47999865445302532888655567983028532324888896330677999999999499-99999999953178999
Q 006522          502 LLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGR-LPDAGPENDGKGLESLV  580 (642)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~-~P~~~~~~~~~~l~~~~  580 (642)
                      .+.......          ......|+..|+|||.+.. ..++.++||||||+++|||+||. .||.+     ....++.
T Consensus       182 ~~~~~~~~~----------~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~~~~~~~  245 (308)
T d1p4oa_         182 DIYETDYYR----------KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQG-----LSNEQVL  245 (308)
T ss_dssp             GGGGGGCEE----------GGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----SCHHHHH
T ss_pred             ECCCCCCEE----------ECCCEECCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCC-----CCHHHHH
T ss_conf             235776303----------1340231632378888736-99883334443789999999689999999-----8999999


Q ss_pred             HHHHHCCC-CCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf             99985159-87533384554110479999999999986377899999997899999985424
Q 006522          581 RKAFRERR-PLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVKL  641 (642)
Q Consensus       581 ~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~  641 (642)
                      ........ +..+.+++             .+.+++.+||+.+|++||||.+|+++|++..+
T Consensus       246 ~~i~~~~~~~~p~~~~~-------------~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFVMEGGLLDKPDNCPD-------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHTTCCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHCCCCCCCCCCHH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             99980888888633539-------------99999999757796589399999999787617

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=337.26  Aligned_cols=241  Identities=15%  Similarity=0.217  Sum_probs=198.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCC--CCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             3002755776118999358999999729999991289--83210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG--DATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||++....++     ..||||.+...  ......+.+.+|+.+|++++|||||++++++...+..++|+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g-----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEECCCCCEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             889611768089999998999-----899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+.+|+|.+++...+     .+++..+..|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECC
T ss_conf             2334662266675158-----98999999999999998999985---998617679999360778978861010333225


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ...               ....||..|||||++.. ..++.++||||+||++|||+||+.||.+.     ..........
T Consensus       193 ~~~---------------~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~i~  251 (350)
T d1rdqe_         193 GRT---------------WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEKIV  251 (350)
T ss_dssp             SCB---------------CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHH
T ss_pred             CCC---------------CCCCCCCCCCCHHHHCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             666---------------43367635678899717-99885331145007899997588998995-----9999999986


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             5159875333845541104799999999999863778999999-----9789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-----RMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~  634 (642)
                      .........+++++             .+++.+|++.||.+|+     |+.++++
T Consensus       252 ~~~~~~p~~~s~~~-------------~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         252 SGKVRFPSHFSSDL-------------KDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HCCCCCCTTCCHHH-------------HHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCCCCHHH-------------HHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             17988976689999-------------9999998340998606553454999971

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.83  Aligned_cols=256  Identities=22%  Similarity=0.337  Sum_probs=200.8

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf             30027557761189993589999997299999912898--3210899999999986156897114889999589148999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLIS  424 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  424 (642)
                      ...||+|+||.||+|......+  ....||||.+....  .....++|.+|+.+|++++|||||+++|+|.+ +..++||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~--~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~   89 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSG--KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT   89 (273)
T ss_dssp             EEECC----CCCEEEEEECTTS--CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEECCCCEEEEEEEEECCCC--CEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHHEEE
T ss_conf             7898038883999999988999--079999999983555798999999999999986899998789877740-1001146


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf             50569968888723999999999999999999999999999870399995105889999123899980891125533479
Q 006522          425 DFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLP  504 (642)
Q Consensus       425 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~  504 (642)
                      ||+++|++.+++.....    ++++..++.++.|||.||.|||+   ++|+||||||+||+++.++.+||+|||+++...
T Consensus        90 e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             ECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEECCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf             54238612544421268----99999999999999999987521---787520566888156556543325611555303


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             998654453025328886555679830285323248888963306779999999994-9999999999953178999999
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILT-GRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~t-G~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      ......         .......|+..|+|||++.. ..++.++||||||+++|||+| |+.||.+.     ...+.....
T Consensus       163 ~~~~~~---------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~~~~~i  227 (273)
T d1u46a_         163 QNDDHY---------VMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQILHKI  227 (273)
T ss_dssp             C-CCEE---------EC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHH
T ss_pred             CCCCCC---------EECCCCCCCCCCCCHHHHHC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHH
T ss_conf             588752---------65476325731079999837-999942156614899999996899999996-----999999999


Q ss_pred             HHCCCC--CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             851598--753338455411047999999999998637789999999789999998542
Q 006522          584 FRERRP--LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRVK  640 (642)
Q Consensus       584 ~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~  640 (642)
                      ......  ..+.+.+             .+.+++.+||+.||++||||.+|++.|++.+
T Consensus       228 ~~~~~~~~~~~~~~~-------------~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         228 DKEGERLPRPEDCPQ-------------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             HTSCCCCCCCTTCCH-------------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHCCCCCCCCCCCCH-------------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf             847999998544539-------------9999999976889667929999999999649

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=335.69  Aligned_cols=258  Identities=22%  Similarity=0.283  Sum_probs=203.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC--CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCC----E
Q ss_conf             300275577611899935899999972999999128983--2108999999999861568971148899995891----4
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA--TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDE----K  420 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~  420 (642)
                      ...||+|+||.||++.....+     +.||+|.+.....  ......|.+|++++++++|||||++++++...+.    .
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf             689960899299999999999-----899999985566469899999999999998569998873114354326887669


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89995056996888872399999999999999999999999999987039999510588999912389998089112553
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla  500 (642)
                      ++||||+++|+|.+++...+     ++++..+..|+.||+.||+|||+   .+|+||||||+|||++.+...+++|||.+
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEECCCCCEEHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf             99997788987101120358-----99999999999999999999985---79527634675566575432010034443


Q ss_pred             CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf             34799986544530253288865556798302853232488889633067799999999949999999999953178999
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +........         ........||..|+|||++. +..++.++||||+||++|||+||+.||.+.     ...+..
T Consensus       159 ~~~~~~~~~---------~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~~~~  223 (277)
T d1o6ya_         159 RAIADSGNS---------VTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVA  223 (277)
T ss_dssp             EECC-------------------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHH
T ss_pred             HHHCCCCCC---------CCCCCCCCCCCCCCCHHHHC-CCCCCCCEECCCCHHHHHHHHHCCCCCCCC-----CHHHHH
T ss_conf             221235443---------33346425762436999983-999996632026528999997697998996-----999999


Q ss_pred             HHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHC
Q ss_conf             99985159875333845541104799999999999863778999999-97899999985424
Q 006522          581 RKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRP-RMRTVSESLDRVKL  641 (642)
Q Consensus       581 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-t~~ev~~~L~~i~~  641 (642)
                      ...............+.+.         ..+.+++.+|++.||++|| |++++...|.+++-
T Consensus       224 ~~~~~~~~~~~~~~~~~~s---------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         224 YQHVREDPIPPSARHEGLS---------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHHCCCCCGGGTSSSCC---------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHHCCCCCCCHHCCCCC---------HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf             9998469999710034789---------9999999998667976777399999999999758

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.58  Aligned_cols=243  Identities=19%  Similarity=0.282  Sum_probs=196.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC--CCCCHHHHHHHHHHHH-CCCCCCEEEEEEEEEECCCEEEE
Q ss_conf             30027557761189993589999997299999912898--3210899999999986-15689711488999958914899
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD--ATWRFKDFESEVEAIA-RVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv  423 (642)
                      .+.||+|+||+||++....++     +.||||.+....  .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~-----~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEECCCCCEEEEEEECCCC-----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             658940878289999999999-----899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             95056996888872399999999999999999999999999987039999510588999912389998089112553347
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~  503 (642)
                      |||+++|+|.+++....     .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+|++|||+++..
T Consensus        82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEECCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHC
T ss_conf             75037980899864047-----89999999999999999999986---89340347654044448996301555302323


Q ss_pred             CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             99986544530253288865556798302853232488889633067799999999949999999999953178999999
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....            ......||..|+|||++.. ..++.++||||+||++|||+||+.||.+.     ...+.....
T Consensus       154 ~~~~~------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~~~~~~i  215 (320)
T d1xjda_         154 MLGDA------------KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEEELFHSI  215 (320)
T ss_dssp             CCTTC------------CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHH
T ss_pred             CCCCC------------CCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHH
T ss_conf             56653------------3454578777689999827-99883232011227898987388999998-----999999999


Q ss_pred             HHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHH
Q ss_conf             85159875333845541104799999999999863778999999978-999
Q 006522          584 FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMR-TVS  633 (642)
Q Consensus       584 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~-ev~  633 (642)
                      ......+...++++             +.+++.+|+..||++||++. +++
T Consensus       216 ~~~~~~~p~~~s~~-------------~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         216 RMDNPFYPRWLEKE-------------AKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHCCCCCCTTSCHH-------------HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HCCCCCCCCCCCHH-------------HHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf             71899897567999-------------999999965448987838899998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.73  Aligned_cols=246  Identities=16%  Similarity=0.222  Sum_probs=196.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615689711488999958914899950
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ...||+|+||.||++....++     ..||+|.+......  ...+.+|+++|.+++|||||++++++.+.+..++||||
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~-----~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             789831778399999998999-----69999997578665--99999999999857997989098999889988999953


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC--CCCEEEECCCCCCCCC
Q ss_conf             56996888872399999999999999999999999999987039999510588999912389--9980891125533479
Q 006522          427 IRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD--ELHPCISGFGLNRLLP  504 (642)
Q Consensus       427 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~--~~~~ki~DfGla~~~~  504 (642)
                      +++|+|.+++.....    .+++..+..|+.||+.||.|||+   .+|+||||||+|||++.  ...+|++|||+++...
T Consensus        83 ~~gg~L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          83 ISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC
T ss_conf             899808899875389----99999999999999999999987---69975135544434437885189976441110034


Q ss_pred             CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             99865445302532888655567983028532324888896330677999999999499999999999531789999998
Q 006522          505 GTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAF  584 (642)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~  584 (642)
                      ....             .....++..|+|||.... ..++.++||||+||++|||+||+.||...     ...+......
T Consensus       156 ~~~~-------------~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~-----~~~~~~~~i~  216 (321)
T d1tkia_         156 PGDN-------------FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAE-----TNQQIIENIM  216 (321)
T ss_dssp             TTCE-------------EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHHHH
T ss_pred             CCCC-------------CCCCCCCCCCCCCHHCCC-CCCCCHHHCCCHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
T ss_conf             6775-------------321223322234021048-77784011302799999998289999998-----9999999998


Q ss_pred             HCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             51598753338455411047999999999998637789999999789999
Q 006522          585 RERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       585 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .....+.....+.    ..     ..+.+++.+|+..||++|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~----~s-----~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         217 NAEYTFDEEAFKE----IS-----IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTCCCCCHHHHTT----SC-----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HCCCCCCHHHCCC----CC-----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             3899988022367----89-----99999999986699668909999963

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.70  Aligned_cols=247  Identities=18%  Similarity=0.290  Sum_probs=189.8

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEE----CCCEE
Q ss_conf             30027557761189993589999997299999912898321089999999998615-68971148899995----89148
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARV-QHPNIVRLKAFYYA----NDEKL  421 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~  421 (642)
                      ..+||+|+||.||++....++     ..||||.+...      ..+.+|+.++.++ +|||||++++++.+    ....+
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTC-----CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEECCC------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf             079654548699999988999-----89999998974------7799999999986699997829899950346897899


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC---CCCEEEECCC
Q ss_conf             9995056996888872399999999999999999999999999987039999510588999912389---9980891125
Q 006522          422 LISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD---ELHPCISGFG  498 (642)
Q Consensus       422 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~---~~~~ki~DfG  498 (642)
                      +|||||++|+|.+++...+.   ..+++..+..|+.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus        86 ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             99977899849999986278---775799999999999999999997---698644410022011355556631135455


Q ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
Q ss_conf             53347999865445302532888655567983028532324888896330677999999999499999999999531789
Q 006522          499 LNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLES  578 (642)
Q Consensus       499 la~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~  578 (642)
                      +|+.......             .....||+.|+|||++.. ..++.++||||+||++|||+||+.||.+..... ....
T Consensus       160 ~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~  224 (335)
T d2ozaa1         160 FAKETTSHNS-------------LTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPG  224 (335)
T ss_dssp             TCEECCCCCC-------------CCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred             EEEECCCCCC-------------CCCCCCCCCCCCCHHHCC-CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH-HHHH
T ss_conf             1233368886-------------432267756379277748-988888888764516778865889988988778-8999


Q ss_pred             HHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             99999851598753338455411047999999999998637789999999789999
Q 006522          579 LVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       579 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ..........   ..-.+..      .....++.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~i~~~~~---~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         225 MKTRIRMGQY---EFPNPEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---CCCSCSS---SCCTTHH------HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHCCCC---CCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9999853888---8898543------469999999999975699657909999970

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=331.99  Aligned_cols=259  Identities=17%  Similarity=0.206  Sum_probs=192.9

Q ss_pred             CCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCC----CHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEE
Q ss_conf             0027557761189993589999997299999912898321----089999999998615689711488999958914899
Q 006522          348 YVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATW----RFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLI  423 (642)
Q Consensus       348 ~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  423 (642)
                      ++||+|+||+||++....++     +.||||++.......    ..+.+.+|+.++++++|||||++++++...+..++|
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv   78 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   78 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             EEECCCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEH
T ss_conf             38512728299999999999-----6999999842021245679999999999999867999986898542258740220


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             95056996888872399999999999999999999999999987039999510588999912389998089112553347
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLL  503 (642)
Q Consensus       424 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~  503 (642)
                      |||++++++........     .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        79 mE~~~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             EECCSEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             HHHHCCHHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCC
T ss_conf             45534507765541266-----77899999999999999988631---63550357762588537784114657610005


Q ss_pred             CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             99986544530253288865556798302853232488889633067799999999949999999999953178999999
Q 006522          504 PGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKA  583 (642)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~  583 (642)
                      .....            ......||..|+|||++..+..++.++||||+||++|||+||+.||.+... ...+....+..
T Consensus       151 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~  217 (299)
T d1ua2a_         151 GSPNR------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETL  217 (299)
T ss_dssp             TSCCC------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred             CCCCC------------CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCH-HHHHHHHHHHC
T ss_conf             78755------------433020473336399972677888056436304289999859699999999-99999999851


Q ss_pred             HHCCC-CCCCCC------------CHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             85159-875333------------8455411047999999999998637789999999789999
Q 006522          584 FRERR-PLSEVI------------DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       584 ~~~~~-~~~~~~------------d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ..... ...+..            ...+....  ......+.+++.+|+..||++|||+.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF--SAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC--TTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             89972545210002134430347898867856--568999999999976389456908999967

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=326.88  Aligned_cols=248  Identities=20%  Similarity=0.268  Sum_probs=195.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCC--------CCHHHHHHHHHHHHCCC-CCCEEEEEEEEEEC
Q ss_conf             3002755776118999358999999729999991289832--------10899999999986156-89711488999958
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT--------WRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN  417 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  417 (642)
                      ...||+|+||.||++....++     ..+|||++......        ...+.+.+|+.++++++ |||||++++++.+.
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CEEEECCCCEEEEEEEECCCC-----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             528841768499999999999-----899999996244641147888999999999999999850799747997621467


Q ss_pred             CCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECC
Q ss_conf             91489995056996888872399999999999999999999999999987039999510588999912389998089112
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~Df  497 (642)
                      +..++||||+++|+|.+++...+     ++++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCC
T ss_conf             60599997689866899998659-----99999999999999999999987---59943234625489868998387124


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             553347999865445302532888655567983028532324-----888896330677999999999499999999999
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIY-----GSKFTQKCDVYSFGIVLLEILTGRLPDAGPEND  572 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~  572 (642)
                      |+++......             ..+...||..|+|||+...     ...++.++||||+||++|||+||+.||.+..  
T Consensus       155 G~a~~~~~~~-------------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--  219 (277)
T d1phka_         155 GFSCQLDPGE-------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--  219 (277)
T ss_dssp             TTCEECCTTC-------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             HHEEECCCCC-------------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC--
T ss_conf             0316726887-------------2134524678889888605344567889923318565602310322888988999--


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             53178999999851598753338455411047999999999998637789999999789999
Q 006522          573 GKGLESLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       573 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                         ....................+.+    .     .++.+++.+|++.||++|||+.|+++
T Consensus       220 ---~~~~~~~i~~~~~~~~~~~~~~~----s-----~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         220 ---QMLMLRMIMSGNYQFGSPEWDDY----S-----DTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ---HHHHHHHHHHTCCCCCTTTGGGS----C-----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHHHHHHCCCCCCCCCCCCC----C-----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---99999999818988898543468----9-----99999999976589668919999973

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=323.66  Aligned_cols=260  Identities=20%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             3002755776118999358999999729999991289832-108999999999861568971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      .+.||+|+||.||++.....+     +.||+|++...... .....+.+|++++++++|||||++++++.+.+..++|||
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTC-----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEEECCCCEEEEEEEECCCC-----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             517723768099999999999-----799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      |+.+ ++.+.+.....   ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+..+|++|||+|+....
T Consensus        82 ~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ECCC-CHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCC
T ss_conf             2377-44555442025---688889999999999999998652---8899213571140113467621035786134368


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             98654453025328886555679830285323248888963306779999999994999999999995317899999985
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......||..|+|||.......++.++||||+||++|||++|+.||.+...    ...+......
T Consensus       155 ~~~------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~  218 (298)
T d1gz8a_         155 PVR------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRT  218 (298)
T ss_dssp             CSB------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHH
T ss_pred             CCC------------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCH----HHHHHHHHHH
T ss_conf             864------------100103652154112213665777422103333134279668799898899----9999999983


Q ss_pred             CCCCCCCCCCHHHHH-------------C-HHH--HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             159875333845541-------------1-047--9999999999986377899999997899999
Q 006522          586 ERRPLSEVIDPALVK-------------E-IHA--KRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       586 ~~~~~~~~~d~~l~~-------------~-~~~--~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~  635 (642)
                      ...+ .+...+....             . ...  ......+.+++.+|+..||++|||+.|+++-
T Consensus       219 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         219 LGTP-DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HCCC-CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCC-CHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             2898-3331444222421243454322220444166789999999999763995579189999678

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=315.84  Aligned_cols=261  Identities=17%  Similarity=0.229  Sum_probs=192.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----CEEE
Q ss_conf             300275577611899935899999972999999128983210899999999986156897114889999589----1489
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND----EKLL  422 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  422 (642)
                      ...||+|+||+||++....++     ..||||++.........+.+.+|+++|.+++||||+++++++....    ..++
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             EEECC---CCCEEEEEETTTC-----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf             789940648099999999999-----499999980310958999999999999976898988588899505645541499


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99505699688887239999999999999999999999999998703999951058899991238999808911255334
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~  502 (642)
                      +++|+.+|+|.+++...      .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        88 l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEECCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             99962598656644058------99999999999999999999997---8986777876437887999778754570565


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             79998654453025328886555679830285323248888963306779999999994999999999995317899999
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      .......         ........|+..|+|||++..+..++.++||||+||++|||+||+.||......  +.......
T Consensus       159 ~~~~~~~---------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~  227 (345)
T d1pmea_         159 ADPDHDH---------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILG  227 (345)
T ss_dssp             CCGGGCB---------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHH
T ss_pred             CCCCCCC---------CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHH--HHHHHHHH
T ss_conf             0477764---------101011026520003878604788874101004670133776697997888889--99998765


Q ss_pred             HHHCCCC-----------------CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9851598-----------------753338455411047999999999998637789999999789999
Q 006522          583 AFRERRP-----------------LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~~~~~~~-----------------~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .......                 .............  .....++.+++.+|++.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF--PNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2069975664234332222024467755778777837--899999999999976489567908999861

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.81  Aligned_cols=237  Identities=20%  Similarity=0.259  Sum_probs=188.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCC-----CCHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCC
Q ss_conf             3002755776118999358999999729999991289832-----10899999999986156--8971148899995891
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-----WRFKDFESEVEAIARVQ--HPNIVRLKAFYYANDE  419 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~  419 (642)
                      ...||+|+||.||++....++     ..||||.+......     .....+.+|+.++++++  |||||++++++.+.+.
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf             679840878399999999999-----799999985688443345567999999999999743589881279999830996


Q ss_pred             EEEEEEECCC-CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCC-CCEEEECC
Q ss_conf             4899950569-968888723999999999999999999999999999870399995105889999123899-98089112
Q 006522          420 KLLISDFIRN-GSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDE-LHPCISGF  497 (642)
Q Consensus       420 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~-~~~ki~Df  497 (642)
                      .++||||+.+ +++.+++....     .+++..+..++.|++.||+|||+   ++|+||||||+|||++.+ +.+||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEECCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf             8999983368622899986158-----99999999999999999999987---797556676111477447884897754


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf             55334799986544530253288865556798302853232488889633067799999999949999999999953178
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+|+......              .+...||..|+|||++.....++.++||||+||++|||+||+.||...        
T Consensus       156 G~a~~~~~~~--------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------  213 (273)
T d1xwsa_         156 GSGALLKDTV--------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------  213 (273)
T ss_dssp             TTCEECCSSC--------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------
T ss_pred             CCCEECCCCC--------------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC--------
T ss_conf             6535324445--------------566565877479999848997886533255403453675688998873--------


Q ss_pred             HHHHHHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             999999851598753338455411047999999999998637789999999789999
Q 006522          578 SLVRKAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                         .........+...++++             +.+++.+|++.||++|||+.|+++
T Consensus       214 ---~~i~~~~~~~~~~~s~~-------------~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         214 ---EEIIRGQVFFRQRVSSE-------------CQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---HHHHHCCCCCSSCCCHH-------------HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHCCCCCCCCCCHH-------------HHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---67761544778779999-------------999999976089758939999853

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=317.17  Aligned_cols=258  Identities=23%  Similarity=0.314  Sum_probs=184.5

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC------CE
Q ss_conf             300275577611899935899999972999999128983210899999999986156897114889999589------14
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------EK  420 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~  420 (642)
                      .++||+|+||+||++.....+     +.||||++......     +.+|+++|++++|||||++++++....      +.
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEECCCCHH-----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf             169821768399999999999-----79999998816068-----99999999866898987387899744765773189


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC-CEEEECCCC
Q ss_conf             8999505699688887239999999999999999999999999998703999951058899991238999-808911255
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGL  499 (642)
Q Consensus       421 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~-~~ki~DfGl  499 (642)
                      ++||||+++|.+....+....  ...+++..+..|+.||+.||+|||+   .+|+||||||+|||++.+. .+||+|||+
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEEEECCCCCCHHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf             999841688607888863103--6899999999999999999999986---68764578860378735897116733660


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf             33479998654453025328886555679830285323248888963306779999999994999999999995317899
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++.......             .....|+..|+|||.......++.++||||+||++|||++|+.||...... ..+...
T Consensus       170 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i  235 (350)
T d1q5ka_         170 AKQLVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEI  235 (350)
T ss_dssp             CEECCTTSC-------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHH
T ss_pred             HHHCCCCCC-------------CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH-HHHHHH
T ss_conf             544047765-------------320025555568277640468882100024652778550287998987999-999999


Q ss_pred             HHHH-------HHC------CCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9999-------851------598753338455411047999999999998637789999999789999
Q 006522          580 VRKA-------FRE------RRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~~~~-------~~~------~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ++..       +..      ...+.......... .........+.+++.+|+..||++|||+.|+++
T Consensus       236 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHH-HCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9974898177654306210110355445674444-315689999999999976589557929999966

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.95  Aligned_cols=265  Identities=16%  Similarity=0.183  Sum_probs=192.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEE--------C
Q ss_conf             300275577611899935899999972999999128983-2108999999999861568971148899995--------8
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYA--------N  417 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~  417 (642)
                      ...||+|+||+||++.....+     +.||||++..... ....+++.+|+.+|++++|||++++++++..        .
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTC-----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf             999722748299999998999-----799999984222463789999999999998359996606765402465444457


Q ss_pred             CCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECC
Q ss_conf             91489995056996888872399999999999999999999999999987039999510588999912389998089112
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~Df  497 (642)
                      +..++||||++++.+........     .++...+..|+.|++.||.|||+   .+|+||||||+|||++.++.+|++||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEECCCCCCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEEC
T ss_conf             63899985357874101222034-----43308999999999999988522---99885676722203668996876313


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf             55334799986544530253288865556798302853232488889633067799999999949999999999953178
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++..........        .......||..|+|||.+.....++.++||||+||++|||+||+.||.+...  ....
T Consensus       162 g~~~~~~~~~~~~~--------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~  231 (318)
T d3blha1         162 GLARAFSLAKNSQP--------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQL  231 (318)
T ss_dssp             TTCEECCC-----C--------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH
T ss_pred             CEEEECCCCCCCCC--------CCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH--HHHH
T ss_conf             50022355444321--------1356602497874289970799989178700678646617448799899899--9999


Q ss_pred             HHHHHHHHCC-CCCCCCCC---------------HHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9999998515-98753338---------------455411047999999999998637789999999789999
Q 006522          578 SLVRKAFRER-RPLSEVID---------------PALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~~-~~~~~~~d---------------~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .......... .......+               +..............+.+++.+|++.||++|||++|+++
T Consensus       232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9999841899825534432034443320133445550334044459989999999987389658909999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=314.94  Aligned_cols=261  Identities=19%  Similarity=0.256  Sum_probs=192.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             300275577611899935899999972999999128983-2108999999999861568971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      -+.||+|+||.||++....+      +.||||++..... ....+.+.+|+.+|++++|||||++++++...+..++++|
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTS------CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCEEECCCCCEEEEEEECCC------CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf             31872277818999996899------999999981232685899999999999986799868766012046773158997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      |+.++.+........     .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+|++|||.+.....
T Consensus        81 ~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             CCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EEHHHHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf             400456789986047-----75144568999999999998605---7488267877505686899787323664301146


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             98654453025328886555679830285323248888963306779999999994999999999995317899999985
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ...            ......|+..|+|||.+.....++.++||||+||++|||++|+.||.+... ...+.........
T Consensus       153 ~~~------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~  219 (286)
T d1ob3a_         153 PVR------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGT  219 (286)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCC
T ss_pred             CCC------------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH-HHHHHHHHHHHCC
T ss_conf             765------------410102431101378871788888410021117589999779799898898-9999999986389


Q ss_pred             CCCC-CCCCC-----CHHHHH------CHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1598-75333-----845541------1047999999999998637789999999789999
Q 006522          586 ERRP-LSEVI-----DPALVK------EIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~-~~~~~-----d~~l~~------~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .... .....     +.....      ..........+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9711042123332214333335676466651258999999999986689668909999856

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.08  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=190.1

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEECC------C
Q ss_conf             300275577611899935899999972999999128983-210899999999986156897114889999589------1
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAND------E  419 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~  419 (642)
                      ...||+|+||.||++.....+     +.||||++..... ....+.+.+|+++|++++|||||+++++|...+      +
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             EEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf             889801778199999999999-----899999985222596999999999999986689875479998635765555415


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             48999505699688887239999999999999999999999999998703999951058899991238999808911255
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGl  499 (642)
                      .++||||+ +++|....+..      .+++..+..|+.|++.||.|||+   .+|+||||||+|||++.++.+|++|||+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEECC-CCCHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf             99998405-52189998740------22699999999999999999873---7876456685111121001221134310


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf             33479998654453025328886555679830285323248888963306779999999994999999999995317899
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      |+......               +...||..|+|||.+.....++.++||||+||++|||++|+.||.+... ...+...
T Consensus       168 a~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~  231 (346)
T d1cm8a_         168 ARQADSEM---------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEI  231 (346)
T ss_dssp             CEECCSSC---------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred             EECCCCCC---------------CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCH-HHHHHHH
T ss_conf             22068763---------------1024553335889981787899650103003899999978699888976-8999999


Q ss_pred             HHHHHHCCCC------------------CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             9999851598------------------7533384554110479999999999986377899999997899999
Q 006522          580 VRKAFRERRP------------------LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSES  635 (642)
Q Consensus       580 ~~~~~~~~~~------------------~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~  635 (642)
                      ....  ...+                  ..+.....+....  ...-..+.+++.+|+..||++|||+.|+++-
T Consensus       232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         232 MKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL--TNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC--TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCC--CCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             8503--78848888653000344331157866655667755--6899999999999772995579299999639

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.61  Aligned_cols=260  Identities=18%  Similarity=0.239  Sum_probs=184.7

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCC---CCCCEEEEEEEEEEC-----
Q ss_conf             300275577611899935899999972999999128983-21089999999998615---689711488999958-----
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARV---QHPNIVRLKAFYYAN-----  417 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----  417 (642)
                      ...||+|+||.||++.....++    +.||||++..... ......+.+|+.+++.+   +||||++++++|...     
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTT----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             EEEEECCCCEEEEEEEEECCCC----EEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf             8899215586999999988899----899999980232451679999999999998742589880236632214666667


Q ss_pred             CCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECC
Q ss_conf             91489995056996888872399999999999999999999999999987039999510588999912389998089112
Q 006522          418 DEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGF  497 (642)
Q Consensus       418 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~Df  497 (642)
                      ...++++||+++|++.........    .+++..+..|+.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CEEEEEEEECCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCH
T ss_conf             469999974058714444430378----99989999999999999999975---88983579862789858997542100


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf             55334799986544530253288865556798302853232488889633067799999999949999999999953178
Q 006522          498 GLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLE  577 (642)
Q Consensus       498 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~  577 (642)
                      |+++......             ......||..|+|||++.. ..++.++||||+||++|||+||+.||.+... ...+.
T Consensus       161 g~~~~~~~~~-------------~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~  225 (305)
T d1blxa_         161 GLARIYSFQM-------------ALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLG  225 (305)
T ss_dssp             CSCCCCCGGG-------------GGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH
T ss_pred             HHHHHHCCCC-------------CCCCCCCCHHHCCCCHHCC-CCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH-HHHHH
T ss_conf             0101100234-------------5777654851148310017-9888111000328999999878799899898-99999


Q ss_pred             HHHHHHHHC---CCCCC---------CCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             999999851---59875---------3338455411047999999999998637789999999789999
Q 006522          578 SLVRKAFRE---RRPLS---------EVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       578 ~~~~~~~~~---~~~~~---------~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .........   ..+..         ...........  ......+.+++.+|++.||++|||+.|+++
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             9998407996110532111103330223456454404--458999999999987489667918999966

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=307.08  Aligned_cols=260  Identities=16%  Similarity=0.166  Sum_probs=190.9

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCCE-EEEEEEEEECCCEEEEEE
Q ss_conf             3002755776118999358999999729999991289832108999999999861568971-148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPNI-VRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||+|....++     ..||||.+......   .++..|++++++++|+++ +.+.++..+.+..++|||
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTT-----EEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEECCCCEEEEEEECCCC-----CEEEEEEECHHCCC---HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             689850788099999998899-----89999997210058---8899999999970389960179999951987789998


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEEC---CCCCEEEECCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238---999808911255334
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLD---DELHPCISGFGLNRL  502 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld---~~~~~ki~DfGla~~  502 (642)
                      |+ +|+|.+.+.....    .+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+|++|||+|+.
T Consensus        84 ~~-~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             CC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EC-CCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf             73-8713332443068----87689999999999999999997---9944266787660643357776156504675134


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             79998654453025328886555679830285323248888963306779999999994999999999995317899999
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      +..........     ........||..|+|||.... ..++.++|||||||++|||+||+.||.......... .....
T Consensus       156 ~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~  228 (299)
T d1ckia_         156 YRDARTHQHIP-----YRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERI  228 (299)
T ss_dssp             CBCTTTCCBCC-----CCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHH
T ss_pred             CCCCCCCCCEE-----CCCCCCCCCCCCCCCHHHHHC-CCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHH-HHHHH
T ss_conf             25544554100-----013577678735329999918-998983218861778999984987665530577999-99985


Q ss_pred             H-HHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             9-85159875333845541104799999999999863778999999978999999854
Q 006522          583 A-FRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       583 ~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      . .....+ .+.    +...     ...++.+++..||+.+|++||++.++.+.|+.+
T Consensus       229 ~~~~~~~~-~~~----~~~~-----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         229 SEKKMSTP-IEV----LCKG-----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHHSC-HHH----HTTT-----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HCCCCCCC-HHH----HCCC-----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             23567898-357----5347-----889999999998439955791999999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.20  Aligned_cols=253  Identities=19%  Similarity=0.275  Sum_probs=197.8

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCC---CCCCHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCCEEE
Q ss_conf             30027557761189993589999997299999912898---32108999999999861568-971148899995891489
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGD---ATWRFKDFESEVEAIARVQH-PNIVRLKAFYYANDEKLL  422 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~l  422 (642)
                      ...||+|+||.||++....+..  ..+.||+|.+....   .....+.+.+|++++.+++| |||+++++++.+.+..++
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~--~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~  106 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHD--TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  106 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTT--TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCC--CCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEEE
T ss_conf             9898328783999999876588--79489999983677210168999999999999864679839996200024873001


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99505699688887239999999999999999999999999998703999951058899991238999808911255334
Q 006522          423 ISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRL  502 (642)
Q Consensus       423 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~  502 (642)
                      |+||+++|+|.+++.....     ++......++.|++.||.|+|+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       107 v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         107 ILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEECCCCCHHHHHHHHCCC-----CCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf             2312341179999873045-----4378888889999999988514---9989654773201246999888741320222


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Q ss_conf             79998654453025328886555679830285323248-88896330677999999999499999999999531789999
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYG-SKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVR  581 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~  581 (642)
                      +......           ......|+..|+|||..... ..++.++||||+||+||||+||+.||..... ........+
T Consensus       179 ~~~~~~~-----------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~-~~~~~~i~~  246 (322)
T d1vzoa_         179 FVADETE-----------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE-KNSQAEISR  246 (322)
T ss_dssp             CCGGGGG-----------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS-CCCHHHHHH
T ss_pred             HCCCCCC-----------CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHH
T ss_conf             0344443-----------2212223333310687605776887132517777999999768999888877-779999998


Q ss_pred             HHHHCCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             99851598753338455411047999999999998637789999999-----789999
Q 006522          582 KAFRERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPR-----MRTVSE  634 (642)
Q Consensus       582 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~  634 (642)
                      .......+....++++             +.+++.+|+++||++|||     ++|+++
T Consensus       247 ~~~~~~~~~~~~~s~~-------------~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         247 RILKSEPPYPQEMSAL-------------AKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHCCCCCCTTSCHH-------------HHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HCCCCCCCCCCCCCHH-------------HHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             3356899886547999-------------99999997445898819997450999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=303.69  Aligned_cols=259  Identities=14%  Similarity=0.162  Sum_probs=196.9

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCCEEEEEE
Q ss_conf             3002755776118999358999999729999991289832108999999999861568-971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH-PNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e  425 (642)
                      ...||+|+||.||+|....++     +.||||.+......   ..+.+|++.+..++| +|++.+++++......++|||
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             799841788299999998899-----79999997502582---9999999999996489998779999601881179999


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC-----CCCEEEECCCCC
Q ss_conf             056996888872399999999999999999999999999987039999510588999912389-----998089112553
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD-----ELHPCISGFGLN  500 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~-----~~~~ki~DfGla  500 (642)
                      |+ +|+|.+++.....    .+++..+..|+.|++.||+|||+   .+|+||||||+|||++.     +..+|++|||+|
T Consensus        82 ~~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             CC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EC-CCCHHHHHHHHCC----CHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEE
T ss_conf             64-8887999975203----11068999999999999999997---7966266771315234754344795687236605


Q ss_pred             CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf             34799986544530253288865556798302853232488889633067799999999949999999999953178999
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      +.+.........     .........||+.|||||.+.. ..++.++||||||+++|||+||+.||.+......  ....
T Consensus       154 ~~~~~~~~~~~~-----~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--~~~~  225 (293)
T d1csna_         154 KFYRDPVTKQHI-----PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKY  225 (293)
T ss_dssp             EESBCTTTCCBC-----CCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHH
T ss_pred             EECCCCCCCCCE-----EECCCCCEEECHHHCCHHHHCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHH
T ss_conf             771467665411-----1024676277510267989648-8888699989831999999869876788530219--9999


Q ss_pred             HHHHH--CCCCCCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             99985--159875333845541104799999999999863778999999978999999854
Q 006522          581 RKAFR--ERRPLSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSESLDRV  639 (642)
Q Consensus       581 ~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i  639 (642)
                      .....  ...+ .+.+.+.+         ..++.+++..|+..+|++||++..+.+.|+++
T Consensus       226 ~~i~~~~~~~~-~~~l~~~~---------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         226 ERIGEKKQSTP-LRELCAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHHHHHSC-HHHHTTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHCCCCCC-HHHHCCCC---------CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             99970567999-58965799---------89999999998439930085999999999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=304.32  Aligned_cols=255  Identities=15%  Similarity=0.202  Sum_probs=188.3

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEEC--CCEEEE
Q ss_conf             300275577611899935899999972999999128983210899999999986156-89711488999958--914899
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYAN--DEKLLI  423 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv  423 (642)
                      ...||+|+||.||++....++     ..||+|+++...    .+.+.+|+++|.+++ ||||+++++++...  ...++|
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTT-----EEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHH----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf             789831748199999988999-----799999988899----99999999999851579987679999981687712688


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC-CEEEECCCCCCC
Q ss_conf             9505699688887239999999999999999999999999998703999951058899991238999-808911255334
Q 006522          424 SDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL-HPCISGFGLNRL  502 (642)
Q Consensus       424 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~-~~ki~DfGla~~  502 (642)
                      |||+++|+|.+..+        .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.+. .+|++|||+|+.
T Consensus       111 ~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEECCCCCHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf             86317985899746--------89999999999999999988764---33443456441237748998366415654266


Q ss_pred             CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             79998654453025328886555679830285323248888963306779999999994999999999995317899999
Q 006522          503 LPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRK  582 (642)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~  582 (642)
                      ......             .....+|..|+|||.......++.++||||+||++||+++|+.||................
T Consensus       180 ~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         180 YHPGQE-------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             CCTTCC-------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             CCCCCC-------------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf             468874-------------4432248642476102688888845232335455587604889998876018999999998


Q ss_pred             H--------H-HCCCCC----CCCC-------CHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9--------8-515987----5333-------8455411047999999999998637789999999789999
Q 006522          583 A--------F-RERRPL----SEVI-------DPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       583 ~--------~-~~~~~~----~~~~-------d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .        . ......    ....       ...............++.+++.+|+..||++|||++|+++
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             788415555542254447430000033343311211552112448999999999986699568908999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=302.82  Aligned_cols=259  Identities=17%  Similarity=0.207  Sum_probs=195.4

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf             3002755776118999358999999729999991289832-108999999999861568971148899995891489995
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-WRFKDFESEVEAIARVQHPNIVRLKAFYYANDEKLLISD  425 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  425 (642)
                      -..||+|+||+||++....++     ..||||+++..... ...+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             269712868199999999999-----699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             05699688887239999999999999999999999999998703999951058899991238999808911255334799
Q 006522          426 FIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLNRLLPG  505 (642)
Q Consensus       426 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~~~~~  505 (642)
                      ++.+++|..++...+     .+++..+..++.|++.||+|||+   .+|+||||||+|||++.+..+|++|||.++....
T Consensus        82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ECCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCC
T ss_conf             023322211212356-----54036789999999999877433---9986001467612113378266520460110468


Q ss_pred             CCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             98654453025328886555679830285323248888963306779999999994999999999995317899999985
Q 006522          506 TSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLVRKAFR  585 (642)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~~~~~~  585 (642)
                      ....            .....++..|+|||.+.....++.++||||+||++|||++|+.||.....    ..+.......
T Consensus       154 ~~~~------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~  217 (292)
T d1unla_         154 PVRC------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFR  217 (292)
T ss_dssp             CCSC------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHH
T ss_pred             CCCC------------CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCC----HHHHHHHHHH
T ss_conf             8751------------00103443101466750698888044402654188998518999988999----9999999986


Q ss_pred             CCCCCCCCCCHHHH---------------HC-HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             15987533384554---------------11-047999999999998637789999999789999
Q 006522          586 ERRPLSEVIDPALV---------------KE-IHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       586 ~~~~~~~~~d~~l~---------------~~-~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      ......+..-+...               .. .........+.+++.+|++.||++|||+.|+++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             11899735513443222113344454431043306568999999999986499668909999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=302.77  Aligned_cols=255  Identities=18%  Similarity=0.232  Sum_probs=189.2

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-----CCE
Q ss_conf             300275577611899935899999972999999128983-21089999999998615689711488999958-----914
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN-----DEK  420 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  420 (642)
                      ...||+|+||+||++.....+     +.||||++..... ....+.+.+|+++|++++|||+|++++++...     ...
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTT-----EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCE
T ss_conf             889831788399999999999-----799999988200286899999999999986689874259999963464566864


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             89995056996888872399999999999999999999999999987039999510588999912389998089112553
Q 006522          421 LLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGLN  500 (642)
Q Consensus       421 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGla  500 (642)
                      +++++|+.+|+|.+++...      .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+|++|||++
T Consensus        98 ~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEEEEECCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             9999962588623200224------53099999999999999999973---88765166776334554322001321000


Q ss_pred             CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Q ss_conf             34799986544530253288865556798302853232488889633067799999999949999999999953178999
Q 006522          501 RLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESLV  580 (642)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~~  580 (642)
                      ......               .....|+..|+|||.......++.++||||+||++|||++|+.||.+...  ......+
T Consensus       169 ~~~~~~---------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~~~~i  231 (348)
T d2gfsa1         169 RHTDDE---------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLI  231 (348)
T ss_dssp             -CCTGG---------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHH
T ss_pred             CCCCCC---------------CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
T ss_conf             125754---------------44434543555835533775678551243205899999768899788988--9999999


Q ss_pred             HHHHHCCCC-----------------CCCCCCHHHHHCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             999851598-----------------753338455411047999999999998637789999999789999
Q 006522          581 RKAFRERRP-----------------LSEVIDPALVKEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       581 ~~~~~~~~~-----------------~~~~~d~~l~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .........                 ....-...+....  ......+.+++.+|+..||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             973079975773200102445444303557875556626--789999999999977588345938999855

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=299.01  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=190.6

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEEC------CC
Q ss_conf             300275577611899935899999972999999128983-21089999999998615689711488999958------91
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDA-TWRFKDFESEVEAIARVQHPNIVRLKAFYYAN------DE  419 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  419 (642)
                      ...||+|+||+||++....++     ..||||++..... ......+.+|+.++++++|||||++++++...      .+
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTT-----EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             EEEEECCCCEEEEEEEECCCC-----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             889621758599999999999-----899999988233697999999999999986489876489989702564345762


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             48999505699688887239999999999999999999999999998703999951058899991238999808911255
Q 006522          420 KLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDELHPCISGFGL  499 (642)
Q Consensus       420 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~~~ki~DfGl  499 (642)
                      .++||||+.+ ++.+.+..       .+++..+..++.||+.||.|||+   .+|+||||||+|||++.+...|++|||+
T Consensus        97 ~~iv~Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEECCCH-HHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHH
T ss_conf             6999841446-77876503-------89999999999999999988652---2112456776321136544313201023


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf             33479998654453025328886555679830285323248888963306779999999994999999999995317899
Q 006522          500 NRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPDAGPENDGKGLESL  579 (642)
Q Consensus       500 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~~~~~~~~~~l~~~  579 (642)
                      ++......             ......+|..|+|||++.. ..+++++||||+||++|||++|+.||.+.... ..+...
T Consensus       166 ~~~~~~~~-------------~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i  230 (355)
T d2b1pa1         166 ARTAGTSF-------------MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKV  230 (355)
T ss_dssp             ----------------------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             HHCCCCCC-------------CCCCCCCCCCCCCHHHHCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHH-HHHHHH
T ss_conf             21146665-------------5332214655558133147-77787743335662578986598998889778-899999


Q ss_pred             H------------------HHHHHCCCCCCCCCCHHHH-------HCHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9------------------9998515987533384554-------11047999999999998637789999999789999
Q 006522          580 V------------------RKAFRERRPLSEVIDPALV-------KEIHAKRQVLATFHIALNCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       580 ~------------------~~~~~~~~~~~~~~d~~l~-------~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~  634 (642)
                      .                  .............-.+...       ...........+.+++.+|+..||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             97205898799987656677776417543566642126433354321013337999999999987699457908999966

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-44  Score=265.80  Aligned_cols=260  Identities=17%  Similarity=0.159  Sum_probs=182.0

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEEEEEE
Q ss_conf             300275577611899935899999972999999128983210899999999986156-----------897114889999
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-----------HPNIVRLKAFYY  415 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  415 (642)
                      ...||+|+||.||+++....+     ..||||+++....  ..+.+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g-----~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCC-----CEEEEEEEECCCC--CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf             899750778189999999999-----7999999834313--368999999999984014555554227676478998763


Q ss_pred             EC--CCEEEEEEECCCCCHHHH-HHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECCCC--
Q ss_conf             58--914899950569968888-7239999999999999999999999999998703999951058899991238999--
Q 006522          416 AN--DEKLLISDFIRNGSLYAA-LHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDDEL--  490 (642)
Q Consensus       416 ~~--~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~~~--  490 (642)
                      ..  ...+++++++..+..... ......   ..+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++  
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred             ECCCCCEEEEEEECCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCC
T ss_conf             12565202343200035420000012234---6786899999999999998887640--586465677057056305765


Q ss_pred             ----CEEEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf             ----8089112553347999865445302532888655567983028532324888896330677999999999499999
Q 006522          491 ----HPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLAPEARIYGSKFTQKCDVYSFGIVLLEILTGRLPD  566 (642)
Q Consensus       491 ----~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~SfGviL~el~tG~~P~  566 (642)
                          .++++|||.++......               ....||..|+|||+... ..++.++||||+||+++||++|+.||
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEHY---------------TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBCC---------------CSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCCEEEEEECCCCCCCCCCC---------------CCCCCCCCCCCHHHCCC-CCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf             644305675314421234454---------------22366521057132146-67776432012378999998788998


Q ss_pred             CCCCCCC--CCHHHHHHHHHHCCCC-------------------CCCCCC----HHHHH-----CHHHHHHHHHHHHHHH
Q ss_conf             9999995--3178999999851598-------------------753338----45541-----1047999999999998
Q 006522          567 AGPENDG--KGLESLVRKAFRERRP-------------------LSEVID----PALVK-----EIHAKRQVLATFHIAL  616 (642)
Q Consensus       567 ~~~~~~~--~~l~~~~~~~~~~~~~-------------------~~~~~d----~~l~~-----~~~~~~~~~~~~~l~~  616 (642)
                      .......  ................                   ....+.    .....     ..........+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf             98755432102689999999837998788624532200013201220243235776444210001567435899999999


Q ss_pred             HCCCCCCCCCCCHHHHHH
Q ss_conf             637789999999789999
Q 006522          617 NCTELDPEFRPRMRTVSE  634 (642)
Q Consensus       617 ~C~~~dP~~RPt~~ev~~  634 (642)
                      +|+..||.+|||++|+++
T Consensus       310 ~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHT
T ss_pred             HHCCCCHHHCCCHHHHHC
T ss_conf             987799457908999966

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=7.4e-40  Score=240.09  Aligned_cols=184  Identities=36%  Similarity=0.616  Sum_probs=165.4

Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CCEEEEECC----CCEEEEECCCCCCCC--CCCCCCCCCCCC
Q ss_conf             784476999999999513599898899999999998--730268449----978699928999632--489211289999
Q 006522           20 FSLNQDGLALLALKAAIAQDPTRALDSWSESDSTPC--HWSGIHCIR----NRVTSLYLPNRNLTG--YMPSELGLLNSL   91 (642)
Q Consensus        20 ~~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c--~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L   91 (642)
                      .|..+|++||++||+++. ||. .+++|..+ .+||  .|.||+|+.    .+|+.|+|+++++.|  .+|++++.|+.|
T Consensus         2 ~c~~~e~~aLl~~k~~~~-~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCC-CCC-CCCCCCCC-CCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf             989899999999999779-998-67788999-999889488969748999479889989899888888798478467533


Q ss_pred             CEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECC
Q ss_conf             7898138-978776560000687666652257756445830003889868685105668886506765010134423255
Q 006522           92 TRLSLAS-NNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLS  170 (642)
Q Consensus        92 ~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~  170 (642)
                      ++|+|++ |+++|.+|..+.++++|++|+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+..++.++ .++++
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~-~l~l~  157 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV-GITFD  157 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC-EEECC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCC-EEECC
T ss_conf             52020265433300243114542001102035643443322222011100111122455556851220674000-00023


Q ss_pred             CCCCCCCCCCCCCCCCCC-CEEEEECCCCCCCCCCCCC
Q ss_conf             541113578645999997-6898006988777576554
Q 006522          171 FNQFSGQIPEMYGHFPVM-VSLDLRNNNLSGEIPQVGS  207 (642)
Q Consensus       171 ~N~l~g~~p~~~~~l~~L-~~l~l~~N~l~g~~p~~~~  207 (642)
                      +|.+++.+|..+..+..+ ..+++++|++++..|....
T Consensus       158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~  195 (313)
T d1ogqa_         158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA  195 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             55335620312144311232310224643533243322

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.1e-25  Score=157.21  Aligned_cols=163  Identities=14%  Similarity=0.166  Sum_probs=117.6

Q ss_pred             CCCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCCCCC-----------------CCHHHHHHHHHHHHCCCCCCEE
Q ss_conf             13002755776118999358999999729999991289832-----------------1089999999998615689711
Q 006522          346 SAYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDAT-----------------WRFKDFESEVEAIARVQHPNIV  408 (642)
Q Consensus       346 ~~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~H~niv  408 (642)
                      -++.||+|+||.||++...+|      ..||||.++.....                 .....+..|...+.++.|.+++
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g------~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~   77 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKF------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP   77 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTT------EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred             HCCEEEECCCEEEEEEECCCC------CEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             277802485659999997999------99999998604434666556563000888999999778999999981699914


Q ss_pred             EEEEEEEECCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCEEECC
Q ss_conf             48899995891489995056996888872399999999999999999999999999987039999510588999912389
Q 006522          409 RLKAFYYANDEKLLISDFIRNGSLYAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYSPRKYVHGNIKSTKILLDD  488 (642)
Q Consensus       409 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrdlk~~NILld~  488 (642)
                      ..+++.    ..+++|||++++.+.+            +++.....++.|++.+++|||+   .+|+||||||+|||+++
T Consensus        78 ~~~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~  138 (191)
T d1zara2          78 KVYAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             CEEEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEET
T ss_pred             EEEEEC----CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEEC
T ss_conf             499862----8889999504565420------------0157899999999999999826---88898368903611428


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             998089112553347999865445302532888655567983028------53232488889633067799999
Q 006522          489 ELHPCISGFGLNRLLPGTSKVTKNETIVTSGTGSRISAISNVYLA------PEARIYGSKFTQKCDVYSFGIVL  556 (642)
Q Consensus       489 ~~~~ki~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~DV~SfGviL  556 (642)
                      + .++++|||+|+........                    .|..      .+.+  .+.++.++|+||..--+
T Consensus       139 ~-~~~liDFG~a~~~~~~~~~--------------------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEEGWR--------------------EILERDVRNIITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             T-EEEECCCTTCEETTSTTHH--------------------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             C-CEEEEECCCCCCCCCCCCH--------------------HHHHHHHHHHHHHH--CCCCCCCCCHHHHHHHH
T ss_conf             9-8999877884308998709--------------------99987799999997--57899844689999987

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=6.5e-21  Score=132.69  Aligned_cols=155  Identities=28%  Similarity=0.266  Sum_probs=99.4

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             78699928999632489211289999789813897877656000068766665225775644583000388986868510
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  145 (642)
                      .++.|+|++|.+.+..+..|..+++|+.|+|++|.|+. +| .+..+++|+.|+|++|++.+ .+..+..+++|+.|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf             88989884992898597786345655221356654444-31-11112232111112222211-11121222222222222


Q ss_pred             CCCCCC------------------------CCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             566888------------------------65067650101344232555411135786459999976898006988777
Q 006522          146 SNLLNG------------------------SLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       146 ~N~l~g------------------------~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  201 (642)
                      +|.+..                        ..+..+..++.+. .+++++|++++..+..|+.+++|+.|+|++|+|+ .
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~-~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~  186 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T  186 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCH-HCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-C
T ss_conf             2311011001122221111221243421022123332211100-0000015652237200134212423430139785-5


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             57-6554235587556899988899
Q 006522          202 IP-QVGSLLNQGPTAFSGNPGLCGF  225 (642)
Q Consensus       202 ~p-~~~~~~~~~~~~~~~n~~~c~~  225 (642)
                      +| .+..+..+....+.|||+.|++
T Consensus       187 lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         187 IPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCHHHCCCCCCCEEEECCCCCCCCC
T ss_conf             6866777888999983699987886

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.85  E-value=4.2e-21  Score=133.75  Aligned_cols=161  Identities=24%  Similarity=0.353  Sum_probs=124.1

Q ss_pred             CCCCCCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf             999873026844997869992899963248921128999978981389787765-6000068766665225775644583
Q 006522           52 STPCHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPI-PANLFNATNLVYLDLAHNSFCGPIP  130 (642)
Q Consensus        52 ~~~c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p  130 (642)
                      .|.|+|..|.|..          ++++ .+|..+  .+.+++|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..+
T Consensus         5 ~C~C~~~~v~Cs~----------~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~   71 (192)
T d1w8aa_           5 MCHCEGTTVDCTG----------RGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP   71 (192)
T ss_dssp             TSEEETTEEECTT----------SCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred             CCEECCCEEEEEC----------CCCC-CCCCCC--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCC
T ss_conf             9897699999708----------9967-029898--97878898489877553020025787627213013632212121


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             00038898686851056688865067650101344232555411135786459999976898006988777576554235
Q 006522          131 DRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN  210 (642)
Q Consensus       131 ~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~  210 (642)
                      ..+..+++|+.|+|++|.+....|..|..++.|+ .|+|++|+|++..+..|..+++|+.++|++|.+.+..+.......
T Consensus        72 ~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~-~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~  150 (192)
T d1w8aa_          72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLK-TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEW  150 (192)
T ss_dssp             TTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCC-EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHH
T ss_pred             CCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHH
T ss_conf             2221122221010035534434979980797465-524577453535977856875334200036443435302777642


Q ss_pred             CCCCCCCCCCCCCCCC
Q ss_conf             5875568999888999
Q 006522          211 QGPTAFSGNPGLCGFP  226 (642)
Q Consensus       211 ~~~~~~~~n~~~c~~~  226 (642)
                      +....+..|...|..|
T Consensus       151 l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_         151 LRKKSLNGGAARCGAP  166 (192)
T ss_dssp             HHHHCCSGGGCBBCSS
T ss_pred             HHHHCCCCCCEEECCC
T ss_conf             3540356898276898

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.84  E-value=8.2e-22  Score=137.78  Aligned_cols=166  Identities=33%  Similarity=0.539  Sum_probs=135.4

Q ss_pred             CCEEEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             9786999289-996324892112899997898138978776560000687666652257756445830003889868685
Q 006522           65 NRVTSLYLPN-RNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLD  143 (642)
Q Consensus        65 ~~v~~l~l~~-~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~  143 (642)
                      ..++.|+|++ |++.|.+|++++.+++|++|+|++|++.+..+..+..++.|++++++.|.+.+.+|..+..++.|+.++
T Consensus        76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~  155 (313)
T d1ogqa_          76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT  155 (313)
T ss_dssp             TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             53352020265433300243114542001102035643443322222011100111122455556851220674000000


Q ss_pred             CCCCCCCCCCHHHH------------------------------------------------------------------
Q ss_conf             10566888650676------------------------------------------------------------------
Q 006522          144 LSSNLLNGSLPEFL------------------------------------------------------------------  157 (642)
Q Consensus       144 ls~N~l~g~~p~~~------------------------------------------------------------------  157 (642)
                      +++|.+.|.+|..+                                                                  
T Consensus       156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~  235 (313)
T d1ogqa_         156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF  235 (313)
T ss_dssp             CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             23553356203121443112323102246435332433222222233333343322222222222221112222222222


Q ss_pred             -----HHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             -----501013442325554111357864599999768980069887775765542355875568999888999989999
Q 006522          158 -----LDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCGFPLQSPCP  232 (642)
Q Consensus       158 -----~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~c~  232 (642)
                           ..++.++ .|++++|+++|.+|..++++++|+.|+|++|+|+|.+|....+.++....+.+|+.+||.|++ +|.
T Consensus       236 ~~~~~~~~~~L~-~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c~  313 (313)
T d1ogqa_         236 DLGKVGLSKNLN-GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-ACT  313 (313)
T ss_dssp             BGGGCCCCTTCC-EEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CCC
T ss_pred             CCCCCCCCCCCC-CCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC-CCC
T ss_conf             222222455444-444765706660876884799999897958835166898666799897886889500198988-989

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=6.1e-19  Score=121.50  Aligned_cols=149  Identities=28%  Similarity=0.261  Sum_probs=118.4

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             78699928999632489211289999789813897877656000068766665225775644583000388986868510
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  145 (642)
                      +...++.++++|+ .+|+.+.  +.|+.|+|++|.|++..+..|.++++|++|+|++|+++. +| .+..+++|+.|+|+
T Consensus        11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLS   85 (266)
T ss_dssp             TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECC
T ss_pred             CCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCC
T ss_conf             9869980699988-6196757--688989884992898597786345655221356654444-31-11112232111112


Q ss_pred             CCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCC
Q ss_conf             5668886506765010134423255541113578645999997689800698877757655-423558755689998
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVG-SLLNQGPTAFSGNPG  221 (642)
Q Consensus       146 ~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~~~~~~~~~~~n~~  221 (642)
                      +|.+.+ ++..+..++.|+ .|++++|.+....+..+..+.++..|++++|.++...+... .+..+....+.+|..
T Consensus        86 ~N~l~~-~~~~~~~l~~L~-~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l  160 (266)
T d1p9ag_          86 HNQLQS-LPLLGQTLPALT-VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (266)
T ss_dssp             SSCCSS-CCCCTTTCTTCC-EEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             CCCCCC-CCCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCC
T ss_conf             222211-111212222222-222222311011001122221111221243421022123332211100000001565

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.9e-19  Score=123.31  Aligned_cols=138  Identities=21%  Similarity=0.198  Sum_probs=81.9

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             978699928999632489211289999789813897877656000068766665225-7756445830003889868685
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLA-HNSFCGPIPDRIKTLKNLTHLD  143 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~-~N~l~g~~p~~~~~l~~L~~L~  143 (642)
                      ..++.|+|++|.++...+..+..++.|++|++++|.+....+..+..++.+..++.. .|.+....+..|.++++|+.|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             99888977488179879778641421300001344543321112122222222222210223544620101010277875


Q ss_pred             CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             105668886506765010134423255541113578645999997689800698877757
Q 006522          144 LSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       144 ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p  203 (642)
                      +++|.+....+..+.....|. .+++++|++++..+..|..+++|+.|++++|++++..+
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~-~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQ-YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCCCCCCCCCCCCCCHHCCCC-HHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCH
T ss_conf             688544320135332000121-10200143144580574043405022314176566256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.79  E-value=1.3e-18  Score=119.72  Aligned_cols=144  Identities=20%  Similarity=0.312  Sum_probs=76.7

Q ss_pred             CCCCCCEEEEECCC-----------CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             99987302684499-----------7869992899963248921128999978981389787765600006876666522
Q 006522           52 STPCHWSGIHCIRN-----------RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDL  120 (642)
Q Consensus        52 ~~~c~w~gv~C~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l  120 (642)
                      .|-|.|.+|.|...           .++.|+|++|.++...+..|..++.|+.|++++|.+....|..|.+++.|+.|++
T Consensus         7 ~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_           7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECC
T ss_conf             88955999985599988519888999798978499189869657604656523112344344523566527985578315


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEEEECCCC
Q ss_conf             5775644583000388986868510566888650676501013442325554111--35786459999976898006988
Q 006522          121 AHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFS--GQIPEMYGHFPVMVSLDLRNNNL  198 (642)
Q Consensus       121 ~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~--g~~p~~~~~l~~L~~l~l~~N~l  198 (642)
                      ++|++.. +|..+  ...+..|++++|.+.+..+..+.....+. .+....|...  ...+..+..+++|+.+++++|.+
T Consensus        87 ~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~-~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l  162 (305)
T d1xkua_          87 SKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  162 (305)
T ss_dssp             CSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCC-EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCCCCCC-CCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             6875676-76400--11132321024610234444540133110-00012333334677764223456567120346774


Q ss_pred             C
Q ss_conf             7
Q 006522          199 S  199 (642)
Q Consensus       199 ~  199 (642)
                      +
T Consensus       163 ~  163 (305)
T d1xkua_         163 T  163 (305)
T ss_dssp             C
T ss_pred             C
T ss_conf             5

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=6.4e-19  Score=121.38  Aligned_cols=148  Identities=25%  Similarity=0.285  Sum_probs=102.0

Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHH
Q ss_conf             63248921128999978981389787765600006876666522577564458300038898686851056688865067
Q 006522           77 LTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEF  156 (642)
Q Consensus        77 l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~  156 (642)
                      +....+..+..+++|+.|++++|.+....+..+...++|+.+++++|.+++..+..|..+++|+.|++++|.+.+..+..
T Consensus        93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~  172 (284)
T d1ozna_          93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA  172 (284)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred             CCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHH
T ss_conf             35446201010102778756885443201353320001211020014314458057404340502231417656625666


Q ss_pred             HHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC
Q ss_conf             650101344232555411135786459999976898006988777576-554235587556899988899
Q 006522          157 LLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQ-VGSLLNQGPTAFSGNPGLCGF  225 (642)
Q Consensus       157 ~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~~~~~~~~~~~~n~~~c~~  225 (642)
                      +..++.|. .+++++|++++..|..|..+++|+.|++++|.+++..|. +..+.++....+.+||+.|.+
T Consensus       173 f~~l~~L~-~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C  241 (284)
T d1ozna_         173 FRGLHSLD-RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (284)
T ss_dssp             TTTCTTCC-EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             HCCCCCCC-HHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC
T ss_conf             54656341-3142114346628167665320002333335221000002355465688981199887875

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=1.1e-17  Score=114.42  Aligned_cols=157  Identities=20%  Similarity=0.230  Sum_probs=89.5

Q ss_pred             CEEEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             7869992899963248-921128999978981389787765600006876666522577564458300038898686851
Q 006522           66 RVTSLYLPNRNLTGYM-PSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  144 (642)
                      .++.|+|++|.+++.+ +..+..+++|+.|+|++|.+.+..+..+..+++|++|+|++|++....|..|.++++|+.|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf             87889848987755302002578762721301363221212122211222210100355344349799807974655245


Q ss_pred             CCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             05668886506765010134423255541113578645999997689800698877757655423558755689998889
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNPGLCG  224 (642)
Q Consensus       145 s~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~~~c~  224 (642)
                      ++|.|++..|..|..++.|+ ++++++|.+........ -...+..+.+..|.+++..|  ..+.+..-..+..|...|.
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~-~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p--~~l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLT-SLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP--SKVRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCC-EEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS--TTTTTSBGGGSCTTTCCCC
T ss_pred             CCCCCCCCCHHHHCCCCCCC-CCCCCCCCCCCCCCHHH-HHHHHHHHCCCCCCEEECCC--HHHCCCEEEECCHHHCCCC
T ss_conf             77453535977856875334-20003644343530277-76423540356898276898--4336988614487557589


Q ss_pred             CC
Q ss_conf             99
Q 006522          225 FP  226 (642)
Q Consensus       225 ~~  226 (642)
                      .+
T Consensus       186 ~~  187 (192)
T d1w8aa_         186 SE  187 (192)
T ss_dssp             CC
T ss_pred             CC
T ss_conf             98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.69  E-value=3.9e-16  Score=105.58  Aligned_cols=132  Identities=23%  Similarity=0.323  Sum_probs=101.6

Q ss_pred             EEECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             68449978699928999632489211289999789813897877656000068766665225775644583000388986
Q 006522           60 IHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNL  139 (642)
Q Consensus        60 v~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  139 (642)
                      -.|.   .+.++-++++++ .+|+.+  .+.+++|+|++|.++...+..|.++++|++|++++|.+....|..|..+++|
T Consensus         8 c~c~---~~~~~C~~~~L~-~lP~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L   81 (305)
T d1xkua_           8 CQCH---LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL   81 (305)
T ss_dssp             CEEE---TTEEECTTSCCC-SCCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             CEEC---CCEEEECCCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCC
T ss_conf             8955---999985599988-519888--9997989784991898696576046565231123443445235665279855


Q ss_pred             CEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             86851056688865067650101344232555411135786459999976898006988777
Q 006522          140 THLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       140 ~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  201 (642)
                      +.|++++|.+. .+|..+  ...+. .|.+.+|.+.+..+..+.....+..++...|.....
T Consensus        82 ~~L~l~~n~l~-~l~~~~--~~~l~-~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~  139 (305)
T d1xkua_          82 ERLYLSKNQLK-ELPEKM--PKTLQ-ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS  139 (305)
T ss_dssp             CEEECCSSCCS-BCCSSC--CTTCC-EEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred             CEECCCCCCCC-CCCCCH--HHHHH-HHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             78315687567-676400--11132-321024610234444540133110000123333346

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.63  E-value=2.9e-15  Score=100.68  Aligned_cols=84  Identities=29%  Similarity=0.421  Sum_probs=62.2

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             97869992899963248921128999978981389787765600006876666522577564458300038898686851
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  144 (642)
                      ..++.|+++++++.. + +.+..+++|++|+|++|.+++ +| .+.++++|++|++++|++.+..|  +..+++|+.|++
T Consensus        44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~  117 (384)
T d2omza2          44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL  117 (384)
T ss_dssp             TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCC
T ss_conf             787899899989877-6-242458999989681881798-86-33477110103013433322221--112334333443


Q ss_pred             CCCCCCCCCH
Q ss_conf             0566888650
Q 006522          145 SSNLLNGSLP  154 (642)
Q Consensus       145 s~N~l~g~~p  154 (642)
                      ++|.+++..+
T Consensus       118 ~~~~~~~~~~  127 (384)
T d2omza2         118 FNNQITDIDP  127 (384)
T ss_dssp             CSSCCCCCGG
T ss_pred             CCCCCCCCCC
T ss_conf             3222222222

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.58  E-value=2.8e-14  Score=95.07  Aligned_cols=143  Identities=25%  Similarity=0.324  Sum_probs=84.3

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             78699928999632489211289999789813897877656000068766665225775644583000388986868510
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  145 (642)
                      .++.|+++++++.. + +.+..+++|++|++++|.+++. + .+.++++|++|++++|.+.. ++ .+..++.|+.|+++
T Consensus        41 ~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          41 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred             CCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCC
T ss_conf             87899899999977-5-2021378867575456556676-4-01677522311112222222-21-11112232221112


Q ss_pred             CCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             566888650676501013442325554111357864599999768980069887775765542355875568999
Q 006522          146 SNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGNP  220 (642)
Q Consensus       146 ~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n~  220 (642)
                      +|.+....  .+..++.|. .+++++|++.. ++ .+..+++++.|++.+|++++. +.+..+.++....+++|+
T Consensus       115 ~~~~~~~~--~~~~l~~L~-~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         115 NNQITDID--PLKNLTNLN-RLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNK  183 (199)
T ss_dssp             SSCCCCCG--GGTTCTTCS-EEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSC
T ss_pred             CCCCCCCC--CCCHHHHHH-HHHHHHHHHCC-CC-CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCEEECCCCC
T ss_conf             22222321--000122367-76431111002-34-333211111122345555677-011679989999787997

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.57  E-value=2.4e-14  Score=95.43  Aligned_cols=134  Identities=32%  Similarity=0.425  Sum_probs=110.7

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             97869992899963248921128999978981389787765600006876666522577564458300038898686851
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  144 (642)
                      ..++.|+|++|.+++..  .++.+++|+.|++++|.+.. ++ .+.+++.|+.|++++|.+...  ..+..+++|+.|++
T Consensus        62 ~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l  135 (199)
T d2omxa2          62 NNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLEL  135 (199)
T ss_dssp             TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred             CCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHH
T ss_conf             88675754565566764--01677522311112222222-21-111122322211122222232--10001223677643


Q ss_pred             CCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             056688865067650101344232555411135786459999976898006988777576554235
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLN  210 (642)
Q Consensus       145 s~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~  210 (642)
                      ++|.+.. ++ .+..++.+. .|++.+|++++. + .++.+++|+.|++++|+++. ++.+..+.+
T Consensus       136 ~~n~l~~-~~-~l~~~~~L~-~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~  195 (199)
T d2omxa2         136 SSNTISD-IS-ALSGLTSLQ-QLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-ISVLAKLTN  195 (199)
T ss_dssp             CSSCCCC-CG-GGTTCTTCS-EEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTT
T ss_pred             HHHHHCC-CC-CCCCCCCCC-CCCCCCCCCCCC-C-CCCCCCCCCEEECCCCCCCC-CCCCCCCCC
T ss_conf             1111002-34-333211111-122345555677-0-11679989999787997998-810127899

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.57  E-value=1.4e-14  Score=96.75  Aligned_cols=120  Identities=24%  Similarity=0.313  Sum_probs=78.7

Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             92899963248921128999978981389787765600006876666522577564458300038898686851056688
Q 006522           71 YLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLN  150 (642)
Q Consensus        71 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~  150 (642)
                      .+...++++.++  ...+.+|++|+++++.++. + ..+..+++|++|+|++|++++..|  +.++++|+.|++++|.+.
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~  101 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA  101 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             HHCCCCCCCCCC--HHHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
T ss_conf             867777788639--8895787899899989877-6-242458999989681881798863--347711010301343332


Q ss_pred             CCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             865067650101344232555411135786459999976898006988777
Q 006522          151 GSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       151 g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  201 (642)
                      +..|  +..++.|+ .+++++|.+++..+.  .....+..+....|.+...
T Consensus       102 ~i~~--l~~l~~L~-~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~  147 (384)
T d2omza2         102 DITP--LANLTNLT-GLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDI  147 (384)
T ss_dssp             CCGG--GTTCTTCC-EEECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCC
T ss_pred             CCCC--CCCCCCCC-CCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf             2221--11233433-344332222222222--2222221121346631310

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.57  E-value=1.7e-14  Score=96.32  Aligned_cols=141  Identities=24%  Similarity=0.325  Sum_probs=60.8

Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             86999289996324892112899997898138978776560000687666652257756445830003889868685105
Q 006522           67 VTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSS  146 (642)
Q Consensus        67 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~  146 (642)
                      ++.|+++++.+....  .+..+++|++|+|++|.+++ ++ .+..+++|++|++++|++++ +| .+..+++|+.|++++
T Consensus        48 L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~  121 (210)
T d1h6ta2          48 IDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH  121 (210)
T ss_dssp             CCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred             CCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf             458978279888744--47648998987698960258-60-11358621201433333212-22-121222111223456


Q ss_pred             CCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             6688865067650101344232555411135786459999976898006988777576554235587556899
Q 006522          147 NLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTAFSGN  219 (642)
Q Consensus       147 N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~~~~n  219 (642)
                      |.+.. ++ .+..++.+. .++++.|.++..  ..+..+++|+.+++++|++++. +.+..+.++....+++|
T Consensus       122 ~~~~~-~~-~l~~l~~l~-~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N  188 (210)
T d1h6ta2         122 NGISD-IN-GLVHLPQLE-SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKN  188 (210)
T ss_dssp             SCCCC-CG-GGGGCTTCC-EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred             CCCCC-CC-CCCCCCCCC-CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCEEECCCC
T ss_conf             53221-12-201111122-211222333454--3100013321001346430256-45367898999989799

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=2.9e-14  Score=94.97  Aligned_cols=151  Identities=15%  Similarity=0.096  Sum_probs=96.2

Q ss_pred             CCCCCCEEEEECC-----------CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEE
Q ss_conf             9998730268449-----------9786999289996324892112899997898138978776560-000687666652
Q 006522           52 STPCHWSGIHCIR-----------NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPA-NLFNATNLVYLD  119 (642)
Q Consensus        52 ~~~c~w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~  119 (642)
                      .|.|....|.|..           ..++.|+|++|.+....+..|.++++|++|++++|.+...++. .|.+++.++.|+
T Consensus         5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1           5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             CCCCCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf             28873999998189988768888998899987699189649668614643232110221124201001122222222211


Q ss_pred             CC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH-HHHHHHCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEEEECC
Q ss_conf             25-775644583000388986868510566888650-67650101344232555411135786459999-9768980069
Q 006522          120 LA-HNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPEMYGHFP-VMVSLDLRNN  196 (642)
Q Consensus       120 l~-~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~-~L~~l~l~~N  196 (642)
                      +. .|.+....+..|..+++|+.+++++|.+....+ ..+..+..+. .+..+++++....+..+..++ .+..+++++|
T Consensus        85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~-~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n  163 (242)
T d1xwdc1          85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL-LDIQDNINIHTIERNSFVGLSFESVILWLNKN  163 (242)
T ss_dssp             EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEE-EEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf             11123432222221222222222234211112554333222111122-22222121112222222222331001220012


Q ss_pred             CCCCCCC
Q ss_conf             8877757
Q 006522          197 NLSGEIP  203 (642)
Q Consensus       197 ~l~g~~p  203 (642)
                      +++...+
T Consensus       164 ~l~~i~~  170 (242)
T d1xwdc1         164 GIQEIHN  170 (242)
T ss_dssp             CCCEECT
T ss_pred             CCCCCCC
T ss_conf             3333222

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.1e-14  Score=97.29  Aligned_cols=113  Identities=15%  Similarity=0.064  Sum_probs=65.8

Q ss_pred             CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCC
Q ss_conf             11289999789813897877656000068766665225775644583000388986868510566888650676501013
Q 006522           84 ELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRAL  163 (642)
Q Consensus        84 ~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l  163 (642)
                      .+.+...|+.|+|++|.++. ++..+..+++|+.|||++|.++.. + .+..+++|+.|++++|.++...+..+..++.|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             HCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCC-C-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf             51685748489788997886-576200414599898979978764-7-74457613064310213457776322334534


Q ss_pred             CCEEECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCC
Q ss_conf             4423255541113578-645999997689800698877
Q 006522          164 TGTLNLSFNQFSGQIP-EMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       164 ~~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g  200 (642)
                      + .|++++|+++.... ..+..+++|+.+++++|.++.
T Consensus        90 ~-~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          90 T-ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             C-EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             C-CCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCC
T ss_conf             4-342030001665421100136532066407996345

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=8.8e-15  Score=97.94  Aligned_cols=124  Identities=22%  Similarity=0.216  Sum_probs=102.2

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             78699928999632489211289999789813897877656000068766665225775644583000388986868510
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  145 (642)
                      .+..|+|++|.++. ++..+..++.|+.|+|++|.++. ++ .+..+++|+.|++++|++....+..+..+++|+.|+++
T Consensus        19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             CCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEC
T ss_conf             48489788997886-57620041459989897997876-47-74457613064310213457776322334534434203


Q ss_pred             CCCCCCCCH--HHHHHHCCCCCEEECCCCCCCCCC---CCCCCCCCCCCEEEEE
Q ss_conf             566888650--676501013442325554111357---8645999997689800
Q 006522          146 SNLLNGSLP--EFLLDLRALTGTLNLSFNQFSGQI---PEMYGHFPVMVSLDLR  194 (642)
Q Consensus       146 ~N~l~g~~p--~~~~~l~~l~~~l~l~~N~l~g~~---p~~~~~l~~L~~l~l~  194 (642)
                      +|.+.. ++  ..+..++.|+ .+++++|+++...   +..+..+++|+.||-.
T Consensus        96 ~N~i~~-~~~l~~l~~l~~L~-~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~~  147 (162)
T d1a9na_          96 NNSLVE-LGDLDPLASLKSLT-YLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQ  147 (162)
T ss_dssp             SCCCCC-GGGGGGGGGCTTCC-EEECCSSGGGGSTTHHHHHHHHCTTCSEETTE
T ss_pred             CCCCCC-CCCCCCCCCCCCCC-HHHCCCCCCCCCCCHHHHHHHHCCCCCEECCC
T ss_conf             000166-54211001365320-66407996345610699999878995833797

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=1.9e-14  Score=96.07  Aligned_cols=103  Identities=26%  Similarity=0.325  Sum_probs=49.3

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCC
Q ss_conf             78981389787765600006876666522577564458300038898686851056688865067650101344232555
Q 006522           92 TRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSF  171 (642)
Q Consensus        92 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~  171 (642)
                      |.|+|++|.++. ++ .+..+++|++|++++|++. .+|+.+..+++|+.|++++|.++. +| .+..++.|+ .+++++
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~-~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQ-ELLLCN   74 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCC-EEECCS
T ss_pred             CEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCC-EEECCC
T ss_conf             989868998988-71-0105898898979787168-652156554313545324321123-57-412335557-688889


Q ss_pred             CCCCCCC-CCCCCCCCCCCEEEEECCCCCC
Q ss_conf             4111357-8645999997689800698877
Q 006522          172 NQFSGQI-PEMYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       172 N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g  200 (642)
                      |+++... ...++.+++|+.+++++|.++.
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             CCCCCCCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf             865888882565379999999897996886

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.53  E-value=1.1e-13  Score=91.81  Aligned_cols=139  Identities=28%  Similarity=0.333  Sum_probs=113.4

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             97869992899963248921128999978981389787765600006876666522577564458300038898686851
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  144 (642)
                      ..++.|+|++|.+++. + .++.+++|+.|++++|.+++ +| .+.++++|+.|++++|.+.. + ..+..++.++.+++
T Consensus        68 ~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~  141 (210)
T d1h6ta2          68 PNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL  141 (210)
T ss_dssp             TTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCC
T ss_conf             9989876989602586-0-11358621201433333212-22-12122211122345653221-1-22011111222112


Q ss_pred             CCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             05668886506765010134423255541113578645999997689800698877757655423558755
Q 006522          145 SSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQVGSLLNQGPTA  215 (642)
Q Consensus       145 s~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~~~~~~~~  215 (642)
                      ++|.+.+.  ..+..++.|+ .+++++|++++. ++ +.++++|+.|++++|+++. +|.+..+.+++...
T Consensus       142 ~~n~l~~~--~~~~~l~~L~-~l~l~~n~l~~i-~~-l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~  206 (210)
T d1h6ta2         142 GNNKITDI--TVLSRLTKLD-TLSLEDNQISDI-VP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLE  206 (210)
T ss_dssp             CSSCCCCC--GGGGGCTTCS-EEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEE
T ss_pred             CCCCCCCC--CCCCCCCCCC-CCCCCCCCCCCC-CC-CCCCCCCCEEECCCCCCCC-CHHHCCCCCCCEEE
T ss_conf             22333454--3100013321-001346430256-45-3678989999897998998-72116999989997

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=5.9e-14  Score=93.25  Aligned_cols=117  Identities=26%  Similarity=0.300  Sum_probs=94.5

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             99928999632489211289999789813897877656000068766665225775644583000388986868510566
Q 006522           69 SLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNL  148 (642)
Q Consensus        69 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~  148 (642)
                      .|+|++|+++ .++ .+..++.|++|++++|.++. +|+.+..+++|+.|++++|.+++ +| .+..+++|+.|++++|.
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCCC-CHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf             8986899898-871-01058988989797871686-52156554313545324321123-57-41233555768888986


Q ss_pred             CCCCC-HHHHHHHCCCCCEEECCCCCCCCCC---CCCCCCCCCCCEE
Q ss_conf             88865-0676501013442325554111357---8645999997689
Q 006522          149 LNGSL-PEFLLDLRALTGTLNLSFNQFSGQI---PEMYGHFPVMVSL  191 (642)
Q Consensus       149 l~g~~-p~~~~~l~~l~~~l~l~~N~l~g~~---p~~~~~l~~L~~l  191 (642)
                      +.... ...+..++.|+ .+++++|+++...   ......+++++.+
T Consensus        77 i~~~~~~~~l~~~~~L~-~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLV-LLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCSSSTTGGGGGCTTCC-EEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCHHHCCCCCCC-EEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             58888825653799999-99897996886826799999989673138

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.49  E-value=5.1e-13  Score=87.93  Aligned_cols=145  Identities=26%  Similarity=0.335  Sum_probs=84.2

Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             78699928999632489211289999789813897877656000068766665225775644583000388986868510
Q 006522           66 RVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLS  145 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls  145 (642)
                      .++.|++.++++.. + +.+..+++|+.|++++|.+++..|  +..+++|++|++++|.++. ++ .+..+++|+.++++
T Consensus        42 ~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~  115 (227)
T d1h6ua2          42 GITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLT  115 (227)
T ss_dssp             TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECT
T ss_pred             CCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCC
T ss_conf             86899777999976-6-457448888376357853202543--1123343201211122222-22-22222222122122


Q ss_pred             CCCCCCCCH--------------------HHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf             566888650--------------------676501013442325554111357864599999768980069887775765
Q 006522          146 SNLLNGSLP--------------------EFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGEIPQV  205 (642)
Q Consensus       146 ~N~l~g~~p--------------------~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~~p~~  205 (642)
                      ++...+..+                    ..+...+.|+ .|++++|.+....  .++.+++|+.|++++|++++ ++.+
T Consensus       116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~-~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l  191 (227)
T d1h6ua2         116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQ-YLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPL  191 (227)
T ss_dssp             TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCC-EEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGG
T ss_pred             CCCCCCCCHHCCCCCHHHHHCHHHHHCHHHHHCCCCCCC-CCCCCCCCCCCCH--HHCCCCCCEECCCCCCCCCC-CHHH
T ss_conf             244331100000230122200000000000001021110-0233333333100--10564633564458884177-8534


Q ss_pred             CCCCCCCCCCCCCCC
Q ss_conf             542355875568999
Q 006522          206 GSLLNQGPTAFSGNP  220 (642)
Q Consensus       206 ~~~~~~~~~~~~~n~  220 (642)
                      ..+.++....+++|.
T Consensus       192 ~~l~~L~~L~Ls~N~  206 (227)
T d1h6ua2         192 ASLPNLIEVHLKNNQ  206 (227)
T ss_dssp             GGCTTCCEEECTTSC
T ss_pred             CCCCCCCEEECCCCC
T ss_conf             479999989795996

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=5.3e-14  Score=93.49  Aligned_cols=110  Identities=24%  Similarity=0.192  Sum_probs=65.2

Q ss_pred             CCCC-CCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf             9998-73026844997869992899963248921128999978981389-787765600006876666522577564458
Q 006522           52 STPC-HWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASN-NFSKPIPANLFNATNLVYLDLAHNSFCGPI  129 (642)
Q Consensus        52 ~~~c-~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  129 (642)
                      .|.| .+++|+|...          ++. ..|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+++...
T Consensus         4 ~C~c~~~~~l~c~~~----------~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~   72 (156)
T d2ifga3           4 ACCPHGSSGLRCTRD----------GAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA   72 (156)
T ss_dssp             SSCCSSSSCEECCSS----------CCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred             CCCCCCCCEEEECCC----------CCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCC
T ss_conf             788699996985289----------976-586002576565743168986644369212256666672162021247742


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCC
Q ss_conf             300038898686851056688865067650101344232555411
Q 006522          130 PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQF  174 (642)
Q Consensus       130 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l  174 (642)
                      |..|..+++|+.|+|++|.+. .+|........|. .|++++|.+
T Consensus        73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~-~L~L~~Np~  115 (156)
T d2ifga3          73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPL  115 (156)
T ss_dssp             TTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCC-EEECCSSCC
T ss_pred             CCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCC-CCCCCCCCC
T ss_conf             011124554333322678785-1574563353212-433579863

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=3.5e-13  Score=88.89  Aligned_cols=113  Identities=19%  Similarity=0.117  Sum_probs=93.1

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCC
Q ss_conf             28999978981389787765600006876666522577-56445830003889868685105668886506765010134
Q 006522           86 GLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN-SFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT  164 (642)
Q Consensus        86 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~  164 (642)
                      ........++.+++.+.. +|..+..+++|+.|++++| .+....+..|.++++|+.|+|++|.++...|..|..++.|+
T Consensus         5 C~c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCCCCCCEEEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
T ss_conf             886999969852899765-8600257656574316898664436921225666667216202124774201112455433


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             4232555411135786459999976898006988777
Q 006522          165 GTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       165 ~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  201 (642)
                       .|++++|+++...+..+.. ..|+.|+|++|.+...
T Consensus        84 -~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          84 -RLNLSFNALESLSWKTVQG-LSLQELVLSGNPLHCS  118 (156)
T ss_dssp             -EEECCSSCCSCCCSTTTCS-CCCCEEECCSSCCCCC
T ss_pred             -CEECCCCCCCCCCHHHHCC-CCCCCCCCCCCCCCCC
T ss_conf             -3322678785157456335-3212433579863388

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.42  E-value=1.1e-12  Score=85.98  Aligned_cols=148  Identities=24%  Similarity=0.361  Sum_probs=106.2

Q ss_pred             CCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-----
Q ss_conf             730268449978699928999632489211289999789813897877656000068766665225775644583-----
Q 006522           56 HWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIP-----  130 (642)
Q Consensus        56 ~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-----  130 (642)
                      +..|+... ..++.|++++|.+.+..  .+..++.|+.|++++|.++. ++ .+.++++|+.++++++...+..+     
T Consensus        55 ~l~~l~~l-~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~  129 (227)
T d1h6ua2          55 TIEGVQYL-NNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLS  129 (227)
T ss_dssp             CCTTGGGC-TTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCT
T ss_pred             CCHHHHCC-CCCCEEECCCCEEECCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCHHCCCC
T ss_conf             66457448-88837635785320254--31123343201211122222-22-2222222212212224433110000023


Q ss_pred             ---------------CCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf             ---------------00038898686851056688865067650101344232555411135786459999976898006
Q 006522          131 ---------------DRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRN  195 (642)
Q Consensus       131 ---------------~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~  195 (642)
                                     ..+..+++|+.|++++|.+....+  +..++.|+ .|++++|++++ +++ ++.+++|+.|++++
T Consensus       130 ~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~-~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~  204 (227)
T d1h6ua2         130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT-TLKADDNKISD-ISP-LASLPNLIEVHLKN  204 (227)
T ss_dssp             TCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCC-EEECCSSCCCC-CGG-GGGCTTCCEEECTT
T ss_pred             CHHHHHCHHHHHCHHHHHCCCCCCCCCCCCCCCCCCCHH--HCCCCCCE-ECCCCCCCCCC-CHH-HCCCCCCCEEECCC
T ss_conf             012220000000000000102111002333333331001--05646335-64458884177-853-44799999897959


Q ss_pred             CCCCCCCCCCCCCCCCCCC
Q ss_conf             9887775765542355875
Q 006522          196 NNLSGEIPQVGSLLNQGPT  214 (642)
Q Consensus       196 N~l~g~~p~~~~~~~~~~~  214 (642)
                      |+++.. +.+..+.++...
T Consensus       205 N~lt~i-~~l~~l~~L~~L  222 (227)
T d1h6ua2         205 NQISDV-SPLANTSNLFIV  222 (227)
T ss_dssp             SCCCBC-GGGTTCTTCCEE
T ss_pred             CCCCCC-CCCCCCCCCCEE
T ss_conf             968998-020369998989

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.33  E-value=1.1e-14  Score=97.32  Aligned_cols=117  Identities=26%  Similarity=0.258  Sum_probs=97.2

Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHH
Q ss_conf             89211289999789813897877656000068766665225775644583000388986868510566888650676501
Q 006522           81 MPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDL  160 (642)
Q Consensus        81 ~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l  160 (642)
                      ++.++..+++|+.|+|++|.++. ++ .+..+++|+.|+|++|.+. .+|..+..+++|+.|++++|.++. ++ .+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHH
T ss_pred             HHHHHHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCC
T ss_conf             24677626046151994468998-64-4247825357341353432-100003322123333333322222-22-22222


Q ss_pred             CCCCCEEECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf             0134423255541113578-645999997689800698877757
Q 006522          161 RALTGTLNLSFNQFSGQIP-EMYGHFPVMVSLDLRNNNLSGEIP  203 (642)
Q Consensus       161 ~~l~~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~~p  203 (642)
                      +.|+ .|++++|+++.... ..+..+++|+.|++++|.++...+
T Consensus       115 ~~L~-~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         115 VNLR-VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHSS-EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             CCCC-CCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
T ss_conf             2341-112341021255422123677763023427984346763

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.25  E-value=4.6e-14  Score=93.86  Aligned_cols=122  Identities=26%  Similarity=0.229  Sum_probs=73.3

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             97869992899963248921128999978981389787765600006876666522577564458300038898686851
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDL  144 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  144 (642)
                      ..++.|+|++|.+.. ++ .+..+++|+.|+|++|.++. +|..+..+++|+.|++++|+++..  +.+..+++|+.|++
T Consensus        48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L  122 (198)
T d1m9la_          48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYM  122 (198)
T ss_dssp             TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEE
T ss_pred             CCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf             046151994468998-64-42478253573413534321-000033221233333333222222--22222223411123


Q ss_pred             CCCCCCCCCH-HHHHHHCCCCCEEECCCCCCCCCCCCC----------CCCCCCCCEEE
Q ss_conf             0566888650-676501013442325554111357864----------59999976898
Q 006522          145 SSNLLNGSLP-EFLLDLRALTGTLNLSFNQFSGQIPEM----------YGHFPVMVSLD  192 (642)
Q Consensus       145 s~N~l~g~~p-~~~~~l~~l~~~l~l~~N~l~g~~p~~----------~~~l~~L~~l~  192 (642)
                      ++|.++.... ..+..++.|+ .|++++|++....+..          +..+++|+.||
T Consensus       123 ~~N~i~~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         123 SNNKITNWGEIDKLAALDKLE-DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             SEEECCCHHHHHHHTTTTTCS-EEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             CCCHHCCCCCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCEEC
T ss_conf             410212554221236777630-2342798434676322220558999998788958769

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=6.4e-11  Score=76.04  Aligned_cols=139  Identities=18%  Similarity=0.184  Sum_probs=97.6

Q ss_pred             CCCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCC
Q ss_conf             8730268449978699928999632489211289999789813897877656000068766665225775644583-000
Q 006522           55 CHWSGIHCIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIP-DRI  133 (642)
Q Consensus        55 c~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~  133 (642)
                      |.-.--.|..   ..++.++.++. .+|..+  .+.+++|+|++|.++...+..|.++++|++|++++|.+...++ ..|
T Consensus         1 ~~~~~C~C~~---~~i~c~~~~l~-~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f   74 (242)
T d1xwdc1           1 CHHRICHCSN---RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF   74 (242)
T ss_dssp             CCCSSEEECS---SEEEEESCSCS-SCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSE
T ss_pred             CCCCCCCCCC---CEEEEECCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCC
T ss_conf             9498288739---99998189988-768888--99889998769918964966861464323211022112420100112


Q ss_pred             CCCCCCCEEECCC-CCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEEEECCCCCC
Q ss_conf             3889868685105-6688865067650101344232555411135786-45999997689800698877
Q 006522          134 KTLKNLTHLDLSS-NLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPE-MYGHFPVMVSLDLRNNNLSG  200 (642)
Q Consensus       134 ~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g  200 (642)
                      ..++.++.+++.. |.+....+..+..++.|+ .+++++|.+....+. .+..+..+..+...++.+..
T Consensus        75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~-~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~  142 (242)
T d1xwdc1          75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ-YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT  142 (242)
T ss_dssp             ESCTTCCEEEEECCTTCCEECTTSEECCTTCC-EEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             22222222111112343222222122222222-223421111255433322211112222222121112

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.09  E-value=7.9e-10  Score=69.86  Aligned_cols=119  Identities=25%  Similarity=0.363  Sum_probs=81.3

Q ss_pred             ECCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             44997869992899963248921128999978981389787765600006876666522577564458300038898686
Q 006522           62 CIRNRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTH  141 (642)
Q Consensus        62 C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  141 (642)
                      |...+++.|+|++++++ .+|+   .+++|++|+|++|.|+ .+|..   +.+|+.|++++|+++. ++.   -.+.|++
T Consensus        35 c~~~~l~~LdLs~~~L~-~lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~---lp~~L~~  102 (353)
T d1jl5a_          35 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD---LPPLLEY  102 (353)
T ss_dssp             HHHHTCSEEECTTSCCS-CCCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS---CCTTCCE
T ss_pred             HHHCCCCEEEECCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCCH-HHH---HCCCCCC
T ss_conf             98769989993799988-7889---8789888989999796-33620---3320332665514320-321---0221111


Q ss_pred             EECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             8510566888650676501013442325554111357864599999768980069887
Q 006522          142 LDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       142 L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  199 (642)
                      |++++|.+. .+|. +..++.|+ .+++++|.+.... ..   ...+..+.+.++...
T Consensus       103 L~L~~n~l~-~lp~-~~~l~~L~-~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         103 LGVSNNQLE-KLPE-LQNSSFLK-IIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             EECCSSCCS-SCCC-CTTCTTCC-EEECCSSCCSCCC-CC---CTTCCEEECCSSCCS
T ss_pred             CCCCCCCCC-CCCC-HHHHCCCE-EECCCCCCCCCCC-CC---CCCCCCHHHCCCCCC
T ss_conf             133455432-2210-01101312-3113565100132-23---333210000122222

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.99  E-value=2.7e-09  Score=66.82  Aligned_cols=97  Identities=26%  Similarity=0.350  Sum_probs=42.2

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCCCEEEC
Q ss_conf             99789813897877656000068766665225775644583000388986868510566888650676501013442325
Q 006522           90 SLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNL  169 (642)
Q Consensus        90 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l  169 (642)
                      .++.|+|++|.++. +|.   .+++|++|+|++|+++ .+|..   +.+|+.|++++|.++ .++..   .+.|+ .|++
T Consensus        39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~-~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLE-YLGV  105 (353)
T ss_dssp             TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCC-EEEC
T ss_pred             CCCEEEECCCCCCC-CCC---CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCC-CCCC
T ss_conf             99899937999887-889---8789888989999796-33620---332033266551432-03210---22111-1133


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf             55411135786459999976898006988777
Q 006522          170 SFNQFSGQIPEMYGHFPVMVSLDLRNNNLSGE  201 (642)
Q Consensus       170 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  201 (642)
                      ++|++. .+|. ++.++.|+.|++++|.++..
T Consensus       106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~  135 (353)
T d1jl5a_         106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL  135 (353)
T ss_dssp             CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred             CCCCCC-CCCC-HHHHCCCEEECCCCCCCCCC
T ss_conf             455432-2210-01101312311356510013

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=1.7e-10  Score=73.63  Aligned_cols=134  Identities=25%  Similarity=0.314  Sum_probs=65.5

Q ss_pred             CEEEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCCCCCCCEE
Q ss_conf             786999289996324-8921128999978981389787765600006876666522577-56445-83000388986868
Q 006522           66 RVTSLYLPNRNLTGY-MPSELGLLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHN-SFCGP-IPDRIKTLKNLTHL  142 (642)
Q Consensus        66 ~v~~l~l~~~~l~g~-~~~~l~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~L  142 (642)
                      +++.|+|+++.+... +..-+..+++|++|+|+++.+++..+..+..+++|++|+++++ .++.. +......+++|+.|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCC
T ss_conf             78878898984577799999974877651452346798678999851899757151001341235540365788743565


Q ss_pred             ECCCC-CCCC-CCHHHHHHH-CCCCCEEECCCC--CCCCC-CCCCCCCCCCCCEEEEECC-CCCC
Q ss_conf             51056-6888-650676501-013442325554--11135-7864599999768980069-8877
Q 006522          143 DLSSN-LLNG-SLPEFLLDL-RALTGTLNLSFN--QFSGQ-IPEMYGHFPVMVSLDLRNN-NLSG  200 (642)
Q Consensus       143 ~ls~N-~l~g-~~p~~~~~l-~~l~~~l~l~~N--~l~g~-~p~~~~~l~~L~~l~l~~N-~l~g  200 (642)
                      ++++. .++. .+...+... +.|+ .|++++.  .++.. +...+..+++|+.|++++| .++.
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~-~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd  190 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETIT-QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN  190 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCC-EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCCCC-HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             2245332333220001000111110-122135542444443434232322212355322347783

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.86  E-value=7.7e-10  Score=69.92  Aligned_cols=153  Identities=20%  Similarity=0.248  Sum_probs=102.7

Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCC-CCCC
Q ss_conf             97869992899963248921128999978981389-78776-5600006876666522577-56445-8300038-8986
Q 006522           65 NRVTSLYLPNRNLTGYMPSELGLLNSLTRLSLASN-NFSKP-IPANLFNATNLVYLDLAHN-SFCGP-IPDRIKT-LKNL  139 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~-l~~L  139 (642)
                      ..++.|+|.++.+.+.....++.+++|+.|+++++ .++.. +..-+.++++|++|+++++ .++.. +...+.. .++|
T Consensus        71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L  150 (284)
T d2astb2          71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  150 (284)
T ss_dssp             CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             CCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf             77651452346798678999851899757151001341235540365788743565224533233322000100011111


Q ss_pred             CEEECCCC--CCCC-CCHHHHHHHCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEEEEC-CCCCCCCC-CCCCCCCCCC
Q ss_conf             86851056--6888-650676501013442325554-11135786459999976898006-98877757-6554235587
Q 006522          140 THLDLSSN--LLNG-SLPEFLLDLRALTGTLNLSFN-QFSGQIPEMYGHFPVMVSLDLRN-NNLSGEIP-QVGSLLNQGP  213 (642)
Q Consensus       140 ~~L~ls~N--~l~g-~~p~~~~~l~~l~~~l~l~~N-~l~g~~p~~~~~l~~L~~l~l~~-N~l~g~~p-~~~~~~~~~~  213 (642)
                      +.|++++.  .++. .+......+++|+ .|++++| .+++.....+..+++|+.|++++ +.++.... .+..++++..
T Consensus       151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~-~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~  229 (284)
T d2astb2         151 TQLNLSGYRKNLQKSDLSTLVRRCPNLV-HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT  229 (284)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTTCS-EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred             CHHHHCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCE
T ss_conf             0122135542444443434232322212-355322347783033332135768779899999787378999726999898


Q ss_pred             CCCCC
Q ss_conf             55689
Q 006522          214 TAFSG  218 (642)
Q Consensus       214 ~~~~~  218 (642)
                      ..+.|
T Consensus       230 L~l~~  234 (284)
T d2astb2         230 LQVFG  234 (284)
T ss_dssp             EECTT
T ss_pred             EEEEC
T ss_conf             96448

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.81  E-value=5e-10  Score=70.99  Aligned_cols=113  Identities=20%  Similarity=0.184  Sum_probs=48.9

Q ss_pred             CCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCC-------------CCCCCCCCEEECCCCC
Q ss_conf             2899997898138978776----5600006876666522577564458300-------------0388986868510566
Q 006522           86 GLLNSLTRLSLASNNFSKP----IPANLFNATNLVYLDLAHNSFCGPIPDR-------------IKTLKNLTHLDLSSNL  148 (642)
Q Consensus        86 ~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------------~~~l~~L~~L~ls~N~  148 (642)
                      ...+.|+.|+|++|.+...    +...+...++|+.|++++|.+...-...             ....+.|+.+++++|.
T Consensus        90 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~  169 (344)
T d2ca6a1          90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  169 (344)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCC
T ss_conf             54777563300001345543331011100234321000002466665431111212222110001467642111013650


Q ss_pred             CCCC----CHHHHHHHCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEEEECCCCC
Q ss_conf             8886----5067650101344232555411135-----7864599999768980069887
Q 006522          149 LNGS----LPEFLLDLRALTGTLNLSFNQFSGQ-----IPEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       149 l~g~----~p~~~~~l~~l~~~l~l~~N~l~g~-----~p~~~~~l~~L~~l~l~~N~l~  199 (642)
                      +...    +...+...+.++ .|+++.|+++..     +...+...++|+.|++++|.++
T Consensus       170 i~~~~~~~l~~~l~~~~~L~-~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         170 LENGSMKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             CTGGGHHHHHHHHHHCTTCC-EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             CCCCCCCCCCCHHHHHHHHC-CCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCC
T ss_conf             13554332211112333213-354333222222232002433211012112223333222

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.80  E-value=4.5e-10  Score=71.21  Aligned_cols=112  Identities=21%  Similarity=0.232  Sum_probs=47.2

Q ss_pred             EEEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCCC-C
Q ss_conf             86999289996324-89211289999789813897877----65600006876666522577564458----300038-8
Q 006522           67 VTSLYLPNRNLTGY-MPSELGLLNSLTRLSLASNNFSK----PIPANLFNATNLVYLDLAHNSFCGPI----PDRIKT-L  136 (642)
Q Consensus        67 v~~l~l~~~~l~g~-~~~~l~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~~----p~~~~~-l  136 (642)
                      ++.|+++++++++. +..-+..++.+++|+|++|.++.    .+...+...++|+.|||++|.++..-    ...+.. .
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCC
T ss_conf             77798208958868999999767799999828999988999999999853999888979598597289999999984378


Q ss_pred             CCCCEEECCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             986868510566888650676501013442325554111357864599999768980069887
Q 006522          137 KNLTHLDLSSNLLNGSLPEFLLDLRALTGTLNLSFNQFSGQIPEMYGHFPVMVSLDLRNNNLS  199 (642)
Q Consensus       137 ~~L~~L~ls~N~l~g~~p~~~~~l~~l~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  199 (642)
                      .+|+.|+|++|.++..--.                     .++..+...++|+.|++++|.++
T Consensus        84 ~~L~~L~L~~n~it~~~~~---------------------~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCG---------------------VLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHH---------------------HHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCEEECCCCCCCCCCCC---------------------CCCCHHHCCCCCCCCCCCCCCCH
T ss_conf             8778877888775432210---------------------12110000343200244433202

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.77  E-value=6e-10  Score=70.55  Aligned_cols=86  Identities=27%  Similarity=0.377  Sum_probs=50.6

Q ss_pred             CEEEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-CCCCCCEEECCCCCCCCC----CCCC
Q ss_conf             78699928999632----4892112899997898138978776----560000-687666652257756445----8300
Q 006522           66 RVTSLYLPNRNLTG----YMPSELGLLNSLTRLSLASNNFSKP----IPANLF-NATNLVYLDLAHNSFCGP----IPDR  132 (642)
Q Consensus        66 ~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~L~~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~  132 (642)
                      .++.|+|++++++.    .+...+...++|+.|+|++|.++..    +...+. ..++|+.|+|++|.+++.    ++..
T Consensus        28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~  107 (460)
T d1z7xw1          28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST  107 (460)
T ss_dssp             TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             CCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCH
T ss_conf             99999828999988999999999853999888979598597289999999984378877887788877543221012110


Q ss_pred             CCCCCCCCEEECCCCCCCC
Q ss_conf             0388986868510566888
Q 006522          133 IKTLKNLTHLDLSSNLLNG  151 (642)
Q Consensus       133 ~~~l~~L~~L~ls~N~l~g  151 (642)
                      +..+++|+.|+|++|.+..
T Consensus       108 l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1         108 LRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTSCTTCCEEECCSSBCHH
T ss_pred             HHCCCCCCCCCCCCCCCHH
T ss_conf             0003432002444332023

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.74  E-value=8.9e-10  Score=69.55  Aligned_cols=135  Identities=14%  Similarity=0.181  Sum_probs=74.0

Q ss_pred             CCEEEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----------CCCCCCCCCCCCEEECCCCCCCCCC-
Q ss_conf             9786999289996324----892112899997898138978776----------5600006876666522577564458-
Q 006522           65 NRVTSLYLPNRNLTGY----MPSELGLLNSLTRLSLASNNFSKP----------IPANLFNATNLVYLDLAHNSFCGPI-  129 (642)
Q Consensus        65 ~~v~~l~l~~~~l~g~----~~~~l~~l~~L~~L~L~~N~l~g~----------~p~~~~~l~~L~~L~l~~N~l~g~~-  129 (642)
                      ..++.|+|++|.++..    +...+...+.|+.|+++++.+...          +...+...++|+.|+|++|.+...- 
T Consensus        31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  110 (344)
T d2ca6a1          31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ  110 (344)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf             99788978498377899999999998589988888877754334542106787999887547775633000013455433


Q ss_pred             ---CCCCCCCCCCCEEECCCCCCCCCCHHH----H---------HHHCCCCCEEECCCCCCCCC----CCCCCCCCCCCC
Q ss_conf             ---300038898686851056688865067----6---------50101344232555411135----786459999976
Q 006522          130 ---PDRIKTLKNLTHLDLSSNLLNGSLPEF----L---------LDLRALTGTLNLSFNQFSGQ----IPEMYGHFPVMV  189 (642)
Q Consensus       130 ---p~~~~~l~~L~~L~ls~N~l~g~~p~~----~---------~~l~~l~~~l~l~~N~l~g~----~p~~~~~l~~L~  189 (642)
                         ...+...++|+.|++++|.+...-...    +         .....+. .+.++.|+++..    +...+.....++
T Consensus       111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~-~l~l~~n~i~~~~~~~l~~~l~~~~~L~  189 (344)
T d2ca6a1         111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR-SIICGRNRLENGSMKEWAKTFQSHRLLH  189 (344)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC-EEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred             CCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-EEECCCCCCCCCCCCCCCCHHHHHHHHC
T ss_conf             310111002343210000024666654311112122221100014676421-1101365013554332211112333213


Q ss_pred             EEEEECCCCCC
Q ss_conf             89800698877
Q 006522          190 SLDLRNNNLSG  200 (642)
Q Consensus       190 ~l~l~~N~l~g  200 (642)
                      .|++++|.++.
T Consensus       190 ~L~L~~n~i~~  200 (344)
T d2ca6a1         190 TVKMVQNGIRP  200 (344)
T ss_dssp             EEECCSSCCCH
T ss_pred             CCCCCCCCCCC
T ss_conf             35433322222

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=9.3e-10  Score=69.44  Aligned_cols=104  Identities=23%  Similarity=0.184  Sum_probs=52.3

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCHHHHHHHCCCC
Q ss_conf             8999978981389787765600006876666522577564458--30003889868685105668886506765010134
Q 006522           87 LLNSLTRLSLASNNFSKPIPANLFNATNLVYLDLAHNSFCGPI--PDRIKTLKNLTHLDLSSNLLNGSLPEFLLDLRALT  164 (642)
Q Consensus        87 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~--p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~l~  164 (642)
                      .+..+..+++.+|... .++..+..+++|++|+|++|+++..-  +..+..+++|+.|+|++|.++..-+-.......|.
T Consensus        40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~  118 (162)
T d1koha1          40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE  118 (162)
T ss_dssp             TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred             HCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCC
T ss_conf             4664011225556766-607889748787886377766667731588986588561000435721342344222033104


Q ss_pred             CEEECCCCCCCCCCCC-------CCCCCCCCCEEE
Q ss_conf             4232555411135786-------459999976898
Q 006522          165 GTLNLSFNQFSGQIPE-------MYGHFPVMVSLD  192 (642)
Q Consensus       165 ~~l~l~~N~l~g~~p~-------~~~~l~~L~~l~  192 (642)
                       .+++++|.++.....       .+..+++|+.||
T Consensus       119 -~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         119 -ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             -SCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             -EEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf             -2664899767676661569999999889978799

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=4.2e-07  Score=54.40  Aligned_cols=130  Identities=13%  Similarity=0.120  Sum_probs=84.3

Q ss_pred             CCCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCCEEEEEEECCCCCH
Q ss_conf             77611899935899999972999999128983210899999999986156-89711488999958914899950569968
Q 006522          354 KNGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDFIRNGSL  432 (642)
Q Consensus       354 ~~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g~L  432 (642)
                      +...||++....       ..+.+|+....... ....+.+|...+..+. +--+.++++++...+..++||+++++..+
T Consensus        26 s~~~v~rv~~~~-------~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~   97 (263)
T d1j7la_          26 SPAKVYKLVGEN-------ENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             SSSEEEEEECSS-------CEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             CCCCEEEEEECC-------CEEEEEECCCCCCC-CHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCC
T ss_conf             877189999089-------86999984887653-2556999999999876069987289997508964999986043343


Q ss_pred             HHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------------
Q ss_conf             88872399999999999999999999999999987039------------------------------------------
Q 006522          433 YAALHAGPSDSLPPLPWEARLKIAQGTARGLMYIHEYS------------------------------------------  470 (642)
Q Consensus       433 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------  470 (642)
                      .+.....          .....++.++++.++.||+..                                          
T Consensus        98 ~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          98 SEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             HHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             CCCCCCC----------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHH
T ss_conf             5433440----------269999998999999985568421435764465655577899877655554303323200579


Q ss_pred             --------------CCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             --------------9995105889999123899980891125533
Q 006522          471 --------------PRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       471 --------------~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                                    ...++|+|+.+.||+++++...-+.||+.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             999999984498678178986004764236499659996023144

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=6.9e-07  Score=53.17  Aligned_cols=141  Identities=11%  Similarity=0.108  Sum_probs=78.5

Q ss_pred             CCCC-CCEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCC--CCEEEEEEEEEECCCEEEEEEEC
Q ss_conf             7557-76118999358999999729999991289832108999999999861568--97114889999589148999505
Q 006522          351 GKSK-NGIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQH--PNIVRLKAFYYANDEKLLISDFI  427 (642)
Q Consensus       351 g~g~-~g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~  427 (642)
                      ..|. ...||+.....+      ..+.+|.......    ..+..|+..+..+..  -.+.++++++.+.+..++||+++
T Consensus        19 ~~G~s~~~v~r~~~~~~------~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGR------PVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             SCTTSSCEEEEEECTTS------CCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCCCCCCEEEEEEECCC------CEEEEEECCCCCH----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEE
T ss_conf             78654775899993898------7899995896677----6899999999999865999886132224566159998744


Q ss_pred             CCCCHHH-----------------HHHCCCCCCC-CCCCHHHHHHHHH--------------------HHHHHHHHHHHC
Q ss_conf             6996888-----------------8723999999-9999999999999--------------------999999998703
Q 006522          428 RNGSLYA-----------------ALHAGPSDSL-PPLPWEARLKIAQ--------------------GTARGLMYIHEY  469 (642)
Q Consensus       428 ~~g~L~~-----------------~l~~~~~~~~-~~l~~~~~~~i~~--------------------~ia~gL~yLH~~  469 (642)
                      ++-++.+                 .||....... ..-.+.....-..                    .....+..+...
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             ECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf             13554322126899999999999987368854488755412468899999987541101134011213799999999871


Q ss_pred             ----CCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             ----99995105889999123899980891125533
Q 006522          470 ----SPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       470 ----~~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                          .+..++|+|+.+.||+++++..+-|.||+.+.
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             876579567867888763577379658999853326

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=1.3e-07  Score=57.27  Aligned_cols=83  Identities=20%  Similarity=0.177  Sum_probs=50.4

Q ss_pred             CCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHH-------
Q ss_conf             12899997898138978776--560000687666652257756445830003889868685105668886506-------
Q 006522           85 LGLLNSLTRLSLASNNFSKP--IPANLFNATNLVYLDLAHNSFCGPIPDRIKTLKNLTHLDLSSNLLNGSLPE-------  155 (642)
Q Consensus        85 l~~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~ls~N~l~g~~p~-------  155 (642)
                      ...++.|++|+|++|.++..  ++..+..+++|+.|+|++|.+....+-.+.....|+.|++++|.+......       
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHH
T ss_conf             97487878863777666677315889865885610004357213423442220331042664899767676661569999


Q ss_pred             HHHHHCCCCCEEE
Q ss_conf             7650101344232
Q 006522          156 FLLDLRALTGTLN  168 (642)
Q Consensus       156 ~~~~l~~l~~~l~  168 (642)
                      .+..+++|+ .||
T Consensus       141 i~~~~P~L~-~LD  152 (162)
T d1koha1         141 IRERFPKLL-RLD  152 (162)
T ss_dssp             HHTTSTTCC-EET
T ss_pred             HHHHCCCCC-EEC
T ss_conf             999889978-799

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.21  E-value=4.8e-06  Score=48.39  Aligned_cols=79  Identities=8%  Similarity=0.100  Sum_probs=48.3

Q ss_pred             CCCCCCCCCCEEEEEEECCCCCCCCCEEEEEEEECCC-----C-CCCCHHHHHHHHHHHHCCC-C--CCEEEEEEEEEEC
Q ss_conf             3002755776118999358999999729999991289-----8-3210899999999986156-8--9711488999958
Q 006522          347 AYVVGKSKNGIMYKVVVGRGSGMGAPTVVAVRRLTEG-----D-ATWRFKDFESEVEAIARVQ-H--PNIVRLKAFYYAN  417 (642)
Q Consensus       347 ~~~ig~g~~g~vy~~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~  417 (642)
                      ...+|.|....||++....++     ..+.+|.-...     . ..........|.+.|..+. +  ..+.+++.  .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~-----~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHD-----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDT  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EET
T ss_pred             EEEECCCCEEEEEEEEECCCC-----EEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECC
T ss_conf             998079852768999957998-----4899961771303467778887789999999999865057988552899--859


Q ss_pred             CCEEEEEEECCCCCH
Q ss_conf             914899950569968
Q 006522          418 DEKLLISDFIRNGSL  432 (642)
Q Consensus       418 ~~~~lv~e~~~~g~L  432 (642)
                      +..++|||++++..+
T Consensus       104 ~~~~lvmE~L~~~~~  118 (392)
T d2pula1         104 EMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTEEEECCCTTSEE
T ss_pred             CCCEEEEECCCCCCC
T ss_conf             887798713577653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.84  E-value=3.9e-06  Score=48.90  Aligned_cols=13  Identities=15%  Similarity=0.235  Sum_probs=5.5

Q ss_pred             CCCCEEEEECCCC
Q ss_conf             9976898006988
Q 006522          186 PVMVSLDLRNNNL  198 (642)
Q Consensus       186 ~~L~~l~l~~N~l  198 (642)
                      ++|+.|++++|.+
T Consensus       100 ~sL~~L~l~~n~~  112 (167)
T d1pgva_         100 QSIVEFKADNQRQ  112 (167)
T ss_dssp             CCCSEEECCCCSS
T ss_pred             CCCCEEECCCCCC
T ss_conf             9389877887768

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.76  E-value=1.8e-05  Score=45.11  Aligned_cols=86  Identities=9%  Similarity=0.120  Sum_probs=40.9

Q ss_pred             CCEEEEECCCC-CCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCC----C
Q ss_conf             97869992899-96324----892112899997898138978776----56000068766665225775644583----0
Q 006522           65 NRVTSLYLPNR-NLTGY----MPSELGLLNSLTRLSLASNNFSKP----IPANLFNATNLVYLDLAHNSFCGPIP----D  131 (642)
Q Consensus        65 ~~v~~l~l~~~-~l~g~----~~~~l~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p----~  131 (642)
                      ..++.|+|+++ .+...    +...+...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.+...-.    .
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHH
T ss_conf             99819782799998989999999997637764540120156215679887531000234330033010214599999999


Q ss_pred             CCCCCCCCCEEECCCCCCC
Q ss_conf             0038898686851056688
Q 006522          132 RIKTLKNLTHLDLSSNLLN  150 (642)
Q Consensus       132 ~~~~l~~L~~L~ls~N~l~  150 (642)
                      .+..-++|+.|+|++|.+.
T Consensus        95 aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSC
T ss_pred             HHHHCCCCCEEECCCCCCC
T ss_conf             9984893898778877688

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.47  E-value=0.00073  Score=36.05  Aligned_cols=136  Identities=10%  Similarity=0.067  Sum_probs=72.2

Q ss_pred             CEEEEEEECCCCCCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCCCCC--EEEEE-----EEEEECCCEEEEEEECC
Q ss_conf             611899935899999972999999128983210899999999986156897--11488-----99995891489995056
Q 006522          356 GIMYKVVVGRGSGMGAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQHPN--IVRLK-----AFYYANDEKLLISDFIR  428 (642)
Q Consensus       356 g~vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~-----~~~~~~~~~~lv~e~~~  428 (642)
                      -.||++...+|      ..+++|.......+  .+++..|...+..+....  ++..+     ......+..+.++++++
T Consensus        36 N~vy~v~~~dg------~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          36 NRVYQFQDEDR------RRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SEEEEECCTTC------CCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             CEEEEEECCCC------CEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECC
T ss_conf             02699983899------97999984787788--99999999999999855998787520689805665347999986527


Q ss_pred             CCCHH--------------HHHHC----CCCCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHH---
Q ss_conf             99688--------------88723----999999999999-------------------999999999999999870---
Q 006522          429 NGSLY--------------AALHA----GPSDSLPPLPWE-------------------ARLKIAQGTARGLMYIHE---  468 (642)
Q Consensus       429 ~g~L~--------------~~l~~----~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~---  468 (642)
                      |..+.              ..+|.    .....+..+++.                   .+..+...+...++.+..   
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf             76889999999999899999988630357865567789788766568999874769988989999999999999998454


Q ss_pred             -CCCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             -399995105889999123899980891125533
Q 006522          469 -YSPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       469 -~~~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                       ..+.+++|+|+.+.|||++++  ..+.||+-+.
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CCCCCEEECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf             5687120247888042878389--3588652014

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.0011  Score=35.10  Aligned_cols=76  Identities=11%  Similarity=0.110  Sum_probs=44.4

Q ss_pred             CCCCCCCEEEEEEECCCCCC--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCCEEEEEEE
Q ss_conf             27557761189993589999--9972999999128983210899999999986156-89711488999958914899950
Q 006522          350 VGKSKNGIMYKVVVGRGSGM--GAPTVVAVRRLTEGDATWRFKDFESEVEAIARVQ-HPNIVRLKAFYYANDEKLLISDF  426 (642)
Q Consensus       350 ig~g~~g~vy~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  426 (642)
                      ++-|-.-.+|++....+...  ..+..|.++..... ..  ..+..+|..+++.+. +.-..++++++..    .+|+||
T Consensus        50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             CCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CH--HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEEE
T ss_conf             178533434899968877544578981799965996-11--65899999999999757999808998189----569997


Q ss_pred             CCCCCH
Q ss_conf             569968
Q 006522          427 IRNGSL  432 (642)
Q Consensus       427 ~~~g~L  432 (642)
                      +++-.+
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             ECCCCC
T ss_conf             345548

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.18  E-value=5.4e-05  Score=42.46  Aligned_cols=63  Identities=19%  Similarity=0.292  Sum_probs=25.4

Q ss_pred             CCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCC----CCCCCCCCCCEEECCCCCCC
Q ss_conf             99997898138-978776----56000068766665225775644583----00038898686851056688
Q 006522           88 LNSLTRLSLAS-NNFSKP----IPANLFNATNLVYLDLAHNSFCGPIP----DRIKTLKNLTHLDLSSNLLN  150 (642)
Q Consensus        88 l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p----~~~~~l~~L~~L~ls~N~l~  150 (642)
                      .+.|+.|+|++ +.++..    +-..+...+.|+.|+|++|.+.....    ..+....+++.+++++|.+.
T Consensus        16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             CCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCC
T ss_conf             999868876899998989999999888419825743015896117789999987752122101210254322

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.76  E-value=0.00039  Score=37.59  Aligned_cols=107  Identities=17%  Similarity=0.229  Sum_probs=56.1

Q ss_pred             CCEEEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCCCCC----CCCCCCCCCCCEEECCCCCCCCCC----CC
Q ss_conf             9786999289-996324----8921128999978981389787765----600006876666522577564458----30
Q 006522           65 NRVTSLYLPN-RNLTGY----MPSELGLLNSLTRLSLASNNFSKPI----PANLFNATNLVYLDLAHNSFCGPI----PD  131 (642)
Q Consensus        65 ~~v~~l~l~~-~~l~g~----~~~~l~~l~~L~~L~L~~N~l~g~~----p~~~~~l~~L~~L~l~~N~l~g~~----p~  131 (642)
                      ..++.|+|++ +.++..    +...+...+.|+.|+|++|.++...    -..+...++++.++++.|.+....    ..
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHH
T ss_conf             99868876899998989999999888419825743015896117789999987752122101210254322014788999


Q ss_pred             CCCCCCCCCEEEC--CCCCCCC----CCHHHHHHHCCCCCEEECCCC
Q ss_conf             0038898686851--0566888----650676501013442325554
Q 006522          132 RIKTLKNLTHLDL--SSNLLNG----SLPEFLLDLRALTGTLNLSFN  172 (642)
Q Consensus       132 ~~~~l~~L~~L~l--s~N~l~g----~~p~~~~~l~~l~~~l~l~~N  172 (642)
                      .+...++|+.++|  ++|.+..    .+...+...+.|. .|+++.+
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~-~L~l~~~  142 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLL-KFGYHFT  142 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCC-EEECCCS
T ss_pred             HHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCC-EEECCCC
T ss_conf             998486524773216778676799999999998499847-8858189

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.89  E-value=0.014  Score=28.81  Aligned_cols=32  Identities=9%  Similarity=0.191  Sum_probs=27.1

Q ss_pred             CCCCCEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             99995105889999123899980891125533
Q 006522          470 SPRKYVHGNIKSTKILLDDELHPCISGFGLNR  501 (642)
Q Consensus       470 ~~~~iiHrdlk~~NILld~~~~~ki~DfGla~  501 (642)
                      .+.+++|+|+.+.||+++.+...-+.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             54503337863656402045412674222123